{"doc_id": 66000, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "In colon cancer, a recent report indicated that miR-211 promotes cell proliferation, tumor growth and cell migration of HCT-116 cells.", "Although they are less well characterized compared with small non- coding microRNAs (1–5), increasing evidence suggests that lncRNAs could play a critical role in regulation of diverse cellular processes such as stem cell pluripotency, development, cell growth and apoptosis and cancer metastasis (6–13).", "For example, miR-211 enhances the proliferation, migration and anchorage-independent colony formation of oral carcinoma cells (35).", "Alterations in the primary structure, secondary structure and expression levels of lncRNAs as well as their cognate RNA-binding proteins are often associated with human diseases, in particular cancer (36)."]}
{"doc_id": 66001, "title": "", "abstract": ["We present evidence that loc285194 is a direct target for p53 and functions as a tumor suppressor in part through negative regulation of miR-211.", "Apparently, at least two important lncRNAs, mouse lincRNA-p21 and human PANDA, have been shown to be p53 transcription targets (8,48), involved in the p53-mediated cellular processes.", "In this study, we show that loc285194 is a p53 transcription target; ectopic expression of loc285194 inhibits tumor cell growth both in vitro and in vivo.", "LncRNA loc285194 is a p53-regulated tumor suppressor", "LncRNA loc285194 was previously shown to be within a tumor suppressor unit in osteosarcoma and to suppress tumor cell growth."]}
{"doc_id": 66002, "title": "", "abstract": ["Finally, we demonstrate that loc285194 negatively regulates miR-211, which may in part account for loc285194-mediated cell growth inhibition.", "It also implies that loc285194 and miR-211 may regulate each other in a way similar to the microRNA-mediated silencing of protein- coding genes.", "Although lncRNAs impact cellular functions through various mechanisms, such as interactions with chromatin remodeling proteins (17,30), they are able to regulate other non-coding RNAs, in particular microRNAs.", "To detect mature miR-211 expression, and to perform microRNA profiling to determine which microRNAs interact with loc285194, we used the poly A polymerase-based SYBR Green method (QuantMiR kit from SBI).", "Together, these results suggest that both loc285194 and miR-211 are associated with the RISC complex through which loc285194 is able to reduce the miR-211 level and vice versa."]}
{"doc_id": 66003, "title": "", "abstract": ["This miR-211-promoted cell growth was also seen in breast cancer MCF-7 cells (Figure 6B), suggesting that loc285194 inhibits tumor cell growth in part through negative regulation of miR-211.", "Finally, we demonstrate that loc285194 negatively regulates miR-211, which may in part account for loc285194-mediated cell growth inhibition.", "We present evidence that loc285194 is a direct target for p53 and functions as a tumor suppressor in part through negative regulation of miR-211.", "These results provide further supporting evidence that there exists a competitive endogenous RNA regulatory network (19) where loc285194 and miR-211 negatively regulate each other.", "Together, these results suggest that loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211."]}
{"doc_id": 66004, "title": "", "abstract": ["Moreover, a muscle-specific lncRNA, linc-MD1, may act as a ‘sponges’ for miR-133 (16).", "In this regard, loc285194 may function as the endogenous sponge, similar to what has been reported for ncRNA UC34A (31), HULC (37) and linc-MD1 (16).", "Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Although they are less well characterized compared with small non- coding microRNAs (1–5), increasing evidence suggests that lncRNAs could play a critical role in regulation of diverse cellular processes such as stem cell pluripotency, development, cell growth and apoptosis and cancer metastasis (6–13).", "An additional function may include serving as a ‘sponge’ to titrate microRNAs (16)."]}
{"doc_id": 66005, "title": "", "abstract": ["Accordingly, lncRNAs may function as oncogenes and tumor suppressors in cancer just like protein-coding genes and microRNAs.", "As p53 is the well-known tumor suppressor that regulates a variety of cellular functions and disease processes, we simply asked whether any of these lncRNAs is induced by p53.", "Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Although they are less well characterized compared with small non- coding microRNAs (1–5), increasing evidence suggests that lncRNAs could play a critical role in regulation of diverse cellular processes such as stem cell pluripotency, development, cell growth and apoptosis and cancer metastasis (6–13).", "LncRNA loc285194 was previously shown to be within a tumor suppressor unit in osteosarcoma and to suppress tumor cell growth."]}
{"doc_id": 66006, "title": "", "abstract": ["Thus, further characterization of those potential lncRNAs would strengthen the notion that, like protein- coding genes, lncRNAs are also a component of the p53-regulatory network.", "The present study suggests that lncRNAs can also be subject to p53 regulation.", "Apparently, at least two important lncRNAs, mouse lincRNA-p21 and human PANDA, have been shown to be p53 transcription targets (8,48), involved in the p53-mediated cellular processes.", "Therefore, the identification of loc285194 as a p53 inducible lncRNA expands the repertoire of p53-regulated genes.", "As p53 is the well-known tumor suppressor that regulates a variety of cellular functions and disease processes, we simply asked whether any of these lncRNAs is induced by p53."]}
{"doc_id": 66007, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Moreover, a major feature for lncRNAs is their ability to interact with either protein, DNA or RNA to exert their functions.", "In this regard, several lncRNAs have been shown to interact with Polycomb Repressive Complex 2 components such as Ezh2 (12).", "In this regard, lncRNAs may function (i) as signals for transcription; (ii) as decoys to titrate transcription factors; (iii) as guides so that chromatin-modifying enzymes can be recruited to target genes; and (iv) as scaffolds to bring together multiple proteins to form ribonucleoprotein complexes (14,15).", "The present study suggests that lncRNAs can also be subject to p53 regulation."]}
{"doc_id": 66008, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Although they are less well characterized compared with small non- coding microRNAs (1–5), increasing evidence suggests that lncRNAs could play a critical role in regulation of diverse cellular processes such as stem cell pluripotency, development, cell growth and apoptosis and cancer metastasis (6–13).", "Recent advances in functional genomics have led to the discovery of a new type of regulatory genes, i.e. long non-coding RNAs (lncRNAs), which are >200 bases in length.", "Accordingly, lncRNAs may function as oncogenes and tumor suppressors in cancer just like protein-coding genes and microRNAs.", "For example, HOTAIR is one of the first identified lncRNAs and plays a critical role in cancer through epigenetic regulation mechanisms."]}
{"doc_id": 66009, "title": "", "abstract": ["In situ hybridization (ISH) was used to detect loc285194 in clinical specimen and cancer cell lines after doxo treatment based on a previously described method (25) with some modifications.", "We also determined the expression of loc285194 in colon cancer tissue microarrays by in situ hybridization.", "Finally, we detect downregulation of loc285194 in colon cancer specimens by quantitative PCR arrays and in situ hybridization of tissue microarrays.", "(B) and (C) Detection of loc285194 in colon cancer tissue microarrays by ISH as described in ‘Materials and Methods’ section.", "Moreover, we performed in situ hybridization to detect the level of loc285194 in the cells after doxo treatment."]}
{"doc_id": 66010, "title": "", "abstract": ["For example, several groups have reported that the miR-34 family, including miR-34a, miR-34b and miR-34c, are induced by DNA damage and oncogenic stress in a p53-dependent manner (45–47).", "Although CNAs may account in part for the downregulation of loc285194, our study indicates that other factors such as p53 status may also contribute to this downregulation because p53 mutation or deletion could account for up to 50% cancer cases.", "Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Of considerable interest, p53 with a point mutation (R175H) at the DNA-binding domain, a frequent mutant in cancer (28), had no effect on loc285194 expression, suggesting that loc285194 is specifically induced by wild-type p53.", "Moreover, loc285194 suppresses cell growth both in vitro and in vivo; consistently, loc285194 is downregulated in colon tumor specimens."]}
{"doc_id": 66011, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Accordingly, lncRNAs may function as oncogenes and tumor suppressors in cancer just like protein-coding genes and microRNAs.", "Thus, further characterization of those potential lncRNAs would strengthen the notion that, like protein- coding genes, lncRNAs are also a component of the p53-regulatory network.", "Recent advances in functional genomics have led to the discovery of a new type of regulatory genes, i.e. long non-coding RNAs (lncRNAs), which are >200 bases in length.", "In this regard, lncRNAs may function (i) as signals for transcription; (ii) as decoys to titrate transcription factors; (iii) as guides so that chromatin-modifying enzymes can be recruited to target genes; and (iv) as scaffolds to bring together multiple proteins to form ribonucleoprotein complexes (14,15)."]}
{"doc_id": 66012, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Although they are less well characterized compared with small non- coding microRNAs (1–5), increasing evidence suggests that lncRNAs could play a critical role in regulation of diverse cellular processes such as stem cell pluripotency, development, cell growth and apoptosis and cancer metastasis (6–13).", "Accordingly, lncRNAs may function as oncogenes and tumor suppressors in cancer just like protein-coding genes and microRNAs.", "For example, HOTAIR is one of the first identified lncRNAs and plays a critical role in cancer through epigenetic regulation mechanisms.", "The present study suggests that lncRNAs can also be subject to p53 regulation."]}
{"doc_id": 66013, "title": "", "abstract": ["The present study suggests that lncRNAs can also be subject to p53 regulation.", "Thus, further characterization of those potential lncRNAs would strengthen the notion that, like protein- coding genes, lncRNAs are also a component of the p53-regulatory network.", "Therefore, we searched for potential interactions with microRNAs because emerging evidence suggests that non-coding RNAs may participate in ‘competitive endogenous RNAs’ regulatory network (19).", "Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "For example, our initial profiling identified that a number of lncRNAs, in addition to loc285194, might be induced by p53."]}
{"doc_id": 66014, "title": "", "abstract": ["Recent advances in functional genomics have led to the discovery of a new type of regulatory genes, i.e. long non-coding RNAs (lncRNAs), which are >200 bases in length.", "As a newly discovered class of non-coding genes, lncRNAs have been recently found to be pervasively transcribed in the genome.", "In this regard, several lncRNAs have been shown to interact with Polycomb Repressive Complex 2 components such as Ezh2 (12).", "Therefore, we searched for potential interactions with microRNAs because emerging evidence suggests that non-coding RNAs may participate in ‘competitive endogenous RNAs’ regulatory network (19).", "Although lncRNAs impact cellular functions through various mechanisms, such as interactions with chromatin remodeling proteins (17,30), they are able to regulate other non-coding RNAs, in particular microRNAs."]}
{"doc_id": 66015, "title": "", "abstract": ["Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "In this regard, several lncRNAs have been shown to interact with Polycomb Repressive Complex 2 components such as Ezh2 (12).", "The present study suggests that lncRNAs can also be subject to p53 regulation.", "Although CNAs may account in part for the downregulation of loc285194, our study indicates that other factors such as p53 status may also contribute to this downregulation because p53 mutation or deletion could account for up to 50% cancer cases.", "For example, HOTAIR is one of the first identified lncRNAs and plays a critical role in cancer through epigenetic regulation mechanisms."]}
{"doc_id": 52000, "title": "", "abstract": ["Thus, we have demonstrated that metformin's inhibitory effects on cancer progression are cancer cell autonomous and depend on its ability to inhibit mitochondrial complex I.", "Taken together, these results indicate that the anti-proliferative and cell death promoting effects of metformin require mitochondrial complex I inhibition.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "In the present study, we genetically demonstrate that metformin acts as a complex I inhibitor in vitro and in vivo to inhibit tumorigenesis.", "Metformin inhibits cellular proliferation and pro- proliferative signaling via complex I inhibition."]}
{"doc_id": 52001, "title": "", "abstract": ["Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Metformin inhibits mitochondrial complex I to diminish tumor growth.", "Finally, we directly tested whether tumor cell autonomous inhibition of mitochondrial complex I by metformin was required to decrease tumor progression in vivo.", "In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo."]}
{"doc_id": 52002, "title": "", "abstract": ["Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "To determine the reversibility of metformin inhibition of complex I, cells were permeabilized with saponin and concurrently treated with complex I substrates (pyruvate 10 mM, malate 2 mM).", "Interestingly, in saponin-permeabilized cells, metformin significantly inhibited complex I-dependent respiration at a much lower concentration than that required to inhibit oxygen consumption of intact cells, suggesting that transport across the plasma membrane is a barrier to metformin's inhibition of complex I. Metformin is known to slowly accumulate in cells in which its uptake is mediated by organic cation transporters (OCTs) (Emami Riedmaier et al., 2013).", "We tested whether the mitochondrial membrane potential is necessary for metformin-dependent inhibition of complex I. Saponin-permeabilized Control-HCT 116 p53−/− cells were induced to respire on pyruvate/malate in the presence of either ADP or CCCP."]}
{"doc_id": 52003, "title": "", "abstract": ["Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone.", "Metformin inhibition of complex I requires an intact mitochondrial inner membrane potential.", "Metformin inhibits mitochondrial complex I to diminish tumor growth.", "Metformin inhibited ADP but not CCCP stimulated oxygen consumption indicating that the metformin-mediated inhibition of mitochondrial complex I required polarized mitochondria (Figure 4A,B).", "Metformin reversibly inhibits mitochondrial complex I."]}
{"doc_id": 52004, "title": "", "abstract": ["In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo.", "Collectively, our results indicate that will inhibit mitochondrial complex I and decrease tumorigenesis in cancer cells that have transporters across the plasma membrane, as well as a robust inner mitochondrial membrane potential to allow metformin to reach the mitochondrial matrix.", "Finally, we directly tested whether tumor cell autonomous inhibition of mitochondrial complex I by metformin was required to decrease tumor progression in vivo.", "While our study highlights the importance of mitochondrial complex I inhibition within cancer cells as a major mechanism by which metformin reduces tumor burden, it does not necessarily preclude any additional organismal effects of metformin that might reduce tumor progression in certain cancers.", "We also examined whether phenformin, a more lipophilic biguanide, also exert its anti-proliferative effects on cancer cells through inhibition of complex I. Phenformin inhibited oxygen consumption in Control-HCT 116 p53−/− cells and saponin-permeabilized Control HCT 116 p53−/− cells at 100-fold lower concentration compared to metformin (Figure 3A,C)."]}
{"doc_id": 52005, "title": "", "abstract": ["Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Metformin reversibly inhibits mitochondrial complex I.", "Metformin inhibits mitochondrial complex I function.", "Metformin reduces HIF-1 activation through inhibition of mitochondrial complex I.", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010)."]}
{"doc_id": 52006, "title": "", "abstract": ["Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Wheaton, Weinberg et al. have now demonstrated that metformin does target complex I in cancer cells, and that its effects depend on the amount of glucose available for cells to convert, without involving mitochondria, into energy.", "Indeed, we found that metformin reduced hypoxic stabilization of HIF-1α protein and HIF-dependent target genes.", "Alternatively, metformin could target cancer cells more directly by cutting the energy supply produced by their mitochondria.", "Interestingly, in saponin-permeabilized cells, metformin significantly inhibited complex I-dependent respiration at a much lower concentration than that required to inhibit oxygen consumption of intact cells, suggesting that transport across the plasma membrane is a barrier to metformin's inhibition of complex I. Metformin is known to slowly accumulate in cells in which its uptake is mediated by organic cation transporters (OCTs) (Emami Riedmaier et al., 2013)."]}
{"doc_id": 52007, "title": "", "abstract": ["Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "Metformin inhibits tumorigenesis through multiple mechanisms including the induction of cancer cell death in conditions, when glucose is limited and through inhibition of mitochondrial ROS-dependent signaling pathways that promote tumorigenesis (i.e., HIF).", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012)."]}
{"doc_id": 52008, "title": "", "abstract": ["We also examined whether phenformin, a more lipophilic biguanide, also exert its anti-proliferative effects on cancer cells through inhibition of complex I. Phenformin inhibited oxygen consumption in Control-HCT 116 p53−/− cells and saponin-permeabilized Control HCT 116 p53−/− cells at 100-fold lower concentration compared to metformin (Figure 3A,C).", "In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration.", "In the presence of ADP and the complex I substrates pyruvate and malate, metformin fully inhibited oxygen consumption in permeabilized Control-HCT 116 p53−/− cells (Figure 1C).", "As metformin accumulation requires mitochondrial membrane polarization (Figure 4A,B), these results indicate that metformin reversibly inhibits mitochondrial complex I. If the metformin that accumulated in the mitochondrial matrix irreversibly inhibited complex I, then oxygen consumption would have remained attenuated in CCCP- treated cells after metformin treatment.", "To determine whether metformin's inhibition of cellular oxygen consumption depended on mitochondrial complex I, we stably overexpressed the Saccharomyces cerevisiae protein NDI1 in HCT 116 p53−/− cells (hereon referred to as NDI1-HCT 116 p53−/− cells)."]}
{"doc_id": 52009, "title": "", "abstract": ["Thus, it is not clear whether inhibition of complex I by metformin would result in decreasing tumor growth.", "However, if metformin acts at the organismal level to diminish tumorigenesis then NDI1-HCT 116 p53−/− xenograft tumor growth would be suppressed similar to control tumors.", "NDI1 expressing A549 cells are refractory to metformin treatment in a xenograft model of tumor growth.", "Recently, several studies have suggested that patients taking metformin who also develop cancer have tumors that grow more slowly than average.", "However, the underlying mechanism by which metformin diminishes tumor growth is not fully understood."]}
{"doc_id": 52010, "title": "", "abstract": ["Metformin decreases cellular proliferation through inhibition of mitochondrial complex I function in HCT 116 p53+/+ cells.", "The inhibition of electron transport at complex I by metformin should reduce the mitochondrial membrane potential as proton pumping is linked to electron transport.", "Metformin decreases cell proliferation by inhibiting mitochondrial complex I.", "Metformin decreases cellular proliferation through inhibition of mitochondrial complex I function in A549 cells.", "Metformin inhibits mitochondrial complex I to diminish tumor growth."]}
{"doc_id": 52011, "title": "", "abstract": ["Metformin-mediated inhibition of the electron transport chain diminishes proton pumping, which might depolarize the mitochondrial membrane, thus limiting accumulation of the drug.", "Metformin has been shown to disrupt complex I of the electron transport chain that is used by cells to generate energy.", "The inhibition of electron transport at complex I by metformin should reduce the mitochondrial membrane potential as proton pumping is linked to electron transport.", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "To determine the reversibility of metformin inhibition of complex I, cells were permeabilized with saponin and concurrently treated with complex I substrates (pyruvate 10 mM, malate 2 mM)."]}
{"doc_id": 52012, "title": "", "abstract": ["In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "While our study highlights the importance of mitochondrial complex I inhibition within cancer cells as a major mechanism by which metformin reduces tumor burden, it does not necessarily preclude any additional organismal effects of metformin that might reduce tumor progression in certain cancers.", "In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo.", "Thus, we have demonstrated that metformin's inhibitory effects on cancer progression are cancer cell autonomous and depend on its ability to inhibit mitochondrial complex I."]}
{"doc_id": 52013, "title": "", "abstract": ["However, based on our results from HCT116 cells in vivo and extensive analysis of A549 cells in vitro, we find that it is likely that NDI1 expressing A549 cells are also resistant to metformin in vivo due to rescue of complex I activity by the NDI1 protein.", "NDI1 is a single-subunit NADH dehydrogenase, which oxidizes NADH in a process similar to the multi-subunit mammalian complex I; however without proton pumping or ROS generation (Seo et al., 1998).", "We replaced the endogenous mitochondrial complex I by expressing the NDI1 protein in A549 cells stably expressing shRNA against NDUFS3 (Figure 7—figure supplement 2A), referred to as NDI1-shNDUFS3-A549 cells.", "Rotenone irreversibly inhibits complex I, which contributes to its high toxicity in vivo.", "To determine whether metformin's inhibition of cellular oxygen consumption depended on mitochondrial complex I, we stably overexpressed the Saccharomyces cerevisiae protein NDI1 in HCT 116 p53−/− cells (hereon referred to as NDI1-HCT 116 p53−/− cells)."]}
{"doc_id": 52014, "title": "", "abstract": ["It will be of interest to determine whether metformin treatment might provide a useful adjunct to therapies that limit glucose uptake (e.g., PI3K inhibitors) or drive tumors to low glucose and oxygen levels (e.g., anti-angiogenic inhibitors).", "As clinical trials have already started to investigate if metformin is an effective anti-cancer treatment, it is important to understand how it might restrict tumor growth.", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "These data have prompted several prospective clinical trials to determine the efficacy of metformin as an anti-cancer agent.", "This means that metformin may combat cancer more effectively if used alongside other treatments that reduce the availability of both oxygen and glucose inside cells."]}
{"doc_id": 52015, "title": "", "abstract": ["Wheaton, Weinberg et al. have now demonstrated that metformin does target complex I in cancer cells, and that its effects depend on the amount of glucose available for cells to convert, without involving mitochondria, into energy.", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin has been shown to disrupt complex I of the electron transport chain that is used by cells to generate energy.", "In the present study, we genetically demonstrate that metformin acts as a complex I inhibitor in vitro and in vivo to inhibit tumorigenesis."]}
{"doc_id": 52016, "title": "", "abstract": ["A consequence of mitochondrial complex III ROS generation is the hypoxic activation of HIF-1 (Bell et al., 2007).", "DFO is an iron chelator known to directly stabilize HIF-1α protein independent of upstream signaling events.", "One biological consequence of mitochondrial-generated H2O2 is hypoxic stabilization of the hypoxia-inducible factors (HIFs) (Chandel et al., 2000).", "Indeed, we found that metformin reduced hypoxic stabilization of HIF-1α protein and HIF-dependent target genes.", "Metformin did not decrease deferoxamine (DFO) stabilization of HIF-1α protein."]}
{"doc_id": 52017, "title": "", "abstract": ["Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "To ensure that the inhibition of cellular oxygen consumption by metformin was a direct effect of metformin on complex I, we examined mitochondrial respiratory function in saponin-permeabilized cells.", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone.", "The inhibition of electron transport at complex I by metformin should reduce the mitochondrial membrane potential as proton pumping is linked to electron transport."]}
{"doc_id": 52018, "title": "", "abstract": ["Metformin inhibition of complex I requires an intact mitochondrial inner membrane potential.", "Therefore, metformin by inhibiting the complex I would limit electron flow to complex III thereby reducing ROS generation from complex III.", "The inhibition of electron transport at complex I by metformin should reduce the mitochondrial membrane potential as proton pumping is linked to electron transport.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone."]}
{"doc_id": 52019, "title": "", "abstract": ["Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "Wheaton, Weinberg et al. have now demonstrated that metformin does target complex I in cancer cells, and that its effects depend on the amount of glucose available for cells to convert, without involving mitochondria, into energy.", "Interestingly, in saponin-permeabilized cells, metformin significantly inhibited complex I-dependent respiration at a much lower concentration than that required to inhibit oxygen consumption of intact cells, suggesting that transport across the plasma membrane is a barrier to metformin's inhibition of complex I. Metformin is known to slowly accumulate in cells in which its uptake is mediated by organic cation transporters (OCTs) (Emami Riedmaier et al., 2013).", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone.", "Metformin inhibition of complex I requires an intact mitochondrial inner membrane potential."]}
{"doc_id": 52020, "title": "", "abstract": ["To ensure that the inhibition of cellular oxygen consumption by metformin was a direct effect of metformin on complex I, we examined mitochondrial respiratory function in saponin-permeabilized cells.", "To determine whether metformin's inhibition of cellular oxygen consumption depended on mitochondrial complex I, we stably overexpressed the Saccharomyces cerevisiae protein NDI1 in HCT 116 p53−/− cells (hereon referred to as NDI1-HCT 116 p53−/− cells).", "To determine the reversibility of metformin inhibition of complex I, cells were permeabilized with saponin and concurrently treated with complex I substrates (pyruvate 10 mM, malate 2 mM).", "We tested whether the mitochondrial membrane potential is necessary for metformin-dependent inhibition of complex I. Saponin-permeabilized Control-HCT 116 p53−/− cells were induced to respire on pyruvate/malate in the presence of either ADP or CCCP.", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone."]}
{"doc_id": 52021, "title": "", "abstract": ["Metformin inhibits cellular proliferation and pro- proliferative signaling via complex I inhibition.", "In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration.", "Interestingly, in saponin-permeabilized cells, metformin significantly inhibited complex I-dependent respiration at a much lower concentration than that required to inhibit oxygen consumption of intact cells, suggesting that transport across the plasma membrane is a barrier to metformin's inhibition of complex I. Metformin is known to slowly accumulate in cells in which its uptake is mediated by organic cation transporters (OCTs) (Emami Riedmaier et al., 2013).", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin inhibited cellular oxygen consumption of HCT 116 p53−/− cells at concentrations (0.25–1.0 mM) similar to those reported to affect bioenergetics and gluconeogenesis in primary hepatocytes in vitro (Figure 1A; Foretz et al., 2010; Miller et al., 2013)."]}
{"doc_id": 52022, "title": "", "abstract": ["Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin inhibits tumorigenesis through multiple mechanisms including the induction of cancer cell death in conditions, when glucose is limited and through inhibition of mitochondrial ROS-dependent signaling pathways that promote tumorigenesis (i.e., HIF).", "Furthermore, cancer cells have been shown to conduct glutamine-dependent reductive carboxylation to generate the TCA cycle intermediates required for cell proliferation when the electron transport chain is inhibited (Mullen et al., 2012; Fendt et al., 2013).", "Wheaton, Weinberg et al. have now demonstrated that metformin does target complex I in cancer cells, and that its effects depend on the amount of glucose available for cells to convert, without involving mitochondria, into energy.", "Recently, several studies have suggested that patients taking metformin who also develop cancer have tumors that grow more slowly than average."]}
{"doc_id": 52023, "title": "", "abstract": ["Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "Metformin inhibits mitochondrial complex I to diminish tumor growth."]}
{"doc_id": 52024, "title": "", "abstract": ["Metformin inhibited cellular oxygen consumption of HCT 116 p53−/− cells at concentrations (0.25–1.0 mM) similar to those reported to affect bioenergetics and gluconeogenesis in primary hepatocytes in vitro (Figure 1A; Foretz et al., 2010; Miller et al., 2013).", "Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "To ensure that the inhibition of cellular oxygen consumption by metformin was a direct effect of metformin on complex I, we examined mitochondrial respiratory function in saponin-permeabilized cells.", "We also examined whether phenformin, a more lipophilic biguanide, also exert its anti-proliferative effects on cancer cells through inhibition of complex I. Phenformin inhibited oxygen consumption in Control-HCT 116 p53−/− cells and saponin-permeabilized Control HCT 116 p53−/− cells at 100-fold lower concentration compared to metformin (Figure 3A,C).", "In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration."]}
{"doc_id": 52025, "title": "", "abstract": ["These inhibitory effects of metformin were not specific to HCT116 p53−/− cells as metformin inhibited oxygen consumption and cellular proliferation of Control-HCT 116 p53+/+ cells and Control-A549 human lung cancer cells but not NDI1-HCT 116 p53+/+ or NDI1-A549 cells (Figure 2—figure supplement 1 and 2).", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone.", "Metformin inhibits mitochondrial complex I function.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin inhibits mitochondrial complex I of CCL16 cells."]}
{"doc_id": 52026, "title": "", "abstract": ["The inhibition of electron transport at complex I by metformin should reduce the mitochondrial membrane potential as proton pumping is linked to electron transport.", "Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Collectively, these results indicate that phenformin also exerts its biological effects through inhibition of mitochondrial complex I.", "Taken together, these results indicate that the anti-proliferative and cell death promoting effects of metformin require mitochondrial complex I inhibition.", "Collectively, our results indicate that will inhibit mitochondrial complex I and decrease tumorigenesis in cancer cells that have transporters across the plasma membrane, as well as a robust inner mitochondrial membrane potential to allow metformin to reach the mitochondrial matrix."]}
{"doc_id": 52027, "title": "", "abstract": ["Metformin has been previously shown to inhibit mitochondrial complex I, yet it is not known whether metformin exhibits its anti-tumor effects through inhibition of complex I. It is important to note that many commonly utilized drugs have been shown to inhibit mitochondrial function in vitro; however, for many of these drugs it is not clear whether the in vivo mechanism of action is through modulating mitochondrial metabolism (Gohil et al., 2010).", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012).", "As metformin accumulation requires mitochondrial membrane polarization (Figure 4A,B), these results indicate that metformin reversibly inhibits mitochondrial complex I. If the metformin that accumulated in the mitochondrial matrix irreversibly inhibited complex I, then oxygen consumption would have remained attenuated in CCCP- treated cells after metformin treatment.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Our study also reveals that metformin's inhibition on mitochondrial complex I is distinct from the classical complex I inhibitor rotenone."]}
{"doc_id": 96000, "title": "", "abstract": ["For inference, we assumed the excess proportion of cases carrying de novo mutations, relative to control siblings, conferred liability.", "By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%).", "The common variation imparting this heritability was distributed roughly uniformly across chromosomes (Fig. 1b), an expectation of polygenic inheritance that is reflected in the significant correlation between heritability per chromosome and its size (r=0.49, p-value=0.018).", "The genetic factors include: ‘A’ additive effects, ‘D’ non-additive effects (dominant, recessive, epistatic), and ‘N’ de novo mutations.", "For each simulation a random set of causal variants were chosen: 1000 rare (MAF < .01) and 1000 common variants."]}
{"doc_id": 96001, "title": "", "abstract": ["In contrast, a recent, large study of twins places heritability at 38%20 (Figs. 1a, 2) under the same assumptions.", "In any case, neither of these values approaches early twin studies, which place autism heritability close to 1 (Supplementary Table 1 for data and discussion).", "Previous work has shown that autism heritability could fluctuate substantially when the bulk of the sample was comprised of simplex families, which lowers heritability, versus multiplex families, which raises heritability9.", "SNP-based estimates of heritability: 4, Swedish family study (95% confidence interval: 44–64%)21; 5, simplex cases versus population controls (95% confidence interval: 26–73%)9; 6, multiplex autism cases versus population controls (95% confidence interval: 38–93%)9.", "Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation."]}
{"doc_id": 96002, "title": "", "abstract": ["Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation.", "While uncertainty is inherent in all of these estimates (Fig. 1), results converge on total heritability in the range of 50–60% with common variants explaining the bulk of it.", "Summing these estimates suggests that genetic variation accounts for roughly 60% of the variation in risk for autism in Sweden, implying that the majority of risk is due to genetic variation.", "Two recent studies estimate heritability attributable to common variation to be substantial9,10, yet one estimates heritability at roughly 50% (Fig. 1a), the other at 17%.", "By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%)."]}
{"doc_id": 96003, "title": "", "abstract": ["Next we asked how much of the variance in liability to autism could be explained by de novo mutations, applying the standard liability model to reported rates of de novo CNVs and loss-of-function (LoF) mutations in autistic subjects and their siblings from the Simons Simplex Collection.", "The resulting estimate of total variance in liability explained by measured SNPs was 49.4% (SE=9.6) (Fig. 1a).", "Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Summing these estimates suggests that genetic variation accounts for roughly 60% of the variation in risk for autism in Sweden, implying that the majority of risk is due to genetic variation.", "Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation."]}
{"doc_id": 96004, "title": "", "abstract": ["Some of the SNPs conferring risk to schizophrenia appear to confer risk to autism17, a result that compliments results for copy number variants (CNV)18,19.", "Individual risk genes have been identified from rare variation, especially de novo mutations1–8.", "Rare variants clearly play a role, with the contribution of de novo variation being the most obvious and easy to characterize, but inherited variation also has a role in liability11,12.", "The genetic factors include: ‘A’ additive effects, ‘D’ non-additive effects (dominant, recessive, epistatic), and ‘N’ de novo mutations.", "Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals."]}
{"doc_id": 96005, "title": "", "abstract": ["Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation.", "Next, to determine if IQ has a substantial impact on heritability, we contrast two estimates from data from the Autism Genome Project: using the full sample, heritability equaled 51.1% (SE=4.8, N=2097); whereas, for subjects with IQ > 80, it was slightly but not significantly larger (59.3%, SE=7.8, N=871).", "Results for PAGES (Population-based Autism Genetics and Environment Study), the Swedish study of the heritability of autism.", "Clinical phenotypes could also affect heritability/genetic load, although how much impact they might have is an open question.", "By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%)."]}
{"doc_id": 96006, "title": "", "abstract": ["Most genetic risk for autism resides with common variation", "Results regarding the genetic architecture of autism spectrum disorder.", "By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%).", "We have ascertained subjects with strict autism (“autistic disorder”) from a Swedish epidemiological sample (“Population-based Autism Genetics and Environment Study” or PAGES).", "(f) Synthesis of results for the genetic architecture of autism."]}
{"doc_id": 96007, "title": "", "abstract": ["The variance of autism liability is determined by genetic and environmental factors.", "Autism is a neurodevelopmental disorder typified by striking deficits in social communication, and genetically by a mix of de novo and inherited variation contributing to liability.", "### Estimating the contribution of de novo mutations and heritable variation to liability and variation in liability to autism", "Most genetic risk for autism resides with common variation", "Results for PAGES (Population-based Autism Genetics and Environment Study), the Swedish study of the heritability of autism."]}
{"doc_id": 96008, "title": "", "abstract": ["Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Summing these estimates suggests that genetic variation accounts for roughly 60% of the variation in risk for autism in Sweden, implying that the majority of risk is due to genetic variation.", "Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation.", "Most genetic risk for autism resides with common variation", "Next we asked how much of the variance in liability to autism could be explained by de novo mutations, applying the standard liability model to reported rates of de novo CNVs and loss-of-function (LoF) mutations in autistic subjects and their siblings from the Simons Simplex Collection."]}
{"doc_id": 96009, "title": "", "abstract": ["Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Two recent studies estimate heritability attributable to common variation to be substantial9,10, yet one estimates heritability at roughly 50% (Fig. 1a), the other at 17%.", "Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation.", "Based on the conjecture that subjects with intellectual disability and autism have a greater fraction of liability determined by de novo variants, one obvious bias would be misclassification of individuals who are comorbid for intellectual disability and autism as one or the other.", "### Estimating the contribution of de novo mutations and heritable variation to liability and variation in liability to autism"]}
{"doc_id": 96010, "title": "", "abstract": ["By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%).", "This massive homogeneous sample permits precise estimation of relative recurrence risk of autism, given the diagnosis in relatives from monozygotic twins to first cousins, and after modeling covariates such as sex, birth year, parental psychiatric history and parental age at birth.", "Consistent with quantitative genetics theory it has already been shown that families who are multiplex for autism carry a larger load of liability alleles relative to simplex families (defined as families with only one affected subject within the set of first and second degree relatives).", "SNP-based estimates of heritability: 4, Swedish family study (95% confidence interval: 44–64%)21; 5, simplex cases versus population controls (95% confidence interval: 26–73%)9; 6, multiplex autism cases versus population controls (95% confidence interval: 38–93%)9.", "In this population 43.6% of subjects with autism also have intellectual disability, a rate comparable to other populations (note that strict autism has a higher rate of comorbid intellectual disability than broad autism)."]}
{"doc_id": 96011, "title": "", "abstract": ["Most genetic risk for autism resides with common variation", "These different populations could have different genetic architectures or there could be an unknown sampling bias.", "A key component of genetic architecture is the allelic spectrum influencing trait variability.", "Autism is a neurodevelopmental disorder typified by striking deficits in social communication, and genetically by a mix of de novo and inherited variation contributing to liability.", "Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation."]}
{"doc_id": 96012, "title": "", "abstract": ["Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation.", "Individual risk genes have been identified from rare variation, especially de novo mutations1–8.", "Autism is a neurodevelopmental disorder typified by striking deficits in social communication, and genetically by a mix of de novo and inherited variation contributing to liability.", "Rare variants clearly play a role, with the contribution of de novo variation being the most obvious and easy to characterize, but inherited variation also has a role in liability11,12.", "A handful of genome-wide association studies (GWAS) have been conducted, significant findings have been few, and those are specific to a single GWAS13–15."]}
{"doc_id": 96013, "title": "", "abstract": ["Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Most genetic risk for autism resides with common variation", "By analyzing these recurrence risks for additive and non-additive genetic effects and shared and non-shared environmental effects, the best model consists of only additive genetic and non-shared environmental effects and yields quite precise estimates of the narrow-sense heritability of autism (h2=54%, SE=5%).", "Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation.", "Summing these estimates suggests that genetic variation accounts for roughly 60% of the variation in risk for autism in Sweden, implying that the majority of risk is due to genetic variation."]}
{"doc_id": 96014, "title": "", "abstract": ["Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation.", "Summing these estimates suggests that genetic variation accounts for roughly 60% of the variation in risk for autism in Sweden, implying that the majority of risk is due to genetic variation.", "Most genetic risk for autism resides with common variation", "Two recent studies estimate heritability attributable to common variation to be substantial9,10, yet one estimates heritability at roughly 50% (Fig. 1a), the other at 17%."]}
{"doc_id": 96015, "title": "", "abstract": ["Results regarding the genetic architecture of autism spectrum disorder.", "Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation.", "(f) Synthesis of results for the genetic architecture of autism.", "Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "The Swedish family study provides a sound foundation from which to address other questions about the genetic architecture of autism using PAGES."]}
{"doc_id": 96016, "title": "", "abstract": ["Nonetheless, that all Swedish studies, regardless of design, converge on similar estimates of heritability lends strong support for our conclusion that the bulk of risk for autism arises from genetic variation.", "Results regarding the genetic architecture of autism spectrum disorder.", "We have ascertained subjects with strict autism (“autistic disorder”) from a Swedish epidemiological sample (“Population-based Autism Genetics and Environment Study” or PAGES).", "Autism is a neurodevelopmental disorder typified by striking deficits in social communication, and genetically by a mix of de novo and inherited variation contributing to liability.", "Results for PAGES (Population-based Autism Genetics and Environment Study), the Swedish study of the heritability of autism."]}
{"doc_id": 96017, "title": "", "abstract": ["Using a unique epidemiological sample from Sweden, novel methods that distinguish total narrow-sense heritability from that due to common variation, and by synthesizing results from other studies, we reach several conclusions about autism’s genetic architecture: its narrow-sense heritability is ≈54% and most traces to common variation; rare de novo mutations contribute substantially to individuals’ liability; still their contribution to variance in liability, 2.6%, is modest compared to heritable variation.", "Next we asked how much of the variance in liability to autism could be explained by de novo mutations, applying the standard liability model to reported rates of de novo CNVs and loss-of-function (LoF) mutations in autistic subjects and their siblings from the Simons Simplex Collection.", "In this sample, structured to enrich for de novo CNV and LoF mutations, their contribution to the variance in liability is 2.6% (Supplementary Note; Supplementary Tables 2–3).", "Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "And, while 14% of affected subjects carry de novo CNV and LoF mutations, the contribution of these mutations to the variance in liability is only 2.6%."]}
{"doc_id": 96018, "title": "", "abstract": ["Two recent studies estimate heritability attributable to common variation to be substantial9,10, yet one estimates heritability at roughly 50% (Fig. 1a), the other at 17%.", "A meta estimate of h2 due to common variants can be derived by taking a weighted average of two estimates of this quantity obtained from two independent samples: the PAGES study (h2 = 49.4%, SE = 9.5) and, the other, 1242 strict autism subjects from AGP data (h2 = 52.3%, SE = 6.2).", "While uncertainty is inherent in all of these estimates (Fig. 1), results converge on total heritability in the range of 50–60% with common variants explaining the bulk of it.", "Hence we conclude that common variants explain the bulk of the heritability for autism, at least 41% of the variability, and rare variants explain at most 17%, based on the upper and lower bounds of the respective 95% confidence intervals.", "Still results from early studies could be compatible with estimates from common variants (Fig. 2)."]}
{"doc_id": 61000, "title": "", "abstract": ["Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection", "We predicted that interference with IFNγ signaling would abrogate the HSC response to M. avium infection.", "A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9.", "Furthermore, other interferon-regulated genes including Stat1, Irf1, and Irf9 were upregulated in HSCs after in vitro IFNγ exposure when measured by real- time quantitative PCR, indicating that typical IFNγ-signaling pathways were activated in the purified cells (Supplementary Fig. 6)27.", "Infection with Mycobacterium avium induces changes in hematopoietic stem cells."]}
{"doc_id": 61001, "title": "", "abstract": ["A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9.", "Deepened understanding of the molecular mechanisms used by HSCs to respond to chronic inflammatory stimuli could lead to improved clinical insight into the pathophysiology of bone marrow suppression in patients with chronic infections such as tuberculosis and HIV/AIDS3, 4.", "This work provides evidence that long-term repopulating HSCs can respond directly to IFNγ stimulation in the context of a chronic infection.", "The signals that trigger HSC activation remain largely unknown.", "Maintenance of the blood and immune systems imposes different stresses on HSCs, ranging from the routine demands of cellular senescence to the extreme stress of acute bleeding, when the production of peripheral blood cells must be increased many-fold8."]}
{"doc_id": 61002, "title": "", "abstract": ["We show here that increased proliferation in the context of chronic infection or direct exposure to IFNγ can lead to at least transient impairment of HSC function.", "Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization.", "A recent report found that acute treatment of mice with purified IFNα or the IFNα-inducing agent poly(I:C) leads to cell-autonomous HSC proliferation, which was absent in Ifnar-/- and Stat1-/- mice28.", "This work provides evidence that long-term repopulating HSCs can respond directly to IFNγ stimulation in the context of a chronic infection.", "These results suggest that IFNγ stimulates HSCs even in the steady state, and that baseline IFNγ tone may influence HSC turnover and quality during normal homeostasis."]}
{"doc_id": 61003, "title": "", "abstract": ["A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9.", "Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection", "To confirm that M. avium infection in mice leads to an increase of IFNγ in bone marrow, where HSCs reside, we collected bone marrow supernatants from naive and infected mice at 4 weeks postinfection.", "Using an in vivo mouse model of Mycobacterium avium infection, we show that an increased proportion of long-term repopulating HSCs (LT-HSCs) proliferate during M. avium infection, and that this response requires interferon-gamma (IFNγ) but not interferon-alpha (IFNα) signaling.", "The HSC response to M. avium infection is dependent upon intact IFNγ signaling."]}
{"doc_id": 61004, "title": "", "abstract": ["Because many different cytokines are active during periods of infectious stress, we sought to determine if IFNγ is necessary to influence the behavior of HSCs.", "A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "These findings are the first to implicate IFNγ both as a regulator of HSCs during homeostasis and under conditions of infectious stress.", "Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner."]}
{"doc_id": 61005, "title": "", "abstract": ["Given our findings that IFNγ is both necessary and sufficient for HSC proliferation and mobilization during M. avium infection, we hypothesized that mice lacking the IFNγ cytokine may show alterations in their HSC compartments.", "Using an in vivo mouse model of Mycobacterium avium infection, we show that an increased proportion of long-term repopulating HSCs (LT-HSCs) proliferate during M. avium infection, and that this response requires interferon-gamma (IFNγ) but not interferon-alpha (IFNα) signaling.", "Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization.", "To confirm that M. avium infection in mice leads to an increase of IFNγ in bone marrow, where HSCs reside, we collected bone marrow supernatants from naive and infected mice at 4 weeks postinfection.", "A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9."]}
{"doc_id": 61006, "title": "", "abstract": ["These results suggest that IFNγ stimulates HSCs even in the steady state, and that baseline IFNγ tone may influence HSC turnover and quality during normal homeostasis.", "These findings are the first to implicate IFNγ both as a regulator of HSCs during homeostasis and under conditions of infectious stress.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection", "Basal IFNγ tone affects HSC cycling and function."]}
{"doc_id": 61007, "title": "", "abstract": ["Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization.", "This work provides evidence that long-term repopulating HSCs can respond directly to IFNγ stimulation in the context of a chronic infection.", "Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "We show here that increased proliferation in the context of chronic infection or direct exposure to IFNγ can lead to at least transient impairment of HSC function."]}
{"doc_id": 61008, "title": "", "abstract": ["These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "Basal IFNγ tone affects HSC cycling and function.", "We show here that increased proliferation in the context of chronic infection or direct exposure to IFNγ can lead to at least transient impairment of HSC function.", "IFNγ is sufficient to induce HSC proliferation in vitro.", "IFNγ is sufficient to induce HSC proliferation in vivo."]}
{"doc_id": 61009, "title": "", "abstract": ["Progenitor and HSC populations were identified, and HSC BrdU analysis performed as described21.", "Progenitor and HSC populations were identified and purified as previously described34,35.", "For assessment of functional self-renewal capacity, whole bone marrow from donor CD45.2 animals was admixed with an equal radioprotective dose of whole bone marrow from a wild type, uninfected CD45.1 mouse.", "The bone marrow showed a loss of granulocyte-monocyte progenitors, common myeloid progenitors, and macrophage-erythroid progenitors from 2 to 4 weeks postinfection with a concomitant increase in common lymphoid progenitors (Supplementary Fig. 3).", "Therefore, we analyzed the HSCs in bone marrow samples from naïve and infected mice lacking essential components of the IFNγ-signaling pathway, including mice lacking the interferon-gamma receptor 1 (Ifngr1) gene or the Stat1 gene encoding the downstream signal transducer for IFNGR1."]}
{"doc_id": 61010, "title": "", "abstract": ["Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner.", "Given our findings that IFNγ is both necessary and sufficient for HSC proliferation and mobilization during M. avium infection, we hypothesized that mice lacking the IFNγ cytokine may show alterations in their HSC compartments.", "Further, we investigated the role of the interferon family of inflammatory cytokines in influencing HSC activation.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "Furthermore, other interferon-regulated genes including Stat1, Irf1, and Irf9 were upregulated in HSCs after in vitro IFNγ exposure when measured by real- time quantitative PCR, indicating that typical IFNγ-signaling pathways were activated in the purified cells (Supplementary Fig. 6)27."]}
{"doc_id": 61011, "title": "", "abstract": ["These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "The expansion in ST-HSCs with minimal increase in LT-HSC number suggested that the LT-HSCs may be proliferating to meet the increased demand for their immediate downstream progeny, namely ST-HSC and MPP.", "In contrast to the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFNγ under normal physiological conditions (top panel), our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFNγ, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool (lower panel).", "Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner.", "This work provides evidence that long-term repopulating HSCs can respond directly to IFNγ stimulation in the context of a chronic infection."]}
{"doc_id": 61012, "title": "", "abstract": ["We conclude from these data that chronic mycobacterial infection induces proliferation of HSCs, with functional consequences that cannot be attributed to infection of the stem cells themselves.", "We speculate that in some contexts, chronic infection or inflammation can ultimately lead to more substantive deficits in the ability of the LT-HSC compartment to sustain blood production.", "Deepened understanding of the molecular mechanisms used by HSCs to respond to chronic inflammatory stimuli could lead to improved clinical insight into the pathophysiology of bone marrow suppression in patients with chronic infections such as tuberculosis and HIV/AIDS3, 4.", "We show here that increased proliferation in the context of chronic infection or direct exposure to IFNγ can lead to at least transient impairment of HSC function.", "This rapid in vitro response suggests the IFNγ–dependent effects on the HSC are independent of other physiologic changes in the bone marrow."]}
{"doc_id": 80000, "title": "", "abstract": ["Not only were these GI microbiomes characterized by shifts in bacterial populations during disease as previously described, but these dysbioses were highly functionally coordinated.", "Dysbioses in IBD are correspondingly not simply structural changes in the gut microbiota, but are instead associated with major impairments in many fundamental microbial metabolic functions with potential impact on the host.", "Together, these results support the centrality of host-microbiota crosstalk for gut homeostasis and in turn the role of dysfunctional crosstalk between the host and GI microbiome in IBD.", "These studies have described typical changes in composition of the IBD gut community, but the functional roles of these organisms - or of the entirety of a dysbiotic community - remain less clear.", "This underscores the fact that phylogenetically diverse changes in the composition of the GI microbiome can be functionally coordinated and lead to major modifications in the metabolic potential of the microbiota."]}
{"doc_id": 80001, "title": "", "abstract": ["OSCCAR is a state-based, prospective inception IBD cohort, and PRISM is a referral center-based, prospective IBD cohort (see Materials and methods).", "The Prospective Registry in IBD Study at MGH (PRISM) is a referral center- based, prospective cohort of IBD patients.", "Few studies of the IBD gut microbiome have investigated microbiome function [33], and these have not systematically accounted for the influences of treatments and environmental factors.", "Further studies, particularly including transcriptomic, proteomic, or metabolomic characterization, longitudinal data, and dietary metadata, will be needed to additionally define the consequences of the IBD- associated microbiome dysfunction on the host and the specific mechanisms by which they are carried out or regulated by the microbiota.", "Inflammatory bowel disease (IBD), a chronic and relapsing inflammatory condition of the gastrointestinal (GI) tract, is intimately linked to the microbial communities of the human gut."]}
{"doc_id": 80002, "title": "", "abstract": ["Fifteen microbial clades were significantly associated specifically with IBD status (q < 0.25) using a multivariate linear model incorporating clinical metadata (see Materials and methods).", "Taxa significantly associated with IBD status or subject metadata using a boosted general linear model.", "The association of Bifidobacterium abundance with disease status and clinical metadata (including age) was determined to be significant in these data using a sparse general linear model.", "A multivariate analysis was performed to associate each microbial clade with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods).", "A multivariate linear model associating all available metadata with each clade independently was boosted, and any metadata selected in at least 1% of these iterations was finally tested for significance in a standard generalized linear model."]}
{"doc_id": 80003, "title": "", "abstract": ["Many studies have observed imbalances or dysbioses in the GI microbiomes of IBD patients [6-13]; in both CD and UC patients, there is decreased biodiversity, a lower proportion of Firmicutes, and an increase in Gammaproteobacteria [14].", "The Firmicutes phylum also significantly decreased while Bacteroides increased with age in this cohort (Additional file 1); this agrees with previous studies [38,39] and potentially reflects dietary or body mass- related changes with increasing age, which were not directly measured in these subjects, or host metabolism modifications [58].", "The data presented here show that IBD and iCD in particular are associated with a dysbiosis characterized by changes in Firmicutes and Proteobacteria phyla.", "Firmicutes and Enterobacteriaceae abundances were associated with disease status as expected, but also with treatment and subject characteristics.", "The GI microbiome of healthy humans is dominated by four major bacterial phyla: Firmicutes, Bacteroidetes, and to a lesser degree Proteobacteria and Actinobacteria [4,5]."]}
{"doc_id": 80004, "title": "", "abstract": ["This study's inferred IBD metagenomes include broadly increased oxidative metabolism, decreased SCFA production, and increased mucin degradation relative to healthy subjects.", "The microbiome of ileal Crohn's disease was notable for increases in virulence and secretion pathways.", "An important consideration that informed the remainder of our analysis, and which is often overlooked in studies of the microbiome, was the consistent covariation among disease status, aspects of subject environment, and microbiome structure.", "We have thus analyzed the GI microbiomes of 121 CD patients, 75 UC patients, and 27 healthy controls using a novel multivariate metagenomic analysis pipeline specifically accounting for environmental factors (including treatment, age, and tobacco use).", "In addition to assessing microbiome composition, we have analyzed the inferred metagenome as determined from phylogenetically-associated reference genomes, including metabolic modules and pathways also associated with disease status and with environmental factors such as medications and smoking."]}
{"doc_id": 80005, "title": "", "abstract": ["Dysbioses in IBD are correspondingly not simply structural changes in the gut microbiota, but are instead associated with major impairments in many fundamental microbial metabolic functions with potential impact on the host.", "The data presented here show that IBD and iCD in particular are associated with a dysbiosis characterized by changes in Firmicutes and Proteobacteria phyla.", "Critical to determining causality in links between IBD and the gut microbiome, IBD treatments were also associated with alterations in microbiome composition.", "Although it is now widely accepted that IBD results from altered interactions between gut microbes and the intestinal immune system, the precise nature of the intestinal microbiota dysfunction in IBD remains to be elucidated [1].", "Microbial metabolic pathways with significantly altered abundances in the gut communities of IBD patients."]}
{"doc_id": 80006, "title": "", "abstract": ["A multivariate linear model associating all available metadata with each clade independently was boosted, and any metadata selected in at least 1% of these iterations was finally tested for significance in a standard generalized linear model.", "A multivariate analysis was performed to associate each pathway with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods).", "A multivariate analysis was performed to associate each microbial clade with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods).", "Metadata features potentially associated with each clade were first selected using boosting, and the significance of these associations was then assessed using a multivariate linear model with false discovery rate correction (see Materials and methods).", "A multivariate analysis was performed to associate each Gene Ontology term with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods)."]}
{"doc_id": 80007, "title": "", "abstract": ["We used a sparse multivariate statistical approach to relate disease phenotype to microbiome structure and function while accounting for potential correlates and confounding factors such as treatment or smoking.", "Within each metadatum/clade association independently, multiple comparisons over factor levels were adjusted using a Bonferonni correction; multiple hypothesis tests over all clades and metadata were adjusted to produce a final Benjamini and Hochberg false discovery rate [100].", "Metadata features potentially associated with each clade were first selected using boosting, and the significance of these associations was then assessed using a multivariate linear model with false discovery rate correction (see Materials and methods).", "After adjusting for these covariates, we determined microbial clades differing significantly in abundance between healthy and IBD subjects (Figure 2a; Additional file 1).", "Missing data were imputed for significance testing with the mean abundance of the sample; missing factor metadata were imputed with a 'NA' factor level using the na.gam.replace function from the R package [98]."]}
{"doc_id": 80008, "title": "", "abstract": ["This allowed us to identify unique functional perturbations in the microbiomes of IBD patients.", "We have thus analyzed the GI microbiomes of 121 CD patients, 75 UC patients, and 27 healthy controls using a novel multivariate metagenomic analysis pipeline specifically accounting for environmental factors (including treatment, age, and tobacco use).", "In addition to assessing microbiome composition, we have analyzed the inferred metagenome as determined from phylogenetically-associated reference genomes, including metabolic modules and pathways also associated with disease status and with environmental factors such as medications and smoking.", "The normal gut microbiome exhibits tremendous functional diversity encoded by a collection of bacterial genes numbering more than 100 times the human gene set [4,20].", "Univariate analysis of associations between microbial composition and biopsy location."]}
{"doc_id": 80009, "title": "", "abstract": ["To gain insight into the functional consequences of IBD-associated dysbiosis, we used a novel approach pairing microbial community 16S gene sequence profiles with information from the closest available whole-genome sequences.", "Ancestral state reconstruction was used to infer metagenomes using 16S gene pyrosequencing of samples from multiple body sites from the Human Microbiome Project (see Materials and methods).", "In addition to assessing microbiome composition, we have analyzed the inferred metagenome as determined from phylogenetically-associated reference genomes, including metabolic modules and pathways also associated with disease status and with environmental factors such as medications and smoking.", "The metagenomes inferred from our 16S data were supported by shotgun sequencing of a subset of samples, providing one confirmation that they were representative of community functional capability.", "This inferred functional metagenomic information provides the first insights into community-wide microbial processes and pathways that underpin IBD pathogenesis."]}
{"doc_id": 80010, "title": "", "abstract": ["We observed a decrease in both butanoate and propanoate metabolism in iCD (Figure 4), suggesting a potential decrease in SCFA production by the microbiome, possibly due to the observed decrease in Roseburia and Faecalibacterium.", "As Odoribacter splanchnus is a known producer of acetate, propionate, and butyrate [57], decreased Odoribacter may affect host inflammation via reduced SCFA availability.", "Consistent reductions in all of these clades may thus have functional consequences on the ability of the host to repair the epithelium and to regulate inflammation.", "Basic metabolism (for example, most amino acid biosynthesis) and SCFA production were reduced in abundance in disease, while biosynthesis and transport of compounds advantageous for oxidative stress (for example, sulfur, cysteine, riboflavin) and adherence/pathogenesis (for example, secretion) were increased.", "This study's inferred IBD metagenomes include broadly increased oxidative metabolism, decreased SCFA production, and increased mucin degradation relative to healthy subjects."]}
{"doc_id": 80011, "title": "", "abstract": ["A multivariate analysis was performed to associate each microbial clade with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods).", "The association of Bifidobacterium abundance with disease status and clinical metadata (including age) was determined to be significant in these data using a sparse general linear model.", "Finally, clades and functions were tested for statistically significant associations with clinical metadata of interest by using a novel multivariate algorithm.", "Fifteen microbial clades were significantly associated specifically with IBD status (q < 0.25) using a multivariate linear model incorporating clinical metadata (see Materials and methods).", "A multivariate analysis was performed to associate each pathway with a sparse selection of disease status and clinical metadata (selected through boosting; see Materials and methods)."]}
{"doc_id": 80012, "title": "", "abstract": ["Each clade (excluding ecological measures) was normalized with a variance-stabilizing arcsine square-root transformation and evaluated with a general linear model (in R using the glm package).", "Clade abundances were transformed with the arcsine square-root transformation for proportional data (y-axis).", "Clade abundances were transformed with the arcsine square root transformation for proportional data and are plotted along the y-axis as two notched box plots (samples without and with mesalamine use).", "arcsin(yi))=β0+ ∑pβpXi,p+εi,i=1,...,n", "Sqrt, square root."]}
{"doc_id": 80013, "title": "", "abstract": ["The microbiome of ileal Crohn's disease was notable for increases in virulence and secretion pathways.", "There were large increases in pentose phosphate pathway and fructose/mannose metabolism gene abundance in iCD (Figure 4), which were accompanied by increase in carbohydrate metabolism, but they were not significant in UC and CD.", "In CD patients with ileal involvement, sequences of the Ruminococcaceae family and of Faecalibacterium in particular were dramatically reduced compared to other subjects (Figure 2a), confirming previous studies [48,49].", "### Crohn's disease with ileal involvement presents a distinct microbiome phenotype including reduced Faecalibacterium, and Odoribacter is reduced both in iCD and in pancolonic UC", "Of the modules highlighted below and in Figure 5, one (cobalamin biosynthesis) fell below the limit of detection, and the remaining six retained the expected trend of over- or under-enrichment in Crohn's disease, as did additional processes detailed below, including glycolysis and bacterial secretion."]}
{"doc_id": 80014, "title": "", "abstract": ["Many studies have observed imbalances or dysbioses in the GI microbiomes of IBD patients [6-13]; in both CD and UC patients, there is decreased biodiversity, a lower proportion of Firmicutes, and an increase in Gammaproteobacteria [14].", "In particular, the microbial mechanisms and metabolism underlying the role of the GI microbiome in IBD onset and its alteration in the course of active treatment and recovery are still unknown.", "This suggests that CD-involved ileum is a favorable milieu for establishment of E. coli with pathobiont features, which may have implications for IBD exacerbations and its chronicity.", "Dysbioses in IBD are correspondingly not simply structural changes in the gut microbiota, but are instead associated with major impairments in many fundamental microbial metabolic functions with potential impact on the host.", "We observed a decrease in both butanoate and propanoate metabolism in iCD (Figure 4), suggesting a potential decrease in SCFA production by the microbiome, possibly due to the observed decrease in Roseburia and Faecalibacterium."]}
{"doc_id": 80015, "title": "", "abstract": ["Although it is now widely accepted that IBD results from altered interactions between gut microbes and the intestinal immune system, the precise nature of the intestinal microbiota dysfunction in IBD remains to be elucidated [1].", "The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system.", "Inflammatory bowel disease (IBD), a chronic and relapsing inflammatory condition of the gastrointestinal (GI) tract, is intimately linked to the microbial communities of the human gut.", "Many studies have observed imbalances or dysbioses in the GI microbiomes of IBD patients [6-13]; in both CD and UC patients, there is decreased biodiversity, a lower proportion of Firmicutes, and an increase in Gammaproteobacteria [14].", "IBD further includes two main subtypes, ulcerative colitis (UC) and Crohn's disease (CD), which each include distinct microbial perturbations and tissue localizations."]}
{"doc_id": 80016, "title": "", "abstract": ["The GI microbiome of healthy humans is dominated by four major bacterial phyla: Firmicutes, Bacteroidetes, and to a lesser degree Proteobacteria and Actinobacteria [4,5].", "Many studies have observed imbalances or dysbioses in the GI microbiomes of IBD patients [6-13]; in both CD and UC patients, there is decreased biodiversity, a lower proportion of Firmicutes, and an increase in Gammaproteobacteria [14].", "The data presented here show that IBD and iCD in particular are associated with a dysbiosis characterized by changes in Firmicutes and Proteobacteria phyla.", "The Firmicutes phylum also significantly decreased while Bacteroides increased with age in this cohort (Additional file 1); this agrees with previous studies [38,39] and potentially reflects dietary or body mass- related changes with increasing age, which were not directly measured in these subjects, or host metabolism modifications [58].", "Firmicutes and Enterobacteriaceae abundances were associated with disease status as expected, but also with treatment and subject characteristics."]}
{"doc_id": 80017, "title": "", "abstract": ["Although it is now widely accepted that IBD results from altered interactions between gut microbes and the intestinal immune system, the precise nature of the intestinal microbiota dysfunction in IBD remains to be elucidated [1].", "The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system.", "Dysbioses in IBD are correspondingly not simply structural changes in the gut microbiota, but are instead associated with major impairments in many fundamental microbial metabolic functions with potential impact on the host.", "The GI microbiome influences dietary energy extraction, immune system development, vitamin production, and drug metabolism, yet most molecular and metabolic functions of the bacteria of the GI microbiome are uncharacterized [20].", "This underscores the fact that phylogenetically diverse changes in the composition of the GI microbiome can be functionally coordinated and lead to major modifications in the metabolic potential of the microbiota."]}
{"doc_id": 80018, "title": "", "abstract": ["The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system.", "Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment", "Inflammatory bowel disease (IBD), a chronic and relapsing inflammatory condition of the gastrointestinal (GI) tract, is intimately linked to the microbial communities of the human gut.", "Thus, metatranscriptomic, proteomic, and metabolomic data will continue to add to our understanding of which of a community's potential functions are most strongly affecting the host during inflammatory disease.", "These perturbations in bacterial composition, although modest, were associated with major perturbations of GI microbiome function, which revolved around metabolism in the presence of oxidative stress and perturbed nutrient availability during tissue damage."]}
{"doc_id": 80019, "title": "", "abstract": ["Basic metabolism (for example, most amino acid biosynthesis) and SCFA production were reduced in abundance in disease, while biosynthesis and transport of compounds advantageous for oxidative stress (for example, sulfur, cysteine, riboflavin) and adherence/pathogenesis (for example, secretion) were increased.", "As Odoribacter splanchnus is a known producer of acetate, propionate, and butyrate [57], decreased Odoribacter may affect host inflammation via reduced SCFA availability.", "Fibrolytic bacteria degrade polysaccharides into smaller carbohydrates, which are then fermented into short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate.", "This study's inferred IBD metagenomes include broadly increased oxidative metabolism, decreased SCFA production, and increased mucin degradation relative to healthy subjects.", "We observed a decrease in both butanoate and propanoate metabolism in iCD (Figure 4), suggesting a potential decrease in SCFA production by the microbiome, possibly due to the observed decrease in Roseburia and Faecalibacterium."]}
{"doc_id": 80020, "title": "", "abstract": ["A univariate analysis for associations between taxa and biopsy sites was conducted using LEfSe [102] considering the six regions annotated for these samples: 1) terminal ileum (TI), 2) cecum, 3) left colon, 4) transverse colon, 5) right colon, and 6) sigmoid colon and rectum.", "Multiple factor analysis was performed to visualize the relationships within heterogeneous factor data as well as with a select group of taxa found to be significantly associated with metadata (using the FactoMineR R package [101]).", "A multivariate linear model associating all available metadata with each clade independently was boosted, and any metadata selected in at least 1% of these iterations was finally tested for significance in a standard generalized linear model.", "These associations were significant even in a multivariate model accounting for sample biogeography and disease status.", "Metadata features potentially associated with each clade were first selected using boosting, and the significance of these associations was then assessed using a multivariate linear model with false discovery rate correction (see Materials and methods)."]}
{"doc_id": 50000, "title": "", "abstract": ["Second, we could not use laboratory measures of pesticides or their metabolites to estimate exposure.", "Such measures are not available for many of the pesticides we studied, and when available, they are poor predictors of past or long-term use.", "Exposures to rotenone and paraquat were not correlated (r = 0.004), and ORs from a model that included both pesticides (paraquat OR = 2.6; 95% CI, 1.4–4.9; rotenone OR = 2.9; 95% CI, 1.5–5.5) were comparable with those from models without mutual adjustment (Table 3).", "Cumulative exposure was associated with greater risk, but paraquat use in the Taiwanese study was highly correlated with use of other herbicides.", "To continue the interplay between human and experimental studies, future mechanistic studies of these pesticides should model exposure conditions similar to those occurring in humans, including chronic low-dose exposure, exposure to multiple agents, and assessment of gene–exposure interactions."]}
{"doc_id": 50001, "title": "", "abstract": ["Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008).", "Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "We found significant associations of PD with use of groups of pesticides classified as complex I inhibitors or as oxidative stressors, providing support in humans for findings from decades of experimental work.", "To continue the interplay between human and experimental studies, future mechanistic studies of these pesticides should model exposure conditions similar to those occurring in humans, including chronic low-dose exposure, exposure to multiple agents, and assessment of gene–exposure interactions.", "Cumulative exposure was associated with greater risk, but paraquat use in the Taiwanese study was highly correlated with use of other herbicides."]}
{"doc_id": 50002, "title": "", "abstract": ["Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008).", "This study provides strong evidence of an association between rotenone use and PD in humans.", "In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008)."]}
{"doc_id": 50003, "title": "", "abstract": ["Rotenone and paraquat have been linked experimentally to pathophysiological mechanisms implicated in human PD.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxicant known to cause parkinsonism in humans, rotenone directly inhibits mitochondrial complex I (Langston et al. 1983; Sherer et al. 2007).", "Our goal was to determine whether pesticides that cause mitochondrial dysfunction or oxidative stress are associated with PD or clinical features of parkinsonism in humans.", "This study provides strong evidence of an association between rotenone use and PD in humans."]}
{"doc_id": 50004, "title": "", "abstract": ["Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008).", "Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "This study provides strong evidence of an association between rotenone use and PD in humans.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory."]}
{"doc_id": 50005, "title": "", "abstract": ["Previously, we found an association between paraquat use and PD in prevalent but not incident self-reported cases in the AHS (Kamel et al. 2007) and a nonsignificant association between PD and occupational paraquat use in a multicenter case–control study (Tanner et al. 2009).", "Use of paraquat (OR = 2.5; 95% CI, 1.4–4.7) or any of the group of oxidative stressors (OR = 2.0; 95% CI, 1.2–3.6) was associated with PD (Table 3).", "Experimentally, paraquat produces subcellular changes associated with PD, including increased production of reactive oxygen species, alpha-synuclein aggregation, and selective nigral injury (Dinis-Oliveira et al. 2006; Kuter et al. 2010; McCormack et al. 2002).", "Although the inconsistency of findings in human populations has been used as a basis for suggesting that paraquat is not associated with PD (Li et al. 2005; Miller 2007), an alternative explanation is that few studies have had adequate size and sufficiently detailed exposure information to allow the association to be observed.", "Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative."]}
{"doc_id": 50006, "title": "", "abstract": ["Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "We also assessed the combination of paraquat plus any dithiocarbamate (ferbam, mancozeb, maneb, metam sodium, vegedex, zineb, ziram), because previous studies reported an association of PD with the combination of paraquat and the dithiocarbamate maneb (Costello et al. 2009; Thiruchelvam et al. 2000).", "Although the inconsistency of findings in human populations has been used as a basis for suggesting that paraquat is not associated with PD (Li et al. 2005; Miller 2007), an alternative explanation is that few studies have had adequate size and sufficiently detailed exposure information to allow the association to be observed.", "Cumulative exposure was associated with greater risk, but paraquat use in the Taiwanese study was highly correlated with use of other herbicides.", "Groups of pesticides linked to the mechanisms of mitochondrial dysfunction or oxidative stress were also associated with PD in our study, thus extending experimental work to provide strong evidence that these mechanisms play a role in PD in humans."]}
{"doc_id": 50007, "title": "", "abstract": ["Importantly, the potential for exposure to many of these pesticides, including rotenone and paraquat, extends well beyond the occupational setting.", "In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory.", "Exposures to rotenone and paraquat were not correlated (r = 0.004), and ORs from a model that included both pesticides (paraquat OR = 2.6; 95% CI, 1.4–4.9; rotenone OR = 2.9; 95% CI, 1.5–5.5) were comparable with those from models without mutual adjustment (Table 3).", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Rotenone and paraquat have been linked experimentally to pathophysiological mechanisms implicated in human PD."]}
{"doc_id": 50008, "title": "", "abstract": ["For pesticides reported by ≥ 10 subjects, we evaluated associations between pesticide use and PD using unconditional logistic regression to derive odds ratios (ORs) and 95% confidence intervals (CIs) [Supplemental Material, Table 2 (doi:10.1289/ehp.1002839)].", "In the only other report of rotenone-like compounds and PD, use of organic pesticides such as rotenone in the previous year was determined for PD clinic attendees, who reported current use more often than did cases with other neurologic diseases (Dhillon et al. 2008).", "Despite an average lapse of 9 years, agreement was good [DDT (dichlorodiphenyltrichloroethane) 79%, 2,4-D (2,4-dichlorophenoxyacetic acid) 84%, paraquat 85%, rotenone 93%].", "In contrast, in the present population-based study, we evaluated rotenone use before PD diagnosis in cases and during a comparable time period in neurologically healthy controls.", "We conducted study evaluations in 137 (88%) of eligible suspect cases (including four initially identified as potential controls who self- reported PD at screening) and 383 (71%) of eligible potential controls."]}
{"doc_id": 50009, "title": "", "abstract": ["Relationship of PD to paraquat or rotenone exposure in human populations.", "Although the inconsistency of findings in human populations has been used as a basis for suggesting that paraquat is not associated with PD (Li et al. 2005; Miller 2007), an alternative explanation is that few studies have had adequate size and sufficiently detailed exposure information to allow the association to be observed.", "Strengths include the size of the study; the focus on an agricultural cohort with many exposed individuals and wide variability in exposure; the quality of diagnosis, which was based on in-person assessment and agreement of movement disorders experts; and the completeness and reliability of the pesticide exposure information.", "Previously, we found an association between paraquat use and PD in prevalent but not incident self-reported cases in the AHS (Kamel et al. 2007) and a nonsignificant association between PD and occupational paraquat use in a multicenter case–control study (Tanner et al. 2009).", "Associations between ever use of paraquat or rotenone and PD were similar when exposures were truncated at 5, 10, or 15 years before the diagnosis or reference date [paraquat: 5 years prior OR = 2.7 (95% CI, 1.4–4.9), 10 years OR = 2.9 (95% CI, 1.6–5.5), 15 years OR = 3.1 (95% CI, 1.6–5.8); rotenone: 5 years prior OR = 2.3 (95% CI, 1.2–4.4), 10 years OR = 2.4 (95% CI, 1.3–4.6), 15 years OR = 2.4 (95% CI, 1.3–4.6]."]}
{"doc_id": 50010, "title": "", "abstract": ["Rotenone and paraquat have been linked experimentally to pathophysiological mechanisms implicated in human PD.", "Cases who did or did not use rotenone, paraquat, or groups of pesticides with similar mechanisms were generally similar, suggesting that PD associated with these agents is clinically typical and indirectly supporting a role for pesticide exposure in the etiology of typical PD.", "However, recent work in rodent models indicated that a temporally limited exposure to rotenone later caused progressive functional and pathologic changes in the enteric nervous system of rodents, mimicking changes found in human PD; as in PD, these enteric nervous system changes preceded central nervous system pathology (Abbott et al. 2001; Braak et al. 2006; Drolet et al. 2009; Greene et al. 2009; Pan-Montojo et al. 2010).", "The pathogenesis of PD is thought to involve several critical abnormalities, each of which can be the result of genetic or environmental factors.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008)."]}
{"doc_id": 50011, "title": "", "abstract": ["Our findings, considered together with earlier results, suggest that paraquat use plays a role in human PD.", "Because paraquat remains one of the most widely used herbicides worldwide (Frabotta 2009), this finding potentially has great public health significance.", "Previously, we found an association between paraquat use and PD in prevalent but not incident self-reported cases in the AHS (Kamel et al. 2007) and a nonsignificant association between PD and occupational paraquat use in a multicenter case–control study (Tanner et al. 2009).", "Experimentally, paraquat produces subcellular changes associated with PD, including increased production of reactive oxygen species, alpha-synuclein aggregation, and selective nigral injury (Dinis-Oliveira et al. 2006; Kuter et al. 2010; McCormack et al. 2002).", "Mitochondrial dysfunction and oxidative stress have long been implicated as pathophysiologic mechanisms underlying Parkinson’s disease (PD) (Betarbet et al. 2000; Di Monte et al. 2002)."]}
{"doc_id": 50012, "title": "", "abstract": ["To our knowledge, we have performed the first analysis of pesticides classified by presumed mechanism, rather than by functional categories (e.g., herbicides) or chemical class (e.g., organochlorines).", "We performed analyses for pesticide exposure groups classified by mechanism as complex I inhibitors or oxidative stressors, based on literature review (Degli Esposti 1998; Krieger 2001; Uversky et al. 2001) and information in public databases [Agency for Toxic Substances and Disease Registry (ATSDR) 2002; Extension Toxicology Network (EXTOXNET) 2002; National Center for Biotechnology Information 2002].", "It is likely that we have misclassified some pesticides with regard to mechanism.", "Finally, we selected pesticides presumed to act through specific toxic mechanisms, but for most pesticides there is very little information regarding toxic effects in humans, as most studies are directed toward effects on plant or animal pests.", "However, the likely effect of any misclassification would be to attenuate an association with pesticides grouped according to a common mechanism."]}
{"doc_id": 50013, "title": "", "abstract": ["We found significant associations of PD with use of groups of pesticides classified as complex I inhibitors or as oxidative stressors, providing support in humans for findings from decades of experimental work.", "Cases who did or did not use rotenone, paraquat, or groups of pesticides with similar mechanisms were generally similar, suggesting that PD associated with these agents is clinically typical and indirectly supporting a role for pesticide exposure in the etiology of typical PD.", "Groups of pesticides linked to the mechanisms of mitochondrial dysfunction or oxidative stress were also associated with PD in our study, thus extending experimental work to provide strong evidence that these mechanisms play a role in PD in humans.", "For pesticides reported by ≥ 10 subjects, we evaluated associations between pesticide use and PD using unconditional logistic regression to derive odds ratios (ORs) and 95% confidence intervals (CIs) [Supplemental Material, Table 2 (doi:10.1289/ehp.1002839)].", "In the only other report of rotenone-like compounds and PD, use of organic pesticides such as rotenone in the previous year was determined for PD clinic attendees, who reported current use more often than did cases with other neurologic diseases (Dhillon et al. 2008)."]}
{"doc_id": 50014, "title": "", "abstract": ["To control potential confounding, we included reference age (tertiles 40–57, 58–65, 66–87 years), sex, state, and cigarette smoking (ever/never) in all models.", "Analyses used logistic regression adjusted for reference age tertile, sex, state, and cigarette smoking.", "For cigarette smoking, we classified individuals who smoked > 100 cigarettes before their reference date as exposed (Grant et al. 2004).", "Controls were frequency-matched to cases by age (< 40, 40–49, 50–59, 60–64, 65–69, ≥ 70 years), sex, and state (Iowa or North Carolina) at a ratio of approximately three controls per case.", "Results from analyses stratified by race/ethnicity, cigarette use, state, or duration of disease (in cases) were not appreciably different between subgroups (data not shown)."]}
{"doc_id": 50015, "title": "", "abstract": ["In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Cumulative exposure was associated with greater risk, but paraquat use in the Taiwanese study was highly correlated with use of other herbicides.", "Importantly, the potential for exposure to many of these pesticides, including rotenone and paraquat, extends well beyond the occupational setting.", "Exposures to rotenone and paraquat were not correlated (r = 0.004), and ORs from a model that included both pesticides (paraquat OR = 2.6; 95% CI, 1.4–4.9; rotenone OR = 2.9; 95% CI, 1.5–5.5) were comparable with those from models without mutual adjustment (Table 3).", "In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory."]}
{"doc_id": 50016, "title": "", "abstract": ["Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008).", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "In experimental models, both MPTP and rotenone cause selective injury of dopaminergic neurons in the substantia nigra, a key pathological feature of PD (Greenamyre et al. 1999; Langston et al. 1984).", "Rotenone and paraquat have been linked experimentally to pathophysiological mechanisms implicated in human PD.", "In the only other report of rotenone-like compounds and PD, use of organic pesticides such as rotenone in the previous year was determined for PD clinic attendees, who reported current use more often than did cases with other neurologic diseases (Dhillon et al. 2008)."]}
{"doc_id": 50017, "title": "", "abstract": ["In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxicant known to cause parkinsonism in humans, rotenone directly inhibits mitochondrial complex I (Langston et al. 1983; Sherer et al. 2007).", "In experimental models, both MPTP and rotenone cause selective injury of dopaminergic neurons in the substantia nigra, a key pathological feature of PD (Greenamyre et al. 1999; Langston et al. 1984).", "This study provides strong evidence of an association between rotenone use and PD in humans."]}
{"doc_id": 50018, "title": "", "abstract": ["Experimentally, paraquat produces subcellular changes associated with PD, including increased production of reactive oxygen species, alpha-synuclein aggregation, and selective nigral injury (Dinis-Oliveira et al. 2006; Kuter et al. 2010; McCormack et al. 2002).", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Rotenone and paraquat have been linked experimentally to pathophysiological mechanisms implicated in human PD.", "Previously, we found an association between paraquat use and PD in prevalent but not incident self-reported cases in the AHS (Kamel et al. 2007) and a nonsignificant association between PD and occupational paraquat use in a multicenter case–control study (Tanner et al. 2009).", "Although the inconsistency of findings in human populations has been used as a basis for suggesting that paraquat is not associated with PD (Li et al. 2005; Miller 2007), an alternative explanation is that few studies have had adequate size and sufficiently detailed exposure information to allow the association to be observed."]}
{"doc_id": 50019, "title": "", "abstract": ["In experimental models, both MPTP and rotenone cause selective injury of dopaminergic neurons in the substantia nigra, a key pathological feature of PD (Greenamyre et al. 1999; Langston et al. 1984).", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "However, recent work in rodent models indicated that a temporally limited exposure to rotenone later caused progressive functional and pathologic changes in the enteric nervous system of rodents, mimicking changes found in human PD; as in PD, these enteric nervous system changes preceded central nervous system pathology (Abbott et al. 2001; Braak et al. 2006; Drolet et al. 2009; Greene et al. 2009; Pan-Montojo et al. 2010).", "Clinical features of PD cases by use of paraquat or rotenone or mechanistic group.", "Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008)."]}
{"doc_id": 50020, "title": "", "abstract": ["We found significant associations of PD with use of groups of pesticides classified as complex I inhibitors or as oxidative stressors, providing support in humans for findings from decades of experimental work.", "We previously reported that self-reported PD was associated with increasing lifetime days of use of any pesticide, but no specific pesticide could be definitely implicated (Kamel et al. 2007).", "Association of PD with ever use of pesticides before diagnosis or reference date by mechanism.", "In 110 PD cases and 358 controls, PD was associated with use of a group of pesticides that inhibit mitochondrial complex I [odds ratio (OR) = 1.7; 95% confidence interval (CI), 1.0–2.8] including rotenone (OR = 2.5; 95% CI, 1.3–4.7) and with use of a group of pesticides that cause oxidative stress (OR = 2.0; 95% CI, 1.2–3.6), including paraquat (OR = 2.5; 95% CI, 1.4–4.7).", "Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative."]}
{"doc_id": 50021, "title": "", "abstract": ["This study provides strong evidence of an association between rotenone use and PD in humans.", "We previously reported that self-reported PD was associated with increasing lifetime days of use of any pesticide, but no specific pesticide could be definitely implicated (Kamel et al. 2007).", "* * *      Kamel et al. 2007| Case–control| Specific question re: rotenone use in a supplementary questionnaire| 83 prevalent cases| Association of PD with ever use| 1.7 (0.6–4.7)| 4 prevalent   79,557 controls| 671 controls   78 incident cases| Could not determine| | 1 incident   55,931 controls| 565 controls      * * *      Tanner et al. 2009| Case–control| Specific question re: occupational rotenone use| 519 cases| No association with PD| 0.82 (0.05–13.34)| 1 case   511 controls| 1 control      * * *      Dhillon et al. 2008| Case–control| General question re: “organic pesticides”| 100 cases| Greater use of “organic pesticides such as rotenone” in PD patients| 10.0 (2.9–34.3)| 27 cases   84 controls| 3 controls", "In 110 PD cases and 358 controls, PD was associated with use of a group of pesticides that inhibit mitochondrial complex I [odds ratio (OR) = 1.7; 95% confidence interval (CI), 1.0–2.8] including rotenone (OR = 2.5; 95% CI, 1.3–4.7) and with use of a group of pesticides that cause oxidative stress (OR = 2.0; 95% CI, 1.2–3.6), including paraquat (OR = 2.5; 95% CI, 1.4–4.7).", "In the only other report of rotenone-like compounds and PD, use of organic pesticides such as rotenone in the previous year was determined for PD clinic attendees, who reported current use more often than did cases with other neurologic diseases (Dhillon et al. 2008)."]}
{"doc_id": 50022, "title": "", "abstract": ["We previously reported that self-reported PD was associated with increasing lifetime days of use of any pesticide, but no specific pesticide could be definitely implicated (Kamel et al. 2007).", "Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "Previous studies have reported associations with paraquat, but results are inconsistent and, in general, studies included few exposed cases; evidence concerning rotenone is sparse (Table 1).", "Yet despite decades of laboratory study, neither pesticide has been definitively associated with PD in humans.", "Certain pesticides may affect these mechanisms, but no pesticide has been definitively associated with PD in humans."]}
{"doc_id": 50023, "title": "", "abstract": ["Interestingly, Hancock et al. (2008) similarly found pesticide exposure to be associated with PD risk only in those without an affected first-degree relative.", "In the only other report of rotenone-like compounds and PD, use of organic pesticides such as rotenone in the previous year was determined for PD clinic attendees, who reported current use more often than did cases with other neurologic diseases (Dhillon et al. 2008).", "We were unable to determine whether exposure to both paraquat and rotenone was associated with unique clinical features because only five cases reported use of both pesticides (data not shown).", "Our goal was to determine whether pesticides that cause mitochondrial dysfunction or oxidative stress are associated with PD or clinical features of parkinsonism in humans.", "Cases who did or did not use rotenone, paraquat, or groups of pesticides with similar mechanisms were generally similar, suggesting that PD associated with these agents is clinically typical and indirectly supporting a role for pesticide exposure in the etiology of typical PD."]}
{"doc_id": 50024, "title": "", "abstract": ["In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Parkinsonism in humans due to high-dose exposure to toxicants such as carbon monoxide or manganese has characteristic clinical features including less prominent tremor, more prominent postural instability, symmetric distribution of signs, and poor response to dopaminergic therapy (Tanner 1992).", "In experimental models, both MPTP and rotenone cause selective injury of dopaminergic neurons in the substantia nigra, a key pathological feature of PD (Greenamyre et al. 1999; Langston et al. 1984).", "Experimentally, paraquat produces subcellular changes associated with PD, including increased production of reactive oxygen species, alpha-synuclein aggregation, and selective nigral injury (Dinis-Oliveira et al. 2006; Kuter et al. 2010; McCormack et al. 2002).", "Chronic rotenone exposure in the laboratory has been reported to have additional effects associated with PD pathogenesis, including ones similar to changes observed in monogenic forms of PD (Henchcliffe and Beal 2008)."]}
{"doc_id": 11000, "title": "", "abstract": ["However, our estimates for these values lie within the ranges of estimates from the literature.", "According to the best-fit model parameters, the R0 for HCoV-OC43 and HCoV-HKU1 varies between 1.7 in the summer and 2.2 in the winter and peaks in the 2nd week of January, consistent with the seasonal spline estimated from the data.", "For a representative set of parameter values, we measured annual SARS-CoV-2 infections (tables S2 to S4 and fig. S7) and the peak annual SARS- CoV-2 prevalence (tables S5 to S7 and fig. S7) through 2025.", "We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission.", "Informed by the transmission model fits, we assumed a latent period of 4.6 days and an infectious period of 5 days, in agreement with estimates from other studies (26)."]}
{"doc_id": 11001, "title": "", "abstract": ["Still, countries that have achieved this level of control of the outbreak should prepare for the possibility of substantial resurgences of infection and a return to social distancing measures, especially if seasonal forcing contributes to a rise in transmissibility in the winter.", "Preventing widespread infection during the summer can flatten and prolong the epidemic but can also lead to a high density of susceptible individuals who could become infected in an intense autumn wave.", "However, stronger seasonal forcing leads to a greater accumulation of susceptible individuals during periods of low transmission in the summer, leading to recurrent outbreaks with higher peaks in the post-pandemic period (Fig. 3C).", "(C) Higher seasonal variation in transmission (f = 0.4) would reduce the peak size of the invasion wave, but could lead to more severe wintertime outbreaks thereafter [compare with (B)].", "The observation that strong, temporary social distancing can lead to especially large resurgences agrees with data from the 1918 influenza pandemic in the United States (44), in which the size of the autumn 1918 peak of infection was inversely associated with that of a subsequent winter peak after interventions were no longer in place."]}
{"doc_id": 11002, "title": "", "abstract": ["To avoid this, prolonged or intermittent social distancing may be necessary into 2022.", "In the absence of such interventions, surveillance and intermittent distancing (or sustained distancing if it is highly effective) may need to be maintained into 2022, which would present a substantial social and economic burden.", "We do not take a position on the advisability of these scenarios given the economic burden that sustained distancing may impose, but we note the potentially catastrophic burden on the healthcare system that is predicted if distancing is poorly effective and/or not sustained for long enough.", "Furthermore, social distancing measures may need to last for months to effectively control transmission and mitigate the possibility of resurgence (25).", "Still, SARS-CoV-2 has demonstrated an ability to challenge robust healthcare systems, and the development and widespread adoption of pharmaceutical interventions will take months at best, so a period of sustained or intermittent social distancing will almost certainly be necessary."]}
{"doc_id": 11003, "title": "", "abstract": ["The intensity of the initial pandemic wave will depend fundamentally on the basic reproduction number at the time of epidemic establishment: if establishment occurs in the autumn when the reproduction number is rising, which could occur in countries that maintain epidemic control by contact tracing and quarantine through the summer, or if SARS-CoV-2 is not subject to the same summertime decline in transmissibility as HCoV-OC43 and HCoV-HKU1, then a high peak prevalence of infection is likely.", "We anticipate that such cross-immunity would lessen the intensity of SARS-CoV-2 outbreaks, though some speculate that antibody-dependent enhancement (ADE) induced by prior coronavirus infection may increase susceptibility to SARS-CoV-2 and exacerbate the severity of infection (51, 52).", "Alternatively, the transmission of SARS-CoV-2 could resemble that of pandemic influenza by circulating seasonally after causing an initial global wave of infection (7).", "A modelling study using data from Sweden found that seasonal establishment of SARS-CoV-2 transmission is likely in the post-pandemic period (11).", "However, we expect that if post-pandemic transmission of SARS-CoV-2 does take hold in temperate regions, there will also be continued transmission in tropical regions seeded by the seasonal outbreaks to the north and south."]}
{"doc_id": 11004, "title": "", "abstract": ["If immunity to SARS-CoV-2 wanes in the same manner as related coronaviruses, recurrent wintertime outbreaks are likely to occur in coming years.", "Short-term immunity (on the order of 40 weeks, similar to HCoV-OC43 and HCoV-HKU1) favors the establishment of annual SARS- CoV-2 outbreaks, while longer-term immunity (two years) favors biennial outbreaks.", "(A) A short duration (1/σ3 = 40 weeks) of SARS-CoV-2 immunity could yield annual SARS-CoV-2 outbreaks.", "(B) Longer-term SARS-CoV-2 immunity (1/σ3 = 104 weeks) could yield biennial outbreaks, possibly with smaller outbreaks in the intervening years.", "Much like pandemic influenza, many scenarios lead to SARS-CoV-2 entering into long-term circulation alongside the other human betacoronaviruses (e.g., Fig. 3, A and B), possibly in annual, biennial, or sporadic patterns over the next five years (tables S2 to S4)."]}
{"doc_id": 11005, "title": "", "abstract": ["Moreover, a winter peak for COVID-19 would coincide with peak influenza incidence (54), further straining health care systems.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1.", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts."]}
{"doc_id": 11006, "title": "", "abstract": ["Sustained, widespread surveillance will be needed both in the short term to effectively implement intermittent social distancing measures and in the long term to assess the possibility of resurgences of SARS-CoV-2 infection, which could occur as late as 2025 even after a prolonged period of apparent elimination.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "Intermittent distancing may be required into 2022 unless critical care capacity is increased substantially or a treatment or vaccine becomes available.", "In the absence of such interventions, surveillance and intermittent distancing (or sustained distancing if it is highly effective) may need to be maintained into 2022, which would present a substantial social and economic burden.", "To avoid this, prolonged or intermittent social distancing may be necessary into 2022."]}
{"doc_id": 11007, "title": "", "abstract": ["Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "Still, countries that have achieved this level of control of the outbreak should prepare for the possibility of substantial resurgences of infection and a return to social distancing measures, especially if seasonal forcing contributes to a rise in transmissibility in the winter.", "The goal of these strategies is to reduce the peak intensity of the epidemic (“flatten the curve”) (22), reducing the risk of overwhelming health systems and buying time to develop treatments and vaccines.", "Social distancing measures have been adopted in many countries with widespread SARS-CoV-2 transmission."]}
{"doc_id": 11008, "title": "", "abstract": ["The ongoing severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) pandemic has caused nearly 500,000 detected cases of coronavirus disease 2019 (COVID-19) illness and claimed over 20,000 lives worldwide as of 26 Mar 2020 (1).", "We assumed an establishment time of sustained transmission on 11 March 2020, when the World Health Organization declared the SARS-CoV-2 outbreak a pandemic (40) and we varied the establishment time in a sensitivity analysis (fig. S7).", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "Under current critical care capacities, however, the overall duration of the SARS-CoV-2 epidemic could last into 2022, requiring social distancing measures to be in place between 25% (for wintertime R0 = 2 and seasonality; fig. S11A) and 75% (for wintertime R0 = 2.6 and no seasonality; fig. S9C) of that time.", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1."]}
{"doc_id": 11009, "title": "", "abstract": ["Still, countries that have achieved this level of control of the outbreak should prepare for the possibility of substantial resurgences of infection and a return to social distancing measures, especially if seasonal forcing contributes to a rise in transmissibility in the winter.", "Moreover, a winter peak for COVID-19 would coincide with peak influenza incidence (54), further straining health care systems.", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1.", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4)."]}
{"doc_id": 11010, "title": "", "abstract": ["It also does not incorporate geographic structure, so the possibility of spatially heterogeneous transmission cannot be assessed.", "The model will have to be tailored to local conditions and updated as more accurate data become available.", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "Under all scenarios, there was a resurgence of infection when the simulated social distancing measures were lifted."]}
{"doc_id": 11011, "title": "", "abstract": ["The scenarios were obtained by varying the cross immunity between SARS-CoV-2 and HCoVs OC43/HKU1 (χ3X) and vice-versa (χX3), the duration of SARS-CoV-2 immunity (1/σ3), and the seasonal variation in R0 (f), assuming an epidemic establishment time of 11 March 2020 (depicted as a vertical grey bar).", "We anticipate that such cross-immunity would lessen the intensity of SARS-CoV-2 outbreaks, though some speculate that antibody-dependent enhancement (ADE) induced by prior coronavirus infection may increase susceptibility to SARS-CoV-2 and exacerbate the severity of infection (51, 52).", "Much like pandemic influenza, many scenarios lead to SARS-CoV-2 entering into long-term circulation alongside the other human betacoronaviruses (e.g., Fig. 3, A and B), possibly in annual, biennial, or sporadic patterns over the next five years (tables S2 to S4).", "We integrate our findings in a mathematical model to project potential scenarios for SARS-CoV-2 transmission through the pandemic and post-pandemic periods and identify key data still needed to determine which scenarios are likely to play out.", "In all modeled scenarios, SARS-CoV-2 was capable of producing a substantial outbreak regardless of establishment time."]}
{"doc_id": 11012, "title": "", "abstract": ["The timing and strength of post-pandemic outbreaks may also depend on stochastic introductions from abroad, which can be assessed using more complex, global models.", "Our findings generalize only to temperate regions, comprising 60% of the world’s population (47), and the size and intensity of outbreaks could be further modulated by differences in average interpersonal contact rates by location and the timing and effectiveness of non-pharmaceutical and pharmaceutical interventions.", "In our model, this rate is the key modulator of the total SARS-CoV-2 incidence in the coming years.", "Measuring the distributions of these times, and not just their means, will help to set more effective thresholds for distancing interventions.", "The intensity and timing of pandemic and post-pandemic outbreaks will depend on the time of year when widespread SARS-CoV-2 infection becomes established and, to a lesser degree, upon the magnitude of seasonal variation in transmissibility and the level of cross-immunity that exists between the betacoronaviruses."]}
{"doc_id": 11013, "title": "", "abstract": ["We anticipate that such cross-immunity would lessen the intensity of SARS-CoV-2 outbreaks, though some speculate that antibody-dependent enhancement (ADE) induced by prior coronavirus infection may increase susceptibility to SARS-CoV-2 and exacerbate the severity of infection (51, 52).", "### Low levels of cross immunity from the other betacoronaviruses against SARS-CoV-2 could make SARS-CoV-2 appear to die out, only to resurge after a few years", "If SARS-CoV-2 induces cross immunity against HCoV-OC43 and HCoV-HKU1, the incidence of all betacoronaviruses could decline and even virtually disappear (Fig. 3D).", "Serology could also indicate whether cross-immunity exists between SARS-CoV-2, HCoV-OC43, and HCoV-HKU1, which could affect the post-pandemic transmission of SARS-CoV-2.", "The betacoronaviruses can induce immune responses against one another: SARS-CoV-1 infection can generate neutralizing antibodies against HCoV-OC43 (16) and HCoV-OC43 infection can generate cross- reactive antibodies against SARS-CoV-1 (17)."]}
{"doc_id": 11014, "title": "", "abstract": ["During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "The timing and strength of post-pandemic outbreaks may also depend on stochastic introductions from abroad, which can be assessed using more complex, global models.", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1."]}
{"doc_id": 11015, "title": "", "abstract": ["We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "We integrate our findings in a mathematical model to project potential scenarios for SARS-CoV-2 transmission through the pandemic and post-pandemic periods and identify key data still needed to determine which scenarios are likely to play out.", "To quantify the relative contribution of immunity versus seasonal forcing on the transmission dynamics of the betacoronaviruses, we adapted a regression model (36) that expressed the effective reproduction number for each strain (HKU1 and OC43) as the product of a baseline transmissibility constant (related to the basic reproduction number (R0) and the proportion of the population susceptible at the start of each season), the depletion of susceptibles due to infection with the same strain, the depletion of susceptibles due to infection with the other strain, and a spline to capture further unexplained seasonal variation in transmission strength (seasonal forcing).", "Our model presents a variety of scenarios intended to anticipate possible SARS-CoV-2 transmission dynamics under specific assumptions.", "We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission."]}
{"doc_id": 11016, "title": "", "abstract": ["It also does not incorporate geographic structure, so the possibility of spatially heterogeneous transmission cannot be assessed.", "Our findings generalize only to temperate regions, comprising 60% of the world’s population (47), and the size and intensity of outbreaks could be further modulated by differences in average interpersonal contact rates by location and the timing and effectiveness of non-pharmaceutical and pharmaceutical interventions.", "The amount of seasonal variation in SARS-CoV-2 transmission could differ between geographic locations, as for influenza (12).", "The construction of spatially explicit models will become more feasible as more data on SARS-CoV-2 incidence becomes available; these will help determine whether there are differences in seasonal forcing between geographic locations, as for influenza (12), and will also help to assess the possibility of epidemic extinction while accounting for re-introductions.", "We limited our analysis to “in-season” estimates based on adequate samples, defined as week 40 through week 20 of the following year, roughly October to May."]}
{"doc_id": 11017, "title": "", "abstract": ["When the latent, infectious, and hospitalization periods are gamma-distributed, incidence rises more quickly, requiring a lower threshold for implementing distancing measures (25 cases per 10,000 individuals for R0 = 2.2 in our model) and more frequent interventions (fig. S16).", "We assumed a latent period of 4.6 days (26, 37–39) and an infectious period of 5 days, informed by the best-fit values for the other betacoronaviruses (table S8).", "(E) χ3X = 0.3, χX3 = 0.3, 1/σ3 = 104 weeks, f = 0.4.", "Preventing widespread infection during the summer can flatten and prolong the epidemic but can also lead to a high density of susceptible individuals who could become infected in an intense autumn wave.", "We also implemented a model with extra compartments for the latent period, infectious period, and each hospitalization period so that the waiting times in these states were gamma- distributed instead of exponentially distributed (see the supplementary materials and methods and figs. S16 and S17)."]}
{"doc_id": 11018, "title": "", "abstract": ["Model simulations demonstrated the following key points.", "Although disease dynamics may differ by age, we did not have sufficient data to parameterize an age-structured model.", "We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission.", "For simulations with seasonal forcing, the post-intervention resurgent peak could exceed the size of the unconstrained epidemic (Fig. 5 and fig. S13), both in terms of peak prevalence and in terms of total number infected.", "For a representative set of parameter values, we measured annual SARS-CoV-2 infections (tables S2 to S4 and fig. S7) and the peak annual SARS- CoV-2 prevalence (tables S5 to S7 and fig. S7) through 2025."]}
{"doc_id": 11019, "title": "", "abstract": ["A 40% summertime decline in R0 would reduce the unmitigated peak incidence of the initial SARS-CoV-2 pandemic wave.", "Under current critical care capacities, however, the overall duration of the SARS-CoV-2 epidemic could last into 2022, requiring social distancing measures to be in place between 25% (for wintertime R0 = 2 and seasonality; fig. S11A) and 75% (for wintertime R0 = 2.6 and no seasonality; fig. S9C) of that time.", "One-time social distancing efforts may push the SARS-CoV-2 epidemic peak into the autumn, potentially exacerbating the load on critical care resources if there is increased wintertime transmissibility.", "The amount of seasonal variation in SARS-CoV-2 transmission could differ between geographic locations, as for influenza (12).", "For a representative set of parameter values, we measured annual SARS-CoV-2 infections (tables S2 to S4 and fig. S7) and the peak annual SARS- CoV-2 prevalence (tables S5 to S7 and fig. S7) through 2025."]}
{"doc_id": 11020, "title": "", "abstract": ["The model will have to be tailored to local conditions and updated as more accurate data become available.", "To address this, we adapted the SEIRS transmission model (fig. S9) to capture moderate/mild/asymptomatic infections (95.6% of infections), infections that lead to hospitalization but not critical care (3.08% of infections), and infections that require critical care (1.32% of infections) (26).", "We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "Also in agreement with the findings of the regression model, the duration of immunity for both strains in the best-fit SEIRS model is about 45 weeks, and each strain induces cross- immunity against the other, though the cross-immunity that HCoV-OC43 infection induces against HCoV-HKU1 is stronger than the reverse.", "We integrate our findings in a mathematical model to project potential scenarios for SARS-CoV-2 transmission through the pandemic and post-pandemic periods and identify key data still needed to determine which scenarios are likely to play out."]}
{"doc_id": 11021, "title": "", "abstract": ["The SARS-CoV-1 and MERS coronaviruses cause severe illness with approximate case fatality rates of 9 and 36% respectively, but the transmission of both has remained limited (9).", "Even if SARS-CoV-2 immunity only lasts for two years, mild (30%) cross- immunity from HCoV-OC43 and HCoV-HKU1 could effectively eliminate the transmission of SARS-CoV-2 for up to three years before a resurgence in 2024, as long as SARS-CoV-2 does not fully die out (Fig. 3E).", "Regardless of the post-pandemic transmission dynamics of SARS-CoV-2, urgent measures are required to address the ongoing epidemic.", "Short-term immunity (on the order of 40 weeks, similar to HCoV-OC43 and HCoV-HKU1) favors the establishment of annual SARS- CoV-2 outbreaks, while longer-term immunity (two years) favors biennial outbreaks.", "The high infectiousness near the start of often mild symptoms makes SARS-CoV-2 considerably harder to control with case-based interventions such as intensive testing, isolation and tracing, compared to SARS-CoV-1 and MERS coronaviruses (21)."]}
{"doc_id": 11022, "title": "", "abstract": ["### High seasonal variation in transmission leads to smaller peak incidence during the initial pandemic wave but larger recurrent wintertime outbreaks", "During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "The pandemic and post-pandemic transmission dynamics of SARS-CoV-2 will depend on factors including the degree of seasonal variation in transmission, the duration of immunity, and the degree of cross-immunity between SARS-CoV-2 and other coronaviruses, as well as the intensity and timing of control measures.", "However, stronger seasonal forcing leads to a greater accumulation of susceptible individuals during periods of low transmission in the summer, leading to recurrent outbreaks with higher peaks in the post-pandemic period (Fig. 3C).", "The intensity of the initial pandemic wave will depend fundamentally on the basic reproduction number at the time of epidemic establishment: if establishment occurs in the autumn when the reproduction number is rising, which could occur in countries that maintain epidemic control by contact tracing and quarantine through the summer, or if SARS-CoV-2 is not subject to the same summertime decline in transmissibility as HCoV-OC43 and HCoV-HKU1, then a high peak prevalence of infection is likely."]}
{"doc_id": 11023, "title": "", "abstract": ["However, we expect that if post-pandemic transmission of SARS-CoV-2 does take hold in temperate regions, there will also be continued transmission in tropical regions seeded by the seasonal outbreaks to the north and south.", "We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave.", "We used data from the United States to model betacoronavirus transmission in temperate regions and to project the possible dynamics of SARS-CoV-2 infection through the year 2025.", "One-time social distancing efforts may push the SARS-CoV-2 epidemic peak into the autumn, potentially exacerbating the load on critical care resources if there is increased wintertime transmissibility.", "HCoV-OC43 and HCoV-HKU1 cause annual wintertime outbreaks of respiratory illness in temperate regions (10, 11), suggesting that wintertime climate and host behaviors may facilitate transmission, as is true for influenza (12–14)."]}
{"doc_id": 11024, "title": "", "abstract": ["Alternatively, the transmission of SARS-CoV-2 could resemble that of pandemic influenza by circulating seasonally after causing an initial global wave of infection (7).", "A modelling study using data from Sweden found that seasonal establishment of SARS-CoV-2 transmission is likely in the post-pandemic period (11).", "Much like pandemic influenza, many scenarios lead to SARS-CoV-2 entering into long-term circulation alongside the other human betacoronaviruses (e.g., Fig. 3, A and B), possibly in annual, biennial, or sporadic patterns over the next five years (tables S2 to S4).", "The pandemic and post-pandemic transmission dynamics of SARS-CoV-2 will depend on factors including the degree of seasonal variation in transmission, the duration of immunity, and the degree of cross-immunity between SARS-CoV-2 and other coronaviruses, as well as the intensity and timing of control measures.", "The amount of seasonal variation in SARS-CoV-2 transmission could differ between geographic locations, as for influenza (12)."]}
{"doc_id": 11025, "title": "", "abstract": ["### High seasonal variation in transmission leads to smaller peak incidence during the initial pandemic wave but larger recurrent wintertime outbreaks", "During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "However, stronger seasonal forcing leads to a greater accumulation of susceptible individuals during periods of low transmission in the summer, leading to recurrent outbreaks with higher peaks in the post-pandemic period (Fig. 3C).", "The pandemic and post-pandemic transmission dynamics of SARS-CoV-2 will depend on factors including the degree of seasonal variation in transmission, the duration of immunity, and the degree of cross-immunity between SARS-CoV-2 and other coronaviruses, as well as the intensity and timing of control measures.", "The intensity of the initial pandemic wave will depend fundamentally on the basic reproduction number at the time of epidemic establishment: if establishment occurs in the autumn when the reproduction number is rising, which could occur in countries that maintain epidemic control by contact tracing and quarantine through the summer, or if SARS-CoV-2 is not subject to the same summertime decline in transmissibility as HCoV-OC43 and HCoV-HKU1, then a high peak prevalence of infection is likely."]}
{"doc_id": 11026, "title": "", "abstract": ["Such a scenario could reflect the previous emergence of known human coronaviruses from zoonotic origins e.g. human coronavirus (HCoV) OC43 (8).", "Overall, shorter durations of immunity and smaller degrees of cross- immunity from the other betacoronaviruses were associated with greater total incidence of infection due to SARS-CoV-2, and autumn establishments and smaller seasonal fluctuations in transmissibility were associated with larger pandemic peak sizes.", "HCoV-OC43 and HCoV-HKU1 cause annual wintertime outbreaks of respiratory illness in temperate regions (10, 11), suggesting that wintertime climate and host behaviors may facilitate transmission, as is true for influenza (12–14).", "Only five seasons of observational data on coronaviruses were available, though the incidence patterns resemble those from 10 years of data from a hospital in Sweden (11).", "To quantify the relative contribution of immunity versus seasonal forcing on the transmission dynamics of the betacoronaviruses, we adapted a regression model (36) that expressed the effective reproduction number for each strain (HKU1 and OC43) as the product of a baseline transmissibility constant (related to the basic reproduction number (R0) and the proportion of the population susceptible at the start of each season), the depletion of susceptibles due to infection with the same strain, the depletion of susceptibles due to infection with the other strain, and a spline to capture further unexplained seasonal variation in transmission strength (seasonal forcing)."]}
{"doc_id": 11027, "title": "", "abstract": ["Model simulations demonstrated the following key points.", "These thresholds were chosen to qualitatively illustrate the intermittent intervention scenario; in practice, the thresholds will need to be tuned to local epidemic dynamics and hospital capacities.", "Under all scenarios, there was a resurgence of infection when the simulated social distancing measures were lifted.", "For simulations with seasonal forcing, the post-intervention resurgent peak could exceed the size of the unconstrained epidemic (Fig. 5 and fig. S13), both in terms of peak prevalence and in terms of total number infected.", "## Assessing intervention scenarios during the initial pandemic wave"]}
{"doc_id": 11028, "title": "", "abstract": ["The pandemic and post-pandemic transmission dynamics of SARS-CoV-2 will depend on factors including the degree of seasonal variation in transmission, the duration of immunity, and the degree of cross-immunity between SARS-CoV-2 and other coronaviruses, as well as the intensity and timing of control measures.", "A modelling study using data from Sweden found that seasonal establishment of SARS-CoV-2 transmission is likely in the post-pandemic period (11).", "The amount of seasonal variation in SARS-CoV-2 transmission could differ between geographic locations, as for influenza (12).", "Alternatively, the transmission of SARS-CoV-2 could resemble that of pandemic influenza by circulating seasonally after causing an initial global wave of infection (7).", "Overall, shorter durations of immunity and smaller degrees of cross- immunity from the other betacoronaviruses were associated with greater total incidence of infection due to SARS-CoV-2, and autumn establishments and smaller seasonal fluctuations in transmissibility were associated with larger pandemic peak sizes."]}
{"doc_id": 11029, "title": "", "abstract": ["During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "## Assessing intervention scenarios during the initial pandemic wave", "### High seasonal variation in transmission leads to smaller peak incidence during the initial pandemic wave but larger recurrent wintertime outbreaks", "The required intensity, duration, and urgency of these responses will depend both on how the initial pandemic wave unfolds and on the subsequent transmission dynamics of SARS-CoV-2."]}
{"doc_id": 11030, "title": "", "abstract": ["Overall, shorter durations of immunity and smaller degrees of cross- immunity from the other betacoronaviruses were associated with greater total incidence of infection due to SARS-CoV-2, and autumn establishments and smaller seasonal fluctuations in transmissibility were associated with larger pandemic peak sizes.", "(A) A short duration (1/σ3 = 40 weeks) of SARS-CoV-2 immunity could yield annual SARS-CoV-2 outbreaks.", "Short-term immunity (on the order of 40 weeks, similar to HCoV-OC43 and HCoV-HKU1) favors the establishment of annual SARS- CoV-2 outbreaks, while longer-term immunity (two years) favors biennial outbreaks.", "Long-term immunity consistently led to effective elimination of SARS-CoV-2 and lower overall incidence of infection.", "In our assessment of control measures in the initial pandemic period, we assumed that SARS-CoV-2 infection induces immunity that lasts for at least two years, but social distancing measures may need to be extended if SARS-CoV-2 immunity wanes more rapidly."]}
{"doc_id": 11031, "title": "", "abstract": ["We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "Our model presents a variety of scenarios intended to anticipate possible SARS-CoV-2 transmission dynamics under specific assumptions.", "To quantify the relative contribution of immunity versus seasonal forcing on the transmission dynamics of the betacoronaviruses, we adapted a regression model (36) that expressed the effective reproduction number for each strain (HKU1 and OC43) as the product of a baseline transmissibility constant (related to the basic reproduction number (R0) and the proportion of the population susceptible at the start of each season), the depletion of susceptibles due to infection with the same strain, the depletion of susceptibles due to infection with the other strain, and a spline to capture further unexplained seasonal variation in transmission strength (seasonal forcing).", "# Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period", "## Transmission dynamics of HCoV-OC43 and HCoV-HKU1"]}
{"doc_id": 11032, "title": "", "abstract": ["Seasonal forcing appears to drive the rise in transmissibility at the start of the season (late October through early December), while depletion of susceptibles plays a comparatively larger role in the decline in transmissibility toward the end of the season.", "The intensity and timing of pandemic and post-pandemic outbreaks will depend on the time of year when widespread SARS-CoV-2 infection becomes established and, to a lesser degree, upon the magnitude of seasonal variation in transmissibility and the level of cross-immunity that exists between the betacoronaviruses.", "(C) Higher seasonal variation in transmission (f = 0.4) would reduce the peak size of the invasion wave, but could lead to more severe wintertime outbreaks thereafter [compare with (B)].", "When transmission was not subject to seasonal forcing, one-time social distancing measures reduced the epidemic peak size (Fig. 4 and fig. S12).", "While the frequency and duration of the social distancing measures was similar between the scenarios with current and expanded critical care capacity, the epidemic concluded by July 2022 and social distancing measures could be fully relaxed by early- to mid- 2021, depending again on the degree of seasonal forcing of transmission (Fig. 6, C and D)."]}
{"doc_id": 11033, "title": "", "abstract": ["SARS-CoV-2 belongs to the betacoronavirus genus, which includes the SARS-CoV-1 coronavirus, MERS coronavirus, and two other human coronaviruses, HCoV-OC43 and HCoV-HKU1.", "We anticipate that such cross-immunity would lessen the intensity of SARS-CoV-2 outbreaks, though some speculate that antibody-dependent enhancement (ADE) induced by prior coronavirus infection may increase susceptibility to SARS-CoV-2 and exacerbate the severity of infection (51, 52).", "If SARS-CoV-2 induces cross immunity against HCoV-OC43 and HCoV-HKU1, the incidence of all betacoronaviruses could decline and even virtually disappear (Fig. 3D).", "While investigations into the spectrum of illness caused by SARS-CoV-2 are ongoing, recent evidence indicates the majority of cases experience mild to moderate illness with more limited occurrence of severe lower respiratory infection (18).", "Much like pandemic influenza, many scenarios lead to SARS-CoV-2 entering into long-term circulation alongside the other human betacoronaviruses (e.g., Fig. 3, A and B), possibly in annual, biennial, or sporadic patterns over the next five years (tables S2 to S4)."]}
{"doc_id": 11034, "title": "", "abstract": ["In the absence of such interventions, surveillance and intermittent distancing (or sustained distancing if it is highly effective) may need to be maintained into 2022, which would present a substantial social and economic burden.", "To avoid this, prolonged or intermittent social distancing may be necessary into 2022.", "Intermittent distancing may be required into 2022 unless critical care capacity is increased substantially or a treatment or vaccine becomes available.", "While the frequency and duration of the social distancing measures was similar between the scenarios with current and expanded critical care capacity, the epidemic concluded by July 2022 and social distancing measures could be fully relaxed by early- to mid- 2021, depending again on the degree of seasonal forcing of transmission (Fig. 6, C and D).", "Under current critical care capacities, however, the overall duration of the SARS-CoV-2 epidemic could last into 2022, requiring social distancing measures to be in place between 25% (for wintertime R0 = 2 and seasonality; fig. S11A) and 75% (for wintertime R0 = 2.6 and no seasonality; fig. S9C) of that time."]}
{"doc_id": 11035, "title": "", "abstract": ["New therapeutics, vaccines, or other interventions such as aggressive contact tracing and quarantine – impractical now in many places but more practical once case numbers have been reduced and testing scaled up (43) – could alleviate the need for stringent social distancing to maintain control of the epidemic.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "Social distancing strategies could reduce the extent to which SARS-CoV-2 infections strain health care systems.", "Highly-effective distancing could reduce SARS- CoV-2 incidence enough to make a strategy based on contact tracing and quarantine feasible, as in South Korea and Singapore.", "Observational and modelling studies (2, 26) that find that early implementation of strong social distancing is essential for controlling the spread of SARS-CoV-2 and that, in the absence of the development of new therapies or preventative measures, such as aggressive case finding and quarantining (21), intermittent distancing measures may be the only way to avoid overwhelming critical care capacity while building population immunity."]}
{"doc_id": 11036, "title": "", "abstract": ["Model simulations demonstrated the following key points.", "The model will have to be tailored to local conditions and updated as more accurate data become available.", "On the x-axis, the first “week in season” corresponds to epidemiological week 40.", "We performed a sensitivity analysis around these threshold values (figs. S10 and S11) to assess how they affected the duration and frequency of the interventions.", "We limited our analysis to “in-season” estimates based on adequate samples, defined as week 40 through week 20 of the following year, roughly October to May."]}
{"doc_id": 11037, "title": "", "abstract": ["The ratio of cross-immunization to self-immunization effects was larger for HCoV-HKU1 than for HCoV-OC43, suggesting that HCoV-OC43 confers stronger cross-immunity.", "Also in agreement with the findings of the regression model, the duration of immunity for both strains in the best-fit SEIRS model is about 45 weeks, and each strain induces cross- immunity against the other, though the cross-immunity that HCoV-OC43 infection induces against HCoV-HKU1 is stronger than the reverse.", "Depletion of susceptibles for each strain was also negatively correlated with the reproduction number of the other betacoronavirus strain, providing evidence of cross-immunity.", "Serology could also indicate whether cross-immunity exists between SARS-CoV-2, HCoV-OC43, and HCoV-HKU1, which could affect the post-pandemic transmission of SARS-CoV-2.", "We assumed the worst-case scenario of no cross-immunity from HCoV-OC43 and HCoV-HKU1 against SARS-CoV-2, which makes the SARS-CoV-2 model unaffected by the transmission dynamics of those viruses."]}
{"doc_id": 11038, "title": "", "abstract": ["We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "Strong social distancing maintained a high proportion of susceptible individuals in the population, leading to an intense epidemic when R0 rises in the late autumn and winter.", "To quantify the relative contribution of immunity versus seasonal forcing on the transmission dynamics of the betacoronaviruses, we adapted a regression model (36) that expressed the effective reproduction number for each strain (HKU1 and OC43) as the product of a baseline transmissibility constant (related to the basic reproduction number (R0) and the proportion of the population susceptible at the start of each season), the depletion of susceptibles due to infection with the same strain, the depletion of susceptibles due to infection with the other strain, and a spline to capture further unexplained seasonal variation in transmission strength (seasonal forcing).", "We evaluated the impact of one-time social distancing efforts of varying effectiveness and duration on the peak and timing of the epidemic with and without seasonal forcing.", "As expected, depletion of susceptibles for each strain was negatively correlated with transmissibility of that strain."]}
{"doc_id": 11039, "title": "", "abstract": ["The model will have to be tailored to local conditions and updated as more accurate data become available.", "To address this, we adapted the SEIRS transmission model (fig. S9) to capture moderate/mild/asymptomatic infections (95.6% of infections), infections that lead to hospitalization but not critical care (3.08% of infections), and infections that require critical care (1.32% of infections) (26).", "We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "We integrate our findings in a mathematical model to project potential scenarios for SARS-CoV-2 transmission through the pandemic and post-pandemic periods and identify key data still needed to determine which scenarios are likely to play out.", "Also in agreement with the findings of the regression model, the duration of immunity for both strains in the best-fit SEIRS model is about 45 weeks, and each strain induces cross- immunity against the other, though the cross-immunity that HCoV-OC43 infection induces against HCoV-HKU1 is stronger than the reverse."]}
{"doc_id": 11040, "title": "", "abstract": ["Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "To alleviate these problems, approaches to increase critical care capacity have included rapid construction or repurposing of hospital facilities and consideration of increased manufacturing and distribution of ventilators (27–30).", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1.", "Introducing a hypothetical treatment that halved the proportion of infections that required hospitalization had a similar effect as doubling critical care capacity (fig. S15).", "Treatments could reduce the proportion of infections that require critical care and could reduce the duration of infectiousness, which would both directly and indirectly (through a reduction in R0) reduce the demand for critical care resources."]}
{"doc_id": 11041, "title": "", "abstract": ["The model will have to be tailored to local conditions and updated as more accurate data become available.", "Model simulations demonstrated the following key points.", "We performed a sensitivity analysis around these threshold values (figs. S10 and S11) to assess how they affected the duration and frequency of the interventions.", "On the x-axis, the first “week in season” corresponds to epidemiological week 40.", "We limited our analysis to “in-season” estimates based on adequate samples, defined as week 40 through week 20 of the following year, roughly October to May."]}
{"doc_id": 11042, "title": "", "abstract": ["A modelling study using data from Sweden found that seasonal establishment of SARS-CoV-2 transmission is likely in the post-pandemic period (11).", "The amount of seasonal variation in SARS-CoV-2 transmission could differ between geographic locations, as for influenza (12).", "Overall, shorter durations of immunity and smaller degrees of cross- immunity from the other betacoronaviruses were associated with greater total incidence of infection due to SARS-CoV-2, and autumn establishments and smaller seasonal fluctuations in transmissibility were associated with larger pandemic peak sizes.", "We used data from the United States to model betacoronavirus transmission in temperate regions and to project the possible dynamics of SARS-CoV-2 infection through the year 2025.", "Still, countries that have achieved this level of control of the outbreak should prepare for the possibility of substantial resurgences of infection and a return to social distancing measures, especially if seasonal forcing contributes to a rise in transmissibility in the winter."]}
{"doc_id": 11043, "title": "", "abstract": ["Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024.", "Sustained, widespread surveillance will be needed both in the short term to effectively implement intermittent social distancing measures and in the long term to assess the possibility of resurgences of SARS-CoV-2 infection, which could occur as late as 2025 even after a prolonged period of apparent elimination.", "Longitudinal serological studies are urgently required to determine the extent and duration of immunity to SARS-CoV-2, and epidemiological surveillance should be maintained in the coming years to anticipate the possibility of resurgence.", "(E) However, a resurgence of SARS-CoV-2 could occur as late as 2024 after a period of apparent elimination if the duration of immunity is intermediate (1/σ3 = 104 weeks) and if HCoVs OC43/HKU1 impart intermediate cross immunity against SARS-CoV-2 (χ3X = 0.3).", "If immunity to SARS-CoV-2 wanes in the same manner as related coronaviruses, recurrent wintertime outbreaks are likely to occur in coming years."]}
{"doc_id": 53000, "title": "", "abstract": ["Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "We directly evaluated the role of PPARγ in specifying the VAT Treg phenotype by retrovirally transducing Foxp3 alone or together with Pparg into naïve CD4+ T cells activated in vitro with anti-CD3/CD28-coated beads (neither transcription factor being expressed at detectable levels in the host CD4+ T cells).", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function."]}
{"doc_id": 53001, "title": "", "abstract": ["Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "The striking increase in the representation of and alterations in the phenotype of VAT Tregs provoked by Pio treatment of obese mice raised the question of whether this population contributes to the insulin-sensitizing effect of Pio.", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "In analogy to the human context, we compared immunologic and metabolic parameters in obese (HFD-fed) Pparg wt and Treg-Pparg mut mice as a function of Pio co-treatment."]}
{"doc_id": 53002, "title": "", "abstract": ["While invasion of VAT by pro-inflammatory macrophages is considered to be a key event driving adipose-tissue inflammation and insulin resistance, little is known about the roles of other immune-system cell-types in these processes.", "Adipose-tissue inflammation and both local and systemic metabolic indices were improved or worsened by global enrichment or impoverishment, respectively, of Tregs 2–4.", "Prolonged nutrient excess promotes the accumulation and activation of leukocytes in visceral adipose tissue (VAT) and ultimately other tissues, which provokes metabolic abnormalities such as insulin resistance, T2D and fatty-liver disease.", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "In analogy to the human context, we compared immunologic and metabolic parameters in obese (HFD-fed) Pparg wt and Treg-Pparg mut mice as a function of Pio co-treatment."]}
{"doc_id": 53003, "title": "", "abstract": ["We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Comparing the gene-expression profiles of visceral-fat and lymphoid- organ Tregs, we were struck by the elevated level of transcripts encoding the nuclear receptor PPARγ in the former (Fig. 1a, Suppl.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs."]}
{"doc_id": 53004, "title": "", "abstract": ["Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "Pio had differential effects on conventional adipose-tissue monocyte/macrophage populations in HFD- fed mutant mice: pro-inflammatory macrophages (CD11b+CD11c+F4/80+) were diminished, though not to the degree seen in wt littermates (Suppl.", "This process was PPARγ-dependent as the Pio-induced increase in CD36 expression and Nile red staining were both greatly dampened in Treg-Pparg mutant mice (Suppl.", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "Pio is a well-known insulin-sensitizing agent that improves metabolic indices in obese mice and humans."]}
{"doc_id": 53005, "title": "", "abstract": ["We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs.", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "Altogether, our data indicate that PPARγ may control both the establishment and maintenance of the VAT Treg phenotype."]}
{"doc_id": 53006, "title": "", "abstract": ["A newly discovered property was that VAT, but not lymphoid-tissue, Tregs can take up lipids, an intriguing adaptation to the tissular environment, not shared by conventional T cells residing at the same site.", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "The emerging notion that the Foxp3+CD4+ Treg compartment includes a number of sub-types with distinct phenotypes, localizations and effector functions 15 has evoked the exciting possibility of developing strategies to precisely expand or contract disease-relevant Tregs, leaving the bulk of the compartment intact to maintain immune homeostasis.", "VAT Tregs had a phenotype readily distinguishable from that of their counterparts in the spleen and lymph nodes (LNs), including a distinct gene-expression profile, T cell receptor repertoire, and pattern of chemokine and chemokine receptor expression.", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio."]}
{"doc_id": 53007, "title": "", "abstract": ["We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots."]}
{"doc_id": 53008, "title": "", "abstract": ["Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots.", "We directly evaluated the role of PPARγ in specifying the VAT Treg phenotype by retrovirally transducing Foxp3 alone or together with Pparg into naïve CD4+ T cells activated in vitro with anti-CD3/CD28-coated beads (neither transcription factor being expressed at detectable levels in the host CD4+ T cells)."]}
{"doc_id": 53009, "title": "", "abstract": ["Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "A unique population of Foxp3+CD4+ Tregs was recently found in the VAT of normal individuals 2, as a much higher fraction of the CD4+ T cell compartment than that usually observed in lymphoid or other non-lymphoid tissues.", "A newly discovered property was that VAT, but not lymphoid-tissue, Tregs can take up lipids, an intriguing adaptation to the tissular environment, not shared by conventional T cells residing at the same site.", "These findings suggest a previously unknown cellular mechanism for this important class of T2D drugs, and provide proof-of-principle that discrete populations of Tregs with unique functions can be precisely targeted to therapeutic ends.", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs."]}
{"doc_id": 53010, "title": "", "abstract": ["To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs.", "Feature-level analysis of Pparg transcripts, exploiting our existing Affymetrix ST 1.0 microarray data, revealed that mRNAs corresponding to both PPARγ1 and PPARγ2 were expressed by VAT Tregs, with predominance of the former (Suppl."]}
{"doc_id": 53011, "title": "", "abstract": ["To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "We directly evaluated the role of PPARγ in specifying the VAT Treg phenotype by retrovirally transducing Foxp3 alone or together with Pparg into naïve CD4+ T cells activated in vitro with anti-CD3/CD28-coated beads (neither transcription factor being expressed at detectable levels in the host CD4+ T cells).", "In vivo effects of abrogating PPARγ expression specifically in Tregs", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue."]}
{"doc_id": 53012, "title": "", "abstract": ["Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "It was initially assumed, given this transcription factor’s role in fat-cell differentiation, that TZD drugs improve metabolic parameters in obese individuals by activating PPARγ in adipocytes."]}
{"doc_id": 53013, "title": "", "abstract": ["Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features."]}
{"doc_id": 53014, "title": "", "abstract": ["Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "The striking increase in the representation of and alterations in the phenotype of VAT Tregs provoked by Pio treatment of obese mice raised the question of whether this population contributes to the insulin-sensitizing effect of Pio.", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "Feature-level analysis of Pparg transcripts, exploiting our existing Affymetrix ST 1.0 microarray data, revealed that mRNAs corresponding to both PPARγ1 and PPARγ2 were expressed by VAT Tregs, with predominance of the former (Suppl."]}
{"doc_id": 53015, "title": "", "abstract": ["Some genes involved in lipid metabolism are indicated.", "A newly discovered property was that VAT, but not lymphoid-tissue, Tregs can take up lipids, an intriguing adaptation to the tissular environment, not shared by conventional T cells residing at the same site.", "The most striking effect of this agonist, whether in the context of Pparg1 or Pparg2, was the augmentation of a set of “lipid metabolism” genes, some of which were reported to be differentially expressed in VAT vis-á-vis LN Tregs in a previous ex vivo microarray analysis 2.", "Up-regulated genes involved in lipid metabolism included those coding for: fatty-acid transporters (Cd36, Slc27a2), enzymes involved in fatty-acid synthesis (Lipe and Scd1), an enzyme essential for fatty-acid oxidation (Cpt1a), an enzyme responsible for the synthesis of triglycerides (Dgat1), and a lipid-droplet-associated protein (Plin2).", "VAT, but not spleen, Tregs readily took up lipids, especially in response to Pio (Fig. 4d)."]}
{"doc_id": 53016, "title": "", "abstract": ["Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features."]}
{"doc_id": 53017, "title": "", "abstract": ["Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots.", "The striking increase in the representation of and alterations in the phenotype of VAT Tregs provoked by Pio treatment of obese mice raised the question of whether this population contributes to the insulin-sensitizing effect of Pio.", "This process was PPARγ-dependent as the Pio-induced increase in CD36 expression and Nile red staining were both greatly dampened in Treg-Pparg mutant mice (Suppl."]}
{"doc_id": 53018, "title": "", "abstract": ["We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots.", "Altogether, our data indicate that PPARγ may control both the establishment and maintenance of the VAT Treg phenotype.", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements."]}
{"doc_id": 53019, "title": "", "abstract": ["Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "We directly evaluated the role of PPARγ in specifying the VAT Treg phenotype by retrovirally transducing Foxp3 alone or together with Pparg into naïve CD4+ T cells activated in vitro with anti-CD3/CD28-coated beads (neither transcription factor being expressed at detectable levels in the host CD4+ T cells).", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features."]}
{"doc_id": 91000, "title": "", "abstract": ["Modest alcohol intake was associated with lower stroke incidence and mortality, but the risk increased substantially with heavier drinking (that is, a J shaped relation).", "Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "For cardiovascular disease mortality and both end points for coronary heart disease, alcohol consumption was associated with lower risk, with relative risks of about 0.75 (table 2).", "Systematic reviews and meta-analyses have addressed the association of alcohol consumption with cardiovascular disease outcomes1 2 3 4 5 6 7 8 but have not uniformly addressed associations between alcohol use and mortality from cardiovascular disease, as well as the incidence and mortality from coronary heart disease and stroke."]}
{"doc_id": 91001, "title": "", "abstract": ["However, when the present results are coupled with those from our companion review paper summarising interventional mechanistic studies focusing on biomarkers associated with cardiovascular disease,110 the argument for causation becomes more compelling.", "### An argument for causation", "Therefore, we can now examine the argument for causation based on Hill’s criteria.111", "Given the consistency observed in our findings and compelling mechanistic data pointing to causation in our companion review, additional observational studies will have limited value except to elucidate more precisely the association of alcohol and stroke.116", "Clearly, observational studies cannot establish causation."]}
{"doc_id": 91002, "title": "", "abstract": ["For cardiovascular disease mortality as well as stroke incidence and mortality, the dose-response relations were less clear and more consistent with U or J shaped curves, suggesting an increased risk among drinkers of greater amounts of alcohol.", "Modest alcohol intake was associated with lower stroke incidence and mortality, but the risk increased substantially with heavier drinking (that is, a J shaped relation).", "Corrao et al reported a J shaped relation between alcohol intake and coronary heart disease,2 whereas the review by Maclure described this relation as L shaped because he did not observe an increase in coronary heart disease risk associated with higher alcohol consumption.6", "However, the association was J shaped, with the lowest risk for those consuming 2.5–14.9 g/day (relative risk 0.83 (0.80 to 0.86), 16 studies) and an elevated risk in those consuming >60 g/day (relative risk 1.30 (1.22 to 1.38), 8 studies).", "In an analysis of differences in associations by sex, any amount of alcohol consumption relative to none was associated with greater reduction in cardiovascular disease mortality, stroke incidence, and stroke mortality for women than men."]}
{"doc_id": 91003, "title": "", "abstract": ["From the extensive body of literature summarised here, the association between alcohol consumption and decreased cardiovascular risk is not in question, as additional research has not changed this conclusion.", "Systematic reviews and meta-analyses have addressed the association of alcohol consumption with cardiovascular disease outcomes1 2 3 4 5 6 7 8 but have not uniformly addressed associations between alcohol use and mortality from cardiovascular disease, as well as the incidence and mortality from coronary heart disease and stroke.", "Corrao et al reported a J shaped relation between alcohol intake and coronary heart disease,2 whereas the review by Maclure described this relation as L shaped because he did not observe an increase in coronary heart disease risk associated with higher alcohol consumption.6", "Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis", "All abstracts reporting on the association between alcohol intake and cardiovascular disease events were selected for full text review."]}
{"doc_id": 91004, "title": "", "abstract": ["Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "In support of implementation trials, our two papers show that alcohol consumption in moderation has reproducible and plausible effects on markers of coronary heart disease risk.", "Our updated meta-analysis supports the latter association for coronary heart disease, with a 25–35% risk reduction for light to moderate drinking106 that also is present with heavier drinking.", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol."]}
{"doc_id": 91005, "title": "", "abstract": ["Despite the latter concerns, results of our secondary analysis of overall mortality (fig 5) support the notion that moderate alcohol consumption is associated with net benefit, at least in populations similar to those studied in the extant literature.", "* The results confirm the beneficial effects of moderate alcohol consumption and the need to elucidate the underlying pathophysiological mechanisms", "From the extensive body of literature summarised here, the association between alcohol consumption and decreased cardiovascular risk is not in question, as additional research has not changed this conclusion.", "Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "In support of implementation trials, our two papers show that alcohol consumption in moderation has reproducible and plausible effects on markers of coronary heart disease risk."]}
{"doc_id": 91006, "title": "", "abstract": ["Inclusion criteria Prospective cohort studies on the association between alcohol consumption and overall mortality from cardiovascular disease, incidence of and mortality from coronary heart disease, and incidence of and mortality from stroke.", "Fig 7 Forest plot of mortality from all causes associated with alcohol consumption", "* This meta-analysis provides a summary of current knowledge regarding alcohol associations with six meaningful clinical end points—cardiovascular disease mortality, coronary heart disease incidence and mortality, stroke incidence and mortality, and all cause mortality", "Fig 2 Forest plot of mortality from cardiovascular disease associated with alcohol consumption", "Of the 84 studies addressing alcohol and cardiovascular disease events, 31 also examined the association of alcohol consumption with all cause mortality."]}
{"doc_id": 91007, "title": "", "abstract": ["Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "From the extensive body of literature summarised here, the association between alcohol consumption and decreased cardiovascular risk is not in question, as additional research has not changed this conclusion.", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "Our updated meta-analysis supports the latter association for coronary heart disease, with a 25–35% risk reduction for light to moderate drinking106 that also is present with heavier drinking."]}
{"doc_id": 91008, "title": "", "abstract": ["Modest alcohol intake was associated with lower stroke incidence and mortality, but the risk increased substantially with heavier drinking (that is, a J shaped relation).", "Our updated meta-analysis supports the latter association for coronary heart disease, with a 25–35% risk reduction for light to moderate drinking106 that also is present with heavier drinking.", "Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "From the extensive body of literature summarised here, the association between alcohol consumption and decreased cardiovascular risk is not in question, as additional research has not changed this conclusion.", "Firstly, the lower risk of coronary heart disease associated with alcohol consumption was at least as strong for women as for men."]}
{"doc_id": 91009, "title": "", "abstract": ["In support of implementation trials, our two papers show that alcohol consumption in moderation has reproducible and plausible effects on markers of coronary heart disease risk.", "Our updated meta-analysis supports the latter association for coronary heart disease, with a 25–35% risk reduction for light to moderate drinking106 that also is present with heavier drinking.", "Firstly, the lower risk of coronary heart disease associated with alcohol consumption was at least as strong for women as for men.", "Indeed, the mechanistic biomarker review shows biological plausibility for a causal association by showing favourable changes in pathophysiologically relevant molecules.", "Beyond the biological plausibility argument discussed above, there is an appropriate temporal relation with alcohol use preventing cardiovascular disease."]}
{"doc_id": 91010, "title": "", "abstract": ["Specifically, those who consumed >60 g/day were at a significantly increased risk of incident stroke compared with abstainers (relative risk 1.62 (1.32 to 1.98)).", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "Analyses of the dose of alcohol consumed showed that 2.5–14.9 g alcohol (about ≤1 drink) per day was protective for all five outcomes compared with no alcohol (table 2).", "For cardiovascular disease mortality as well as stroke incidence and mortality, the dose-response relations were less clear and more consistent with U or J shaped curves, suggesting an increased risk among drinkers of greater amounts of alcohol.", "Modest alcohol intake was associated with lower stroke incidence and mortality, but the risk increased substantially with heavier drinking (that is, a J shaped relation)."]}
{"doc_id": 91011, "title": "", "abstract": ["Possible cardioprotective effects of alcohol consumption seen in observational studies continue to be hotly debated in the medical literature and popular media.", "For example, injury risk probably disproportionately affects younger individuals, whereas cardiovascular disease mainly affects older adults.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "Robust studies that examine multiple outcomes simultaneously are needed to identify those subsets of the population in which reduced cardiovascular risk might dominate against those for whom the risks of social and medical problems (including several cancers and injury112 117) are too great.", "Using the pooled median number of years as the cut point, we found that studies with shorter follow-up reported a greater risk reduction for all outcomes except cardiovascular disease and coronary heart disease mortality (table 2)."]}
{"doc_id": 91012, "title": "", "abstract": ["A secondary analysis was performed within these selected studies to determine the association between alcohol consumption and the risk of death from all causes.", "Fig 7 Forest plot of mortality from all causes associated with alcohol consumption", "Because of the many biological effects of alcohol consumption, we also examine the association of alcohol with mortality from all causes when this is reported in studies.", "The pooled estimates from these studies showed a lower risk of all cause mortality for drinkers compared with non-drinkers (relative risk 0.87 (0.83 to 0.92)) (fig 7).", "Inclusion criteria Prospective cohort studies on the association between alcohol consumption and overall mortality from cardiovascular disease, incidence of and mortality from coronary heart disease, and incidence of and mortality from stroke."]}
{"doc_id": 91013, "title": "", "abstract": ["Where necessary, odds ratios were transformed into relative risks with this formula:", "* SElog(relative risk)=SElog(odds ratio)×log(relative risk)/log(odds ratio).", "Because these transformations can underestimate the variance of the relative risks derived from the odds ratios,14 15 we performed a sensitivity analysis that excluded four studies for which this transformation had been applied.", "The standard error of the resulting converted relative risk was then determined with this formula:", "* Relative risk=odds ratio/[(1–Po)+(Po×odds ratio)], in which Po is the incidence of the outcome of interest in the non-exposed group.13"]}
{"doc_id": 91014, "title": "", "abstract": ["Despite the latter concerns, results of our secondary analysis of overall mortality (fig 5) support the notion that moderate alcohol consumption is associated with net benefit, at least in populations similar to those studied in the extant literature.", "Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "With respect to public health messages, there may now be an impetus to better communicate to the public that alcohol, in moderation, may have overall health benefits that outweigh the risks in selected subsets of patients.", "Our updated meta-analysis supports the latter association for coronary heart disease, with a 25–35% risk reduction for light to moderate drinking106 that also is present with heavier drinking."]}
{"doc_id": 91015, "title": "", "abstract": ["Dose-response analysis revealed that the lowest risk of coronary heart disease mortality occurred with 1–2 drinks a day, but for stroke mortality it occurred with ≤1 drink per day.", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "For cardiovascular disease mortality and both end points for coronary heart disease, alcohol consumption was associated with lower risk, with relative risks of about 0.75 (table 2).", "Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis"]}
{"doc_id": 91016, "title": "", "abstract": ["Thirdly, when studies were summarised chronologically, we found that the overall association between drinking and cardiovascular disease and coronary heart disease became apparent at least a decade ago, and ongoing studies have done little to revise the estimated associations.", "All abstracts reporting on the association between alcohol intake and cardiovascular disease events were selected for full text review.", "Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis", "* Systematic reviews have addressed the association of alcohol consumption with various cardiovascular outcomes", "Secondly, inclusion of former drinkers did not seem to bias the association of alcohol consumption with cardiovascular disease."]}
{"doc_id": 91017, "title": "", "abstract": ["Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis", "* Systematic reviews have addressed the association of alcohol consumption with various cardiovascular outcomes", "Our two systematic review papers summarise a surprisingly extensive body of literature on the relation between alcohol and cardiovascular disease.", "With respect to public health messages, there may now be an impetus to better communicate to the public that alcohol, in moderation, may have overall health benefits that outweigh the risks in selected subsets of patients.", "Systematic reviews and meta-analyses have addressed the association of alcohol consumption with cardiovascular disease outcomes1 2 3 4 5 6 7 8 but have not uniformly addressed associations between alcohol use and mortality from cardiovascular disease, as well as the incidence and mortality from coronary heart disease and stroke."]}
{"doc_id": 91018, "title": "", "abstract": ["Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112", "Possible cardioprotective effects of alcohol consumption seen in observational studies continue to be hotly debated in the medical literature and popular media.", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "Secondly, inclusion of former drinkers did not seem to bias the association of alcohol consumption with cardiovascular disease.", "Systematic reviews and meta-analyses have addressed the association of alcohol consumption with cardiovascular disease outcomes1 2 3 4 5 6 7 8 but have not uniformly addressed associations between alcohol use and mortality from cardiovascular disease, as well as the incidence and mortality from coronary heart disease and stroke."]}
{"doc_id": 91019, "title": "", "abstract": ["Hazard ratios and incidence density ratios were directly considered as relative risks.", "The results of our meta-analysis should be interpreted in context of the limitations of available data.", "* Relative risk=odds ratio/[(1–Po)+(Po×odds ratio)], in which Po is the incidence of the outcome of interest in the non-exposed group.13", "In cumulative meta-analyses of cardiovascular disease and coronary heart disease outcomes (appendix figs 1–3 on bmj.com), there was little variation in the relative risk associated with alcohol consumption on cardiovascular disease mortality or incident coronary heart disease with addition of new studies after 1999; for coronary heart disease mortality, this plateau in incremental change from new studies occurred as early as 1992–3.", "We performed a systematic review and meta-analysis following a predetermined protocol in accordance with the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines.9"]}
{"doc_id": 83000, "title": "", "abstract": ["An imbalance in intestinal microbial ecology, in which SFB is dominant, may result in reduced proportions or functions of anti-inflammatory regulatory T cells (Treg) and a predisposition towards autoimmunity.", "Thus, T cells whose functions are dictated by intestinal commensal bacteria can be effectors of pathogenesis in tissue-specific autoimmune disease.", "Moreover, an imbalance in the composition of the gut microbiota can alter local T-cell responses and modulate systemic inflammation.", "Although a role for the gut microbiota has been clearly established in animal models of arthritis, it is not known if dysbiosis influences human RA.", "Among environmental factors, the intestinal microbiota has emerged as a possible candidate responsible for the priming of aberrant systemic immunity in RA (Scher and Abramson, 2011)."]}
{"doc_id": 83001, "title": "", "abstract": ["Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA.", "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis", "Thus, T cells whose functions are dictated by intestinal commensal bacteria can be effectors of pathogenesis in tissue-specific autoimmune disease.", "In our cohort, we found the microbiota of many subjects to be defined by a single taxon—P. copri—which was associated with the majority of untreated, new-onset rheumatoid arthritis (NORA) patients.", "Upon mono-colonization of arthritis-prone K/BxN mice with SFB, the induced Th17 cells potentiate inflammatory disease (Wu et al., 2010)."]}
{"doc_id": 83002, "title": "", "abstract": ["While treatment with antibiotics has been a therapeutic modality in RA for decades, no microbial organism has been shown to be associated with the disease.", "Although recent studies of the human microbiome (Arumugam et al., 2011; Human Microbiome Project Consortium, 2012) have characterized the composition and diversity of the healthy gut microbiome, and disease-associated studies revealed correlations between taxonomic abundance and some clinical phenotypes (Frank et al., 2011; Morgan et al., 2012; Qin et al., 2012), a role for distinct microbial taxa and metagenomic markers in systemic inflammatory disease has not been defined.", "Multiple mucosal sites and their residing microbial communities have been implicated, including the airways, the periodontal tissue and the intestinal lamina propria (Mcinnes and Schett, 2011; Scher et al., 2012).", "Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA.", "Consistent with recently published mouse data (Gomez et al., 2012), the presence of SE alleles correlated with the composition of the gut microbiota."]}
{"doc_id": 83003, "title": "", "abstract": ["We identified the presence of Prevotella copri as strongly correlated with disease in new-onset untreated rheumatoid arthritis (NORA) patients.", "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis", "A bacterial species called Prevotella copri was more abundant in patients suffering from untreated rheumatoid arthritis than in healthy individuals.", "This observation suggested that the presence or absence of particular genes in these strains might correlate with health or disease phenotypes in this cohort.", "We also identified unique Prevotella genes that correlated with disease."]}
{"doc_id": 83004, "title": "", "abstract": ["Arthritis-susceptible DRB1*04:01 transgenic mice had a markedly different intestinal microbiota when compared to arthritis-resistant DRB1*04:02 animals, and this was associated with altered mucosal immune function (i.e., increased gene transcripts for Th17-related cytokines) and increased intestinal permeability.", "Thus, T cells whose functions are dictated by intestinal commensal bacteria can be effectors of pathogenesis in tissue-specific autoimmune disease.", "Animal models suggest a role for intestinal bacteria in supporting the systemic immune response required for joint inflammation.", "A recently published study with HLA-DR transgenic mice revealed that the gut microbiota was, at least partially, regulated by the HLA genes (Gomez et al., 2012).", "However, the introduction of specific gut bacterial species is sufficient to induce joint inflammation (Rath et al., 1996; Abdollahi-Roodsaz et al., 2008; Wu et al., 2010), and antibiotic treatment both prevents and abrogates a rheumatoid arthritis-like phenotype in several mouse models."]}
{"doc_id": 83005, "title": "", "abstract": ["Scher, , et al., 2013, Intestinal microbiota of patients with arthritis, ; http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA203810, Publicly available at the NCBI BioProject database (http://www.ncbi.nlm.nih.gov/bioproject).", "Here, Scher et al. used genome sequencing to compare gut bacteria from patients with rheumatoid arthritis and healthy controls.", "However, by highlighting the role played by gut bacteria, the work of Scher et al. suggests that novel treatment options focused on curbing the spread of P. copri in the gut could delay or prevent the onset of this disease.", "Among environmental factors, the intestinal microbiota has emerged as a possible candidate responsible for the priming of aberrant systemic immunity in RA (Scher and Abramson, 2011).", "Rheumatoid arthritis (RA) is a highly prevalent systemic autoimmune disease with predilection for the joints."]}
{"doc_id": 83006, "title": "", "abstract": ["Failure of this process may increase the risk of autoimmune diseases in which the body mistakenly attacks its own cells and tissues.", "Figure 1.", "#### Supplementary file 1.", "Current treatments for rheumatoid arthritis target symptoms.", "CRP is characteristically high in early and flaring RA, but not in other autoimmune diseases (e.g., systemic lupus erythematous, scleroderma, and PsA)."]}
{"doc_id": 83007, "title": "", "abstract": ["Many genetic susceptibility risk alleles have been discovered and validated (Stahl et al., 2010) but are insufficient to explain disease incidence.", "For example, uniquely present superoxide reductase in P. copri may facilitate resistance to or allow the use of host-derived reactive oxygen species (ROS) generated during inflammation, perhaps as terminal electron acceptors for respiration (Winter et al., 2013).", "Although PsA patients revealed a reduction in sample diversity similar to that of IBD patients (Morgan et al., 2012), diversity was comparable between NORA, CRA and healthy groups at 3.02 +/− 0.66 (mean, SD) overall by Shannon Diversity Index (Figure 1—figure supplement 1A).", "Notably, there is a prolonged period of autoimmunity (i.e., presence of circulating auto-antibodies such as rheumatoid factor and anti-citrullinated peptide antibodies) in a pre-clinical state that lasts many years, during which time there is no clinical or histologic evidence of inflammatory arthritis (Deane et al., 2010).", "In our cohort, we found the microbiota of many subjects to be defined by a single taxon—P. copri—which was associated with the majority of untreated, new-onset rheumatoid arthritis (NORA) patients."]}
{"doc_id": 83008, "title": "", "abstract": ["Thus, T cells whose functions are dictated by intestinal commensal bacteria can be effectors of pathogenesis in tissue-specific autoimmune disease.", "Furthermore, in contrast to mice colonized with mouse commensal Bacteroides thetaiotamicron (Figure 6—figure supplement 1A), P. copri colonized mice similarly showed significantly decreased weight loss at day 7 following DSS exposure (Figure 6—figure supplement 1B).", "Before the onset of clinical disease, there is an increase in autoantibody titers and epitope spreading coupled with elevation in circulating pro-inflammatory cytokines.", "Mice rendered deficient for the microbiota (germ-free) lack pro- inflammatory Th17 cells, and colonization of the gastrointestinal tract with segmented filamentous bacteria (SFB), a commensal microbe commonly found in mammals, is sufficient to induce accumulation of Th17 cells in the lamina propria (Ivanov et al., 2009; Sczesnak et al., 2011).", "Colonization of mice with P. copri recapitulated the differences in relative abundances of Prevotella and Bacteroides previously reported in humans, and confirmed the ability of P. copri to dominate the colonic commensal microbiota in the absence of apparent disease (Faust et al., 2012)."]}
{"doc_id": 83009, "title": "", "abstract": ["We identified the presence of Prevotella copri as strongly correlated with disease in new-onset untreated rheumatoid arthritis (NORA) patients.", "Prevotella was found to be over-represented in NORA patients, while Bacteroides was over-represented in all other groups.", "The human gut microbiota has been classified into unique enterotypes, one of which is defined by the predominance of Prevotella (Arumugam et al., 2011).", "We found a marked association of Prevotella copri with new-onset RA (NORA) patients and not with other patient groups.", "These data suggest that a Prevotella-defined microbiome may have the propensity to support inflammation in the context of a genetically susceptible host."]}
{"doc_id": 83010, "title": "", "abstract": ["Mice rendered deficient for the microbiota (germ-free) lack pro- inflammatory Th17 cells, and colonization of the gastrointestinal tract with segmented filamentous bacteria (SFB), a commensal microbe commonly found in mammals, is sufficient to induce accumulation of Th17 cells in the lamina propria (Ivanov et al., 2009; Sczesnak et al., 2011).", "An imbalance in intestinal microbial ecology, in which SFB is dominant, may result in reduced proportions or functions of anti-inflammatory regulatory T cells (Treg) and a predisposition towards autoimmunity.", "Arthritis-susceptible DRB1*04:01 transgenic mice had a markedly different intestinal microbiota when compared to arthritis-resistant DRB1*04:02 animals, and this was associated with altered mucosal immune function (i.e., increased gene transcripts for Th17-related cytokines) and increased intestinal permeability.", "Moreover, an imbalance in the composition of the gut microbiota can alter local T-cell responses and modulate systemic inflammation.", "Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA."]}
{"doc_id": 83011, "title": "", "abstract": ["We used 16S ribosomal RNA gene sequencing to classify the microbiota in patients with new-onset (untreated) RA, chronic (treated) RA, psoriatic arthritis, and age- and ethnicity-matched healthy controls.", "To determine if particular bacterial clades are associated with rheumatoid arthritis, we performed sequencing of the 16S gene (regions V1–V2, 454 platform) on 114 fecal DNA samples—44 samples collected from NORA patients at time of initial diagnosis and prior to immunosuppressive treatment, 26 samples from patients with chronic, treated rheumatoid arthritis (CRA), 16 samples from patients with psoriatic arthritis (PsA), and 28 samples from healthy controls (HLT) (Table 1).", "Sequencing of the 16S gene (regions V1–V2, 454 platform) in fecal DNA from two representative mice colonized with P. copri revealed the ability of Prevotella to dominate the gut microbiota (Figure 6B).", "Here we performed 16S sequencing on 114 stool samples from rheumatoid arthritis patients and controls, and shotgun sequencing on a subset of 44 such samples.", "Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA."]}
{"doc_id": 83012, "title": "", "abstract": ["Although recent studies of the human microbiome (Arumugam et al., 2011; Human Microbiome Project Consortium, 2012) have characterized the composition and diversity of the healthy gut microbiome, and disease-associated studies revealed correlations between taxonomic abundance and some clinical phenotypes (Frank et al., 2011; Morgan et al., 2012; Qin et al., 2012), a role for distinct microbial taxa and metagenomic markers in systemic inflammatory disease has not been defined.", "Moreover, an imbalance in the composition of the gut microbiota can alter local T-cell responses and modulate systemic inflammation.", "Moreover, the presence of P. copri corresponded to a reduction in the abundance of other bacterial groups—including a number of beneficial microbes.", "These data suggest that a Prevotella-defined microbiome may have the propensity to support inflammation in the context of a genetically susceptible host.", "One hypothesis is that the Prevotella-defined microbiota fail to thrive when there is less inflammation, perhaps due to a lack of inflammation-derived terminal electron acceptors, as seen for E. coli in inflammatory bowel disease (Winter et al., 2013)."]}
{"doc_id": 83013, "title": "", "abstract": ["Arthritis-susceptible DRB1*04:01 transgenic mice had a markedly different intestinal microbiota when compared to arthritis-resistant DRB1*04:02 animals, and this was associated with altered mucosal immune function (i.e., increased gene transcripts for Th17-related cytokines) and increased intestinal permeability.", "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis", "However, the introduction of specific gut bacterial species is sufficient to induce joint inflammation (Rath et al., 1996; Abdollahi-Roodsaz et al., 2008; Wu et al., 2010), and antibiotic treatment both prevents and abrogates a rheumatoid arthritis-like phenotype in several mouse models.", "Multiple mucosal sites and their residing microbial communities have been implicated, including the airways, the periodontal tissue and the intestinal lamina propria (Mcinnes and Schett, 2011; Scher et al., 2012).", "Scher, , et al., 2013, Intestinal microbiota of patients with arthritis, ; http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA203810, Publicly available at the NCBI BioProject database (http://www.ncbi.nlm.nih.gov/bioproject)."]}
{"doc_id": 83014, "title": "", "abstract": ["These data suggest that a Prevotella-defined microbiome may have the propensity to support inflammation in the context of a genetically susceptible host.", "Interestingly, Prevotella- dominated healthy omnivore individuals were recently reported to have increased basal levels of serum TMAO (trimethylamine N-oxide), a product of inflammation linked to atherogenesis, compared to Bacteroides-dominated healthy individuals (Koeth et al., 2013).", "At the level of family abundances, however, we noted a significant enrichment of Prevotellaceae in NORA subjects (Figure 1A, Figure 1—figure supplement 1D).", "A bacterial species called Prevotella copri was more abundant in patients suffering from untreated rheumatoid arthritis than in healthy individuals.", "Subjects with an abundance of Prevotella greater than 10% were colored red."]}
{"doc_id": 83015, "title": "", "abstract": ["To determine if particular bacterial clades are associated with rheumatoid arthritis, we performed sequencing of the 16S gene (regions V1–V2, 454 platform) on 114 fecal DNA samples—44 samples collected from NORA patients at time of initial diagnosis and prior to immunosuppressive treatment, 26 samples from patients with chronic, treated rheumatoid arthritis (CRA), 16 samples from patients with psoriatic arthritis (PsA), and 28 samples from healthy controls (HLT) (Table 1).", "While treatment with antibiotics has been a therapeutic modality in RA for decades, no microbial organism has been shown to be associated with the disease.", "However, by highlighting the role played by gut bacteria, the work of Scher et al. suggests that novel treatment options focused on curbing the spread of P. copri in the gut could delay or prevent the onset of this disease.", "Multiple mucosal sites and their residing microbial communities have been implicated, including the airways, the periodontal tissue and the intestinal lamina propria (Mcinnes and Schett, 2011; Scher et al., 2012).", "Analysis of DNA extracted from fecal samples 2 weeks post-gavage revealed robust colonization with P. copri (Figure 6A)."]}
{"doc_id": 83016, "title": "", "abstract": ["Alternatively, the gut microbiota changes observed in newly diagnosed RA patients may be the consequence of a unique, NORA-specific systemic inflammatory response.", "Moreover, an imbalance in the composition of the gut microbiota can alter local T-cell responses and modulate systemic inflammation.", "Our results suggest that, similarly, SE risk-alleles in humans may have an impact on the composition of the gut microbiota.", "Consistent with recently published mouse data (Gomez et al., 2012), the presence of SE alleles correlated with the composition of the gut microbiota.", "Although recent studies of the human microbiome (Arumugam et al., 2011; Human Microbiome Project Consortium, 2012) have characterized the composition and diversity of the healthy gut microbiome, and disease-associated studies revealed correlations between taxonomic abundance and some clinical phenotypes (Frank et al., 2011; Morgan et al., 2012; Qin et al., 2012), a role for distinct microbial taxa and metagenomic markers in systemic inflammatory disease has not been defined."]}
{"doc_id": 67000, "title": "", "abstract": ["Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "We also examined the link between diet-induced hedonic dysregulation and the emergence of compulsive food seeking.", "Moreover, Hoebel and colleagues have also shown that repeatedly force-feeding rats through intra-gastric tube until their weight had increased by ~200 g similarly decreased rates of responding for BSR stimulation, an effect that persisted until body weight had normalized; described in Ref.23.", "Similar reward dysfunction to that reported here in obese rats is also detected in rats with a history of extended but not restricted access to intravenous cocaine or heroin self-administration 12–14.", "Animals were trained to respond for BSR stimulation according to a discrete- trial current-threshold procedure similar to that described in detail elsewhere 10, 14."]}
{"doc_id": 67001, "title": "", "abstract": ["Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior.", "Accordingly, we detected compulsive-like feeding behavior in obese but not lean rats, measured as palatable food consumption that was resistant to disruption by an aversive conditioned stimulus.", "Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors", "These data demonstrate that knockdown of striatal D2R dramatically accelerates the emergence of compulsive-like eating of palatable food, but only in rats with a prior history of extended access.", "These maladaptive behavioral responses in obese rats likely arise from diet-induced deficits in striatal D2R signaling."]}
{"doc_id": 67002, "title": "", "abstract": ["It has been unclear if such reward hyposensitivity in obese individuals is manifested before the development of obesity and related solely to genetic factors (“reward deficiency syndrome”) or if overeating can cause disruption in reward processing.", "Based on these and similar observations it has been proposed that deficits in reward processing may be an important risk factor for the development of obesity, and that obese individuals may compulsively consume palatable food to compensate for reward hyposensitivity 6.", "Our data demonstrate that extended access to palatable high-energy food and subsequent overeating blunts reward sensitivity and may therefore represent an important hedonic mechanism that promotes the development of obesity.", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "These data demonstrate that overconsumption of palatable food triggers addiction- like neuroadaptive responses in brain reward circuitries and drives the development of compulsive eating."]}
{"doc_id": 67003, "title": "", "abstract": ["It was shown recently that activation of the striatum is blunted in obese individuals when compared with lean controls in response to highly palatable food 4.", "Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors", "Such a scenario is also consistent with data from human brain imaging studies in which blunted activation of the striatum in response to highly palatable food, particularly in individuals with genetic polymorphisms thought to decrease striatal D2R expression, is associated with long-term weight gain 4.", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts."]}
{"doc_id": 67004, "title": "", "abstract": ["Common hedonic mechanisms may therefore underlie obesity and drug addiction.", "Thus, our data suggest that obesity and drug addiction may share common underlying hedonic mechanisms.", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "Our data demonstrate that extended access to palatable high-energy food and subsequent overeating blunts reward sensitivity and may therefore represent an important hedonic mechanism that promotes the development of obesity.", "Nevertheless, hedonic mechanisms contributing to obesity remain poorly understood."]}
{"doc_id": 67005, "title": "", "abstract": ["Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4.", "Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior.", "Reward deficits in overweight rats may reflect counteradaptive decreases in the baseline sensitivity of brain reward circuitries to oppose their overstimulation by palatable food.", "Based on these and similar observations it has been proposed that deficits in reward processing may be an important risk factor for the development of obesity, and that obese individuals may compulsively consume palatable food to compensate for reward hyposensitivity 6.", "Our data demonstrate that extended access to palatable high-energy food and subsequent overeating blunts reward sensitivity and may therefore represent an important hedonic mechanism that promotes the development of obesity."]}
{"doc_id": 67006, "title": "", "abstract": ["Thus, our data suggest that obesity and drug addiction may share common underlying hedonic mechanisms.", "Common hedonic mechanisms may therefore underlie obesity and drug addiction.", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior.", "Loss of inhibitory control over behavior that can have a negative outcome is a characteristic feature of both obesity and drug addiction, in which consummatory behaviors persist despite negative social, health or financial consequences."]}
{"doc_id": 67007, "title": "", "abstract": ["Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Moreover, lentivirus-mediated knockdown of striatal D2R rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food.", "This suggests that the chow-only and restricted access rats binged on the palatable food during the intermittent 30 min access sessions, reflected in the fact that these rats consumed ~40–50% of their daily caloric intake, typically ~100 kCal, during the 30 min access sessions (Fig. 7a, b).", "Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior.", "Thus, extended access to palatable high-fat food can induce addiction- like deficits in brain reward function, considered an important source of motivation that may drive overeating and contribute to the development of obesity 1, 6."]}
{"doc_id": 67008, "title": "", "abstract": ["It has been unclear if such reward hyposensitivity in obese individuals is manifested before the development of obesity and related solely to genetic factors (“reward deficiency syndrome”) or if overeating can cause disruption in reward processing.", "Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "### Addiction-like reward deficits in obese rats", "Based on these and similar observations it has been proposed that deficits in reward processing may be an important risk factor for the development of obesity, and that obese individuals may compulsively consume palatable food to compensate for reward hyposensitivity 6."]}
{"doc_id": 67009, "title": "", "abstract": ["This effect on BSR thresholds can be explained by gradually decreasing responsiveness of brain reward circuitries, an interpretation consistent with the fact that food restriction and weight loss can increase 20, whereas acute overfeeding can transiently decrease 21, responding for BSR stimulation in rats.", "In summary, we have shown that over-stimulation of brain reward systems through excessive consumption of palatable energy-dense food induces a profound state of reward hyposensitivity and the development of compulsive- like eating.", "In hyperphagic human patients with congenital leptin deficiency, activity in the dorsal and ventral striatum, core components of brain reward circuitries, is markedly increased in response to images of food 3, and leptin replacement therapy attenuates both striatal activity and self-reported “liking” of food 3.", "Sensitivity of reward-related neurons in this area is increased in food restriction in a manner sensitive to the fat-derived hormone leptin, and this brain region is considered an important substrate for food reward 27.", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4."]}
{"doc_id": 67010, "title": "", "abstract": ["We next tested the hypothesis that compulsive-like eating may emerge in rats with extended access to the cafeteria diet and that deficits in striatal D2R signaling may contribute to this effect.", "Consistent with a role for striatal D2Rs in this effect, compulsive-like eating was detected in the striatal D2R knockdown rats that previously had 14 days extended access to the cafeteria diet but not in the control groups of rats.", "These data demonstrate that knockdown of striatal D2R dramatically accelerates the emergence of compulsive-like eating of palatable food, but only in rats with a prior history of extended access.", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Moreover, lentivirus-mediated knockdown of striatal D2R rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food."]}
{"doc_id": 67011, "title": "", "abstract": ["Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Thus, extended access to palatable high-fat food can induce addiction- like deficits in brain reward function, considered an important source of motivation that may drive overeating and contribute to the development of obesity 1, 6.", "Reductions in striatal D2R density occurring either through constitutive genetic factors or as a consequence of overeating may therefore play a role in the neurobiological mechanisms of obesity.", "Such diet-induced reward hypofunctionality may have a pathophysiological role in the development of obesity by increasing the motivation to consume high-reward “obesogenic” diets to avoid or alleviate this state of negative reward 6."]}
{"doc_id": 67012, "title": "", "abstract": ["### Reduced striatal D2R levels in obese rats: Role in brain reward deficits", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4.", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Indeed, deficits in striatal D2R density in obese individuals is correlated with reduced metabolism in prefrontal and orbitofrontal cortical areas 42, brain regions that exert inhibitory control over behavior 43.", "Knockdown of striatal D2R increases vulnerability to reward dysfunction in rats with extended access to a cafeteria diet"]}
{"doc_id": 67013, "title": "", "abstract": ["Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Indeed, deficits in striatal D2R density in obese individuals is correlated with reduced metabolism in prefrontal and orbitofrontal cortical areas 42, brain regions that exert inhibitory control over behavior 43.", "Reductions in striatal D2R density occurring either through constitutive genetic factors or as a consequence of overeating may therefore play a role in the neurobiological mechanisms of obesity.", "These maladaptive behavioral responses in obese rats likely arise from diet-induced deficits in striatal D2R signaling.", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4."]}
{"doc_id": 67014, "title": "", "abstract": ["Indeed, deficits in striatal D2R density in obese individuals is correlated with reduced metabolism in prefrontal and orbitofrontal cortical areas 42, brain regions that exert inhibitory control over behavior 43.", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors", "### Compulsive eating in obese rats: Role for striatal D2R", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4."]}
{"doc_id": 67015, "title": "", "abstract": ["In summary, we have shown that over-stimulation of brain reward systems through excessive consumption of palatable energy-dense food induces a profound state of reward hyposensitivity and the development of compulsive- like eating.", "Our data demonstrate that extended access to palatable high-energy food and subsequent overeating blunts reward sensitivity and may therefore represent an important hedonic mechanism that promotes the development of obesity.", "Similar to these findings in rats, responding for lateral hypothalamic BSR was inhibited by prior feeding of cats to satiation 26, demonstrating that interactions between brain reward function and metabolic state is highly-conserved and likely to also occur in humans.", "In contrast, restricted access to palatable food gives rise to binge-like patterns of consumption, but does not disrupt homeostatic levels of energy balance nor brain reward function.", "Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior."]}
{"doc_id": 67016, "title": "", "abstract": ["Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4.", "Moreover, lentivirus-mediated knockdown of striatal D2R rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food.", "This suggests that reduced striatal D2R expression alone is not sufficient to induce reward hyposensitivity, but instead seems to interact with overconsumption of palatable food to accelerate the emergence of this state of negative reward.", "Knockdown of striatal D2R therefore increases vulnerability to diet-induced reward hypofunctionality but does not alter the baseline activity of brain reward systems.", "Knockdown of striatal D2R increases vulnerability to reward dysfunction in rats with extended access to a cafeteria diet"]}
{"doc_id": 67017, "title": "", "abstract": ["Loss of inhibitory control over behavior that can have a negative outcome is a characteristic feature of both obesity and drug addiction, in which consummatory behaviors persist despite negative social, health or financial consequences.", "These data demonstrate that knockdown of striatal D2R dramatically accelerates the emergence of compulsive-like eating of palatable food, but only in rats with a prior history of extended access.", "By targeting predominately the dorsolateral striatum we may have impacted populations of D2Rs that regulate vulnerability to develop compulsive-like consummatory behaviors.", "In keeping with a role for striatal D2Rs in compulsive behaviors, the human TaqIA allele of the D2R gene locus that results in deficits in striatal D2R density 5, blunted striatal activation in response to palatable food 4, and increased vulnerability to obesity 4, is also associated with deficits in learning to avoid actions with negative consequences 40.", "Moreover, lentivirus-mediated knockdown of striatal D2R rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food."]}
{"doc_id": 67018, "title": "", "abstract": ["Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Indeed, reductions in striatal D2R density are seen in overweight individuals 4, 33, and rodents 34, 35.", "Reductions in striatal D2R density occurring either through constitutive genetic factors or as a consequence of overeating may therefore play a role in the neurobiological mechanisms of obesity.", "Indeed, deficits in striatal D2R density in obese individuals is correlated with reduced metabolism in prefrontal and orbitofrontal cortical areas 42, brain regions that exert inhibitory control over behavior 43.", "### Reduced striatal D2R levels in obese rats: Role in brain reward deficits"]}
{"doc_id": 67019, "title": "", "abstract": ["Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "The development of obesity in extended access rats was closely associated with a worsening deficit in brain reward function, reflected in progressively elevated BSR thresholds (Fig. 1b).", "Whatever the underlying mechanisms, our findings demonstrate that addiction-like compulsive responding for palatable food can emerge in obese rats, and suggest that deficits in striatal D2R signaling increases vulnerability to develop this behavior.", "These maladaptive behavioral responses in obese rats likely arise from diet-induced deficits in striatal D2R signaling.", "Addiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors"]}
{"doc_id": 15000, "title": "", "abstract": ["A total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo).", "Of the 1114 patients who were assessed for eligibility, 1062 underwent randomization; 541 were assigned to the remdesivir group and 521 to the placebo group (intention-to-treat population) (Figure 1); 159 (15.0%) were categorized as having mild-to-moderate disease, and 903 (85.0%) were in the severe disease stratum.", "The as-treated population included 1048 patients who received the assigned treatment (532 in the remdesivir group, including one patient who had been randomly assigned to placebo and received remdesivir, and 516 in the placebo group).", "Patients were randomly assigned to receive either remdesivir (200 mg loading dose on day 1, followed by 100 mg daily for up to 9 additional days) or placebo for up to 10 days.", "A total of 517 patients in the remdesivir group and 508 in the placebo group completed the trial through day 29, recovered, or died."]}
{"doc_id": 15001, "title": "", "abstract": ["# Remdesivir for the Treatment of Covid-19 — Final Report", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious."]}
{"doc_id": 15002, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our data also suggest that treatment with remdesivir may have prevented the progression to more severe respiratory disease, as shown by the lower proportion of serious adverse events due to respiratory failure among patients in the remdesivir group, as well as a lower incidence of new oxygen use among patients who were not receiving oxygen at enrollment and a lower proportion of patients needing higher levels of respiratory support during the study.", "Cumulatively, these findings suggest that treatment with remdesivir may not only reduce the disease burden but may also decrease the use of scarce health care resources during this pandemic.", "Sensitivity analyses in which data were censored at earliest reported use of glucocorticoids or hydroxychloroquine still showed efficacy of remdesivir (9.0 days to recovery with remdesivir vs. 14.0 days to recovery with placebo; rate ratio, 1.28; 95% CI, 1.09 to 1.50, and 10.0 vs. 16.0 days to recovery; rate ratio, 1.32; 95% CI, 1.11 to 1.58, respectively) (Table S8).", "However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient for all patients."]}
{"doc_id": 15003, "title": "", "abstract": ["Remdesivir has also received full or conditional approval in several other countries since that time.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Of the 1114 patients who were assessed for eligibility, 1062 underwent randomization; 541 were assigned to the remdesivir group and 521 to the placebo group (intention-to-treat population) (Figure 1); 159 (15.0%) were categorized as having mild-to-moderate disease, and 903 (85.0%) were in the severe disease stratum.", "A variety of therapeutic approaches including novel antivirals, modifiers of the immune response or other intrinsic pathways, and combination approaches are needed to continue to improve outcomes in patients with Covid-19."]}
{"doc_id": 15004, "title": "", "abstract": ["# Remdesivir for the Treatment of Covid-19 — Final Report", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19."]}
{"doc_id": 15005, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02)."]}
{"doc_id": 15006, "title": "", "abstract": ["The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient for all patients.", "Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.", "(See the protocol for more information about the trial methods.) To assess the effect of disease severity on treatment benefit (recovery and mortality), post hoc analyses evaluated interactions of efficacy with baseline ordinal score (as a continuous variable)."]}
{"doc_id": 15007, "title": "", "abstract": ["In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection."]}
{"doc_id": 15008, "title": "", "abstract": ["Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Patients in the remdesivir group had a shorter time to improvement of one or of two categories on the ordinal scale from baseline than patients in the placebo group (one-category improvement: median, 7 vs. 9 days; rate ratio for recovery, 1.23; 95% CI, 1.08 to 1.41; two-category improvement: median, 11 vs. 14 days; rate ratio, 1.29; 95% CI, 1.12 to 1.48) (Table 3).", "Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).", "Patients in the remdesivir group had a shorter time to discharge or to a National Early Warning Score of 2 or lower than those in the placebo group (median, 8 days vs. 12 days; hazard ratio, 1.27; 95% CI, 1.10 to 1.46)."]}
{"doc_id": 15009, "title": "", "abstract": ["The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "Among the 573 patients who were not receiving noninvasive ventilation, high- flow oxygen, invasive ventilation, or ECMO at baseline, the incidence of new noninvasive ventilation or high-flow oxygen use was lower in the remdesivir group than in the placebo group (17% [95% CI, 13 to 22] vs. 24% [95% CI, 19 to 30]).", "For the 193 patients receiving noninvasive ventilation or high-flow oxygen at enrollment, the median duration of use of these interventions was 6 days in both the remdesivir and placebo groups.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02)."]}
{"doc_id": 15010, "title": "", "abstract": ["In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Given the preliminary results about remdesivir, the Food and Drug Administration issued an Emergency Use Authorization on May 1, 2020 (modified on August 28, 2020), to permit the use of remdesivir for treatment in adults and children hospitalized with suspected or laboratory-confirmed Covid-19."]}
{"doc_id": 15011, "title": "", "abstract": ["Other secondary outcomes included the time to improvement of one category and of two categories from the baseline ordinal score; clinical status as assessed on the ordinal scale at days 3, 5, 8, 11, 15, 22, and 29; mean change in status on the ordinal scale from day 1 to days 3, 5, 8, 11, 15, 22, and 29; time to discharge or National Early Warning Score of 2 or less (maintained for 24 hours), whichever occurred first; change in the National Early Warning Score from day 1 to days 3, 5, 8, 11, 15, 22, and 29; number of days with supplemental oxygen, with noninvasive ventilation or high-flow oxygen, and with invasive ventilation or ECMO up to day 29 (if these were being used at baseline); the incidence and duration of new oxygen use, of noninvasive ventilation or high-flow oxygen, and of invasive ventilation or ECMO; number of days of hospitalization up to day 29; and mortality at 14 and 28 days after enrollment.", "Secondary safety outcome measures included grade 3 and 4 adverse events and serious adverse events that occurred during the trial, discontinuation or temporary suspension of infusions, and changes in assessed laboratory values over time.", "The primary outcome of the current trial was changed early in the trial, from a comparison of the eight-category ordinal scale scores on day 15 to a comparison of time to recovery up to day 29.", "The primary outcome was the time to recovery, defined by either discharge from the hospital or hospitalization for infection-control purposes only.", "(See the protocol for more information about the trial methods.) To assess the effect of disease severity on treatment benefit (recovery and mortality), post hoc analyses evaluated interactions of efficacy with baseline ordinal score (as a continuous variable)."]}
{"doc_id": 15012, "title": "", "abstract": ["A variety of therapeutic approaches including novel antivirals, modifiers of the immune response or other intrinsic pathways, and combination approaches are needed to continue to improve outcomes in patients with Covid-19.", "Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.", "A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), was first identified in December 2019 as the cause of a respiratory illness designated coronavirus disease 2019, or Covid-19.1", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3"]}
{"doc_id": 15013, "title": "", "abstract": ["Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "A variety of therapeutic approaches including novel antivirals, modifiers of the immune response or other intrinsic pathways, and combination approaches are needed to continue to improve outcomes in patients with Covid-19.", "Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.", "# Remdesivir for the Treatment of Covid-19 — Final Report"]}
{"doc_id": 15014, "title": "", "abstract": ["Secondary safety outcome measures included grade 3 and 4 adverse events and serious adverse events that occurred during the trial, discontinuation or temporary suspension of infusions, and changes in assessed laboratory values over time.", "All serious adverse events and grade 3 or 4 adverse events that represented an increase in severity from day 1 and any grade 2 or higher suspected drug-related hypersensitivity reactions were recorded.", "†Race and ethnic group were reported by the patients.", "### Table 1 Demographic and Clinical Characteristics of the Patients at Baseline.*", "(Funded by the National Institute of Allergy and Infectious Diseases and others; ACTT-1 ClinicalTrials.gov number, NCT04280705.)"]}
{"doc_id": 15015, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test)."]}
{"doc_id": 15016, "title": "", "abstract": ["Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "# Remdesivir for the Treatment of Covid-19 — Final Report"]}
{"doc_id": 15017, "title": "", "abstract": ["In the severe disease stratum (957 patients) the median time to recovery was 11 days, as compared with 18 days (rate ratio for recovery, 1.31; 95% CI, 1.12 to 1.52) (Table S4).", "Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "In an analysis that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clinical improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity)."]}
{"doc_id": 15018, "title": "", "abstract": ["Our data also suggest that treatment with remdesivir may have prevented the progression to more severe respiratory disease, as shown by the lower proportion of serious adverse events due to respiratory failure among patients in the remdesivir group, as well as a lower incidence of new oxygen use among patients who were not receiving oxygen at enrollment and a lower proportion of patients needing higher levels of respiratory support during the study.", "The benefit in recovery persisted when adjustment was made for glucocorticoid use, which suggests that the benefit of dexamethasone as shown in the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial4 may be additive to that of remdesivir.", "Current strategies are evaluating remdesivir in combination with modifiers of the immune response (e.g., the Janus kinase [JAK] inhibitor baricitinib in ACTT-2, and interferon beta-1a in ACTT-3).", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Since the publication of our preliminary report, dexamethasone has been shown to decrease mortality (25.7% in the usual care group vs. 22.9% in the dexamethasone group; P<0.001), with the largest benefit seen among patients receiving invasive mechanical ventilation.4"]}
{"doc_id": 15019, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection."]}
{"doc_id": 15020, "title": "", "abstract": ["Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2)."]}
{"doc_id": 15021, "title": "", "abstract": ["Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "That trial did not complete full enrollment owing to local control of the outbreak, had lower power than ACTT-1 owing to the smaller sample size and a 2:1 randomization, and was unable to demonstrate any statistically significant clinical benefits of remdesivir.", "The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "Given the preliminary results about remdesivir, the Food and Drug Administration issued an Emergency Use Authorization on May 1, 2020 (modified on August 28, 2020), to permit the use of remdesivir for treatment in adults and children hospitalized with suspected or laboratory-confirmed Covid-19."]}
{"doc_id": 15022, "title": "", "abstract": ["The primary outcome was initially a comparison of clinical status at day 15 on the eight-category ordinal scale.", "The key secondary outcome was clinical status at day 15, as assessed on the ordinal scale.", "Other secondary outcomes included the time to improvement of one category and of two categories from the baseline ordinal score; clinical status as assessed on the ordinal scale at days 3, 5, 8, 11, 15, 22, and 29; mean change in status on the ordinal scale from day 1 to days 3, 5, 8, 11, 15, 22, and 29; time to discharge or National Early Warning Score of 2 or less (maintained for 24 hours), whichever occurred first; change in the National Early Warning Score from day 1 to days 3, 5, 8, 11, 15, 22, and 29; number of days with supplemental oxygen, with noninvasive ventilation or high-flow oxygen, and with invasive ventilation or ECMO up to day 29 (if these were being used at baseline); the incidence and duration of new oxygen use, of noninvasive ventilation or high-flow oxygen, and of invasive ventilation or ECMO; number of days of hospitalization up to day 29; and mortality at 14 and 28 days after enrollment.", "The primary outcome was the time to recovery, defined as the first day, during the 28 days after enrollment, on which a patient met the criteria for category 1, 2, or 3 on the eight-category ordinal scale.", "Scores on the ordinal scale are as follows: 1, not hospitalized, no limitations of activities; 2, not hospitalized, limitation of activities, home oxygen requirement, or both; 3, hospitalized, not requiring supplemental oxygen and no longer requiring ongoing medical care (used if hospitalization was extended for infection- control reasons); 4, hospitalized, not requiring supplemental oxygen but requiring ongoing medical care (Covid-19–related or other medical conditions); 5, hospitalized, requiring any supplemental oxygen; 6, hospitalized, requiring noninvasive ventilation or use of high-flow oxygen devices; 7, hospitalized, receiving invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); and 8, death."]}
{"doc_id": 15023, "title": "", "abstract": ["The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "Among the 573 patients who were not receiving noninvasive ventilation, high- flow oxygen, invasive ventilation, or ECMO at baseline, the incidence of new noninvasive ventilation or high-flow oxygen use was lower in the remdesivir group than in the placebo group (17% [95% CI, 13 to 22] vs. 24% [95% CI, 19 to 30]).", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "Our data also suggest that treatment with remdesivir may have prevented the progression to more severe respiratory disease, as shown by the lower proportion of serious adverse events due to respiratory failure among patients in the remdesivir group, as well as a lower incidence of new oxygen use among patients who were not receiving oxygen at enrollment and a lower proportion of patients needing higher levels of respiratory support during the study."]}
{"doc_id": 15024, "title": "", "abstract": ["Among the 285 patients who were receiving mechanical ventilation or ECMO at enrollment, patients in the remdesivir group received these interventions for fewer subsequent days than those in the placebo group (median, 17 days vs. 20 days), and the incidence of new mechanical ventilation or ECMO use among the 766 patients who were not receiving these interventions at enrollment was lower in the remdesivir group than in the placebo group (13% [95% CI, 10 to 17] vs. 23% [95% CI, 19 to 27]) (Table 3).", "Among the 573 patients who were not receiving noninvasive ventilation, high- flow oxygen, invasive ventilation, or ECMO at baseline, the incidence of new noninvasive ventilation or high-flow oxygen use was lower in the remdesivir group than in the placebo group (17% [95% CI, 13 to 22] vs. 24% [95% CI, 19 to 30]).", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "Among the 913 patients receiving oxygen at enrollment, those in the remdesivir group continued to receive oxygen for fewer days than patients in the placebo group (median, 13 days vs. 21 days), and the incidence of new oxygen use among patients who were not receiving oxygen at enrollment was lower in the remdesivir group than in the placebo group (incidence, 36% [95% CI, 26 to 47] vs. 44% [95% CI, 33 to 57]).", "In an analysis that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clinical improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity)."]}
{"doc_id": 15025, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo."]}
{"doc_id": 15026, "title": "", "abstract": ["The primary analysis was a stratified log-rank test of time to recovery with remdesivir as compared with placebo, with stratification by disease severity (the actual severity at baseline).", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "In an analysis that used a proportional-odds model with an eight-category ordinal scale, the patients who received remdesivir were found to be more likely than those who received placebo to have clinical improvement at day 15 (odds ratio, 1.5; 95% CI, 1.2 to 1.9, after adjustment for actual disease severity).", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Of the 1114 patients who were assessed for eligibility, 1062 underwent randomization; 541 were assigned to the remdesivir group and 521 to the placebo group (intention-to-treat population) (Figure 1); 159 (15.0%) were categorized as having mild-to-moderate disease, and 903 (85.0%) were in the severe disease stratum."]}
{"doc_id": 15027, "title": "", "abstract": ["Scores on the ordinal scale are as follows: 1, not hospitalized, no limitations of activities; 2, not hospitalized, limitation of activities, home oxygen requirement, or both; 3, hospitalized, not requiring supplemental oxygen and no longer requiring ongoing medical care (used if hospitalization was extended for infection- control reasons); 4, hospitalized, not requiring supplemental oxygen but requiring ongoing medical care (Covid-19–related or other medical conditions); 5, hospitalized, requiring any supplemental oxygen; 6, hospitalized, requiring noninvasive ventilation or use of high-flow oxygen devices; 7, hospitalized, receiving invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); and 8, death.", "To evaluate the clinical efficacy and safety of putative investigational therapeutic agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform trial to rapidly conduct a series of phase 3, randomized, double-blind, placebo-controlled trials.", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Other secondary outcomes included the time to improvement of one category and of two categories from the baseline ordinal score; clinical status as assessed on the ordinal scale at days 3, 5, 8, 11, 15, 22, and 29; mean change in status on the ordinal scale from day 1 to days 3, 5, 8, 11, 15, 22, and 29; time to discharge or National Early Warning Score of 2 or less (maintained for 24 hours), whichever occurred first; change in the National Early Warning Score from day 1 to days 3, 5, 8, 11, 15, 22, and 29; number of days with supplemental oxygen, with noninvasive ventilation or high-flow oxygen, and with invasive ventilation or ECMO up to day 29 (if these were being used at baseline); the incidence and duration of new oxygen use, of noninvasive ventilation or high-flow oxygen, and of invasive ventilation or ECMO; number of days of hospitalization up to day 29; and mortality at 14 and 28 days after enrollment.", "Secondary safety outcome measures included grade 3 and 4 adverse events and serious adverse events that occurred during the trial, discontinuation or temporary suspension of infusions, and changes in assessed laboratory values over time."]}
{"doc_id": 15028, "title": "", "abstract": ["The mean age of the patients was 58.9 years, and 64.4% were male (Table 1).", "Characteristic| All   (N=1062)| Remdesivir   (N=541)| Placebo   (N=521)   ---|---|---|---   Age — yr| 58.9±15.0| 58.6±14.6| 59.2±15.4", "A total of 957 patients (90.1%) had severe disease at enrollment; 285 patients (26.8%) met category 7 criteria on the ordinal scale, 193 (18.2%) category 6, 435 (41.0%) category 5, and 138 (13.0%) category 4.", "During the study, 373 patients (35.6% of the 1048 patients in the as-treated population) received hydroxychloroquine and 241 (23.0%) received a glucocorticoid (Table S3).", "Prespecified subgroups in these analyses were defined according to sex, baseline disease severity (according to stratification criteria and on the basis of the ordinal scale), age (18 to 39 years, 40 to 64 years, or ≥65 years), race, ethnic group, duration of symptoms before randomization (measured as ≤10 days or >10 days, in quartiles, and as the median), site location, and presence of coexisting conditions."]}
{"doc_id": 15029, "title": "", "abstract": ["The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "Among the 573 patients who were not receiving noninvasive ventilation, high- flow oxygen, invasive ventilation, or ECMO at baseline, the incidence of new noninvasive ventilation or high-flow oxygen use was lower in the remdesivir group than in the placebo group (17% [95% CI, 13 to 22] vs. 24% [95% CI, 19 to 30]).", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "For the 193 patients receiving noninvasive ventilation or high-flow oxygen at enrollment, the median duration of use of these interventions was 6 days in both the remdesivir and placebo groups."]}
{"doc_id": 15030, "title": "", "abstract": ["Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Patients in the remdesivir group had a shorter time to improvement of one or of two categories on the ordinal scale from baseline than patients in the placebo group (one-category improvement: median, 7 vs. 9 days; rate ratio for recovery, 1.23; 95% CI, 1.08 to 1.41; two-category improvement: median, 11 vs. 14 days; rate ratio, 1.29; 95% CI, 1.12 to 1.48) (Table 3).", "The initial length of hospital stay was shorter in the remdesivir group than in the placebo group (median, 12 days vs. 17 days); 5% of patients in the remdesivir group were readmitted to the hospital, as compared with 3% in the placebo group."]}
{"doc_id": 15031, "title": "", "abstract": ["This adjusted analysis produced a similar treatment-effect estimate (rate ratio for recovery, 1.26; 95% CI, 1.09 to 1.46).", "Mortality over the entire study period uses the totality of the study data and censors data from patients who completed follow-up alive at 28 days postenrollment.", "Of the 1114 patients who were assessed for eligibility, 1062 underwent randomization; 541 were assigned to the remdesivir group and 521 to the placebo group (intention-to-treat population) (Figure 1); 159 (15.0%) were categorized as having mild-to-moderate disease, and 903 (85.0%) were in the severe disease stratum.", "Some of this difference may be due to the larger sample size in this category since confidence intervals for baseline ordinal scores of 4 (not receiving oxygen), 6 (receiving high-flow oxygen), and 7 (receiving ECMO or mechanical ventilation) were wide.", "The median recovery time for patients in category 7 could not be estimated, which suggests that the follow-up time may have been too short to evaluate that subgroup."]}
{"doc_id": 15032, "title": "", "abstract": ["The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "The benefit in recovery persisted when adjustment was made for glucocorticoid use, which suggests that the benefit of dexamethasone as shown in the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial4 may be additive to that of remdesivir.", "Since the publication of our preliminary report, dexamethasone has been shown to decrease mortality (25.7% in the usual care group vs. 22.9% in the dexamethasone group; P<0.001), with the largest benefit seen among patients receiving invasive mechanical ventilation.4", "# Remdesivir for the Treatment of Covid-19 — Final Report", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19."]}
{"doc_id": 15033, "title": "", "abstract": ["Given the preliminary results about remdesivir, the Food and Drug Administration issued an Emergency Use Authorization on May 1, 2020 (modified on August 28, 2020), to permit the use of remdesivir for treatment in adults and children hospitalized with suspected or laboratory-confirmed Covid-19.", "Cumulatively, these findings suggest that treatment with remdesivir may not only reduce the disease burden but may also decrease the use of scarce health care resources during this pandemic.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "After the data and safety monitoring board recommended that the preliminary primary analysis report be provided to the sponsor, data on a total of 51 patients (4.8% of the total study enrollment) — 16 (3.0%) in the remdesivir group and 35 (6.7%) in the placebo group — were unblinded; 26 (74.3%) of those in the placebo group whose data were unblinded were given remdesivir."]}
{"doc_id": 15034, "title": "", "abstract": ["Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "Remdesivir has also received full or conditional approval in several other countries since that time.", "Current strategies are evaluating remdesivir in combination with modifiers of the immune response (e.g., the Janus kinase [JAK] inhibitor baricitinib in ACTT-2, and interferon beta-1a in ACTT-3).", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "In addition, in nonhuman primate studies, remdesivir initiated 12 hours after inoculation with MERS-CoV10,11 reduced lung virus levels and lung damage."]}
{"doc_id": 15035, "title": "", "abstract": ["A variety of therapeutic approaches including novel antivirals, modifiers of the immune response or other intrinsic pathways, and combination approaches are needed to continue to improve outcomes in patients with Covid-19.", "Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.", "Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9"]}
{"doc_id": 15036, "title": "", "abstract": ["# Remdesivir for the Treatment of Covid-19 — Final Report", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "Several therapeutic agents have been evaluated for the treatment of Covid-19, but no antiviral agents have yet been shown to be efficacious.2,3", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "If a hospital had a written policy or guideline for use of other treatments for Covid-19, patients could receive those treatments."]}
{"doc_id": 15037, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "The initial length of hospital stay was shorter in the remdesivir group than in the placebo group (median, 12 days vs. 17 days); 5% of patients in the remdesivir group were readmitted to the hospital, as compared with 3% in the placebo group."]}
{"doc_id": 15038, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9"]}
{"doc_id": 15039, "title": "", "abstract": ["The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "The benefit of remdesivir was larger when given earlier in the illness, though the benefit persisted in most analyses of duration of symptoms (Table S6).", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Recovery rate ratios greater than 1 indicate a benefit with remdesivir; hazard ratios less than 1 indicate a benefit with remdesivir.", "Additional secondary end points supporting these findings include remdesivir treatment resulting in a shorter time to improvement of one and of two ordinal scale categories, a shorter time to discharge or to a sustained National Early Warning Score of 2 or lower, and a shorter length of initial hospital stay (median, 12 days vs. 17 days)."]}
{"doc_id": 15040, "title": "", "abstract": ["In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "The benefit in recovery persisted when adjustment was made for glucocorticoid use, which suggests that the benefit of dexamethasone as shown in the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial4 may be additive to that of remdesivir.", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9)."]}
{"doc_id": 15041, "title": "", "abstract": ["Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "However, given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient for all patients.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "†The duration of initial hospitalization for patients who died was imputed as 28 days.", "Mortality over the entire study period uses the totality of the study data and censors data from patients who completed follow-up alive at 28 days postenrollment."]}
{"doc_id": 15042, "title": "", "abstract": ["Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo.", "To evaluate the clinical efficacy and safety of putative investigational therapeutic agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform trial to rapidly conduct a series of phase 3, randomized, double-blind, placebo-controlled trials.", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "On the basis of the evolving epidemiology of Covid-19 during the trial, 79.8% of patients were enrolled at sites in North America, 15.3% in Europe, and 4.9% in Asia (Table S1 in the Supplementary Appendix)."]}
{"doc_id": 15043, "title": "", "abstract": ["In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "To evaluate the clinical efficacy and safety of putative investigational therapeutic agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform trial to rapidly conduct a series of phase 3, randomized, double-blind, placebo-controlled trials.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection."]}
{"doc_id": 15044, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "# Remdesivir for the Treatment of Covid-19 — Final Report", "Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo."]}
{"doc_id": 15045, "title": "", "abstract": ["Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "# Remdesivir for the Treatment of Covid-19 — Final Report", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Given the preliminary results about remdesivir, the Food and Drug Administration issued an Emergency Use Authorization on May 1, 2020 (modified on August 28, 2020), to permit the use of remdesivir for treatment in adults and children hospitalized with suspected or laboratory-confirmed Covid-19."]}
{"doc_id": 15046, "title": "", "abstract": ["The change was proposed on March 22, 2020 (after 72 patients had been enrolled), by trial statisticians who were unaware of treatment assignments and had no knowledge of outcome data.", "Eleven patients (1.0%) had missing ordinal scale data at enrollment; all these patients discontinued the study before treatment.", "The amendment was proposed on March 22, 2020, by trial statisticians who were unaware of treatment assignment and had no knowledge of outcome data; when this change was proposed 72 patients had been enrolled.", "A total of 957 patients (90.1%) had severe disease at enrollment; 285 patients (26.8%) met category 7 criteria on the ordinal scale, 193 (18.2%) category 6, 435 (41.0%) category 5, and 138 (13.0%) category 4.", "(See the protocol for more information about the trial methods.) To assess the effect of disease severity on treatment benefit (recovery and mortality), post hoc analyses evaluated interactions of efficacy with baseline ordinal score (as a continuous variable)."]}
{"doc_id": 15047, "title": "", "abstract": ["Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "The benefit in recovery persisted when adjustment was made for glucocorticoid use, which suggests that the benefit of dexamethasone as shown in the Randomized Evaluation of Covid-19 Therapy (RECOVERY) trial4 may be additive to that of remdesivir.", "Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo."]}
{"doc_id": 15048, "title": "", "abstract": ["Patients in the remdesivir group had a shorter time to recovery than patients in the placebo group (median, 10 days, as compared with 15 days; rate ratio for recovery, 1.29; 95% confidence interval [CI], 1.12 to 1.49; P<0.001) (Figure 2 and Table 2).", "Patients in the remdesivir group had a shorter time to improvement of one or of two categories on the ordinal scale from baseline than patients in the placebo group (one-category improvement: median, 7 vs. 9 days; rate ratio for recovery, 1.23; 95% CI, 1.08 to 1.41; two-category improvement: median, 11 vs. 14 days; rate ratio, 1.29; 95% CI, 1.12 to 1.48) (Table 3).", "Patients who received remdesivir had a shorter time to recovery (the primary end point) than those who received placebo (median, 10 days vs. 15 days; rate ratio for recovery, 1.29 [95% CI, 1.12 to 1.49]) and were more likely to have improvement in the ordinal scale score at day 15 (key secondary end point; odds ratio, 1.5; 95% CI, 1.2 to 1.9).", "Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test).", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection."]}
{"doc_id": 77000, "title": "", "abstract": ["However, a higher rate of hypoglycaemia was seen in the intensive treatment arm than in the standard treatment arm, leading to speculation that this increase alone (with the increased risk of death among those with hypoglycaemia) could account for the high mortality in the intensive treatment group.", "The mechanism underlying the increased mortality among patients with severe hypoglycaemia has yet to be elucidated.", "Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study.", "* The intensive glycaemia control intervention used in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was associated with increased mortality", "These studies and our findings raise the possibility that although a discrete hypoglycaemic episode may not be an immediate contributor to death, susceptibility to hypoglycaemia may predict an increased risk of death."]}
{"doc_id": 77001, "title": "", "abstract": ["Two randomised controlled trials conducted in critically ill patients in the intensive care unit setting also identified severe hypoglycaemia as an independent risk factor for mortality.25 26", "* Patients with type 2 diabetes who experience symptomatic, severe hypoglycaemia are at increased risk of death, regardless of the intensity of glucose control", "Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "A case-control study of patients with and without diabetes in an intensive care unit found that hypoglycaemia was an independent risk factor for mortality (relative risk of 2.28).24"]}
{"doc_id": 77002, "title": "", "abstract": ["Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study.", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "Little evidence was found that linked either HA or HMA as measured and recorded in the study to the increased number of deaths among participants in the intensive arm of the ACCORD trial.", "The objectives of this particular analysis were threefold: a) to determine if participants in the ACCORD trial who experienced one or more severe symptomatic hypoglycaemic episodes had an increased risk of death; b) to determine whether that risk differed by glycaemic control study arm; and c) to establish whether the risk can explain all or any of the excess mortality in the intensive arm compared with the standard arm."]}
{"doc_id": 77003, "title": "", "abstract": ["This model also contained terms representing the glycaemia control study arm plus terms accounting for the following stratifying variables: assignment to the blood pressure control trial or the lipid control trial; assignment to the intensive blood pressure intervention in the blood pressure control trial; and assignment to receive fibrate in the lipid control trial.", "* The intensive glycaemia control intervention used in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was associated with increased mortality", "Two randomised controlled trials conducted in critically ill patients in the intensive care unit setting also identified severe hypoglycaemia as an independent risk factor for mortality.25 26", "In this study, there are 19 fewer hypoglycaemic events at the time the intensive glycaemia control intervention was stopped than in previous reports6 because this paper’s analyses only include hypoglycaemic events that occurred before an official four month assessment for vital status within each glycaemia arm.", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants"]}
{"doc_id": 77004, "title": "", "abstract": ["Few studies have examined the association between severe hypoglycaemia and mortality in patients with type 2 diabetes.", "These studies and our findings raise the possibility that although a discrete hypoglycaemic episode may not be an immediate contributor to death, susceptibility to hypoglycaemia may predict an increased risk of death.", "A case-control study of patients with and without diabetes in an intensive care unit found that hypoglycaemia was an independent risk factor for mortality (relative risk of 2.28).24", "Several epidemiological studies have reported an increased risk of death and cardiovascular disease with increased levels of glycated haemoglobin (haemoglobin A1C).2 3 4", "Susceptibility to severe hypoglycaemia may be a marker for an underlying disorder that increases the risk for death in patients with diabetes, even when glycaemia is controlled according to current guidelines."]}
{"doc_id": 77005, "title": "", "abstract": ["In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study", "* The intensive glycaemia control intervention used in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was associated with increased mortality", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants"]}
{"doc_id": 77006, "title": "", "abstract": ["It is also possible that the high frequency of episodes of mild hypoglycaemia experienced by participants in the intensive treatment arm provided “training” in management techniques that could then be applied to manage the more severe episodes that later occurred, resulting in reduced rate of mortality in this arm.", "In this study, the risk of death was found to be higher in participants who had experienced at least one episode of symptomatic, severe hypoglycaemia than in those that did not report an event, although no temporal relation was found.", "Those participants who experienced a severe hypoglycaemic event—both in the intensive treatment arm and in the standard treatment arm—had a higher risk of death.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "However, a higher rate of hypoglycaemia was seen in the intensive treatment arm than in the standard treatment arm, leading to speculation that this increase alone (with the increased risk of death among those with hypoglycaemia) could account for the high mortality in the intensive treatment group."]}
{"doc_id": 77007, "title": "", "abstract": ["The intensive glycaemia intervention was stopped early owing to increased mortality in the glycaemia control arm, and all participants were transitioned to the standard glycaemia control intervention.", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "The underlying cause of the increased mortality in the intensive arm was unclear at the time that the intervention was stopped, although several hypotheses were proposed, including severe hypoglycaemia.", "In February 2008, the ACCORD intensive glycaemia control intervention was stopped early because of higher mortality in this study arm: 1.42% of patients died each year compared with 1.14% a year in the standard intervention arm (hazard ratio (HR) 1.22, 95% confidence interval (CI) 1.01 to 1.46; P=0.04).6", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia."]}
{"doc_id": 77008, "title": "", "abstract": ["In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study.", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia.", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants", "The objectives of this particular analysis were threefold: a) to determine if participants in the ACCORD trial who experienced one or more severe symptomatic hypoglycaemic episodes had an increased risk of death; b) to determine whether that risk differed by glycaemic control study arm; and c) to establish whether the risk can explain all or any of the excess mortality in the intensive arm compared with the standard arm."]}
{"doc_id": 77009, "title": "", "abstract": ["In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia.", "In this study, the risk of death was found to be higher in participants who had experienced at least one episode of symptomatic, severe hypoglycaemia than in those that did not report an event, although no temporal relation was found.", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "The objectives of this particular analysis were threefold: a) to determine if participants in the ACCORD trial who experienced one or more severe symptomatic hypoglycaemic episodes had an increased risk of death; b) to determine whether that risk differed by glycaemic control study arm; and c) to establish whether the risk can explain all or any of the excess mortality in the intensive arm compared with the standard arm.", "Those participants who experienced a severe hypoglycaemic event—both in the intensive treatment arm and in the standard treatment arm—had a higher risk of death."]}
{"doc_id": 77010, "title": "", "abstract": ["A higher rate of severe hypoglycaemia was expected a priori in the ACCORD intensive arm participants compared with the normal arm participants and, as expected, was seen in the intensive arm at the time of discontinuation of the intensive glycaemia intervention.6", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "* Intensive glycaemia control results in increased rates of severe hypoglycaemia", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia."]}
{"doc_id": 77011, "title": "", "abstract": ["Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.", "* The intensive glycaemia control intervention used in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was associated with increased mortality", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm."]}
{"doc_id": 77012, "title": "", "abstract": ["The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study", "* Patients with type 2 diabetes who experience symptomatic, severe hypoglycaemia are at increased risk of death, regardless of the intensity of glucose control", "Few studies have examined the association between severe hypoglycaemia and mortality in patients with type 2 diabetes.", "Susceptibility to severe hypoglycaemia may be a marker for an underlying disorder that increases the risk for death in patients with diabetes, even when glycaemia is controlled according to current guidelines.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm."]}
{"doc_id": 77013, "title": "", "abstract": ["The objectives of this particular analysis were threefold: a) to determine if participants in the ACCORD trial who experienced one or more severe symptomatic hypoglycaemic episodes had an increased risk of death; b) to determine whether that risk differed by glycaemic control study arm; and c) to establish whether the risk can explain all or any of the excess mortality in the intensive arm compared with the standard arm.", "Those participants who experienced a severe hypoglycaemic event—both in the intensive treatment arm and in the standard treatment arm—had a higher risk of death.", "In this study, the risk of death was found to be higher in participants who had experienced at least one episode of symptomatic, severe hypoglycaemia than in those that did not report an event, although no temporal relation was found.", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia.", "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study"]}
{"doc_id": 77014, "title": "", "abstract": ["However, a higher rate of hypoglycaemia was seen in the intensive treatment arm than in the standard treatment arm, leading to speculation that this increase alone (with the increased risk of death among those with hypoglycaemia) could account for the high mortality in the intensive treatment group.", "Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.", "Hypoglycaemia was felt to have had a definite role in the death of one participant in the intensive treatment arm.", "It is also possible that the high frequency of episodes of mild hypoglycaemia experienced by participants in the intensive treatment arm provided “training” in management techniques that could then be applied to manage the more severe episodes that later occurred, resulting in reduced rate of mortality in this arm.", "Thus, symptomatic, severe hypoglycaemia may have been a potent marker of underlying illness or frailty in the standard treatment arm, whereas in the intensive treatment arm severe hypoglycaemia, in addition to any risk related to glycaemic instability, was instead likely to be the result of excessive hypoglycaemic treatment relative to glycaemic level, because the limits of tolerance to mild hypoglycaemia was pushed by protocol."]}
{"doc_id": 77015, "title": "", "abstract": ["It is also possible that the high frequency of episodes of mild hypoglycaemia experienced by participants in the intensive treatment arm provided “training” in management techniques that could then be applied to manage the more severe episodes that later occurred, resulting in reduced rate of mortality in this arm.", "Thus, symptomatic, severe hypoglycaemia may have been a potent marker of underlying illness or frailty in the standard treatment arm, whereas in the intensive treatment arm severe hypoglycaemia, in addition to any risk related to glycaemic instability, was instead likely to be the result of excessive hypoglycaemic treatment relative to glycaemic level, because the limits of tolerance to mild hypoglycaemia was pushed by protocol.", "The mechanism underlying the increased mortality among patients with severe hypoglycaemia has yet to be elucidated.", "Susceptibility to severe hypoglycaemia may be a marker for an underlying disorder that increases the risk for death in patients with diabetes, even when glycaemia is controlled according to current guidelines.", "The underlying cause of the increased mortality in the intensive arm was unclear at the time that the intervention was stopped, although several hypotheses were proposed, including severe hypoglycaemia."]}
{"doc_id": 77016, "title": "", "abstract": ["A higher rate of severe hypoglycaemia was expected a priori in the ACCORD intensive arm participants compared with the normal arm participants and, as expected, was seen in the intensive arm at the time of discontinuation of the intensive glycaemia intervention.6", "In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "* The increased risk of death seen in the ACCORD trial among participants in the intensive glycaemia control arm cannot be attributed to the increased rate of severe hypoglycaemia in intensive arm participants", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia.", "Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study."]}
{"doc_id": 77017, "title": "", "abstract": ["Susceptibility to severe hypoglycaemia may be a marker for an underlying disorder that increases the risk for death in patients with diabetes, even when glycaemia is controlled according to current guidelines.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "* Intensive glycaemia control results in increased rates of severe hypoglycaemia", "It is also possible that the high frequency of episodes of mild hypoglycaemia experienced by participants in the intensive treatment arm provided “training” in management techniques that could then be applied to manage the more severe episodes that later occurred, resulting in reduced rate of mortality in this arm.", "Diabetes care was provided in a variety of settings (diabetes clinics, research clinics, and primary care clinics) by physicians with diverse training."]}
{"doc_id": 81000, "title": "", "abstract": ["After 24 h of treatment with CCCP, overexpression of p97QQ strongly inhibited mitochondrial elimination, which suggests that degradation of Mfn (or other ubiquitinated mitochondrial proteins) is required for Parkin-induced mitophagy (Fig. 6, c and d).", "These results suggest that Mfn1/2 degradation promoted by Parkin maintains mitochondria fragmentation after mitochondrial depolarization.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "We found that PARK2 knockdown inhibits Mfn degradation upon CCCP treatment (Fig. 2, c and d, PARK2 siRNA), which confirmed the essential role of Parkin in CCCP-induced Mfn degradation."]}
{"doc_id": 81001, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "However, as mitochondria express at least one membrane-spanning E3 Ub ligase, MARCH5 (Karbowski et al., 2007), Parkin could be activating another E3 ligase to ubiquitinate mitofusins.", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "### Parkin and PINK1 mediate Mitofusin ubiquitination and proteasomal degradation"]}
{"doc_id": 81002, "title": "", "abstract": ["The results shown here indicate that Mitofusin degradation by the proteasome is an example of a related process occurring at the OMM.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "These data indicate that Parkin expression, when combined with mitochondrial uncoupling, induces mitofusin degradation via the Ub–proteasome system (UPS).", "Degradation of mitofusin is regulated by p97 (purple) and is important to prevent impaired mitochondria from fusing with the vital mitochondrial network."]}
{"doc_id": 81003, "title": "", "abstract": ["Although this role of p97 in mitophagy correlates with its role in Mfn elimination, which suggests that Mfn elimination is required for Parkin-mediated mitophagy, p97 may mediate OMMAD of other mitochondrial substrates or play a role in the maturation of autophagosomes as proposed by Tresse et al. (2010) downstream of Mfn elimination.", "Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin", "p97, a AAA+ ATPase, accumulates on mitochondria upon uncoupling of Parkin-expressing cells, and both p97 and proteasome activity are required for Parkin-mediated mitophagy.", "We examined if p97 activity is required for PINK1–Parkin -mediated mitophagy after mitochondrial depolarization.", "Inhibition of Drp1-mediated mitochondrial fission, the proteasome, or p97 prevents Parkin-induced mitophagy."]}
{"doc_id": 81004, "title": "", "abstract": ["As PINK1 functions upstream of Parkin, the model proposed here of Parkin-mediated Mfn degradation would argue the converse: that activation of the PINK1–Parkin pathway would promote fragmentation of mitochondria as suggested by results in fly models.", "To reconcile the differences described in fly and mammalian systems, we suggest that loss of PINK1 or Parkin function might exacerbate the accumulation of mitochondrial damage due to defective removal of damaged mitochondria, and that this excessive damage results in mitochondrial fragmentation.", "We also show that inhibition of p97 activity by the overexpression of dominant-negative p97 mutant prevents the PINK1–Parkin-mediated mitochondrial elimination.", "p97 recruitment to ubiquitinated mitochondria mediates PINK1–Parkin-induced mitochondrial elimination.", "In Drosophila, either promoting fission of mitochondria or suppressing fusion partially rescues the swollen mitochondrial phenotype of the pink1 and parkin mutant flies (Deng et al., 2008; Poole et al., 2008; Yang et al., 2008; Park et al., 2009)."]}
{"doc_id": 81005, "title": "", "abstract": ["We propose that inhibition of mitochondrial fusion during Parkin-driven mitophagy contributes to an enhanced rate and selectivity of mitophagy, facilitating mitochondrial quality control.", "We suggest that the inhibition of mitochondrial fusion may isolate damaged mitochondria from healthy mitochondria and thereby promote autophagy of defective organelles.", "Collectively, we hypothesize that mitofusin degradation by mitochondria- associated Parkin inhibits the fusion of damaged mitochondria with healthy mitochondria, thereby segregating the impaired mitochondria from the network of fully functional mitochondria to facilitate their selective elimination by autophagy.", "Loss of mitofusins would be expected to inhibit mitochondrial fusion, perhaps fostering the autophagic elimination of depolarized mitochondria by segregating them from the mitochondrial network.", "These results indicate that inhibiting mitochondrial fission hinders Parkin-induced mitophagy."]}
{"doc_id": 81006, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "This suggests that the PINK1–Parkin pathway may normally promote fission of mitochondria.", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation.", "Parkin-promoted mitofusin degradation prevents refusion of damaged mitochondria with healthy mitochondria."]}
{"doc_id": 81007, "title": "", "abstract": ["We found that Parkin- mediated Mfn1 ubiquitination was more apparent, and Mfn1 degradation was largely prevented by expression of the p97QQ (Fig. 5, a–c, p97QQ), which suggests that p97 mediates degradation of ubiquitinated Mfn1.", "Here we show that Parkin can mediate the ubiquitination and proteasomal degradation of Mfn1 and Mfn2.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "We found that PARK2 knockdown inhibits Mfn degradation upon CCCP treatment (Fig. 2, c and d, PARK2 siRNA), which confirmed the essential role of Parkin in CCCP-induced Mfn degradation."]}
{"doc_id": 81008, "title": "", "abstract": ["Dysfunctional mitochondria may be selectively eliminated by autophagy, termed mitophagy (Kim et al., 2007), through pathways distinct from bulk autophagy that provide starved cells with nutrients.", "However, once mitochondria are seriously damaged, they are removed from a cell by autophagy.", "Damage to mitochondria can lead to the depolarization of the inner mitochondrial membrane, thereby sensitizing impaired mitochondria for selective elimination by autophagy.", "In this pathway, mitochondrial fission accelerates the isolation of damaged mitochondria, and recent work has shown that fission precedes mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009).", "Damaged mitochondria isolated by Parkin are engaged with autophagosomes and eliminated by auto-lysosomes."]}
{"doc_id": 81009, "title": "", "abstract": ["Although this role of p97 in mitophagy correlates with its role in Mfn elimination, which suggests that Mfn elimination is required for Parkin-mediated mitophagy, p97 may mediate OMMAD of other mitochondrial substrates or play a role in the maturation of autophagosomes as proposed by Tresse et al. (2010) downstream of Mfn elimination.", "### Inhibition of mitochondrial fission hinders CCCP- and Parkin-dependent mitophagy", "In addition, recent work indicates that mitochondrial fission is required for the progression of mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009), which suggests that promoting mitochondrial fission could compensate for a mitophagy deficit in Parkin-defective flies.", "We also investigated whether proteasome activity is required for Parkin-mediated mitophagy.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy."]}
{"doc_id": 81010, "title": "", "abstract": ["Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "Mitochondrial depolarization induces selective degradation of mitofusins by Parkin.", "We found that upon mitochondrial depolarization, Opa1 cleavage (Ishihara et al., 2006; Griparic et al., 2007) occurs more rapidly than mitofusin degradation (unpublished data), which suggests that the elimination of mitofusins does not cause the initial mitochondrial fragmentation but might delay fusion of mitochondria after uncoupler-induced fragmentation.", "First, immediately after depolarization, Opa1 is processed by proteases into a fusion-inactive form; second, after Parkin translocation to depolarized mitochondria, Mfn1 and Mfn2 are degraded in a Parkin-, p97-, and proteasome- dependent manner to prevent mitochondrial refusion.", "2 h after adding the mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) to depolarize the mitochondria, we observed the selective reduction in expression of endogenous Mfn1 and Mfn2, human homologues of yeast Fzo1 that is known to be degraded by the proteasome (Fig. 1 a and b; Neutzner and Youle, 2005)."]}
{"doc_id": 81011, "title": "", "abstract": ["In addition, recent work indicates that mitochondrial fission is required for the progression of mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009), which suggests that promoting mitochondrial fission could compensate for a mitophagy deficit in Parkin-defective flies.", "Mitochondrial fission is required for Parkin-mediated mitophagy.", "Inhibition of Drp1-mediated mitochondrial fission, the proteasome, or p97 prevents Parkin-induced mitophagy.", "These results indicate that inhibiting mitochondrial fission hinders Parkin-induced mitophagy.", "Thus, in both DRP1−/− MEFs and DRP1 knockdown cells, mitophagy is inhibited."]}
{"doc_id": 81012, "title": "", "abstract": ["These data indicate that p97 accumulation on mitochondria requires Parkin expression and mitochondrial depolarization, and occurs independently of p97 ATPase activity.", "To further test the role and mechanism of p97 in Parkin-dependent degradation of Mfn proteins, we examined the subcellular localization of p97 under conditions of inducing Parkin translocation to mitochondria.", "In PINK1 knockout mouse embryonic fibroblasts (PINK1−/−MEFs), mitochondrial accumulation of p97 was not detectable upon CCCP treatment (Fig. 6 a), which indicates that p97 translocation is triggered by the activation of PINK1–Parkin activity upon depolarization of mitochondria.", "How membrane-spanning proteins such as the mitofusins are extracted from the OMM before their proteasomal degradation is currently unknown.", "Although this role of p97 in mitophagy correlates with its role in Mfn elimination, which suggests that Mfn elimination is required for Parkin-mediated mitophagy, p97 may mediate OMMAD of other mitochondrial substrates or play a role in the maturation of autophagosomes as proposed by Tresse et al. (2010) downstream of Mfn elimination."]}
{"doc_id": 81013, "title": "", "abstract": ["p97, a AAA+ ATPase, accumulates on mitochondria upon uncoupling of Parkin-expressing cells, and both p97 and proteasome activity are required for Parkin-mediated mitophagy.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "AAA+ ATPase p97 mediates mitofusin degradation and accumulates on mitochondria after depolarization.", "The accumulation p97 on mitochondria upon Parkin translocation was confirmed by the data showing that Myc-p97 also translocated to the mitochondria in CCCP-treated Parkin- expressing cells.", "To further test the role and mechanism of p97 in Parkin-dependent degradation of Mfn proteins, we examined the subcellular localization of p97 under conditions of inducing Parkin translocation to mitochondria."]}
{"doc_id": 81014, "title": "", "abstract": ["Collectively, we hypothesize that mitofusin degradation by mitochondria- associated Parkin inhibits the fusion of damaged mitochondria with healthy mitochondria, thereby segregating the impaired mitochondria from the network of fully functional mitochondria to facilitate their selective elimination by autophagy.", "Degradation of mitofusin is regulated by p97 (purple) and is important to prevent impaired mitochondria from fusing with the vital mitochondrial network.", "Our finding that the uncoupling of mitochondria, a condition that causes Parkin translocation to mitochondria, stimulates mitofusin degradation also points to a vital role for mitofusin degradation in Parkin-mediated mitophagy.", "Therefore we propose that mitofusin degradation does not serve as a signal for mitophagy activation, but Mfn1 and Mfn2 removal might be important for the promotion of mitochondrial fragmentation that might facilitate subsequent mitophagy.", "Parkin-promoted mitofusin degradation prevents refusion of damaged mitochondria with healthy mitochondria."]}
{"doc_id": 81015, "title": "", "abstract": ["Additionally, we found that overexpression of p97QQ slowed down the turnover rate of Mfn1 (Fig. S4, c and d) in control HeLa cells, which suggests that the UPS, through the p97 activity, might also mediate steady-state Mfn1 ubiquitination and degradation in the absence of mitochondrial uncoupling and Parkin expression.", "We found that upon mitochondrial depolarization, Opa1 cleavage (Ishihara et al., 2006; Griparic et al., 2007) occurs more rapidly than mitofusin degradation (unpublished data), which suggests that the elimination of mitofusins does not cause the initial mitochondrial fragmentation but might delay fusion of mitochondria after uncoupler-induced fragmentation.", "First, immediately after depolarization, Opa1 is processed by proteases into a fusion-inactive form; second, after Parkin translocation to depolarized mitochondria, Mfn1 and Mfn2 are degraded in a Parkin-, p97-, and proteasome- dependent manner to prevent mitochondrial refusion.", "As the mitochondrial respiratory chain inhibitor rotenone has been used to generate an animal model of Parkinsonism (Betarbet et al., 2000) and the oxidizing agent and herbicide paraquat has been linked to human Parkinsonism (Cochemé and Murphy, 2008; Brooks et al., 1999), we examined their effects on Mfn degradation.", "Therefore we propose that mitofusin degradation does not serve as a signal for mitophagy activation, but Mfn1 and Mfn2 removal might be important for the promotion of mitochondrial fragmentation that might facilitate subsequent mitophagy."]}
{"doc_id": 81016, "title": "", "abstract": ["In addition, recent work indicates that mitochondrial fission is required for the progression of mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009), which suggests that promoting mitochondrial fission could compensate for a mitophagy deficit in Parkin-defective flies.", "These results indicate that inhibiting mitochondrial fission hinders Parkin-induced mitophagy.", "Mitochondrial fission is required for Parkin-mediated mitophagy.", "### Inhibition of mitochondrial fission hinders CCCP- and Parkin-dependent mitophagy", "In this pathway, mitochondrial fission accelerates the isolation of damaged mitochondria, and recent work has shown that fission precedes mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009)."]}
{"doc_id": 81017, "title": "", "abstract": ["This indicates that counteracting mitochondrial fission, which is a normal function of Mfn1/2, inhibits Parkin-mediated mitophagy.", "When damaged mitochondria lose membrane potential, fission, or lack of fusion, can segregate them from the mitochondrial network, where they can be engulfed by autophagosomes (Twig et al., 2008).", "In addition, recent work indicates that mitochondrial fission is required for the progression of mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009), which suggests that promoting mitochondrial fission could compensate for a mitophagy deficit in Parkin-defective flies.", "In this pathway, mitochondrial fission accelerates the isolation of damaged mitochondria, and recent work has shown that fission precedes mitophagy (Nowikovsky et al., 2007; Twig et al., 2008; Kanki et al., 2009).", "We suggest that the inhibition of mitochondrial fusion may isolate damaged mitochondria from healthy mitochondria and thereby promote autophagy of defective organelles."]}
{"doc_id": 81018, "title": "", "abstract": ["How membrane-spanning proteins such as the mitofusins are extracted from the OMM before their proteasomal degradation is currently unknown.", "Membrane-spanning proteins resident in the ER can be degraded by the proteasome after ubiquitination and retrotranslocation from the ER membrane.", "We therefore examined if Mfn degradation requires the activity of p97, a AAA+ ATPase involved in the retrotranslocation of ER membrane-spanning proteins after ubiquitination and en route to proteasomal degradation (Ye et al., 2001; Rabinovich et al., 2002).", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "The results shown here indicate that Mitofusin degradation by the proteasome is an example of a related process occurring at the OMM."]}
{"doc_id": 81019, "title": "", "abstract": ["UPS Ub–proteasome system", "These data indicate that Parkin expression, when combined with mitochondrial uncoupling, induces mitofusin degradation via the Ub–proteasome system (UPS).", "Additionally, we found that overexpression of p97QQ slowed down the turnover rate of Mfn1 (Fig. S4, c and d) in control HeLa cells, which suggests that the UPS, through the p97 activity, might also mediate steady-state Mfn1 ubiquitination and degradation in the absence of mitochondrial uncoupling and Parkin expression.", "Because YFP-Parkin showed a similar efficiency of translocation to mitochondria after CCCP with and without MG132 treatment (Fig. 6 e, 60’ and 4 h), the inhibition of mitochondrial elimination by MG132 suggests that Parkin-dependent degradation of dysfunctional mitochondria requires not only autophagy, but also the UPS.", "We propose that inhibition of mitochondrial fusion during Parkin-driven mitophagy contributes to an enhanced rate and selectivity of mitophagy, facilitating mitochondrial quality control."]}
{"doc_id": 81020, "title": "", "abstract": ["Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "The results shown here indicate that Mitofusin degradation by the proteasome is an example of a related process occurring at the OMM.", "In addition, as indicated by the effect of p97QQ on Mfn1 ubiquitination in the absence of Parkin expression, degradation of mitofusins in mammalian cells might be mediated by other E3 Ub ligases during steady-state proteasome- mediated turnover.", "### Parkin and PINK1 mediate Mitofusin ubiquitination and proteasomal degradation", "Mitofusin degradation requires PINK1 expression."]}
{"doc_id": 81021, "title": "", "abstract": ["Although this role of p97 in mitophagy correlates with its role in Mfn elimination, which suggests that Mfn elimination is required for Parkin-mediated mitophagy, p97 may mediate OMMAD of other mitochondrial substrates or play a role in the maturation of autophagosomes as proposed by Tresse et al. (2010) downstream of Mfn elimination.", "After 24 h of treatment with CCCP, overexpression of p97QQ strongly inhibited mitochondrial elimination, which suggests that degradation of Mfn (or other ubiquitinated mitochondrial proteins) is required for Parkin-induced mitophagy (Fig. 6, c and d).", "One pathway of mitophagy appears to be activated by Parkin after its translocation from the cytosol specifically to dysfunctional mitochondria (Narendra et al., 2008).", "Parkin can initiate mitophagy in MFN1/MFN2 double knockout cells, which indicates that mitofusin ubiquitination and proteasomal degradation are not essential to activate mitophagy (Fig. 8, j and k).", "Consistent with genetic studies in flies that indicated that they work in the same pathway, Parkin translocation and mitophagy induction require PINK1 activity (Geisler et al., 2010; Matsuda et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010)."]}
{"doc_id": 81022, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "How membrane-spanning proteins such as the mitofusins are extracted from the OMM before their proteasomal degradation is currently unknown.", "Recent studies further show that upon Parkin translocation to damaged mitochondria, Parkin E3 Ub ligase activity increases (Matsuda et al., 2010), and mitochondrial substrates such as VDAC1 become ubiquitinated (Geisler et al., 2010), followed by recruitment of p62 and aggregation of mitochondria by the HDAC6 deacetylase (Lee et al., 2010) .", "Damaged mitochondria isolated by Parkin are engaged with autophagosomes and eliminated by auto-lysosomes."]}
{"doc_id": 81023, "title": "", "abstract": ["The results shown here indicate that Mitofusin degradation by the proteasome is an example of a related process occurring at the OMM.", "Parkin-promoted mitofusin degradation prevents refusion of damaged mitochondria with healthy mitochondria.", "Mitochondrial depolarization induces selective degradation of mitofusins by Parkin.", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation.", "Collectively, we hypothesize that mitofusin degradation by mitochondria- associated Parkin inhibits the fusion of damaged mitochondria with healthy mitochondria, thereby segregating the impaired mitochondria from the network of fully functional mitochondria to facilitate their selective elimination by autophagy."]}
{"doc_id": 81024, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Collectively, we hypothesize that mitofusin degradation by mitochondria- associated Parkin inhibits the fusion of damaged mitochondria with healthy mitochondria, thereby segregating the impaired mitochondria from the network of fully functional mitochondria to facilitate their selective elimination by autophagy.", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation.", "These results suggest how Parkin might intersect the mitochondrial fission and fusion pathways consistent with a normal role in promoting mitochondrial fission.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner."]}
{"doc_id": 81025, "title": "", "abstract": ["Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "Both Mfn1 and Mfn2 are degraded in a Parkin-dependent manner, although Mfn1 degradation appears to be generally more robust than Mfn2 degradation.", "Mfn1 appears to be more rapidly degraded than Mfn2 via Parkin, and this may relate to differential activity of the two proteins in mitochondrial fusion (Cipolat et al., 2004).", "Additionally, we found that overexpression of p97QQ slowed down the turnover rate of Mfn1 (Fig. S4, c and d) in control HeLa cells, which suggests that the UPS, through the p97 activity, might also mediate steady-state Mfn1 ubiquitination and degradation in the absence of mitochondrial uncoupling and Parkin expression.", "Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy."]}
{"doc_id": 78000, "title": "", "abstract": ["LC3-II insertion into the autophagosomal membrane is a consistent key step in autophagosomal formation, and its level reflects the relative amount of autophagosomes in the cell.", "In the latter scenario, when autophagic flux is blocked, the degradation of the inner membrane-localized LC3-II cannot occur; and the number of LC3-positive puncta increases as a result of the accumulation of autophagosomes.", "The puncta formed by LC3-II and the electrophoretic separation of LC3-I and LC3-II are used as a marker for autophagosomal accumulation.", "The thiol reduced form of Atg4 enables the conversion of LC3-I into LC3-II, lipidation and insertion into the autophagosome, and then recycles LC3-II after the autophagosome fuses with the lysosome [80].", "LC3-I is modified with PE (phosphatidylethanolamine) and is now referred to as LC3-II; this step involves a ubiquitination-like reaction mediated by Atg7 (E1-like activating enzyme), Atg3 (E2-like conjugating enzyme) and the Atg16L complex (E3-like ligase enzyme)."]}
{"doc_id": 78001, "title": "", "abstract": ["The highly abundant mitochondria in brain cells are a major site of generation and action of ROS/RNS.", "ROS and RNS production can be induced by protein aggregates, generated by the mitochondrial respiratory activities and by other cellular oxidases.", "Mitochondria generate ROS from a number of different redox centres in the respiratory chain and other metabolic pathways [16].", "Genes involved in ROS generation are significantly altered in Atg5−/− T-cells [284]|   Atg7| Reticulocyte maturation is diminished, but not abolished in Atg7−/− mice [286].", "In support of specific mechanisms mediated by redox signalling proteins, starvation-induced ROS formation has been shown to play a key role in autophagic induction through thiol modification of the Cys81 site of Atg4 [80]."]}
{"doc_id": 78002, "title": "", "abstract": ["It is then essential to regulate autophagy at multiple levels, including removal of defective proteins generating uncontrolled ROS and the entire organelle by mitophagy.", "Therefore, indirectly, autophagy can be regulated by transcriptional mechanisms in response to ROS/RNS.", "How ROS/RNS signals and mitochondrial dysfunction regulate autophagy has not been fully understood.", "Genetically engineered mouse models have provided abundant evidence for the important role of autophagy in mitochondrial integrity, intracellular protein clearance and ROS control.", "Mitochondrial ROS production and oxidation of mitochondrial lipids have been shown to play a role in autophagy."]}
{"doc_id": 78003, "title": "", "abstract": ["Autophagy plays an important role in both sensing oxidative stress and removing oxidatively damaged proteins and organelles, as well as the cellular machineries responsible for excessive ROS/RNS production.", "A role of autophagy in protection against accumulation of oxidized proteins is a conserved process through evolution.", "Mitophagy may also be important in attenuating apoptosis or necrosis, by clearance of damaged mitochondria.", "These binding domains may work in concert or separately to target mitochondria to the autophagic pathway.", "It is then essential to regulate autophagy at multiple levels, including removal of defective proteins generating uncontrolled ROS and the entire organelle by mitophagy."]}
{"doc_id": 78004, "title": "", "abstract": ["Additional molecules involved in macroautophagy regulation include AMPK (5′-AMP-activated protein kinase) [58], DAPK (death-associated protein kinase) [59] and IP3R (IP3 receptor) [60].", "p53-regulated sestrin proteins enhance autophagy via activation of AMPK which inhibits mTOR [128], although evidence for whether sestrin 2 acts as a reductase of sulfinylated peroxidredoxins or has other functions is being investigated [129,130].", "The understanding of how nutrient regulation of autophagy regulation occurs has advanced in the last few decades, especially at the junction of the mTOR/Atg1/Atg13 cascades.", "Conversely, during starvation, mTOR co-localizes with LC3 after autolysosome formation, suggesting that it may regulate autophagosome and lysosome reformation directly [45].", "The autophagosome and the lysosome fuse to degrade the cargo by lysosomal acidic hydrolases, including cathepsins D, B and L. Macroautophagy is regulated by starvation through the Atg1–Atg13 complex, which is inhibited by mTOR activation."]}
{"doc_id": 78005, "title": "", "abstract": ["Dysregulation of autophagy leads to increases in oxidative stress, as shown by many pharmacological inhibitor and knockout studies (summarized in Table 1).", "In mammalian cells, starvation-induced autophagy is associated with increased oxidative stress, and both H2O2 and O2•− have been shown to induce autophagy [80,82].", "Some possibilities include the accumulation of toxic proteins and the decrease in mitochondrial function, leading to further oxidative stress when the autophagic process is disrupted [17–19].", "It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress.", "Mitochondrial ROS production and oxidation of mitochondrial lipids have been shown to play a role in autophagy."]}
{"doc_id": 78006, "title": "", "abstract": ["Specific forms of ROS and RNS include hydrogen peroxide (H2O2), superoxide (O2•−), nitric oxide (NO), peroxynitrite (ONOO−) and RLS (reactive lipid species).", "Mitochondrially produced superoxide (O2•−) can react with NO to produce peroxynitrite (ONOOH).", "These ROS/RNS species can modify signalling molecules to stimulate or inhibit autophagy.", "For example, NO reacts with O2•− and generates ONOO−, which is capable of initiating further protein oxidation and nitration [11,12].", "ROS/RNS production and signalling"]}
{"doc_id": 78007, "title": "", "abstract": ["Oxidative stress is inseparably linked to mitochondrial dysfunction, as mitochondria are both generators of and targets for reactive species [16].", "Oxidative damage and the associated mitochondrial dysfunction may result in energy depletion, accumulation of cytotoxic mediators and cell death.", "It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress.", "This is particularly relevant to degenerative diseases in which oxidative stress occurs over time, and dysfunction in both the mitochondrial and autophagic pathways play a role.", "Since mitochondria are both a source and target of ROS/RNS, a major effort is needed to determine how the organelle communicates with the lysosome to combat protein oxidation, mitochondrial damage and the maintenance of mitochondrial networks through fission and fusion."]}
{"doc_id": 78008, "title": "", "abstract": ["How ROS/RNS signals and mitochondrial dysfunction regulate autophagy has not been fully understood.", "The cross-talk between autophagy, redox signalling and mitochondrial dysfunction is not well understood.", "One of the major questions in autophagy, redox signalling, oxidative and nitrative stress is whether autophagy regulation of ROS/RNS levels, intracellular location and effects play different roles in distinct cell types or tissues and in different chronic pathologies.", "To understand the impact of ROS/RNS on autophagy, we briefly outline key elements of the molecular mechanisms and their control.", "ROS regulation of yeast autophagy is evident by an up-regulation of yeast lysosomal cathepsin D homologue (PEP4) in response to H2O2."]}
{"doc_id": 78009, "title": "", "abstract": ["This autophagic process is the sole known mechanism for mitochondrial turnover.", "Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling", "Autophagy is emerging as an important mediator of pathological responses and engages in cross-talk with ROS (reactive oxygen species) and RNS (reactive nitrogen species) in both cell signalling and protein damage.", "The cross-talk between autophagy, redox signalling and mitochondrial dysfunction is not well understood.", "Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is controlled, and the impact of autophagic dysfunction on cellular oxidative stress."]}
{"doc_id": 78010, "title": "", "abstract": ["During starvation, mTOR is inhibited, resulting in the activation of phosphatases and partial dephosphorylation of Atg13 leading to autophagosomal formation (Figure 1).", "Another p53-regulated gene, DRAM (damage-regulated autophagy modulator) promotes autophagy [127].", "Dephosphorylated Atg13 associates with and activates Atg1 homologues {ULK [unc (unco-ordinated family member)-51-like kinase] 1 and 2}, leading to the recruitment of FIP200 (focal adhesion kinase family-interacting protein of 200 kDa), an orthologue of yeast Atg17.", "Downstream of p53, both autophagy- attenuating and autophagy-promoting genes have been found.", "In mammalian cells, when the signalling protein TOR (target of rapamycin) is inhibited in response to starvation, dephosphorylation of Atg13 occurs."]}
{"doc_id": 78011, "title": "", "abstract": ["Dysregulated redox signalling or mitochondrial dysfunction can also influence autophagic activities.", "Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is controlled, and the impact of autophagic dysfunction on cellular oxidative stress.", "Furthermore, we discuss the impact of autophagy on mitochondrial function and accumulation of reactive species.", "The cross-talk between autophagy, redox signalling and mitochondrial dysfunction is not well understood.", "It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress."]}
{"doc_id": 78012, "title": "", "abstract": ["Both O2•− and H2O2 have been shown to mediate autophagy induction [80,82].", "Although exogenous exposure to H2O2 induces autophagy, some evidence suggests that endogenously produced O2•− may also play an important role in the induction of autophagy.", "Autophagy is emerging as an important mediator of pathological responses and engages in cross-talk with ROS (reactive oxygen species) and RNS (reactive nitrogen species) in both cell signalling and protein damage.", "In support of specific mechanisms mediated by redox signalling proteins, starvation-induced ROS formation has been shown to play a key role in autophagic induction through thiol modification of the Cys81 site of Atg4 [80].", "Autophagy plays an important role in both sensing oxidative stress and removing oxidatively damaged proteins and organelles, as well as the cellular machineries responsible for excessive ROS/RNS production."]}
{"doc_id": 78013, "title": "", "abstract": ["Both O2•− and H2O2 have been shown to mediate autophagy induction [80,82].", "Dysregulation of autophagy leads to increases in oxidative stress, as shown by many pharmacological inhibitor and knockout studies (summarized in Table 1).", "Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling", "In mammalian cells, starvation-induced autophagy is associated with increased oxidative stress, and both H2O2 and O2•− have been shown to induce autophagy [80,82].", "The availability of domain-specific redox sensors offers an interesting opportunity to map the progression of autophagy in the cell with oxidative stress [74]."]}
{"doc_id": 78014, "title": "", "abstract": ["Much evidence suggests an involvement of α-synuclein in autophagy, mitochondrial function and ROS-induced cellular damage.", "Although exogenous exposure to H2O2 induces autophagy, some evidence suggests that endogenously produced O2•− may also play an important role in the induction of autophagy.", "Mitochondrial membrane depolarization has been shown to precede the induction of autophagy by nutrient deprivation in hepatocytes, and the depolarized mitochondria co-localize with autophagosomes [177].", "Mitochondrial ROS production and oxidation of mitochondrial lipids have been shown to play a role in autophagy.", "In support of specific mechanisms mediated by redox signalling proteins, starvation-induced ROS formation has been shown to play a key role in autophagic induction through thiol modification of the Cys81 site of Atg4 [80]."]}
{"doc_id": 78015, "title": "", "abstract": ["Dysregulated redox signalling or mitochondrial dysfunction can also influence autophagic activities.", "Some possibilities include the accumulation of toxic proteins and the decrease in mitochondrial function, leading to further oxidative stress when the autophagic process is disrupted [17–19].", "The mechanisms stimulating mitochondrial O2•− are not clear, but they must be independent of class III PI3K, since the inhibitors 3-methyladenine and wortmannin did not change O2•− or H2O2 levels [82].", "This is particularly relevant to degenerative diseases in which oxidative stress occurs over time, and dysfunction in both the mitochondrial and autophagic pathways play a role.", "Parkin-deficient fibroblasts exhibit altered mitochondrial morphology and activities [240]."]}
{"doc_id": 78016, "title": "", "abstract": ["Additional molecules involved in macroautophagy regulation include AMPK (5′-AMP-activated protein kinase) [58], DAPK (death-associated protein kinase) [59] and IP3R (IP3 receptor) [60].", "Many members of the cathepsin family that are important in regulation of autophagy have a cysteine at the active group, which may be susceptible to oxidative modification by metals and redox regulation [43].", "p53-regulated sestrin proteins enhance autophagy via activation of AMPK which inhibits mTOR [128], although evidence for whether sestrin 2 acts as a reductase of sulfinylated peroxidredoxins or has other functions is being investigated [129,130].", "Redox reactions in protein modification are involved in signalling of autophagy.", "Autophagic activities are mediated by a complex molecular machinery including more than 30 Atg (AuTophaGy- related) proteins and 50 lysosomal hydrolases."]}
{"doc_id": 78017, "title": "", "abstract": ["Therefore, indirectly, autophagy can be regulated by transcriptional mechanisms in response to ROS/RNS.", "In support of specific mechanisms mediated by redox signalling proteins, starvation-induced ROS formation has been shown to play a key role in autophagic induction through thiol modification of the Cys81 site of Atg4 [80].", "Although many ROS/RNS have effects on autophagy, besides a handful of known ROS/RNS-targeted autophagy regulators, the exact mechanisms for the effect of ROS/RNS on autophagy are largely unknown.", "Although the general inclination is to categorize autophagy as the activity that decreases ROS/RNS damage, experimental proof is still lacking regarding whether this is true for different species of ROS/RNS produced endogenously at different intracellular locations.", "Much evidence suggests an involvement of α-synuclein in autophagy, mitochondrial function and ROS-induced cellular damage."]}
{"doc_id": 89000, "title": "", "abstract": ["The NLRP3 inflammasome has been implicated in several chronic inflammatory diseases as it can sense inflammatory crystals and aggregated proteins, including Aβ3,4.", "These results reveal an important role for the NLRP3 / caspase-1 axis in AD pathogenesis, and suggest that NLRP3 inflammasome inhibition represents a novel therapeutic intervention for AD.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of Aβ in the APP/PS1 model of Alzheimer’s disease.", "This key role of the NLRP3 inflammasome in Aβ-mediated inflammatory responses suggests that a therapeutic that blocks the activity of the NLRP3 inflammasome or inflammasome-derived cytokines, might effectively interfere with the progression of AD."]}
{"doc_id": 89001, "title": "", "abstract": ["Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "First, the NLRP3/caspase-1-axis may employ substrates other than IL-1β to constrain microglial Aβ phagocytosis.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "Inflammatory mediators that result from NLRP3 inflammasome activation are likely involved in mediating synaptic dysfunction, cognitive impairment and the restriction of beneficial microglial clearance functions.", "This key role of the NLRP3 inflammasome in Aβ-mediated inflammatory responses suggests that a therapeutic that blocks the activity of the NLRP3 inflammasome or inflammasome-derived cytokines, might effectively interfere with the progression of AD."]}
{"doc_id": 89002, "title": "", "abstract": ["To assess the effect of NLRP3 or caspase-1 gene deficiency on neuronal function in murine AD, we determined hippocampal synaptic plasticity, which is considered to represent the basis of newly formed declarative memories and is often analyzed by measuring long term potentiation (LTP)6,7.", "NLRP3−/− mice were crossed into APP/PS1 mice to obtain APP/PS1/NLRP3−/− mice in order to assess the contribution of the NLRP3 inflammasome to the pathogenesis of AD.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "These results reveal an important role for the NLRP3 / caspase-1 axis in AD pathogenesis, and suggest that NLRP3 inflammasome inhibition represents a novel therapeutic intervention for AD.", "Here, we demonstrate strongly enhanced active caspase-1 expression in human MCI and AD brains suggesting a role for the inflammasome in this neurodegenerative disease."]}
{"doc_id": 89003, "title": "", "abstract": ["Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "Inflammasome activation was confirmed by detection of ASC speck formation in microglia isolated from adult mouse.", "Cytokines, including IL-1β, were found to impair microglial clearance functions16,17.", "Immunohistochemistry for the inflammasome component ASC detected microglial “speck” formation in activated (Iba1+) microglia cells from APP/PS1 mice, consistent with inflammasome activation (Fig. 1d).", "Likewise, suppression of inflammatory cytokine production resets microglial phagocytosis in APP/PS1 mice17."]}
{"doc_id": 89004, "title": "", "abstract": ["Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of Aβ in the APP/PS1 model of Alzheimer’s disease.", "NLRP3 gene deficiency conveys a M2 microglial phenotype, decreases NOS2 expression and strongly reduces 3NTyr-Aβ formation", "NLRP3−/− or caspase-1−/− mice carrying mutations associated with familiar AD were largely protected from loss of spatial memory and other AD-associated sequelae and demonstrated reduced brain caspase-1 and IL-1β activation as well as enhanced Aβ clearance.", "Thus, NLRP3- or caspase-1-deficiency results in a skewing of activated microglial cells towards an M2-like activated state.", "NLRP3 gene deficiency leads to decreased Aβ levels and deposition"]}
{"doc_id": 89005, "title": "", "abstract": ["These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "This key role of the NLRP3 inflammasome in Aβ-mediated inflammatory responses suggests that a therapeutic that blocks the activity of the NLRP3 inflammasome or inflammasome-derived cytokines, might effectively interfere with the progression of AD.", "Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "These data suggest that NLRP3 activation negatively impacts the microglial clearance function in AD.", "These results support a fundamental role for NLRP3/caspase-1 mediated inflammation in behavioural and cognitive dysfunction in AD."]}
{"doc_id": 89006, "title": "", "abstract": ["Deposition of amyloid beta peptide (Aβ) drives cerebral neuroinflammation by activating microglia1,2.", "The chronic deposition of Aβ stimulates the persistent activation of microglial cells in Alzheimer´s disease (AD)1.", "APP/PS1 mice express a human/mouse chimeric amyloid precursor protein and human presenilin-1, each carrying mutations associated with familial AD5, leading to the chronic deposition of Aβ, neuroinflammation and cognitive impairment.", "In addition, we observed that inflammasome activation occurred in an age- and Aβ deposition- related fashion (Suppl.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response."]}
{"doc_id": 89007, "title": "", "abstract": ["Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of Aβ in the APP/PS1 model of Alzheimer’s disease.", "NLRP3 or caspase-1 deficiency increases microglial Aβ phagocytosis", "Thus, NLRP3- or caspase-1-deficiency results in a skewing of activated microglial cells towards an M2-like activated state.", "NLRP3 gene deficiency conveys a M2 microglial phenotype, decreases NOS2 expression and strongly reduces 3NTyr-Aβ formation", "Nearly a two-fold increase in Aβ phagocytosis was found in APP/PS1/NLRP3−/− or APP/PS1/Casp-1−/− compared to APP/PS1 mice (Fig. 3a, b), suggesting that NLRP3/caspase-1 inflammasome activation reduces Aβ phagocytosis."]}
{"doc_id": 89008, "title": "", "abstract": ["Prolonged exposure to Aβ leads to persistent activation of microglial cells in AD.", "As AD progresses, microglial cells adopt a chronically activated phenotype.", "Microglia are found in increased numbers in close proximity to Aβ plaques in AD.", "Microglia assembly in the vicinity of plaques is interpreted as an attempt to clear the pathological deposits of Aβ via phagocytosis and degradation.", "In addition to phagocytosis, microglia also contribute to Aβ clearance via proteolytic enzymes, including insulin-degrading enzyme (IDE) and neprilysin (NEP)21."]}
{"doc_id": 89009, "title": "", "abstract": ["Here, we demonstrate strongly enhanced active caspase-1 expression in human MCI and AD brains suggesting a role for the inflammasome in this neurodegenerative disease.", "NLRP3−/− or caspase-1−/− mice carrying mutations associated with familiar AD were largely protected from loss of spatial memory and other AD-associated sequelae and demonstrated reduced brain caspase-1 and IL-1β activation as well as enhanced Aβ clearance.", "Again, NLRP3 or caspase-1 deficient APP/PS1 mice were protected from memory deficits (Suppl.", "However, APP/PS1/NLRP3−/− and APP/PS1/Casp-1−/− mice were largely protected from spatial memory impairment (Fig. 1e, f, Suppl.", "We observed substantially increased amounts of cleaved caspase-1 in hippocampal or cortical lysates from AD, EOAD and MCI patients compared to controls (Fig. 1a, Suppl."]}
{"doc_id": 89010, "title": "", "abstract": ["These results reveal an important role for the NLRP3 / caspase-1 axis in AD pathogenesis, and suggest that NLRP3 inflammasome inhibition represents a novel therapeutic intervention for AD.", "This key role of the NLRP3 inflammasome in Aβ-mediated inflammatory responses suggests that a therapeutic that blocks the activity of the NLRP3 inflammasome or inflammasome-derived cytokines, might effectively interfere with the progression of AD.", "These results support a fundamental role for NLRP3/caspase-1 mediated inflammation in behavioural and cognitive dysfunction in AD.", "NLRP3−/− mice were crossed into APP/PS1 mice to obtain APP/PS1/NLRP3−/− mice in order to assess the contribution of the NLRP3 inflammasome to the pathogenesis of AD.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response."]}
{"doc_id": 89011, "title": "", "abstract": ["Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of Aβ in the APP/PS1 model of Alzheimer’s disease.", "Thus, NLRP3- or caspase-1-deficiency results in a skewing of activated microglial cells towards an M2-like activated state.", "This M2 phenotype is also characterized by increased Aβ clearance and enhanced tissue remodelling.", "NLRP3 gene deficiency conveys a M2 microglial phenotype, decreases NOS2 expression and strongly reduces 3NTyr-Aβ formation", "As AD progresses, microglial cells adopt a chronically activated phenotype."]}
{"doc_id": 89012, "title": "", "abstract": ["Microglia assembly in the vicinity of plaques is interpreted as an attempt to clear the pathological deposits of Aβ via phagocytosis and degradation.", "Microglia are found in increased numbers in close proximity to Aβ plaques in AD.", "Cytokines, including IL-1β, were found to impair microglial clearance functions16,17.", "Furthermore, microglial cells surrounding Aβ plaques in APP/PS1 mice phagocytosed Aβ to a lesser extent (Fig. 3e, g, Suppl.", "In addition to phagocytosis, microglia also contribute to Aβ clearance via proteolytic enzymes, including insulin-degrading enzyme (IDE) and neprilysin (NEP)21."]}
{"doc_id": 89013, "title": "", "abstract": ["These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "The NLRP3 inflammasome has been implicated in several chronic inflammatory diseases as it can sense inflammatory crystals and aggregated proteins, including Aβ3,4.", "However, it remains unknown whether NLRP3 activation contributes to AD in vivo.", "NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice", "Inflammatory mediators that result from NLRP3 inflammasome activation are likely involved in mediating synaptic dysfunction, cognitive impairment and the restriction of beneficial microglial clearance functions."]}
{"doc_id": 19000, "title": "", "abstract": ["The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "Briefly, to generate a standard curve, the SARS-CoV-2 E gene sgRNA was cloned into a pcDNA3.1 expression plasmid; this insert was transcribed using an AmpliCap-Max T7 High Yield Message Maker Kit (Cellscript) to obtain RNA for standards.", "(a) Comparison of pseudovirus NAb in macaques vaccinated with Ad26-S.PP (n=6 biologically independent animals) with previously reported cohorts of convalescent macaques9 (n=9 biologically independent animals) and convalescent humans10 (n=27 biologically independent humans) who had recovered from SARS- CoV-2 infection."]}
{"doc_id": 19001, "title": "", "abstract": ["All 20 sham controls were infected and showed a median peak of 4.89 (range 3.85–6.51) log10 sgRNA copies/ml in BAL (Fig. 4a).", "The Ad26-S.PP vaccine provided complete protection in both the lower and upper respiratory tract with the exception of one animal that showed a low amount of virus in NS, and resulted in >3.2 and >3.9 log10 reductions of median peak sgRNA in BAL and NS, respectively, as compared with sham controls (P<0.0001 and P<0.0001, respectively, two-sided Mann-Whitney tests) (Fig. 5).", "Peak viral loads occurred variably on day 1–4 following challenge.", "Similarly, sham controls showed a median peak of 5.59 (range 3.78–8.01) log10 sgRNA in NS (Fig. 4c).", "Peak viral loads in BAL and NS following challenge."]}
{"doc_id": 19002, "title": "", "abstract": ["In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines.", "These data suggest that NAbs are primarily responsible for protection against SARS-CoV-2 but that other binding and functional antibodies may also play a role.", "These data suggest that serum NAb titers may be a potential biomarker for vaccine protection, although this will need to be confirmed in additional SARS-CoV-2 vaccine efficacy studies in both nonhuman primates and humans."]}
{"doc_id": 19003, "title": "", "abstract": ["In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS."]}
{"doc_id": 19004, "title": "", "abstract": ["(b) S-specific IgG and IgA at week 4 in BAL by ELISA in sham controls and in Ad26-S.PP vaccinated animals.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "A customized multiplexed approach to quantify relative antigen-specific antibody titers was used, as previously described30.", "These data suggest minimal to no virus replication in the Ad26-S.PP vaccinated animals following SARS-CoV-2 challenge.", "The Ad26-S.PP vaccine provided complete protection in both the lower and upper respiratory tract with the exception of one animal that showed a low amount of virus in NS, and resulted in >3.2 and >3.9 log10 reductions of median peak sgRNA in BAL and NS, respectively, as compared with sham controls (P<0.0001 and P<0.0001, respectively, two-sided Mann-Whitney tests) (Fig. 5)."]}
{"doc_id": 19005, "title": "", "abstract": ["The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "The optimal Ad26-S.PP vaccine from this study, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques."]}
{"doc_id": 19006, "title": "", "abstract": ["The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Therefore, microspheres (Luminex) with a unique fluorescence were coupled with SARS-CoV-2 antigens including spike protein (S) and Receptor Binding Domain (RBD) via covalent N-hydroxysuccinimide (NHS)–ester linkages via EDC (Thermo Scientific) and Sulfo-NHS (Thermo Scientific).", "CD8+ and CD4+ T cell responses were directed against multiple SARS-CoV-2 proteins, including spike (S1, S2), nucleocapsid (NCAP), and non-structural proteins (NS6, NS7a, NS8), in the sham controls.", "In contrast, sham controls and animals that received the other vaccines generated higher NAb titers and T cell responses to multiple SARS-CoV-2 proteins following challenge, consistent with our previous observations with DNA vaccines10."]}
{"doc_id": 19007, "title": "", "abstract": ["Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "The optimal Ad26-S.PP vaccine from this study, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "The animals that received the other vaccines generally demonstrated reduced viral loads in NS compared with controls, although protection was optimal with Ad26-S.PP (Fig. 4d).", "These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates."]}
{"doc_id": 19008, "title": "", "abstract": ["The optimal Ad26-S.PP vaccine from this study, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "A principal component analysis showed substantial overlap of the groups, although Ad26-S.PP was the most divergent group (Extended Data Fig. 3).", "The Ad26-S.PP vaccine elicited the highest pseudovirus NAb titers (median 408; range 208–643) and live virus NAb titers (median 113; range 53–233) at week 4 (P<0.05, two-sided Mann-Whitney tests).", "The highest binding antibody responses were observed with the Ad26-tPA.S.PP and Ad26-S.PP vaccines, and the highest effector function responses were seen with the Ad26-S.PP vaccine."]}
{"doc_id": 19009, "title": "", "abstract": ["Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Vaccine-elicited NAb titers prior to challenge correlated with protection in both BAL and NS following challenge, consistent with our previous findings10.", "Antibody correlates of protection.", "These data suggest that serum NAb titers may be a potential biomarker for vaccine protection, although this will need to be confirmed in additional SARS-CoV-2 vaccine efficacy studies in both nonhuman primates and humans.", "To gain further insight into antibody correlates of protection, we defined antibody parameters that distinguished completely protected animals (defined as animals with no detectable sgRNA in BAL or NS following challenge) and partially protected or non-protected animals."]}
{"doc_id": 19010, "title": "", "abstract": ["RBD-specific binding antibodies were assessed by ELISA essentially as described9,10.", "A customized multiplexed approach to quantify relative antigen-specific antibody titers was used, as previously described30.", "We observed RBD-specific binding antibodies by ELISA in 31 of 32 vaccinated animals by week 2 and in all vaccinated animals by week 4 (Fig. 2a).", "ADNP, ADCP, and ADCD assays were performed as previously described31–33.", "Humoral immune responses were assessed at weeks 0, 2, and 4 by (a) RBD- specific binding antibody ELISA, (b) pseudovirus neutralization assays, and (c) live virus neutralization assays."]}
{"doc_id": 19011, "title": "", "abstract": ["The optimal Ad26-S.PP vaccine from this study, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "The highest binding antibody responses were observed with the Ad26-tPA.S.PP and Ad26-S.PP vaccines, and the highest effector function responses were seen with the Ad26-S.PP vaccine."]}
{"doc_id": 19012, "title": "", "abstract": ["The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "The development of a safe and effective SARS-CoV-2 vaccine is a critical global priority.", "The rapid expansion of the COVID-19 pandemic has made the development of a SARS-CoV-2 vaccine a global health and economic priority.", "A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines."]}
{"doc_id": 19013, "title": "", "abstract": ["Cellular immune responses were assessed at week 4 following immunization by (a) IFN-γ ELISPOT assays and (b) IFN-γ+CD4+ and IFN-γ+CD8+ T cell intracellular cytokine staining assays in response to pooled S peptides.", "Cellular immune responses were induced in 30 of 32 vaccinated animals at week 4 by IFN-γ ELISPOT assays using pooled S peptides (Fig. 3a), and multiparameter intracellular cytokine staining assays were utilized to assess IFN-γ+ CD4+ and CD8+ T cell responses (Fig. 3b).", "IFN-γ and IL-4 ELISPOT responses in response to pooled S peptides were assessed in a separate cohort of 10 animals that received 1011 vp of the Ad26-S.PP vaccine at week 2 following vaccination.", "SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "Humoral immune responses were assessed at weeks 0, 2, and 4 by (a) RBD- specific binding antibody ELISA, (b) pseudovirus neutralization assays, and (c) live virus neutralization assays."]}
{"doc_id": 19014, "title": "", "abstract": ["RBD-specific binding antibodies were assessed by ELISA essentially as described9,10.", "Cellular immune responses were induced in 30 of 32 vaccinated animals at week 4 by IFN-γ ELISPOT assays using pooled S peptides (Fig. 3a), and multiparameter intracellular cytokine staining assays were utilized to assess IFN-γ+ CD4+ and CD8+ T cell responses (Fig. 3b).", "### IFN-γ enzyme-linked immunospot (ELISPOT) assay.", "ELISPOT plates were coated with mouse anti-human IFN-γ monoclonal antibody from BD Pharmingen at a concentration of 5 μg/well overnight at 4°C. Plates were washed with DPBS containing 0.25% Tween 20, and blocked with R10 media (RPMI with 11% FBS and 1.1% penicillin-streptomycin) for 1 h at 37°C. The Spike 1 and Spike 2 peptide pools contain 15 amino acid peptides overlapping by 11 amino acids that span the protein sequence and reflect the N- and C- terminal halves of the protein, respectively.", "IFN-γ and IL-4 ELISPOT responses in response to pooled S peptides were assessed in a separate cohort of 10 animals that received 1011 vp of the Ad26-S.PP vaccine at week 2 following vaccination."]}
{"doc_id": 19015, "title": "", "abstract": ["In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "52 rhesus macaques were immunized with Ad26 vectors encoding S variants or sham control and were challenged with SARS-CoV-2 by the intranasal and intratracheal routes9,10.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials."]}
{"doc_id": 19016, "title": "", "abstract": ["These findings are consistent with the largely undetectable viral loads in the Ad26-S.PP vaccinated animals (Fig. 4–5) and suggest exceedingly low levels of virus replication in these animals, if any at all, following challenge.", "To indicate significances in the heatmap, a Benjamini-Hochberg correction was used to correct for multiple comparisons.", "P-values of less than 0.05 were considered significant.", "Indicated samples collected from challenged animals were serially diluted, added to wells, and incubated at 37°C for 1 h.", "Consistent with our prior observations, clinical disease was minimal in all animals following challenge9,10."]}
{"doc_id": 19017, "title": "", "abstract": ["The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "Briefly, the packaging construct psPAX2 (AIDS Resource and Reagent Program), luciferase reporter plasmid pLenti-CMV Puro-Luc (Addgene), and spike protein expressing pcDNA3.1-SARS-CoV-2 SΔCT were co-transfected into HEK293T cells with calcium phosphate.", "SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "Briefly, to generate a standard curve, the SARS-CoV-2 E gene sgRNA was cloned into a pcDNA3.1 expression plasmid; this insert was transcribed using an AmpliCap-Max T7 High Yield Message Maker Kit (Cellscript) to obtain RNA for standards."]}
{"doc_id": 19018, "title": "", "abstract": ["Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Neutralizing antibody (NAb) responses were assessed using both a pseudovirus neutralization assay9,10,16 (Fig. 2b) and a live virus neutralization assay9,10,17,18 (Fig. 2c).", "Vaccine-elicited NAb titers prior to challenge correlated with protection in both BAL and NS following challenge, consistent with our previous findings10.", "To gain further insight into antibody correlates of protection, we defined antibody parameters that distinguished completely protected animals (defined as animals with no detectable sgRNA in BAL or NS following challenge) and partially protected or non-protected animals.", "Antibody correlates of protection."]}
{"doc_id": 19019, "title": "", "abstract": ["It is likely that protection in both the upper and lower respiratory tracts will be required to prevent transmission and disease in humans.", "The Ad26-S.PP vaccine also induced detectable S-specific IgG and IgA responses in bronchoalveolar lavage (BAL) (Extended Data Fig. 2b).", "By contrast, vaccine-elicited ELISPOT responses, CD4+ ICS responses, and CD8+ ICS responses did not correlate with protection (data not shown).", "Our studies also were not specifically designed to assess safety or the possibility of vaccine-associated enhanced respiratory disease or antibody-dependent enhancement of infection29.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection."]}
{"doc_id": 19020, "title": "", "abstract": ["(a) Seven Ad26 vectors were produced expressing SARS-CoV-2 S protein variants: (i) tPA leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S as a strategy to enhance expression (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail, reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP).", "We produced seven Ad26 vectors expressing SARS-CoV-2 S variants that reflected different leader sequences, antigen forms, and stabilization mutations: (i) tissue plasminogen activator (tPA) leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP) (Fig. 1a).", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Briefly, the packaging construct psPAX2 (AIDS Resource and Reagent Program), luciferase reporter plasmid pLenti-CMV Puro-Luc (Addgene), and spike protein expressing pcDNA3.1-SARS-CoV-2 SΔCT were co-transfected into HEK293T cells with calcium phosphate."]}
{"doc_id": 19021, "title": "", "abstract": ["Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "These data suggest that NAbs are primarily responsible for protection against SARS-CoV-2 but that other binding and functional antibodies may also play a role."]}
{"doc_id": 19022, "title": "", "abstract": ["SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "Briefly, to generate a standard curve, the SARS-CoV-2 E gene sgRNA was cloned into a pcDNA3.1 expression plasmid; this insert was transcribed using an AmpliCap-Max T7 High Yield Message Maker Kit (Cellscript) to obtain RNA for standards.", "Viral loads in bronchoalveolar lavage (BAL) and nasal swabs (NS) were assessed by RT-PCR specific for subgenomic mRNA (sgRNA), which is believed to measure replicating virus9,20.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18."]}
{"doc_id": 19023, "title": "", "abstract": ["Generation and Immunogenicity of Ad26 Vaccine Candidates", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "However, we would expect that a two-dose vaccine with Ad26-S.PP would be more immunogenic.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "### Protective Efficacy of Ad26 Vaccine Candidates"]}
{"doc_id": 19024, "title": "", "abstract": ["These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "A single-shot SARS-CoV-2 vaccine would have important logistic and practical advantages compared with a two- dose vaccine for mass vaccination campaigns and pandemic control.", "Analysis of a cohort of 10 similarly immunized animals demonstrated that a single immunization of 1011 vp Ad26-S.PP elicited consistent IFN-γ ELISPOT responses but minimal to no IL-4 ELISPOT responses (Extended Data Fig. 4), suggesting induction of Th1-biased responses.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals."]}
{"doc_id": 19025, "title": "", "abstract": ["Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "However, we would expect that a two-dose vaccine with Ad26-S.PP would be more immunogenic.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "The optimal Ad26 vector-based vaccine for SARS-CoV-2, termed Ad26.COV2.S, is currently being evaluated in clinical trials.", "Whereas inactivated virus vaccines and nucleic acid vaccines typically require two or more immunizations, certain adenovirus vectors can induce robust and durable NAb responses after a single immunization22–24."]}
{"doc_id": 19026, "title": "", "abstract": ["We produced seven Ad26 vectors expressing SARS-CoV-2 S variants that reflected different leader sequences, antigen forms, and stabilization mutations: (i) tissue plasminogen activator (tPA) leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP) (Fig. 1a).", "(a) Seven Ad26 vectors were produced expressing SARS-CoV-2 S protein variants: (i) tPA leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S as a strategy to enhance expression (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail, reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP).", "The S.PP immunogen contains the wildtype leader sequence, the full-length membrane- bound S, mutation of the furin cleavage site, and two proline stabilizing mutations15.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Western blot analyses confirmed S expression in cell lysates from all vectors (Fig. 1b)."]}
{"doc_id": 19027, "title": "", "abstract": ["Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines.", "Antibody correlates of protection.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques."]}
{"doc_id": 19028, "title": "", "abstract": ["52 rhesus macaques were immunized with Ad26 vectors encoding S variants or sham control and were challenged with SARS-CoV-2 by the intranasal and intratracheal routes9,10.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Ad26 vectors were constructed with seven variants of the SARS-CoV-2 spike (S) protein sequence (Wuhan/WIV04/2019; Genbank MN996528.1).", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques."]}
{"doc_id": 19029, "title": "", "abstract": ["Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "(a) Seven Ad26 vectors were produced expressing SARS-CoV-2 S protein variants: (i) tPA leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S as a strategy to enhance expression (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail, reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP).", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "We produced seven Ad26 vectors expressing SARS-CoV-2 S variants that reflected different leader sequences, antigen forms, and stabilization mutations: (i) tissue plasminogen activator (tPA) leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP) (Fig. 1a).", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS."]}
{"doc_id": 19030, "title": "", "abstract": ["The Ad26-S.PP vaccine provided complete protection in both the lower and upper respiratory tract with the exception of one animal that showed a low amount of virus in NS, and resulted in >3.2 and >3.9 log10 reductions of median peak sgRNA in BAL and NS, respectively, as compared with sham controls (P<0.0001 and P<0.0001, respectively, two-sided Mann-Whitney tests) (Fig. 5).", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "It is likely that protection in both the upper and lower respiratory tracts will be required to prevent transmission and disease in humans.", "A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8.", "Correlates of protection in nasal swabs."]}
{"doc_id": 19031, "title": "", "abstract": ["Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Neutralizing antibody (NAb) responses were assessed using both a pseudovirus neutralization assay9,10,16 (Fig. 2b) and a live virus neutralization assay9,10,17,18 (Fig. 2c).", "Adenovirus serotype 26 (Ad26) vectors11 encoding viral antigens have been shown to induce robust humoral and cellular immune responses to various pathogens in both nonhuman primates and humans.", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials."]}
{"doc_id": 19032, "title": "", "abstract": ["SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "Briefly, to generate a standard curve, the SARS-CoV-2 E gene sgRNA was cloned into a pcDNA3.1 expression plasmid; this insert was transcribed using an AmpliCap-Max T7 High Yield Message Maker Kit (Cellscript) to obtain RNA for standards.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "The SARS-CoV-2 nLuc-GFP virus titer was measured in Vero E6 USAMRIID cells, as defined by plaque forming units (PFU) per ml, in a 6-well plate format in quadruplicate biological replicates for accuracy."]}
{"doc_id": 19033, "title": "", "abstract": ["The Ad26-S.PP vaccine elicited the highest pseudovirus NAb titers (median 408; range 208–643) and live virus NAb titers (median 113; range 53–233) at week 4 (P<0.05, two-sided Mann-Whitney tests).", "Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "In contrast, sham controls and animals that received the other vaccines generated higher NAb titers and T cell responses to multiple SARS-CoV-2 proteins following challenge, consistent with our previous observations with DNA vaccines10.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals."]}
{"doc_id": 19034, "title": "", "abstract": ["Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates."]}
{"doc_id": 19035, "title": "", "abstract": ["In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "### Protective Efficacy of Ad26 Vaccine Candidates", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals."]}
{"doc_id": 19036, "title": "", "abstract": ["Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "Sham controls and most of the vaccinated animals (excluding Ad26-S.PP vaccinated animals) developed substantially higher pseudovirus NAb responses (Extended Data Figs. 7–8) as well as CD8+ and CD4+ T cell responses (Extended Data Fig. 9) by day 14 following SARS-CoV-2 challenge.", "Median NAb titers in the Ad26-S.PP vaccinated macaques were 4-fold higher than median NAb titers in previously reported cohorts of 9 convalescent macaques9 and 27 convalescent humans following recovery from SARS-CoV-2 infection10 (P<0.0001, two-sided Mann-Whitney test; Extended Data Fig. 2a).", "In contrast, sham controls and animals that received the other vaccines generated higher NAb titers and T cell responses to multiple SARS-CoV-2 proteins following challenge, consistent with our previous observations with DNA vaccines10."]}
{"doc_id": 19037, "title": "", "abstract": ["Viral loads in bronchoalveolar lavage (BAL) and nasal swabs (NS) were assessed by RT-PCR specific for subgenomic mRNA (sgRNA), which is believed to measure replicating virus9,20.", "(c, d) Log10 sgRNA copies/swab (limit of quantification 50 copies/swab) were assessed in nasal swabs (NS) in sham controls and in vaccinated animals following challenge.", "### Subgenomic mRNA assay.", "All vaccinated animals showed no detectable infectious virus in NS by PFU assays (Extended Data Fig. 5).", "Among the 32 vaccinated macaques, 17 animals were completely protected and had no detectable sgRNA in BAL or NS following challenge, and 5 additional animals had no sgRNA in BAL but showed some virus in NS."]}
{"doc_id": 19038, "title": "", "abstract": ["We also acknowledge support from Janssen Vaccines & Prevention BV, the Ragon Institute of MGH, MIT, and Harvard, Mark and Lisa Schwartz Foundation, Massachusetts Consortium on Pathogen Readiness (MassCPR), and the National Institutes of Health (OD024917, AI129797, AI124377, AI128751, AI126603 to D.H.B.; AI007151 and AI152296 to D.R.M.; AI146779 to A.G.S.; 272201700036I-0-759301900131-1, AI100625, AI110700, AI132178, AI149644, AI108197 to R.S.B.).", "A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8.", "(b) Western blot analyses for expression from Ad26 vaccine vectors encoding tPA.S (lane 2), tPA.S.PP (lane 3), S (lane 4), S.dCT (lane 5), tPA.WT.S (lane 6), S.dTM.PP (lane 7), or S.PP (lane 9) under non-reduced conditions in MRC-5 cell lysates using a human monoclonal antibody (CR3046).", "The Ad26-S.PP vaccine provided complete protection in both the lower and upper respiratory tract with the exception of one animal that showed a low amount of virus in NS, and resulted in >3.2 and >3.9 log10 reductions of median peak sgRNA in BAL and NS, respectively, as compared with sham controls (P<0.0001 and P<0.0001, respectively, two-sided Mann-Whitney tests) (Fig. 5).", "The rapid expansion of the COVID-19 pandemic has made the development of a SARS-CoV-2 vaccine a global health and economic priority."]}
{"doc_id": 19039, "title": "", "abstract": ["Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS."]}
{"doc_id": 19040, "title": "", "abstract": ["Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "However, we would expect that a two-dose vaccine with Ad26-S.PP would be more immunogenic.", "Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS."]}
{"doc_id": 19041, "title": "", "abstract": ["Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "(a) Comparison of pseudovirus NAb in macaques vaccinated with Ad26-S.PP (n=6 biologically independent animals) with previously reported cohorts of convalescent macaques9 (n=9 biologically independent animals) and convalescent humans10 (n=27 biologically independent humans) who had recovered from SARS- CoV-2 infection.", "# Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques"]}
{"doc_id": 19042, "title": "", "abstract": ["Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge.", "These data suggest that NAbs are primarily responsible for protection against SARS-CoV-2 but that other binding and functional antibodies may also play a role."]}
{"doc_id": 19043, "title": "", "abstract": ["Correlation of pseudovirus NAb titers and ELISA or live virus NAb assays in vaccinated macaques.", "Pseudovirus NAb titers correlated with both ELISA titers and live virus NAb titers (P<0.0001, R=0.8314 and P<0.0001, R=0.8427, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 1).", "Cellular immune responses in vaccinated rhesus macaques.", "Cellular immune responses in vaccinated rhesus macaques.", "Correlations of (a) binding ELISA titers, (b) pseudovirus NAb titers, and (c) live virus NAb titers at week 2 and week 4 with log peak sgRNA copies/swab in NS following challenge."]}
{"doc_id": 19044, "title": "", "abstract": ["The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "SARS-CoV-2 E gene subgenomic mRNA (sgRNA or sgmRNA) was assessed by RT-PCR using primers and probes as previously described9,10,20.", "Briefly, to generate a standard curve, the SARS-CoV-2 E gene sgRNA was cloned into a pcDNA3.1 expression plasmid; this insert was transcribed using an AmpliCap-Max T7 High Yield Message Maker Kit (Cellscript) to obtain RNA for standards.", "(a) Comparison of pseudovirus NAb in macaques vaccinated with Ad26-S.PP (n=6 biologically independent animals) with previously reported cohorts of convalescent macaques9 (n=9 biologically independent animals) and convalescent humans10 (n=27 biologically independent humans) who had recovered from SARS- CoV-2 infection."]}
{"doc_id": 19045, "title": "", "abstract": ["RBD-specific binding antibodies were assessed by ELISA essentially as described9,10.", "### IFN-γ enzyme-linked immunospot (ELISPOT) assay.", "### Enzyme-linked immunosorbent assay (ELISA).", "The assay was then performed as described above except the development time with NBT/BCIP chromagen substrate solution was 12 min.", "Cellular immune responses were induced in 30 of 32 vaccinated animals at week 4 by IFN-γ ELISPOT assays using pooled S peptides (Fig. 3a), and multiparameter intracellular cytokine staining assays were utilized to assess IFN-γ+ CD4+ and CD8+ T cell responses (Fig. 3b)."]}
{"doc_id": 19046, "title": "", "abstract": ["However, we would expect that a two-dose vaccine with Ad26-S.PP would be more immunogenic.", "However, it is worth noting that the Ad26-S.PP vaccine elicited Th1-biased rather than Th2-biased T cell responses, and animals with sub-protective NAb titers did not demonstrate enhanced viral replication or clinical disease.", "In contrast, animals that received the Ad26-S.PP vaccine did not demonstrate anamnestic NAb responses (Extended Data Fig. 7) and only showed low T cell responses against spike (S1, S2) (Extended Data Fig. 9), which was the vaccine antigen, following challenge.", "We immunized 52 adult rhesus macaques, 6–12 years old, with Ad26 vectors expressing tPA.S (N=4), tPA.S.PP (N=4), S (N=4), S.dCT (N=4), tPA.WT.S (N=4), S.dTM.PP (N=6), S.PP (N=6), and sham controls (N=20).", "### Ad26 vectors."]}
{"doc_id": 19047, "title": "", "abstract": ["Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "These data suggest that serum NAb titers may be a potential biomarker for vaccine protection, although this will need to be confirmed in additional SARS-CoV-2 vaccine efficacy studies in both nonhuman primates and humans."]}
{"doc_id": 19048, "title": "", "abstract": ["Whereas inactivated virus vaccines and nucleic acid vaccines typically require two or more immunizations, certain adenovirus vectors can induce robust and durable NAb responses after a single immunization22–24.", "NAb titers as measured by both assays were observed in the majority of vaccinated animals at week 2 and generally increased by week 4.", "Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS."]}
{"doc_id": 19049, "title": "", "abstract": ["Neutralizing antibody (NAb) responses were assessed using both a pseudovirus neutralization assay9,10,16 (Fig. 2b) and a live virus neutralization assay9,10,17,18 (Fig. 2c).", "Together with our previously published data10, these findings suggest that serum antibody titers may prove a useful immune correlate of protection for SARS-CoV-2 vaccines.", "In contrast, sham controls and animals that received the other vaccines generated higher NAb titers and T cell responses to multiple SARS-CoV-2 proteins following challenge, consistent with our previous observations with DNA vaccines10.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "SARS-CoV-2 neutralization titers were defined as the sample dilution at which a 50% reduction in RLU was observed relative to the average of the virus control wells."]}
{"doc_id": 19050, "title": "", "abstract": ["RBD-specific binding antibodies were assessed by ELISA essentially as described9,10.", "A customized multiplexed approach to quantify relative antigen-specific antibody titers was used, as previously described30.", "We observed RBD-specific binding antibodies by ELISA in 31 of 32 vaccinated animals by week 2 and in all vaccinated animals by week 4 (Fig. 2a).", "ADNP, ADCP, and ADCD assays were performed as previously described31–33.", "Humoral immune responses were assessed at weeks 0, 2, and 4 by (a) RBD- specific binding antibody ELISA, (b) pseudovirus neutralization assays, and (c) live virus neutralization assays."]}
{"doc_id": 19051, "title": "", "abstract": ["SARS-CoV-2 neutralization titers were defined as the sample dilution at which a 50% reduction in RLU was observed relative to the average of the virus control wells.", "SARS-CoV-2 neutralization titers were defined as the sample dilution at which a 50% reduction in RLU was observed relative to the average of the virus control wells.", "The log10 pseudovirus NAb titer and live virus NAb titer at week 4 inversely correlated with peak log10 sgRNA in BAL (P<0.0001, R=−0.6880 and P<0.0001, R=−0.6562, respectively, two-sided Spearman rank-correlation test) (Fig. 6b–c) and in NS (P<0.0001, R=−0.5839, and P<0.0001, R=−0.5714, respectively, two-sided Spearman rank-correlation test) (Extended Data Fig. 6b–c).", "(a) Comparison of pseudovirus NAb in macaques vaccinated with Ad26-S.PP (n=6 biologically independent animals) with previously reported cohorts of convalescent macaques9 (n=9 biologically independent animals) and convalescent humans10 (n=27 biologically independent humans) who had recovered from SARS- CoV-2 infection.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines."]}
{"doc_id": 19052, "title": "", "abstract": ["The SARS-CoV-2 pseudoviruses expressing a luciferase reporter gene were generated in an approach similar to as described previously9,10,16.", "Briefly, the packaging construct psPAX2 (AIDS Resource and Reagent Program), luciferase reporter plasmid pLenti-CMV Puro-Luc (Addgene), and spike protein expressing pcDNA3.1-SARS-CoV-2 SΔCT were co-transfected into HEK293T cells with calcium phosphate.", "A full-length SARS-CoV-2 virus based on the Seattle Washington isolate was designed to express nanoluciferase (nLuc) and GFP and was recovered via reverse genetics and described previously17,18.", "(a) Comparison of pseudovirus NAb in macaques vaccinated with Ad26-S.PP (n=6 biologically independent animals) with previously reported cohorts of convalescent macaques9 (n=9 biologically independent animals) and convalescent humans10 (n=27 biologically independent humans) who had recovered from SARS- CoV-2 infection.", "Two-fold serial dilutions of heat inactivated serum samples were prepared and mixed with 50 μL of pseudovirus."]}
{"doc_id": 19053, "title": "", "abstract": ["(a) Seven Ad26 vectors were produced expressing SARS-CoV-2 S protein variants: (i) tPA leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S as a strategy to enhance expression (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail, reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP).", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "The S.PP immunogen contains the wildtype leader sequence, the full-length membrane- bound S, mutation of the furin cleavage site, and two proline stabilizing mutations15.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8."]}
{"doc_id": 19054, "title": "", "abstract": ["Neutralizing antibody (NAb) responses were assessed using both a pseudovirus neutralization assay9,10,16 (Fig. 2b) and a live virus neutralization assay9,10,17,18 (Fig. 2c).", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "### Pseudovirus neutralization assay.", "Correlation of pseudovirus NAb titers and ELISA or live virus NAb assays in vaccinated macaques.", "A customized multiplexed approach to quantify relative antigen-specific antibody titers was used, as previously described30."]}
{"doc_id": 97000, "title": "", "abstract": ["These results indicate that GFP+ EMT cells are more resistant to chemotherapy both in vitro and in vivo.", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "e, EMT tumor cells (GFP+ cells) showed resistance to multiple commonly used chemotherapies.", "EMT tumor cells are resistant to chemotherapy", "Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23."]}
{"doc_id": 97001, "title": "", "abstract": ["e, EMT tumor cells (GFP+ cells) showed resistance to multiple commonly used chemotherapies.", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "These results indicate that GFP+ EMT cells are more resistant to chemotherapy both in vitro and in vivo.", "Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23.", "EMT tumor cells are resistant to chemotherapy"]}
{"doc_id": 97002, "title": "", "abstract": ["Given that both epithelial and mesenchymal tumor cells have the potential to disseminate, it is plausible that the larger fraction of highly proliferative epithelial cells out-compete the minor EMT tumor cell population in generating macrometastatic lesions.", "The role of epithelial to mesenchymal transition (EMT) in metastasis is a longstanding source of controversy, largely due to an inability to monitor transient and reversible EMT phenotypes in vivo.", "The epithelial to mesenchymal transition (EMT), wherein epithelial cells depolarize, lose their cell-cell contacts, and gain an elongated, fibroblast-like morphology, is a potential mechanism by which tumor cells gain metastatic features.", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "In this study, we employed multiple transgenic mouse models, establishing a cell lineage tracing approach together with characterization of epithelial and mesenchymal markers, to address the requirement of EMT in metastasis."]}
{"doc_id": 97003, "title": "", "abstract": ["EMT is not required for lung metastasis but contributes to chemoresistance", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "Using two independent EMT lineage tracing strategies in two disparate oncogene-driven autochthonous models of breast cancer, we demonstrated that lung metastases are derived from non-EMT tumor cells, contradicting the original EMT/MET hypothesis2,31.", "Inhibiting EMT by overexpressing miR-200 did not impact lung metastasis development."]}
{"doc_id": 97004, "title": "", "abstract": ["The role of epithelial to mesenchymal transition (EMT) in metastasis is a longstanding source of controversy, largely due to an inability to monitor transient and reversible EMT phenotypes in vivo.", "Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "However, the importance of EMT in vivo is fiercely debated due to significant challenges: mesenchymal tumor cells cannot easily be distinguished from neighboring stromal cells, and metastatic lesions mostly exhibit epithelial phenotypes7.", "Without evidence for the dissemination, colonization, and metastatic outgrowth of mesenchymal tumor cells, the role of EMT will remain contested."]}
{"doc_id": 97005, "title": "", "abstract": ["EMT is not required for lung metastasis but contributes to chemoresistance", "Thus, EMT contributes to the development of chemoresistant metastasis.", "This is in contrast to untreated mice, where all metastatic lesions were derived from RFP+ cells (Fig. 2d), suggesting that the EMT process may be involved in metastatic outgrowth in the context of chemotherapy.", "Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23.", "## EMT is involved in chemoresistance"]}
{"doc_id": 97006, "title": "", "abstract": ["EMT is not required for lung metastasis but contributes to chemoresistance", "Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "However, EMT cells significantly contribute to recurrent lung metastasis formation after chemotherapy.", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "Thus, EMT contributes to the development of chemoresistant metastasis."]}
{"doc_id": 97007, "title": "", "abstract": ["Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23.", "Moreover, through EMT tumor cells acquire cancer stem cell, secondary tumor-initiating and chemoresistance properties4–6.", "To determine if the acquisition of chemoresistance induces specific molecular changes consistent with EMT, we evaluated the orthotopic Tri-PyMT model under chemotherapy.", "The newly established transgenic model also provided us a unique opportunity to study the contribution of EMT to chemoresistance.", "Until now, the majority of data connecting EMT with chemoresistance was largely derived from in vitro studies, or clinical prognostic data."]}
{"doc_id": 97008, "title": "", "abstract": ["Therefore, the absence of EMT during metastasis formation is an oncogene-independent phenomenon, manifesting in both PyMT and Neu-driven tumors.", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "Thus, tumor cells may not undergo EMT to form metastatic lesions.", "To explore the impact of inhibiting EMT on metastasis formation in vivo, we orthotopically injected miR-200 overexpressing Tri-PyMT cells."]}
{"doc_id": 97009, "title": "", "abstract": ["Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "To exclude the possibility that the absence of EMT in metastasis may be unique to PyMT-driven breast tumors, we established EMT lineage tracing in the Neu oncogene-driven16 spontaneous breast cancer model (MMTV-neu/Rosa26-RFP- GFP/Fsp1-Cre, Tri-neu mouse).", "Using two independent EMT lineage tracing strategies in two disparate oncogene-driven autochthonous models of breast cancer, we demonstrated that lung metastases are derived from non-EMT tumor cells, contradicting the original EMT/MET hypothesis2,31.", "Therefore, the absence of EMT during metastasis formation is an oncogene-independent phenomenon, manifesting in both PyMT and Neu-driven tumors.", "To track EMT during metastasis in vivo, we generated a mesenchymal-specific, Cre-mediated fluorescent marker switch strategy and established a triple transgenic mouse model (Tri-PyMT, MMTV-PyMT/Rosa26-RFP-GFP/Fsp1-Cre, Fig. 1a)."]}
{"doc_id": 97010, "title": "", "abstract": ["Thus, EMT contributes to the development of chemoresistant metastasis.", "This is in contrast to untreated mice, where all metastatic lesions were derived from RFP+ cells (Fig. 2d), suggesting that the EMT process may be involved in metastatic outgrowth in the context of chemotherapy.", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "## EMT is involved in chemoresistance", "To determine if the acquisition of chemoresistance induces specific molecular changes consistent with EMT, we evaluated the orthotopic Tri-PyMT model under chemotherapy."]}
{"doc_id": 97011, "title": "", "abstract": ["To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "There is a great emphasis towards developing EMT- targeting therapies35,36, and our studies suggest that while EMT blockade may not affect metastasis formation, specifically targeting EMT tumor cells will be synergistic with conventional chemotherapy.", "EMT is not required for lung metastasis but contributes to chemoresistance", "To exclude the possibility that the absence of EMT in metastasis may be unique to PyMT-driven breast tumors, we established EMT lineage tracing in the Neu oncogene-driven16 spontaneous breast cancer model (MMTV-neu/Rosa26-RFP- GFP/Fsp1-Cre, Tri-neu mouse).", "These results demonstrate that inhibition of EMT by miR-200 overexpression does not impair the ability of tumor cells to form distant lung metastases."]}
{"doc_id": 97012, "title": "", "abstract": ["These cells survived cyclophosphamide treatment due to reduced proliferation, apoptotic tolerance, and elevated expression of chemoresistance-related genes.", "Animals with established primary tumors were treated with cyclophosphamide, a commonly used drug in breast cancer treatment24 (CTX, 100mg/kg, once per week, for 2 weeks prior, and 2 weeks after surgery Fig. 4a).", "These properties of reduced proliferation, increased apoptotic resistance, and upregulation of chemoresistance and drug metabolizing genes in GFP+ EMT tumor cells may contribute to their insensitivity to CTX.", "Tri-PyMT cells were subjected to 2 weeks cyclophosphamide (+CTX) treatment (4 µM).", "a, Schema of cyclophosphamide (CTX) treatment in Tri-PyMT orthotopic model."]}
{"doc_id": 97013, "title": "", "abstract": ["Overexpression of miR-200 abrogated this resistance.", "Animals with established primary tumors were treated with cyclophosphamide, a commonly used drug in breast cancer treatment24 (CTX, 100mg/kg, once per week, for 2 weeks prior, and 2 weeks after surgery Fig. 4a).", "miR-200 overexpression abrogates CTX resistance", "As expected, overexpression of miR-200 inhibited the RFP to GFP conversion (> 90% remaining RFP+, Fig. 3a).", "With increasing concentrations of CTX, the miR-200 cells were significantly more susceptible to therapy (Fig. 5a)."]}
{"doc_id": 97014, "title": "", "abstract": ["e, EMT tumor cells (GFP+ cells) showed resistance to multiple commonly used chemotherapies.", "These results indicate that GFP+ EMT cells are more resistant to chemotherapy both in vitro and in vivo.", "Using two independent EMT lineage tracing strategies in two disparate oncogene-driven autochthonous models of breast cancer, we demonstrated that lung metastases are derived from non-EMT tumor cells, contradicting the original EMT/MET hypothesis2,31.", "However, EMT cells significantly contribute to recurrent lung metastasis formation after chemotherapy.", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy."]}
{"doc_id": 86000, "title": "", "abstract": ["Regarding the mechanism of MYC regulation, it is also possible that CCAT2 participates in the loop formation between the genomic loci of rs6983267 with MYC promoter (Pomerantz et al. 2009) and works together with the enhancer element to activate MYC transcription.", "Consistent with previous findings, we identified TCF7L2 binding to the MYC promoter region and observed enhanced binding in the OC1 clone when compared with the E1 clone (Fig. 5C).", "The direct involvement of MYC in CIN has been previously demonstrated by showing that transient excess of MYC activity could elicit genomic instability and carcinogenesis (Felsher and Bishop 1999).", "Overall, these results suggest that the main mechanism through which CCAT2 increases MYC expression relies on activation of WNT signaling by enhancing TCF7L2 transcriptional activity.", "In view of these associative data and of previous reports describing a long-range interaction between rs6983267 and MYC (Pomerantz et al. 2009; Sotelo et al. 2010), we asked whether CCAT2 plays a role in regulating MYC expression."]}
{"doc_id": 86001, "title": "", "abstract": ["The discovery of short (19–22 nt), noncoding RNAs (ncRNAs)—called microRNAs (miRNAs) (Ambros 2001)—not only revealed a novel mechanism of gene regulation but also led to the identification of miRNAs directly involved in cancer development (Spizzo et al. 2009).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "It is therefore plausible that as- yet-unidentified members of the broader category of ncRNA mapping to cancer- associated genomic regions play rate-limiting roles in tumor initiation and/or progression (Rinn and Chang 2012).", "### CCAT2 promotes cancer growth and metastasis", "For instance, we previously reported that highly conserved genomic regions (ultraconserved regions, or UCRs) (Bejerano et al. 2004) are frequently transcribed as long (>200 bp) ncRNAs (lncRNAs) in both normal and tumor tissues (Calin et al. 2007)."]}
{"doc_id": 86002, "title": "", "abstract": ["Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "This regulation by CCAT2, possibly through its physical interaction with TCF7L2, may lead to genomic instability and promote cell growth.", "(C,D) CCAT2 induces chromosomal instability in an independent set of CCAT2-overexpressing clones.", "CCAT2 promotes tumor growth and metastasis.", "### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples"]}
{"doc_id": 86003, "title": "", "abstract": ["We further identify the physical interaction between CCAT2 and TCF7L2 resulting in an enhancement of WNT signaling activity.", "Overall, these results suggest that the main mechanism through which CCAT2 increases MYC expression relies on activation of WNT signaling by enhancing TCF7L2 transcriptional activity.", "Various mechanisms can be envisaged to explain how the CCAT2/TCF7L2 association can enhance WNT activity.", "Coimmunoprecipitation of CCAT2 (RNA) and TCF7L2 (protein) suggests that CCAT2 may broadly regulate WNT target genes by binding to TCF7L2 and modulating its transcriptional activity.", "Finally, we demonstrated that CCAT2 expression is regulated by transcriptional factors TCF7L2, indicating a positive feedback loop between CCAT2 and WNT signaling."]}
{"doc_id": 86004, "title": "", "abstract": ["We report the identification of CCAT2, a novel lncRNA encompassing the cancer- related rs6983267 SNP and located in a highly conserved genomic region enriched for markers of regulatory elements, such as H3K4me1, p300, and H3K27ac (Pomerantz et al. 2009).", "Furthermore, germline mutations, as well as single nucleotide polymorphisms (SNPs) in ultraconserved ncRNAs, were found to occur more frequently in patients with colon cancer and chronic leukemia than in the general population (Wojcik et al. 2010).", "### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples", "Recent studies have identified RNA–protein interaction as one of the main regulatory mechanisms of lncRNAs (Rinn and Chang 2012).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86005, "title": "", "abstract": ["A model of CCAT2 locus involvement in CRC. (Upper panel) An ∼335-kb DNA loop brings the rs6983267 genomic region close to the MYC locus, and this physical association may contribute to the enhancer function of the SNP-containing region on MYC transcription (Pomerantz et al. 2009).", "Finally, we demonstrated that CCAT2 expression is regulated by transcriptional factors TCF7L2, indicating a positive feedback loop between CCAT2 and WNT signaling.", "A significant positive correlation between CCAT2 and MYC expression was observed in GG samples (n = 52, coefficient = 0.43; P = 0.001), but not in TT samples (n = 45, coefficient = 0.26; P = 0.078) of CRCs (Supplemental Fig. S18).", "Thus, this study lends further support to the oncogenic function of CCAT2 in CRC pathogenesis.", "We show that CCAT2 is itself a WNT downstream target, which suggests the existence of a feedback loop."]}
{"doc_id": 86006, "title": "", "abstract": ["Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples", "In addition, in the Italian cohort of CRC samples (which was the larger available set), we found significantly higher CCAT2 expression levels in primary CRC tumors from patients with metastasis (TNM category M1) than in those without metastasis (M0; P = 0.003) (Fig. 2E).", "CCAT2, a novel lncRNA spanning rs6983267, is overexpressed in colorectal cancer samples.", "(A) Increased CCAT2 and MYC expression in MSS CRC samples."]}
{"doc_id": 86007, "title": "", "abstract": ["CCAT2-enhanced invasion and metastasis appear to occur through the MYC- regulated miRNAs miR-17-5p and miR-20a.", "We demonstrated that MYC-regulated miR-17-5p and miR-20a participate in the CCAT2-enhanced cell invasion and speculate that other mechanisms, such as MYC-related mechanisms (CDC25A) or enhanced WNT signaling (VIM and CD44), may exist to coordinate the metastatic phenotype elicited by CCAT2.", "We demonstrate that MYC, miR–17–5p, and miR–20a are up-regulated by CCAT2 through TCF7L2-mediated transcriptional regulation.", "The observation according to which CCAT2-enhanced invasion is mediated by MYC-regulated miRNAs and also possibly by other pro-metastatic targets such as CDC25A (Feng et al. 2011), rather than by MYC itself, suggests a complex regulatory network that needs to be further explored in the future.", "However, consistent with the consensus that the MIR17HG increases metastasis (Bartley et al. 2011; Zhang et al. 2012), knockdown of miR-17-5p or miR-20a in CCAT2-overexpressing cells led to a significant decrease in cell migration (Fig. 4G; Supplemental Fig. S6I)."]}
{"doc_id": 86008, "title": "", "abstract": ["### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples", "We report the identification of CCAT2, a novel lncRNA encompassing the cancer- related rs6983267 SNP and located in a highly conserved genomic region enriched for markers of regulatory elements, such as H3K4me1, p300, and H3K27ac (Pomerantz et al. 2009).", "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", "(A) Genomic features of the 8q24.21 region spanning SNP rs6983267 and the genomic location of CCAT2.", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86009, "title": "", "abstract": ["Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", "Because chromosomal instability (CIN) represents a main feature of MSS CRCs, and in view of the high CCAT2 expression levels among MSS colon cancers (Fig. 1B,C), we hypothesized that CCAT2 may underlie CIN development.", "The discovery of CCAT2 introduces a novel mechanism for the involvement of ncRNAs in WNT signaling and colon cancer pathogenesis.", "Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk."]}
{"doc_id": 86010, "title": "", "abstract": ["The functional roles of SNPs within the 8q24 gene desert in the cancer phenotype are not yet well understood.", "### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples", "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "We report the identification of CCAT2, a novel lncRNA encompassing the cancer- related rs6983267 SNP and located in a highly conserved genomic region enriched for markers of regulatory elements, such as H3K4me1, p300, and H3K27ac (Pomerantz et al. 2009)."]}
{"doc_id": 86011, "title": "", "abstract": ["CCAT2-enhanced invasion and metastasis appear to occur through the MYC- regulated miRNAs miR-17-5p and miR-20a.", "The observation according to which CCAT2-enhanced invasion is mediated by MYC-regulated miRNAs and also possibly by other pro-metastatic targets such as CDC25A (Feng et al. 2011), rather than by MYC itself, suggests a complex regulatory network that needs to be further explored in the future.", "Overall, these results suggest that the main mechanism through which CCAT2 increases MYC expression relies on activation of WNT signaling by enhancing TCF7L2 transcriptional activity.", "We demonstrated that MYC-regulated miR-17-5p and miR-20a participate in the CCAT2-enhanced cell invasion and speculate that other mechanisms, such as MYC-related mechanisms (CDC25A) or enhanced WNT signaling (VIM and CD44), may exist to coordinate the metastatic phenotype elicited by CCAT2.", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86012, "title": "", "abstract": ["Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "### CCAT2, a novel lncRNA transcript maps to the highly conserved 8q24.21 region encompassing rs6983267 and is overexpressed in microsatellite-stable CRC samples", "CCAT2, a novel lncRNA spanning rs6983267, is overexpressed in colorectal cancer samples.", "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", "We report the identification of CCAT2, a novel lncRNA encompassing the cancer- related rs6983267 SNP and located in a highly conserved genomic region enriched for markers of regulatory elements, such as H3K4me1, p300, and H3K27ac (Pomerantz et al. 2009)."]}
{"doc_id": 86013, "title": "", "abstract": ["These findings suggest that CCAT2 augments TCF7L2 transcriptional activity without increasing the quantity of TCF7L2.", "Overall, these results suggest that the main mechanism through which CCAT2 increases MYC expression relies on activation of WNT signaling by enhancing TCF7L2 transcriptional activity.", "In addition, the findings of decreased MYC expression and reduced TCF7L2 binding upstream of MYC in knockout mice from the same study are also consistent with our findings that CCAT2 regulates MYC transcriptional activity.", "Since MYC is an established target of TCF7L2 as confirmed by the presence of TCF7L2-binding sites in its promoter as well as by functional studies (He et al. 1998), it is possible that CCAT2 affects MYC expression through the mediation of TCF7L2.", "(C) CCAT2 increased TCF7L2 binding to the MYC promoter."]}
{"doc_id": 86014, "title": "", "abstract": ["It is therefore plausible that as- yet-unidentified members of the broader category of ncRNA mapping to cancer- associated genomic regions play rate-limiting roles in tumor initiation and/or progression (Rinn and Chang 2012).", "Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.", "Recent studies have identified RNA–protein interaction as one of the main regulatory mechanisms of lncRNAs (Rinn and Chang 2012).", "The discovery of short (19–22 nt), noncoding RNAs (ncRNAs)—called microRNAs (miRNAs) (Ambros 2001)—not only revealed a novel mechanism of gene regulation but also led to the identification of miRNAs directly involved in cancer development (Spizzo et al. 2009).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86015, "title": "", "abstract": ["Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.", "This is also in agreement with the recent observation by The Cancer Genome Atlas (TCGA) Consortium that MYC-driven transcriptional activation and repression play important roles in colon cancer (The Cancer Genome Atlas Network 2012).", "Although most of the previous studies failed to identify a correlation between this SNP and MYC expression, recent research found higher MYC expression in CRC samples containing GG alleles, probably due to the improved purity of the cancer tissues owing to the use of laser microdissection (Takatsuno et al. 2012).", "This lncRNA is expressed at high levels in MSS CRC tumor tissues and influences MYC levels, but has very low-level expression in normal colon tissues.", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86016, "title": "", "abstract": ["It is therefore plausible that as- yet-unidentified members of the broader category of ncRNA mapping to cancer- associated genomic regions play rate-limiting roles in tumor initiation and/or progression (Rinn and Chang 2012).", "Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "The discovery of short (19–22 nt), noncoding RNAs (ncRNAs)—called microRNAs (miRNAs) (Ambros 2001)—not only revealed a novel mechanism of gene regulation but also led to the identification of miRNAs directly involved in cancer development (Spizzo et al. 2009).", "Furthermore, germline mutations, as well as single nucleotide polymorphisms (SNPs) in ultraconserved ncRNAs, were found to occur more frequently in patients with colon cancer and chronic leukemia than in the general population (Wojcik et al. 2010)."]}
{"doc_id": 86017, "title": "", "abstract": ["We report the identification of CCAT2, a novel lncRNA encompassing the cancer- related rs6983267 SNP and located in a highly conserved genomic region enriched for markers of regulatory elements, such as H3K4me1, p300, and H3K27ac (Pomerantz et al. 2009).", "To explore the molecular mechanism underlying CCAT2's oncogenic potential, we characterized the expression of other transcripts located in the same region: MYC and exons 6 and 8 of DQ515897 (but not POU5F1B) showed expression patterns similar to that of CCAT2, although with smaller differences among MSI-H, and MSS cancers and normal colorectal mucosa (Fig. 4A; Supplemental Fig. S6A).", "The discovery of CCAT2 introduces a novel mechanism for the involvement of ncRNAs in WNT signaling and colon cancer pathogenesis.", "It is therefore plausible that as- yet-unidentified members of the broader category of ncRNA mapping to cancer- associated genomic regions play rate-limiting roles in tumor initiation and/or progression (Rinn and Chang 2012).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability."]}
{"doc_id": 86018, "title": "", "abstract": ["Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", "CCAT2 promotes tumor growth and metastasis.", "### CCAT2 promotes cancer growth and metastasis", "However, it should be noted that although CIN can be the underlying mechanism for CCAT2-promoted tumor growth and metastasis, mechanistic connections of these phenotypes are not established in this study."]}
{"doc_id": 86019, "title": "", "abstract": ["To explore the molecular mechanism underlying CCAT2's oncogenic potential, we characterized the expression of other transcripts located in the same region: MYC and exons 6 and 8 of DQ515897 (but not POU5F1B) showed expression patterns similar to that of CCAT2, although with smaller differences among MSI-H, and MSS cancers and normal colorectal mucosa (Fig. 4A; Supplemental Fig. S6A).", "In addition, the findings of decreased MYC expression and reduced TCF7L2 binding upstream of MYC in knockout mice from the same study are also consistent with our findings that CCAT2 regulates MYC transcriptional activity.", "Regarding the mechanism of MYC regulation, it is also possible that CCAT2 participates in the loop formation between the genomic loci of rs6983267 with MYC promoter (Pomerantz et al. 2009) and works together with the enhancer element to activate MYC transcription.", "A model of CCAT2 locus involvement in CRC. (Upper panel) An ∼335-kb DNA loop brings the rs6983267 genomic region close to the MYC locus, and this physical association may contribute to the enhancer function of the SNP-containing region on MYC transcription (Pomerantz et al. 2009).", "We demonstrate that MYC, miR–17–5p, and miR–20a are up-regulated by CCAT2 through TCF7L2-mediated transcriptional regulation."]}
{"doc_id": 86020, "title": "", "abstract": ["More importantly, spleen injection of CCAT2-overexpressing HCT116 cells into Swiss nu-nu/Ncr nude mice resulted in a higher incidence of liver metastasis (six of nine mice vs. one of five mice) as well as a greater number of metastatic tumors (P = 0.025) than in the control group (Fig. 2D).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "(D) CCAT2 enhances liver metastasis in mice that were incubated by intrasplenic injection with HCT116 cells.", "High CCAT2 RNA levels were associated with shorter metastasis-free survival when analyzed as both a continuous variable (Supplemental Table S1) and as a dichotomized variable using the median level as a cutoff point (Fig. 2F).", "Knockdown of CCAT2 by siRNA, which reduced the CCAT2 expression by 70%, significantly reduced the invasive ability of KM12SM cells (that express high levels of CCAT2), suggesting the involvement of CCAT2 in metastasis (Fig. 2C; Supplemental Fig. S4)."]}
{"doc_id": 86021, "title": "", "abstract": ["This could explain how this new gene has escaped identification, until now, after genome-wide association studies identified the association between the SNP rs6983267 and cancer risk, as well as why tiling arrays did not identify it.", "Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.", "Our findings on SNP-induced differential CCAT2 expression and function, together with the DNA enhancer element (Pomerantz et al. 2009; Tuupanen et al. 2009), provide an explanation on the cancer risk conferred by the rs6983267 risk allele (Fig. 7).", "The rs6983267 SNP, mapping to the 8q24.21 chromosomal region, has been consistently associated with an increased risk of colorectal cancer (CRC) (Haiman et al. 2007): The G allele was associated with greater predisposition to CRC than the T allele (odds ratios of 1.27 and 1.47 for heterozygotes and homozygotes, respectively; P = 1.27 × 10−14) (Tomlinson et al. 2007).", "The increased cancer risk from this SNP variant was also observed in other cancer types, including prostate, ovarian, and inflammatory breast cancer (Ghoussaini et al. 2008; Bertucci et al. 2012)."]}
{"doc_id": 94000, "title": "", "abstract": ["In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%.", "Among white MSM, the group most affected 2006–2008 was men 30–39 years of age, who accounted for 35%, 34%, and 31% of new infections by year and in 2009, men 40–49 years of age, who accounted 30% of new infections (Table 5).", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Among black/African American and Hispanic/Latino MSM, most new infections occurred in the youngest MSM, with MSM 13–29 accounting for 49%, 57%, 62%, and 60% of new infections by year among blacks/African Americans and 40%, 43%, 46%, and 45% of new infections by year among Hispanics/Latinos, compared with 23%, 25%, 28%, and 28% among whites (Table 5).", "Among the 13–29 year age group, by year, MSM made up 62%, 64%, 65%, and 69% of new infections, including 59%, 58%, 62%, and 66% of new infections among blacks/African Americans, 63%, 68% 65%, and 72% of new infections among Hispanics/Latinos, and 65%, 70%, 71%, and 72% of new infections among whites."]}
{"doc_id": 94001, "title": "", "abstract": ["Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Overall, HIV incidence in the United States was relatively stable 2006–2009; however, among young MSM, particularly black/African American MSM, incidence increased.", "Although there was a significant increase in new infections from 2006 to 2009 (34%, 95%CI: 8.4%–60.4%; p = 0.002) among young MSM overall (EAPC = 8.1%, 95% CI: 1.9%–14.9%; p = 0.01), the only significant increase in any MSM subgroup 2006–2009 was among young, black/African American MSM (48%, 95% CI: 12.3%–83.0%; p = 0.001), with EAPC 12.2% (95% CI: 4.2%–20.9%; p = 0.002).", "Among people aged 13–29, only MSM experienced significant increases in incidence, and among 13–29 year-old MSM, incidence increased significantly among young, black/African American MSM."]}
{"doc_id": 94002, "title": "", "abstract": ["Overall, HIV incidence in the United States was relatively stable 2006–2009; however, among young MSM, particularly black/African American MSM, incidence increased.", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities.", "Consistent with the higher rates of HIV diagnoses among MSM in general [13], and of both HIV diagnoses and HIV incidence in African American and Hispanic/Latino men and women [14]–[15], the 2006–2009 HIV incidence estimates continue to demonstrate the disproportionate impact of HIV disease in these groups.", "Based on the revised stratified extrapolation approach for estimating HIV incidence, the number of new infections in the United States remained relatively stable between 2006 and 2009."]}
{"doc_id": 94003, "title": "", "abstract": ["The increase in HIV incidence in young MSM is in line with the increase seen in new diagnoses in MSM in recent years in the United States [16] and internationally [17] as well as with increases in HIV incidence seen in the United States using an extended back-calculation model [4] and with international trends in incidence in MSM [18]–[19].", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "Among people aged 13–29, only MSM experienced significant increases in incidence, and among 13–29 year-old MSM, incidence increased significantly among young, black/African American MSM.", "Although there was a significant increase in new infections from 2006 to 2009 (34%, 95%CI: 8.4%–60.4%; p = 0.002) among young MSM overall (EAPC = 8.1%, 95% CI: 1.9%–14.9%; p = 0.01), the only significant increase in any MSM subgroup 2006–2009 was among young, black/African American MSM (48%, 95% CI: 12.3%–83.0%; p = 0.001), with EAPC 12.2% (95% CI: 4.2%–20.9%; p = 0.002)."]}
{"doc_id": 94004, "title": "", "abstract": ["Overall, HIV incidence in the United States was relatively stable 2006–2009; however, among young MSM, particularly black/African American MSM, incidence increased.", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "The increase in HIV incidence in young MSM is in line with the increase seen in new diagnoses in MSM in recent years in the United States [16] and internationally [17] as well as with increases in HIV incidence seen in the United States using an extended back-calculation model [4] and with international trends in incidence in MSM [18]–[19].", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Among people aged 13–29, only MSM experienced significant increases in incidence, and among 13–29 year-old MSM, incidence increased significantly among young, black/African American MSM."]}
{"doc_id": 94005, "title": "", "abstract": ["Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Although there was a significant increase in new infections from 2006 to 2009 (34%, 95%CI: 8.4%–60.4%; p = 0.002) among young MSM overall (EAPC = 8.1%, 95% CI: 1.9%–14.9%; p = 0.01), the only significant increase in any MSM subgroup 2006–2009 was among young, black/African American MSM (48%, 95% CI: 12.3%–83.0%; p = 0.001), with EAPC 12.2% (95% CI: 4.2%–20.9%; p = 0.002).", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "Within the youngest age group only black/African American males experienced a statistically significant increase in HIV incidence from 5,300 (95% CI: 4,200–6,400) in 2006 to 7,600 (95% CI: 6,300–8,900) in 2009, a 43% increase (95% CI: 11.6%–75.2%; p = 0.001) (Table 2).", "Among people aged 13–29, only MSM experienced significant increases in incidence, and among 13–29 year-old MSM, incidence increased significantly among young, black/African American MSM."]}
{"doc_id": 94006, "title": "", "abstract": ["Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "Because HIV incidence in an area is driven by both risk behavior and HIV prevalence, the HIV incidence estimate may have been higher if these areas had been included.", "The increase in HIV incidence in young MSM is in line with the increase seen in new diagnoses in MSM in recent years in the United States [16] and internationally [17] as well as with increases in HIV incidence seen in the United States using an extended back-calculation model [4] and with international trends in incidence in MSM [18]–[19].", "bHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.", "dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection."]}
{"doc_id": 94007, "title": "", "abstract": ["With an estimated 21% of people living with HIV unaware of their HIV status [24], and the majority of new HIV infections transmitted by these individuals [25], it is important to expand testing to those people most at risk and provide them with care and prevention services.", "In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%.", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities.", "In each year, the most new infections occurred in males (accounting for 75%, 76%, 75%, and 77% of new infections respectively), MSM (56%, 58%, 56%, and 61%), and blacks/African Americans (44%, 42%, 46%, and 44%).", "Consistent with the higher rates of HIV diagnoses among MSM in general [13], and of both HIV diagnoses and HIV incidence in African American and Hispanic/Latino men and women [14]–[15], the 2006–2009 HIV incidence estimates continue to demonstrate the disproportionate impact of HIV disease in these groups."]}
{"doc_id": 94008, "title": "", "abstract": ["Among black/African American and Hispanic/Latino MSM, most new infections occurred in the youngest MSM, with MSM 13–29 accounting for 49%, 57%, 62%, and 60% of new infections by year among blacks/African Americans and 40%, 43%, 46%, and 45% of new infections by year among Hispanics/Latinos, compared with 23%, 25%, 28%, and 28% among whites (Table 5).", "Blacks/African Americans and Hispanics/Latinos experienced the heaviest impact of the epidemic with rates that were 7.4 and 2.8 times the rate in whites respectively in 2006, 7.1 and 3.0 times the rate in whites in 2007, 8.4 and 3.0 times the rate in whites in 2008, and 7.7 and 2.9 times the rate in whites in 2009 (Table 1).", "Among the 13–29 year age group, by year, MSM made up 62%, 64%, 65%, and 69% of new infections, including 59%, 58%, 62%, and 66% of new infections among blacks/African Americans, 63%, 68% 65%, and 72% of new infections among Hispanics/Latinos, and 65%, 70%, 71%, and 72% of new infections among whites.", "In each year, the most new infections occurred in males (accounting for 75%, 76%, 75%, and 77% of new infections respectively), MSM (56%, 58%, 56%, and 61%), and blacks/African Americans (44%, 42%, 46%, and 44%).", "Each year blacks/African American males had the highest rate of new infections, and among women, black/African American women also experienced the highest HIV incidence rates (Figure 1)."]}
{"doc_id": 94009, "title": "", "abstract": ["Based on the revised stratified extrapolation approach with a recalculated mean STARHS recency period using the BED of 162 days and using new diagnoses of HIV infection reported through June 2010, an estimated 48,600 individuals aged 13 years or older in the United States were infected with HIV in 2006 (95% CI: 42,400–54,700), with an additional 56,000 (95% CI: 49,100–62,900), 47,800 (95% CI: 41,800–53,800) and 48,100 (95% CI: 42,200–54,000) infected in 2007, 2008 and 2009, respectively.", "It was estimated that in 2006 approximately 56,300 (95% confidence interval [CI]: 48,200–64,500) individuals were infected with HIV.", "Previously, CDC estimated HIV incidence in the United States in 2006 as 56,300 (95% CI: 48,200–64,500).", "The estimates for 2006–2009 continue to underscore the disproportionate toll that the HIV epidemic has taken on several populations in the United States including racial/ethnic and sexual minorities and injection drug users with 95% of new infections 2006–2009 estimated to have occurred in individuals in one or more of these groups.", "Estimated Incidence of Human Immunodeficiency Virus Infection and Rate per 100,000, 50 U.S. States and the District of Columbia, 2006–2009."]}
{"doc_id": 94010, "title": "", "abstract": ["Based on the revised stratified extrapolation approach with a recalculated mean STARHS recency period using the BED of 162 days and using new diagnoses of HIV infection reported through June 2010, an estimated 48,600 individuals aged 13 years or older in the United States were infected with HIV in 2006 (95% CI: 42,400–54,700), with an additional 56,000 (95% CI: 49,100–62,900), 47,800 (95% CI: 41,800–53,800) and 48,100 (95% CI: 42,200–54,000) infected in 2007, 2008 and 2009, respectively.", "Estimated HIV incidence among persons aged 13 years and older was 48,600 (95% CI: 42,400–54,700) in 2006, 56,000 (95% CI: 49,100–62,900) in 2007, 47,800 (95% CI: 41,800–53,800) in 2008 and 48,100 (95% CI: 42,200–54,000) in 2009.", "(%) [95% CI]a | Rate [95% CI]   Totalb | | 48,600 [42,400–54,700]| 19.8 [17.3–22.2]| 56,000 [49,100–62,900]* | 22.5 [19.7–25.3]", "(%) [95% CI]a | Rate [95% CI]   Totalb | | 47,800 [41,800–53,800]** | 19.0 [16.6–21.4]| 48,100 [42,200–54,000]** | 19.0 [16.6–21.3]", "The rate of new infections overall for 2006 through 2009 was estimated to be 19.8 (95% CI: 17.3–22.2), 22.5 (95% CI: 19.7–25.3), 19.0 (95% CI: 16.6–21.4), and 19.0 (95% CI: 16.6–21.3) per 100,000 individuals, respectively."]}
{"doc_id": 94011, "title": "", "abstract": ["Based on the revised stratified extrapolation approach with a recalculated mean STARHS recency period using the BED of 162 days and using new diagnoses of HIV infection reported through June 2010, an estimated 48,600 individuals aged 13 years or older in the United States were infected with HIV in 2006 (95% CI: 42,400–54,700), with an additional 56,000 (95% CI: 49,100–62,900), 47,800 (95% CI: 41,800–53,800) and 48,100 (95% CI: 42,200–54,000) infected in 2007, 2008 and 2009, respectively.", "Previously, the probability of being detected in the STARHS recency period (P) was simply calculated as the product of two probabilities: (1) that of being tested within one year after infection (P1), and (2) that of an infection being classified recent using STARHS, given a test within one year after infection (Pw).", "We used a nonparametric step function to estimate SW(t), with a mean of 162 days, based on recently-updated estimates of the recency period distribution [7].", "Additionally, using newly available information on the length and distribution of the STARHS recency period would be expected to decrease the estimate by approximately 4% even if no other revisions to the model had been made because the updated mean recency period is 4% higher than the mean recency period used for the previous estimate.", "The BED has been used with STARHS in the United States since 2005 to classify new diagnoses of HIV infection as either recent or long-standing."]}
{"doc_id": 94012, "title": "", "abstract": ["With an estimated 21% of people living with HIV unaware of their HIV status [24], and the majority of new HIV infections transmitted by these individuals [25], it is important to expand testing to those people most at risk and provide them with care and prevention services.", "There is a need to address the prevention needs both of people at risk for HIV infection as well as of those living with HIV disease—those who are aware of their HIV status and those who are not.", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "The estimates for 2006–2009 continue to underscore the disproportionate toll that the HIV epidemic has taken on several populations in the United States including racial/ethnic and sexual minorities and injection drug users with 95% of new infections 2006–2009 estimated to have occurred in individuals in one or more of these groups.", "HIV incidence was essentially unchanged 2006–2009 in Hispanic/Latino, and white males aged 13–29 (Tables 3 and 4)."]}
{"doc_id": 94013, "title": "", "abstract": ["cHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.", "dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.", "bHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.", "bHeterosexual contact with a person known to have, or to be at high risk for, HIV infection.", "In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%."]}
{"doc_id": 94014, "title": "", "abstract": ["In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%.", "Among white MSM, the group most affected 2006–2008 was men 30–39 years of age, who accounted for 35%, 34%, and 31% of new infections by year and in 2009, men 40–49 years of age, who accounted 30% of new infections (Table 5).", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Among the 13–29 year age group, by year, MSM made up 62%, 64%, 65%, and 69% of new infections, including 59%, 58%, 62%, and 66% of new infections among blacks/African Americans, 63%, 68% 65%, and 72% of new infections among Hispanics/Latinos, and 65%, 70%, 71%, and 72% of new infections among whites.", "In each year, the most new infections occurred in males (accounting for 75%, 76%, 75%, and 77% of new infections respectively), MSM (56%, 58%, 56%, and 61%), and blacks/African Americans (44%, 42%, 46%, and 44%)."]}
{"doc_id": 94015, "title": "", "abstract": ["The estimates for 2006–2009 continue to underscore the disproportionate toll that the HIV epidemic has taken on several populations in the United States including racial/ethnic and sexual minorities and injection drug users with 95% of new infections 2006–2009 estimated to have occurred in individuals in one or more of these groups.", "In young people aged 13–29 years the estimated incidence of HIV infection decreased in 2008 as compared to 2007, but remained higher than in 2006, and this group was the only group to evidence a statistically significant increase in HIV incidence between 2006 and 2009 (Table 1).", "If we had expanded the analysis, the HIV incidence estimate for 2006 would have been higher by approximately 1.4% new infections and the estimates for 2007–2009 would have been lower than those presented by 2.3%%, 1.5%, and 3.1%respectively.", "Estimated HIV incidence among persons aged 13 years and older was 48,600 (95% CI: 42,400–54,700) in 2006, 56,000 (95% CI: 49,100–62,900) in 2007, 47,800 (95% CI: 41,800–53,800) in 2008 and 48,100 (95% CI: 42,200–54,000) in 2009.", "The total number of persons aged 13 years and older diagnosed with HIV infection in the surveillance areas for the years 2006–2009 and reported through June 2010 was 29,279, 29,943, 28,831, and 27,040, respectively."]}
{"doc_id": 94016, "title": "", "abstract": ["The increase in HIV incidence in young MSM is in line with the increase seen in new diagnoses in MSM in recent years in the United States [16] and internationally [17] as well as with increases in HIV incidence seen in the United States using an extended back-calculation model [4] and with international trends in incidence in MSM [18]–[19].", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "There was an overall significant increase in HIV incidence from 2006 to 2007 (15%, 95% CI: 3.6%–26.8%; p = 0.006) with increases in men (17%, 95% CI: 3.0%–31.1%; p = 0.01), Hispanics/Latinos (24%, 95%CI: 0.2%–49.7%; p = 0.027), young people 13–29 years old (29%, 95% CI: 8.6%–49.7%; p = 0.002), and MSM (20%, 95% CI: 2.7%–36.8%; p = 0.013).", "However, there was a 21% (95% CI:1.9%–39.8%; p = 0.017) increase in incidence for people aged 13–29 years, driven by a 34% (95% CI: 8.4%–60.4%) increase in young men who have sex with men (MSM).", "HIV incidence among 13–29 year old men who have sex with men (MSM) overall and by race/ethnicity – United States, 2006–2009."]}
{"doc_id": 94017, "title": "", "abstract": ["Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities.", "Consistent with the higher rates of HIV diagnoses among MSM in general [13], and of both HIV diagnoses and HIV incidence in African American and Hispanic/Latino men and women [14]–[15], the 2006–2009 HIV incidence estimates continue to demonstrate the disproportionate impact of HIV disease in these groups.", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "Overall, HIV incidence in the United States was relatively stable 2006–2009; however, among young MSM, particularly black/African American MSM, incidence increased."]}
{"doc_id": 94018, "title": "", "abstract": ["The rate of new infections overall for 2006 through 2009 was estimated to be 19.8 (95% CI: 17.3–22.2), 22.5 (95% CI: 19.7–25.3), 19.0 (95% CI: 16.6–21.4), and 19.0 (95% CI: 16.6–21.3) per 100,000 individuals, respectively.", "We estimated incidence using incidence surveillance data from 16 states and 2 cities and a modification of our previously described stratified extrapolation method based on a sample survey approach with multiple imputation, stratification, and extrapolation to account for missing data and heterogeneity of HIV testing behavior among population groups.", "The estimated incidence in this group was then redistributed to other risk groups consistent with methods previously used to address missing risk factor information in national HIV surveillance data.", "We have applied those same methods in the revised incidence estimation model, imputing missing transmission category values.", "Finally, the estimated incidence within the areas contributing data for estimation was extrapolated to the remaining U.S. areas to obtain a national estimate by applying the group-specific ratio of HIV incidence to diagnoses of AIDS within the areas contributing data to the number of new diagnoses of AIDS in the remaining U.S. areas."]}
{"doc_id": 94019, "title": "", "abstract": ["Each year, the highest rate of new infections was in black/African American males.", "Consistent with the higher rates of HIV diagnoses among MSM in general [13], and of both HIV diagnoses and HIV incidence in African American and Hispanic/Latino men and women [14]–[15], the 2006–2009 HIV incidence estimates continue to demonstrate the disproportionate impact of HIV disease in these groups.", "Among females, blacks/African Americans also had the highest rates of new infections annually.", "Within the youngest age group only black/African American males experienced a statistically significant increase in HIV incidence from 5,300 (95% CI: 4,200–6,400) in 2006 to 7,600 (95% CI: 6,300–8,900) in 2009, a 43% increase (95% CI: 11.6%–75.2%; p = 0.001) (Table 2).", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities."]}
{"doc_id": 94020, "title": "", "abstract": ["The increase in HIV incidence in young MSM is in line with the increase seen in new diagnoses in MSM in recent years in the United States [16] and internationally [17] as well as with increases in HIV incidence seen in the United States using an extended back-calculation model [4] and with international trends in incidence in MSM [18]–[19].", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM.", "The only population with a change in HIV incidence over the entire four-year period was 13–29 year olds, and within that age group, the only risk group experiencing increases was MSM.", "However, there was a 21% (95% CI:1.9%–39.8%; p = 0.017) increase in incidence for people aged 13–29 years, driven by a 34% (95% CI: 8.4%–60.4%) increase in young men who have sex with men (MSM)."]}
{"doc_id": 48000, "title": "", "abstract": ["We used naturalistic stimuli (e.g., dynamic rather than static stimuli, and realistic rather than abstracted or reductive scenes) in light of past research indicating that older children with ASD exhibit large discrepancies between their actual adaptive behavior skills in the real world relative to their cognitive potential in more structured situations30; exhibit larger between-group effect sizes for face-processing deficits with dynamic relative to static stimuli31; and exhibit marked difficulties when attempting to generalize skills from structured, rote environments (in which the skills were initially learned) to environments that are open-ended and rapidly-changing4.", "To examine the longitudinal development of social visual attention, for individual participants and across both ASD and TD groups, we used Functional Data Analysis (FDA)21 and Principal Analysis by Conditional Expectation (PACE)22,34–36 (main text, Figure 1d and 1e for example individual fits, and Figure 2 for group results; also Extended Data Figure 7).", "Contrary to our initial hypothesis2, the data for children with ASD show developmental decline in eye fixation from 2 until 24 months of age (Figure 2c,2d), with average levels of ASD eye looking that appear to begin in the normative range.", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months.", "Eye movements identified as fixations were coded into 4 regions of interest that were defined within each frame of all video stimuli: eyes, mouth, body (neck, shoulders, and contours around eyes and mouth, such as hair), and object (surrounding inanimate stimuli) (Figure 1c, main text)."]}
{"doc_id": 48001, "title": "", "abstract": ["Deficits in eye contact have been a hallmark of autism1,2 since the condition’s initial description3.", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "Contrary to our initial hypothesis2, the data for children with ASD show developmental decline in eye fixation from 2 until 24 months of age (Figure 2c,2d), with average levels of ASD eye looking that appear to begin in the normative range.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months."]}
{"doc_id": 48002, "title": "", "abstract": ["Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "In infants later diagnosed with ASD, decline in eye fixation during the first 2 years is significantly associated with outcome levels of symptom severity", "This contradicts prior hypotheses of a congenital absence of social adaptive orientation2,3,17,18 and suggests instead that some social-adaptive behaviors may initially be intact in newborns later diagnosed with ASD."]}
{"doc_id": 48003, "title": "", "abstract": ["Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "One eye-tracking laboratory was optimized for infants between the ages of 2 and 6 months, and a second setting was optimized for infants and toddlers from 9 to 36 months.", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "Raw data for eyes fixation (a–c), mouth fixation (d–f), body fixation (g–i), and object fixation (j–l) between 2 and 6 months for typically-developing infants (in blue) and infants later diagnosed with autism spectrum disorders (in red).", "Attention to Eyes is Present But in Decline in 2–6 Month-Olds Later Diagnosed with Autism"]}
{"doc_id": 48004, "title": "", "abstract": ["Attention to Eyes is Present But in Decline in 2–6 Month-Olds Later Diagnosed with Autism", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months.", "These observations mark the earliest known indicators of social disability in infancy, but also falsify a prior hypothesis: in the first months of life, this basic mechanism of social adaptive action—eye looking—is not immediately diminished in infants later diagnosed with ASD; instead, eye looking appears to begin at normative levels prior to decline."]}
{"doc_id": 48005, "title": "", "abstract": ["Deficits in eye contact have been a hallmark of autism1,2 since the condition’s initial description3.", "The eye-tracking data collection hardware and software were identical in both settings, and all aspects of automated stimuli presentation, data collection, and analysis were also identical; these have previously been described in 2.", "Two settings for eye-tracking data collection were utilized in this study.", "Visual fixation patterns were measured with eye-tracking hardware (ISCAN, Inc).", "These observations mark the earliest known indicators of social disability in infancy, but also falsify a prior hypothesis: in the first months of life, this basic mechanism of social adaptive action—eye looking—is not immediately diminished in infants later diagnosed with ASD; instead, eye looking appears to begin at normative levels prior to decline."]}
{"doc_id": 48006, "title": "", "abstract": ["One answer is that while the specific biological mechanisms may vary (in genes or pathways affected, in dosage or in timing), any such disruptions will contribute to an individual deviation from normative developmental processes9,10; the mechanisms may initially be different, but a divergence from typical development is shared.", "In the current study, we tested the extent to which measures of these early- emerging normative processes may reveal disruptions in ASD at a point prior to the manifestation of overt symptoms.", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "These results, while still limited in sample size, document the derailment of skills that would otherwise guide typical socialization10,17,18, and this early divergence from normative experience suggests a means by which diverse genetic liabilities are instantiated, developmentally, into a spectrum of affectedness.", "We used naturalistic stimuli (e.g., dynamic rather than static stimuli, and realistic rather than abstracted or reductive scenes) in light of past research indicating that older children with ASD exhibit large discrepancies between their actual adaptive behavior skills in the real world relative to their cognitive potential in more structured situations30; exhibit larger between-group effect sizes for face-processing deficits with dynamic relative to static stimuli31; and exhibit marked difficulties when attempting to generalize skills from structured, rote environments (in which the skills were initially learned) to environments that are open-ended and rapidly-changing4."]}
{"doc_id": 48007, "title": "", "abstract": ["In infants later diagnosed with ASD, growth curves of social visual engagement follow a different developmental course (Figure 2b and Extended Data Figures 2,5,7).", "At 36 months, infant siblings at high-risk for ASD were confirmed either as having ASD; as having subthreshold signs of ASD (HR-ASD_BAP, Broader Autism Phenotype); or as unaffected (HR-ASD_No-Dx).", "Growth charts of social visual engagement for typically-developing children and children diagnosed with ASD", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "Siblings with subthreshold symptoms show neither increasing nor decreasing eye fixation (light purple), and infants later diagnosed with ASD show declining eye fixation (red)."]}
{"doc_id": 48008, "title": "", "abstract": ["The genetic heterogeneity of ASD, however, poses a stark challenge for understanding its biology: how are so many different “causes” instantiated into common forms of disability?", "Contrary to our initial hypothesis2, the data for children with ASD show developmental decline in eye fixation from 2 until 24 months of age (Figure 2c,2d), with average levels of ASD eye looking that appear to begin in the normative range.", "In the current study, we tested the extent to which measures of these early- emerging normative processes may reveal disruptions in ASD at a point prior to the manifestation of overt symptoms.", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "Two settings for eye-tracking data collection were utilized in this study."]}
{"doc_id": 48009, "title": "", "abstract": ["We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "We measured preferential attention to the eyes of others, a skill present in typical infants12 but significantly impaired in 2-year-olds with ASD2.", "To examine the longitudinal development of social visual attention, for individual participants and across both ASD and TD groups, we used Functional Data Analysis (FDA)21 and Principal Analysis by Conditional Expectation (PACE)22,34–36 (main text, Figure 1d and 1e for example individual fits, and Figure 2 for group results; also Extended Data Figure 7).", "Attention to Eyes is Present But in Decline in 2–6 Month-Olds Later Diagnosed with Autism", "In typical development, the processes of normative social interaction are extremely early-emerging: from the first hours and weeks of life, preferential attention to familiar voices11, faces12, face-like stimuli13, and biological motion14 guide typical infants15."]}
{"doc_id": 48010, "title": "", "abstract": ["Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "Attention to Eyes is Present But in Decline in 2–6 Month-Olds Later Diagnosed with Autism", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months.", "In infants later diagnosed with ASD, decline in eye fixation during the first 2 years is significantly associated with outcome levels of symptom severity", "Contrary to our initial hypothesis2, the data for children with ASD show developmental decline in eye fixation from 2 until 24 months of age (Figure 2c,2d), with average levels of ASD eye looking that appear to begin in the normative range."]}
{"doc_id": 48011, "title": "", "abstract": ["In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "In infants later diagnosed with ASD, growth curves of social visual engagement follow a different developmental course (Figure 2b and Extended Data Figures 2,5,7).", "In infants later diagnosed with ASD, decline in eye fixation during the first 2 years is significantly associated with outcome levels of symptom severity", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months."]}
{"doc_id": 48012, "title": "", "abstract": ["We used naturalistic stimuli (e.g., dynamic rather than static stimuli, and realistic rather than abstracted or reductive scenes) in light of past research indicating that older children with ASD exhibit large discrepancies between their actual adaptive behavior skills in the real world relative to their cognitive potential in more structured situations30; exhibit larger between-group effect sizes for face-processing deficits with dynamic relative to static stimuli31; and exhibit marked difficulties when attempting to generalize skills from structured, rote environments (in which the skills were initially learned) to environments that are open-ended and rapidly-changing4.", "To examine the longitudinal development of social visual attention, for individual participants and across both ASD and TD groups, we used Functional Data Analysis (FDA)21 and Principal Analysis by Conditional Expectation (PACE)22,34–36 (main text, Figure 1d and 1e for example individual fits, and Figure 2 for group results; also Extended Data Figure 7).", "In infants later diagnosed with ASD, growth curves of social visual engagement follow a different developmental course (Figure 2b and Extended Data Figures 2,5,7).", "This contradicts prior hypotheses of a congenital absence of social adaptive orientation2,3,17,18 and suggests instead that some social-adaptive behaviors may initially be intact in newborns later diagnosed with ASD.", "Having observed these differences between clearly-defined extremes of social functioning at outcome (ASD and TD), we then analysed data from the remaining high-risk males."]}
{"doc_id": 48013, "title": "", "abstract": ["As a control, we tested whether there were between-group differences in levels of looking at the video stimuli, irrespective of content region.", "Having observed these differences between clearly-defined extremes of social functioning at outcome (ASD and TD), we then analysed data from the remaining high-risk males.", "There were no between-group differences in levels of fixation or saccading, respectively, either as a main effect of diagnosis [F(1,21.652) = 0.958, P = 0.339; F(1,27.189) = 0.250, P = 0.621] or as an interaction of diagnosis by age [F(1,20.026) = 0.880, P = 0.359; F(1,26.430) = 0.561, P = 0.460] (Extended Data Figure 3).", "Control comparisons tested for between-group differences in attention to task and completion of procedures.", "Calibration accuracy was not significantly different between groups, cross-sectionally, at any data collection session (all P > 0.15, t < 1.44; mean P = 0.428), nor longitudinally, as a main effect of diagnosis (F1,2968.336 = 0.202, P = 0.65) or interaction of diagnosis by time (F1,130.551 = 0.027, P = 0.87) (by hierarchical linear modeling; see Methods, Supplementary Materials and Extended Data Figure 8)."]}
{"doc_id": 48014, "title": "", "abstract": ["Calibration accuracy from 2 until 24 months of life in typically-developing children (TD) and in children diagnosed with an autism spectrum disorder (ASD)", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "Raw data for eyes fixation (a–c), mouth fixation (d–f), body fixation (g–i), and object fixation (j–l) between 2 and 6 months for typically-developing infants (in blue) and infants later diagnosed with autism spectrum disorders (in red).", "Individual curve fits for, a, eye fixation data, and, b, change-in-fixation data for typically-developing infants (blue) and infants later diagnosed with ASD (red).", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD."]}
{"doc_id": 48015, "title": "", "abstract": ["In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "This contradicts prior hypotheses of a congenital absence of social adaptive orientation2,3,17,18 and suggests instead that some social-adaptive behaviors may initially be intact in newborns later diagnosed with ASD.", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "a, Data from 6-month-old later diagnosed with ASD, red."]}
{"doc_id": 48016, "title": "", "abstract": ["There were no between-group differences in duration of data collected per child (TD = 71.25(27.66) min, ASD = 64.16(30.77) min, t34 = 0.685, P = 0.498); nor in the distribution of ages at which successful data collection occurred (k = .0759, P = 0.9556; 2-sample Kolmogorov-Smirnov).", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "There were no between-group differences in duration of data collected per child, either in total (t34 = 0.685, P = 0.498) or specifically for the caregiver stimuli (t34 = 0.205, P = 0.839).", "We studied 110 infants, enrolled as risk-based cohorts: N=59 at high- risk for ASD (full siblings of a child with ASD19) and N=51 at low-risk (without 1st, 2nd, or 3rd degree relatives with ASD).", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD."]}
{"doc_id": 48017, "title": "", "abstract": ["From 2–6 months, TD infants look more at the eyes than at mouth, body, or object regions (all F1,23 > 15.74, P < 0.001, by functional ANOVA21) (2a,2e).", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "Raw data for eyes fixation (a–c), mouth fixation (d–f), body fixation (g–i), and object fixation (j–l) between 2 and 6 months for typically-developing infants (in blue) and infants later diagnosed with autism spectrum disorders (in red).", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17."]}
{"doc_id": 48018, "title": "", "abstract": ["Attention to Eyes is Present But in Decline in 2–6 Month-Olds Later Diagnosed with Autism", "Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "In relation to the original sample’s change in eye and body fixation (Figure 3m), these 6 independent test cases show similar trajectories within the first 6 months (Figure 3n).", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months.", "We measured preferential attention to the eyes of others, a skill present in typical infants12 but significantly impaired in 2-year-olds with ASD2."]}
{"doc_id": 48019, "title": "", "abstract": ["To examine the longitudinal development of social visual attention, for individual participants and across both ASD and TD groups, we used Functional Data Analysis (FDA)21 and Principal Analysis by Conditional Expectation (PACE)22,34–36 (main text, Figure 1d and 1e for example individual fits, and Figure 2 for group results; also Extended Data Figure 7).", "The eye-tracking data collection hardware and software were identical in both settings, and all aspects of automated stimuli presentation, data collection, and analysis were also identical; these have previously been described in 2.", "We measured preferential attention to the eyes of others, a skill present in typical infants12 but significantly impaired in 2-year-olds with ASD2.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "We used naturalistic stimuli (e.g., dynamic rather than static stimuli, and realistic rather than abstracted or reductive scenes) in light of past research indicating that older children with ASD exhibit large discrepancies between their actual adaptive behavior skills in the real world relative to their cognitive potential in more structured situations30; exhibit larger between-group effect sizes for face-processing deficits with dynamic relative to static stimuli31; and exhibit marked difficulties when attempting to generalize skills from structured, rote environments (in which the skills were initially learned) to environments that are open-ended and rapidly-changing4."]}
{"doc_id": 48020, "title": "", "abstract": ["Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "In infants later diagnosed with ASD, decline in eye fixation during the first 2 years is significantly associated with outcome levels of symptom severity", "In summary, the current results indicate that the development of infants later diagnosed with ASD differs from that of their typical peers by 2–6 months of age.", "Contrary to our initial hypothesis2, the data for children with ASD show developmental decline in eye fixation from 2 until 24 months of age (Figure 2c,2d), with average levels of ASD eye looking that appear to begin in the normative range.", "In children later diagnosed with ASD, eye looking shows mean decline by at least 2 months."]}
{"doc_id": 48021, "title": "", "abstract": ["Given the small number of girls in the ASD group, we constrained current analyses to males only, N=11 ASD (10 from the high-risk cohort and 1 from the low-risk), and N=25 typically-developing (TD) (all from the low-risk cohort).", "However, such estimates (depending as they do on the data used to build the model, with known diagnostic outcomes) are likely to be optimistic24; to assess bias, we performed an internal validation.", "For details on study design, clinical characterization of participants, and experimental procedures, see Methods and Supplementary Materials.", "Stimuli were sound and luminosity equalized, and were piloted prior to the start of study in order to optimize engagement for typical infant and toddler viewers.", "As an internal validation (Figures 3d–3f), we used leave-one-out cross- validation (LOOCV), partitioning our data into subsamples so that each infant was tested as a validation case (ie, presuming unknown diagnostic outcome) in relation to the remainder of the data set25."]}
{"doc_id": 48022, "title": "", "abstract": ["As shown in Extended Data Figure 1, steeper decline in eye fixation is associated with more severe social disability5: r(9) = −0.750 [−0.27 – −0.93, 95% CI], P = 0.007.", "Saccades were identified by eye velocity using a threshold of 30°/second33.", "The relationship between longitudinal eye fixation and dimensional level of social-communicative disability was tested via regression.", "In both cases saccades were identified with equivalent reliability as compared with both hand coding of the raw eye position data and with high-speed video of the child’s eyes.", "(c) Outcome levels of social disability as a function of decline in eye fixation using subsets of the longitudinal data (i.e., measuring decline in eye fixation using only data collected between months 2–6, excluding data thereafter; then between months 2–9, etc.)."]}
{"doc_id": 92000, "title": "", "abstract": ["But the rapid and high- throughput quantification of the transcriptome became a possibility only with the development of gene expression microarrays [3].", "Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "Another strength of RNA-Seq is in the quantification of individual transcript isoforms [33,34].", "Both sequencing and hybridizing mRNA to arrays are high-throughput ways to profile the transcriptome and for problems that can be addressed by both, they show similar performance and complement each other [29,47,49].", "There is a large range of expression values at the low end on arrays that that are undetectable by RNA- Seq."]}
{"doc_id": 92001, "title": "", "abstract": ["In our experiment, we used biological replicate samples for the arrays and applied moderated t-tests to detect those genes that were differentially expressed between females and males.", "Figure 1 describes an expression experiment designed to identify genes that are differentially expressed in D. pseudoobscura female and male heads, which were manually dissected from flies over dry ice, after which total RNA was extracted followed by a poly A+ selection.", "Colored circles are genes identified as differentially expressed between females and males by microarray analysis with four biological replicates.", "Gene expression microarray results have produced much important information about how the transcriptome is deployed in different cell types [4] and tissues [5], how gene expression changes across development states [6,7] and disease phenotypes [8,9], and how it varies within [10] and between species [11].", "The Gene Expression Omnibus (GEO), the repository of transcriptome datasets managed by the National Center for Biotechnology Information, has more than 520,000 individual experiments archived and around 21,000 project submissions, most produced from microarrays."]}
{"doc_id": 92002, "title": "", "abstract": ["Gene expression microarray results have produced much important information about how the transcriptome is deployed in different cell types [4] and tissues [5], how gene expression changes across development states [6,7] and disease phenotypes [8,9], and how it varies within [10] and between species [11].", "Microarrays first made the analysis of the transcriptome possible, and have produced much important information.", "But the rapid and high- throughput quantification of the transcriptome became a possibility only with the development of gene expression microarrays [3].", "Microarrays require labeling of target material, hybridization to arrays, washing, and scanning to obtain measures of gene expression.", "As a way to introduce and discuss microarrays and deep sequencing for measuring the transcriptome we will use a fly example from our own laboratory: specifically, experiments designed to profile gene expression in female and male heads of Drosophila pseudoobscura."]}
{"doc_id": 92003, "title": "", "abstract": ["RNA-Seq does not depend upon hybridization and thus does not suffer from this potential artifact.", "## Do arrays and RNA-Seq tell a consistent story?", "Data production workflow for RNA-Seq.", "Microarrays require labeling of target material, hybridization to arrays, washing, and scanning to obtain measures of gene expression.", "We conclude that microarrays remain useful and accurate tools for measuring expression levels, and RNA-Seq complements and extends microarray measurements."]}
{"doc_id": 92004, "title": "", "abstract": ["A key first question is whether, when used to ask exactly the same question, both techniques give the same answer.", "Given the substantial agreement between the two methods, the array data in the literature should be durable.", "The relationship is not quite linear, as there appears to be a slight compression in the array data at the high end, but the vast majority of the expression values are similar between the methods.", "Comparing expression metrics from array intensities to RNA-Seq density shows a strong congruence (Figure 3).", "In this article, we discuss the relative merits of the two techniques, the inherent biases in each, and whether all of the vast body of array work needs to be revisited using the newer technology."]}
{"doc_id": 92005, "title": "", "abstract": ["As a way to introduce and discuss microarrays and deep sequencing for measuring the transcriptome we will use a fly example from our own laboratory: specifically, experiments designed to profile gene expression in female and male heads of Drosophila pseudoobscura.", "This technology allows a DNA fragment to be repeatedly sequenced in a very short time - a procedure that is known as deep sequencing and delivers greatly increased sensitivity and accuracy.", "Figure 1 describes an expression experiment designed to identify genes that are differentially expressed in D. pseudoobscura female and male heads, which were manually dissected from flies over dry ice, after which total RNA was extracted followed by a poly A+ selection.", "The gene doublesex, a transcription factor involved in sexual dimorphism in flies, is not detected by RNA-Seq in the deeply sequenced modENCODE embryo samples [37] where it is known to be expressed in a few cells.", "Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice."]}
{"doc_id": 92006, "title": "", "abstract": ["Sequencing by contrast provides direct access to reads that span exon/exon boundaries and in theory makes it possible to study the expression of different isoforms for a gene and to make comparisons of isoform diversity and abundance.", "There are also several general problems with measuring gene expression levels genome-wide that sequencing RNA might make easier.", "Alternative splicing, the mechanism whereby different isoforms of proteins are generated, is acknowledged to be an important source of functional diversity in eukaryotes, but it has been relatively little studied at the level of the transcriptome, principally because of the difficulty of measuring expression for each isoform.", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "In the analysis in Figure 3, our goal was to compare expression measurements between the platforms."]}
{"doc_id": 92007, "title": "", "abstract": ["Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice.", "Finally, because RNA-Seq provides direct access to the sequence this technique can be used on species for which a full genome sequence is not available, whereas the only option in this case for microarrays is to hybridize RNA to a microarray designed for another species, which has limitations because of sequence divergence.", "Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "Another strength of RNA-Seq is in the quantification of individual transcript isoforms [33,34].", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression."]}
{"doc_id": 92008, "title": "", "abstract": ["Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice.", "The RNA-Seq measure of gene expression is density of reads mapping to a particular transcript.", "For highly expressed genes, small amounts of sequencing are sufficient, but for the middle and low end of expression levels, it is clear that many reads are needed.", "We conclude that microarrays remain useful and accurate tools for measuring expression levels, and RNA-Seq complements and extends microarray measurements."]}
{"doc_id": 92009, "title": "", "abstract": ["For example, experimental and computational methods have been developed for dealing with systematic variation between laboratories [12,17-19].", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "For example, many of the tools for sequencing data analysis are now available in Galaxy software, a web interface that provides a user friendly graphical interface [41,42].", "Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "Similarly, RNA-Seq is a sampling method and stochastic events become a source of error in the quantification of rare transcripts [47]."]}
{"doc_id": 92010, "title": "", "abstract": ["That limitation of microarrays can, however, be overcome by what are known as tiling arrays, in which overlapping probes are designed to assay sequences over the entire genome [29-32].", "The greatest current advantage of arrays is their relatively low cost compared with sequencing (in our lab about 10X).", "However it is difficult using tiling arrays to balance the design of probes to achieve full genome coverage while avoiding as far as possible cross-hybridization potential, and this has led to controversy about the extent of the non-coding transcriptome.", "Both sequencing and hybridizing mRNA to arrays are high-throughput ways to profile the transcriptome and for problems that can be addressed by both, they show similar performance and complement each other [29,47,49].", "Presently, using a 12-plex array from Nimblegen our array costs are less than $100 per sample whereas sequencing is around $1,000 per sample."]}
{"doc_id": 92011, "title": "", "abstract": ["Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice.", "There is a large range of expression values at the low end on arrays that that are undetectable by RNA- Seq.", "We conclude that microarrays remain useful and accurate tools for measuring expression levels, and RNA-Seq complements and extends microarray measurements.", "This gene and others at similar expression levels missed by sequencing highlight the problem of detecting genes with low expression no matter what the technique, be it arrays or sequencing.", "Similarly, RNA-Seq is a sampling method and stochastic events become a source of error in the quantification of rare transcripts [47]."]}
{"doc_id": 92012, "title": "", "abstract": ["Figure 2 shows the same analysis performed by RNA-Seq, using an Illumina Genome Analyzer and a commonly deployed protocol for preparing libraries [44].", "For these analyses, we generated about 6 million 36 base pair reads from the Illumina GA I platform and the number of reads per kilobase per million mapped reads (RPKM) was calculated by counting the number of unique mapping reads from the default Illumina mapper (ELAND but the same pattern holds for Bowtie) to the same coding sequence models that were used for constructing probes for the microarray.", "We performed microarray and RNA-Seq experiments on the same samples and then compared expression measurements between microarrays and RNA- Seq.", "We have observed similar congruence in the extremely deep RNA-Seq data in modENCODE D. melanogaster female and male samples [37].", "Both sequencing and hybridizing mRNA to arrays are high-throughput ways to profile the transcriptome and for problems that can be addressed by both, they show similar performance and complement each other [29,47,49]."]}
{"doc_id": 92013, "title": "", "abstract": ["RNA-Seq does not depend upon hybridization and thus does not suffer from this potential artifact.", "Finally, because RNA-Seq provides direct access to the sequence this technique can be used on species for which a full genome sequence is not available, whereas the only option in this case for microarrays is to hybridize RNA to a microarray designed for another species, which has limitations because of sequence divergence.", "That limitation of microarrays can, however, be overcome by what are known as tiling arrays, in which overlapping probes are designed to assay sequences over the entire genome [29-32].", "Because microarray probes are designed on the basis of inferences from prior genomic sequence data, and light intensity is used as surrogate of gene expression, microarrays will miss exon junctions for novel expressed regions and RNA editing events, and cannot easily detect allele-specific differences in gene expression.", "Instead of using molecular hybridization to 'capture' transcript molecules of interest, RNA-Seq samples transcripts present in the starting material by direct sequencing."]}
{"doc_id": 92014, "title": "", "abstract": ["Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice.", "Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "The RNA-Seq measure of gene expression is density of reads mapping to a particular transcript.", "We conclude that microarrays remain useful and accurate tools for measuring expression levels, and RNA-Seq complements and extends microarray measurements."]}
{"doc_id": 92015, "title": "", "abstract": ["Recognition of biases and other artifacts by individual labs and organizations, such as the MicroArray Quality Control (MAQC) consortium, has led to the development of quality control standards that operate to ensure the utility of a well performed microarray experiment [16].", "That limitation of microarrays can, however, be overcome by what are known as tiling arrays, in which overlapping probes are designed to assay sequences over the entire genome [29-32].", "For microarrays, it has taken a decade to understand these biases but for microarrays this has now been achieved and stable analytical solutions have been developed.", "As we have learned more about the design, chemistry and kinetics of array assays, the quality of microarray data has improved dramatically.", "## Microarrays"]}
{"doc_id": 92016, "title": "", "abstract": ["Comparing expression metrics from array intensities to RNA-Seq density shows a strong congruence (Figure 3).", "The correlation between fluorescence intensity as a surrogate for gene expression and the RPKM metric as obtained by mRNA-Seq is high (Pearson's r = 0.90-0.91; Spearman's rho = 0.90-0.91) and slightly higher for just the genes identified as differentially expressed by microarrays (Pearson's r = 0.89-0.92; Spearman's rho = 0.90-0.94).", "The RNA-Seq measure of gene expression is density of reads mapping to a particular transcript.", "Two expression metrics are commonly used which provide a value normalized by overall sequencing depth, FPKM (expected fragments per kilobase of transcript per million fragments mapped) and RPKM (reads per kilobase per million mapped reads) [23,33,40], which are conceptually similar.", "In the case of fold change (c) measurements (female/male), the congruence is reasonable for the entire data set (Pearson's r = 0.62; Spearman's rho = 0.54) but high in the case of the fold change measurements for the genes with sex-biased expression (Pearson's r = 0.92; Spearman's rho = 0.89)."]}
{"doc_id": 92017, "title": "", "abstract": ["In the early days, microarrays designed by different companies appeared to produce different results with the same samples [13].", "We performed microarray and RNA-Seq experiments on the same samples and then compared expression measurements between microarrays and RNA- Seq.", "Because microarray probes are designed on the basis of inferences from prior genomic sequence data, and light intensity is used as surrogate of gene expression, microarrays will miss exon junctions for novel expressed regions and RNA editing events, and cannot easily detect allele-specific differences in gene expression.", "In this article, we discuss the relative merits of the two techniques, the inherent biases in each, and whether all of the vast body of array work needs to be revisited using the newer technology.", "We conclude that microarrays remain useful and accurate tools for measuring expression levels, and RNA-Seq complements and extends microarray measurements."]}
{"doc_id": 84000, "title": "", "abstract": ["A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "This collection is the quasispecies and is organized around a master sequence [12].", "These results suggest that quasispecies diversity, rather than the selection of individual variants, correlates with enhanced virulence [76].", "Flat quasispecies accept mutation without a corresponding effect on fitness, and these mutationally robust populations form a large, selectively neutral network of variants in sequence space."]}
{"doc_id": 84001, "title": "", "abstract": ["These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity.", "A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the course of a few generations.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "This ensemble of mutants forms a “cloud” of variants, or quasispecies, in which mutation generates a swarm of candidate genomes that is pruned by natural selection."]}
{"doc_id": 84002, "title": "", "abstract": ["The demonstration of cooperative interactions among mutants in a population established the relevance of quasispecies theory to studies of viral pathogenesis.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Quasispecies theory suggests that viruses could also achieve resistance by moving to flatter regions of the fitness landscape, where the density of neutral mutations is higher.", "Subpopulations within the diverse quasispecies cooperated with the neurovirulent clone to facilitate its entry into the CNS."]}
{"doc_id": 84003, "title": "", "abstract": ["The unit of selection is the population as a whole, and the nature of the functional interactions among genetically distinct variants is therefore of critical importance to pathogenesis in infected hosts.", "This diversity allows a viral population to rapidly adapt to dynamic environments and evolve resistance to vaccines and antiviral drugs.", "Conversely, a homogeneous population, generated by high replicative fidelity, would lack this flexibility and might be less successful in the dynamic host environment.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Population diversity is a virulence determinant."]}
{"doc_id": 84004, "title": "", "abstract": ["Together, these data suggested that high mutation rates confer an evolutionary advantage to RNA viruses.", "In RNA viruses, elevated mutation rates mean that a fast replicator will give rise to genetically diverse progeny, many of which are significantly less fit than the parent.", "Given their high mutation rates, it is not surprising that many discussions of RNA virus evolution focus on the relationship between genetic diversity and adaptability.", "The evolutionary dynamics of RNA viruses are complex and their high mutation rates, rapid replication kinetics, and large population sizes present a challenge to traditional population genetics [10].", "These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity."]}
{"doc_id": 84005, "title": "", "abstract": ["A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "The demonstration of cooperative interactions among mutants in a population established the relevance of quasispecies theory to studies of viral pathogenesis.", "For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution.", "RNA viruses exist as a quasispecies."]}
{"doc_id": 84006, "title": "", "abstract": ["RNA viruses exist as a quasispecies.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Quasispecies Theory and the Behavior of RNA Viruses", "Because RNA viruses exist as swarms of similar variants that are continuously regenerated by mutation of related sequences, our ability to predict the outcome of an infection or a therapeutic intervention from studies of isolated clones is limited."]}
{"doc_id": 84007, "title": "", "abstract": ["Considerably less is known about how its population-based models apply to the evolutionary behavior of RNA viruses in infected hosts, and it will be challenging to translate them to the complex reality of viral infection in patients.", "How does population diversity influence pathogenesis?", "The rapid evolution of RNA viruses complicates the management of chronic infections and the control of emerging infectious agents [1]–[3].", "The evolutionary dynamics of RNA viruses are complex and their high mutation rates, rapid replication kinetics, and large population sizes present a challenge to traditional population genetics [10].", "A clearer understanding of viral evolutionary dynamics and its relationship to virulence and drug resistance may facilitate the development of more effective therapeutics."]}
{"doc_id": 84008, "title": "", "abstract": ["This ensemble of mutants forms a “cloud” of variants, or quasispecies, in which mutation generates a swarm of candidate genomes that is pruned by natural selection.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A flat quasispecies with an expansive mutant repertoire can explore vast regions of sequence space without consequence and is poised to adapt to rapid environmental change.", "The phenomenon of mutational coupling is one of the defining characteristics of a quasispecies, as it places individual mutants within a functional network of variants [2].", "In quasispecies theory, a network of mutationally coupled variants will span the corresponding peaks and valleys of the fitness landscape."]}
{"doc_id": 84009, "title": "", "abstract": ["These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity.", "A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the course of a few generations.", "This steady accumulation of genetic diversity is punctuated by epochal shifts in antigenicity [33].", "Subsequent rounds of replication will generate a more complex mutant distribution with variants lying farther away from each other in sequence space.", "Absent a true mutational meltdown, a large pre-extinction population could serve as a reservoir for novel mutants that mediate antiviral resistance or immune escape [68]–[70]."]}
{"doc_id": 84010, "title": "", "abstract": ["A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "The demonstration of cooperative interactions among mutants in a population established the relevance of quasispecies theory to studies of viral pathogenesis.", "Flat quasispecies accept mutation without a corresponding effect on fitness, and these mutationally robust populations form a large, selectively neutral network of variants in sequence space.", "This ensemble of mutants forms a “cloud” of variants, or quasispecies, in which mutation generates a swarm of candidate genomes that is pruned by natural selection."]}
{"doc_id": 84011, "title": "", "abstract": ["Given their high mutation rates, it is not surprising that many discussions of RNA virus evolution focus on the relationship between genetic diversity and adaptability.", "The evolutionary dynamics of RNA viruses are complex and their high mutation rates, rapid replication kinetics, and large population sizes present a challenge to traditional population genetics [10].", "Together, these data suggested that high mutation rates confer an evolutionary advantage to RNA viruses.", "Because RNA viruses exist as swarms of similar variants that are continuously regenerated by mutation of related sequences, our ability to predict the outcome of an infection or a therapeutic intervention from studies of isolated clones is limited.", "In RNA viruses, elevated mutation rates mean that a fast replicator will give rise to genetically diverse progeny, many of which are significantly less fit than the parent."]}
{"doc_id": 84012, "title": "", "abstract": ["For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution.", "Here, we discuss basic principles of quasispecies theory and describe its relevance for our understanding of viral fitness, virulence, and antiviral therapeutic strategy.", "Many predictions of quasispecies theory run counter to traditional views of microbial behavior and evolution and have profound implications for our understanding of viral disease.", "Quasispecies theory suggests that viruses could also achieve resistance by moving to flatter regions of the fitness landscape, where the density of neutral mutations is higher.", "Quasispecies theory has had a profound influence on virology, and experiments with model RNA viruses have validated many of its predictions."]}
{"doc_id": 84013, "title": "", "abstract": ["Third, increasing the fidelity of genome replication may paradoxically attenuate viruses.", "Subpopulations within the diverse quasispecies cooperated with the neurovirulent clone to facilitate its entry into the CNS.", "As in the case of lethal mutagenesis, the modulation of fidelity offers an opportunity to use mutation rate as a therapeutic strategy for the control of viral disease.", "This diversity allows a viral population to rapidly adapt to dynamic environments and evolve resistance to vaccines and antiviral drugs.", "Quasispecies theory suggests that viruses could also achieve resistance by moving to flatter regions of the fitness landscape, where the density of neutral mutations is higher."]}
{"doc_id": 84014, "title": "", "abstract": ["RNA viruses exist as a quasispecies.", "Quasispecies Theory and the Behavior of RNA Viruses", "Discerning quasispecies structure from the wealth of sequencing data presents significant computational challenges as well, since current techniques are underdeveloped and do not permit us to determine which mutations are linked on the same genome.", "The demonstration of cooperative interactions among mutants in a population established the relevance of quasispecies theory to studies of viral pathogenesis.", "Quasispecies theory has had a profound influence on virology, and experiments with model RNA viruses have validated many of its predictions."]}
{"doc_id": 84015, "title": "", "abstract": ["These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity.", "A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the course of a few generations.", "Given the large population sizes observed in both experimental and natural infections, it is estimated that every possible point mutation and many double mutations are generated with each viral replication cycle and may be present within the population at any time [17].", "In RNA viruses, elevated mutation rates mean that a fast replicator will give rise to genetically diverse progeny, many of which are significantly less fit than the parent.", "Conversely, longitudinal studies of dengue virus isolates have identified defective clones that are stably maintained at a high frequency in the population [23]."]}
{"doc_id": 84016, "title": "", "abstract": ["For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "RNA viruses exist as a quasispecies.", "More recently, quasispecies theory has been used to describe the evolutionary dynamics of RNA viruses, and many of its predictions have been validated experimentally in model systems [2], [14], [15].", "Quasispecies theory has had a profound influence on virology, and experiments with model RNA viruses have validated many of its predictions."]}
{"doc_id": 84017, "title": "", "abstract": ["Given their high mutation rates, it is not surprising that many discussions of RNA virus evolution focus on the relationship between genetic diversity and adaptability.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Together, these data suggested that high mutation rates confer an evolutionary advantage to RNA viruses.", "The evolutionary dynamics of RNA viruses are complex and their high mutation rates, rapid replication kinetics, and large population sizes present a challenge to traditional population genetics [10]."]}
{"doc_id": 84018, "title": "", "abstract": ["RNA viruses exist as a quasispecies.", "Because RNA viruses exist as swarms of similar variants that are continuously regenerated by mutation of related sequences, our ability to predict the outcome of an infection or a therapeutic intervention from studies of isolated clones is limited.", "A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution."]}
{"doc_id": 84019, "title": "", "abstract": ["Quasispecies theory is a mathematical framework that was initially formulated to explain the evolution of life in the “precellular RNA world [11].”", "Here, we discuss basic principles of quasispecies theory and describe its relevance for our understanding of viral fitness, virulence, and antiviral therapeutic strategy.", "Quasispecies theory predicts that slower replicators will be favored if they give rise to progeny that are on average more fit; these populations occupy short, flat regions of the fitness landscape [18].", "More recently, quasispecies theory has been used to describe the evolutionary dynamics of RNA viruses, and many of its predictions have been validated experimentally in model systems [2], [14], [15].", "For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution."]}
{"doc_id": 84020, "title": "", "abstract": ["RNA viruses exist as a quasispecies.", "A quasispecies that occupies a broad, flat region of sequence space could access neutral networks and local fitness peaks in either environment.", "Quasispecies Theory and the Behavior of RNA Viruses", "More recently, quasispecies theory has been used to describe the evolutionary dynamics of RNA viruses, and many of its predictions have been validated experimentally in model systems [2], [14], [15].", "A flat quasispecies with an expansive mutant repertoire can explore vast regions of sequence space without consequence and is poised to adapt to rapid environmental change."]}
{"doc_id": 84021, "title": "", "abstract": ["A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Many predictions of quasispecies theory run counter to traditional views of microbial behavior and evolution and have profound implications for our understanding of viral disease.", "## Error-Prone Replication and Viral Quasispecies", "These results suggest that quasispecies diversity, rather than the selection of individual variants, correlates with enhanced virulence [76].", "The demonstration of cooperative interactions among mutants in a population established the relevance of quasispecies theory to studies of viral pathogenesis."]}
{"doc_id": 84022, "title": "", "abstract": ["In RNA viruses, elevated mutation rates mean that a fast replicator will give rise to genetically diverse progeny, many of which are significantly less fit than the parent.", "The evolutionary dynamics of RNA viruses are complex and their high mutation rates, rapid replication kinetics, and large population sizes present a challenge to traditional population genetics [10].", "Given their high mutation rates, it is not surprising that many discussions of RNA virus evolution focus on the relationship between genetic diversity and adaptability.", "Together, these data suggested that high mutation rates confer an evolutionary advantage to RNA viruses.", "A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the course of a few generations."]}
{"doc_id": 84023, "title": "", "abstract": ["This effect, termed survival of the flattest, has been observed in digital organisms, bacteriophages, and VSV [24]–[28].", "The effect is dramatic—a 4-fold increase in mutation rate resulted in a 95% reduction in viral titer.", "At low mutation rates, the fast replicator will triumph because its progeny are genetically identical and generated more quickly.", "The fitness landscape and survival of the flattest.", "Do the principles of mutational robustness and survival of the flattest determine the behavior of populations in the host ecosystem?"]}
{"doc_id": 84024, "title": "", "abstract": ["That is, a low fitness variant can be maintained at a higher than expected frequency because it is coupled to a well-represented, higher fitness genotype in sequence space.", "Early experiments with vesicular stomatitis virus (VSV) established that high fitness variants could be suppressed to low levels within a complex population [22].", "(B) At low mutation rates, variants will be genotypically stable and cluster at the top of the fitness peak.", "The variant with the highest fitness will easily outcompete all others.", "While these variants are generally less fit, they may quickly dominate if a sudden change in environment, such as immune pressure, shifts the corresponding fitness landscape."]}
{"doc_id": 84025, "title": "", "abstract": ["Because of their high mutation rates, these viruses are moving targets for therapeutic intervention and frequently develop resistance to vaccines and antiviral drugs [9].", "This diversity allows a viral population to rapidly adapt to dynamic environments and evolve resistance to vaccines and antiviral drugs.", "These viruses replicate with extremely high mutation rates and exhibit significant genetic diversity.", "A virus replicating with a high mutation rate will generate a diverse mutant repertoire over the course of a few generations.", "At high mutation rates, variants spread out over the corresponding peaks."]}
{"doc_id": 84026, "title": "", "abstract": ["Because RNA viruses exist as swarms of similar variants that are continuously regenerated by mutation of related sequences, our ability to predict the outcome of an infection or a therapeutic intervention from studies of isolated clones is limited.", "For RNA viruses, low replicative fidelity generates a diverse population of variants.", "RNA viruses exist as a quasispecies.", "In the case of influenza, detailed antigenic mapping of the hemagglutinin protein suggests that interpandemic strains remain antigenically stable for years despite genetic drift and evolve over a neutral region of sequence space.", "Given their high mutation rates, it is not surprising that many discussions of RNA virus evolution focus on the relationship between genetic diversity and adaptability."]}
{"doc_id": 56000, "title": "", "abstract": ["Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "All hESC-CM grafts identified in every transplanted animal showed 1:1 coupling.", "In contrast to small animal models 7, non-fatal ventricular arrhythmias were observed in hESC-CM engrafted primates.", "Large animal models are important forerunners to human trials, because they impart real-world rigor to issues such as cell production, delivery and end-point analyses, while permitting mechanistic studies not possible in patients 18,19.", "Few CD3+ T-lymphocytes or CD20+ B-lymphocytes were found within or around the hESC-CM grafts, suggesting our immunosuppression successfully prevented graft rejection (Extended Data Fig. 9)."]}
{"doc_id": 56001, "title": "", "abstract": ["Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "The cell-treated animals showed variable responses, with some having increased function and some having decreased function.", "Large animal models are important forerunners to human trials, because they impart real-world rigor to issues such as cell production, delivery and end-point analyses, while permitting mechanistic studies not possible in patients 18,19.", "Whilst iPSCs have promising therapeutic potential 10,12 a number of factors are likely to slow their regulatory approval 2.", "Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure 1 by providing human cardiomyocytes to support heart regeneration 2."]}
{"doc_id": 56002, "title": "", "abstract": ["Human pluripotent stem cells have indisputable cardiomyocyte generating abilities and have been extensively investigated for repair of the injured heart 3,4,6–10.", "Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure 1 by providing human cardiomyocytes to support heart regeneration 2.", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "These stem cells are derived either from developing blastocytsts (human Embryonic Stem Cells; hESCs) or from reprogrammed somatic cells (Induced Pluripotent Stem Cells; iPSC) 11.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts"]}
{"doc_id": 56003, "title": "", "abstract": ["Importantly, all of the human cardiomyocytes showed complete electrical coupling to the primate heart and responded normally to pacing up to 240 beats/min (the fastest rate attempted).", "Large animal models are important forerunners to human trials, because they impart real-world rigor to issues such as cell production, delivery and end-point analyses, while permitting mechanistic studies not possible in patients 18,19.", "Furthermore, it remains unclear if the favorable cardiac repair findings in small animal models will be reproduced in more clinically relevant large animal models.", "Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts"]}
{"doc_id": 56004, "title": "", "abstract": ["In contrast to small animal models 7, non-fatal ventricular arrhythmias were observed in hESC-CM engrafted primates.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Our previous studies in mice 15, rats 6,8 and guinea pigs 7 gave no evidence of arrhythmias after hESC-CM engraftment, whereas arrhythmias were consistently observed in the current study.", "No arrhythmias were noted in hESC-CM treated monkeys during the period after MI but before hESC-CM delivery (Fig. 5 e–h).", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI)."]}
{"doc_id": 56005, "title": "", "abstract": ["Our previous studies in mice 15, rats 6,8 and guinea pigs 7 gave no evidence of arrhythmias after hESC-CM engraftment, whereas arrhythmias were consistently observed in the current study.", "In contrast, all macaques that received hESC-CMs displayed arrhythmias.", "There are several possible mechanisms for the observed arrhythmias, including re-entrant circuits or graft automaticity 20–22.", "Secondary endpoints were 1) detection of arrhythmias by telemetric electrocardiogram analysis and 2) analysis of left ventricular functional change by trans- esophageal echocardiography.", "Consequently, we cannot determine with statistical certainty that the observed arrhythmias directly result from transplanted hESC-CM."]}
{"doc_id": 56006, "title": "", "abstract": ["As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "These were used to prove exogenously delivered hESC-CMs could electrically couple to the host heart in a guinea pig MI model 7.", "Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "All hESC-CM-treated monkeys showed significant remuscularization of the infarct areas (Fig. 1 a–g, Extended Data Fig. 7).", "Thus, hESC-CMs can remuscularize substantial amounts of the infarcted monkey heart."]}
{"doc_id": 56007, "title": "", "abstract": ["Human pluripotent stem cells have indisputable cardiomyocyte generating abilities and have been extensively investigated for repair of the injured heart 3,4,6–10.", "Cardiomyocytes at the edges of grafts (g,j,m,p) display greater maturation compared to those at central core (h,k,n,q) evidenced by increased size, α-actinin staining intensity, sarcomere alignment (g–k) and N-cadherin expression (m–q).", "hESCs were then differentiated into cardiomyocytes using a previously reported directed differentiation protocol.", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Flow cytometry was used to assess cardiomyocyte purity, and the hESC-CMs used in these studies were 73+/−12% positive for cardiac TroponinT (cTnT; Extended Data Fig. 4)."]}
{"doc_id": 56008, "title": "", "abstract": ["In contrast to small animal models 7, non-fatal ventricular arrhythmias were observed in hESC-CM engrafted primates.", "No arrhythmias were noted in hESC-CM treated monkeys during the period after MI but before hESC-CM delivery (Fig. 5 e–h).", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Our previous studies in mice 15, rats 6,8 and guinea pigs 7 gave no evidence of arrhythmias after hESC-CM engraftment, whereas arrhythmias were consistently observed in the current study."]}
{"doc_id": 56009, "title": "", "abstract": ["Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Extrapolating results from our previous studies 6–8,15, we reasoned that significant engraftment in the larger NHP heart required delivery of 1 × 109 cells.", "Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Greater than 98% of engrafted human cells expressed the sarcomeric protein α-actinin (Extended Data Fig. 8a), indicating that almost all graft cells were cardiomyocytes."]}
{"doc_id": 56010, "title": "", "abstract": ["Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Importantly, all of the human cardiomyocytes showed complete electrical coupling to the primate heart and responded normally to pacing up to 240 beats/min (the fastest rate attempted).", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Nevertheless, the extent of remuscularization and electromechanical coupling seen here encourages further development of human cardiomyocyte transplantation as a clinical therapy for heart failure."]}
{"doc_id": 56011, "title": "", "abstract": ["MI was confirmed by ST segment elevation on ECG and by subsequent serum assays for cardiac troponin and creatine kinase.", "Flow cytometry was used to assess cardiomyocyte purity, and the hESC-CMs used in these studies were 73+/−12% positive for cardiac TroponinT (cTnT; Extended Data Fig. 4).", "cTnT = cardiac troponin T.", "Myocardial infarction (MI) was created by advancing a balloon catheter into the distal left anterior descending artery and inflating it to create ischemia (90 minutes) followed by reperfusion.", "Eight macaques were subjected to myocardial infarction."]}
{"doc_id": 56012, "title": "", "abstract": ["As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "These experiments demonstrate that hESCs can be grown, differentiated into cardiomyocytes and cryopreserved at a scale sufficient to treat a large animal model of MI."]}
{"doc_id": 56013, "title": "", "abstract": ["We previously used zinc-finger nuclease (ZFN)-mediated gene targeting to create hESC-CMs (H7 parental ESC line) stably expressing the genetically encoded fluorescent calcium indicator, GCaMP3, from the AAVS1 locus (Extended Data Fig. 2) 7.", "For both of these hESC-GCaMP3 lines we used our well-established monolayer protocol of directed differentiation (as above) to produce a high yield of cardiomyoctes 8.", "The ZFN approach was again used to target the GCaMP3 construct to the AAVS1 locus (Extended Data Fig. 2a) in Rockefeller University Embryonic Stem Cell line 2 (RUES2) hESCs.", "For the initial NHP experiments we used this same cell line.", "A genomic probe was generated using the following primers: GGAGGTGGTGCGCTTCTTGG (forward), CGCATCCCCTCCCAGAAAGAC (reverse), and neomycin cassette probe: ATGGGATCGGCCATTGAACAAG (forward), GAAGAACTCGTCAAGAAGGCG (reverse)."]}
{"doc_id": 56014, "title": "", "abstract": ["Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "### Non-Human Primate Surgery", "In contrast to small animal models 7, non-fatal ventricular arrhythmias were observed in hESC-CM engrafted primates."]}
{"doc_id": 56015, "title": "", "abstract": ["Human pluripotent stem cells have indisputable cardiomyocyte generating abilities and have been extensively investigated for repair of the injured heart 3,4,6–10.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure 1 by providing human cardiomyocytes to support heart regeneration 2.", "These stem cells are derived either from developing blastocytsts (human Embryonic Stem Cells; hESCs) or from reprogrammed somatic cells (Induced Pluripotent Stem Cells; iPSC) 11."]}
{"doc_id": 56016, "title": "", "abstract": ["The ZFN approach was again used to target the GCaMP3 construct to the AAVS1 locus (Extended Data Fig. 2a) in Rockefeller University Embryonic Stem Cell line 2 (RUES2) hESCs.", "A transgene encoding for the constitutive expression of GCaMP3 was inserted into the AAVS1 locus in H7 and RUES2 hESCs, using methods adapted from a previous study 30 (see Extended Data Fig. 2).", "These were used to prove exogenously delivered hESC-CMs could electrically couple to the host heart in a guinea pig MI model 7.", "AAVS1 ZFN (5-mg) and AAVS1 CAG GCaMP3 targeting vector plasmids were co-electroporated (Lonza, Nucleofection system) into hESCs cultured in MEF-CM supplemented with 10 mM Y-27632.", "We previously used zinc-finger nuclease (ZFN)-mediated gene targeting to create hESC-CMs (H7 parental ESC line) stably expressing the genetically encoded fluorescent calcium indicator, GCaMP3, from the AAVS1 locus (Extended Data Fig. 2) 7."]}
{"doc_id": 56017, "title": "", "abstract": ["Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "These experiments demonstrate that hESCs can be grown, differentiated into cardiomyocytes and cryopreserved at a scale sufficient to treat a large animal model of MI.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "It remains unknown, however, whether clinical scale hESC-CMs transplantation is feasible, safe or can provide large-scale myocardial regeneration.", "Flow cytometry was used to assess cardiomyocyte purity, and the hESC-CMs used in these studies were 73+/−12% positive for cardiac TroponinT (cTnT; Extended Data Fig. 4)."]}
{"doc_id": 56018, "title": "", "abstract": ["hESCs were then differentiated into cardiomyocytes using a previously reported directed differentiation protocol.", "Undifferentiated H7 24 or RUES2 hESCs 25 were expanded using mouse embryonic fibroblast-conditioned medium (MEF-CM) 26 supplemented with basic fibroblast growth factor (R&D Systems).", "These experiments demonstrate that hESCs can be grown, differentiated into cardiomyocytes and cryopreserved at a scale sufficient to treat a large animal model of MI.", "For both of these hESC-GCaMP3 lines we used our well-established monolayer protocol of directed differentiation (as above) to produce a high yield of cardiomyoctes 8.", "hESC-CMs were collected and cryopreserved after 16 to 20 days of CM differentiation."]}
{"doc_id": 56019, "title": "", "abstract": ["Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Thus, hESC-CMs can remuscularize substantial amounts of the infarcted monkey heart.", "These experiments demonstrate that hESCs can be grown, differentiated into cardiomyocytes and cryopreserved at a scale sufficient to treat a large animal model of MI.", "Furthermore, 100% of the visible hESC-CM grafts in every monkey showed electromechanical coupling to the host heart (Table 1).", "All hESC-CM-treated monkeys showed significant remuscularization of the infarct areas (Fig. 1 a–g, Extended Data Fig. 7)."]}
{"doc_id": 56020, "title": "", "abstract": ["Human pluripotent stem cells have indisputable cardiomyocyte generating abilities and have been extensively investigated for repair of the injured heart 3,4,6–10.", "Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure 1 by providing human cardiomyocytes to support heart regeneration 2.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Nevertheless, the extent of remuscularization and electromechanical coupling seen here encourages further development of human cardiomyocyte transplantation as a clinical therapy for heart failure.", "It remains unknown, however, whether clinical scale hESC-CMs transplantation is feasible, safe or can provide large-scale myocardial regeneration."]}
{"doc_id": 47000, "title": "", "abstract": ["The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART.", "Based on current patterns of ART use among participants observed from 2000 to 2007 in the NA-ACCORD, a 20-year-old individual on ART today in the U.S. or Canada would expect to live into their early 70 s, a life expectancy that approaches that of a 20-year-old person in the general population [12].", "A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use."]}
{"doc_id": 47001, "title": "", "abstract": ["Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "The health gains associated with ART use have been substantial at both the individual and societal level [1], [2].", "The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART."]}
{"doc_id": 47002, "title": "", "abstract": ["We further stratified the calendar- and age-specific mortality rates by sex (male vs. female), race (non-white vs. white), HIV transmission risk (men who have sex with men (MSM), injection drug use (IDU) including MSM who inject drugs, and other transmission groups), and baseline CD4 cell count measured at, or within 6 months of, ART initiation (<350 cells/mm3 vs. ≥350 cells/mm3) to examine differences in life expectancy by these characteristics.", "In a sensitivity analysis restricted to only those who were observed to initiate ART during our study period (18,591 participants contributing 1,057 deaths), the overall unweighted mortality rate was 18.9 (95% CI: 17.8, 20.1) per 1,000 person-years.", "Estimates of life expectancy were obtained from mortality rates from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), a multi-site collaboration of interval and clinical cohorts of HIV-positive individuals in Canada and the U.S. NA-ACCORD is the North American regional collaboration sponsored by the National Institute of Health's International Epidemiological Databases to Evaluate AIDS (IeDEA) consortium.", "Similar life expectancies by sex or higher life expectancy for men suggest that women may be accessing HIV-related care at later stages of HIV disease than men in Canada and the U.S., which has significant public health ramifications.", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25]."]}
{"doc_id": 47003, "title": "", "abstract": ["While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "We further stratified the calendar- and age-specific mortality rates by sex (male vs. female), race (non-white vs. white), HIV transmission risk (men who have sex with men (MSM), injection drug use (IDU) including MSM who inject drugs, and other transmission groups), and baseline CD4 cell count measured at, or within 6 months of, ART initiation (<350 cells/mm3 vs. ≥350 cells/mm3) to examine differences in life expectancy by these characteristics.", "In a sensitivity analysis restricted to only those who were observed to initiate ART during our study period (18,591 participants contributing 1,057 deaths), the overall unweighted mortality rate was 18.9 (95% CI: 17.8, 20.1) per 1,000 person-years.", "Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm3.", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized."]}
{"doc_id": 47004, "title": "", "abstract": ["This finding is consistent with previous findings from the ART Cohort Collaboration (a multisite cohort collaboration that includes seven sites in North America) and work done in British Columbia, Canada [2], [27].", "Our results are consistent with previous studies that have examined the life expectancy of HIV-positive individuals on ART [22].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "In general, in high- income countries such as the U.S. and Canada we expect women to have higher life expectancies than men, which was not evident in our findings [12].", "These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society- USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4 cell count, except in the case of long-term non- progressors and elite controllers [3]."]}
{"doc_id": 47005, "title": "", "abstract": ["In general, mortality rates were highest among individuals with IDU history (34.5, 95% CI: 31.9, 37.4) compared with MSM and other transmission groups, non-whites (22.4, 95% CI: 21.1, 23.8) compared with whites, and individuals with CD4 counts <350 cells/mm3 (23.3, 95% CI: 22.1, 24.6) compared with those with CD4 ≥350 cells/mm3.", "These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society- USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4 cell count, except in the case of long-term non- progressors and elite controllers [3].", "There are also considerable differences in life expectancy by HIV transmission group, with lower life expectancies reported in all periods for individuals with a history of IDU.", "Differences by sex, race, HIV transmission risk group, and CD4 count remain.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use."]}
{"doc_id": 47006, "title": "", "abstract": ["The modern ART era, in which mortality has become increasingly dependent on duration of ART, is characterized by a greater proportion of patients with longer follow-up.", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "The study period was restricted to 1 January 2000 and 31 December 2007, a time period often characterized as the modern ART era [14], in order to produce estimates that are more relevant to the current context of HIV antiretroviral management."]}
{"doc_id": 47007, "title": "", "abstract": ["A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.", "Based on current patterns of ART use among participants observed from 2000 to 2007 in the NA-ACCORD, a 20-year-old individual on ART today in the U.S. or Canada would expect to live into their early 70 s, a life expectancy that approaches that of a 20-year-old person in the general population [12].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.", "The objective of this study is to examine temporal changes in life expectancy from 2000 to 2007 among HIV-positive individuals on ART in the U.S. and Canada and to compare life expectancy by selected sociodemographic and clinical characteristics."]}
{"doc_id": 47008, "title": "", "abstract": ["These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society- USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4 cell count, except in the case of long-term non- progressors and elite controllers [3].", "Our results are consistent with previous studies that have examined the life expectancy of HIV-positive individuals on ART [22].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "This finding is consistent with previous findings from the ART Cohort Collaboration (a multisite cohort collaboration that includes seven sites in North America) and work done in British Columbia, Canada [2], [27].", "In a sensitivity analysis restricted to only those who were observed to initiate ART during our study period (18,591 participants contributing 1,057 deaths), the overall unweighted mortality rate was 18.9 (95% CI: 17.8, 20.1) per 1,000 person-years."]}
{"doc_id": 47009, "title": "", "abstract": ["However, in tandem with increases in life expectancy following the introduction of ART, HIV-positive individuals are increasingly experiencing age-related co-morbid conditions, which are impacting both the length and quality of their lives [7], [8].", "Finally, due to the increased risk of age-related co- morbidities among HIV-positive adults, it is possible life expectancy may plateau or decrease in the future; it will be important to monitor life expectancy estimates as more adults age with HIV.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada", "The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART."]}
{"doc_id": 47010, "title": "", "abstract": ["Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "ART is effective in increasing the life span of HIV-positive individuals [2] and is associated with a reduction in new infections [4]–[6].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "Note: ART, combination antiretroviral therapy."]}
{"doc_id": 47011, "title": "", "abstract": ["No study has had a sufficient sample size to determine whether gains in life expectancy for HIV-positive individuals are similar to those observed in the general population, or are similar across sex, race, or transmission groups.", "Over the entire study period, women had similar life expectancies to men, IDUs had lower life expectancies than MSM and individuals with other risk factors, non-whites had lower life expectancies than whites, and those with CD4 count <350 cells/mm3 had a lower life expectancy than those with CD4 count ≥350 cells/mm3.", "Based on current patterns of ART use among participants observed from 2000 to 2007 in the NA-ACCORD, a 20-year-old individual on ART today in the U.S. or Canada would expect to live into their early 70 s, a life expectancy that approaches that of a 20-year-old person in the general population [12].", "Life expectancy estimates for the general population at age 20 years in 2009 were 59.7 and 57.0 years for men and 63.9 and 61.7 years for women, in Canada and the U.S., respectively [12].", "In general, in high- income countries such as the U.S. and Canada we expect women to have higher life expectancies than men, which was not evident in our findings [12]."]}
{"doc_id": 47012, "title": "", "abstract": ["Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "The objective of this study is to examine temporal changes in life expectancy from 2000 to 2007 among HIV-positive individuals on ART in the U.S. and Canada and to compare life expectancy by selected sociodemographic and clinical characteristics.", "We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.", "Life expectancy does differ markedly by transmission group, race, and CD4 cell count at ART initiation; in particular, it is notably lower in individuals with a history of IDU, who are non-white, and who began ART with lower CD4 cell counts.", "These findings may lend additional support to the earlier initiation of ART, in accordance with both the DHHS guidelines recommending universal therapy [30] and the 2012 International AIDS Society- USA (IAS-USA) guidelines, which recommend use of ART for all HIV-positive individuals regardless of CD4 cell count, except in the case of long-term non- progressors and elite controllers [3]."]}
{"doc_id": 47013, "title": "", "abstract": ["ART was defined as a multi-class regimen containing at least three antiretroviral drugs, including a protease inhibitor, a non- nucleoside reverse-transcriptase inhibitor, or three nucleoside reverse- transcriptase inhibitors.", "ART is effective in increasing the life span of HIV-positive individuals [2] and is associated with a reduction in new infections [4]–[6].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "Based on current patterns of ART use among participants observed from 2000 to 2007 in the NA-ACCORD, a 20-year-old individual on ART today in the U.S. or Canada would expect to live into their early 70 s, a life expectancy that approaches that of a 20-year-old person in the general population [12]."]}
{"doc_id": 47014, "title": "", "abstract": ["Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.", "However, in tandem with increases in life expectancy following the introduction of ART, HIV-positive individuals are increasingly experiencing age-related co-morbid conditions, which are impacting both the length and quality of their lives [7], [8].", "The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART."]}
{"doc_id": 47015, "title": "", "abstract": ["Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "ART is effective in increasing the life span of HIV-positive individuals [2] and is associated with a reduction in new infections [4]–[6].", "While ART has led to significant increases in survival among HIV-positive adults globally, the effect of ART on life expectancy in the U.S. and Canada has not been well characterized."]}
{"doc_id": 47016, "title": "", "abstract": ["While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "In general, mortality rates were highest among individuals with IDU history (34.5, 95% CI: 31.9, 37.4) compared with MSM and other transmission groups, non-whites (22.4, 95% CI: 21.1, 23.8) compared with whites, and individuals with CD4 counts <350 cells/mm3 (23.3, 95% CI: 22.1, 24.6) compared with those with CD4 ≥350 cells/mm3.", "We further stratified the calendar- and age-specific mortality rates by sex (male vs. female), race (non-white vs. white), HIV transmission risk (men who have sex with men (MSM), injection drug use (IDU) including MSM who inject drugs, and other transmission groups), and baseline CD4 cell count measured at, or within 6 months of, ART initiation (<350 cells/mm3 vs. ≥350 cells/mm3) to examine differences in life expectancy by these characteristics.", "Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm3.", "Over the entire study period, women had similar life expectancies to men, IDUs had lower life expectancies than MSM and individuals with other risk factors, non-whites had lower life expectancies than whites, and those with CD4 count <350 cells/mm3 had a lower life expectancy than those with CD4 count ≥350 cells/mm3."]}
{"doc_id": 47017, "title": "", "abstract": ["While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "ART was defined as a multi-class regimen containing at least three antiretroviral drugs, including a protease inhibitor, a non- nucleoside reverse-transcriptase inhibitor, or three nucleoside reverse- transcriptase inhibitors.", "Studies show a small but persistent gap in the life span between HIV-positive and -negative individuals, particularly within key affected populations [2], [9]–[11].", "In conclusion, the results of this study document increasing longevity for individuals living with HIV in the U.S. and Canada.", "Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3]."]}
{"doc_id": 47018, "title": "", "abstract": ["Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "While ART has led to significant increases in survival among HIV-positive adults globally, the effect of ART on life expectancy in the U.S. and Canada has not been well characterized.", "ART is effective in increasing the life span of HIV-positive individuals [2] and is associated with a reduction in new infections [4]–[6].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25]."]}
{"doc_id": 47019, "title": "", "abstract": ["A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population.", "Estimates of life expectancy were obtained from mortality rates from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), a multi-site collaboration of interval and clinical cohorts of HIV-positive individuals in Canada and the U.S. NA-ACCORD is the North American regional collaboration sponsored by the National Institute of Health's International Epidemiological Databases to Evaluate AIDS (IeDEA) consortium.", "Indeed, given that many individuals living with HIV have demographic, clinical, and behavioral characteristics associated with greater morbidity and mortality than the general population [20], [21], the gap in life expectancy may be attributable to other lifestyle factors and not just HIV infection.", "No study has had a sufficient sample size to determine whether gains in life expectancy for HIV-positive individuals are similar to those observed in the general population, or are similar across sex, race, or transmission groups.", "Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART."]}
{"doc_id": 47020, "title": "", "abstract": ["Estimates of life expectancy were obtained from mortality rates from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), a multi-site collaboration of interval and clinical cohorts of HIV-positive individuals in Canada and the U.S. NA-ACCORD is the North American regional collaboration sponsored by the National Institute of Health's International Epidemiological Databases to Evaluate AIDS (IeDEA) consortium.", "Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000–2002 to 2006–2007.", "We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.", "The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART.", "Membership for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA is provided in Appendix S1."]}
{"doc_id": 73000, "title": "", "abstract": ["Investigators have examined the role of psychological factors, such as personality type, cognition, and psychological stress, in the cause of coronary heart disease.", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Individuals were defined as having incident coronary heart disease according to the type and time of diagnosis of their first disease event.", "Exclusion from analysis of coronary heart disease events that occur in the first years of follow-up can reduce such bias, but few studies have been sufficiently powered to do this analysis.", "Of these factors, psychosocial stress is the most commonly investigated.1–3"]}
{"doc_id": 73001, "title": "", "abstract": ["Investigators have examined the role of psychological factors, such as personality type, cognition, and psychological stress, in the cause of coronary heart disease.", "In addition to age, sex, and socioeconomic status,24 we used lifestyle factors and conventional coronary risk factors as covariates because they could be related to both job strain and coronary heart disease, and might therefore mediate or confound the association between job strain and disease.", "Second, previous reviews were based on prospective studies with follow-up for coronary heart disease starting immediately after the assessment of job strain.", "We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies.", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data"]}
{"doc_id": 73002, "title": "", "abstract": ["We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies.", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "All studies were part of the individual-participant-data meta- analysis in working populations (IPD-Work) consortium, which was established at the Four Centres meeting in London, in 2008.24", "We did a collaborative meta-analysis of individual participant data from published and unpublished studies of job strain and coronary heart disease to address the limitations of previous studies and the discordant evidence base."]}
{"doc_id": 73003, "title": "", "abstract": ["These mechanisms might include dysregulation of the hypothalamus-pituitary-adrenal cortex axis and autonomic nervous system,3,43 a conversion of temporary increases in blood pressure to chronic high blood pressure in relation to long-term stress,2,44 and deteriorations in health habits (eg, reduced physical activity).29,42", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Job strain—the combination of high job demands and low control at work—is one of the most widely studied definitions of psychosocial stress.2", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Of these factors, psychosocial stress is the most commonly investigated.1–3"]}
{"doc_id": 73004, "title": "", "abstract": ["We excluded from analyses participants with missing data for age, sex, job strain, or incident events of coronary heart disease, and those with a diagnosis of coronary heart disease before the study baseline.", "We excluded from analyses 5124 (3%) of 203 816 participants who had missing data for age, sex, job strain, or incident coronary heart disease events, and 1219 (1%) with a diagnosis of coronary heart disease before the study baseline.", "We used individual records from 13 European cohort studies (1985–2006) of men and women without coronary heart disease who were employed at time of baseline assessment.", "All studies were part of the individual-participant-data meta- analysis in working populations (IPD-Work) consortium, which was established at the Four Centres meeting in London, in 2008.24", "Our analyses were based on participants who were employed at baseline assessment between 1985 and 2006, dependent on the study (table)."]}
{"doc_id": 73005, "title": "", "abstract": ["In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "The population attributable risk for job strain was 3·4%.", "Figure 3 shows analysis of the association between job strain and coronary heart disease by demographic characteristics, with exclusion of disease events in the first 3 years of follow-up.", "Association of job strain with incident coronary heart disease in subgroups"]}
{"doc_id": 73006, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "We measured exposure to job strain on the basis of one baseline assessment; however, some studies have suggested that cumulative exposure to job strain, ascertained by several assessments repeated in time, could be a stronger predictor of coronary heart disease.42", "The pooling of published and unpublished studies allowed us to investigate the association between coronary heart disease and exposure to job strain with greater precision than has previously been possible.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1)."]}
{"doc_id": 73007, "title": "", "abstract": ["The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.", "The first limitation is publication bias—ie, studies with significant results in the expected direction are more likely to be published and cited in scientific literature than are those with non-significant findings.8", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "The summary estimate that we obtained from published studies11,33,34 was the same as that reported in previous reviews,7 whereas the estimate from unpublished data was much lower, indicating publication bias.", "All authors participated in designing the study, generation of hypotheses, interpretation of the data, and writing and critically reviewing of the paper."]}
{"doc_id": 73008, "title": "", "abstract": ["Estimates are adjusted, when appropriate, for age and sex.", "Estimates are adjusted for age and sex.", "Estimates are adjusted for age and sex unless otherwise stated.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "The age-adjusted and sex-adjusted HR attenuated to 1·17 (1·05–1·31) after further adjustment for socioeconomic status."]}
{"doc_id": 73009, "title": "", "abstract": ["We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "In addition to age, sex, and socioeconomic status,24 we used lifestyle factors and conventional coronary risk factors as covariates because they could be related to both job strain and coronary heart disease, and might therefore mediate or confound the association between job strain and disease.", "Previous studies have reported differences in findings for the association between job strain and coronary heart disease between sexes, with some showing increased HRs in women35 and others in men.33,36"]}
{"doc_id": 73010, "title": "", "abstract": ["Although some studies4–6 have shown that job strain is associated with a more than doubling in risk of coronary heart disease, findings from a meta-analysis7 of cohort studies suggest that this excess risk is probably modest, at about 40%.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations.", "We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies."]}
{"doc_id": 73011, "title": "", "abstract": ["We did a collaborative meta-analysis of individual participant data from published and unpublished studies of job strain and coronary heart disease to address the limitations of previous studies and the discordant evidence base.", "Our findings suggest that prevention of workplace stress might decrease disease incidence; however, this strategy would have a much smaller effect than would tackling of standard risk factors, such as smoking.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Similarly, we noted few differences in the effect of job strain on coronary heart disease between studies from Nordic countries, continental Europe, and the UK (figure 2).", "We used individual records from 13 European cohort studies (1985–2006) of men and women without coronary heart disease who were employed at time of baseline assessment."]}
{"doc_id": 73012, "title": "", "abstract": ["Although some studies4–6 have shown that job strain is associated with a more than doubling in risk of coronary heart disease, findings from a meta-analysis7 of cohort studies suggest that this excess risk is probably modest, at about 40%.", "Our study is twice as large as the most recent meta-analysis of this topic (n=83 000), which uses only published data.7", "We modelled job strain as a binary exposure (strain vs no strain).", "We did a collaborative meta-analysis of individual participant data from published and unpublished studies of job strain and coronary heart disease to address the limitations of previous studies and the discordant evidence base.", "We assume that our estimate is less biased than those reported previously for two reasons."]}
{"doc_id": 73013, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Stress is a recognised health hazard2,3,48 and European guidelines for prevention of coronary heart disease recommend stress management for high-risk individuals.49", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Second, previous reviews were based on prospective studies with follow-up for coronary heart disease starting immediately after the assessment of job strain.", "Measurement of job strain and health behaviours was based on self-reports; thus, reporting bias might have overestimated or underestimated associations."]}
{"doc_id": 73014, "title": "", "abstract": ["In our study, the magnitude of the relation between job strain and incident coronary heart disease was slightly strengthened in models that excluded disease events that occurred in the first 3 years or 5 years of follow-up.", "Figure 3 shows analysis of the association between job strain and coronary heart disease by demographic characteristics, with exclusion of disease events in the first 3 years of follow-up.", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations.", "Association of job strain with incident coronary heart disease in relation to study follow-up periods, adjustments, publication status for data, and geographical region", "Although some studies4–6 have shown that job strain is associated with a more than doubling in risk of coronary heart disease, findings from a meta-analysis7 of cohort studies suggest that this excess risk is probably modest, at about 40%."]}
{"doc_id": 73015, "title": "", "abstract": ["Moreover, the importance of job strain as a risk factor for coronary heart disease continues to be debated because of several methodological shortcomings.", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies."]}
{"doc_id": 73016, "title": "", "abstract": ["In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Nevertheless, studies that focus on external sources of stress, such as organisational downsizing, death of a child, and caring for a sick spouse at home, have confirmed that stress at work and in private life might be associated with an increased risk of coronary heart disease.45–47"]}
{"doc_id": 73017, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Similarly, we noted few differences in the effect of job strain on coronary heart disease between studies from Nordic countries, continental Europe, and the UK (figure 2).", "Nevertheless, studies that focus on external sources of stress, such as organisational downsizing, death of a child, and caring for a sick spouse at home, have confirmed that stress at work and in private life might be associated with an increased risk of coronary heart disease.45–47", "In our study, the magnitude of the relation between job strain and incident coronary heart disease was slightly strengthened in models that excluded disease events that occurred in the first 3 years or 5 years of follow-up."]}
{"doc_id": 73018, "title": "", "abstract": ["The population attributable risk for job strain was 3·4%.", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations.", "We calculated population attributable risk (PAR) for job strain with accompanying 95% CIs.", "The corresponding PAR for job strain was 3·4% (95% CI 1·5–5·4).", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease."]}
{"doc_id": 73019, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Association of job strain with incident coronary heart disease in subgroups", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "Random-effects meta-analysis of the association between job strain and incident coronary heart disease", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1)."]}
{"doc_id": 73020, "title": "", "abstract": ["| Country| Baseline| Number of participants| Number (%) of women| Number (%) of participants with job strain| Mean (SD) age at baseline (years)| Person- years| Number of CHD events (incidence per 10 000 person-years)   ---|---|---|---|---|---|---|---|---   Whitehall II21| UK| 1985–88| 10 250| 3398 (33%)| 1437 (14%)| 44·4 (6·1)| 154 980| 382 (24·6)   Still working20| Finland| 1986| 9129| 2082 (23%)| 1423 (16%)| 40·9 (9·1)| 193 809| 729 (37·6)   WOLF-S22| Sweden| 1992–95| 5653| 2447 (43%)| 917 (16%)| 41·5 (11·0)| 81 516| 106 (13·0)   Belstress11| Belgium| 1994–98| 14 226| 0 (0%)| 2190 (15%)| 45·8 (6·0)| 44 812| 85 (19·0)   IPAW17| Denmark| 1996–97| 2022| 1356 (67%)| 355 (18%)| 41·2 (10·5)| 25 801| 35 (13·6)   WOLF-N23| Sweden| 1996–98| 4678| 780 (17%)| 599 (13%)| 44·0 (10·3)| 53 891| 122 (22·6)   COPSOQ-I12| Denmark| 1997| 1724| 824 (48%)| 354 (21%)| 40·8 (10·5)| 20 171| 33 (16·4)   GAZEL15| France| 1997| 11 237| 3132 (28%)| 1630 (15%)| 50·3 (3·0)| 125 180| 277 (22·1)   POLS19| Netherlands| 1997–2002| 24 473| 10 093 (41%)| 3904 (16%)| 38·1 (11·1)| 240 570| 241 (10·0)   HeSSup16| Finland| 1998| 16 345| 9102 (56%)| 2866 (18%)| 39·5 (10·2)| 113 761| 67 (5·9)   DWECS13| Denmark| 2000| 5463| 2556 (47%)| 1217 (22%)| 41·8 (11·0)| 48 074| 55 (11·4)   FPS14| Finland| 2000| 47 373| 38 317 (81%)| 7728 (16%)| 44·6 (9·4)| 224 074| 109 (4·9)   NWCS18| Netherlands| 2005–06| 44 900| 23 085 (51%)| 5594 (13%)| 39·9 (11·8)| 162 089| 117 (7·2)   Total| ..| 1985–2006| 197 473| 97 172 (49%)| 30 214 (15%)| 42·3 (9·8)| 1 488 728| 2358 (15·8)", "The INTERHEART study50 of 15 000 patients with myocardial infarction and 15 000 healthy controls, the largest case-control study in this domain, showed that work stress doubled risk of coronary heart disease,37 whereas prospective data from published cohort studies suggest a 1·4 times increased risk.7", "In 1·49 million person-years at risk (mean follow-up 7·5 years [SD 1·7]), we recorded 2358 events of incident coronary heart disease.", "During 1 488 728 person-years at risk (mean follow-up 7·5 years [SD 1·7]), we recorded 2358 incident coronary heart disease events.", "The summary estimate that we obtained from published studies11,33,34 was the same as that reported in previous reviews,7 whereas the estimate from unpublished data was much lower, indicating publication bias."]}
{"doc_id": 73021, "title": "", "abstract": ["Our study is twice as large as the most recent meta-analysis of this topic (n=83 000), which uses only published data.7", "We used individual records from 13 European cohort studies (1985–2006) of men and women without coronary heart disease who were employed at time of baseline assessment.", "We used data from 13 independent cohort studies started between 1985 and 2006, in Finland, Sweden, Denmark, the Netherlands, Belgium, France, and the UK.11–23", "The INTERHEART study50 of 15 000 patients with myocardial infarction and 15 000 healthy controls, the largest case-control study in this domain, showed that work stress doubled risk of coronary heart disease,37 whereas prospective data from published cohort studies suggest a 1·4 times increased risk.7", "The summary estimate that we obtained from published studies11,33,34 was the same as that reported in previous reviews,7 whereas the estimate from unpublished data was much lower, indicating publication bias."]}
{"doc_id": 73022, "title": "", "abstract": ["Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Nevertheless, studies that focus on external sources of stress, such as organisational downsizing, death of a child, and caring for a sick spouse at home, have confirmed that stress at work and in private life might be associated with an increased risk of coronary heart disease.45–47", "Our findings suggest that prevention of workplace stress might decrease disease incidence; however, this strategy would have a much smaller effect than would tackling of standard risk factors, such as smoking.", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations."]}
{"doc_id": 73023, "title": "", "abstract": ["Association of job strain with incident coronary heart disease in subgroups", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Association of job strain with incident coronary heart disease in relation to study follow-up periods, adjustments, publication status for data, and geographical region", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "We analysed the relation between job strain and coronary heart disease with a meta-analysis of published and unpublished studies."]}
{"doc_id": 73024, "title": "", "abstract": ["Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "We did a collaborative meta-analysis of individual participant data from published and unpublished studies of job strain and coronary heart disease to address the limitations of previous studies and the discordant evidence base.", "The pooling of published and unpublished studies allowed us to investigate the association between coronary heart disease and exposure to job strain with greater precision than has previously been possible.", "Briefly, participants were asked to answer questions about the psychosocial aspects of their job.", "We modelled job strain as a binary exposure (strain vs no strain)."]}
{"doc_id": 73025, "title": "", "abstract": ["All studies were part of the individual-participant-data meta- analysis in working populations (IPD-Work) consortium, which was established at the Four Centres meeting in London, in 2008.24", "The IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish Work Environment Research Fund, Denmark), the Academy of Finland (grant number 132944), the BUPA Foundation (grant number 22094477), and the Dutch Ministry of Social Affairs and Employment, Netherlands.", "Each constituent study in the consortium was approved by the relevant local or national ethics committees and all participants gave informed consent to participate (appendix).", "We extracted data in two stages such that acquisition and harmonisation of job strain measure and covariables occurred before linkage to records for coronary heart disease.", "Two exceptions were the Belstress study11 in which disease events were registered by the human resources department and occupational health service, and the Electricité De France-Gaz De France (GAZEL) cohort study15 in which registry data for admission were not available and non-fatal events were based on self- report questionnaires distributed yearly."]}
{"doc_id": 73026, "title": "", "abstract": ["Published work assessing psychosocial stress (job strain) as a risk factor for coronary heart disease is inconsistent and subject to publication bias and reverse causation bias.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Association of job strain with incident coronary heart disease in subgroups", "Measurement of job strain and health behaviours was based on self-reports; thus, reporting bias might have overestimated or underestimated associations.", "The pooling of published and unpublished studies allowed us to investigate the association between coronary heart disease and exposure to job strain with greater precision than has previously been possible."]}
{"doc_id": 73027, "title": "", "abstract": ["We did a collaborative meta-analysis of individual participant data from published and unpublished studies of job strain and coronary heart disease to address the limitations of previous studies and the discordant evidence base.", "The pooling of published and unpublished studies allowed us to investigate the association between coronary heart disease and exposure to job strain with greater precision than has previously been possible.", "All studies were part of the individual-participant-data meta- analysis in working populations (IPD-Work) consortium, which was established at the Four Centres meeting in London, in 2008.24", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "The IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish Work Environment Research Fund, Denmark), the Academy of Finland (grant number 132944), the BUPA Foundation (grant number 22094477), and the Dutch Ministry of Social Affairs and Employment, Netherlands."]}
{"doc_id": 44000, "title": "", "abstract": ["Although the pathology of these forms of dementia differs from that of AD and often involves demyelination, our study suggests that TREM2 may be required for microglia to sense glycolipids such as SM and sulfatides that are exposed on damaged myelin sheaths; thus, TREM2 binding to these glycolipids may trigger the microglial response to damaged myelin, which is necessary to clear myelin residues and produce trophic factors that induce repair and remyelination.", "The association between the R47H mutation of TREM2 and the increased risk for late onset AD suggests that microglia may require TREM2 to respond to Aβ deposition and to limit neuronal degeneration.", "We first hypothesized that TREM2 may be necessary for Aβ uptake and microglia activation.", "This corroborates our previous observation that TREM2 haploinsufficiency correlates with fewer amyloid- associated microglia in APPPS1–21xCx3cr1GFP/+ mice (Ulrich et al., 2014).", "Our findings demonstrated that TREM2 functions as a microglial sensor that is alerted by damage-induced molecules that share a common lipidic backbone and an anionic group."]}
{"doc_id": 44001, "title": "", "abstract": ["TREM2 acts in microglia by supporting Aβ-reactive microgliosis, a process of expansion and activation that leads to microglia clustering around Aβ plaques and subsequent Aβ removal (Ransohoff and Cardona, 2010).", "Indeed, a recently published RNA-seq dataset demonstrated that Trem2 is specifically expressed in microglia, but not other cells in the CNS under steady state conditions (Butovsky et al., 2014).", "We conclude that TREM2 is a receptor that detects damage-associated lipids, thereby enabling microglia to sense Aβ accumulation and cell damage, as well as supporting microglia survival and Aβ reactive microgliosis.", "We further demonstrate that TREM2 senses a broad array of anionic and zwitterionic lipids known to associate with fibrillar Aβ in lipid membranes and to be exposed on the surface of damaged neurons.", "We found that TREM2 deficiency and haploinsufficiency augment β-amyloid (Aβ) accumulation due to dysfunctional response of microglia, which become apoptotic and fail to cluster around Aβ plaques."]}
{"doc_id": 44002, "title": "", "abstract": ["Remarkably, the R47H mutation impairs TREM2 detection of lipid ligands.", "### R47H mutation impairs Trem2 recognition of lipid ligands", "Remarkably, we found that the R47H mutation associated with AD affected the binding of multiple lipid ligands, although to differing extents.", "R47H mutation attenuates TREM2 recognition of lipids", "Remarkably, the R47H mutation associated with AD impairs TREM2 binding to anionic lipids."]}
{"doc_id": 44003, "title": "", "abstract": ["However, in Trem2−/− 5XFAD mice, these changes were markedly attenuated (Fig. 2D, E and Fig. S2C–L).", "However, co-staining coronal brain sections of Trem2−/−5XFAD and 5XFAD mice with Iba-1 and X-34 to visualize microglia and amyloid plaques respectively, showed remarkable differences.", "The lack of a significant difference in Aβ accumulation in the cortices of Trem2−/−5XFAD mice and 5XFAD mice may be the result of the fast kinetics of Aβ deposition in 5XFAD mice, such that the potential cortical differences are no longer detectable at 8.5 month of age.", "Examination of a second model of AD, APPPS1–21 mice that have been bred to Cx3cr1GFP/+ mice in order to visualize endogenous microglia, confirmed that complete TREM2 deficiency results in a marked reduction of GFP+ microglia clusters around amyloid plaques (Fig. S3D–F).", "Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014)."]}
{"doc_id": 44004, "title": "", "abstract": ["Moreover, TREM2 deficiency had very little impact on microglia uptake of Aβ aggregates (Fig. S5E, Movie S4) or their subsequent proteolytic processing, as demonstrated by similar degradation of the intracellular concentration of Aβ after initial loading (Fig. S5F).", "Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014).", "TREM2 deficiency impairs Aβ-induced transcriptional program in microglia", "TREM2 deficiency leads to reduced microgliosis in 5XFAD mice", "To evaluate the impact of TREM2 deficiency on Aβ-induced microglia responses in 5XFAD mice, we examined transcriptional profiles of microglia purified from 5XFAD and Trem2−/−5XFAD mice as well as transgene negative WT and Trem2−/− littermates (Fig. S2A)."]}
{"doc_id": 44005, "title": "", "abstract": []}
{"doc_id": 44006, "title": "", "abstract": ["Remarkably, the R47H mutation impairs TREM2 detection of lipid ligands.", "### R47H mutation impairs Trem2 recognition of lipid ligands", "What is the impact of the R47H mutation on TREM2 ligand recognition?", "R47H mutation attenuates TREM2 recognition of lipids", "This corroborates our previous observation that TREM2 haploinsufficiency correlates with fewer amyloid- associated microglia in APPPS1–21xCx3cr1GFP/+ mice (Ulrich et al., 2014)."]}
{"doc_id": 44007, "title": "", "abstract": ["We conclude that TREM2 is a receptor that detects damage-associated lipids, thereby enabling microglia to sense Aβ accumulation and cell damage, as well as supporting microglia survival and Aβ reactive microgliosis.", "TREM2 acts in microglia by supporting Aβ-reactive microgliosis, a process of expansion and activation that leads to microglia clustering around Aβ plaques and subsequent Aβ removal (Ransohoff and Cardona, 2010).", "Thus, TREM2 detects damage-associated lipid patterns associated with neurodegeneration, sustaining microglia response to Aβ accumulation.", "TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model", "We postulate that TREM2 acts as a costimulatory molecule that sustains survival of microglia, which are activated and proliferate in the presence of Aβ."]}
{"doc_id": 44008, "title": "", "abstract": ["Previous studies of cultured myeloid cells indicate that TREM2 may synergize with CSF-1-CSF-1R signaling to activate the protein tyrosine kinase Syk, which in turns activates multiple downstream mediators, such as ERK, PI-3K and Akt (Zou et al., 2008).", "In addition, TREM2 may provide survival signals through activation of anti-apoptotic mediators such as β-catenin (Otero et al., 2009) and Mcl-1 (Peng et al., 2010).", "Finally, we demonstrate that TREM2 binds to a broad array of anionic lipids, which were found in association with fibrillar Aβ and are also exposed during neuronal and glial cell death.", "Cells involved in TREM2-dependent microgliosis had phenotypic features of brain resident microglia, such as expression of CX3CR1.", "Thus, TREM2 is not directly involved in phagocytosis of apoptotic cells."]}
{"doc_id": 44009, "title": "", "abstract": ["In contrast with previous reports (Hsieh et al., 2009; Takahashi et al., 2007; Takahashi et al., 2005), we found that the engagement of TREM2 does not directly mediate phagocytosis of apoptotic cells.", "However, TREM2 signaling may indirectly supports phagocytosis by promoting survival of activated microglia.", "We conclude that TREM2 is a receptor that detects damage-associated lipids, thereby enabling microglia to sense Aβ accumulation and cell damage, as well as supporting microglia survival and Aβ reactive microgliosis.", "TREM2 deficiency impairs Aβ-induced transcriptional program in microglia", "Our results demonstrate that TREM2 provides a signal that is necessary for survival of microglia at low CSF-1 concentrations."]}
{"doc_id": 44010, "title": "", "abstract": ["We also found that Trem2 expression is further upregulated in microglia isolated from 5XFAD mice during Aβ deposition (Fig. S2A, B).", "TREM2 promotes microglia survival ex vivo and in vivo", "We further show that TREM2 sustains microglia survival by synergizing with colony stimulating factor-1 receptor (CSF-1R) signaling.", "We postulate that TREM2 acts as a costimulatory molecule that sustains survival of microglia, which are activated and proliferate in the presence of Aβ.", "To further interrogate how TREM2 deficiency affected microglia response to Aβ deposition, we selected the transcripts upregulated two-fold between 5XFAD and WT microglia (Fig. 2C) and compared the expression of these transcripts among the entire dataset."]}
{"doc_id": 44011, "title": "", "abstract": ["Thus, these data suggest that the R47H may reduce the overall capacity of TREM2 to bind anionic ligands.", "Most likely, the R47H mutation is sufficient to considerably reduce the binding affinity of TREM2 extracellular domain for most anionic ligands.", "Remarkably, the R47H mutation associated with AD impairs TREM2 binding to anionic lipids.", "Remarkably, the R47H mutation impairs TREM2 detection of lipid ligands.", "Remarkably, we found that the R47H mutation associated with AD affected the binding of multiple lipid ligands, although to differing extents."]}
{"doc_id": 44012, "title": "", "abstract": ["Recent genome-wide association studies (GWAS) have shown that a rare Arginine-47-Histidine (R47H) mutation of the triggering receptor expressed on myeloid cells 2 (TREM2) is associated with a substantial increase in the risk of developing AD (Guerreiro et al., 2013b; Jonsson et al., 2013).", "Recent genome-wide association studies have shown that a rare R47H mutation of TREM2 correlates with a substantial increase in the risk of developing Alzheimer's disease (AD).", "TREM2 deficient 5XFAD mice have increased hippocampal Aβ burden and accelerated loss of layer-V cortical neurons", "The association between the R47H mutation of TREM2 and the increased risk for late onset AD suggests that microglia may require TREM2 to respond to Aβ deposition and to limit neuronal degeneration.", "This study showed that TREM2 modulates Aβ accumulation in the 5XFAD mouse model of AD, thereby reducing neuronal damage."]}
{"doc_id": 44013, "title": "", "abstract": ["We further show that TREM2 sustains microglia survival by synergizing with colony stimulating factor-1 receptor (CSF-1R) signaling.", "TREM2 promotes microglia survival ex vivo and in vivo", "We conclude that TREM2 is a receptor that detects damage-associated lipids, thereby enabling microglia to sense Aβ accumulation and cell damage, as well as supporting microglia survival and Aβ reactive microgliosis.", "We postulate that TREM2 acts as a costimulatory molecule that sustains survival of microglia, which are activated and proliferate in the presence of Aβ.", "Our results demonstrate that TREM2 provides a signal that is necessary for survival of microglia at low CSF-1 concentrations."]}
{"doc_id": 44014, "title": "", "abstract": ["Examination of a second model of AD, APPPS1–21 mice that have been bred to Cx3cr1GFP/+ mice in order to visualize endogenous microglia, confirmed that complete TREM2 deficiency results in a marked reduction of GFP+ microglia clusters around amyloid plaques (Fig. S3D–F).", "Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014).", "Early studies have shown that brain microglia accumulate around Aβ deposits and occasionally contain Aβ in AD patients (D'Andrea et al., 2004; McGeer et al., 1987; Perlmutter et al., 1990) and transgenic mouse models of AD (Dickson, 1999; Frautschy et al., 1998; Stalder et al., 1999).", "Flow cytometric analysis of isolated microglia confirmed phenotypic changes in 5XFAD microglia consistent with increased activation, including a marked increase in cell size and strong upregulation of MHC-II, CD11c and CD11b (Fig. S2C–G).", "In 5XFAD mice, plaque-associated microglia showed morphological changes associated with microglia activation including a partial retraction and a slight hypertrophy of the microglial cell processes as well as an increase in size (Fig. 4E–G)."]}
{"doc_id": 65000, "title": "", "abstract": ["CXCR6 is also expressed on hepatic NK cells22, but its significance for NK-cell biology had been unclear.", "Although CXCR6 is expressed on some human NK-cells44, it is uknown whether this or other human NK populations possess distinct functional properties, such as the capacity to carry Ag- specific memory.", "NK cell-expressed CXCR6 is required for NK cell-mediated adaptive immunity to viruses.", "NK cell-expressed CXCR6 is required for NK cell-mediated adaptive immunity to haptens.", "CXCR6 has a single ligand, CXCL16, a chemokine that is constitutively expressed on liver sinusoidal endothelium24, 25."]}
{"doc_id": 65001, "title": "", "abstract": ["Hence, hepatic NK-cells can develop adaptive immunity to structurally diverse Ags, an activity that requires NK-cell-expressed CXCR6.", "NK cell-expressed CXCR6 is required for NK cell-mediated adaptive immunity to haptens.", "NK cell-expressed CXCR6 is required for NK cell-mediated adaptive immunity to viruses.", "Thus, for each of the five antigenic entities tested, CXCR6 was essential for NK-cell-mediated adaptive immunity irrespective of the genetic background.", "While CXCR6 alone is apparently insufficient to enable NK-cell memory, our adoptive transfer experiments are consistent with a role in NK-cell-mediated adaptive immunity."]}
{"doc_id": 65002, "title": "", "abstract": ["(a) Frequencies of GFP+ and GFP− NK-cell subsets were determined in different organs of Cxcr6+/− and Cxcr6−/− mice.", "Virus- specific DTH was determined after 24h by subtracting background swelling in naïve mice from that in NK-cell recipients.", "Notable examples of murine NK receptors that detect specific pathogen-associated structures include NKp46 and Ly49H, which recognize influenza A-encoded hemaglutinin (HA)8, 9 and mouse cytomegalovirus (MCMV)-encoded m15710, respectively.", "However, murine NK cells also recognized and remembered HIV-1, which does not infect mice and, therefore, is unlikely to have driven the evolution of specific recognition mechanisms.", "This question may also be clinically relevant, since certain NK-cell subsets are implicated in the ability of rare HIV-infected individuals to exert long- term control over HIV-1 replication15, 16."]}
{"doc_id": 65003, "title": "", "abstract": ["Notable examples of murine NK receptors that detect specific pathogen-associated structures include NKp46 and Ly49H, which recognize influenza A-encoded hemaglutinin (HA)8, 9 and mouse cytomegalovirus (MCMV)-encoded m15710, respectively.", "However, since Ly49H is only found in the C57BL/6 strain14, it has been unclear whether NK-cells can develop virus-specific memory in other genetic backgrounds or in response to viruses other than MCMV.", "NK-cells in C57BL/6 mice express LY49H, a germline-encoded activating receptor that is necessary for MCMV recognition and memory13.", "However, unlike hapten-specific memory NK-cells, MCMV-restricted NK-cells are not liver-restricted13 and have not been found in other mouse strains, most of which do not express Ly49H14.", "Ly49H is a member of this family and confers NK-cell-mediated resistance to MCMV infection in C57BL/6 mice."]}
{"doc_id": 65004, "title": "", "abstract": ["Hepatic natural killer (NK) cells mediate antigen (Ag)-specific contact hypersensitivity (CHS) in T-cell and B-cell deficient mice.", "We conclude that memory NK-cells not only discriminate between hapten-based Ags to mediate specific CHS responses, but also their recruitment and/or retention at sites of challenge is hapten-specific.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "Furthermore, adoptive transfer of DNFB primed GFP+ hepatic NK-cells to naïve hosts only conferred hapten responsiveness when NK-cells were from CXCR6+/gfp donors, whereas the same number of Cxcr6−/− NK-cells did not transfer hapten sensitivity (Fig. 6e) and survived poorly even upon rechallenge with DNFB (Supplementary Fig. 5b).", "Hepatic memory NK-cells mediate hapten-specific killing in vitro."]}
{"doc_id": 65005, "title": "", "abstract": ["In conclusion, besides the wide-spread capacity of NK-cells to respond to `missing self'39, the hepatic memory NK-cell subset has the unique ability to exert cytotoxic activity also upon encounter of MHC-I sufficient target cells that are decorated with an Ag to which they were previously sensitized.", "Thus, in the absence of T and B-cells, memory NK-cells can provide effective and specific protection against certain viruses, at least when the infectious agent is administered locally and at a moderate dose.", "Remarkably, Ly49H+ NK-cells display features of adaptive immunity upon infection with this virus13.", "Primed hepatic, but not splenic or naïve NK-cells mounted a vigorous recall response to HIV-1, but not influenza A (Fig. 3a).", "WT recipients of DNFB or OXA primed hepatic NK-cells also mounted vigorous CHS responses when challenged with the sensitizing but not the non-sensitizing hapten, while recipients of sensitized splenic or naïve NK-cells remained unresponsive (Fig. 1c)."]}
{"doc_id": 65006, "title": "", "abstract": ["While the experiments above suggest that NK-cells may be attractive vaccine targets, all recipients of memory NK-cells eventually succumbed to VSV infection (Fig. 2d).", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "We conclude that memory NK-cells not only discriminate between hapten-based Ags to mediate specific CHS responses, but also their recruitment and/or retention at sites of challenge is hapten-specific.", "By contrast, the second hepatic NK-cell subset constitutively transcribes the cxcr6 locus and contains cells that can acquire long-lived specific memory to diverse Ags, including haptens and complex assemblies of viral glycoproteins.", "To assess more broadly whether NK-cells can develop anti-viral memory, we immunized Rag1−/− mice subcutaneously with either noninfectious virus-like particles (VLPs) containing hemagglutinin (HA) and matrix protein (M1) from influenza A/PR/8/3430, 31 (Supplementary Fig. 2) or UV-inactivated vesicular stomatitis virus (UV-VSV)32."]}
{"doc_id": 65007, "title": "", "abstract": ["We conclude that memory NK-cells not only discriminate between hapten-based Ags to mediate specific CHS responses, but also their recruitment and/or retention at sites of challenge is hapten-specific.", "Liver NK-cells develop specific memory to haptens.", "In this regard, hapten-specific NK-cells differ from MCMV-specific memory NK-cells, which upregulate KLRG1,CD43, Ly6C, and Ly49H and are found in both liver and spleen13.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "### Murine NK-cells develop memory to HIV-1"]}
{"doc_id": 65008, "title": "", "abstract": ["NK cell memory to haptens and viruses depended upon CXCR6, a chemokine receptor on hepatic NK cells that was required for memory NK cell persistence but not for Ag recognition.", "Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses", "NK cell-expressed CXCR6 is required for NK cell-mediated adaptive immunity to haptens.", "To assess the role of CXCR6, we explored its contribution to hapten-induced CHS using three complementary approaches: adoptive transfer of sensitized Cxcr6+/gfp NK-cells that were sorted into CXCR6-expressing (GFP+) and non- expressing (GFP−) subsets (Fig. 4b, Supplementary Fig. 3a–c); direct sensitization and challenge of WT or Rag1−/−Cxcr6gfp/gfp and Rag1−/−Cxcr6+/gfp littermates (Fig. 4c, Supplementary Fig. 4a); and treatment of sensitized WT or Rag1−/− mice with anti-CXCR6 (Fig. 4d, Supplementary Fig. 4b).", "Having established that memory NK-cells require CXCR6 for CHS, we asked if this pathway plays a role in anti-viral NK-cell memory."]}
{"doc_id": 65009, "title": "", "abstract": ["Third, we explored the role of CXCR6 in both hapten- and virus-specific memory NK-cells.", "In each case, memory NK-cells were concentrated in the liver and were critically dependent upon CXCR6, which was not required for Ag recognition but appears to regulate effector function and survival of memory NK-cells.", "Liver NK-cells develop specific memory to haptens.", "Liver NK-cells develop specific memory to viral Ags.", "(c) Liver- restricted memory NK-cells arise in the presence of T and B-cells."]}
{"doc_id": 65010, "title": "", "abstract": ["Thus, the pathway(s) triggered in memory NK cells by cognate Ag overrides inhibitory signals from MHC-I. Moreover, NK-cell memory to haptens and viruses developed in both Balb/c and C57BL/6 mice, which express distinct MHC and Ly49 haplotypes, suggesting that Ag recognition by hepatic memory NK-cells differs from the way by which conventional NK-cells detect pathological cells with altered or absent MHC-I.", "By contrast, the second hepatic NK-cell subset constitutively transcribes the cxcr6 locus and contains cells that can acquire long-lived specific memory to diverse Ags, including haptens and complex assemblies of viral glycoproteins.", "NK cell memory to haptens and viruses depended upon CXCR6, a chemokine receptor on hepatic NK cells that was required for memory NK cell persistence but not for Ag recognition.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "We now report that hepatic, but not splenic or naïve NK cells also develop specific memory to vaccines containing Ags from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus-1 (HIV)."]}
{"doc_id": 65011, "title": "", "abstract": ["Hence, hepatic NK-cells can develop adaptive immunity to structurally diverse Ags, an activity that requires NK-cell-expressed CXCR6.", "Moreover, Rag-independent memory to HIV-1 and influenza was inducible in both C57BL/6 and BALB/c mice and was always specific for the virus used during sensitization (Fig. 3b), indicating that hepatic NK-cells can develop specific memory to diverse viral Ags irrespective of viral host restrictions or genetic background", "We now report that hepatic, but not splenic or naïve NK cells also develop specific memory to vaccines containing Ags from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus-1 (HIV).", "Our results obtained in two different mouse strains indicate that a discrete subset of CXCR6+ NK-cells can acquire and retain Ag-specific memory to at least five structurally, chemically and biologically distinct exogenous Ags without requiring Ag persistence.", "Moreover, anti-CXCR6 enhanced the Ag-specific cytotoxicity of memory NK-cells in vitro, whereas CXCL16 attenuated cytotoxicity."]}
{"doc_id": 65012, "title": "", "abstract": ["The paucity of GFP+ NK-cells in livers of CXCR6gfp/gfp mice indicates that the CXCR6+ subset, unlike CXCR6− NK-cells, requires sustenance from sinusoidal endothelium, which constitutively presents CXCL16, a chemokine that exists as both a secreted polypeptide and a luminal surface transmembrane protein.", "The hepatic milieu might have two effects on memory NK-cells: on one hand, continuous CXCR6 signaling, presumably triggered by transmembrane and/or secreted CXCL16 in sinusoids, promotes long-term survival and effector potential.", "Since Ag recognition by NK-cells remained intact after anti-CXCR6 exposure in vitro, the in vivo effects most likely reflect a role for CXCR6–CXCL16 in maintaining memory NK-cell differentiation and/or function.", "CXCR6 has a single ligand, CXCL16, a chemokine that is constitutively expressed on liver sinusoidal endothelium24, 25.", "The restricted steady-state distribution of CXCl16, the only known ligand of CXCR6, may explain why memory NK-cells are undetectable in blood40 or spleen17."]}
{"doc_id": 65013, "title": "", "abstract": ["We now report that hepatic, but not splenic or naïve NK cells also develop specific memory to vaccines containing Ags from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus-1 (HIV).", "These results are consistent with recent investigations on NK cell memory to MCMV13, although there are differences between the tissue distribution of the ensuing memory NK-cells, genetic background restriction and possibly also the viral recognition mechanism.", "Once memory NK-cells are released from the liver and access peripheral sites of Ag challenge, the absence of CXCR6 ligands may unleash their full effector potential but might also limit their persistence.", "The hepatic milieu might have two effects on memory NK-cells: on one hand, continuous CXCR6 signaling, presumably triggered by transmembrane and/or secreted CXCL16 in sinusoids, promotes long-term survival and effector potential.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags."]}
{"doc_id": 65014, "title": "", "abstract": ["Furthermore, adoptive transfer of DNFB primed GFP+ hepatic NK-cells to naïve hosts only conferred hapten responsiveness when NK-cells were from CXCR6+/gfp donors, whereas the same number of Cxcr6−/− NK-cells did not transfer hapten sensitivity (Fig. 6e) and survived poorly even upon rechallenge with DNFB (Supplementary Fig. 5b).", "Moreover, following sensitization of donor mice with 2,4-dinitro-1-fluorobenzene (DNFB), adoptive transfer of NK-cells from donor livers, but not from spleens conferred vigorous CHS to naïve Rag2−/−Il2rg−/− recipients.", "Adoptive transfer of virus-sensitized NK cells to naïve recipients enhanced the animals' survival upon lethal challenge with the sensitizing virus, but not a different virus.", "Concomitantly, four weeks after adoptive transfer of equal numbers of GFP+ and GFP− hapten-sensitized NK-cells from Cxcr6+/− donors, the GFP− NK-cells were equally distributed between spleens and livers, while the distribution of the GFP+ subset was strongly biased toward the liver (Fig. 6c).", "(a) Hapten-specific CHS responses in naïve Rag2−/−Il2rg−/− recipients of hepatic CD45+NK1.1+Thy1+ NK- cells (1×105) from naïve (vehicle-exposed), DNFB or OXA sensitized Rag1−/− donors."]}
{"doc_id": 65015, "title": "", "abstract": ["These results are consistent with recent investigations on NK cell memory to MCMV13, although there are differences between the tissue distribution of the ensuing memory NK-cells, genetic background restriction and possibly also the viral recognition mechanism.", "While CXCR6 alone is apparently insufficient to enable NK-cell memory, our adoptive transfer experiments are consistent with a role in NK-cell-mediated adaptive immunity.", "We conclude that memory NK-cells not only discriminate between hapten-based Ags to mediate specific CHS responses, but also their recruitment and/or retention at sites of challenge is hapten-specific.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "Thus, the pathway(s) triggered in memory NK cells by cognate Ag overrides inhibitory signals from MHC-I. Moreover, NK-cell memory to haptens and viruses developed in both Balb/c and C57BL/6 mice, which express distinct MHC and Ly49 haplotypes, suggesting that Ag recognition by hepatic memory NK-cells differs from the way by which conventional NK-cells detect pathological cells with altered or absent MHC-I."]}
{"doc_id": 65016, "title": "", "abstract": ["Importantly, the protection afforded by NK-cells was virus-specific, since immunization of Rag1−/− mice with two different formulations of influenza VLPs protected vaccinated animals against lethal challenge with influenza, but not VSV (Fig. 2d).", "We now report that hepatic, but not splenic or naïve NK cells also develop specific memory to vaccines containing Ags from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus-1 (HIV).", "To assess more broadly whether NK-cells can develop anti-viral memory, we immunized Rag1−/− mice subcutaneously with either noninfectious virus-like particles (VLPs) containing hemagglutinin (HA) and matrix protein (M1) from influenza A/PR/8/3430, 31 (Supplementary Fig. 2) or UV-inactivated vesicular stomatitis virus (UV-VSV)32.", "Whatever the mechanism, the finding that T and B cell-deficient mice can develop protective memory against lethal infections with influenza A and VSV has intriguing implications for vaccine development and anti-viral immunity.", "Therefore, we tested whether HA recognition is required for influenza-specific memory NK-cells by immunizing Rag1−/− mice with HA-free M1-VLPs (Supplementary Fig. 2) and comparing the ensuing DTH response to that elicited by HA+ PR8-VLPs."]}
{"doc_id": 65017, "title": "", "abstract": ["It was reported recently that NK-cells display features of adaptive immunity in MCMV-infected C57BL/6 mice13, in which ~50% of NK-cells express Ly49H, which recognizes MCMV-encoded m157 protein.", "The idea that NK-cells can mediate adaptive immunity was initially suggested by observations that mouse strains that lacked T- and B-cells developed vigorous CHS responses to different haptens17, 18.", "Remarkably, Ly49H+ NK-cells display features of adaptive immunity upon infection with this virus13.", "While CXCR6 alone is apparently insufficient to enable NK-cell memory, our adoptive transfer experiments are consistent with a role in NK-cell-mediated adaptive immunity.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags."]}
{"doc_id": 65018, "title": "", "abstract": ["It was reported recently that NK-cells display features of adaptive immunity in MCMV-infected C57BL/6 mice13, in which ~50% of NK-cells express Ly49H, which recognizes MCMV-encoded m157 protein.", "Remarkably, Ly49H+ NK-cells display features of adaptive immunity upon infection with this virus13.", "The idea that NK-cells can mediate adaptive immunity was initially suggested by observations that mouse strains that lacked T- and B-cells developed vigorous CHS responses to different haptens17, 18.", "Thus, although classic NK receptors contribute to the function of NK-cells, it is unclear whether and to what extent they are involved in the unique adaptive properties of hapten-specific hepatic NK-cells.", "Adaptive immune responses mediated by this population depend upon CXCR6, which is expressed on ~half of helpatic NK-cells, suggesting that the liver harbors two different NK-cell populations."]}
{"doc_id": 45000, "title": "", "abstract": ["Although the burden of diabetes is often described in terms of its impact on working-age adults, diabetes in older adults is linked to higher mortality, reduced functional status, and increased risk of institutionalization (2).", "Older adults with diabetes have the highest rates of major lower-extremity amputation (9), myocardial infarction (MI), visual impairment, and end-stage renal disease of any age-group.", "In a study of patient preferences regarding diabetes complications and treatments, end-stage complications had the greatest perceived burden on quality of life; however, comprehensive diabetes treatments had significant negative perceived quality-of-life effects, similar to those of intermediate complications (116).", "Older adults with diabetes are at substantial risk for both acute and chronic microvascular and cardiovascular complications of the disease.", "Hearing impairment involving both high- and low/mid-frequency sound is about twice as prevalent in people with diabetes, even after controlling for age (82) and may be linked to both vascular disease and neuropathy (83)."]}
{"doc_id": 45001, "title": "", "abstract": ["After review of the available evidence and consideration of issues that might influence treatment decisions in older adults with diabetes, the authors have developed recommendations in a number of areas.", "What issues need to be considered in individualizing treatment recommendations for older adults?", "Additional consensus recommendations for care of older adults with diabetes", "Consensus recommendations for research questions about diabetes in older adults", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults ranging from CVD to cancer and potentially impacting treatment decisions, such as whether stringent glycemic control would be of net benefit (36,37)."]}
{"doc_id": 45002, "title": "", "abstract": ["* Screening for diabetes complications should be individualized in older adults, but particular attention should be paid to complications that would lead to functional impairment.", "* Older adults who are functional, are cognitively intact, and have significant life expectancy should receive diabetes care using goals developed for younger adults.", "As a result, older adults with diabetes may either have incident disease (diagnosed after age 65 years) or long-standing diabetes with onset in middle age or earlier.", "In light of the paucity of data for diabetes care in older adults, treatment decisions are frequently made with considerable uncertainty.", "However, given the heterogeneity of the older adult population, the risk of hypoglycemia must be carefully considered before using an insulin regimen to achieve an aggressive target for hyperglycemia control."]}
{"doc_id": 45003, "title": "", "abstract": ["Although it is appropriate to relax glycemic targets for older patients with a history of hypoglycemia, a high burden of comorbidities, and limited life expectancy, goals that minimize severe hyperglycemia are indicated for almost all patients.", "A range of 7–7.5% is suggested for older patients with type 2 diabetes without major comorbidities and 7.6–8.5% for frail patients (dependent, multisystem disease, home care residency including those with dementia) where the hypoglycemia risk may be high and the likelihood of benefit relatively low.", "In the ACCORD trial, older participants in both glycemic intervention arms had ∼50% higher rates of severe hypoglycemia (hypoglycemia requiring third-party assistance) than participants under age 65 years (M. Miller, personal communication).", "Prespecified subgroup analyses suggested that the disproportionate cardiovascular mortality risk in the intensive glycemic control group was in participants under the age of 65 years as opposed to older participants.", "While these trials have provided invaluable data and insights, they were not designed to evaluate the health effects of glucose control in patients aged ≥75 years or in older adults with poor health status."]}
{"doc_id": 45004, "title": "", "abstract": ["Additional consensus recommendations for care of older adults with diabetes", "Consensus recommendations for research questions about diabetes in older adults", "What are consensus recommendations for treating older adults with or at risk for diabetes?", "To address these issues, the American Diabetes Association (ADA) convened a Consensus Development Conference on Diabetes and Older Adults (defined as those aged ≥65 years) in February 2012.", "## What are consensus recommendations for clinicians treating older adults with or at risk for diabetes?"]}
{"doc_id": 45005, "title": "", "abstract": ["Other projections suggest that the number of cases of diagnosed diabetes in those aged ≥65 years will increase by 4.5-fold (compared to 3-fold in the total population) between 2005 and 2050 (7).", "Although increasing numbers of individuals with type 1 diabetes are living into old age (11), this discussion of pathophysiology concerns type 2 diabetes—overwhelmingly the most common incident and prevalent type in older age-groups.", "More than 25% of the U.S. population aged ≥65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic.", "The UK Prospective Diabetes Study (UKPDS), which provided valuable evidence of the benefits of glycemic control on microvascular complications, enrolled middle-aged patients with newly diagnosed type 2 diabetes, excluding those aged ≥65 years at the time of enrollment (24,25).", "Most would agree that a functional and generally healthy 66-year-old individual should be offered diabetes screening since interventions to prevent type 2 diabetes or the complications of type 2 diabetes would likely be beneficial given the presumption of decades of remaining life."]}
{"doc_id": 45006, "title": "", "abstract": ["According to the most recent surveillance data, the prevalence of diabetes among U.S. adults aged ≥65 years varies from 22 to 33%, depending on the diagnostic criteria used.", "More than 25% of the U.S. population aged ≥65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic.", "Although the burden of diabetes is often described in terms of its impact on working-age adults, diabetes in older adults is linked to higher mortality, reduced functional status, and increased risk of institutionalization (2).", "Older adults are at high risk for both diabetes and prediabetes, with surveillance data suggesting that half of older adults have the latter (1).", "Older adults are at high risk for the development of type 2 diabetes due to the combined effects of increasing insulin resistance and impaired pancreatic islet function with aging."]}
{"doc_id": 45007, "title": "", "abstract": ["An ADA position statement surmised that the combination of the UKPDS follow-up study and subset analyses of the later trials ‘‘… suggest the hypothesis that patients with shorter duration of type 2 diabetes and without established atherosclerosis might reap cardiovascular benefit from intensive glycemic control, [while] … potential risks of intensive glycemic control may outweigh its benefits in other patients, such as those with a very long duration of diabetes, known history of severe hypoglycemia, advanced atherosclerosis, and advanced age/frailty” (32).", "To address these issues, the American Diabetes Association (ADA) convened a Consensus Development Conference on Diabetes and Older Adults (defined as those aged ≥65 years) in February 2012.", "The ADA thanks the following individuals for their excellent presentations at the Consensus Development Conference on Diabetes and Older Adults: Edward Gregg, PhD; Nicolas Musi, MD; M.E. Miller, PhD; R. Harsha Rao, MD, FRCP; Craig Williams, PharmD, BCPS, FNLA; Barbara Resnick, PhD, CRNP, FAAN, FAANP; Carol M. Mangione, MD, MSPH; Jill P. Crandall, MD; Caroline S. Blaum, MD, MS; Jeff D. Williamson, MD, MHS; John M. Jakicic, PhD; Tamara Harris, MD, MS; and Naushira Pandya, MD, CMD.", "The screening and interventions for chronic diabetes complications recommended by the ADA have a strong evidence base and are cost-effective (54).", "The ADA recommends that overweight adults with risk factors—and all adults aged ≥45 years—be screened in the clinical setting every 1–3 years using either an FPG test, A1C, or oral glucose tolerance test."]}
{"doc_id": 45008, "title": "", "abstract": ["According to the most recent surveillance data, the prevalence of diabetes among U.S. adults aged ≥65 years varies from 22 to 33%, depending on the diagnostic criteria used.", "More than 25% of the U.S. population aged ≥65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic.", "Older adults with diabetes are at substantial risk for both acute and chronic microvascular and cardiovascular complications of the disease.", "Older adults are at high risk for both diabetes and prediabetes, with surveillance data suggesting that half of older adults have the latter (1).", "In light of the paucity of data for diabetes care in older adults, treatment decisions are frequently made with considerable uncertainty."]}
{"doc_id": 45009, "title": "", "abstract": ["According to the most recent surveillance data, the prevalence of diabetes among U.S. adults aged ≥65 years varies from 22 to 33%, depending on the diagnostic criteria used.", "More than 25% of the U.S. population aged ≥65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic.", "Older adults are at high risk for the development of type 2 diabetes due to the combined effects of increasing insulin resistance and impaired pancreatic islet function with aging.", "Among older adults, African Americans and Hispanics have higher incidence and prevalence of type 2 diabetes than non-Hispanic whites, and those with diagnosed diabetes have worse glycemic control and higher rates of comorbid conditions and complications (119).", "The incidence of diabetes increases with age until about age 65 years, after which both incidence and prevalence seem to level off (www.cdc.gov/diabetes/statistics)."]}
{"doc_id": 45010, "title": "", "abstract": ["* Glycemic goals for older adults not meeting the above criteria may be relaxed using individualized criteria, but hyperglycemia leading to symptoms or risk of acute hyperglycemic complications should be avoided in all patients.", "Although it is appropriate to relax glycemic targets for older patients with a history of hypoglycemia, a high burden of comorbidities, and limited life expectancy, goals that minimize severe hyperglycemia are indicated for almost all patients.", "Less stringent glycemic targets may be appropriate for patients with multiple comorbidities and reduced life expectancy—criteria that could be applicable to many hospitalized older adults.", "Glucagon-like peptide-1 agonists also target postprandial hyperglycemia and impart low risk of hypoglycemia, but their associated nausea and weight loss may be problematic in frail older patients.", "Studies of glycemic control targets in critically ill patients did include older adults, and therefore the recommendations for insulin infusions and glycemic goals of the ADA (17) are reasonable for older adults in intensive care units."]}
{"doc_id": 45011, "title": "", "abstract": ["These extensive guidelines recommend that “the decision to offer treatment should be based on the likely benefit/risk ratio of the intervention for the individual concerned, but factors such as vulnerability to hypoglycemia, ability to self- manage, the presence or absence of other pathologies, the cognitive status, and life expectancy must be considered” (57).", "As with other guidelines, the VA/DOD guidelines do not distinguish by age-group.", "A central concept in geriatric diabetes care guidelines is that providers should base decisions regarding treatment targets or interventions on life expectancy (2,17,56,57).", "Extensive review of the guidelines is beyond the scope of this report, but there are similar themes, which suggest pursuing an individualized approach with a focus on clinical and functional heterogeneity and comorbidities, and weighing the expected time frame of benefit of interventions against life expectancy.", "Current guidelines recommend preprandial glycemic targets of 100–140 mg/dL with maximal random values of 180 mg/dL in the majority of noncritically ill hospitalized patients, provided these targets can be safely achieved with low risk for hypoglycemia."]}
{"doc_id": 45012, "title": "", "abstract": ["Older patients are at increased risk for adverse drug events from most medications due to age-related changes in pharmacokinetics (in particular reduced renal elimination) and pharmacodynamics (increased sensitivity to certain medications) affecting drug disposition.", "Sulfonylureas are also a low-cost class of medications, but the risk of hypoglycemia with these agents may be problematic for older patients.", "Older adults with diabetes are at high risk of polypharmacy, increasing the risk of drug side effects and drug-to-drug interactions.", "Issues particularly relevant to older patients are described for each drug class.", "In one study, polypharmacy (defined as the use of six or more prescription medications) was associated with an increased risk of falling in older people (75)."]}
{"doc_id": 45013, "title": "", "abstract": ["Persistent pain from neuropathy or other causes or its inadequate treatment is associated with adverse outcomes in older adults including functional impairment, falls, slow rehabilitation, depression and anxiety, decreased socialization, sleep and appetite disturbances, and higher health care costs and utilization (2).", "Older adults may be at risk for undernutrition due to anorexia, altered taste and smell, swallowing difficulties, oral/dental issues, and functional impairments leading to difficulties in preparing or consuming food.", "What issues need to be considered in individualizing treatment recommendations for older adults?", "Vulnerable older adults, particularly those with cognitive dysfunction, may have impaired thirst sensation, contributing to the risk of volume depletion and hyperglycemic crises.", "However, there are few data on such regimens in people over age 75 years or in older adults with multiple comorbidities and/or limited functional status who were excluded from these trials."]}
{"doc_id": 45014, "title": "", "abstract": ["More than 25% of the U.S. population aged ≥65 years has diabetes (1), and the aging of the overall population is a significant driver of the diabetes epidemic.", "According to the most recent surveillance data, the prevalence of diabetes among U.S. adults aged ≥65 years varies from 22 to 33%, depending on the diagnostic criteria used.", "As a result, older adults with diabetes may either have incident disease (diagnosed after age 65 years) or long-standing diabetes with onset in middle age or earlier.", "Other projections suggest that the number of cases of diagnosed diabetes in those aged ≥65 years will increase by 4.5-fold (compared to 3-fold in the total population) between 2005 and 2050 (7).", "To address these issues, the American Diabetes Association (ADA) convened a Consensus Development Conference on Diabetes and Older Adults (defined as those aged ≥65 years) in February 2012."]}
{"doc_id": 45015, "title": "", "abstract": ["Less stringent glycemic targets may be appropriate for patients with multiple comorbidities and reduced life expectancy—criteria that could be applicable to many hospitalized older adults.", "Although it is appropriate to relax glycemic targets for older patients with a history of hypoglycemia, a high burden of comorbidities, and limited life expectancy, goals that minimize severe hyperglycemia are indicated for almost all patients.", "Older adults with diabetes who are otherwise healthy and functional should be encouraged to exercise to targets recommended for all adults with diabetes (17).", "The recommendation for many adults is an A1C <7%, but less stringent goals are recommended for those with limited life expectancy, advanced diabetes complications, or extensive comorbid conditions (17).", "Insulin therapy can be used to achieve glycemic goals in selected older adults with type 2 diabetes with similar efficacy and hypoglycemia risk as in younger patients."]}
{"doc_id": 45016, "title": "", "abstract": ["Older patients are at increased risk for adverse drug events from most medications due to age-related changes in pharmacokinetics (in particular reduced renal elimination) and pharmacodynamics (increased sensitivity to certain medications) affecting drug disposition.", "Older adults with diabetes are at high risk of polypharmacy, increasing the risk of drug side effects and drug-to-drug interactions.", "The risk for medication-related problems is compounded by the use of complex regimens, high-cost therapies, and polypharmacy or medication burden.", "In one study, polypharmacy (defined as the use of six or more prescription medications) was associated with an increased risk of falling in older people (75).", "Since older patients are at higher risk, absolute risk reductions with statin therapy would be greater in older patients."]}
{"doc_id": 45017, "title": "", "abstract": ["Its low risk for hypoglycemia may be beneficial in older adults, but gastrointestinal intolerance and weight loss from the drug may be detrimental in frail patients.", "A range of 7–7.5% is suggested for older patients with type 2 diabetes without major comorbidities and 7.6–8.5% for frail patients (dependent, multisystem disease, home care residency including those with dementia) where the hypoglycemia risk may be high and the likelihood of benefit relatively low.", "There is a dearth of studies addressing older adults with diabetes, particularly more frail older adults, in the hospital.", "The exclusion of older, and especially frail older, participants from most traditional randomized controlled trials of diabetes interventions has left us with large gaps in our knowledge of how best to address diabetes in the age- group with the highest prevalence rates.", "Older adults with diabetes are at substantial risk for both acute and chronic microvascular and cardiovascular complications of the disease."]}
{"doc_id": 45018, "title": "", "abstract": ["Overweight and obesity are prevalent among older adults.", "The Institute of Medicine found that although health care access and demographic variables account for some racial and ethnic disparities, there are persistent, residual gaps in outcomes attributed to differences in the quality of care received (120).", "Older adults with diabetes have the highest rates of major lower-extremity amputation (9), myocardial infarction (MI), visual impairment, and end-stage renal disease of any age-group.", "There is clearly a need for more research into the disparities in diabetes, particularly to understand the full impact of quality improvement programs and culturally tailored interventions among vulnerable older adults with diabetes.", "The epidemic of type 2 diabetes is clearly linked to increasing rates of overweight and obesity in the U.S. population, but projections by the Centers for Disease Control and Prevention (CDC) suggest that even if diabetes incidence rates level off, the prevalence of diabetes will double in the next 20 years, in part due to the aging of the population (6)."]}
{"doc_id": 45019, "title": "", "abstract": ["Consensus recommendations for research questions about diabetes in older adults", "To address these issues, the American Diabetes Association (ADA) convened a Consensus Development Conference on Diabetes and Older Adults (defined as those aged ≥65 years) in February 2012.", "The ADA thanks the following individuals for their excellent presentations at the Consensus Development Conference on Diabetes and Older Adults: Edward Gregg, PhD; Nicolas Musi, MD; M.E. Miller, PhD; R. Harsha Rao, MD, FRCP; Craig Williams, PharmD, BCPS, FNLA; Barbara Resnick, PhD, CRNP, FAAN, FAANP; Carol M. Mangione, MD, MSPH; Jill P. Crandall, MD; Caroline S. Blaum, MD, MS; Jeff D. Williamson, MD, MHS; John M. Jakicic, PhD; Tamara Harris, MD, MS; and Naushira Pandya, MD, CMD.", "Additional consensus recommendations for care of older adults with diabetes", "The ADA includes a section on older adults in its annual Standards of Medical Care in Diabetes (17)."]}
{"doc_id": 45020, "title": "", "abstract": ["Although the burden of diabetes is often described in terms of its impact on working-age adults, diabetes in older adults is linked to higher mortality, reduced functional status, and increased risk of institutionalization (2).", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults.", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults ranging from CVD to cancer and potentially impacting treatment decisions, such as whether stringent glycemic control would be of net benefit (36,37).", "Although age and diabetes conspire to reduce fitness and strength, physical activity interventions improve functional status in older adults (91) with and without diabetes.", "Older adults are at high risk for the development of type 2 diabetes due to the combined effects of increasing insulin resistance and impaired pancreatic islet function with aging."]}
{"doc_id": 45021, "title": "", "abstract": ["Other projections suggest that the number of cases of diagnosed diabetes in those aged ≥65 years will increase by 4.5-fold (compared to 3-fold in the total population) between 2005 and 2050 (7).", "Although the burden of diabetes is often described in terms of its impact on working-age adults, diabetes in older adults is linked to higher mortality, reduced functional status, and increased risk of institutionalization (2).", "The epidemic of type 2 diabetes is clearly linked to increasing rates of overweight and obesity in the U.S. population, but projections by the Centers for Disease Control and Prevention (CDC) suggest that even if diabetes incidence rates level off, the prevalence of diabetes will double in the next 20 years, in part due to the aging of the population (6).", "For the latter group, particular attention should be paid to screening for risk factors of complications that might further impair functional status or quality of life over a relatively short period of time, such as foot ulcers/amputations and visual impairment.", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults."]}
{"doc_id": 45022, "title": "", "abstract": ["Although attention has rightly been paid to the risks of overtreatment of hyperglycemia in older adults (hypoglycemia, treatment burden, possibly increased mortality), untreated or undertreated hyperglycemia also has risks, even in patients with life expectancy too short to be impacted by the development of chronic complications.", "However, hypoglycemia and other adverse effects of treatment were more common in older participants (28).", "Persistent pain from neuropathy or other causes or its inadequate treatment is associated with adverse outcomes in older adults including functional impairment, falls, slow rehabilitation, depression and anxiety, decreased socialization, sleep and appetite disturbances, and higher health care costs and utilization (2).", "The risk factors for hypoglycemia in diabetes in general (use of insulin or insulin secretagogues, duration of diabetes, antecedent hypoglycemia, erratic meals, exercise, renal insufficiency) (104) presumably apply to older patients as well.", "In older patients with cognitive dysfunction, regimens should be simplified, caregivers involved, and the occurrence of hypoglycemia carefully assessed."]}
{"doc_id": 45023, "title": "", "abstract": ["Although several organizations have developed guidelines that pertain to older adults and/or those with significant comorbidity, lack of evidence makes it somewhat difficult to provide concrete guidance for clinicians.", "Less stringent glycemic targets may be appropriate for patients with multiple comorbidities and reduced life expectancy—criteria that could be applicable to many hospitalized older adults.", "A combination of multiple comorbid illnesses and functional impairments was a better predictor of limited life expectancy and diminished benefits of intensive glucose control than age alone.", "In the case of the older person with cognitive deficits, the family member or friend may in fact be serving as a surrogate decision maker.", "Despite having the highest prevalence of diabetes of any age-group, older persons and/or those with multiple comorbidities have often been excluded from randomized controlled trials of treatments—and treatment targets—for diabetes and its associated conditions."]}
{"doc_id": 45024, "title": "", "abstract": ["Additional consensus recommendations for care of older adults with diabetes", "A range of 7–7.5% is suggested for older patients with type 2 diabetes without major comorbidities and 7.6–8.5% for frail patients (dependent, multisystem disease, home care residency including those with dementia) where the hypoglycemia risk may be high and the likelihood of benefit relatively low.", "What are consensus recommendations for treating older adults with or at risk for diabetes?", "What issues need to be considered in individualizing treatment recommendations for older adults?", "Consensus recommendations for research questions about diabetes in older adults"]}
{"doc_id": 45025, "title": "", "abstract": ["Consensus recommendations for research questions about diabetes in older adults", "Additional consensus recommendations for care of older adults with diabetes", "After review of the available evidence and consideration of issues that might influence treatment decisions in older adults with diabetes, the authors have developed recommendations in a number of areas.", "What are consensus recommendations for treating older adults with or at risk for diabetes?", "## What are consensus recommendations for clinicians treating older adults with or at risk for diabetes?"]}
{"doc_id": 45026, "title": "", "abstract": ["Older adults are at high risk for the development of type 2 diabetes due to the combined effects of increasing insulin resistance and impaired pancreatic islet function with aging.", "As a result, older adults with diabetes may either have incident disease (diagnosed after age 65 years) or long-standing diabetes with onset in middle age or earlier.", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults.", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults ranging from CVD to cancer and potentially impacting treatment decisions, such as whether stringent glycemic control would be of net benefit (36,37).", "Although increasing numbers of individuals with type 1 diabetes are living into old age (11), this discussion of pathophysiology concerns type 2 diabetes—overwhelmingly the most common incident and prevalent type in older age-groups."]}
{"doc_id": 45027, "title": "", "abstract": ["Consensus recommendations for research questions about diabetes in older adults", "Additional consensus recommendations for care of older adults with diabetes", "What are consensus recommendations for treating older adults with or at risk for diabetes?", "Older adults with diabetes have the highest rates of major lower-extremity amputation (9), myocardial infarction (MI), visual impairment, and end-stage renal disease of any age-group.", "Although these results suggest that diabetes prevention through lifestyle intervention be pursued in relatively healthy older adults, the DPP did not enroll significant numbers over the age of 70 years or those with functional or cognitive impairments."]}
{"doc_id": 45028, "title": "", "abstract": ["Its low risk for hypoglycemia may be beneficial in older adults, but gastrointestinal intolerance and weight loss from the drug may be detrimental in frail patients.", "A range of 7–7.5% is suggested for older patients with type 2 diabetes without major comorbidities and 7.6–8.5% for frail patients (dependent, multisystem disease, home care residency including those with dementia) where the hypoglycemia risk may be high and the likelihood of benefit relatively low.", "Diabetes is associated with increased risk of multiple coexisting medical conditions in older adults ranging from CVD to cancer and potentially impacting treatment decisions, such as whether stringent glycemic control would be of net benefit (36,37).", "An ADA position statement surmised that the combination of the UKPDS follow-up study and subset analyses of the later trials ‘‘… suggest the hypothesis that patients with shorter duration of type 2 diabetes and without established atherosclerosis might reap cardiovascular benefit from intensive glycemic control, [while] … potential risks of intensive glycemic control may outweigh its benefits in other patients, such as those with a very long duration of diabetes, known history of severe hypoglycemia, advanced atherosclerosis, and advanced age/frailty” (32).", "The exclusion of older, and especially frail older, participants from most traditional randomized controlled trials of diabetes interventions has left us with large gaps in our knowledge of how best to address diabetes in the age- group with the highest prevalence rates."]}
{"doc_id": 45029, "title": "", "abstract": ["These extensive guidelines recommend that “the decision to offer treatment should be based on the likely benefit/risk ratio of the intervention for the individual concerned, but factors such as vulnerability to hypoglycemia, ability to self- manage, the presence or absence of other pathologies, the cognitive status, and life expectancy must be considered” (57).", "Prior studies of older cognitively intact patients have shown that surrogate decision makers often report treatment preferences for the patient that have little correlation with the patient’s views (118), highlighting the importance of eliciting patient preferences whenever possible.", "What issues need to be considered in individualizing treatment recommendations for older adults?", "Thus, providers must first educate patients and their caregivers about what is known about the role of risk factors in the development of complications and then discuss the possible harms and benefits of interventions to reduce these risk factors.", "Even in the absence of cognitive impairment, educators should consider that many patients may have low health literacy and numeracy skills or may be overwhelmed by the presence of multiple comorbidities."]}
{"doc_id": 82000, "title": "", "abstract": ["These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "The odds of clinically significant improvements in risk factors were increased further with greater weight losses, such that those who lost 5–10% had greater odds of improvements than those who lost 2–5%, and those who lost 10–15% had greater odds of improvement than those who lost 5–10% (see the Supplemental Materials).", "Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "Separate logistic regression models were fit to examine the effect of weight loss on the odds of meeting predefined criteria indicating clinical meaningful improvement in CVD risk factors, defined as follows: 5 mmHg decrease in SBP or DBP; a 20 mg/dL decrease in fasting glucose; a 0.5% point decrease in HbA1c; a 5 mg/dL increase in HDL cholesterol; a 10 mg/dL decrease in LDL cholesterol; and a 40 mg/dL decrease in triglycerides.", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits."]}
{"doc_id": 82001, "title": "", "abstract": ["These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes.", "We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes."]}
{"doc_id": 82002, "title": "", "abstract": ["These analyses provide important data to address the recommendations regarding modest weight loss.", "In conclusion, Look AHEAD provides empirical support for the benefits of modest weight losses at 1 year.", "*A complete list of the Look AHEAD Research Group can be found in the Supplementary Data.", "We focused on the weight changes, per se, in keeping with our goal of addressing the clinical recommendations related to weight loss.", "In addition, Table 2 shows the magnitude of the association between weight loss and changes in risk factors."]}
{"doc_id": 82003, "title": "", "abstract": ["Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "Look AHEAD is continuing to follow its participants over time and, thus, will be able to determine the longer-term impact of modest weight losses on risk factors and whether these modest weight losses ultimately affect cardiovascular morbidity and mortality."]}
{"doc_id": 82004, "title": "", "abstract": ["Separate logistic regression models were fit to examine the effect of weight loss on the odds of meeting predefined criteria indicating clinical meaningful improvement in CVD risk factors, defined as follows: 5 mmHg decrease in SBP or DBP; a 20 mg/dL decrease in fasting glucose; a 0.5% point decrease in HbA1c; a 5 mg/dL increase in HDL cholesterol; a 10 mg/dL decrease in LDL cholesterol; and a 40 mg/dL decrease in triglycerides.", "Compared with weight- stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]).", "However, those who lost 2–5% of their body weight had increased odds of having significant improvements in SBP (odds ratio 1.24 [95% CI 1.02–1.50]), glucose (1.75 [1.40–2.19]), HbA1c (1.80 [1.44–2.24]), and triglycerides (1.46 [1.14–1.87]), and those who lost 5 to <10% of their body weight had increased odds of significant improvement in all risk factors.", "Clinical criteria| Gained >2%| Stable Gained ≤2 or lost <2%| Lost ≥2 to <5%| Lost ≥5 to <10%| Lost ≥10 to <15%| Lost ≥15%   ---|---|---|---|---|---|---   5 mmHg decrease in SBP| 0.86 (0.70–1.06)| 1.0| 1.24 (1.02–1.50)| 1.56 (1.27–1.91)| 2.29 (1.79–2.93)| 2.65 (2.00–3.50)   5 mmHg decrease in DBP| 1.03 (0.83–1.28)| 1.0| 1.05 (0.86–1.28)| 1.48 (1.20–1.82)| 1.60 (1.25–2.06)| 2.39 (1.81–3.16)   20 mg/dL decrease in glucose| 1.13 (0.87–1.46)| 1.0| 1.75 (1.40–2.19)| 3.24 (2.57–4.09)| 4.07 (3.09–5.36)| 7.92 (5.78–10.85)   0.05% decrease in HbA1c| 1.17 (0.91–1.50)| 1.0| 1.80 (1.44–2.24)| 3.52 (2.81–4.40)| 5.44 (4.15–7.13)| 10.02 (7.31–13.73)   5 mg/dL increase in HDL| 0.88 (0.71–1.11)| 1.0| 1.13 (0.93–1.39)| 1.69 (1.37–2.07)| 2.30 (1.80–2.93)| 4.34 (3.30–5.72)   5 mg/dL increase in HDL (not on medications)| 0.79 (0.54–1.15)| 1.0| 0.99 (0.71–1.39)| 1.52 (1.08–2.15)| 2.54 (1.68–3.82)| 5.27 (3.36–8.27)   10 mg/dL decrease in LDL| 1.17 (0.95–1.45)| 1.0| 1.05 (0.86–1.29)| 1.34 (1.09–1.64)| 1.26 (0.98–1.62)| 1.34 (1.02–1.78)   10 mg/dL decrease in LDL (not on medications)| 1.39 (0.97–1.99)| 1.0| 0.97 (0.69–1.36)| 1.41 (1.00–2.00)| 1.28 (0.83–1.96)| 1.52 (0.96–2.41)   40 mg/dL decrease in triglycerides| 0.80 (0.60–1.06)| 1.0| 1.46 (1.14–1.87)| 2.20 (1.71–2.83)| 3.99 (2.97–5.35)| 7.18 (5.19–9.93)", "The odds of having a clinically meaningful improvement in risk factors also were strongly related to the magnitude of weight loss achieved (Table 3)."]}
{"doc_id": 82005, "title": "", "abstract": ["Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Overweight and obese individuals are frequently encouraged to lose 5–10% of their weight and are told that weight losses of that magnitude will help improve their cardiovascular disease (CVD) risk factors.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits."]}
{"doc_id": 82006, "title": "", "abstract": ["Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes.", "Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.", "This finding confirms a large number of previous studies indicating that modest weight losses markedly improve glycemic control (12)."]}
{"doc_id": 82007, "title": "", "abstract": ["Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "For example, the Centers for Disease Control and Prevention website (www.cdc.gov/healthyweight/losing_weight/index.html) states, “The good news is that no matter what your weight loss goal is, even a modest weight loss, such as 5 to 10% of your total body weight, is likely to produce health benefits, such as improvements in blood pressure, blood cholesterol, and blood sugars.”", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes."]}
{"doc_id": 82008, "title": "", "abstract": ["Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Separate logistic regression models were fit to examine the effect of weight loss on the odds of meeting predefined criteria indicating clinical meaningful improvement in CVD risk factors, defined as follows: 5 mmHg decrease in SBP or DBP; a 20 mg/dL decrease in fasting glucose; a 0.5% point decrease in HbA1c; a 5 mg/dL increase in HDL cholesterol; a 10 mg/dL decrease in LDL cholesterol; and a 40 mg/dL decrease in triglycerides.", "The odds of clinically significant improvements in risk factors were increased further with greater weight losses, such that those who lost 5–10% had greater odds of improvements than those who lost 2–5%, and those who lost 10–15% had greater odds of improvement than those who lost 5–10% (see the Supplemental Materials)."]}
{"doc_id": 82009, "title": "", "abstract": ["Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Look AHEAD is a multicenter, randomized clinical trial examining the long-term effects of lifestyle interventions on cardiovascular morbidity and mortality in 5,145 overweight or obese participants with type 2 diabetes who were randomly assigned to intensive lifestyle intervention (ILI) or to usual care, referred to as diabetes support and education (DSE) (8,9).", "This finding confirms a large number of previous studies indicating that modest weight losses markedly improve glycemic control (12).", "Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes."]}
{"doc_id": 82010, "title": "", "abstract": ["We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes.", "Table 1 presents the baseline characteristics of 5,145 participants in Look AHEAD.", "Compared with weight- stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]).", "Odds ratio (95% CI) for the percentage of Look AHEAD cohort achieving clinically meaningful changes in CVD risk factors", "Look AHEAD is a multicenter, randomized clinical trial examining the long-term effects of lifestyle interventions on cardiovascular morbidity and mortality in 5,145 overweight or obese participants with type 2 diabetes who were randomly assigned to intensive lifestyle intervention (ILI) or to usual care, referred to as diabetes support and education (DSE) (8,9)."]}
{"doc_id": 82011, "title": "", "abstract": ["The odds of having a clinically meaningful improvement in risk factors also were strongly related to the magnitude of weight loss achieved (Table 3).", "The fact that all participants in this study had type 2 diabetes, whereas only some had hypertension or hyperlipidemia, may be related to this finding.", "In this article, we examine the associations between the magnitude of weight loss and the degree of improvement in glycemic control, blood pressure, and lipid levels at 1 year in the full cohort.", "The magnitude of weight loss at 1 year was strongly (P < 0.0001) associated with improvements in glycemia, blood pressure, tryiglycerides, and HDL cholesterol but not with LDL cholesterol (P = 0.79).", "Compared with weight- stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83])."]}
{"doc_id": 82012, "title": "", "abstract": ["Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "To better describe the associations between weight change and improvements in CVD risk factors, Look AHEAD participants were categorized by their percent weight changes over the first year.", "We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes.", "Look AHEAD (Action for Health in Diabetes) provides a unique opportunity to carefully assess the effects of modest weight loss on CVD risk factors in individuals with type 2 diabetes, a population at high risk for CVD."]}
{"doc_id": 82013, "title": "", "abstract": ["Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes.", "For example, the Centers for Disease Control and Prevention website (www.cdc.gov/healthyweight/losing_weight/index.html) states, “The good news is that no matter what your weight loss goal is, even a modest weight loss, such as 5 to 10% of your total body weight, is likely to produce health benefits, such as improvements in blood pressure, blood cholesterol, and blood sugars.”", "However, those who lost 2–5% of their body weight had increased odds of having significant improvements in SBP (odds ratio 1.24 [95% CI 1.02–1.50]), glucose (1.75 [1.40–2.19]), HbA1c (1.80 [1.44–2.24]), and triglycerides (1.46 [1.14–1.87]), and those who lost 5 to <10% of their body weight had increased odds of significant improvement in all risk factors.", "Compared with weight- stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83])."]}
{"doc_id": 82014, "title": "", "abstract": ["Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "The odds of clinically significant improvements in most risk factors were even greater in those who lost 10–15% of their body weight.", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "Overweight and obese individuals are frequently encouraged to lose 5–10% of their weight and are told that weight losses of that magnitude will help improve their cardiovascular disease (CVD) risk factors."]}
{"doc_id": 82015, "title": "", "abstract": ["However, the studies included in these reviews often had limited sample sizes, focused on nondiabetic individuals, and typically presented only average weight loss and the average reduction in risk factors, which did not allow a careful analysis of the association between specific magnitudes of weight loss and consequent improvements in CVD risk factors.", "All analyses also adjusted for age, sex, baseline level of the outcome variables, baseline weight, and race/ethnicity.", "Although a meta-analysis (15) of studies assessing the effect of weight loss on lipids over at least a 2-year follow-up concluded that there was a positive linear relationship between weight loss and improvements in both total and LDL cholesterol, some studies (14,16,17) have not confirmed this.", "Results remained similar after adjusting for starting or stopping medications.", "Data in all figures are presented as least square means and 95% CIs adjusted for clinical sites, age, sex, race/ethnicity, baseline weight, baseline measurement of the outcome variable, and treatment group assignment."]}
{"doc_id": 82016, "title": "", "abstract": ["Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "This finding confirms a large number of previous studies indicating that modest weight losses markedly improve glycemic control (12).", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Separate logistic regression models were fit to examine the effect of weight loss on the odds of meeting predefined criteria indicating clinical meaningful improvement in CVD risk factors, defined as follows: 5 mmHg decrease in SBP or DBP; a 20 mg/dL decrease in fasting glucose; a 0.5% point decrease in HbA1c; a 5 mg/dL increase in HDL cholesterol; a 10 mg/dL decrease in LDL cholesterol; and a 40 mg/dL decrease in triglycerides."]}
{"doc_id": 82017, "title": "", "abstract": ["Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "In conclusion, Look AHEAD provides empirical support for the benefits of modest weight losses at 1 year.", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes."]}
{"doc_id": 82018, "title": "", "abstract": ["These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes."]}
{"doc_id": 82019, "title": "", "abstract": ["These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes.", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes.", "Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.", "The strongest associations between changes in weight and risk factors were seen for measures of glycemic control, and clinically significant improvements were observed with just a 2 to <5% reduction in initial weight.", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes"]}
{"doc_id": 95000, "title": "", "abstract": ["Overall, EMT is characterized as a downregulation of epithelial markers, particularly E-cadherin, and an upregulation of mesenchymal markers, particularly vimentin or fibronectin, accompanied by an increase in cell migration and invasion.", "Interestingly, MMTV-Cripto transgenic mice develop tumors that display properties of EMT including downregulation of E-cadherin and upregulation of vimentin and N-cadherin [98].", "Furthermore, cells at the sites of branching activate the promoter of the mesenchymal marker, vimentin, and express MMP3, an inducer of EMT [66].", "Activation of the Wnt pathway in breast cancer cells induces the EMT regulator, Snail, and upregulates the mesenchymal marker, vimentin [109, 139].", "In the context of cancer, loss of Sim2 in mammary carcinoma cells also induces an EMT as measured by the loss of E-cadherin and concomitant gain of vimentin and N-cadherin [112]."]}
{"doc_id": 95001, "title": "", "abstract": ["Recently, a novel hypothesis for the role of EMT in cancer progression has been proposed, whereby epithelial and mesenchymal cells cooperate during metastatic dissemination, potentially eliminating the need for MET at the distant site [77].", "Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression", "In this review, we will discuss EMT and epithelial plasticity in development, as well as the evidence for reactivation of these developmental programs in cancer progression and metastasis.", "Oncogenic EMT is associated with loss of apico-basal polarity [27], disintegration of tight junctions [28] and adherens junctions, cytoskeletal changes, including the downregulation of cytokeratins and the upregulation of vimentin [29], and the acquisition of a motile and invasive phenotype paralleling changes observed during developmental EMT.", "Recent work in breast cancer and other cancers has postulated EMT as a potential mechanism by which epithelial tumor cells acquire a more motile and invasive phenotype and escape from the primary tumor [69]."]}
{"doc_id": 95002, "title": "", "abstract": ["During EMT, epithelial cells lose their apico- basal polarity.", "EMT begins with the loss of apico-basal polarity as tight junctions dissolve, permitting intermingling of apical and basolateral membrane components [19].", "Oncogenic EMT is associated with loss of apico-basal polarity [27], disintegration of tight junctions [28] and adherens junctions, cytoskeletal changes, including the downregulation of cytokeratins and the upregulation of vimentin [29], and the acquisition of a motile and invasive phenotype paralleling changes observed during developmental EMT.", "In the context of epithelial cancer, EMT provides a mechanism for tumor cells to leave the primary tumor and invade into the local tissue and blood vessels, setting the stage for metastatic spread (Fig. 2).", "Then, with the proper extracellular inputs, including activation of TGF-β and Wnt signaling at the leading edge of the tumor coupled with the expression of EMT regulators such as Snail/Slug/Twist, Cripto-1 and Six1, the cells acquire a mesenchymal phenotype that permit them to locally invade and escape from the primary tumor, setting the stage for metastatic dissemination (Fig. 5b)."]}
{"doc_id": 95003, "title": "", "abstract": ["However, the recent use of cell fate mapping of epithelial tumor cells in the Whey Acidic Protein (WAP)-Myc transgenic mice provides direct evidence of EMT in the local invasion of tumor cells in breast cancer [23], finally putting an end to the argument as to whether EMT can occur in mammary/breast cancer.", "This work supports the existence of EMT in breast cancer and suggests that the cells undergo MET at the site of metastatic colonization.", "Consistent with the hypothesis that developmental programs are reactivated during tumorigenesis and contribute to tumor progression, numerous EMT regulators in development are also inappropriately expressed in human cancer and correlate with features of EMT, albeit with less order and coordination than observed in developmental EMT [30].", "Together these results suggest that EMT programs beyond those critical for mammary gland development may be activated in human breast cancer and contribute to an oncogenic EMT and breast cancer aggressiveness.", "The spectrum of EMT inducers implicated in breast cancer includes both signaling pathways such as TGF-β, Wnt/β-catenin, and Cripto, as well as transcription factors including Twist, Snail/Slug, Lbx1, and Six1."]}
{"doc_id": 95004, "title": "", "abstract": ["Because TGF-β signaling is critical for EMT during cardiogenesis and palatogenesis, and because it also promotes EMT in a tumorigenic context, it is likely that the ability of TGF-β to promote metastasis is at least in part due to of its ability to induce an EMT.", "The underlying mechanism of Six1-induced EMT and metastasis appears to be, at least in part, through the activation of TGF-β signaling [37], a pathway that is well -established as a strong inducer of EMT in breast cancer [31].", "Interestingly, TGF-β signaling, which induces EMT and single cell migration, is necessary for intravasation, extravasation and blood borne metastasis [82, 85].", "During primary tumor formation, the genetic and epigenetic changes in the tumor cells coupled with alterations in the tumor microenvironment promote EMT.", "Finally, the induction of EMT not only regulates features intrinsic to the tumor cells, but also regulates the tumor cell’s interaction with its microenvironment, including the immune cells."]}
{"doc_id": 95005, "title": "", "abstract": ["In addition to developmental examples of partial EMT, wound healing also exhibits features of epithelial plasticity.", "In addition to EMT, epithelial cell plasticity has also been observed in a process termed collective migration.", "Then, with the proper extracellular inputs, including activation of TGF-β and Wnt signaling at the leading edge of the tumor coupled with the expression of EMT regulators such as Snail/Slug/Twist, Cripto-1 and Six1, the cells acquire a mesenchymal phenotype that permit them to locally invade and escape from the primary tumor, setting the stage for metastatic dissemination (Fig. 5b).", "In addition, epithelial plasticity and the acquisition of invasive properties without the full commitment to a mesenchymal phenotype are critical in development, particularly during branching morphogenesis in the mammary gland.", "Indeed, recent evidence shows that this is the case: therapies do select for more mesenchymal and cancer stem cell-like cancer cells, pointing to a need for chemotherapeutic agents that specifically target cells that have undergone EMT and display enhanced tumor-initiating capabilities [90, 91]."]}
{"doc_id": 95006, "title": "", "abstract": ["The Wnt pathway is activated during multiple stages of mammary development from the earliest stage during embryogenesis where Wnt signaling is necessary for mammary bud formation, to the alveolar differentiation and side branching observed during pregnancy.", "Similar to the TGF-β pathway, the Wnt/β-catenin pathway is also implicated in EMT and epithelial plasticity during development and cancer.", "Wnt signaling likely plays a role in numerous aspects of mammary development including cell fate determination, maintenance of mammary progenitor cell populations, branching morphogenesis and alveolar differentiation [135].", "Not only is the Wnt pathway important for normal mammary development, but it also regulates EMT in other developmental contexts including gastrulation and cardiac valve formation [51, 137, 138].", "Taken together, these data implicate the Wnt/β-catenin pathway in epithelial plasticity and EMT in both development and cancer."]}
{"doc_id": 95007, "title": "", "abstract": ["In sum, the concept of an oncogenic EMT and its resemblance to developmental EMT is an important framework for understanding the mechanisms of cancer metastasis and will likely provide new therapeutic targets.", "Therefore, EMT is hypothesized to contribute to tumor progression, and indeed clinical evidence suggests that regulators of EMT in cancer cells correlate with poor patient outcomes and tumor aggressiveness [41, 42].", "Future work will continue to investigate the parallels between development and cancer and begin to consider oncogenic EMT pathways as potential therapeutic targets.", "This idea extends beyond tumor formation; the reactivation of developmental programs such as EMT could facilitate tumor cell invasion, spread and metastasis, and therefore may also represent a major mechanism of tumor progression.", "Recently, a novel hypothesis for the role of EMT in cancer progression has been proposed, whereby epithelial and mesenchymal cells cooperate during metastatic dissemination, potentially eliminating the need for MET at the distant site [77]."]}
{"doc_id": 95008, "title": "", "abstract": ["Snail, Slug and Twist are also significant inducers of EMT in cancer cells and repress E-cadherin expression [35, 104–106].", "Overall, Twist, Snail and Slug all can induce EMT in the context of normal tissue and cancer.", "These results beg the question as to whether EMT in cancer is transdifferentiation of epithelial cells to mesenchymal cells, or rather dedifferentiation to a more progenitor/stem-like phenotype that is accompanied by an increased invasive ability.", "Overall, EMT is characterized as a downregulation of epithelial markers, particularly E-cadherin, and an upregulation of mesenchymal markers, particularly vimentin or fibronectin, accompanied by an increase in cell migration and invasion.", "Activation of the Wnt pathway in breast cancer cells induces the EMT regulator, Snail, and upregulates the mesenchymal marker, vimentin [109, 139]."]}
{"doc_id": 95009, "title": "", "abstract": ["While distinct from a complete EMT, during branching morphogenesis the tip epithelial cells transiently exhibit mesenchymal features, ranging from loss of apico-basal polarity, degradation of the basement membrane, and increased cell protrusions and mesenchymal marker expression, depending on the tissue [59].", "EMT and epithelial plasticity enable the tumor cells to de-adhere from their neighboring cells, invade through the underlying basement membrane and move into the surrounding tissue either as single cells (blue) or as clusters (light blue) of cells.", "Cell surface proteins like E-cadherin and integrins, that mediate epithelial connections to neighboring cells and the basement membrane, respectively, are replaced by N-cadherin and integrins that provide more transient adhesive properties priming the cell for the mesenchymal phenotype.", "In addition, epithelial plasticity and the acquisition of invasive properties without the full commitment to a mesenchymal phenotype are critical in development, particularly during branching morphogenesis in the mammary gland.", "Overall, EMT is characterized as a downregulation of epithelial markers, particularly E-cadherin, and an upregulation of mesenchymal markers, particularly vimentin or fibronectin, accompanied by an increase in cell migration and invasion."]}
{"doc_id": 95010, "title": "", "abstract": ["Consistent with the hypothesis that developmental programs are reactivated during tumorigenesis and contribute to tumor progression, numerous EMT regulators in development are also inappropriately expressed in human cancer and correlate with features of EMT, albeit with less order and coordination than observed in developmental EMT [30].", "This idea extends beyond tumor formation; the reactivation of developmental programs such as EMT could facilitate tumor cell invasion, spread and metastasis, and therefore may also represent a major mechanism of tumor progression.", "The reactivation of embryonic programs that are potentially not functional in normal adult tissue provides an opportunity to selectively target these pathways in cancer cells while conferring minimal side effects.", "These similarities have led to the hypothesis that in tumorigenesis, developmental pathways are activated inappropriately that contribute to tumor progression.", "The implication of this observation is that cancer cells may readily reactivate developmental properties out of context in the adult, which then contribute to tumorigenesis via inducing accelerated proliferation, resistance to apoptosis and evasion of senescence."]}
{"doc_id": 95011, "title": "", "abstract": ["However, these phenotypes are not always permanent, and instead, under the appropriate conditions, epithelial and mesenchymal cells convert between these two phenotypes.", "The similarities between EMT and collective migration suggest that the transition between epithelial and mesenchymal cell phenotypes may not always represent two absolute and independent cellular states, but instead a continuous spectrum of epithelial and mesenchymal properties.", "However, depending on the cell type and its particular environment, epithelial and mesenchymal cell phenotypes are not static and instead can be highly dynamic.", "Interconversion between epithelial and mesenchymal cell phenotypes, processes termed Epithelial-Mesenchymal Transition (EMT) and the reverse Mesenchymal-Epithelial Transition (MET), provides additional flexibility particularly during embryogenesis, but also permits dynamic cellular remodeling during wound healing and regeneration of fully differentiated tissues [1, 6].", "During developmental EMT, a highly coordinated and specific series of events define the transition between epithelial cells and mesenchymal cells (Fig. 1) [1]."]}
{"doc_id": 95012, "title": "", "abstract": ["While distinct from a complete EMT, during branching morphogenesis the tip epithelial cells transiently exhibit mesenchymal features, ranging from loss of apico-basal polarity, degradation of the basement membrane, and increased cell protrusions and mesenchymal marker expression, depending on the tissue [59].", "These leading or pioneer cells (light blue) do not undergo a full EMT but exhibit mesenchymal features such as directed movement, development of cell protrusions, and loss of apico-basal polarity.", "When breast cancer cells lines are similarly classified, those cells classified as basal B, a subdivision of the basal cluster, also display a mesenchymal phenotype [76].", "Recent work in cancer has identified an analogous plasticity of cellular phenotypes whereby epithelial cancer cells acquire mesenchymal features that permit escape from the primary tumor.", "Cells exhibiting a mesenchymal phenotype provide support and structure to the epithelial cells particularly through the production of an extracellular matrix and, unlike the rather confined and immobile epithelial cell, are highly motile and invasive [5]."]}
{"doc_id": 95013, "title": "", "abstract": ["Interconversion between epithelial and mesenchymal cell phenotypes, processes termed Epithelial-Mesenchymal Transition (EMT) and the reverse Mesenchymal-Epithelial Transition (MET), provides additional flexibility particularly during embryogenesis, but also permits dynamic cellular remodeling during wound healing and regeneration of fully differentiated tissues [1, 6].", "EMT, and the reverse process MET, have both been thoroughly studied in mammalian development, where numerous embryonic events and developing organs depend on the switch between epithelial and mesenchymal phenotypes including gastrulation [4], neural crest formation [7], palatogenesis [8], heart valve formation [9], nephrogenesis [10] and myogenesis [11].", "In the context of epithelial cancer, EMT provides a mechanism for tumor cells to leave the primary tumor and invade into the local tissue and blood vessels, setting the stage for metastatic spread (Fig. 2).", "While the basic features of EMT are similar among the different conditions, a recent series of reviews has proposed classifying EMT into three different subtypes, based on the functional consequences and biological context, in an attempt to better reflect the distinctive properties of EMT in development.", "However, unlike developmental EMT, which typically proceeds stepwise under the tight control of morphogenic signals and generally correlates with a cell fate change, oncogenic EMT occurs in the context of unpredictable genetic changes present in the tumor cells, as well as an abnormal local tumor environment."]}
{"doc_id": 95014, "title": "", "abstract": ["While distinct from a complete EMT, during branching morphogenesis the tip epithelial cells transiently exhibit mesenchymal features, ranging from loss of apico-basal polarity, degradation of the basement membrane, and increased cell protrusions and mesenchymal marker expression, depending on the tissue [59].", "Although during collective migration epithelial cells maintain cell-cell junctions, many properties of collective migration parallel changes observed during EMT, including alteration of apico-basal polarity, modification of the extracellular matrix and the acquisition of an invasive and motile phenotype [15].", "During EMT, epithelial cells lose their apico- basal polarity.", "Overall, EMT is characterized as a downregulation of epithelial markers, particularly E-cadherin, and an upregulation of mesenchymal markers, particularly vimentin or fibronectin, accompanied by an increase in cell migration and invasion.", "EMT and epithelial plasticity enable the tumor cells to de-adhere from their neighboring cells, invade through the underlying basement membrane and move into the surrounding tissue either as single cells (blue) or as clusters (light blue) of cells."]}
{"doc_id": 95015, "title": "", "abstract": ["Parallels between normal mammary development and breast cancer progression.", "This review focuses on the parallels between epithelial plasticity/EMT in the mammary gland and other organs during development, and on a selection of developmental EMT regulators that are misexpressed specifically during breast cancer.", "As the mechanisms of spread in epithelial-derived cancer are becoming clear, similarities have been recognized to developmental programs of migration and invasion.", "Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression", "Paralleling the observations from early embryonic development, the expression of Cripto in breast cancer prior to the acquisition of invasive properties suggests that Cripto expression likely cooperates with other pathways to induce an invasive phenotype and may prime the cells for EMT."]}
{"doc_id": 95016, "title": "", "abstract": ["Recent work in breast cancer and other cancers has postulated EMT as a potential mechanism by which epithelial tumor cells acquire a more motile and invasive phenotype and escape from the primary tumor [69].", "These results beg the question as to whether EMT in cancer is transdifferentiation of epithelial cells to mesenchymal cells, or rather dedifferentiation to a more progenitor/stem-like phenotype that is accompanied by an increased invasive ability.", "Then, with the proper extracellular inputs, including activation of TGF-β and Wnt signaling at the leading edge of the tumor coupled with the expression of EMT regulators such as Snail/Slug/Twist, Cripto-1 and Six1, the cells acquire a mesenchymal phenotype that permit them to locally invade and escape from the primary tumor, setting the stage for metastatic dissemination (Fig. 5b).", "Overall, these results suggest that the induction of EMT is not simply a migratory mechanism of local spread of tumor cells from the primary site, but instead induces a comprehensive program of properties necessary for tumor progression.", "Evidence for the role of EMT in cancer is complicated by the fact that at the secondary site the metastatic cells likely undergo a reversion or MET, permitting colonization of the distant site."]}
{"doc_id": 95017, "title": "", "abstract": ["Then, with the proper extracellular inputs, including activation of TGF-β and Wnt signaling at the leading edge of the tumor coupled with the expression of EMT regulators such as Snail/Slug/Twist, Cripto-1 and Six1, the cells acquire a mesenchymal phenotype that permit them to locally invade and escape from the primary tumor, setting the stage for metastatic dissemination (Fig. 5b).", "Because TGF-β signaling is critical for EMT during cardiogenesis and palatogenesis, and because it also promotes EMT in a tumorigenic context, it is likely that the ability of TGF-β to promote metastasis is at least in part due to of its ability to induce an EMT.", "Much of the recent work on inducers of EMT has utilized tissue culture models to assess the epithelial and mesenchymal phenotype of cancer cell lines.", "Numerous inducers of EMT in cancer cell lines have been identified including Transforming Growth Factor-β (TGF-β) [31], Wnt [32], Snail/Slug [33, 34], Twist [35] and Six1 [36, 37], and these oncogenic EMT inducers are also critical during developmental EMT [9, 38–40].", "Overall, these results suggest that the induction of EMT is not simply a migratory mechanism of local spread of tumor cells from the primary site, but instead induces a comprehensive program of properties necessary for tumor progression."]}
{"doc_id": 95018, "title": "", "abstract": ["In infiltrating ductal carcinoma, Snail expression correlates with lymph node metastasis and with decreased relapse free survival [115, 116], while Slug correlates with metastasis [117].", "Then, with the proper extracellular inputs, including activation of TGF-β and Wnt signaling at the leading edge of the tumor coupled with the expression of EMT regulators such as Snail/Slug/Twist, Cripto-1 and Six1, the cells acquire a mesenchymal phenotype that permit them to locally invade and escape from the primary tumor, setting the stage for metastatic dissemination (Fig. 5b).", "Snail, Slug and Twist are also significant inducers of EMT in cancer cells and repress E-cadherin expression [35, 104–106].", "The molecular basis of neural crest EMT includes expression of the E-cadherin repressor, Snail [46].", "In addition to gastrulation, the E-cadherin repressor proteins are also expressed during other developmental EMT events including palatal fusion (Snail and Twist) and neural crest migration (Snail and Slug depending on the species) [7]."]}
{"doc_id": 51000, "title": "", "abstract": ["Accumulating evidence indicates that mucin plays an important role in several stages of metastatic processes of colorectal cancer.", "The changes in mucins that occur in colorectal cancer may be broadly classified into two main types: aberrant mucin gene regulation and glycosylation.", "Second, colon cancer cells selected for high mucin production showed increased liver colonization and metastasis.", "Alterations of mucin production and glycosylation occur in IBD, but whether they contribute to initiation of inflammation or are the result of inflammation is unknown.", "Keywords: Intestinal goblet cell, Mucin, Glycan, Mucus barrier, Microbiota, Parasites, Intestinal infections, Cystic fibrosis, Inflammatory bowel disease, Mucinous adenocarcinoma, Colorectal cancer"]}
{"doc_id": 51001, "title": "", "abstract": ["Balanced and dynamic interactions among mucus layers, intestinal epithelial cells, microbiota, and host immune defense is essential for the maintenance of the intestinal mucosal homeostasis.", "The trefoil factor family comprises a group of small peptides (6.5–12 kDa) with three intramolecular disulphide bonds, which is highly expressed in the mucus-producing cells of the gastrointestinal tract and plays a significant role in epithelial restitution (Table 2) [8, 52].", "Furthermore, TFF3 has been suggested to increase the viscosity of mucin by binding to the vWF C domain of MUC2, enhancing the structural integrity of the intestinal mucus barrier [55].", "Increases mucus viscosity and structural integrity of mucus layers.", "### Intestinal Mucus Layer"]}
{"doc_id": 51002, "title": "", "abstract": ["Goblet cells are reduced in number and size in ulcerative colitis.", "These mice showed aberrant assembly and processing of mucin complex and biochemical and histologic evidence of endoplasmic reticulum stress in goblet cells and Paneth cells, the phenomena observed in the patients with ulcerative colitis [73••].", "Two strains of mice with single missense mutations in oligomerization domains (vWF D3 and vWF C, respectively) showed aberrant Muc2 synthesis, reduced storage of mucin in the theca of goblet cells, diminished mucus layers with increased permeability and increased production of Th1 and Th2 cytokines, and developed spontaneous distal colitis and increased susceptibility to DSS-induced colitis [73••].", "However, with sustained hypersecretion of stored mucins, depletion of goblet cells occurs, resulting in defective mucin synthesis and mucus barrier.", "There are fewer and smaller goblet cells in the intestine of the germ-free mice compared to those of conventionally raised mice, indicating the microbial modulation of goblet cells [10]."]}
{"doc_id": 51003, "title": "", "abstract": ["The proportion of goblet cells among epithelial cell types increases caudally from duodenum (4%) to distal colon (16%), similar to the increasing number of microbial organisms present in the proximal intestine to colon [9].", "The human adult intestinal microbiota colonizing the outer loosely adherent mucus layer is made up of more than 1014 bacteria with increasing gradient of concentration and complexity of bacterial population from jejunum to colon; stomach, duodenum, and jejunum with 102–103 aerobic bacteria per gram luminal content, and 107–108 and 1011–1012 predominantly anaerobic bacteria per gram in distal ileum and colon, respectively [45•].", "Goblet cells appear early in development (in the human fetal small intestine, at 9–10 weeks’ gestation) and relatively undifferentiated oligomucous and mature goblet cells are present in both the stratified and simple columnar epithelium; however, once the villi have formed, most goblet cells are indistinguishable from those found in the adult intestine.", "The intestinal mucosal epithelium consists of four main cell types—absorptive enterocytes, goblet cells, Paneth cells, and enteroendocrine cells—which undergo continuous cycles of renewal.", "The outer loosely adherent mucus layer formed by proteolytic and glycosidic degradation of highly polymerized gel-like MUC2 mucin was similar in thickness in stomach and jejunum, but markedly increased in ileum, and thickest in colon (Table 1) [36]."]}
{"doc_id": 51004, "title": "", "abstract": ["Goblet cells synthesize and secrete bioactive molecules such as secretory and membrane-bound mucins, trefoil peptides, resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp), which are components of mucus [2•].", "Goblet cells synthesize secretory mucin glycoproteins (MUC2) and bioactive molecules such as epithelial membrane-bound mucins (MUC1, MUC3, MUC17), trefoil factor peptides (TFF), resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp).", "Intestinal mucus layers secreted by goblet cells consist mainly of compact mesh-like network of viscous, permeable, gel-forming MUC2 mucin, which provides the frontline host defense against endogenous and exogenous irritants and microbial attachment and invasion but allows the transport of nutrients.", "The major function of intestinal goblet cells and their main secretory product, mucin, is the formation of mucus layers which serve as the front line innate host defense mechanism.", "Mucin secretion is frequently coupled with increased synthesis of mucins, but chronic secretion may result in goblet cell depletion and decreased synthesis of mucins."]}
{"doc_id": 51005, "title": "", "abstract": ["The major component of the mucus is secreted mucins, large glycoproteins with highly polymeric protein backbone structure, linked to numerous hygroscopic and hydrophilic oligosaccharide side-chains that contribute to the formation of gel-like structure [3, 4].", "Mucins are highly glycosylated large glycoproteins with protein backbone structures rich in serine and threonine, which are linked to a wide variety of O-linked oligosaccharide side chains that make up more than 70% of the weight of the molecule [3, 4].", "The highly glycosylated central tandem repeat domains of MUC2 mucin monomers are flanked on either side by the cysteine-rich domains, including C-terminal cysteine knot domain and four D domains of von Willebrand factor (vWF), which are involved in dimerization and oligomerization, respectively, resulting in highly viscous gel-forming mucin network (Fig. 1) [16–18].", "MUC2 mucin monomer has more than 5000 amino acids and consists of central tandem repeat domains rich in proline, serine, and threonine, the latter of which are linked O-glycosidically to many oligosaccharide side chains of varying lengths and compositions (also called “PTS” domains).", "MUC2 mucin has structural and physicochemical properties similar to those of other gel-forming secretory mucin such as MUC5AC, MUC5B, and MUC6, expressed in gastric and respiratory glandular epithelium."]}
{"doc_id": 51006, "title": "", "abstract": ["It is possible that other mucin proteins, such as MUC5B, may polymerize with a different pattern, forming linear chains rather than trimers at the amino terminal region as with MUC2 [24].", "Accumulating evidence indicates that mucin plays an important role in several stages of metastatic processes of colorectal cancer.", "Mucin genes are expressed in tissue and cell type–specific manner and are broadly classified into two types, secretory and membrane-associated.", "In addition, MUC1 membrane mucin is expressed at lower level in mucinous carcinoma compared to nonmucinous cancer [78].", "First, colon cancer cell lines selected for high capacity for metastasis express high levels of MUC2."]}
{"doc_id": 51007, "title": "", "abstract": ["The cysteine-rich EGF-like domains of the mouse Muc3 and human MUC17 mucins have been shown to inhibit apoptosis and stimulate cell migration, implying a bioactive role in maintaining the integrity of the surface epithelial layer [22, 23].", "The important role of membrane-bound mucins at the apical cell surface and at the interface of the cell surface and the inner mucus layer was demonstrated by Muc1-deficient mice showing increased susceptibility to invasion by Campylobacter jejuni [44].", "The mucus layers play key roles in the establishment of the commensal intestinal microbiota and the protection from colonization and invasion by the pathogenic microbiota.", "Microbes are associated mostly in the outer loose mucus layer and absent from the inner firm mucus layer, indicating that the inner firm mucus layer functions as a critical protective barrier against bacterial adhesion and invasion of underlying epithelial cells [41••].", "The outer loose mucus layer provides a good habitat for microbial colonization, because oligosaccharides of MUC2 mucin provide numerous microbial attachment sites and energy source (Fig. 1) [42••]."]}
{"doc_id": 51008, "title": "", "abstract": ["Fc-γ binding protein (Fcgbp) is expressed in the mucus granule of goblet cells [62].", "Recently, TFF3 was reported to form disulfide-linked heteromer with Fcgbp protein, which could interact with MUC2 mucin in a covalent and non-covalent manner, contributing to the stability of mucin network in the mucus layer [56].", "It was suggested that covalent attachment of Fcgbp protein to MUC2 contributes to cross linking and stabilization of mucin network in the inner mucus layer [37].", "Goblet cells synthesize and secrete bioactive molecules such as secretory and membrane-bound mucins, trefoil peptides, resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp), which are components of mucus [2•].", "Fcgbp contains 13 vWF D domains and was reported to bind IgG antibodies through Fc part of IgGs."]}
{"doc_id": 51009, "title": "", "abstract": ["The highly glycosylated central tandem repeat domains of MUC2 mucin monomers are flanked on either side by the cysteine-rich domains, including C-terminal cysteine knot domain and four D domains of von Willebrand factor (vWF), which are involved in dimerization and oligomerization, respectively, resulting in highly viscous gel-forming mucin network (Fig. 1) [16–18].", "Like other gel-forming secretory mucins, MUC2 mucin monomers form dimers in the endoplasmic reticulum via intermolecular disulfide bonding between the c-terminal cysteine knot domains.", "The MUC2 mucin protein forms trimers by disulfide bonding in cysteine-rich amino terminal von Willebrand factor (vWF) domains, coupled with crosslinking provided by TFF and Fcgbp proteins with MUC2 vWF domains, resulting in a highly viscous extracellular layer.", "During transit through Golgi apparatus, MUC2 mucin proteins become heavily O-glycosylated and undergo trimerization via disulfide bonding in the amino terminal region, resulting in the formation of very large polymers [17, 18].", "The domain structure of MUC2 monomer shows central tandem repeat (TR) regions rich in proline, threonine, and serine (PTS domain), to which many oligosaccharide side chains (O-linked glycan) are linked, and four von Willebrand factor D domains flanking the tandem repeat (PTS) domains and C-terminal cysteine knot (CK) domain, which is involved in initial MUC2 dimerization."]}
{"doc_id": 51010, "title": "", "abstract": ["Balanced and dynamic interactions among mucus layers, intestinal epithelial cells, microbiota, and host immune defense is essential for the maintenance of the intestinal mucosal homeostasis.", "The functional integrity of the intestinal mucosal epithelial cells depends on the coordinated regulation of the mucus layer, the intercellular tight junction, epithelial cells, and host innate and adaptive immune response [1, 2•].", "Intestinal commensal microbiota depends on mucus and undigested dietary carbohydrates for binding sites and energy source and affects intestinal epithelial functions, including those of goblet cells and mucus layers, by a “cross talk” feedback mechanism.", "The normal intestinal mucosal epithelium has tolerance to commensal microbiota because of its ability to distinguish commensal microbiota from pathogenic microorganisms by their molecular patterns, such as microbe-associated molecular patterns and pathogen-associated molecular patterns, through pattern recognition receptors (PRRs) such as cell surface Toll-like receptors (TLRs) and cytoplasmic nucleotide-binding oligomerization domain (NOD) proteins [48, 49].", "The intestinal mucosal epithelium consists of four main cell types—absorptive enterocytes, goblet cells, Paneth cells, and enteroendocrine cells—which undergo continuous cycles of renewal."]}
{"doc_id": 51011, "title": "", "abstract": ["Epithelial cell surface is covered by glycocalyx, which consists of membrane-bound mucins (MUC3 and MUC17 in the small intestine) and other membrane glycoproteins.", "Intestinal epithelial cell surface is covered by two mucus layers (inner, firmly adherent layer and outer, loosely adherent layer) consisting largely of MUC2 mucin network produced by the goblet cells and other host defense molecules produced by goblet cells, Paneth cells, and absorptive enterocytes.", "Intestinal mucus layers secreted by goblet cells consist mainly of compact mesh-like network of viscous, permeable, gel-forming MUC2 mucin, which provides the frontline host defense against endogenous and exogenous irritants and microbial attachment and invasion but allows the transport of nutrients.", "The mucus layer overlying the epithelium secreted by the goblet cells promotes the elimination of gut contents and provides the first line of defense against physical and chemical injury caused by ingested food, microbes and the microbial products.", "Rapid and massive secretion of goblet cell mucus not only facilitates the expulsion of pathogens but also maintains the integrity of mucus protective layers."]}
{"doc_id": 51012, "title": "", "abstract": ["Identification of the specific epitopes in mucin glycoproteins as binding sites for commensal and pathogenic microbes in health and disease, and analysis of the effect of native and altered mucins on the ratio of protective/aggressive commensal microbes in the intestine, will contribute significantly to the development of novel therapeutic approaches in the management of intestinal diseases.", "Probiotics such as Lactobacillus plantarium were reported to induce MUC2 and MUC3 mucins and inhibit the adherence of EPEC (enteropathogenic Escherichia coli), indicating that enhanced mucus layers and glycocalyx overlying the intestinal epithelium and the occupancy of the microbial binding sites by Lactobacillus spp provide protection against invasion by the pathogens [50, 51].", "Intestinal commensal microbiota depends on mucus and undigested dietary carbohydrates for binding sites and energy source and affects intestinal epithelial functions, including those of goblet cells and mucus layers, by a “cross talk” feedback mechanism.", "Diverse oligosaccharides of mucin glycoproteins were evolved to promote symbiotic relationship with commensal bacteria and to evade pathogens [1, 2, 42••].", "Most commensal and pathogenic bacteria attach to the intestinal mucosal cells through interaction of adhesins to the mucosal receptors, such as integrins, carcinoembryonic antigen-related cell adhesion molecules (CEACAM) or sialylated, galactosylated, or mannosylated glycoproteins or glycolipids."]}
{"doc_id": 51013, "title": "", "abstract": ["Many experimental helminth infections such as Nippostrongylus brasiliensis and Trichinella spiralis have been shown to cause intestinal goblet cell hyperplasia and increased mucus secretion, mediated by Th2 immune responses (IL-13 and IL-4), contributing to increased intestinal mucosal protection and worm expulsion [48, 63].", "There are fewer and smaller goblet cells in the intestine of the germ-free mice compared to those of conventionally raised mice, indicating the microbial modulation of goblet cells [10].", "However, chronic infection results in the depletion of goblet cells and quantitative and qualitative alteration in mucus layers due both to altered synthesis and secretion of mucins and to microbial glycosidases and proteases [1, 2, 48].", "The proportion of goblet cells among epithelial cell types increases caudally from duodenum (4%) to distal colon (16%), similar to the increasing number of microbial organisms present in the proximal intestine to colon [9].", "In most intestinal infections, induction of goblet cells and mucin synthesis and secretion occur frequently during acute phase."]}
{"doc_id": 51014, "title": "", "abstract": ["The fully glycosylated and processed MUC2 mucin is densely packed and stored in secretory granules/vesicles and released by two pathways, constitutive/basal and Ca2+-dependent stimulated/regulated pathways described in the previous section.", "Third, inhibition of mucin O-glycosylation in colon cancer cells decreased cancer cell binding to E-selectin expressed on endothelial cells, and liver colonization.", "P. aeruginosa also binds to a glycolipid receptor, asialo GM1, at the cell surface through flagellin, causing the release of adenosine triphosphate (ATP), which in turn increases the intracellular Ca2+ concentration, leading to the activation of NF-κB mediated by downstream signaling pathways [29].", "Changes in mucin glycosylation have been reported to cause defective mucus barrier and increased permeability and increased susceptibility to DSS-induced colitis, which may be caused by early thinning and weakening of the mucous layer allowing increased bacterial translocation [74].", "The glycosylated MUC2 monomer has a mass of about 2.5 MDa and the polymer may be more than 100 MDa."]}
{"doc_id": 51015, "title": "", "abstract": ["Mucin secretion is frequently coupled with increased synthesis of mucins, but chronic secretion may result in goblet cell depletion and decreased synthesis of mucins.", "In addition, activation of transcription factors, Klf4 and Elf3, is involved in the terminal differentiation of goblet cells [6•].", "However, with sustained hypersecretion of stored mucins, depletion of goblet cells occurs, resulting in defective mucin synthesis and mucus barrier.", "Two strains of mice with single missense mutations in oligomerization domains (vWF D3 and vWF C, respectively) showed aberrant Muc2 synthesis, reduced storage of mucin in the theca of goblet cells, diminished mucus layers with increased permeability and increased production of Th1 and Th2 cytokines, and developed spontaneous distal colitis and increased susceptibility to DSS-induced colitis [73••].", "In mice deficient in the major goblet cell mucin, Muc2 (Muc2 -/-), no morphologically identifiable goblet cells can be identified as the theca collapse, despite the continued presence of other goblet cell products, such as intestinal trefoil factor (TFF3) [7]."]}
{"doc_id": 51016, "title": "", "abstract": ["The outer loose mucus layer provides a good habitat for microbial colonization, because oligosaccharides of MUC2 mucin provide numerous microbial attachment sites and energy source (Fig. 1) [42••].", "The mucus layers play key roles in the establishment of the commensal intestinal microbiota and the protection from colonization and invasion by the pathogenic microbiota.", "The human adult intestinal microbiota colonizing the outer loosely adherent mucus layer is made up of more than 1014 bacteria with increasing gradient of concentration and complexity of bacterial population from jejunum to colon; stomach, duodenum, and jejunum with 102–103 aerobic bacteria per gram luminal content, and 107–108 and 1011–1012 predominantly anaerobic bacteria per gram in distal ileum and colon, respectively [45•].", "The important role of membrane-bound mucins at the apical cell surface and at the interface of the cell surface and the inner mucus layer was demonstrated by Muc1-deficient mice showing increased susceptibility to invasion by Campylobacter jejuni [44].", "Microbes are associated mostly in the outer loose mucus layer and absent from the inner firm mucus layer, indicating that the inner firm mucus layer functions as a critical protective barrier against bacterial adhesion and invasion of underlying epithelial cells [41••]."]}
{"doc_id": 51017, "title": "", "abstract": ["The mucus layer overlying the epithelium secreted by the goblet cells promotes the elimination of gut contents and provides the first line of defense against physical and chemical injury caused by ingested food, microbes and the microbial products.", "The major function of intestinal goblet cells and their main secretory product, mucin, is the formation of mucus layers which serve as the front line innate host defense mechanism.", "The mucus layer coating the gastrointestinal tract is the front line of innate host defense, largely because of the secretory products of intestinal goblet cells.", "The mucus layers play key roles in the establishment of the commensal intestinal microbiota and the protection from colonization and invasion by the pathogenic microbiota.", "Balanced and dynamic interactions among mucus layers, intestinal epithelial cells, microbiota, and host immune defense is essential for the maintenance of the intestinal mucosal homeostasis."]}
{"doc_id": 51018, "title": "", "abstract": ["CF mice exhibited decreased intestinal motility with longer exposure to the bacteria entrapped in the mucus and small intestinal bacterial overgrowth, which responded to treatment with antibiotics and laxatives [71].", "The outer loose mucus layer provides a good habitat for microbial colonization, because oligosaccharides of MUC2 mucin provide numerous microbial attachment sites and energy source (Fig. 1) [42••].", "These commensal bacteria are trapped in the mucus layer, failing to reach the epithelial cell surface, and are eliminated by peristaltic movement [1, 2•].", "Intestinal mucus layers secreted by goblet cells consist mainly of compact mesh-like network of viscous, permeable, gel-forming MUC2 mucin, which provides the frontline host defense against endogenous and exogenous irritants and microbial attachment and invasion but allows the transport of nutrients.", "Microfold (M) cells in the intestinal mucosal epithelium are devoid of overlying mucus layers and have the ability for transepithelial transport of foreign antigens and microbes to be captured by the underlying dendritic cells [40]."]}
{"doc_id": 51019, "title": "", "abstract": ["Intestinal mucus layers secreted by goblet cells consist mainly of compact mesh-like network of viscous, permeable, gel-forming MUC2 mucin, which provides the frontline host defense against endogenous and exogenous irritants and microbial attachment and invasion but allows the transport of nutrients.", "During transit through Golgi apparatus, MUC2 mucin proteins become heavily O-glycosylated and undergo trimerization via disulfide bonding in the amino terminal region, resulting in the formation of very large polymers [17, 18].", "Goblet cells synthesize secretory mucin glycoproteins (MUC2) and bioactive molecules such as epithelial membrane-bound mucins (MUC1, MUC3, MUC17), trefoil factor peptides (TFF), resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp).", "Goblet cells synthesize and secrete bioactive molecules such as secretory and membrane-bound mucins, trefoil peptides, resistin-like molecule β (RELMβ), and Fc-γ binding protein (Fcgbp), which are components of mucus [2•].", "The major function of intestinal goblet cells and their main secretory product, mucin, is the formation of mucus layers which serve as the front line innate host defense mechanism."]}
{"doc_id": 51020, "title": "", "abstract": ["However, chronic infection results in the depletion of goblet cells and quantitative and qualitative alteration in mucus layers due both to altered synthesis and secretion of mucins and to microbial glycosidases and proteases [1, 2, 48].", "Alterations of mucin production and glycosylation occur in IBD, but whether they contribute to initiation of inflammation or are the result of inflammation is unknown.", "Accumulating evidence indicates that complex interactions of the following events are involved in the pathogenesis of IBD: 1) altered and/or dysbiosis of commensal microbiota, such as decreased ratio of protective to aggressive commensal bacterial species or functional alteration of commensal bacteria; 2) defective bacterial killing and processing by the intestinal mucosal cells due to genetic defect; 3) defective mucosal barrier function resulting from abnormal synthesis and or processing of mucins and TFF3; and 4) defective host immune response, such as defective innate and or adaptive immunity.", "Many experimental helminth infections such as Nippostrongylus brasiliensis and Trichinella spiralis have been shown to cause intestinal goblet cell hyperplasia and increased mucus secretion, mediated by Th2 immune responses (IL-13 and IL-4), contributing to increased intestinal mucosal protection and worm expulsion [48, 63].", "Increased numbers of mucosa-associated (adherent invasive) E. coli are observed in IBD."]}
{"doc_id": 51021, "title": "", "abstract": ["In vitro and in vivo studies indicate that TFF3 facilitates not only intestinal epithelial restitution but also mucosal protection [8, 52].", "Furthermore, RELMβ upregulates Muc2 transcription and secretion, contributing to the mucosal barrier integrity.", "The functional integrity of the intestinal mucosal epithelial cells depends on the coordinated regulation of the mucus layer, the intercellular tight junction, epithelial cells, and host innate and adaptive immune response [1, 2•].", "Furthermore, TFF3 has been suggested to increase the viscosity of mucin by binding to the vWF C domain of MUC2, enhancing the structural integrity of the intestinal mucus barrier [55].", "Intestinal mucosal epithelia cells also express epithelial membrane-bound mucins, MUC1, MUC3, MUC4, MUC12, MUC13, and MUC17, which have structural similarity."]}
{"doc_id": 51022, "title": "", "abstract": ["The outer loose mucus layer provides a good habitat for microbial colonization, because oligosaccharides of MUC2 mucin provide numerous microbial attachment sites and energy source (Fig. 1) [42••].", "The human adult intestinal microbiota colonizing the outer loosely adherent mucus layer is made up of more than 1014 bacteria with increasing gradient of concentration and complexity of bacterial population from jejunum to colon; stomach, duodenum, and jejunum with 102–103 aerobic bacteria per gram luminal content, and 107–108 and 1011–1012 predominantly anaerobic bacteria per gram in distal ileum and colon, respectively [45•].", "Microbes are associated mostly in the outer loose mucus layer and absent from the inner firm mucus layer, indicating that the inner firm mucus layer functions as a critical protective barrier against bacterial adhesion and invasion of underlying epithelial cells [41••].", "Colonization by commensal intestinal microbiota is limited to an outer “loose” mucus layer, and interacts with the diverse oligosaccharides of mucin glycoproteins, whereas an “inner” adherent mucus layer is largely devoid of bacteria.", "Microbes are associated with the outer, loosely adherent mucus layer, but are absent in the inner, firmly adherent mucus layer."]}
{"doc_id": 76000, "title": "", "abstract": ["Thus, if the outcomes of HIV/AIDS programs in resource-limited settings are to be improved, all individuals testing positive for HIV must receive continuous pre-ART care that includes regular CD4 counts to ensure that ART is initiated as soon as they become eligible for treatment.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "They defined three stages of pre-ART care: Stage 1, the interval between testing positive for HIV and receiving CD4 count results or being clinically assessed; Stage 2, the interval between enrollment in pre-ART care and the determination of eligibility for ART; and Stage 3, the interval between being deemed eligible for ART and treatment initiation.", "Stage 1, in which the patient is staged for referral to either pre-ART care or ART, starts immediately after a patient tests positive for HIV infection.", "The first eight studies in Table 3 reported the proportion of patients who enrolled in an HIV care program after testing."]}
{"doc_id": 76001, "title": "", "abstract": ["These findings suggest that there is a substantial loss of HIV-positive patients at every stage of pre-ART care in sub-Saharan Africa.", "Loss to follow-up at any one site may or may not indicate that a patient has dropped out of care permanently.", "Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility.", "The rate of early mortality and loss to follow-up, which itself portends mortality for many, averages 23% across the region [2].", "HIV testing to staging, retention in pre-ART care, and ART eligibility to ART initiation| Proportions of patients in WHO stage 1 or 2 and CD4 >250 cells/mm3 at enrollment who enrolled in HIV care, provided sample for CD4 count, and initiated ART by date of data censoring| 1,633| 808| 49%| 95% of losses to follow-up occurred in Stage 1; does not report stage completion for patients still in pre-ART care at data censoring   SA 6| Stages 1–3."]}
{"doc_id": 76002, "title": "", "abstract": ["Thus, if the outcomes of HIV/AIDS programs in resource-limited settings are to be improved, all individuals testing positive for HIV must receive continuous pre-ART care that includes regular CD4 counts to ensure that ART is initiated as soon as they become eligible for treatment.", "They defined three stages of pre-ART care: Stage 1, the interval between testing positive for HIV and receiving CD4 count results or being clinically assessed; Stage 2, the interval between enrollment in pre-ART care and the determination of eligibility for ART; and Stage 3, the interval between being deemed eligible for ART and treatment initiation.", "Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation.", "ART is more successful if it is started before the CD4 count falls far below 350 cells/mm3 of blood, the threshold recommended by the World Health Organization for ART initiation.", "For example, patients who enroll in pre-ART care (Stage 2) with low CD4 counts, close to the ART eligibility threshold, have less time at risk of being lost from care than those who enroll earlier, with higher CD4 counts, but few studies reported this information."]}
{"doc_id": 76003, "title": "", "abstract": ["While pre-ART loss to care may not pose as immediate a mortality threat as loss of patients who already have clinical AIDS, it is still a major impediment to improving the outcomes of HIV care and treatment overall, is itself a contributor to the high mortality observed during the first year on ART, and wastes scarce health system resources.", "Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility.", "Difficult as this problem is for managing ART patients, it is even worse during the pre-ART period, because patients are expected to visit the clinic less frequently, and more clinics are able to provide pre-ART services than are accredited to offer ART.", "In particular, the estimate of the overall loss of patients during pre-ART care is likely to be imprecise.", "These findings suggest that there is a substantial loss of HIV-positive patients at every stage of pre-ART care in sub-Saharan Africa."]}
{"doc_id": 76004, "title": "", "abstract": ["Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "Research on retention in pre-ART care is challenging, as it requires long periods of follow-up and consistent information systems that allow individuals to be tracked as they move in and out of care at multiple facilities.", "At a minimum, retention in pre-ART care requires regular clinic visits for monitoring of patient condition.", "The persistence of low starting CD4 counts points to a problem that has just begun to be recognized in the research literature: poor pre-ART retention in care, or the failure to link patients from HIV testing to HIV care and retain them in care until they are eligible for ART."]}
{"doc_id": 76005, "title": "", "abstract": ["Better health information systems that allow patients to be tracked between service delivery points are needed to properly evaluate pre- ART loss to care, and researchers should attempt to standardize the terminology, definitions, and time periods reported.", "The researchers call, therefore, for the implementation of better health information systems that would allow patients to be tracked between service delivery points as a way to improve the evaluation and understanding of the loss of HIV-positive patients to pre-ART care in resource-limited countries.", "Loss to follow-up at any one site may or may not indicate that a patient has dropped out of care permanently.", "We defined “loss to care” as failing to reach the next step in the care sequence for any reason (death or discontinuation), but we also accepted each study's own criteria for determining which patients died or discontinued care.", "For individual patients, dropping out of pre-ART care is less likely to represent a death sentence than is loss to follow-up after initiating treatment."]}
{"doc_id": 76006, "title": "", "abstract": ["During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment.", "Across all the studies in Table 4, a median of 68% (range 14%–84%) of patients eligible for ART actually initiated treatment within the study periods of observation.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "Nevertheless, the researchers estimate that, taking all the studies together, less than one-third of patients testing positive for HIV but not eligible for ART when diagnosed were retained in pre-ART care continuously.", "Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility."]}
{"doc_id": 76007, "title": "", "abstract": ["Many patients may have simply transferred, usually informally, from one site to another.", "The persistence of low starting CD4 counts points to a problem that has just begun to be recognized in the research literature: poor pre-ART retention in care, or the failure to link patients from HIV testing to HIV care and retain them in care until they are eligible for ART.", "Without an effective health information system that allows patients to be tracked from site to site and over time, as they come and go from care, it is nearly impossible to assess the extent to which patient mobility mitigates the observed loss to care rates.", "Patients who are lost from one stage of care can return to care later and either successfully complete the stage or be lost again.", "There appear to be several main reasons for the poor performance of pre-ART care in retaining patients."]}
{"doc_id": 76008, "title": "", "abstract": ["Without an effective health information system that allows patients to be tracked from site to site and over time, as they come and go from care, it is nearly impossible to assess the extent to which patient mobility mitigates the observed loss to care rates.", "The second issue highlighted by this review is the absence of health information systems that allow patients to be tracked between service delivery points.", "The researchers call, therefore, for the implementation of better health information systems that would allow patients to be tracked between service delivery points as a way to improve the evaluation and understanding of the loss of HIV-positive patients to pre-ART care in resource-limited countries.", "Better health information systems that allow patients to be tracked between service delivery points are needed to properly evaluate pre- ART loss to care, and researchers should attempt to standardize the terminology, definitions, and time periods reported.", "A prerequisite to developing interventions to retain patients in care between testing and treatment is an understanding of where and when they are being lost."]}
{"doc_id": 76009, "title": "", "abstract": ["These findings suggest that there is a substantial loss of HIV-positive patients at every stage of pre-ART care in sub-Saharan Africa.", "The remarkable expansion of access to antiretroviral therapy (ART) for HIV/AIDS in resource-constrained countries has given nearly four million HIV- positive adults in sub-Saharan Africa the opportunity to achieve what for many may be nearly normal life expectancies [1].", "During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment.", "We conducted a systematic literature review of patient retention between HIV testing and ART initiation in sub-Saharan Africa.", "Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility."]}
{"doc_id": 76010, "title": "", "abstract": ["Following a detailed search protocol and standard systematic review procedures (Texts S1 and S2), we searched the published literature and major conference abstract archives for reports containing primary, patient- or facility-level data from routine health-care delivery settings on the proportion of patients retained in care between HIV testing and ART initiation and/or rates of linkage between any two intermediate points between testing and ART.", "As a result, only a handful of quantitative studies reporting on rates of pre-ART linkage and loss have been published.", "Study Code| Outcome Assessed|  N | Number Achieving Outcome| Percent (95% CI) Achieving Outcome| Comments   ---|---|---|---|---|---   HIV test to enrollment in care   Ethiopia 1| “Immediate” linkage to HIV care after HIV test| 1,314| 623| 47% (45%–50%)| “Linked to care” and “immediately” not defined in report   Ethiopia 2| Visited referral site (HIV clinic) after HIV test| 1,102| 474| 43% (40%–46%)| Of 474 visiting referral site, 84% visited ≤8 wk of HIV test   Kenya 2| Self-reported attendance at HIV care services 2–4 mo after HIV test| 737| 312| 42% (39%–46%)|   SA 8| Attended first pre-ART medical appointment ≤1 y of staging| 356| 112| 31% (27%–36%)|   SA 12| Visited referral site (HIV clinic) after HIV test| 199| 92| 46% (39%–53%)| Self-reported data; time allowed to reach end point not stated   SA 14| Self-reported access of HIV care| 135| 49| 36% (28%–44%)| Of those not linked, 1% died and 41% not reached by phone.", "Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation.", "The persistence of low starting CD4 counts points to a problem that has just begun to be recognized in the research literature: poor pre-ART retention in care, or the failure to link patients from HIV testing to HIV care and retain them in care until they are eligible for ART."]}
{"doc_id": 76011, "title": "", "abstract": []}
{"doc_id": 76012, "title": "", "abstract": ["In most of these cases, the outcome assessed was the proportion of patients who either initiated ART or remained in pre-ART care at the censoring date.", "In these studies, a median of 55% (range 42%–95%) of patients reached the study end point (repeat CD4 count, ART initiation, 12 months of follow-up, or data censoring), while the rest died or were lost to follow-up before the end point.", "The lack of standard definitions among reports, or even clear definitions of outcome measures within some (but not all) of the reports, combined with inconsistent or unreported durations of follow-up, stymied aggregate analysis.", "The researchers identified 28 studies that included data on the proportion of adult patients retained between any two time points between testing positive for HIV and starting ART in HIV/AIDS care programs in sub-Saharan Africa.", "Across all the studies in Table 4, a median of 68% (range 14%–84%) of patients eligible for ART actually initiated treatment within the study periods of observation."]}
{"doc_id": 76013, "title": "", "abstract": ["We conducted a systematic literature review of patient retention between HIV testing and ART initiation in sub-Saharan Africa.", "Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review", "The researchers identified 28 studies that included data on the proportion of adult patients retained between any two time points between testing positive for HIV and starting ART in HIV/AIDS care programs in sub-Saharan Africa.", "We searched PubMed, ISI Web of Knowledge, conference abstracts, and reference lists for reports on the proportion of adult patients retained between any two points between testing positive for HIV and initiating ART in sub-Saharan African HIV/AIDS care programs.", "During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment."]}
{"doc_id": 76014, "title": "", "abstract": ["Most studies reported a substantial reduction in patient numbers at every step of the process.", "A number of the papers we reviewed stratified results by CD4 count range and/or identified other factors associated with pre-ART attrition, and a review of these findings would be valuable.", "Studies of retention in pre-ART care report substantial loss of patients at every step, starting with patients who do not return for their initial CD4 count results and ending with those who do not initiate ART despite eligibility.", "A starting point for understanding the nature and scope of the problem of pre- ART loss to care might thus be to implement effective patient tracking systems in selected geographic catchment areas that will generate accurate information on attrition between and within stages and help researchers assess the role of patient mobility in offsetting observed attrition, identify characteristics of patients most likely to be lost, and explore the extent to which attrition from pre-ART care is temporary—i.e., delay in action by patients who will later return to care, albeit sicker—or represents permanent loss from the health-care system, which will likely ultimately lead to death.", "Our analysis of 24 studies documenting rates of retention of patients from testing positive for HIV infection to initiating ART suggests that patient management during this period poses serious challenges."]}
{"doc_id": 76015, "title": "", "abstract": ["Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation.", "Thus, if the outcomes of HIV/AIDS programs in resource-limited settings are to be improved, all individuals testing positive for HIV must receive continuous pre-ART care that includes regular CD4 counts to ensure that ART is initiated as soon as they become eligible for treatment.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "While pre-ART loss to care may not pose as immediate a mortality threat as loss of patients who already have clinical AIDS, it is still a major impediment to improving the outcomes of HIV care and treatment overall, is itself a contributor to the high mortality observed during the first year on ART, and wastes scarce health system resources.", "At a minimum, retention in pre-ART care requires regular clinic visits for monitoring of patient condition."]}
{"doc_id": 76016, "title": "", "abstract": ["We conducted a systematic literature review of patient retention between HIV testing and ART initiation in sub-Saharan Africa.", "During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment.", "These findings suggest that there is a substantial loss of HIV-positive patients at every stage of pre-ART care in sub-Saharan Africa.", "In this systematic review (a study that uses predefined criteria to identify all the research on a given topic), the researchers investigate the retention of HIV-positive adults in pre-ART care in sub-Saharan Africa.", "We conducted a systematic review of pre-ART retention in care in Africa."]}
{"doc_id": 76017, "title": "", "abstract": ["We did not find a single study that was able to follow a cohort of HIV-positive adults all the way from testing to treatment initiation if they were not already eligible for ART when diagnosed.", "The rate of early mortality and loss to follow-up, which itself portends mortality for many, averages 23% across the region [2].", "In these studies, a median of 55% (range 42%–95%) of patients reached the study end point (repeat CD4 count, ART initiation, 12 months of follow-up, or data censoring), while the rest died or were lost to follow-up before the end point.", "The researchers identified 28 studies that included data on the proportion of adult patients retained between any two time points between testing positive for HIV and starting ART in HIV/AIDS care programs in sub-Saharan Africa.", "During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment."]}
{"doc_id": 93000, "title": "", "abstract": ["The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "Insulin resistance (IR) represents a major component of metabolic syndrome (MS) and is commonly observed in older adults (2).", "Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action.", "The Critical Role of Metabolic Pathways in Aging", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease."]}
{"doc_id": 93001, "title": "", "abstract": ["Specifically, IR might actually serve as an adaptive mechanism in some tissues by preventing excess uptake of nutrients by cells.", "Adapted from Barzilai et al. (74).", "How impaired mitochondrial function may impinge on insulin signaling is complex but is thought to involve reduced or incomplete β-oxidation of fatty acid substrates in metabolically active tissues such as liver and skeletal muscle (20).", "Moreover, mice that overexpress the transcription factor peroxisome proliferator-activated receptor-γ coactivator-1α in muscle become severely insulin resistant in spite of increased mitochondrial content (27).", "Similarly, young insulin-resistant offspring of diabetic parents had reduced mitochondrial activity and increased fat content in skeletal muscle compared with insulin- sensitive control subjects (23)."]}
{"doc_id": 93002, "title": "", "abstract": ["3: The collective response of these pathways to CR is believed to promote cellular fitness and ultimately longevity via activation of autophagy, stress defense mechanisms, and survival pathways while attenuating proinflammatory mediators and cellular growth.", "The mTOR signaling pathway is highly conserved and integrates energy and growth factor signaling to cell growth and basic cellular processes such as RNA translation, stress resistance, and autophagy (64).", "AMPK plays a critical role in regulating whole-body energy balance with effects that are tissue-specific.", "Moreover, the antagonistic pleiotropy hypothesis of aging suggests that some pathways that are evolutionarily favorable for facilitation of development and reproduction can become unfavorable with aging.", "2: In response to these changes, numerous downstream cellular pathways are engaged, including SIRT1 activation (gray), IIS/phosphatidylinositol 3-kinase (PI3K)/Akt signaling (yellow), AMPK/mTOR signaling (purple), and extracellular signal- regulated kinase 1/2 (Erk1/2) signaling (green)."]}
{"doc_id": 93003, "title": "", "abstract": ["### Caloric restriction.", "Likewise, inhibition of the downstream effector of mTOR, S6K, increases life span in worms and flies (66) and protects against diet- induced obesity and enhances insulin sensitivity in mice (67).", "Remarkably, the association of FOXO3A polymorphisms with human longevity has been replicated by eight independent groups in unrelated cohorts of long-lived subjects (74), a finding that supports evidence from model organisms that first identified FOXO transcription factors as regulators of life span.", "Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents.", "3: The collective response of these pathways to CR is believed to promote cellular fitness and ultimately longevity via activation of autophagy, stress defense mechanisms, and survival pathways while attenuating proinflammatory mediators and cellular growth."]}
{"doc_id": 93004, "title": "", "abstract": ["However, as discussed below, directly altering the activities of three key nutrient sensors—AMPK, SIRT1, and mammalian target of rapamycin (mTOR)—has been reported to impact life span.", "Please note that there is some evidence that Akt activation of NF-κB may be mTOR-dependent, whereas SIRT1 may be a direct stimulator of AMPK activity and autophagy (not shown).", "2: In response to these changes, numerous downstream cellular pathways are engaged, including SIRT1 activation (gray), IIS/phosphatidylinositol 3-kinase (PI3K)/Akt signaling (yellow), AMPK/mTOR signaling (purple), and extracellular signal- regulated kinase 1/2 (Erk1/2) signaling (green).", "Aberrant activation of mTOR signaling has been linked to several age-related diseases such as T2DM, cancer, Alzheimer disease, Parkinson disease, and CVD, leading to studies on the role of this pathway in metabolism, aging, and life span.", "Likewise, inhibition of the downstream effector of mTOR, S6K, increases life span in worms and flies (66) and protects against diet- induced obesity and enhances insulin sensitivity in mice (67)."]}
{"doc_id": 93005, "title": "", "abstract": ["Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action.", "Likewise, another study concluded that reductions in insulin sensitivity with aging were explained by increases in adiposity rather than advanced chronological age or decreased muscle mitochondrial function (26).", "Although there is no consistent evidence that SIRT1 content and/or activity declines with aging, activating this pathway might still be beneficial in preventing some manifestations of aging.", "Moreover, the antagonistic pleiotropy hypothesis of aging suggests that some pathways that are evolutionarily favorable for facilitation of development and reproduction can become unfavorable with aging.", "Some of these effects represent preservation or restoration to levels typical of younger individuals (such as lower insulin and glucose concentrations), whereas, paradoxically, other changes resemble aging (such as low GH/IGF-1)."]}
{"doc_id": 93006, "title": "", "abstract": ["The Critical Role of Metabolic Pathways in Aging", "Aberrant activation of mTOR signaling has been linked to several age-related diseases such as T2DM, cancer, Alzheimer disease, Parkinson disease, and CVD, leading to studies on the role of this pathway in metabolism, aging, and life span.", "We have described in this study how key features of metabolic signaling pathways can modulate age-related disease risk and longevity.", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries."]}
{"doc_id": 93007, "title": "", "abstract": ["Sarcopenia represents another unfavorable phenotypic change observed with aging in humans.", "Furthermore, human skeletal muscle from older adults has been shown to have impaired mTOR complex 1 activation and protein synthesis in response to an acute resistance exercise bout (73).", "One of the most robust observations in the biology of aging is the ability of CR to delay or prevent a range of age-related processes and significantly extend life span (40).", "This has led many to embrace the mitochondrial theory of aging, which posits that mitochondrial dysfunction is a fundamental cause of cellular aging and senescence.", "Abdominal obesity, which is commonly observed with aging, is a major contributor to IR and MS (3)."]}
{"doc_id": 93008, "title": "", "abstract": ["Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action.", "The causes of sarcopenia are multifactorial, but the proinflammatory state associated with aging and obesity appears to be one key contributor (15).", "In humans, IR accompanied by compensatory hyperinsulinemia has clearly been implicated as a risk factor for multiple age-related diseases (1).", "Abdominal obesity, which is commonly observed with aging, is a major contributor to IR and MS (3).", "A controversy exists over the physiologic role of IR in aging."]}
{"doc_id": 93009, "title": "", "abstract": ["Furthermore, there is evidence supporting that life span extension can be achieved with pharmacologic approaches, such as rapamycin, via mTOR signaling blockade, resveratrol, by activating SIRT1 activity, and metformin, which seems to be a robust stimulator of AMPK activity.", "Life span has been verifiably modulated by genetic, pharmacologic, and dietary interventions in model systems.", "Inhibition of the mTOR signaling pathway by genetic or pharmacological intervention extends life span in invertebrates, including yeast, nematodes, and fruit flies (64).", "Pharmacologic inhibition of mTOR (with rapamycin) was also shown to extend median and maximal life span in mice (68).", "Meanwhile, pharmacologic interventions and hormonal perturbations have increased the life span of several mammalian species without necessarily addressing features of age-related metabolic decline."]}
{"doc_id": 93010, "title": "", "abstract": ["The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "The Critical Role of Metabolic Pathways in Aging", "### The metabolic syndrome of aging.", "Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and stroke (1)."]}
{"doc_id": 93011, "title": "", "abstract": ["Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death.", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "The Critical Role of Metabolic Pathways in Aging", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and stroke (1)."]}
{"doc_id": 93012, "title": "", "abstract": ["In mammals, SIRT1 appears to play an important role in controlling glucose metabolism, insulin action, fat storage, and nutrient sensing (52).", "Mammalian SIRT1 shares the closest similarity to Sir2, a protein that was first shown to play an essential role in the control of yeast replicative life span (51).", "It has been suggested that through activation of SIRT1, resveratrol may function as a CR mimetic.", "Please note that there is some evidence that Akt activation of NF-κB may be mTOR-dependent, whereas SIRT1 may be a direct stimulator of AMPK activity and autophagy (not shown).", "More recently, treatment of obese mice with SRT1720, a synthetic activator of SIRT1, resulted in similar improvements in survival as were observed in resveratrol-treated mice (56)."]}
{"doc_id": 93013, "title": "", "abstract": ["One of the most robust observations in the biology of aging is the ability of CR to delay or prevent a range of age-related processes and significantly extend life span (40).", "1: CR represents the most robust intervention to extend both mean and maximum life span in mammals, perhaps due to the magnitude of pathways affected by CR, including reduced cytokine levels, adiposity, IIS signaling, thyroid hormone levels, and increased adiponectin.", "### Caloric restriction.", "Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents.", "Age-related declines in various hormones have been linked to the aging process, prompting human studies investigating the potential for hormone- replacement strategies to modulate features of aging."]}
{"doc_id": 93014, "title": "", "abstract": ["Although some characteristics of exceptionally long-lived people may be unique to this highly selected group, further studies utilizing unbiased approaches and high-throughput platforms are virtually certain to lead to additional breakthroughs in the field.", "We have described in this study how key features of metabolic signaling pathways can modulate age-related disease risk and longevity.", "Furthermore, genetic discovery in long-lived human populations (including epigenetics, which is rapidly emerging as a critical mechanism in transcriptional control) will undoubtedly lead to exciting breakthroughs in the field.", "Perhaps the strongest example of a longevity gene is FOXO3A, which is one member of a family of transcription factors that mediate insulin action and stress resistance.", "Life span has been verifiably modulated by genetic, pharmacologic, and dietary interventions in model systems."]}
{"doc_id": 57000, "title": "", "abstract": ["ECM role in tumor angiogenesis, lymphangiogenesis, and inflammation.", "For example, mice lacking the ECM glycoprotein SPARC (secreted protein acidic and rich in cysteine) have an increased number of macrophages in tumors, suggesting that the ECM can influence the number of immune cells.", "Recent studies show that the ECM receptor integrin α9β1 plays an important role in the formation of lymphatic vessels (Huang et al., 2000; Avraamides et al., 2008), suggesting that the ECM is likely to play a role in tumor lymphangiogenesis as well.", "Furthermore, tumor vasculature, together with the lymphatic system, is the main route through which cancer cells metastasize and immune cells infiltrate.", "As in tumor angiogenesis, abnormal ECM affects many aspects of immune cell behaviors, including infiltration, differentiation, and functional activation."]}
{"doc_id": 57001, "title": "", "abstract": ["Thus, abnormal changes in the amount and composition of the ECM can greatly alter ECM biochemical properties, potentiate the oncogenic effects of various growth factor signaling pathways, and deregulate cell behaviors during malignant transformation.", "Although tightly controlled during embryonic development and organ homeostasis, the ECM is commonly deregulated and becomes disorganized in diseases such as cancer.", "Changes of ECM composition are important for continued recruitment of hematopoietic progenitor cells to the premetastatic niche.", "Retrospectively, such a convergence is inevitable, as many of the same cell behaviors and processes essential for embryonic development are also indispensable for cancer progression (Egeblad et al., 2010a).", "Additionally, changes in ECM topography may also facilitate cancer cell migration."]}
{"doc_id": 57002, "title": "", "abstract": ["Abnormal ECM stiffness, as observed in tissue fibrosis, clearly plays an important role in cancer progression.", "Because the ECM plays an important role in MSC differentiation (Engler et al., 2006), it is likely that MSCs may be yet another target cell population of abnormal ECM dynamics in the formation of a cancer niche.", "Collectively, a picture has started to emerge with regard to ECM’s roles in cancer progression: normal ECM dynamics are essential for embryonic organ development and postnatal function (Fig. 4 A); deregulated ECM dynamics disrupt tissue polarity, architecture, and integrity and promote epithelial cell transformation and invasion (Fig. 4 B).", "Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment.", "However, recent progress has also highlighted the importance of noncellular components of the niche, especially the ECM, during cancer progression (Sternlicht et al., 1999; Paszek et al., 2005; Erler et al., 2006, 2009; Levental et al., 2009)."]}
{"doc_id": 57003, "title": "", "abstract": ["ECM remodeling is tightly regulated during development and primarily accomplished by controlling the expression or activities of ECM enzymes at multiple levels.", "Consistent with these changes, expression of many ECM remodeling enzymes is often deregulated in human cancers.", "As a result, ECM remodeling enzymes are not only regulated at the transcriptional and translational levels but also posttranslationally with the use of their functionally inhibitive prodomains and selective proteinase inhibitors (Page-McCaw et al., 2007; Aitken and Bägli, 2009).", "Consistent with ECM’s many important roles, multiple regulatory mechanisms exist to ensure that ECM dynamics, collectively measured by its production, degradation, and remodeling, are normal during organ development and function (Page-McCaw et al., 2007).", "To achieve this goal, we must understand how ECM composition and organization are normally maintained and regulated and how they may be deregulated in cancer."]}
{"doc_id": 57004, "title": "", "abstract": ["Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment.", "Furthermore, abnormal ECM dynamics derail stromal cell behavior, leading to tumor-promoting angiogenesis and inflammation by endothelial cells and immune cells, respectively, both at the primary and metastatic sites.", "As a result, abnormal ECM further perpetuates the local niche and promotes the formation of a tumorigenic microenvironment.", "### Abnormal ECM promotes formation of a tumor microenvironment", "In summary, abnormal ECM dynamics deregulate behaviors of both cancer cells and stromal cells."]}
{"doc_id": 57005, "title": "", "abstract": ["The resultant changes in the stromal components further exacerbate the tumorigenic microenvironment and facilitate the process of oncogenic transformation, tissue invasion, and metastasis during cancer initiation and progression (Fig. 4, C and D).", "As a result, abnormal ECM further perpetuates the local niche and promotes the formation of a tumorigenic microenvironment.", "Abnormal ECM also indirectly affects cancer cells by influencing the behavior of stromal cells, including endothelial cells, immune cells, and fibroblasts, which are the main initial culprits that cause abnormal ECM production (Bhowmick et al., 2004; Orimo et al., 2005; Quante et al., 2011).", "Together, these data reinforce the possibility that, once beyond a certain threshold, deregulated ECM dynamics may cause irreversible changes to the normal niche and convert it into a cancer-promoting environment.", "The concept that local microenvironments, or niches, play an important role in regulating cell behavior, which is one of the central themes in classical embryology, has become increasingly accepted in cancer biology (Bissell and Radisky, 2001; Wiseman and Werb, 2002; Bissell and Labarge, 2005)."]}
{"doc_id": 57006, "title": "", "abstract": ["When put together in an orderly manner, the ECM components, with their remarkable structural and biochemical diversity and functional versatility, confer upon the matrices unique physical, biochemical, and biomechanical properties that are essential for regulating cell behavior.", "The ECM is composed of a large collection of biochemically distinct components including proteins, glycoproteins, proteoglycans, and polysaccharides with different physical and biochemical properties (Whittaker et al., 2006; Ozbek et al., 2010).", "For example, the physical properties of the ECM refer to its rigidity, porosity, insolubility, spatial arrangement and orientation (or topography), and other physical features that together determine its role in scaffolding to support tissue architecture and integrity.", "As a result, ECM’s biomechanical properties regulate various essential cell behaviors, including cell fate determination, differentiation, and tissue function (Fig. 1, stage 8; Engler et al., 2006; Lutolf et al., 2009; Gilbert et al., 2010).", "In contrast, the biochemical properties of the ECM pertain to its indirect and direct signaling capabilities that allow cells to sense and interact with their environments using various signal transduction cascades emanating from the cell surface to the nucleus, resulting in gene expression or other changes of cell behavior."]}
{"doc_id": 57007, "title": "", "abstract": ["However, recent progress has also highlighted the importance of noncellular components of the niche, especially the ECM, during cancer progression (Sternlicht et al., 1999; Paszek et al., 2005; Erler et al., 2006, 2009; Levental et al., 2009).", "The extracellular matrix: A dynamic niche in cancer progression", "A major component of the niche is the extracellular matrix (ECM), a complex network of macromolecules with distinctive physical, biochemical, and biomechanical properties.", "The concept that local microenvironments, or niches, play an important role in regulating cell behavior, which is one of the central themes in classical embryology, has become increasingly accepted in cancer biology (Bissell and Radisky, 2001; Wiseman and Werb, 2002; Bissell and Labarge, 2005).", "In addition, hypoxia can lead to overproduction of LOX-like protein-2 and a subsequent increase in ECM cross- linking and stiffening, resulting in sprouting angiogenesis (Bignon et al., 2011)."]}
{"doc_id": 57008, "title": "", "abstract": ["A major component of the niche is the extracellular matrix (ECM), a complex network of macromolecules with distinctive physical, biochemical, and biomechanical properties.", "The ECM is composed of a large collection of biochemically distinct components including proteins, glycoproteins, proteoglycans, and polysaccharides with different physical and biochemical properties (Whittaker et al., 2006; Ozbek et al., 2010).", "In contrast, interstitial matrix is rich in fibrillar collagens, proteoglycans, and various glycoproteins such as tenascin C and fibronectin and is thus highly charged, hydrated, and contributes greatly to the tensile strength of tissues (Egeblad et al., 2010b).", "The extracellular matrix: A dynamic niche in cancer progression", "Certain ECM components, including heparan sulfate proteoglycans and the hyaluronic acid receptor CD44, can selectively bind to different growth factors and function as a signal coreceptor (stage 5) or a presenter (stage 6) and help determine the direction of cell–cell communication (Lu et al., 2011)."]}
{"doc_id": 57009, "title": "", "abstract": ["Various collagens, including collagen I, II, III, V, and IX, show increased deposition during tumor formation (Zhu et al., 1995; Kauppila et al., 1998; Huijbers et al., 2010).", "Thickening and linearization of collagen fibers are common in cancers, and they are often found in areas where active tissue invasion and tumor vasculature are observed (Condeelis and Segall, 2003; Provenzano et al., 2006; Levental et al., 2009), suggesting that they play an active role in facilitating cancer cell invasion.", "In addition to changes in its biochemical properties, the architecture and other physical properties of tumor-associated ECM are fundamentally different from that of the normal tissue stroma; rather than relaxed nonoriented fibrils, the collagen I in breast tumors is often highly linearized and either oriented adjacent to the epithelium or projecting perpendicularly into the tissue (Provenzano et al., 2006; Levental et al., 2009).", "Increased collagen cross-linking and ECM stiffness as a result of LOX overproduction promote focal adhesion assembly and ERK and PI3 kinase signaling and facilitate Neu-mediated oncogenic transformation (Levental et al., 2009).", "Indeed, studies using live imaging have shown that cancer cells migrate rapidly on collagen fibers in areas enriched in collagen (Wang et al., 2002; Condeelis and Segall, 2003; Wyckoff et al., 2007)."]}
{"doc_id": 57010, "title": "", "abstract": ["Thickening and linearization of collagen fibers are common in cancers, and they are often found in areas where active tissue invasion and tumor vasculature are observed (Condeelis and Segall, 2003; Provenzano et al., 2006; Levental et al., 2009), suggesting that they play an active role in facilitating cancer cell invasion.", "Various collagens, including collagen I, II, III, V, and IX, show increased deposition during tumor formation (Zhu et al., 1995; Kauppila et al., 1998; Huijbers et al., 2010).", "Indeed, studies using live imaging have shown that cancer cells migrate rapidly on collagen fibers in areas enriched in collagen (Wang et al., 2002; Condeelis and Segall, 2003; Wyckoff et al., 2007).", "As we age, there is a reduction of collagen deposition and increased MMP activity (Norton et al., 2005; Butcher et al., 2009).", "An increase in collagen deposition or ECM stiffness, alone or in combination, up-regulates integrin signaling and can thus promote cell survival and proliferation (Wozniak et al., 2003; Paszek et al., 2005)."]}
{"doc_id": 57011, "title": "", "abstract": ["However, recent progress has also highlighted the importance of noncellular components of the niche, especially the ECM, during cancer progression (Sternlicht et al., 1999; Paszek et al., 2005; Erler et al., 2006, 2009; Levental et al., 2009).", "### Abnormal ECM dynamics during cancer progression", "Collectively, a picture has started to emerge with regard to ECM’s roles in cancer progression: normal ECM dynamics are essential for embryonic organ development and postnatal function (Fig. 4 A); deregulated ECM dynamics disrupt tissue polarity, architecture, and integrity and promote epithelial cell transformation and invasion (Fig. 4 B).", "Abnormal ECM stiffness, as observed in tissue fibrosis, clearly plays an important role in cancer progression.", "On the one hand, ECM anomalies promote cancer cell transformation and tissue invasion; on the other hand, they help generate a tumorigenic niche that further facilitates cancer progression."]}
{"doc_id": 57012, "title": "", "abstract": ["Recent studies show that the ECM receptor integrin α9β1 plays an important role in the formation of lymphatic vessels (Huang et al., 2000; Avraamides et al., 2008), suggesting that the ECM is likely to play a role in tumor lymphangiogenesis as well.", "For example, mice lacking the ECM glycoprotein SPARC (secreted protein acidic and rich in cysteine) have an increased number of macrophages in tumors, suggesting that the ECM can influence the number of immune cells.", "Abnormal ECM also indirectly affects cancer cells by influencing the behavior of stromal cells, including endothelial cells, immune cells, and fibroblasts, which are the main initial culprits that cause abnormal ECM production (Bhowmick et al., 2004; Orimo et al., 2005; Quante et al., 2011).", "The role of abnormal ECM in tumor angiogenesis is a result of the various functions that ECM components play in blood vessel formation during normal development.", "As in the cases of tumor and endothelial cells, ECM topography such as collagen fibril size and density can influence migration of immune cells (Fig. 3 B, stage a; Lämmermann et al., 2008)."]}
{"doc_id": 57013, "title": "", "abstract": ["As a result, ECM’s biomechanical properties regulate various essential cell behaviors, including cell fate determination, differentiation, and tissue function (Fig. 1, stage 8; Engler et al., 2006; Lutolf et al., 2009; Gilbert et al., 2010).", "Second, the ECM is highly dynamic, constantly being remodeled in different tissues at various embryonic and postnatal stages.", "This feedback regulatory mechanism between cells and the ECM allows cells and tissues to swiftly adapt to their environment (Samuel et al., 2011).", "Therefore, deregulation of ECM remodeling can lead to apoptotic evasion by mutant cells.", "Normal ECM dynamics are essential for maintaining tissue integrity and keep rare tumor-prone cells, together with resident fibroblasts, eosinophils, macrophages, and other stromal cells, in check by maintaining an overall healthy microenvironment."]}
{"doc_id": 57014, "title": "", "abstract": ["An increase in collagen deposition or ECM stiffness, alone or in combination, up-regulates integrin signaling and can thus promote cell survival and proliferation (Wozniak et al., 2003; Paszek et al., 2005).", "Part of the increase in tissue stiffness can be attributed to excess activities of lysyl oxidase (LOX), which cross-links collagen fibers and other ECM components.", "Increased collagen cross-linking and ECM stiffness as a result of LOX overproduction promote focal adhesion assembly and ERK and PI3 kinase signaling and facilitate Neu-mediated oncogenic transformation (Levental et al., 2009).", "Thickening and linearization of collagen fibers are common in cancers, and they are often found in areas where active tissue invasion and tumor vasculature are observed (Condeelis and Segall, 2003; Provenzano et al., 2006; Levental et al., 2009), suggesting that they play an active role in facilitating cancer cell invasion.", "Thus, linearized cross-linked collagen bundles, which are quite stiff, potentiate cell migration, whereas a dense network of stiff cross-linked matrix fibers impedes migration, unless matrix metalloproteinases (MMPs) are simultaneously activated (Egeblad et al., 2010b)."]}
{"doc_id": 57015, "title": "", "abstract": ["The extracellular matrix: A dynamic niche in cancer progression", "Collectively, a picture has started to emerge with regard to ECM’s roles in cancer progression: normal ECM dynamics are essential for embryonic organ development and postnatal function (Fig. 4 A); deregulated ECM dynamics disrupt tissue polarity, architecture, and integrity and promote epithelial cell transformation and invasion (Fig. 4 B).", "Because the ECM plays an important role in MSC differentiation (Engler et al., 2006), it is likely that MSCs may be yet another target cell population of abnormal ECM dynamics in the formation of a cancer niche.", "However, recent progress has also highlighted the importance of noncellular components of the niche, especially the ECM, during cancer progression (Sternlicht et al., 1999; Paszek et al., 2005; Erler et al., 2006, 2009; Levental et al., 2009).", "Its functional diversity and dynamic nature, which allows the ECM to be an active participant in most major cell behavior and developmental processes, also makes it a necessary target whose deregulation may be a rate-limiting step in cancer progression."]}
{"doc_id": 57016, "title": "", "abstract": ["Various collagens, including collagen I, II, III, V, and IX, show increased deposition during tumor formation (Zhu et al., 1995; Kauppila et al., 1998; Huijbers et al., 2010).", "An increase in collagen deposition or ECM stiffness, alone or in combination, up-regulates integrin signaling and can thus promote cell survival and proliferation (Wozniak et al., 2003; Paszek et al., 2005).", "Thickening and linearization of collagen fibers are common in cancers, and they are often found in areas where active tissue invasion and tumor vasculature are observed (Condeelis and Segall, 2003; Provenzano et al., 2006; Levental et al., 2009), suggesting that they play an active role in facilitating cancer cell invasion.", "Increased collagen cross-linking and ECM stiffness as a result of LOX overproduction promote focal adhesion assembly and ERK and PI3 kinase signaling and facilitate Neu-mediated oncogenic transformation (Levental et al., 2009).", "As we age, there is a reduction of collagen deposition and increased MMP activity (Norton et al., 2005; Butcher et al., 2009)."]}
{"doc_id": 13000, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "The high occupancy of N-linked glycan sequons of SARS-CoV-2 S indicates that recombinant immunogens will not require further optimization to enhance site occupancy.", "Two sites on SARS-CoV-2 S are principally oligomannose-type: N234 and N709.", "Fig. 2 Site-specific N-linked glycosylation of the SARS-CoV-2 S glycoprotein.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples."]}
{"doc_id": 13001, "title": "", "abstract": ["For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "For example, the more densely glycosylated spikes of HIV-1 Env and Lassa virus (LASV) GPC exhibit numerous sites dominated by Man9GlcNAc2 (21–24).", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "SARS-CoV-2 uses an extensively glycosylated spike (S) protein that protrudes from the viral surface to bind to angiotensin-converting enzyme 2 (ACE2) to mediate host-cell entry (3).", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike."]}
{"doc_id": 13002, "title": "", "abstract": ["Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "The high occupancy of N-linked glycan sequons of SARS-CoV-2 S indicates that recombinant immunogens will not require further optimization to enhance site occupancy.", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike.", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies."]}
{"doc_id": 13003, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "The SARS-CoV-2 S gene encodes 22 N-linked glycan sequons per protomer, which likely play a role in protein folding and immune evasion.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "Although unoccupied glycosylation sites were detected on SARS-CoV-2 S, when quantified they were revealed to form a very minor component of the total peptide pool (table S2).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples."]}
{"doc_id": 13004, "title": "", "abstract": ["SARS-CoV-2 uses an extensively glycosylated spike (S) protein that protrudes from the viral surface to bind to angiotensin-converting enzyme 2 (ACE2) to mediate host-cell entry (3).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "The S protein is a trimeric class I fusion protein, composed of two functional subunits, responsible for receptor binding (S1 subunit) and membrane fusion (S2 subunit) (4, 5).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4)."]}
{"doc_id": 13005, "title": "", "abstract": ["Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "This variant of the S protein contains all 22 glycans on the SARS-CoV-2 S protein (Fig. 1A).", "The S protein is a trimeric class I fusion protein, composed of two functional subunits, responsible for receptor binding (S1 subunit) and membrane fusion (S2 subunit) (4, 5)."]}
{"doc_id": 13006, "title": "", "abstract": ["Glycan modifications can be heavily influenced by the cellular expression system used.", "The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14).", "Viral glycosylation has wide-ranging roles in viral pathobiology, including mediating protein folding and stability and shaping viral tropism (9).", "We note the dispersion of oligomannose-type glycans across both the S1 and S2 subunits.", "However, observations of complex-type glycans on virally derived material suggests that the viral glycoproteins are subjected to Golgi-resident processing enzymes (13, 17)."]}
{"doc_id": 13007, "title": "", "abstract": ["Last, we detected trace levels of O-linked glycosylation at Thr323/Ser325 (T323/S325), with over 99% of these sites unmodified (fig. S4), suggesting that O-linked glycosylation of this region is minimal when the structure is native-like.", "However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no observed mutations to N-linked glycosylation sites (10).", "Given the functional constraints of receptor binding sites and the resulting low mutation rates of these residues, there is likely selective pressure to use N-linked glycans to camouflage one of the most conserved and potentially vulnerable areas of their respective glycoproteins (30, 31).", "Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation."]}
{"doc_id": 13008, "title": "", "abstract": ["Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "The SARS-CoV-2 S gene encodes 22 N-linked glycan sequons per protomer, which likely play a role in protein folding and immune evasion.", "This variant of the S protein contains all 22 glycans on the SARS-CoV-2 S protein (Fig. 1A).", "The glycopeptides were analyzed by liquid chromatography–mass spectrometry, and the glycan compositions were determined for all 22 N-linked glycan sites (Fig. 2)."]}
{"doc_id": 13009, "title": "", "abstract": ["Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4)."]}
{"doc_id": 13010, "title": "", "abstract": ["The SARS-CoV-2 S gene encodes 22 N-linked glycan sequons per protomer, which likely play a role in protein folding and immune evasion.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Fig. 2 Site-specific N-linked glycosylation of the SARS-CoV-2 S glycoprotein.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples."]}
{"doc_id": 13011, "title": "", "abstract": ["The positions of N-linked glycosylation sequons (N-X-S/T, where X ≠ P) are shown as branches (N, Asn; X, any residue; S, Ser; T, Thr; P, Pro).", "Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "Although unoccupied glycosylation sites were detected on SARS-CoV-2 S, when quantified they were revealed to form a very minor component of the total peptide pool (table S2).", "Y.W. built glycosylated models.", "Additionally, glycosylation can influence the trafficking of recombinant immunogen to germinal centers (19)."]}
{"doc_id": 13012, "title": "", "abstract": ["In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3).", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "Whereas small mannose-type clusters have been characterized on the S1 subunit of Middle East respiratory syndrome (MERS)–CoV S (10), no such phenomenon has been observed for the SARS-CoV-1 or SARS-CoV-2 S proteins.", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation."]}
{"doc_id": 13013, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike."]}
{"doc_id": 13014, "title": "", "abstract": ["Highly dense glycan shields, such as those observed on LASV GPC and HIV-1 Env, feature so-called mannose clusters (22, 24) on the protein surface (Fig. 4).", "The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Fig. 4 Underprocessing of viral glycan shields.", "These were determined to be complex-type glycans, consistent with steric accessibility of these residues."]}
{"doc_id": 13015, "title": "", "abstract": ["Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35).", "Additionally, glycosylation can influence the trafficking of recombinant immunogen to germinal centers (19)."]}
{"doc_id": 13016, "title": "", "abstract": ["The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "The oligomannose-type glycan series (M9 to M5; Man9GlcNAc2 to Man5GlcNAc2) is colored green, afucosylated and fucosylated hybrid-type glycans (hybrid and F hybrid) are dashed pink, and complex glycans are grouped according to the number of antennae and presence of core fucosylation (A1 to FA4) and are colored pink.", "A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "To convey the main processing features at each site, the abundances of each glycan are summed into oligomannose-type, hybrid-type, and categories of complex-type glycosylation based on branching and fucosylation.", "In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3)."]}
{"doc_id": 13017, "title": "", "abstract": ["Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "Additionally, glycosylation can influence the trafficking of recombinant immunogen to germinal centers (19).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14).", "Viral glycosylation has wide-ranging roles in viral pathobiology, including mediating protein folding and stability and shaping viral tropism (9)."]}
{"doc_id": 13018, "title": "", "abstract": ["The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Viral glycosylation has wide-ranging roles in viral pathobiology, including mediating protein folding and stability and shaping viral tropism (9).", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "However, observations of complex-type glycans on virally derived material suggests that the viral glycoproteins are subjected to Golgi-resident processing enzymes (13, 17)."]}
{"doc_id": 13019, "title": "", "abstract": ["Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34)."]}
{"doc_id": 13020, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "The oligomannose-type glycan series (M9 to M5; Man9GlcNAc2 to Man5GlcNAc2) is colored green, afucosylated and fucosylated hybrid-type glycans (hybrid and F hybrid) are dashed pink, and complex glycans are grouped according to the number of antennae and presence of core fucosylation (A1 to FA4) and are colored pink.", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike."]}
{"doc_id": 13021, "title": "", "abstract": ["Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Here, using a site- specific mass spectrometric approach, we reveal the glycan structures on a recombinant SARS-CoV-2 S immunogen.", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4)."]}
{"doc_id": 13022, "title": "", "abstract": ["Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no observed mutations to N-linked glycosylation sites (10).", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation."]}
{"doc_id": 13023, "title": "", "abstract": ["SARS-CoV-2 uses an extensively glycosylated spike (S) protein that protrudes from the viral surface to bind to angiotensin-converting enzyme 2 (ACE2) to mediate host-cell entry (3).", "The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "We show how SARS- CoV-2 S glycans differ from typical host glycan processing, which may have implications in viral pathobiology and vaccine design.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies."]}
{"doc_id": 13024, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "Fig. 2 Site-specific N-linked glycosylation of the SARS-CoV-2 S glycoprotein.", "# Site-specific glycan analysis of the SARS-CoV-2 spike", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples."]}
{"doc_id": 13025, "title": "", "abstract": ["Stabilization of the trimeric prefusion structure was achieved by using the 2P stabilizing mutations (20) at residues 986 and 987, a GSAS (Gly-Ser-Ala-Ser) substitution at the furin cleavage site (residues 682 to 685), and a C-terminal trimerization motif.", "Representative glycans are modeled onto the prefusion structure of the trimeric SARS-CoV-2 S glycoprotein (PDB ID 6VSB) (4), with one RBD in the “up” conformation and the other two RBDs in the “down” conformation.", "From left to right, MERS-CoV S (10), SARS-CoV-1 S (10), SARS-CoV-2 S, LASV GPC (24), and HIV-1 Env (8, 21).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25)."]}
{"doc_id": 13026, "title": "", "abstract": ["Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "Y.W. built glycosylated models."]}
{"doc_id": 13027, "title": "", "abstract": ["Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no observed mutations to N-linked glycosylation sites (10).", "Last, we detected trace levels of O-linked glycosylation at Thr323/Ser325 (T323/S325), with over 99% of these sites unmodified (fig. S4), suggesting that O-linked glycosylation of this region is minimal when the structure is native-like."]}
{"doc_id": 13028, "title": "", "abstract": ["This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation.", "The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "From left to right, MERS-CoV S (10), SARS-CoV-1 S (10), SARS-CoV-2 S, LASV GPC (24), and HIV-1 Env (8, 21).", "Whereas small mannose-type clusters have been characterized on the S1 subunit of Middle East respiratory syndrome (MERS)–CoV S (10), no such phenomenon has been observed for the SARS-CoV-1 or SARS-CoV-2 S proteins."]}
{"doc_id": 13029, "title": "", "abstract": ["A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "We note the dispersion of oligomannose-type glycans across both the S1 and S2 subunits.", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus."]}
{"doc_id": 13030, "title": "", "abstract": ["Viral glycosylation has wide-ranging roles in viral pathobiology, including mediating protein folding and stability and shaping viral tropism (9).", "The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "Additionally, glycosylation can influence the trafficking of recombinant immunogen to germinal centers (19).", "However, observations of complex-type glycans on virally derived material suggests that the viral glycoproteins are subjected to Golgi-resident processing enzymes (13, 17)."]}
{"doc_id": 13031, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "# Site-specific glycan analysis of the SARS-CoV-2 spike", "Here, using a site- specific mass spectrometric approach, we reveal the glycan structures on a recombinant SARS-CoV-2 S immunogen.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3)."]}
{"doc_id": 13032, "title": "", "abstract": ["To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Last, we detected trace levels of O-linked glycosylation at Thr323/Ser325 (T323/S325), with over 99% of these sites unmodified (fig. S4), suggesting that O-linked glycosylation of this region is minimal when the structure is native-like.", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3)."]}
{"doc_id": 13033, "title": "", "abstract": ["The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Whereas the oligomannose-type glycan content (28%) (table S2) is above that observed on typical host glycoproteins, it is lower than other viral glycoproteins.", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "We have previously demonstrated for HIV-1 Env glycosylation that the processing of complex-type glycans is driven by the producer cell but that the levels of oligomannose-type glycans were largely independent of the expression system and are much more closely related to the protein structure and glycan density (36).", "This is in contrast to other viral glycoproteins; for example, the dense glycan clusters in several strains of HIV-1 Env induce oligomannose-type glycans that are recognized by antibodies (32, 33)."]}
{"doc_id": 13034, "title": "", "abstract": ["To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "# Site-specific glycan analysis of the SARS-CoV-2 spike"]}
{"doc_id": 13035, "title": "", "abstract": ["However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no observed mutations to N-linked glycosylation sites (10).", "Given the functional constraints of receptor binding sites and the resulting low mutation rates of these residues, there is likely selective pressure to use N-linked glycans to camouflage one of the most conserved and potentially vulnerable areas of their respective glycoproteins (30, 31).", "The high occupancy of N-linked glycan sequons of SARS-CoV-2 S indicates that recombinant immunogens will not require further optimization to enhance site occupancy.", "We characterized the N-linked glycans on extended flexible loop structures (N74 and N149) and at the membrane-proximal C terminus (N1158, N1173, N1194) that were not resolved in the cryo-EM maps (4).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3)."]}
{"doc_id": 13036, "title": "", "abstract": ["Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "Y.W. built glycosylated models.", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike."]}
{"doc_id": 13037, "title": "", "abstract": ["The glycopeptides were analyzed by liquid chromatography–mass spectrometry, and the glycan compositions were determined for all 22 N-linked glycan sites (Fig. 2).", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike.", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "The graphs summarize quantitative mass spectrometric analysis of the glycan population present at individual N-linked glycosylation sites simplified into categories of glycans."]}
{"doc_id": 13038, "title": "", "abstract": ["The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "We note the dispersion of oligomannose-type glycans across both the S1 and S2 subunits.", "Whereas the oligomannose-type glycan content (28%) (table S2) is above that observed on typical host glycoproteins, it is lower than other viral glycoproteins."]}
{"doc_id": 13039, "title": "", "abstract": ["The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "However, observations of complex-type glycans on virally derived material suggests that the viral glycoproteins are subjected to Golgi-resident processing enzymes (13, 17).", "Whereas the oligomannose-type glycan content (28%) (table S2) is above that observed on typical host glycoproteins, it is lower than other viral glycoproteins.", "All glycoproteins were expressed as soluble trimers in HEK 293F cells apart from LASV GPC, which was derived from virus-like particles from Madin-Darby canine kidney II cells.", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4)."]}
{"doc_id": 13040, "title": "", "abstract": ["These were determined to be complex-type glycans, consistent with steric accessibility of these residues.", "The remaining 14 sites are dominated by processed, complex-type glycans.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35)."]}
{"doc_id": 13041, "title": "", "abstract": ["We have previously demonstrated for HIV-1 Env glycosylation that the processing of complex-type glycans is driven by the producer cell but that the levels of oligomannose-type glycans were largely independent of the expression system and are much more closely related to the protein structure and glycan density (36).", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "The oligomannose-type glycan series (M9 to M5; Man9GlcNAc2 to Man5GlcNAc2) is colored green, afucosylated and fucosylated hybrid-type glycans (hybrid and F hybrid) are dashed pink, and complex glycans are grouped according to the number of antennae and presence of core fucosylation (A1 to FA4) and are colored pink.", "These were determined to be complex-type glycans, consistent with steric accessibility of these residues.", "A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2)."]}
{"doc_id": 13042, "title": "", "abstract": ["The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "For example, the more densely glycosylated spikes of HIV-1 Env and Lassa virus (LASV) GPC exhibit numerous sites dominated by Man9GlcNAc2 (21–24)."]}
{"doc_id": 13043, "title": "", "abstract": ["The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14).", "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus 2019 (COVID-19) (1, 2), induces fever, severe respiratory illness, and pneumonia.", "The emergence of the betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), represents a considerable threat to global human health.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35)."]}
{"doc_id": 13044, "title": "", "abstract": ["This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "SARS-CoV-2 uses an extensively glycosylated spike (S) protein that protrudes from the viral surface to bind to angiotensin-converting enzyme 2 (ACE2) to mediate host-cell entry (3).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4)."]}
{"doc_id": 13045, "title": "", "abstract": ["Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "Additionally, glycosylation can influence the trafficking of recombinant immunogen to germinal centers (19).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "Viral glycosylation has wide-ranging roles in viral pathobiology, including mediating protein folding and stability and shaping viral tropism (9).", "The role of glycosylation in camouflaging immunogenic protein epitopes has been studied for other coronaviruses (10, 13, 14)."]}
{"doc_id": 13046, "title": "", "abstract": ["Here, using a site- specific mass spectrometric approach, we reveal the glycan structures on a recombinant SARS-CoV-2 S immunogen.", "An extended version of the site-specific analysis showing the heterogeneity within each category can be found in table S1 and fig. S2.", "The graphs summarize quantitative mass spectrometric analysis of the glycan population present at individual N-linked glycosylation sites simplified into categories of glycans.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "# Site-specific glycan analysis of the SARS-CoV-2 spike"]}
{"doc_id": 13047, "title": "", "abstract": ["The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Stabilization of the trimeric prefusion structure was achieved by using the 2P stabilizing mutations (20) at residues 986 and 987, a GSAS (Gly-Ser-Ala-Ser) substitution at the furin cleavage site (residues 682 to 685), and a C-terminal trimerization motif.", "In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3).", "Representative glycans are modeled onto the prefusion structure of the trimeric SARS-CoV-2 S glycoprotein (PDB ID 6VSB) (4), with one RBD in the “up” conformation and the other two RBDs in the “down” conformation.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10)."]}
{"doc_id": 13048, "title": "", "abstract": ["Whereas the oligomannose-type glycan content (28%) (table S2) is above that observed on typical host glycoproteins, it is lower than other viral glycoproteins.", "Impaired glycan maturation resulting in the presence of oligomannose-type glycans can be a sensitive reporter of native- like protein architecture (8), and site-specific glycan analysis can be used to compare different immunogens and monitor manufacturing processes (18).", "High viral glycan density and local protein architecture can sterically impair the glycan maturation pathway.", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "This is in contrast to other viral glycoproteins; for example, the dense glycan clusters in several strains of HIV-1 Env induce oligomannose-type glycans that are recognized by antibodies (32, 33)."]}
{"doc_id": 13049, "title": "", "abstract": ["The glycopeptides were analyzed by liquid chromatography–mass spectrometry, and the glycan compositions were determined for all 22 N-linked glycan sites (Fig. 2).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike.", "The graphs summarize quantitative mass spectrometric analysis of the glycan population present at individual N-linked glycosylation sites simplified into categories of glycans.", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites."]}
{"doc_id": 13050, "title": "", "abstract": ["To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "The glycopeptides were analyzed by liquid chromatography–mass spectrometry, and the glycan compositions were determined for all 22 N-linked glycan sites (Fig. 2).", "Glycan sites are colored according to oligomannose-type glycan content, with the glycan sites labeled in green (80 to 100%), orange (30 to 79%), and pink (0 to 29%)."]}
{"doc_id": 13051, "title": "", "abstract": ["Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3)."]}
{"doc_id": 13052, "title": "", "abstract": ["The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3).", "Two sites on SARS-CoV-2 S are principally oligomannose-type: N234 and N709.", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation.", "The high occupancy of N-linked glycan sequons of SARS-CoV-2 S indicates that recombinant immunogens will not require further optimization to enhance site occupancy."]}
{"doc_id": 13053, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples."]}
{"doc_id": 13054, "title": "", "abstract": ["To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "2D class averages of the SARS-CoV-2 S protein are shown, confirming that the protein adopts the trimeric prefusion conformation matching the material used to determine the structure (4).", "Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "This combined mass spectrometric and cryo-EM analysis reveals how the N-linked glycans occlude distinct regions across the surface of the SARS-CoV-2 spike."]}
{"doc_id": 13055, "title": "", "abstract": ["This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization.", "The shielding of receptor binding sites by glycans is a common feature of viral glycoproteins, as observed on SARS-CoV-1 S (10, 13), HIV-1 Env (27), influenza hemagglutinin (28, 29), and LASV GPC (24).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10)."]}
{"doc_id": 13056, "title": "", "abstract": ["Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site- specific glycan signatures characteristic of a natively folded trimeric spike.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies."]}
{"doc_id": 13057, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "To resolve the site-specific glycosylation of the SARS-CoV-2 S protein and visualize the distribution of glycoforms across the protein surface, we expressed and purified three biological replicates of recombinant soluble material in an identical manner to that which was used to obtain the high- resolution cryo–electron microscopy (cryo-EM) structure, albeit without a glycan-processing blockade using kifunensine (4).", "Y.W. built glycosylated models.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization."]}
{"doc_id": 13058, "title": "", "abstract": ["The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Although unoccupied glycosylation sites were detected on SARS-CoV-2 S, when quantified they were revealed to form a very minor component of the total peptide pool (table S2).", "Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation.", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35)."]}
{"doc_id": 13059, "title": "", "abstract": ["Representative glycans are modeled onto the prefusion structure of the trimeric SARS-CoV-2 S glycoprotein (PDB ID 6VSB) (4), with one RBD in the “up” conformation and the other two RBDs in the “down” conformation.", "These were determined to be complex-type glycans, consistent with steric accessibility of these residues.", "Our analysis reveals that N343 is highly fucosylated with 98% of detected glycans bearing fucose residues.", "The oligomannose-type glycan series (M9 to M5; Man9GlcNAc2 to Man5GlcNAc2) is colored green, afucosylated and fucosylated hybrid-type glycans (hybrid and F hybrid) are dashed pink, and complex glycans are grouped according to the number of antennae and presence of core fucosylation (A1 to FA4) and are colored pink.", "Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35)."]}
{"doc_id": 13060, "title": "", "abstract": ["A mixture of oligomannose- and complex-type glycans can be found at sites N61, N122, N603, N717, N801, and N1074 (Fig. 2).", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "The oligomannose-type glycan series (M9 to M5; Man9GlcNAc2 to Man5GlcNAc2) is colored green, afucosylated and fucosylated hybrid-type glycans (hybrid and F hybrid) are dashed pink, and complex glycans are grouped according to the number of antennae and presence of core fucosylation (A1 to FA4) and are colored pink.", "Site-specific N-linked glycan oligomannose quantifications are colored according to the key."]}
{"doc_id": 13061, "title": "", "abstract": ["The SARS-CoV-2 S gene encodes 22 N-linked glycan sequons per protomer, which likely play a role in protein folding and immune evasion.", "Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "This variant of the S protein contains all 22 glycans on the SARS-CoV-2 S protein (Fig. 1A).", "The high occupancy of N-linked glycan sequons of SARS-CoV-2 S indicates that recombinant immunogens will not require further optimization to enhance site occupancy."]}
{"doc_id": 13062, "title": "", "abstract": ["Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation.", "The S protein is a trimeric class I fusion protein, composed of two functional subunits, responsible for receptor binding (S1 subunit) and membrane fusion (S2 subunit) (4, 5).", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "Vaccine development is focused on the principal target of the humoral immune response, the spike (S) glycoprotein, which mediates cell entry and membrane fusion.", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8)."]}
{"doc_id": 46000, "title": "", "abstract": ["If TRIM5 were a PRR specific for the retroviral capsid lattice, infection with retroviruses would activate signaling, the magnitude of which would correlate with TRIM5 avidity for the capsid of the challenge virus.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8."]}
{"doc_id": 46001, "title": "", "abstract": ["Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Though TRIM5 is not sufficient to activate IFN-β (Fig. 1c), it promotes the first wave of innate immune signaling upstream of IFN-β and thereby contributes to the antiviral state established by LPS (Supplementary Fig. 1f).", "TRIM5 promotes innate immune signaling", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Given the contribution of TRIM5 to the production of inflammatory mediators by LPS, the effect of TRIM5 on the previously reported anti-HIV-1 activity of LPS12 was examined."]}
{"doc_id": 46002, "title": "", "abstract": ["Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13/UEV1A, TRIM5 catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (MAP3K7) kinase complex and stimulate AP-1 and NFκB signaling.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "These experiments show that, like TRAF611, TRIM5 synthesizes free K63-linked Ub chains which activate TAK1 autophosphorylation.", "With UBC13/UEV1A, TRIM5 synthesizes free K63 Ub chains that are recognized by TAB2, which multimerizes and activates the TAK1 kinase complex.", "TRIM5 acts with UBC13/UEV1A to synthesize free K63-linked Ub chains that activate TAK1"]}
{"doc_id": 46003, "title": "", "abstract": ["Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "This activity was greatly increased by the hexameric capsid lattice, a molecular signature of HIV-1 and other retroviruses."]}
{"doc_id": 46004, "title": "", "abstract": ["Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "Interestingly, TRIM5 spontaneously forms an hexagonal lattice that is complementary to the capsid lattice2525 but the efficiency of TRIM5 lattice formation is greatly stimulated by the capsid hexamer25 (Fig. 4h).", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8."]}
{"doc_id": 46005, "title": "", "abstract": ["Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by HIV-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm1,2.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid."]}
{"doc_id": 46006, "title": "", "abstract": ["The TRIM5-cyclophilin A fusion protein from owl monkey1 activated AP-1 and NF-κB to similar levels as human TRIM5α (Supplementary Fig. 1d and e).", "Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13/UEV1A, TRIM5 catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (MAP3K7) kinase complex and stimulate AP-1 and NFκB signaling.", "These results demonstrate that TRIM5 activates MAPK- and NF-κB-dependent genes and makes a major contribution to LPS signaling and gene induction (Supplementary Figure 1f).", "To understand how TRIM5 activates AP-1 and NF-κB, 20 candidate proteins, selected based on signaling activity above the MAPK/NF-κB bifurcation in the LPS signaling pathway, were tested for the ability to immunoprecipitate with TRIM5.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice."]}
{"doc_id": 46007, "title": "", "abstract": ["Like TRIM5, TAK1 potently activated AP-1 and modestly activated NF-κB (Fig 2b).", "The TRIM5-cyclophilin A fusion protein from owl monkey1 activated AP-1 and NF-κB to similar levels as human TRIM5α (Supplementary Fig. 1d and e).", "Since TRIM5 interacted biochemically and functionally with TAK1, TAB2, TAB3, UBC13, UEV1A, and K63-Ub, the ability of TRIM5 to synthesize K63-linked Ub chains was assessed.", "b, c, and f, HEK-293 cells were transfected with the indicated pcDNA-based expression plasmids and an AP-1 luciferase reporter and show the effect of TAK1 inhibitor 5z-7-oxozeaenol (b) or TAK1 KD (c).", "Like TRIM5 KD, TAK1 KD rescued HIV-1 from the LPS-induced antiviral state (Fig. 2e and Supplementary Fig. 5d), and either TAB2 or TAB3 acted synergistically with TRIM5 to activate AP-1 (Fig. 2f)."]}
{"doc_id": 46008, "title": "", "abstract": ["Transduction of MDDC, MDM, or THP-1 macrophages by VSV G-pseudotyped HIV-1 was blocked by LPS, by other PAMPs, and by type 1 IFN (Supplementary Fig. 3a–c).", "Monocyte-derived dendritic cells (MDDC), macrophages (MDM) and THP-1 cells were challenged with LPS and induction of the AP-1- and NF-κB- dependent genes CXCL9, CXCL10, CCL8, IL-6, IL-8, and PTGS2 (COX2), was found to be attenuated by TRIM5 KD (Fig. 1e and f and Supplementary Figure 2d and e).", "g–j, THP-1 macrophages transduced with miR30-based lentivirus KD vectors targeting either TRIM5 (g and i), IRF3 (h), or STAT2 (i), were treated 24 hrs with the indicated compounds and challenged with VSV-G pseudotyped HIV-1 luciferase reporter virus (g–i) or with the indicated GFP reporter viruses (j).", "Finally, two factors that disrupt the HIV-1 capsid-TRIM5Cyp interaction and block restriction activity - a non-immunosuppressive cyclosporine analogue1 or the TRIM5Cyp H436Q mutant protein13 \\- each eliminated the enhancement of E3 Ub ligase activity by the A14C/E45C capsid cylinders, without effect on the baseline activity in the absence of capsid (Fig. 4g and Supplementary Figs. 7d and 12b–d).", "KD of UBC13 or UEV1A severely blocked AP-1 activation by TRIM5 (Fig. 3c and Supplementary Fig. 6a–c), rescued HIV-1 from the LPS-induced antiviral state in THP-1 macrophages (Fig. 3d and Supplementary Fig. 6d), and rescued HIV-1 and EIAV from TRIM5-mediated restriction (Fig. 2g–i)."]}
{"doc_id": 46009, "title": "", "abstract": ["Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "The experiments presented here demonstrate that TRIM5 is a multifunctional component of the innate immune system."]}
{"doc_id": 46010, "title": "", "abstract": ["Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13/UEV1A, TRIM5 catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (MAP3K7) kinase complex and stimulate AP-1 and NFκB signaling.", "TRIM5 senses retrovirus capsids in the target cell cytoplasm (Fig 4a–f) and activates MAPK- and NF-κB-dependent transcription via the synthesis of TAK1-activating, K63-linked Ub chains (Fig. 3g–j).", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h)."]}
{"doc_id": 46011, "title": "", "abstract": ["Though TRIM5 was not sufficient to activate IFN-β, induction of IFN-β by IRF3 was greatly enhanced by TRIM5 (Fig. 1c), consistent with the fact that IFN-β transcription requires NF-κB and AP-1, as well as IRF3 (Supplementary Fig. 1f)9.", "Though TRIM5 is not sufficient to activate IFN-β (Fig. 1c), it promotes the first wave of innate immune signaling upstream of IFN-β and thereby contributes to the antiviral state established by LPS (Supplementary Fig. 1f).", "TRIM5 also stimulated NF-κB (Fig. 1b) but minimally activated IFN-β-, or IRF3-dependent, luciferase reporters (Fig. 1c and Supplementary Fig. 1b and c).", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "TRIM5 mRNA increased 10-fold in response to these factors (Supplementary Fig. 3d and e) but this increase was not sufficient for the anti-HIV-1 state (Supplementary Fig. 3f and g)."]}
{"doc_id": 46012, "title": "", "abstract": ["Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "These experiments indicate that the heterodimeric E2 UBC13/UEV1A and the K63-linked Ub chains that it produces play a role in TRIM5-mediated signaling.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "LPS, a pathogen-associated molecular pattern (PAMP) recognized by the pattern recognition receptor (PRR) TLR4, activates AP-1 and NF-κB-signaling and this culminates in the expression of inflammatory genes like those perturbed by TRIM5 KD10,11."]}
{"doc_id": 46013, "title": "", "abstract": ["Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "If TRIM5 were a PRR specific for the retroviral capsid lattice, infection with retroviruses would activate signaling, the magnitude of which would correlate with TRIM5 avidity for the capsid of the challenge virus.", "TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid."]}
{"doc_id": 46014, "title": "", "abstract": ["TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by HIV-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm1,2.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "Little is known about how the innate immune system detects retroviruses26 and the discovery that TRIM5 acts as a PRR is an important step towards filling this critical gap."]}
{"doc_id": 46015, "title": "", "abstract": ["Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "The experiments presented here demonstrate that TRIM5 is a multifunctional component of the innate immune system.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Little is known about how the innate immune system detects retroviruses26 and the discovery that TRIM5 acts as a PRR is an important step towards filling this critical gap.", "TRIM5 promotes innate immune signaling"]}
{"doc_id": 46016, "title": "", "abstract": ["Current models of the HIV-1 capsid lattice are based on cylinders generated under high salt with either capsid or capsid-nucleocapsid fusion protein17,24; both preparations were generated but the high salt necessary to maintain capsid cylinders blocked E3 Ub ligase activity.", "The cellular factors required for TRIM5 E3 activity and inflammatory gene induction, UBC13, UEV1A and TAK1, also promoted capsid-specific restriction activity, indicating that the multiple functions of TRIM5 are mechanistically linked.", "Unrestricted capsids were B-tropic MLV (a and b), N/B-tropic MLV (c and d) or SIVMAC239 (e and f).", "If TRIM5 were a PRR specific for the retroviral capsid lattice, infection with retroviruses would activate signaling, the magnitude of which would correlate with TRIM5 avidity for the capsid of the challenge virus.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid."]}
{"doc_id": 46017, "title": "", "abstract": ["The TRIM5-cyclophilin A fusion protein from owl monkey1 activated AP-1 and NF-κB to similar levels as human TRIM5α (Supplementary Fig. 1d and e).", "To understand how TRIM5 activates AP-1 and NF-κB, 20 candidate proteins, selected based on signaling activity above the MAPK/NF-κB bifurcation in the LPS signaling pathway, were tested for the ability to immunoprecipitate with TRIM5.", "Though TRIM5 was not sufficient to activate IFN-β, induction of IFN-β by IRF3 was greatly enhanced by TRIM5 (Fig. 1c), consistent with the fact that IFN-β transcription requires NF-κB and AP-1, as well as IRF3 (Supplementary Fig. 1f)9.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "TRIM5 senses retrovirus capsids in the target cell cytoplasm (Fig 4a–f) and activates MAPK- and NF-κB-dependent transcription via the synthesis of TAK1-activating, K63-linked Ub chains (Fig. 3g–j)."]}
{"doc_id": 46018, "title": "", "abstract": ["These experiments indicate that the heterodimeric E2 UBC13/UEV1A and the K63-linked Ub chains that it produces play a role in TRIM5-mediated signaling.", "These results indicate that TRIM5 and the TAK1 kinase complex cooperate to promote signal transduction, and given that TAK1 phosphorylates both IKKs and MKKs11, explains how TRIM5 activates both MAPK and NF-κB signaling pathways.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by HIV-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm1,2.", "Human TRIM5α, produced by transfection of 293T cells and enriched by immunoprecipitation, catalyzed the synthesis of free K63 Ub chains like those of TRIM5Cyp, in a RING domain-dependent manner (Fig. 3i and Supplementary Fig. 8c and d)."]}
{"doc_id": 46019, "title": "", "abstract": ["To understand how TRIM5 activates AP-1 and NF-κB, 20 candidate proteins, selected based on signaling activity above the MAPK/NF-κB bifurcation in the LPS signaling pathway, were tested for the ability to immunoprecipitate with TRIM5.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "TRIM5 senses retrovirus capsids in the target cell cytoplasm (Fig 4a–f) and activates MAPK- and NF-κB-dependent transcription via the synthesis of TAK1-activating, K63-linked Ub chains (Fig. 3g–j).", "Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13/UEV1A, TRIM5 catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (MAP3K7) kinase complex and stimulate AP-1 and NFκB signaling.", "The TRIM5-cyclophilin A fusion protein from owl monkey1 activated AP-1 and NF-κB to similar levels as human TRIM5α (Supplementary Fig. 1d and e)."]}
{"doc_id": 46020, "title": "", "abstract": ["In contrast, KD of STAT2, a factor that acts downstream of the type I IFN receptor, blocked the anti-HIV-1 activity of either LPS or type 1 IFN (Fig. 1i and Supplementary Fig. 4d).", "If these observations were linked functionally, interaction with capsid would be expected to stimulate the synthesis of Ub chains by TRIM5Cyp.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "As with the mRNA, soluble IL8, CCL5, CXCL9, and CXCL10 protein was differentially induced by N-MLV (Fig. 4d)."]}
{"doc_id": 46021, "title": "", "abstract": ["To determine if endogenous TRIM5 regulates AP-1 and NF-κB signaling pathways, the effect of TRIM5 knockdown (KD) was assessed in myeloid cells.", "These results demonstrate that TRIM5 activates MAPK- and NF-κB-dependent genes and makes a major contribution to LPS signaling and gene induction (Supplementary Figure 1f).", "To understand how TRIM5 activates AP-1 and NF-κB, 20 candidate proteins, selected based on signaling activity above the MAPK/NF-κB bifurcation in the LPS signaling pathway, were tested for the ability to immunoprecipitate with TRIM5.", "The TRIM5-cyclophilin A fusion protein from owl monkey1 activated AP-1 and NF-κB to similar levels as human TRIM5α (Supplementary Fig. 1d and e).", "TRIM5 senses retrovirus capsids in the target cell cytoplasm (Fig 4a–f) and activates MAPK- and NF-κB-dependent transcription via the synthesis of TAK1-activating, K63-linked Ub chains (Fig. 3g–j)."]}
{"doc_id": 46022, "title": "", "abstract": ["The cellular factors required for TRIM5 E3 activity and inflammatory gene induction, UBC13, UEV1A and TAK1, also promoted capsid-specific restriction activity, indicating that the multiple functions of TRIM5 are mechanistically linked.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Given the contribution of TRIM5 to the production of inflammatory mediators by LPS, the effect of TRIM5 on the previously reported anti-HIV-1 activity of LPS12 was examined.", "TRIM5 KD suppressed the higher inflammatory gene induction by N-MLV indicating its dependence upon endogenous TRIM5 (Fig. 4b).", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8."]}
{"doc_id": 46023, "title": "", "abstract": ["In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by HIV-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm1,2.", "These experiments indicate that the heterodimeric E2 UBC13/UEV1A and the K63-linked Ub chains that it produces play a role in TRIM5-mediated signaling.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice."]}
{"doc_id": 46024, "title": "", "abstract": ["Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13/UEV1A, TRIM5 catalyzes the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (MAP3K7) kinase complex and stimulate AP-1 and NFκB signaling.", "To understand how TRIM5 activates AP-1 and NF-κB, 20 candidate proteins, selected based on signaling activity above the MAPK/NF-κB bifurcation in the LPS signaling pathway, were tested for the ability to immunoprecipitate with TRIM5.", "TRIM5 senses retrovirus capsids in the target cell cytoplasm (Fig 4a–f) and activates MAPK- and NF-κB-dependent transcription via the synthesis of TAK1-activating, K63-linked Ub chains (Fig. 3g–j).", "To test the effect of K63-linked Ub chains generated by TRIM5 on TAK1 activation, the essential components of a TAK1 kinase complex, TAK1, TAB1, and TAB211, were purified and combined (Supplementary Fig. 10)."]}
{"doc_id": 46025, "title": "", "abstract": ["Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "If TRIM5 were a PRR specific for the retroviral capsid lattice, infection with retroviruses would activate signaling, the magnitude of which would correlate with TRIM5 avidity for the capsid of the challenge virus.", "These results indicate that TAK1 contributes to capsid-specific restriction mediated by TRIM5."]}
{"doc_id": 46026, "title": "", "abstract": ["TRIM5 is an innate immune sensor for the retrovirus capsid lattice", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "If TRIM5 were a PRR specific for the retroviral capsid lattice, infection with retroviruses would activate signaling, the magnitude of which would correlate with TRIM5 avidity for the capsid of the challenge virus."]}
{"doc_id": 46027, "title": "", "abstract": ["Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8.", "Interaction with the HIV-1 capsid lattice greatly enhances the UBC13/UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NFκB-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Rescue from LPS appears to be independent of capsid-recognition by TRIM5 in that TRIM5 KD rescued SIVMAC, a retrovirus that differs greatly from HIV-1 in terms of its sensitivity to TRIM5-mediated restriction1,2, as well as two non- retroviruses, the rhabdovirus vesicular stomatitis virus and the paramyxovirus Newcastle disease virus (Fig. 1j and Supplementary Fig. 4e–i)."]}
{"doc_id": 46028, "title": "", "abstract": ["Free K63-linked Ub chains generated by TRAF6 result in TAK1 autophosphorylation on threonine 18711, a modification required for TAK1 activation.", "To test the effect of K63-linked Ub chains generated by TRIM5 on TAK1 activation, the essential components of a TAK1 kinase complex, TAK1, TAB1, and TAB211, were purified and combined (Supplementary Fig. 10).", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "The UBC13/UEV1A E2 heterodimer is notable in that it generates K63-linked Ub chains that are unlinked to substrates; these free Ub chains multimerize and activate the TAK1 kinase complex via the Ub binding components, TAB2 and TAB311.", "These experiments show that, like TRAF611, TRIM5 synthesizes free K63-linked Ub chains which activate TAK1 autophosphorylation."]}
{"doc_id": 46029, "title": "", "abstract": ["Since TRIM5 interacted biochemically and functionally with TAK1, TAB2, TAB3, UBC13, UEV1A, and K63-Ub, the ability of TRIM5 to synthesize K63-linked Ub chains was assessed.", "These experiments show that, like TRAF611, TRIM5 synthesizes free K63-linked Ub chains which activate TAK1 autophosphorylation.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Human TRIM5α, produced by transfection of 293T cells and enriched by immunoprecipitation, catalyzed the synthesis of free K63 Ub chains like those of TRIM5Cyp, in a RING domain-dependent manner (Fig. 3i and Supplementary Fig. 8c and d).", "With UBC13/UEV1A, TRIM5 synthesizes free K63 Ub chains that are recognized by TAB2, which multimerizes and activates the TAK1 kinase complex."]}
{"doc_id": 46030, "title": "", "abstract": ["To test the effect of K63-linked Ub chains generated by TRIM5 on TAK1 activation, the essential components of a TAK1 kinase complex, TAK1, TAB1, and TAB211, were purified and combined (Supplementary Fig. 10).", "Free K63-linked Ub chains generated by TRAF6 result in TAK1 autophosphorylation on threonine 18711, a modification required for TAK1 activation.", "The UBC13/UEV1A E2 heterodimer is notable in that it generates K63-linked Ub chains that are unlinked to substrates; these free Ub chains multimerize and activate the TAK1 kinase complex via the Ub binding components, TAB2 and TAB311.", "These experiments show that, like TRAF611, TRIM5 synthesizes free K63-linked Ub chains which activate TAK1 autophosphorylation.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h)."]}
{"doc_id": 46031, "title": "", "abstract": ["These results demonstrate that TRIM5 activates MAPK- and NF-κB-dependent genes and makes a major contribution to LPS signaling and gene induction (Supplementary Figure 1f).", "To determine if TRIM5 contributes to signal transduction, the effect of ectopic human TRIM5α expression on transcriptional reporters in HEK-293 cells was examined.", "LPS, a pathogen-associated molecular pattern (PAMP) recognized by the pattern recognition receptor (PRR) TLR4, activates AP-1 and NF-κB-signaling and this culminates in the expression of inflammatory genes like those perturbed by TRIM5 KD10,11.", "The contribution of TAK1 to restriction of N-tropic MLV by human TRIM5α was examined using miR30-based KD vectors in THP-1, HeLa, and HT1080 cells.", "Though TRIM5 is not sufficient to activate IFN-β (Fig. 1c), it promotes the first wave of innate immune signaling upstream of IFN-β and thereby contributes to the antiviral state established by LPS (Supplementary Fig. 1f)."]}
{"doc_id": 55000, "title": "", "abstract": ["When mitochondria lose membrane potential or amass unfolded protein, PINK1 accumulates on the outer membrane via TOM7 in association with the TOM complex (Hasson et al., 2013).", "On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013).", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria.", "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Furthermore, expression of ubiquitin S65A, a mutant that cannot be phosphorylated by PINK1, inhibited Parkin translocation to damaged mitochondria."]}
{"doc_id": 55001, "title": "", "abstract": ["PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "These data indicate that phospho-Ub stimulates Parkin ligase activity and represents a mechanism of PINK1 activation of Parkin (Fig. 5 A).", "Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays.", "Phosphorylation of Ub S65 by PINK1 mirrors PINK1 phosphorylation of Parkin’s UBL domain on the homologous Parkin S65 residue (Kondapalli et al., 2012).", "A model of PINK1 phosphorylation of ubiquitin to activate Parkin and the conservation of S65 among UBL proteins and domains."]}
{"doc_id": 55002, "title": "", "abstract": ["Other phosphoproteome analyses have indicated Ub may also be phosphorylated at T7 (Lee et al., 2009; Shiromizu et al., 2013), T12 (Lee et al., 2009), Y59 (Rikova et al., 2007; Bodenmiller et al., 2008; Moritz et al., 2010; Gu et al., 2011), and S57 (Villén et al., 2007; Malik et al., 2009; Bennetzen et al., 2010; Phanstiel et al., 2011), although the kinases involved remain unknown.", "The same Ub phosphopeptide was observed in three separate forms with different charge states, quadruply, triply, and doubly charged (at m/z 553.29, 737.38, and 1105.57, respectively), and all of these forms were observed only in His-Ub samples exposed to mitochondria from CCCP-treated cells (Fig. 2 D, red) and not from untreated controls (Fig. 2 D, blue).", "Phosphorylation of Ub S65 by PINK1 mirrors PINK1 phosphorylation of Parkin’s UBL domain on the homologous Parkin S65 residue (Kondapalli et al., 2012).", "Interestingly, PINK1 phosphorylates Ub at S65, a residue that is homologous with the S65 site PINK1 phosphorylates on the Parkin ubiquitin-like (UBL) domain.", "PINK1 phosphorylation of Ub to activate Parkin would also explain how PINK1 experimentally located on peroxisomes and lysosomes recruits and activates Parkin ectopically (Lazarou et al., 2012), as PINK1 could phosphorylate Ub present on peroxisomal or lysosomal proteins."]}
{"doc_id": 55003, "title": "", "abstract": ["On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013).", "This leads to proteasomal degradation of OMM proteins (Tanaka et al., 2010; Chan et al., 2011; Yoshii et al., 2011) and to selective autophagy of damaged mitochondria (Narendra et al., 2008), suggesting that PINK1 and Parkin mediate a mitochondrial quality control pathway.", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria.", "Furthermore, expression of ubiquitin S65A, a mutant that cannot be phosphorylated by PINK1, inhibited Parkin translocation to damaged mitochondria.", "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity"]}
{"doc_id": 55004, "title": "", "abstract": ["PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays.", "These data indicate that phospho-Ub stimulates Parkin ligase activity and represents a mechanism of PINK1 activation of Parkin (Fig. 5 A).", "The mechanism of PINK1-mediated activation of Parkin has remained elusive (Trempe et al., 2013; Wauer and Komander, 2013).", "A model of PINK1 phosphorylation of ubiquitin to activate Parkin and the conservation of S65 among UBL proteins and domains."]}
{"doc_id": 55005, "title": "", "abstract": ["Here we show that PINK1 recruits Parkin to mitochondria despite mutation of S65 to alanine or individual mutation of all other Ser/Thr residues conserved between Drosophila and human Parkin.", "Although PINK1 phosphorylates Parkin, other PINK1 substrates appear to activate Parkin, as the mutation of all serine and threonine residues conserved between Drosophila and human, including Parkin S65, did not wholly impair Parkin translocation to mitochondria.", "PINK1 phosphorylation of free Ub in the vicinity of the OMM may activate Parkin proximal to mitochondria, or PINK1 phosphorylation of Ub already linked to OMM proteins, such as Mfn and mitoneet, may bind and activate Parkin.", "A model of PINK1 phosphorylation of ubiquitin to activate Parkin and the conservation of S65 among UBL proteins and domains.", "On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013)."]}
{"doc_id": 55006, "title": "", "abstract": ["Beyond PINK1 activation of Parkin, this novel modification of Ub may have other implications.", "Although PINK1 phosphorylates Parkin, other PINK1 substrates appear to activate Parkin, as the mutation of all serine and threonine residues conserved between Drosophila and human, including Parkin S65, did not wholly impair Parkin translocation to mitochondria.", "PINK1 phosphorylation of free Ub in the vicinity of the OMM may activate Parkin proximal to mitochondria, or PINK1 phosphorylation of Ub already linked to OMM proteins, such as Mfn and mitoneet, may bind and activate Parkin.", "(A) A model of the cyclical activation of Parkin by PINK1 phosphorylation and amplification of the cascade via PINK1 phosphorylation of ubiquitin.", "In both cases the addition of phospho-Ub to the reaction caused an increase in Parkin activity (Ubn)."]}
{"doc_id": 55007, "title": "", "abstract": ["PINK1 phosphorylation of free Ub in the vicinity of the OMM may activate Parkin proximal to mitochondria, or PINK1 phosphorylation of Ub already linked to OMM proteins, such as Mfn and mitoneet, may bind and activate Parkin.", "We investigated if phosphorylated Ub could activate Parkin in vitro.", "On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013).", "PINK1 phosphorylation of Ub to activate Parkin would also explain how PINK1 experimentally located on peroxisomes and lysosomes recruits and activates Parkin ectopically (Lazarou et al., 2012), as PINK1 could phosphorylate Ub present on peroxisomal or lysosomal proteins.", "These data indicate that phospho-Ub stimulates Parkin ligase activity and represents a mechanism of PINK1 activation of Parkin (Fig. 5 A)."]}
{"doc_id": 55008, "title": "", "abstract": ["PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays.", "On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013).", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria.", "PINK1 phosphorylation of free Ub in the vicinity of the OMM may activate Parkin proximal to mitochondria, or PINK1 phosphorylation of Ub already linked to OMM proteins, such as Mfn and mitoneet, may bind and activate Parkin."]}
{"doc_id": 55009, "title": "", "abstract": ["Phosphorylation of Ub S65 by PINK1 mirrors PINK1 phosphorylation of Parkin’s UBL domain on the homologous Parkin S65 residue (Kondapalli et al., 2012).", "Using mass spectrometry, we discovered that endogenous PINK1 phosphorylated ubiquitin at serine 65, homologous to the site phosphorylated by PINK1 in Parkin’s ubiquitin-like domain.", "Interestingly, PINK1 phosphorylates Ub at S65, a residue that is homologous with the S65 site PINK1 phosphorylates on the Parkin ubiquitin-like (UBL) domain.", "Three independent methods (MS, Phos-tag, and radiolabeling) showed that PINK1 is a Ub kinase, and MS unambiguously identifies this phosphorylation to occur specifically at Ub S65.", "To confirm that PINK1 directly phosphorylates Ub, we used recombinant Tribolium castaneum PINK1 (TcPINK1; Woodroof et al., 2011) to phosphorylate recombinant HA-Ub in vitro (Fig. 3 A)."]}
{"doc_id": 55010, "title": "", "abstract": ["Here we show that PINK1 recruits Parkin to mitochondria despite mutation of S65 to alanine or individual mutation of all other Ser/Thr residues conserved between Drosophila and human Parkin.", "Although PINK1 phosphorylates Parkin, other PINK1 substrates appear to activate Parkin, as the mutation of all serine and threonine residues conserved between Drosophila and human, including Parkin S65, did not wholly impair Parkin translocation to mitochondria.", "Abolishing Parkin phosphorylation at S65 did not completely inhibit its PINK1-dependent activation, indicating that another PINK1 substrate must be involved.", "However, it has been unclear how PINK1 activates and recruits Parkin to mitochondria.", "It is also consistent with the stoichiometry of Parkin activation that its addition of Ub chains on the mitochondria would increase the mitochondrial-localized substrate for PINK1 Ub kinase activity to further recruit and activate more Parkin (Fig. 5 A)."]}
{"doc_id": 55011, "title": "", "abstract": ["This leads to proteasomal degradation of OMM proteins (Tanaka et al., 2010; Chan et al., 2011; Yoshii et al., 2011) and to selective autophagy of damaged mitochondria (Narendra et al., 2008), suggesting that PINK1 and Parkin mediate a mitochondrial quality control pathway.", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria.", "Phospho-ubiquitin activates Parkin.", "The mechanism of PINK1-mediated activation of Parkin has remained elusive (Trempe et al., 2013; Wauer and Komander, 2013).", "PINK1 phosphorylation of free Ub in the vicinity of the OMM may activate Parkin proximal to mitochondria, or PINK1 phosphorylation of Ub already linked to OMM proteins, such as Mfn and mitoneet, may bind and activate Parkin."]}
{"doc_id": 55012, "title": "", "abstract": ["On the outer mitochondrial membrane (OMM), PINK1 recruits the E3 ubiquitin ligase Parkin (Geisler et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010) and activates latent Parkin activity (Matsuda et al., 2010) to ubiquitinate scores of OMM proteins (Sarraf et al., 2013).", "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Using mass spectrometry, we discovered that endogenous PINK1 phosphorylated ubiquitin at serine 65, homologous to the site phosphorylated by PINK1 in Parkin’s ubiquitin-like domain.", "Phosphorylation of Ub S65 by PINK1 mirrors PINK1 phosphorylation of Parkin’s UBL domain on the homologous Parkin S65 residue (Kondapalli et al., 2012).", "Furthermore, expression of ubiquitin S65A, a mutant that cannot be phosphorylated by PINK1, inhibited Parkin translocation to damaged mitochondria."]}
{"doc_id": 69000, "title": "", "abstract": ["Data are based on population-based cross-sectional surveys conducted in China (Chan et al. [3] and Yang et al. [4]).", "In China, increased use of automobiles instead of public transportation is associated with reduced physical activity.", "These numbers suggest that China has overtaken India as the global epicenter of the diabetes epidemic.", "This hypothesis has been widely used to explain the role of nutrition transition in the development of chronic diseases.", "Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition."]}
{"doc_id": 69001, "title": "", "abstract": ["Globally, it was estimated that diabetes accounted for 12% of health expenditures in 2010, or at least $376 billion—a figure expected to hit $490 billion in 2030 (2).", "## THE GLOBAL BURDEN OF TYPE 2 DIABETES", "Type 2 diabetes is a global public health crisis that threatens the economies of all nations, particularly developing countries.", "Type 2 diabetes is a global crisis that threatens the health and economy of all nations, particularly developing countries.", "Overweight and obesity are driving the global diabetes epidemic."]}
{"doc_id": 69002, "title": "", "abstract": ["Fueled by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity.", "Excessive caloric intake is a major driving force behind escalating obesity and type 2 diabetes epidemics worldwide, but diet quality also has independent effects.", "Once a disease of the West, type 2 diabetes has now spread to every country in the world.", "Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "Overweight and obesity are driving the global diabetes epidemic."]}
{"doc_id": 69003, "title": "", "abstract": ["According to the International Diabetes Federation (1), diabetes affects at least 285 million people worldwide, and that number is expected to reach 438 million by the year 2030, with two-thirds of all diabetes cases occurring in low- to middle-income countries.", "The number of adults with impaired glucose tolerance will rise from 344 million in 2010 to an estimated 472 million by 2030.", "However, in urban areas of south India, the prevalence of diabetes has reached nearly 20% (5).", "These numbers suggest that China has overtaken India as the global epicenter of the diabetes epidemic.", "These have led to an explosive increase in diabetes prevalence within a relatively short time."]}
{"doc_id": 69004, "title": "", "abstract": ["Type 2 diabetes is a global public health crisis that threatens the economies of all nations, particularly developing countries.", "Type 2 diabetes is a global crisis that threatens the health and economy of all nations, particularly developing countries.", "## THE GLOBAL BURDEN OF TYPE 2 DIABETES", "Once a disease of the West, type 2 diabetes has now spread to every country in the world.", "Many epidemiologic studies have implicated individual dietary and lifestyle factors in the development of type 2 diabetes in diverse populations, yet few studies have investigated multiple risk factors simultaneously."]}
{"doc_id": 69005, "title": "", "abstract": ["Type 2 diabetes is a global crisis that threatens the health and economy of all nations, particularly developing countries.", "Type 2 diabetes is a global public health crisis that threatens the economies of all nations, particularly developing countries.", "Its increasing prevalence and associated health complications threaten to reverse economic gains in developing countries.", "Once a disease of the West, type 2 diabetes has now spread to every country in the world.", "These numbers suggest that China has overtaken India as the global epicenter of the diabetes epidemic."]}
{"doc_id": 69006, "title": "", "abstract": ["Fueled by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity.", "This epidemic is primarily driven by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles.", "Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "Several factors contribute to accelerated diabetes epidemic in Asians, including the “normal-weight metabolically obese” phenotype; high prevalence of smoking and heavy alcohol use; high intake of refined carbohydrates (e.g., white rice); and dramatically decreased physical activity levels.", "Compared with Western populations, the prevalence of overweight and obesity in Asia is relatively low, but it is increasing precipitously in parallel with economic development and rapid urbanization."]}
{"doc_id": 69007, "title": "", "abstract": ["Many epidemiologic studies have implicated individual dietary and lifestyle factors in the development of type 2 diabetes in diverse populations, yet few studies have investigated multiple risk factors simultaneously.", "Together, these clinical trials demonstrate that diet and lifestyle modification is highly effective in preventing type 2 diabetes in different ethnic and racial groups.", "Asian populations tend to develop diabetes at younger ages and lower BMI levels than Caucasians.", "Compared with Western populations, Asians develop diabetes at younger ages, at lower degrees of obesity, and at much higher rates given the same amount of weight gain (3).", "A tendency toward greater abdominal obesity and less muscle mass among Asians results in an increased propensity for insulin resistance compared with Western populations."]}
{"doc_id": 69008, "title": "", "abstract": ["Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "In the Nurses’ Health Study (NHS), we found that the quality of fats and carbohydrates play an important role in the development of diabetes, independent of BMI and other risk factors (11).", "Poor nutrition in utero and in early life combined with overnutrition in later life may also play a role in Asia's diabetes epidemic.", "Poor nutrition in utero and in early life plus overnutrition in later life may also contribute to the current diabetes epidemic in Asian populations.", "Many epidemiologic studies have implicated individual dietary and lifestyle factors in the development of type 2 diabetes in diverse populations, yet few studies have investigated multiple risk factors simultaneously."]}
{"doc_id": 69009, "title": "", "abstract": ["## THE GLOBAL BURDEN OF TYPE 2 DIABETES", "## PREVENTABILITY OF TYPE 2 DIABETES", "Once a disease of the West, type 2 diabetes has now spread to every country in the world.", "These data provide strong epidemiologic evidence that the majority of cases of type 2 diabetes could be prevented by a healthier lifestyle.", "Epidemiologic studies and randomized clinical trials show that type 2 diabetes is largely preventable through diet and lifestyle modifications."]}
{"doc_id": 69010, "title": "", "abstract": ["## THE GLOBAL BURDEN OF TYPE 2 DIABETES", "This trend is increasing in developing countries as well.", "Its increasing prevalence and associated health complications threaten to reverse economic gains in developing countries.", "These have led to an explosive increase in diabetes prevalence within a relatively short time.", "Type 2 diabetes is a global crisis that threatens the health and economy of all nations, particularly developing countries."]}
{"doc_id": 69011, "title": "", "abstract": ["In addition, rapid shifts toward a service sector economy and growing use of new technologies have led to a marked decline in physical activity levels.", "In China, increased use of automobiles instead of public transportation is associated with reduced physical activity.", "At the same time, the traditional diets of many Asian countries, which are largely based on polished white rice and refined wheat, have high glycemic index (GI) and GL values.", "Prior to rapid urbanization throughout Asia, the metabolic effects of high GI/GL diets were offset by high levels of physical activity.", "Several factors contribute to accelerated diabetes epidemic in Asians, including the “normal-weight metabolically obese” phenotype; high prevalence of smoking and heavy alcohol use; high intake of refined carbohydrates (e.g., white rice); and dramatically decreased physical activity levels."]}
{"doc_id": 69012, "title": "", "abstract": ["Compared with Western populations, the prevalence of overweight and obesity in Asia is relatively low, but it is increasing precipitously in parallel with economic development and rapid urbanization.", "Because many Asian adults who experienced undernutrition in early life are now adapting Westernized diets and lifestyles, their risk of developing diabetes and other metabolic diseases is substantially elevated.", "Fueled by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity.", "A tendency toward greater abdominal obesity and less muscle mass among Asians results in an increased propensity for insulin resistance compared with Western populations.", "Several factors contribute to accelerated diabetes epidemic in Asians, including the “normal-weight metabolically obese” phenotype; high prevalence of smoking and heavy alcohol use; high intake of refined carbohydrates (e.g., white rice); and dramatically decreased physical activity levels."]}
{"doc_id": 69013, "title": "", "abstract": ["Excessive caloric intake is a major driving force behind escalating obesity and type 2 diabetes epidemics worldwide, but diet quality also has independent effects.", "Several factors contribute to accelerated diabetes epidemic in Asians, including the “normal-weight metabolically obese” phenotype; high prevalence of smoking and heavy alcohol use; high intake of refined carbohydrates (e.g., white rice); and dramatically decreased physical activity levels.", "Overweight and obesity are driving the global diabetes epidemic.", "To curb the escalating diabetes epidemic, primary prevention through promotion of a healthy diet and lifestyle should be a global public policy priority.", "Poor nutrition in utero and in early life combined with overnutrition in later life may also play a role in Asia's diabetes epidemic."]}
{"doc_id": 69014, "title": "", "abstract": ["However, high rates of heavy drinking are also starting to appear in the urban middle and upper classes as the alcohol industry increases social marketing to encourage more people to adopt Westernized lifestyles, which are symbolized by drinking and affluence.", "In Asia, alcohol use is rising with rapid globalization and socioeconomic development.", "Traditionally, heavy drinking was more prevalent in poor rural regions.", "These results suggest that the detrimental effects of a Westernized diet may be enhanced by greater genetic susceptibility.", "In Asia, traditional dietary patterns are being lost as the population adapts to more industrialized and urban food environments."]}
{"doc_id": 69015, "title": "", "abstract": ["A tendency toward greater abdominal obesity and less muscle mass among Asians results in an increased propensity for insulin resistance compared with Western populations.", "A high GL diet, which increases insulin demand and may lead to pancreatic β-cell exhaustion in the long run, has been implicated in increased risk of type 2 diabetes and cardiovascular disease (14).", "The combination of excessive energy intake and reduced energy output leads to increased obesity and insulin resistance.", "The adverse effects of high dietary GI and GL are more evident in overweight or obese individuals who are prone to insulin resistance (24).", "These factors may promote abdominal fat accumulation and insulin resistance, especially in men."]}
{"doc_id": 69016, "title": "", "abstract": ["The risks of adverse long-term consequences are likely to be exacerbated in a nutritionally rich environment in later life.", "These findings indicate that exposure to severe famine in fetal life increases the risk of hyperglycemia in adulthood, and that this association is exacerbated by a nutritionally “rich” environment in later life.", "Poor nutrition in utero and in early life combined with overnutrition in later life may also play a role in Asia's diabetes epidemic.", "Poor nutrition in utero and in early life plus overnutrition in later life may also contribute to the current diabetes epidemic in Asian populations.", "These effects may be meditated by the regulation of gene expression through chromatin modification or DNA methylation (epigenetics) because of intrauterine or early childhood exposures rather than changes in genotypes (53)."]}
{"doc_id": 69017, "title": "", "abstract": ["These results suggest that the detrimental effects of a Westernized diet may be enhanced by greater genetic susceptibility.", "Fructose from high fructose corn syrup or any sugar may also play a role.", "A recent study that compared the effects of consuming 25% of energy from glucose- or fructose-sweetened beverages showed similar weight gain, but only the fructose group had a significant increase in visceral adiposity (16).", "Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "At the same time, built living environments have become increasingly sedentary."]}
{"doc_id": 69018, "title": "", "abstract": ["Asia accounts for 60% of the world's diabetic population.", "These numbers suggest that China has overtaken India as the global epicenter of the diabetes epidemic.", "Several factors contribute to accelerated diabetes epidemic in Asians, including the “normal-weight metabolically obese” phenotype; high prevalence of smoking and heavy alcohol use; high intake of refined carbohydrates (e.g., white rice); and dramatically decreased physical activity levels.", "The diabetes epidemic in Asia is characterized by onset at lower BMI levels and younger ages compared with Caucasian populations.", "Asia's large population and rapid economic development have made it an epicenter of the epidemic."]}
{"doc_id": 69019, "title": "", "abstract": ["It was estimated that more than 92 million Chinese adults had diabetes, and another 148 million were prediabetic.", "Time trends of diabetes prevalence in Chinese adults.", "These have led to an explosive increase in diabetes prevalence within a relatively short time.", "These numbers suggest that China has overtaken India as the global epicenter of the diabetes epidemic.", "Its increasing prevalence and associated health complications threaten to reverse economic gains in developing countries."]}
{"doc_id": 69020, "title": "", "abstract": ["For example, common variants of the TCF7L2 gene that are significantly associated with diabetes risk are present in 20–30% of Caucasian populations but only 3–5% of Asians (41,42).", "Asian populations tend to develop diabetes at younger ages and lower BMI levels than Caucasians.", "The diabetes epidemic in Asia is characterized by onset at lower BMI levels and younger ages compared with Caucasian populations.", "Many diabetes genes recently discovered through GWAS in Caucasian populations have been replicated in Asians; however, there were significant interethnic differences in the location and frequency of these risk alleles.", "Asian women are also at greater risk of gestational diabetes, thereby putting their children at risk for type 2 diabetes later in life."]}
{"doc_id": 69021, "title": "", "abstract": ["Both vegetable and animal ghee, which are used for cooking in India and other South Asian countries, have an extremely high trans fatty acid content.", "Dalda, which is a type of vegetable ghee and major source of edible oil in India, has a trans fat level of about 50% (19).", "Major changes that have occurred in Asia in the last several decades include 1) a large shift from consumption of coarse grains to polished rice and refined wheat, especially in India and China; 2) reduced intake of cereals particularly among urban populations and higher-income groups; 3) higher energy intake among the poor, lower energy intake among the rich, and greater consumption of fat in all income groups; and 4) increased intake of meat, edible oil, and fruits and vegetables in China and increased consumption of dairy products, especially highly saturated ghee (clarified butter), and added sugar in India (7).", "The identified dietary pattern, which was strongly related to inflammatory markers, was characterized by high intakes of SSBs, refined grains, and red and processed meat, but low consumption of wine, coffee, cruciferous vegetables, and yellow vegetables.", "In India, the percentage of energy from animal products increased substantially between 1975 and 1995, mostly among urban residents who consumed 32% of energy from fat compared with 17% of those in rural areas (18)."]}
{"doc_id": 88000, "title": "", "abstract": ["It should be noted that our data present a correlative link between the dysregulation of IL-1β and IL-18 and the development of gastrointestinal disease; however, it is still unclear if this dysregulation is directly related to the increase in colitis and colitis-associated tumorigenesis.", "Caspase-1 is responsible for the subsequent cleavage of the IL-1β/IL-18 precursor into their functional forms.", "Likewise, caspase-1–mediated cell death has been shown to be suppressed by BCL2 overexpression (Miura et al., 1993).", "This is consistent with the roles of PYCARD and caspase-1 in inflammasome processing of IL-1β and IL-18.", "Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation."]}
{"doc_id": 88001, "title": "", "abstract": ["Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation.", "All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "All animals challenged with AOM/DSS also demonstrated a significant increase in colon histopathology (Fig. 3 G) with Pycard−/− and Casp1−/− mice exhibiting a significant increase in HAI compared with similarly treated WT animals.", "All DSS-challenged mice presented with significantly increased features of gastrointestinal disease, but Pycard−/−, Casp1−/−, and Nlrp3−/− mice demonstrated significantly elevated clinical scores (0.67, 0.83, and 0.73, respectively) compared with the WT animals (0.22; Fig. 2 E).", "Mice receiving Nlrp3−/− but not WT bone marrow also demonstrated significantly increased colonic lesions (Fig. 7 E), including increased distal colon inflammation, hyperplasia, dysplasia, and area associated with disease (Fig. S4, A–F)."]}
{"doc_id": 88002, "title": "", "abstract": ["Our data show that the inflammasome component NLRP3 also plays a role in reducing acute colitis and colitis-associated colon cancer.", "The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "Together, these data suggest a protective role for both Pycard and Nlrp3 in acute colitis induced by DSS.", "In this study, we show that components of the inflammasome have a profound protective influence on colitis and colitis-associated cancer (CAC).", "These data indicate a stronger protective role of PYCARD and caspase-1 than NLRP3 in recurring colitis."]}
{"doc_id": 88003, "title": "", "abstract": ["However, the data presented throughout this study, have led us to propose a protective role for the inflammasome during chronic colitis and colitis-associated colon cancer.", "In this study, we show that components of the inflammasome have a profound protective influence on colitis and colitis-associated cancer (CAC).", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models.", "Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied.", "Together, these data suggest that inflammasome components attenuate both acute and recurring models of colitis."]}
{"doc_id": 88004, "title": "", "abstract": ["All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "These highly abnormal ulcerated sections of colon are indicative of precancerous lesions, thus leading us to examine if Nlrp3−/− mice would develop increased tumorigenesis during later stages of the CAC model.", "To determine the cellular compartment responsible for the phenotype observed in the Nlrp3−/− mice, we generated chimeric animals by adoptive bone marrow transplantation, and then subjected the mice to the AOM/DSS colon tumorigenesis model (Fig. 7 A).", "All animals challenged with AOM/DSS also demonstrated a significant increase in colon histopathology (Fig. 3 G) with Pycard−/− and Casp1−/− mice exhibiting a significant increase in HAI compared with similarly treated WT animals.", "Increased weight loss was also observed in Nlrc4−/− mice after the final treatment of DSS (Fig. 5 C)."]}
{"doc_id": 88005, "title": "", "abstract": ["Nlrp3−/− mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3−/− mice than in Pycard−/− or Casp1−/− animals.", "It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "Together, these data suggest that inflammasome components attenuate both acute and recurring models of colitis.", "In our work, we also find that deficiencies in diverse inflammasome components can lead to enhanced colitis, as well as CAC that is associated with reduced inflammasome function at the tumor site.", "As seen in Fig. 7 B, WT-irradiated recipients that received WT bone marrow did not demonstrate substantial weight loss during the recurring colitis model, whereas Nlrp3−/− recipients of Nlrp3−/− bone marrow experienced a significant decrease in weight, indicating that the bone marrow chimerization procedure did not alter the more significant weight loss observed in the Nlrp3−/− mice."]}
{"doc_id": 88006, "title": "", "abstract": ["The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis.", "Together, the clinical and histopathology data indicate that NLRP3 regulates gastrointestinal tumorigenesis through hematopoietic-derived cells in models of CAC.", "These clinical data suggest that the phenotype observed in the Nlrp3−/− mice is associated with hematopoietic- derived cells rather than the intestinal epithelial cells, tumor-derived cells, or stroma.", "Our data suggest that NLRP3 regulates tumorigenesis through the hematopoietic/myeloid compartment."]}
{"doc_id": 88007, "title": "", "abstract": ["Together, these data suggest a protective role for both Pycard and Nlrp3 in acute colitis induced by DSS.", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models.", "These data indicate a stronger protective role of PYCARD and caspase-1 than NLRP3 in recurring colitis.", "It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation."]}
{"doc_id": 88008, "title": "", "abstract": ["In this study, we show that components of the inflammasome have a profound protective influence on colitis and colitis-associated cancer (CAC).", "However, the data presented throughout this study, have led us to propose a protective role for the inflammasome during chronic colitis and colitis-associated colon cancer.", "Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied.", "Together, these data suggest that inflammasome components attenuate both acute and recurring models of colitis.", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models."]}
{"doc_id": 88009, "title": "", "abstract": ["It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation.", "Our findings are also unexpected based on previously published findings on the role of caspase-1 in models of colitis (Siegmund et al., 2001; Bauer et al., 2007).", "Caspase-1 is responsible for the subsequent cleavage of the IL-1β/IL-18 precursor into their functional forms.", "PYCARD and caspase-1 are both required for the proper functioning of the majority of characterized NLR inflammasomes."]}
{"doc_id": 88010, "title": "", "abstract": ["All DSS-challenged mice presented with significantly increased features of gastrointestinal disease, but Pycard−/−, Casp1−/−, and Nlrp3−/− mice demonstrated significantly elevated clinical scores (0.67, 0.83, and 0.73, respectively) compared with the WT animals (0.22; Fig. 2 E).", "Consistent with the weight loss data, animals receiving Nlrp3−/− bone marrow demonstrated significantly increased clinical scores compared with mice receiving WT bone marrow (Fig. 7 C).", "Consistent with the weight loss phenotype, Nlrp3−/− mice demonstrate a significant increase in clinical scores associated with gastrointestinal disease compared with WT and Nlrc4−/− animals (Fig. 5 D).", "Increased HAI scores were observed for Nlrp3−/− mice compared with WT and Nlrc4−/− animals (Fig. 6 D).", "No significant differences in histopathology were observed between the DSS- treated WT and Nlrp3−/− mice; however, Pycard−/− and Casp1−/− animals demonstrated significantly increased HAI scores compared with the other genotypes (Fig. 2 G)."]}
{"doc_id": 88011, "title": "", "abstract": ["Nlrp3−/− mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3−/− mice than in Pycard−/− or Casp1−/− animals.", "Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation.", "All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "Mice receiving Nlrp3−/− but not WT bone marrow also demonstrated significantly increased colonic lesions (Fig. 7 E), including increased distal colon inflammation, hyperplasia, dysplasia, and area associated with disease (Fig. S4, A–F).", "All animals challenged with AOM/DSS also demonstrated a significant increase in colon histopathology (Fig. 3 G) with Pycard−/− and Casp1−/− mice exhibiting a significant increase in HAI compared with similarly treated WT animals."]}
{"doc_id": 88012, "title": "", "abstract": ["These highly abnormal ulcerated sections of colon are indicative of precancerous lesions, thus leading us to examine if Nlrp3−/− mice would develop increased tumorigenesis during later stages of the CAC model.", "These data indicate that Nlrp3−/− mice exhibit an attenuated disease when compared with Pycard−/− and Casp1−/− mice; however, the composite data support the hypothesis that this gene product negatively regulates tumorigenesis in the CAC model.", "### NLRP3 deficiency enhances gastrointestinal tumorigenesis", "Our data show that the NLR inflammasome components PYCARD, caspase-1, and NLRP3 might function as inflammation and tumor suppressors in the inflammation-driven colon tumorigenesis model.", "To determine the role of a specific NLR inflammasome, mice lacking either NLRP3 or NLRC4 were assessed in the inflammation-driven colon tumorigenesis model (Fig. 5 A)."]}
{"doc_id": 88013, "title": "", "abstract": ["All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "The majority of Casp1−/− animals demonstrated significantly increased sensitivity to repeated challenges with DSS, with a drastic decrease in body weight (range, −15.7 to −42.7%) observed after the completion of two rounds of treatment (Fig. 3 C).", "No significant differences in histopathology were observed between the DSS- treated WT and Nlrp3−/− mice; however, Pycard−/− and Casp1−/− animals demonstrated significantly increased HAI scores compared with the other genotypes (Fig. 2 G).", "These data indicate that Nlrp3−/− mice exhibit an attenuated disease when compared with Pycard−/− and Casp1−/− mice; however, the composite data support the hypothesis that this gene product negatively regulates tumorigenesis in the CAC model.", "The rapid progression to a moribund state observed in the Pycard−/− and Casp1−/− mice upon AOM/DSS treatment suggests an increased pathological condition."]}
{"doc_id": 88014, "title": "", "abstract": ["Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis.", "### NLRP3 deficiency enhances gastrointestinal tumorigenesis", "Together, these data suggest a protective role for both Pycard and Nlrp3 in acute colitis induced by DSS.", "The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "All DSS-challenged mice presented with significantly increased features of gastrointestinal disease, but Pycard−/−, Casp1−/−, and Nlrp3−/− mice demonstrated significantly elevated clinical scores (0.67, 0.83, and 0.73, respectively) compared with the WT animals (0.22; Fig. 2 E)."]}
{"doc_id": 88015, "title": "", "abstract": ["To evaluate the role of NLR inflammasomes in the initiation and progression of CAC, Pycard−/−, and Casp1−/− mice were subjected to an AOM/DSS recurring inflammation-driven colon tumorigenesis model.", "The rapid progression to a moribund state observed in the Pycard−/− and Casp1−/− mice upon AOM/DSS treatment suggests an increased pathological condition.", "Casp1−/− and Pycard−/− mice are highly susceptible to inflammation-driven colon tumorigenesis.", "All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "These data indicate that Nlrp3−/− mice exhibit an attenuated disease when compared with Pycard−/− and Casp1−/− mice; however, the composite data support the hypothesis that this gene product negatively regulates tumorigenesis in the CAC model."]}
{"doc_id": 88016, "title": "", "abstract": ["Our data show that the NLR inflammasome components PYCARD, caspase-1, and NLRP3 might function as inflammation and tumor suppressors in the inflammation-driven colon tumorigenesis model.", "However, the modulating effect of NLRP3 on colon cancer is both attenuated and delayed during CAC development compared with the roles played by PYCARD and caspase-1.", "The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "Further understanding of the specific roles of the NLRs and inflammasome-associated adaptor proteins in mediating the host innate immune response to cancer will allow the generation of improved cancer therapeutics.", "These data demonstrate that the inflammasome components, PYCARD and caspase-1, function to attenuate inflammation and hyperplasia/dysplasia in the inflammation-driven colon tumorigenesis model."]}
{"doc_id": 88017, "title": "", "abstract": ["It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation.", "This is consistent with the roles of PYCARD and caspase-1 in inflammasome processing of IL-1β and IL-18.", "PYCARD and caspase-1 are required for NLR- and absence in melanoma 2 (AIM2)–dependent inflammasome processing of IL-1β and IL-18.", "However, similar to the findings of the acute colitis study, Casp1−/− animals were also highly sensitive to the recurring colitis model, with the majority requiring euthanasia by day 41 (Fig. 2 D)."]}
{"doc_id": 88018, "title": "", "abstract": ["Nlrp3−/− mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3−/− mice than in Pycard−/− or Casp1−/− animals.", "The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "These data indicate that Nlrp3, but not Nlrc4, attenuates morbidity and clinical outcome associated with CAC, although the effects are reduced compared with those observed for Pycard−/− and Casp1−/− mice.", "To determine the role of a specific NLR inflammasome, mice lacking either NLRP3 or NLRC4 were assessed in the inflammation-driven colon tumorigenesis model (Fig. 5 A).", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models."]}
{"doc_id": 88019, "title": "", "abstract": ["No significant differences were observed in disease progression or outcome in Nlrc4−/− mice compared with similarly treated wild-type animals.", "No significant differences in histopathology were observed between the DSS- treated WT and Nlrp3−/− mice; however, Pycard−/− and Casp1−/− animals demonstrated significantly increased HAI scores compared with the other genotypes (Fig. 2 G).", "However, a dramatic increase in the mean number of polyps was observed in the colons of Nlrp3−/− mice (4.5 ± 0.95) compared with those isolated from the WT (1 ± 0.45) or Nlrc4−/− animals (0.57 ± 0.30; Fig. 6 B).", "All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "In contrast to the findings for the Pycard−/− and Casp1−/− mice, inflammation and midcolon disease parameters were similar between the WT, Nlrc4−/−, and Nlrp3−/− animals (Fig. S3)."]}
{"doc_id": 88020, "title": "", "abstract": ["Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied.", "Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis.", "Although NLRP3 and NLRC4 are the most extensively characterized NLRs that mediate inflammasome formation, NLRC4 does not have a significant role in CAC.", "Although it has long been speculated that inflammation is associated with cancer, the underlying mechanisms have been elusive and are only now beginning to be defined (Coussens and Werb, 2002).", "These clinical data suggest that the phenotype observed in the Nlrp3−/− mice is associated with hematopoietic- derived cells rather than the intestinal epithelial cells, tumor-derived cells, or stroma."]}
{"doc_id": 88021, "title": "", "abstract": ["Nlrp3−/− mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3−/− mice than in Pycard−/− or Casp1−/− animals.", "To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice.", "Our data show that the inflammasome component NLRP3 also plays a role in reducing acute colitis and colitis-associated colon cancer.", "It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "As seen in Fig. 7 B, WT-irradiated recipients that received WT bone marrow did not demonstrate substantial weight loss during the recurring colitis model, whereas Nlrp3−/− recipients of Nlrp3−/− bone marrow experienced a significant decrease in weight, indicating that the bone marrow chimerization procedure did not alter the more significant weight loss observed in the Nlrp3−/− mice."]}
{"doc_id": 88022, "title": "", "abstract": ["However, monocytes/macrophages are also involved in the antitumor response of the host by functioning as cytotoxic effector cells, inducing reactive oxygen species and producing cytokines such as IL-12, which has antiproliferative, antiangiogenic, and cytotoxic effects through the subsequent generation of IFN-γ (Nardin and Abastado, 2008).", "These data confirm that PYCARD and caspase-1 are required for the production of IL-1β and IL-18 in the inflammation-driven colon tumorigenesis model.", "The increased tumor burden is correlated with attenuated levels of IL-1β and IL-18 at the tumor site.", "To assess the local levels of IL-1β, IL-18, and TNF, we generated organ cultures from control, DSS, and AOM/DSS challenged mice as previously described (Greten et al., 2004).", "Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied."]}
{"doc_id": 88023, "title": "", "abstract": ["However, the data presented throughout this study, have led us to propose a protective role for the inflammasome during chronic colitis and colitis-associated colon cancer.", "We attempted to directly activate the inflammasome with DSS in bone marrow–derived macrophages, and our initial analysis suggests that DSS does not directly induce the production of IL-1β (unpublished data).", "Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied.", "In this study, we show that components of the inflammasome have a profound protective influence on colitis and colitis-associated cancer (CAC).", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models."]}
{"doc_id": 17000, "title": "", "abstract": ["For example, GD-Pangolin has higher affinity for ACE2 than SARS-CoV-2 (Figures 1C and 2D), and this can be explained by the affinity-enhancing Q498H mutation present in this virus’s RBD sequence (Figure 5F).", "Within the newly described SARS-CoV-2 clade, GD-Pangolin binds ACE2 with slightly higher affinity than SARS-CoV-2, while the bat isolate RaTG13 binds with two orders of magnitude lower affinity, consistent with prior reports (Shang et al., 2020; Wrobel et al., 2020).", "For instance, 46% of single amino acid mutations to SARS-CoV-2 RBD maintain an affinity to ACE2 at least as high as that of SARS-CoV-1, suggesting that there is a substantial mutational space consistent with sufficient affinity to maintain human infectivity.", "An initially surprising feature of SARS-CoV-2 was that its RBD tightly binds ACE2 despite differing in sequence from SARS-CoV-1 at many residues that had been defined as important for ACE2 binding (Andersen et al., 2020; Wan et al., 2020).", "Consistent with previous studies (Shang et al., 2020; Walls et al., 2020; Wrapp et al., 2020a), the SARS-CoV-1 RBD binds ACE2 with lower affinity than SARS-CoV-2 (Figures 1C and 1D)."]}
{"doc_id": 17001, "title": "", "abstract": ["We determined the binding constant KD,app describing the affinity of each RBD variant for human ACE2 ligand along with free parameters a (titration response range) and b (titration curve baseline) via nonlinear least-squares regression using a standard non-cooperative Hill equation relating the mean bin response variable to the ACE2 labeling concentration:", "RBD surface expression and ACE2-binding levels were determined via flow cytometry using a BD LSRFortessa X-50.", "We then used flow cytometry to measure ACE2 binding across 11 ACE2 concentrations, enabling the calculation of a dissociation constant for the binding of each RBD to ACE2 (Figure 1C).", "For each library barcode at each ACE2 sample concentration, we determined its simple mean bin of ACE2-binding via the equation used above in isogenic titrations.", "Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F)."]}
{"doc_id": 17002, "title": "", "abstract": ["# Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "We purified mammalian-expressed RBDs from six sarbecoviruses (SARS-CoV-2, SARS-CoV-1, WIV1, RaTG13, ZXC21, and ZC45) and measured their 1:1 binding affinities for monomeric human ACE2 using biolayer interferometry, which agreed with the measurements from our deep mutational scan (Figures 4D and S4A–S4F).", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "The contribution of RBD stability to ACE2 binding may be influenced by other factors in the full spike trimer, though our measurements on pseudotyped lentiviral particles (Figure 4H) indicate that a destabilizing RBD mutation (C432D) reduces ACE2-mediated cellular entry in the context of spike trimer."]}
{"doc_id": 17003, "title": "", "abstract": ["The RBD is the dominant target of neutralizing antibodies (Cao et al., 2020; Ju et al., 2020; Pinto et al., 2020; Rogers et al., 2020; Seydoux et al., 2020; Shi et al., 2020; Wu et al., 2020b; Zost et al., 2020), and so any antigenic drift will be constrained by its mutational tolerance.", "The RBD is the dominant target of neutralizing antibodies to SARS-CoV-2 (Brouwer et al., 2020; Cao et al., 2020; Ju et al., 2020; Pinto et al., 2020; Premkumar et al., 2020; Rogers et al., 2020; Suthar et al., 2020; Yuan et al., 2020a; Zhang et al., 2020; Zost et al., 2020).", "The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor and is a major determinant of host range and a dominant target of neutralizing antibodies.", "In addition, the RBD is the target of the most potent anti-SARS- CoV-2-neutralizing antibodies identified to date (Cao et al., 2020; Ju et al., 2020; Pinto et al., 2020; Rogers et al., 2020; Seydoux et al., 2020; Shi et al., 2020; Wu et al., 2020b; Zost et al., 2020), and several promising vaccine candidates use the RBD as the sole antigen (Chen et al., 2020a, 2020b; Mulligan et al., 2020; Quinlan et al., 2020; Ravichandran et al., 2020; Yang et al., 2020; Zang et al., 2020).", "Most mutations are deleterious for RBD expression and ACE2 binding, and we identify constrained regions on the RBD’s surface that may be desirable targets for vaccines and antibody-based therapeutics."]}
{"doc_id": 17004, "title": "", "abstract": ["Although these residues are involved in a dense network of polar contacts with ACE2 (Shang et al., 2020; Figure 5E), our measurements show there is substantial plasticity in this network, as mutations that reduce the polar character of these residues can enhance affinity.", "But a substantial number of mutations are well tolerated or even enhance ACE2 binding, including at ACE2 interface residues that vary across SARS-related coronaviruses.", "(B) Mutations to polar residues at positions Y449, L455, F486, and Y505 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface.", "An initially surprising feature of SARS-CoV-2 was that its RBD tightly binds ACE2 despite differing in sequence from SARS-CoV-1 at many residues that had been defined as important for ACE2 binding (Andersen et al., 2020; Wan et al., 2020).", "Within the SARS-CoV-2 clade of sarbecoviruses, our maps of mutational effects on binding explain variation in ACE2 affinity among different viruses."]}
{"doc_id": 17005, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "These high-throughput measurements of expression and ACE2 binding were consistent with expectations about the effects of mutations.", "In contrast, RaTG13 has substantially lower affinity for ACE2 than SARS-CoV-2 (Figures 1C and 2D), consistent with the presence of affinity-decreasing mutations including Y449F and N501D (Figure 5F).", "The fact that differences in binding affinity of GD- Pangolin and RaTG13 are well explained by summing the effects of individual mutations relative to SARS-CoV-2 suggests that our deep mutational scanning is useful for sequence-based predictions of the ACE2-binding potential of future viruses isolated from the SARS-CoV-2 clade.", "The observed mutations are significantly less deleterious for ACE2 binding and RBD expression than random single- nucleotide-accessible mutations (Figures 7A, S7A, and S7B, p < 10−6, permutation tests), consistent with the action of purifying selection."]}
{"doc_id": 17006, "title": "", "abstract": ["A substantial number of sites (e.g., 382–395) are tolerant of mutations with respect to ACE2 binding but are constrained with respect to expression—consistent with folding and stability being global constraints common to many sites (Fane et al., 1991; Poteete et al., 1997).", "Many sites are highly tolerant of mutations with respect to one or both of expression and ACE2 binding, while other sites are constrained to the wild-type amino acid.", "Our results show that many mutations to the RBD are well tolerated with respect to both protein folding and ACE2 binding.", "The structural view shows sites that are under strong constraint for ACE2 binding but are tolerant of mutations for expression (cyan spheres).", "But a substantial number of mutations are well tolerated or even enhance ACE2 binding, including at ACE2 interface residues that vary across SARS-related coronaviruses."]}
{"doc_id": 17007, "title": "", "abstract": ["Post-sort plasmid samples were PCR amplified from 10uL plasmid template input using primers flanking the N16 barcode that append remaining Illumina sequencing handles that are not already plasmid encoded, and unique NextFlex sample indices (https://github.com/jbloomlab/SARS- CoV-2-RBD_DMS/tree/master/data/primers).", "To facilitate sequencing and obtain linkage among amino acid mutations within a single variant, we appended 16-nucleotide barcodes downstream of the coding sequence (Hiatt et al., 2010), bottlenecked each library to ∼100,000 barcoded variants, and linked each RBD variant to its barcode via long-read PacBio SMRT sequencing (Matreyek et al., 2018; Figure S1A).", "We then processed the CCSs to identify the RBD sequence (SARS-CoV-2 or one of the 11 homologs), call any mutations in the RBD sequence, and determine the associated 16-nucleotide barcode.", "The final joined products were amplified for 10 cycles with primers that append a unique identifier N16 barcode sequence to the 3′ end of each mutagenized insert, downstream of the RBD stop codon and mRNA 3′ UTR.", "Barcodes were also PCR appended to the un-mutagenized RBD homologs via the same primer addition PCR."]}
{"doc_id": 17008, "title": "", "abstract": ["Taken together, our results suggest that there is little phenotypic diversity in ACE2 binding among circulating variants at this early stage of the pandemic—although it will be interesting to use our maps to continually assess the phenotypic effects of future mutations as the virus evolves.", "However, we find no evidence that these ACE2-affinity-enhancing mutations have been selected in current SARS- CoV-2 pandemic isolates.", "Taken together, we see no clear evidence of selection for stronger ACE2 binding, consistent with SARS-CoV-2 already possessing adequate ACE2 affinity at the beginning of the pandemic.", "Based on prior work, all these RBDs are expected to bind human ACE2 except those from BM48-31 and HKU3-1 (Lam et al., 2020; Letko et al., 2020; Shang et al., 2020).", "The panel of RBD homologs from other sarbecovirus strains all expressed well but exhibited a wide range of ACE2-binding affinities (Figures 2C and 2D; Table S1), as expected since only some are derived from viruses that can enter cells using human ACE2 (Letko et al., 2020)."]}
{"doc_id": 17009, "title": "", "abstract": ["This process yielded KD,app estimates for 75.2 and 75.4% of variants in libraries 1 and 2, respectively.", "Because many variants contain multiple mutations, we used global epistasis models to determine the effects of individual mutations from all singly and multiply mutated variants (Otwinowski et al., 2018; Figures S2E–S2K).", "For (A), the P4 RBD+ gate was used to enrich the library for expressing variants, which were grown up and re-induced for binding experiments as in (B).", "The relevance of V367F’s stability-enhancing effect for viral fitness is unclear, though this mutation has independently arisen multiple times (van Dorp et al., 2020).", "We also tested two ACE2 affinity-enhancing mutations and found that both increased pseudovirus entry."]}
{"doc_id": 17010, "title": "", "abstract": ["The importance of such focusing is demonstrated by a recent study that identified RBD mutations enabling escape from RBM-directed neutralizing antibodies (Baum et al., 2020)—our data indicate that the escape occurs at sites that have high mutational tolerance (Figures S6C and S6D).", "To better define the RBD’s evolutionary capacity for antibody escape, we examined mutational constraint in the epitopes of antibodies that bind the SARS-CoV-1 or SARS-CoV-2 RBD (Figures 6A, S6A, and S6B; Hwang et al., 2006; Pak et al., 2009; Pinto et al., 2020; Prabakaran et al., 2006; Walls et al., 2019; Wrapp et al., 2020b; Wu et al., 2020b; Yuan et al., 2020b).", "It is unclear to what extent the RBD will evolve to escape such antibodies in a manner reminiscent of some other viruses (Smith et al., 2004; Trkola et al., 2005), although in vitro studies suggest that SARS-CoV-2 and SARS-CoV-1 RBDs are capable of fixing mutations that escape neutralizing antibodies (Baum et al., 2020; Rockx et al., 2010).", "The antibody escape involved mutations that were better tolerated than typical mutations in the RBM or ACE2-binding interface.", "These findings provide a framework that could inform the formulation of antibody cocktails aiming to limit the emergence of viral escape mutants (Baum et al., 2020; Pinto et al., 2020; Wu et al., 2020b; Zost et al., 2020), particularly if deep mutational scanning approaches like our own are extended to define antibody epitopes in functional as well as structural terms (Dingens et al., 2019)."]}
{"doc_id": 17011, "title": "", "abstract": ["Furthermore, RBD mutations have already appeared among SARS-CoV-2 pandemic isolates, including some near the ACE2-binding interface—but their impacts on receptor recognition and other biochemical phenotypes remain largely uncharacterized.", "# Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding", "For example, GD-Pangolin has higher affinity for ACE2 than SARS-CoV-2 (Figures 1C and 2D), and this can be explained by the affinity-enhancing Q498H mutation present in this virus’s RBD sequence (Figure 5F).", "Affinity-enhancing mutations are accessible via single-nucleotide mutation from SARS-CoV-2 (Figure S7C), but none are observed among circulating viral sequences (Figure 7A), and observed mutations do not enhance ACE2 affinity more than randomly drawn samples of single-nucleotide mutations (Figure S7D).", "For instance, 46% of single amino acid mutations to SARS-CoV-2 RBD maintain an affinity to ACE2 at least as high as that of SARS-CoV-1, suggesting that there is a substantial mutational space consistent with sufficient affinity to maintain human infectivity."]}
{"doc_id": 17012, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F).", "Mutations that enhance affinity are notable at RBD sites Q493, Q498, and N501.", "Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017).", "There are 10 surface- exposed asparagines for which RBD expression is unaffected or enhanced (top) when an NLGS motif is introduced via mutations to S or T at the i+2 site; for eight of these putative NLGS knock-ins (blue labels), the putative glycan is also tolerated for ACE2 binding (bottom), but for two (red labels), introduction of the NLGS motif is not tolerated for ACE2 binding."]}
{"doc_id": 17013, "title": "", "abstract": ["Amino acid mutations that require more than one nucleotide change are in gray.", "This process yielded KD,app estimates for 75.2 and 75.4% of variants in libraries 1 and 2, respectively.", "The distribution of mutation effects is shown for all amino acid mutations accessible via single-nucleotide mutation from the SARS-CoV-2 Wuhan-Hu-1 gene sequence, compared to the distributions for subsets of mutations that are observed in sequenced SARS-CoV-2 isolates deposited in GISAID at increasing observation count thresholds.", "We filtered out four coefficients from library 1 and three from library 2 that had nonsensically high model estimates, likely to do partial collinearities among some low- coverage mutations.", "Affinity-enhancing mutations are accessible via single-nucleotide mutation from SARS-CoV-2 (Figure S7C), but none are observed among circulating viral sequences (Figure 7A), and observed mutations do not enhance ACE2 affinity more than randomly drawn samples of single-nucleotide mutations (Figure S7D)."]}
{"doc_id": 17014, "title": "", "abstract": ["To assess the phenotypic impacts of mutations that have appeared in the SARS- CoV-2 RBD to date, we downloaded all 31,570 spike sequences available from GISAID (Elbe and Buckland-Merrett, 2017) on May 27, 2020 and identified RBD amino acid mutations present in high-quality clinical isolates.", "Our libraries covered 3,804 of the 3,819 possible RBD amino acid mutations, of which 95.7% were present as the sole amino acid mutation in at least one barcoded variant (Figures S1D and S1E).", "We also validated that N439K, the most prevalent RBD mutation, which may have a very slight affinity-enhancing effect (Figures 7B and 7C), has no measurable impact on entry of spike-pseudotyped lentiviral particles (Figure 4H).", "Although residues in these epitopes are constrained for stability even in our measurements on the isolated RBD, some of them likely exhibit additional constraint due to quaternary contacts in the full spike trimer (Walls et al., 2020; Wrapp et al., 2020a; Yuan et al., 2020b).", "However, on a hopeful note, our measurements correlate well with cellular entry by spike- pseudotyped viral particles expressing sarbecovirus RBD homologs (Figure 1D) and single mutants of the SARS-CoV-2 RBD (Figure 4H)."]}
{"doc_id": 17015, "title": "", "abstract": ["The two RBD N-linked glycans contribute to RBD stability, as mutations that ablate the NxS/T glycosylation motif decrease RBD expression (Figure S5F).", "The contribution of RBD stability to ACE2 binding may be influenced by other factors in the full spike trimer, though our measurements on pseudotyped lentiviral particles (Figure 4H) indicate that a destabilizing RBD mutation (C432D) reduces ACE2-mediated cellular entry in the context of spike trimer.", "Our results show that many mutations to the RBD are well tolerated with respect to both protein folding and ACE2 binding.", "Four of the mutations also increased RBD stability (Figures 4G and S4H), including one (V367F) that increased the melting temperature by 3.9°C. All five mutations also maintained ACE2 binding and antigenicity (Figure S4I), suggesting they could be useful for enhancing production of RBD-based vaccine immunogens.", "Consistent with the deep mutational scanning, the only large phenotypic effect was increased expression of V367F (Figures 7C and 7D), which we also validated enhances thermal stability of mammalian-expressed RBD (Figures 4G and S4H)."]}
{"doc_id": 17016, "title": "", "abstract": ["Barcodes were also PCR appended to the un-mutagenized RBD homologs via the same primer addition PCR.", "The final joined products were amplified for 10 cycles with primers that append a unique identifier N16 barcode sequence to the 3′ end of each mutagenized insert, downstream of the RBD stop codon and mRNA 3′ UTR.", "PacBio sequencing was used to acquire long sequence reads spanning the N16 barcode and the RBD gene sequence.", "Post-sort plasmid samples were PCR amplified from 10uL plasmid template input using primers flanking the N16 barcode that append remaining Illumina sequencing handles that are not already plasmid encoded, and unique NextFlex sample indices (https://github.com/jbloomlab/SARS- CoV-2-RBD_DMS/tree/master/data/primers).", "To facilitate sequencing and obtain linkage among amino acid mutations within a single variant, we appended 16-nucleotide barcodes downstream of the coding sequence (Hiatt et al., 2010), bottlenecked each library to ∼100,000 barcoded variants, and linked each RBD variant to its barcode via long-read PacBio SMRT sequencing (Matreyek et al., 2018; Figure S1A)."]}
{"doc_id": 17017, "title": "", "abstract": ["The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor and is a major determinant of host range and a dominant target of neutralizing antibodies.", "The RBD is the dominant target of neutralizing antibodies (Cao et al., 2020; Ju et al., 2020; Pinto et al., 2020; Rogers et al., 2020; Seydoux et al., 2020; Shi et al., 2020; Wu et al., 2020b; Zost et al., 2020), and so any antigenic drift will be constrained by its mutational tolerance.", "Many antibodies have epitopes that overlap the RBD ACE2-contact interface and are therefore strongly constrained by mutation effects on binding.", "The RBD is the dominant target of neutralizing antibodies to SARS-CoV-2 (Brouwer et al., 2020; Cao et al., 2020; Ju et al., 2020; Pinto et al., 2020; Premkumar et al., 2020; Rogers et al., 2020; Suthar et al., 2020; Yuan et al., 2020a; Zhang et al., 2020; Zost et al., 2020).", "The importance of such focusing is demonstrated by a recent study that identified RBD mutations enabling escape from RBM-directed neutralizing antibodies (Baum et al., 2020)—our data indicate that the escape occurs at sites that have high mutational tolerance (Figures S6C and S6D)."]}
{"doc_id": 17018, "title": "", "abstract": ["Therefore, our current SARS-CoV-2 deep mutational scanning data are likely to be most useful for predicting the effects of mutations to RBDs closely related to that of SARS- CoV-2.", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "Consistent with the deep mutational scanning, the only large phenotypic effect was increased expression of V367F (Figures 7C and 7D), which we also validated enhances thermal stability of mammalian-expressed RBD (Figures 4G and S4H).", "The fact that differences in binding affinity of GD- Pangolin and RaTG13 are well explained by summing the effects of individual mutations relative to SARS-CoV-2 suggests that our deep mutational scanning is useful for sequence-based predictions of the ACE2-binding potential of future viruses isolated from the SARS-CoV-2 clade.", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2."]}
{"doc_id": 17019, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "For quantitative analysis of deep mutational scanning binding phenotypes (see Method Details section, “Calculating variant phenotypes for ACE2-binding affinity”), we determined per-variant titration curves via weighted least- squares nonlinear regression in R.", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "# Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding"]}
{"doc_id": 17020, "title": "", "abstract": ["(B) Mutations to polar residues at positions Y449, L455, F486, and Y505 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface.", "Furthermore, RBD mutations have already appeared among SARS-CoV-2 pandemic isolates, including some near the ACE2-binding interface—but their impacts on receptor recognition and other biochemical phenotypes remain largely uncharacterized.", "To determine how mutations affect RBD expression and ACE2 binding, we combined fluorescence-activated cell sorting (FACS) with deep sequencing of variant barcodes (Adams et al., 2016; Peterman and Levine, 2016).", "The correlation between mutation effects on binding and expression in Figure 5C could emerge from trivial correlation between phenotypes (e.g., yeast with higher RBD surface expression can bind more ACE2).", "Our map of mutational effects explains this observation by revealing remarkable degeneracy at ACE2 contact positions, with many interface mutations being tolerated or even enhancing affinity (Figure 5D)."]}
{"doc_id": 17021, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "Our discovery of affinity-enhancing mutations to the SARS-CoV-2 RBD raises the question of whether positive selection favors such mutations, since the relationship between receptor affinity and fitness can be complex for viruses that are well adapted to their hosts (Callaway et al., 2018; Hensley et al., 2009; Lang et al., 2020).", "Affinity-enhancing mutations are accessible via single-nucleotide mutation from SARS-CoV-2 (Figure S7C), but none are observed among circulating viral sequences (Figure 7A), and observed mutations do not enhance ACE2 affinity more than randomly drawn samples of single-nucleotide mutations (Figure S7D).", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2."]}
{"doc_id": 17022, "title": "", "abstract": ["(B) RBD yeast-surface display enables fluorescent detection of RBD expression and ACE2 binding.", "These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "We re-cloned and tested most of these prevalent mutations for expression and ACE2 binding in isogenic yeast-display assays.", "(D) Comparisons of dissociation constants measured for mammalian-expressed purified RBD binding to monomeric human ACE2 (Figures S4A–S4F) and yeast displayed RBD binding to natively dimeric ACE2 from our deep mutational scan.", "We cloned the RBDs into a vector for yeast display, induced RBD expression, and incubated with varying concentrations of fluorescently labeled human ACE2 (Figure 1B)."]}
{"doc_id": 17023, "title": "", "abstract": ["Mutagenized SARS-CoV-2 libraries and pooled wild-type homolog RBDs were cloned into EcoRI-HF/SacI-HF digested pETcon 2649 vector (sequence linked above) using NEBuilder HiFi DNA Assembly (NEB E2621).", "Barcodes were also PCR appended to the un-mutagenized RBD homologs via the same primer addition PCR.", "RBD variant plasmids were transformed into the AWY101 Saccharomyces cerevisiae strain (Wentz and Shusta, 2007), selecting for the plasmid Trp auxotrophic marker on SD-CAA selective plates (6.7g/L Yeast Nitrogen Base, 5.0g/L Casamino acids, 1.065 g/L MES acid, and 2% w/v dextrose).", "Codon-optimized RBDs of SARS-CoV-2 with its unmutated sequence or with single mutations (I358F, Y365F, Y365W, V367F or F392W) were synthesized by IDT as gBlocks with an N-terminal EGT secretion signal (MGILPSPGMPALLSLVSLLSVLLMGCVA) and C-terminal Avi- and octa-histidine tags (GLNDIFEAQKIEWHEHHHHHHHH) and cloned into the CMV/R (VRC 8400) mammalian expression vector.", "To facilitate sequencing and obtain linkage among amino acid mutations within a single variant, we appended 16-nucleotide barcodes downstream of the coding sequence (Hiatt et al., 2010), bottlenecked each library to ∼100,000 barcoded variants, and linked each RBD variant to its barcode via long-read PacBio SMRT sequencing (Matreyek et al., 2018; Figure S1A)."]}
{"doc_id": 17024, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "We purified mammalian-expressed RBDs from six sarbecoviruses (SARS-CoV-2, SARS-CoV-1, WIV1, RaTG13, ZXC21, and ZC45) and measured their 1:1 binding affinities for monomeric human ACE2 using biolayer interferometry, which agreed with the measurements from our deep mutational scan (Figures 4D and S4A–S4F).", "Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017).", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2."]}
{"doc_id": 17025, "title": "", "abstract": ["Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F).", "We do not see evidence for selection for enhanced ACE2 binding, as randomly sampled mutations generally contain mutations with stronger affinity-enhancing effects than observed in the GISAID mutation set.", "But a substantial number of mutations are well tolerated or even enhance ACE2 binding, including at ACE2 interface residues that vary across SARS-related coronaviruses.", "Notably, there has been no selection to date for any of the evolutionarily accessible mutations that enhance ACE2 binding affinity.", "Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017)."]}
{"doc_id": 17026, "title": "", "abstract": ["PacBio sequencing was used to acquire long sequence reads spanning the N16 barcode and the RBD gene sequence.", "To facilitate sequencing and obtain linkage among amino acid mutations within a single variant, we appended 16-nucleotide barcodes downstream of the coding sequence (Hiatt et al., 2010), bottlenecked each library to ∼100,000 barcoded variants, and linked each RBD variant to its barcode via long-read PacBio SMRT sequencing (Matreyek et al., 2018; Figure S1A).", "By examining the concordance of RBD variant sequences for barcodes sampled by multiple PacBio reads, we validated that this process correctly determined the sequence of >99.8% of the variants (Figure S1B).", "To do this, we first filtered only for CCSs where the PacBio ccs-reported accuracy was at least 99.99% in both the RBD gene sequence and the barcode (the vast majority of CCSs passed this filter).", "SARS-CoV-2 RBD mutant libraries were constructed in fully independent duplicates, and variants were linked to barcodes by long-read PacBio sequencing."]}
{"doc_id": 17027, "title": "", "abstract": ["We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability).", "Here, we experimentally measure how all amino acid mutations to the RBD affect expression of folded protein and its affinity for ACE2.", "To relate our sequence-phenotype maps to the RBD structure, we mapped the effects of mutations onto the ACE2-bound SARS-CoV-2 RBD crystal structure (Lan et al., 2020), coloring each residue’s Cɑ by the mean effect of mutations at that site on expression (Figure 5A) or binding (Figure 5B).", "Here, we take a step toward providing phenotypic maps commensurate with the scale of genomic data by experimentally characterizing how all amino acid mutations to the RBD affect the expression of folded protein and its affinity for ACE2, two key factors for viral fitness."]}
{"doc_id": 17028, "title": "", "abstract": ["We selected seven single mutations from our deep mutational scanning measurements for validation of phenotypic effects in a spike-pseudotyped lentivirus assay (Crawford et al., 2020).", "It should be possible to shed further experimental light on the potential for antigenic drift by extending our deep mutational scanning methodology to directly map immune-escape mutations as has been done for other viruses (Dingens et al., 2019; Lee et al., 2019; Wu et al., 2020a).", "Taken together, these experiments help validate the accuracy and relevance of the deep mutational scanning.", "The deep mutational scanning suggests small phenotypic effects for the most prevalent mutations, with the exception of V367F, which substantially enhances expression (Figure 7B).", "To validate the dynamic range of our deep mutational scanning, we re-cloned and tested RBD mutants in isogenic yeast-display assays."]}
{"doc_id": 17029, "title": "", "abstract": ["In general, mutation effects on RBD binding and expression are correlated (Figures 5C and S5C), with residues that deviate from this trend clustering at the ACE2 interface (Figure 5C, cyan points).", "The correlation between mutation effects on binding and expression in Figure 5C could emerge from trivial correlation between phenotypes (e.g., yeast with higher RBD surface expression can bind more ACE2).", "These high-throughput measurements of expression and ACE2 binding were consistent with expectations about the effects of mutations.", "The observed mutations are significantly less deleterious for ACE2 binding and RBD expression than random single- nucleotide-accessible mutations (Figures 7A, S7A, and S7B, p < 10−6, permutation tests), consistent with the action of purifying selection.", "The observation that the set of mutations observed in GISAID have a more favorable median mutational effect on binding and expression than randomly sampled mutations indicates the action of purifying selection for ACE2 binding and RBD stability."]}
{"doc_id": 17030, "title": "", "abstract": ["(C) Heatmaps depicting effects of mutations on ACE2 binding, indicating only those mutations that are accessible via single-nucleotide mutation from the SARS-CoV-2 Wuhan-Hu-1 isolate gene sequence.", "Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F).", "The complete measurements of how amino acid mutations affect expression and ACE2 binding represent rich sequence-to-phenotype maps for the RBD.", "These high-throughput measurements of expression and ACE2 binding were consistent with expectations about the effects of mutations.", "Here, we experimentally measure how all amino acid mutations to the RBD affect expression of folded protein and its affinity for ACE2."]}
{"doc_id": 17031, "title": "", "abstract": ["Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017).", "Although these residues are involved in a dense network of polar contacts with ACE2 (Shang et al., 2020; Figure 5E), our measurements show there is substantial plasticity in this network, as mutations that reduce the polar character of these residues can enhance affinity.", "Because ACE2 binding is influenced by both global RBD stability and interface-specific constraints, a site’s tolerance to mutation is better explained by its extent of burial in the ACE2-bound RBD structure than its burial in the free RBD structure alone (Figure S5D).", "To determine how mutations affect RBD expression and ACE2 binding, we combined fluorescence-activated cell sorting (FACS) with deep sequencing of variant barcodes (Adams et al., 2016; Peterman and Levine, 2016).", "For quantitative analysis of deep mutational scanning binding phenotypes (see Method Details section, “Calculating variant phenotypes for ACE2-binding affinity”), we determined per-variant titration curves via weighted least- squares nonlinear regression in R."]}
{"doc_id": 17032, "title": "", "abstract": ["RBD variants contained an average of 2.7 amino acid mutations, with the number of mutations per variant roughly following a Poisson distribution (Figure S1C).", "These point mutations were introduced via site-directed mutagenesis (New England Biolabs E0554S) into the HDM vector containing codon-optimized SARS-CoV-2 Spike from Wuhan-Hu-1, with an upstream Kozak sequence.", "The Spike receptor binding domain (RBD) from SARS-CoV-2 (isolate Wuhan-Hu-1, GenBank : MN908947, residues N331-T531) and additional sarbecovirus homologs (RaTG13, GenBank: MN996532; GD-Pangolin consensus from Lam et al. (2020); SARS-CoV-1 Urbani, GenBank: AY278741; WIV1, GenBank: KF367457 (identical RBD sequence to WIV16); LYRa11, GenBank: KF569996; Rp3, GenBank: DQ071615; HKU3-1, GenBank: DQ022305; Rf1, GenBank: DQ412042; ZXC21, GenBank: MG772934; ZC45, GenBank: MG772933; and BM48-31, GenBank: NC014470) were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector.", "The distribution of mutation effects is shown for all amino acid mutations accessible via single-nucleotide mutation from the SARS-CoV-2 Wuhan-Hu-1 gene sequence, compared to the distributions for subsets of mutations that are observed in sequenced SARS-CoV-2 isolates deposited in GISAID at increasing observation count thresholds.", "To validate the yeast-display platform, we selected RBDs from the Wuhan-Hu-1 SARS-CoV-2 isolate and six related sarbecoviruses (Figure 1A)."]}
{"doc_id": 17033, "title": "", "abstract": ["Similarly, mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 (Figure 3A), consistent with the destabilizing effect of surface-exposed hydrophobic patches (Schwehm et al., 1998)—but these hydrophobic residues form ACE2-packing contacts and are required for binding (Figures 3B and S5B).", "(B) Mutations to polar residues at positions Y449, L455, F486, and Y505 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface.", "Consistent with the deep mutational scanning, the only large phenotypic effect was increased expression of V367F (Figures 7C and 7D), which we also validated enhances thermal stability of mammalian-expressed RBD (Figures 4G and S4H).", "Consistent with the modularity of core-RBD-encoded stability and RBM-encoded binding, constraint on expression primarily focuses on buried residues within the core-RBD (Figure 5A), while constraint on binding focuses on the RBM-proximal core-RBD in addition to the RBM itself (Figure 5B), particularly on RBM residues that contact K31ACE2 and K353ACE2, which are “hotspots” of binding for SARS-CoV-1 and SARS-CoV-2 (Li, 2008; Shang et al., 2020; Wu et al., 2012).", "(B and C) Correlation in binding (B) and expression (C) effects between deep mutational scanning and isogenic yeast validations, including mutants shown in (A) and Figure 7C."]}
{"doc_id": 17034, "title": "", "abstract": ["These point mutations were introduced via site-directed mutagenesis (New England Biolabs E0554S) into the HDM vector containing codon-optimized SARS-CoV-2 Spike from Wuhan-Hu-1, with an upstream Kozak sequence.", "We constructed two independent mutant libraries of the RBD using a PCR-based mutagenesis method that introduces all 19 mutant amino acids at each position (Bloom, 2014).", "The distribution of mutation effects is shown for all amino acid mutations accessible via single-nucleotide mutation from the SARS-CoV-2 Wuhan-Hu-1 gene sequence, compared to the distributions for subsets of mutations that are observed in sequenced SARS-CoV-2 isolates deposited in GISAID at increasing observation count thresholds.", "Our libraries covered 3,804 of the 3,819 possible RBD amino acid mutations, of which 95.7% were present as the sole amino acid mutation in at least one barcoded variant (Figures S1D and S1E).", "The Spike receptor binding domain (RBD) from SARS-CoV-2 (isolate Wuhan-Hu-1, GenBank : MN908947, residues N331-T531) and additional sarbecovirus homologs (RaTG13, GenBank: MN996532; GD-Pangolin consensus from Lam et al. (2020); SARS-CoV-1 Urbani, GenBank: AY278741; WIV1, GenBank: KF367457 (identical RBD sequence to WIV16); LYRa11, GenBank: KF569996; Rp3, GenBank: DQ071615; HKU3-1, GenBank: DQ022305; Rf1, GenBank: DQ412042; ZXC21, GenBank: MG772934; ZC45, GenBank: MG772933; and BM48-31, GenBank: NC014470) were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector."]}
{"doc_id": 17035, "title": "", "abstract": ["For quantitative analysis of deep mutational scanning binding phenotypes (see Method Details section, “Calculating variant phenotypes for ACE2-binding affinity”), we determined per-variant titration curves via weighted least- squares nonlinear regression in R.", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "# Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding", "To address this need, we used a quantitative deep mutational scanning approach (Adams et al., 2016; Fowler and Fields, 2014; Weile and Roth, 2018) to experimentally measure how all possible SARS-CoV-2 RBD amino acid mutations affect ACE2-binding affinity and protein expression (a correlate of protein folding stability)."]}
{"doc_id": 17036, "title": "", "abstract": ["Consistent with previous studies (Shang et al., 2020; Walls et al., 2020; Wrapp et al., 2020a), the SARS-CoV-1 RBD binds ACE2 with lower affinity than SARS-CoV-2 (Figures 1C and 1D).", "All RBDs exhibited ACE2-binding affinities consistent with prior knowledge.", "For example, GD-Pangolin has higher affinity for ACE2 than SARS-CoV-2 (Figures 1C and 2D), and this can be explained by the affinity-enhancing Q498H mutation present in this virus’s RBD sequence (Figure 5F).", "Within the newly described SARS-CoV-2 clade, GD-Pangolin binds ACE2 with slightly higher affinity than SARS-CoV-2, while the bat isolate RaTG13 binds with two orders of magnitude lower affinity, consistent with prior reports (Shang et al., 2020; Wrobel et al., 2020).", "However, our data also indicate that global RBD stability contributes to ACE2-binding affinity."]}
{"doc_id": 17037, "title": "", "abstract": ["To determine how mutations affect RBD expression and ACE2 binding, we combined fluorescence-activated cell sorting (FACS) with deep sequencing of variant barcodes (Adams et al., 2016; Peterman and Levine, 2016).", "Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F).", "We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "Figure 3 provides heatmaps that show how each mutation affects expression or ACE2 binding, with sites annotated by whether they contact ACE2, their relative solvent accessibility, and their amino acid identities in SARS-CoV-2 and SARS-CoV-1.", "To relate our sequence-phenotype maps to the RBD structure, we mapped the effects of mutations onto the ACE2-bound SARS-CoV-2 RBD crystal structure (Lan et al., 2020), coloring each residue’s Cɑ by the mean effect of mutations at that site on expression (Figure 5A) or binding (Figure 5B)."]}
{"doc_id": 85000, "title": "", "abstract": ["There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide.", "Extrapolating these prevalence rates to the 2010 world diabetes population, we estimate that 92.6 million (91.2–94.0) adults had any DR, 17.2 million (16.6–17.7) had PDR, 20.6 million (19.6–21.6) had DME, and 28.4 million (27.6–29.2) had VTDR.", "Extrapolated to the world diabetes population in 2010, we estimate that approximately 93 million may have some DR, and 28 million may have sight-threatening stages of DR.", "Despite the significance of this problem, and the rising prevalence of diabetes notably in emerging Asian countries such as India and China (2,3), there are few precise contemporary estimates of the worldwide prevalence of DR, particularly severe vision-threatening stages of the disease, including proliferative DR (PDR) and diabetic macular edema (DME).", "We estimate that in 2010, approximately 93 million were affected by DR, and 28 million by VTDR."]}
{"doc_id": 85001, "title": "", "abstract": ["Extrapolated to the world diabetes population in 2010, we estimate that approximately 93 million may have some DR, and 28 million may have sight-threatening stages of DR.", "Our study shows that 35% of people with diabetes had some form of DR, and that 7% had PDR, 7% had DME, and 10% were affected by these vision-threatening stages.", "Despite the significance of this problem, and the rising prevalence of diabetes notably in emerging Asian countries such as India and China (2,3), there are few precise contemporary estimates of the worldwide prevalence of DR, particularly severe vision-threatening stages of the disease, including proliferative DR (PDR) and diabetic macular edema (DME).", "In conclusion, our current study provides the first global estimate of DR and, more important, the two sight-threatening end points (PDR and DME), based on a pooled individual participant analysis of more than 20,000 participants from 35 studies around the world.", "There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide."]}
{"doc_id": 85002, "title": "", "abstract": ["There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide.", "Extrapolating these prevalence rates to the 2010 world diabetes population, we estimate that 92.6 million (91.2–94.0) adults had any DR, 17.2 million (16.6–17.7) had PDR, 20.6 million (19.6–21.6) had DME, and 28.4 million (27.6–29.2) had VTDR.", "Extrapolated to the world diabetes population in 2010, we estimate that approximately 93 million may have some DR, and 28 million may have sight-threatening stages of DR.", "Despite the significance of this problem, and the rising prevalence of diabetes notably in emerging Asian countries such as India and China (2,3), there are few precise contemporary estimates of the worldwide prevalence of DR, particularly severe vision-threatening stages of the disease, including proliferative DR (PDR) and diabetic macular edema (DME).", "We estimate that in 2010, approximately 93 million were affected by DR, and 28 million by VTDR."]}
{"doc_id": 85003, "title": "", "abstract": ["After adjusting for known risk factors, individuals with type 1 diabetes for ≥20 years were 2.7 times more likely to have any DR (relative risk 2.69 [96% CI 2.47–2.93]), 15 times more likely to have PDR (15.3 [11.3–20.8]), 5 times more likely to have DME (4.83 [3.71–6.30]), and 8.7 times more likely to have VTDR (8.69 [7.10–10.63]) compared with those with type 2 diabetes for <10 years (Table 4).", "The prevalence of any DR increased with diabetes duration (21.1 vs. 76.3%, comparing <10 with ≥20 years), HbA1c (18.0 vs. 51.2%, comparing levels ≤7.0 with >9.0%), and blood pressure (30.8 vs. 39.6%, comparing blood pressure ≤140/90 or >140/90), and was higher in people with type 1 than type 2 diabetes (77.3 vs. 25.2%).", "Age-standardized prevalence of DR in diabetic subjects aged 20–79 years, using studies with similar methodologies and ophthalmologic definitions", "Previous individual studies have shown considerable variability in DR prevalence estimates among individuals with both diagnosed and undiagnosed diabetes, with rates ranging from 17.6% in a study in India (4) to 33.2% in a large U.S. study (5).", "We showed that the prevalence of DR is substantially higher in type 1 than in type 2 diabetes (11,37), an outcome independent of diabetes duration."]}
{"doc_id": 85004, "title": "", "abstract": ["Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years.", "Study-specific and pooled-data estimates of the prevalence of any DR, PDR, DME, and VTDR were directly age-standardized to the 2010 world diabetes population aged 20–79 years (8) using age strata 20–39, 40–59, and 60–79 years.", "This study provides a global estimate of the prevalence of DR and the severe stages of DR (PDR, DME) using individual-level data from population-based studies worldwide.", "Age-standardized prevalence of DR in diabetic subjects aged 20–79 years, using studies with similar methodologies and ophthalmologic definitions", "The total number of patients with diabetes with DR aged between 20 and 79 years was estimated by multiplying the 2010 country-specific totals of people with diabetes (sourced from Diabetes Atlas) by our pooled racial group–specific rates of DR using the most predominant racial group per country; for example, in Brazil, where 53.7% of country is “white” (according to 2000 census results listed in Central Intelligence Agency, The World Factbook) (10), our pooled Caucasian rate was applied, and in countries where the predominant racial group did not easily align with our limited pooled racial groups (e.g., Melanesians in Papua New Guinea), the overall pooled world rate was applied."]}
{"doc_id": 85005, "title": "", "abstract": ["On the basis of the data from all 35 studies on more than 20,000 participants with diabetes, we estimated that among individuals with diabetes, the overall prevalence of any DR was 34.6%, PDR was 7.0%, DME was 6.8%, and VTDR was 10.2%.", "The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR.", "Previous individual studies have shown considerable variability in DR prevalence estimates among individuals with both diagnosed and undiagnosed diabetes, with rates ranging from 17.6% in a study in India (4) to 33.2% in a large U.S. study (5).", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes."]}
{"doc_id": 85006, "title": "", "abstract": ["On the basis of the data from all 35 studies on more than 20,000 participants with diabetes, we estimated that among individuals with diabetes, the overall prevalence of any DR was 34.6%, PDR was 7.0%, DME was 6.8%, and VTDR was 10.2%.", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR.", "Extrapolating these prevalence rates to the 2010 world diabetes population, we estimate that 92.6 million (91.2–94.0) adults had any DR, 17.2 million (16.6–17.7) had PDR, 20.6 million (19.6–21.6) had DME, and 28.4 million (27.6–29.2) had VTDR."]}
{"doc_id": 85007, "title": "", "abstract": ["There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide.", "We estimate that in 2010, approximately 93 million were affected by DR, and 28 million by VTDR.", "Extrapolated to the world diabetes population in 2010, we estimate that approximately 93 million may have some DR, and 28 million may have sight-threatening stages of DR.", "Extrapolating these prevalence rates to the 2010 world diabetes population, we estimate that 92.6 million (91.2–94.0) adults had any DR, 17.2 million (16.6–17.7) had PDR, 20.6 million (19.6–21.6) had DME, and 28.4 million (27.6–29.2) had VTDR.", "The total number of patients with diabetes with DR aged between 20 and 79 years was estimated by multiplying the 2010 country-specific totals of people with diabetes (sourced from Diabetes Atlas) by our pooled racial group–specific rates of DR using the most predominant racial group per country; for example, in Brazil, where 53.7% of country is “white” (according to 2000 census results listed in Central Intelligence Agency, The World Factbook) (10), our pooled Caucasian rate was applied, and in countries where the predominant racial group did not easily align with our limited pooled racial groups (e.g., Melanesians in Papua New Guinea), the overall pooled world rate was applied."]}
{"doc_id": 85008, "title": "", "abstract": ["Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR.", "In addition, racial differences in the effect of DR risk factors could also have accounted for some of these variations (23,27).", "In some studies (5), after adjusting for putative DR risk factors, racial differences in the prevalence of DR was attributed to differing levels of risk factors for DR, but in others, the excess risk was unexplained (22,23,25).", "Global Prevalence and Major Risk Factors of Diabetic Retinopathy", "To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes."]}
{"doc_id": 85009, "title": "", "abstract": ["Analyses confined to studies with similar methodologies and rigorous outcome definitions showed that the age-standardized prevalence was 35.4% (35.2–35.6) for any DR, 7.24% (7.15–7.33) for PDR, 7.48% (7.39–7.57) for DME, and 11.7% (11.6–11.8) for VTDR (Table 2).", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "This study provides a global estimate of the prevalence of DR and the severe stages of DR (PDR, DME) using individual-level data from population-based studies worldwide.", "Ours is the first synthesis of individual-level data from all eligible population-based studies worldwide with a sufficiently large sample to allow a more precise estimation of the prevalence of PDR and DME.", "Study-specific and pooled-data estimates of the prevalence of any DR, PDR, DME, and VTDR were directly age-standardized to the 2010 world diabetes population aged 20–79 years (8) using age strata 20–39, 40–59, and 60–79 years."]}
{"doc_id": 85010, "title": "", "abstract": ["Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "Analyses confined to studies with similar methodologies and rigorous outcome definitions showed that the age-standardized prevalence was 35.4% (35.2–35.6) for any DR, 7.24% (7.15–7.33) for PDR, 7.48% (7.39–7.57) for DME, and 11.7% (11.6–11.8) for VTDR (Table 2).", "Study methodology and heterogeneity were assessed independently by two investigators (J.Y., R.Kaw.).", "Age-standardized prevalence of DR in diabetic subjects aged 20–79 years, using studies with similar methodologies and ophthalmologic definitions", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes."]}
{"doc_id": 85011, "title": "", "abstract": ["Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults around the world (1).", "This suggests that DR has the potential to be the leading cause of visual impairment and blindness worldwide.", "The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR.", "Despite the significance of this problem, and the rising prevalence of diabetes notably in emerging Asian countries such as India and China (2,3), there are few precise contemporary estimates of the worldwide prevalence of DR, particularly severe vision-threatening stages of the disease, including proliferative DR (PDR) and diabetic macular edema (DME).", "There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide."]}
{"doc_id": 85012, "title": "", "abstract": ["More important, this study did not include Asians, and an estimated 100 million people in China and 80 million in India have diabetes (2,3).", "The strengths of our study include a large sample size to determine prevalence and risk factor associations for sight-threatening end points (PDR, DME), the inclusion of diverse ethnic population samples from around the world, and studies that had used photographic documentation of DR.", "To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes.", "Differences in socioeconomic factors, including access to and the level of diabetes care, and possibly genetic susceptibility (26), may also possibly explain some of the disparities in rates and severity of DR in the different ethnic groups.", "In addition, racial differences in the effect of DR risk factors could also have accounted for some of these variations (23,27)."]}
{"doc_id": 85013, "title": "", "abstract": ["After adjusting for known risk factors, individuals with type 1 diabetes for ≥20 years were 2.7 times more likely to have any DR (relative risk 2.69 [96% CI 2.47–2.93]), 15 times more likely to have PDR (15.3 [11.3–20.8]), 5 times more likely to have DME (4.83 [3.71–6.30]), and 8.7 times more likely to have VTDR (8.69 [7.10–10.63]) compared with those with type 2 diabetes for <10 years (Table 4).", "These estimates, however, represented findings limited to individuals aged older than 40 years and only with type 2 diabetes, were largely derived from individuals of Caucasian background, did not evaluate PDR and DME separately, and did not include studies from Asia.", "A meta-analysis summarized the U.S. prevalence of DR (6), but this study was limited to individuals with type 2 diabetes aged 40 years and older, and the data were largely derived from individuals of Caucasian background, with limited data on other racial groups.", "We showed that the prevalence of DR is substantially higher in type 1 than in type 2 diabetes (11,37), an outcome independent of diabetes duration.", "Analyses confined to studies with similar methodologies and rigorous outcome definitions showed that the age-standardized prevalence was 35.4% (35.2–35.6) for any DR, 7.24% (7.15–7.33) for PDR, 7.48% (7.39–7.57) for DME, and 11.7% (11.6–11.8) for VTDR (Table 2)."]}
{"doc_id": 85014, "title": "", "abstract": ["A meta-analysis summarized the U.S. prevalence of DR (6), but this study was limited to individuals with type 2 diabetes aged 40 years and older, and the data were largely derived from individuals of Caucasian background, with limited data on other racial groups.", "The prevalence of any DR increased with diabetes duration (21.1 vs. 76.3%, comparing <10 with ≥20 years), HbA1c (18.0 vs. 51.2%, comparing levels ≤7.0 with >9.0%), and blood pressure (30.8 vs. 39.6%, comparing blood pressure ≤140/90 or >140/90), and was higher in people with type 1 than type 2 diabetes (77.3 vs. 25.2%).", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "We showed that the prevalence of DR is substantially higher in type 1 than in type 2 diabetes (11,37), an outcome independent of diabetes duration.", "All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes."]}
{"doc_id": 85015, "title": "", "abstract": ["This, however, would not have affected the overall prevalence estimates but could have had a small effect of attenuating the comparative estimates between the type 1 and type 2 diabetes groups.", "Previous individual studies have shown considerable variability in DR prevalence estimates among individuals with both diagnosed and undiagnosed diabetes, with rates ranging from 17.6% in a study in India (4) to 33.2% in a large U.S. study (5).", "On the basis of the data from all 35 studies on more than 20,000 participants with diabetes, we estimated that among individuals with diabetes, the overall prevalence of any DR was 34.6%, PDR was 7.0%, DME was 6.8%, and VTDR was 10.2%.", "Extrapolating these prevalence rates to the 2010 world diabetes population, we estimate that 92.6 million (91.2–94.0) adults had any DR, 17.2 million (16.6–17.7) had PDR, 20.6 million (19.6–21.6) had DME, and 28.4 million (27.6–29.2) had VTDR.", "These estimates, however, represented findings limited to individuals aged older than 40 years and only with type 2 diabetes, were largely derived from individuals of Caucasian background, did not evaluate PDR and DME separately, and did not include studies from Asia."]}
{"doc_id": 85016, "title": "", "abstract": ["Some of the differences in DR prevalence between individual studies may be partly attributed to the differing periods of the studies (Table 1 and Supplementary Table 3).", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "Age-standardized prevalence of DR in diabetic subjects aged 20–79 years, using studies with similar methodologies and ophthalmologic definitions", "Differences in study methodologies, population characteristics, and ascertainment and classification of DR have made direct comparisons between studies difficult.", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown)."]}
{"doc_id": 85017, "title": "", "abstract": ["Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults around the world (1).", "This suggests that DR has the potential to be the leading cause of visual impairment and blindness worldwide.", "Global Prevalence and Major Risk Factors of Diabetic Retinopathy", "To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes.", "Most of the studies graded for DR using the Early Treatment Diabetic Retinopathy Scale (ETDRS) and its modification or the American Academy of Ophthalmology (AAO) International Clinical Diabetic Retinopathy Disease Severity Scale (Table 1)."]}
{"doc_id": 85018, "title": "", "abstract": ["Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR.", "We identified 58 population-based studies in which fundus photographs were potentially assessed for DR.", "We confirmed the importance and impact of three major modifiable risk factors—hyperglycemia, hypertension, and dyslipidemia—on the risk of all DR end points, including for the first time, PDR and DME.", "We highlight several key points regarding the major risk factors for DR: First, we confirm the importance of the three major risk factors for DR—diabetes duration (17,19,28), HbA1c (17,28–32), and blood pressure (17,28,33)—and suggest that they apply broadly across the mild to vision- threatening stages of DR.", "Differences in study methodologies, population characteristics, and ascertainment and classification of DR have made direct comparisons between studies difficult."]}
{"doc_id": 85019, "title": "", "abstract": ["Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR.", "Global Prevalence and Major Risk Factors of Diabetic Retinopathy", "Although the major risk factors for DR (e.g., hyperglycemia, hypertension, dyslipidemia) have been examined in many epidemiologic studies and clinical trials (1), there is considerable variation in the consistency, pattern, and strength of these risk factors.", "Poisson regression models with robust error variance were used to estimate relative risks for DR, PDR, DME, and VTDR by categories of risk factors (e.g., hypertension, duration), adjusting for age (continuous, from 20–79 years), race (five categories), hypertension (yes/no), HbA1c (four categories) and study, as appropriate.", "We confirmed the importance and impact of three major modifiable risk factors—hyperglycemia, hypertension, and dyslipidemia—on the risk of all DR end points, including for the first time, PDR and DME."]}
{"doc_id": 85020, "title": "", "abstract": ["All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes.", "The prevalence of any DR increased with diabetes duration (21.1 vs. 76.3%, comparing <10 with ≥20 years), HbA1c (18.0 vs. 51.2%, comparing levels ≤7.0 with >9.0%), and blood pressure (30.8 vs. 39.6%, comparing blood pressure ≤140/90 or >140/90), and was higher in people with type 1 than type 2 diabetes (77.3 vs. 25.2%).", "Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR.", "We showed that the prevalence of DR is substantially higher in type 1 than in type 2 diabetes (11,37), an outcome independent of diabetes duration.", "We highlight several key points regarding the major risk factors for DR: First, we confirm the importance of the three major risk factors for DR—diabetes duration (17,19,28), HbA1c (17,28–32), and blood pressure (17,28,33)—and suggest that they apply broadly across the mild to vision- threatening stages of DR."]}
{"doc_id": 85021, "title": "", "abstract": ["Our study has limitations.", "This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.", "A meta-analysis summarized the U.S. prevalence of DR (6), but this study was limited to individuals with type 2 diabetes aged 40 years and older, and the data were largely derived from individuals of Caucasian background, with limited data on other racial groups.", "These estimates, however, represented findings limited to individuals aged older than 40 years and only with type 2 diabetes, were largely derived from individuals of Caucasian background, did not evaluate PDR and DME separately, and did not include studies from Asia.", "This is particularly so with respect to severe stages of DR, because individual studies generally lack power to detect significant associations for PDR and DME."]}
{"doc_id": 85022, "title": "", "abstract": ["We highlight several key points regarding the major risk factors for DR: First, we confirm the importance of the three major risk factors for DR—diabetes duration (17,19,28), HbA1c (17,28–32), and blood pressure (17,28,33)—and suggest that they apply broadly across the mild to vision- threatening stages of DR.", "We confirmed the importance and impact of three major modifiable risk factors—hyperglycemia, hypertension, and dyslipidemia—on the risk of all DR end points, including for the first time, PDR and DME.", "Although the major risk factors for DR (e.g., hyperglycemia, hypertension, dyslipidemia) have been examined in many epidemiologic studies and clinical trials (1), there is considerable variation in the consistency, pattern, and strength of these risk factors.", "Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR.", "To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes."]}
{"doc_id": 85023, "title": "", "abstract": ["Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR.", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "This suggests that DR has the potential to be the leading cause of visual impairment and blindness worldwide.", "Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults around the world (1)."]}
{"doc_id": 54000, "title": "", "abstract": ["While human BRCA1-mutated tumors can develop resistance to carboplatin by genetic reversion of the BRCA1 mutation48 – stressing the importance of BRCA1 function for HR – mouse mammary tumor models with large deletions in Brca1 cannot employ this mechanism and remain sensitive to cisplatin or carboplatin, even after multiple rounds of treatment47.", "In contrast, Brca1Δ11/Δ11 mouse mammary tumors, which only express the BRCA1-Δ11 isoform, readily become resistant to cisplatin despite the fact that Brca1 exon 11 sequences are irreversibly deleted49.", "shRNA-mediated loss of 53BP1 fully abolished the cisplatin sensitivity induced by Brca1 inactivation (Fig. 1d).", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "(a) RAD51 foci formation in R26CreERT2;Brca1SCo/Δ ES cells untreated or treated with 4OHT and transduced with lentiviruses expressing non-targeting shRNAs (NTsh) or shRNAs targeting 53bp1(53BP1sh)."]}
{"doc_id": 54001, "title": "", "abstract": ["The latter possibility is supported by the restoration of IR-induced RAD51 foci formation and the partial restoration of HR in 53BP1-depleted Brca1 null cells.", "Similar to the observations with Brca1Δ11 hypomorphic mutants, clonal outgrowth of Brca1 null cells was rescued by a loss of function mutation of 53BP1.", "The observed abrogation of G2 accumulation, sensitivity to DNA cross-linkers, and DDR may be due to a stimulation of BRCA1 independent DNA repair.", "While human BRCA1-mutated tumors can develop resistance to carboplatin by genetic reversion of the BRCA1 mutation48 – stressing the importance of BRCA1 function for HR – mouse mammary tumor models with large deletions in Brca1 cannot employ this mechanism and remain sensitive to cisplatin or carboplatin, even after multiple rounds of treatment47.", "Other questions concern the mechanism by which deletion of 53BP1 rescues BRCA1-deficient cells and the potential relevance of 53BP1 status for BRCA1 associated cancers."]}
{"doc_id": 54002, "title": "", "abstract": ["Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "To determine whether 53BP1 depletion rescues homology-directed repair (HDR) in BRCA1-deficient cells we measured gene targeting efficiencies in R26CreERT2;Brca1SCo/Δ ES cells with or without shRNA-mediated depletion of 53BP1 or p53, using an isogenic Rb targeting construct with a PGK-neo selection marker28.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway."]}
{"doc_id": 54003, "title": "", "abstract": ["53BP1, a DNA damage response (DDR) factor involved in both HR and non-homologous end joining (NHEJ), is known to be an activator of p5313.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents.", "Although our data suggest that a certain level of HR repair can take place in the absence of both BRCA1 and 53BP1, 53BP1-depleted Brca1 null cells remain HR defective since gene targeting frequencies in these cells are reduced by a factor of 2–10 when compared to wildtype cells.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner."]}
{"doc_id": 54004, "title": "", "abstract": ["53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers", "These observations suggest a selection for loss of 53BP1 function in a subset of sporadic triple-negative breast cancers and cancers arising in BRCA mutation carriers.", "The clinical relevance of these findings is indicated by our data showing that 53BP1 expression is reduced in a subset of basal-like/triple-negative breast cancers and in BRCA1/2 associated breast tumors.", "Furthermore, aberrant expression of 53BP1 is more common in BRCA1/2 associated breast cancers, which may hint at a role for 53BP1 loss in these tumors.", "It is possible that 53BP1 loss may have different effects in BRCA1-deficient tumors vs. sporadic triple- negative breast cancers."]}
{"doc_id": 54005, "title": "", "abstract": ["shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "While human BRCA1-mutated tumors can develop resistance to carboplatin by genetic reversion of the BRCA1 mutation48 – stressing the importance of BRCA1 function for HR – mouse mammary tumor models with large deletions in Brca1 cannot employ this mechanism and remain sensitive to cisplatin or carboplatin, even after multiple rounds of treatment47.", "Although our data suggest that a certain level of HR repair can take place in the absence of both BRCA1 and 53BP1, 53BP1-depleted Brca1 null cells remain HR defective since gene targeting frequencies in these cells are reduced by a factor of 2–10 when compared to wildtype cells.", "BRCA1-mutated tumors show genomic instability, mainly as a consequence of impaired recombinatorial DNA repair.", "In line with this, BRCA1-deficient tumors show excellent responses to therapies exploiting a HR defect, such as platinum drugs44 or PARP inhibitors45."]}
{"doc_id": 54006, "title": "", "abstract": ["We find reduced 53BP1 expression in subsets of sporadic triple-negative and BRCA-associated breast cancers, indicating the potential clinical implications of our findings.", "The clinical relevance of these findings is indicated by our data showing that 53BP1 expression is reduced in a subset of basal-like/triple-negative breast cancers and in BRCA1/2 associated breast tumors.", "53BP1 is also lost in a subset of sporadic triple-negative breast cancers, suggesting a broader role for abnormalities in this pathway in breast tumorigenesis.", "These observations suggest a selection for loss of 53BP1 function in a subset of sporadic triple-negative breast cancers and cancers arising in BRCA mutation carriers.", "Overall, these results demonstrate that loss of 53BP1 is more frequent among the most aggressive and difficult-to-treat triple-negative tumors, and in tumors with BRCA1/2 mutations."]}
{"doc_id": 54007, "title": "", "abstract": ["In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents.", "### 53BP1 loss partially restores HR in Brca1 null cells", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells."]}
{"doc_id": 54008, "title": "", "abstract": ["Other questions concern the mechanism by which deletion of 53BP1 rescues BRCA1-deficient cells and the potential relevance of 53BP1 status for BRCA1 associated cancers.", "53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers", "In an unbiased genetic screen we found that loss of 53BP1 rescues clonal outgrowth of Brca1 null ES cells.", "### 53BP1 loss is associated with BRCA1/2 mutation status", "As cancers in this data set were mostly early stage, lymph node-negative cancers that did not receive any adjuvant treatment, these data suggest that early stage triple-negative tumors with reduced 53BP1 may have a greater likelihood of metastasis in the absence of systemic treatment, when compared with triple-negative tumors with intact 53BP1."]}
{"doc_id": 54009, "title": "", "abstract": ["Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "To determine whether 53BP1 depletion rescues homology-directed repair (HDR) in BRCA1-deficient cells we measured gene targeting efficiencies in R26CreERT2;Brca1SCo/Δ ES cells with or without shRNA-mediated depletion of 53BP1 or p53, using an isogenic Rb targeting construct with a PGK-neo selection marker28.", "In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner."]}
{"doc_id": 54010, "title": "", "abstract": ["In the absence of BRCA1, ES cells accumulate in G2 (Fig. 2b), which could reflect a checkpoint response induced by accumulation of unrepaired DNA damage.", "Alternatively, checkpoint release might prevent the formation of DNA breaks by collapsing replication forks or allow the cells to continue cycling without actual repair of the damage.", "Together, these results suggest that 53BP1 is required for efficient ATM- dependent checkpoint signaling to arrest cell cycle progression in response to DNA damage accumulation in Brca1-deleted cells.", "Consistent with unrepaired DNA damage being the cause of the observed G2/M arrest and checkpoint activation triggered by Brca1 deletion, we observed a marked increase in chromatid and chromosome breaks in BRCA1-deficient MEFs (Fig. 3b).", "shRNA-mediated 53BP1 depletion in these cells led to a decrease in the occurrence of DNA breaks, reflected in diminished checkpoint responses."]}
{"doc_id": 54011, "title": "", "abstract": ["After induction of CreERT2-mediated deletion of the Brca1SCo allele with 4OHT, we assayed for clonal survival of BRCA1-deficient ES cells under puromycin selection (Supplementary Fig. 2a).", "While CreERT2-mediated deletion of Brca1 by addition of 4OHT abolished Rb gene targeting in R26CreERT2;Brca1SCo/Δ ES cells, this effect could not be reversed by shRNA-mediated depletion of p53 (Table 1).", "Addition of 4OHT leads to CreERT2-mediated deletion of Brca1 exons 5–6, resulting in BRCA1 inactivation and concomitant expression of puromycin from the PGK promoter, thereby enabling selection of BRCA1-deficient R26CreERT2;Brca1Δ/Δ ES cells.", "To overcome this problem, we generated R26CreERT2;Brca1SCo/Δ mouse embryonic stem (ES) cells, which contain, in addition to a Brca1Δ5-13 null allele18, a Brca1SCo Selectable Conditional knockout allele in which exons 5 and 6 are flanked by loxP recombination sites and a split puromycin resistance marker (Fig. 1a; Supplementary Fig. 1a).", "In contrast, correct integration of the targeting vector at the Rb locus was observed in 2/160 53BP1-depleted R26CreERT2;Brca1Δ/Δ ES cell colonies, compared to 8/78 R26CreERT2;Brca1SCo/Δ colonies, suggesting that 53BP1 loss leads to partial restoration of HDR in Brca1 null cells."]}
{"doc_id": 54012, "title": "", "abstract": ["Concomitant loss of 53BP1 expression was detected when MEFs were co-transduced with the H&R Cre and 53BP1 shRNA-encoding viruses.", "Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "At present it is not clear whether 53BP1 loss contributes to development, therapy response and/or acquired resistance of BRCA1-deficient tumors.", "Regardless, 53BP1 might represent a candidate biomarker for predicting response of HR defective tumors to PARP inhibitors or platinum drugs.", "Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation."]}
{"doc_id": 54013, "title": "", "abstract": ["At present it is not clear whether 53BP1 loss contributes to development, therapy response and/or acquired resistance of BRCA1-deficient tumors.", "Regardless, 53BP1 might represent a candidate biomarker for predicting response of HR defective tumors to PARP inhibitors or platinum drugs.", "### 53BP1 loss is associated with triple-negative phenotype", "shRNA-mediated loss of 53BP1 fully abolished the cisplatin sensitivity induced by Brca1 inactivation (Fig. 1d).", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents."]}
{"doc_id": 54014, "title": "", "abstract": ["In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents.", "### 53BP1 loss rescues proliferation defects of Brca1 null cells", "Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation.", "At present it is not clear whether 53BP1 loss contributes to development, therapy response and/or acquired resistance of BRCA1-deficient tumors."]}
{"doc_id": 54015, "title": "", "abstract": ["In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "Together, these results suggest that 53BP1 is required for efficient ATM- dependent checkpoint signaling to arrest cell cycle progression in response to DNA damage accumulation in Brca1-deleted cells.", "Two clones that were completely Brca1 deleted showed identical patterns of piggyBac transposon integrations (Supplementary Fig. 2b); one of which mapped to intron 16 of the 53bp1 gene (Supplementary Fig. 2c) and correlated with abrogation of 53BP1 expression (Supplementary Fig. 2d), consistent with the reported ability of 53BP1 deletion to abrogate senescence and cell death in Brca1Δ11/Δ11 hypomorphic cells12.", "Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway."]}
{"doc_id": 54016, "title": "", "abstract": ["53BP1, a DNA damage response (DDR) factor involved in both HR and non-homologous end joining (NHEJ), is known to be an activator of p5313.", "Although our data suggest that a certain level of HR repair can take place in the absence of both BRCA1 and 53BP1, 53BP1-depleted Brca1 null cells remain HR defective since gene targeting frequencies in these cells are reduced by a factor of 2–10 when compared to wildtype cells.", "Consistent with the role of BRCA2 as the loader of RAD51 onto DSBs, the initiating step of recombinational DNA repair, we did not detect any rescue of RAD51 foci in BRCA2-deficient cells when either p53 or 53BP1 were depleted (data not shown).", "Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "Alternatively, 53BP1 loss might lead to more efficient DNA double-strand break (DSB) repair and thereby reduce DDR activation."]}
{"doc_id": 54017, "title": "", "abstract": ["Although our data suggest that a certain level of HR repair can take place in the absence of both BRCA1 and 53BP1, 53BP1-depleted Brca1 null cells remain HR defective since gene targeting frequencies in these cells are reduced by a factor of 2–10 when compared to wildtype cells.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway.", "To determine whether 53BP1 depletion rescues homology-directed repair (HDR) in BRCA1-deficient cells we measured gene targeting efficiencies in R26CreERT2;Brca1SCo/Δ ES cells with or without shRNA-mediated depletion of 53BP1 or p53, using an isogenic Rb targeting construct with a PGK-neo selection marker28.", "The latter possibility is supported by the restoration of IR-induced RAD51 foci formation and the partial restoration of HR in 53BP1-depleted Brca1 null cells.", "In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells."]}
{"doc_id": 54018, "title": "", "abstract": ["In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents.", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "### 53BP1 loss rescues drug hypersensitivity of Brca1 null cells", "Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation."]}
{"doc_id": 54019, "title": "", "abstract": ["Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "53BP1, a DNA damage response (DDR) factor involved in both HR and non-homologous end joining (NHEJ), is known to be an activator of p5313.", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "To determine whether 53BP1 depletion rescues homology-directed repair (HDR) in BRCA1-deficient cells we measured gene targeting efficiencies in R26CreERT2;Brca1SCo/Δ ES cells with or without shRNA-mediated depletion of 53BP1 or p53, using an isogenic Rb targeting construct with a PGK-neo selection marker28.", "Although our data suggest that a certain level of HR repair can take place in the absence of both BRCA1 and 53BP1, 53BP1-depleted Brca1 null cells remain HR defective since gene targeting frequencies in these cells are reduced by a factor of 2–10 when compared to wildtype cells."]}
{"doc_id": 54020, "title": "", "abstract": ["R26CreERT2;Brca1SCo/Δ ES cells were seeded in triplicate at 1000 or 3000 (in case of switched cells with non-targeting shRNA) cells per well in 96-well plates.", "Addition of 4OHT leads to CreERT2-mediated deletion of Brca1 exons 5–6, resulting in BRCA1 inactivation and concomitant expression of puromycin from the PGK promoter, thereby enabling selection of BRCA1-deficient R26CreERT2;Brca1Δ/Δ ES cells.", "Incubation of these cells with 4-hydroxytamoxifen (4OHT) results in nearly complete switching of the Brca1SCo allele and consequent loss of BRCA1 protein expression (Supplementary Fig. 1b–c).", "*4-hydroxytamoxifen (4OHT) was added to induce CreERT2-mediated deletion of the Brca1SCo allele", "Samples were taken before or at 4 and 9 days after 4-hydroxytamoxifen (4OHT) induced deletion of Brca1."]}
{"doc_id": 100000, "title": "", "abstract": ["We therefore propose that obesity is an FGF21-resistant state.", "Thus, it seems unlikely that FGF21 resistance has a major contributory role toward the development of obesity.", "These data have led us to hypothesize that obesity is an FGF21-resistant state.", "To determine whether reduced expression of FGF21 receptors might contribute to the attenuated FGF21 signaling in obese mice, we assessed FGF21 receptor and co-receptor expression in the liver and WAT from obese and lean mice.", "To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration."]}
{"doc_id": 100001, "title": "", "abstract": ["Nevertheless, FGF21 resistance likely contributes significantly toward the complications associated with weight gain and obesity, such as glucose intolerance and elevated circulating NEFAs.", "Furthermore, we were able to show that resistance extends to physiologic actions of FGF21.", "We also analyzed the physiologic impact of FGF21 resistance by assessing serum parameters that are acutely regulated by FGF21.", "We found a 20-fold increase in liver mRNA expression of FGF21 (Fig. 1A; lean 1.13 ± 0.29; obese 21.72 ± 3.18; P < 0.0001).", "In addition, other studies have found that FGF21 increases insulin-independent glucose uptake in 3T3L1 adipocytes."]}
{"doc_id": 100002, "title": "", "abstract": ["Circulating levels of FGF21 are increased in mice with diet-induced obesity.", "We found a 20-fold increase in liver mRNA expression of FGF21 (Fig. 1A; lean 1.13 ± 0.29; obese 21.72 ± 3.18; P < 0.0001).", "However, there was no effect of FGF21 administration on Egr1 expression in the liver of the obese mice.", "When obese mice are treated with FGF21, they display both a significantly attenuated signaling response as assessed by extracellular mitogen-activated protein kinase 1 and 2 (ERK1/2) phosphorylation as well as an impaired induction of FGF21 target genes, including cFos and EGR1.", "Surprisingly, however, FGF21 levels are elevated in obese ob/ob and db/db mice and correlate positively with BMI in humans."]}
{"doc_id": 100003, "title": "", "abstract": ["In fact, in both rodent diet-induced obese (DIO) (16) and in genetically obese db/db (17) and ob/ob mice, FGF21 expression is increased in WAT and liver (18).", "Because increased FGF21 levels have been reported in genetically obese mice and obese humans, we assessed serum and liver and WAT mRNA levels in mice with diet-induced obesity.", "Circulating levels of FGF21 are increased in mice with diet-induced obesity.", "We found a 20-fold increase in liver mRNA expression of FGF21 (Fig. 1A; lean 1.13 ± 0.29; obese 21.72 ± 3.18; P < 0.0001).", "To determine whether reduced expression of FGF21 receptors might contribute to the attenuated FGF21 signaling in obese mice, we assessed FGF21 receptor and co-receptor expression in the liver and WAT from obese and lean mice."]}
{"doc_id": 100004, "title": "", "abstract": ["In doing this, we assessed the impact of diet-induced obesity on FGF21 signaling and resultant transcriptional events in the liver and white adipose tissue.", "Fibroblast growth factor 21 (FGF21) has emerged as a key mediator of the fasted state and contributes to regulating lipolysis in white adipose tissue (WAT) (1–3) as well as increasing substrate utilization by increasing fatty acid oxidation in the liver (4).", "To test this hypothesis, we assessed the ability of FGF21 to recruit FGF signaling pathways in the liver and WAT of obese mice.", "FGF21 signaling is attenuated in liver and WAT of obese mice.", "### FGF21 signaling is attenuated in liver and WAT of obese mice."]}
{"doc_id": 100005, "title": "", "abstract": ["These findings are consistent with obesity being an FGF21-resistant state.", "We therefore propose that obesity is an FGF21-resistant state.", "Nevertheless, FGF21 resistance can be added to the hormone- resistant states observed in obesity.", "These data have led us to hypothesize that obesity is an FGF21-resistant state.", "As we demonstrate in this article, obesity is also a state of FGF21 resistance."]}
{"doc_id": 100006, "title": "", "abstract": ["Nevertheless, FGF21 resistance can be added to the hormone- resistant states observed in obesity.", "Nevertheless, FGF21 resistance likely contributes significantly toward the complications associated with weight gain and obesity, such as glucose intolerance and elevated circulating NEFAs.", "We therefore propose that obesity is an FGF21-resistant state.", "These findings are consistent with obesity being an FGF21-resistant state.", "To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration."]}
{"doc_id": 100007, "title": "", "abstract": ["These findings are consistent with obesity being an FGF21-resistant state.", "This is consistent with our hypothesis that obese mice are resistant to FGF21.", "Nevertheless, FGF21 resistance likely contributes significantly toward the complications associated with weight gain and obesity, such as glucose intolerance and elevated circulating NEFAs.", "We therefore propose that obesity is an FGF21-resistant state.", "These data have led us to hypothesize that obesity is an FGF21-resistant state."]}
{"doc_id": 100008, "title": "", "abstract": ["To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration.", "Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State", "We therefore propose that obesity is an FGF21-resistant state.", "These findings are consistent with obesity being an FGF21-resistant state.", "To examine the possible contribution of FGF21 resistance to obesity, we evaluated resistance at several time points after initiation of a high-fat diet."]}
{"doc_id": 100009, "title": "", "abstract": ["To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration.", "These data demonstrate that DIO mice have increased endogenous levels of FGF21 and respond poorly to exogenous FGF21.", "Circulating levels of FGF21 are increased in mice with diet-induced obesity.", "### Diet-induced obese mice have elevated circulating levels of FGF21.", "This is consistent with our hypothesis that obese mice are resistant to FGF21."]}
{"doc_id": 100010, "title": "", "abstract": ["It is now clear that increased tissue expression and serum levels of FGF21 are associated with the obese state.", "We therefore propose that obesity is an FGF21-resistant state.", "Nevertheless, FGF21 resistance can be added to the hormone- resistant states observed in obesity.", "These findings are consistent with obesity being an FGF21-resistant state.", "To examine the possible contribution of FGF21 resistance to obesity, we evaluated resistance at several time points after initiation of a high-fat diet."]}
{"doc_id": 100011, "title": "", "abstract": ["Nevertheless, FGF21 resistance likely contributes significantly toward the complications associated with weight gain and obesity, such as glucose intolerance and elevated circulating NEFAs.", "Nevertheless, FGF21 resistance can be added to the hormone- resistant states observed in obesity.", "As we demonstrate in this article, obesity is also a state of FGF21 resistance.", "Thus, it seems unlikely that FGF21 resistance has a major contributory role toward the development of obesity.", "To examine the possible contribution of FGF21 resistance to obesity, we evaluated resistance at several time points after initiation of a high-fat diet."]}
{"doc_id": 100012, "title": "", "abstract": ["When obese mice are treated with FGF21, they display both a significantly attenuated signaling response as assessed by extracellular mitogen-activated protein kinase 1 and 2 (ERK1/2) phosphorylation as well as an impaired induction of FGF21 target genes, including cFos and EGR1.", "To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration.", "To determine whether reduced expression of FGF21 receptors might contribute to the attenuated FGF21 signaling in obese mice, we assessed FGF21 receptor and co-receptor expression in the liver and WAT from obese and lean mice.", "FGF21 signaling is attenuated in liver and WAT of obese mice.", "Although attenuated responses to FGF21 were not universal, these data suggest FGF21 resistance begins to manifest early during weight gain."]}
{"doc_id": 60000, "title": "", "abstract": ["Tetanus had the largest reduction in neonatal deaths between 2005 and 2015, falling 57·7% (50·0–64·2) to 19 900 deaths (17 000–23 400), followed by malaria, which fell by 55·9% (41·1–67·8) to 13 900 deaths (8 930–19 800).", "Other communicable diseases that had significant reductions in mortality included tetanus (decreased by 47·5% [95% UI 39·0–54·6], to 56 700 deaths [48 200–80 000]), measles (decreased by 75·0% [58·8–84·5], to 73 400 deaths [26 100–161 400]), and African trypanosomiasis (decreased by 75·3% [67·9–81·4], to 3510 deaths [1790–5660]).", "Deaths due to measles fell by 75·1% (59·6–84·5), the largest reduction among this age group, to 62 600 deaths (22 400–136 000), followed by tetanus, which fell by 55·2% (39·3–66·4) to 5560 deaths (4140–7760), and HIV/AIDS, which fell by 51·9% (49·6–54·2), to 88 900 deaths (84 300–93 700).", "In 2015, 55·8 million deaths (55·0 million to 56·6 million) occurred worldwide, an increase of 7·9 million deaths since 1990 and 2·2 million deaths since 2005 (table 4).", "Below an SDI of 0·50, Group 1 causes, especially infectious diseases such as diarrhoeal diseases and lower respiratory infections, accounted for most premature mortality (as much as 72·5%, or roughly 141 513 YLLs per 100 000)."]}
{"doc_id": 60001, "title": "", "abstract": ["The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14·1% (12·6–16·0) to 39·8 million (39·2 million to 40·5 million) in 2015, whereas age-standardised rates decreased by 13·1% (11·9–14·3).", "Non-communicable diseases (NCDs) and injuries claimed increasingly more lives throughout the world, although age-standardised death rates fell for many causes and countries.7", "Total deaths increased by 4·1% (2·6–5·6) from 2005 to 2015, rising to 55·8 million (54·9 million to 56·6 million) in 2015, but age- standardised death rates fell by 17·0% (15·8–18·1) during this time, underscoring changes in population growth and shifts in global age structures.", "Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause.", "By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42·1%, 39·1–44·6), malaria (43·1%, 34·7–51·8), neonatal preterm birth complications (29·8%, 24·8–34·9), and maternal disorders (29·1%, 19·3–37·1)."]}
{"doc_id": 60002, "title": "", "abstract": ["To ensure a coherent set of estimated death rates for Levels 1, 2, and 3 in the GBD cause hierarchy for each level of SDI, the Level 2 death rates were rescaled such that for each age–sex–cause bin, the sum of Level 2 death rates equalled the Level 1 death rate.", "All included sources were corrected to be 100% complete by multiplying the cause fraction in a source for a country–age–sex–year by the estimate of all-cause mortality for that country–age–sex–year.", "This calibration method is based on tracking incidence cohorts through Spectrum and adjusting incidence to fit the observed deaths for that cohort in each year in a specific age group (methods appendix p 44).", "In CodCorrect, for each draw from the posterior distribution of each cause, the sum of cause-specific estimates is rescaled to equal the draw from the all-cause distribution (methods appendix p 285).", "We generated a set of underlying cause of death estimates, with uncertainty intervals, that equalled all-cause mortality, with uncertainty intervals, for each age–sex–year–geography and cause and all-cause mortality at the individual draw level.24"]}
{"doc_id": 60003, "title": "", "abstract": ["Given the strong association between diabetes and obesity and the global rise of obesity, the finding that age-standardised death rates for diabetes, including chronic kidney disease due to diabetes mellitus, are not increasing suggests that other protective factors such as treatment might have an effect.117, 118", "Traditionally, this evidence has been limited to the findings of relatively conventional and straightforward mortality analyses.", "Correctly establishing the relative public health importance of pandemic preparedness investments is non-trivial, because even if there are no deaths in a year from a potential pandemic cause, such as pandemic influenza, substantial excess mortality risk remains.90", "With global life expectancy or other mortality metrics improving faster than expected on the basis of SDI, this general trend was tempered by stagnant or increasing mortality rates due to a subset of causes such as diabetes, cardiovascular disease, and some types of cancer.", "Cancers, for example, began to exact a larger toll for males than females at SDI levels of about 0·40; this was mainly associated with rising mortality due to lung cancer."]}
{"doc_id": 60004, "title": "", "abstract": ["Chronic kidney disease due to diabetes mellitus caused significantly more deaths in 2015 than in 2005 (an increase of 39·5% [35·4–43·5], to 418 000 deaths [389 000–441 000]), and age-standardised death rates also rose 6·4% (3·3–9·3).", "The GBD cause list is the crucial organising framework for the analysis of causes of death and premature mortality, as well as disease incidence and prevalence and years lived with disability.21", "Globally, ischaemic heart disease and stroke were the leading two causes of premature mortality in 2015; 119 countries and territories also had ischaemic heart disease or stroke as the leading cause of YLLs that year.", "GBD 2015=Global Burden of Disease 2015 Study.", "The estimate of 1·5 million deaths (95% UI 1·5 million to 1·6 million) due to diabetes, plus 418 000 deaths (389 000–441 000) from chronic kidney disease due to diabetes mellitus, still underestimates the full impact of diabetes on all-cause mortality because of the increased risk of ischaemic heart disease, stroke, and tuberculosis associated with diabetes.113, 114, 115"]}
{"doc_id": 60005, "title": "", "abstract": ["In 2015, we estimated that 1·3 million deaths (95% UI 1·2 million to 1·4 million) were caused by diarrhoeal diseases, including 499 000 (447 000–558 000) in children younger than 5 years, representing 8·6% (7·7–9·5) of all deaths in this age group.", "Our estimates of under-5 deaths due to diarrhoea for 2015 were also lower, at 499 000 (447 000–558 000), than those of the MCEE group (526 000), although we attributed more diarrhoeal deaths among neonates.", "In 2015, we estimated the number of under-5 deaths as 5·8 million (95% UI 5·7 million to 6·0 million), which was lower than the MCEE's estimate of 5 945 000 (95% CI 5 707 000–6 395 000) for that year.165", "Age-standardised death rates due to diarrhoeal diseases fell 32·2% (27·7–36·5) from 2005 to 2015, although total deaths fell more slowly (20·8%, 15·4–26·1) to 1·3 million deaths (1·2 million to 1·4 million).", "Lower respiratory infections, diarrhoeal diseases, and malaria caused 57·0% (49·7–64·6) of deaths among children aged 1–59 months, leading to a total of 1·8 million deaths (1·6 million to 2·1 million)."]}
{"doc_id": 60006, "title": "", "abstract": ["For every country in sub-Saharan Africa, the leading cause of early death was one of four communicable diseases—HIV/AIDS, malaria, lower respiratory infection, or diarrhoeal diseases—yet patterns in observed and expected levels of YLLs strikingly differed within the continent.", "Although still among the leading causes of early death in western sub-Saharan Africa, YLLs due to lower respiratory infections and diarrhoeal diseases were much lower than expected for most countries, with YLL ratios as low as 0·29 in Mali and 0·28 in The Gambia, respectively.", "In southern sub-Saharan Africa, HIV/AIDS was the leading cause of premature mortality and resulted in exceedingly more YLLs than expected given SDI; Namibia, with a YLL ratio for HIV/AIDS of 7·97, was the lowest among these countries, whereas Swaziland had the highest ratio (19·98).", "Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death.", "Within eastern sub-Saharan Africa, eight of 15 countries had YLL ratios less than 0·60 for YLLs due to diarrhoeal diseases (eg, Rwanda [0·40] and Uganda [0·47]), emphasising the region's rising SDI."]}
{"doc_id": 60007, "title": "", "abstract": ["Globally, ischaemic heart disease and stroke were the leading two causes of premature mortality in 2015; 119 countries and territories also had ischaemic heart disease or stroke as the leading cause of YLLs that year.", "Globally, deaths due to ischaemic heart disease increased by 16·6% (14·6–18·6) from 2005 to 2015 to 8·9 million deaths (8·8 million to 9·1 million), whereas age-standardised mortality rates for ischaemic heart disease decreased at a more moderate pace (fell by 12·8%, 11·4–14·2).", "Although ischaemic heart disease was a leading cause of early death for many Latin American countries, several had ratios of observed and expected YLLs lower than 0·60, including Peru (0·33), Panama (0·50), and Colombia (0·51).", "Global cardiovascular disease deaths rose by 12·5% (95% UI 10·6–14·4) between 2005 and 2015, whereas age-standardised rates of death due to cardiovascular disease fell 15·6% (14·2–16·9).", "Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias."]}
{"doc_id": 60008, "title": "", "abstract": ["The categorical attribution of causes of death differs from a counterfactual approach, which answers the question “in the absence of the disease of interest how many deaths would not have occurred?”, similar to how we estimate burden due to risk factors in GBD.", "Estimates of deaths due to rotavirus in GBD 2015 and CHERG were similar, which is not surprising given the good diagnostic validity of ELISA for rotavirus.", "The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015.", "The GBD analytical approach to estimation is guided by standardised solutions to some general analytical problems: inconsistent case definitions or coding over time or across geographies; missing data; conflicting data for the same year and geography; and population groups (eg, the poor, minorities, and vulnerable groups) who are often missed in administrative data sources.", "We used the ICD principle of underlying cause of death for the primary tabulations in this Article."]}
{"doc_id": 60009, "title": "", "abstract": ["Population ageing led to increasing mortality for most causes, but its relative contribution ranged from less than 4% for interpersonal violence and diarrhoeal diseases to 29·6% for Alzheimer's disease and other dementias.", "Rotavirus was also the leading cause of mortality due to diarrhoea in all ages (15·2% [12·9–18·1], 199 200 deaths [165 500–241 200]), followed by Shigella (12·5% [6·4–21·2], 164 300 deaths [85 000–278 700]) and other Salmonella infections (6·9% [2·7–13·9], 90 300 deaths [34 100–183 100]; table 7).", "The estimate of 1·5 million deaths (95% UI 1·5 million to 1·6 million) due to diabetes, plus 418 000 deaths (389 000–441 000) from chronic kidney disease due to diabetes mellitus, still underestimates the full impact of diabetes on all-cause mortality because of the increased risk of ischaemic heart disease, stroke, and tuberculosis associated with diabetes.113, 114, 115", "Globally, ischaemic heart disease and stroke were the leading two causes of premature mortality in 2015; 119 countries and territories also had ischaemic heart disease or stroke as the leading cause of YLLs that year.", "Mortality due to Clostridium difficile was the lowest among all diarrhoea causes, but was a major cause of diarrhoea mortality in high-income countries."]}
{"doc_id": 60010, "title": "", "abstract": ["62 Group 1 causes of under-5 deaths were lower respiratory infections (12·1% [11·2–13·1], 703 000 deaths [651 000–763 000]); diarrhoeal diseases (8·5% [7·7–9·5], 499 000 deaths [447 000–558 000]); malaria (8·1% [5·7–10·7], 474 000 deaths [333 000–624 000]); nutritional deficiencies (3·3% [2·6–4·3], 193 000 deaths [147 000–248 000]); and meningitis (3·0% [2·3–3·9], 173 000 deaths [137 000–229 000]).", "In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000–183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000–532 000), although pathogen- specific mortality varied by region.", "We estimated that 2·7 million (95% UI 2·5 million to 2·9 million) deaths occurred in 2015 due to lower respiratory infections, of which 704 000 (651 000–763 000) occurred among children younger than 5 years, representing 12·1% of deaths in this age group.", "From 2005 to 2015, the number of deaths due to lower respiratory infections decreased by 3·25% (−0·45 to 6·94) globally in all age groups, but decreased by 36·9% (31·6–42·0) in children younger than 5 years.", "Respiratory syncytial virus (5·2% [2·9–8·6], 36 400 deaths [20 400–61 500]) and influenza (1·4% [0·8–2·4], 10 200 deaths [5700–16 800]) together accounted for less than 10% of deaths due to lower respiratory infections in children younger than 5 years, and the remaining 29% of such deaths in this age group remain unattributed."]}
{"doc_id": 60011, "title": "", "abstract": ["Mortality due to Clostridium difficile was the lowest among all diarrhoea causes, but was a major cause of diarrhoea mortality in high-income countries.", "Examination of epidemiological convergence among high-income, middle-income, and low-income countries showed the importance of evaluating both absolute and relative changes in mortality, as solely focusing on absolutes can mask rising relative inequality among certain age groups and causes.", "Evidence from previous research has shown that a combination of preventive approaches addressing multiple factors, such as increased public awareness, programmes based on behavioural change and coping strategies, physician education, and decreased access to means of self-harm is needed.140, 141, 142, 143", "We expect the availability of cancer registry data in low-income and middle-income countries to increase due to the Global Initiative for Cancer Registry Development, which is led by IARC.", "Whereas colorectal, breast, and pancreatic cancer are the leading causes of cancer YLLs for most high-income countries, stomach, liver, and oesophageal cancer dominate in countries with low SDI."]}
{"doc_id": 60012, "title": "", "abstract": ["The normative standard life expectancy at birth is 86·59 years, which is based on the lowest observed death rates for each 5-year age group in populations larger than 5 million.", "The red line shows the GBD 2015 life table system estimates of age-specific mortality rates from birth through age 75 years in log space, compared with observed age-specific mortality (blue line).", "WHO has also generated estimates of YLLs, but comparisons of WHO estimates with those of GBD are limited because WHO chose to use the highest projected life expectancy for 2050—91·9 years—rather than the GBD 2010 normative standard life expectancy of 86·0 years for 2010.172 GBD 2010 did not include mortality estimates for the year 2012, so WHO estimates for that year were interpolated.", "For the 189 countries for which both series provide estimates, GBD 2015 tends to have higher estimates of life expectancy at birth for both males (111 countries) and females (112 countries).", "Age-specific mortality estimation with GBD life table method versus observed data excluded from the model"]}
{"doc_id": 60013, "title": "", "abstract": ["The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14·1% (12·6–16·0) to 39·8 million (39·2 million to 40·5 million) in 2015, whereas age-standardised rates decreased by 13·1% (11·9–14·3).", "In 2015, the leading causes of NCD deaths were cardiovascular disease (17·9 million, 95% UI 17·6 million to 18·3 million), cancers (8·8 million, 8·6 million to 8·9 million), and chronic respiratory diseases (3·8 million, 3·7 million to 3·9 million).", "Total mortality also increased from 2005 to 2015 for diabetes, which rose by 32·1% (95% UI 27·7–36·3), to 1·5 million deaths (1·5 million to 1·6 million), and chronic kidney disease, which rose by 31·7% (27·7–35·6), to 1·2 million deaths (1·1 million to 1·3 million); by contrast, changes in age- standardised death rates due to diabetes and chronic kidney disease were not statistically significant.", "Broadly, communicable, maternal, neonatal, and nutritional diseases, known as Group 1 causes for GBD, accounted for 20·2% (95% UI 19·7–20·7) of global deaths in 2015 (11·3 million, 95% UI 10·9 million to 11·6 million), NCDs caused 71·3% (70·9–72·0) of deaths (39·8 million, 39·2 million to 40·5 million), and injuries resulted in 8·5% (7·9–8·5) of deaths (4·7 million, 4·4 million to 4·9 million).", "Mortality due to Clostridium difficile was the lowest among all diarrhoea causes, but was a major cause of diarrhoea mortality in high-income countries."]}
{"doc_id": 60014, "title": "", "abstract": ["Globally, ischaemic heart disease and stroke were the leading two causes of premature mortality in 2015; 119 countries and territories also had ischaemic heart disease or stroke as the leading cause of YLLs that year.", "In 2015, self-harm was the second-leading cause of death from injury.", "For many high-income countries, observed YLLs due to stroke—a cause consistently among the leading three causes of early death—fell below the levels expected on the basis of SDI in 2015.", "Furthermore, interpersonal violence ranked as the first or second leading cause of early death for seven of 11 countries in central and Tropical Latin America.", "Ischaemic heart disease and stroke accounted for 15·2 million deaths (15·0 million to 15·6 million) in 2015, equating to 85·1% (84·7–85·5) of all deaths due to cardiovascular disease that year."]}
{"doc_id": 60015, "title": "", "abstract": ["In 2015, 55·8 million deaths (55·0 million to 56·6 million) occurred worldwide, an increase of 7·9 million deaths since 1990 and 2·2 million deaths since 2005 (table 4).", "Road injuries, COPD, and congenital anomalies, ranked as ninth, tenth, and 11th leading causes of YLLs in 2005, remained largely the same in terms of ranks in 2015, with only road injuries moving up by one spot to rank eighth.", "In 2015, 30·9 million (30·3 million to 31·5 million) males and 24·9 million (24·5 million to 25·5 million) females died, representing an increase of 5·6 million male deaths and 2·3 million female deaths since 1990.", "Total deaths increased by 4·1% (2·6–5·6) from 2005 to 2015, rising to 55·8 million (54·9 million to 56·6 million) in 2015, but age- standardised death rates fell by 17·0% (15·8–18·1) during this time, underscoring changes in population growth and shifts in global age structures.", "Total mortality also increased from 2005 to 2015 for diabetes, which rose by 32·1% (95% UI 27·7–36·3), to 1·5 million deaths (1·5 million to 1·6 million), and chronic kidney disease, which rose by 31·7% (27·7–35·6), to 1·2 million deaths (1·1 million to 1·3 million); by contrast, changes in age- standardised death rates due to diabetes and chronic kidney disease were not statistically significant."]}
{"doc_id": 20000, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "A key secondary end point evaluated the efficacy of mRNA-1273 at preventing severe Covid-19.", "Participants younger than 65 years of age were categorized as having risk for severe Covid-19 if they had at least one of the following risk factors, based on the Centers for Disease Control and Prevention (CDC) criteria available at the time of trial design: chronic lung disease (e.g., emphysema, chronic bronchitis, idiopathic pulmonary fibrosis, cystic fibrosis, or moderate-to-severe asthma); cardiac disease (e.g., heart failure, congenital coronary artery disease, cardiomyopathies, or pulmonary hypertension); severe obesity (body mass index [the weight in kilograms divided by the square of the height in meters] ≥40); diabetes (type 1, type 2, or gestational); liver disease; or infection with the human immunodeficiency virus.18", "A secondary end point was the efficacy of mRNA-1273 in the prevention of severe Covid-19 as defined by one of the following criteria: respiratory rate of 30 or more breaths per minute; heart rate at or exceeding 125 beats per minute; oxygen saturation at 93% or less while the participant was breathing ambient air at sea level or a ratio of the partial pressure of oxygen to the fraction of inspired oxygen below 300 mm Hg; respiratory failure; acute respiratory distress syndrome; evidence of shock (systolic blood pressure <90 mm Hg, diastolic blood pressure <60 mm Hg, or a need for vasopressors); clinically significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; or death.", "It is important to note that all the severe Covid-19 cases were in the placebo group, which suggests that mRNA-1273 is likely to have an effect on preventing severe illness, which is the major cause of health care utilization, complications, and death."]}
{"doc_id": 20001, "title": "", "abstract": ["Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications.", "Vaccines are needed to reduce the morbidity and mortality associated with Covid-19, and multiple vaccine platforms have been involved in the rapid development of vaccine candidates.1-9", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "The primary end point was prevention of Covid-19 illness with onset at least 14 days after the second injection in participants who had not previously been infected with SARS-CoV-2.", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001)."]}
{"doc_id": 20002, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "The vaccine efficacy to prevent Covid-19 was consistent across subgroups stratified by demographic and baseline characteristics (Figure 4): age groups (18 to <65 years of age and ≥65 years), presence of risk for severe Covid-19, sex, and race and ethnic group (non- Hispanic White and communities of color).", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "The trial Investigational New Drug sponsor, Moderna, was responsible for the overall trial design (with input from the Biomedical Advanced Research and Development Authority, the NIAID, the Covid-19 Prevention Network, and the trial cochairs), site selection and monitoring, and data analysis.", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline."]}
{"doc_id": 20003, "title": "", "abstract": ["A total of 151 cases of Covid-19 would provide 90% power to detect a 60% reduction in the hazard rate (i.e., 60% vaccine efficacy), with two planned interim analyses at approximately 35% and 70% of the target total number of cases (151) and with a one-sided O’Brien–Fleming boundary for efficacy and an overall one-sided error rate of 0.025.", "Participants younger than 65 years of age were categorized as having risk for severe Covid-19 if they had at least one of the following risk factors, based on the Centers for Disease Control and Prevention (CDC) criteria available at the time of trial design: chronic lung disease (e.g., emphysema, chronic bronchitis, idiopathic pulmonary fibrosis, cystic fibrosis, or moderate-to-severe asthma); cardiac disease (e.g., heart failure, congenital coronary artery disease, cardiomyopathies, or pulmonary hypertension); severe obesity (body mass index [the weight in kilograms divided by the square of the height in meters] ≥40); diabetes (type 1, type 2, or gestational); liver disease; or infection with the human immunodeficiency virus.18", "†Risk was based on a stratification factor from the Internet-based interactive response system used for randomization; participants who were younger than 65 years of age were categorized as at risk for severe Covid-19 illness if they had at least one of the risk factors specified in the trial protocol at screening.", "For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "Thirty participants in the trial had severe Covid-19; all 30 were in the placebo group (indicating vaccine efficacy of 100% [95% CI, could not be estimated to 1.0]), and one death among these participants was attributed to Covid-19 (Table S16)."]}
{"doc_id": 20004, "title": "", "abstract": ["The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.", "Shortly after the SARS-CoV-2 genetic sequence was determined in January 2020, mRNA-1273, a lipid-nanoparticle (LNP)–encapsulated mRNA vaccine expressing the prefusion-stabilized spike glycoprotein, was developed by Moderna and the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID), within the National Institutes of Health (NIH).14", "Earlier work had suggested that the spike protein of the coronavirus responsible for the 2002 SARS outbreak was a suitable target for protective immunity.10", "The magnitude of mRNA-1273 vaccine efficacy at preventing symptomatic SARS- CoV-2 infection is higher than the efficacy observed for vaccines for respiratory viruses, such as the inactivated influenza vaccine against symptomatic, virologically confirmed disease in adults, for which studies have shown a pooled efficacy of 59%.19", "The COVE trial provides evidence of short-term efficacy of the mRNA-1273 vaccine in preventing symptomatic SARS-CoV-2 infection in a diverse adult trial population."]}
{"doc_id": 20005, "title": "", "abstract": ["For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "The magnitude of mRNA-1273 vaccine efficacy at preventing symptomatic SARS- CoV-2 infection is higher than the efficacy observed for vaccines for respiratory viruses, such as the inactivated influenza vaccine against symptomatic, virologically confirmed disease in adults, for which studies have shown a pooled efficacy of 59%.19", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline."]}
{"doc_id": 20006, "title": "", "abstract": ["In the overall population, the incidence of treatment-related severe adverse events was higher in the mRNA-1273 group (71 participants [0.5%]) than in the placebo group (28 participants [0.2%]) (Tables S8 and S15).", "Solicited adverse events at the injection site occurred more frequently in the mRNA-1273 group than in the placebo group after both the first dose (84.2%, vs. 19.8%) and the second dose (88.6%, vs. 18.8%) (Figure 2 and Tables S3 and S4).", "Solicited systemic adverse events occurred more often in the mRNA-1273 group than in the placebo group after both the first dose (54.9%, vs. 42.2%) and the second dose (79.4%, vs. 36.5%).", "Overall, 0.5% of participants in the placebo group and 0.3% in the mRNA-1273 group had adverse events that resulted in their not receiving the second dose, and less than 0.1% of participants in both groups discontinued participation in the trial because of adverse events after any dose (Table S8).", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease."]}
{"doc_id": 20007, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline.", "Thirty participants in the trial had severe Covid-19; all 30 were in the placebo group (indicating vaccine efficacy of 100% [95% CI, could not be estimated to 1.0]), and one death among these participants was attributed to Covid-19 (Table S16)."]}
{"doc_id": 20008, "title": "", "abstract": ["Overall, the local reactions to vaccination were mild; however, moderate-to-severe systemic side effects, such as fatigue, myalgia, arthralgia, and headache, were noted in about 50% of participants in the mRNA-1273 group after the second dose.", "The most common treatment-related adverse events (those reported in at least 1% of participants) in the placebo group and the mRNA-1273 group were fatigue (1.2% and 1.5%) and headache (0.9% and 1.4%).", "Solicited adverse events at the injection site occurred more frequently in the mRNA-1273 group than in the placebo group after both the first dose (84.2%, vs. 19.8%) and the second dose (88.6%, vs. 18.8%) (Figure 2 and Tables S3 and S4).", "In the mRNA-1273 group, injection-site events were mainly grade 1 or 2 in severity and lasted a mean of 2.6 and 3.2 days after the first and second doses, respectively (Table S5).", "The overall incidence of unsolicited adverse events reported up to 28 days after vaccination and of serious adverse events reported throughout the entire trial was similar for mRNA-1273 and placebo."]}
{"doc_id": 20009, "title": "", "abstract": ["Between days 1 and 42, seven cases of Covid-19 were identified in the mRNA-1273 group, as compared with 65 cases in the placebo group (Figure 3B).", "No evidence of vaccine-associated enhanced respiratory disease was noted, and fewer cases of severe Covid-19 or any Covid-19 were observed among participants who received mRNA-1273 than among those who received placebo (Tables S13 and S14).", "As of the data cutoff, 11 cases of Covid-19 had occurred in the mRNA-1273 group, a finding that limits our ability to detect a correlate of protection.", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "After day 1 and through November 25, 2020, a total of 269 Covid-19 cases were identified, with an incidence of 79.8 cases per 1000 person-years (95% confidence interval [CI], 70.5 to 89.9) among participants in the placebo group with no evidence of previous SARS-CoV-2 infection."]}
{"doc_id": 20010, "title": "", "abstract": ["Among participants who were positive for SARS-CoV-2, by serologic or virologic testing, at baseline (337 in the placebo group and 343 in the mRNA-1273 group), one case of Covid-19 was diagnosed by RT-PCR testing in a placebo recipient and no cases were diagnosed in mRNA-1273 recipients (Table S17).", "Eligible participants were persons 18 years of age or older with no known history of SARS-CoV-2 infection and with locations or circumstances that put them at an appreciable risk of SARS-CoV-2 infection, a high risk of severe Covid-19, or both.", "Among participants who were negative for SARS-CoV-2 at baseline (by RT-PCR or antibody testing), in addition to symptomatic Covid-19 cases 39 (0.3%) in the placebo group and 15 (0.1%) in the mRNA-1273 group had nasopharyngeal swabs that were positive for SARS-CoV-2 by RT-PCR at the second dose visit (surveillance swab) but had no evidence of Covid-19 symptoms (Table S18).", "More than 96% of participants received both injections, and 2.2% had evidence (serologic, virologic, or both) of SARS-CoV-2 infection at baseline.", "After day 1 and through November 25, 2020, a total of 269 Covid-19 cases were identified, with an incidence of 79.8 cases per 1000 person-years (95% confidence interval [CI], 70.5 to 89.9) among participants in the placebo group with no evidence of previous SARS-CoV-2 infection."]}
{"doc_id": 20011, "title": "", "abstract": ["The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline.", "The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "A key secondary end point evaluated the efficacy of mRNA-1273 at preventing severe Covid-19.", "Vaccines are needed to reduce the morbidity and mortality associated with Covid-19, and multiple vaccine platforms have been involved in the rapid development of vaccine candidates.1-9"]}
{"doc_id": 20012, "title": "", "abstract": ["For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "The magnitude of mRNA-1273 vaccine efficacy at preventing symptomatic SARS- CoV-2 infection is higher than the efficacy observed for vaccines for respiratory viruses, such as the inactivated influenza vaccine against symptomatic, virologically confirmed disease in adults, for which studies have shown a pooled efficacy of 59%.19", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline."]}
{"doc_id": 20013, "title": "", "abstract": ["In addition, although our trial showed that mRNA-1273 reduces the incidence of symptomatic SARS-CoV-2 infection, the data were not sufficient to assess asymptomatic infection, although our results from a preliminary exploratory analysis suggest that some degree of prevention may be afforded after the first dose.", "The magnitude of mRNA-1273 vaccine efficacy at preventing symptomatic SARS- CoV-2 infection is higher than the efficacy observed for vaccines for respiratory viruses, such as the inactivated influenza vaccine against symptomatic, virologically confirmed disease in adults, for which studies have shown a pooled efficacy of 59%.19", "The efficacy of the mRNA-1273 vaccine could be demonstrated at either the interim or the primary analysis, performed when the target total number of cases had been observed.", "Earlier work had suggested that the spike protein of the coronavirus responsible for the 2002 SARS outbreak was a suitable target for protective immunity.10", "Of the participants who received a first injection, 14,073 of those in the placebo group and 14,134 in the mRNA-1273 group were included in the primary efficacy analysis; 525 participants in the placebo group and 416 in the mRNA-1273 group were excluded from the per-protocol population, including those who had not received a second dose by the day 29 data cutoff (Figure 1)."]}
{"doc_id": 20014, "title": "", "abstract": ["The mRNA-1273 vaccine, provided as a sterile liquid at a concentration of 0.2 mg per milliliter, was administered by injection into the deltoid muscle according to a two-dose regimen.", "Solicited adverse events at the injection site occurred more frequently in the mRNA-1273 group than in the placebo group after both the first dose (84.2%, vs. 19.8%) and the second dose (88.6%, vs. 18.8%) (Figure 2 and Tables S3 and S4).", "Between July 27, 2020, and October 23, 2020, a total of 30,420 participants underwent randomization, and the 15,210 participants in each group were assigned to receive two doses of either placebo or mRNA-1273 (100 μg) (Figure 1).", "Solicited systemic adverse events occurred more often in the mRNA-1273 group than in the placebo group after both the first dose (54.9%, vs. 42.2%) and the second dose (79.4%, vs. 36.5%).", "The degree of reactogenicity after one dose of mRNA-1273 was less than that observed for the recently approved recombinant adjuvanted zoster vaccine and after the second mRNA-1273 dose was similar to that of the zoster vaccine.21,22"]}
{"doc_id": 20015, "title": "", "abstract": ["The most common treatment-related adverse events (those reported in at least 1% of participants) in the placebo group and the mRNA-1273 group were fatigue (1.2% and 1.5%) and headache (0.9% and 1.4%).", "Overall, the local reactions to vaccination were mild; however, moderate-to-severe systemic side effects, such as fatigue, myalgia, arthralgia, and headache, were noted in about 50% of participants in the mRNA-1273 group after the second dose.", "Figure 2 Solicited Local and Systemic Adverse Events.", "Solicited systemic adverse events occurred more often in the mRNA-1273 group than in the placebo group after both the first dose (54.9%, vs. 42.2%) and the second dose (79.4%, vs. 36.5%).", "The frequency of unsolicited adverse events, unsolicited severe adverse events, and serious adverse events reported during the 28 days after injection was generally similar among participants in the two groups (Tables S8 through S11)."]}
{"doc_id": 20016, "title": "", "abstract": ["Dr. Baden reports being funded by the NIH to conduct clinical trials in collaboration with Crucell/Janssen and Moderna; Dr. Rouphael, receiving grant support from Pfizer, Merck, Sanofi–Pasteur, Eli Lilly, and Quidel; Dr. Creech, receiving grant support from Merck, consulting fees from Horizon Pharma and GSK, and fees for serving on a data and safety monitoring board from Astellas; Dr. Neuzil, receiving grant support from Pfizer; Dr. Graham, holding pending patent WO/2018/081318 on prefusion coronavirus spike proteins and their use and pending patent 62/972,886 on 2019-nCoV vaccine; Dr. Bennett, being employed by and owning stock and stock options in Moderna; Dr. Pajon, being employed by and owning stock in Moderna; Dr. Knightly, being employed by and owning stock and stock options in Moderna; Drs. Leav, Deng, and Zhou being employees of Moderna; Dr. Han, being employed by and owning stock and stock options in Moderna; Dr. Ivarsson, being employed by and owning share options in Moderna; Dr. Miller, being employed by and owning stock and stock options in Moderna; and Dr. Zaks, being employed by and owning stock options in Moderna.", "Designated team members within Moderna have unblinded access to the data, to facilitate interface with the regulatory agencies and the data and safety monitoring board; all other trial staff and participants remain unaware of the treatment assignments.", "The trial Investigational New Drug sponsor, Moderna, was responsible for the overall trial design (with input from the Biomedical Advanced Research and Development Authority, the NIAID, the Covid-19 Prevention Network, and the trial cochairs), site selection and monitoring, and data analysis.", "Shortly after the SARS-CoV-2 genetic sequence was determined in January 2020, mRNA-1273, a lipid-nanoparticle (LNP)–encapsulated mRNA vaccine expressing the prefusion-stabilized spike glycoprotein, was developed by Moderna and the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID), within the National Institutes of Health (NIH).14", "A medical writer funded by Moderna assisted in drafting the manuscript for submission."]}
{"doc_id": 90000, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "However, nearly 85% of adults aged >65 years achieved the less stringent A1C <8.0% (<64 mmol/mol) goal, but less than half of younger individuals achieved the more stringent goal of <7.0% (<53 mmol/mol) in 2007–2010.", "In 2007–2010, the overall prevalence of persons with diabetes achieving A1C <7.0% (<53 mmol/mol) was 52.5% (Fig. 1 and Table 1).", "Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "National Health and Nutrition Examination Survey (NHANES) data indicate that the prevalence of achieving an A1C <7.0% (<53 mmol/mol) increased from 44% in 1988–1994 to 57% in 2003–2006; achieving a BP <130/80 mmHg increased from 29 to 46% during the same interval (5,6)."]}
{"doc_id": 90001, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "Between 1988 and 2010, the proportion of people who achieved BP <130/80 mmHg significantly improved, with 33.2% in 1988–1994, 38.1% in 1999–2002, 44.2% in 2003–2006, and 51.1% in 2007–2010 meeting the goal (P < 0.05 for all estimates compared with 2007–2010).", "National Health and Nutrition Examination Survey (NHANES) data indicate that the prevalence of achieving an A1C <7.0% (<53 mmol/mol) increased from 44% in 1988–1994 to 57% in 2003–2006; achieving a BP <130/80 mmHg increased from 29 to 46% during the same interval (5,6).", "In 2007–2010, the prevalence of individuals with diabetes having BP <130/80 mmHg was 51.1% (Fig. 1 and Table 2).", "The prevalence of achieving BP <130/80 mmHg and BP <140/90 mmHg among adults with previously diagnosed diabetes in NHANES 1988–2010‡"]}
{"doc_id": 90002, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "Target goals for A1C, BP, and LDL measures were based on the ADA’s Standards of Medical Care for most people with diabetes, including A1C <7.0% (<53 mmol/mol), BP <130/80 mmHg, and LDL <100 mg/dL (3).", "On the basis of this research, the American Diabetes Association (ADA) recommends that most adults with diabetes achieve an A1C <7.0% (<53 mmol/mol), BP <130/80 mmHg, and LDL cholesterol <100 mg/dL (ABCs) (3).", "In addition, less stringent cut points were assessed, as recommended by the ADA (A1C <8.0% [<64 mmol/mol], BP <140/90 mmHg).", "This analysis only reports ABC control for individuals who self-reported diabetes."]}
{"doc_id": 90003, "title": "", "abstract": ["However, despite the strong scientific evidence showing the benefits of ABC control and statin use in reducing complications, many patients are not achieving ABC targets or taking statins.", "First, achieving ADA recommendations may be biologically unattainable for some patients due to severity of disease or other complications.", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups.", "Dissemination of knowledge from these pivotal studies (4), together with an increasing array of glycemic, antihypertensive, and lipid medications available for therapy, have made achievement of ADA goals more attainable, especially for those with less severe disease.", "Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals."]}
{"doc_id": 90004, "title": "", "abstract": ["Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "The full effects of improved therapy for diabetes are often realized over decades.", "Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality.", "Although the percentage of people with diabetes who achieve the ABC goals has increased since NDEP was initiated, the most recent estimates indicate that control remains suboptimal.", "Previous studies suggest that people with diabetes are taking steps to improve lifestyle factors."]}
{"doc_id": 90005, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "Only 7% of people with diabetes in 1999–2002 and 12% in 2003–2006 met all three ABC goals (5).", "Notably, only 30% of those taking insulin achieved an A1C <7.0% (<53 mmol/mol), and more than one-third of this population did not achieve A1C <8.0% (<64 mmol/mol).", "Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "National Health and Nutrition Examination Survey (NHANES) data indicate that the prevalence of achieving an A1C <7.0% (<53 mmol/mol) increased from 44% in 1988–1994 to 57% in 2003–2006; achieving a BP <130/80 mmHg increased from 29 to 46% during the same interval (5,6)."]}
{"doc_id": 90006, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "In 2007–2010, 18.8% of people achieved all three ABC goals (Fig. 1).", "In 2007–2010, the prevalence of individuals with diabetes having BP <130/80 mmHg was 51.1% (Fig. 1 and Table 2).", "In 2007–2010, the overall prevalence of persons with diabetes achieving A1C <7.0% (<53 mmol/mol) was 52.5% (Fig. 1 and Table 1).", "Between 1988 and 2010, the proportion of people who achieved BP <130/80 mmHg significantly improved, with 33.2% in 1988–1994, 38.1% in 1999–2002, 44.2% in 2003–2006, and 51.1% in 2007–2010 meeting the goal (P < 0.05 for all estimates compared with 2007–2010)."]}
{"doc_id": 90007, "title": "", "abstract": ["Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "Data from a national sample of overweight and obese subjects with diabetes indicated that the majority reported trying to lose weight (75%), increase physical activity (57%), and reduce the number of calories and fat in their diet (71%) (21).", "Finally, because goals are increasingly being tailored on the basis of individual factors, it is not expected or desirable that everyone with diabetes should attain these targets.", "However, despite the strong scientific evidence showing the benefits of ABC control and statin use in reducing complications, many patients are not achieving ABC targets or taking statins.", "Regardless of time since diagnosis, whether patients had retinopathy or a history of CVD or were taking antihypertensive or lipid medications, all adults showed improvements in meeting all three goals between 1988–1994 and 2007–2010."]}
{"doc_id": 90008, "title": "", "abstract": ["However, despite the strong scientific evidence showing the benefits of ABC control and statin use in reducing complications, many patients are not achieving ABC targets or taking statins.", "In addition, BP and lipid control substantially reduce cardiovascular disease (CVD), the major cause of death for individuals with diabetes (2).", "Furthermore, in 1997, the Scandinavian Simvastatin Survival Study found that lipid control significantly reduced major CVD events among people with diabetes (15).", "In 1998, the Hypertension Optimal Treatment trial established the benefit of a diastolic BP goal <80 mmHg in reducing CVD in diabetes (14).", "Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality."]}
{"doc_id": 90009, "title": "", "abstract": ["Only 7% of people with diabetes in 1999–2002 and 12% in 2003–2006 met all three ABC goals (5).", "Previous studies suggest that people with diabetes are taking steps to improve lifestyle factors.", "Although the percentage of people with diabetes who achieve the ABC goals has increased since NDEP was initiated, the most recent estimates indicate that control remains suboptimal.", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups.", "On the basis of this research, the American Diabetes Association (ADA) recommends that most adults with diabetes achieve an A1C <7.0% (<53 mmol/mol), BP <130/80 mmHg, and LDL cholesterol <100 mg/dL (ABCs) (3)."]}
{"doc_id": 90010, "title": "", "abstract": ["Glycemic control is more difficult in individuals with more severe β-cell loss.", "In addition, BP and lipid control substantially reduce cardiovascular disease (CVD), the major cause of death for individuals with diabetes (2).", "Dissemination of knowledge from these pivotal studies (4), together with an increasing array of glycemic, antihypertensive, and lipid medications available for therapy, have made achievement of ADA goals more attainable, especially for those with less severe disease.", "People not taking antihypertensive medications were more likely to achieve the BP goal compared with those taking medication (P < 0.0001).", "Meeting the BP goal did not significantly differ by diabetes medication use or duration of diabetes."]}
{"doc_id": 90011, "title": "", "abstract": ["Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality.", "The greatest potential to reduce type 2 diabetes-related complications may lie in focusing on controlling A1C, BP, and LDL collectively.", "On the basis of this research, the American Diabetes Association (ADA) recommends that most adults with diabetes achieve an A1C <7.0% (<53 mmol/mol), BP <130/80 mmHg, and LDL cholesterol <100 mg/dL (ABCs) (3).", "In addition, BP and lipid control substantially reduce cardiovascular disease (CVD), the major cause of death for individuals with diabetes (2).", "Falling rates of amputation, end-stage renal disease, and death among those with diabetes attest to the effect of the improved control of the risk factors for complications we report here."]}
{"doc_id": 90012, "title": "", "abstract": ["Falling rates of amputation, end-stage renal disease, and death among those with diabetes attest to the effect of the improved control of the risk factors for complications we report here.", "Those who lowered BP by 5 to 10 mmHg also significantly reduced their risk of stroke, diabetes-related death, heart failure, microvascular complications, and vision loss.", "However, that a reduction in hemoglobin A1c (A1C) and blood pressure (BP) levels significantly reduces microvascular complications has been well established (2).", "The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute of Diabetes and Digestive and Kidney Diseases or the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry.", "This work was financially supported by the National Institute of Diabetes and Digestive and Kidney Diseases (GS-10F-0381L)."]}
{"doc_id": 90013, "title": "", "abstract": ["In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "In 2007–2010, the overall prevalence of persons with diabetes achieving A1C <7.0% (<53 mmol/mol) was 52.5% (Fig. 1 and Table 1).", "The proportion of participants with diabetes achieving A1C <8.0% (<64 mmol/mol) was 77.9% in 2007–2010; similar relationships by demographics and diabetes- related characteristics were evident.", "However, nearly 85% of adults aged >65 years achieved the less stringent A1C <8.0% (<64 mmol/mol) goal, but less than half of younger individuals achieved the more stringent goal of <7.0% (<53 mmol/mol) in 2007–2010.", "Not only did a much larger proportion achieve the less stringent A1C <8.0% (<64 mmol/mol; 77.9%) than A1C <7.0% (<53 mmol/mol; 52.5%) in 2007–2010, but the disparity in achieving these goals according to time since diagnosis was much less with a goal of A1C <8.0% (<64 mmol/mol) than the goal of A1C <7.0% (<53 mmol/mol)."]}
{"doc_id": 90014, "title": "", "abstract": ["However, nearly 85% of adults aged >65 years achieved the less stringent A1C <8.0% (<64 mmol/mol) goal, but less than half of younger individuals achieved the more stringent goal of <7.0% (<53 mmol/mol) in 2007–2010.", "Not only did a much larger proportion achieve the less stringent A1C <8.0% (<64 mmol/mol; 77.9%) than A1C <7.0% (<53 mmol/mol; 52.5%) in 2007–2010, but the disparity in achieving these goals according to time since diagnosis was much less with a goal of A1C <8.0% (<64 mmol/mol) than the goal of A1C <7.0% (<53 mmol/mol).", "Thus, the ADA recommends more stringent A1C goals (<7.0%, <53 mmol/mol) for individuals with a longer life expectancy and shorter time since diagnosis and less stringent goals for those with longer time since diagnosis, established complications, or conditions limiting life expectancy (24).", "Improvement in meeting A1C <8.0% (<64 mmol/mol) was even more marked than for A1C <7.0% (<53 mmol/mol), with prevalence significantly increased between 1988–1994 (60.1%) and 2007–2010 (77.9%) and between 1999–2002 (66.3%) and 2007–2010 (all P < 0.01; Fig. 1).", "National Health and Nutrition Examination Survey (NHANES) data indicate that the prevalence of achieving an A1C <7.0% (<53 mmol/mol) increased from 44% in 1988–1994 to 57% in 2003–2006; achieving a BP <130/80 mmHg increased from 29 to 46% during the same interval (5,6)."]}
{"doc_id": 90015, "title": "", "abstract": ["The greatest potential to reduce type 2 diabetes-related complications may lie in focusing on controlling A1C, BP, and LDL collectively.", "Landmark studies in the 1990s, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, and the UK Prospective Diabetes Study (UKPDS), provided strong evidence that intensive glycemic therapy early in the course of type 1 and type 2 diabetes significantly reduced the risk of microvascular disease.", "In the UKPDS, tight glycemic control alone in patients with newly diagnosed type 2 diabetes yielded a nonsignificant 16% decrease in CVD events and a significant 25% reduction in microvascular events (2).", "Management of diabetes remains very complex and challenging, requiring access to a skilled team of clinicians and diabetes educators and imposing major burdens on families and health systems.", "Access to care, education, and self-management support; personal knowledge, behavior, and adherence to therapy; healthy environments; as well as variation in the pathophysiology underlying diabetes all play important roles in achieving diabetes management goals that can improve long-term health of individuals with diabetes."]}
{"doc_id": 90016, "title": "", "abstract": ["Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "Moreover, whereas those without retinopathy and with shorter time since diagnosis were more likely to achieve an A1C <7.0% (<53 mmol/mol), nearly half of those without established CVD or retinopathy did not achieve this goal.", "However, despite the strong scientific evidence showing the benefits of ABC control and statin use in reducing complications, many patients are not achieving ABC targets or taking statins.", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups.", "In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs."]}
{"doc_id": 90017, "title": "", "abstract": ["It is noteworthy that we found younger people with diabetes were less likely to meet A1C and LDL goals and showed smaller improvements in meeting each ABC goal.", "The prevalence of meeting the A1C goal <7.0% (<53 mmol/mol) was higher for those aged ≥75 years than for those aged 20–49 years (P = 0.022) and was greater for non-Hispanic whites and non-Hispanic blacks than for Mexican Americans (P < 0.03 for both).", "Younger individuals were less likely to meet A1C and LDL goals.", "However, nearly 85% of adults aged >65 years achieved the less stringent A1C <8.0% (<64 mmol/mol) goal, but less than half of younger individuals achieved the more stringent goal of <7.0% (<53 mmol/mol) in 2007–2010.", "Indeed, persons not taking any diabetes medications, having shorter time since diagnosis, and not having retinopathy, all of which are proxies for less advanced disease, were more likely to achieve A1C <7.0% (<53 mmol/mol)."]}
{"doc_id": 90018, "title": "", "abstract": ["However, despite the strong scientific evidence showing the benefits of ABC control and statin use in reducing complications, many patients are not achieving ABC targets or taking statins.", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups.", "The prevalence of people with diabetes achieving BP <140/90 mmHg also significantly improved between 1988–1994 (62.0%) and 2007–2010 (72.0%) and between 1999–2002 (63.3%) and 2007–2010 (all P < 0.01; Fig. 1).", "Although the percentage of people with diabetes who achieve the ABC goals has increased since NDEP was initiated, the most recent estimates indicate that control remains suboptimal.", "Finally, because goals are increasingly being tailored on the basis of individual factors, it is not expected or desirable that everyone with diabetes should attain these targets."]}
{"doc_id": 90019, "title": "", "abstract": ["The prevalence of people with diabetes achieving BP <140/90 mmHg also significantly improved between 1988–1994 (62.0%) and 2007–2010 (72.0%) and between 1999–2002 (63.3%) and 2007–2010 (all P < 0.01; Fig. 1).", "Between 1988 and 2010, the proportion of people who achieved BP <130/80 mmHg significantly improved, with 33.2% in 1988–1994, 38.1% in 1999–2002, 44.2% in 2003–2006, and 51.1% in 2007–2010 meeting the goal (P < 0.05 for all estimates compared with 2007–2010).", "In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "Although the percentage of people with diabetes who achieve the ABC goals has increased since NDEP was initiated, the most recent estimates indicate that control remains suboptimal.", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups."]}
{"doc_id": 90020, "title": "", "abstract": ["In the UKPDS, tight glycemic control alone in patients with newly diagnosed type 2 diabetes yielded a nonsignificant 16% decrease in CVD events and a significant 25% reduction in microvascular events (2).", "Landmark studies in the 1990s, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, and the UK Prospective Diabetes Study (UKPDS), provided strong evidence that intensive glycemic therapy early in the course of type 1 and type 2 diabetes significantly reduced the risk of microvascular disease.", "In addition, BP and lipid control substantially reduce cardiovascular disease (CVD), the major cause of death for individuals with diabetes (2).", "Hazard ratios were significantly reduced (0.41 for CVD events and 0.54 for overall mortality) in intensively treated participants compared with participants who received standard treatment from their general practitioner.", "Improvements in BP control were evident between 1988–1994 and 2007–2010 for all levels of education and for all adults, regardless of the presence of retinopathy, antihypertensive medication use, history of CVD, or level of eGFR."]}
{"doc_id": 90021, "title": "", "abstract": ["Notably, only 30% of those taking insulin achieved an A1C <7.0% (<53 mmol/mol), and more than one-third of this population did not achieve A1C <8.0% (<64 mmol/mol).", "Almost half of Americans with diabetes did not meet each ABC goal, and 81.2% did not achieve all three goals.", "Only 7% of people with diabetes in 1999–2002 and 12% in 2003–2006 met all three ABC goals (5).", "Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups.", "In addition, individuals with diabetes using oral diabetes medication or a combination of oral medication with insulin and those recently diagnosed with diabetes (duration <10 years) demonstrated a significant improvement in reaching the A1C goal (P < 0.05 for all)."]}
{"doc_id": 90022, "title": "", "abstract": ["The proportion of participants with diabetes achieving A1C <8.0% (<64 mmol/mol) was 77.9% in 2007–2010; similar relationships by demographics and diabetes- related characteristics were evident.", "In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs.", "In 2007–2010, the overall prevalence of persons with diabetes achieving A1C <7.0% (<53 mmol/mol) was 52.5% (Fig. 1 and Table 1).", "The prevalence of achieving A1C <7.0% (<53 mmol/mol) and A1C <8.0% (<64 mmol/mol) among adults with previously diagnosed diabetes in NHANES 1988–2010‡", "On the basis of this research, the American Diabetes Association (ADA) recommends that most adults with diabetes achieve an A1C <7.0% (<53 mmol/mol), BP <130/80 mmHg, and LDL cholesterol <100 mg/dL (ABCs) (3)."]}
{"doc_id": 43000, "title": "", "abstract": ["These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels.", "Here we show that adult-born hippocampal neurons are required for normal expression of the endocrine and behavioral components of the stress response."]}
{"doc_id": 43001, "title": "", "abstract": ["Mice lacking neurogenesis show increased anxiety/depression-like behaviors.", "However, normal anxiety- and depressive- like behavior in animals lacking neurogenesis has led to speculation that impaired neurogenesis does not directly contribute to the etiology of depression in adulthood4, 5.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5."]}
{"doc_id": 43002, "title": "", "abstract": ["Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "However, normal anxiety- and depressive- like behavior in animals lacking neurogenesis has led to speculation that impaired neurogenesis does not directly contribute to the etiology of depression in adulthood4, 5.", "A functional link between new neurons and anxiety/depression has been suggested by the demonstration that some antidepressant effects on behavior are blocked by irradiation12, 16-18.", "Mice lacking neurogenesis show increased anxiety/depression-like behaviors.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors."]}
{"doc_id": 43003, "title": "", "abstract": ["Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Using transgenic and radiation methods to specifically inhibit adult neurogenesis, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis- deficient mice compared with intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis6, 7.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "The hippocampus provides negative control of the HPA axis6, 7, but the circuitry involved is not well understood."]}
{"doc_id": 43004, "title": "", "abstract": ["Mice lacking neurogenesis show increased anxiety/depression-like behaviors.", "Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "A functional link between new neurons and anxiety/depression has been suggested by the demonstration that some antidepressant effects on behavior are blocked by irradiation12, 16-18."]}
{"doc_id": 43005, "title": "", "abstract": ["Transgenic mice expressing HSV-TK under the GFAP promoter (GFAP-TK) were generated on a C57Bl/6 background using the pGfa2-v-TK1 plasmid28 applying standard techniques and were outcrossed onto a mixed C57Bl/6:CD-1 background.", "Transgenic mice expressing HSV-TK under the GFAP promoter were generated from a previously-generated plasmid28 using standard techniques and bred on a mixed C57Bl/6:CD-1 background.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "GFAP-TK mice show specific inhibition of adult neurogenesis.", "Stellate astrocytes and radial neuronal precursor cells both express GFAP, and both cell types express TK in the transgenic mice."]}
{"doc_id": 43006, "title": "", "abstract": ["The glucocorticoid response to stress is increased in neurogenesis-deficient mice.", "In addition, there was no relationship between the extent of SVZ neurogenesis inhibition and the corticosterone response in irradiated mice (Fig. 3).", "Using transgenic and radiation methods to specifically inhibit adult neurogenesis, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis- deficient mice compared with intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis6, 7.", "Therefore, the most parsimonious interpretation of our results is that inhibition of adult neurogenesis in the dentate gyrus leads to hypersecretion of glucocorticoids in response to stress.", "Green squares at the 30 min time point indicate corticosterone levels in irradiated mice that showed unaffected neurogenesis in the subventricular zone (SVZ)."]}
{"doc_id": 43007, "title": "", "abstract": ["Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Thus, neurogenesis-deficient mice displayed a depressive phenotype at baseline, which could be induced in intact mice by acute stress.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior"]}
{"doc_id": 43008, "title": "", "abstract": ["Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors.", "In addition to its effects on emotional behavior, stress is an important modulator of learning and memory.26", "However, dysregulation of glucocorticoids is associated with cognitive impairments and depressive illness1, 2.", "However, maladaptive progression of such a feed- forward loop could potentially lead to increased stress responsiveness and depressive behaviors that persist even in the absence of stressful events."]}
{"doc_id": 43009, "title": "", "abstract": ["To directly test the contribution of adult neurogenesis in other regions, we exploited the spatial specificity of X-irradiation to reduce hippocampal neurogenesis while sparing neurogenesis in the subventricular zone (SVZ)12, 14, a source of GFAP+ neuronal precursors added to the olfactory bulb throughout adulthood8, 15.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Thus, neurogenesis-deficient mice displayed a depressive phenotype at baseline, which could be induced in intact mice by acute stress.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a)."]}
{"doc_id": 43010, "title": "", "abstract": ["A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis."]}
{"doc_id": 43011, "title": "", "abstract": ["Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "In addition to its effects on emotional behavior, stress is an important modulator of learning and memory.26", "c) Confocal images of BrdU+ and DCX+ cells illustrating sparing of neurogenesis in the SVZ.", "Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25."]}
{"doc_id": 43012, "title": "", "abstract": ["c) Neurogenesis-deficient v-TK mice became immobile faster in the forced swim test.", "GFAP-TK mice show specific inhibition of adult neurogenesis.", "Restraint stress significantly increased total immobility in v-WT mice but had no effect on v-TK mice (genotype effect F1,88=0.3, P=0.6; stress effect F1,88=4.2, P=0.04; genotype × stress interaction F1,88=9.1, P=0.003; *P<0.05 vs. control v-TK, *P<0.001 vs. stressed v-WT, stressed v-WT vs. stressed v-TK P>0.05; n=22-26/group).", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "In contrast to protocols designed to detect reductions in immobility23 (e.g. scoring minutes 2-6 of testing, when immobility is very high in controls, to detect antidepressant effects), the first 2 min of the test were scored separately to better detect potential increases in immobility."]}
{"doc_id": 43013, "title": "", "abstract": ["These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "The hippocampus provides negative control of the HPA axis6, 7, but the circuitry involved is not well understood.", "Therefore, the most parsimonious interpretation of our results is that inhibition of adult neurogenesis in the dentate gyrus leads to hypersecretion of glucocorticoids in response to stress."]}
{"doc_id": 43014, "title": "", "abstract": ["Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "We next examined whether adult neurogenesis regulates the behavioral response to stress in the novelty-suppressed feeding (NSF) test, which shows robust effects of antidepressants that are blocked by irradiation12, 18.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "Taken together, our behavioral results suggest that adult neurogenesis buffers the effect of prior stress in the NSF test, buffers the effect of inescapable stress in the forced swim test, and enhances reward- seeking behavior independent of stress in the sucrose preference test.", "Thus, adult neurogenesis does not alter behavior under baseline conditions in this test, consistent with previous observations,12, 18 but buffers the effects of stress on feeding behavior."]}
{"doc_id": 43015, "title": "", "abstract": ["Since the production of new granule neurons is itself strongly regulated by stress and glucocorticoids,3 this system forms a loop through which stress, by inhibiting adult neurogenesis, could lead to enhanced responsiveness to future stress.", "Our results therefore also suggest that buffering of stress responses by new neurons may play a role in learning and memory under novel or aversive conditions, in addition to any more direct function of young neurons in encoding of information.", "Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels.", "Using transgenic and radiation methods to specifically inhibit adult neurogenesis, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis- deficient mice compared with intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis6, 7.", "In the hippocampus, a brain region densely populated with receptors for stress hormones, stress and glucocorticoids strongly inhibit adult neurogenesis3."]}
{"doc_id": 43016, "title": "", "abstract": ["Different cohorts of mice were tested in the NSF test, elevated plus maze, forced swim test and sucrose preference test as previously described.12, 18, 21, 30", "Bottles were weighed prior to testing and again after 10 min, and sucrose preference was expressed as (Δweightsucrose)/ (Δweightsucrose \\+ Δweightwater) × 100.", "While v-WT mice showed a preference for sucrose as before, neurogenesis-deficient v-TK mice showed no sucrose preference during the test (Fig. 4e).", "Then, following water and sucrose deprivation, the bottles were reintroduced and preference was measured during a 10 min test.", "The bottles were weighed again at 1 hour and on the subsequent morning and sucrose preference over this interval was used as a long-term, overnight measure."]}
{"doc_id": 43017, "title": "", "abstract": ["A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors.", "Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "However, normal anxiety- and depressive- like behavior in animals lacking neurogenesis has led to speculation that impaired neurogenesis does not directly contribute to the etiology of depression in adulthood4, 5.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior"]}
{"doc_id": 43018, "title": "", "abstract": ["Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "The hippocampus has long been known to regulate the HPA axis6, 7, and the importance of the hippocampus for emotional behavior is emerging24.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "Using transgenic and radiation methods to specifically inhibit adult neurogenesis, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis- deficient mice compared with intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis6, 7."]}
{"doc_id": 43019, "title": "", "abstract": ["The hippocampus has long been known to regulate the HPA axis6, 7, and the importance of the hippocampus for emotional behavior is emerging24.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis.", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels."]}
{"doc_id": 43020, "title": "", "abstract": ["Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "To directly test the contribution of adult neurogenesis in other regions, we exploited the spatial specificity of X-irradiation to reduce hippocampal neurogenesis while sparing neurogenesis in the subventricular zone (SVZ)12, 14, a source of GFAP+ neuronal precursors added to the olfactory bulb throughout adulthood8, 15."]}
{"doc_id": 43021, "title": "", "abstract": ["Functional granule neurons are generated in the hippocampus throughout life via a multistep process that begins with glial fibrillary acidic protein (GFAP)-expressing radial cell precursors8, 9.", "Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "To investigate the role of adult neurogenesis in hippocampal function, we created mice that express herpes simplex virus thymidine kinase (TK) under control of the GFAP promoter (TK mice; Fig. 1a).", "Adult hippocampal neurogenesis buffers stress responses and depressive behavior"]}
{"doc_id": 43022, "title": "", "abstract": ["The hippocampus provides negative control of the HPA axis6, 7, but the circuitry involved is not well understood.", "The hippocampus has long been known to regulate the HPA axis6, 7, and the importance of the hippocampus for emotional behavior is emerging24.", "These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.", "Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels.", "Since adult hippocampal neurogenesis is highly sensitive to stress and glucocorticoids3, we hypothesized that adult neurogenesis may be important for hippocampal regulation of the HPA axis."]}
{"doc_id": 43023, "title": "", "abstract": ["Adult hippocampal neurogenesis buffers stress responses and depressive behavior", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "Taken together, our behavioral results suggest that adult neurogenesis buffers the effect of prior stress in the NSF test, buffers the effect of inescapable stress in the forced swim test, and enhances reward- seeking behavior independent of stress in the sucrose preference test.", "Thus, adult neurogenesis does not alter behavior under baseline conditions in this test, consistent with previous observations,12, 18 but buffers the effects of stress on feeding behavior.", "We next examined whether adult neurogenesis regulates the behavioral response to stress in the novelty-suppressed feeding (NSF) test, which shows robust effects of antidepressants that are blocked by irradiation12, 18."]}
{"doc_id": 43024, "title": "", "abstract": ["Thus, neurogenesis-deficient mice displayed a depressive phenotype at baseline, which could be induced in intact mice by acute stress.", "Mice lacking neurogenesis show increased anxiety/depression-like behaviors.", "Relative to controls, neurogenesis-deficient mice showed increased food avoidance in a novel environment after acute stress, increased behavioral despair in the forced swim test, and decreased sucrose preference, a measure of anhedonia.", "The glucocorticoid response to stress is increased in neurogenesis-deficient mice.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25."]}
{"doc_id": 62000, "title": "", "abstract": ["As noted in the introduction, a previous cross-national WHO study carried out in primary-care waiting-room samples found that depressed respondents in countries in which the prevalence of depression was estimated to be highest reported the lowest average levels of impairment associated with their depression, whereas the highest impairment was reported by depressed respondents in countries in which the prevalence of depression was estimated to be lowest [15].", "A justification for this line of thinking comes from an earlier cross-national WHO study of major depression in primary-care patients, which found strong similarity in the latent structure of depressive symptoms across 14 different countries in different parts of the world, but also found that countries with the highest prevalence estimates generally reported the lowest impairment associated with depression [15].", "Although direct information on the prevalence of depression does not exist for most countries, the available data indicate wide variability in the prevalence rates.", "Most recently, Moussavi et al. [9] summarized data on depressive episodes as defined by the International Classification of Diseases, 10th revision (ICD-10) in participants in the WHO World Health Survey used in 60 countries, noting that the 1-year prevalence was 3.2% in participants without comorbid physical disease, and 9.3% to 23.0% in participants with chronic conditions.", "Taken together, these results argue against the suggestion that the wide cross-national variation in depression prevalence estimates in the WMH surveys and previous epidemiologic studies is due to the threshold for defining clinically significant depression in standard diagnostic interviews differing across countries."]}
{"doc_id": 62001, "title": "", "abstract": ["Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].", "Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries.", "Our results confirm the public-health importance of major depression as a commonly occurring and seriously impairing condition with a generally early AOO and persistent course in a wide range of countries.", "We also documented an intriguing opposite-sign pattern of differences between high and low- to middle-income countries in estimates of lifetime prevalence and persistence of MDE, which might be due to differences in recall error.", "The associations between age group and MDE varied considerably between countries."]}
{"doc_id": 62002, "title": "", "abstract": ["Almost all studies find that gender, age and marital status are associated with depression.", "Overall, the association between marital status and MDE differed significantly between high and low- to middle-income countries (χ23 = 124.4, P < 0.001), due to stronger associations of being separated and never married with depression in high-income countries, and stronger associations of being divorced and widowed with depression in low- to middle-income countries.", "This means that even though variables such as education and marital status were considered predictors of depression, they might actually have been consequences or involved in reciprocal causal relationships with depression.", "Other socioeconomic factors have less consistent relationships with depression in different countries [7].", "We examined gender, age (18 to 34, 35 to 49, 50 to 64, 65+), current marital status (separated, divorced, widowed, never married, currently married), living arrangement (alone, with others but not spouse/partner, with spouse/partner), income (low, low average, high average, and high, which were based on country-specific quartiles of gross household earnings in the past 12 months [21]) and education (low, low average, high average or high, which were based on country-specific quartiles that take into consideration the fact that distributions of educational attainment vary widely between countries [22])."]}
{"doc_id": 62003, "title": "", "abstract": ["World Mental Health (WMH) Survey sample characteristics", "Prevalence (%) of DSM-IV/CIDI major depressive episodes in the 18 countries participating in the WMH surveys a", "The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation.", "This report is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative.", "The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-Shogai-023, H14-Tokubetsu-026, H16-Kokoro-013) from the Japan Ministry of Health, Labour and Welfare."]}
{"doc_id": 62004, "title": "", "abstract": ["A question can be raised by our results regarding why the associations between prevalence and impairment were so different from those reported in the earlier WHO study [15]; however, it is important to bear in mind that this earlier study was based on primary-care samples, for which selection bias regarding seeking help on the basis of either distress or impairment might induce a more negative association between these two variables than exists in the population.", "As noted in the introduction, a previous cross-national WHO study carried out in primary-care waiting-room samples found that depressed respondents in countries in which the prevalence of depression was estimated to be highest reported the lowest average levels of impairment associated with their depression, whereas the highest impairment was reported by depressed respondents in countries in which the prevalence of depression was estimated to be lowest [15].", "Unlike the earlier primary-care study, we found that the association between prevalence and impairment was positive.", "The WMH surveys, by contrast, are based on general population samples, for which the selection bias issues that occur in treatment samples do not arise.", "A justification for this line of thinking comes from an earlier cross-national WHO study of major depression in primary-care patients, which found strong similarity in the latent structure of depressive symptoms across 14 different countries in different parts of the world, but also found that countries with the highest prevalence estimates generally reported the lowest impairment associated with depression [15]."]}
{"doc_id": 62005, "title": "", "abstract": ["Indeed, the four lowest lifetime prevalence estimates (< 10%) were in low- to middle-income countries (India, Mexico, China, South Africa).", "This difference was significant in 15 of the eighteen countries, and even in the three exceptions (Belgium, Germany and China), women had higher rates than men.", "We previously reported that the pooled 12-month prevalence of MDE was similar in high-income (5.5%) and low- to middle-income (5.9%) countries (t = 1.2, P = 0.25), with the specific estimates varying from 2.2% (Japan) to 8.3% (USA) in high-income countries, and from 3.8% (China) to 10.4% (Brazil) in low- to middle-income countries [11].", "Among the high-income countries, these conditional prevalence estimates were relatively low (< 25%) in Germany, Italy, Israel and Japan, and higher (> 30%) in the Netherlands and USA.", "Among the low- to middle-income countries, the lowest ratios were in Colombia (46.7%) and South Africa (49.6%), and the highest (57-58%) in Brazil, China and Ukraine."]}
{"doc_id": 62006, "title": "", "abstract": ["The World Health Organization ranks depression as the fourth leading cause of disability worldwide [3], and projects that by 2020, it will be the second leading cause [4].", "Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries.", "It might be that these results reflect genuinely lower lifetime prevalence but higher persistence of depression in low- to middle-income than high-income countries, but another plausible and more parsimonious explanation is that error in recall of previous lifetime episodes is higher in low- to middle-income than high-income countries.", "In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.", "On average, the estimated lifetime prevalence was higher in high-income (14.6%) than low- to middle-income (11.1%) countries (t = 5.7, P < 0.001)."]}
{"doc_id": 62007, "title": "", "abstract": ["The 12-month prevalence of DSM-IV major depressive episode (MDE) in 18 countries ranged from 2.2% (Japan) to 10.4% (Brazil) [12].", "Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].", "Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to- face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI).", "The wide variability in lifetime and 12-month prevalence estimates of major depression is presumably due to a combination of substantive (genetic vulnerability and environmental risk factors) and measurement (cultural differences in the acceptance and meaning of items, and the psychometric properties of the instruments) factors.", "The authors concluded from these results that although cross-national differences in the estimated prevalence of depression cannot be attributed to differences in the nature or validity of the concept of a depressive episode, it is possible that DSM criteria may define different levels of depression severity in different countries."]}
{"doc_id": 62008, "title": "", "abstract": ["Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries.", "The World Health Organization ranks depression as the fourth leading cause of disability worldwide [3], and projects that by 2020, it will be the second leading cause [4].", "In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.", "Although direct information on the prevalence of depression does not exist for most countries, the available data indicate wide variability in the prevalence rates.", "However, contrary to our initial expectation, we did not find that cross-national differences in prevalence estimates were inversely related to differences in average level of impairment associated with depression; indeed, the opposite pattern was found."]}
{"doc_id": 62009, "title": "", "abstract": ["Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries.", "The World Health Organization ranks depression as the fourth leading cause of disability worldwide [3], and projects that by 2020, it will be the second leading cause [4].", "As expected, we also found that MDE was associated with substantial impairment.", "Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].", "Given the high level of exposure to trauma in extremely poor countries such as these [36], research is urgently needed to determine the best approaches to study the prevalence of mental disorders in these settings."]}
{"doc_id": 62010, "title": "", "abstract": ["It might be that these results reflect genuinely lower lifetime prevalence but higher persistence of depression in low- to middle-income than high-income countries, but another plausible and more parsimonious explanation is that error in recall of previous lifetime episodes is higher in low- to middle-income than high-income countries.", "The wide variability in lifetime and 12-month prevalence estimates of major depression is presumably due to a combination of substantive (genetic vulnerability and environmental risk factors) and measurement (cultural differences in the acceptance and meaning of items, and the psychometric properties of the instruments) factors.", "As noted in the introduction, we distinguished results from low- to middle-income versus higher-income countries based on the suspicion that optimal thresholds for defining clinically significant depression might be lower than the CIDI thresholds in the former countries, resulting in underestimation of the prevalence of MDE in the CIDI in those countries.", "The percentage of the screen-positive respondents who had lifetime MDE was also higher in high-income (28.1%) than in low- to middle-income (19.8%) countries, although both the lowest and the highest percentages were in low- to middle-income countries (12.0% in China vs. 35.9% in India).", "We previously reported that the pooled 12-month prevalence of MDE was similar in high-income (5.5%) and low- to middle-income (5.9%) countries (t = 1.2, P = 0.25), with the specific estimates varying from 2.2% (Japan) to 8.3% (USA) in high-income countries, and from 3.8% (China) to 10.4% (Brazil) in low- to middle-income countries [11]."]}
{"doc_id": 62011, "title": "", "abstract": ["On average, the estimated lifetime prevalence was higher in high-income (14.6%) than low- to middle-income (11.1%) countries (t = 5.7, P < 0.001).", "In considering a substantive interpretation of our findings, it is noteworthy that although lifetime prevalence estimates were found to be significantly higher in high than low- to middle-income countries overall, no significant difference in 12-month prevalence was found.", "The ratio of 12-month to lifetime prevalence estimates, furthermore, was significantly higher in low- to middle- income than in high-income countries.", "The percentage of the screen-positive respondents who had lifetime MDE was also higher in high-income (28.1%) than in low- to middle-income (19.8%) countries, although both the lowest and the highest percentages were in low- to middle-income countries (12.0% in China vs. 35.9% in India).", "We also documented an intriguing opposite-sign pattern of differences between high and low- to middle-income countries in estimates of lifetime prevalence and persistence of MDE, which might be due to differences in recall error."]}
{"doc_id": 62012, "title": "", "abstract": ["The Epidemiological Study on Mental Disorders in India was funded jointly by Government of India and WHO.", "MDE is a significant public-health concern across all regions of the world and is strongly linked to social conditions.", "Our results confirm the public-health importance of major depression as a commonly occurring and seriously impairing condition with a generally early AOO and persistent course in a wide range of countries.", "In India, respondents with the lowest education were 14 times as likely to have MDE as those with the highest education.", "There were 48 cases in India, 35 in Brazil, 664 in Ukraine and 1 case in South Africa."]}
{"doc_id": 62013, "title": "", "abstract": ["Women have a twofold increased risk of MDE compared with men [13], people who are separated or divorced have significantly higher rates of depression than the currently married [5,7], and the rate of depression generally goes down with age [5,7].", "Overall, the association between marital status and MDE differed significantly between high and low- to middle-income countries (χ23 = 124.4, P < 0.001), due to stronger associations of being separated and never married with depression in high-income countries, and stronger associations of being divorced and widowed with depression in low- to middle-income countries.", "Being separated was associated with increased risk of MDE in twelve countries, with odds ratios varying from < 4.0 in five countries to > 8.0 in India (OR = 8.2), Japan (OR = 10.8) and Lebanon (OR = 19.3).", "Being divorced was associated with MDE in seven of the ten developed and four of the eight developing countries, with unusually high ORs in Japan (OR = 5.1), China (OR = 6.2) and Ukraine (OR = 4.2).", "Almost all studies find that gender, age and marital status are associated with depression."]}
{"doc_id": 62014, "title": "", "abstract": ["Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].", "Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to- face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI).", "Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries.", "The wide variability in lifetime and 12-month prevalence estimates of major depression is presumably due to a combination of substantive (genetic vulnerability and environmental risk factors) and measurement (cultural differences in the acceptance and meaning of items, and the psychometric properties of the instruments) factors.", "Prevalence (%) of DSM-IV/CIDI major depressive episodes in the 18 countries participating in the WMH surveys a"]}
{"doc_id": 62015, "title": "", "abstract": ["On average, about half of the respondents in both high-income (52.3%) and low- to middle-income (54.1%) countries endorsed at least one depression diagnostic stem question (screen-positive).", "It might be that these results reflect genuinely lower lifetime prevalence but higher persistence of depression in low- to middle-income than high-income countries, but another plausible and more parsimonious explanation is that error in recall of previous lifetime episodes is higher in low- to middle-income than high-income countries.", "In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.", "A related argument is that income inequality, which is for the most part greater in high than low- to middle-income countries, promotes a wide variety of chronic conditions that includes depression [27].", "As noted in the introduction, we distinguished results from low- to middle-income versus higher-income countries based on the suspicion that optimal thresholds for defining clinically significant depression might be lower than the CIDI thresholds in the former countries, resulting in underestimation of the prevalence of MDE in the CIDI in those countries."]}
{"doc_id": 62016, "title": "", "abstract": ["It might be that these results reflect genuinely lower lifetime prevalence but higher persistence of depression in low- to middle-income than high-income countries, but another plausible and more parsimonious explanation is that error in recall of previous lifetime episodes is higher in low- to middle-income than high-income countries.", "The authors concluded from these results that although cross-national differences in the estimated prevalence of depression cannot be attributed to differences in the nature or validity of the concept of a depressive episode, it is possible that DSM criteria may define different levels of depression severity in different countries.", "Taken together, these results argue against the suggestion that the wide cross-national variation in depression prevalence estimates in the WMH surveys and previous epidemiologic studies is due to the threshold for defining clinically significant depression in standard diagnostic interviews differing across countries.", "However, contrary to our initial expectation, we did not find that cross-national differences in prevalence estimates were inversely related to differences in average level of impairment associated with depression; indeed, the opposite pattern was found.", "Future research on cross-national differences in depression needs to take this pattern into consideration, and to develop a workable strategy to deal with the possibility of differential recall error as a plausible contributor to cross-national differences in prevalence estimates."]}
{"doc_id": 62017, "title": "", "abstract": ["The lifetime prevalence ranged from 1.5% (Taiwan) to 19.0% (Beirut), with the midpoints at 9.2% (West Germany) and 9.6% (Edmonton, Canada).", "The 12-month prevalence ranged from 0.8% (Taiwan) to 5.8% (Christchurch, New Zealand), with the midpoints at 3.0% (US) and 4.5% (Paris).", "The 12-month prevalence ranged from 0.3% (Czech Republic) to 10% (USA), with midpoints at 4.5% (Mexico) and 5.2% (West Germany).", "The average lifetime and 12-month prevalence estimates of DSM-IV MDE were 14.6% and 5.5% in the ten high-income and 11.1% and 5.9% in the eight low- to middle-income countries.", "The ratio of 12-month to lifetime prevalence estimates, furthermore, was significantly higher in low- to middle- income than in high-income countries."]}
{"doc_id": 62018, "title": "", "abstract": ["In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.", "On average, about half of the respondents in both high-income (52.3%) and low- to middle-income (54.1%) countries endorsed at least one depression diagnostic stem question (screen-positive).", "The 12-month prevalence of DSM-IV major depressive episode (MDE) in 18 countries ranged from 2.2% (Japan) to 10.4% (Brazil) [12].", "In the group of screen-positive respondents, the percentage with 12-month MDE was also similar for high-income (10.6%) and low- to middle-income (10.5%) countries (Table 2).", "We previously reported that the pooled 12-month prevalence of MDE was similar in high-income (5.5%) and low- to middle-income (5.9%) countries (t = 1.2, P = 0.25), with the specific estimates varying from 2.2% (Japan) to 8.3% (USA) in high-income countries, and from 3.8% (China) to 10.4% (Brazil) in low- to middle-income countries [11]."]}
{"doc_id": 62019, "title": "", "abstract": ["We previously reported that the pooled 12-month prevalence of MDE was similar in high-income (5.5%) and low- to middle-income (5.9%) countries (t = 1.2, P = 0.25), with the specific estimates varying from 2.2% (Japan) to 8.3% (USA) in high-income countries, and from 3.8% (China) to 10.4% (Brazil) in low- to middle-income countries [11].", "In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.", "Associations of demographic characteristics with 12-month DSM-IV/CIDI major depressive episode in high-income countries (bivariate analyses)a", "The 12-month prevalence of DSM-IV major depressive episode (MDE) in 18 countries ranged from 2.2% (Japan) to 10.4% (Brazil) [12].", "Associations of demographic characteristics with 12-month DSM-IV/CIDI major depressive episode in low- to middle-income countries: bivariate analyses)a"]}
{"doc_id": 62020, "title": "", "abstract": ["The average lifetime and 12-month prevalence estimates of DSM-IV MDE were 14.6% and 5.5% in the ten high-income and 11.1% and 5.9% in the eight low- to middle-income countries.", "The 12-month prevalence of DSM-IV major depressive episode (MDE) in 18 countries ranged from 2.2% (Japan) to 10.4% (Brazil) [12].", "Associations of demographic characteristics with 12-month DSM-IV/CIDI major depressive episode in high-income countries (bivariate analyses)a", "Associations of demographic characteristics with 12-month DSM-IV/CIDI major depressive episode in low- to middle-income countries: bivariate analyses)a", "Prevalence (%) of DSM-IV/CIDI major depressive episodes in the 18 countries participating in the WMH surveys a"]}
{"doc_id": 62021, "title": "", "abstract": ["Although the response rates did not appear to be related to depression prevalence, it is possible that in some settings, particularly those where treatment is unavailable, the most depressed people were unable to participate.", "They also reduced our statistical power to examine the associations of depression considered in the Nigerian data.", "Although direct information on the prevalence of depression does not exist for most countries, the available data indicate wide variability in the prevalence rates.", "The results reported here have several other limitations, relating more generally to the WMH findings [30].", "Other socioeconomic factors have less consistent relationships with depression in different countries [7]."]}
{"doc_id": 63000, "title": "", "abstract": ["Immunomagnetic purification of CD44high/CD24low and CD44low/CD24high cells was performed according to Shipitsin et al27.", "All breast cancer cells were from ATCC cultured according to Neve et al.24."]}
{"doc_id": 63001, "title": "", "abstract": ["Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II.", "To establish whether HIF1α contributes to XBP1's function in TNBC, we performed rescue experiments using a HA-tagged constitutively activated hydroxylation-mutant HIF1α construct (HA-HIF1α dPA: P402A/P564A).", "In conclusion, we uncover a key function for XBP1 in the tumorigenicity, progression and recurrence of TNBC and identified XBP1's control of the HIF1α transcriptional program as the major mechanism.", "We found that high occupancy by XBP1 was associated with increased occurrence of the HIF1α motif across the genome in TNBC (Fig. 3f).", "Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis."]}
{"doc_id": 63002, "title": "", "abstract": ["These data reveal a state of basal ER stress in TNBC cells.", "h, Effect of XBP1 knockdown on ER stress marker BIP expression in MDA-MB-231 derived xenograft tumors.", "One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE12 and its substrate XBP13.", "Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization1.", "In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression."]}
{"doc_id": 63003, "title": "", "abstract": ["Nuclear protein (150 μg) was incubated for 1 h at 4 °C with a biotinylated probe containing wild-type or mutated HIF1α binding site plus streptavidin- dynabeads (Invitrogen) in binding buffer (100 mM NaCl, 10 mM Tris-HCl, pH 7.6, 0.1 mM EDTA, 1 mM dithiothreitol, 5% glycerol, 1 mg/ml of BSA and 20 μg/ml of poly(dI:dC), plus protease inhibitors).", "Hypoxia-inducing factor (HIF)1α is known to be hyperactivated in TNBCs 9, 10.", "A similar analysis was performed for the HIF pathway signature (VEGFA, PDK1, DDIT4, SLC2A1, KDM3A, NDRG1, PFKFB3, PIK3CA, RORB, CREBBP, PIK3CB, HK2 and EGLN1).", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors.", "We next used an orthotopic xenograft mouse model with inducible expression of two XBP1 shRNAs in MDA- MB-231 cells."]}
{"doc_id": 63004, "title": "", "abstract": ["In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "Co-IP experiments revealed a physical interaction of HIF1α, but not HIF2α, with XBP1 in 293T cells co-expressing HIF1 and XBP1s cultured under hypoxic conditions, also observed with endogenous proteins in two TNBC cell lines: MDA-MB-231 and Hs578T (Fig. 3b, Extended Data 4h-j).", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors.", "c, XBP1 and HIF1α co-bind to JMJD1A and JMJD2C promoters under hypoxic conditions.", "b, XBP1 and HIF1α co-bind to DDIT4, VEGFA, and PDK1 promoters under hypoxic conditions."]}
{"doc_id": 63005, "title": "", "abstract": ["Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors.", "One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE12 and its substrate XBP13.", "Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "These data establish a critical role of XBP1 in CD44high/CD24low cells within TNBC.", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer."]}
{"doc_id": 63006, "title": "", "abstract": ["Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype.", "In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "Role of XBP1 in luminal breast cancer"]}
{"doc_id": 63007, "title": "", "abstract": ["CD44high/CD24low cells sorted from TNBC patient samples confirmed increased XBP1 splicing and other UPR markers, and XBP1 silencing impaired mammosphere-forming ability (Fig. 2e, f, Extended Data 3a).", "XBP1 pathway activation correlates with poor patient survival in TNBC patients implying that UPR inhibitors in combination with standard chemotherapy may improve the effectiveness of anti-tumor therapies.", "PERK but not ATF6 was also activated (Extended Data 1a) and transmission electron microscopy revealed more abundant and dilated ER in multiple TNBC cell lines (Extended Data 1b).", "These data reveal a state of basal ER stress in TNBC cells.", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer."]}
{"doc_id": 63008, "title": "", "abstract": ["Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype.", "XBP1 pathway activation correlates with poor patient survival in TNBC patients implying that UPR inhibitors in combination with standard chemotherapy may improve the effectiveness of anti-tumor therapies.", "XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "Importantly, the XBP1 signature did not correlate with clinical outcome of ER+ breast cancer patients (p=0.553) (Extended Data 9c), indicating its specific prognostic value for TNBC.", "Survival analysis using an aggregate breast cancer dataset for 193 TNBC patient samples21 demonstrated that tumors with an elevated XBP1 signature displayed shorter relapse-free survival (Log-rank test, p =0.00677) (Fig. 4b)."]}
{"doc_id": 63009, "title": "", "abstract": ["In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "XBP1 depletion downregulated HIF1α targets VEGFA, PDK1, GLUT1, and DDIT4 expression in both normoxic and hypoxic conditions (Extended Data 6b), and these results were validated in breast cancer xenografts (Fig. 3e) and Hs578T cells (Extended Data 6c).", "When we profiled the differential transcriptome induced by XBP1 silencing in MDA-MB-231 cells, gene set enrichment analysis identified significant enrichment of HIF1α mediated hypoxia response pathway genes (Fig. 3d, Extended Data 6a).", "XBP1 and HIF1α cooperatively regulate HIF1α targets in TNBC.", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors."]}
{"doc_id": 63010, "title": "", "abstract": ["These data establish a critical role of XBP1 in CD44high/CD24low cells within TNBC.", "Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype.", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.", "We found that high occupancy by XBP1 was associated with increased occurrence of the HIF1α motif across the genome in TNBC (Fig. 3f).", "XBP1 silencing impaired soft agar colony forming ability and invasiveness (Extended Data 1c) of multiple TNBC cell lines, indicating that XBP1 regulates TNBC anchorage-independent growth and invasiveness."]}
{"doc_id": 63011, "title": "", "abstract": ["In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors.", "The scatter-plot of XBP1 and two publicly available HIF1α signature (Left panel: HIF1α pathway; Right panel: Hypoxia via HIF1α pathway) across different tumors were drawn for TNBC (a) and ER+ breast cancer patients (b), respectively.", "Hypoxia is a physiological UPR inducer in cancer19and XBP1s co-localizes with hypoxia marker CA9 in tumors20.", "When we profiled the differential transcriptome induced by XBP1 silencing in MDA-MB-231 cells, gene set enrichment analysis identified significant enrichment of HIF1α mediated hypoxia response pathway genes (Fig. 3d, Extended Data 6a)."]}
{"doc_id": 63012, "title": "", "abstract": ["XBP1 expression was readily detected in both luminal and basal-like BCCL, but was higher in the latter which consist primarily of TNBC cells and also in primary TNBC patient samples (Fig. 1a, b).", "Its expression was highly correlated with hypoxia-driven signatures in TNBC (Pearson's correlation coefficient=0.61; p=2.28×10-60), but not in ER+ breast cancer patients (coefficient=0.03; p=0.64) (Extended Data 9a, b).", "Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis.", "Exposure to these stressors increased XBP1 splicing, resulting in a corresponding increase in signal intensity (Extended Data 4b-f) and further enrichment of HIF1α motifs in TNBC (Fig. 3a), but interestingly not in luminal breast cancer cells (Extended Data 4g).", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer."]}
{"doc_id": 63013, "title": "", "abstract": ["Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype.", "XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "In conclusion, we uncover a key function for XBP1 in the tumorigenicity, progression and recurrence of TNBC and identified XBP1's control of the HIF1α transcriptional program as the major mechanism.", "Although XBP1 silencing also affects luminal breast cancer growth, it does so via a mechanism not involving HIF1α (Extended Data 10, 4g, 6d)."]}
{"doc_id": 63014, "title": "", "abstract": ["When we profiled the differential transcriptome induced by XBP1 silencing in MDA-MB-231 cells, gene set enrichment analysis identified significant enrichment of HIF1α mediated hypoxia response pathway genes (Fig. 3d, Extended Data 6a).", "a, Plot from GSEA showing enrichment of the HIF1α mediated hypoxia response pathway in XBP1-upregulated genes.", "d, Plot from GSEA showing no enrichment of the HIF1α mediated hypoxia response pathway in XBP1-regulated genes in T47D cells (p=0.1684).", "A similar analysis was performed for the HIF pathway signature (VEGFA, PDK1, DDIT4, SLC2A1, KDM3A, NDRG1, PFKFB3, PIK3CA, RORB, CREBBP, PIK3CB, HK2 and EGLN1).", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors."]}
{"doc_id": 63015, "title": "", "abstract": ["c-d, Kaplan-Meier graphs demonstrating no significant association of the expression of the XBP1 signature (red line) (c) or HIF signature (d) with relapse free survival in estrogen receptor positive breast cancer patients.", "Importantly, the XBP1 signature did not correlate with clinical outcome of ER+ breast cancer patients (p=0.553) (Extended Data 9c), indicating its specific prognostic value for TNBC.", "a-b, Expression of XBP1 signature is highly correlated with two public available hypoxia-driven signatures in TNBC patients (a), but not in ER+ breast cancer patients (b).", "The scatter-plot of XBP1 and two publicly available HIF1α signature (Left panel: HIF1α pathway; Right panel: Hypoxia via HIF1α pathway) across different tumors were drawn for TNBC (a) and ER+ breast cancer patients (b), respectively.", "Survival analysis using an aggregate breast cancer dataset for 193 TNBC patient samples21 demonstrated that tumors with an elevated XBP1 signature displayed shorter relapse-free survival (Log-rank test, p =0.00677) (Fig. 4b)."]}
{"doc_id": 63016, "title": "", "abstract": ["Enforced overexpression of HIF1α dPA in XBP1 depleted cells restored expression of HIF1α targets and rescued anchorage independent growth, mammosphere-forming ability, angiogenesis and in vivo tumor growth (Fig. 3i; Extended Data 7d-h).", "XBP1 regulates HIF1α targets", "d, Knockdown efficiency of XBP1 in MCF10A-ER-Src cells.", "h, Effect of XBP1 knockdown on ER stress marker BIP expression in MDA-MB-231 derived xenograft tumors.", "Integrated analysis of XBP1 ChIP-seq data and gene expression profiles identified 96 genes directly bound and up-regulated by XBP1."]}
{"doc_id": 63017, "title": "", "abstract": ["Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "a, Activation of UPR in different breast cancer cells.", "We determined UPR activation status in several breast cancer cell lines (BCCL).", "XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer."]}
{"doc_id": 63018, "title": "", "abstract": ["XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "XBP1 regulates HIF1α targets", "XBP1 and HIF1α cooperatively regulate HIF1α targets in TNBC.", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer."]}
{"doc_id": 68000, "title": "", "abstract": ["During the course of this study, the ENCODE project released a large scale analysis of RNA-seq data that provided clear evidence that the human genome is pervasively transcribed [14].", "In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs", "This analysis resulted in a clear corroboration of the observations of pervasive transcription across the human genome by the ENCODE project [14].", "Overcoming these prior shortcomings, the ENCODE project used RNA-seq analysis in combination with other technologies to profile 15 human cell lines, providing evidence for transcription across 83.7% of the human genome and firmly establishing the reality of pervasive transcription [14]."]}
{"doc_id": 68001, "title": "", "abstract": ["The vast majority of these transcripts (including most GENCODEv6 “lincRNAs” and “processed transcripts”) overlap known or predicted protein coding genes, pseudogenes, or non-lincRNA noncoding RNAs (e.g. microRNAs)(Table S3).", "Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs).", "Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs", "At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "These observations clearly demonstrate that the human genome is pervasively transcribed, and that lincRNAs make up an extremely common class of intergenic transcripts."]}
{"doc_id": 68002, "title": "", "abstract": ["It should be expected that intergenic regions encode far more lincRNAs than are currently annotated.", "Catalog of lincRNAs in Dataset S2 (FPKM>1) that are statistically significantly (p<0.1) expressed above a random sample of other size-matched intergenic regions in at least one RNA-seq dataset (5,267 transcripts) (BED format, hg18).", "In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "Additionally, an alternative lincRNA catalog containing only those lincRNAs expressed significantly higher than randomly sampled intergenic regions (see Methods) were included (5,267 lincRNAs, Datasets S6, S7).", "The intergenic sequence used includes all portions of the uniquely mappable genome excluding RefSeq NM, NR and XR genes, Ensembl v61 genes including “lincRNAs” and “processed transcripts”, GENCODEv6 genes including “lincRNAs” and “processed transcripts”, H-Invitational “noncoding” transcripts, alternative and extended 5′ and 3′ UTRs of known human genes from UTRdb, extended protein coding gene structures derived from RNA-seq data (extended gene filter, described above), and published lincRNAs from Khalil et al. [18] and Cabili et al. [16]."]}
{"doc_id": 68003, "title": "", "abstract": ["Consistent with prior studies, lincRNAs display detectable but modest conservation [16], [19].", "We applied this same method to known functional human lincRNAs and found that the majority of the lincRNAs identified in this study display a level of conservation consistent with known functional lincRNAs (Figure 3C).", "Comparison of conservation of the full lincRNA catalog (53,864 lincRNAs, Dataset S2, FPKM>1) to GENCODEv6 lincRNAs.", "We found that the lincRNAs we identified have many characteristics that are inconsistent with noise, including specific regulation of their expression, the presence of conserved sequence and evidence for regulated processing.", "The lincRNAs we describe are specifically regulated and contain conserved sequence, attributes inconsistent with transcriptional noise (Figure 3)."]}
{"doc_id": 68004, "title": "", "abstract": ["In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14].", "At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "There is an apparent discrepancy between this observed pervasive transcription and the relative paucity of annotated lincRNAs, the most numerous intergenic RNAs.", "(A) 85.2% of the genome has evidence of transcription, with RNA-seq reads mapping directly to 78.9% of genomic sequence."]}
{"doc_id": 68005, "title": "", "abstract": ["From these analyses we conclude that our filtering approach effectively removed protein coding transcripts from the catalog.", "Consistent with observations based on earlier long noncoding RNA annotations [18], [19], [26], [27], analysis of ChIP-seq and RNA-seq data [28], [29] revealed that the catalog of lincRNAs shows patterns of epigenetic modification similar to protein coding genes (Figure 3A).", "As expected, lincRNAs resemble the 3′ untranslated region exons of protein coding genes, with very few transcripts showing significant engagement with the ribosome.", "Further analysis of these removed large ORF-containing intergenic transcripts is outside the scope of this study, but we have included these annotations for investigators interested in further analyzing their coding potential in search of novel protein coding genes (Dataset S10).", "In order to avoid cataloging transcripts in these regions as lincRNAs, we created a filter based on extended boundaries of protein coding genes using RNA-seq data."]}
{"doc_id": 68006, "title": "", "abstract": ["In total, we identified tens of thousands of putative lincRNAs expressed at a minimum of one copy per cell, significantly expanding upon prior lincRNA annotation sets.", "To decrease redundancy, and with the goal of identifying lincRNA “genes” rather than potentially redundant overlapping “transcripts”, the remaining transcripts were merged if they shared at least one exon (see Methods) resulting in 53,864 distinct putative lincRNAs at FPKM>1, 3,676 lincRNAs at FPKM>10, and 925 lincRNAs at FPKM>30 (Dataset S2 and Figure S3).", "Furthermore, using de novo transcriptome assembly of this RNA-seq data, we found that intergenic regions encode far more long intergenic noncoding RNAs (lincRNAs) than previously described, helping to resolve the discrepancy between the vast amount of observed intergenic transcription and the limited number of previously known lincRNAs.", "(A) Discovery of lincRNAs consisted of de novo assembly of transcripts from RNA-seq data and compilation of annotated and putative noncoding RNAs (see Methods), followed by a series of filters designed to remove all known and novel protein coding transcripts and non-lincRNA noncoding RNAs.", "We have identified a large number of putative lincRNAs with characteristics suggesting functionality."]}
{"doc_id": 68007, "title": "", "abstract": ["Furthermore, using de novo transcriptome assembly of this RNA-seq data, we found that intergenic regions encode far more long intergenic noncoding RNAs (lincRNAs) than previously described, helping to resolve the discrepancy between the vast amount of observed intergenic transcription and the limited number of previously known lincRNAs.", "Because nearly half of all TASs are intergenic, it is possible that lincRNAs play a significant role in the majority of human traits and diseases thus far analyzed in GWASs.", "Furthermore, these lincRNAs are strongly enriched with intergenic sequences that were previously known to be functional in human traits and diseases.", "One functional lincRNA (MIAT) was first identified during the experimental interrogation of an intergenic TAS [35], and another lincRNA PTCSC3, was identified nearby a TAS found from a papillary thyroid carcinoma GWAS, perhaps representing the first of many such discoveries to come from intergenic TASs.", "Furthermore, recent findings have shown that the intergenic transcriptome may be vastly more complex than currently appreciated when very lowly expressed transcripts are considered [7]."]}
{"doc_id": 68008, "title": "", "abstract": ["At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "(A) 85.2% of the genome has evidence of transcription, with RNA-seq reads mapping directly to 78.9% of genomic sequence.", "In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14].", "Known protein coding gene exons compose less than 3% of the human genome."]}
{"doc_id": 68009, "title": "", "abstract": ["Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs).", "Consistent with observations based on earlier long noncoding RNA annotations [18], [19], [26], [27], analysis of ChIP-seq and RNA-seq data [28], [29] revealed that the catalog of lincRNAs shows patterns of epigenetic modification similar to protein coding genes (Figure 3A).", "These observations clearly demonstrate that the human genome is pervasively transcribed, and that lincRNAs make up an extremely common class of intergenic transcripts.", "In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "Furthermore, using de novo transcriptome assembly of this RNA-seq data, we found that intergenic regions encode far more long intergenic noncoding RNAs (lincRNAs) than previously described, helping to resolve the discrepancy between the vast amount of observed intergenic transcription and the limited number of previously known lincRNAs."]}
{"doc_id": 68010, "title": "", "abstract": ["Publicly available paired-end ditag (PET) cluster annotations derived from 7 cell lines or tissues, generated by the ENCODE project, were downloaded from http://genome.ucsc.edu/cgi-bin/hgFileUi?db=hg19&g=wgEncodeGisRnaPet.", "LincRNA (Dataset S2) and RefSeq NM gene analysis for experimental support of 5′ and 3′ end annotations using combined paired-end ditag (PET) data from 7 tissues/cell lines generated by the ENCODE project (see Methods).", "The PET cluster annotation files used were (by cell or tissue type):", "Overcoming these prior shortcomings, the ENCODE project used RNA-seq analysis in combination with other technologies to profile 15 human cell lines, providing evidence for transcription across 83.7% of the human genome and firmly establishing the reality of pervasive transcription [14].", "The first attempts to generate lincRNA annotation sets either profiled lincRNAs specific to a small number of tissues or required that transcripts harbor specific structural features such as splicing and polyadenylation [16]–[18]."]}
{"doc_id": 68011, "title": "", "abstract": ["In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs).", "At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14].", "Here we directly observed with a large set of RNA-seq data covering a wide array of human tissue types that the majority of the genome is indeed transcribed, corroborating recent observations by the ENCODE project."]}
{"doc_id": 68012, "title": "", "abstract": ["A key question in the field is whether the transcripts resulting from pervasive transcription of intergenic regions are functional or the result of noisy transcription.", "A key question in the field is whether these intergenic transcripts are functional or transcriptional noise.", "In order to evaluate whether the lincRNAs identified in the present study are specifically regulated as opposed to transcriptional noise, we determined if the lincRNA genes harbor canonical epigenetic marks for activation and repression with the reasoning that noise transcripts should lack coherent epigenetic modification patterns.", "These studies suggested that intergenic transcription is pervasive, but concerns about cross-hybridization have fueled a debate about the data [9]–[12].", "We found that the lincRNAs we identified have many characteristics that are inconsistent with noise, including specific regulation of their expression, the presence of conserved sequence and evidence for regulated processing."]}
{"doc_id": 68013, "title": "", "abstract": ["In order to evaluate whether the lincRNAs identified in the present study are specifically regulated as opposed to transcriptional noise, we determined if the lincRNA genes harbor canonical epigenetic marks for activation and repression with the reasoning that noise transcripts should lack coherent epigenetic modification patterns.", "These lincRNAs are specifically regulated and conserved rather than being the product of transcriptional noise.", "We found that the lincRNAs we identified have many characteristics that are inconsistent with noise, including specific regulation of their expression, the presence of conserved sequence and evidence for regulated processing.", "If lincRNAs are specifically regulated at the level of transcription, it is expected that their expression levels are specific to their tissue source.", "The lincRNAs we describe are specifically regulated and contain conserved sequence, attributes inconsistent with transcriptional noise (Figure 3)."]}
{"doc_id": 68014, "title": "", "abstract": ["LincRNA (Dataset S2) and RefSeq NM gene analysis for experimental support of 5′ and 3′ end annotations using combined paired-end ditag (PET) data from 7 tissues/cell lines generated by the ENCODE project (see Methods).", "This catalog (Dataset S3) includes 54,784 lincRNAs at FPKM>1 (920 additional lincRNAs compared to Dataset S2), 3,764 lincRNAs at FPKM>10 (88 additional lincRNAs), and 942 lincRNAs at FPKM>30 (17 additional lincRNAs).", "An additional set of annotated lincRNA transcripts from Cabili et al. [16] passed all our filters except were not expressed at FPKM>1 in any of the datasets analyzed here and were therefore removed from the lincRNA catalog in Dataset S2.", "To compare enrichment of trait-associated SNPs in lincRNAs versus background loci (nonexpressed intergenic regions), regions of the uniquely mappable genome longer than 200 bp that exclude all evidence of transcription (RNA-seq reads, RefSeq NM, NR and XR genes and pseudogenes, Ensembl v61 genes, GENCODE v10 genes, spliced ESTs, spliced H-Invitational cDNAs, 5′ and 3′ UTRs from UTRdb, extended RefSeq NM genes derived using reference annotation based de novo transcriptome assembly (see above and Dataset S1) and all lincRNAs) were compiled and served as background loci for this analysis.", "Furthermore, as an additional resource we provide the expression level (FPKM and raw RNA-seq read counts) of all lincRNAs (in Dataset S2) and RefSeq protein coding genes across all 127 RNA-seq datasets (Dataset S8)."]}
{"doc_id": 68015, "title": "", "abstract": ["We have identified a large number of putative lincRNAs with characteristics suggesting functionality.", "In total, we identified tens of thousands of putative lincRNAs expressed at a minimum of one copy per cell, significantly expanding upon prior lincRNA annotation sets.", "Furthermore, using de novo transcriptome assembly of this RNA-seq data, we found that intergenic regions encode far more long intergenic noncoding RNAs (lincRNAs) than previously described, helping to resolve the discrepancy between the vast amount of observed intergenic transcription and the limited number of previously known lincRNAs.", "We applied this same method to known functional human lincRNAs and found that the majority of the lincRNAs identified in this study display a level of conservation consistent with known functional lincRNAs (Figure 3C).", "Primary catalog of lincRNAs identified and analyzed in this study (53,864 FPKM>1, 3,676 FPKM>10, and 925 FPKM>30 transcripts) (BED format; hg18)."]}
{"doc_id": 68016, "title": "", "abstract": ["In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs).", "Until recently, a key missing component to this debate has been an analysis of ultra deep RNA-seq data sampling a wide array of tissue types.", "(A) 85.2% of the genome has evidence of transcription, with RNA-seq reads mapping directly to 78.9% of genomic sequence.", "Overcoming these prior shortcomings, the ENCODE project used RNA-seq analysis in combination with other technologies to profile 15 human cell lines, providing evidence for transcription across 83.7% of the human genome and firmly establishing the reality of pervasive transcription [14]."]}
{"doc_id": 68017, "title": "", "abstract": ["This analysis resulted in a clear corroboration of the observations of pervasive transcription across the human genome by the ENCODE project [14].", "During the course of this study, the ENCODE project released a large scale analysis of RNA-seq data that provided clear evidence that the human genome is pervasively transcribed [14].", "Because our analysis utilized a wide range of novel and previously existing RNA-seq datasets of unknown genomic DNA contamination content, we took multiple steps to mitigate this possibility.", "In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "There is an apparent discrepancy between this observed pervasive transcription and the relative paucity of annotated lincRNAs, the most numerous intergenic RNAs."]}
{"doc_id": 68018, "title": "", "abstract": ["The reproducibility of this lincRNA bimorphic state suggests that lincRNA polyadenylation is regulated and that many lincRNAs exist at least partially as nonpolyadenylated transcripts (Figure 3B and Figure S5).", "In agreement with these studies, we found that the polyadenylation status of lincRNAs in our catalog is reproducibly bimorphic across multiple cell types while protein coding transcripts are strongly enriched in the polyA+ sample.", "### Analysis of Distribution of LincRNAs Between Polyadenylated and Nonpolyadenylated RNA-seq Data", "LincRNAs do not need to be polyadenylated to be functional [30].", "In fact, earlier tiling array studies revealed that intergenic transcripts tend to be bimorphic; that is, they appear in both polyA+ and polyA− fractions, as opposed to protein coding transcripts that are primarily polyA+ [3]."]}
{"doc_id": 68019, "title": "", "abstract": ["Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs).", "(A) 85.2% of the genome has evidence of transcription, with RNA-seq reads mapping directly to 78.9% of genomic sequence.", "At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14]."]}
{"doc_id": 68020, "title": "", "abstract": ["Additionally, an alternative lincRNA catalog containing only those lincRNAs expressed significantly higher than randomly sampled intergenic regions (see Methods) were included (5,267 lincRNAs, Datasets S6, S7).", "To determine which putative lincRNAs (in Dataset S2, FPKM>1) were expressed significantly above background in at least one dataset the probability of observing a transcript at any given expression level was estimated using the dataset-specific background distribution and adjusted for multiple testing according to the Bonferroni correction assuming one test per RNA-seq dataset.", "RNA-seq dataset names, P values and FPKMs corresponding to each significantly expressed lincRNA in Dataset S6.", "Catalog of lincRNAs in Dataset S2 (FPKM>1) that are statistically significantly (p<0.1) expressed above a random sample of other size-matched intergenic regions in at least one RNA-seq dataset (5,267 transcripts) (BED format, hg18).", "Those lincRNA annotations with a corrected P value < = 0.1 in at least one dataset are cataloged in Datasets S6, S7."]}
{"doc_id": 68021, "title": "", "abstract": ["In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14].", "At a threshold of one RNA-seq read, we observed reads mapping to 78.9% of the genome and, if additional evidence of transcription is taken into account including the full structures of known genes, spliced ESTs and cDNAs, we found evidence that 85.2% of the genome is transcribed (Figure 1A).", "(A) 85.2% of the genome has evidence of transcription, with RNA-seq reads mapping directly to 78.9% of genomic sequence.", "Here, by analyzing a large set of RNA-seq data, we found that >85% of the genome is transcribed, allowing us to generate a comprehensive catalog of an important class of intergenic transcripts: long intergenic noncoding RNAs (lincRNAs)."]}
{"doc_id": 68022, "title": "", "abstract": ["In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "This result closely agrees with the recently published findings from the ENCODE project in which evidence for transcription of 83.7% of the genome was uncovered [14].", "Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs", "In strong agreement with the ENCODE results, we observed that approximately 85% of the genome is transcribed, supporting prior observations of pervasive transcription based on tiling arrays that have been recently questioned [2]–[5].", "We found that the genome encodes far more lincRNAs than previously known."]}
{"doc_id": 99000, "title": "", "abstract": ["In the livers of metformin-treated mice, a decline in pNF-κB by 64% (p< 0.01, t-test two tailed) and pJNK by 79% (p< 0.01, t-test two tailed) levels was observed (Fig. 4f) together with attenuated expression of NF-κB gene (Fig. 4f).", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "While the effect of metformin on longevity was obvious, it was important to determine whether the healthspan of the animals was preserved.", "### Metformin increases healthspan and longevity of mice", "The mechanism of action of metformin involves, at least in part, activation of adenosine monophosphate-activated protein kinase (AMPK), an enzyme involved in cellular and whole-organism energy balance, as well as glucose and fat metabolism16,17."]}
{"doc_id": 99001, "title": "", "abstract": ["Several reports suggest that the actions of metformin resemble the effects of CR to some extent; microarray analyses have shown that metformin induces a gene expression profile that aligns with that of CR, although conflicting results have been shown in lifespan extension9–15.", "Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "Metformin improves healthspan and lifespan in mice", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan."]}
{"doc_id": 99002, "title": "", "abstract": ["Diet supplementation with 0.1% metformin led to a 5.83% extension of mean lifespan (Fig. 1a), χ2 = 5.46 and p= 0.02 in Gehan-Breslow survival test.", "Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans."]}
{"doc_id": 99003, "title": "", "abstract": ["Taken together, these results strongly suggest that metformin prevents the onset of metabolic syndrome.", "Thus, while the pleotropic effects of metformin in vivo presents challenges in the identification of the specific mechanisms that are critical for the observed improvements on health and aging, pharmacokinetic issues must be addressed before results from our model can be extrapolated to other species.", "As mentioned earlier, metformin is widely prescribed to improve insulin sensitivity.", "The effects of metformin resembled to some extent the effects of caloric restriction, even though food intake was increased.", "The mechanism of action of metformin involves, at least in part, activation of adenosine monophosphate-activated protein kinase (AMPK), an enzyme involved in cellular and whole-organism energy balance, as well as glucose and fat metabolism16,17."]}
{"doc_id": 99004, "title": "", "abstract": ["Mice on metformin tended to preserve body weight with advancing age, which has been associated with increased survival in rodent and human studies31,32.", "The fact that metformin treatment has been associated with reduced risk of cancer4 and cardiovascular disease raises the possibility of a beneficial role of metformin for other age-related diseases5.", "However, the beneficial effects of metformin might be explained, at least in part, by changes in the gut microbiota34, a process that has not been addressed in our study.", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "Our model reveals a level of chronic metformin exposure that lengthens lifespan and also attenuates the deleterious effects of aging in male mice."]}
{"doc_id": 99005, "title": "", "abstract": ["Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Diet supplementation with 0.1% metformin led to a 5.83% extension of mean lifespan (Fig. 1a), χ2 = 5.46 and p= 0.02 in Gehan-Breslow survival test.", "Metformin improves healthspan and lifespan in mice"]}
{"doc_id": 99006, "title": "", "abstract": ["It has been proposed that mild inhibition of the mitochondrial ETC complex I activity by metformin21,22 reduces ATP production and contributes to increase the AMP/ATP ratio, which, in turn, results in AMPK activation.", "Metformin activates AMPK without altering in vivo electron transport chain activities", "Thus, metformin may compromise ATP production in mitochondria leading to an increase of the AMP/ATP ratio.", "Furthermore, the inhibition of mitochondrial respiration by metformin is reported to be concentration-dependent, with no effect at concentrations lower than 1 mM42.", "(a) Activation of AMPK by metformin in MEFs."]}
{"doc_id": 99007, "title": "", "abstract": ["In summary, the ability of metformin to reduce oxidative stress and inflammation suggests that this could partly be the reason why this drug confers health and lifespan benefits in laboratory mice.", "Under the metformin and CR regimen, the expression of serum amyloid protein genes (Saa1 and Saa2) was markedly decreased in the liver, suggesting the suppression of inflammatory responses36.", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "The differential effects of metformin in vitro and in vivo may be due to the hepatocytes adapting to long-term inhibition of complex I activity."]}
{"doc_id": 99008, "title": "", "abstract": ["over 5 min); total distance ran in the treadmill test until exhaustion; and the speed of the animals in the open-field.", "The maximum trial length was 5 min, and there was a 30-min rest period between each trial (n = 16 per group; age = 95 weeks; diet = 41 weeks).", "In contrast, mice treated with metformin had a remarkable increase in hepatic complex I activity (Fig. 3j).", "The degree of inhibition of oxidative phosphorylation as a function of metformin serum levels cannot be quantitated because of the fact that active uptake of metformin occurs via transporters on the cell surface and, possibly, mitochondria.", "The cellular reduction of the tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), an assay that measures NADH-oxidase activity, was lower in metformin-treated cells, with an IC50 of ~ 3.3 mM (Supplementary Fig. S6)."]}
{"doc_id": 99009, "title": "", "abstract": ["The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "Metformin improves healthspan and lifespan in mice", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans."]}
{"doc_id": 99010, "title": "", "abstract": ["Cohorts of middle-aged male C57BL/6 and B6C3F1 mice were provided with either a standard diet (SD) or SD supplemented with 0.1% (w/w) or 1% (w/w) metformin for the remainder of their lives.", "n = 64 for metformin 0.1% group and n = 83 for their untreated counterparts; n = 90 for metformin 1% group and n = 88 for their untreated counterparts.", "(i) MEFs treated with 1 mM metformin (n = 3 per group) and (j) Liver lysates from 0.1% metformin-treated mice (n = 5–6 per group).", "In accordance with previous reports demonstrating that metformin increases the use of lipids as a source of energy35, the respiratory exchange ratio was decreased during both the light and dark phases and liver glyceride content was reduced in metformin-treated mice, indicating the preference for fat utilization (Fig. 1f and Supplementary Fig. S1).", "To test whether metformin shifts the physiology of ad lib-fed mice towards that of animals on CR after 30 weeks of treatment, we performed a genome-wide microarray analysis on liver and muscle tissues of three groups of mice ad lib-fed with SD, 0.1% metformin or CR."]}
{"doc_id": 99011, "title": "", "abstract": ["Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "On the other hand, a higher concentration of the drug (1% w/w) was toxic and significantly shortened mean lifespan of C57BL/6 mice by 14.4% (Fig. 1b), likely due to renal failure (Supplementary Fig. S1 and Supplementary Table S1), χ2 = 51,70 and P< 0.001 in Gehan-Breslow survival test.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "Metformin improves healthspan and lifespan in mice"]}
{"doc_id": 99012, "title": "", "abstract": ["The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "Metformin improves healthspan and lifespan in mice", "### Metformin increases healthspan and longevity of mice", "Several reports suggest that the actions of metformin resemble the effects of CR to some extent; microarray analyses have shown that metformin induces a gene expression profile that aligns with that of CR, although conflicting results have been shown in lifespan extension9–15.", "Further studies are required to determine the effects of chronic exposure levels to biguanides in health and aging in humans."]}
{"doc_id": 99013, "title": "", "abstract": ["Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "Metformin improves healthspan and lifespan in mice", "Our model reveals a level of chronic metformin exposure that lengthens lifespan and also attenuates the deleterious effects of aging in male mice."]}
{"doc_id": 99014, "title": "", "abstract": ["Our model reveals a level of chronic metformin exposure that lengthens lifespan and also attenuates the deleterious effects of aging in male mice.", "At a molecular level, metformin increases AMP- activated protein kinase activity and increases antioxidant protection, resulting in reductions in both oxidative damage accumulation and chronic inflammation.", "While it is clear that in short-term in vitro models, metformin partially inhibits oxidative phosphorylation, we find no evidence for this with long-term exposure in vivo, suggesting that adaptation to metformin occurs, and is associated with benefits, including reduced oxidative stress and increased antioxidant defenses, leading to lower oxidative damage accumulation and inhibition of chronic inflammation.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "Metformin improves healthspan and lifespan in mice"]}
{"doc_id": 99015, "title": "", "abstract": ["Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "Metformin improves healthspan and lifespan in mice", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan."]}
{"doc_id": 99016, "title": "", "abstract": ["While the effect of metformin on longevity was obvious, it was important to determine whether the healthspan of the animals was preserved.", "In the livers of metformin-treated mice, a decline in pNF-κB by 64% (p< 0.01, t-test two tailed) and pJNK by 79% (p< 0.01, t-test two tailed) levels was observed (Fig. 4f) together with attenuated expression of NF-κB gene (Fig. 4f).", "Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan.", "### Metformin increases healthspan and longevity of mice", "Thus, while the pleotropic effects of metformin in vivo presents challenges in the identification of the specific mechanisms that are critical for the observed improvements on health and aging, pharmacokinetic issues must be addressed before results from our model can be extrapolated to other species."]}
{"doc_id": 70000, "title": "", "abstract": ["Collectively, our data suggest that deficient caspase-8 expression renders Paneth cells susceptible to TNF-α induced necroptosis highlighting a regulatory role of caspase-8 in antimicrobial defence and in maintaining immune homeostasis in the gut.", "Since it has recently been shown that anti-TNF treatment partially restores the deficient expression of antimicrobial peptides in Crohn's disease patients24, our data suggest that the high levels of TNF-α present in the lamina propria of the inflamed ileum induce Paneth cell necroptosis and may provide a molecular explanation for the defects in antimicrobial defence observed in these patients.", "Inhibition of TNF-α induced epithelial necroptosis in Casp8ΔIEC mice", "Since anti-TNF treatment has been shown to restore expression of certain antimicrobial peptides24, it is tempting to speculate, that TNF-α induced necroptosis of intestinal epithelial cells contributes to the pathogenesis of IBD and that Paneth and goblet cell sensitivity towards TNF induced necroptosis may be an early event in IBD development.", "Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis"]}
{"doc_id": 70001, "title": "", "abstract": ["TNF-α was a strong promoter of intestinal epithelial necroptosis in our experiments.", "Recent data from other experimental systems have shown that inhibition of caspase activity in genetic models or by using specific caspase inhibitors can result in an apoptosis-independent type of programmed necrosis called necroptosis14.", "Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a pathogenic mechanism driving Crohn's disease (CD) in humans3.", "Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IEC) and terminal ileitis.", "Since anti-TNF treatment has been shown to restore expression of certain antimicrobial peptides24, it is tempting to speculate, that TNF-α induced necroptosis of intestinal epithelial cells contributes to the pathogenesis of IBD and that Paneth and goblet cell sensitivity towards TNF induced necroptosis may be an early event in IBD development."]}
{"doc_id": 70002, "title": "", "abstract": ["Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8ΔIEC) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis.", "Together, our data indicate that a lack of caspase-8 in IEC renders mice highly susceptible to spontaneous ileitis and experimentally induced colitis.", "To investigate whether caspase-8 deficiency sensitizes mice to experimental intestinal inflammation in the large bowel, we subjected Casp8ΔIEC and control mice to dextran sodium sulfate (DSS), a well established model of experimental colitis.", "All Casp8ΔIEC but none of the control mice developed rectal bleeding, endoscopic and histological signs of very severe colitis with epithelial erosions, a finding which was confirmed by quantitative PCR for the IEC marker villin.", "Colitis development was monitored by analysis of rectal bleeding and high resolution mouse video endoscopy as previously described29."]}
{"doc_id": 70003, "title": "", "abstract": ["Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IEC) and terminal ileitis.", "Taken together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IEC from TNF-α induced necroptotic cell death.", "On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Caspase-8 is a cystein protease critically involved in regulating cellular apoptosis.", "Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18."]}
{"doc_id": 70004, "title": "", "abstract": ["Crohn's disease patients frequently show reduced Paneth and goblet cell numbers and reduced expression of Paneth cell derived defensins in areas of acute inflammation, suggesting that necroptosis might be involved in the pathogenesis of human IBD22.", "Thus, our data suggest that necroptosis of Paneth cells is a feature of Crohn's disease.", "Finally, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease.", "Ultimately, our data for the first time demonstrate necroptosis in the terminal ileum of patients with Crohn's disease and suggest that regulating necroptosis in the intestinal epithelium is critical for the maintenance of intestinal immune homeostasis.", "However, it remains to be determined, whether Paneth cell necroptosis in Crohn's disease patients is quantitatively sufficient to affect the disease process."]}
{"doc_id": 70005, "title": "", "abstract": ["Crohn's disease patients frequently show reduced Paneth and goblet cell numbers and reduced expression of Paneth cell derived defensins in areas of acute inflammation, suggesting that necroptosis might be involved in the pathogenesis of human IBD22.", "Dysfunction of the intestinal epithelium is believed to result in excessive translocation of commensal bacteria into the bowel wall that drives chronic mucosal inflammation in Crohn's disease; an incurable inflammatory bowel disease in humans characterized by inflammation of the terminal ileum1.", "Since anti-TNF treatment has been shown to restore expression of certain antimicrobial peptides24, it is tempting to speculate, that TNF-α induced necroptosis of intestinal epithelial cells contributes to the pathogenesis of IBD and that Paneth and goblet cell sensitivity towards TNF induced necroptosis may be an early event in IBD development.", "Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IEC) and terminal ileitis.", "Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a pathogenic mechanism driving Crohn's disease (CD) in humans3."]}
{"doc_id": 70006, "title": "", "abstract": ["Cell death was analyzed using CaspACE FITC-VAD-FMK (Promega) for early apoptosis and the in situ cell death detection kit (Roche) for TUNEL.", "Epithelial cell death was induced by tumor necrosis factor (TNF) -α, was associated with increased expression of receptor-interacting protein 3 (RIP3) and could be inhibited upon blockade of necroptosis.", "Indeed, studies using electron microscopy have shown various different cell death morphologies in the small intestine including morphological changes usually seen in necrosis such as cell swelling and a degradation of organelles and membranes25.", "Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a pathogenic mechanism driving Crohn's disease (CD) in humans3.", "Increased caspase-8 independent cell death within crypts of Casp8ΔIEC mice"]}
{"doc_id": 70007, "title": "", "abstract": ["Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8ΔIEC) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis.", "Casp8ΔIEC mice spontaneously develop ileitis and lack Paneth cells", "This finding of spontaneous ileitis in the absence of caspase-8 in IEC was further supported by increased expression of the inflammation markers S100A9 and TNF-α and by elevated infiltration of the lamina propria with CD4+ T cells and granulocytes (Fig. 1c, Supplementary Fig. 3).", "Together, our data indicate that a lack of caspase-8 in IEC renders mice highly susceptible to spontaneous ileitis and experimentally induced colitis.", "(c) RT-PCR showing increased level of inflammatory markers in the terminal ileum of Casp8ΔIEC mice (6 mice per group +SEM, relative to HPRT)."]}
{"doc_id": 70008, "title": "", "abstract": ["Necroptosis has been shown to be mediated by the kinases RIP1 and RIP315,16.", "Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Thus it is getting increasingly clear, that caspase-8 has an essential function in controlling RIP-3 mediated necroptosis.", "Moreover RIP3 was overexpressed in the small intestine of TNF-α treated Casp8ΔIEC mice when compared to control littermate mice (Fig. 3b, Supplementary Fig. 8d), suggesting that the lack of caspase-8 in the intestinal epithelium might sensitize IEC to RIP-mediated necroptotic cell death."]}
{"doc_id": 70009, "title": "", "abstract": ["Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8ΔIEC) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis.", "Together, our data indicate that a lack of caspase-8 in IEC renders mice highly susceptible to spontaneous ileitis and experimentally induced colitis.", "Ultimately, our data for the first time demonstrate necroptosis in the terminal ileum of patients with Crohn's disease and suggest that regulating necroptosis in the intestinal epithelium is critical for the maintenance of intestinal immune homeostasis.", "Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IEC) and terminal ileitis.", "Casp8ΔIEC mice spontaneously develop ileitis and lack Paneth cells"]}
{"doc_id": 70010, "title": "", "abstract": ["Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "Taken together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IEC from TNF-α induced necroptotic cell death.", "In summary our data uncover an unexpected function of caspase-8 in regulating necroptosis of intestinal epithelial cells and in maintaining immune homeostasis in the gut.", "On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Thus it is getting increasingly clear, that caspase-8 has an essential function in controlling RIP-3 mediated necroptosis."]}
{"doc_id": 70011, "title": "", "abstract": ["Recent data from other experimental systems have shown that inhibition of caspase activity in genetic models or by using specific caspase inhibitors can result in an apoptosis-independent type of programmed necrosis called necroptosis14.", "Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "Upon activation of death receptors, including TNF-receptor and Fas, caspase-8 is activated by limited autoproteolysis and the processed caspase-8 subsequently triggers the caspase cascade which finally leads to apoptotic cell death.", "Given the low expression of caspase-8 and high expression of RIP3 at the base of crypts, cells residing in this area may be susceptible to necroptosis upon stimulation with death receptor ligands such as TNF-α.", "Collectively, our data suggest that deficient caspase-8 expression renders Paneth cells susceptible to TNF-α induced necroptosis highlighting a regulatory role of caspase-8 in antimicrobial defence and in maintaining immune homeostasis in the gut."]}
{"doc_id": 70012, "title": "", "abstract": ["Interestingly, defects in Paneth cell function and in the expression of antimicrobial peptides have been described in Crohn's disease patients and accumulating evidence support a role for Paneth cells in the pathogenesis of this disease1,7,22.", "Furthermore, recent data have indicated a role of caspase-mediated apoptosis of IEC in the pathogenesis of inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis5,6.", "Finally, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease.", "Crohn's disease patients frequently show reduced Paneth and goblet cell numbers and reduced expression of Paneth cell derived defensins in areas of acute inflammation, suggesting that necroptosis might be involved in the pathogenesis of human IBD22.", "Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a pathogenic mechanism driving Crohn's disease (CD) in humans3."]}
{"doc_id": 70013, "title": "", "abstract": ["In addition to controlling apoptosis, there is growing evidence that caspase-8 regulates several non-apoptotic cellular mechanisms including proliferation, migration and differentiation8,9.", "Accordingly, caspase-8 has been shown to promote the terminal differentiation of macrophages and keratinocytes10.", "Primary isolated intestinal epithelial cells were cultured with RPMI (Gibco), (10% FCS (PAA), Penicillin (100 U/ml, Gibco), Streptomycin (100 μg/ml, Gibco) in fibronectin (BD Bioscience) coated 48 well plates and caspase-3/-7 activity was measured using the Caspase-Glo3/7 Assay from Promega according to the manufacturer's instructions.", "For organoid culture, intestinal crypts were isolated from mice and cultured as previously described11.", "Organ culture of freshly isolated human small intestinal biopsies was performed in RPMI medium (Gibco)."]}
{"doc_id": 70014, "title": "", "abstract": ["Collectively, our data suggest that deficient caspase-8 expression renders Paneth cells susceptible to TNF-α induced necroptosis highlighting a regulatory role of caspase-8 in antimicrobial defence and in maintaining immune homeostasis in the gut.", "On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis", "Caspase-8 deficient mice completely lacked Paneth cells, suggesting that these cell types are highly susceptible to necroptosis.", "Thus it is getting increasingly clear, that caspase-8 has an essential function in controlling RIP-3 mediated necroptosis."]}
{"doc_id": 98000, "title": "", "abstract": ["Blocking TLR4 in cells originating from bone marrow or ablating CD11c+ macrophages reduces insulin resistance in obese mice (Patsouris et al., 2008; Saberi et al., 2009).", "Conversely, expressing dominant-negative p53 in fat cells and macrophages confers protection against the insulin resistance and increased fat tissue cytokines, macrophage infiltration, and SA β-gal activity caused by high fat diets (Minamino et al., 2009).", "For example, antibody-mediated CD8+ depletion reduces high fat diet-induced TNFα, IL-6, and M1 macrophage abundance and improves insulin responsiveness in mice (Nishimura et al., 2009).", "Consistent with this, upregulating p53 in fat cells and macrophages induces senescence and increases insulin resistance and inflammatory cytokines in mouse fat (Minamino et al., 2009).", "Reducing mast cells by genetic manipulation or pharmacologic stabilization with disodium chromoglycate reduces hepatic steatosis, circulating inflammatory cytokines and chemokines, angiogenesis, and insulin resistance in obese mice (Liu et al., 2009)."]}
{"doc_id": 98001, "title": "", "abstract": ["Substantial changes in fat tissue metabolic function occur during aging, with declines in insulin, lipolytic, and fatty acid responsiveness (Bertrand et al., 1980; Yu et al., 1982; Kirkland & Dax, 1984; Yki-Jarvinen et al., 1986; Silver et al., 1993; Gregerman, 1994; Kirkland & Dobson, 1997; Kirkland et al., 2002; Das et al., 2004; Tchkonia et al., 2006a).", "We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation.", "Extensive changes in preadipocyte function occur with aging [Fig. 2; (Djian et al., 1983; Wang et al., 1989; Kirkland et al., 1990, 1993, 1994, 1997; Kirkland & Dobson, 1997; Kirkland & Hollenberg, 1998; Caserta et al., 2001; Karagiannides et al., 2001; Kirkland et al., 2002; Karagiannides et al., 2006b; Guo et al., 2007; Tchkonia et al., 2007a; Cartwright et al., 2010)].", "Age-related changes in fat tissue inflammatory profiles resemble those in obesity, in which senescent preadipocytes and endothelial cells accumulate, as well as the senescent secretory phenotype reported in skin fibroblasts and other cell types in vitro [Table 2; (Krtolica & Campisi, 2002; Parrinello et al., 2005; Xue et al., 2007; Coppéet al., 2008; Minamino et al., 2009; Tchkonia et al., 2009; Cartwright et al., 2010)].", "Thus, age-related changes in preadipocyte and fat cell adipogenic transcription factors may contribute not only to morbidity, manipulating them may also prove to delay age-related dysfunction."]}
{"doc_id": 98002, "title": "", "abstract": ["Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "Together, these findings suggest senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction.", "These senescent progenitors in fat tissue might initiate the infiltration of immune cells that commonly occurs in obesity, a speculation that merits testing.", "Senescent preadipocytes can accumulate in fat tissue of even young individuals.", "Fat cell progenitors, preadipocytes, are abundant, closely related to macrophages, and dysdifferentiate in old age, switching into a pro-inflammatory, tissue-remodeling, senescent-like state."]}
{"doc_id": 98003, "title": "", "abstract": ["Visceral fat enlargement is more strongly associated with ectopic fat deposition, lipotoxicity, and metabolic disease than generalized obesity, especially in old age (Carr et al., 2004; Tchkonia et al., 2006a; Wannamethee et al., 2007; Gustafson et al., 2009; Thomou et al., 2010).", "As in aging, genetic and acquired lipodystrophic syndromes are associated with fat tissue dysfunction, subcutaneous fat loss, increased visceral and ectopic fat, and metabolic syndrome [glucose intolerance, insulin resistance, central obesity, dyslipidemia, and hypertension (Garg & Agarwal, 2009)].", "Thus, fat redistribution with aging occurs across species and is associated with age-related diseases, lipotoxicity, and reduced longevity, while retention of a high ratio of functioning subcutaneous to visceral fat is associated with enhanced longevity.", "Age-related increases in fat tissue inflammatory cytokine and chemokine expression vary among fat depots (Starr et al., 2009; Cartwright et al., 2010).", "In old age, fat is redistributed outside fat depots, accumulating in bone marrow, muscle, liver, and other ectopic sites."]}
{"doc_id": 98004, "title": "", "abstract": ["Cell dynamic processes that vary with aging are in bold, obesity are underlined, anatomic origin in Italics, and serial passage in parentheses.", "The stromal vascular fraction of adipose tissue (comprising preadipocytes, endothelial cells, immune cells, and other cell types) may be the main source of inflammatory cytokines and chemokines produced by fat (Fain et al. 2009; Wu et al., 2007; Gustafson et al., 2009).", "Impact of aging, obesity, anatomic origin, and serial passage on cell dynamic mechanisms of fat tissue turnover.", "The balance among these cell dynamic properties determines preadipocyte and fat cell numbers.", "Cell dynamic and molecular mechanisms underlying fat tissue dysfunction in obesity in younger individuals are strikingly similar to aging."]}
{"doc_id": 98005, "title": "", "abstract": ["Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "Amount of fat tissue was increased considerably in the obese subjects, resulting in many more preadipocytes/obese subject.", "Age-related changes in fat tissue inflammatory profiles resemble those in obesity, in which senescent preadipocytes and endothelial cells accumulate, as well as the senescent secretory phenotype reported in skin fibroblasts and other cell types in vitro [Table 2; (Krtolica & Campisi, 2002; Parrinello et al., 2005; Xue et al., 2007; Coppéet al., 2008; Minamino et al., 2009; Tchkonia et al., 2009; Cartwright et al., 2010)].", "Cytokines and chemokines produced by senescent cells appear to be capable of activating adaptive and innate immune responses that could spread cellular senescence locally and systemically.", "This is consistent with the possibility that fat cells and preadipocytes could be the main sources of the increased fat tissue inflammatory cytokines and chemokines with aging."]}
{"doc_id": 98006, "title": "", "abstract": ["Cellular senescence leads to a senescent secretory phenotype with increased inflammatory cytokines, altered production of ECM-modifying proteases, and production of ROS (Freund et al.; Passos et al. 2010; Krtolica & Campisi, 2002; Parrinello et al., 2005; Xue et al., 2007; Coppéet al., 2008).", "Cytokines and chemokines produced by senescent cells appear to be capable of activating adaptive and innate immune responses that could spread cellular senescence locally and systemically.", "Generation of cytokines, chemokines, and ECM modifiers by senescent cells leads to death of cells around them, tissue remodeling, and attraction of immune elements.", "Preadipocytes and fat tissue endothelial cells may acquire an activated, pro-inflammatory, senescent-like phenotype in response to repeated replication, fatty acids, toxic metabolites, chronically high IGF-1, glucose, or other stimuli (gray = inflamed).", "Thus, cellular senescence owing to high p53 and the resulting pro-inflammatory secretory phenotype could contribute to morbidity associated with obesity."]}
{"doc_id": 98007, "title": "", "abstract": ["We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation.", "The preadipocyte pro-inflammatory phenotype might impede protection against lipotoxicity, contributing to systemic consequences in aging similar to those in lipodystrophies and obesity.", "Impaired adipogenesis in obesity, associated with reduced downregulation of preadipocyte pro-inflammatory genes and restricted capacity to store excess fatty acid as triglyceride, may contribute to fat tissue inflammation, ectopic lipid accumulation, lipotoxicity, and insulin resistance, as occurs in aging (Unger, 2002; Xu et al., 2002; Listenberger et al., 2003; DeFronzo, 2004; Tchkonia et al., 2006a; Kim et al., 2007).", "These include declines in preadipocyte replication (Djian et al., 1983; Kirkland et al., 1990; Kirkland & Hollenberg, 1998; Schipper et al., 2008), decreased adipogenesis (Kirkland et al., 1990, 1993; Karagiannides et al., 2001, 2006b), increased susceptibility to lipotoxicity (Guo et al., 2007), and increased pro-inflammatory cytokine, chemokine, ECM-modifying protease, and stress response element expression (Tchkonia et al., 2007a; Cartwright et al., 2010).", "Fat cell progenitors, preadipocytes, are abundant, closely related to macrophages, and dysdifferentiate in old age, switching into a pro-inflammatory, tissue-remodeling, senescent-like state."]}
{"doc_id": 98008, "title": "", "abstract": ["Excess or dysfunctional fat tissue appears to accelerate onset of multiple age-related diseases, while interventions that delay or limit fat tissue turnover, redistribution, or dysfunction in experimental animals are associated with enhanced healthspan and maximum life span.", "Is cellular senescence at the root of age- and obesity-related fat tissue inflammation and metabolic dysfunction?", "While obesity is associated with accelerated development of diseases common in old age, mechanisms of fat tissue dysfunction in obesity differ from aging in important ways.", "Similar processes could be involved in age-related fat tissue dysregulation and metabolic dysfunction.", "As in obesity, aging is frequently associated with increased fat tissue and circulating pro-inflammatory cytokines, including TNFα and IL-6 (Morin et al., 1997; Starr et al., 2009)."]}
{"doc_id": 98009, "title": "", "abstract": ["These changes occur at different rates in different depots, with subcutaneous depots being particularly affected, potentially contributing to fat redistribution, lipodystrophy, ectopic lipid accumulation, lipotoxicity, and metabolic dysfunction.", "Similar processes could be involved in age-related fat tissue dysregulation and metabolic dysfunction.", "Is cellular senescence at the root of age- and obesity-related fat tissue inflammation and metabolic dysfunction?", "These differences among depots in the trajectory of age-related preadipocyte dysfunction may contribute to disproportional loss of subcutaneous fat.", "Dysregulated activation of fat tissue immune responses may predispose individuals to the metabolic dysfunction common in both obesity and aging."]}
{"doc_id": 98010, "title": "", "abstract": ["We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation.", "While influences extrinsic to fat tissue, including systemic disease and changes in diet, activity, and hormones, likely contribute to fat dysfunction in old age, inherent, age- related changes in preadipocytes set the stage for fat tissue and systemic metabolic dysfunction.", "Conversely, decreased ability of subcutaneous adipocytes to store lipid, as occurs with aging, may contribute to metabolic complications by causing systemic lipotoxicity (Lelliott & Vidal-Puig, 2004; Carley & Severson, 2005; Unger, 2005; Uranga et al., 2005; Tchkonia et al., 2006a; Kuk et al., 2009).", "Together with preadipocyte dysfunction, impairments in ability to accumulate or mobilize lipid with aging reduce the dynamic range over which fat cells can store or release energy or respond to excess systemic lipotoxic fatty acids.", "Is cellular senescence at the root of age- and obesity-related fat tissue inflammation and metabolic dysfunction?"]}
{"doc_id": 98011, "title": "", "abstract": ["Together, these findings suggest senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction.", "Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation.", "Cellular senescence, arguably a normally adaptive response to injury or infection, could instead become a root cause of inflammation, failure to sequester fatty acids, and dysfunction both in fat tissue and systemically during aging and in obesity (Fig. 1).", "If this hypothetical model is valid, senescent cells and their products would be a logical target for therapeutic intervention in age- and obesity-related metabolic disease."]}
{"doc_id": 98012, "title": "", "abstract": ["Together, these findings suggest senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction.", "Cellular senescence, arguably a normally adaptive response to injury or infection, could instead become a root cause of inflammation, failure to sequester fatty acids, and dysfunction both in fat tissue and systemically during aging and in obesity (Fig. 1).", "Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "Age-related changes in fat tissue inflammatory profiles resemble those in obesity, in which senescent preadipocytes and endothelial cells accumulate, as well as the senescent secretory phenotype reported in skin fibroblasts and other cell types in vitro [Table 2; (Krtolica & Campisi, 2002; Parrinello et al., 2005; Xue et al., 2007; Coppéet al., 2008; Minamino et al., 2009; Tchkonia et al., 2009; Cartwright et al., 2010)].", "Failure to remove senescent cells may contribute to their accumulation, both because of age- related macrophage dysfunction and effects of ECM-modifying proteases on receptors and other proteins required for optimal immune clearance."]}
{"doc_id": 98013, "title": "", "abstract": ["Fat cell progenitors, preadipocytes, are abundant, closely related to macrophages, and dysdifferentiate in old age, switching into a pro-inflammatory, tissue-remodeling, senescent-like state.", "Preadipocytes and fat tissue endothelial cells may acquire an activated, pro-inflammatory, senescent-like phenotype in response to repeated replication, fatty acids, toxic metabolites, chronically high IGF-1, glucose, or other stimuli (gray = inflamed).", "Consistent with this, preadipocyte pro-inflammatory cytokine, chemokine, and ECM modifier production is greater in extra- than intra- peritoneal fat in old age (Cartwright et al., 2010).", "While influences extrinsic to fat tissue, including systemic disease and changes in diet, activity, and hormones, likely contribute to fat dysfunction in old age, inherent, age- related changes in preadipocytes set the stage for fat tissue and systemic metabolic dysfunction.", "Preadipocytes from old rats and the cytokines they produce can impede adipogenesis in nearby fat cells, potentially contributing to age-related lipodystrophy and fat redistribution (Tchkonia et al., 2007a; Gustafson et al., 2009)."]}
{"doc_id": 98014, "title": "", "abstract": ["Thus, fat redistribution with aging occurs across species and is associated with age-related diseases, lipotoxicity, and reduced longevity, while retention of a high ratio of functioning subcutaneous to visceral fat is associated with enhanced longevity.", "As in humans, mice and rats have fat redistribution and ectopic fat deposition with aging.", "In old age, fat is redistributed outside fat depots, accumulating in bone marrow, muscle, liver, and other ectopic sites.", "Visceral fat enlargement is more strongly associated with ectopic fat deposition, lipotoxicity, and metabolic disease than generalized obesity, especially in old age (Carr et al., 2004; Tchkonia et al., 2006a; Wannamethee et al., 2007; Gustafson et al., 2009; Thomou et al., 2010).", "These changes occur at different rates in different depots, with subcutaneous depots being particularly affected, potentially contributing to fat redistribution, lipodystrophy, ectopic lipid accumulation, lipotoxicity, and metabolic dysfunction."]}
{"doc_id": 98015, "title": "", "abstract": ["Terminally differentiated fat cells might be able to acquire a senescent-like state in both aging and obesity (Wu et al., 2007; Minamino et al., 2009).", "While macrophages increase in particular fat depots with aging, these increases are less impressive than in obesity, and macrophage numbers do not increase at all in some fat depots with aging (Harris et al., 1999; Jerschow et al., 2007).", "Thus, fat redistribution with aging occurs across species and is associated with age-related diseases, lipotoxicity, and reduced longevity, while retention of a high ratio of functioning subcutaneous to visceral fat is associated with enhanced longevity.", "Fat distribution and function change dramatically throughout life.", "Major changes in fat distribution and function occur throughout life."]}
{"doc_id": 98016, "title": "", "abstract": ["Excess or dysfunctional fat tissue appears to accelerate onset of multiple age-related diseases, while interventions that delay or limit fat tissue turnover, redistribution, or dysfunction in experimental animals are associated with enhanced healthspan and maximum life span.", "Substantial changes in fat tissue metabolic function occur during aging, with declines in insulin, lipolytic, and fatty acid responsiveness (Bertrand et al., 1980; Yu et al., 1982; Kirkland & Dax, 1984; Yki-Jarvinen et al., 1986; Silver et al., 1993; Gregerman, 1994; Kirkland & Dobson, 1997; Kirkland et al., 2002; Das et al., 2004; Tchkonia et al., 2006a).", "Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "As in aging, genetic and acquired lipodystrophic syndromes are associated with fat tissue dysfunction, subcutaneous fat loss, increased visceral and ectopic fat, and metabolic syndrome [glucose intolerance, insulin resistance, central obesity, dyslipidemia, and hypertension (Garg & Agarwal, 2009)].", "Together, these findings suggest senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction."]}
{"doc_id": 98017, "title": "", "abstract": ["Capacity of macrophages to be activated into a pro-inflammatory state by chemokines and cytokines generally declines with aging (Sebastian et al., 2009).", "The innate immune response capacity of macrophages appears to be compromised with aging (Sebastian et al., 2009), potentially contributing to senescent cell accumulation in old age.", "Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "Age-related alterations in the stromal microenvironment, including cytokine imbalance, could further impede macrophage function (Stout & Suttles, 2005), possibly augmenting senescent cell accumulation.", "Macrophage function generally declines with aging (Sebastian et al., 2009)."]}
{"doc_id": 98018, "title": "", "abstract": ["Clinical consequences of obesity are increasingly close to being amenable to novel interventions based on targeting inflammation and fat tissue cellular composition.", "Obesity and aging are both associated with chronic, low-grade inflammation and insulin resistance, increased local and circulating proinflammatory, chemotactic, and procoagulant proteins, and ectopic lipid deposition with lipotoxicity (Hotamisligil & Spiegelman, 1994; Samad et al., 1996, 1997; Vgontzas et al., 1997; Fried et al., 1998; Loffreda et al., 1998; Samad et al., 1998; Ferri et al., 1999; Visser et al., 1999; Perreault & Marette, 2001; De Pergola & Pannacciulli, 2002; Weyer et al., 2002; Sartipy & Loskutoff, 2003; Takahashi et al., 2003; Weisberg et al., 2003; Xu et al., 2003; Curat et al., 2004; Tchkonia et al., 2006a).", "The preadipocyte pro-inflammatory phenotype might impede protection against lipotoxicity, contributing to systemic consequences in aging similar to those in lipodystrophies and obesity.", "As in obesity, aging is frequently associated with increased fat tissue and circulating pro-inflammatory cytokines, including TNFα and IL-6 (Morin et al., 1997; Starr et al., 2009).", "If this hypothetical model is valid, senescent cells and their products would be a logical target for therapeutic intervention in age- and obesity-related metabolic disease."]}
{"doc_id": 98019, "title": "", "abstract": ["Inflammatory cytokines could spread this activated secretory phenotype from cell to cell and block full differentiation of preadipocytes into insulin-responsive fat cells, amplifying the process.", "We propose a hypothetical model in which cellular stress and preadipocyte overutilization with aging induce cellular senescence, leading to impaired adipogenesis, failure to sequester lipotoxic fatty acids, inflammatory cytokine and chemokine generation, and innate and adaptive immune response activation.", "Increased pro-inflammatory cytokine release by preadipocytes activates adjacent cells into a pro-inflammatory state: TNFα exposure increases preadipocyte TNFα mRNA (Mack et al., 2009).", "In preadipocytes, cellular senescence, the age-associated MAD state, the pro-inflammatory secretory state activated by cytokines, LPS, fatty acids, ROS, ceramide, cellular stress pathways, or other signals, and the macrophage-like phenotype that preadipocytes can assume may all be related.", "Although TNFα and hypoxia also increase preadipocyte cytokines that promote endothelial cell-monocyte adhesion and macrophage infiltration (Mack et al., 2009), macrophages do not appear to be a major source of pro-inflammatory cytokines with aging in fat tissue (Wu et al., 2007)."]}
{"doc_id": 98020, "title": "", "abstract": ["Impaired adipogenesis in obesity, associated with reduced downregulation of preadipocyte pro-inflammatory genes and restricted capacity to store excess fatty acid as triglyceride, may contribute to fat tissue inflammation, ectopic lipid accumulation, lipotoxicity, and insulin resistance, as occurs in aging (Unger, 2002; Xu et al., 2002; Listenberger et al., 2003; DeFronzo, 2004; Tchkonia et al., 2006a; Kim et al., 2007).", "The age-related impairment in adipogenesis occurs at a point between the early increase in C/EBPβ transcription and subsequent increases in PPARγ and C/EBPα (Karagiannides et al., 2001).", "Age-related increases in fat tissue inflammatory cytokine and chemokine expression vary among fat depots (Starr et al., 2009; Cartwright et al., 2010).", "Different fat depots make distinct contributions to the pro-inflammatory and clinical consequences of obesity and, potentially, aging.", "While macrophages increase in particular fat depots with aging, these increases are less impressive than in obesity, and macrophage numbers do not increase at all in some fat depots with aging (Harris et al., 1999; Jerschow et al., 2007)."]}
{"doc_id": 98021, "title": "", "abstract": ["Cytokines secreted by activated preadipocytes, macrophages, and endothelial cells can induce chemokine and cytokine expression in bystander cells in a pattern like that of the senescent secretory phenotype (Suganami et al., 2005; Mack et al., 2009).", "Increased pro-inflammatory cytokine release by preadipocytes activates adjacent cells into a pro-inflammatory state: TNFα exposure increases preadipocyte TNFα mRNA (Mack et al., 2009).", "TNFα and hypoxia induce preadipocytes to release cytokines and chemokines that activate endothelial cells and promote macrophage infiltration (Mack et al., 2009).", "In preadipocytes, cellular senescence, the age-associated MAD state, the pro-inflammatory secretory state activated by cytokines, LPS, fatty acids, ROS, ceramide, cellular stress pathways, or other signals, and the macrophage-like phenotype that preadipocytes can assume may all be related.", "These appear to activate innate immune responses in preadipocytes, causing further cytokine and chemokine generation, potentially inducing spread of activation of pro-inflammatory responses to nearby preadipocytes and other cell types and attraction of immune cells."]}
{"doc_id": 98022, "title": "", "abstract": ["For example, obesity leads to reduced life span and clinical consequences similar to those common in aging (Ahima, 2009).", "Obesity is associated with accelerated onset of diseases common in old age, while fat ablation and certain mutations affecting fat increase life span.", "Excess or dysfunctional fat tissue appears to accelerate onset of multiple age-related diseases, while interventions that delay or limit fat tissue turnover, redistribution, or dysfunction in experimental animals are associated with enhanced healthspan and maximum life span.", "While obesity is associated with accelerated development of diseases common in old age, mechanisms of fat tissue dysfunction in obesity differ from aging in important ways.", "Thus, fat redistribution with aging occurs across species and is associated with age-related diseases, lipotoxicity, and reduced longevity, while retention of a high ratio of functioning subcutaneous to visceral fat is associated with enhanced longevity."]}
{"doc_id": 98023, "title": "", "abstract": ["Consistent with this, the percent of meal fat stored in subcutaneous depots is lower in older than younger men and women, and abdominal circumference increases by 4.0 cm every 9 years in adult women (Hughes et al., 2004; Koutsari et al., 2009).", "Fat is redistributed among different fat depots over time, especially during and after middle age, when fat redistributes from subcutaneous to intra-abdominal visceral depots (Meunier et al., 1971; Kotani et al., 1994; Matsuzawa et al., 1995; Kyle et al., 2001; Raguso et al., 2006; Slawik & Vidal-Puig, 2006; Cartwright et al., 2007; Rabkin, 2007; Kuk et al., 2009).", "These differences among depots in the trajectory of age-related preadipocyte dysfunction may contribute to disproportional loss of subcutaneous fat.", "Age-related increases in fat tissue inflammatory cytokine and chemokine expression vary among fat depots (Starr et al., 2009; Cartwright et al., 2010).", "Macrophage abundance increases in subcutaneous fat with aging in mice (Jerschow et al., 2007)."]}
{"doc_id": 12000, "title": "", "abstract": ["Postulated Mechanisms of Coagulopathy and Pathogenesis of Thrombosis in COVID-19", "Myocardial injury in COVID-19, as evidenced by elevated cardiac troponin levels or electrocardiographic and echocardiographic abnormalities, is associated with severe disease (5,36).", "Recently, Tang et al. (7) assessed 183 patients with COVID-19, 21 (11.5%) of whom died.", "In a study from 3 hospitals from the Netherlands, 31% of 184 critically ill patients with COVID-19 had thrombosis, with most events being VTE.", "However, the differential diagnosis for elevated troponin in COVID-19 is broad (37) and includes nonspecific myocardial injury, impaired renal function (leading to troponin accumulation), myocarditis, pulmonary embolism (PE), and type 1 and 2 myocardial infarction (MI) (38,39)."]}
{"doc_id": 12001, "title": "", "abstract": ["Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "First, the direct effects of COVID-19 or the indirect effects of infection, such as through severe illness and hypoxia, may predispose patients to thrombotic events.", "Inflammatory response, increased age, and bedridden status—which are more frequently observed in severe coronavirus disease-2019 (COVID-19)—may contribute to thrombosis and adverse outcomes.", "Additionally, the severe inflammatory response, critical illness, and underlying traditional risk factors may all predispose to thrombotic events, similar to prior virulent zoonotic coronavirus outbreaks (Table 1 ) (9,10).", "(A) Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection activates an inflammatory response, leading to release of inflammatory mediators."]}
{"doc_id": 12002, "title": "", "abstract": ["In a study from 3 hospitals from the Netherlands, 31% of 184 critically ill patients with COVID-19 had thrombosis, with most events being VTE.", "In a retrospective study from China, among 81 patients with severe COVID-19 admitted to ICU, 20 (25%) developed incident VTE.", "In conclusion, thrombotic disease may be precedent factors or incident complications in patients with COVID-19.", "Although limited data are available, pregnant women admitted to hospital with COVID-19 infection are likely to be at an increased risk of VTE.", "Aside from hemostatic derangements, immobility (a systemic inflammatory state), mechanical ventilation, and central venous catheters contribute to VTE risk within the ICU (105, 106, 107), nutritional deficiencies and liver dysfunction may also interfere with the production of coagulation factors (108)."]}
{"doc_id": 12003, "title": "", "abstract": ["The approach to safe evaluation and management of thrombotic disease in patients with COVID-19 has several levels of involvement.", "In a study from 3 hospitals from the Netherlands, 31% of 184 critically ill patients with COVID-19 had thrombosis, with most events being VTE.", "Although no data specific to COVID-19 exist, it is reasonable to employ individualized risk stratification for thrombotic and hemorrhagic risk, followed by consideration of extended prophylaxis (for up to 45 days) for patients with elevated risk of VTE (e.g., reduced mobility, comorbidities such as active cancer, and [according to some authors in the writing group] elevated D-dimer >2 times the upper limit of normal) who have low risk of bleeding (74,77,78).", "However, similar to other acutely ill medical patients, VTE risk stratification for hospitalized patients with COVID-19 should be undertaken.", "At this moment, while practitioners use a variety of prophylactic, intermediate, or therapeutic doses of anticoagulants in patients, the optimal dosing in patients with severe COVID-19 remains unknown and warrants further prospective investigation."]}
{"doc_id": 12004, "title": "", "abstract": ["For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "For patients with moderate or severe COVID-19 and an indication for dual antiplatelet therapy (e.g., PCI within the past 3 months or recent MI) and with suspected or confirmed DIC without overt bleeding, in the absence of evidence decisions for antiplatelet therapy need to be individualized.", "In many ill inpatients with VTE, parenteral anticoagulation (e.g., UFH) is preferred as it may be temporarily withheld and has no known drug-drug interactions with investigational COVID-19 therapies.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression."]}
{"doc_id": 12005, "title": "", "abstract": ["Subcutaneous heparin (5,000 U twice to 3 times daily) can be considered for patients with renal dysfunction (i.e., creatinine clearance <30 ml/min).", "If DOACs are not available or approved by insurance, low-molecular-weight heparin (LMWHs) could be used in select cases.", "The potential risk (especially in the setting or organ dysfunction) may include clinical deterioration and lack of timely availability of effective reversal agents at some centers.", "In patients with perceived elevated bleeding risk, regimens with less potent antiplatelet agents, such as with clopidogrel, should be considered, given that hemorrhagic complications are not uncommon.", "The World Health Organization interim guidance statement recommends prophylactic daily low-molecular-weight heparins (LMWHs), or twice daily subcutaneous unfractionated heparin (UFH) (64)."]}
{"doc_id": 12006, "title": "", "abstract": ["For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "However, similar to other acutely ill medical patients, VTE risk stratification for hospitalized patients with COVID-19 should be undertaken.", "A recent study from China, using the Padua model, reported that 40% of hospitalized patients with COVID-19 were at high risk of VTE."]}
{"doc_id": 12007, "title": "", "abstract": ["Common laboratory abnormalities found in patients with COVID-19 include lymphopenia (15) and elevation in lactate dehydrogenase and inflammatory markers such as C-reactive protein, D-dimer, ferritin, and interleukin-6 (IL-6) (20).", "Association Between Coagulation Abnormalities or Markers of Thrombosis and Hemostasis and Clinical Outcomes in Patients With COVID-19", "However, the differential diagnosis for elevated troponin in COVID-19 is broad (37) and includes nonspecific myocardial injury, impaired renal function (leading to troponin accumulation), myocarditis, pulmonary embolism (PE), and type 1 and 2 myocardial infarction (MI) (38,39).", "Elevated troponin levels are associated with poor outcomes in several studies of COVID-19 (36).", "As described previously, elevated D-dimer levels represent a common finding in patients with COVID-19 (23), and do not currently warrant routine investigation for acute VTE in absence of clinical manifestations or other supporting information."]}
{"doc_id": 12008, "title": "", "abstract": ["Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "Endothelial and hemostatic activation ensues, with increase in von Willebrand factor and increased tissue factor.", "Aside from hemostatic derangements, immobility (a systemic inflammatory state), mechanical ventilation, and central venous catheters contribute to VTE risk within the ICU (105, 106, 107), nutritional deficiencies and liver dysfunction may also interfere with the production of coagulation factors (108).", "The inflammatory response to severe infection is marked by lymphopenia and thrombocytopenia.", "*  Platelet aggregation over inflamed atherosclerotic plaques noted in animal models (148)"]}
{"doc_id": 12009, "title": "", "abstract": ["# COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up", "The questions included considerations for prophylactic or therapeutic anticoagulant regimens among various subgroups of patients with COVID-19, and antithrombotic therapy in the setting of suspected or confirmed DIC.", "Summary of Consensus Recommendation on Antithrombotic Therapy During the COVID-19 Pandemic", "There are several ways in which the COVID-19 pandemic may affect the prevention and management of thrombotic and thromboembolic disease (hereafter collectively referred to as thrombotic disease for brevity).", "The current paper has provided an interim summary and guidance for considerations related to thrombotic disease and antithrombotic therapy during the COVID-19 pandemic."]}
{"doc_id": 12010, "title": "", "abstract": ["Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "Additionally, the severe inflammatory response, critical illness, and underlying traditional risk factors may all predispose to thrombotic events, similar to prior virulent zoonotic coronavirus outbreaks (Table 1 ) (9,10).", "First, the direct effects of COVID-19 or the indirect effects of infection, such as through severe illness and hypoxia, may predispose patients to thrombotic events.", "It is uncertain whether COVID-19 has unique characteristics to cause direct activation of coagulation.", "(A) Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection activates an inflammatory response, leading to release of inflammatory mediators."]}
{"doc_id": 12011, "title": "", "abstract": ["Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "Although anecdotal cases of patients with COVID-19 presenting with ACS due to plaque rupture have been described (type 1 MI), currently no such cases have been published.", "The current paper, authored by an international collaborative of clinicians and investigators, summarizes the pathogenesis, epidemiology, treatment, and available outcome data related to thrombotic disease in patients with COVID-19, as well as management of thrombotic events in patients without COVID-19 during this pandemic.", "COVID-19 has a number of important cardiovascular implications (4, 5, 6).", "Herein, the authors review the current understanding of the pathogenesis, epidemiology, management, and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, of those with pre-existing thrombotic disease who develop COVID-19, or those who need prevention or care for their thrombotic disease during the COVID-19 pandemic."]}
{"doc_id": 12012, "title": "", "abstract": ["The majority of panel members consider prophylactic anticoagulation, although a minority consider an intermediate or therapeutic dose to be reasonable.", "§Although the majority of the writing group did make this recommendation, 31.6% of the group were in favor of intermediate-dose anticoagulation (e.g., enoxaparin 1 mg/kg/day, or enoxaparin 40 mg twice daily, or UFH with target aPTT of 50–70 s) and 5.2% considered therapeutic anticoagulation.", "A minority of investigators (29.7%) voted for intermediate-dose parenteral anticoagulation in this setting, and 16.2% considered therapeutic anticoagulation.", "At this moment, while practitioners use a variety of prophylactic, intermediate, or therapeutic doses of anticoagulants in patients, the optimal dosing in patients with severe COVID-19 remains unknown and warrants further prospective investigation.", "¶The majority of the investigators recommended prophylactic anticoagulation (54%)."]}
{"doc_id": 12013, "title": "", "abstract": []}
{"doc_id": 12014, "title": "", "abstract": ["The World Health Organization interim guidance statement recommends prophylactic daily low-molecular-weight heparins (LMWHs), or twice daily subcutaneous unfractionated heparin (UFH) (64).", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "Coronavirus disease-2019 (COVID-19) is a viral illness caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), and now has been deemed a pandemic by the World Health Organization (1, 2, 3)."]}
{"doc_id": 12015, "title": "", "abstract": ["Other drugs being studied to treat COVID-19 include azithromycin, bevacizumab, chloroquine/hydroxychloroquine, eculizumab, fingolimod, interferon, losartan, methylprednisolone, pirfenidone, and ribavirin.", "Alternatively, fingolimod, an immunomodulating agent being tried for COVID-19, may reduce reperfusion injury and improve outcomes in patients suffering from acute ischemic stroke (42).", "Several investigational agents are being tested in the management of COVID-19, especially for patients who develop severe disease.", "In view of the hemostatic derangements discussed previously and observations from prior viral illnesses (80), some clinicians use intermediate- or full- dose (therapeutic) parenteral anticoagulation (rather than prophylactic dosing) for routine care of patients with COVID-19 (81), hypothesizing that it may confer benefit to prevent microvascular thrombosis.", "Key Words: anticoagulant, antiplatelet, antithrombotic therapy, COVID-19, SARS-CoV-2, thrombosis"]}
{"doc_id": 12016, "title": "", "abstract": ["In a study from 3 hospitals from the Netherlands, 31% of 184 critically ill patients with COVID-19 had thrombosis, with most events being VTE.", "In conclusion, thrombotic disease may be precedent factors or incident complications in patients with COVID-19.", "In a study of 184 patients with severe COVID-19 from 3 academic medical centers in the Netherlands, the authors reported that 31% (95% confidence interval: 20% to 41%) of patients developed incident VTE.", "Although anecdotal cases of patients with COVID-19 presenting with ACS due to plaque rupture have been described (type 1 MI), currently no such cases have been published.", "First, the direct effects of COVID-19 or the indirect effects of infection, such as through severe illness and hypoxia, may predispose patients to thrombotic events."]}
{"doc_id": 12017, "title": "", "abstract": ["Lopinavir/ritonavir has the potential to also affect choice and dosage of a number of anticoagulants.", "Lopinavir/ritonavir is a protease inhibitor and inhibits CYP3A4 metabolism.", "* * *      ---|---|---|---   Clopidogrel| Prasugrel| Ticagrelor| Cilostazol   Lopinavir/ritonavir| Lopinavir is a protease inhibitor; Ritonavir inhibits CYP3A4 metabolism increasing lopinavir levels.| CYP 3A4 Inhibition (minor pathway): Reduction in clopidogrel active metabolite.", "Therefore, the concomitant use of these agents along with lopinavir/ritonavir should be cautioned.", "Remdesivir, a nucleotide- analog inhibitor of RNA-dependent RNA polymerase, is reportedly an inducer of CYP3A4; however, dose adjustments for oral antiplatelet agents are currently not recommended."]}
{"doc_id": 12018, "title": "", "abstract": ["The current paper, authored by an international collaborative of clinicians and investigators, summarizes the pathogenesis, epidemiology, treatment, and available outcome data related to thrombotic disease in patients with COVID-19, as well as management of thrombotic events in patients without COVID-19 during this pandemic.", "Systematic review of literature published prior to February 24, 2020, suggests elevations in PT and D-dimer levels were associated with poor prognosis in patients with COVID-19 (25).", "Although no data specific to COVID-19 exist, it is reasonable to employ individualized risk stratification for thrombotic and hemorrhagic risk, followed by consideration of extended prophylaxis (for up to 45 days) for patients with elevated risk of VTE (e.g., reduced mobility, comorbidities such as active cancer, and [according to some authors in the writing group] elevated D-dimer >2 times the upper limit of normal) who have low risk of bleeding (74,77,78).", "Common laboratory abnormalities found in patients with COVID-19 include lymphopenia (15) and elevation in lactate dehydrogenase and inflammatory markers such as C-reactive protein, D-dimer, ferritin, and interleukin-6 (IL-6) (20).", "The majority of authors of this paper recommended reducing the intensity of anticoagulation in this clinical circumstance, unless the risk of thrombosis is considered to be exceedingly high.#    For patients with moderate or severe COVID-19 and an indication for dual antiplatelet therapy (e.g., percutaneous coronary intervention within the past 3 months or recent myocardial infarction) and with suspected or confirmed DIC without overt bleeding, in the absence of evidence, decisions for antiplatelet therapy need to be individualized."]}
{"doc_id": 12019, "title": "", "abstract": ["Missed doses of pharmacologic VTE prophylaxis are common and are likely associated with worse outcomes (66).", "Arterial thrombotic events| A self-controlled study of 364 patients hospitalized with acute myocardial infarction found an increased incidence ratio (6.05; 95% confidence interval: 3.86–9.50) for myocardial infarction during periods after influenza compared with controls (97).", "Additionally, the severe inflammatory response, critical illness, and underlying traditional risk factors may all predispose to thrombotic events, similar to prior virulent zoonotic coronavirus outbreaks (Table 1 ) (9,10).", "Important considerations for the preventive and therapeutic use of antithrombotic agents should be kept in mind to mitigate the thrombotic and hemorrhagic events in these high-risk patients.", "Pharmacological prophylaxis should be considered if there is elevated risk for thrombotic events, without high bleeding risk.∗∗   Ambulation and physical activity should be encouraged."]}
{"doc_id": 12020, "title": "", "abstract": ["§Although the majority of the writing group did make this recommendation, 31.6% of the group were in favor of intermediate-dose anticoagulation (e.g., enoxaparin 1 mg/kg/day, or enoxaparin 40 mg twice daily, or UFH with target aPTT of 50–70 s) and 5.2% considered therapeutic anticoagulation.", "For patients who were admitted and are now being discharged for COVID-19, routine screening for VTE risk is reasonable for consideration of pharmacological prophylaxis for up to 45 days post-discharge.", "‡If VTE prophylaxis is considered, enoxaparin 40 mg daily or similar LMWH regimen (e.g., dalteparin 5,000 U daily) can be administered.", "For example, vitamin K antagonists, apixaban, and betrixaban may all require dose adjustment, while edoxaban and rivaroxaban should not be coadministered with lopinavir/ritonavir.", "Investigational COVID-19 Therapies| Vitamin K Antagonists| Dabigatran| Apixaban| Betrixaban| Edoxaban| Rivaroxaban   ---|---|---|---|---|---|---   Lopinavir/ritonavir| CYP2C9 induction:   May decrease plasma concentration."]}
{"doc_id": 12021, "title": "", "abstract": ["Selection of an agent requires consideration of comorbidities such as renal or hepatic dysfunction, thrombocytopenia, and gastrointestinal tract function, and the agent will likely change across the hospital course to the time of discharge.", "Therapeutic anticoagulation is the mainstay of VTE treatment (49,86,87).", "Hospitalized patients with existing VTE should continue on anticoagulation with consideration of drug-drug interactions, especially with antiviral medications (Table 4).", "Alterations in pharmacokinetics in critically ill patients may necessitate anticoagulation dose adjustment (109), owing to factors relating to absorption, metabolism, and renal (or hepatic) elimination of these drugs in the setting of potential organ dysfunction.", "However, the index of suspicion for VTE should be high in the case of typical deep vein thrombosis (DVT) symptoms, hypoxemia disproportionate to known respiratory pathologies, or acute unexplained right ventricular dysfunction."]}
{"doc_id": 12022, "title": "", "abstract": ["Hydroxychloroquine, recently receiving Emergency Use Authorization from the U.S. Food and Drug Administration for treatment of COVID-19, may potentially exert antithrombotic properties, especially against antiphospholipid antibodies (43).", "If DOACs are not approved or available, LMWH can be considered as alternative.∗   Patients with moderate or severe COVID-19 without DIC (hospitalized)    Hospitalized patients with COVID-19 should undergo risk stratification for VTE prophylaxis.", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "To determine the incidence and predictors of type 1 acute myocardial infarction in patients with COVID-19, and to compare their process measures and outcomes with noninfected patients|    To determine the potential role of agents including danaparoid, fondaparinux, and sulodexide in select patients with moderate/severe COVID-19|   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)|    To determine if routine use of pharmacological VTE prophylaxis or low- or standard-dose anticoagulation with UFH or LMWH is warranted (if no overt bleeding)| A relevant question is whether prophylactic, or other, dose anticoagulation should be given to patients with DIC who do not have bleeding, even without immobility.", "Furthermore, higher troponin levels are associated with severe COVID-19 (5,36)."]}
{"doc_id": 12023, "title": "", "abstract": ["Autopsy identified PE in 4, and DVT in 3 individuals (138).", "A diagnostic challenge arises among patients with COVID-19, as imaging studies used to diagnose DVT or PE may not be pursued given risk of transmitting infection to other patients or health care workers and potentially due to patient instability.", "To determine the incidence ACS in population-based studies|   Patients with moderate or severe COVID-19 without DIC (hospitalized)|    To determine the incidence and predictors of VTE among patients with COVID-19 who present with respiratory insufficiency and/or hemodynamic instability; these include lower extremity DVTs, central line–associated DVT in upper or lower extremities, and also PE| Prospective multicenter cohort (observational) data are needed, and these protocols should not interfere, and could run in parallel with, interventional trials that are planned or already underway.", "Proposed Mechanisms| Event Type| Epidemiological Data   ---|---|---   SARS    Inflammatory cytokine release| VTE| Retrospective analysis of 46 critically ill patients with SARS showed 11 DVT and 7 PE events (9).", "Specific areas of concern included limited data on use in the prone position as well as potential high incidence of pre-existing asymptomatic DVT."]}
{"doc_id": 12024, "title": "", "abstract": ["At this moment, while practitioners use a variety of prophylactic, intermediate, or therapeutic doses of anticoagulants in patients, the optimal dosing in patients with severe COVID-19 remains unknown and warrants further prospective investigation.", "To determine the optimal dose of prophylactic anticoagulation in specific populations (e.g., those with obesity or advanced kidney disease)| Weight- adjusted prophylactic dosing for patients with obesity, or dosing based on creatinine clearance in patients with kidney disease require further investigation.", "Alterations in pharmacokinetics in critically ill patients may necessitate anticoagulation dose adjustment (109), owing to factors relating to absorption, metabolism, and renal (or hepatic) elimination of these drugs in the setting of potential organ dysfunction.", "The majority of authors of this paper recommended reducing the intensity of anticoagulation in this clinical circumstance, unless the risk of thrombosis is considered to be exceedingly high.#    For patients with moderate or severe COVID-19 and an indication for dual antiplatelet therapy (e.g., percutaneous coronary intervention within the past 3 months or recent myocardial infarction) and with suspected or confirmed DIC without overt bleeding, in the absence of evidence, decisions for antiplatelet therapy need to be individualized.", "#Although the majority of investigators voted to reduce the intensity of anticoagulation if the indication were not acute (62%), this survey question did not meet the prespecified cutoff of 66%."]}
{"doc_id": 12025, "title": "", "abstract": ["Additionally, the severe inflammatory response, critical illness, and underlying traditional risk factors may all predispose to thrombotic events, similar to prior virulent zoonotic coronavirus outbreaks (Table 1 ) (9,10).", "The inflammatory response to severe infection is marked by lymphopenia and thrombocytopenia.", "Inflammatory response, increased age, and bedridden status—which are more frequently observed in severe coronavirus disease-2019 (COVID-19)—may contribute to thrombosis and adverse outcomes.", "Factors may include inflammatory cytokine release and critical illness/underlying risk factors| Arterial thrombotic events| Data are continuing to emerge regarding the risk of thrombotic events associated with COVID-19 infection, and an international registry for ACS is planned.", "Nevertheless, it is yet unknown whether these hemostatic changes are a specific effect of SARS-CoV-2 or are a consequence of cytokine storm that precipitates the onset of SIRS, as observed in other viral diseases (30, 31, 32, 33)."]}
{"doc_id": 12026, "title": "", "abstract": ["Few published studies have commented on incident VTE in patients with COVID-19 (83,84).", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "Although no data specific to COVID-19 exist, it is reasonable to employ individualized risk stratification for thrombotic and hemorrhagic risk, followed by consideration of extended prophylaxis (for up to 45 days) for patients with elevated risk of VTE (e.g., reduced mobility, comorbidities such as active cancer, and [according to some authors in the writing group] elevated D-dimer >2 times the upper limit of normal) who have low risk of bleeding (74,77,78).", "In many ill inpatients with VTE, parenteral anticoagulation (e.g., UFH) is preferred as it may be temporarily withheld and has no known drug-drug interactions with investigational COVID-19 therapies.", "†Although high-quality data are lacking, some panel members (55%) considered it reasonable to use intermittent pneumatic compression in patients with severe COVID-19, in addition to pharmacological prophylaxis."]}
{"doc_id": 12027, "title": "", "abstract": ["For patients with overt hemodynamic instability (high-risk PE according to the ESC classification, massive PE according to prior classifications) (49,87,91,94) systemic fibrinolysis is indicated, with catheter-based therapies reserved for scenarios that are not suitable for systemic fibrinolysis.", "Indiscriminate use of inferior vena cava filters should be avoided (93).", "Recurrent PE despite optimal anticoagulation, or clinically significant VTE in the setting of absolute contraindications to anticoagulation, would be among the few scenarios in which placement of an inferior vena cava filter may be considered (11).", "Even after inferior vena cava filter placement, anticoagulation should be resumed as soon as feasible, and this is often done with gradually increasing doses and close observation for bleeding.", "In case of further deterioration, rescue systemic fibrinolysis should be considered, with catheter-directed options as an alternative."]}
{"doc_id": 12028, "title": "", "abstract": ["Although no data specific to COVID-19 exist, it is reasonable to employ individualized risk stratification for thrombotic and hemorrhagic risk, followed by consideration of extended prophylaxis (for up to 45 days) for patients with elevated risk of VTE (e.g., reduced mobility, comorbidities such as active cancer, and [according to some authors in the writing group] elevated D-dimer >2 times the upper limit of normal) who have low risk of bleeding (74,77,78).", "Multiple risk stratification tools are available for VTE risk assessment in this setting (e.g., the Caprini score, IMPROVE [International Medical Prevention Registry on Venous Thromboembolism] model, and Padua model) (55, 56, 57, 58, 59, 60).", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "Regular laboratory monitoring of platelet count, PT, D-dimer, and fibrinogen in patients with COVID-19 is important to diagnose worsening coagulopathy.", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation."]}
{"doc_id": 12029, "title": "", "abstract": ["Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "Pharmacologic prophylaxis could be considered after risk assessment on an individual case basis for patients who have elevated risk VTE, without high bleeding risk.∗    There is no known risk of developing severe COVD-19 due to taking antithrombotic agents (i.e., antiplatelet agents or anticoagulants).", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "In the absence of high-quality data, pharmacological prophylaxis should be reserved for those patients at highest risk, including those with limited mobility and history of prior VTE or active malignancy.", "The majority of authors of this paper recommended reducing the intensity of anticoagulation in this clinical circumstance, unless the risk of thrombosis is considered to be exceedingly high.#    For patients with moderate or severe COVID-19 and an indication for dual antiplatelet therapy (e.g., percutaneous coronary intervention within the past 3 months or recent myocardial infarction) and with suspected or confirmed DIC without overt bleeding, in the absence of evidence, decisions for antiplatelet therapy need to be individualized."]}
{"doc_id": 12030, "title": "", "abstract": ["This is important, as ARDS in patients with COVID-19 is itself a potential etiology for hypoxic pulmonary vasoconstriction, pulmonary hypertension, and right ventricular failure.", "Moreover, imaging studies may be challenging in the setting of patients with severe ARDS who require prone positioning.", "However, it may be argued that the prognosis of patients with ARDS requiring prone position is so grave that investigation for underlying VTE may not alter the course.", "Endothelial and hemostatic activation ensues, with increase in von Willebrand factor and increased tissue factor.", "As with other virulent zoonotic coronavirus infections such as SARS and Middle East respiratory syndrome, COVID-19 has the potential to result in severe illness including systemic inflammatory response syndrome (SIRS), acute respiratory disease syndrome (ARDS), multiorgan involvement, and shock (18)."]}
{"doc_id": 12031, "title": "", "abstract": ["It is uncertain whether COVID-19 has unique characteristics to cause direct activation of coagulation.", "Endothelial and hemostatic activation ensues, with increase in von Willebrand factor and increased tissue factor.", "Tocilizumab, an IL-6 inhibitor, increases expression of CYP3A4; however, no anticoagulant dose adjustments are currently recommended with concomitant use of tocilizumab at this time.", "If invasive procedures are planned, prophylactic transfusion of platelets, fresh frozen plasma, fibrinogen, and prothrombin complex concentrate may be considered (29).", "Although limited clinical data exist, use of P2Y12 platelet function testing to guide the use of clopidogrel or ticagrelor in this setting might be considered."]}
{"doc_id": 12032, "title": "", "abstract": ["After hospital discharge from acute medical illness, extended prophylaxis with LMWH (70) or direct oral anticoagulants (DOACs) (71, 72, 73, 74) can reduce the risk of VTE, at the cost of increase in bleeding events, including major bleeding (75,76).", "For patients who were admitted and are now being discharged for COVID-19, routine screening for VTE risk is reasonable for consideration of pharmacological prophylaxis for up to 45 days post-discharge.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "To determine if LMWH constitutes the preferred method of pharmacological prophylaxis|    To determine the optimal method for risk stratification and VTE prophylaxis after hospital discharge| The options include the Caprini model, the IMPROVE model, and the Padua model, and others for assessment of the risk of VTE.", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression."]}
{"doc_id": 12033, "title": "", "abstract": ["In a study of 184 patients with severe COVID-19 from 3 academic medical centers in the Netherlands, the authors reported that 31% (95% confidence interval: 20% to 41%) of patients developed incident VTE.", "In a retrospective study from China, among 81 patients with severe COVID-19 admitted to ICU, 20 (25%) developed incident VTE.", "A recent study from China, using the Padua model, reported that 40% of hospitalized patients with COVID-19 were at high risk of VTE.", "To determine the incidence ACS in population-based studies|   Patients with moderate or severe COVID-19 without DIC (hospitalized)|    To determine the incidence and predictors of VTE among patients with COVID-19 who present with respiratory insufficiency and/or hemodynamic instability; these include lower extremity DVTs, central line–associated DVT in upper or lower extremities, and also PE| Prospective multicenter cohort (observational) data are needed, and these protocols should not interfere, and could run in parallel with, interventional trials that are planned or already underway.", "Although limited data are available, pregnant women admitted to hospital with COVID-19 infection are likely to be at an increased risk of VTE."]}
{"doc_id": 12034, "title": "", "abstract": ["Common laboratory abnormalities found in patients with COVID-19 include lymphopenia (15) and elevation in lactate dehydrogenase and inflammatory markers such as C-reactive protein, D-dimer, ferritin, and interleukin-6 (IL-6) (20).", "As described previously, elevated D-dimer levels represent a common finding in patients with COVID-19 (23), and do not currently warrant routine investigation for acute VTE in absence of clinical manifestations or other supporting information.", "Whether antiphospholipid antibodies play a major role in pathophysiology of thrombosis associated with COVID-19 requires further investigation (35).", "Inflammatory response, increased age, and bedridden status—which are more frequently observed in severe coronavirus disease-2019 (COVID-19)—may contribute to thrombosis and adverse outcomes.", "Myocardial injury in COVID-19, as evidenced by elevated cardiac troponin levels or electrocardiographic and echocardiographic abnormalities, is associated with severe disease (5,36)."]}
{"doc_id": 12035, "title": "", "abstract": ["Inflammatory response, increased age, and bedridden status—which are more frequently observed in severe coronavirus disease-2019 (COVID-19)—may contribute to thrombosis and adverse outcomes.", "Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "First, the direct effects of COVID-19 or the indirect effects of infection, such as through severe illness and hypoxia, may predispose patients to thrombotic events.", "Factors may include inflammatory cytokine release and critical illness/underlying risk factors| Arterial thrombotic events| Data are continuing to emerge regarding the risk of thrombotic events associated with COVID-19 infection, and an international registry for ACS is planned.", "The most consistent hemostatic abnormalities with COVID-19 include mild thrombocytopenia (22) and increased D-dimer levels (23), which are associated with a higher risk of requiring mechanical ventilation; intensive care unit (ICU) admission; or death (Table 2 )."]}
{"doc_id": 12036, "title": "", "abstract": ["Among the notable differences between patients who died and those who survived were increased levels of D-dimer and fibrin degradation products (∼3.5- and ∼1.9-fold, respectively) and PT prolongation (by 14%) (p < 0.001).", "Common laboratory abnormalities found in patients with COVID-19 include lymphopenia (15) and elevation in lactate dehydrogenase and inflammatory markers such as C-reactive protein, D-dimer, ferritin, and interleukin-6 (IL-6) (20).", "The most consistent hemostatic abnormalities with COVID-19 include mild thrombocytopenia (22) and increased D-dimer levels (23), which are associated with a higher risk of requiring mechanical ventilation; intensive care unit (ICU) admission; or death (Table 2 ).", "Systematic review of literature published prior to February 24, 2020, suggests elevations in PT and D-dimer levels were associated with poor prognosis in patients with COVID-19 (25).", "Regular laboratory monitoring of platelet count, PT, D-dimer, and fibrinogen in patients with COVID-19 is important to diagnose worsening coagulopathy."]}
{"doc_id": 12037, "title": "", "abstract": ["For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "Further, 71% of COVID-19 patients who died fulfilled the International Society on Thrombosis and Haemostasis (ISTH) criteria (29) for DIC, compared with only 0.6% among survivors.", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "In view of the hemostatic derangements discussed previously and observations from prior viral illnesses (80), some clinicians use intermediate- or full- dose (therapeutic) parenteral anticoagulation (rather than prophylactic dosing) for routine care of patients with COVID-19 (81), hypothesizing that it may confer benefit to prevent microvascular thrombosis."]}
{"doc_id": 12038, "title": "", "abstract": ["Among the notable differences between patients who died and those who survived were increased levels of D-dimer and fibrin degradation products (∼3.5- and ∼1.9-fold, respectively) and PT prolongation (by 14%) (p < 0.001).", "Systematic review of literature published prior to February 24, 2020, suggests elevations in PT and D-dimer levels were associated with poor prognosis in patients with COVID-19 (25).", "Last, patients requiring targeted temperature management may exhibit prolongations of both PT and aPTT without evidence of bleeding diathesis (112).", "Disease severity is variably associated with prolongation of the prothrombin time (PT) and international normalized ratio (INR) (1,20,26), and thrombin time (TT) (27), and variably by a trend toward shortened activated partial thromboplastin time (aPTT) (1,16,19,28).", "(C) Increased prothrombotic state results in venous thromboembolism, myocardial infarction, or in case of further hemostatic derangement, disseminated intravascular coagulation."]}
{"doc_id": 87000, "title": "", "abstract": ["As most studies have focused on neurodegenerative disorders, a number of disease-specific mechanisms have been proposed to account for the observed relationships between neuropathology and brain network organization (Zhou et al., 2012).", "As a secondary criterion of hubness, we used participation coefficient, which measures the proportion of intermodular connections for each node (Guimera and Nunes Amaral, 2005), to show that the brain regions most critical to intermodular communication were also more likely to be pathologically lesioned.", "One immediately interesting observation is that, in the pooled meta-analysis of MRI lesions across all disorders, a certain subset of brain regions was more likely to be affected ‘on average’ across a range of pathogenic processes.", "Disorder-specific factors will presumably determine which brain regions are affected first and how different neurodevelopmental and neurodegenerative disease processes then propagate over the network architecture.", "Our primary measure of ‘hubness’ has been degree centrality, meaning that brain regional nodes with the highest number of connections (edges) to other regions are the most frequently lesioned by diseases."]}
{"doc_id": 87001, "title": "", "abstract": ["Several graph analytic measures were estimated on the binary network built from the DTI data, including degree (number of connections) and betweenness centrality of each nodal region; global efficiency, rich club and modularity of the network, and participation coefficient of each node in the context of this modular structure (Rubinov and Sporns, 2010).", "In line with previous studies (van den Heuvel and Sporns, 2011; Alexander-Bloch et al., 2013), long-range connections were concentrated on high degree nodes, and there was a significant positive correlation between nodal degree and the mean connection distance of the edges linking each node to the rest of the network (Spearman’s ρ = 0.71, Fig. 1D).", "See the online Supplementary material for more detail on graph theoretical metrics.", "Two regional nodes defined by this template were connected by an edge if they were significantly co-activated by experimental tasks.", "Connectomes or brain networks derived from neuroimaging data have several non- random or complex topological properties (Bullmore and Sporns, 2009), including fat-tailed degree distributions that reflect the existence of a minority of high degree (highly connected) hub nodes (Eguiluz et al., 2005; Achard et al., 2006; Sporns et al., 2007; van den Heuvel and Sporns, 2013)."]}
{"doc_id": 87002, "title": "", "abstract": ["In other words, high degree hub nodes, and the longer distance edges that tended to connect them to the rest of the network, rendered the topological efficiency of the brain network especially vulnerable to targeted attack.", "Resilience analysis of the functional coactivation network demonstrated that its global efficiency was vulnerable to targeted attack on hubs (Supplementary Fig. 4).", "Topological analysis of complex networks has previously demonstrated that scale-free networks, with fat-tailed degree distributions indicating the existence of hubs, are vulnerable to attack on hub nodes (Albert et al., 2000).", "The hub vulnerability hypothesis would predict that an acute severe global insult would cause greater structural and functional damage to hub regions than to non-hubs.", "To test this general hypothesis, we first identified the hubs of brain anatomical networks estimated from diffusion tensor imaging data on healthy volunteers (n = 56), and showed that computational attacks targeted on hubs disproportionally degraded the efficiency of brain networks compared to random attacks."]}
{"doc_id": 87003, "title": "", "abstract": ["We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "High cost/high value hubs in normal human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "Specifically, nine brain disorders had lesions that were significantly more likely to be located in hubs (P < 0.05, permutation test), including schizophrenia and Alzheimer’s disease.", "Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network.", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012)."]}
{"doc_id": 87004, "title": "", "abstract": ["Connectomes or brain networks derived from neuroimaging data have several non- random or complex topological properties (Bullmore and Sporns, 2009), including fat-tailed degree distributions that reflect the existence of a minority of high degree (highly connected) hub nodes (Eguiluz et al., 2005; Achard et al., 2006; Sporns et al., 2007; van den Heuvel and Sporns, 2013).", "Brain networks or ‘connectomes’ include a minority of highly connected hub nodes that are functionally valuable, because their topological centrality supports integrative processing and adaptive behaviours.", "Conceptualizing the brain as a network (the ‘connectome’) (Sporns et al., 2005) has potentially important implications for understanding clinical brain disorders (Bullmore and Sporns, 2012; Fornito et al., 2012; Menon, 2013; Rubinov and Bullmore, 2013; van den Heuvel and Sporns, 2013).", "The hubs of the human connectome are generally implicated in the anatomy of brain disorders", "The connectome had a modular community structure [(Newman, 2006), Q = 0.38, five modules, Fig. 1F], with hubs mediating many of the intermodular connections (Guimera and Nunes Amaral, 2005) (participation coefficients ranging from 0.63 to 0.75 for the top 5% hubs)."]}
{"doc_id": 87005, "title": "", "abstract": ["By using a completely different approach to build the connectome, based on meta-analysis of task-based functional neuroimaging studies, we were able to replicate all the key results linking MRI lesions to network hubs.", "Here we investigate a more general theory of the relationship between the topology of the connectome and the anatomy of brain disorders, particularly focusing on the role of hubs.", "We reasoned that the high cost/high value hubs of the connectome will be particularly crucial for brain disorders for two main reasons.", "It has been suggested that these topological features are functionally valuable for integrative information processing and adaptive behaviour (van den Heuvel et al., 2012; Crossley et al., 2013).", "In other words, high degree hub nodes, and the longer distance edges that tended to connect them to the rest of the network, rendered the topological efficiency of the brain network especially vulnerable to targeted attack."]}
{"doc_id": 87006, "title": "", "abstract": ["It has also been proposed that hubs may have greater susceptibility to oxidative stress, due to their higher rates of metabolic activity (Buckner et al., 2009; Saxena and Caroni, 2011); and a computational model of this pathological mechanism mirrored several neurophysiological aspects of Alzheimer’s disease (de Haan et al., 2012).", "Recent studies also suggest that hubs have higher metabolic demands and longer-distance connections than other brain regions, and therefore could be considered biologically costly.", "The hub vulnerability hypothesis would predict that an acute severe global insult would cause greater structural and functional damage to hub regions than to non-hubs.", "We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "In other words, high degree hub nodes, and the longer distance edges that tended to connect them to the rest of the network, rendered the topological efficiency of the brain network especially vulnerable to targeted attack."]}
{"doc_id": 87007, "title": "", "abstract": ["We therefore conducted a parallel analysis based on a different normative human brain network model, estimated meta-analytically from a large sample of previously published functional neuroimaging data (Crossley et al., 2013).", "In contrast, the experimental observation is more compatible with previous suggestions (Saxena and Caroni, 2011; Jagust, 2013; Menon, 2013) that an anatomically defined subset of brain regions are generally more implicated in brain disorders; in other words, that some brain regions are relative hotspots for clinical abnormality of grey matter volume.", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012).", "We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "This co-activation network has several topological and physical properties in common with resting state functional MRI networks (Crossley et al., 2013)."]}
{"doc_id": 87008, "title": "", "abstract": ["However, targeted attack on high degree nodes caused the global efficiency of the brain network to deteriorate more rapidly than the efficiency of a random graph (Fig. 2A).", "From the perspective of brain and cognition, studies have shown that higher global efficiency of functional brain networks (derived from resting-state functional MRI data) is positively correlated with better cognitive performance (van den Heuvel et al., 2009; Giessing et al., 2013); and that cognitively more demanding tasks lead to the appearance of long-range integrative connections in task-related MEG data (Kitzbichler et al., 2011).", "Comparable high cost / high value properties of network hubs have been described in brains of other species (Iturria-Medina et al., 2010; Harriger et al., 2012; Towlson et al., 2013), suggesting that an economical trade-off between topological value and biological cost may be a general and scale- invariant selection pressure on the formation of nervous systems (Bullmore and Sporns, 2012; Vertes et al., 2012).", "Connectomes or brain networks derived from neuroimaging data have several non- random or complex topological properties (Bullmore and Sporns, 2009), including fat-tailed degree distributions that reflect the existence of a minority of high degree (highly connected) hub nodes (Eguiluz et al., 2005; Achard et al., 2006; Sporns et al., 2007; van den Heuvel and Sporns, 2013).", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012)."]}
{"doc_id": 87009, "title": "", "abstract": ["Such high degree nodes are often connector hubs, connecting to regions in different brain modules.", "It has also been proposed that hubs may have greater susceptibility to oxidative stress, due to their higher rates of metabolic activity (Buckner et al., 2009; Saxena and Caroni, 2011); and a computational model of this pathological mechanism mirrored several neurophysiological aspects of Alzheimer’s disease (de Haan et al., 2012).", "Our primary measure of ‘hubness’ has been degree centrality, meaning that brain regional nodes with the highest number of connections (edges) to other regions are the most frequently lesioned by diseases.", "Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network.", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012)."]}
{"doc_id": 87010, "title": "", "abstract": ["These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012).", "We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "Specifically, nine brain disorders had lesions that were significantly more likely to be located in hubs (P < 0.05, permutation test), including schizophrenia and Alzheimer’s disease.", "Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network.", "High cost/high value hubs in normal human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders."]}
{"doc_id": 87011, "title": "", "abstract": ["These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012).", "Other studies have highlighted the role of topological modularity in the anatomy of brain disorders, showing that focal grey matter abnormalities in neurodegenerative disorders are not randomly located with respect to the modular organization of the normal brain network (Seeley et al., 2009).", "From the perspective of brain and cognition, studies have shown that higher global efficiency of functional brain networks (derived from resting-state functional MRI data) is positively correlated with better cognitive performance (van den Heuvel et al., 2009; Giessing et al., 2013); and that cognitively more demanding tasks lead to the appearance of long-range integrative connections in task-related MEG data (Kitzbichler et al., 2011).", "Conceptualizing the brain as a network (the ‘connectome’) (Sporns et al., 2005) has potentially important implications for understanding clinical brain disorders (Bullmore and Sporns, 2012; Fornito et al., 2012; Menon, 2013; Rubinov and Bullmore, 2013; van den Heuvel and Sporns, 2013).", "We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders."]}
{"doc_id": 87012, "title": "", "abstract": ["From the perspective of brain and cognition, studies have shown that higher global efficiency of functional brain networks (derived from resting-state functional MRI data) is positively correlated with better cognitive performance (van den Heuvel et al., 2009; Giessing et al., 2013); and that cognitively more demanding tasks lead to the appearance of long-range integrative connections in task-related MEG data (Kitzbichler et al., 2011).", "On this basis, it seems intuitive that pathological lesions to network hubs are especially likely to be associated with clinically significant cognitive impairments.", "It has been suggested that these topological features are functionally valuable for integrative information processing and adaptive behaviour (van den Heuvel et al., 2012; Crossley et al., 2013).", "First, their topologically central role could mean that pathological attack on a hub will have a disproportionate impact on the network’s global efficiency of information processing (Albert et al., 2000); and thus be more likely to lead to clinical symptoms such as impairment of cognitive functions, that normally depend on integrative network processes.", "These data are broadly aligned with workspace theories that ‘higher order’ cognitive functions depend on a more integrative network topology (Dehaene and Changeux, 2011)."]}
{"doc_id": 87013, "title": "", "abstract": ["One immediately interesting observation is that, in the pooled meta-analysis of MRI lesions across all disorders, a certain subset of brain regions was more likely to be affected ‘on average’ across a range of pathogenic processes.", "Our meta-analytic pooling of all disorders balanced the weight each disorder contributed to the general estimate, and we also showed that results were consistent across several subgroups of disorders, e.g. after excluding all neurodegenerative disorders.", "In contrast, the experimental observation is more compatible with previous suggestions (Saxena and Caroni, 2011; Jagust, 2013; Menon, 2013) that an anatomically defined subset of brain regions are generally more implicated in brain disorders; in other words, that some brain regions are relative hotspots for clinical abnormality of grey matter volume.", "These disorder-general MRI abnormalities of grey matter were located in bilateral thalamus and striatum (putamen and caudate); bilateral hippocampus, insula and superior temporal gyrus; bilateral anterior cingulate cortex, dorsolateral prefrontal cortex and motor cortex; and bilateral superior parietal cortex (Fig. 3A and Supplementary Table 1 for anatomical details).", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012)."]}
{"doc_id": 87014, "title": "", "abstract": ["We therefore conducted a parallel analysis based on a different normative human brain network model, estimated meta-analytically from a large sample of previously published functional neuroimaging data (Crossley et al., 2013).", "This co-activation network has several topological and physical properties in common with resting state functional MRI networks (Crossley et al., 2013).", "We included structural MRI studies analysed using voxel-based morphometry (VBM) that reported significant grey matter volume or density reductions in patients with any neurological or psychiatric disorder compared to healthy volunteers.", "Parietal regions showed the opposite trend—of lesions being concentrated in low degree nodes (2% decrease in lesion probability per increase in degree, P < 0.002), although this was not replicated when using the functional co-activation network (see below).", "To explore the relationship between VBM lesions and network hubs in a different (functional) network, we used the network of functionally co- activated brain regions, as previously reported in detail (Crossley et al., 2013)."]}
{"doc_id": 87015, "title": "", "abstract": ["Echoing these results, here we provide evidence that the hubs of brain networks are generally central to clinical disorders.", "Overall, these results provide evidence in support of the theoretical prediction that brain hubs are central to brain disorders in general.", "To test this general hypothesis, we first identified the hubs of brain anatomical networks estimated from diffusion tensor imaging data on healthy volunteers (n = 56), and showed that computational attacks targeted on hubs disproportionally degraded the efficiency of brain networks compared to random attacks.", "The main distinction of this theory is its generality: we predicted that any brain disorder, irrespective of its particular aetiology, was likely to impact preferentially on normal brain network hubs.", "On this basis, it seems intuitive that pathological lesions to network hubs are especially likely to be associated with clinically significant cognitive impairments."]}
{"doc_id": 87016, "title": "", "abstract": ["We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "High cost/high value hubs in normal human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network.", "First, hubs are more functionally valuable, especially for ‘higher-order’ cognitive tasks and adaptive behaviour; therefore lesioned hubs are more likely to be symptomatic than lesioned non- hubs.", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012)."]}
{"doc_id": 87017, "title": "", "abstract": ["These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012).", "We conclude that the high cost/high value hubs of human brain networks are more likely to be anatomically abnormal than non-hubs in many (if not all) brain disorders.", "Overall, these results provide evidence in support of the theoretical prediction that brain hubs are central to brain disorders in general.", "(E) Small-world properties of the network (γ = normalized clustering coefficient; λ = normalized path length; σ = ratio of γ to λ; dotted line = 1, the expected value of all these metrics in a random graph).", "The network had a small-world organization (Watts and Strogatz, 1998), with a higher clustering coefficient than null models with similar degree distribution (γ = 2.07, 95% CI: 2.05–2.08), whereas its characteristic path length was not much greater than comparable random graphs (λ = 1.135, 95% CI: 1.134–1.136; Fig. 1E)."]}
{"doc_id": 87018, "title": "", "abstract": ["Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network.", "Magnetic resonance imaging lesions that were common across all brain disorders were more likely to be located in hubs of the normal brain connectome (P < 10−4, permutation test).", "Recent studies have indeed shown that high degree and highly efficient hub nodes of normal functional MRI connectomes have higher blood flow, glucose metabolic rates, and longer connection distance, than non-hub nodes (van den Heuvel and Sporns, 2011; Alexander-Bloch et al., 2013; Liang et al., 2013; Tomasi et al., 2013).", "MRI lesions identified meta-analytically from the primary literature on 26 clinical brain disorders impact preferentially on the hubs of the normal connectome.", "Specifically, nine brain disorders had lesions that were significantly more likely to be located in hubs (P < 0.05, permutation test), including schizophrenia and Alzheimer’s disease."]}
{"doc_id": 87019, "title": "", "abstract": ["It has also been proposed that hubs may have greater susceptibility to oxidative stress, due to their higher rates of metabolic activity (Buckner et al., 2009; Saxena and Caroni, 2011); and a computational model of this pathological mechanism mirrored several neurophysiological aspects of Alzheimer’s disease (de Haan et al., 2012).", "Specifically, nine brain disorders had lesions that were significantly more likely to be located in hubs (P < 0.05, permutation test), including schizophrenia and Alzheimer’s disease.", "These results based on meta-analysis of case-control VBM studies are in line with recent graph theoretical analyses of resting state functional MRI or DTI data that demonstrated abnormalities of hubs in several disorders including, for example, schizophrenia (Rubinov and Bullmore, 2013), Alzheimer’s disease (Buckner et al., 2009), frontotemporal dementia (Agosta et al., 2013), Parkinson’s disease (Baggio et al., 2014), temporal lobe epilepsy (Liu et al., 2014a), Gilles de la Tourette syndrome (Worbe et al., 2012), acute brain injury (Achard et al., 2012), and migraine (Liu et al., 2012).", "For example, cortical hubs have been suggested to be critical regions in Alzheimer’s disease, concentrating most of the amyloid-β deposition (Buckner et al., 2009).", "Although we claim that the anatomical lesions of brain disorders are generally concentrated on normal network hubs, this does not mean that different disorders will necessarily involve an identical set of hubs, as shown for Alzheimer’s disease and schizophrenia."]}
{"doc_id": 87020, "title": "", "abstract": ["In other words, high degree hub nodes, and the longer distance edges that tended to connect them to the rest of the network, rendered the topological efficiency of the brain network especially vulnerable to targeted attack.", "In line with previous studies (van den Heuvel and Sporns, 2011; Alexander-Bloch et al., 2013), long-range connections were concentrated on high degree nodes, and there was a significant positive correlation between nodal degree and the mean connection distance of the edges linking each node to the rest of the network (Spearman’s ρ = 0.71, Fig. 1D).", "In both disorders, high degree nodes were significantly more likely to be lesioned (Figs 6, 7B and C), but the anatomical location of lesions was largely disorder-specific: medial frontal and anterior cingulate regions were most affected in schizophrenia, whereas medial temporal and parietal regions were most affected in Alzheimer’s disease (Fig. 7A).", "However, targeted attack on high degree nodes caused the global efficiency of the brain network to deteriorate more rapidly than the efficiency of a random graph (Fig. 2A).", "Lesions in specific disorders such as Alzheimer’s disease and schizophrenia are located in high degree regions, but not necessarily in the highest degree hubs, and not hub-concentrated to the same extent within different lobes of the cortex."]}
{"doc_id": 87021, "title": "", "abstract": ["Likewise any disease process that damages long-distance axonal projections (e.g. disseminated sclerosis or traumatic brain injury), or disrupts active axonal transport mechanisms, might be expected to disconnect hubs and/or to disrupt long-range communication between network modules.", "This was illustrated by the examples of Alzheimer’s disease and schizophrenia, the two disorders most frequently studied in the primary literature.", "For example, cortical hubs have been suggested to be critical regions in Alzheimer’s disease, concentrating most of the amyloid-β deposition (Buckner et al., 2009).", "Schizophrenia and Alzheimer’s disease impact mainly on anatomically distinct subsets of hubs.", "Conceptualizing the brain as a network (the ‘connectome’) (Sporns et al., 2005) has potentially important implications for understanding clinical brain disorders (Bullmore and Sporns, 2012; Fornito et al., 2012; Menon, 2013; Rubinov and Bullmore, 2013; van den Heuvel and Sporns, 2013)."]}
{"doc_id": 16000, "title": "", "abstract": ["The nAbs described here have very low somatic hypermutation (SHM), typically only one or two mutations in the VH gene and one or two in the VL gene.", "SARS-CoV-2 has shown some propensity for mutation as it has circulated worldwide, as evidenced, for example, in the emergence of the D614G variant (9).", "The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "(A) SARS-CoV-2–specific human neutralizing mAb CC12.1 isolated from natural infection was administered at a starting dose of 2 mg per animal (average: 16.5 mg/kg) and subsequent serial fourfold dilutions.", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins."]}
{"doc_id": 16001, "title": "", "abstract": ["Neutralizing antibodies (nAbs) to the causative agent of the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent potential prophylactic and therapeutic options and could help guide vaccine design.", "The study suggests a role for nAbs in prophylaxis, and potentially therapy, of COVID-19.", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11).", "The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C)."]}
{"doc_id": 16002, "title": "", "abstract": ["Using a high-throughput rapid system for antibody discovery, we isolated more than 1000 mAbs from three convalescent donors by memory B cell selection using SARS-CoV-2 S or RBD recombinant proteins.", "Among the antibodies evaluated, the results reveal three epitope bins for RBD (designated RBD-A, RBD-B, and RBD-C) and three epitope bins for the S protein (designated S-A, S-B, and S-C) (Fig. 4A and fig. S7).", "The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "In the first experiment, we tested nAb CC12.1, which targets the RBD-A epitope and has an in vitro IC50 neutralization of 0.019 μg/ml against pseudovirus, and in the second experiment, we tested nAb C12.23, which targets the S-B epitope with an IC50 neutralization of 22 μg/ml.", "The antibody hits that were identified in the high-throughput screening were next evaluated for epitope specificity by biolayer interferometry using S and RBD proteins as capture antigens."]}
{"doc_id": 16003, "title": "", "abstract": ["The titers in the PSV assay and the replicating virus assay were largely similar (figs. S2 and S3).", "In parallel, a PSV assay was established for both SARS-CoV-1 and SARS-CoV-2 using murine leukemia virus–based PSV (MLV-PSV) (5).", "The supernatants were next evaluated for neutralization activity using SARS-CoV-2 and SARS-CoV-1 pseudoviruses.", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "Two platforms were established to evaluate plasma neutralization activity against SARS-CoV-2, one using replication-competent virus and another using pseudovirus (PSV)."]}
{"doc_id": 16004, "title": "", "abstract": ["The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F).", "Neutralizing antibodies (nAbs) to the causative agent of the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent potential prophylactic and therapeutic options and could help guide vaccine design.", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "Overall, the data highlight epitope RBD-A as the preferred target for eliciting neutralizing antibodies and suggest that corresponding increases in affinity of mAbs to RBD-A will likely result in corresponding increases in neutralization potency."]}
{"doc_id": 16005, "title": "", "abstract": ["The other antibodies grouped in the S-A epitope bin that compete with CC12.19 either showed no binding to RBD or RBD- SD constructs (CC12.20 and CC12.21) or showed binding to RBD-SD1 and RBD-SD1-2 but not RBD (CC12.23).", "Among the antibodies evaluated, the results reveal three epitope bins for RBD (designated RBD-A, RBD-B, and RBD-C) and three epitope bins for the S protein (designated S-A, S-B, and S-C) (Fig. 4A and fig. S7).", "The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "In the first experiment, we tested nAb CC12.1, which targets the RBD-A epitope and has an in vitro IC50 neutralization of 0.019 μg/ml against pseudovirus, and in the second experiment, we tested nAb C12.23, which targets the S-B epitope with an IC50 neutralization of 22 μg/ml.", "In comparison, antibodies directed to RBD-B tended to have a higher IC50 and many plateaued below 100% neutralization."]}
{"doc_id": 16006, "title": "", "abstract": ["In contrast, there are fewer RBD-binding antibodies, but a larger proportion of these neutralize SARS-CoV-2 pseudovirus.", "A small proportion of the binding antibodies showed neutralization activity, and, unexpectedly, that activity was equally distributed between RBD+/S+ and S+-only binders, despite a much larger number of S+-only binding supernatants, as exemplified by the three donors, CC6, CC12, and CC25 (Fig. 3A).", "The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F).", "Only a small fraction of these Abs were neutralizing, which highlights the value of deep mining of responses to access the most potent Abs (4)."]}
{"doc_id": 16007, "title": "", "abstract": ["To investigate the antibody response against SARS-CoV-2 and discover nAbs, we adapted our pipeline to rapidly isolate and characterize monoclonal antibodies (mAbs) from convalescent donors (Fig. 1).", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "(A) SARS-CoV-2–specific human neutralizing mAb CC12.1 isolated from natural infection was administered at a starting dose of 2 mg per animal (average: 16.5 mg/kg) and subsequent serial fourfold dilutions.", "Using a high-throughput rapid system for antibody discovery, we isolated more than 1000 mAbs from three convalescent donors by memory B cell selection using SARS-CoV-2 S or RBD recombinant proteins.", "First, they suggest a focus on the RBD—strong nAb responses have indeed been demonstrated by immunizing mice with a multivalent presentation of RBD (18)."]}
{"doc_id": 16008, "title": "", "abstract": ["A cohort of previously swab-positive SARS-CoV-2 donors was recruited for peripheral blood mononuclear cell (PBMC) and plasma collection.", "Using a high-throughput rapid system for antibody discovery, we isolated more than 1000 mAbs from three convalescent donors by memory B cell selection using SARS-CoV-2 S or RBD recombinant proteins.", "To investigate the antibody response against SARS-CoV-2 and discover nAbs, we adapted our pipeline to rapidly isolate and characterize monoclonal antibodies (mAbs) from convalescent donors (Fig. 1).", "We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "Thirty-three antibodies were prioritized for in-depth characterization from the three donors, CC6, CC12, and CC25."]}
{"doc_id": 16009, "title": "", "abstract": ["In parallel, functional assays were developed to rapidly screen plasma samples for SARS-CoV-2 neutralizing activity.", "Given concerns about antibody- mediated enhanced disease in SARS-CoV-2 infection, this observation merits further attention using larger animal group sizes.", "We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11).", "Two platforms were established to evaluate plasma neutralization activity against SARS-CoV-2, one using replication-competent virus and another using pseudovirus (PSV)."]}
{"doc_id": 16010, "title": "", "abstract": ["We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "The failure of the non-RBD S-protein nAb to protect in the animal model is consistent with its lower potency and, likely most importantly, its inability to fully neutralize challenge virus.", "As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters.", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "Nevertheless, as for any animal model, there are many limitations, including, in the context of antibody protection, differences in effector cells and Fc receptors between humans and hamsters."]}
{"doc_id": 16011, "title": "", "abstract": ["SARS-CoV-2 recombinant surface proteins were also produced for use as baits in single-memory B cell sorting and downstream functional characterization of isolated mAbs.", "Vero-E6 cells were first used as target cells for neutralization assays, but this system was relatively insensitive at detecting replicating virus compared with a HeLa cell line that stably expressed the cell surface ACE2 receptor (fig. S1A).", "The bulk-transformed ligation products for both the heavy chain and light chain were transfected and tested for binding to RBD and S protein and for neutralization in the SARS-CoV-2 PSV assay using HeLa-ACE2 target cells (fig. S5).", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "To prepare high titers of infectious SARS-CoV-1 and SARS-CoV-2 PSV particles, various truncations of SARS-CoV-1 and SARS-CoV-2 S protein were expressed in which the ER retrieval signal was removed to improve exocytosis of the virus."]}
{"doc_id": 16012, "title": "", "abstract": ["The availability of both neutralizing and non-neutralizing antibodies generated in this study will facilitate evaluation of S protein immunogens for presentation of neutralizing and non-neutralizing epitopes and will promote effective vaccine design.", "Neutralizing antibodies (nAbs) to the causative agent of the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent potential prophylactic and therapeutic options and could help guide vaccine design.", "The antibodies can find clinical application and will aid in vaccine design.", "RBD binding and PSV neutralization were notably well correlated (Fig. 2E).", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F)."]}
{"doc_id": 16013, "title": "", "abstract": ["The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "We isolated potent neutralizing antibodies (nAbs) to two epitopes on the receptor binding domain (RBD) and to distinct non-RBD epitopes on the spike (S) protein.", "Unlike MLV-PSV, which buds at the plasma membrane, coronaviruses assemble in the endoplasmic reticulum (ER)–Golgi intermediate compartment, so the C terminus of the SARS-CoV-1 spike (S) protein contains an ER retrieval signal (6).", "SARS-CoV-2 recombinant surface proteins were also produced for use as baits in single-memory B cell sorting and downstream functional characterization of isolated mAbs.", "Monoclonal antibody epitope binning was completed using RBD and SARS-CoV-2 S protein as target antigens."]}
{"doc_id": 16014, "title": "", "abstract": ["The cause(s) of these incomplete neutralization phenomena is unclear but presumably originates in some S protein heterogeneity that is either glycan, cleavage, or conformationally based.", "Control VSV-G pseudotyped virions showed a similar transduction efficiency in all target cells.", "The strong preponderance of non-neutralizing antibodies and the very few nAbs to S protein that we isolated could arise for a number of reasons, including the following: (i) The recombinant S protein that we used to select B cells is a poor representation of the native spike on virions.", "Nevertheless, as for any animal model, there are many limitations, including, in the context of antibody protection, differences in effector cells and Fc receptors between humans and hamsters.", "These data suggest two competing epitopes within the S-A epitope bin: one that is confined to the non-RBD region of the S protein, and one that includes some element of RBD-SD1-2."]}
{"doc_id": 16015, "title": "", "abstract": ["The data highlight that an antibody serum concentration of ~22 μg/ml of nAb (1160 × PSV neutralization IC50) enables full protection and a serum concentration of 12 μg/ml (630 × PSV neutralization IC50) is adequate for a 50% reduction in disease, as measured by weight loss.", "Fig. 5 A potent SARS-CoV-2 RBD-specific neutralizing mAb protects against weight loss and lung viral replication in Syrian hamsters.", "As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters.", "The anti-SARS-CoV-2 nAbs were delivered at five different concentrations to evaluate dose-dependent protection, starting at 2 mg per animal (average: 16.5 mg/kg) at the highest dose and 8 μg per animal at the lowest dose.", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11)."]}
{"doc_id": 16016, "title": "", "abstract": ["The antibodies can find clinical application and will aid in vaccine design.", "Accordingly, only antibodies that bind to a noncompeting site would be detected in the assay.", "We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "The availability of both neutralizing and non-neutralizing antibodies generated in this study will facilitate evaluation of S protein immunogens for presentation of neutralizing and non-neutralizing epitopes and will promote effective vaccine design.", "The assay used single-cycle infectious viral particles bearing a firefly luciferase reporter for high-throughput screening."]}
{"doc_id": 16017, "title": "", "abstract": ["As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters.", "Potent neutralizing mAbs were selected to evaluate protection in the Syrian hamster model.", "Fig. 5 A potent SARS-CoV-2 RBD-specific neutralizing mAb protects against weight loss and lung viral replication in Syrian hamsters.", "## Passive transfer of neutralizing antibodies and SARS-CoV-2 challenge in Syrian hamsters", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11)."]}
{"doc_id": 16018, "title": "", "abstract": ["Monoclonal antibody epitope binning was completed using RBD and SARS-CoV-2 S protein as target antigens.", "SARS-CoV-2 recombinant surface proteins were also produced for use as baits in single-memory B cell sorting and downstream functional characterization of isolated mAbs.", "(A) SARS-CoV-2–specific human neutralizing mAb CC12.1 isolated from natural infection was administered at a starting dose of 2 mg per animal (average: 16.5 mg/kg) and subsequent serial fourfold dilutions.", "Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "Donor plasma were tested for binding to recombinant SARS-CoV-2 and SARS-CoV-1 S and receptor binding domain (RBD) proteins, for binding to cell surface–expressed spikes, and for neutralization in both live replicating virus and PSV assays [Fig. 2, B to D, and fig. S2B; three donors (CC6, CC12, and CC25) that are further discussed below are highlighted]."]}
{"doc_id": 16019, "title": "", "abstract": ["The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "The most potent Abs, reaching single-digit nanogram per milliliter IC50 values in PSV assays, are targeted to a site that, judged by competition studies, overlaps the ACE2 binding site.", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F).", "The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "Regardless, the RBD-A nAbs that directly compete with ACE2 are clearly the most preferred for prophylactic and therapeutic applications and as reagents to define nAb epitopes for vaccine design."]}
{"doc_id": 16020, "title": "", "abstract": ["In parallel, we developed both live replicating and pseudovirus neutralization assays using a HeLa-ACE2 (angiotensin-converting enzyme 2) cell line that gave robust and reproducible virus titers.", "(D) Plasma was also tested for neutralization of pseudotyped (PSV) SARS-CoV-1 and SARS-CoV-2 virions.", "The supernatants were next evaluated for neutralization activity using SARS-CoV-2 and SARS-CoV-1 pseudoviruses.", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "Control VSV-G pseudotyped virions showed a similar transduction efficiency in all target cells."]}
{"doc_id": 16021, "title": "", "abstract": ["The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins.", "Fig. 5 A potent SARS-CoV-2 RBD-specific neutralizing mAb protects against weight loss and lung viral replication in Syrian hamsters.", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F)."]}
{"doc_id": 16022, "title": "", "abstract": ["# Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model", "We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "Given concerns about antibody- mediated enhanced disease in SARS-CoV-2 infection, this observation merits further attention using larger animal group sizes.", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11)."]}
{"doc_id": 16023, "title": "", "abstract": ["Among the antibodies evaluated, the results reveal three epitope bins for RBD (designated RBD-A, RBD-B, and RBD-C) and three epitope bins for the S protein (designated S-A, S-B, and S-C) (Fig. 4A and fig. S7).", "Overall, the data highlight epitope RBD-A as the preferred target for eliciting neutralizing antibodies and suggest that corresponding increases in affinity of mAbs to RBD-A will likely result in corresponding increases in neutralization potency.", "The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "The other antibodies grouped in the S-A epitope bin that compete with CC12.19 either showed no binding to RBD or RBD- SD constructs (CC12.20 and CC12.21) or showed binding to RBD-SD1 and RBD-SD1-2 but not RBD (CC12.23).", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F)."]}
{"doc_id": 16024, "title": "", "abstract": ["Furthermore, nAbs prevent death from the emerging Ebola virus in macaques, even when given relatively late in infection, and thus have been proposed for use in outbreaks (2, 3).", "(A) SARS-CoV-2–specific human neutralizing mAb CC12.1 isolated from natural infection was administered at a starting dose of 2 mg per animal (average: 16.5 mg/kg) and subsequent serial fourfold dilutions.", "Potent neutralizing mAbs were selected to evaluate protection in the Syrian hamster model.", "The standard mAb isolation pipeline was optimized to facilitate high-throughput amplification, cloning, expression, and functional screening of hundreds of unpurified Ab heavy and light chain pairs isolated from each of several selected neutralizers in only 10 days.", "(D) Serum titers of the passively administered mAb, as assessed by ELISA at the time of challenge [12 hours after intraperitoneal (i.p.) administration]."]}
{"doc_id": 72000, "title": "", "abstract": ["To evaluate the therapeutic potential of broad and potent HIV-1-specific mAbs in primates with an intact immune system, we infused cocktails of mAbs, as well as single mAbs, into chronically SHIV-infected rhesus monkeys.", "More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "Previous studies in humanized mice and humans using the earlier generation of HIV-1 Env-specific mAbs suggested that the therapeutic potential of mAbs would be severely limited by the rapid emergence of viral escape mutations in the context of diverse virus swarms15–17.", "Previous studies in humanized mice and humans showed that the earlier generation of neutralizing HIV-1-specific mAbs was unable to control viremia15–17."]}
{"doc_id": 72001, "title": "", "abstract": ["Nevertheless, given the differences between SHIV-infected rhesus monkeys and HIV-1-infected humans, clinical trials are required to establish the therapeutic efficacy of potent neutralizing HIV-1-specific mAbs in humans.", "Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys", "HIV-1-specific neutralizing antibody (NAb) responses against primary infectious stocks of SHIV-SF162P3 and SHIV-SF162P4 were assessed by TZM-bl luciferase-based neutralization assays22.", "Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3.", "However, cocktails of 3 or 5 of the new generation of more potent mAbs targeting multiple epitopes have recently been shown to suppress HIV-1 replication in humanized mice18,19."]}
{"doc_id": 72002, "title": "", "abstract": ["More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "HIV-1-specific monoclonal antibodies (mAbs) with extraordinary potency and breadth have recently been described.", "However, cocktails of 3 or 5 of the new generation of more potent mAbs targeting multiple epitopes have recently been shown to suppress HIV-1 replication in humanized mice18,19.", "A series of broad and potent HIV-1 Env-specific mAbs have recently been isolated1,2 and have been shown to target the CD4 binding site3–7, the V1/V2 loops8,9, the V3/V4 loops and N332 glycans10–13, and the membrane proximal external region (MPER)14.", "Previous studies in humanized mice and humans using the earlier generation of HIV-1 Env-specific mAbs suggested that the therapeutic potential of mAbs would be severely limited by the rapid emergence of viral escape mutations in the context of diverse virus swarms15–17."]}
{"doc_id": 72003, "title": "", "abstract": ["More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "Previous studies in humanized mice and humans using the earlier generation of HIV-1 Env-specific mAbs suggested that the therapeutic potential of mAbs would be severely limited by the rapid emergence of viral escape mutations in the context of diverse virus swarms15–17.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys."]}
{"doc_id": 72004, "title": "", "abstract": ["These data indicate that the potent mAbs not only suppressed viremia but also reduced proviral DNA in tissues without the generation of viral resistance.", "The 2 animals that failed to achieve complete virologic suppression had the highest baseline plasma viral loads of 5.4 and 5.6 log RNA copies/ml before the mAb infusion and exhibited 2.8 and 2.9 log declines, respectively, in plasma viremia prior to rapid viral rebound on day 21 (monkeys 4907, 4909; Fig. 2a).", "The animals that suppressed viral loads to undetectable levels exhibited up to a 3.1 log decline of plasma viral RNA copies/ml by day 7 (monkey 4912; Fig. 2b).", "In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "Moreover, CD8+ T lymphocytes from these animals exhibited increased functional capacity to suppress virus replication following mAb administration25 (Fig. 1f; P=0.03)."]}
{"doc_id": 72005, "title": "", "abstract": ["In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "However, cocktails of 3 or 5 of the new generation of more potent mAbs targeting multiple epitopes have recently been shown to suppress HIV-1 replication in humanized mice18,19.", "Another key difference is the functional immune system in rhesus monkeys as compared with immunosuppressed humanized mice, and the profound virologic suppression without the development of resistance in the present study may reflect functional host antibody effector activity and intact antiviral cellular immune responses in rhesus monkeys.", "The 2 animals that failed to achieve complete virologic suppression had the highest baseline plasma viral loads of 5.4 and 5.6 log RNA copies/ml before the mAb infusion and exhibited 2.8 and 2.9 log declines, respectively, in plasma viremia prior to rapid viral rebound on day 21 (monkeys 4907, 4909; Fig. 2a)."]}
{"doc_id": 72006, "title": "", "abstract": ["Moreover, in a separate study35, our SHIV-SF162P3 stock led to AIDS-related mortality in 5 of 12 (42%) rhesus monkeys by 1 year following infection, which is comparable to the reported pathogenicity of SIVmac25136,37 and SHIV-AD838,39.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys.", "In the first study, we utilized 8 Indian origin adult rhesus monkeys (Macaca mulatta) that did not express the class I alleles Mamu-A*01, Mamu-B*08, and Mamu-B*17 and that were infected intrarectally with the pathogenic virus SHIV-SF162P3 for 9 months before the mAb infusions.", "Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3.", "Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3."]}
{"doc_id": 72007, "title": "", "abstract": ["In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "Moreover, CD8+ T lymphocytes from these animals exhibited increased functional capacity to suppress virus replication following mAb administration25 (Fig. 1f; P=0.03).", "More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "However, cocktails of 3 or 5 of the new generation of more potent mAbs targeting multiple epitopes have recently been shown to suppress HIV-1 replication in humanized mice18,19.", "Viral re-suppression was observed in 4 of 4 animals following the second mAb infusion (Fig. 2d; Supplementary Information)."]}
{"doc_id": 72008, "title": "", "abstract": ["Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys.", "Plasma viral RNA (log copies/ml) in rhesus monkeys chronically infected with SHIV-SF162P3 following a single infusion (arrows) of PGT121, 3BCN117, and b12 (a); PGT121 and 3BNC117 (b); or the control mAb DEN3 (c).", "Plasma viral RNA (log copies/ml) in rhesus monkeys chronically infected with SHIV-SF162P3 following infusions of PGT121, 3BCN117, and b12 on day 0 and day 7 (arrows) for 14 days (a) and 224 days (b).", "14 rhesus monkeys infected with SHIV-SF162P3 for 9 months prior to the mAb infusion with chronic setpoint viral loads of 3.2–5.6 log RNA copies/ml received a single infusion on day 0 with 10 mg/kg of each of the mAbs PGT121, 3BNC117, and b12 (N=5); PGT121 and 3BNC117 (N=5); or the isotype matched control mAb DEN3 (N=4)."]}
{"doc_id": 72009, "title": "", "abstract": ["### Neutralizing antibody assays", "Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys", "*Computed using viral load measurements at day 0 and day 12 (J. B. W., unpublished).", "Although these reflect different models, the rapid control of virus following mAb administration is striking and consistent with a mechanism that involves direct elimination of free virus in plasma in addition to virus-infected cells in tissues.", "A series of broad and potent HIV-1 Env-specific mAbs have recently been isolated1,2 and have been shown to target the CD4 binding site3–7, the V1/V2 loops8,9, the V3/V4 loops and N332 glycans10–13, and the membrane proximal external region (MPER)14."]}
{"doc_id": 72010, "title": "", "abstract": ["Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3.", "Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3.", "Following the initial mAb infusion, we observed rapid and precipitous declines of plasma viral loads to undetectable levels by day 7 in 4 of 4 monkeys (Fig. 1a).", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys."]}
{"doc_id": 72011, "title": "", "abstract": ["Moreover, the ability of these mAbs to reduce proviral DNA in tissues suggests that these mAbs should also be evaluated in the context of viral eradication strategies.", "We speculate that the therapeutic impact of these mAbs reflected not only their direct antiviral activity but also their impact on host antiviral immune responses.", "Therapeutic efficacy of the triple PGT121/3BNC117/b12 mAb cocktail", "Previous studies in humanized mice and humans using the earlier generation of HIV-1 Env-specific mAbs suggested that the therapeutic potential of mAbs would be severely limited by the rapid emergence of viral escape mutations in the context of diverse virus swarms15–17.", "Therapeutic efficacy of the single mAbs PGT121 and 3BNC117"]}
{"doc_id": 72012, "title": "", "abstract": ["Following mAb infusion, we observed modest increases in host virus- specific NAb activity (Extended Data Fig. 2) as well as reduced activation and improved functionality of host virus-specific T lymphocyte responses (Fig. 1f–h; Fig. 2e, f; Fig. 3g, h).", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "Following the initial mAb infusion, we observed rapid and precipitous declines of plasma viral loads to undetectable levels by day 7 in 4 of 4 monkeys (Fig. 1a).", "Viral re-suppression was observed in 4 of 4 animals following the second mAb infusion (Fig. 2d; Supplementary Information).", "Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3."]}
{"doc_id": 72013, "title": "", "abstract": ["The rapid reduction of proviral DNA in PBMC by day 1 (Fig. 1e) suggests direct antibody-mediated cytotoxic effects on infected cells29, although we cannot exclude the possibility of an effect of CD4+ T cell trafficking.", "Moreover, the ability of these mAbs to reduce proviral DNA in tissues suggests that these mAbs should also be evaluated in the context of viral eradication strategies.", "Proviral DNA in PBMC also declined rapidly by 10-fold in the monkeys that received the mAbs (Fig. 1e).", "These data indicate that the potent mAbs not only suppressed viremia but also reduced proviral DNA in tissues without the generation of viral resistance.", "A single mAb infusion afforded up to a 3.1 log decline of plasma viral RNA in 7 days and also reduced proviral DNA in peripheral blood, gastrointestinal mucosa, and lymph nodes without the development of viral resistance."]}
{"doc_id": 72014, "title": "", "abstract": ["In contrast, 3BNC117 alone, to which our SHIV-SF162P3 stock was relatively resistant, resulted in only a transient 0.2–1.1 log reduction of plasma viral loads (Fig. 3b), and one animal in this group (monkey CW9G) was euthanized for progressive clinical AIDS during this experiment.", "Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3.", "a, Summary of the therapeutic effect of PGT121 alone or PGT121-containing mAb cocktails in the 18 rhesus monkeys chronically infected with SHIV-SF162P3, as well as in the subgroups of animals with baseline viral loads of <3.5 log RNA copies/ml (N=3) (b), 3.5–5.3 log RNA copies/ml (N=13) (c), and >5.3 log RNA copies/ml (N=2) (d).", "PGT121 and 3BNC117 administration also resulted in 3- and 4-fold reductions in the percentage of PD-1+Ki67+ Gag-specific CD8+ and CD4+ T lymphocytes, respectively (Fig. 2e, f).", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys."]}
{"doc_id": 72015, "title": "", "abstract": ["Although these reflect different models, the rapid control of virus following mAb administration is striking and consistent with a mechanism that involves direct elimination of free virus in plasma in addition to virus-infected cells in tissues.", "These data suggest that mAb administration not only exerted direct antiviral effects but also improved host immune responses.", "In the 11% of animals (2 of 18) with high baseline viral loads >5.3 log RNA copies/ml, incomplete control of plasma viremia and rapid viral rebound was observed, suggesting a therapeutic ceiling in this model (Fig. 4d).", "Virologic control was not observed in the monkeys that received DEN3 or saline (Fig. 1c, d), and viral loads on day 14 were significantly lower in the mAb treated monkeys than in the controls (P=0.02, Mann-Whitney test).", "The therapeutic efficacy in the 18 animals that received PGT121 alone or as part of a cocktail (Fig. 4a) was dependent on baseline viral loads before mAb administration."]}
{"doc_id": 72016, "title": "", "abstract": ["In the first study, we utilized 8 Indian origin adult rhesus monkeys (Macaca mulatta) that did not express the class I alleles Mamu-A*01, Mamu-B*08, and Mamu-B*17 and that were infected intrarectally with the pathogenic virus SHIV-SF162P3 for 9 months before the mAb infusions.", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "To confirm that viral rebound was not associated with the development of viral resistance to the mAbs, we performed a second infusion of mAbs on day 105 in the monkeys that received PGT121 and 3BNC117.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys.", "Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3."]}
{"doc_id": 72017, "title": "", "abstract": ["Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3.", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys.", "Therapeutic efficacy of PGT121 or PGT121-containing mAb cocktails in chronically SHIV-infected rhesus monkeys", "Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys"]}
{"doc_id": 72018, "title": "", "abstract": ["In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system.", "More recent studies in humanized mice have shown that combinations of 3 or 5 of the new generation of more potent mAbs suppressed HIV-1 replication, although single mAbs still rapidly selected for resistance18,19.", "Another key difference is the functional immune system in rhesus monkeys as compared with immunosuppressed humanized mice, and the profound virologic suppression without the development of resistance in the present study may reflect functional host antibody effector activity and intact antiviral cellular immune responses in rhesus monkeys.", "To evaluate the therapeutic potential of broad and potent HIV-1-specific mAbs in primates with an intact immune system, we infused cocktails of mAbs, as well as single mAbs, into chronically SHIV-infected rhesus monkeys.", "Nevertheless, given the differences between SHIV-infected rhesus monkeys and HIV-1-infected humans, clinical trials are required to establish the therapeutic efficacy of potent neutralizing HIV-1-specific mAbs in humans."]}
{"doc_id": 58000, "title": "", "abstract": ["HOTAIR is a negative prognostic factor for breast, colon and liver cancer patient survival, and increased HOTAIR expression in patients has been correlated with enhanced breast and colon cancer metastasis.14, 20–23", "HOTAIR has also been characterized as a negative prognostic factor in breast, liver and colon cancer patients,20–23 and results of this study demonstrate that HOTAIR is also overexpressed in human pancreatic tumors compared to non- tumor tissue (Fig. 1).", "In summary, we show that HOTAIR is a negative prognostic factor for pancreatic cancer patients and exhibits pro-oncogenic activity in both in vitro and in vivo bioassays.", "HOTAIR IS A NEGATIVE PROGNOSTIC FACTOR AND EXHIBITS PRO-ONCOGENIC ACTIVITY IN PANCREATIC CANCER", "Thus, HOTAIR not only plays a role in invasion of pancreatic, breast, colon and liver cancer cells 20, 22, 23 but also exerts distinct pro- oncogenic activities in pancreatic cancer associated with increased cell survival and proliferation and repression of interferon-related genes."]}
{"doc_id": 58001, "title": "", "abstract": ["Results of gene array studies showed that there was minimal overlap between HOTAIR-regulated genes in pancreatic vs. breast cancer cells and HOTAIR uniquely suppressed several interferon-related genes and gene sets related to cell cycle progression in pancreatic cancer cells and tumors.", "Previous studies show that all seven genes exhibit tumor suppressor-like activities,27–36 and four genes, namely IL29, IL28A, IL28B and IFTM1, were among a subset of several interferon-regulated genes suppressed by HOTAIR in Panc1 cells (Supplemental Table S4).", "HOTAIR-dependent gene regulation in pancreatic cancer cells was investigated by HOTAIR knockdown in Panc1 and L3.6pL cells and HOTAIR overexpression in Panc28 and MiaPaCa2 cells using a set of genes repressed (JAM2, PCDH10, PCDHB5) and induced (ABL2, SNAIL, LAMB3 and LAMC2) by HOTAIR overexpression in MDA-MB-231 cells.20", "These results suggest that HOTAIR/PRC2 coordinately regulate GDF15 in pancreatic cancer cells; in contrast, this gene was not affected by HOTAIR overexpression in MDA-MB-231 cells,20 further demonstrating cell context-dependent differences in HOTAIR/PRC2-regulated genes.", "Knockdown of HOTAIR in Panc1 cells resulted in significant (>1.5) changes in expression of 1006 genes and analysis of the data suggested that HOTAIR-mediated gene regulation plays a critical role in pancreatic cancer progression and will be a novel epigenetic molecular target for treating pancreatic cancer patients."]}
{"doc_id": 58002, "title": "", "abstract": ["There is evidence that many lincRNAs act as scaffolds that regulate molecular (protein, RNA, DNA) interactions required for various signaling networks15–17 and this is accomplished, in part, by association with chromatin-modifying complexes.", "Rinn and coworkers have identified up to 3000 human long intervening non- coding RNAs (lincRNAs),14, 15 and biological characterization studies suggest that lincRNAs have important functions in both normal and cancer tissues.14–19", "The functions of some ncRNAs have been characterized and it is evident that they are key factors in gene regulation and influence normal and cancer cell phenotypes.4–8", "Significantly enriched biological pathways were identified, which produced nominal p-value < 0.05 and false discovery rates (FDR) < 0.25.", "HOTAIRM1 and HOTTIP are lincRNAs associated with the HOXA locus, and both ncRNAs differentially modulate gene expression in various cell and tissue types, but genes/pathways modulated by these lincRNAs are PRC2-independent.37, 38"]}
{"doc_id": 58003, "title": "", "abstract": ["The RT primer sets for HOTAIR, PCDHB5, PCDH10, JAM2, LAMB3, ABL2, SNAI and LAMC2 were used as previously described.20", "Pancreatic cancer cells either transfected with siRNAs (HOTAIR vs. control) or expression vectors (empty vs. HOTAIR) and cell invasion assay was performed as described previously.41", "Antibodies for RNA polymerase, EZH2 and Histone H3 trimethyl Lys 27 antibodies were obtained from Active Motif (Carlsbad, CA), and ChIP assay was performed as previously described.41", "L3.6pL cells (6×104 mL) were transfected with 100 nM siHOTAIR or siCT using Lipofectamine and after 48 hr, cells were collected and 1×106 cells injected into either side of the flank area of female nude mice (Harlan), and tumor volumes and weights were determined in mice from the siHOTAIR (6 mice) or siCT (6 mice) groups as described,43 and siHOTAIR levels were determined by real time PCR.", "Luciferase activities were measured after 24 hr as previously described.40, 41"]}
{"doc_id": 58004, "title": "", "abstract": ["In summary, we show that HOTAIR is a negative prognostic factor for pancreatic cancer patients and exhibits pro-oncogenic activity in both in vitro and in vivo bioassays.", "HOTAIR IS A NEGATIVE PROGNOSTIC FACTOR AND EXHIBITS PRO-ONCOGENIC ACTIVITY IN PANCREATIC CANCER", "HOTAIR has also been characterized as a negative prognostic factor in breast, liver and colon cancer patients,20–23 and results of this study demonstrate that HOTAIR is also overexpressed in human pancreatic tumors compared to non- tumor tissue (Fig. 1).", "HOTAIR is a negative prognostic factor for breast, colon and liver cancer patient survival, and increased HOTAIR expression in patients has been correlated with enhanced breast and colon cancer metastasis.14, 20–23", "Results of gene array studies showed that there was minimal overlap between HOTAIR-regulated genes in pancreatic vs. breast cancer cells and HOTAIR uniquely suppressed several interferon-related genes and gene sets related to cell cycle progression in pancreatic cancer cells and tumors."]}
{"doc_id": 58005, "title": "", "abstract": ["HOTAIR-dependent gene regulation in pancreatic cancer cells was investigated by HOTAIR knockdown in Panc1 and L3.6pL cells and HOTAIR overexpression in Panc28 and MiaPaCa2 cells using a set of genes repressed (JAM2, PCDH10, PCDHB5) and induced (ABL2, SNAIL, LAMB3 and LAMC2) by HOTAIR overexpression in MDA-MB-231 cells.20", "Modulation of HOTAIR expression in breast and colon cancer cells and tumors results in both enhanced and suppressed expression of genes, and a subset of genes repressed by HOTAIR in these cancer cells were also coregulated by PRC2.20, 23 A comparison of the gene expression data modulated by HOTAIR overexpression in MDA-MB-231 cells and HOTAIR knockdown in Panc1 cells showed some overlap in expression of individual genes; however, a heat map of induced/repressed genes illustrates significant differences between the cell lines (Fig. 2).", "HOTAIR has also been characterized as a negative prognostic factor in breast, liver and colon cancer patients,20–23 and results of this study demonstrate that HOTAIR is also overexpressed in human pancreatic tumors compared to non- tumor tissue (Fig. 1).", "Consistent results were observed for the HOTAIR-regulated gene sets in pancreatic cancer patients (Fig. 1C) and after HOTAIR knockdown in pancreatic cancer cells (Fig. 2A), suggesting that knockdown of endogenous HOTAIR rather than overexpression may be preferable for investigating ncRNA-dependent gene regulation and function.", "These results suggest that HOTAIR/PRC2 coordinately regulate GDF15 in pancreatic cancer cells; in contrast, this gene was not affected by HOTAIR overexpression in MDA-MB-231 cells,20 further demonstrating cell context-dependent differences in HOTAIR/PRC2-regulated genes."]}
{"doc_id": 58006, "title": "", "abstract": ["(C) GSEA analysis of GO terms showed that there was enriched expression of gene sets involved in cell cycle progression in pancreatic cancer patients.", "These observations are consistent with recent reports showing that HOTAIR regulation of multiple genes is EZH2-indendent.21, 39", "(A) HOTAIR knockdown and GSEA analysis of GO terms showed that HOTAIR knockdown enriched expression of genes involved in cell cycle progression."]}
{"doc_id": 58007, "title": "", "abstract": ["In contrast, HOTAIR knockdown in Panc1 and L3.6pL pancreatic cancer cells that overexpress this lincRNA decreased cell proliferation, altered cell cycle progression, and induced apoptosis, demonstrating an expanded function for HOTAIR in pancreatic cancer cells compared to other cancer cell lines.", "HOTAIR exhibited variable expression in pancreatic cancer cells, and knockdown of HOTAIR in Panc1 and L3.6pL pancreatic cancer cells by RNAi showed that HOTAIR was associated with enhanced cell invasion, cell proliferation, modulation of cell cycle progression, and induction of apoptosis.", "HOTAIR expression has been linked to increased breast, liver and colon cancer cell invasiveness, whereas RNA interference (RNAi) studies in liver cancer cells showed that HOTAIR alone had minimal effects alone on cell viability or apoptosis but enhanced the activities of other agents.22", "HOTAIR function was investigated in knockdown studies and indicates that this ncRNA enhances pancreatic cancer cell invasion, inhibits cell growth, modulates cell cycle progression, and induces apoptosis in vitro, and HOTAIR knockdown in L3.6pL cell inhibited tumor growth in athymic nude mice bearing these cells as xenografts (Fig. 5).", "HOTAIR overexpression enhanced MiaPaCa2 and Panc28 cell invasion in a Boyden chamber assay (Fig. 4A) and this was consistent with previous functional studies in breast and colon cancer cells.20, 23"]}
{"doc_id": 58008, "title": "", "abstract": ["HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients.", "HOTAIR is a negative prognostic factor for breast, colon and liver cancer patient survival, and increased HOTAIR expression in patients has been correlated with enhanced breast and colon cancer metastasis.14, 20–23", "These results suggest that HOTAIR/PRC2 coordinately regulate GDF15 in pancreatic cancer cells; in contrast, this gene was not affected by HOTAIR overexpression in MDA-MB-231 cells,20 further demonstrating cell context-dependent differences in HOTAIR/PRC2-regulated genes.", "The activity of HOTAIR is due, in part, to interaction of HOTAIR with the Polycomb Repressive Complex 2 (PRC2) (EZH2, SUZ12 and EED) which enhances H3K27 trimethylation to decrease expression of multiple genes.", "HOTAIR function was investigated in knockdown studies and indicates that this ncRNA enhances pancreatic cancer cell invasion, inhibits cell growth, modulates cell cycle progression, and induces apoptosis in vitro, and HOTAIR knockdown in L3.6pL cell inhibited tumor growth in athymic nude mice bearing these cells as xenografts (Fig. 5)."]}
{"doc_id": 58009, "title": "", "abstract": ["Other lincRNAs also associate with PRC2 and other chromatin complexes, suggesting potential gene repressive activity similar to that described for HOTAIR.15", "There is evidence that many lincRNAs act as scaffolds that regulate molecular (protein, RNA, DNA) interactions required for various signaling networks15–17 and this is accomplished, in part, by association with chromatin-modifying complexes.", "Several miRs are overexpressed in different tumors and their functional pro-oncogenic activity is usually associated with induction of oncogenes or inhibition of multiple genes with tumor suppressor-like activity.11–13", "Significant (p < 0.05) induction of gene expression (A and B) is indicated (*).", "Previous studies show that all seven genes exhibit tumor suppressor-like activities,27–36 and four genes, namely IL29, IL28A, IL28B and IFTM1, were among a subset of several interferon-regulated genes suppressed by HOTAIR in Panc1 cells (Supplemental Table S4)."]}
{"doc_id": 58010, "title": "", "abstract": ["HOTAIR is a 2,158 bp lincRNA localized to a boundary in the HOXC gene cluster.", "Moreover, there is also evidence that HOTAIR is more highly expressed in more aggressive and invasive pancreatic tumors (Figs. 1A and 1B).", "Data mining of publically available gene profiling results 24–26 showed that among 36 pancreatic cancer patients,25 HOTAIR was more highly expressed in pancreatic tumors compared to non-tumor tissue (Fig. 1A) and HOTAIR was more highly expressed in tumors extending beyond the pancreas (T3) compared to tumors only detected in the pancreas (T2) and more highly expressed in tumors spread to regional lymph nodes (N1) compared to tumors localized only in the pancreas (NO) (Fig. 1B).24", "Initial data mining studies of publically available data bases24–26 showed that HOTAIR was overexpressed in pancreatic tumors compared to the normal pancreas and more highly expressed in advanced tumors.24", "HOTAIR exhibited variable expression in pancreatic cancer cells, and knockdown of HOTAIR in Panc1 and L3.6pL pancreatic cancer cells by RNAi showed that HOTAIR was associated with enhanced cell invasion, cell proliferation, modulation of cell cycle progression, and induction of apoptosis."]}
{"doc_id": 58011, "title": "", "abstract": ["Modulation of HOTAIR expression in breast and colon cancer cells and tumors results in both enhanced and suppressed expression of genes, and a subset of genes repressed by HOTAIR in these cancer cells were also coregulated by PRC2.20, 23 A comparison of the gene expression data modulated by HOTAIR overexpression in MDA-MB-231 cells and HOTAIR knockdown in Panc1 cells showed some overlap in expression of individual genes; however, a heat map of induced/repressed genes illustrates significant differences between the cell lines (Fig. 2).", "HOTAIR overexpression enhanced MiaPaCa2 and Panc28 cell invasion in a Boyden chamber assay (Fig. 4A) and this was consistent with previous functional studies in breast and colon cancer cells.20, 23", "HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients.", "HOTAIR expression has been linked to increased breast, liver and colon cancer cell invasiveness, whereas RNA interference (RNAi) studies in liver cancer cells showed that HOTAIR alone had minimal effects alone on cell viability or apoptosis but enhanced the activities of other agents.22", "HOTAIR-dependent gene regulation in pancreatic cancer cells was investigated by HOTAIR knockdown in Panc1 and L3.6pL cells and HOTAIR overexpression in Panc28 and MiaPaCa2 cells using a set of genes repressed (JAM2, PCDH10, PCDHB5) and induced (ABL2, SNAIL, LAMB3 and LAMC2) by HOTAIR overexpression in MDA-MB-231 cells.20"]}
{"doc_id": 58012, "title": "", "abstract": ["Gene expression was determined by real time PCR and results are expressed as mean ± SE for 3 replicate determinations and significant (p < 0.05) is indicated (*).", "Results are expressed as means ± SE for 3 replicate determinations and significant (p < 0.05) induction or inhibition is indicated (*).", "Results are expressed as means ± SE for 3 separate determinations and significantly (p < 0.05) enhanced invasion is indicated.", "Quantitative results are means ± SE for at least 3 replicate determinations for each data point and significant (p < 0.05) induction (*) or inhibition (**) of a response by siHOTAIR (compared to siCT) are indicated.", "Significant (p < 0.05) induction of gene expression (A and B) is indicated (*)."]}
{"doc_id": 58013, "title": "", "abstract": ["HOTAIR-dependent gene regulation in pancreatic cancer cells was investigated by HOTAIR knockdown in Panc1 and L3.6pL cells and HOTAIR overexpression in Panc28 and MiaPaCa2 cells using a set of genes repressed (JAM2, PCDH10, PCDHB5) and induced (ABL2, SNAIL, LAMB3 and LAMC2) by HOTAIR overexpression in MDA-MB-231 cells.20", "In this study, we show that HOTAIR expression is increased in pancreatic tumors compared to non- tumor tissue and is associated with more aggressive tumors.", "Initial data mining studies of publically available data bases24–26 showed that HOTAIR was overexpressed in pancreatic tumors compared to the normal pancreas and more highly expressed in advanced tumors.24", "HOTAIR exhibited variable expression in pancreatic cancer cells, and knockdown of HOTAIR in Panc1 and L3.6pL pancreatic cancer cells by RNAi showed that HOTAIR was associated with enhanced cell invasion, cell proliferation, modulation of cell cycle progression, and induction of apoptosis.", "Modulation of HOTAIR expression in breast and colon cancer cells and tumors results in both enhanced and suppressed expression of genes, and a subset of genes repressed by HOTAIR in these cancer cells were also coregulated by PRC2.20, 23 A comparison of the gene expression data modulated by HOTAIR overexpression in MDA-MB-231 cells and HOTAIR knockdown in Panc1 cells showed some overlap in expression of individual genes; however, a heat map of induced/repressed genes illustrates significant differences between the cell lines (Fig. 2)."]}
{"doc_id": 58014, "title": "", "abstract": ["The functions of some ncRNAs have been characterized and it is evident that they are key factors in gene regulation and influence normal and cancer cell phenotypes.4–8", "HOTAIR function was investigated in knockdown studies and indicates that this ncRNA enhances pancreatic cancer cell invasion, inhibits cell growth, modulates cell cycle progression, and induces apoptosis in vitro, and HOTAIR knockdown in L3.6pL cell inhibited tumor growth in athymic nude mice bearing these cells as xenografts (Fig. 5).", "Rinn and coworkers have identified up to 3000 human long intervening non- coding RNAs (lincRNAs),14, 15 and biological characterization studies suggest that lincRNAs have important functions in both normal and cancer tissues.14–19", "In contrast, HOTAIR knockdown in Panc1 and L3.6pL pancreatic cancer cells that overexpress this lincRNA decreased cell proliferation, altered cell cycle progression, and induced apoptosis, demonstrating an expanded function for HOTAIR in pancreatic cancer cells compared to other cancer cell lines.", "HOTAIR expression has been linked to increased breast, liver and colon cancer cell invasiveness, whereas RNA interference (RNAi) studies in liver cancer cells showed that HOTAIR alone had minimal effects alone on cell viability or apoptosis but enhanced the activities of other agents.22"]}
{"doc_id": 58015, "title": "", "abstract": ["Tumor volumes were measured (0.5 × length × width2) and after 16 days, the mice were sacrificed and tumor weights were measured and also used for further analysis as described.41–43", "(D) siHOTAIR or siCT were transfected into L3.6pL cells which were then used in a xenograft model in athymic nude mice (6 per group), and tumor volumes and weights were determined.", "L3.6pL cells (6×104 mL) were transfected with 100 nM siHOTAIR or siCT using Lipofectamine and after 48 hr, cells were collected and 1×106 cells injected into either side of the flank area of female nude mice (Harlan), and tumor volumes and weights were determined in mice from the siHOTAIR (6 mice) or siCT (6 mice) groups as described,43 and siHOTAIR levels were determined by real time PCR.", "Cox proportional hazard regression model was also used to evaluate independent prognostic factors correlated with tumor stage and lymph node metastasis.", "Supplemental Figure 3 also shows that immunohistochemical staining of tumor tissue indicates an increase in TUNEL staining and a decrease in proliferation markers (Ki67 and PCNA) in siHOTAIR vs. siCT transfected tumors."]}
{"doc_id": 21000, "title": "", "abstract": ["After the first dose of BNT162b2, 16 733 (20·7%) of 80 879 people aged 55 years or younger reported at least one systemic effect compared with 21 422 (10·6%) of 201 224 people older than 55 years (OR 2·19 [95% CI 2·14–2·24]; p<0·0001).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "For ChAdOx1 nCoV-19, 30 487 (46·9%) of 65 034 people aged 55 years or younger reported at least one systemic effect after the first dose compared with 85 986 (30·7%) of 280 243 older than 55 years (1·99 [1·96–2·03]; p<0·0001).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown)."]}
{"doc_id": 21001, "title": "", "abstract": ["In conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived.", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "Similarly, rates of side-effects following the ChAdOx1 nCoV-19 vaccine were lower than expected.7", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21002, "title": "", "abstract": ["Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Additionally, our data provide evidence from the community to support early reports of higher frequency of side-effects in younger than in older individuals.3, 7", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11)."]}
{"doc_id": 21003, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "Similar levels of side-effects were seen regardless of the levels of completeness of reporting by app users (appendix p 12)."]}
{"doc_id": 21004, "title": "", "abstract": ["The ChAdOx1 nCoV-19 trial found efficacy against symptomatic disease of 76% at 22–90 days after at least one standard dose.6, 7, 8", "For ChAdOx1 nCoV-19, 30 487 (46·9%) of 65 034 people aged 55 years or younger reported at least one systemic effect after the first dose compared with 85 986 (30·7%) of 280 243 older than 55 years (1·99 [1·96–2·03]; p<0·0001).", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "We also investigated infection rates after the first vaccine dose in a subset of 67 293 app users who received BNT162b2 and 36 329 who received ChAdOx1 nCoV-19 in the study period and logged at least one PCR or lateral flow test after vaccination.", "The RR after one dose of ChAdOx1 nCoV-19 compared with unvaccinated controls was −60% (95% CI −68 to −49) at 21–44 days after vaccination."]}
{"doc_id": 21005, "title": "", "abstract": ["For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "By contrast, local effects were less commonly reported after the second dose than after the first dose of BNT162b2 (9025 [68·5%] of 13 179 vs 150 023 [71·9%] of 208 767; p<0·0001).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "When comparing the second BNT162b2 dose with the first ChAdOx1 nCoV-19 dose, we found that systemic effects occurred more frequently after the first ChAdOx1 nCoV-19 dose than after the second BNT162b2 dose (adjusted p<0·0001; figure 2), whereas local effects were less likely to appear after the first ChAdOx1 nCoV-19 injection than after the second BNT162b2 dose (adjusted p<0·0001; figure 2)."]}
{"doc_id": 21006, "title": "", "abstract": ["The first two vaccines have been rolled out across the UK since Dec 8, 2020, and Jan 4, 2021, respectively.1", "Other side-effects, including allergic skin reactions such as skin burning, rashes, and red welts on the lips and face, were reported by 10 860 (1·7%) of 627 383 users across both types of vaccine (table; appendix p 9).", "In conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived.", "No study investigated the prevalence of adverse effects of the vaccines and all studies reported both vaccines to be highly effective.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK."]}
{"doc_id": 21007, "title": "", "abstract": ["After the first dose of BNT162b2, 16 733 (20·7%) of 80 879 people aged 55 years or younger reported at least one systemic effect compared with 21 422 (10·6%) of 201 224 people older than 55 years (OR 2·19 [95% CI 2·14–2·24]; p<0·0001).", "Individuals vaccinated with a single dose of BNT162b2 were more likely to report systemic effects if they had a previous SARS-CoV-2 positive test than were those without known past infection (5148 [35·8%] of 14 369 vs 33 007 [12·3%] of 267 734; OR 3·97 [95% CI 3·83–4·12], p<0·0001).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection.", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown)."]}
{"doc_id": 21008, "title": "", "abstract": ["In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "The COVID Symptom Study app14 was developed by health data company ZOE Global, with input from King's College London (London, UK), the Massachusetts General Hospital (Boston, MA, USA), Lund University (Lund, Sweden), and Uppsala University (Uppsala, Sweden).", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "We used data from 627 383 individuals who received the BNT162b2 or ChAdOx1 nCoV-19 vaccines between December, 2020, and March, 2021, and reported symptoms in real-time via the COVID Symptom Study app.14", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine."]}
{"doc_id": 21009, "title": "", "abstract": ["Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "Additionally, our data provide evidence from the community to support early reports of higher frequency of side-effects in younger than in older individuals.3, 7", "Local effects were similarly higher in individuals previously infected than in those without known past infection for both vaccines (figure 3).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11)."]}
{"doc_id": 21010, "title": "", "abstract": ["We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "The reduction of infection was lower in individuals older than 55 years than those aged 55 years or younger, in those with one or more comorbidities than in those without comorbidities, and in individuals with a BMI of 30 kg/m2 or higher than in those with a BMI of less than 30 kg/m2 (appendix p 5).", "We observed a larger risk reduction in vaccinated participants aged 55 years or younger (RR −70% [95% CI −72 to −68) than in those older than 55 years (−61% [–64 to −57])."]}
{"doc_id": 21011, "title": "", "abstract": ["Tenderness and local pain around the injection site were the most frequently reported local effects (table), occurring most often on the day after injection and lasting a mean of 1·02 days (SD 0·15; figure 1).", "For example, in phase 3 clinical trials of the BNT162b2 vaccine,3 the most common events after the first dose were injection-site pain (71–83%), fatigue (34–47%), and headache (25–42%).", "However, in our community analysis, less than 30% of users complained of injection-site pain and less than 25% of fatigue and headache after the first dose.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "Other side-effects, including allergic skin reactions such as skin burning, rashes, and red welts on the lips and face, were reported by 10 860 (1·7%) of 627 383 users across both types of vaccine (table; appendix p 9)."]}
{"doc_id": 21012, "title": "", "abstract": ["Our primary outcome was the proportion of app users reporting adverse effects within 8 days after vaccination and the probability of having an adverse event.", "Users reporting vaccination were then asked daily for the following 8 days whether they experienced adverse effects, including both systemic (whole body) and local effects.", "We estimated the ratio of the daily number of users reporting at least one adverse effect (systemic or local) after vaccination to the total number of vaccinated users logging into the app that day.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "Vaccinated individuals who logged their systemic or local effects (or the absence of them) at least once within 8 days from the vaccination date were included in the adverse effects analysis (appendix p 2)."]}
{"doc_id": 21013, "title": "", "abstract": ["Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "The ChAdOx1 nCoV-19 trial found efficacy against symptomatic disease of 76% at 22–90 days after at least one standard dose.6, 7, 8", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Systemic side-effects were reported by 13·5% (38 155 of 282 103) of individuals after the first dose of BNT162b2, by 22·0% (6216 of 28 207) after the second dose of BNT162b2, and by 33·7% (116 473 of 345 280) after the first dose of ChAdOx1 nCoV-19.", "Local side-effects were reported by 71·9% (150 023 of 208 767) of individuals after the first dose of BNT162b2, by 68·5% (9025 of 13 179) after the second dose of BNT162b2, and by 58·7% (104 282 of 177 655) after the first dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21014, "title": "", "abstract": ["# Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "However, in our community analysis, less than 30% of users complained of injection-site pain and less than 25% of fatigue and headache after the first dose.", "The aim of this study was to investigate the adverse effects and infection rate of vaccinated people in a community (general population app users) scenario."]}
{"doc_id": 21015, "title": "", "abstract": ["Women were more likely to report adverse effects than men (28 140 [16·2%] of 173 866 vs 10 015 [9·3%] of 108 237 after the first dose of BNT162b2, OR 1·89 [95% CI 1·85–1·94], p<0·0001; 78 222 [39·3%] of 199 269 vs 38 251 [26·2%] of 146 011 after the first dose of ChAdOx1 nCoV-19, 1·82 [1·79–1·85], p<0·0001).", "Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Users who reported receiving a BNT162b2 vaccine were slightly younger, had more comorbidities, and were more frequently female than users who reported receiving a ChAdOx1 nCoV-19 inoculation (table).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "Individuals with evidence of past SARS-CoV-2 infection were also more likely to have adverse effects than those without evidence of past infection with both vaccines."]}
{"doc_id": 21016, "title": "", "abstract": ["In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "We observed a further reduction in infection risk after one dose of the BNT162b2 vaccine when compared with unvaccinated controls at 21–44 days after vaccination (RR −69% [95% CI −72 to −66]) and at 45–59 days after vaccination (−72% [–79 to −63]; figure 4).", "Systemic and local side-effects after BNT162b2 and ChAdOx1 nCoV-19 vaccination occur at frequencies lower than reported in phase 3 trials.", "Individuals vaccinated with the ChAdOx1 nCoV-19 vaccine were more likely to experience systemic side-effects than those who had been given the BNT162b2 vaccine, but in our study 89% of respondents who logged at least one systemic effect after the ChAdOx1 nCoV-19 vaccine did not report any systemic effects after 3 days, and 98·3% did not report any after 1 week.", "For example, in phase 3 clinical trials of the BNT162b2 vaccine,3 the most common events after the first dose were injection-site pain (71–83%), fatigue (34–47%), and headache (25–42%)."]}
{"doc_id": 21017, "title": "", "abstract": ["Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "No study investigated the prevalence of adverse effects of the vaccines and all studies reported both vaccines to be highly effective.", "In conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived.", "Users started logging adverse effects reports 0·79 days (SD 1·2) after they had the vaccine.", "Users reporting vaccination were then asked daily for the following 8 days whether they experienced adverse effects, including both systemic (whole body) and local effects."]}
{"doc_id": 21018, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "Systemic solicited side-effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea; solicited local side-effects included local pain, swelling, tenderness, redness, itch, warmth, and swollen armpit glands (appendix p 6).", "We found that systemic adverse effects, including headache and fatigue, affected fewer than one in four people and were less common in the community than expected from clinical trials.", "The most commonly reported systemic side- effects were fatigue and headache overall (table) and by strata (appendix p 9)."]}
{"doc_id": 21019, "title": "", "abstract": ["We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Additionally, our data provide evidence from the community to support early reports of higher frequency of side-effects in younger than in older individuals.3, 7", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature."]}
{"doc_id": 21020, "title": "", "abstract": ["However, in our community analysis, less than 30% of users complained of injection-site pain and less than 25% of fatigue and headache after the first dose.", "Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "We found that systemic adverse effects, including headache and fatigue, affected fewer than one in four people and were less common in the community than expected from clinical trials.", "Headache and fatigue were more common in women than in men, in people aged 55 years or younger than in people older than 55 years, and after the second than after the first dose.", "The post-vaccine symptoms (both systemic and local) often last 1–2 days from the injection."]}
{"doc_id": 21021, "title": "", "abstract": ["Users who reported receiving a BNT162b2 vaccine were slightly younger, had more comorbidities, and were more frequently female than users who reported receiving a ChAdOx1 nCoV-19 inoculation (table).", "Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "Headache and fatigue were more common in women than in men, in people aged 55 years or younger than in people older than 55 years, and after the second than after the first dose."]}
{"doc_id": 21022, "title": "", "abstract": ["Similar levels of side-effects were seen regardless of the levels of completeness of reporting by app users (appendix p 12).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "The overall mean age of the vaccinated app users was higher than that of the general population (40·3 years)24 yet was lower than those of the samples within other UK COVID-19 effectiveness studies,11, 12 largely because of the presence of a small proportion of health-care workers among the participants of this study.", "Among vaccinated app users, 159 101 (25·4%) of 627 383 indicated having one or more systemic adverse effect, and 257 209 (66·2%) of 388 430 reported one or more local adverse effect (table).", "However, we saw substantially lower rates of severe and mild side-effects than observed in phase 3 trials, making the missing of severe side-effects an unlikely explanation for the lower prevalence of side-effects seen in our data."]}
{"doc_id": 21023, "title": "", "abstract": ["Other side-effects, including allergic skin reactions such as skin burning, rashes, and red welts on the lips and face, were reported by 10 860 (1·7%) of 627 383 users across both types of vaccine (table; appendix p 9).", "Similar levels of side-effects were seen regardless of the levels of completeness of reporting by app users (appendix p 12).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "Individuals vaccinated with the ChAdOx1 nCoV-19 vaccine were more likely to experience systemic side-effects than those who had been given the BNT162b2 vaccine, but in our study 89% of respondents who logged at least one systemic effect after the ChAdOx1 nCoV-19 vaccine did not report any systemic effects after 3 days, and 98·3% did not report any after 1 week.", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines."]}
{"doc_id": 21024, "title": "", "abstract": ["Systemic and local side-effects after BNT162b2 and ChAdOx1 nCoV-19 vaccination occur at frequencies lower than reported in phase 3 trials.", "Finally, the systemic side-effects were collected from daily reports within 1 week from the injection date, so we cannot rule out that these effects might not be vaccine related.", "Our secondary outcome was infection rates in individuals after receiving a first dose of either the BNT162b2 or ChAdOx1 nCoV-19 vaccines.", "Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "The top row shows systemic effects and the bottom row shows local effects within 8 days after receipt of the first dose (A, D) or second dose (B, E) of the BNT162b2 vaccine or the first dose of the ChAdOx1 nCoV-19 vaccine (C, F)."]}
{"doc_id": 21025, "title": "", "abstract": ["These were most frequently reported within the first 24 h after vaccination and lasted a mean of 1·01 days (SD 0·1; figure 1).", "Users started logging adverse effects reports 0·79 days (SD 1·2) after they had the vaccine.", "Moreover, as there was a two-times increase in daily incidence in England followed by a decrease of a similar proportion during the data collection period,17 we also included incidence as a covariate in the Poisson regression model, with incidence calculated as previously described.18", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Women were more likely to report adverse effects than men (28 140 [16·2%] of 173 866 vs 10 015 [9·3%] of 108 237 after the first dose of BNT162b2, OR 1·89 [95% CI 1·85–1·94], p<0·0001; 78 222 [39·3%] of 199 269 vs 38 251 [26·2%] of 146 011 after the first dose of ChAdOx1 nCoV-19, 1·82 [1·79–1·85], p<0·0001)."]}
{"doc_id": 21026, "title": "", "abstract": ["Individuals vaccinated with the ChAdOx1 nCoV-19 vaccine were more likely to experience systemic side-effects than those who had been given the BNT162b2 vaccine, but in our study 89% of respondents who logged at least one systemic effect after the ChAdOx1 nCoV-19 vaccine did not report any systemic effects after 3 days, and 98·3% did not report any after 1 week.", "The effectiveness of this vaccine in reducing infection, severe disease, hospitalisation, and death with COVID-19 has been reported for the whole of Israel,4 with reanalysis of the data from Israel revealing it to be 90% effective 2 weeks after the first dose.5", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Moreover, local effects were less commonly reported after the first ChAdOx1 nCoV-19 injection (104 282 [58·7%] of 177 655) than after the first BNT162b2 injection (adjusted p<0·0001; figure 2).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine."]}
{"doc_id": 21027, "title": "", "abstract": ["As UK guidelines stipulate that individuals need to be free of symptoms to be vaccinated, we found vaccinated participants to have a lower infection risk at the time of the vaccination than unvaccinated participants (RR for BNT162b2 −64% [95% CI −69 to −59]; RR for ChAdOx1 nCoV-19 −52% [95% CI −65 to −34]).", "Between Dec 8, 2020, and March 10, 2021, 655 590 vaccine doses were logged in the app in the UK, corresponding to 282 103 individuals (aged 16–99 years) who reported having received the first dose of the BNT162b2 vaccine, of whom 28 207 reported having had both doses of the BNT162b2 vaccine (a median of 41 days [IQR 21–63] apart), and 345 280 individuals who reported having had the first dose of ChAdOx1 nCoV-19.", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "The first two vaccines have been rolled out across the UK since Dec 8, 2020, and Jan 4, 2021, respectively.1", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination."]}
{"doc_id": 21028, "title": "", "abstract": ["Furthermore, we cannot rule out the presence of selection bias in who was tested after vaccination, as we know that health-care workers are tested more frequently than people in the general population, even if they are asymptomatic.", "However, given that strong reductions in COVID hospitalisations after vaccination were observed in nationwide studies in Scotland12 and England,11 we believe that collider bias is unlikely to underlie the reduction in infections seen in our data.", "Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "The completeness of reporting was higher for systemic effects than for local effects, which might have introduced some bias (appendix p 12).", "We used self- reported data, which can introduce information bias, including misclassification, or effect bias exposure."]}
{"doc_id": 21029, "title": "", "abstract": ["In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "The UK's Medicines and Healthcare products Regulatory Agency has given emergency use authorisation to three COVID-19 vaccines: the Pfizer-BioNTech mRNA vaccine (BNT162b2), the Oxford-AstraZeneca adenovirus-vectored vaccine (ChAdOx1 nCoV-19), and the Moderna mRNA vaccine (mRNA-1273).", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "The OpenSAFELY collaboration10 implemented a framework for monitoring vaccine rollout and coverage in the UK via record linkage, Public Health England has reported early data on effectiveness in the older population prioritised for vaccination,11 and a prospective observational study investigated the association between the rollout of the first vaccine dose and COVID-19 hospital admission in Scotland.12"]}
{"doc_id": 21030, "title": "", "abstract": ["By contrast, local effects were less commonly reported after the second dose than after the first dose of BNT162b2 (9025 [68·5%] of 13 179 vs 150 023 [71·9%] of 208 767; p<0·0001).", "Local side-effects were reported by 71·9% (150 023 of 208 767) of individuals after the first dose of BNT162b2, by 68·5% (9025 of 13 179) after the second dose of BNT162b2, and by 58·7% (104 282 of 177 655) after the first dose of ChAdOx1 nCoV-19.", "Among vaccinated app users, 159 101 (25·4%) of 627 383 indicated having one or more systemic adverse effect, and 257 209 (66·2%) of 388 430 reported one or more local adverse effect (table).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "Vaccinated individuals who logged their systemic or local effects (or the absence of them) at least once within 8 days from the vaccination date were included in the adverse effects analysis (appendix p 2)."]}
{"doc_id": 21031, "title": "", "abstract": ["Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "However, we saw substantially lower rates of severe and mild side-effects than observed in phase 3 trials, making the missing of severe side-effects an unlikely explanation for the lower prevalence of side-effects seen in our data.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "We observed a larger risk reduction in vaccinated participants aged 55 years or younger (RR −70% [95% CI −72 to −68) than in those older than 55 years (−61% [–64 to −57]).", "However, our study population was considerably older than the study populations of the phase 3 trials.3, 6, 7"]}
{"doc_id": 21032, "title": "", "abstract": ["Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection.", "Local effects were similarly higher in individuals previously infected than in those without known past infection (1·4 times after the first dose of ChAdOx1 nCoV-19 and 1·2 times after the first dose of BNT162b2).", "Systemic side-effects were reported by 13·5% (38 155 of 282 103) of individuals after the first dose of BNT162b2, by 22·0% (6216 of 28 207) after the second dose of BNT162b2, and by 33·7% (116 473 of 345 280) after the first dose of ChAdOx1 nCoV-19.", "Local side-effects were reported by 71·9% (150 023 of 208 767) of individuals after the first dose of BNT162b2, by 68·5% (9025 of 13 179) after the second dose of BNT162b2, and by 58·7% (104 282 of 177 655) after the first dose of ChAdOx1 nCoV-19.", "Individuals vaccinated with the ChAdOx1 nCoV-19 vaccine were more likely to experience systemic side-effects than those who had been given the BNT162b2 vaccine, but in our study 89% of respondents who logged at least one systemic effect after the ChAdOx1 nCoV-19 vaccine did not report any systemic effects after 3 days, and 98·3% did not report any after 1 week."]}
{"doc_id": 21033, "title": "", "abstract": ["Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "No consistent difference in occurrence of systemic or local adverse effects was observed between individuals who reported a positive test result within the past 6 months and those who reported they received a positive test result at least 6 months ago (figure 3).", "The overall mean age of the vaccinated app users was higher than that of the general population (40·3 years)24 yet was lower than those of the samples within other UK COVID-19 effectiveness studies,11, 12 largely because of the presence of a small proportion of health-care workers among the participants of this study.", "Participants using the app were a self-selected group and not representative of the general population, as has been observed in other digital platform studies.27"]}
{"doc_id": 21034, "title": "", "abstract": ["We found that systemic adverse effects, including headache and fatigue, affected fewer than one in four people and were less common in the community than expected from clinical trials.", "A similar effect was seen for ChAdOx1 nCoV-19 first dose inoculation (7551 [53·1%] of 14 231 with past infection vs 108 922 [32·9%] of 331 049 without past infection; 2·31 [2·23–2·38], p<0·0001; figure 3) and BNT162b2 second dose inoculation (859 [38·2%] of 2251 vs 5357 [20·6%] of 25 956; 2·37 [2·17–2·60], p<0·0001).", "Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection.", "Local effects were similarly higher in individuals previously infected than in those without known past infection (1·4 times after the first dose of ChAdOx1 nCoV-19 and 1·2 times after the first dose of BNT162b2).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11)."]}
{"doc_id": 21035, "title": "", "abstract": ["Although our data, due to their observational nature, does not allow us to comment directly on effectiveness, the observed decrease of infection over time seems to be in line with efficacy reported in the BNT162b2 phase 3 trial3 and supports the UK Government's decision to delay the timing of the second injection to 12 weeks to maximise the number of people receiving at least one dose.", "For example, in phase 3 clinical trials of the BNT162b2 vaccine,3 the most common events after the first dose were injection-site pain (71–83%), fatigue (34–47%), and headache (25–42%).", "Phase 3 trials reported the BNT162b2 vaccine to have an efficacy of 52% at 12 days after the first dose and of 95% after the second dose if administered 3–4 weeks apart in participants without previous SARS-CoV-2 infection.3", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials."]}
{"doc_id": 21036, "title": "", "abstract": ["Individuals vaccinated with the ChAdOx1 nCoV-19 vaccine were more likely to experience systemic side-effects than those who had been given the BNT162b2 vaccine, but in our study 89% of respondents who logged at least one systemic effect after the ChAdOx1 nCoV-19 vaccine did not report any systemic effects after 3 days, and 98·3% did not report any after 1 week.", "Logistic regressions were used for each of the specified strata to investigate whether adverse effects varied across different participant groups, and in individuals who had previously reported a positive test for COVID-19 (PCR or lateral flow positive at least 6 months before vaccination, PCR or lateral flow positive within the 6 months before vaccination, and no previously detected infection).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "When comparing systemic effects after one dose of each vaccine, reactogenicity was significantly higher in individuals who had one dose of the ChAdOx1 nCoV-19 vaccine than in those who had one dose of the BNT162b2 vaccine (116 473 [33·7%] of 345 280 compared with 38 155 [13·5%] of 282 103; adjusted p<0·0001)."]}
{"doc_id": 21037, "title": "", "abstract": ["Systemic side-effects were reported by 13·5% (38 155 of 282 103) of individuals after the first dose of BNT162b2, by 22·0% (6216 of 28 207) after the second dose of BNT162b2, and by 33·7% (116 473 of 345 280) after the first dose of ChAdOx1 nCoV-19.", "By contrast, local effects were less commonly reported after the second dose than after the first dose of BNT162b2 (9025 [68·5%] of 13 179 vs 150 023 [71·9%] of 208 767; p<0·0001).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "Headache and fatigue were more common in women than in men, in people aged 55 years or younger than in people older than 55 years, and after the second than after the first dose.", "In the 28 207 individuals who reported having two BNT162b2 doses, 3325 (11·7%) reported at least one systemic effect after the first dose compared with 6216 (22·0%) after the second dose (p<0·0001; figure 2)."]}
{"doc_id": 21038, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "The UK's Medicines and Healthcare products Regulatory Agency has given emergency use authorisation to three COVID-19 vaccines: the Pfizer-BioNTech mRNA vaccine (BNT162b2), the Oxford-AstraZeneca adenovirus-vectored vaccine (ChAdOx1 nCoV-19), and the Moderna mRNA vaccine (mRNA-1273).", "No study investigated the prevalence of adverse effects of the vaccines and all studies reported both vaccines to be highly effective.", "Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting."]}
{"doc_id": 21039, "title": "", "abstract": ["In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Our data will enable prediction of side-effects based on age, sex, and past COVID-19 status to help update guidance to health professionals to reassure the population about the safety of vaccines.", "Figure 3 Adverse effects self-reported to the COVID Symptom Study app after COVID-19 vaccination, stratified by sex, age, BMI, health status, and previous SARS- CoV-2 test status", "As with other studies examining COVID-19 vaccine effects in the general community, our data are limited by the vaccine rollout's focus on health-care workers, elderly people, and people who are clinically vulnerable.2"]}
{"doc_id": 21040, "title": "", "abstract": ["Finally, the systemic side-effects were collected from daily reports within 1 week from the injection date, so we cannot rule out that these effects might not be vaccine related.", "Users reporting vaccination were then asked daily for the following 8 days whether they experienced adverse effects, including both systemic (whole body) and local effects.", "Documented infection rates in our app after a single vaccine dose decreased by 58% (95% CI 54–62) at 12–20 days, 69% (66–72) at 21–44 days, and 72% (63–79) after 45–59 days following BNT162b2, and 39% (21–53) at 12–20 days and 60% (49–68) at 21–44 days following ChAdOx1 nCoV-19, compared with unvaccinated controls.", "The OpenSAFELY collaboration10 implemented a framework for monitoring vaccine rollout and coverage in the UK via record linkage, Public Health England has reported early data on effectiveness in the older population prioritised for vaccination,11 and a prospective observational study investigated the association between the rollout of the first vaccine dose and COVID-19 hospital admission in Scotland.12", "The effectiveness of this vaccine in reducing infection, severe disease, hospitalisation, and death with COVID-19 has been reported for the whole of Israel,4 with reanalysis of the data from Israel revealing it to be 90% effective 2 weeks after the first dose.5"]}
{"doc_id": 21041, "title": "", "abstract": ["Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Women were more likely to report adverse effects than men (28 140 [16·2%] of 173 866 vs 10 015 [9·3%] of 108 237 after the first dose of BNT162b2, OR 1·89 [95% CI 1·85–1·94], p<0·0001; 78 222 [39·3%] of 199 269 vs 38 251 [26·2%] of 146 011 after the first dose of ChAdOx1 nCoV-19, 1·82 [1·79–1·85], p<0·0001).", "Figure 3 Adverse effects self-reported to the COVID Symptom Study app after COVID-19 vaccination, stratified by sex, age, BMI, health status, and previous SARS- CoV-2 test status", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Logistic regressions were used for each of the specified strata to investigate whether adverse effects varied across different participant groups, and in individuals who had previously reported a positive test for COVID-19 (PCR or lateral flow positive at least 6 months before vaccination, PCR or lateral flow positive within the 6 months before vaccination, and no previously detected infection)."]}
{"doc_id": 21042, "title": "", "abstract": ["The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "We observed a larger risk reduction in vaccinated participants aged 55 years or younger (RR −70% [95% CI −72 to −68) than in those older than 55 years (−61% [–64 to −57])."]}
{"doc_id": 21043, "title": "", "abstract": ["We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Additionally, our data provide evidence from the community to support early reports of higher frequency of side-effects in younger than in older individuals.3, 7", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature."]}
{"doc_id": 21044, "title": "", "abstract": ["When comparing the second BNT162b2 dose with the first ChAdOx1 nCoV-19 dose, we found that systemic effects occurred more frequently after the first ChAdOx1 nCoV-19 dose than after the second BNT162b2 dose (adjusted p<0·0001; figure 2), whereas local effects were less likely to appear after the first ChAdOx1 nCoV-19 injection than after the second BNT162b2 dose (adjusted p<0·0001; figure 2).", "Systemic side-effects were reported by 13·5% (38 155 of 282 103) of individuals after the first dose of BNT162b2, by 22·0% (6216 of 28 207) after the second dose of BNT162b2, and by 33·7% (116 473 of 345 280) after the first dose of ChAdOx1 nCoV-19.", "By contrast, local effects were less commonly reported after the second dose than after the first dose of BNT162b2 (9025 [68·5%] of 13 179 vs 150 023 [71·9%] of 208 767; p<0·0001).", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "Local side-effects were reported by 71·9% (150 023 of 208 767) of individuals after the first dose of BNT162b2, by 68·5% (9025 of 13 179) after the second dose of BNT162b2, and by 58·7% (104 282 of 177 655) after the first dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21045, "title": "", "abstract": ["We observed a larger risk reduction in vaccinated participants aged 55 years or younger (RR −70% [95% CI −72 to −68) than in those older than 55 years (−61% [–64 to −57]).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "The reduction of infection was lower in individuals older than 55 years than those aged 55 years or younger, in those with one or more comorbidities than in those without comorbidities, and in individuals with a BMI of 30 kg/m2 or higher than in those with a BMI of less than 30 kg/m2 (appendix p 5)."]}
{"doc_id": 21046, "title": "", "abstract": ["Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "Previous work has shown that data from our app is able to produce estimates of population-level disease prevalence that agree well with surveys with random, representative designs,18, 28 suggesting that behavioural issues are not substantially biasing our app population.", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "Although our data, due to their observational nature, does not allow us to comment directly on effectiveness, the observed decrease of infection over time seems to be in line with efficacy reported in the BNT162b2 phase 3 trial3 and supports the UK Government's decision to delay the timing of the second injection to 12 weeks to maximise the number of people receiving at least one dose.", "A similar effect was seen for ChAdOx1 nCoV-19 first dose inoculation (7551 [53·1%] of 14 231 with past infection vs 108 922 [32·9%] of 331 049 without past infection; 2·31 [2·23–2·38], p<0·0001; figure 3) and BNT162b2 second dose inoculation (859 [38·2%] of 2251 vs 5357 [20·6%] of 25 956; 2·37 [2·17–2·60], p<0·0001)."]}
{"doc_id": 21047, "title": "", "abstract": ["Recipients of the ChAdOx1 nCoV-19 vaccine might differ from recipients of the BNT162b2 vaccine by age or dependency.", "Moreover, health-care workers were more likely to receive a BNT162b2 vaccine than ChAdOx1 nCoV-19 (appendix p 8).", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Participants were asked if they had been vaccinated for COVID-19 and, if so, to record the type of vaccine and date of administration.", "Our data will enable prediction of side-effects based on age, sex, and past COVID-19 status to help update guidance to health professionals to reassure the population about the safety of vaccines."]}
{"doc_id": 21048, "title": "", "abstract": ["Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "For example, in phase 3 clinical trials of the BNT162b2 vaccine,3 the most common events after the first dose were injection-site pain (71–83%), fatigue (34–47%), and headache (25–42%).", "In conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived.", "Reported side-effects were minor in severity and of short duration.", "Other side-effects, including allergic skin reactions such as skin burning, rashes, and red welts on the lips and face, were reported by 10 860 (1·7%) of 627 383 users across both types of vaccine (table; appendix p 9)."]}
{"doc_id": 21049, "title": "", "abstract": ["Given preliminary evidence from small studies21, 22, 23 suggesting that reactogenicity is higher among individuals previously infected with SARS- CoV-2, we investigated the extent to which previous SARS-CoV-2 infection (based on self-reported previous positive PCR or lateral flow result) was associated with reports of adverse effects.", "Individuals vaccinated with a single dose of BNT162b2 were more likely to report systemic effects if they had a previous SARS-CoV-2 positive test than were those without known past infection (5148 [35·8%] of 14 369 vs 33 007 [12·3%] of 267 734; OR 3·97 [95% CI 3·83–4·12], p<0·0001).", "Individuals with known past SARS-CoV-2 infection were more likely to have adverse effects after the first dose than were those without known past infection.", "Individuals with evidence of past SARS-CoV-2 infection were also more likely to have adverse effects than those without evidence of past infection with both vaccines.", "Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection."]}
{"doc_id": 21050, "title": "", "abstract": ["Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "Figure 1 Proportion of participants self-reporting adverse effects to the COVID Symptom Study app within 8 days after vaccination"]}
{"doc_id": 21051, "title": "", "abstract": ["Adverse effects are more frequently reported in younger individuals, women, and among those who previously had COVID-19.", "Headache and fatigue were more common in women than in men, in people aged 55 years or younger than in people older than 55 years, and after the second than after the first dose.", "Women were more likely to report adverse effects than men (28 140 [16·2%] of 173 866 vs 10 015 [9·3%] of 108 237 after the first dose of BNT162b2, OR 1·89 [95% CI 1·85–1·94], p<0·0001; 78 222 [39·3%] of 199 269 vs 38 251 [26·2%] of 146 011 after the first dose of ChAdOx1 nCoV-19, 1·82 [1·79–1·85], p<0·0001).", "Users who reported receiving a BNT162b2 vaccine were slightly younger, had more comorbidities, and were more frequently female than users who reported receiving a ChAdOx1 nCoV-19 inoculation (table).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature."]}
{"doc_id": 21052, "title": "", "abstract": ["After the first dose of BNT162b2, 16 733 (20·7%) of 80 879 people aged 55 years or younger reported at least one systemic effect compared with 21 422 (10·6%) of 201 224 people older than 55 years (OR 2·19 [95% CI 2·14–2·24]; p<0·0001).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "Headache and fatigue were more common in women than in men, in people aged 55 years or younger than in people older than 55 years, and after the second than after the first dose."]}
{"doc_id": 21053, "title": "", "abstract": ["We used data from 627 383 individuals who received the BNT162b2 or ChAdOx1 nCoV-19 vaccines between December, 2020, and March, 2021, and reported symptoms in real-time via the COVID Symptom Study app.14", "Logistic regressions were used for each of the specified strata to investigate whether adverse effects varied across different participant groups, and in individuals who had previously reported a positive test for COVID-19 (PCR or lateral flow positive at least 6 months before vaccination, PCR or lateral flow positive within the 6 months before vaccination, and no previously detected infection).", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "As with other studies examining COVID-19 vaccine effects in the general community, our data are limited by the vaccine rollout's focus on health-care workers, elderly people, and people who are clinically vulnerable.2", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21054, "title": "", "abstract": ["It is possible, although it remains to be tested, that this increased reactogenicity relates to increased immunogenicity.", "When comparing systemic effects after one dose of each vaccine, reactogenicity was significantly higher in individuals who had one dose of the ChAdOx1 nCoV-19 vaccine than in those who had one dose of the BNT162b2 vaccine (116 473 [33·7%] of 345 280 compared with 38 155 [13·5%] of 282 103; adjusted p<0·0001).", "It has been shown that vaccines have increased immunogenicity in individuals with past infection and these people have higher antibody titres than those without previous infection.22, 23, 25", "By contrast, local effects were less commonly reported after the second dose than after the first dose of BNT162b2 (9025 [68·5%] of 13 179 vs 150 023 [71·9%] of 208 767; p<0·0001).", "In the 28 207 individuals who reported having two BNT162b2 doses, 3325 (11·7%) reported at least one systemic effect after the first dose compared with 6216 (22·0%) after the second dose (p<0·0001; figure 2)."]}
{"doc_id": 21055, "title": "", "abstract": ["Data were extracted and preprocessed using ExeTera version 0.3.2,19 a Python library developed at King's College London, and we did statistical analysis using Python version 3.7 (pandas, NumPy, and SciPy).", "PL, CHS, LHN, DAD, JM, MA, LSC, EM, MSG, MMo, ADJ, MMa, AH, ATC, CJS, SO, SS, and CH contributed data and software.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "BM and JC curated the data.", "Participants using the app were a self-selected group and not representative of the general population, as has been observed in other digital platform studies.27"]}
{"doc_id": 21056, "title": "", "abstract": ["Systemic solicited side-effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea; solicited local side-effects included local pain, swelling, tenderness, redness, itch, warmth, and swollen armpit glands (appendix p 6).", "Localised and systemic side-effects after vaccination are less common in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting.", "Local effects were similarly higher in individuals previously infected than in those without known past infection for both vaccines (figure 3).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11).", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK."]}
{"doc_id": 21057, "title": "", "abstract": ["Although there were some differences between strata of BMI and co-morbidities, there was no clear trend across vaccines and doses (figure 3).", "We aimed to investigate the safety and effectiveness of these vaccines in a UK community setting.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "We found, in a community setting, that self-reported infection rates of those vaccinated with the BNT162b2 or ChAdOx1 nCoV-19 vaccines were significantly lower than infection rates in unvaccinated controls.", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21058, "title": "", "abstract": ["Other side-effects, including allergic skin reactions such as skin burning, rashes, and red welts on the lips and face, were reported by 10 860 (1·7%) of 627 383 users across both types of vaccine (table; appendix p 9).", "These were most frequently reported within the first 24 h after vaccination and lasted a mean of 1·01 days (SD 0·1; figure 1).", "Vaccinated individuals who logged their systemic or local effects (or the absence of them) at least once within 8 days from the vaccination date were included in the adverse effects analysis (appendix p 2).", "We investigated the evolution of systemic and local adverse effects within 8 days from the vaccination date, computing the percentage of users experiencing side-effects after having received the vaccine.", "Our primary outcome was the proportion of app users reporting adverse effects within 8 days after vaccination and the probability of having an adverse event."]}
{"doc_id": 21059, "title": "", "abstract": ["Local effects were similarly higher in individuals previously infected than in those without known past infection (1·4 times after the first dose of ChAdOx1 nCoV-19 and 1·2 times after the first dose of BNT162b2).", "Local effects were similarly higher in individuals previously infected than in those without known past infection for both vaccines (figure 3).", "Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection.", "The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "A similar effect was seen for ChAdOx1 nCoV-19 first dose inoculation (7551 [53·1%] of 14 231 with past infection vs 108 922 [32·9%] of 331 049 without past infection; 2·31 [2·23–2·38], p<0·0001; figure 3) and BNT162b2 second dose inoculation (859 [38·2%] of 2251 vs 5357 [20·6%] of 25 956; 2·37 [2·17–2·60], p<0·0001)."]}
{"doc_id": 21060, "title": "", "abstract": ["The proportion of participants who reported at least one systemic effect after the first dose was significantly higher among people aged 55 years or younger than among those older than 55 years for both vaccines.", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Although side-effects were significantly more prevalent in women than in men, in people aged 55 years or younger than in those older than 55 years, and after the second than after the first dose, they occurred at much lower frequencies than expected from the published literature.", "We observed a larger risk reduction in vaccinated participants aged 55 years or younger (RR −70% [95% CI −72 to −68) than in those older than 55 years (−61% [–64 to −57]).", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11)."]}
{"doc_id": 75000, "title": "", "abstract": ["Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.", "Although the role of miR-200s in regulating E-cadherin expression and epithelial-mesenchymal transition is well established, their influence on metastatic colonization remains controversial.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome."]}
{"doc_id": 75001, "title": "", "abstract": ["Importantly, we showed that the expression of Sec23a is directly suppressed by miR-200s through two evolutionarily conserved target sequences in its 3’-UTR (see Supplementary Discussion for summary of evidence supporting Sec23a as a functional target miR-200s).", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome."]}
{"doc_id": 75002, "title": "", "abstract": ["However, contrary to the clinical associations observed for miR-200s, E-cadherin expression alone did not have any prognostic power (Fig. 1f), suggesting that the influence of miR-200s on breast cancer metastasis goes beyond the regulation of E-cadherin and the epithelial phenotype and likely involves novel genetic targets.", "MiR-200s are associated with poor prognosis in breast cancer.", "The miR-200 family expression was associated with ER- positive status (P = 0.019, median expression) and correlated with poor DRFS only in the ER-positive tumors (P = 0.028, n = 122) but not ER-negative tumors (P = 0.48, n = 77).", "A composite miR-200 family expression score calculated in each sample as either the median (Fig. 1a, P = 0.034) or the mean (P = 0.030) expression was significantly associated with poor distant relapse-fee survival (DRFS)33.", "Indeed, evaluation of SEC23A expression as a primary tumor prognostic marker in a large public clinical database of breast cancer42 failed to show significant associations."]}
{"doc_id": 75003, "title": "", "abstract": ["Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "In summary, results from both clinical and experimental analyses collectively show that miR-200s can promote distant colonization of breast cancer cells.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome.", "We confirmed reduced expression of the nine candidate MDA-MB-231 and TSU-PR1 human breast and bladder cancer cell lines, respectively (Fig. 4d).", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome."]}
{"doc_id": 75004, "title": "", "abstract": ["Histological analysis has revealed morphological similarities of primary tumors and metastatic lesions4,and it has been reported that E-cadherin levels are elevated in lymph node metastases relative to matched primary tumor samples, both suggesting that EMT in primary tumors may be followed by MET at distant sites5,6.", "Furthermore, miR-200 expression was increased in lung metastases compared to primary tumors.", "However, the fact that E-cadherin overexpression alone cannot fully recapitulate the metastasis potential of miR-200 overexpressing lines, suggests that other genes or signaling pathways are also likely to be simultaneously targeted to enhance colonization efficiency.", "However, contrary to the clinical associations observed for miR-200s, E-cadherin expression alone did not have any prognostic power (Fig. 1f), suggesting that the influence of miR-200s on breast cancer metastasis goes beyond the regulation of E-cadherin and the epithelial phenotype and likely involves novel genetic targets.", "Furthermore, profiling miR-200 levels in ten human primary and lung-pleural metastasis samples, including six matched pairs (Meldola collection),revealed higher expression in metastases, reinforcing the potential role of miR-200s in metastatic colonization (Fig. 1b)."]}
{"doc_id": 75005, "title": "", "abstract": ["Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "These contradictory findings may in part due to the different models applied in these studies, where miR-200s may promote metastasis of breast cancer cells31 and hinder metastasis of lung adenocarcinoma29 and pancreatic neuroendocrine cells30.", "MiR-200s simultaneously target several genes including Zeb1, ZEB2 and Sec23a to inhibit local invasion but promote metastatic colonization.", "### MiR-200 overexpression enhances lung colonization", "Ectopic miR-200 expression enhances spontaneous metastasis and colonization of distant organs."]}
{"doc_id": 75006, "title": "", "abstract": ["Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "These findings provide novel insights into the molecular functions of miR-200s as well as the role of MET and tumor secretome in metastasis.", "These findings are consistent with a clinical correlation observed in serous ovarian carcinoma patients34 and an earlier observation in xenograft studies31.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.", "These contradictory findings may in part due to the different models applied in these studies, where miR-200s may promote metastasis of breast cancer cells31 and hinder metastasis of lung adenocarcinoma29 and pancreatic neuroendocrine cells30."]}
{"doc_id": 75007, "title": "", "abstract": ["Importantly, both TINAGL1 and IGFBP4 were also significantly associated with better distant metastasis-free survival in an independent EMC286 clinical dataset47 (Fig. 6e), again supporting their role in reducing metastasis.", "We further identified Tinagl1 and Igfbp4 as important Sec23a-mediated secretory proteins that significantly reduce metastatic colonization.", "In aggregate, our data implicates a significant role for the secretome as an important downstream mediator of miR-200s in metastasis, and uncovers Tinagl1 and Igfbp4 as secreted suppressors of lung metastasis with potential therapeutic applications.", "### Igfbp4 and Tinagl1 are Sec23a-dependent metastasis suppressors", "MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies."]}
{"doc_id": 75008, "title": "", "abstract": ["Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.", "These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.", "Early events of metastatic dissemination are thought to be initiated by epithelial-mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and invasion1-3.", "Overall, both clinical data analysis and experimental animal models suggest that Sec23a plays an important role in suppressing metastasis specifically at the step of colonization."]}
{"doc_id": 75009, "title": "", "abstract": ["We further identified Tinagl1 and Igfbp4 as important Sec23a-mediated secretory proteins that significantly reduce metastatic colonization.", "### Igfbp4 and Tinagl1 are Sec23a-dependent metastasis suppressors", "MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies.", "In support of the functional data, endogenous Sec23a levels are less abundant in highly metastatic 4T1 and MCFCA1a lines relative to the weakly metastatic 4TO7 and MCFCA1h lines and is reduced in 4TO7 line upon miR-200 overexpression (Supplementary Fig. 8d–e).", "Furthermore, SEC23A levels are significantly lower in clinical metastases relative to primary tumors (Fig. 5d–e), consistent with its role as a suppressor of metastatic colonization."]}
{"doc_id": 75010, "title": "", "abstract": ["Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies.", "We further identified Tinagl1 and Igfbp4 as important Sec23a-mediated secretory proteins that significantly reduce metastatic colonization.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.", "In aggregate, our data implicates a significant role for the secretome as an important downstream mediator of miR-200s in metastasis, and uncovers Tinagl1 and Igfbp4 as secreted suppressors of lung metastasis with potential therapeutic applications."]}
{"doc_id": 75011, "title": "", "abstract": ["Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "The fact that miR-200 targeting of Sec23a appears to have dichotomous roles in metastasis, hindering early steps of migration and invasion while promoting late step of metastatic colonization, may explain the contradictory roles of miR-200s in various models of metastasis.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.", "MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies.", "The fact that the miR-200 family has been shown to enforce the epithelial phenotype and inhibit EMT and invasion in vitro suggested that these miRNAs are likely to suppress metastasis."]}
{"doc_id": 75012, "title": "", "abstract": ["MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "MiR-200s simultaneously target several genes including Zeb1, ZEB2 and Sec23a to inhibit local invasion but promote metastatic colonization.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome."]}
{"doc_id": 75013, "title": "", "abstract": ["Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.", "Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "However, relatively little is known about the role of miRNAs in the late step — metastatic colonization of distant organs.", "In aggregate, these data suggested that although miR-200 expression can hinder entry of tumor cells into circulation, those that do intravasate may be more capable of colonizing distant organs.", "Histological analysis has revealed morphological similarities of primary tumors and metastatic lesions4,and it has been reported that E-cadherin levels are elevated in lymph node metastases relative to matched primary tumor samples, both suggesting that EMT in primary tumors may be followed by MET at distant sites5,6."]}
{"doc_id": 75014, "title": "", "abstract": ["Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.", "Early events of metastatic dissemination are thought to be initiated by epithelial-mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and invasion1-3.", "Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome."]}
{"doc_id": 75015, "title": "", "abstract": ["Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.", "Histological analysis has revealed morphological similarities of primary tumors and metastatic lesions4,and it has been reported that E-cadherin levels are elevated in lymph node metastases relative to matched primary tumor samples, both suggesting that EMT in primary tumors may be followed by MET at distant sites5,6.", "Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.", "The fact that the miR-200 family has been shown to enforce the epithelial phenotype and inhibit EMT and invasion in vitro suggested that these miRNAs are likely to suppress metastasis."]}
{"doc_id": 75016, "title": "", "abstract": ["Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "Similar correlations between elevated expression of miR-200s with epithelial traits and increased metastatic ability were also made for the MCF10A human breast cancer38 (Fig. 1e and Supplementary Fig. 1b) and the TSU bladder carcinoma39 progression series (Supplementary Fig. 2c–e and Supplementary Table 1; see Supplementary Results).", "Here, we use clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype.", "Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome."]}
{"doc_id": 75017, "title": "", "abstract": ["Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "To further investigate the importance of miR-200s in metastasis, we profiled miR-200 expression levels in three cancer cell line series that model the progression of breast and bladder cancer.", "These contradictory findings may in part due to the different models applied in these studies, where miR-200s may promote metastasis of breast cancer cells31 and hinder metastasis of lung adenocarcinoma29 and pancreatic neuroendocrine cells30.", "In summary, results from both clinical and experimental analyses collectively show that miR-200s can promote distant colonization of breast cancer cells.", "Several recent studies in animal metastasis models have reported conflicting roles of miR-200s in metastatic progression29-31."]}
{"doc_id": 75018, "title": "", "abstract": ["We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "Ectopic miR-200 expression enhances spontaneous metastasis and colonization of distant organs.", "Of these lines, only 4T1 cells are capable of spontaneously metastasizing and colonizing distant organs following orthotopic implantation35,36."]}
{"doc_id": 75019, "title": "", "abstract": ["These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome.", "Importantly, miR-200s have recently been shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional repressors Zeb1 and Zeb225-28.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "The fact that the miR-200 family has been shown to enforce the epithelial phenotype and inhibit EMT and invasion in vitro suggested that these miRNAs are likely to suppress metastasis."]}
{"doc_id": 75020, "title": "", "abstract": ["Early events of metastatic dissemination are thought to be initiated by epithelial-mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and invasion1-3.", "Our findings support the dynamic roles of EMT and MET during different stages of metastasis — while EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs.", "While implications for EMT in cancer progression are widely recognized, the potential role of the reverse process, mesenchymal-epithelial transition (MET) is less clear.", "These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.", "Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce."]}
{"doc_id": 75021, "title": "", "abstract": ["Several recent studies in animal metastasis models have reported conflicting roles of miR-200s in metastatic progression29-31.", "However, functional studies have yielded conflicting results in different models of metastasis29-31, casting doubt on the potential therapeutic utility of miR-200s.", "The fact that miR-200 targeting of Sec23a appears to have dichotomous roles in metastasis, hindering early steps of migration and invasion while promoting late step of metastatic colonization, may explain the contradictory roles of miR-200s in various models of metastasis.", "Here, we use clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype.", "Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome."]}
{"doc_id": 75022, "title": "", "abstract": ["However, contrary to the clinical associations observed for miR-200s, E-cadherin expression alone did not have any prognostic power (Fig. 1f), suggesting that the influence of miR-200s on breast cancer metastasis goes beyond the regulation of E-cadherin and the epithelial phenotype and likely involves novel genetic targets.", "MiR-200s are associated with poor prognosis in breast cancer.", "Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1.", "Importantly, miR-200s have recently been shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional repressors Zeb1 and Zeb225-28."]}
{"doc_id": 75023, "title": "", "abstract": ["Importantly, miR-200s have recently been shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional repressors Zeb1 and Zeb225-28.", "The fact that the miR-200 family has been shown to enforce the epithelial phenotype and inhibit EMT and invasion in vitro suggested that these miRNAs are likely to suppress metastasis.", "In contrast to the results obtained from the lung colony assays, miR-200 expression reduced tumor cell entry into circulation from primary tumors (Fig. 2d and Supplementary Fig. 5a), possibly through inhibition of EMT, migration and invasion as observed in vitro (Supplementary Fig. 5c).", "In aggregate, these data suggested that although miR-200 expression can hinder entry of tumor cells into circulation, those that do intravasate may be more capable of colonizing distant organs.", "We showed that miR-200s promote metastatic colonization by enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting Sec23a-dependent regulation of tumor secretome."]}
{"doc_id": 74000, "title": "", "abstract": ["Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "To further substantiate the role of myeloid cells in arrest of Rett pathology, we used a genetic approach.", "Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development."]}
{"doc_id": 74001, "title": "", "abstract": ["Mecp2-null microglia were reported to be toxic to neurons in vitro through production of high levels of glutamate 10.", "To substantiate the specific role of microglia in bone marrow transplantation- mediated disease arrest, we repeated transplantation experiments at P28, but with the addition of lead shielding to block cranial irradiation, which results in repopulation of peripheral immunity (Fig. 3b, c) but no parenchymal engraftment (Fig. 3d), supporting previously published works 13,18.", "Still, the idea of repopulation of brain microglia from bone marrow-derived cells in adult mice under normal physiological conditions is controversial 12.", "We first studied microglial function in the context of Mecp2−/y male mice.", "Microglia have received increasing attention in the pathophysiology of several neurodegenerative and neuropsychiatric diseases 14–18."]}
{"doc_id": 74002, "title": "", "abstract": ["Moreover, we have recently shown that intravenous injection of annexin V results in substantial blockade of phagocytic activity in the brain 24.", "The results of this study open the possibility for a new approach in the amelioration of Rett pathology.", "Future studies should be aimed at understanding the connections between glial phagocytic activity and neuronal function, and possible interactions between microglia and astrocytes in Rett pathology.", "N.C.D. – performed the majority of the experiments, analyzed the data and prepared it for presentation, contributed to experimental design and manuscript writing; J.C.C. – performed the experiments with phagocytic activity of microglia in vivo and assisted with additional immunohistochemistry experiments along with data analysis and presentation, contributed to experimental design and to manuscript editing; Z.L. – assisted with in vitro phagocytic activity experiments; E.X. – assisted with animal behavior scoring; S.B.G.A. – assisted with plethysmography experiments and data analysis; P.G.G. – assisted with plethysmography experimental design, data analysis and presentation of plethysmography-related data, contributed to manuscript editing; J.K. – designed the study, assisted with data analysis and presentation, wrote the manuscript.", "We first studied microglial function in the context of Mecp2−/y male mice."]}
{"doc_id": 74003, "title": "", "abstract": ["Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "Our present findings support previous publications describing the potential for clinical treatment of Rett pathology 6,29, while also suggesting the possibility of achieving this goal via augmentation or repopulation of brain phagocytes, or improvement of their phagocytic activity.", "The results of this study open the possibility for a new approach in the amelioration of Rett pathology.", "Interestingly, in mice in which bone marrow transplantation was performed later (P40 or P45), only slight improvements in disease pathology were observed (Supplementary Fig. 4a)."]}
{"doc_id": 74004, "title": "", "abstract": ["Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome.", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder."]}
{"doc_id": 74005, "title": "", "abstract": ["Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Along these lines, supplementation of wild type microglia could reduce debris levels and allow for improved neuronal function.", "Overall, these results suggest active engagement of wild type microglia in clearance of apoptotic cells or cell remnants within the context of otherwise Mecp2-null brain a task that probably cannot be sufficiently performed by Mecp2-null microglia."]}
{"doc_id": 74006, "title": "", "abstract": ["We first studied microglial function in the context of Mecp2−/y male mice.", "Microglial phagocytic activity is necessary for their beneficial effect in Mecp2−/y mouse brains", "Microglia, the brain-resident macrophages, are of hematopoietic origin 11.", "Overall, these results suggest active engagement of wild type microglia in clearance of apoptotic cells or cell remnants within the context of otherwise Mecp2-null brain a task that probably cannot be sufficiently performed by Mecp2-null microglia.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved."]}
{"doc_id": 74007, "title": "", "abstract": ["Newly-engrafted microglia expressed detectable levels of wild type Mecp2 (data not shown) but nearby cells did not show any Mecp2 labeling, arguing against the possibility of protein or mRNA transfer from engrafted microglia into nearby cells as an underlying mechanism for the beneficial effect of bone marrow transplantation.", "Mecp2+/− females also exhibited significant improvements as a result of wild type microglial engraftment.", "We first studied microglial function in the context of Mecp2−/y male mice.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Microglia from Mecp2-null mice were deficient in their response to immunological stimuli (Supplementary Fig. 5) and in phagocytic capacity, as examined by feeding cultured microglia with pre-labeled UV-irradiated neural progenitor cells, used as apoptotic targets 24 (Fig. 4a–c)."]}
{"doc_id": 74008, "title": "", "abstract": ["The role of glia in Rett syndrome has recently been recognized 7–9.", "However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology.", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome.", "To further substantiate the role of myeloid cells in arrest of Rett pathology, we used a genetic approach."]}
{"doc_id": 74009, "title": "", "abstract": ["Surprisingly, the lifespan of Mecp2-null recipients of wild type bone marrow (Wild type→Mecp2−/y) was significantly extended compared to Mecp2−/y mice receiving autologous bone marrow (Mecp2−/y→Mecp2−/y) or to naïve Mecp2−/y mice (Fig. 1b; Supplementary Movie 2).", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development.", "When bone marrow transplantation was performed at P2 without irradiation, minimal peripheral chimerism was achieved without detectable microglia engraftment and no lifespan extension was observed (Supplementary Fig. 4a, c).", "Wild type bone marrow transplantation at P28 arrests disease progression in Mecp2−/y mice"]}
{"doc_id": 74010, "title": "", "abstract": ["Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Mecp2+/− females also exhibited significant improvements as a result of wild type microglial engraftment.", "Wild type bone marrow transplantation at P28 arrests disease progression in Mecp2−/y mice", "Newly-engrafted microglia expressed detectable levels of wild type Mecp2 (data not shown) but nearby cells did not show any Mecp2 labeling, arguing against the possibility of protein or mRNA transfer from engrafted microglia into nearby cells as an underlying mechanism for the beneficial effect of bone marrow transplantation."]}
{"doc_id": 74011, "title": "", "abstract": ["Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "The results of this study open the possibility for a new approach in the amelioration of Rett pathology.", "Our present findings support previous publications describing the potential for clinical treatment of Rett pathology 6,29, while also suggesting the possibility of achieving this goal via augmentation or repopulation of brain phagocytes, or improvement of their phagocytic activity.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "Interestingly, in mice in which bone marrow transplantation was performed later (P40 or P45), only slight improvements in disease pathology were observed (Supplementary Fig. 4a)."]}
{"doc_id": 74012, "title": "", "abstract": ["Mecp2+/− females also exhibited significant improvements as a result of wild type microglial engraftment.", "Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder."]}
{"doc_id": 74013, "title": "", "abstract": ["Mecp2-null astrocytes were unable to support the normal dendritic ramification of wild type neurons growing in culture 7, and expression of wild type Mecp2 protein in astrocytes of Mecp2-null hosts dramatically ameliorated disease pathology 9.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Although MeCP2 is expressed in many tissues, the disease is generally attributed to a primary neuronal dysfunction 6.", "Similarly, targeted expression of Mecp2 in myeloid cells, driven by Lysmcre on an Mecp2-null background, dramatically attenuated disease symptoms.", "Mecp2+/− females also exhibited significant improvements as a result of wild type microglial engraftment."]}
{"doc_id": 74014, "title": "", "abstract": ["The results of this study open the possibility for a new approach in the amelioration of Rett pathology.", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "Transplantation of wild type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone marrow-derived myeloid cells of microglial phenotype, and arrest of disease development.", "Brain parenchymal engraftment of cells after bone marrow transplantation is required to arrest Rett syndrome", "The severe involuntary tremors normally seen in mutant mice were absent following wild type bone marrow transplantation (Fig. 2a), and gait was improved."]}
{"doc_id": 74015, "title": "", "abstract": ["These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome", "These benefits mediated by wild type microglia, however, were diminished when phagocytic activity was inhibited pharmacologically using annexin V to block phosphatydilserine residues on apoptotic targets, thus preventing recognition and engulfment by tissue- resident phagocytes.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved.", "Accordingly, inhibition of phagocytosis might result in exacerbation of Rett pathology via these yet- unknown processes, even in the absence of deposits of easily observable cellular debris."]}
{"doc_id": 74016, "title": "", "abstract": ["The results of this study open the possibility for a new approach in the amelioration of Rett pathology.", "Interestingly, in mice in which bone marrow transplantation was performed later (P40 or P45), only slight improvements in disease pathology were observed (Supplementary Fig. 4a).", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "Brain parenchymal engraftment of cells after bone marrow transplantation is required to arrest Rett syndrome", "Our present findings support previous publications describing the potential for clinical treatment of Rett pathology 6,29, while also suggesting the possibility of achieving this goal via augmentation or repopulation of brain phagocytes, or improvement of their phagocytic activity."]}
{"doc_id": 74017, "title": "", "abstract": ["These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome.", "Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "The role of glia in Rett syndrome has recently been recognized 7–9.", "We first studied microglial function in the context of Mecp2−/y male mice."]}
{"doc_id": 59000, "title": "", "abstract": ["Obesity had a significantly larger association with both coronary heart disease and stroke than did overweight: the confounder-adjusted HR of obesity versus normal weight was 1·69 (1·58–1·81) for coronary heart disease and 1·47 (1·36–1·59) for stroke.", "PERM for the association of overweight with coronary heart disease was larger than that of obesity for most combinations of mediators, but the CIs overlapped (table 3).", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16)."]}
{"doc_id": 59001, "title": "", "abstract": ["We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16).", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Several pathways link adiposity and excess weight to cardiovascular disease via the mediators analysed in this study.", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "Our results also suggest that the association between adiposity and cardiovascular disease is not completely explained by the three mediators in our analysis."]}
{"doc_id": 59002, "title": "", "abstract": ["Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16).", "Obesity had a significantly larger association with both coronary heart disease and stroke than did overweight: the confounder-adjusted HR of obesity versus normal weight was 1·69 (1·58–1·81) for coronary heart disease and 1·47 (1·36–1·59) for stroke."]}
{"doc_id": 59003, "title": "", "abstract": ["Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "We also analysed categories of overweight (BMI ≥25–<30 kg/m2) and obesity (BMI ≥30 kg/m2) as compared with normal weight (BMI ≥20–<25 kg/m2) with the same methods as continuous analysis.", "Sensitivity analyses showed that our results were robust to the choice of metrics used for mediators.", "HRs and excess risk of overweight and obesity mediated through different combinations of metabolic risk factors", "We analysed data from 97 prospective cohort studies to estimate the effects of high body-mass index (BMI) on coronary heart disease and stroke, with and without adjustment for selected metabolic factors (blood pressure, serum cholesterol, and glucose)."]}
{"doc_id": 59004, "title": "", "abstract": ["Interventions related to diet that lower the intake of salt, saturated and trans fats, and processed carbohydrates, and increase the consumption of fruits, vegetables, unsaturated fats, and whole grains, can improve the metabolic risk profile even when total calories remain unchanged,47–50 but access to these interventions needs to be improved worldwide.43,51", "Interventions that reduce high blood pressure, cholesterol, and glucose might address a substantial proportion of the effect of high BMI on cardiovascular disease.", "By contrast, effective clinical and lifestyle interventions are available to control blood pressure and serum cholesterol,36–39 with evidence that these risk factors have been successfully reduced, in individual patients and whole populations.16,17,40,41", "## The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects)", "Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI."]}
{"doc_id": 59005, "title": "", "abstract": ["Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "Obesity had a significantly larger association with both coronary heart disease and stroke than did overweight: the confounder-adjusted HR of obesity versus normal weight was 1·69 (1·58–1·81) for coronary heart disease and 1·47 (1·36–1·59) for stroke.", "PERM for the association of overweight with coronary heart disease was larger than that of obesity for most combinations of mediators, but the CIs overlapped (table 3).", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators."]}
{"doc_id": 59006, "title": "", "abstract": ["Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "Obesity had a significantly larger association with both coronary heart disease and stroke than did overweight: the confounder-adjusted HR of obesity versus normal weight was 1·69 (1·58–1·81) for coronary heart disease and 1·47 (1·36–1·59) for stroke.", "Similar to analysis using continuous BMI, blood pressure was the most important mediator for the association of overweight and obesity with both coronary heart disease and stroke (table 3)."]}
{"doc_id": 59007, "title": "", "abstract": ["We recorded higher HRs per 5 kg/m2 BMI for both coronary heart disease and stroke in east and southeast Asia than HRs in western cohorts (North America, western Europe, Australia, and New Zealand; figure 2, appendix pp 73–90).", "Western European cohorts (32 cohorts) had the largest number of coronary heart disease and stroke events, contributing 31 289 (55%) of coronary heart disease and 13 591 (44%) of stroke events.", "## The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects)", "The role of blood pressure as a mediator for excess risk of coronary heart disease was similar in Asian and western cohorts (32%, 22–44 vs 30%, 26–34).", "Additional adjustment for the three metabolic risk factors reduced the HRs to 1·15 (1·12–1·18) for coronary heart disease and 1·04 (1·01–1·08) for stroke, suggesting that 46% (95% CI 42–50) of the excess risk of BMI for coronary heart disease and 76% (65–91) for stroke is mediated by these factors."]}
{"doc_id": 59008, "title": "", "abstract": ["In this pooled analysis of 97 prospective cohort studies, we estimated that nearly half of excess risk for coronary heart disease and three-quarters of excess risk for stroke due to high BMI were mediated through three metabolic risk factors: blood pressure, cholesterol, and glucose.", "The consistent stratified analysis suggested the important role of blood pressure as a mediator in the effect of BMI on stroke in Asian populations, in whom high blood pressure and large stroke burden have made this risk factor the leading cause of disease burden.16,33", "We found that about half of the excess risk of BMI on coronary heart disease and three-quarters of the excess risk of BMI on stroke was mediated by blood pressure, glucose, and cholesterol collectively.", "Blood pressure was the most important mediator for the effects of BMI on both coronary heart disease and stroke; the HR for coronary heart disease fell to 1·19 (1·16–1·22) and for stroke to 1·06 (1·03–1·09) after we adjusted for blood pressure.", "The most important mediator was blood pressure, which mediated a third of the excess risk of BMI on coronary heart disease and two-thirds for stroke."]}
{"doc_id": 59009, "title": "", "abstract": ["Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants", "In this pooled analysis of 97 prospective cohort studies, we estimated that nearly half of excess risk for coronary heart disease and three-quarters of excess risk for stroke due to high BMI were mediated through three metabolic risk factors: blood pressure, cholesterol, and glucose.", "This situation has created concerns about a potentially massive worldwide increase in cardiovascular diseases as a result of increased BMI and prevalence of overweight and obesity in most countries.13–15", "To answer this question we need a detailed understanding of how much of the effect of excess weight on cardiovascular disease is mediated by these metabolic factors, separately and in combinations, which are relevant for individual patients or populations.", "High body-mass index (BMI) is an important cardiovascular disease risk factor,2–4 and raised blood pressure, cholesterol, and glucose partly mediate its effects.5,6"]}
{"doc_id": 59010, "title": "", "abstract": ["Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "The metabolic factors also mediated more excess risk of overweight on stroke than of obesity, although the CIs overlapped (table 3).", "Obese individuals also benefit from interventions on mediators but will continue to have significantly raised risk.", "We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16)."]}
{"doc_id": 59011, "title": "", "abstract": ["Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "Similar to analysis using continuous BMI, blood pressure was the most important mediator for the association of overweight and obesity with both coronary heart disease and stroke (table 3).", "Duesseldorf Obesity Mortality Study (DOMS): Ralf Bender (IQWiG, Cologne, Germany), Silke Matthies (Department of Mathematics and Technology, RheinAhrCampus, Koblenz University of Applied Sciences, Remagen, Germany).", "Obesity had a significantly larger association with both coronary heart disease and stroke than did overweight: the confounder-adjusted HR of obesity versus normal weight was 1·69 (1·58–1·81) for coronary heart disease and 1·47 (1·36–1·59) for stroke."]}
{"doc_id": 59012, "title": "", "abstract": ["High body-mass index (BMI) is an important cardiovascular disease risk factor,2–4 and raised blood pressure, cholesterol, and glucose partly mediate its effects.5,6", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "BMI=body-mass index.", "BMI=body-mass index.", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators."]}
{"doc_id": 59013, "title": "", "abstract": ["Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades.", "Despite the potentially large benefits of weight loss, interventions have had small long-term success, especially at the population level,7,8 leading to a worldwide rise in overweight and obesity.14", "By contrast, effective clinical and lifestyle interventions are available to control blood pressure and serum cholesterol,36–39 with evidence that these risk factors have been successfully reduced, in individual patients and whole populations.16,17,40,41", "Additionally, adiposity increases the risk of diabetes, and prevalence of blood glucose and diabetes has increased worldwide.52", "This situation has created concerns about a potentially massive worldwide increase in cardiovascular diseases as a result of increased BMI and prevalence of overweight and obesity in most countries.13–15"]}
{"doc_id": 59014, "title": "", "abstract": ["## The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects)", "We obtained additional data from nine cohorts through a special request to the NHLBI and from 27 cohorts in the Asia Pacific Cohort Studies Collaboration (APCSC) through its participation in the Global Burden of Metabolic Risk Factors for Chronic Diseases Study.14–17", "We noted that metabolic factors mediate a larger proportion of the excess risk for overweight individuals than do those for obese individuals (although the 95% CIs overlapped).", "Therefore, reliance on control of the metabolic mediators might be only a partial and temporary response to the obesity epidemic.", "Despite the potentially large benefits of weight loss, interventions have had small long-term success, especially at the population level,7,8 leading to a worldwide rise in overweight and obesity.14"]}
{"doc_id": 59015, "title": "", "abstract": ["We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16).", "We analysed data from 97 prospective cohort studies to estimate the effects of high body-mass index (BMI) on coronary heart disease and stroke, with and without adjustment for selected metabolic factors (blood pressure, serum cholesterol, and glucose).", "Our results for the overall association between BMI and coronary heart disease or stroke are consistent with those of other large pooled analyses of prospective cohorts.2,3,24", "We used BMI as the main measure of adiposity because it was measured in every cohort; data for waist circumference or waist-to-hip ratio were available in 17 cohorts and were analysed in sensitivity analyses.", "A meta-analysis18 of 21 cohorts (including 16 analysed here) reported that 45% of excess risk of coronary heart disease was mediated through blood pressure and total cholesterol, compared with 39% in our analysis (both effects reported for 5 kg/m2 higher BMI)."]}
{"doc_id": 14000, "title": "", "abstract": ["Differentially expressed genes (DEGs) were characterized for each sample (|L2FC| > 1, p-adjusted-value < 0.05) and were used as query to search for enriched biological processes (Gene ontology BP) and network analysis of protein interactions using STRING (Szklarczyk et al., 2019).", "Treatment of NHBE cells with IFN-I resulted in significant induction of 381 genes, most of these also differentially expressed in IAVΔNS1 infection, together outlining a robust innate immune response in these cells (Figure 2A).", "Gene enrichment analyses were performed using STRING against the GO dataset for biological processes.", "Gene enrichment analyses were performed using STRING against the GO dataset for biological processes.", "The included genes have a log2(fold change) of more than 2 and a p-adjusted value of less than 0.05."]}
{"doc_id": 14001, "title": "", "abstract": ["In agreement with others (Harcourt et al., 2020), we found A549 lung alveolar cells to be relatively non-permissive to SARS-CoV-2 replication, in contrast to Calu-3 cells (0.1% versus 15% total reads, respectively).", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "Taken together, the data presented here suggest that the response to SARS- CoV-2 is imbalanced with regard to controlling virus replication versus activation of the adaptive immune response.", "Based on animal models, SARS-CoV-1 has been found to induce a robust cytokine response that generally shows a delay in IFN-I, culminating in improper recruitment of inflammatory monocyte-macrophage populations (Channappanavar et al., 2016).", "In addition to genes implicated in innate antiviral immunity, SARS- CoV-2 also induced robust levels of chemokines, including CCL2, CCL8, and CCL11 (Figure 4A)."]}
{"doc_id": 14002, "title": "", "abstract": ["Scatterplot of the log2(Fold Change) of individual genes in SARS- CoV-2-infected A549-ACE2 cells treated with or without Ruxolitinib.", "In this space, SARS-CoV-2 elicits the most modest transcriptional changes, followed by IAV, IFNβ treatment, and IAVΔNS1 (Figure 2B).", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "To determine whether SARS-CoV-2 is sensitive to IFN-I, we next treated cells with universal IFNβ and assessed viral levels at the RNA and protein levels (Figures S1B and S1C).", "Furthermore, qPCR analyses of these cells demonstrated that the levels of Envelope (E) and non-structural protein 14 (nsp14) were more than three orders of magnitude higher in the presence of ACE2 (Figure 1D)."]}
{"doc_id": 14003, "title": "", "abstract": ["Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "More severe cases of COVID-19 develop acute respiratory distress syndrome and acute lung injury, leading to morbidity and mortality caused by damage to the alveolar lumen leading to inflammation and pneumonia (Wolfel et al., 2020, Xu et al., 2020).", "We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C)."]}
{"doc_id": 14004, "title": "", "abstract": ["# Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "The discrepancy between the levels of viral replication and IFN production/signaling suggests that, although SARS-CoV-2 is capable of engaging the IFN-I and IFN-III systems, this response is prevented by an antagonist that is rendered ineffective under high-MOI conditions.", "We also observed no increase in viral Spike levels (or a considerable effect on viral reads) when IFN-I signaling was blocked by addition of ruxolitinib, a JAK1 and 2 kinase inhibitor, despite significantly preventing induction of ISGs (Figures S1D–S1H).", "The first is engagement of cellular antiviral defenses, which is mediated by transcriptional induction of type I and III interferons (IFN-I and IFN-III, respectively) and subsequent upregulation of IFN-stimulated genes (ISGs) (Lazear et al., 2019)."]}
{"doc_id": 14005, "title": "", "abstract": ["Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "Approximately 5 × 105 NHBE cells were infected with either SARS-CoV-2 at an MOI of 2 for 24 h or influenza A/Puerto Rico/8/1934 (H1N1) virus or influenza A/Puerto Rico/8/1934 (H1N1) virus lacking the NS1 gene at an MOI of 3 for 12 h in bronchial epithelial growth media supplemented with BEGM SingleQuots.", "In addition to the modest IFN-I response, SARS-CoV-2 in NHBE cells also triggers some unique pathways, including a response to IFN-II (which is also observed in response to IAVΔNS1), and significant enrichment in chemokine signaling (Figure 2C).", "Figure S2 Infectivity and Host Response to SARS-CoV-2 Infection in NHBE Cells, Related to Figure 2", "In general, our data show that the overall transcriptional footprint of SARS-CoV-2 infection was distinct in comparison with other highly pathogenic coronaviruses and common respiratory viruses such as IAV, HPIV3, and RSV."]}
{"doc_id": 14006, "title": "", "abstract": ["Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "The discrepancy between the levels of viral replication and IFN production/signaling suggests that, although SARS-CoV-2 is capable of engaging the IFN-I and IFN-III systems, this response is prevented by an antagonist that is rendered ineffective under high-MOI conditions.", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "In contrast, ruxolitinib treatment had a minimal effect on induction of cytokines and chemokines, indicating that the high induction of these genes in SARS-CoV-2 infection is independent of IFN-I and -III signaling (Figure S1G).", "Intriguingly, unique gene signatures from SARS-CoV-2-infected trachea that were largely absent in response to IAV align with those of progenitor cells from the hematopoietic lineage, suggesting that infection may be inducing hematopoiesis (Figures 3D and S3C) (Lefrançais et al., 2017, Yoshida et al., 2019)."]}
{"doc_id": 14007, "title": "", "abstract": ["Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "Image indicates the relative expression of SARS-CoV-2 nsp14, IFNB and tubulin transcripts in healthy human biopsies and biological replicates of lung tissue from COVID-19 patients.", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures", "Gene enrichment analysis of differentially expressed transcripts implicated two populations of immune cell signatures (Figure 3D)."]}
{"doc_id": 14008, "title": "", "abstract": ["These data demonstrate that addition of IFN-I resulted in a dramatic reduction in virus replication, in agreement with the findings of others (Lokugamage et al., 2020).", "We also observed no increase in viral Spike levels (or a considerable effect on viral reads) when IFN-I signaling was blocked by addition of ruxolitinib, a JAK1 and 2 kinase inhibitor, despite significantly preventing induction of ISGs (Figures S1D–S1H).", "In contrast, ruxolitinib treatment had a minimal effect on induction of cytokines and chemokines, indicating that the high induction of these genes in SARS-CoV-2 infection is independent of IFN-I and -III signaling (Figure S1G).", "Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "Furthermore, high-MOI infection in these cells also led to high induction of IFNs and ISGs observed for HPIV3 and RSV, despite remarkable differences in viral replication (∼60% total reads in A549-ACE2 cells compared with ∼15% in Calu-3 cells) (Figures 1A and 1F)."]}
{"doc_id": 14009, "title": "", "abstract": ["Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "In contrast, ruxolitinib treatment had a minimal effect on induction of cytokines and chemokines, indicating that the high induction of these genes in SARS-CoV-2 infection is independent of IFN-I and -III signaling (Figure S1G).", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "### SARS-CoV-2 in Primary Cells Induces a Limited IFN-I and III Response"]}
{"doc_id": 14010, "title": "", "abstract": ["### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures", "A recent study analyzing severe versus mild cases of COVID-19 showed that peripherally derived macrophages predominated in the lungs of severe cases (Liao et al., 2020).", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties."]}
{"doc_id": 14011, "title": "", "abstract": ["The raw sequencing datasets generated during this study are available on the NCBI Gene Expression Omnibus (GEO) server under the accession number GSE147507.", "All RNA-Seq data performed in this paper can be found on the NCBI Gene Expression Omnibus (GEO) under accession number GSE147507.", "Non-significant differentially expressed Genes with a |Log2(Fold Change)| > 2 are indicated in green.", "Gene enrichment analyses were performed using STRING against the GO dataset for biological processes.", "Gene enrichment analyses were performed using STRING against the GO dataset for biological processes."]}
{"doc_id": 14012, "title": "", "abstract": ["All work involving live SARS- CoV-2 was performed in the CDC/USDA-approved BSL-3 facility of the Icahn School of Medicine at Mount Sinai in accordance with institutional biosafety requirements.", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "To compare the transcriptional response of SARS-CoV-2 with other respiratory viruses, including MERS-CoV, SARS-CoV-1, human parainfluenza virus 3 (HPIV3), respiratory syncytial virus (RSV), and IAV, we first chose to focus on infection in a variety of respiratory cell lines (Figure 1 ).", "The genomes used for this study were: SARS-CoV-2 (GenBank: NC_045512.2), SARS-CoV-1 (GenBank: NC_004718.3), MERS-CoV (GenBank: NC_038294.1), HPIV3 (GenBank: Z11575.1), RSV (GenBank: NC_001803.1), IAV PR8 (GenBank: AF389115.1, AF389116.1, AF389117.1, AF389118.1, AF389119.1, AF389120.1, AF389121.1, AF389122.1) and IAV A/California/VRDL6/2010(H1N1) (GenBank: CY064994, CY064993, CY064992, CY064987, CY064990, CY064989, CY064988, CY064991).", "Image indicates the relative expression of SARS-CoV-2 nsp14, IFNB and tubulin transcripts in healthy human biopsies and biological replicates of lung tissue from COVID-19 patients."]}
{"doc_id": 14013, "title": "", "abstract": ["In agreement with others (Harcourt et al., 2020), we found A549 lung alveolar cells to be relatively non-permissive to SARS-CoV-2 replication, in contrast to Calu-3 cells (0.1% versus 15% total reads, respectively).", "Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "(C) Western blot analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2.", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "To bypass this restriction, we supplemented A549 cells with a vector expressing mCherry or ACE2 (Figures 1B–1D)."]}
{"doc_id": 14014, "title": "", "abstract": ["Figure 1 Host Transcriptional Response to Respiratory Infection in Human Lung Epithelium-Derived Cell Lines", "More severe cases of COVID-19 develop acute respiratory distress syndrome and acute lung injury, leading to morbidity and mortality caused by damage to the alveolar lumen leading to inflammation and pneumonia (Wolfel et al., 2020, Xu et al., 2020).", "A recent study analyzing severe versus mild cases of COVID-19 showed that peripherally derived macrophages predominated in the lungs of severe cases (Liao et al., 2020).", "To next determine how each of these in vitro infections alters the host transcriptional landscape, we first performed a differential expression analysis, comparing infected cell conditions with their respective mock conditions.", "We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19."]}
{"doc_id": 14015, "title": "", "abstract": ["Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "All RNA-Seq data performed in this paper can be found on the NCBI Gene Expression Omnibus (GEO) under accession number GSE147507.", "(C) Western blot analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2.", "Scatterplot of the log2(Fold Change) of individual genes in SARS- CoV-2-infected A549-ACE2 cells treated with or without Ruxolitinib."]}
{"doc_id": 14016, "title": "", "abstract": ["By day 7, despite waning levels of virus, the cytokine response continued to expand and included CCL2, CCL8, and CXCL9, among others (Figure 3B; Table S3).", "Nasal washes were collected from anesthetized ferrets challenged with influenza A/California/04/2009 (pH1N1) virus on day 7 post infection and preserved at −80°C. Trachea were collected from euthanized ferrets challenged with influenza A/Texas/71/2017 (H3N2) virus on day 3 post infection and preserved at −80°C. For SARS-CoV-2 virus infections, all naive ferrets were infected with 5 × 104 PFU of SARS-CoV-2 isolate USA-WA1/2020.", "(B) Volcano plots indicating differentially expressed genes of ferrets infected with SARS-CoV-2 or IAV for 7 days.", "Graph indicates the number of viral reads per each position of the IAV virus genome identified in RNA extracted from nasal washes of ferrets at 7 days post infection.", "With both infections, we observed very low levels of virus but a robust transcriptional response (Table S3)."]}
{"doc_id": 14017, "title": "", "abstract": ["Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "In general, our data show that the overall transcriptional footprint of SARS-CoV-2 infection was distinct in comparison with other highly pathogenic coronaviruses and common respiratory viruses such as IAV, HPIV3, and RSV.", "The original sequencing datasets for SARS-CoV-1 and MERS-CoV infections can be found on the NCBI Gene Expression Omnibus (GEO) server under the accession number GSE56192.", "In the present study, we focus on defining the host response to SARS-CoV-2 and other human respiratory viruses in cell lines, primary cell cultures, ferrets, and COVID-19 patients.", "Following the characterization of SARS-CoV-2 infection in ferrets, we next sought to correlate these results with natural human infections."]}
{"doc_id": 14018, "title": "", "abstract": ["These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020).", "More severe cases of COVID-19 develop acute respiratory distress syndrome and acute lung injury, leading to morbidity and mortality caused by damage to the alveolar lumen leading to inflammation and pneumonia (Wolfel et al., 2020, Xu et al., 2020).", "Given this dynamic, treatments for COVID-19 have less to do with the IFN response and more to do with controlling inflammation.", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease."]}
{"doc_id": 14019, "title": "", "abstract": ["In low-MOI infections (MOI, 0.2), exogenous expression of ACE2 enabled SARS-CoV-2 to replicate and comprise ∼54% of the total reads mapping more than 300× coverage across the ∼30-kb genome (Figures 1A and 1B).", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "Infections with SARS-CoV-2 were performed at an MOI of 0.2 or 2 for 24 h in DMEM supplemented with 2% FBS, 4.5 g/L D-glucose, 4 mM L-glutamine, 10 mM Non-Essential Amino Acids, 1 mM Sodium Pyruvate and 10 mM HEPES.", "Approximately 2.5 × 105 A549 cells transduced with an ACE2 Adenovector were pre-treated with 500 nM Ruxolitinib or DMSO control for 1 h in infection media before infection with SARS-CoV-2 at an MOI of 2 for 24 h."]}
{"doc_id": 14020, "title": "", "abstract": ["Image indicates the relative expression of SARS-CoV-2 nsp14, IFNB and tubulin transcripts in healthy human biopsies and biological replicates of lung tissue from COVID-19 patients.", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020)."]}
{"doc_id": 14021, "title": "", "abstract": ["Nasal washes were collected from anesthetized ferrets challenged with influenza A/California/04/2009 (pH1N1) virus on day 7 post infection and preserved at −80°C. Trachea were collected from euthanized ferrets challenged with influenza A/Texas/71/2017 (H3N2) virus on day 3 post infection and preserved at −80°C. For SARS-CoV-2 virus infections, all naive ferrets were infected with 5 × 104 PFU of SARS-CoV-2 isolate USA-WA1/2020.", "Ferrets were randomly assigned to the different treatment groups (naive, n = 2; SARS-CoV-2 infection, n = 6; IAV [pH1N1] infection, n = 2; IAV [H3N2] infection, n = 2).", "Ferrets were infected intranasally with SARS-CoV-2 or influenza A/California/04/2009 and monitored by nasal wash, which generates a small pellet of cells from the upper respiratory tract.", "Approximately 2.5 × 105 A549 cells transduced with an ACE2 Adenovector were pre-treated with 500 nM Ruxolitinib or DMSO control for 1 h in infection media before infection with SARS-CoV-2 at an MOI of 2 for 24 h.", "To this end, we chose to perform SARS-CoV-2 infections in ferrets because this has been described as an appropriate animal model (Kim et al., 2020)."]}
{"doc_id": 14022, "title": "", "abstract": ["eGFP/ GLuc-expressing human parainfluenza virus 3, strain JS (rHPIV3JS-GlucP2AeGFP) was described previously (Blanco-Melo et al., 2020).", "Differentially expressed genes (DEGs) were characterized for each sample (|L2FC| > 1, p-adjusted-value < 0.05) and were used as query to search for enriched biological processes (Gene ontology BP) and network analysis of protein interactions using STRING (Szklarczyk et al., 2019).", "D.H. was supported in part by USPHS Institutional Research Training Award T32-AI07647.", "All procedures are described in our previous study (Liu et al., 2019).", "Raw reads were aligned to the human genome (hg19) using the RNA-Seq Aligment App on Basespace (Illumina, CA), following differential expression analysis using DESeq2 (Love et al., 2014)."]}
{"doc_id": 14023, "title": "", "abstract": ["Image indicates the relative expression of SARS-CoV-2 nsp14, IFNB and tubulin transcripts in healthy human biopsies and biological replicates of lung tissue from COVID-19 patients.", "In the present study, we focus on defining the host response to SARS-CoV-2 and other human respiratory viruses in cell lines, primary cell cultures, ferrets, and COVID-19 patients.", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "Differential Gene Expression Analysis of COVID-19 Patients, Related to Figure 4:", "Following the characterization of SARS-CoV-2 infection in ferrets, we next sought to correlate these results with natural human infections."]}
{"doc_id": 14024, "title": "", "abstract": ["In general, our data show that the overall transcriptional footprint of SARS-CoV-2 infection was distinct in comparison with other highly pathogenic coronaviruses and common respiratory viruses such as IAV, HPIV3, and RSV.", "To compare the transcriptional response of SARS-CoV-2 with other respiratory viruses, including MERS-CoV, SARS-CoV-1, human parainfluenza virus 3 (HPIV3), respiratory syncytial virus (RSV), and IAV, we first chose to focus on infection in a variety of respiratory cell lines (Figure 1 ).", "Gene enrichment analyses of differentially expressed transcripts illustrate a diminished IFN-I signaling biology for SARS-CoV-2 and IAV infections (Figures 2C and 2D).", "We chose to characterize the transcriptional response to SARS-CoV-2 and determine how it compares with common respiratory viruses, including influenza A virus (IAV).", "Intriguingly, unique gene signatures from SARS-CoV-2-infected trachea that were largely absent in response to IAV align with those of progenitor cells from the hematopoietic lineage, suggesting that infection may be inducing hematopoiesis (Figures 3D and S3C) (Lefrançais et al., 2017, Yoshida et al., 2019)."]}
{"doc_id": 14025, "title": "", "abstract": ["At present, the world is suffering from a pandemic of SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19) and has a global mortality rate that remains to be determined (Wu et al., 2020, Zhu et al., 2020).", "Furthermore, qPCR analyses of these cells demonstrated that the levels of Envelope (E) and non-structural protein 14 (nsp14) were more than three orders of magnitude higher in the presence of ACE2 (Figure 1D).", "These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020).", "# Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19", "The genomes used for this study were: SARS-CoV-2 (GenBank: NC_045512.2), SARS-CoV-1 (GenBank: NC_004718.3), MERS-CoV (GenBank: NC_038294.1), HPIV3 (GenBank: Z11575.1), RSV (GenBank: NC_001803.1), IAV PR8 (GenBank: AF389115.1, AF389116.1, AF389117.1, AF389118.1, AF389119.1, AF389120.1, AF389121.1, AF389122.1) and IAV A/California/VRDL6/2010(H1N1) (GenBank: CY064994, CY064993, CY064992, CY064987, CY064990, CY064989, CY064988, CY064991)."]}
{"doc_id": 14026, "title": "", "abstract": ["Approximately 5 × 105 NHBE cells were infected with either SARS-CoV-2 at an MOI of 2 for 24 h or influenza A/Puerto Rico/8/1934 (H1N1) virus or influenza A/Puerto Rico/8/1934 (H1N1) virus lacking the NS1 gene at an MOI of 3 for 12 h in bronchial epithelial growth media supplemented with BEGM SingleQuots.", "Undifferentiated normal human bronchial epithelial (NHBE) cells (Lonza, CC-2540 Lot# 580580) were isolated from a 79-year-old Caucasian female and were maintained in bronchial epithelial growth media (Lonza, CC-3171) supplemented with BEGM SingleQuots as per the manufacturer’s instructions (Lonza, CC-4175) at 37°C and 5% CO2.", "Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "The raw sequencing data (fastq files) for the SARS-CoV-1 and MERS infections were downloaded from GEO (GSE56192, including their corresponding mock-treated controls) and processed in the same way as the rest of our experimental conditions.", "Despite a complete lack of IFN expression, the response to SARS-CoV-2 in NHBE cells still elicited a strong chemotactic and inflammatory response, indicated by expression of CCL20, CXCL1, IL-1B, IL-6, CXCL3, CXCL5, CXCL6, CXCL2, CXCL16, and TNF (Figures 2C and 2E; Table S2)."]}
{"doc_id": 14027, "title": "", "abstract": ["We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "In addition to genes implicated in innate antiviral immunity, SARS- CoV-2 also induced robust levels of chemokines, including CCL2, CCL8, and CCL11 (Figure 4A).", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures", "It is also noteworthy that two of the cytokines uniquely elevated in response to SARS-CoV-2 are IL-6 and IL1RA, suggesting that there might be a parallel between COVID-19 and cytokine release syndrome (CRS), a complication commonly seen following CAR T-cell treatment (Giavridis et al., 2018)."]}
{"doc_id": 14028, "title": "", "abstract": ["Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "### SARS-CoV-2 in Primary Cells Induces a Limited IFN-I and III Response", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "In addition to the modest IFN-I response, SARS-CoV-2 in NHBE cells also triggers some unique pathways, including a response to IFN-II (which is also observed in response to IAVΔNS1), and significant enrichment in chemokine signaling (Figure 2C)."]}
{"doc_id": 14029, "title": "", "abstract": ["Scatterplot of the log2(Fold Change) of individual genes in SARS- CoV-2-infected A549-ACE2 cells treated with or without Ruxolitinib.", "In agreement with others (Harcourt et al., 2020), we found A549 lung alveolar cells to be relatively non-permissive to SARS-CoV-2 replication, in contrast to Calu-3 cells (0.1% versus 15% total reads, respectively).", "The lack of IFN-I and -III engagement in ACE2-expressing A549 cells could, however, be overcome by using a 10-fold increase in virus (MOI, 2) despite the fact that total viral reads after 24 h of replication where comparable with low-MOI conditions (Figures 1A, 1B, and 1F).", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "Approximately 2.5 × 105 A549 cells transduced with an ACE2 Adenovector were pre-treated with 500 nM Ruxolitinib or DMSO control for 1 h in infection media before infection with SARS-CoV-2 at an MOI of 2 for 24 h."]}
{"doc_id": 14030, "title": "", "abstract": ["Gene enrichment analyses of differentially expressed transcripts illustrate a diminished IFN-I signaling biology for SARS-CoV-2 and IAV infections (Figures 2C and 2D).", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "This signature is also present in high-MOI infections of SARS-CoV-2 in A549-ACE2 and Calu-3 cells, together with more than 6,000 other differentially expressed genes, further explaining their extreme coordinates on the principal-component analysis (PCA) (Figures 1E and 1F; Table S1).", "Intriguingly, unique gene signatures from SARS-CoV-2-infected trachea that were largely absent in response to IAV align with those of progenitor cells from the hematopoietic lineage, suggesting that infection may be inducing hematopoiesis (Figures 3D and S3C) (Lefrançais et al., 2017, Yoshida et al., 2019).", "(C) Cellular profiling from a subset of genes selectively enriched in response to SARS-CoV-2 compared to IAV, as determined by the Immunological Genome Project."]}
{"doc_id": 14031, "title": "", "abstract": ["Transcriptional profiling of these samples, all derived from males older than 60 years (n = 2 for each group), demonstrated ∼2,000 differentially expressed genes with enrichment for the innate and humoral responses (Figures 4 A and S4 A).", "It is noteworthy that, despite this dramatic increase in viral load, we observed neither activation of TBK1, the kinase responsible for IFN-I and IFN-III expression, nor induction of STAT1 and MX1, IFN-I-stimulated genes (Figure S1 A; Sharma et al., 2003).", "To next determine how each of these in vitro infections alters the host transcriptional landscape, we first performed a differential expression analysis, comparing infected cell conditions with their respective mock conditions.", "Alternatively, these data may instead indicate that high-MOI conditions in cell culture result in formation of pathogen-associated molecular patterns (PAMPs), which may or may not reflect physiological conditions in vivo.", "Heatmaps of gene expression levels were constructing using heatmap.2"]}
{"doc_id": 14032, "title": "", "abstract": ["# Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19", "It is also noteworthy that two of the cytokines uniquely elevated in response to SARS-CoV-2 are IL-6 and IL1RA, suggesting that there might be a parallel between COVID-19 and cytokine release syndrome (CRS), a complication commonly seen following CAR T-cell treatment (Giavridis et al., 2018).", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "In contrast, ruxolitinib treatment had a minimal effect on induction of cytokines and chemokines, indicating that the high induction of these genes in SARS-CoV-2 infection is independent of IFN-I and -III signaling (Figure S1G).", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4)."]}
{"doc_id": 14033, "title": "", "abstract": ["Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "This dynamic seems to be in line with what we observed with SARS- CoV-2 because low levels of IFN-I and -III are likely produced in response to infection.", "The first is engagement of cellular antiviral defenses, which is mediated by transcriptional induction of type I and III interferons (IFN-I and IFN-III, respectively) and subsequent upregulation of IFN-stimulated genes (ISGs) (Lazear et al., 2019)."]}
{"doc_id": 14034, "title": "", "abstract": ["In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "More severe cases of COVID-19 develop acute respiratory distress syndrome and acute lung injury, leading to morbidity and mortality caused by damage to the alveolar lumen leading to inflammation and pneumonia (Wolfel et al., 2020, Xu et al., 2020).", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C)."]}
{"doc_id": 14035, "title": "", "abstract": ["Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "It is also noteworthy that two of the cytokines uniquely elevated in response to SARS-CoV-2 are IL-6 and IL1RA, suggesting that there might be a parallel between COVID-19 and cytokine release syndrome (CRS), a complication commonly seen following CAR T-cell treatment (Giavridis et al., 2018).", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties."]}
{"doc_id": 14036, "title": "", "abstract": ["Based on animal models, SARS-CoV-1 has been found to induce a robust cytokine response that generally shows a delay in IFN-I, culminating in improper recruitment of inflammatory monocyte-macrophage populations (Channappanavar et al., 2016).", "These data demonstrate that the overall transcriptional induction to SARS-CoV-2 is aberrant.", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "### SARS-CoV-2 in Primary Cells Induces a Limited IFN-I and III Response", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response."]}
{"doc_id": 14037, "title": "", "abstract": ["Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "In general, our data show that the overall transcriptional footprint of SARS-CoV-2 infection was distinct in comparison with other highly pathogenic coronaviruses and common respiratory viruses such as IAV, HPIV3, and RSV.", "In the present study, we focus on defining the host response to SARS-CoV-2 and other human respiratory viruses in cell lines, primary cell cultures, ferrets, and COVID-19 patients.", "The original sequencing datasets for SARS-CoV-1 and MERS-CoV infections can be found on the NCBI Gene Expression Omnibus (GEO) server under the accession number GSE56192.", "Following the characterization of SARS-CoV-2 infection in ferrets, we next sought to correlate these results with natural human infections."]}
{"doc_id": 14038, "title": "", "abstract": ["Despite a complete lack of IFN expression, the response to SARS-CoV-2 in NHBE cells still elicited a strong chemotactic and inflammatory response, indicated by expression of CCL20, CXCL1, IL-1B, IL-6, CXCL3, CXCL5, CXCL6, CXCL2, CXCL16, and TNF (Figures 2C and 2E; Table S2).", "Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4)."]}
{"doc_id": 14039, "title": "", "abstract": ["Should this be true, drugs such as tocilizumab and anakinra may prove to be beneficial for treatment of COVID-19 (Norelli et al., 2018).", "Here we compare the transcriptional response of SARS-CoV-2 with other respiratory viruses to identify transcriptional signatures that may underlie COVID-19 biology.", "(B) Semiquantitative PCR analysis of healthy and COVID-19 derived lung tissues.", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease."]}
{"doc_id": 14040, "title": "", "abstract": ["Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "The discrepancy between the levels of viral replication and IFN production/signaling suggests that, although SARS-CoV-2 is capable of engaging the IFN-I and IFN-III systems, this response is prevented by an antagonist that is rendered ineffective under high-MOI conditions.", "This dynamic seems to be in line with what we observed with SARS- CoV-2 because low levels of IFN-I and -III are likely produced in response to infection.", "### SARS-CoV-2 in Primary Cells Induces a Limited IFN-I and III Response", "Based on animal models, SARS-CoV-1 has been found to induce a robust cytokine response that generally shows a delay in IFN-I, culminating in improper recruitment of inflammatory monocyte-macrophage populations (Channappanavar et al., 2016)."]}
{"doc_id": 14041, "title": "", "abstract": ["Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "Despite a complete lack of IFN expression, the response to SARS-CoV-2 in NHBE cells still elicited a strong chemotactic and inflammatory response, indicated by expression of CCL20, CXCL1, IL-1B, IL-6, CXCL3, CXCL5, CXCL6, CXCL2, CXCL16, and TNF (Figures 2C and 2E; Table S2).", "Approximately 5 × 105 NHBE cells were infected with either SARS-CoV-2 at an MOI of 2 for 24 h or influenza A/Puerto Rico/8/1934 (H1N1) virus or influenza A/Puerto Rico/8/1934 (H1N1) virus lacking the NS1 gene at an MOI of 3 for 12 h in bronchial epithelial growth media supplemented with BEGM SingleQuots.", "Undifferentiated normal human bronchial epithelial (NHBE) cells (Lonza, CC-2540 Lot# 580580) were isolated from a 79-year-old Caucasian female and were maintained in bronchial epithelial growth media (Lonza, CC-3171) supplemented with BEGM SingleQuots as per the manufacturer’s instructions (Lonza, CC-4175) at 37°C and 5% CO2.", "In addition to the modest IFN-I response, SARS-CoV-2 in NHBE cells also triggers some unique pathways, including a response to IFN-II (which is also observed in response to IAVΔNS1), and significant enrichment in chemokine signaling (Figure 2C)."]}
{"doc_id": 14042, "title": "", "abstract": ["Differential Gene Expression Analysis of COVID-19 Patients, Related to Figure 4:", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Image indicates the relative expression of SARS-CoV-2 nsp14, IFNB and tubulin transcripts in healthy human biopsies and biological replicates of lung tissue from COVID-19 patients.", "Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction."]}
{"doc_id": 14043, "title": "", "abstract": ["Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "In addition to genes implicated in innate antiviral immunity, SARS- CoV-2 also induced robust levels of chemokines, including CCL2, CCL8, and CCL11 (Figure 4A).", "However, although IAV induces a greater number of genes, SARS-CoV-2 generates a unique gene signature enriched for cell death and leukocyte activation, including transcripts such as IL1A and CXCL8 (GO: 0008219 and GO: 0045431; Table S3).", "The first population included common markers for monocytes and lymphocytes, and the induction of these genes was comparable between SARS-CoV-2 and IAV (Figures 3D and S3C).", "In general, our data show that the overall transcriptional footprint of SARS-CoV-2 infection was distinct in comparison with other highly pathogenic coronaviruses and common respiratory viruses such as IAV, HPIV3, and RSV."]}
{"doc_id": 14044, "title": "", "abstract": ["### SARS-CoV-2 in Primary Cells Induces a Limited IFN-I and III Response", "To determine whether the limited response to SARS-CoV-2 observed so far was a by-product of cell culture, we next pursued an in vivo longitudinal study in animals.", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "Ferrets were randomly assigned to the different treatment groups (naive, n = 2; SARS-CoV-2 infection, n = 6; IAV [pH1N1] infection, n = 2; IAV [H3N2] infection, n = 2)."]}
{"doc_id": 14045, "title": "", "abstract": ["These data demonstrate that addition of IFN-I resulted in a dramatic reduction in virus replication, in agreement with the findings of others (Lokugamage et al., 2020).", "Differential Gene Expression Analysis of COVID-19 Patients, Related to Figure 4:", "(B and C) Cytokine profiles of COVID-19 patients.", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "Vero E6 cells were treated with 100 units of universal Type-I IFNB 2 h post-infection."]}
{"doc_id": 14046, "title": "", "abstract": ["We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "Given this dynamic, treatments for COVID-19 have less to do with the IFN response and more to do with controlling inflammation.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "(B and C) Cytokine profiles of COVID-19 patients."]}
{"doc_id": 14047, "title": "", "abstract": ["# Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19", "Despite virus replication, the host response to SARS-CoV-2 fails to launch a robust IFN-I and -III response while simultaneously inducing high levels of chemokines needed to recruit effector cells.", "The discrepancy between the levels of viral replication and IFN production/signaling suggests that, although SARS-CoV-2 is capable of engaging the IFN-I and IFN-III systems, this response is prevented by an antagonist that is rendered ineffective under high-MOI conditions.", "The first is engagement of cellular antiviral defenses, which is mediated by transcriptional induction of type I and III interferons (IFN-I and IFN-III, respectively) and subsequent upregulation of IFN-stimulated genes (ISGs) (Lazear et al., 2019).", "We also observed no increase in viral Spike levels (or a considerable effect on viral reads) when IFN-I signaling was blocked by addition of ruxolitinib, a JAK1 and 2 kinase inhibitor, despite significantly preventing induction of ISGs (Figures S1D–S1H)."]}
{"doc_id": 14048, "title": "", "abstract": ["Given the disparate results of our in vitro cell culture systems, we next sought to determine how normal human bronchial epithelial (NHBE) cells respond to SARS-CoV-2 infection, in contrast to treatment with IFN-I alone or infection with wild-type (WT) IAV or a mutant IAV lacking its antiviral antagonist (IAVΔNS1) (Figure 2 ).", "In addition to the modest IFN-I response, SARS-CoV-2 in NHBE cells also triggers some unique pathways, including a response to IFN-II (which is also observed in response to IAVΔNS1), and significant enrichment in chemokine signaling (Figure 2C).", "Figure S2 Infectivity and Host Response to SARS-CoV-2 Infection in NHBE Cells, Related to Figure 2", "Approximately 5 × 105 NHBE cells were infected with either SARS-CoV-2 at an MOI of 2 for 24 h or influenza A/Puerto Rico/8/1934 (H1N1) virus or influenza A/Puerto Rico/8/1934 (H1N1) virus lacking the NS1 gene at an MOI of 3 for 12 h in bronchial epithelial growth media supplemented with BEGM SingleQuots.", "NHBE cells were treated with 100 units of human IFNβ as indicated."]}
{"doc_id": 14049, "title": "", "abstract": ["Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties."]}
{"doc_id": 14050, "title": "", "abstract": ["Interestingly, low-MOI SARS-CoV-2-infected A549 cells expressing ACE2 (A549-ACE2) show no significant IFN-I or IFN-III expression but instead display moderate levels of a subset of ISGs and a unique proinflammatory cytokine signature (Figure 1F).", "This signature is also present in high-MOI infections of SARS-CoV-2 in A549-ACE2 and Calu-3 cells, together with more than 6,000 other differentially expressed genes, further explaining their extreme coordinates on the principal-component analysis (PCA) (Figures 1E and 1F; Table S1).", "(D) qRT-PCR analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2 (MOI, 0.2).", "One exception to this observation is the response to high-MOI infection in A549-ACE2 and Calu-3 cells, where replication was robust and an IFN-I and -III signature could be observed.", "(C) Western blot analysis of mCherry- or ACE2-expressing A549 cells infected with SARS-CoV-2."]}
{"doc_id": 14051, "title": "", "abstract": ["In addition to the modest IFN-I response, SARS-CoV-2 in NHBE cells also triggers some unique pathways, including a response to IFN-II (which is also observed in response to IAVΔNS1), and significant enrichment in chemokine signaling (Figure 2C).", "Transcriptional activation of IRFs and NF-κB results in the launch of two general antiviral programs.", "Despite a complete lack of IFN expression, the response to SARS-CoV-2 in NHBE cells still elicited a strong chemotactic and inflammatory response, indicated by expression of CCL20, CXCL1, IL-1B, IL-6, CXCL3, CXCL5, CXCL6, CXCL2, CXCL16, and TNF (Figures 2C and 2E; Table S2).", "Gene enrichment analyses of differentially expressed transcripts illustrate a diminished IFN-I signaling biology for SARS-CoV-2 and IAV infections (Figures 2C and 2D).", "Engagement of virus-specific RNA structures culminates in oligomerization of these receptors and activation of downstream transcription factors, most notably interferon regulator factors (IRFs) and nuclear factor κB (NF-κB) (Hur, 2019)."]}
{"doc_id": 79000, "title": "", "abstract": ["Directly linking IRX3 expression with regulation of body mass and composition, Irx3-deficient mice exhibit a 25–30% reduction in body weight, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue.", "Our human eQTL data suggest that the obesity-associated SNPs are associated with IRX3 expression in brain.", "This difference becomes more pronounced if animals were subjected to a high-fat diet (HFD), with Irx3KO animals showing no significant body weight gain, contrasting to a 63% increase in control animals (Fig. 3a, b).", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO.", "Next, we exploited animal models to determine a potential role for IRX3 expression in the regulation of BMI and/or metabolism."]}
{"doc_id": 79001, "title": "", "abstract": ["Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Here, we show that the obesity-associated noncoding sequences within FTO are functionally connected, at megabase distances, with the homeobox gene IRX3.", "Having uncovered evidence of direct looping between FTO intronic regions and IRX3, we next showed that enhancers within the obesity-associated interval possess functional characteristics compatible with IRX3 expression.", "Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type-2 diabetes (T2D) 1–3."]}
{"doc_id": 79002, "title": "", "abstract": ["Together, our data support the notion that the hypothalamic expression of Irx3 regulates energy homeostasis and body composition.", "Directly linking IRX3 expression with regulation of body mass and composition, Irx3-deficient mice exhibit a 25–30% reduction in body weight, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Having uncovered evidence of direct looping between FTO intronic regions and IRX3, we next showed that enhancers within the obesity-associated interval possess functional characteristics compatible with IRX3 expression.", "Furthermore, long-range enhancers within this region recapitulate aspects of IRX3 expression, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3."]}
{"doc_id": 79003, "title": "", "abstract": ["Our data suggest that the regulatory landscape of IRX3 spreads over megabase distances, whereas FTO expression is primarily regulated by regions proximal to its promoter.", "Our human eQTL data suggest that the obesity-associated SNPs are associated with IRX3 expression in brain.", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO.", "Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "In contrast, a 2.8-kb region corresponding to the IRX3 promoter does not recapitulate any of the endogenous expression patterns of IRX3, suggesting that IRX3 expression relies on long-range cis-regulatory elements."]}
{"doc_id": 79004, "title": "", "abstract": ["Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO.", "Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "Importantly, Fto expression was not altered in Irx3KO hypothalamus or PWAT, suggesting that the lean phenotype of Irx3KO mice is not associated with Fto (Fig. 3f).", "Under these models, our data support the notion that the broad expression patterns of FTO are primarily regulated by elements proximal to the promoter, and that IRX3 is endowed with an ancient, extensive cis-regulatory circuitry extending into FTO."]}
{"doc_id": 79005, "title": "", "abstract": ["Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "Multiple follow-up studies directly implicated FTO as a gene controlling body mass and composition.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Directly linking IRX3 expression with regulation of body mass and composition, Irx3-deficient mice exhibit a 25–30% reduction in body weight, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue.", "While our data represent the first demonstration of the intersection of IRX3 biology with body mass composition and metabolism, previous work identified IRX3 overexpression in adipocytes as a hallmark of the molecular switch seen in patients after profound weight loss following bariatric surgery26."]}
{"doc_id": 79006, "title": "", "abstract": ["b, Hi-C data previously generated{Jin, 2013 #49} in human IMR-90 (fetal lung) cells.", "In those cases in which the nearest gene differs from the anchor gene, we propose that the anchor gene be used as the putative target and additional experimentation as shown in this work should be performed to precisely determine which is the target gene for the GWAS-affected regulatory element.", "Gene expression assay was conducted using SYBR Green methods on Viia7 (Applied Biosystems), and relative Ct values were normalized by β-actin.", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO.", "These observations have direct implication on how to interpret the associations characterized for thousands of noncoding variants with human disease and related quantitative traits."]}
{"doc_id": 79007, "title": "", "abstract": ["GWAS identified SNPs that might affect non-coding regulatory elements that, by their turn, regulate specific target genes.", "The hg19 GWAS catalog from the UCSC Genome browser was downloaded and the tagging SNPs contained in GRBs with more than 1 gene (making SNP assigning doubtful) were kept for further annotation.", "The nearest gene was considered to be the RefSeq gene whose transcription start site was the nearest, or the gene where the SNP is contained.", "Obesity-associated SNPs from the National Human Genome Research Institute (NHGRI) GWAS catalog are shown above, in green, demonstrating why this LD block is considered to define the “association interval.", "We profiled the genomic interactions with promoters of genes located within a megabase window around the obesity-associated SNPs (mm9, chr8:93,725,000–94,725,000), including Fto and Rpgrip1l, and Irx3, a half-megabase downstream."]}
{"doc_id": 79008, "title": "", "abstract": ["Together, these data posit that the obesity-associated FTO intron is mediating functional interactions with IRX3 in the human, mouse, and zebrafish genomes.", "We confirmed these interactions between Irx3 and the Fto obesity-associated region using chromatin conformation capture (3C) in adult mouse brains (Extended Data Fig. 2c).", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "In marked contrast, the promoter of Irx3 participates in numerous long-range interactions across a broad genomic region encompassing nearly 2 megabases, including robust interactions with the obesity-associated interval within FTO (Fig. 1a).", "Having uncovered evidence of direct looping between FTO intronic regions and IRX3, we next showed that enhancers within the obesity-associated interval possess functional characteristics compatible with IRX3 expression."]}
{"doc_id": 79009, "title": "", "abstract": ["The obesity- associated FTO region directly interacts with the promoters of IRX3 as well as FTO in the human, mouse, and zebrafish genomes.", "We confirmed these interactions between Irx3 and the Fto obesity-associated region using chromatin conformation capture (3C) in adult mouse brains (Extended Data Fig. 2c).", "In marked contrast, the promoter of Irx3 participates in numerous long-range interactions across a broad genomic region encompassing nearly 2 megabases, including robust interactions with the obesity-associated interval within FTO (Fig. 1a).", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Having uncovered evidence of direct looping between FTO intronic regions and IRX3, we next showed that enhancers within the obesity-associated interval possess functional characteristics compatible with IRX3 expression."]}
{"doc_id": 79010, "title": "", "abstract": ["Yet, no direct connection between the obesity-associated variants and FTO expression or function has been made 7–9.", "Lacking, however, is direct evidence that enhancers within the obesity-associated FTO introns are connected with regulation of FTO expression.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Scuteri A, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.", "Gerken T, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase."]}
{"doc_id": 79011, "title": "", "abstract": ["Toward that end, expression quantitative trait locus (eQTL) analyses have systematically failed to show association between the obesity- associated SNPs and FTO expression in human tissues 7–9.", "Our human eQTL data suggest that the obesity-associated SNPs are associated with IRX3 expression in brain.", "Gamazon ER, et al. Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants.", "E.R.G and N.J.C. performed eQTL analyses.", "Under these models, our data support the notion that the broad expression patterns of FTO are primarily regulated by elements proximal to the promoter, and that IRX3 is endowed with an ancient, extensive cis-regulatory circuitry extending into FTO."]}
{"doc_id": 79012, "title": "", "abstract": ["Furthermore, hypothalamic expression of a dominant negative form of Irx3 reproduces the metabolic phenotypes of Irx3-deficient mice.", "Directly linking IRX3 expression with regulation of body mass and composition, Irx3-deficient mice exhibit a 25–30% reduction in body weight, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue.", "hypothalamus-specific dominant negative Irx3 mice recapitulate the metabolic phenotype of Irx3 deficient mice", "We observed a 25–30% reduction of body weight in Irx3KO mice compared to control littermates (wild-type; WT), independent of gender (Fig. 3a and Extended Data Fig. 6a, b and 7a, b).", "To investigate a possible role of Irx3 expression in the hypothalamus mediating the body composition and energy homeostasis phenotypes in Irx3KO mice, we utilized Rosa26EnR-Irx3 conditional transgenic mice expressing a dominant negative form of Irx3 (EnR-Irx3) by crossing with Ins2-Cre (Extended Data Fig. 9a, b)23,25."]}
{"doc_id": 79013, "title": "", "abstract": ["Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO.", "It is the aggregate of our data on chromatin looping, patterns of in vivo enhancer function, human eQTL mapping and mouse model data that collectively place IRX3 as an important target gene of the genetic association with human obesity.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Together, these data posit that the obesity-associated FTO intron is mediating functional interactions with IRX3 in the human, mouse, and zebrafish genomes."]}
{"doc_id": 79014, "title": "", "abstract": ["Lacking, however, is direct evidence that enhancers within the obesity-associated FTO introns are connected with regulation of FTO expression.", "Church C, et al. Overexpression of Fto leads to increased food intake and results in obesity.", "Scuteri A, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.", "Toward that end, expression quantitative trait locus (eQTL) analyses have systematically failed to show association between the obesity- associated SNPs and FTO expression in human tissues 7–9.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition."]}
{"doc_id": 79015, "title": "", "abstract": ["We observe more than 150 genomic regulatory blocks, similar to that containing FTO and IRX3, overlapping with noncoding SNPs associated with human disease and complex traits in GWAS (Methods and Supplementary Table 5), highlighting the need for a careful experimental pipeline to define the target gene(s) for each disease- associated noncoding SNP.", "Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type-2 diabetes (T2D) 1–3.", "Scuteri A, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.", "Obesity-associated variants within FTO form long-range functional connections with IRX3", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition."]}
{"doc_id": 79016, "title": "", "abstract": ["Obesity-associated variants within FTO form long-range functional connections with IRX3", "Here, we show that the obesity-associated noncoding sequences within FTO are functionally connected, at megabase distances, with the homeobox gene IRX3.", "We profiled the genomic interactions with promoters of genes located within a megabase window around the obesity-associated SNPs (mm9, chr8:93,725,000–94,725,000), including Fto and Rpgrip1l, and Irx3, a half-megabase downstream.", "Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition."]}
{"doc_id": 79017, "title": "", "abstract": ["30.", "GWAS identified SNPs that might affect non-coding regulatory elements that, by their turn, regulate specific target genes.", "Individuals homozygous for risk alleles of the associated SNPs weigh approximately 3 kilograms more than individuals homozygous for non-risk alleles, underscoring the significant phenotypic impact of these common variants 2.", "In contrast, a 2.8-kb region corresponding to the IRX3 promoter does not recapitulate any of the endogenous expression patterns of IRX3, suggesting that IRX3 expression relies on long-range cis-regulatory elements.", "We extracted the p-values for those SNPs in the locus with significant association (p<0.05) with IRX3 or FTO expression in adipose or cerebellum."]}
{"doc_id": 79018, "title": "", "abstract": ["These observations have direct implication on how to interpret the associations characterized for thousands of noncoding variants with human disease and related quantitative traits.", "3C assays were performed as referred in27.", "### 3C", "Nearly one third (2,166; 29%) of gene knock- outs in mice show alteration of these phenotypes, underscoring that animal models alone are not sufficient to definitively establish a functional relationship between a given gene and long-range noncoding variants (Supplementary Table 4).", "### Primers used for 3C experiments"]}
{"doc_id": 64000, "title": "", "abstract": ["By utilizing a mammalian expression vector (phCMV1) driven by a CMV promoter and by adding two tandem repeats of the Maltose Binding Protein (designated 2XMBP) to the N-terminus of human BRCA2 (470 kDa including the two MBP tags), we expressed significant amounts of protein that could be purified to near homogeneity (Fig. 1a and Supplementary Fig. 2).", "Human BRCA2 cDNA was cloned into phCMV1 with two repeats of (MBP) at the N-terminus.", "We found that 2XMBP-BRCA2 fully complemented brca2 mutant (VC8) cells (Fig. 1b, Supplementary Fig. 3); therefore, the tag was not removed for the studies reported here.", "We incubated BRCA2 with several purified candidate proteins and used the MBP tag to capture the complexes on amylose beads, and analyze the complexes on SDS-PAGE gels stained with SyproOrange, (Fig. 1c, d).", "Hereafter, we refer to the N-terminal 2XMBP-tagged version of full length BRCA2 as BRCA2."]}
{"doc_id": 64001, "title": "", "abstract": ["When RPA was replaced by SSB, BRCA2 could still stimulate DNA strand exchange by RAD51 (Fig. 4d, and Supplementary Fig. 11b, right panel), implying that neither BRCA2 nor RAD51 need to interact directly with the ssDNA binding proteins,.", "In contrast, when substituted for BRCA2, neither human RAD52 nor yeast Rad52 stimulated DNA strand exchange by RAD51 when the ssDNA was complexed with RPA (Supplementary Fig. 12).", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended.", "An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands.", "RAD51 plays a central role in recombination, assembling onto single-stranded DNA (ssDNA) as a nucleoprotein filament, and catalyzing the invasion and exchange of homologous DNA sequences8,9."]}
{"doc_id": 64002, "title": "", "abstract": ["By utilizing a mammalian expression vector (phCMV1) driven by a CMV promoter and by adding two tandem repeats of the Maltose Binding Protein (designated 2XMBP) to the N-terminus of human BRCA2 (470 kDa including the two MBP tags), we expressed significant amounts of protein that could be purified to near homogeneity (Fig. 1a and Supplementary Fig. 2).", "Hereafter, we refer to the N-terminal 2XMBP-tagged version of full length BRCA2 as BRCA2.", "Human BRCA2 cDNA was cloned into phCMV1 with two repeats of (MBP) at the N-terminus.", "We incubated BRCA2 with several purified candidate proteins and used the MBP tag to capture the complexes on amylose beads, and analyze the complexes on SDS-PAGE gels stained with SyproOrange, (Fig. 1c, d).", "We found that 2XMBP-BRCA2 fully complemented brca2 mutant (VC8) cells (Fig. 1b, Supplementary Fig. 3); therefore, the tag was not removed for the studies reported here."]}
{"doc_id": 64003, "title": "", "abstract": ["When RPA was replaced by SSB, BRCA2 could still stimulate DNA strand exchange by RAD51 (Fig. 4d, and Supplementary Fig. 11b, right panel), implying that neither BRCA2 nor RAD51 need to interact directly with the ssDNA binding proteins,.", "BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "In contrast, when substituted for BRCA2, neither human RAD52 nor yeast Rad52 stimulated DNA strand exchange by RAD51 when the ssDNA was complexed with RPA (Supplementary Fig. 12).", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended.", "The capability of BRCA2 to accelerate displacement of RPA by RAD51 without the need for a ssDNA/dsDNA junction has some parallels to yeast Rad52 (yRad52)37–39, but human RAD52 lacks this ability to stimulate RPA replacement40."]}
{"doc_id": 64004, "title": "", "abstract": ["Our findings show that BRCA2 is a key mediator of homologous recombination, and they provide a molecular basis for understanding how this DNA repair process is disrupted by BRCA2 mutations, which lead to chromosomal instability and cancer.", "Prior studies utilizing fragments of BRCA2, fusions of the BRC repeats with the DNA-binding domain (DBD) of BRCA2, and analysis of the Ustilago maydis and Caenorhabditis elegans orthologues, Brh2 and BRC-2 respectively, have provided a framework for understanding the mediator role that BRCA2 plays in DSB repair by RAD51-driven homologous recombination15–23 (see Supplementary Fig. 1 for a model based on this report and the work referenced above).", "Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "Purified human BRCA2 stimulates RAD51-mediated recombination", "In addition, our results show that BRCA2 prevents or slows the assembly of RAD51 onto duplex DNA, an aspect of RAD51 filament assembly that impairs recombination reactions."]}
{"doc_id": 64005, "title": "", "abstract": ["RAD51 plays a central role in recombination, assembling onto single-stranded DNA (ssDNA) as a nucleoprotein filament, and catalyzing the invasion and exchange of homologous DNA sequences8,9.", "Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands.", "Inhibition of ATPase activity was also observed for the C. elegans proteins (RAD51 and BRC-2)23, but not for the U. maydis orthologues (Rad51 and Brh2)17 or the E. coli analogues (RecA and RecFOR)36, suggesting that this mechanism of stimulating RAD51 function is a late adaption of multicellular organisms.", "Purified human BRCA2 stimulates RAD51-mediated recombination"]}
{"doc_id": 64006, "title": "", "abstract": ["## BRCA2 recruits RAD51 onto ssDNA complexed with RPA", "BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "Here we report purification of full length BRCA2 and show that it both binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA).", "Taken together with the results of the previous section, these data support the idea that BRCA2 recruits RAD51 to ssDNA, likely by virtue of its affinity for ssDNA, and inhibits assembly of RAD51 onto dsDNA.", "This capability permits the BRCA2-facilitated loading of RAD51 in both the 5’→3’ and 3’→5’ directions."]}
{"doc_id": 64007, "title": "", "abstract": ["An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands.", "Our results reveal the biochemical functions of full length human BRCA2, and they establish that BRCA2 augments the functions of RAD51 that are essential for recombinational repair of DNA breaks (Supplementary Fig. 1).", "Thus, in vertebrates, these functions have separated: BRCA2 targets RAD51 to ssDNA to mediate DNA strand invasion into a duplex donor to produce joint molecules by a distinctive mechanism, whereas RAD52 anneals RPA-ssDNA complexes in steps or pathways of recombinational repair that could include second-end capture in DSB repair, single-strand annealing (SSA), and synthesis-dependent strand annealing.", "Taken together, these data show that BRCA2 and human RAD52 have assumed divergent roles in mammalian cells.", "Although most models for BRCA2 function have focused on DSB repair, we note that these characteristics are also consistent and suggestive of a role for BRCA2 in the recombinational repair of DNA gaps that occur during DNA replication due to damage in the template (Supplementary Fig. 1b)."]}
{"doc_id": 64008, "title": "", "abstract": ["Prior work utilizing a human BRCA2 polypeptide fusion and U. maydis Brh2 demonstrated the ability of those proteins to promote RAD51 filament formation onto RPA-coated ssDNA15,17.", "BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "Yet RAD52 cannot stimulate the assembly of RAD51 onto ssDNA complexed with RPA40 (Supplementary Fig. 12), but BRCA2 can.", "To optimize filament formation on the ssDNA, BRCA2 and RAD51 were incubated with the 3’ tailed ssDNA first, and then the dsDNA was added to initiate the reaction (Fig. 3d); however, the excess free RAD51 binds the dsDNA partner and inhibits the reaction (Supplementary Fig. 8b, lane 1).", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended."]}
{"doc_id": 64009, "title": "", "abstract": ["Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "Prior work utilizing a human BRCA2 polypeptide fusion and U. maydis Brh2 demonstrated the ability of those proteins to promote RAD51 filament formation onto RPA-coated ssDNA15,17.", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended.", "BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands."]}
{"doc_id": 64010, "title": "", "abstract": ["BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "BRCA2 stimulates DNA strand exchange promoted by RAD51", "Our results reveal the biochemical functions of full length human BRCA2, and they establish that BRCA2 augments the functions of RAD51 that are essential for recombinational repair of DNA breaks (Supplementary Fig. 1).", "BRCA2 acts by: targeting RAD51 to ssDNA over double-stranded DNA; enabling RAD51 to displace Replication protein-A (RPA) from ssDNA; and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis.", "Here we report purification of full length BRCA2 and show that it both binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA)."]}
{"doc_id": 64011, "title": "", "abstract": ["BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "These results suggest that the same mechanism for RAD51 nucleoprotein filament stabilization ascribed to the BRC repeats applies to BRCA221: namely, full length BRCA2 stabilizes the RAD51 bound to the ssDNA substrate by down-regulating its ATPase activity, an activity which is used to inactivate and turnover the RAD51 protein; however, quantitatively, this control is achieved at much lower concentrations of BRCA2 than the BRC repeats.", "Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "Because the rate-limiting step in RAD51 nucleoprotein filament assembly is nucleation of the first several monomers of the filament45–47, BRCA2 can act catalytically to stabilize a nucleus by blocking RAD51 self-inactivation and dissociation via its ATPase activity."]}
{"doc_id": 64012, "title": "", "abstract": ["In contrast, when substituted for BRCA2, neither human RAD52 nor yeast Rad52 stimulated DNA strand exchange by RAD51 when the ssDNA was complexed with RPA (Supplementary Fig. 12).", "The capability of BRCA2 to accelerate displacement of RPA by RAD51 without the need for a ssDNA/dsDNA junction has some parallels to yeast Rad52 (yRad52)37–39, but human RAD52 lacks this ability to stimulate RPA replacement40.", "BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "Thus, in vertebrates, these functions have separated: BRCA2 targets RAD51 to ssDNA to mediate DNA strand invasion into a duplex donor to produce joint molecules by a distinctive mechanism, whereas RAD52 anneals RPA-ssDNA complexes in steps or pathways of recombinational repair that could include second-end capture in DSB repair, single-strand annealing (SSA), and synthesis-dependent strand annealing.", "Prior work utilizing a human BRCA2 polypeptide fusion and U. maydis Brh2 demonstrated the ability of those proteins to promote RAD51 filament formation onto RPA-coated ssDNA15,17."]}
{"doc_id": 64013, "title": "", "abstract": ["It is notable that the lack of polarity in human BRCA2 function differs from analogs such as RecFOR and Brh2, which load RecA and U. maydis Rad51, respectively, specifically onto the 3’ overhanging ssDNA17,36.", "In contrast to U. maydis Brh217 and the E. coli analog, RecFOR36, which show a strict specificity to act at a 3’ ssDNA overhang, stimulation of DNA strand exchange by human BRCA2 was the same for 3’ versus 5’ tailed DNA (Fig. 4b, compare lanes 3–8 and 11–16, and 4c).", "Inhibition of ATPase activity was also observed for the C. elegans proteins (RAD51 and BRC-2)23, but not for the U. maydis orthologues (Rad51 and Brh2)17 or the E. coli analogues (RecA and RecFOR)36, suggesting that this mechanism of stimulating RAD51 function is a late adaption of multicellular organisms.", "Also another important role of the multi-functional yRad52, and bacterial RecO, is the annealing of complementary ssDNA that is bound by the cognate ssDNA- binding protein41,42; both the U. maydis and C. elegans BRCA2 orthologues can anneal ssDNA in the presence of RPA23,43.", "BRCA2 did not appreciably bind the E. coli homolog, RecA, (Fig. 1c, lane 7) showing that interaction did not extend to the evolutionary distant bacterial protein."]}
{"doc_id": 64014, "title": "", "abstract": ["RAD51 plays a central role in recombination, assembling onto single-stranded DNA (ssDNA) as a nucleoprotein filament, and catalyzing the invasion and exchange of homologous DNA sequences8,9.", "An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands.", "Purified human BRCA2 stimulates RAD51-mediated recombination", "To promote this process, RAD51 must assemble onto the 3’ ssDNA tails generated by resection of DNA breaks.", "RAD51 was subsequently introduced in the presence or absence of BRCA2, and finally, the labeled duplex DNA was added to start the reaction."]}
{"doc_id": 64015, "title": "", "abstract": ["Our findings show that BRCA2 is a key mediator of homologous recombination, and they provide a molecular basis for understanding how this DNA repair process is disrupted by BRCA2 mutations, which lead to chromosomal instability and cancer.", "Prior studies utilizing fragments of BRCA2, fusions of the BRC repeats with the DNA-binding domain (DBD) of BRCA2, and analysis of the Ustilago maydis and Caenorhabditis elegans orthologues, Brh2 and BRC-2 respectively, have provided a framework for understanding the mediator role that BRCA2 plays in DSB repair by RAD51-driven homologous recombination15–23 (see Supplementary Fig. 1 for a model based on this report and the work referenced above).", "Although most models for BRCA2 function have focused on DSB repair, we note that these characteristics are also consistent and suggestive of a role for BRCA2 in the recombinational repair of DNA gaps that occur during DNA replication due to damage in the template (Supplementary Fig. 1b).", "Here we report purification of full length BRCA2 and show that it both binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA).", "Given that BRCA2 facilitates growth of the filament in either polarity from internal ssDNA regions or from either junction, BRCA2 could readily contribute to daughter strand DNA gap repair as well as DSB repair."]}
{"doc_id": 64016, "title": "", "abstract": ["The capability of BRCA2 to accelerate displacement of RPA by RAD51 without the need for a ssDNA/dsDNA junction has some parallels to yeast Rad52 (yRad52)37–39, but human RAD52 lacks this ability to stimulate RPA replacement40.", "In contrast, when substituted for BRCA2, neither human RAD52 nor yeast Rad52 stimulated DNA strand exchange by RAD51 when the ssDNA was complexed with RPA (Supplementary Fig. 12).", "BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended.", "BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing."]}
{"doc_id": 42000, "title": "", "abstract": ["Recently, increased awareness of GI problems in ASD has been noted12, 178 and the findings of this review suggest that GI abnormalities in ASD may be related, in part, to mitochondrial dysfunction.", "Two studies reported significant correlations between markers of mitochondrial dysfunction and autism severity.", "A comprehensive literature search was performed to collate evidence of mitochondrial dysfunction in autism spectrum disorders (ASDs) with two primary objectives.", "Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis", "Over the past decade, evidence has accumulated that some individuals with ASD have concomitant mitochondrial dysfunction, and some have proposed a ‘mitochondrial autism' subgroup.25"]}
{"doc_id": 42001, "title": "", "abstract": ["Several studies suggested that treatment with mitochondrial cofactor supplementation, including antioxidants, co-enzyme Q10, carnitine and B-vitamins may improve mitochondrial function and behavior in some children with ASD.", "A limited number of studies reported various improvements in children with ASD and mitochondrial dysfunction with certain treatments.", "Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis", "Several other antioxidants, including vitamin C,236 carnosine237 and galantamine238, 239, 240 have also been reported to significantly improve autistic behaviors.", "A comprehensive literature search was performed to collate evidence of mitochondrial dysfunction in autism spectrum disorders (ASDs) with two primary objectives."]}
{"doc_id": 42002, "title": "", "abstract": ["Population variability, as indexed by the F-value, was significantly greater in the ASD group as compared with the control group for all biochemical markers of mitochondrial dysfunction except ubiquinone, with the difference particularly marked for pyruvate.", "We also found that there is a rather high prevalence of abnormal values in direct (that is, lactate, pyruvate and lactate-to-pyruvate ratio) and indirect (that is, carnitine, ammonia, CK and AST) biochemical markers of mitochondrial dysfunction in the general population of children with ASD, and that children with ASD, as a group, have significantly abnormal values for direct (that is, lactate, pyruvate and ubiquinone) and indirect (that is, carnitine) biochemical markers of mitochondrial dysfunction compared with controls.", "Such a notion is consistent with many of the findings in this review, including the much higher prevalence of abnormal biochemical markers of mitochondrial dysfunction as compared with the prevalence of MD in the general ASD population, and the particularly high variability in biochemical markers of mitochondrial dysfunction in the general ASD population.", "The prevalence of abnormal biomarker values of mitochondrial dysfunction was high in ASD, much higher than the prevalence of MD.", "Indirect biochemical markers of mitochondrial dysfunction also appear to be abnormal in the general ASD population with a much higher prevalence than the aforementioned direct biomarkers (see Table 1)."]}
{"doc_id": 42003, "title": "", "abstract": ["Given the association between ASD and mitochondrial dysfunction, it is possible that mitochondrial dysfunction might have a role in the development, pathogenesis or severity of ASD.", "Given the high energy demands of both the GI tract and cerebrovascular endothelium, mitochondrial dysfunction may also contribute to barrier dysfunction in the brain and GI tract in ASD.", "Further studies are needed to determine the role of mitochondrial dysfunction in barrier dysfunction, lipid abnormalities, GI dysfunction and seizure activity in ASD.", "This finding suggests that abnormal calcium signaling contributes to AGC dysfunction in the brains of some individuals with ASD and may lead to mitochondrial dysfunction.", "Additional studies are needed to further define the role of mitochondrial dysfunction in ASD."]}
{"doc_id": 42004, "title": "", "abstract": ["| Studies| Total N| Overall prevalence| Minimum (%)| Maximum (%)   ---|---|---|---|---|---   General ASD population   Mitochondrial disease in ASD| 3| 536| 5.0% (3.2%, 6.9%)| 3.6| 9.1", "This systematic review and meta-analysis found that abnormal biochemical markers of mitochondrial function are relatively common in the general population of children with ASD and that a relatively high percentage of children with ASD (∼5%) have MD.", "However, this 5% prevalence is most likely an underestimate of the true prevalence of MD in individuals with ASD since these studies excluded children from testing for MD who had either normal lactate or medical disorders potentially related to mitochondrial dysfunction.", "The prevalence of abnormal biomarker values of mitochondrial dysfunction was high in ASD, much higher than the prevalence of MD.", "Meta-analysis of three studies115, 132, 145 indicated that the prevalence of MD in ASD was 5.0% (95% CI 3.2, 6.9%), which is significantly higher than found in the general population (∼0.01%),47 indicating that an association between ASD and MD is likely, at least in a subgroup of individuals with ASD.25"]}
{"doc_id": 42005, "title": "", "abstract": ["Although the effects of the environment on mitochondrial dysfunction are becoming increasingly recognized,223 and environmental pollutants, particularly environmental mercury, have been associated with an increased likelihood of ASD in epidemiological studies,202, 203, 204 the mechanism of such environmental toxicants for increasing the risk of ASD has not been well studied in vivo.", "Identification and longitudinal evaluation of the development of such individuals will allow investigators to better understand how mitochondrial dysfunction may be related to the development of ASD.", "Interestingly, some investigators have suggested that mtDNA deletions reported in some children with ASD may be secondary to elevated levels of ROS caused by environmental factors.146", "These findings suggest that mitochondria from children with ASD may be more vulnerable to damage from environmental toxicants than mitochondria from typically developing children.35", "Several metabolic abnormalities and/or exposures to environmental toxicants could result in secondary mitochondrial dysfunction in children with ASD, or these factors could worsen mild mitochondrial dysfunction in some children, transforming mild dysfunction into more severe dysfunction."]}
{"doc_id": 42006, "title": "", "abstract": ["We also found that there is a rather high prevalence of abnormal values in direct (that is, lactate, pyruvate and lactate-to-pyruvate ratio) and indirect (that is, carnitine, ammonia, CK and AST) biochemical markers of mitochondrial dysfunction in the general population of children with ASD, and that children with ASD, as a group, have significantly abnormal values for direct (that is, lactate, pyruvate and ubiquinone) and indirect (that is, carnitine) biochemical markers of mitochondrial dysfunction compared with controls.", "Lactate was by far the most commonly studied biochemical marker of mitochondrial dysfunction in ASD.", "Despite the lack of information that was derived from published reports, these biomarkers should be strongly considered when screening for MD in children with ASD because abnormal alanine is a recognized marker of MD54 and ammonia, ubiquinone and an acyl-carnitine panel can help identify mitochondrial dysfunction when lactate is not elevated.57, 228, 229", "Biochemical markers of mitochondrial dysfunction described in the literature include direct (lactate, pyruvate, lactate-to-pyruvate ratio, ubiquinone, alanine, alanine-to-lysine ratio and acyl-carnitine) and indirect markers (creatine kinase (CK), carnitine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and ammonia).25, 29, 54, 56, 57", "However, it is difficult to determine the utility of certain biomarkers (alanine, ammonia, carnitine, ubiquinone, alanine-to-lysine ratio and acyl-carnitine panel) for identifying mitochondrial dysfunction in the general population of children with ASD because the number of reports describing these biomarkers in ASD/MD was limited."]}
{"doc_id": 42007, "title": "", "abstract": ["Overall, this evidence supports the notion that mitochondrial dysfunction is associated with ASD.", "Several animal models of ASD reported mitochondrial dysfunction.", "Several animal models of ASD exhibit mitochondrial dysfunction.", "Although many of the studies included in this review have limitations, their cumulative findings suggest that there is evidence for mitochondrial dysfunction in ASD, or at the least, in a subset of children with ASD.", "Given the association between ASD and mitochondrial dysfunction, it is possible that mitochondrial dysfunction might have a role in the development, pathogenesis or severity of ASD."]}
{"doc_id": 42008, "title": "", "abstract": ["Taken together, these findings suggest children with ASD have a spectrum of mitochondrial dysfunction of differing severity.", "Studies were initially included if they (1) involved individuals with ASD, and (2) reported at least one finding that could indicate mitochondrial dysfunction.", "Biochemical abnormalities reported in some children with ASD could contribute to secondary mitochondrial dysfunction.", "We reviewed all studies that included children with ASD and presented biochemical markers that could indicate mitochondrial dysfunction.", "Additionally, as mitochondria have an important role in lipid metabolism, previous reports of abnormalities in lipid metabolism180, 181 and lipid peroxidation182 in some individuals with ASD could be due to mitochondrial dysfunction."]}
{"doc_id": 42009, "title": "", "abstract": ["Increased ROS can impair mitochondrial function36, 190 and may be particularly significant in individuals with ASD because they have been shown, as a group, to be under higher oxidative stress and have reduced levels of antioxidants as compared with controls.35, 110, 130, 185, 186, 187, 188, 189, 191", "These studies suggest that some individuals with ASD manifest increased oxidative stress that may originate from mitochondrial dysfunction.", "Additionally, factors that increase ROS production (such as, environmental toxicants, infections and autoimmune disease) can directly and indirectly lead to impairments in ETC activity,27, 37, 38 deplete GSH,37 and activate mitochondrial and non- mitochondrial-dependent biochemical cascades that result in programmed cell death (apoptosis).39", "Abnormal calcium signaling, which has been implicated in ASD,212, 213 may also contribute to secondary mitochondrial dysfunction.26, 214", "For example, an imbalance in the excitatory (glutamatergic) and inhibitory (GABAergic) neurotransmitter systems has been implicated in the pathogenesis of ASD, with a relative increase in the glutamatergic neurotransmitter system.198"]}
{"doc_id": 42010, "title": "", "abstract": ["Although the effects of the environment on mitochondrial dysfunction are becoming increasingly recognized,223 and environmental pollutants, particularly environmental mercury, have been associated with an increased likelihood of ASD in epidemiological studies,202, 203, 204 the mechanism of such environmental toxicants for increasing the risk of ASD has not been well studied in vivo.", "In this context, exposures to environmental toxicants could contribute to secondary mitochondrial dysfunction in some children with ASD.9, 201", "Several metabolic abnormalities and/or exposures to environmental toxicants could result in secondary mitochondrial dysfunction in children with ASD, or these factors could worsen mild mitochondrial dysfunction in some children, transforming mild dysfunction into more severe dysfunction.", "Clearly, mitochondrial function is a ripe area of research when investigating the biological mechanism(s) of action of environmental toxicant exposures and indigenous abnormalities associated with ASD.", "For example, in vitro exposure to diesel exhaust particles has been shown to inhibit mitochondrial function,80 and elevated environmental concentrations of diesel exhaust particles have been associated with ASD.202"]}
{"doc_id": 42011, "title": "", "abstract": ["Several metabolic abnormalities and/or exposures to environmental toxicants could result in secondary mitochondrial dysfunction in children with ASD, or these factors could worsen mild mitochondrial dysfunction in some children, transforming mild dysfunction into more severe dysfunction.", "Mitochondrial dysfunction is the most common metabolic abnormality associated with ASD.115, 177", "Neuroimaging studies have also reported abnormalities in biomarkers of energy metabolism in children with ASD.", "This systematic review and meta-analysis found that abnormal biochemical markers of mitochondrial function are relatively common in the general population of children with ASD and that a relatively high percentage of children with ASD (∼5%) have MD.", "Mitochondrial dysfunction can lead to reduced synaptic neurotransmitter release, and neurons that have high firing rates, such as GABAergic interneurons, may be the most adversely affected.27"]}
{"doc_id": 42012, "title": "", "abstract": ["In this context, mitochondrial dysfunction could worsen a vulnerable system that is already under oxidative stress, resulting in an increase in the formation of ROS.", "As increased ROS can cause further damage to already damaged mitochondria and can directly impair mitochondrial function,190 adding mitochondrial dysfunction to a metabolic system that is already under high oxidative stress can result in the initiation of a vicious cycle that progressively impairs cellular function, leading to neurodegeneration, regression or failure of cognitive systems to properly develop.27", "Additionally, factors that increase ROS production (such as, environmental toxicants, infections and autoimmune disease) can directly and indirectly lead to impairments in ETC activity,27, 37, 38 deplete GSH,37 and activate mitochondrial and non- mitochondrial-dependent biochemical cascades that result in programmed cell death (apoptosis).39", "Increased ROS can impair mitochondrial function36, 190 and may be particularly significant in individuals with ASD because they have been shown, as a group, to be under higher oxidative stress and have reduced levels of antioxidants as compared with controls.35, 110, 130, 185, 186, 187, 188, 189, 191", "GSH depletion is associated with impaired mitochondrial function73 and increased ROS production.36"]}
{"doc_id": 42013, "title": "", "abstract": ["This systematic review and meta-analysis found that abnormal biochemical markers of mitochondrial function are relatively common in the general population of children with ASD and that a relatively high percentage of children with ASD (∼5%) have MD.", "Surprisingly, only a relatively modest percentage (21%) of children with ASD/MD had a genetic abnormality that might account for mitochondrial dysfunction.", "However, this 5% prevalence is most likely an underestimate of the true prevalence of MD in individuals with ASD since these studies excluded children from testing for MD who had either normal lactate or medical disorders potentially related to mitochondrial dysfunction.", "In addition, in these two studies, 19%115 to 43%132 of ASD children with an elevated lactate were found to have MD when fully assessed; this finding reflects the specificity of lactate for identifying MD in ASD and the variability in the yield of MD workups in various clinics.", "It is notable that children with ASD/MD demonstrated a relatively high prevalence of motor delay (51%), regression (52%), fatigue/lethargy (54%), ataxia (58%) and GI abnormalities (74%)."]}
{"doc_id": 42014, "title": "", "abstract": ["Several studies suggested that treatment with mitochondrial cofactor supplementation, including antioxidants, co-enzyme Q10, carnitine and B-vitamins may improve mitochondrial function and behavior in some children with ASD.", "Treatment studies for ASD/MD were limited, although improvements were noted in some studies with carnitine, co-enzyme Q10 and B-vitamins.", "Other environmental toxicants that inhibit mitochondrial function and have been associated with ASD include mercury,76, 77, 202, 203, 204 lead,78, 205, 206, 207 cadmium,79, 202 polychlorinated biphenyls81, 208 and pesticides.83, 209, 210, 211", "Two chromosomal abnormalities were reported to be associated with ASD/MD: two children had an inverted duplication of 15q11–q13140, and one child had a deletion in 5q14.3.150", "Overall, this evidence supports the notion that mitochondrial dysfunction is associated with ASD."]}
{"doc_id": 42015, "title": "", "abstract": ["Meta-analysis of three studies115, 132, 145 indicated that the prevalence of MD in ASD was 5.0% (95% CI 3.2, 6.9%), which is significantly higher than found in the general population (∼0.01%),47 indicating that an association between ASD and MD is likely, at least in a subgroup of individuals with ASD.25", "The prevalence of MD in the general population of ASD was 5.0% (95% confidence interval 3.2, 6.9%), much higher than found in the general population (∼0.01%).", "The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/MD compared with the general ASD population.", "Such a notion is consistent with many of the findings in this review, including the much higher prevalence of abnormal biochemical markers of mitochondrial dysfunction as compared with the prevalence of MD in the general ASD population, and the particularly high variability in biochemical markers of mitochondrial dysfunction in the general ASD population.", "Our analysis indicated that the prevalence of regression was significantly higher in children with ASD/MD as compared with the general population of children with ASD (52 vs 25%)."]}
{"doc_id": 42016, "title": "", "abstract": ["Clearly, mitochondrial function is a ripe area of research when investigating the biological mechanism(s) of action of environmental toxicant exposures and indigenous abnormalities associated with ASD.", "Other reported causes of secondary mitochondrial dysfunction include: certain medications;29, 59, 60 enteric short chain fatty acids, such as propionic acid;61, 62, 63, 64, 65 elevated concentrations of tumor necrosis factor-α66, 67, 68 cerebral folate deficiency;69, 70 malnutrition;71 heme, vitamin B6, or iron deficiencies;72 elevated NO;73, 74, 75 GSH deficiency;73 oxidative stress;36 or exposure to environmental toxicants, such as heavy metals,76, 77, 78, 79 chemicals,80 polychlorinated biphenyls81 or pesticides.82, 83", "In vitro studies with limited sample sizes have identified mitochondrial dysfunction, lower mitochondrial GSH reserve and higher mitochondrial oxidative stress in the cells of individuals with ASD compared with controls.", "One case series reported several mitochondrial histological abnormalities, including variations in muscle fiber size, regenerating fibers, atrophic fibers, muscle inflammation, increased myofiber lipid content and reduced cytochrome oxidase staining.25", "Further studies are needed to determine the role of mitochondrial dysfunction in barrier dysfunction, lipid abnormalities, GI dysfunction and seizure activity in ASD."]}
{"doc_id": 42017, "title": "", "abstract": ["We also found that there is a rather high prevalence of abnormal values in direct (that is, lactate, pyruvate and lactate-to-pyruvate ratio) and indirect (that is, carnitine, ammonia, CK and AST) biochemical markers of mitochondrial dysfunction in the general population of children with ASD, and that children with ASD, as a group, have significantly abnormal values for direct (that is, lactate, pyruvate and ubiquinone) and indirect (that is, carnitine) biochemical markers of mitochondrial dysfunction compared with controls.", "Variances and mean values of many mitochondrial biomarkers (lactate, pyruvate, carnitine and ubiquinone) were significantly different between ASD and controls.", "The prevalence of abnormal biomarker values of mitochondrial dysfunction was high in ASD, much higher than the prevalence of MD.", "Carnitine also had a high prevalence of being abnormal in ASD and was significantly depressed in the general ASD population as compared with controls.", "Almost one-third of children with ASD had elevations in lactate and/or the lactate-to-pyruvate ratio, while the prevalence of pyruvate and alanine elevation was lower."]}
{"doc_id": 42018, "title": "", "abstract": ["Neuroimaging, in vitro and post-mortem brain studies were consistent with an elevated prevalence of mitochondrial dysfunction in ASD.", "In vitro studies with limited sample sizes have identified mitochondrial dysfunction, lower mitochondrial GSH reserve and higher mitochondrial oxidative stress in the cells of individuals with ASD compared with controls.", "This finding suggests that abnormal calcium signaling contributes to AGC dysfunction in the brains of some individuals with ASD and may lead to mitochondrial dysfunction.", "These studies support the notion that some individuals with ASD manifest mitochondrial dysfunction and compensatory mechanisms for such dysfunction.", "Additionally, as mitochondria have an important role in lipid metabolism, previous reports of abnormalities in lipid metabolism180, 181 and lipid peroxidation182 in some individuals with ASD could be due to mitochondrial dysfunction."]}
{"doc_id": 42019, "title": "", "abstract": ["This systematic review and meta-analysis found that abnormal biochemical markers of mitochondrial function are relatively common in the general population of children with ASD and that a relatively high percentage of children with ASD (∼5%) have MD.", "The prevalence of abnormal biomarker values of mitochondrial dysfunction was high in ASD, much higher than the prevalence of MD.", "Such a notion is consistent with many of the findings in this review, including the much higher prevalence of abnormal biochemical markers of mitochondrial dysfunction as compared with the prevalence of MD in the general ASD population, and the particularly high variability in biochemical markers of mitochondrial dysfunction in the general ASD population.", "Indirect biochemical markers of mitochondrial dysfunction also appear to be abnormal in the general ASD population with a much higher prevalence than the aforementioned direct biomarkers (see Table 1).", "This is consistent with the notion that a subgroup of ASD children has abnormal mitochondrial biomarker values or that the range of biochemical marker values of mitochondrial dysfunction is much larger for the ASD population in general, suggesting that children with ASD might have a spectrum of mitochondrial dysfunction."]}
{"doc_id": 42020, "title": "", "abstract": ["Neuroimaging, in vitro and post-mortem brain studies were consistent with an elevated prevalence of mitochondrial dysfunction in ASD.", "In one small controlled study, post-mortem brain oxidized (carbonylated) mitochondrial protein content was nonsignificantly (P=0.12) elevated by threefold in the ASD group compared with controls with four of six (67%) ASD brains demonstrating large elevations.101", "The prevalence of abnormal biomarker values of mitochondrial dysfunction was high in ASD, much higher than the prevalence of MD.", "In vitro studies with limited sample sizes have identified mitochondrial dysfunction, lower mitochondrial GSH reserve and higher mitochondrial oxidative stress in the cells of individuals with ASD compared with controls.", "Although many of the studies included in this review have limitations, their cumulative findings suggest that there is evidence for mitochondrial dysfunction in ASD, or at the least, in a subset of children with ASD."]}
{"doc_id": 42021, "title": "", "abstract": ["mtDNA depletion and deletions were reported in three49, 142, 145 and five individuals with ASD/MD,139 respectively.", "However, when specific mtDNA mutations have been investigated in the general ASD population, very few individuals with mutations have been found.", "For example, one study of 810 individuals with ASD that searched for mtDNA mutations (A3243A>G, T8993T>G, T8993T>C and A8344A>G) only identified two individuals (0.2%) with a mutation affecting tRNA (A3243A>G).135", "Table 4 reviews the mtDNA abnormalities reported in ASD/MD, including mtDNA depletion, mutations and deletions.", "Recently, this mouse model was reported to have abnormal mitochondrial morphology and a partial oxidative phosphorylation defect in complex III in the hippocampal region.171"]}
{"doc_id": 42022, "title": "", "abstract": ["Neuroimaging studies have also reported abnormalities in biomarkers of energy metabolism in children with ASD.", "We also included animal models of ASD with abnormal energy pathways.", "Several animal models of ASD reported abnormalities in energy metabolism.", "Meta-analysis of three studies115, 132, 145 indicated that the prevalence of MD in ASD was 5.0% (95% CI 3.2, 6.9%), which is significantly higher than found in the general population (∼0.01%),47 indicating that an association between ASD and MD is likely, at least in a subgroup of individuals with ASD.25", "Several metabolic abnormalities and/or exposures to environmental toxicants could result in secondary mitochondrial dysfunction in children with ASD, or these factors could worsen mild mitochondrial dysfunction in some children, transforming mild dysfunction into more severe dysfunction."]}
{"doc_id": 42023, "title": "", "abstract": ["Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis", "Several studies suggested that treatment with mitochondrial cofactor supplementation, including antioxidants, co-enzyme Q10, carnitine and B-vitamins may improve mitochondrial function and behavior in some children with ASD.", "Two studies reported significant correlations between markers of mitochondrial dysfunction and autism severity.", "Finally, some studies reported specific treatments for mitochondrial dysfunction in ASD.", "A comprehensive literature search was performed to collate evidence of mitochondrial dysfunction in autism spectrum disorders (ASDs) with two primary objectives."]}
{"doc_id": 42024, "title": "", "abstract": ["Several metabolic abnormalities and/or exposures to environmental toxicants could result in secondary mitochondrial dysfunction in children with ASD, or these factors could worsen mild mitochondrial dysfunction in some children, transforming mild dysfunction into more severe dysfunction.", "Biochemical abnormalities reported in some children with ASD could contribute to secondary mitochondrial dysfunction.", "Indeed, it is becoming apparent that many children with ASD have associated underlying medical comorbidities, such as epilepsy, sleep disruption, mitochondrial dysfunction and gastrointestinal (GI) abnormalities.8, 9, 10, 11, 12, 13", "Although many of the studies included in this review have limitations, their cumulative findings suggest that there is evidence for mitochondrial dysfunction in ASD, or at the least, in a subset of children with ASD.", "Given the association between ASD and mitochondrial dysfunction, it is possible that mitochondrial dysfunction might have a role in the development, pathogenesis or severity of ASD."]}
{"doc_id": 42025, "title": "", "abstract": ["These studies suggest that some individuals with ASD manifest increased oxidative stress that may originate from mitochondrial dysfunction.", "Overall, this evidence supports the notion that mitochondrial dysfunction is associated with ASD.", "In vitro studies with limited sample sizes have identified mitochondrial dysfunction, lower mitochondrial GSH reserve and higher mitochondrial oxidative stress in the cells of individuals with ASD compared with controls.", "Although many of the studies included in this review have limitations, their cumulative findings suggest that there is evidence for mitochondrial dysfunction in ASD, or at the least, in a subset of children with ASD.", "A therapeutic trial of mitochondrial cofactors and antioxidants may be reasonable in children with ASD/MD given the fact that: (a) oxidative stress is associated with impaired mitochondrial function;190 (b) antioxidant supplementation in individuals with MD increases GSH levels;235 (c) mitochondria are dependent on cytosolic GSH production;34, 35 and (d) these compounds are generally recognized as safe.9"]}
{"doc_id": 49000, "title": "", "abstract": ["However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "While these data do not support a prokinetic/antikinetic dichotomy in direct versus indirect pathways, they are consistent with other models postulating that the coordinated activation of both pathways is important for action selection, or for precise timing of basal ganglia output12,13,24.", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement."]}
{"doc_id": 49001, "title": "", "abstract": ["According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "Since SPN activity during action generation can depend on the direction and acceleration/speed of the movement, as well as the motivational state of the animal4,23, we compared activity during four frequent types of actions in the operant box that were roughly equivalent in acceleration and speed (Supplementary Fig. 13) but had different directions and different motivational goals (initiating bout of operant presses after magazine entry, or approaching the magazine after a pressing bout, Fig. 4a, Supplementary movie 1).", "Future studies aimed at examining the changes in activity of direct- and indirect-pathway SPNs during basal ganglia disease should shed light onto the origin of the motor symptoms associated with basal ganglia dysfunction.", "To examine the relationship between activity in direct- and indirect-pathway SPNs and specific self-paced voluntary actions we measured GCAMP3 fluorescence while mice performed a lever-pressing operant task.", "However, both direct- and indirect-pathway SPNs were more active during ‘active’ states, and quiet during ‘inactive’ states, as shown by the frequency of GCAMP3 transients during these states (Fig. 3a-d)."]}
{"doc_id": 49002, "title": "", "abstract": ["Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "We aligned the GCAMP3 fluorescence signal to the first video frame that showed movement in each action, and observed that both direct- and indirect- pathway SPNs in the left striatum showed strongest activation during rightward movement - ‘LL to M’ (first column in Fig. 4b,c) and ‘M to RL’ (last column in Fig. 4b,c), irrespective of motivational state.", "GCAMP3 fluorescence showed transient time-locked increases during the initiation of the session (chamber illumination and lever extension), with a similar temporal profile in both direct and indirect pathways in all animals tested (Fig. 2a-d); which is consistent with previous studies showing that SPNs respond to visual and auditory stimuli22."]}
{"doc_id": 49003, "title": "", "abstract": ["Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "To examine the relationship between activity in direct- and indirect-pathway SPNs and specific self-paced voluntary actions we measured GCAMP3 fluorescence while mice performed a lever-pressing operant task.", "Typically during an operant session, animals’ behavior was organized in bouts of lever-pressing and magazine-checking (operationally labeled here as active states) separated by quiet intervals when the mice were not executing operant actions (inactive states) (Fig. 3a,b)."]}
{"doc_id": 49004, "title": "", "abstract": ["Excitatory inputs to striatum arise from cortical and thalamic structures, while striatal inhibitory output diverges, with some neurons projecting directly to basal ganglia output nuclei (striatonigral SPNs) and others to intermediate nuclei (striatopallidal SPNs), giving rise to the direct and the indirect pathways that propagate throughout the basal ganglia6,7.", "Others suggest that coordinated activity of direct and indirect pathway is critical for the appropriate timing/synchrony of basal ganglia circuits during movement12,13.", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "We developed a novel in-vivo method that allowed us to specifically measure direct- and indirect-pathway SPN activity using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCAMP3 in the dorsal striatum of D1-Cre (direct-pathway specific6,7) and A2A-Cre (indirect-pathway specific8,9) mice10.", "The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum5,6 \\- the so-called direct and indirect pathways - have opposing effects on movement: while activity of direct-pathway SPNs purportedly facilitates movement, activity of indirect-pathway SPNs inhibits movement1,2."]}
{"doc_id": 49005, "title": "", "abstract": ["To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "The Plexon system records all the behavioral event timestamps and can be used for simultaneous electrophysiological recording when needed.", "The behavior/control module also sends out commands to synchronize the TCSPC system and the Plexon system so the acquired fluorescence signal can be precisely aligned with the recorded behavior events (temporal shifts ± 10 ms).", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving."]}
{"doc_id": 49006, "title": "", "abstract": ["The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum5,6 \\- the so-called direct and indirect pathways - have opposing effects on movement: while activity of direct-pathway SPNs purportedly facilitates movement, activity of indirect-pathway SPNs inhibits movement1,2.", "If the direct and indirect pathways exert opposing effects on movement, as proposed in the classical model, we should expect to observe a higher frequency of transients in direct-pathway SPNs during ‘active’ states, and increased transient frequency in indirect-pathway SPNs during ‘inactive’ states.", "This model has been difficult to test due to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals.", "Some propose, for example, that activation of the direct pathway could facilitate output of the desired motor programs while activation of the indirect pathway would inhibit competing motor programs3,4,11.", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement."]}
{"doc_id": 49007, "title": "", "abstract": ["According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "While these data do not support a prokinetic/antikinetic dichotomy in direct versus indirect pathways, they are consistent with other models postulating that the coordinated activation of both pathways is important for action selection, or for precise timing of basal ganglia output12,13,24.", "Although we observed some behavior-related activation when transients were aligned to individual actions (e.g. magazine entries or lever presses, Supplementary Figure 14), the strongest phasic activation occurred before the initiation of a set of actions or action sequences (Fig. 3e,f), consistent with previous studies25.", "Thus, a feature of the technique used here is that it reflects the average activity of specific neural populations, and hence activation of a small number of neurons during particular behaviors may not be easily detected compared to the coordinated activity of large numbers of neurons."]}
{"doc_id": 49008, "title": "", "abstract": ["The use of deep brain-inserted fiber optics in freely moving mice allowed us to monitor changes in the fluorescence intensity of a GECI reflecting intracellular calcium transients in specific subgroups of SPNs that control voluntary actions.", "To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "Optical measurement of neural activity-dependent fluorescence changes in direct- and indirect-pathway SPNs in freely moving mice", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive."]}
{"doc_id": 49009, "title": "", "abstract": ["In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "Thus, self-paced movement initiation towards the contralateral side is associated with co-activation of both direct and indirect pathways.", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs."]}
{"doc_id": 49010, "title": "", "abstract": ["Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements, and predicted the occurrence of specific movements within 500 ms.", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "Although the predominant model proposes an ‘opposing’ scheme primarily based on the polarity of neural transmission in these two pathways and their final convergence onto basal ganglia output nuclei2, more recent models propose coordinated activation of both pathways during action selection."]}
{"doc_id": 49011, "title": "", "abstract": ["Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements, and predicted the occurrence of specific movements within 500 ms.", "In contrast, non- selective global activation of an entire population of indirect-pathway SPNs26,27,28 would likely inhibit most motor programs and not only unwanted ones, leading to bradykinesia.", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation"]}
{"doc_id": 49012, "title": "", "abstract": ["The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum5,6 \\- the so-called direct and indirect pathways - have opposing effects on movement: while activity of direct-pathway SPNs purportedly facilitates movement, activity of indirect-pathway SPNs inhibits movement1,2.", "Although the predominant model proposes an ‘opposing’ scheme primarily based on the polarity of neural transmission in these two pathways and their final convergence onto basal ganglia output nuclei2, more recent models propose coordinated activation of both pathways during action selection.", "If the direct and indirect pathways exert opposing effects on movement, as proposed in the classical model, we should expect to observe a higher frequency of transients in direct-pathway SPNs during ‘active’ states, and increased transient frequency in indirect-pathway SPNs during ‘inactive’ states.", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "Our data on indirect-pathway SPNs may appear to be at odds with recent studies showing that optical activation of indirect-pathway SPNs decreases locomotion25, and ablating26 or disrupting the function27 of indirect-pathway SPNs increases locomotion."]}
{"doc_id": 49013, "title": "", "abstract": ["In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "If anything, this feature would predict that if only a small percentage of indirect-pathway SPNs are active during movement initiation we would not be able to detect them, and if a large proportion of neurons are active when the animal is not moving we would detect them (and the converse for the direct-pathway SPNs).", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "We aligned the GCAMP3 fluorescence signal to the first video frame that showed movement in each action, and observed that both direct- and indirect- pathway SPNs in the left striatum showed strongest activation during rightward movement - ‘LL to M’ (first column in Fig. 4b,c) and ‘M to RL’ (last column in Fig. 4b,c), irrespective of motivational state."]}
{"doc_id": 49014, "title": "", "abstract": ["To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "We developed a novel in-vivo method that allowed us to specifically measure direct- and indirect-pathway SPN activity using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCAMP3 in the dorsal striatum of D1-Cre (direct-pathway specific6,7) and A2A-Cre (indirect-pathway specific8,9) mice10.", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "To achieve Cre-dependent expression of GCAMP3 in direct- and indirect-pathway SPNs, AAV vectors containing FlEx-GCAMP3 (AAV2/9.hSynap.Flex.GCaMP3.3.SV40, made by Penn Vector Core, lot# V2178, titer 1.26E+13 GC/ml) were micro- injected unilaterally into the left or right dorsal striatum by stereotaxic surgery.", "We checked the GCAMP3 signals in vivo at different time points after virus injection."]}
{"doc_id": 49015, "title": "", "abstract": ["The use of deep brain-inserted fiber optics in freely moving mice allowed us to monitor changes in the fluorescence intensity of a GECI reflecting intracellular calcium transients in specific subgroups of SPNs that control voluntary actions.", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "Optical measurement of neural activity-dependent fluorescence changes in direct- and indirect-pathway SPNs in freely moving mice", "Author Contributions R.M.C. and S.S.V. conceived the original idea of using the TCSPC technique for optical measurements in freely moving mice."]}
{"doc_id": 49016, "title": "", "abstract": ["However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "These data call into question the predominant model of basal ganglia function postulating more activity in the direct pathway during movement, and increased activity in the indirect pathway during immobility.", "If the direct and indirect pathways exert opposing effects on movement, as proposed in the classical model, we should expect to observe a higher frequency of transients in direct-pathway SPNs during ‘active’ states, and increased transient frequency in indirect-pathway SPNs during ‘inactive’ states.", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive."]}
{"doc_id": 49017, "title": "", "abstract": ["We developed a novel in-vivo method that allowed us to specifically measure direct- and indirect-pathway SPN activity using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCAMP3 in the dorsal striatum of D1-Cre (direct-pathway specific6,7) and A2A-Cre (indirect-pathway specific8,9) mice10.", "In summary, we developed a new in-vivo fiber optic technique for monitoring the activity of specific cell types deep in the brain, and provided the first definitive evidence showing that direct- and indirect-pathway striatal neurons are co-activated during movement initiation, and are inactive when the animal was not moving.", "To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "Using fiber optics and time-correlated single photon counting (TCSPC) in mice performing an operant task, we observed transient increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive.", "This model has been difficult to test due to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals."]}
{"doc_id": 49018, "title": "", "abstract": ["Finally, we showed that activity in both pathways predicted the occurrence of specific movements within 500 ms of transient initiation.", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "Both direct- and indirect-pathway SPNs showed strong activation immediately before and during contraversive movement", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs."]}
{"doc_id": 49019, "title": "", "abstract": ["To circumvent these issues and achieve optical recording of neural activity from striatum in freely moving animals, we developed an in vivo photometry method using time-correlated single photon counting (TCSPC)-based fiber optics.", "This model has been difficult to test due to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals.", "Optical measurement of neural activity-dependent fluorescence changes in direct- and indirect-pathway SPNs in freely moving mice", "However, current in-vivo imaging methods are not ideal for exploring the activity of subcortical structures in freely moving animals due to limitations in the penetration depth (<1mm) and the general requirement for head-restraint during measurement20.", "The use of deep brain-inserted fiber optics in freely moving mice allowed us to monitor changes in the fluorescence intensity of a GECI reflecting intracellular calcium transients in specific subgroups of SPNs that control voluntary actions."]}
{"doc_id": 49020, "title": "", "abstract": ["We aligned the GCAMP3 fluorescence signal to the first video frame that showed movement in each action, and observed that both direct- and indirect- pathway SPNs in the left striatum showed strongest activation during rightward movement - ‘LL to M’ (first column in Fig. 4b,c) and ‘M to RL’ (last column in Fig. 4b,c), irrespective of motivational state.", "Thus for in vivo GCAMP3 measurements included in this study, we used animals that received virus injection at least two months before the measurements.", "We checked the GCAMP3 signals in vivo at different time points after virus injection.", "We developed a novel in-vivo method that allowed us to specifically measure direct- and indirect-pathway SPN activity using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCAMP3 in the dorsal striatum of D1-Cre (direct-pathway specific6,7) and A2A-Cre (indirect-pathway specific8,9) mice10.", "We evoked action potentials via either current injection through the patch pipette or via synaptic stimulation and measured GCAMP3 fluorescence with a sCMOS camera (Supplementary Figs 10, 11; Supplementary Movies 2, 3) and the same TCSPC-based fiber probes we used in vivo (Supplementary Fig. 12)."]}
{"doc_id": 71000, "title": "", "abstract": ["We therefore conclude that continued virus replication contributes to the viral reservoir.", "These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "Here we show that virus evolution and trafficking between tissue compartments continues in patients with undetectable levels of virus in their bloodstream.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "The temporally and compartmentally sampled data show that viral lineages continue to diverge in well-suppressed patients and help explain the persistence of infectious viral reservoirs with scant decay of the virus pool35."]}
{"doc_id": 71001, "title": "", "abstract": ["Models differing in assumptions on mutation rate and effective population size were run for 100 million generations each and compared using the Bayes factor as implemented in Tracer version 1.6.", "The best-fit model included a strict molecular clock and assumed a constant population size, though a model with a relaxed molecular clock gave qualitatively similar results (data not shown).", "We determined that the best-fit model included a strict molecular clock and assumed a constant population size.", "Even if multiple populations are transmitted and are able to establish infection and co-circulate, Bayesian phylodynamics models can properly account for it, and estimate evolutionary rates accurately.", "The high degree of concordance between technical replicates validated our approach for the computational characterization of the viral populations, which is robust with respect to experimental error and stochastic effect20."]}
{"doc_id": 71002, "title": "", "abstract": ["We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "We therefore conclude that continued virus replication contributes to the viral reservoir.", "Persistent HIV-1 replication maintains the tissue reservoir during therapy", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39."]}
{"doc_id": 71003, "title": "", "abstract": ["Consistent with ongoing replication rather than sampling of different virus populations in lymph nodes, viral sequences contemporaneously sampled from lymphoid tissue and blood showed a similar degree of divergence.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "We compared the proportion of substitutions per site (p-distance) for haplotypes within lymph node or blood from each subject at 6 months to the most common haplotype present at day 0.", "To infer evolutionary patterns and population dynamic processes from the time- structured sequence data, we used a Bayesian statistical framework that estimates the substitution rate, divergence time, and demographic history of the sampled viral lineages to structure-rooted, time-resolved phylogenies27,28 (see Methods).", "Ongoing replication is considered unlikely because neither viral genetic divergence over time, nor the emergence of drug resistance mutations have been convincingly documented9,10."]}
{"doc_id": 71004, "title": "", "abstract": ["Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "Persistent HIV-1 replication maintains the tissue reservoir during therapy", "These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "We therefore conclude that continued virus replication contributes to the viral reservoir."]}
{"doc_id": 71005, "title": "", "abstract": ["From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our findings explain the failure of treatment intensification to fully suppress de novo infection and highlight issues surrounding the barriers to delivering antiretroviral drugs at clinically effective concentrations in the infectious viral reservoir.", "As earlier studies only examined viral sequences derived from the blood of patients who continued to suppress viral replication in that anatomic compartment11, the conclusions are not necessarily generalizable to other compartments in the body, particularly to lymphoid tissue where the frequency of infection per cell is mostly higher12 and the intracellular drug concentrations are much lower than in blood13.", "Whilst combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral replication in lymphoid tissue reservoirs.", "These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy."]}
{"doc_id": 71006, "title": "", "abstract": ["We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Consistent with ongoing replication rather than sampling of different virus populations in lymph nodes, viral sequences contemporaneously sampled from lymphoid tissue and blood showed a similar degree of divergence.", "Previous work established that viral sequences contemporaneously sampled from lymphoid tissue in different locations are genetically homogeneous17, consistent with CD4+ T cell homing and trafficking18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue."]}
{"doc_id": 71007, "title": "", "abstract": ["Equally, they cannot repopulate the larger, main compartment where drug concentrations preclude any ongoing replication.", "Though probabilistic models suggest (and this model allows) production of partially drug-resistant strains, any which arise cannot populate the sanctuary site because of low drug penetration and competition from drug- sensitive strains.", "To minimize biased amplification of the target sequence, primer locations in the Gag and Pol regions of HIV-1 were selected on the basis of the alignment positional entropy in the multiple sequences aligned from the Los Alamos National Laboratory HIV-1 sequence database (http://www.hiv.lanl.gov/).", "The dynamic nature of the viral population in lymphoid tissue sanctuaries, where infected cells can still produce new viruses, infect new target cells and replenish the pool, undermines previous estimates of the time necessary to purge the reservoir of latently infected cells and achieve virus eradication3.", "The relative amount of HIV-1 target DNA was normalized to the quantification cycle for a concentration calibrator by using an external standard curve of serial 10-fold dilutions of reference DNA for the Gag region of HIV-1 derived from the plasmid pNL-43."]}
{"doc_id": 71008, "title": "", "abstract": ["From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "Whilst combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral replication in lymphoid tissue reservoirs.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "Achieving optimal cellular pharmacokinetics and spatial distribution of antiretroviral drugs in lymphoid tissue to fully suppress viral replication and preserve immune function is, therefore, a prerequisite to the elimination of the viral reservoir and ultimately a cure for HIV-1 infection."]}
{"doc_id": 71009, "title": "", "abstract": ["Ongoing replication is considered unlikely because neither viral genetic divergence over time, nor the emergence of drug resistance mutations have been convincingly documented9,10.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "Intermittent virus production from reactivation of a small proportion of latently infected CD4+ T cells (rather than low levels of ongoing replication) is thought to drive viral rebound detected in blood of well-suppressed patients on treatment6-8.", "We therefore conclude that continued virus replication contributes to the viral reservoir.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments."]}
{"doc_id": 71010, "title": "", "abstract": ["Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "The dynamic nature of the viral population in lymphoid tissue sanctuaries, where infected cells can still produce new viruses, infect new target cells and replenish the pool, undermines previous estimates of the time necessary to purge the reservoir of latently infected cells and achieve virus eradication3.", "Distinguishing between low amounts of viral replication and pools of latently infected cells that may persist and rekindle HIV-1 infection is methodologically difficult.", "Achieving optimal cellular pharmacokinetics and spatial distribution of antiretroviral drugs in lymphoid tissue to fully suppress viral replication and preserve immune function is, therefore, a prerequisite to the elimination of the viral reservoir and ultimately a cure for HIV-1 infection.", "These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy."]}
{"doc_id": 71011, "title": "", "abstract": ["In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "The pairwise fixation index (FST), a standard measure of genetic differentiation between populations, confirmed significant genetic variation between lymph node and blood at each time point (Extended Data Table 3)22,23.", "The other, smaller volume compartment (<0.01% of the size of the main compartment) has a lower drug concentration and represents a sanctuary site within the lymphoid tissue reservoir 37.", "A structured coalescent model29, less prone to potential bias in spatial inference estimates, shows higher migration rates from lymph node to blood (Extended Data Table 5), confirming that the direction of flow is not due to oversampling of a particular anatomic location that would have increased estimates of traffic into that location30."]}
{"doc_id": 71012, "title": "", "abstract": ["These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "Most comparisons were statistically significant (Mann-Whitney U test, P-values < 0.1), indicating ongoing diversification of the viral populations.", "The temporal structure in the trees shows a strong clock-like signal and rates consistent with HIV-1 within- host evolution.", "Ongoing replication is considered unlikely because neither viral genetic divergence over time, nor the emergence of drug resistance mutations have been convincingly documented9,10.", "In the analyses performed, HIV-1 showed a high degree of clock-like evolution and a mean nucleotide substitution rate expected to be within the bounds necessary to obtain meaningful phyloanatomic information from sequence data."]}
{"doc_id": 71013, "title": "", "abstract": ["In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus."]}
{"doc_id": 71014, "title": "", "abstract": ["These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "To investigate the evolution and spatial dispersion of virus with high accuracy, we deep sequenced (using the Roche 454 Sciences’ GS-FLX sequencing platform) HIV-1 DNA in cells from blood and inguinal lymph nodes collected from three subjects at three separate times (at day 0, and after 3 and 6 months of treatment) described elsewhere13.", "In the analyses performed, HIV-1 showed a high degree of clock-like evolution and a mean nucleotide substitution rate expected to be within the bounds necessary to obtain meaningful phyloanatomic information from sequence data.", "Our sampling approach differs fundamentally from those of previous studies14-16, which do not address evolutionary dynamics within lymphoid tissue, and better suits investigation of the dynamic nature of the viral reservoir during treatment with potent antiretroviral drugs.", "Persistent HIV-1 replication maintains the tissue reservoir during therapy"]}
{"doc_id": 71015, "title": "", "abstract": ["We therefore conclude that continued virus replication contributes to the viral reservoir.", "Intermittent virus production from reactivation of a small proportion of latently infected CD4+ T cells (rather than low levels of ongoing replication) is thought to drive viral rebound detected in blood of well-suppressed patients on treatment6-8.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "Even though viral genetic diversity accumulated over time, the infected cells did not produce new virus with drug-resistance mutations, conferring a putative fitness advantage that might have led to a systemic viral rebound.", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection."]}
{"doc_id": 71016, "title": "", "abstract": ["We therefore conclude that continued virus replication contributes to the viral reservoir.", "We found no significant evidence for recombinant sequences that could bias the analysis.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "This complication emphasizes the challenge in trying to extrapolate from single template sequencing the magnitude and character of the virus population that comprises the viral reservoir.", "Our sampling approach differs fundamentally from those of previous studies14-16, which do not address evolutionary dynamics within lymphoid tissue, and better suits investigation of the dynamic nature of the viral reservoir during treatment with potent antiretroviral drugs."]}
{"doc_id": 71017, "title": "", "abstract": ["These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "Modelling replication dynamics and treatment effectiveness in the viral reservoir", "Our model predictions fit the data well (Extended Data Fig. 5) and confirm that both competition between strains and regional spatial heterogeneity in antiretroviral concentrations help capture the observed dynamics of the viral reservoir in these well-suppressed patients.", "Model of replication dynamics and treatment effectiveness in the viral reservoir fitted to the data"]}
{"doc_id": 71018, "title": "", "abstract": ["In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue."]}
{"doc_id": 71019, "title": "", "abstract": ["Persistent HIV-1 replication maintains the tissue reservoir during therapy", "Achieving optimal cellular pharmacokinetics and spatial distribution of antiretroviral drugs in lymphoid tissue to fully suppress viral replication and preserve immune function is, therefore, a prerequisite to the elimination of the viral reservoir and ultimately a cure for HIV-1 infection.", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "None of the current treatments, however, are capable of eradicating the virus from a long-lived reservoir in resting memory CD4+ T cells and other potential cell types that insulate the virus from antiretroviral drugs or immune surveillance2-5."]}
{"doc_id": 71020, "title": "", "abstract": ["These data provide fresh insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and refill the viral reservoir despite potent antiretroviral therapy.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "We therefore conclude that continued virus replication contributes to the viral reservoir."]}
{"doc_id": 71021, "title": "", "abstract": ["From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "Persistent HIV-1 replication maintains the tissue reservoir during therapy", "Here we show that virus evolution and trafficking between tissue compartments continues in patients with undetectable levels of virus in their bloodstream."]}
{"doc_id": 71022, "title": "", "abstract": ["Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "The other, smaller volume compartment (<0.01% of the size of the main compartment) has a lower drug concentration and represents a sanctuary site within the lymphoid tissue reservoir 37.", "At high effective drug concentrations, the drug- resistant strain outcompetes the drug-sensitive strain and can continuously replicate.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue."]}
{"doc_id": 71023, "title": "", "abstract": ["From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39.", "We discover ongoing replication in lymphoid tissue sanctuaries of patients despite undetectable blood levels of virus.", "The dynamic nature of the viral population in lymphoid tissue sanctuaries, where infected cells can still produce new viruses, infect new target cells and replenish the pool, undermines previous estimates of the time necessary to purge the reservoir of latently infected cells and achieve virus eradication3."]}
{"doc_id": 71024, "title": "", "abstract": ["To investigate the evolution and spatial dispersion of virus with high accuracy, we deep sequenced (using the Roche 454 Sciences’ GS-FLX sequencing platform) HIV-1 DNA in cells from blood and inguinal lymph nodes collected from three subjects at three separate times (at day 0, and after 3 and 6 months of treatment) described elsewhere13.", "Our sampling approach differs fundamentally from those of previous studies14-16, which do not address evolutionary dynamics within lymphoid tissue, and better suits investigation of the dynamic nature of the viral reservoir during treatment with potent antiretroviral drugs.", "We obtained peripheral blood, inguinal lymph node, and terminal ileum and rectum biopsies once again at 3 and 6 months after starting treatment.", "Snn and FST pairwise genetic differentiation (a and b, respectively) between peripheral blood and lymph samples for the Gag and Pol regions of HIV-1 from subjects 1774, 1727, and 1679 at day 0 and after 6 months of antiretroviral therapy.", "Ramon Lorenzo-Redondo,  Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60011, USA."]}
{"doc_id": 18000, "title": "", "abstract": ["We saw substantial immune cell accumulation in the lungs of K18-hACE2 mice, an observation consistent with post-mortem analysis of human patients39.", "Compared to the lungs of uninfected K18-hACE2 control mice, we observed induction of Ifnb, Il28, Ifng, Cxcl10, Cxcl11, and Ccl2 mRNA over the first week (Fig 4c) with highest expression occurring at 2 dpi for all cytokines except Ifng and Ccl2.", "By 7 dpi, we also observed an increase in several lymphoid cell subsets in the lung including NK1.1+ natural killer cells, γδ CD3+ T cells, CD3+CD4+ T cells, CD3+CD8+ T cells, and activated CD44+CD3+CD8+ T cells (Fig 4a).", "The histopathological changes we observed in the infected lungs of K18-hACE2 mice correlate with the impaired pulmonary function.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease."]}
{"doc_id": 18001, "title": "", "abstract": ["Although hACE2 is expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was observed only upon intragastric inoculation or at early time points following intranasal infection11,12.", "In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly in the colon, which correlated with infection seen at later time points.", "The spleen in SARS- CoV-2-infected K18-hACE2 mice appeared normal (Extended Data Fig 2f), and fibrin thrombi were not detected in any of the extra-pulmonary organs examined.", "We saw substantial immune cell accumulation in the lungs of K18-hACE2 mice, an observation consistent with post-mortem analysis of human patients39.", "mRNA expression levels of hACE2 in the lung, kidney, heart, brain, spleen, duodenum, colon, and ileum of naive K18 hACE2 mice (two experiments, n = 5)."]}
{"doc_id": 18002, "title": "", "abstract": ["Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "Although hACE2 is expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was observed only upon intragastric inoculation or at early time points following intranasal infection11,12.", "The expression of ACE2 in K18-hACE2 mice is independent of the complex regulatory systems that governs ACE2 levels46."]}
{"doc_id": 18003, "title": "", "abstract": ["In transcriptional analyses of BAL fluid from infected humans with severe COVID-19, an accumulation of CD8+ T cells, neutrophils, and monocytes coincided with the loss of alveolar macrophages18,19.", "Accumulation of monocytes in the BAL fluid coincided with a decrease in the number of tissue-resident alveolar macrophages, an observation consistent with scRNA-seq analysis of BAL fluid of patients with severe COVID-19 disease18,19.", "These data are consistent with cytokine profiling of serum from human COVID-19 patients and transcriptional analysis of the BAL fluid of human patients, which showed that elevated levels of IL-10, IL-6, IL-2, IL-7, G-CSF, CXCL10, CCL2, CCL3, and TNF-α correlate with disease severity19,23–25.", "In our study, using cytokine analysis and RNA-sequencing of lung homogenates, we detected enhanced expression of several myeloid cell chemoattractants (e.g., CCL2, CCL3, CCL4, CXCL1, and CXCL10) and other key inflammatory cytokines (TNFα, IL-6, and G-CSF) that correlate with COVID-19 disease severity in humans30,31.", "The lymphopenia associated with severe COVID-19 in humans is attributed in part to the immune cell migration into inflamed tissues21,40."]}
{"doc_id": 18004, "title": "", "abstract": ["To evaluate the composition of the immune cell response in SARS-CoV-2-infected K18-hACE2 mice, we performed flow cytometric analysis on lung homogenates and bronchoalveolar lavage (BAL) fluid at three time points after intranasal virus inoculation (Fig 4a–b, Extended Data Fig 3a) Consistent with our histopathological analysis, numbers of CD45+ immune cells trended higher in the BAL beginning at 2 dpi and in the lung at 4 dpi, although these differences did not attain statistical significance.", "Overall, our data suggest that in the context of the inflammatory response to SARS-CoV-2 in the lungs of K18-hACE2 mice, many cytokines and chemokines are induced, with some having sustained expression and others showing rapid up-and down regulation patterns.", "To assess how the kinetics of infection and ensuing inflammation modulate the cytokine and IFN response to SARS-CoV-2, we performed RNA sequencing of lung homogenates of K18-Tg mice at 0 (mock), 2, 4, and 7 dpi.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM ).", "Heat maps of significantly upregulated genes during SARS-CoV-2 infection enriched in neutrophil activation pathways (a), Toll-like receptor signaling pathway (b), and negative regulation of viral genome replication (c) identified through Gene Ontology analysis."]}
{"doc_id": 18005, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "To examine changes to the biophysical properties of the lung over the course of SARS-CoV-2 infection, we mechanically ventilated mice via tracheostomy and performed several forced-oscillation tests to determine various respiratory mechanics parameters (Fig 3n–w).", "To evaluate the composition of the immune cell response in SARS-CoV-2-infected K18-hACE2 mice, we performed flow cytometric analysis on lung homogenates and bronchoalveolar lavage (BAL) fluid at three time points after intranasal virus inoculation (Fig 4a–b, Extended Data Fig 3a) Consistent with our histopathological analysis, numbers of CD45+ immune cells trended higher in the BAL beginning at 2 dpi and in the lung at 4 dpi, although these differences did not attain statistical significance.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "Overall, our data suggest that in the context of the inflammatory response to SARS-CoV-2 in the lungs of K18-hACE2 mice, many cytokines and chemokines are induced, with some having sustained expression and others showing rapid up-and down regulation patterns."]}
{"doc_id": 18006, "title": "", "abstract": ["Copies of SARS-CoV-2 N gene RNA in samples were determined using a previously published assay8.", "High levels of infectious SARS-CoV-2 (Fig 1b) and viral RNA (Fig 1c) were detected in lung homogenates at 2, 4, and 7 dpi, whereas lower levels were present in other tissues (e.g., heart, spleen, kidney).", "To assess how the kinetics of infection and ensuing inflammation modulate the cytokine and IFN response to SARS-CoV-2, we performed RNA sequencing of lung homogenates of K18-Tg mice at 0 (mock), 2, 4, and 7 dpi.", "Our RNA sequencing analysis revealed differences in the type I IFN gene signatures associated with early and late SARS-CoV-2 infection.", "Lung homogenates were incubated with Triton-X-100 (1% final concentration) for 1 h at room temperature to inactivate SARS-CoV-2."]}
{"doc_id": 18007, "title": "", "abstract": ["We saw substantial immune cell accumulation in the lungs of K18-hACE2 mice, an observation consistent with post-mortem analysis of human patients39.", "Overall, our data suggest that in the context of the inflammatory response to SARS-CoV-2 in the lungs of K18-hACE2 mice, many cytokines and chemokines are induced, with some having sustained expression and others showing rapid up-and down regulation patterns.", "Collectively, the RNA sequencing data from the lungs of K18-hACE2 mice show distinct immune signatures associated with early infection (days 2 and 4) and late (day 7) SARS-CoV-2 infection.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "The histopathological changes we observed in the infected lungs of K18-hACE2 mice correlate with the impaired pulmonary function."]}
{"doc_id": 18008, "title": "", "abstract": ["Overall, our data suggest that in the context of the inflammatory response to SARS-CoV-2 in the lungs of K18-hACE2 mice, many cytokines and chemokines are induced, with some having sustained expression and others showing rapid up-and down regulation patterns.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "SARS- CoV-2-infected lung tissues show a massively upregulated innate immune response with signatures of NF-kB-dependent, type I and II interferon signaling, and leukocyte activation pathways.", "To assess how the kinetics of infection and ensuing inflammation modulate the cytokine and IFN response to SARS-CoV-2, we performed RNA sequencing of lung homogenates of K18-Tg mice at 0 (mock), 2, 4, and 7 dpi.", "Analysis of hematoxylin and eosin-stained lung sections from K18-hACE2 mice infected with SARS-CoV-2 (Fig 2a) showed a progressive inflammatory process."]}
{"doc_id": 18009, "title": "", "abstract": ["Collectively, the RNA sequencing data from the lungs of K18-hACE2 mice show distinct immune signatures associated with early infection (days 2 and 4) and late (day 7) SARS-CoV-2 infection.", "Analysis of hematoxylin and eosin-stained lung sections from K18-hACE2 mice infected with SARS-CoV-2 (Fig 2a) showed a progressive inflammatory process.", "To correlate histopathological findings with sites of SARS-CoV-2 infection, we also stained lung sections for viral RNA using in situ hybridization (Fig 2b).", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM ).", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease."]}
{"doc_id": 18010, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "# SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14."]}
{"doc_id": 18011, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "# SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function"]}
{"doc_id": 18012, "title": "", "abstract": ["While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "# SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function", "Here, we evaluate heterozygous hACE2 transgenic mice as a model for severe COVID-19 disease.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures."]}
{"doc_id": 18013, "title": "", "abstract": ["Heterozygous K18-hACE c57BL/6J mice (strain: 2B6.Cg-Tg(K18-ACE2)2Prlmn/J) were obtained from The Jackson Laboratory.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "We thank Sean Whelan, Susan Cook, and Jennifer Philips for facilitating the studies with SARS-CoV-2 in biosafety level-3, Cathleen Lutz and The Jackson Laboratory for providing mice, Arthur Kim for purifying the CR3022 anti-S mAb, Hana Janova and Matthew Cain for experimental advice, and Robert Schmidt for reviewing a brain histology slides.", "Eight to nine-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with 2.5 x 104 PFU of SARS-CoV-2.", "Six-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with the indicated PFU doses of SARS-CoV-2, and weight change was monitored (one experiment, n = 4, symbols represent the mean ± SEM)."]}
{"doc_id": 18014, "title": "", "abstract": ["Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses."]}
{"doc_id": 18015, "title": "", "abstract": ["Brain tissues of K18-hACE2 mice with minimal or no detectable SARS-CoV-2 infection appeared normal without evidence of microglial activation or inflammation, whereas the one brain recovered with a high level of infection at 7 dpi showed inflamed meningeal vessels with extravasation of immune cells (e.g., neutrophils, lymphocytes, and monocytes) into the brain parenchyma, inflammation of the subarachnoid space and underlying parenchyma including microglial activation (Extended Data Fig 2b).", "The tissues supporting SARS-CoV-2 infection in this model mirrored the pattern of hACE2 expression, with the highest receptor levels in the lungs, colon, kidney, and brain (Extended Data Fig 1b).", "The spleen in SARS- CoV-2-infected K18-hACE2 mice appeared normal (Extended Data Fig 2f), and fibrin thrombi were not detected in any of the extra-pulmonary organs examined.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM )."]}
{"doc_id": 18016, "title": "", "abstract": ["Beginning at 4 days post-infection (dpi), K18-hACE2 mice demonstrated marked weight loss, and by 7 dpi most animals had lost approximately 25% of their body weight (Fig 1a), with many becoming moribund.", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight starting at 4 days post infection (dpi) and began to succumb to disease at 7 dpi.", "Intranasal inoculation with a lower (1×102 PFU) dose also resulted in substantial weight loss by 6 dpi, although this was delayed compared to a higher virus inoculum (Extended Data Fig 1a).", "However, by 5 dpi, all infected K18-hACE2 mice had substantially reduced exercise tolerance compared to mock-infected animals or their own pre-infection baseline performance (Fig 3m).", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight after 4 dpi and began to succumb to disease at 7 dpi."]}
{"doc_id": 18017, "title": "", "abstract": ["SARS-CoV-2 infection in extra-pulmonary organs", "The spleen in SARS- CoV-2-infected K18-hACE2 mice appeared normal (Extended Data Fig 2f), and fibrin thrombi were not detected in any of the extra-pulmonary organs examined.", "Pneumocytes become infected early, which led to recruitment of leukocytes into the pulmonary interstitium, production of proinflammatory cytokines, injury to parenchymal cells, collapse of the alveolar space, and compromise of gas exchange, all of which could cause the hypercapnia we observed at 7 dpi.", "Mild to moderate disease is seen in many rodent models of SARS-CoV-2 infection, including those expressing hACE2 via viral vectors or transgenes8,11,12,37.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown."]}
{"doc_id": 18018, "title": "", "abstract": ["Although hACE2 is expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was observed only upon intragastric inoculation or at early time points following intranasal infection11,12.", "In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly in the colon, which correlated with infection seen at later time points.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM )."]}
{"doc_id": 18019, "title": "", "abstract": ["Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases."]}
{"doc_id": 18020, "title": "", "abstract": ["As the onset of severe clinical disease in K18-hACE2 mice occurs days after peak viral infection and is associated with high levels of infiltrating immune cells and inflammatory mediators in the lung, immune responses likely contribute to pathogenesis.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "As such, comorbid conditions (e.g., obesity, hypertension, diabetes, and sex) that alter ACE2 expression in humans46 likely cannot be modelled faithfully in this transgenic mouse.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "The expression of ACE2 in K18-hACE2 mice is independent of the complex regulatory systems that governs ACE2 levels46."]}
{"doc_id": 18021, "title": "", "abstract": ["After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight starting at 4 days post infection (dpi) and began to succumb to disease at 7 dpi.", "Although hACE2 is expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was observed only upon intragastric inoculation or at early time points following intranasal infection11,12.", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight after 4 dpi and began to succumb to disease at 7 dpi.", "In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly in the colon, which correlated with infection seen at later time points.", "Intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice results in high levels of viral infection in lungs with spread to other organs."]}
{"doc_id": 18022, "title": "", "abstract": ["The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "### K18-hACE2 mice are highly susceptible to SARS-CoV-2 infection.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease."]}
{"doc_id": 18023, "title": "", "abstract": ["A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "Infection of the brain also was observed in K18-hACE2 mice infected with SARS-CoV9,14 but occurred earlier (at 3 to 4 dpi) and more uniformly.", "Intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice results in high levels of viral infection in lungs with spread to other organs.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease."]}
{"doc_id": 18024, "title": "", "abstract": ["In K18-hACE2 mice, SARS-CoV-2 infection resulted in a markedly decreased number of B cells, CD4+ T cells, CD8+ T cells, and monocytes in peripheral blood at 5 dpi (Fig 4e, Extended Data Figure 3b).", "Accumulation of monocytes in the BAL fluid coincided with a decrease in the number of tissue-resident alveolar macrophages, an observation consistent with scRNA-seq analysis of BAL fluid of patients with severe COVID-19 disease18,19.", "In transcriptional analyses of BAL fluid from infected humans with severe COVID-19, an accumulation of CD8+ T cells, neutrophils, and monocytes coincided with the loss of alveolar macrophages18,19.", "Of note, decreased lymphocyte numbers were observed with different inoculating doses of SARS-CoV-2 and present even in mice receiving only 102 PFU, prior to the beginning of weight loss at 6 dpi.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown."]}
{"doc_id": 18025, "title": "", "abstract": ["Pneumocytes become infected early, which led to recruitment of leukocytes into the pulmonary interstitium, production of proinflammatory cytokines, injury to parenchymal cells, collapse of the alveolar space, and compromise of gas exchange, all of which could cause the hypercapnia we observed at 7 dpi.", "Brain tissues of K18-hACE2 mice with minimal or no detectable SARS-CoV-2 infection appeared normal without evidence of microglial activation or inflammation, whereas the one brain recovered with a high level of infection at 7 dpi showed inflamed meningeal vessels with extravasation of immune cells (e.g., neutrophils, lymphocytes, and monocytes) into the brain parenchyma, inflammation of the subarachnoid space and underlying parenchyma including microglial activation (Extended Data Fig 2b).", "Hematoxylin and eosin staining of the brain (b), heart (c), liver (d), kidney (e), and spleen (f) from K18-hACE2 mice following SARS CoV-2 infection at 7 dpi.", "By 4 dpi, these immune cell infiltrates involved a greater area of the lung with focal collections into adjacent alveolar spaces with alveolar wall thickening.", "By 7 dpi, immune cells, including neutrophils and mononuclear cells were found throughout the lung in alveolar and interstitial locations along with interstitial edema and consolidation."]}
{"doc_id": 18026, "title": "", "abstract": ["Conventional laboratory strains of mice cannot be infected efficiently by SARS-CoV-2 because hACE2 but not mouse ACE2 supports SARS-CoV-2 binding6,7.", "Although several animal species used in laboratory research have been evaluated for susceptibility to SARS-CoV-2 infection, none have recapitulated the severe disease seen in hospitalized human cases.", "Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection."]}
{"doc_id": 18027, "title": "", "abstract": ["Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Here, we evaluate heterozygous hACE2 transgenic mice as a model for severe COVID-19 disease.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM )."]}
{"doc_id": 18028, "title": "", "abstract": ["We inoculated 8-week-old heterozygous K18-hACE2 mice of both sexes via intranasal route with 2.5×104 plaque forming units (PFU) of SARS-CoV-2 (strain 2019n-CoV/USA_WA1/2020).", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Six-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with the indicated PFU doses of SARS-CoV-2, and weight change was monitored (one experiment, n = 4, symbols represent the mean ± SEM).", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "Eight to nine-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with 2.5 x 104 PFU of SARS-CoV-2."]}
{"doc_id": 18029, "title": "", "abstract": ["In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The spleen in SARS- CoV-2-infected K18-hACE2 mice appeared normal (Extended Data Fig 2f), and fibrin thrombi were not detected in any of the extra-pulmonary organs examined.", "The histopathological changes we observed in the infected lungs of K18-hACE2 mice correlate with the impaired pulmonary function."]}
{"doc_id": 18030, "title": "", "abstract": ["### K18-hACE2 mice are highly susceptible to SARS-CoV-2 infection.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown."]}
{"doc_id": 18031, "title": "", "abstract": ["Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Thus, additional animal models are needed for understanding the biology of severe SARS-CoV-2 infection in the lung and evaluating the efficacy of antiviral and immunomodulatory countermeasures.", "Intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice results in high levels of viral infection in lungs with spread to other organs.", "Although several animal species used in laboratory research have been evaluated for susceptibility to SARS-CoV-2 infection, none have recapitulated the severe disease seen in hospitalized human cases."]}
{"doc_id": 18032, "title": "", "abstract": ["Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "As such, comorbid conditions (e.g., obesity, hypertension, diabetes, and sex) that alter ACE2 expression in humans46 likely cannot be modelled faithfully in this transgenic mouse."]}
{"doc_id": 18033, "title": "", "abstract": ["Infection of the brain also was observed in K18-hACE2 mice infected with SARS-CoV9,14 but occurred earlier (at 3 to 4 dpi) and more uniformly.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "However, by 5 dpi, all infected K18-hACE2 mice had substantially reduced exercise tolerance compared to mock-infected animals or their own pre-infection baseline performance (Fig 3m)."]}
{"doc_id": 18034, "title": "", "abstract": ["The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Given these parallel findings, studies in K18-hACE2 mice evaluating the role of specific immune pathways and cell subsets in disease pathogenesis could inform the selection of immunomodulatory agents for severe COVID-19."]}
{"doc_id": 18035, "title": "", "abstract": ["While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "In our study, using cytokine analysis and RNA-sequencing of lung homogenates, we detected enhanced expression of several myeloid cell chemoattractants (e.g., CCL2, CCL3, CCL4, CXCL1, and CXCL10) and other key inflammatory cytokines (TNFα, IL-6, and G-CSF) that correlate with COVID-19 disease severity in humans30,31.", "Thus, the severity of disease we observed following SARS-CoV-2 infection of K18-hACE2 mouse is unique.", "Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases."]}
{"doc_id": 18036, "title": "", "abstract": ["Although hACE2 is expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was observed only upon intragastric inoculation or at early time points following intranasal infection11,12.", "In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly in the colon, which correlated with infection seen at later time points.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM )."]}
{"doc_id": 18037, "title": "", "abstract": ["Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "Here, we evaluate heterozygous hACE2 transgenic mice as a model for severe COVID-19 disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown."]}
{"doc_id": 18038, "title": "", "abstract": ["Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown."]}
{"doc_id": 18039, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9."]}
{"doc_id": 18040, "title": "", "abstract": ["Serum D-dimer levels of mock-treated or SARS-CoV-2 infected animals at 2, 4, and 7 dpi (two independent experiments, n = 5 for naïve, n = 5 for 2 dpi, n = 6 for 4 dpi, and n = 5 for 7 dpi; one-way ANOVA with Dunnett’s test; * P = 0.0246).", "In contrast, 1,975 unique differentially expressed genes were identified between mock to 7 dpi whereas only 59 and 152 genes were different between mock and 2 and 4 dpi, respectively (Fig 5c).", "Clinical chemistry and hematological parameters from the peripheral blood of mock-treated or SARS-CoV-2 infected animals at 2, 4, and 7 dpi (two independent experiments, n = 15 for naïve, n = 12 for 2 dpi, n = 15 for 4 dpi, and n = 15 for 7 dpi; one-way ANOVA with Dunnett’s test; c, *** P = 0.0009; d, * P = 0.0237 and **** P = 0.0001; e, i-k **** P < 0.0001).", "Heat maps of significantly upregulated genes during SARS-CoV-2 infection enriched in neutrophil activation pathways (a), Toll-like receptor signaling pathway (b), and negative regulation of viral genome replication (c) identified through Gene Ontology analysis.", "Heat maps of significantly up-regulated genes during SARS-CoV-2 infection enriched in cytokine-mediated signaling pathway (e), type I IFN signaling pathway (f), and cellular response to IFNγ (g) identified through Gene Ontology analysis."]}
{"doc_id": 18041, "title": "", "abstract": ["The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "Compared to mock-infected controls, at 4 dpi, a subset of SARS-CoV-2-infected K18-hACE2 mice began to show reduced exercise tolerance, as measured by decreased distance travelled.", "Compared to the lungs of uninfected K18-hACE2 control mice, we observed induction of Ifnb, Il28, Ifng, Cxcl10, Cxcl11, and Ccl2 mRNA over the first week (Fig 4c) with highest expression occurring at 2 dpi for all cytokines except Ifng and Ccl2.", "However, by 5 dpi, all infected K18-hACE2 mice had substantially reduced exercise tolerance compared to mock-infected animals or their own pre-infection baseline performance (Fig 3m).", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14."]}
{"doc_id": 18042, "title": "", "abstract": ["Because of its severe disease and intense immune cell infiltration, the K18-hACE2 model of SARS-CoV-2 infection may facilitate evaluation of immunomodulatory and antiviral drugs against COVID-19 and our understanding of immune-mediated mechanisms of pathogenesis.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9."]}
{"doc_id": 18043, "title": "", "abstract": ["Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "The tissues supporting SARS-CoV-2 infection in this model mirrored the pattern of hACE2 expression, with the highest receptor levels in the lungs, colon, kidney, and brain (Extended Data Fig 1b).", "The binding of the SARS-CoV-2 spike protein to human angiotensin-I converting enzyme-2 (hACE2) targets the virus to type II pneumocytes within the lung, resulting in injury, inflammation, and subsequent respiratory distress1,2.", "Thus, the severity of disease we observed following SARS-CoV-2 infection of K18-hACE2 mouse is unique."]}
{"doc_id": 18044, "title": "", "abstract": ["Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease."]}
{"doc_id": 18045, "title": "", "abstract": ["Six-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with the indicated PFU doses of SARS-CoV-2, and weight change was monitored (one experiment, n = 4, symbols represent the mean ± SEM).", "We inoculated 8-week-old heterozygous K18-hACE2 mice of both sexes via intranasal route with 2.5×104 plaque forming units (PFU) of SARS-CoV-2 (strain 2019n-CoV/USA_WA1/2020).", "Eight to nine-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with 2.5 x 104 PFU of SARS-CoV-2.", "Intranasal inoculation with a lower (1×102 PFU) dose also resulted in substantial weight loss by 6 dpi, although this was delayed compared to a higher virus inoculum (Extended Data Fig 1a).", "Mice of different ages and both sexes were administered 2.5 x 104 PFU of SARS-CoV-2 via intranasal administration."]}
{"doc_id": 18046, "title": "", "abstract": ["A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "SARS-CoV-2 infection in K18-hACE2 mice.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "Histopathological analysis of SARS-CoV-2 infection in K18-hACE2 mice.", "### K18-hACE2 mice are highly susceptible to SARS-CoV-2 infection."]}
{"doc_id": 18047, "title": "", "abstract": ["Thus, the severity of disease we observed following SARS-CoV-2 infection of K18-hACE2 mouse is unique.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "As the onset of severe clinical disease in K18-hACE2 mice occurs days after peak viral infection and is associated with high levels of infiltrating immune cells and inflammatory mediators in the lung, immune responses likely contribute to pathogenesis.", "# SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function"]}
{"doc_id": 18048, "title": "", "abstract": ["Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "In K18-hACE2 mice, SARS-CoV-2 infection resulted in a markedly decreased number of B cells, CD4+ T cells, CD8+ T cells, and monocytes in peripheral blood at 5 dpi (Fig 4e, Extended Data Figure 3b).", "Eight to nine-week-old male and female K18-hACE2 transgenic mice were inoculated via the intranasal route with 2.5 x 104 PFU of SARS-CoV-2."]}
{"doc_id": 18049, "title": "", "abstract": ["mRNA expression levels of hACE2 in the lung, kidney, heart, brain, spleen, duodenum, colon, and ileum of naive K18 hACE2 mice (two experiments, n = 5).", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly in the colon, which correlated with infection seen at later time points.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM ).", "The expression of ACE2 in K18-hACE2 mice is independent of the complex regulatory systems that governs ACE2 levels46."]}
{"doc_id": 18050, "title": "", "abstract": ["Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease."]}
{"doc_id": 18051, "title": "", "abstract": ["### K18-hACE2 mice are highly susceptible to SARS-CoV-2 infection.", "While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "Notwithstanding this data, and unlike SARS-CoV, alterations in smell and taste are features of SARS-CoV-2 infection in humans45, suggesting that cell types within the olfactory system may be susceptible to infection or injury."]}
{"doc_id": 18052, "title": "", "abstract": ["While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses.", "Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases.", "Here, we evaluate heterozygous hACE2 transgenic mice as a model for severe COVID-19 disease.", "As such, comorbid conditions (e.g., obesity, hypertension, diabetes, and sex) that alter ACE2 expression in humans46 likely cannot be modelled faithfully in this transgenic mouse."]}
{"doc_id": 66016, "title": "", "abstract": ["We present evidence that loc285194 is a direct target for p53 and functions as a tumor suppressor in part through negative regulation of miR-211.", "Together, these results suggest that loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211.", "Therefore, loc285194 suppresses tumor cell growth not only in vitro but also in vivo, further suggesting that loc285194 is a p53 downstream effector, functioning as a tumor suppressor.", "Finally, we demonstrate that loc285194 negatively regulates miR-211, which may in part account for loc285194-mediated cell growth inhibition.", "Together, these results suggest that both loc285194 and miR-211 are associated with the RISC complex through which loc285194 is able to reduce the miR-211 level and vice versa."]}
{"doc_id": 66017, "title": "", "abstract": ["Alterations in the primary structure, secondary structure and expression levels of lncRNAs as well as their cognate RNA-binding proteins are often associated with human diseases, in particular cancer (36).", "These results may imply that loc285194 may serve as a diagnostic marker for colon cancer.", "The importance of lncRNAs in human diseases may have to do with their ability to regulate gene expression.", "Accumulating evidence indicates that lncRNAs could play a critical role in regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis.", "Accordingly, lncRNAs may function as oncogenes and tumor suppressors in cancer just like protein-coding genes and microRNAs."]}
{"doc_id": 66018, "title": "", "abstract": ["Identification of loc285194 as a p53-induced lncRNA.", "In this study, we show that loc285194 is a p53 transcription target; ectopic expression of loc285194 inhibits tumor cell growth both in vitro and in vivo.", "Therefore, the identification of loc285194 as a p53 inducible lncRNA expands the repertoire of p53-regulated genes.", "Together, these results suggest that loc285194 is a p53-regulated tumor suppressor, which acts in part through repression of miR-211.", "(C) Identification of the minimal region of loc285194 capable of inhibiting cell growth."]}
{"doc_id": 52028, "title": "", "abstract": ["When electron transport function is inhibited, the ATP synthase can function in reverse such that it uses ATP generated by glycolysis to pump protons across the inner mitochondrial membrane, maintaining membrane potential (Appleby et al., 1999).", "This latter hypothesis has been questioned as cancer cells have the ability to survive on ATP produced exclusively by glycolysis.", "The ATP synthase inhibitor, Oligomycin A, diminished TMRE fluorescence in Control-HCT 116 p53−/− cells treated with metformin suggesting that in the presence of metformin, intact cells maintain their mitochondrial membrane potential by reversal of the ATP synthase (Figure 4E).", "Metformin inhibits cellular proliferation and pro- proliferative signaling via complex I inhibition.", "It is likely that metformin acts upstream of this site, inhibiting complex I activity while also inhibiting ROS generation."]}
{"doc_id": 52029, "title": "", "abstract": ["When electron transport function is inhibited, the ATP synthase can function in reverse such that it uses ATP generated by glycolysis to pump protons across the inner mitochondrial membrane, maintaining membrane potential (Appleby et al., 1999).", "This latter hypothesis has been questioned as cancer cells have the ability to survive on ATP produced exclusively by glycolysis.", "The ATP synthase inhibitor, Oligomycin A, diminished TMRE fluorescence in Control-HCT 116 p53−/− cells treated with metformin suggesting that in the presence of metformin, intact cells maintain their mitochondrial membrane potential by reversal of the ATP synthase (Figure 4E).", "These results indicate that the metformin-dependent inhibition of complex I decreases cell proliferation in the presence of glucose and increases cell death under glucose deprivation.", "However, we observed that metformin-treated cells maintain their mitochondrial membrane potential in part due to the reversal of the ATP synthase thus allowing accumulation of metformin in the mitochondrial matrix (Figure 3)."]}
{"doc_id": 52030, "title": "", "abstract": ["Our current findings bolster our previous findings highlighting the importance of mitochondrial metabolism as essential for cancer proliferation (Weinberg et al., 2010; Sullivan et al., 2013).", "While our study highlights the importance of mitochondrial complex I inhibition within cancer cells as a major mechanism by which metformin reduces tumor burden, it does not necessarily preclude any additional organismal effects of metformin that might reduce tumor progression in certain cancers.", "An emerging function of mitochondria distinct from their ability to perform biosynthetic and bioenergetic reactions is the generation of H2O2, which promotes signaling in normal and cancer cells (Hamanaka and Chandel, 2010; Sena and Chandel, 2012).", "In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis."]}
{"doc_id": 52031, "title": "", "abstract": ["In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "Taken together, these results indicate that the anti-proliferative and cell death promoting effects of metformin require mitochondrial complex I inhibition.", "Metformin is known to inhibit mitochondrial complex I in vitro (Ota et al., 2009; El-Mir et al., 2000; Owen et al., 2000) and it is thus possible that this targeting of the electron transport chain could inhibit tumor cell growth (Birsoy et al., 2012)."]}
{"doc_id": 52032, "title": "", "abstract": ["Metformin inhibits cellular proliferation and pro- proliferative signaling via complex I inhibition.", "In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo.", "Metformin inhibited proliferation of wild-type Control- CCL16 hamster fibroblasts but not that of B2-CCL16 cells or of B2-CCL16 cells reconstituted with NDI1 (NDI1-CCL16).", "Metformin also inhibits the pathways that regulate hypoxia inducible factors (HIFs), which are part of a system that helps cells to survive low-oxygen conditions, a prominent feature of many tumors.", "Metformin decreases cell proliferation by inhibiting mitochondrial complex I."]}
{"doc_id": 52033, "title": "", "abstract": ["In the present study, we directly tested whether inhibition of cancer cell mitochondrial complex I by metformin was required to decrease cell proliferation in vitro and tumor progression in vivo.", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "Finally, we directly tested whether tumor cell autonomous inhibition of mitochondrial complex I by metformin was required to decrease tumor progression in vivo.", "Metformin inhibits tumorigenesis through multiple mechanisms including the induction of cancer cell death in conditions, when glucose is limited and through inhibition of mitochondrial ROS-dependent signaling pathways that promote tumorigenesis (i.e., HIF)."]}
{"doc_id": 52034, "title": "", "abstract": ["We also examined whether phenformin, a more lipophilic biguanide, also exert its anti-proliferative effects on cancer cells through inhibition of complex I. Phenformin inhibited oxygen consumption in Control-HCT 116 p53−/− cells and saponin-permeabilized Control HCT 116 p53−/− cells at 100-fold lower concentration compared to metformin (Figure 3A,C).", "In summary, our results indicate that metformin reversibly inhibits mitochondrial complex I within cancer cells to reduce tumorigenesis.", "Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", "In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration.", "Specifically, cancer cells that express insulin receptors might be affected by metformin's inhibition on hepatic gluconeogenesis to reduce circulating insulin levels (Goodwin et al., 2012)."]}
{"doc_id": 96019, "title": "", "abstract": ["253 out of 599 probands had at least one de novo missense mutation compared with 238 of 599 sibling controls (relative risk =1.11).", "72 of 599 autism probands had a de novo LoF mutation compared with 32 of the 599 sibling controls1,4,35 (relative risk =2.42).", "All three have been shown to be significantly in excess in autism probands, relative to their unaffected siblings, although not all studies found de novo missense variation to be in excess1–5,7,34.", "Next we asked how much of the variance in liability to autism could be explained by de novo mutations, applying the standard liability model to reported rates of de novo CNVs and loss-of-function (LoF) mutations in autistic subjects and their siblings from the Simons Simplex Collection.", "As described further in the Supplementary Note, 75 de novo CNVs were found in 858 probands and 19 de novo CNVs in 863 sibling controls34 (relative risk=4.25)."]}
{"doc_id": 96020, "title": "", "abstract": ["The variance of autism liability is determined by genetic and environmental factors.", "Results regarding the genetic architecture of autism spectrum disorder.", "Results for PAGES (Population-based Autism Genetics and Environment Study), the Swedish study of the heritability of autism.", "Autism is a neurodevelopmental disorder typified by striking deficits in social communication, and genetically by a mix of de novo and inherited variation contributing to liability.", "We have ascertained subjects with strict autism (“autistic disorder”) from a Swedish epidemiological sample (“Population-based Autism Genetics and Environment Study” or PAGES)."]}
{"doc_id": 61013, "title": "", "abstract": ["Because many different cytokines are active during periods of infectious stress, we sought to determine if IFNγ is necessary to influence the behavior of HSCs.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "In contrast to the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFNγ under normal physiological conditions (top panel), our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFNγ, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool (lower panel).", "Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization.", "IFNγ is sufficient to promote LT-HSC proliferation in vivo; furthermore, HSCs from mice deficient in IFNγ have a lower proliferative rate, indicating that baseline IFNγ tone regulates HSC activity."]}
{"doc_id": 61014, "title": "", "abstract": ["Furthermore, other interferon-regulated genes including Stat1, Irf1, and Irf9 were upregulated in HSCs after in vitro IFNγ exposure when measured by real- time quantitative PCR, indicating that typical IFNγ-signaling pathways were activated in the purified cells (Supplementary Fig. 6)27.", "Deepened understanding of the molecular mechanisms used by HSCs to respond to chronic inflammatory stimuli could lead to improved clinical insight into the pathophysiology of bone marrow suppression in patients with chronic infections such as tuberculosis and HIV/AIDS3, 4.", "The M. avium infected mice had a significantly lower percentage of quiescent (G0) HSCs compared to uninfected mice (Supplementary Fig. 5).", "For IFNγ treatments, HSCs were incubated with 100 ng/mL rIFNgR&D [Minneapolis, MN]) at 37°C for 1 hour before real-time PCR, 12 hours for BrdU analysis, and 18 hours before immunofluorescence.", "Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization."]}
{"doc_id": 61015, "title": "", "abstract": ["As the precursors of all blood cells, HSCs remain dormant during most of the life of an organism, entering the cell cycle only when necessary to generate differentiated progeny6, 7.", "For assessment of functional self-renewal capacity, whole bone marrow from donor CD45.2 animals was admixed with an equal radioprotective dose of whole bone marrow from a wild type, uninfected CD45.1 mouse.", "In contrast to the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFNγ under normal physiological conditions (top panel), our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFNγ, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool (lower panel).", "These results suggest that IFNγ stimulates HSCs even in the steady state, and that baseline IFNγ tone may influence HSC turnover and quality during normal homeostasis.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process."]}
{"doc_id": 61016, "title": "", "abstract": ["Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner.", "In contrast to the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFNγ under normal physiological conditions (top panel), our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFNγ, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool (lower panel).", "Because IFNγ is strongly upregulated during M. avium infection15, 22, we focused our attention on the interferons23.", "A working model of IFNγ-mediated stimulation of quiescent HSCs, with increased proliferation and mobilization during a chronic bacterial infection, is shown in Supplementary Figure 9.", "These results were confirmed by an increase in IRGM1 protein levels in IFNγ-treated versus untreated mouse HSCs stained with anti-IRGM1 antibody and FITC-conjugated secondary antibody (green) (Fig. 3C)."]}
{"doc_id": 61017, "title": "", "abstract": ["We also confirmed these findings by Hoechst and Pyronin Y staining to assess the cell cycle status of HSCs from uninfected and infected animals19.", "Furthermore, other interferon-regulated genes including Stat1, Irf1, and Irf9 were upregulated in HSCs after in vitro IFNγ exposure when measured by real- time quantitative PCR, indicating that typical IFNγ-signaling pathways were activated in the purified cells (Supplementary Fig. 6)27.", "Further, we investigated the role of the interferon family of inflammatory cytokines in influencing HSC activation.", "Since the phenotypic HSC number appears to be the same in WT and IFNγ-deficient mice, the improved engraftment is likely to result from the higher level of quiescence, as this property is inextricably linked to engraftment potential and HSC quality7,20.", "Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection"]}
{"doc_id": 61018, "title": "", "abstract": ["To assess this possibility, we measured the number of LT-HSCs detectable in the spleen following infection.", "We next turned our attention to determine whether LT-HSCs respond directly to IFNγ stimulation, and whether IFNγ alone is sufficient to induce these effects.", "Infection with M. avium led to a striking increase in the number of phenotypic-HSCs in the spleen (Fig. 1E), suggesting mobilization of some of these cells during infection.", "We conclude from these data that chronic mycobacterial infection induces proliferation of HSCs, with functional consequences that cannot be attributed to infection of the stem cells themselves.", "In contrast to the very low proliferative/differentiative activity of dormant HSCs associated with low levels of IFNγ under normal physiological conditions (top panel), our model predicts that bacterial infection detected by sentinel immune cells stimulates the increased release of IFNγ, which then travels through the bloodstream to activate HSCs in the bone marrow, leading to expansion and mobilization of the immune progenitor pool (lower panel)."]}
{"doc_id": 61019, "title": "", "abstract": ["Our study raises the intriguing possibility that IFNα and IFNγ can coordinately regulate HSC activation in the context of an infection, most likely in a pathogen-specific manner.", "These results collectively support an essential role for IFNγ but not IFNα in the proliferative activation of HSCs in response to in vivo infection by M. avium.", "Together, these experiments demonstrate that IFNγ directly affects HSCs and that exposure to IFNγ alone is sufficient to induce their proliferation and mobilization.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "A recent report found that acute treatment of mice with purified IFNα or the IFNα-inducing agent poly(I:C) leads to cell-autonomous HSC proliferation, which was absent in Ifnar-/- and Stat1-/- mice28."]}
{"doc_id": 61020, "title": "", "abstract": ["These results suggest that IFNγ stimulates HSCs even in the steady state, and that baseline IFNγ tone may influence HSC turnover and quality during normal homeostasis.", "These findings suggest that IFNγ promotes proliferation of the HSC to feed the generation of the immediate downstream progenitors, which in turn replenish immune effector cells during an ongoing infectious process.", "Because many different cytokines are active during periods of infectious stress, we sought to determine if IFNγ is necessary to influence the behavior of HSCs.", "We hypothesized that IFNγ is responsible for the proliferative response of HSCs during M. avium infection.", "Given our findings that IFNγ is both necessary and sufficient for HSC proliferation and mobilization during M. avium infection, we hypothesized that mice lacking the IFNγ cytokine may show alterations in their HSC compartments."]}
{"doc_id": 61021, "title": "", "abstract": ["Similarly, the modest numerical increase observed in phenotypically-defined HSC in response to infection was abrogated in IFNγ signaling mutants (Fig. 2C).", "We measured HSC proliferation in response to induction by rIFNγ in vitro, and we found that primitive hematopoietic cells are significantly more proliferative after rIFNγ treatment (Fig. 3D) with no increase in apoptosis (Supplementary Figure 7).", "We show here that increased proliferation in the context of chronic infection or direct exposure to IFNγ can lead to at least transient impairment of HSC function.", "A recent report found that acute treatment of mice with purified IFNα or the IFNα-inducing agent poly(I:C) leads to cell-autonomous HSC proliferation, which was absent in Ifnar-/- and Stat1-/- mice28.", "Infection with M. avium led to a striking increase in the number of phenotypic-HSCs in the spleen (Fig. 1E), suggesting mobilization of some of these cells during infection."]}
{"doc_id": 80021, "title": "", "abstract": ["Thus, an IBD-associated decrease in Roseburia and Phascolarctobacterium may reflect a decrease in butyrate and propionate production.", "Microbial metabolic pathways with significantly altered abundances in the gut communities of IBD patients.", "The Roseburia genus, which is significantly reduced in all IBD patients (including iCD), and the Ruminococcaceae are further functionally connected in that the latter consume hydrogen and produce acetate that can be utilized by Roseburia to produce butyrate [41,43].", "Many studies have observed imbalances or dysbioses in the GI microbiomes of IBD patients [6-13]; in both CD and UC patients, there is decreased biodiversity, a lower proportion of Firmicutes, and an increase in Gammaproteobacteria [14].", "In iCD we also observed a decrease in glutamine-related functional modules, which would lead to a lower amount of glutamate required for gamma- aminobutyric acid, ornithine, and arginine biosynthesis; abundance of all three of these modules also decreased."]}
{"doc_id": 80022, "title": "", "abstract": ["Critical to determining causality in links between IBD and the gut microbiome, IBD treatments were also associated with alterations in microbiome composition.", "Inflammatory bowel disease (IBD), a chronic and relapsing inflammatory condition of the gastrointestinal (GI) tract, is intimately linked to the microbial communities of the human gut.", "Dysbioses in IBD are correspondingly not simply structural changes in the gut microbiota, but are instead associated with major impairments in many fundamental microbial metabolic functions with potential impact on the host.", "The data presented here show that IBD and iCD in particular are associated with a dysbiosis characterized by changes in Firmicutes and Proteobacteria phyla.", "The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system."]}
{"doc_id": 80023, "title": "", "abstract": ["We validated these functional shifts by shotgun metagenomic sequencing of the small subset of available samples with appropriate stool DNA, seven healthy controls and four CD patients (Additional file 14).", "These data were first validated by comparison with previous work, recapitulating previously observed changes in microbial community composition during IBD and attributing several to host treatment or environment.", "To provide internal validation of inferred microbial community gene and pathway compositions, stool DNA from seven healthy controls and four CD patients was subjected to metagenomic shotgun sequencing.", "The inference process's accuracy was validated by comparing inferred KO abundances in 16S datasets from the Human Microbiome Project with their metagenomically sequenced counterparts (Additional file 15).", "The Firmicutes phylum also significantly decreased while Bacteroides increased with age in this cohort (Additional file 1); this agrees with previous studies [38,39] and potentially reflects dietary or body mass- related changes with increasing age, which were not directly measured in these subjects, or host metabolism modifications [58]."]}
{"doc_id": 50025, "title": "", "abstract": ["In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "However, recent work in rodent models indicated that a temporally limited exposure to rotenone later caused progressive functional and pathologic changes in the enteric nervous system of rodents, mimicking changes found in human PD; as in PD, these enteric nervous system changes preceded central nervous system pathology (Abbott et al. 2001; Braak et al. 2006; Drolet et al. 2009; Greene et al. 2009; Pan-Montojo et al. 2010).", "We performed analyses for rotenone and paraquat use truncated 5, 10, and 15 years before the index date to evaluate whether the association of PD with pesticide use was influenced by behavioral changes caused by undiagnosed disease.", "Experimentally, paraquat produces subcellular changes associated with PD, including increased production of reactive oxygen species, alpha-synuclein aggregation, and selective nigral injury (Dinis-Oliveira et al. 2006; Kuter et al. 2010; McCormack et al. 2002).", "In particular, PD was strongly associated with rotenone and paraquat, two individual pesticides used extensively to model PD in the laboratory."]}
{"doc_id": 50026, "title": "", "abstract": ["Finally, we selected pesticides presumed to act through specific toxic mechanisms, but for most pesticides there is very little information regarding toxic effects in humans, as most studies are directed toward effects on plant or animal pests.", "In this study, we assessed lifelong use of pesticides with toxicant mechanisms relevant to PD.", "We performed analyses for pesticide exposure groups classified by mechanism as complex I inhibitors or oxidative stressors, based on literature review (Degli Esposti 1998; Krieger 2001; Uversky et al. 2001) and information in public databases [Agency for Toxic Substances and Disease Registry (ATSDR) 2002; Extension Toxicology Network (EXTOXNET) 2002; National Center for Biotechnology Information 2002].", "Yet despite decades of laboratory study, neither pesticide has been definitively associated with PD in humans.", "The potential for exposure to other toxicants with similar mechanisms is even greater."]}
{"doc_id": 50027, "title": "", "abstract": ["Importantly, the potential for exposure to many of these pesticides, including rotenone and paraquat, extends well beyond the occupational setting.", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxicant known to cause parkinsonism in humans, rotenone directly inhibits mitochondrial complex I (Langston et al. 1983; Sherer et al. 2007).", "Exposures to rotenone and paraquat were not correlated (r = 0.004), and ORs from a model that included both pesticides (paraquat OR = 2.6; 95% CI, 1.4–4.9; rotenone OR = 2.9; 95% CI, 1.5–5.5) were comparable with those from models without mutual adjustment (Table 3).", "Cases who did or did not use rotenone, paraquat, or groups of pesticides with similar mechanisms were generally similar, suggesting that PD associated with these agents is clinically typical and indirectly supporting a role for pesticide exposure in the etiology of typical PD."]}
{"doc_id": 50028, "title": "", "abstract": ["In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "Mitochondrial dysfunction and oxidative stress have long been implicated as pathophysiologic mechanisms underlying Parkinson’s disease (PD) (Betarbet et al. 2000; Di Monte et al. 2002).", "Mitochondrial dysfunction and oxidative stress are pathophysiologic mechanisms implicated in experimental models and genetic forms of Parkinson’s disease (PD).", "PD was positively associated with two groups of pesticides defined by mechanisms implicated experimentally—those that impair mitochondrial function and those that increase oxidative stress—supporting a role for these mechanisms in PD pathophysiology.", "Our goal was to determine whether pesticides that cause mitochondrial dysfunction or oxidative stress are associated with PD or clinical features of parkinsonism in humans."]}
{"doc_id": 50029, "title": "", "abstract": ["We assessed lifetime use of pesticides selected by mechanism in a case–control study nested in the Agricultural Health Study (AHS).", "To continue the interplay between human and experimental studies, future mechanistic studies of these pesticides should model exposure conditions similar to those occurring in humans, including chronic low-dose exposure, exposure to multiple agents, and assessment of gene–exposure interactions.", "Finally, we selected pesticides presumed to act through specific toxic mechanisms, but for most pesticides there is very little information regarding toxic effects in humans, as most studies are directed toward effects on plant or animal pests.", "Humans have used rotenone-containing plants as pesticides for centuries (Cabras et al. 2002).", "Although we report here findings for agricultural use of rotenone, the ubiquitous use of rotenone in both work and home settings that occurred until recently suggests that many people may have been exposed."]}
{"doc_id": 50030, "title": "", "abstract": ["Like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxicant known to cause parkinsonism in humans, rotenone directly inhibits mitochondrial complex I (Langston et al. 1983; Sherer et al. 2007).", "Similarly, use of rotenone (OR = 2.5; 95% CI, 1.3–4.7) or any of the group of complex I inhibitors (OR = 1.7; 95% CI, 1.0–2.8) was associated with PD (Table 3).", "In experimental models, the pesticides paraquat, which causes oxidative stress, and rotenone, which inhibits mitochondrial complex I, both induce loss of nigral dopaminergic neurons and behavioral changes associated with human PD (Henchcliffe and Beal 2008).", "For cases, we compared clinical features in persons who did or did not use paraquat or oxidative stressors as a group, or rotenone or complex I inhibitors as a group.", "We compared clinical features of cases who did or did not use paraquat or any oxidative stressor, or rotenone or any complex I inhibitor (Table 4)."]}
{"doc_id": 11044, "title": "", "abstract": ["Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1.", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "In a recent study, an estimated 4% of individuals with coronavirus sought medical care, and only a fraction of these were tested (46)."]}
{"doc_id": 11045, "title": "", "abstract": ["We integrated these findings into a two-strain ordinary differential equation (ODE) susceptible-exposed-infectious-recovered-susceptible (SEIRS) compartmental model to describe the transmission dynamics of HCoV-OC43 and HCoV-HKU1 (fig. S4).", "To address this, we adapted the SEIRS transmission model (fig. S9) to capture moderate/mild/asymptomatic infections (95.6% of infections), infections that lead to hospitalization but not critical care (3.08% of infections), and infections that require critical care (1.32% of infections) (26).", "Our goal in modeling such policies is not to endorse them but to identify likely trajectories of the epidemic under alternative approaches, identify complementary interventions such as expanding ICU capacity and identifying treatments to reduce ICU demand, and to spur innovative ideas (55) to expand the list of options to bring the pandemic under long-term control.", "We also implemented a model with extra compartments for the latent period, infectious period, and each hospitalization period so that the waiting times in these states were gamma- distributed instead of exponentially distributed (see the supplementary materials and methods and figs. S16 and S17).", "Also in agreement with the findings of the regression model, the duration of immunity for both strains in the best-fit SEIRS model is about 45 weeks, and each strain induces cross- immunity against the other, though the cross-immunity that HCoV-OC43 infection induces against HCoV-HKU1 is stronger than the reverse."]}
{"doc_id": 11046, "title": "", "abstract": ["In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "Sustained, widespread surveillance will be needed both in the short term to effectively implement intermittent social distancing measures and in the long term to assess the possibility of resurgences of SARS-CoV-2 infection, which could occur as late as 2025 even after a prolonged period of apparent elimination.", "Current COVID-19 case fatality rates are estimated to lie between 0.6% and 3.5% (19, 20), suggesting lower severity than SARS-CoV-1 and MERS but higher severity than HCoV-OC43 and HCoV-HKU1.", "(A to E) Simulated prevalence, assuming strong seasonal forcing (wintertime R0 = 2.2, summertime R0 = 1.3, or 40% decline), of COVID-19 infections (solid) and critical COVID-19 cases (dashed) following establishment on 11 March 2020 with a period of social distancing (shaded blue region) instated two weeks later, with the duration of social distancing lasting (A) four weeks, (B) eight weeks, (C) twelve weeks, (D) twenty weeks, and (E) indefinitely (see fig. S13 for a scenario with wintertime R0 = 2.6)."]}
{"doc_id": 11047, "title": "", "abstract": ["To alleviate these problems, approaches to increase critical care capacity have included rapid construction or repurposing of hospital facilities and consideration of increased manufacturing and distribution of ventilators (27–30).", "Still, SARS-CoV-2 has demonstrated an ability to challenge robust healthcare systems, and the development and widespread adoption of pharmaceutical interventions will take months at best, so a period of sustained or intermittent social distancing will almost certainly be necessary.", "Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "Without such surveillance, critical care bed availability might be used as a proxy for prevalence, but this metric is far from optimal since the lag between distancing and peak critical care demand could lead to frequent overrunning of critical care resources.", "Our goal in modeling such policies is not to endorse them but to identify likely trajectories of the epidemic under alternative approaches, identify complementary interventions such as expanding ICU capacity and identifying treatments to reduce ICU demand, and to spur innovative ideas (55) to expand the list of options to bring the pandemic under long-term control."]}
{"doc_id": 11048, "title": "", "abstract": ["During the initial pandemic wave, many countries have adopted social distancing measures, and some, like China, are gradually lifting them after achieving adequate control of transmission.", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "## Assessing intervention scenarios during the initial pandemic wave", "The required intensity, duration, and urgency of these responses will depend both on how the initial pandemic wave unfolds and on the subsequent transmission dynamics of SARS-CoV-2.", "### High seasonal variation in transmission leads to smaller peak incidence during the initial pandemic wave but larger recurrent wintertime outbreaks"]}
{"doc_id": 11049, "title": "", "abstract": ["Experience from China, Italy, and the United States demonstrates that COVID-19 can overwhelm even the healthcare capacities of well-resourced nations (2–4).", "Moreover, a winter peak for COVID-19 would coincide with peak influenza incidence (54), further straining health care systems.", "Under some circumstances, intense social distancing may be able to reduce the prevalence of COVID-19 enough to warrant a shift in strategy to contact tracing and containment efforts, as has occurred in many parts of China (21, 23, 53).", "In summary, the total incidence of COVID-19 illness over the next five years will depend critically upon whether or not it enters into regular circulation after the initial pandemic wave, which in turn depends primarily upon the duration of immunity that SARS-CoV-2 infection imparts.", "The model will have to be tailored to local conditions and updated as more accurate data become available."]}
{"doc_id": 11050, "title": "", "abstract": ["This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "These covariates were able to explain most of the observed variability in the effective reproduction numbers (adjusted R2: 74.3%).", "Most crucially, serological studies could indicate the extent of population immunity, whether immunity wanes, and at what rate.", "HCoV-OC43 and HCoV-HKU1 infections may be asymptomatic or associated with mild to moderate upper respiratory tract illness; these HCoVs are considered the second most common cause of the common cold (9).", "In addition, the method that we adopted to estimate the effective reproduction number depends on the serial interval distribution, which has not been well- studied for commonly circulating human coronaviruses; we used the best- available evidence from SARS-CoV-1, the most closely related coronavirus to SARS-CoV-2."]}
{"doc_id": 53020, "title": "", "abstract": ["We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "It was initially assumed, given this transcription factor’s role in fat-cell differentiation, that TZD drugs improve metabolic parameters in obese individuals by activating PPARγ in adipocytes.", "Two isoforms of PPARγ have been described, referred to as PPARγ1 and PPARγ2 5; while adipocytes are known to express both of them, the isoform(s) made by T lymphocytes are not well characterized.", "While this notion has received experimental support 8, other studies have argued for the importance of PPARγ expression in macrophages 9, 10, muscle 11 and the central nervous system 12, 13."]}
{"doc_id": 53021, "title": "", "abstract": ["Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "A unique population of Foxp3+CD4+ Tregs was recently found in the VAT of normal individuals 2, as a much higher fraction of the CD4+ T cell compartment than that usually observed in lymphoid or other non-lymphoid tissues.", "There was an impressive enrichment of the fraction and number of Tregs in epididymal adipose tissue of animals treated with Pio (Figs. 4a and Suppl.", "These findings suggest a previously unknown cellular mechanism for this important class of T2D drugs, and provide proof-of-principle that discrete populations of Tregs with unique functions can be precisely targeted to therapeutic ends.", "A newly discovered property was that VAT, but not lymphoid-tissue, Tregs can take up lipids, an intriguing adaptation to the tissular environment, not shared by conventional T cells residing at the same site."]}
{"doc_id": 53022, "title": "", "abstract": ["There was an impressive enrichment of the fraction and number of Tregs in epididymal adipose tissue of animals treated with Pio (Figs. 4a and Suppl.", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features.", "A newly discovered property was that VAT, but not lymphoid-tissue, Tregs can take up lipids, an intriguing adaptation to the tissular environment, not shared by conventional T cells residing at the same site.", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "While invasion of VAT by pro-inflammatory macrophages is considered to be a key event driving adipose-tissue inflammation and insulin resistance, little is known about the roles of other immune-system cell-types in these processes."]}
{"doc_id": 53023, "title": "", "abstract": ["P determined by the chi-square test.", "P determined by the chi-square test.", "Indeed, both PPARγ isoforms were co-immunoprecipitated with Foxp3 in transduced HEK293 cells, arguing that they have the potential to interact, either directly or within a shared complex (Fig. 2f).", "(f) Association of Foxp3 with PPARγ determined by co- immunoprecipitation.", "Feature-level analysis of Pparg transcripts, exploiting our existing Affymetrix ST 1.0 microarray data, revealed that mRNAs corresponding to both PPARγ1 and PPARγ2 were expressed by VAT Tregs, with predominance of the former (Suppl."]}
{"doc_id": 53024, "title": "", "abstract": ["Comparing the gene-expression profiles of visceral-fat and lymphoid- organ Tregs, we were struck by the elevated level of transcripts encoding the nuclear receptor PPARγ in the former (Fig. 1a, Suppl.", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "To identify genes whose expression was correlated, either positively or negatively, with that of Pparg, we performed a clustering analysis across transcript profiles obtained from VAT and LN Tregs of mice differing in their metabolic state: either lean [C57Bl/6 (B6) animals of various ages kept on normal chow (NC)] or obese [B6.Lepob/ob (ob/ob) animals of varying age on NC or B6 animals on a high-fat diet (HFD)] (Suppl.", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "Experimental manipulation of PPARγ specifically in Foxp3+ cells had a clear and precise impact on the accumulation and phenotype of Tregs in epididymal fat depots."]}
{"doc_id": 53025, "title": "", "abstract": ["While VAT Tregs in wt mice increased >2.5-fold between 15 and 25 weeks to eventually constitute >40% of the CD4+ T cell compartment, this subset remained below ~10% in mutant mice (Suppl.", "Recently, a unique population of VAT-resident regulatory T cells (Tregs) was implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity 2.", "A unique population of Foxp3+CD4+ Tregs was recently found in the VAT of normal individuals 2, as a much higher fraction of the CD4+ T cell compartment than that usually observed in lymphoid or other non-lymphoid tissues.", "Keywords: regulatory T cell, adipose tissue, obesity, type-2 diabetes, nuclear receptor, TZD drug", "Left, representative dot plots (of at least 3 experiments); center, summary data (for fraction of CD4+ cells); right, numbers per gram of tissue."]}
{"doc_id": 53026, "title": "", "abstract": ["Secondly, abrogating PPARγ expression in different cell-types appears to have organ-specific effects on insulin resistance 11–13.", "While this notion has received experimental support 8, other studies have argued for the importance of PPARγ expression in macrophages 9, 10, muscle 11 and the central nervous system 12, 13.", "Our data also indicate that PPARγ expressed by Tregs contributes substantially to the insulin-sensitizing activity of Pio.", "Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "Because of the crucial role of PPARγ in adipocyte differentiation, as well as its anti-inflammatory activities 5, we hypothesized that its expression in VAT Tregs might be responsible for at least some of their unique features."]}
{"doc_id": 53027, "title": "", "abstract": ["Prolonged nutrient excess promotes the accumulation and activation of leukocytes in visceral adipose tissue (VAT) and ultimately other tissues, which provokes metabolic abnormalities such as insulin resistance, T2D and fatty-liver disease.", "Pio treatment of obese mutant mice was less effective than treatment of their wt counterparts at normalizing systemic metabolic parameters: homeostatic model assessment of insulin resistance (HOMA-IR) (Fig. 4f), glucose and insulin tolerance (Fig. 4g and Suppl.", "In analogy to the human context, we compared immunologic and metabolic parameters in obese (HFD-fed) Pparg wt and Treg-Pparg mut mice as a function of Pio co-treatment.", "Adipose-tissue inflammation and both local and systemic metabolic indices were improved or worsened by global enrichment or impoverishment, respectively, of Tregs 2–4.", "Pio had differential effects on conventional adipose-tissue monocyte/macrophage populations in HFD- fed mutant mice: pro-inflammatory macrophages (CD11b+CD11c+F4/80+) were diminished, though not to the degree seen in wt littermates (Suppl."]}
{"doc_id": 53028, "title": "", "abstract": ["Thus, Pio accentuates the accumulation and phenotype of fat Tregs in epididymal fat depots of obese mice.", "There was an impressive enrichment of the fraction and number of Tregs in epididymal adipose tissue of animals treated with Pio (Figs. 4a and Suppl.", "There were also marked phenotypic changes in the epididymal fat Treg population of Pio-treated vis-á-vis untreated obese mice: an overall shift of the gene-expression profile towards that typical of VAT Tregs (Fig. 4b); an increase in the Foxp3 MFI (Suppl.", "Thus, PPARγ is an important factor controlling the accumulation and phenotype of Tregs residing in adipose tissue.", "In analogy to the human context, we compared immunologic and metabolic parameters in obese (HFD-fed) Pparg wt and Treg-Pparg mut mice as a function of Pio co-treatment."]}
{"doc_id": 53029, "title": "", "abstract": ["Unexpectedly, PPARγ expression by VAT Tregs was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione (TZD) drug, pioglitazone (Pio).", "To assess the importance of PPARγ for the VAT Treg phenotype in vivo we abrogated its expression specifically in Tregs by crossing a mouse line carrying “floxed” Pparg with a line expressing the Cre recombinase under the dictates of Foxp3 promoter/enhancer elements.", "We have identified peroxisome proliferator- activated receptor gamma (PPARγ), the “master-regulator” of adipocyte differentiation, as a critical molecular orchestrator of VAT Treg accumulation, phenotype and function.", "The main conclusion from our results is that PPARγ is a major orchestrator of the unique properties of VAT Tregs.", "Feature-level analysis of Pparg transcripts, exploiting our existing Affymetrix ST 1.0 microarray data, revealed that mRNAs corresponding to both PPARγ1 and PPARγ2 were expressed by VAT Tregs, with predominance of the former (Suppl."]}
{"doc_id": 91020, "title": "", "abstract": ["The primary exposure variable was the presence of active alcohol drinking at baseline compared with a reference group of non-drinkers.", "Analyses of the dose of alcohol consumed showed that 2.5–14.9 g alcohol (about ≤1 drink) per day was protective for all five outcomes compared with no alcohol (table 2).", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "Because of the many biological effects of alcohol consumption, we also examine the association of alcohol with mortality from all causes when this is reported in studies.", "In contrast, the overall associations of alcohol intake with stroke incidence and mortality were close to null, both in minimally adjusted and more highly adjusted models (table 2, figs 5 and 6.)."]}
{"doc_id": 91021, "title": "", "abstract": ["CVD=cardiovascular disease.", "Sensitivity analyses and stratified analyses were performed to assess the associations of selected study quality and clinical factors on cardiovascular risk, including number of confounding factors and duration of follow-up dichotomised at the median value.", "However, when the present results are coupled with those from our companion review paper summarising interventional mechanistic studies focusing on biomarkers associated with cardiovascular disease,110 the argument for causation becomes more compelling.", "CHD=coronary heart disease.", "Among studies that evaluated former drinkers separately, the risk of death (from cardiovascular disease and coronary heart disease) was significantly higher in former drinkers than in drinkers."]}
{"doc_id": 91022, "title": "", "abstract": ["Modest alcohol intake was associated with lower stroke incidence and mortality, but the risk increased substantially with heavier drinking (that is, a J shaped relation).", "In contrast, the overall associations of alcohol intake with stroke incidence and mortality were close to null, both in minimally adjusted and more highly adjusted models (table 2, figs 5 and 6.).", "Such a reduction in risk is potentially of clinical importance, but consumption of larger amounts of alcohol was associated with higher risks for stroke incidence and mortality.", "Limited evidence suggests that the risk of stroke related to alcohol is lower for women than men, but this may only reflect lower alcohol intake among women.", "Despite the latter concerns, results of our secondary analysis of overall mortality (fig 5) support the notion that moderate alcohol consumption is associated with net benefit, at least in populations similar to those studied in the extant literature."]}
{"doc_id": 91023, "title": "", "abstract": ["Conclusions Light to moderate alcohol consumption is associated with a reduced risk of multiple cardiovascular outcomes.", "In this review of 84 studies of alcohol consumption and cardiovascular disease, alcohol consumption at 2.5–14.9 g/day (about ≤1 drink a day) was consistently associated with a 14–25% reduction in the risk of all outcomes assessed compared with abstaining from alcohol.", "For cardiovascular disease mortality and both end points for coronary heart disease, alcohol consumption was associated with lower risk, with relative risks of about 0.75 (table 2).", "From the extensive body of literature summarised here, the association between alcohol consumption and decreased cardiovascular risk is not in question, as additional research has not changed this conclusion.", "Fourthly, the association is specific: moderate drinking (up to 1 drink or 12.5 g alcohol per day for women and 2 drinks or 25 g alcohol per day for men106) is associated with lower rates of cardiovascular disease but is not uniformly protective for other conditions, such as cancer.112"]}
{"doc_id": 91024, "title": "", "abstract": ["In support of implementation trials, our two papers show that alcohol consumption in moderation has reproducible and plausible effects on markers of coronary heart disease risk.", "Details of studies included in meta-analysis of association of alcohol consumption with selected cardiovascular disease outcomes", "Corrao et al reported a J shaped relation between alcohol intake and coronary heart disease,2 whereas the review by Maclure described this relation as L shaped because he did not observe an increase in coronary heart disease risk associated with higher alcohol consumption.6", "Possible cardioprotective effects of alcohol consumption seen in observational studies continue to be hotly debated in the medical literature and popular media.", "Thirdly, when studies were summarised chronologically, we found that the overall association between drinking and cardiovascular disease and coronary heart disease became apparent at least a decade ago, and ongoing studies have done little to revise the estimated associations."]}
{"doc_id": 83017, "title": "", "abstract": ["Multiple mucosal sites and their residing microbial communities have been implicated, including the airways, the periodontal tissue and the intestinal lamina propria (Mcinnes and Schett, 2011; Scher et al., 2012).", "Consistent with recently published mouse data (Gomez et al., 2012), the presence of SE alleles correlated with the composition of the gut microbiota.", "Among environmental factors, the intestinal microbiota has emerged as a possible candidate responsible for the priming of aberrant systemic immunity in RA (Scher and Abramson, 2011).", "Although recent studies of the human microbiome (Arumugam et al., 2011; Human Microbiome Project Consortium, 2012) have characterized the composition and diversity of the healthy gut microbiome, and disease-associated studies revealed correlations between taxonomic abundance and some clinical phenotypes (Frank et al., 2011; Morgan et al., 2012; Qin et al., 2012), a role for distinct microbial taxa and metagenomic markers in systemic inflammatory disease has not been defined.", "Arthritis-susceptible DRB1*04:01 transgenic mice had a markedly different intestinal microbiota when compared to arthritis-resistant DRB1*04:02 animals, and this was associated with altered mucosal immune function (i.e., increased gene transcripts for Th17-related cytokines) and increased intestinal permeability."]}
{"doc_id": 83018, "title": "", "abstract": ["We identified the presence of Prevotella copri as strongly correlated with disease in new-onset untreated rheumatoid arthritis (NORA) patients.", "### Association of Prevotella with new-onset rheumatoid arthritis", "These data suggest that a Prevotella-defined microbiome may have the propensity to support inflammation in the context of a genetically susceptible host.", "Interestingly, Prevotella- dominated healthy omnivore individuals were recently reported to have increased basal levels of serum TMAO (trimethylamine N-oxide), a product of inflammation linked to atherogenesis, compared to Bacteroides-dominated healthy individuals (Koeth et al., 2013).", "Homology-based classification of patient-associated Prevotella."]}
{"doc_id": 83019, "title": "", "abstract": ["We identified the presence of Prevotella copri as strongly correlated with disease in new-onset untreated rheumatoid arthritis (NORA) patients.", "### Association of Prevotella with new-onset rheumatoid arthritis", "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis", "These data suggest that a Prevotella-defined microbiome may have the propensity to support inflammation in the context of a genetically susceptible host.", "We found a marked association of Prevotella copri with new-onset RA (NORA) patients and not with other patient groups."]}
{"doc_id": 83020, "title": "", "abstract": ["Colonization of mice with P. copri recapitulated the differences in relative abundances of Prevotella and Bacteroides previously reported in humans, and confirmed the ability of P. copri to dominate the colonic commensal microbiota in the absence of apparent disease (Faust et al., 2012).", "Further, colonization of mice revealed the ability of P. copri to dominate the intestinal microbiota and resulted in an increased sensitivity to chemically induced colitis.", "Mice colonized with P. copri displayed increased inflammation in DSS-induced colitis.", "Colonization of mice with P. copri enhanced susceptibility to chemical colitis, consistent with a pro-inflammatory potential of this organism.", "To determine if the Prevotella-associated metagenome is sufficient to predispose to increased inflammatory responses, antibiotic-treated C57BL/6 mice were colonized with P. copri by oral gavage."]}
{"doc_id": 83021, "title": "", "abstract": ["Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA.", "However, the introduction of specific gut bacterial species is sufficient to induce joint inflammation (Rath et al., 1996; Abdollahi-Roodsaz et al., 2008; Wu et al., 2010), and antibiotic treatment both prevents and abrogates a rheumatoid arthritis-like phenotype in several mouse models.", "Although a role for the gut microbiota has been clearly established in animal models of arthritis, it is not known if dysbiosis influences human RA.", "Arthritis-susceptible DRB1*04:01 transgenic mice had a markedly different intestinal microbiota when compared to arthritis-resistant DRB1*04:02 animals, and this was associated with altered mucosal immune function (i.e., increased gene transcripts for Th17-related cytokines) and increased intestinal permeability.", "Upon mono-colonization of arthritis-prone K/BxN mice with SFB, the induced Th17 cells potentiate inflammatory disease (Wu et al., 2010)."]}
{"doc_id": 83022, "title": "", "abstract": ["The analysis revealed these OTUs to cluster tightly with Prevotella copri, a microbe isolated from human feces (Hayashi et al., 2007) and sequenced as part of the HMP’s reference genome initiative.", "Consistent with other reports of either high Prevotella or high Bacteroides relative abundance, but rarely a high relative abundance of both, (Faust et al., 2012; Yatsunenko et al., 2012), we found segregation of Prevotella or Bacteroides dominance in the intestinal microbiome (Figure 1C).", "One hypothesis is that the Prevotella-defined microbiota fail to thrive when there is less inflammation, perhaps due to a lack of inflammation-derived terminal electron acceptors, as seen for E. coli in inflammatory bowel disease (Winter et al., 2013).", "Prevotella and Bacteroides are closely related both functionally and phylogenetically, yet, surprisingly, are rarely found together in high relative abundance despite their ability to dominate the gut microbiome individually (Faust et al., 2012).", "Interestingly, Prevotella- dominated healthy omnivore individuals were recently reported to have increased basal levels of serum TMAO (trimethylamine N-oxide), a product of inflammation linked to atherogenesis, compared to Bacteroides-dominated healthy individuals (Koeth et al., 2013)."]}
{"doc_id": 83023, "title": "", "abstract": ["Although PsA patients revealed a reduction in sample diversity similar to that of IBD patients (Morgan et al., 2012), diversity was comparable between NORA, CRA and healthy groups at 3.02 +/− 0.66 (mean, SD) overall by Shannon Diversity Index (Figure 1—figure supplement 1A).", "Alternatively, the gut microbiota changes observed in newly diagnosed RA patients may be the consequence of a unique, NORA-specific systemic inflammatory response.", "Surprisingly, the prevalence of P. copri in chronic rheumatoid arthritis (CRA) patients, all of whom had been treated and exhibited reduced disease activity, was similar to that observed in the healthy subjects.", "We found a marked association of Prevotella copri with new-onset RA (NORA) patients and not with other patient groups.", "These findings have led to the ‘second-event’ hypothesis in RA, which proposes that an environmental factor triggers systemic joint inflammation in the context of pre-existent autoimmunity."]}
{"doc_id": 83024, "title": "", "abstract": ["Although PsA patients revealed a reduction in sample diversity similar to that of IBD patients (Morgan et al., 2012), diversity was comparable between NORA, CRA and healthy groups at 3.02 +/− 0.66 (mean, SD) overall by Shannon Diversity Index (Figure 1—figure supplement 1A).", "Moreover, the presence of P. copri corresponded to a reduction in the abundance of other bacterial groups—including a number of beneficial microbes.", "Surprisingly, the prevalence of P. copri in chronic rheumatoid arthritis (CRA) patients, all of whom had been treated and exhibited reduced disease activity, was similar to that observed in the healthy subjects.", "If so, an increase in DHF reductase-high microbiota in some RA subjects (i.e., Bacteroides overabundant) may help explain, at least partially, why only about half of RA patients respond adequately to oral MTX, ultimately requiring either parenteral administration or the addition of complementary immunosuppressants.", "Increases in Prevotella abundance correlated with a reduction in Bacteroides and a loss of reportedly beneficial microbes in NORA subjects."]}
{"doc_id": 83025, "title": "", "abstract": ["In our cohort, we found the microbiota of many subjects to be defined by a single taxon—P. copri—which was associated with the majority of untreated, new-onset rheumatoid arthritis (NORA) patients.", "Although recent studies of the human microbiome (Arumugam et al., 2011; Human Microbiome Project Consortium, 2012) have characterized the composition and diversity of the healthy gut microbiome, and disease-associated studies revealed correlations between taxonomic abundance and some clinical phenotypes (Frank et al., 2011; Morgan et al., 2012; Qin et al., 2012), a role for distinct microbial taxa and metagenomic markers in systemic inflammatory disease has not been defined.", "Based on the discovery that SFB-induced Th17 cells directly contribute to the onset of arthritis in gnotobiotic mice (Wu et al., 2010), we analyzed the fecal microbiota in patients with RA.", "Scher, , et al., 2013, Intestinal microbiota of patients with arthritis, ; http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA203810, Publicly available at the NCBI BioProject database (http://www.ncbi.nlm.nih.gov/bioproject).", "Upon mono-colonization of arthritis-prone K/BxN mice with SFB, the induced Th17 cells potentiate inflammatory disease (Wu et al., 2010)."]}
{"doc_id": 67020, "title": "", "abstract": ["Overconsumption of drugs of abuse similarly decreases striatal D2R density, induces a profound state of reward hypofunctionality and triggers the emergence of compulsive-like drug- taking behaviors.", "Thus, it is an interesting possibility that downregulation of striatal D2R in response to increasing body weight may serve to increase leptin signaling and thereby boost the inhibitory effects of this adipokine on brain reward systems.", "Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "This suggests that reduced striatal D2R expression alone is not sufficient to induce reward hyposensitivity, but instead seems to interact with overconsumption of palatable food to accelerate the emergence of this state of negative reward.", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4."]}
{"doc_id": 67021, "title": "", "abstract": ["In summary, we have shown that over-stimulation of brain reward systems through excessive consumption of palatable energy-dense food induces a profound state of reward hyposensitivity and the development of compulsive- like eating.", "Moreover, because compulsive eating was detected only in Lenti-D2Rsh rats that had elevated BSR thresholds, diet-induced reward hypofunctionality may be a necessary antecedent to the emergence of compulsive food seeking.", "Based on these and similar observations it has been proposed that deficits in reward processing may be an important risk factor for the development of obesity, and that obese individuals may compulsively consume palatable food to compensate for reward hyposensitivity 6.", "Alternatively, it is interesting possibility that diet-induced reward hypofunctionality may serve as a substrate for negative reinforcement that facilitates the development of compulsive-like eating 14, 32.", "These data demonstrate that overconsumption of palatable food triggers addiction- like neuroadaptive responses in brain reward circuitries and drives the development of compulsive eating."]}
{"doc_id": 67022, "title": "", "abstract": ["Our data demonstrate that extended access to palatable high-energy food and subsequent overeating blunts reward sensitivity and may therefore represent an important hedonic mechanism that promotes the development of obesity.", "Brain circuitries regulating food hedonics are therefore inhibited by post-ingestive signals that predict satiety, consistent with recent human imaging studies demonstrating that gastric distention 28 and the gut-derived postprandial factor peptide YY3-36 (PYY) 29 modulate the activity of regions of the brain involved in reward processing.", "Our findings therefore support the previous work of Hoebel and many others 4, 19, 41, 44–46 suggesting that obesity and drug addiction may arise from similar neuroadaptive responses in brain reward circuitries.", "This suggests that the striatum plays an important role in hedonic aspects of feeding behavior.", "We also examined the link between diet-induced hedonic dysregulation and the emergence of compulsive food seeking."]}
{"doc_id": 67023, "title": "", "abstract": ["Consistent with a role for striatal D2Rs in this effect, compulsive-like eating was detected in the striatal D2R knockdown rats that previously had 14 days extended access to the cafeteria diet but not in the control groups of rats.", "The development of obesity in extended access rats was closely associated with a worsening deficit in brain reward function, reflected in progressively elevated BSR thresholds (Fig. 1b).", "### Animals", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4.", "Such a scenario is also consistent with data from human brain imaging studies in which blunted activation of the striatum in response to highly palatable food, particularly in individuals with genetic polymorphisms thought to decrease striatal D2R expression, is associated with long-term weight gain 4."]}
{"doc_id": 67024, "title": "", "abstract": ["Thus, it is possible that targeting of D2Rs for knockdown in other areas of the striatum, particularly the dorsomedial and ventral areas (nucleus accumbens core and shell), may have elevated BSR thresholds even in the absence of the palatable diet.", "This suggests that the striatum plays an important role in hedonic aspects of feeding behavior.", "Brain circuitries regulating food hedonics are therefore inhibited by post-ingestive signals that predict satiety, consistent with recent human imaging studies demonstrating that gastric distention 28 and the gut-derived postprandial factor peptide YY3-36 (PYY) 29 modulate the activity of regions of the brain involved in reward processing.", "By targeting predominately the dorsolateral striatum we may have impacted populations of D2Rs that regulate vulnerability to develop compulsive-like consummatory behaviors.", "We also examined the link between diet-induced hedonic dysregulation and the emergence of compulsive food seeking."]}
{"doc_id": 67025, "title": "", "abstract": ["The development of obesity in extended access rats was closely associated with a worsening deficit in brain reward function, reflected in progressively elevated BSR thresholds (Fig. 1b).", "Such diet-induced reward hypofunctionality may have a pathophysiological role in the development of obesity by increasing the motivation to consume high-reward “obesogenic” diets to avoid or alleviate this state of negative reward 6.", "Decreases in striatal D2R levels therefore rapidly accelerates the emergence of reward hypofunctionality in rats with extended access to highly palatable food, a finding consistent with human brain imaging data in which deficits in striatal D2R density are thought to contribute to reward hypofunctionality in obese individuals 4.", "We found that development of obesity was coupled with the emergence of a progressively worsening brain reward deficit.", "In addition, reward systems are also inhibited by excessive weight gain."]}
{"doc_id": 67026, "title": "", "abstract": ["Striatal dopamine D2 receptors (D2R) were downregulated in obese rats, similar to previous reports in human drug addicts.", "Knockdown of striatal D2R expression, most prominently in dorsolateral regions of the striatum (see Fig. 5), resulted in BSR thresholds elevating almost immediately upon exposure to the cafeteria diet.", "(b) Representative immunoblot of the decreased D2R expression in the striatum of Lenti-D2Rsh rats.", "Moreover, lentivirus-mediated knockdown of striatal D2R rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food.", "In contrast, the aversive CS had no impact on palatable food consumption in the Lenti-D2Rsh rats that previously had 14 days extended access to the cafeteria diet (Fig. 7c)."]}
{"doc_id": 67027, "title": "", "abstract": ["From a neurocircuitry perspective, extended access to palatable food may trigger plasticity in corticostriatal pathways rendering animals more vulnerable to developing compulsive-like behaviors, with deficits in striatal D2R signaling enhancing this process.", "These data demonstrate that overconsumption of palatable food triggers addiction- like neuroadaptive responses in brain reward circuitries and drives the development of compulsive eating.", "These data demonstrate that knockdown of striatal D2R dramatically accelerates the emergence of compulsive-like eating of palatable food, but only in rats with a prior history of extended access.", "In summary, we have shown that over-stimulation of brain reward systems through excessive consumption of palatable energy-dense food induces a profound state of reward hyposensitivity and the development of compulsive- like eating.", "We found that palatable food consumption in extended access rats is similarly insensitive to an aversive CS."]}
{"doc_id": 15049, "title": "", "abstract": ["The initial length of hospital stay was shorter in the remdesivir group than in the placebo group (median, 12 days vs. 17 days); 5% of patients in the remdesivir group were readmitted to the hospital, as compared with 3% in the placebo group.", "Patients in the remdesivir group had a shorter time to discharge or to a National Early Warning Score of 2 or lower than those in the placebo group (median, 8 days vs. 12 days; hazard ratio, 1.27; 95% CI, 1.10 to 1.46).", "Additional secondary end points supporting these findings include remdesivir treatment resulting in a shorter time to improvement of one and of two ordinal scale categories, a shorter time to discharge or to a sustained National Early Warning Score of 2 or lower, and a shorter length of initial hospital stay (median, 12 days vs. 17 days).", "Sensitivity analyses in which data were censored at earliest reported use of glucocorticoids or hydroxychloroquine still showed efficacy of remdesivir (9.0 days to recovery with remdesivir vs. 14.0 days to recovery with placebo; rate ratio, 1.28; 95% CI, 1.09 to 1.50, and 10.0 vs. 16.0 days to recovery; rate ratio, 1.32; 95% CI, 1.11 to 1.58, respectively) (Table S8).", "Those who received remdesivir had a median recovery time of 10 days (95% confidence interval [CI], 9 to 11), as compared with 15 days (95% CI, 13 to 18) among those who received placebo (rate ratio for recovery, 1.29; 95% CI, 1.12 to 1.49; P<0.001, by a log-rank test)."]}
{"doc_id": 15050, "title": "", "abstract": ["Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "This double-blind, randomized, placebo-controlled trial identified an antiviral therapy as beneficial in the treatment of Covid-19."]}
{"doc_id": 15051, "title": "", "abstract": ["Here, we describe the first stage of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as compared with placebo.", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "A total of 517 patients in the remdesivir group and 508 in the placebo group completed the trial through day 29, recovered, or died.", "The benefit of remdesivir was most apparent in patients with a baseline ordinal score of 5 (receiving low-flow oxygen).", "The incidence of these adverse events was generally similar in the remdesivir and placebo groups."]}
{"doc_id": 15052, "title": "", "abstract": ["These results were subsequently made public.", "Grade 3 or 4 adverse events occurred on or before day 29 in 273 patients (51.3%) in the remdesivir group and in 295 (57.2%) in the placebo group (Table S18); 41 events were judged by the investigators to be related to remdesivir and 47 events to placebo (Table S17).", "Numerous challenges were encountered during this trial.", "This trial has been supported in part by the NIAID of the NIHunder award numbers UM1AI148684, UM1AI148576, UM1AI148573, UM1AI148575, UM1AI148452, UM1AI148685, UM1AI148450, and UM1AI148689.", "A data sharing statement provided by the authors is available with the full text of this article at NEJM.org."]}
{"doc_id": 15053, "title": "", "abstract": ["In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "Our overall findings were consistent with the findings of the preliminary report: a 10-day course of remdesivir was superior to placebo in the treatment of hospitalized patients with Covid-19.", "We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.", "To evaluate the clinical efficacy and safety of putative investigational therapeutic agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform trial to rapidly conduct a series of phase 3, randomized, double-blind, placebo-controlled trials."]}
{"doc_id": 15054, "title": "", "abstract": ["Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 and the Middle East respiratory syndrome (MERS-CoV),5-8 was identified early as a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS- CoV-2 in vitro.9", "A total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo).", "These results were subsequently made public.", "Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "Our data also suggest that treatment with remdesivir may have prevented the progression to more severe respiratory disease, as shown by the lower proportion of serious adverse events due to respiratory failure among patients in the remdesivir group, as well as a lower incidence of new oxygen use among patients who were not receiving oxygen at enrollment and a lower proportion of patients needing higher levels of respiratory support during the study."]}
{"doc_id": 15055, "title": "", "abstract": ["The Kaplan–Meier estimates of mortality were 6.7% with remdesivir and 11.9% with placebo by day 15 and 11.4% with remdesivir and 15.2% with placebo by day 29 (hazard ratio, 0.73; 95% CI, 0.52 to 1.03).", "All-cause mortality was 11.4% with remdesivir and 15.2% with placebo (hazard ratio, 0.73; 95% CI, 0.52 to 1.03).", "Kaplan–Meier estimates of mortality by day 15 were 6.7% in the remdesivir group and 11.9% in the placebo group (hazard ratio, 0.55; 95% CI, 0.36 to 0.83); the estimates by day 29 were 11.4% and 15.2% in two groups, respectively (hazard ratio, 0.73; 95% CI, 0.52 to 1.03).", "| Remdesivir   (N=541)| Placebo   (N=521)| Rate Ratio   (95% CI)   ---|---|---|---   Median time to clinical improvement (95% CI) — days| | |   Improvement of one category on ordinal scale| 7.0 (6.0 to 8.0)| 9.0 (8.0 to 11.0)| 1.23 (1.08 to 1.41)   Improvement of two categories on ordinal scale| 11.0 (10.0 to 13.0)| 14.0 (13.0 to 15.0)| 1.29 (1.12 to 1.48)   Discharge or National Early Warning Score ≤2 for 24 hr*| 8.0 (7.0 to 9.0)| 12.0 (10.0 to 15.0)| 1.27 (1.10 to 1.46)   | | | Difference (95% CI)   Hospitalization| | |   Median duration of initial hospitalization (IQR) — days†| 12 (6 to 28)| 17 (8 to 28)| −5.0 (−7.7 to −2.3)   Median duration of initial hospitalization among those who did not die (IQR) — days| 10 (5 to 21)| 14 (7 to 27)| −4.0 (−6.0 to −2.0)   Patients rehospitalized — % (95% CI)| 5 (3 to 7)| 3 (2 to 5)| 2 percentage points   (0 to 4)   Oxygen| | |   Median days receiving oxygen if receiving oxygen at baseline (IQR)| 13 (5 to 28)| 21 (8 to 28)| −8.0 (−11.8 to −4.2)   New use of oxygen| | |   No.", "Recovery rate ratios greater than 1 indicate a benefit with remdesivir; hazard ratios less than 1 indicate a benefit with remdesivir."]}
{"doc_id": 15056, "title": "", "abstract": ["Treatment with remdesivir was associated with fewer days of subsequent oxygen use for patients receiving oxygen at enrollment and shorter subsequent duration of mechanical ventilation or ECMO for those receiving these interventions at enrollment.", "Our data also suggest that treatment with remdesivir may have prevented the progression to more severe respiratory disease, as shown by the lower proportion of serious adverse events due to respiratory failure among patients in the remdesivir group, as well as a lower incidence of new oxygen use among patients who were not receiving oxygen at enrollment and a lower proportion of patients needing higher levels of respiratory support during the study.", "In the recently published, open-label, randomized study of remdesivir in hospitalized patients with moderate-severity Covid-19 (83% were not receiving oxygen at baseline), patients who received remdesivir for 5 days had higher odds of clinical improvement than those receiving standard care (odds ratio, 1.65; 95% CI, 1.09 to 2.48; P=0.02).", "Hospitalized, requiring supplemental oxygen| 435 (41.0)| 232 (42.9)| 203 (39.0)   6.", "The categories are as follows: 1, not hospitalized and no limitations of activities; 2, not hospitalized, with limitation of activities, home oxygen requirement, or both; 3, hospitalized, not requiring supplemental oxygen and no longer requiring ongoing medical care (used if hospitalization was extended for infection- control or other nonmedical reasons); 4, hospitalized, not requiring supplemental oxygen but requiring ongoing medical care (related to Covid-19 or to other medical conditions); 5, hospitalized, requiring any supplemental oxygen; 6, hospitalized, requiring noninvasive ventilation or use of high-flow oxygen devices; 7, hospitalized, receiving invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); and 8, death."]}
{"doc_id": 77018, "title": "", "abstract": ["Several epidemiological studies have reported an increased risk of death and cardiovascular disease with increased levels of glycated haemoglobin (haemoglobin A1C).2 3 4", "A case-control study of patients with and without diabetes in an intensive care unit found that hypoglycaemia was an independent risk factor for mortality (relative risk of 2.28).24", "* Patients with type 2 diabetes who experience symptomatic, severe hypoglycaemia are at increased risk of death, regardless of the intensity of glucose control", "The primary outcome is myocardial infarction, stroke, or cardiovascular death.9", "In this study, the risk of death was found to be higher in participants who had experienced at least one episode of symptomatic, severe hypoglycaemia than in those that did not report an event, although no temporal relation was found."]}
{"doc_id": 77019, "title": "", "abstract": ["These studies and our findings raise the possibility that although a discrete hypoglycaemic episode may not be an immediate contributor to death, susceptibility to hypoglycaemia may predict an increased risk of death.", "In this study, the risk of death was found to be higher in participants who had experienced at least one episode of symptomatic, severe hypoglycaemia than in those that did not report an event, although no temporal relation was found.", "Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "Although hypoglycaemia cannot be excluded as a possible contributor to death in some of the fatal cases, the increased relative risk of mortality observed in the intensive treatment group in the ACCORD trial cannot be explained by severe hypoglycaemia as it was measured in the study.", "It is, therefore, possible that there were unrecognised or unmeasured episodes of severe hypoglycaemia proximal to the death that could have contributed to increased mortality in the intensive group."]}
{"doc_id": 77020, "title": "", "abstract": ["Conclusion Symptomatic, severe hypoglycaemia was associated with an increased risk of death within each study arm.", "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study", "Few studies have examined the association between severe hypoglycaemia and mortality in patients with type 2 diabetes.", "Two randomised controlled trials conducted in critically ill patients in the intensive care unit setting also identified severe hypoglycaemia as an independent risk factor for mortality.25 26", "The mechanism underlying the increased mortality among patients with severe hypoglycaemia has yet to be elucidated."]}
{"doc_id": 77021, "title": "", "abstract": ["It is also possible that the high frequency of episodes of mild hypoglycaemia experienced by participants in the intensive treatment arm provided “training” in management techniques that could then be applied to manage the more severe episodes that later occurred, resulting in reduced rate of mortality in this arm.", "Further supporting this statement is the reduced risk of death among participants in the intensive treatment arm when stratified by history of symptomatic, severe hypoglycaemic events.", "* Intensive glycaemia control results in increased rates of severe hypoglycaemia", "However, a higher rate of hypoglycaemia was seen in the intensive treatment arm than in the standard treatment arm, leading to speculation that this increase alone (with the increased risk of death among those with hypoglycaemia) could account for the high mortality in the intensive treatment group.", "Similarly, frequent, mild hypoglycaemia such as that experienced by participants in the intensive glycaemia control arm may have preconditioned the myocardium, similar to the process seen experimentally in the brain,21 and provided protection against the effects of severe hypoglycaemia."]}
{"doc_id": 77022, "title": "", "abstract": ["In summary, although the majority of the deaths in the ACCORD trial at the time of the closure of the intensive treatment arm occurred among participants who had not reported any episodes of severe hypoglycaemia, an increased relative risk of death was found among those who had experienced at least one symptomatic, severe hypoglycaemic episode.", "In this detailed analysis of participants in the ACCORD glycaemia trial up to the time when the glycaemia intensive intervention was discontinued, both participants in the intensive arm and those in the standard arm who had experienced symptomatic, severe hypoglycaemia were at greater risk of death than those who had not experienced any episodes of hypoglycaemia.", "The objectives of this particular analysis were threefold: a) to determine if participants in the ACCORD trial who experienced one or more severe symptomatic hypoglycaemic episodes had an increased risk of death; b) to determine whether that risk differed by glycaemic control study arm; and c) to establish whether the risk can explain all or any of the excess mortality in the intensive arm compared with the standard arm.", "In addition, two occasions of ischaemia were seen in 28 episodes of asymptomatic hypoglycaemia.18", "These numbers demonstrate that hypoglycaemia as measured in the ACCORD study cannot account for much of the difference in mortality seen between study arms."]}
{"doc_id": 77023, "title": "", "abstract": ["* The intensive glycaemia control intervention used in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was associated with increased mortality", "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study", "Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.", "* Intensive glycaemia control results in increased rates of severe hypoglycaemia", "Few studies have examined the association between severe hypoglycaemia and mortality in patients with type 2 diabetes."]}
{"doc_id": 77024, "title": "", "abstract": ["Susceptibility to severe hypoglycaemia may be a marker for an underlying disorder that increases the risk for death in patients with diabetes, even when glycaemia is controlled according to current guidelines.", "In such patients, some hypoglycaemia would occur because of an inherent instability of glucose control in the patient, whereas other episodes would be a direct result of the treatment regimen.", "Baseline covariates considered for inclusion in this model were: demographic and anthropometric characteristics (age, gender, ethnicity, education level, and BMI); medical history (smoking history, use of alcohol, history of cardiovascular disease, duration of diabetes, history of congestive heart failure, previous amputation, evidence of previous myocardial infarction on baseline electrocardiogram, history of peripheral neuropathy, visual acuity,15 heart rate, and electrocardiogram QT index16); medication use (any use of hypertension medications, angiotensin converting enzyme inhibitors, beta blockers, statins, alpha glucosidase inhibitors, metformin, sulphonylureas, thiazolidinediones, meglitinides, and any insulin (basal insulin, bolus insulin, and premixed insulin)); and laboratory and clinical measures (albumin to creatinine ratio, haemoglobin A1C level, glucose level, systolic blood pressure, diastolic blood pressure, low density lipoprotein concentration, high density lipoprotein concentration, and concentration of triglycerides).", "Exclusion criteria were a history of frequent or recent serious hypoglycaemic events (hypoglycaemic coma or seizure within the past 12 months or hypoglycaemia requiring third party assistance in the past three months with concomitant glucose concentration of less than 3.3 mmol/l (60 mg/dl)), unwillingness to do home glucose monitoring or inject insulin, a BMI of more than 45, a serum creatinine concentration of more than 133 µmol/l (1.5 mg/dl)), or other serious illness.", "The mechanism underlying the increased mortality among patients with severe hypoglycaemia has yet to be elucidated."]}
{"doc_id": 81026, "title": "", "abstract": ["In analogy to ER-associated degradation (ERAD), we have proposed the term OMMAD for this OMM-associated degradation pathway (Neutzner et al., 2007).", "Although this role of p97 in mitophagy correlates with its role in Mfn elimination, which suggests that Mfn elimination is required for Parkin-mediated mitophagy, p97 may mediate OMMAD of other mitochondrial substrates or play a role in the maturation of autophagosomes as proposed by Tresse et al. (2010) downstream of Mfn elimination.", "The results shown here indicate that Mitofusin degradation by the proteasome is an example of a related process occurring at the OMM.", "Corroborating the idea of an ERAD-like process occurring at the mitochondria, we identified a requirement for p97 activity for proteasomal elimination of the OMM-spanning Mfn1 and Mfn2.", "Here we find that the E3 Ub ligase Parkin promotes OMMAD of Mfn1 and Mfn2 in mammalian cells in response to mitochondrial uncoupling."]}
{"doc_id": 81027, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "These data indicate that Parkin expression, when combined with mitochondrial uncoupling, induces mitofusin degradation via the Ub–proteasome system (UPS).", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation.", "### Parkin and PINK1 mediate Mitofusin ubiquitination and proteasomal degradation"]}
{"doc_id": 81028, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "Mitofusin ubiquitination requires Parkin ligase activity.", "Collectively, these results indicate that Parkin promotes ubiquitination of Mfn1 and that this ubiquitination can be recapitulated under in vitro conditions, which suggests a direct role of Parkin in ubiquitination of Mfn1.", "Mitofusin ubiquitination requires Parkin and depolarization of mitochondria."]}
{"doc_id": 81029, "title": "", "abstract": ["We suggest that the inhibition of mitochondrial fusion may isolate damaged mitochondria from healthy mitochondria and thereby promote autophagy of defective organelles.", "Recent studies further show that upon Parkin translocation to damaged mitochondria, Parkin E3 Ub ligase activity increases (Matsuda et al., 2010), and mitochondrial substrates such as VDAC1 become ubiquitinated (Geisler et al., 2010), followed by recruitment of p62 and aggregation of mitochondria by the HDAC6 deacetylase (Lee et al., 2010) .", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "p97 recruitment to ubiquitinated mitochondria mediates PINK1–Parkin-induced mitochondrial elimination.", "After Parkin recruitment to the damaged mitochondria, mitochondrial Parkin induces mitofusin (blue) ubiquitination and degradation."]}
{"doc_id": 81030, "title": "", "abstract": ["Here we show that Parkin induces the ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, leading to their degradation in both a proteasome- and a AAA+ ATPase p97-dependent manner upstream of mitophagy.", "Here we show that ubiquitination of mitofusins Mfn1 and Mfn2, large GTPases that mediate mitochondrial fusion, is induced by Parkin upon membrane depolarization and leads to their degradation in a proteasome- and p97-dependent manner.", "Therefore, we determined using PINK1 RNAi whether PINK1 is also required for CCCP-induced Mfn proteasomal degradation in the context of endogenous Parkin expression.", "These results suggest that Mfn1/2 degradation promoted by Parkin maintains mitochondria fragmentation after mitochondrial depolarization.", "As PINK1 functions upstream of Parkin, the model proposed here of Parkin-mediated Mfn degradation would argue the converse: that activation of the PINK1–Parkin pathway would promote fragmentation of mitochondria as suggested by results in fly models."]}
{"doc_id": 78018, "title": "", "abstract": ["## AUTOPHAGY IN REDOX SIGNALLING, OXIDATIVE AND NITRATIVE STRESS IN THE CONTEXT OF DISEASE PATHOGENESIS", "α-Synuclein can be modified by nitrative stress, which increases its propensity to aggregate [190–192].", "Nrf2-deficient cells exhibit a deficient stress response [116].", "Excessive or abnormal free radical production and accumulation result in oxidative stress which is a significant pathology in many diseases, including neurodegenerative diseases.", "As in neurodegenerative diseases, autophagic stress occurs in hypertension and heart failure."]}
{"doc_id": 78019, "title": "", "abstract": ["A decrease in mitochondrial membrane potential (ψm) can be induced by ROS, and by targeting α-synuclein to the mitochondria.", "Mitochondrial ROS production and oxidation of mitochondrial lipids have been shown to play a role in autophagy.", "Much evidence suggests an involvement of α-synuclein in autophagy, mitochondrial function and ROS-induced cellular damage.", "Autophagy is emerging as an important mediator of pathological responses and engages in cross-talk with ROS (reactive oxygen species) and RNS (reactive nitrogen species) in both cell signalling and protein damage.", "How ROS/RNS signals and mitochondrial dysfunction regulate autophagy has not been fully understood."]}
{"doc_id": 78020, "title": "", "abstract": ["Also involved in mitophagy and being a potential parkin substrate, mitochondrial fission protein Drp1 is S-nitrosated in response also to amyloid β-peptide and is involved in mitochondrial fragmentation [252].", "Drp1 S-nitrosation is also involved in regulation of mitochondrial fission and associated induction of mitophagy.", "DJ-1 senses oxidative stress and serves a parallel pathway to maintain mitochondrial membrane potential and preserve mitochondria from fragmentation.", "Stable knockdown of DJ-1 in neuroblastoma cells led to a reduction in mitochondrial membrane potential, mitochondrial fragmentation and accumulation of LC3 around mitochondria.", "Although mitochondrial membrane potential appears to be preserved in knockout fruitflies [244], stable knockdown of DJ-1 in neuroblastoma cells led to a decrease in mitochondrial membrane potential, increase in mitochondrial fragmentation and accumulation of LC3 around mitochondria."]}
{"doc_id": 78021, "title": "", "abstract": ["To distinguish whether the accumulation of autophagosomes is due to increased autophagosomal formation or decreased fusion of autophagosomes with lysosomes, the tfLC3 (tandem fluorescently tagged LC3) method has been developed [72].", "Deficits in the autophagy pathway lead to accumulation of ubiquitinated proteins [119,140,141,163].", "The accumulation of ubiquitinated proteins in these scenarios can be attributed to the combined consequence of lack of autophagic flux and p62 accumulation, which also inhibits protein targeting to the proteasome [119,140,141,163].", "Furthermore, disruption of the autophagy pathway at earlier steps also leads to accumulation of ubiquitinated proteins, increased ROS and dysfunctional mitochondria.", "In the latter scenario, when autophagic flux is blocked, the degradation of the inner membrane-localized LC3-II cannot occur; and the number of LC3-positive puncta increases as a result of the accumulation of autophagosomes."]}
{"doc_id": 78022, "title": "", "abstract": ["The LC3-related molecules GABARAP [GABAA (γ-aminobutyric acid type A)-receptor-associated protein] and GABARAPL1 (GABARAP-like 1 protein) may play similar roles in the autophagosomal expansion process [34].", "Selective macroautophagy and autophagy of specific organelles are subsets of macroautophagy that depend on selective combination of Atg proteins [20], and are specifically discussed whenever appropriate.", "Expression of exogenously introduced GFP (green fluorescent protein)-fused LC3 has provided a convenient method for measuring autophagy both qualitatively and quantitatively (by measuring the punctate green fluorescence in cells [32].", "LC3-II protein can also be visualized by immunocytochemistry as vesicular puncta when associated with autophagosomes [30–32].", "Interpretation of these studies needs caution, since under specific conditions, LC3 may form protein aggregates independently of autophagy [69], bind to the smooth ER [70] or form puncta in response to detergents [71]."]}
{"doc_id": 78023, "title": "", "abstract": ["At low levels, it is thought that mitochondrial ROS play a role in cell signalling, but, at higher levels, mitochondrial proteins are susceptible to damage because of the concentration of both oxidizable lipids and abundant redox-active proteins which can amplify oxidative damage [16,85].", "Reduction of Atg5 and Atg10 further increases ROS in response to starvation [81].", "Decreased levels of Atg5 and Atg10 further increase ROS in response to starvation [81].", "Much evidence suggests an involvement of α-synuclein in autophagy, mitochondrial function and ROS-induced cellular damage.", "ROS and RNS production can be induced by protein aggregates, generated by the mitochondrial respiratory activities and by other cellular oxidases."]}
{"doc_id": 78024, "title": "", "abstract": ["Impaired mitochondrial function, oxidative stress, accumulation of protein aggregates and autophagic stress are common in many pathologies, including neurodegenerative diseases [3,4].", "Dysregulation of autophagy leads to increases in oxidative stress, as shown by many pharmacological inhibitor and knockout studies (summarized in Table 1).", "Excessive or abnormal free radical production and accumulation result in oxidative stress which is a significant pathology in many diseases, including neurodegenerative diseases.", "It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress.", "Some possibilities include the accumulation of toxic proteins and the decrease in mitochondrial function, leading to further oxidative stress when the autophagic process is disrupted [17–19]."]}
{"doc_id": 89014, "title": "", "abstract": ["Inflammasome activation was confirmed by detection of ASC speck formation in microglia isolated from adult mouse.", "Immunohistochemistry for the inflammasome component ASC detected microglial “speck” formation in activated (Iba1+) microglia cells from APP/PS1 mice, consistent with inflammasome activation (Fig. 1d).", "Inflammatory mediators that result from NLRP3 inflammasome activation are likely involved in mediating synaptic dysfunction, cognitive impairment and the restriction of beneficial microglial clearance functions.", "In addition, we observed that inflammasome activation occurred in an age- and Aβ deposition- related fashion (Suppl.", "Together with the documented suppression of microglial phagocytosis by proinflammatory cytokines, these data argue for an increase in phagocytosis in APP/PS1/NLRP3−/− mice."]}
{"doc_id": 89015, "title": "", "abstract": ["Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "Immunohistochemistry for the inflammasome component ASC detected microglial “speck” formation in activated (Iba1+) microglia cells from APP/PS1 mice, consistent with inflammasome activation (Fig. 1d).", "Deposition of amyloid beta peptide (Aβ) drives cerebral neuroinflammation by activating microglia1,2.", "Here, we demonstrate strongly enhanced active caspase-1 expression in human MCI and AD brains suggesting a role for the inflammasome in this neurodegenerative disease.", "In addition to phagocytosis, microglia also contribute to Aβ clearance via proteolytic enzymes, including insulin-degrading enzyme (IDE) and neprilysin (NEP)21."]}
{"doc_id": 89016, "title": "", "abstract": ["Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "Inflammatory mediators that result from NLRP3 inflammasome activation are likely involved in mediating synaptic dysfunction, cognitive impairment and the restriction of beneficial microglial clearance functions.", "These data suggest that NLRP3 activation negatively impacts the microglial clearance function in AD.", "Thus, NLRP3- or caspase-1-deficiency results in a skewing of activated microglial cells towards an M2-like activated state.", "In addition to phagocytosis, microglia also contribute to Aβ clearance via proteolytic enzymes, including insulin-degrading enzyme (IDE) and neprilysin (NEP)21."]}
{"doc_id": 89017, "title": "", "abstract": ["Inflammasome activation was confirmed by detection of ASC speck formation in microglia isolated from adult mouse.", "Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "We analyzed the impact of NLRP3 or caspase-1 deficiency on the phagocytic capacity of microglia in vivo because immunohistochemistry revealed microglial ASC and NLRP3 expression (Fig. 1d, Suppl.", "The NLRP3 inflammasome has been implicated in several chronic inflammatory diseases as it can sense inflammatory crystals and aggregated proteins, including Aβ3,4."]}
{"doc_id": 89018, "title": "", "abstract": ["These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3.", "Here, we demonstrate strongly enhanced active caspase-1 expression in human MCI and AD brains suggesting a role for the inflammasome in this neurodegenerative disease.", "In addition, we observed that inflammasome activation occurred in an age- and Aβ deposition- related fashion (Suppl.", "Inflammasome activation was confirmed by detection of ASC speck formation in microglia isolated from adult mouse."]}
{"doc_id": 89019, "title": "", "abstract": ["Microglia are found in increased numbers in close proximity to Aβ plaques in AD.", "As AD progresses, microglial cells adopt a chronically activated phenotype.", "Prolonged exposure to Aβ leads to persistent activation of microglial cells in AD.", "These data suggest that NLRP3 activation negatively impacts the microglial clearance function in AD.", "Here, we demonstrate strongly enhanced active caspase-1 expression in human MCI and AD brains suggesting a role for the inflammasome in this neurodegenerative disease."]}
{"doc_id": 89020, "title": "", "abstract": ["In addition to phagocytosis, microglia also contribute to Aβ clearance via proteolytic enzymes, including insulin-degrading enzyme (IDE) and neprilysin (NEP)21.", "Prolonged exposure to Aβ leads to persistent activation of microglial cells in AD.", "AD-associated inflammation interferes with APP metabolism and with mechanisms of Aβ aggregation and clearance at multiple levels9,10.", "Increased IL-1β levels have been implicated in the response to Aβ deposition2.", "These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response."]}
{"doc_id": 89021, "title": "", "abstract": ["These data are consistent with the hypothesis that Aβ-induced activation of the NLRP3 inflammasome enhances AD progression by mediating a harmful chronic inflammatory tissue response.", "NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice", "The NLRP3 inflammasome has been implicated in several chronic inflammatory diseases as it can sense inflammatory crystals and aggregated proteins, including Aβ3,4.", "Inflammatory mediators that result from NLRP3 inflammasome activation are likely involved in mediating synaptic dysfunction, cognitive impairment and the restriction of beneficial microglial clearance functions.", "Indeed, Aβ activation of the NLRP3 inflammasome in microglia is fundamental for IL-1β maturation and subsequent inflammatory events3."]}
{"doc_id": 19055, "title": "", "abstract": ["To gain further insight into antibody correlates of protection, we defined antibody parameters that distinguished completely protected animals (defined as animals with no detectable sgRNA in BAL or NS following challenge) and partially protected or non-protected animals.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Vaccine-elicited NAb titers prior to challenge correlated with protection in both BAL and NS following challenge, consistent with our previous findings10.", "Immune Responses in Vaccinated Animals Following Challenge", "The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge."]}
{"doc_id": 19056, "title": "", "abstract": ["Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "A customized multiplexed approach to quantify relative antigen-specific antibody titers was used, as previously described30.", "(b) S-specific IgG and IgA at week 4 in BAL by ELISA in sham controls and in Ad26-S.PP vaccinated animals.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "The Ad26-S.PP vaccine provided complete protection in both the lower and upper respiratory tract with the exception of one animal that showed a low amount of virus in NS, and resulted in >3.2 and >3.9 log10 reductions of median peak sgRNA in BAL and NS, respectively, as compared with sham controls (P<0.0001 and P<0.0001, respectively, two-sided Mann-Whitney tests) (Fig. 5)."]}
{"doc_id": 19057, "title": "", "abstract": ["Virus was administered as 1 ml by the intranasal (IN) route (0.5 ml in each nare) and 1 ml by the intratracheal (IT) route.", "Moreover, additional functional antibody responses may also contribute to protection, such as ADNKA, ADCP, and ADCD responses.", "Adenovirus serotype 26 (Ad26) vectors11 encoding viral antigens have been shown to induce robust humoral and cellular immune responses to various pathogens in both nonhuman primates and humans.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "Immune Correlates of Protection"]}
{"doc_id": 19058, "title": "", "abstract": ["These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Our data extend recent preclinical studies of inactivated virus vaccines and DNA vaccines for SARS-CoV-2 in nonhuman primates10,21.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals."]}
{"doc_id": 19059, "title": "", "abstract": ["These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Our data extend recent preclinical studies of inactivated virus vaccines and DNA vaccines for SARS-CoV-2 in nonhuman primates10,21.", "In contrast, sham controls and animals that received the other vaccines generated higher NAb titers and T cell responses to multiple SARS-CoV-2 proteins following challenge, consistent with our previous observations with DNA vaccines10.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques."]}
{"doc_id": 19060, "title": "", "abstract": ["Cellular immune responses in vaccinated rhesus macaques.", "Cellular immune responses in vaccinated rhesus macaques.", "Humoral immune responses in vaccinated rhesus macaques.", "Peripheral and mucosal humoral immune responses in vaccinated rhesus macaques.", "Analysis of a cohort of 10 similarly immunized animals demonstrated that a single immunization of 1011 vp Ad26-S.PP elicited consistent IFN-γ ELISPOT responses but minimal to no IL-4 ELISPOT responses (Extended Data Fig. 4), suggesting induction of Th1-biased responses."]}
{"doc_id": 19061, "title": "", "abstract": ["Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Ad26-S.PP induced robust NAb responses after a single immunization and provided complete protection against SARS-CoV-2 challenge in 5 of 6 animals, whereas one animal had low levels of virus in NS.", "Our data demonstrate that a single immunization with an Ad26 vector encoding a prefusion stabilized S immunogen (S.PP) induced robust NAb responses and provided complete protection against SARS-CoV-2 challenge in 5 of 6 rhesus macaques and near-complete protection in 1 of 6 animals.", "Our previous data demonstrate that a homologous boost with Ad26-HIV vectors augmented antibody titers by more than 10-fold in both nonhuman primates and humans25–27, suggesting that both single-dose and two-dose regimens of the Ad26-S.PP vaccine should be evaluated in clinical trials.", "Adenovirus serotype 26 (Ad26) vectors11 encoding viral antigens have been shown to induce robust humoral and cellular immune responses to various pathogens in both nonhuman primates and humans."]}
{"doc_id": 19062, "title": "", "abstract": ["These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "These data suggest that serum NAb titers may be a potential biomarker for vaccine protection, although this will need to be confirmed in additional SARS-CoV-2 vaccine efficacy studies in both nonhuman primates and humans.", "Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in nonhuman primates.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "The identification of a NAb correlate of protection should prove useful in the clinical development of SARS-CoV-2 vaccines."]}
{"doc_id": 19063, "title": "", "abstract": ["We produced seven Ad26 vectors expressing SARS-CoV-2 S variants that reflected different leader sequences, antigen forms, and stabilization mutations: (i) tissue plasminogen activator (tPA) leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP) (Fig. 1a).", "(a) Seven Ad26 vectors were produced expressing SARS-CoV-2 S protein variants: (i) tPA leader sequence with full-length S (tPA.S)12, (ii) tPA leader sequence with full-length S with mutation of the furin cleavage site and two proline stabilizing mutations (tPA.S.PP)13–15, (iii) wildtype leader sequence with native full-length S (S), (iv) wildtype leader sequence with S with deletion of the cytoplasmic tail (S.dCT)16, (v) tandem tPA and wildtype leader sequences with full-length S as a strategy to enhance expression (tPA.WT.S)12, (vi) wildtype leader sequence with S with deletion of the transmembrane region and cytoplasmic tail, reflecting the soluble ectodomain, with mutation of the furin cleavage site, proline stabilizing mutations, and a foldon trimerization domain (S.dTM.PP)15, and (vii) wildtype leader sequence with full-length S with mutation of the furin cleavage site and proline stabilizing mutations (S.PP).", "Ad26 vectors were constructed with seven variants of the SARS-CoV-2 spike (S) protein sequence (Wuhan/WIV04/2019; Genbank MN996528.1).", "### Ad26 vectors.", "Animals received Ad26 vectors expressing tPA.S (N=4), tPA.S.PP (N=4), S (N=4), S.dCT (N=4), tPA.WT.S (N=4), S.dTM.PP (N=6), S.PP (N=6), and sham controls (N=20)."]}
{"doc_id": 19064, "title": "", "abstract": ["Our data extend recent preclinical studies of inactivated virus vaccines and DNA vaccines for SARS-CoV-2 in nonhuman primates10,21.", "These data demonstrate robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates.", "In this study, we developed a series of Ad26 vectors encoding different variants of the SARS-CoV-2 spike (S) protein and evaluated their immunogenicity and protective efficacy against SARS-CoV-2 challenge in rhesus macaques.", "These data suggest that serum NAb titers may be a potential biomarker for vaccine protection, although this will need to be confirmed in additional SARS-CoV-2 vaccine efficacy studies in both nonhuman primates and humans.", "In summary, our data demonstrate that a single immunization of Ad26 vector- based vaccines for SARS-CoV-2 elicited robust NAb titers and provided complete or near-complete protection against SARS-CoV-2 challenge in rhesus macaques."]}
{"doc_id": 19065, "title": "", "abstract": ["Partial protection was observed with the other vaccines, with occasional animals showing low levels of sgRNA in BAL (Fig. 4b).", "The animals that received the other vaccines generally demonstrated reduced viral loads in NS compared with controls, although protection was optimal with Ad26-S.PP (Fig. 4d).", "Responses were comparable across vaccine groups.", "Vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.", "The Ad26-S.PP vaccine elicited the highest pseudovirus NAb titers (median 408; range 208–643) and live virus NAb titers (median 113; range 53–233) at week 4 (P<0.05, two-sided Mann-Whitney tests)."]}
{"doc_id": 97015, "title": "", "abstract": ["Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "We demonstrated that highly proliferative non-EMT cells were sensitive to chemotherapy, and the emergence of recurrent EMT-derived metastases was observed after treatment.", "Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23.", "EMT tumor cells are resistant to chemotherapy", "These results indicate that GFP+ EMT cells are more resistant to chemotherapy both in vitro and in vivo."]}
{"doc_id": 97016, "title": "", "abstract": ["This is in contrast to untreated mice, where all metastatic lesions were derived from RFP+ cells (Fig. 2d), suggesting that the EMT process may be involved in metastatic outgrowth in the context of chemotherapy.", "Therefore, the absence of EMT during metastasis formation is an oncogene-independent phenomenon, manifesting in both PyMT and Neu-driven tumors.", "Thus, EMT contributes to the development of chemoresistant metastasis.", "## EMT is involved in chemoresistance", "Moreover, through EMT tumor cells acquire cancer stem cell, secondary tumor-initiating and chemoresistance properties4–6."]}
{"doc_id": 97017, "title": "", "abstract": ["Moreover, through EMT tumor cells acquire cancer stem cell, secondary tumor-initiating and chemoresistance properties4–6.", "These properties of reduced proliferation, increased apoptotic resistance, and upregulation of chemoresistance and drug metabolizing genes in GFP+ EMT tumor cells may contribute to their insensitivity to CTX.", "e, EMT tumor cells (GFP+ cells) showed resistance to multiple commonly used chemotherapies.", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "EMT tumor cells are resistant to chemotherapy"]}
{"doc_id": 97018, "title": "", "abstract": ["Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "The role of epithelial to mesenchymal transition (EMT) in metastasis is a longstanding source of controversy, largely due to an inability to monitor transient and reversible EMT phenotypes in vivo.", "However, EMT cells significantly contribute to recurrent lung metastasis formation after chemotherapy.", "Without evidence for the dissemination, colonization, and metastatic outgrowth of mesenchymal tumor cells, the role of EMT will remain contested.", "EMT is not required for lung metastasis but contributes to chemoresistance"]}
{"doc_id": 97019, "title": "", "abstract": ["EMT is not required for lung metastasis but contributes to chemoresistance", "To underline that EMT is not required for metastasis, overexpression of miR-200—a microRNA that is incongruously associated with both reduced invasion19,20 and increased metastasis34—resulted in combined suppression of the EMT-promoting transcription factors Snail1/2, Twist, Zeb1 and Zeb2, but had no effect on metastasis.", "Together, results from two oncogene-driven metastatic tumor models (MMTV-PyMT and MMTV-Neu) and two independent mesenchymal-specific reporters (Vim-Cre and Fsp1-Cre) suggest that EMT does not significantly contribute to the development of lung metastases.", "Inhibiting EMT by overexpressing miR-200 did not impact lung metastasis development.", "There is a great emphasis towards developing EMT- targeting therapies35,36, and our studies suggest that while EMT blockade may not affect metastasis formation, specifically targeting EMT tumor cells will be synergistic with conventional chemotherapy."]}
{"doc_id": 97020, "title": "", "abstract": ["To explore the impact of inhibiting EMT on metastasis formation in vivo, we orthotopically injected miR-200 overexpressing Tri-PyMT cells.", "These results demonstrate that inhibition of EMT by miR-200 overexpression does not impair the ability of tumor cells to form distant lung metastases.", "Inhibiting EMT by overexpressing miR-200 did not impact lung metastasis development.", "We ectopically expressed miR-200, a well-known inhibitor of EMT that directly targets ZEB1 and ZEB2 – the transcriptional repressors of E-cadherin19,20.", "Emerging evidence suggests a molecular and phenotypic association between EMT and chemoresistance in several cancers21–23."]}
{"doc_id": 97021, "title": "", "abstract": ["The role of epithelial to mesenchymal transition (EMT) in metastasis is a longstanding source of controversy, largely due to an inability to monitor transient and reversible EMT phenotypes in vivo.", "The epithelial to mesenchymal transition (EMT), wherein epithelial cells depolarize, lose their cell-cell contacts, and gain an elongated, fibroblast-like morphology, is a potential mechanism by which tumor cells gain metastatic features.", "Keywords: Epithelial to mesenchymal transition, EMT, MET, breast cancer, lung metastasis, chemoresistance", "Moreover, through EMT tumor cells acquire cancer stem cell, secondary tumor-initiating and chemoresistance properties4–6.", "To track EMT during metastasis in vivo, we generated a mesenchymal-specific, Cre-mediated fluorescent marker switch strategy and established a triple transgenic mouse model (Tri-PyMT, MMTV-PyMT/Rosa26-RFP-GFP/Fsp1-Cre, Fig. 1a)."]}
{"doc_id": 97022, "title": "", "abstract": ["Of note, the E-cadherin+ cells were either RFP+ (93.6%) or RFP+/GFP+ (6.0%), demonstrating that tumor cells switch their fluorescent marker expression prior to the loss of epithelial markers, and validating the early reporting of EMT in our system.", "EMT marker staining also revealed the epithelial phenotype (E-cad+/Vim-) of the tumor cells in both primary and metastatic lesions (Extended Data Fig. 3).", "Together, these observations suggest that EMT tumor cells that sustain a mesenchymal phenotype are resistant to chemotherapy.", "The epithelial to mesenchymal transition (EMT), wherein epithelial cells depolarize, lose their cell-cell contacts, and gain an elongated, fibroblast-like morphology, is a potential mechanism by which tumor cells gain metastatic features.", "Moreover, through EMT tumor cells acquire cancer stem cell, secondary tumor-initiating and chemoresistance properties4–6."]}
{"doc_id": 97023, "title": "", "abstract": ["Ultimately in our models we found that tumor cells disseminate and form metastases while persisting in their epithelial phenotype, in accordance with a recent study33.", "This study suggests the potential of an EMT-targeting strategy, in conjunction with conventional chemotherapies, for breast cancer treatment.", "The newly established transgenic model also provided us a unique opportunity to study the contribution of EMT to chemoresistance.", "To determine if the acquisition of chemoresistance induces specific molecular changes consistent with EMT, we evaluated the orthotopic Tri-PyMT model under chemotherapy.", "## EMT is involved in chemoresistance"]}
{"doc_id": 86022, "title": "", "abstract": ["We demonstrate that MYC, miR–17–5p, and miR–20a are up-regulated by CCAT2 through TCF7L2-mediated transcriptional regulation.", "We demonstrated that MYC-regulated miR-17-5p and miR-20a participate in the CCAT2-enhanced cell invasion and speculate that other mechanisms, such as MYC-related mechanisms (CDC25A) or enhanced WNT signaling (VIM and CD44), may exist to coordinate the metastatic phenotype elicited by CCAT2.", "The observation according to which CCAT2-enhanced invasion is mediated by MYC-regulated miRNAs and also possibly by other pro-metastatic targets such as CDC25A (Feng et al. 2011), rather than by MYC itself, suggests a complex regulatory network that needs to be further explored in the future.", "Overall, these results suggest that the main mechanism through which CCAT2 increases MYC expression relies on activation of WNT signaling by enhancing TCF7L2 transcriptional activity.", "Regulation of MYC expression by CCAT2."]}
{"doc_id": 86023, "title": "", "abstract": ["Recent studies have identified RNA–protein interaction as one of the main regulatory mechanisms of lncRNAs (Rinn and Chang 2012).", "It is therefore plausible that as- yet-unidentified members of the broader category of ncRNA mapping to cancer- associated genomic regions play rate-limiting roles in tumor initiation and/or progression (Rinn and Chang 2012).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "Our results support a new mechanism of MYC and WNT regulation by the novel lncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.", "For instance, we previously reported that highly conserved genomic regions (ultraconserved regions, or UCRs) (Bejerano et al. 2004) are frequently transcribed as long (>200 bp) ncRNAs (lncRNAs) in both normal and tumor tissues (Calin et al. 2007)."]}
{"doc_id": 86024, "title": "", "abstract": ["By taking advantage of a cohort of nine paired colon specimens, we determined by quantitative real-time PCR (qRT-PCR) analysis that the newly identified transcript was expressed at much higher levels in tumor tissue than in the adjacent normal mucosa, and confirmed that the transcription occurs in the genomic sense orientation (Supplemental Fig. S2C).", "This lncRNA is expressed at high levels in MSS CRC tumor tissues and influences MYC levels, but has very low-level expression in normal colon tissues.", "We identified significantly higher CCAT2 expression in the CRC tissue as compared with the adjacent mucosae (Fig. 1B).", "Here, we report that CCAT2, a novel long noncoding RNA transcript (lncRNA) encompassing the rs6983267 SNP, is highly overexpressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability.", "Using Western blot analysis, we observed a comparable level of total CTNNB1 expression levels with no increase in nuclear CTNNB1 between CCAT2-overexpressing clones and their control cells (Supplemental Fig. S10)."]}
{"doc_id": 86025, "title": "", "abstract": ["In addition, in CRC patients with GG (but not TT) genotype, CCAT2 shows significant association with MYC expression levels, suggesting that the SNP status may also affect CCAT2 function as an RNA transcript.", "We identified significantly higher CCAT2 expression in the CRC tissue as compared with the adjacent mucosae (Fig. 1B).", "Stronger vimentin signal as seen in epithelial–mesenchymal transition was observed in CCAT2-overexpressing clones than in cells with basal CCAT2 expression.", "Conversely, knockdown of CCAT2 expression caused a reduction in the expression level of VIM in both KM12SM (with high endogenous CCAT2 expression) and COLO320 (with very high endogenous CCAT2 expression) cells (Supplemental Fig. S14).", "To test the hypothesis that CCAT2 plays an oncogenic role in CRC, we cloned CCAT2 into a retroviral expression vector and transduced it into HCT116 colon cancer cells."]}
{"doc_id": 94021, "title": "", "abstract": ["The only population with a change in HIV incidence over the entire four-year period was 13–29 year olds, and within that age group, the only risk group experiencing increases was MSM.", "HIV incidence in all MSM 13–29 demonstrated a statistically significant estimated annual percentage change (EAPC) of 8.1% (95% CI: 1.9%–14.9%; p = 0.01).", "These assumptions include that HIV incidence has been stable in recent years, that the likelihood of HIV testing prior to a diagnosis of AIDS is constant both with respect to time and to duration of HIV infection, that all HIV infections will eventually be diagnosed (either through testing or through death), and that individuals accurately report the HIV testing and treatment information, especially the date of their last negative HIV test.", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities.", "From 2006 to 2009 there was no significant change in HIV incidence overall and there was no significant change in incidence in any race/ethnicity group or risk group overall."]}
{"doc_id": 94022, "title": "", "abstract": ["Expanded, improved, and targeted prevention is necessary to reduce HIV incidence.", "We included in the analysis new diagnoses of HIV infection (regardless of the stage of disease) among individuals aged 13 years and older at diagnosis in the years 2006 through 2009, with a residence at diagnosis in one of the aforementioned areas, and reported to CDC through June 2010.", "Among individuals not diagnosed with AIDS within 6 months of HIV diagnosis, the number with BED results by year was 6,096 (31%) for 2006, 7,615 (37%) for 2007, 8,863 (44%) for 2008 and 9,615 (50%) for 2009.", "Based on the revised stratified extrapolation approach for estimating HIV incidence, the number of new infections in the United States remained relatively stable between 2006 and 2009.", "The total number of persons aged 13 years and older diagnosed with HIV infection in the surveillance areas for the years 2006–2009 and reported through June 2010 was 29,279, 29,943, 28,831, and 27,040, respectively."]}
{"doc_id": 94023, "title": "", "abstract": ["The total number of persons aged 13 years and older diagnosed with HIV infection in the surveillance areas for the years 2006–2009 and reported through June 2010 was 29,279, 29,943, 28,831, and 27,040, respectively.", "Although the results did not demonstrate a significant increase in HIV incidence among MSM overall, they indicate an increase among young people aged 13–29 that is largely driven by increases in incidence among young MSM, particularly young black/African American MSM.", "In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%.", "We included in the analysis new diagnoses of HIV infection (regardless of the stage of disease) among individuals aged 13 years and older at diagnosis in the years 2006 through 2009, with a residence at diagnosis in one of the aforementioned areas, and reported to CDC through June 2010.", "If HIV testing has increased recently we may have overestimated HIV incidence in recent years."]}
{"doc_id": 94024, "title": "", "abstract": ["These assumptions include that HIV incidence has been stable in recent years, that the likelihood of HIV testing prior to a diagnosis of AIDS is constant both with respect to time and to duration of HIV infection, that all HIV infections will eventually be diagnosed (either through testing or through death), and that individuals accurately report the HIV testing and treatment information, especially the date of their last negative HIV test.", "Based on the revised stratified extrapolation approach for estimating HIV incidence, the number of new infections in the United States remained relatively stable between 2006 and 2009.", "Overall, HIV incidence in the United States was relatively stable 2006–2009; however, among young MSM, particularly black/African American MSM, incidence increased.", "As additional years' data become available we expect that the HIV incidence estimates presented here will be revised further, consistent with estimates based on surveillance data which are subject to reporting delay.", "Comparing by year, the percentage of persons diagnosed with HIV and AIDS concurrently (within the same month), the percentage of persons classified as repeat testers, and among the repeat testers, the average time since last negative HIV test, the data indicate that HIV testing behavior remained stable over the analysis period."]}
{"doc_id": 94025, "title": "", "abstract": ["The estimates for 2006–2009 continue to underscore the disproportionate toll that the HIV epidemic has taken on several populations in the United States including racial/ethnic and sexual minorities and injection drug users with 95% of new infections 2006–2009 estimated to have occurred in individuals in one or more of these groups.", "In 2007 a higher percentage were women, black/African American and in the youngest age group, and a lower percentage were injection drug users.", "In 2009, MSM accounted for 61% of new infections, heterosexual contact 27%, injection drug use (IDU) 9%, and MSM/IDU 3%.", "Transmission category | Injection drug use| 310 (15) [70–550]| | 330 (16) [80–570]|   | Heterosexual contactc | 1,700 (85) [1,100–2,300]| | 1,700 (84) [1,100–2,300]|   Subtotal c | | 2,000 [1,400–2,600]| 12.9 [9.0–16.7]| 2,100 [1,400–2,700]| 12.7 [8.7–16.8]", "Transmission category | Injection drug use| 860 (31) [310–1,400]| | 830 (28) [430–1,200]|   | Heterosexual contactb | 1,900 (69) [1,200–2,600]| | 2,100 (72) [1,300–3,000]|   Subtotal c | | 2,800 [1,900–3,700]| 3.2 [2.2–4.2]| 3,000 [2,000–4,000]| 3.4 [2.3–4.6]"]}
{"doc_id": 94026, "title": "", "abstract": ["Expanded, improved, and targeted prevention is necessary to reduce HIV incidence.", "With an estimated 21% of people living with HIV unaware of their HIV status [24], and the majority of new HIV infections transmitted by these individuals [25], it is important to expand testing to those people most at risk and provide them with care and prevention services.", "There is a need to address the prevention needs both of people at risk for HIV infection as well as of those living with HIV disease—those who are aware of their HIV status and those who are not.", "Adequate funding and services should be directed to individuals at greatest risk for acquiring and transmitting HIV infection, if we are to make a further impact on the HIV epidemic in the United States.", "By extrapolating from the same surveillance areas each year, we may have underestimated HIV incidence overall by approximately 4%; using different areas each year, we may have underestimated HIV incidence by about 3%."]}
{"doc_id": 94027, "title": "", "abstract": ["Consistent with the higher rates of HIV diagnoses among MSM in general [13], and of both HIV diagnoses and HIV incidence in African American and Hispanic/Latino men and women [14]–[15], the 2006–2009 HIV incidence estimates continue to demonstrate the disproportionate impact of HIV disease in these groups.", "HIV continues to be a major public health burden, disproportionately affecting several populations in the United States, especially MSM and racial and ethnic minorities.", "Each year blacks/African American males had the highest rate of new infections, and among women, black/African American women also experienced the highest HIV incidence rates (Figure 1).", "In each year, the most new infections occurred in males (accounting for 75%, 76%, 75%, and 77% of new infections respectively), MSM (56%, 58%, 56%, and 61%), and blacks/African Americans (44%, 42%, 46%, and 44%).", "Among young MSM the estimated number of new infections increased significantly from 2006–2009; the increase in incidence in this group was largely driven by a statistically significant increase in new HIV infections of 48% (12.2% annually) in young, black/African American MSM."]}
{"doc_id": 48023, "title": "", "abstract": ["In the current study, we tested the extent to which measures of these early- emerging normative processes may reveal disruptions in ASD at a point prior to the manifestation of overt symptoms.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "Autism Spectrum Disorders (ASD) affect approximately 1 in every 88 individuals6.", "In this way, widely varying initial liabilities can be converted into similar manifestations of impairment, giving rise to the spectrum of social disability we then call “autism”.", "a, eyes fixation, b, mouth fixation, c, body fixation, and d, object fixation for both typically-developing infants (in blue) and infants with autism (in red)."]}
{"doc_id": 48024, "title": "", "abstract": ["Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASD) exhibit mean decline in eye fixation within the first 2 to 6 months of life, a pattern not observed in infants who do not develop ASD.", "We hypothesized that in infants later diagnosed with ASD, preferential attention to others’ eyes might be diminished from birth onwards2,3,17.", "In infants later diagnosed with ASD, decline in eye fixation during the first 2 years is significantly associated with outcome levels of symptom severity", "These observations mark the earliest known indicators of social disability in infancy, but also falsify a prior hypothesis: in the first months of life, this basic mechanism of social adaptive action—eye looking—is not immediately diminished in infants later diagnosed with ASD; instead, eye looking appears to begin at normative levels prior to decline.", "This contradicts prior hypotheses of a congenital absence of social adaptive orientation2,3,17,18 and suggests instead that some social-adaptive behaviors may initially be intact in newborns later diagnosed with ASD."]}
{"doc_id": 92018, "title": "", "abstract": ["Microarrays first made the analysis of the transcriptome possible, and have produced much important information.", "A full description of the analysis and all sequencing data can be found in [51].", "These techniques have most recently been extended to the analysis of the transcriptome by what is known as RNA-Seq [22-28].", "Expression profiling by microarrays has been very successful.", "The transcriptome, the entire repertoire of transcripts in a species, represents a key link between information encoded in DNA and phenotype."]}
{"doc_id": 92019, "title": "", "abstract": ["Detecting genes with low expression will remain a problem for both techniques, but there are some applications, such as transcript discovery and isoform identification, where RNA-Seq will be the better choice.", "Expressed regions of the genome that correspond to genes not currently identified might be easier to detect with sequencing than with microarrays, because detection depends only on where reads map in the genome and not on whether that region is annotated.", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "There is a large range of expression values at the low end on arrays that that are undetectable by RNA- Seq.", "For highly expressed genes, small amounts of sequencing are sufficient, but for the middle and low end of expression levels, it is clear that many reads are needed."]}
{"doc_id": 92020, "title": "", "abstract": ["So far, we have discussed the advantages and disadvantages of sequencing and arrays that are inherent in the two techniques.", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "## Practical advantages and drawbacks of microarrays and RNA sequencing", "The greatest current advantage of arrays is their relatively low cost compared with sequencing (in our lab about 10X).", "Because microarray probes are designed on the basis of inferences from prior genomic sequence data, and light intensity is used as surrogate of gene expression, microarrays will miss exon junctions for novel expressed regions and RNA editing events, and cannot easily detect allele-specific differences in gene expression."]}
{"doc_id": 92021, "title": "", "abstract": ["RNA-Seq does not depend upon hybridization and thus does not suffer from this potential artifact.", "Finally, because RNA-Seq provides direct access to the sequence this technique can be used on species for which a full genome sequence is not available, whereas the only option in this case for microarrays is to hybridize RNA to a microarray designed for another species, which has limitations because of sequence divergence.", "That limitation of microarrays can, however, be overcome by what are known as tiling arrays, in which overlapping probes are designed to assay sequences over the entire genome [29-32].", "There are several things that sequencing RNA can do that microarrays cannot.", "Another strength of RNA-Seq is in the quantification of individual transcript isoforms [33,34]."]}
{"doc_id": 92022, "title": "", "abstract": ["Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "Because RNA-Seq provides direct access to the sequence, junctions between exons can be assayed without prior knowledge of the gene structure, RNA editing events can be detected, and knowledge of polymorphisms can provide direct measurements of allele-specific expression.", "These techniques have most recently been extended to the analysis of the transcriptome by what is known as RNA-Seq [22-28].", "With the more recent advent of techniques for direct sequencing of the transcriptional output of the genome, we can now at least begin to think about a complete transcriptional characterization of all the cells of an organism.", "Another strength of RNA-Seq is in the quantification of individual transcript isoforms [33,34]."]}
{"doc_id": 92023, "title": "", "abstract": ["Today, however, researchers are increasingly turning to direct high-throughput sequencing - RNA-Seq - which has considerable advantages for examining transcriptome fine structure - for example in the detection of allele-specific expression and splice junctions.", "But the rapid and high- throughput quantification of the transcriptome became a possibility only with the development of gene expression microarrays [3].", "Both sequencing and hybridizing mRNA to arrays are high-throughput ways to profile the transcriptome and for problems that can be addressed by both, they show similar performance and complement each other [29,47,49].", "Alternative splicing, the mechanism whereby different isoforms of proteins are generated, is acknowledged to be an important source of functional diversity in eukaryotes, but it has been relatively little studied at the level of the transcriptome, principally because of the difficulty of measuring expression for each isoform.", "Deep sequencing of RNA on Illumina's Genome Analyzer and HiSeq instruments as well as Applied Biosystems' SOLiD instrument are now fast- developing alternatives for profiling the transcriptome."]}
{"doc_id": 84027, "title": "", "abstract": ["A quasispecies is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Quasispecies theory accepts this trade-off, and proposes an upper limit to mutation rate, the “error threshold” (Figure 3A).", "RNA viruses exist as a quasispecies.", "A viral quasispecies, then, is a cloud of diverse variants that are genetically linked through mutation, interact cooperatively on a functional level, and collectively contribute to the characteristics of the population.", "Quasispecies Theory and the Behavior of RNA Viruses"]}
{"doc_id": 84028, "title": "", "abstract": ["RNA viruses exist as a quasispecies.", "More recently, quasispecies theory has been used to describe the evolutionary dynamics of RNA viruses, and many of its predictions have been validated experimentally in model systems [2], [14], [15].", "For the last 30 years, quasispecies theory has provided a population-based framework for understanding RNA viral evolution.", "Quasispecies Theory and the Behavior of RNA Viruses", "Quasispecies theory has had a profound influence on virology, and experiments with model RNA viruses have validated many of its predictions."]}
{"doc_id": 56021, "title": "", "abstract": ["These were used to prove exogenously delivered hESC-CMs could electrically couple to the host heart in a guinea pig MI model 7.", "Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Feasibility of this large-scale hESC-CM delivery requires cryopreservation of cells, which we validated in an established immunodeficient mouse model of MI 15."]}
{"doc_id": 56022, "title": "", "abstract": ["Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Pluripotent stem cells provide a potential solution to current epidemic rates of heart failure 1 by providing human cardiomyocytes to support heart regeneration 2.", "Human pluripotent stem cells have indisputable cardiomyocyte generating abilities and have been extensively investigated for repair of the injured heart 3,4,6–10.", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Nevertheless, the extent of remuscularization and electromechanical coupling seen here encourages further development of human cardiomyocyte transplantation as a clinical therapy for heart failure."]}
{"doc_id": 56023, "title": "", "abstract": ["Using a non- human primate (NHP) model of myocardial ischemia-reperfusion, we show that that cryopreservation and intra-myocardial delivery of 1 billion hESC-CMs generates significant remuscularization of the infarcted heart.", "Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts", "Studies of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in small animal models have shown favorable effects of this treatment 3–7.", "Our previous studies in mice 15, rats 6,8 and guinea pigs 7 gave no evidence of arrhythmias after hESC-CM engraftment, whereas arrhythmias were consistently observed in the current study.", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI)."]}
{"doc_id": 56024, "title": "", "abstract": ["These factors are relevant to clinical translation given that the human heart is larger (300g) with a slower basal rate (70 beats/min) than macaques used in this study.", "As an important translational step towards creating a viable clinical therapy, we investigated the ability of exogenously delivered hESC- CMs to engraft and electrically couple to infarcted host myocardium in a non- human primate (NHP) model of myocardial infarction (MI).", "Large animal models are important forerunners to human trials, because they impart real-world rigor to issues such as cell production, delivery and end-point analyses, while permitting mechanistic studies not possible in patients 18,19.", "Because ventricular arrhythmias can be life-threatening, they need to be understood mechanistically and managed en route to safe clinical translation.", "Nevertheless, the extent of remuscularization and electromechanical coupling seen here encourages further development of human cardiomyocyte transplantation as a clinical therapy for heart failure."]}
{"doc_id": 47021, "title": "", "abstract": ["The study period was restricted to 1 January 2000 and 31 December 2007, a time period often characterized as the modern ART era [14], in order to produce estimates that are more relevant to the current context of HIV antiretroviral management.", "The objective of this study is to examine temporal changes in life expectancy from 2000 to 2007 among HIV-positive individuals on ART in the U.S. and Canada and to compare life expectancy by selected sociodemographic and clinical characteristics.", "All study participants were included either when they were first dispensed ART, or from the start of the study period if initiation was pre-2000, regardless of whether they later discontinued or modified their therapeutic regimen.", "In a sensitivity analysis restricted to only those who were observed to initiate ART during our study period (18,591 participants contributing 1,057 deaths), the overall unweighted mortality rate was 18.9 (95% CI: 17.8, 20.1) per 1,000 person-years.", "Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007."]}
{"doc_id": 47022, "title": "", "abstract": ["Finally, due to the increased risk of age-related co- morbidities among HIV-positive adults, it is possible life expectancy may plateau or decrease in the future; it will be important to monitor life expectancy estimates as more adults age with HIV.", "Indeed, given that many individuals living with HIV have demographic, clinical, and behavioral characteristics associated with greater morbidity and mortality than the general population [20], [21], the gap in life expectancy may be attributable to other lifestyle factors and not just HIV infection.", "However, in tandem with increases in life expectancy following the introduction of ART, HIV-positive individuals are increasingly experiencing age-related co-morbid conditions, which are impacting both the length and quality of their lives [7], [8].", "In conclusion, the results of this study document increasing longevity for individuals living with HIV in the U.S. and Canada.", "A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population."]}
{"doc_id": 47023, "title": "", "abstract": ["We hypothesize a number of possible reasons for these differences, including increased comorbidity with greater non-AIDS related mortality, as well as challenges with ART adherence, active drug use, hepatitis C co- infection, housing instability, and lower socioeconomic status.", "Indeed, given that many individuals living with HIV have demographic, clinical, and behavioral characteristics associated with greater morbidity and mortality than the general population [20], [21], the gap in life expectancy may be attributable to other lifestyle factors and not just HIV infection.", "Mortality rates are susceptible to bias from informative censoring.", "There are also considerable differences in life expectancy by HIV transmission group, with lower life expectancies reported in all periods for individuals with a history of IDU.", "Differences in life expectancy by race were also evident, with white individuals having higher life expectancies in all periods."]}
{"doc_id": 47024, "title": "", "abstract": ["Finally, in a sensitivity analysis (further described in Appendix S4), when the sample was restricted to those who initiated therapy after 2000, life expectancy at 20 years increased to 45.1 years (SE 0.3).", "Our results are consistent with previous studies that have examined the life expectancy of HIV-positive individuals on ART [22].", "No study has had a sufficient sample size to determine whether gains in life expectancy for HIV-positive individuals are similar to those observed in the general population, or are similar across sex, race, or transmission groups.", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "A caveat of life expectancy analyses in general is that they may underestimate more recent improvements in extending life since age-specific mortality rates are based on a given point in time and assumed to apply for the duration of an individual's life [22]."]}
{"doc_id": 47025, "title": "", "abstract": ["Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "The health gains associated with ART use have been substantial at both the individual and societal level [1], [2]."]}
{"doc_id": 47026, "title": "", "abstract": ["While ART has led to significant increases in survival among HIV-positive adults globally, the effect of ART on life expectancy in the U.S. and Canada has not been well characterized.", "Therefore, the increase in life expectancy in the more recent time periods may reflect both a lower mortality rate in patients initiating ART and the mortality in those with a longer duration of ART use.", "However, in tandem with increases in life expectancy following the introduction of ART, HIV-positive individuals are increasingly experiencing age-related co-morbid conditions, which are impacting both the length and quality of their lives [7], [8].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.", "The marked increase in life expectancy at age 20 from 36.1 years in 2000–2002 to 51.4 years in 2006–2007 is a testament to the improvements and overall success of ART."]}
{"doc_id": 47027, "title": "", "abstract": ["Since the introduction of combination antiretroviral therapy (ART), there have been considerable improvements in survival among HIV-positive individuals, as regimens have become more effective, simpler, and better tolerated [1]–[3].", "While prior studies have observed similar decreases in mortality and increases in life expectancy among HIV-positive individuals as a result of ART [23], such findings have often been localized at the provincial or state level, and may now be less relevant to the current context of antiretroviral care [24], [25].", "In the early years of ART availability, mortality was highest in the first year after ART initiation, but this has decreased over time.", "However, in tandem with increases in life expectancy following the introduction of ART, HIV-positive individuals are increasingly experiencing age-related co-morbid conditions, which are impacting both the length and quality of their lives [7], [8].", "Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized."]}
{"doc_id": 47028, "title": "", "abstract": ["### Statistical Analyses", "Sensitivity analyses: Restricting to cohorts with death from registries.", "To further investigate this issue, we conducted sensitivity analyses taking into account loss to follow-up, and were reassured to find little differences in our estimates.", "We calculated all-cause mortality rates (per 1,000 person-years) by dividing the total number of deaths by the total number of person-years of observation.", "In effort to reduce bias from informative censoring, we used weighted regression methods to estimate mortality rates, using an indicator variable that was created to identify participants who were lost to follow-up."]}
{"doc_id": 73028, "title": "", "abstract": ["Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "Random-effects meta-analysis of the association between job strain and incident coronary heart disease", "Association of job strain with incident coronary heart disease in subgroups"]}
{"doc_id": 73029, "title": "", "abstract": ["In addition to age, sex, and socioeconomic status,24 we used lifestyle factors and conventional coronary risk factors as covariates because they could be related to both job strain and coronary heart disease, and might therefore mediate or confound the association between job strain and disease.", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "In our study, the magnitude of the relation between job strain and incident coronary heart disease was slightly strengthened in models that excluded disease events that occurred in the first 3 years or 5 years of follow-up.", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations."]}
{"doc_id": 73030, "title": "", "abstract": ["Job strain—the combination of high job demands and low control at work—is one of the most widely studied definitions of psychosocial stress.2", "Moreover, the importance of job strain as a risk factor for coronary heart disease continues to be debated because of several methodological shortcomings.", "Although some studies4–6 have shown that job strain is associated with a more than doubling in risk of coronary heart disease, findings from a meta-analysis7 of cohort studies suggest that this excess risk is probably modest, at about 40%.", "Association of job strain with incident coronary heart disease in subgroups", "Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease."]}
{"doc_id": 73031, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "We noted an association between job strain and coronary heart disease for sex, age groups, socioeconomic strata, and region, and after adjustments for socioeconomic status, and lifestyle and conventional risk factors.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data", "Similarly, we noted few differences in the effect of job strain on coronary heart disease between studies from Nordic countries, continental Europe, and the UK (figure 2)."]}
{"doc_id": 73032, "title": "", "abstract": ["Our findings suggest that job strain is associated with a small, but consistent, increased risk of an incident event of cardiovascular heart disease.", "The population attributable risk in our study suggests that if the recorded association were causal, then job strain would account for a notable proportion of coronary heart disease events in working populations.", "In analysis adjusted for age and sex only, job strain was associated with a significant increase in risk of incident coronary heart disease (figure 1).", "Nevertheless, studies that focus on external sources of stress, such as organisational downsizing, death of a child, and caring for a sick spouse at home, have confirmed that stress at work and in private life might be associated with an increased risk of coronary heart disease.45–47", "Association of job strain with incident coronary heart disease in subgroups"]}
{"doc_id": 73033, "title": "", "abstract": ["Job strain—the combination of high job demands and low control at work—is one of the most widely studied definitions of psychosocial stress.2", "We defined high job demands as having a job-demand score that was greater than the study-specific median score; similarly, we defined low job control as having a job control score that was lower than the study-specific median score.", "Briefly, participants were asked to answer questions about the psychosocial aspects of their job.", "For each participant, mean response scores were calculated for job- demand items (ie, questions about whether the participant had to work very hard, had excessive amounts of work, conflicting demands, or insufficient time) and job-control items (ie, questions about decision freedom and learning new things at work).", "We defined exposure as job strain (high demands and low control) versus no strain (all other combinations) according to the job-strain model.1"]}
{"doc_id": 44015, "title": "", "abstract": ["Early studies have shown that brain microglia accumulate around Aβ deposits and occasionally contain Aβ in AD patients (D'Andrea et al., 2004; McGeer et al., 1987; Perlmutter et al., 1990) and transgenic mouse models of AD (Dickson, 1999; Frautschy et al., 1998; Stalder et al., 1999).", "At late stages of AD, microglia may paradoxically contribute to the disease by releasing pro-inflammatory cytokines in response to Aβ deposition (El Khoury et al., 2007; Hickman et al., 2008).", "Examination of a second model of AD, APPPS1–21 mice that have been bred to Cx3cr1GFP/+ mice in order to visualize endogenous microglia, confirmed that complete TREM2 deficiency results in a marked reduction of GFP+ microglia clusters around amyloid plaques (Fig. S3D–F).", "The association between the R47H mutation of TREM2 and the increased risk for late onset AD suggests that microglia may require TREM2 to respond to Aβ deposition and to limit neuronal degeneration.", "Although the pathology of these forms of dementia differs from that of AD and often involves demyelination, our study suggests that TREM2 may be required for microglia to sense glycolipids such as SM and sulfatides that are exposed on damaged myelin sheaths; thus, TREM2 binding to these glycolipids may trigger the microglial response to damaged myelin, which is necessary to clear myelin residues and produce trophic factors that induce repair and remyelination."]}
{"doc_id": 44016, "title": "", "abstract": ["We conclude that TREM2 is a receptor that detects damage-associated lipids, thereby enabling microglia to sense Aβ accumulation and cell damage, as well as supporting microglia survival and Aβ reactive microgliosis.", "TREM2 promotes microglia survival ex vivo and in vivo", "Our findings demonstrated that TREM2 functions as a microglial sensor that is alerted by damage-induced molecules that share a common lipidic backbone and an anionic group.", "We further show that TREM2 sustains microglia survival by synergizing with colony stimulating factor-1 receptor (CSF-1R) signaling.", "However, TREM2 signaling may indirectly supports phagocytosis by promoting survival of activated microglia."]}
{"doc_id": 44017, "title": "", "abstract": ["Early studies have shown that brain microglia accumulate around Aβ deposits and occasionally contain Aβ in AD patients (D'Andrea et al., 2004; McGeer et al., 1987; Perlmutter et al., 1990) and transgenic mouse models of AD (Dickson, 1999; Frautschy et al., 1998; Stalder et al., 1999).", "At late stages of AD, microglia may paradoxically contribute to the disease by releasing pro-inflammatory cytokines in response to Aβ deposition (El Khoury et al., 2007; Hickman et al., 2008).", "The association between the R47H mutation of TREM2 and the increased risk for late onset AD suggests that microglia may require TREM2 to respond to Aβ deposition and to limit neuronal degeneration.", "Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014).", "One of the many effects of Aβ deposition is the induction of reactive microgliosis, which involves the expansion of microglia and conversion to an activated state (Ransohoff and Cardona, 2010)."]}
{"doc_id": 44018, "title": "", "abstract": ["Microglia contribute to Aβ clearance, at least in the early phases of neurodegeneration (El Khoury et al., 2007); however, the ability of microglia to clear Aβ may wane with age (Streit et al., 2004; Streit and Xue, 2009).", "Previous studies have suggested that the CSF-1-CSF-1R pathway promotes reactive microgliosis (Chitu and Stanley, 2006) and Aβ clearance (Mitrasinovic et al., 2003); consistent with this, CSF1-deficient osteopetrotic (op/op) mice are characterized by increased deposition of Aβ,scarcity of microgliosis and neuronal loss (Kaku et al., 2003).", "One of the many effects of Aβ deposition is the induction of reactive microgliosis, which involves the expansion of microglia and conversion to an activated state (Ransohoff and Cardona, 2010).", "Moreover, some TREM2 lipidic ligands accumulate on the cell surface of neurons and glial cells damaged by Aβ accumulation, such as PS (Eckert et al., 2005; McLaurin and Chakrabartty, 1996), or are released by damaged myelin, such as SM and sulfatides.", "These included: negatively charged phospholipids, which have been shown to associate with Aβ in lipid membranes (Ahyayauch et al., 2012; Nagarathinam et al., 2013); membrane phospholipids, such as phosphatidylserine, which are exposed by damaged neurons and glial cells; and anionic and zwitterionic non-phosphate lipids, such as sulfatides and sphingomyelin, which are released by damaged myelin."]}
{"doc_id": 44019, "title": "", "abstract": ["In 5XFAD mice, plaque-associated microglia showed morphological changes associated with microglia activation including a partial retraction and a slight hypertrophy of the microglial cell processes as well as an increase in size (Fig. 4E–G).", "Flow cytometric analysis of isolated microglia confirmed phenotypic changes in 5XFAD microglia consistent with increased activation, including a marked increase in cell size and strong upregulation of MHC-II, CD11c and CD11b (Fig. S2C–G).", "These changes in microglia morphology were significantly attenuated in Trem2+/−5XFAD and Trem2−/−5XFAD mice (Fig. 4E–G) and were paralleled by an increased distance between microglia and the center of their associated plaques (Fig. 4H).", "Moreover, TREM2 deficiency had very little impact on microglia uptake of Aβ aggregates (Fig. S5E, Movie S4) or their subsequent proteolytic processing, as demonstrated by similar degradation of the intracellular concentration of Aβ after initial loading (Fig. S5F).", "However, microglia isolated from Trem2−/−5XFAD and 5xFAD mice engulfed apoptotic cells equally well (Fig. 6D, E)."]}
{"doc_id": 44020, "title": "", "abstract": ["However, microglia isolated from Trem2−/−5XFAD and 5xFAD mice engulfed apoptotic cells equally well (Fig. 6D, E).", "In contrast with previous reports (Hsieh et al., 2009; Takahashi et al., 2007; Takahashi et al., 2005), we found that the engagement of TREM2 does not directly mediate phagocytosis of apoptotic cells.", "Indeed, a recently published RNA-seq dataset demonstrated that Trem2 is specifically expressed in microglia, but not other cells in the CNS under steady state conditions (Butovsky et al., 2014).", "Flow cytometric analysis of isolated microglia confirmed phenotypic changes in 5XFAD microglia consistent with increased activation, including a marked increase in cell size and strong upregulation of MHC-II, CD11c and CD11b (Fig. S2C–G).", "Although TREM2 expression has been reported in CNS cells other than microglia (Guerreiro et al., 2013b; Sessa et al., 2004), this finding is controversial (Jiang et al., 2014)."]}
{"doc_id": 44021, "title": "", "abstract": ["Examination of a second model of AD, APPPS1–21 mice that have been bred to Cx3cr1GFP/+ mice in order to visualize endogenous microglia, confirmed that complete TREM2 deficiency results in a marked reduction of GFP+ microglia clusters around amyloid plaques (Fig. S3D–F).", "Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014).", "While no statistical significant difference was observed among non-plaque-associated microglia (Fig. S4A), we noted a high degree of microglia clustering around amyloid plaques in 5XFAD mice (average 4.28 microglia per plaque), which gradually decreased in Trem2+/− 5XFAD mice (average 3.42 microglia per plaque) and Trem2−/−5XFAD mice (average 2.36 microglia per plaque) (Fig. 4A, B).", "However, co-staining coronal brain sections of Trem2−/−5XFAD and 5XFAD mice with Iba-1 and X-34 to visualize microglia and amyloid plaques respectively, showed remarkable differences.", "This corroborates our previous observation that TREM2 haploinsufficiency correlates with fewer amyloid- associated microglia in APPPS1–21xCx3cr1GFP/+ mice (Ulrich et al., 2014)."]}
{"doc_id": 44022, "title": "", "abstract": ["Consistent with this hypothesis, we recently showed that APPPS1–21 transgenic mice, an AD model with rapid deposition of Aβ, have a marked decrease in the number and size of Aβ-associated microglia when they lack one copy of the Trem2 gene, although this defect did not increase Aβ accumulation (Ulrich et al., 2014).", "Examination of a second model of AD, APPPS1–21 mice that have been bred to Cx3cr1GFP/+ mice in order to visualize endogenous microglia, confirmed that complete TREM2 deficiency results in a marked reduction of GFP+ microglia clusters around amyloid plaques (Fig. S3D–F).", "However, co-staining coronal brain sections of Trem2−/−5XFAD and 5XFAD mice with Iba-1 and X-34 to visualize microglia and amyloid plaques respectively, showed remarkable differences.", "We found that TREM2 deficiency and haploinsufficiency augment β-amyloid (Aβ) accumulation due to dysfunctional response of microglia, which become apoptotic and fail to cluster around Aβ plaques.", "Moreover, while 27.9% of microglia distribution in 5XFAD mice with respect to amyloid plaques was not explained statistically by chance, the frequency of nonrandom microglia distribution was reduced to 9.5% in Trem2−/− 5XFAD mice (Fig. 4D)."]}
{"doc_id": 65019, "title": "", "abstract": ["NK cell memory to haptens and viruses depended upon CXCR6, a chemokine receptor on hepatic NK cells that was required for memory NK cell persistence but not for Ag recognition.", "Moreover, anti-CXCR6 enhanced the Ag-specific cytotoxicity of memory NK-cells in vitro, whereas CXCL16 attenuated cytotoxicity.", "Although CXCR6 is expressed on some human NK-cells44, it is uknown whether this or other human NK populations possess distinct functional properties, such as the capacity to carry Ag- specific memory.", "Having established that memory NK-cells require CXCR6 for CHS, we asked if this pathway plays a role in anti-viral NK-cell memory.", "In each case, memory NK-cells were concentrated in the liver and were critically dependent upon CXCR6, which was not required for Ag recognition but appears to regulate effector function and survival of memory NK-cells."]}
{"doc_id": 65020, "title": "", "abstract": ["The idea that NK-cells can mediate adaptive immunity was initially suggested by observations that mouse strains that lacked T- and B-cells developed vigorous CHS responses to different haptens17, 18.", "We now report that hepatic, but not splenic or naïve NK cells also develop specific memory to vaccines containing Ags from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus-1 (HIV).", "While CXCR6 alone is apparently insufficient to enable NK-cell memory, our adoptive transfer experiments are consistent with a role in NK-cell-mediated adaptive immunity.", "To assess more broadly whether NK-cells can develop anti-viral memory, we immunized Rag1−/− mice subcutaneously with either noninfectious virus-like particles (VLPs) containing hemagglutinin (HA) and matrix protein (M1) from influenza A/PR/8/3430, 31 (Supplementary Fig. 2) or UV-inactivated vesicular stomatitis virus (UV-VSV)32.", "Moreover, Rag-independent memory to HIV-1 and influenza was inducible in both C57BL/6 and BALB/c mice and was always specific for the virus used during sensitization (Fig. 3b), indicating that hepatic NK-cells can develop specific memory to diverse viral Ags irrespective of viral host restrictions or genetic background"]}
{"doc_id": 65021, "title": "", "abstract": ["While these results indicated that lymphopenia-induced proliferation is not unique to memory NK cells, our findings raised the possibility that NK-cell proliferation was necessary to maintain memory.", "These results are consistent with recent investigations on NK cell memory to MCMV13, although there are differences between the tissue distribution of the ensuing memory NK-cells, genetic background restriction and possibly also the viral recognition mechanism.", "Whatever the mechanism, the finding that T and B cell-deficient mice can develop protective memory against lethal infections with influenza A and VSV has intriguing implications for vaccine development and anti-viral immunity.", "Thus, the pathway(s) triggered in memory NK cells by cognate Ag overrides inhibitory signals from MHC-I. Moreover, NK-cell memory to haptens and viruses developed in both Balb/c and C57BL/6 mice, which express distinct MHC and Ly49 haplotypes, suggesting that Ag recognition by hepatic memory NK-cells differs from the way by which conventional NK-cells detect pathological cells with altered or absent MHC-I.", "Thus, in the absence of T and B-cells, memory NK-cells can provide effective and specific protection against certain viruses, at least when the infectious agent is administered locally and at a moderate dose."]}
{"doc_id": 65022, "title": "", "abstract": ["Liver NK-cells develop specific memory to haptens.", "Having confirmed that hepatic memory NK-cells are long-lived and selectively migrate to sites of hapten challenge to mediate Ag-specific recall responses even after a prolonged Ag-free interval, we asked whether NK-cells also develop memory to other exogenous Ags.", "A response was only elicited when animals were challenged with the sensitizing hapten, but not the other hapten.", "Furthermore, hapten sensitization does not change the expression of Ly49 receptors or NKG2D or mRNAs for any other known NK-cell expressed activating receptors (our unpublished data).", "Liver NK-cells develop specific memory to viral Ags."]}
{"doc_id": 65023, "title": "", "abstract": ["The paucity of GFP+ NK-cells in livers of CXCR6gfp/gfp mice indicates that the CXCR6+ subset, unlike CXCR6− NK-cells, requires sustenance from sinusoidal endothelium, which constitutively presents CXCL16, a chemokine that exists as both a secreted polypeptide and a luminal surface transmembrane protein.", "Adaptive immune responses mediated by this population depend upon CXCR6, which is expressed on ~half of helpatic NK-cells, suggesting that the liver harbors two different NK-cell populations.", "Moreover, when we transferred equal numbers of GFP+ and GFP− hepatic NK-cells sorted from Cxcr6−/− or Cxcr6−/− donors, the CXCR6-heterozygous NK-cells expanded in the liver of Rag2−/−Il2rg−/− recipients irrespective of their GFP expression, while in recipients of CXCR6-deficient NK-cells only the GFP− subset expanded, whereas GFP+ NK-cells were very rare (Fig. 6d).", "Thus, CXCR6 is required for the development and/or survival of CXCR6+ NK-cells exclusively in the liver where CXCL16 is constitutively expressed.", "CXCR6 is also expressed on hepatic NK cells22, but its significance for NK-cell biology had been unclear."]}
{"doc_id": 45030, "title": "", "abstract": ["Several organizations have developed diabetes guidelines specific to, or including, older adults.", "The ADA thanks the following individuals for their excellent presentations at the Consensus Development Conference on Diabetes and Older Adults: Edward Gregg, PhD; Nicolas Musi, MD; M.E. Miller, PhD; R. Harsha Rao, MD, FRCP; Craig Williams, PharmD, BCPS, FNLA; Barbara Resnick, PhD, CRNP, FAAN, FAANP; Carol M. Mangione, MD, MSPH; Jill P. Crandall, MD; Caroline S. Blaum, MD, MS; Jeff D. Williamson, MD, MHS; John M. Jakicic, PhD; Tamara Harris, MD, MS; and Naushira Pandya, MD, CMD.", "Additional consensus recommendations for care of older adults with diabetes", "The European Diabetes Working Party for Older People recently published guidelines for treating people with diabetes aged ≥70 years.", "Although several organizations have developed guidelines that pertain to older adults and/or those with significant comorbidity, lack of evidence makes it somewhat difficult to provide concrete guidance for clinicians."]}
{"doc_id": 45031, "title": "", "abstract": ["Consensus recommendations for research questions about diabetes in older adults", "Additional consensus recommendations for care of older adults with diabetes", "Studies of glycemic control targets in critically ill patients did include older adults, and therefore the recommendations for insulin infusions and glycemic goals of the ADA (17) are reasonable for older adults in intensive care units.", "What issues need to be considered in individualizing treatment recommendations for older adults?", "What are consensus recommendations for treating older adults with or at risk for diabetes?"]}
{"doc_id": 45032, "title": "", "abstract": ["Patterns were generally consistent across age-groups (60–69, 70–79, and ≥80 years) (35).", "Statin trials for secondary prevention of CVD in adults with diabetes have also demonstrated comparable relative reductions in recurrent cardiovascular events and mortality by age-group (42).", "Prespecified subgroup analyses suggested that the disproportionate cardiovascular mortality risk in the intensive glycemic control group was in participants under the age of 65 years as opposed to older participants.", "Older adults with diabetes have the highest rates of major lower-extremity amputation (9), myocardial infarction (MI), visual impairment, and end-stage renal disease of any age-group.", "A study from the U.K. General Practice Research Database showed that for type 2 diabetic patients aged ≥50 years (mean age 64 years) whose treatment was intensified from oral monotherapy to addition of other oral agents or insulin, there was a U-shaped association between A1C and mortality, with the lowest hazard ratio for death at an A1C of about 7.5%."]}
{"doc_id": 82020, "title": "", "abstract": ["The odds of clinically significant improvements in risk factors were increased further with greater weight losses, such that those who lost 5–10% had greater odds of improvements than those who lost 2–5%, and those who lost 10–15% had greater odds of improvement than those who lost 5–10% (see the Supplemental Materials).", "However, those who lost 2–5% of their body weight had increased odds of having significant improvements in SBP (odds ratio 1.24 [95% CI 1.02–1.50]), glucose (1.75 [1.40–2.19]), HbA1c (1.80 [1.44–2.24]), and triglycerides (1.46 [1.14–1.87]), and those who lost 5 to <10% of their body weight had increased odds of significant improvement in all risk factors.", "Clinical criteria| Gained >2%| Stable Gained ≤2 or lost <2%| Lost ≥2 to <5%| Lost ≥5 to <10%| Lost ≥10 to <15%| Lost ≥15%   ---|---|---|---|---|---|---   5 mmHg decrease in SBP| 0.86 (0.70–1.06)| 1.0| 1.24 (1.02–1.50)| 1.56 (1.27–1.91)| 2.29 (1.79–2.93)| 2.65 (2.00–3.50)   5 mmHg decrease in DBP| 1.03 (0.83–1.28)| 1.0| 1.05 (0.86–1.28)| 1.48 (1.20–1.82)| 1.60 (1.25–2.06)| 2.39 (1.81–3.16)   20 mg/dL decrease in glucose| 1.13 (0.87–1.46)| 1.0| 1.75 (1.40–2.19)| 3.24 (2.57–4.09)| 4.07 (3.09–5.36)| 7.92 (5.78–10.85)   0.05% decrease in HbA1c| 1.17 (0.91–1.50)| 1.0| 1.80 (1.44–2.24)| 3.52 (2.81–4.40)| 5.44 (4.15–7.13)| 10.02 (7.31–13.73)   5 mg/dL increase in HDL| 0.88 (0.71–1.11)| 1.0| 1.13 (0.93–1.39)| 1.69 (1.37–2.07)| 2.30 (1.80–2.93)| 4.34 (3.30–5.72)   5 mg/dL increase in HDL (not on medications)| 0.79 (0.54–1.15)| 1.0| 0.99 (0.71–1.39)| 1.52 (1.08–2.15)| 2.54 (1.68–3.82)| 5.27 (3.36–8.27)   10 mg/dL decrease in LDL| 1.17 (0.95–1.45)| 1.0| 1.05 (0.86–1.29)| 1.34 (1.09–1.64)| 1.26 (0.98–1.62)| 1.34 (1.02–1.78)   10 mg/dL decrease in LDL (not on medications)| 1.39 (0.97–1.99)| 1.0| 0.97 (0.69–1.36)| 1.41 (1.00–2.00)| 1.28 (0.83–1.96)| 1.52 (0.96–2.41)   40 mg/dL decrease in triglycerides| 0.80 (0.60–1.06)| 1.0| 1.46 (1.14–1.87)| 2.20 (1.71–2.83)| 3.99 (2.97–5.35)| 7.18 (5.19–9.93)", "For example, the statement from the Centers for Disease Control and Prevention website cites a review by Blackburn (6) for the benefits of 5% weight loss and the National Heart, Lung, and Blood Institute Clinical Guidelines (7) as the reference for the benefit of a 10% weight loss.", "The odds of clinically significant improvements in most risk factors were even greater in those who lost 10–15% of their body weight."]}
{"doc_id": 82021, "title": "", "abstract": ["Look AHEAD is a multicenter, randomized clinical trial examining the long-term effects of lifestyle interventions on cardiovascular morbidity and mortality in 5,145 overweight or obese participants with type 2 diabetes who were randomly assigned to intensive lifestyle intervention (ILI) or to usual care, referred to as diabetes support and education (DSE) (8,9).", "Look AHEAD is continuing to follow its participants over time and, thus, will be able to determine the longer-term impact of modest weight losses on risk factors and whether these modest weight losses ultimately affect cardiovascular morbidity and mortality.", "The odds of clinically significant improvements in risk factors were increased further with greater weight losses, such that those who lost 5–10% had greater odds of improvements than those who lost 2–5%, and those who lost 10–15% had greater odds of improvement than those who lost 5–10% (see the Supplemental Materials).", "Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes.", "Overweight and obese individuals are frequently encouraged to lose 5–10% of their weight and are told that weight losses of that magnitude will help improve their cardiovascular disease (CVD) risk factors."]}
{"doc_id": 82022, "title": "", "abstract": ["Look AHEAD is a multicenter, randomized clinical trial examining the long-term effects of lifestyle interventions on cardiovascular morbidity and mortality in 5,145 overweight or obese participants with type 2 diabetes who were randomly assigned to intensive lifestyle intervention (ILI) or to usual care, referred to as diabetes support and education (DSE) (8,9).", "Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes", "We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes.", "Odds ratio (95% CI) for the percentage of Look AHEAD cohort achieving clinically meaningful changes in CVD risk factors", "These results provide empirical support for the assertion that modest weight losses of 5–10% of initial weight are sufficient to produce significant, clinically relevant improvements in CVD risk factors in overweight and obese patients with type 2 diabetes."]}
{"doc_id": 82023, "title": "", "abstract": ["Compared with weight- stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]).", "The odds of clinically significant improvements in risk factors were increased further with greater weight losses, such that those who lost 5–10% had greater odds of improvements than those who lost 2–5%, and those who lost 10–15% had greater odds of improvement than those who lost 5–10% (see the Supplemental Materials).", "However, those who lost 2–5% of their body weight had increased odds of having significant improvements in SBP (odds ratio 1.24 [95% CI 1.02–1.50]), glucose (1.75 [1.40–2.19]), HbA1c (1.80 [1.44–2.24]), and triglycerides (1.46 [1.14–1.87]), and those who lost 5 to <10% of their body weight had increased odds of significant improvement in all risk factors.", "Previous studies, mostly with nondiabetic participants, and meta-analyses have shown that weight loss is associated with improvements in other CVD risk factors (2,7), including blood pressure (18), triglycerides (19), and HDL cholesterol (20).", "Because weight losses of just 5 to <10% of initial body weight significantly increased the odds of achieving clinically meaningful changes in glycemic control, blood pressure, HDL cholesterol, and triglycerides at 1 year, emphasizing modest weight losses seems to be an appropriate clinical message for overweight and obese patients with type 2 diabetes."]}
{"doc_id": 95019, "title": "", "abstract": ["Similar to the TGF-β pathway, the Wnt/β-catenin pathway is also implicated in EMT and epithelial plasticity during development and cancer.", "Taken together, these data implicate the Wnt/β-catenin pathway in epithelial plasticity and EMT in both development and cancer.", "Furthermore, in vitro studies confirm that the Wnt/β-catenin pathway is capable of inducing epithelial plasticity.", "Wnt signaling likely plays a role in numerous aspects of mammary development including cell fate determination, maintenance of mammary progenitor cell populations, branching morphogenesis and alveolar differentiation [135].", "### Wnt/β-catenin Pathway"]}
{"doc_id": 95020, "title": "", "abstract": ["Instead, in cancer, the highly variable environmental cues coupled with genetic heterogeneity of the tumor may lead to varying degrees of epithelial plasticity and reactivation of developmental migratory programs, resulting in the induction of single cell and/or collective cell migration.", "In contrast to the inducers of EMT, inhibitors of epithelial plasticity may be downregulated during development and cancer, leading to an induction of a more mesenchymal phenotype.", "These changes in epithelial plasticity permit a dynamic cell migratory response dependent on the constitution of the cell, its gene expression, and on input from the local environment.", "However, unlike developmental EMT, which typically proceeds stepwise under the tight control of morphogenic signals and generally correlates with a cell fate change, oncogenic EMT occurs in the context of unpredictable genetic changes present in the tumor cells, as well as an abnormal local tumor environment.", "During primary tumor formation, the genetic and epigenetic changes in the tumor cells coupled with alterations in the tumor microenvironment promote EMT."]}
{"doc_id": 95021, "title": "", "abstract": ["Genes/pathways implicated in EMT and epithelial plasticity and misexpressed in breast cancer progression include Cripto-1, Snail/Slug/Twist, Six1, Wnt and TGF-β signaling (Inset).", "The spectrum of EMT inducers implicated in breast cancer includes both signaling pathways such as TGF-β, Wnt/β-catenin, and Cripto, as well as transcription factors including Twist, Snail/Slug, Lbx1, and Six1.", "The underlying mechanism of Six1-induced EMT and metastasis appears to be, at least in part, through the activation of TGF-β signaling [37], a pathway that is well -established as a strong inducer of EMT in breast cancer [31].", "Additionally, the Wnt/β-catenin pathway induces EMT in numerous models including mammary epithelial and carcinoma cell lines [32, 109].", "Together these results suggest that EMT programs beyond those critical for mammary gland development may be activated in human breast cancer and contribute to an oncogenic EMT and breast cancer aggressiveness."]}
{"doc_id": 95022, "title": "", "abstract": ["Because local invasion is thought to be a necessary first step in metastatic dissemination, EMT and epithelial plasticity are hypothesized to contribute to tumor progression.", "The epithelial plasticity and EMT permits local spread of tumor cells.", "EMT and epithelial plasticity enable the tumor cells to de-adhere from their neighboring cells, invade through the underlying basement membrane and move into the surrounding tissue either as single cells (blue) or as clusters (light blue) of cells.", "Recently, a novel hypothesis for the role of EMT in cancer progression has been proposed, whereby epithelial and mesenchymal cells cooperate during metastatic dissemination, potentially eliminating the need for MET at the distant site [77].", "Evidence for the role of EMT in cancer is complicated by the fact that at the secondary site the metastatic cells likely undergo a reversion or MET, permitting colonization of the distant site."]}
{"doc_id": 95023, "title": "", "abstract": ["After delamination and migration throughout the developing embryo, these cells give rise to various cell types and tissue structures including facial and cervical structures, the neurons of the peripheral nervous system, pigment cells and the cells of the adrenal medulla.", "In addition, migration of single cells and potentially clusters of cells also can access the bloodstream leading to hematogenous spread of tumor cells and the development of distant metastatic disease.", "Interestingly, TGF-β signaling, which induces EMT and single cell migration, is necessary for intravasation, extravasation and blood borne metastasis [82, 85].", "These cells ingress through the primitive streak and migrate into the underlying tissue.", "Therefore EMT and MET are critical in the development of multiple organs, and utilize diverse and tissue specific molecular mechanisms."]}
{"doc_id": 95024, "title": "", "abstract": ["In addition, recently non-coding RNAs, including microRNAs, have been implicated in EMT in cancer and development [93, 94].", "In addition to the induction of EMT, which results in single cell dissemination of tumor cells, collective migration of groups of tumor cells may also be a mechanism by which cancer can spread [63].", "Furthermore, activated TGF-β signaling has been observed in breast cancer bone metastases and contributes to the establishment of these lesions [134].", "In addition, migration of single cells and potentially clusters of cells also can access the bloodstream leading to hematogenous spread of tumor cells and the development of distant metastatic disease.", "The implication of this observation is that cancer cells may readily reactivate developmental properties out of context in the adult, which then contribute to tumorigenesis via inducing accelerated proliferation, resistance to apoptosis and evasion of senescence."]}
{"doc_id": 51023, "title": "", "abstract": ["The disruption in the intestinal homeostasis results in the defective mucus barrier with increased permeability that results in inflammation and injury of the intestinal mucosal cells [1, 5•].", "Increased numbers of mucosa-associated (adherent invasive) E. coli are observed in IBD.", "Many experimental helminth infections such as Nippostrongylus brasiliensis and Trichinella spiralis have been shown to cause intestinal goblet cell hyperplasia and increased mucus secretion, mediated by Th2 immune responses (IL-13 and IL-4), contributing to increased intestinal mucosal protection and worm expulsion [48, 63].", "The pathogens have evolved mechanisms to invade the intestinal mucosal cells by penetrating through the mucus layers.", "The intestinal mucosal epithelium consists of four main cell types—absorptive enterocytes, goblet cells, Paneth cells, and enteroendocrine cells—which undergo continuous cycles of renewal."]}
{"doc_id": 51024, "title": "", "abstract": ["However, chronic infection results in the depletion of goblet cells and quantitative and qualitative alteration in mucus layers due both to altered synthesis and secretion of mucins and to microbial glycosidases and proteases [1, 2, 48].", "Mucin secretion is frequently coupled with increased synthesis of mucins, but chronic secretion may result in goblet cell depletion and decreased synthesis of mucins.", "Goblet cells are reduced in number and size in ulcerative colitis.", "Increased numbers of mucosa-associated (adherent invasive) E. coli are observed in IBD.", "These mice showed aberrant assembly and processing of mucin complex and biochemical and histologic evidence of endoplasmic reticulum stress in goblet cells and Paneth cells, the phenomena observed in the patients with ulcerative colitis [73••]."]}
{"doc_id": 51025, "title": "", "abstract": ["A recent study also showed that MUC2 gene expression is regulated by a tightly associated epigenetic mechanisms of DNA methylation and histone modifications in the 5′ flanking region of MUC2 promoter [35].", "The mucus layer overlying the epithelium secreted by the goblet cells promotes the elimination of gut contents and provides the first line of defense against physical and chemical injury caused by ingested food, microbes and the microbial products.", "Transcriptional regulation of MUC2 is mediated by activation of signaling pathways targeting the transcription factors that bind to specific sites on MUC2 promoter.", "These molecules are secreted by two pathways, constitutive or basal secretion, which is low-level continuous secretion dependent on cytoskeletal movement of secretory granules, or stimulated or regulated secretion, which involves exocytosis of granules in response to external stimuli [14].", "Rapid and massive secretion of goblet cell mucus not only facilitates the expulsion of pathogens but also maintains the integrity of mucus protective layers."]}
{"doc_id": 51026, "title": "", "abstract": ["These findings underscore the important innate defense function of mucins in enteric infection.", "Enteric pathogens circumvent the protective function of mucus layer by developing motility, mucolytic activity, and other virulence factors, causing the degradation and penetration of mucus layers and subsequent attachment and invasion of epithelial cells.", "Mucus layers also contain other goblet cell products, TFF3, RELMβ, and Fcgbp; antimicrobials peptides such as β defensin and lysozymes secreted by Paneth cells; and secretory IgA secreted by enterocytes [1, 2, 5, 10].", "The normal intestinal mucosal epithelium has tolerance to commensal microbiota because of its ability to distinguish commensal microbiota from pathogenic microorganisms by their molecular patterns, such as microbe-associated molecular patterns and pathogen-associated molecular patterns, through pattern recognition receptors (PRRs) such as cell surface Toll-like receptors (TLRs) and cytoplasmic nucleotide-binding oligomerization domain (NOD) proteins [48, 49].", "Most commensal and pathogenic bacteria attach to the intestinal mucosal cells through interaction of adhesins to the mucosal receptors, such as integrins, carcinoembryonic antigen-related cell adhesion molecules (CEACAM) or sialylated, galactosylated, or mannosylated glycoproteins or glycolipids."]}
{"doc_id": 51027, "title": "", "abstract": ["MUC2 mucin has structural and physicochemical properties similar to those of other gel-forming secretory mucin such as MUC5AC, MUC5B, and MUC6, expressed in gastric and respiratory glandular epithelium.", "Activation of a transcription factor, nuclear factor (NF)-κB, is a common event during inflammation in the gastrointestinal tract and MUC2 mucin has been shown to have NF-κB binding sites in the promoter.", "Studies of MUC2 in mucinous and nonmucinous colon cancers showed that methylation of CpG islands in the specific regions of MUC2 promoter downregulates MUC2 expression [34].", "A recent study also showed that MUC2 gene expression is regulated by a tightly associated epigenetic mechanisms of DNA methylation and histone modifications in the 5′ flanking region of MUC2 promoter [35].", "Furthermore, TFF3 has been suggested to increase the viscosity of mucin by binding to the vWF C domain of MUC2, enhancing the structural integrity of the intestinal mucus barrier [55]."]}
{"doc_id": 51028, "title": "", "abstract": ["It showed a markedly preventive effect on trinitrobenzene sulfonic acid (TNBS)—induced colitis in mice [61].", "RELMβ-deficient mice showed reduced susceptibility to T-cell-independent DSS-induced colitis, but increased susceptibility to T-cell-dependent TNBS-induced colitis, indicating that RELMβ may trigger protective or proinflammatory effects, depending on the nature of the chemically induced colitis [59].", "Expulsion of the nematode, Trichuris muris, in resistant, susceptible, and Muc2-deficient mouse strains showed that the increased Muc2 production, observed exclusively in resistant mice, correlated with worm expulsion, whereas worm expulsion from the intestine was significantly delayed in Muc2-deficient mice [64••].", "TLR2-deficient mice showed a selective defect in TFF3 and TFF3 administration improved DSS-induced colitis by suppressing mucosal apoptosis [54].", "CF mice exhibited decreased intestinal motility with longer exposure to the bacteria entrapped in the mucus and small intestinal bacterial overgrowth, which responded to treatment with antibiotics and laxatives [71]."]}
{"doc_id": 76018, "title": "", "abstract": ["These findings suggest that there is a substantial loss of HIV-positive patients at every stage of pre-ART care in sub-Saharan Africa.", "We conducted a systematic literature review of patient retention between HIV testing and ART initiation in sub-Saharan Africa.", "In these studies, a median of 55% (range 42%–95%) of patients reached the study end point (repeat CD4 count, ART initiation, 12 months of follow-up, or data censoring), while the rest died or were lost to follow-up before the end point.", "The researchers identified 28 studies that included data on the proportion of adult patients retained between any two time points between testing positive for HIV and starting ART in HIV/AIDS care programs in sub-Saharan Africa.", "Studies included in this review of retention in pre-ART HIV care in sub- Saharan Africa."]}
{"doc_id": 76019, "title": "", "abstract": ["While pre-ART loss to care may not pose as immediate a mortality threat as loss of patients who already have clinical AIDS, it is still a major impediment to improving the outcomes of HIV care and treatment overall, is itself a contributor to the high mortality observed during the first year on ART, and wastes scarce health system resources.", "Our analysis of 24 studies documenting rates of retention of patients from testing positive for HIV infection to initiating ART suggests that patient management during this period poses serious challenges.", "Even doing this on a relatively small scale will be challenging, as it has been for ART patients [15], but it is a vital intervention for improving pre-ART care.", "Unfortunately, ART was extremely expensive, and HIV/AIDS remained a fatal illness for people living in developing countries.", "Research on retention in pre-ART care is challenging, as it requires long periods of follow-up and consistent information systems that allow individuals to be tracked as they move in and out of care at multiple facilities."]}
{"doc_id": 76020, "title": "", "abstract": ["Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation.", "Study Code| Outcome Assessed|  N | Number Achieving Outcome| Percent (95% CI) Achieving Outcome| Comments   ---|---|---|---|---|---   HIV test to enrollment in care   Ethiopia 1| “Immediate” linkage to HIV care after HIV test| 1,314| 623| 47% (45%–50%)| “Linked to care” and “immediately” not defined in report   Ethiopia 2| Visited referral site (HIV clinic) after HIV test| 1,102| 474| 43% (40%–46%)| Of 474 visiting referral site, 84% visited ≤8 wk of HIV test   Kenya 2| Self-reported attendance at HIV care services 2–4 mo after HIV test| 737| 312| 42% (39%–46%)|   SA 8| Attended first pre-ART medical appointment ≤1 y of staging| 356| 112| 31% (27%–36%)|   SA 12| Visited referral site (HIV clinic) after HIV test| 199| 92| 46% (39%–53%)| Self-reported data; time allowed to reach end point not stated   SA 14| Self-reported access of HIV care| 135| 49| 36% (28%–44%)| Of those not linked, 1% died and 41% not reached by phone.", "We defined “loss to care” as failing to reach the next step in the care sequence for any reason (death or discontinuation), but we also accepted each study's own criteria for determining which patients died or discontinued care.", "Some patients may have returned to the same site after the data for the study were censored or the study's definition of loss to care reached.", "We excluded patients who were in care solely for the purpose of preventing mother-to-child transmission of HIV, patients who were in pediatric care, modeled estimates without primary data, qualitative studies, and clinical trials that did not take place under routine care conditions."]}
{"doc_id": 76021, "title": "", "abstract": ["Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre–antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation.", "Thus, if the outcomes of HIV/AIDS programs in resource-limited settings are to be improved, all individuals testing positive for HIV must receive continuous pre-ART care that includes regular CD4 counts to ensure that ART is initiated as soon as they become eligible for treatment.", "Our analysis of 24 studies documenting rates of retention of patients from testing positive for HIV infection to initiating ART suggests that patient management during this period poses serious challenges.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "During the early years of HIV/AIDS treatment scale up in sub-Saharan Africa, attention was focused on initiating eligible patients on ART and, more recently, on long-term retention in care of those patients on treatment."]}
{"doc_id": 76022, "title": "", "abstract": ["In this systematic review (a study that uses predefined criteria to identify all the research on a given topic), the researchers investigate the retention of HIV-positive adults in pre-ART care in sub-Saharan Africa.", "Without effective retention in pre-ART care, beginning with HIV testing and continuing until the first antiretrovirals are dispensed, even patients who have long been aware of their HIV status will access care only when seriously ill, which is often well after treatment eligibility.", "Our objective is to determine whether existing data allow us to estimate what proportion of adult patients who test positive for HIV are staged, enroll, and remain in pre-ART care until ART-eligible, and initiate ART as soon as eligible.", "The remarkable expansion of access to antiretroviral therapy (ART) for HIV/AIDS in resource-constrained countries has given nearly four million HIV- positive adults in sub-Saharan Africa the opportunity to achieve what for many may be nearly normal life expectancies [1].", "While pre-ART loss to care may not pose as immediate a mortality threat as loss of patients who already have clinical AIDS, it is still a major impediment to improving the outcomes of HIV care and treatment overall, is itself a contributor to the high mortality observed during the first year on ART, and wastes scarce health system resources."]}
{"doc_id": 93015, "title": "", "abstract": ["Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action.", "Abdominal obesity, which is commonly observed with aging, is a major contributor to IR and MS (3).", "Low peripheral IGF-1 levels in humans are associated with increased risk of numerous conditions including T2DM, CVD, sarcopenia, osteoporosis, and frailty (29).", "The causes of sarcopenia are multifactorial, but the proinflammatory state associated with aging and obesity appears to be one key contributor (15).", "Paradoxically, low IGF-1 concentrations in humans have been associated with increased risk for CVD, stroke, T2DM, and osteoporosis."]}
{"doc_id": 93016, "title": "", "abstract": ["Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "The Critical Role of Metabolic Pathways in Aging", "Another metabolic regulator derived from adipose tissue and linked to aging is the hormone adiponectin.", "Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and stroke (1).", "Aberrant activation of mTOR signaling has been linked to several age-related diseases such as T2DM, cancer, Alzheimer disease, Parkinson disease, and CVD, leading to studies on the role of this pathway in metabolism, aging, and life span."]}
{"doc_id": 93017, "title": "", "abstract": ["### The metabolic syndrome of aging.", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and stroke (1).", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "The Critical Role of Metabolic Pathways in Aging"]}
{"doc_id": 93018, "title": "", "abstract": ["These cytokines are derived from both the age-associated accrual of visceral fat (VF) and secretion of proinflammatory cytokines by increasing numbers of senescent cells (4).", "Aging is also associated with an increase in proinflammatory cytokines, which are known to interfere with insulin action.", "Insulin resistance (IR) represents a major component of metabolic syndrome (MS) and is commonly observed in older adults (2).", "These women are characterized biologically by increases in inflammatory cytokines, senescent cells, and breakdown in repair of cells, and estrogen may interact in a harmful way with this type of environment.", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids."]}
{"doc_id": 93019, "title": "", "abstract": ["We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries.", "This has led many to embrace the mitochondrial theory of aging, which posits that mitochondrial dysfunction is a fundamental cause of cellular aging and senescence.", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "Aging is associated with progressive loss in mitochondrial function in various tissues, including skeletal muscle (17).", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease."]}
{"doc_id": 93020, "title": "", "abstract": ["Aging is associated with progressive loss in mitochondrial function in various tissues, including skeletal muscle (17).", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids.", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "This has led many to embrace the mitochondrial theory of aging, which posits that mitochondrial dysfunction is a fundamental cause of cellular aging and senescence.", "Finally, the rate of living theory, which suggests that longevity is negatively related to metabolic rate, has linked hormones regulating energy metabolism with aging."]}
{"doc_id": 93021, "title": "", "abstract": ["Aging is arguably the most universal contributor to the etiologies of metabolic decline and related diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and stroke (1).", "Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death.", "Aging is associated with progressive loss in mitochondrial function in various tissues, including skeletal muscle (17).", "Collectively, these age-related alterations in metabolism and body fat distribution are active participants in a vicious cycle that can accelerate the aging process and the onset of disease.", "The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids."]}
{"doc_id": 93022, "title": "", "abstract": ["Rapamycin use in humans is also limited by its numerous side effects, including hyperglycemia, dyslipidemia, immunosuppression, vasospasm, and renal failure.", "Although systemic knockdown of mTOR signaling in rodents results in longevity, greater fine-tuning will be required before translating to humans.", "However, life span extension has now been described in several mouse mutants that are in fact insulin resistant (31).", "However, it is unknown whether AICAR is capable of reproducing these effects in humans or will prove safe at the necessary dosage.", "These interventions include inhibition of the mammalian target of rapamycin and lifetime deficiency in GH/IGF-1 signaling."]}
{"doc_id": 57017, "title": "", "abstract": ["Abnormal ECM stiffness, as observed in tissue fibrosis, clearly plays an important role in cancer progression.", "Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis.", "Importantly, a study using mouse genetics has shown that overexpression of LOX increases ECM stiffness and promotes tumor cell invasion and progression (Levental et al., 2009).", "Furthermore, abnormal ECM dynamics derail stromal cell behavior, leading to tumor-promoting angiogenesis and inflammation by endothelial cells and immune cells, respectively, both at the primary and metastatic sites.", "Together, these data demonstrate that deregulation of collagen cross-linking and ECM stiffness is more than just a secondary outcome but instead plays a causative role in cancer pathogenesis."]}
{"doc_id": 57018, "title": "", "abstract": ["Abnormal ECM dynamics are well documented in clinical studies of many diseases and are a hallmark of cancer.", "Indeed, abnormal ECM dynamics are one of the most ostensible clinical outcomes in diseases such as tissue fibrosis and cancer (Cox and Erler, 2011).", "A major challenge in ECM biology is to understand the roles of the ECM in normal development and how disruption of ECM dynamics may contribute to diseases such as cancer.", "Importantly, several outstanding characteristics of the properties of the ECM contribute to its importance in development and disease.", "It is possible, at least theoretically, that deregulated ECM dynamics may cause formation of abnormal lineage-specific ECM and lead to cancer stem cell overexpansion and loss of differentiation (Fig. 2 B)."]}
{"doc_id": 57019, "title": "", "abstract": ["Along the way, cancer cells often lose their differentiation state and polarity, disrupt tissue integrity, and corrupt stromal cells to promote their own growth at both primary tumor and distant sites (Feigin and Muthuswamy, 2009; Luo et al., 2009).", "Increase in mechanical force as a result of LOX expression and ECM stiffening presumably facilitates colonization of cancer cells and infiltration of immune cells at the metastatic site.", "Furthermore, tumor vasculature, together with the lymphatic system, is the main route through which cancer cells metastasize and immune cells infiltrate.", "On the one hand, ECM anomalies promote cancer cell transformation and tissue invasion; on the other hand, they help generate a tumorigenic niche that further facilitates cancer progression.", "Abnormal ECM stiffness, as observed in tissue fibrosis, clearly plays an important role in cancer progression."]}
{"doc_id": 57020, "title": "", "abstract": ["Remarkably, mounting evidence suggests that cancer cells may remotely modify, often with the involvement of other cell types including hematopoietic progenitor cells, distant sites and proactively participate in the creation of a premetastatic niche before metastasis (McAllister and Weinberg, 2010; Bateman, 2011).", "As a result, epithelial cells are directly affected by deregulated ECM dynamics, leading to cellular transformation and metastasis.", "The resultant changes in the stromal components further exacerbate the tumorigenic microenvironment and facilitate the process of oncogenic transformation, tissue invasion, and metastasis during cancer initiation and progression (Fig. 4, C and D).", "Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis.", "In addition, deregulated ECM affects various aspects of vascular biology and promotes tumor-associated angiogenesis (stage 5)."]}
{"doc_id": 57021, "title": "", "abstract": ["On the one hand, ECM anomalies promote cancer cell transformation and tissue invasion; on the other hand, they help generate a tumorigenic niche that further facilitates cancer progression.", "Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis.", "Importantly, however, the basement membrane of the tumor vasculature is more porous and leaky than normal (Hewitt et al., 1997; Hashizume et al., 2000), which facilitates tumor cell metastasis and immune cell infiltration and promotes cancer progression (Ruoslahti, 2002; Egeblad et al., 2010a).", "The resultant changes in the stromal components further exacerbate the tumorigenic microenvironment and facilitate the process of oncogenic transformation, tissue invasion, and metastasis during cancer initiation and progression (Fig. 4, C and D).", "Abnormal ECM promotes cancer progression."]}
{"doc_id": 57022, "title": "", "abstract": ["Cancer cell metastasis is a multistep process, consisting of local invasion and intravasation at the primary site, survival in the circulation, and extravasation and colonization at the distant site (Paget, 1889).", "Interestingly, however, overexpression of LOX alone is insufficient to cause tumors to form (Levental et al., 2009), suggesting that deregulation of ECM remodeling is a coconspirator rather than a primary inducer of tumorigenesis in the breast.", "Thus, these data suggest that deregulation of ECM dynamics is an important step during the formation of a premetastatic niche.", "Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment.", "In addition to changes in its biochemical properties, the architecture and other physical properties of tumor-associated ECM are fundamentally different from that of the normal tissue stroma; rather than relaxed nonoriented fibrils, the collagen I in breast tumors is often highly linearized and either oriented adjacent to the epithelium or projecting perpendicularly into the tissue (Provenzano et al., 2006; Levental et al., 2009)."]}
{"doc_id": 13063, "title": "", "abstract": ["This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "To determine the site-specific glycosylation of SARS-CoV-2 S, we used trypsin, chymotrypsin, and α-lytic protease to generate three glycopeptide samples.", "Using the cryo-EM structure of the trimeric SARS-CoV-2 S protein [Protein Data Bank (PDB) ID 6VSB] (4), we mapped the glycosylation status of the coronavirus spike mimetic onto the experimentally determined three-dimensional (3D) structure (Fig. 3).", "Fig. 2 Site-specific N-linked glycosylation of the SARS-CoV-2 S glycoprotein."]}
{"doc_id": 13064, "title": "", "abstract": ["SARS-CoV-2 uses an extensively glycosylated spike (S) protein that protrudes from the viral surface to bind to angiotensin-converting enzyme 2 (ACE2) to mediate host-cell entry (3).", "The S protein is a key target in vaccine design efforts (6), and understanding the glycosylation of recombinant viral spikes can reveal fundamental features of viral biology and guide vaccine design strategies (7, 8).", "This suggests that the SARS-CoV-2 S protein is less densely glycosylated and that the glycans form less of a shield compared with other viral glycoproteins, including HIV-1 Env and LASV GPC, which may be beneficial for the elicitation of neutralizing antibodies.", "The site-specific glycosylation analysis reported here suggests that the glycan shield of SARS- CoV-2 S is consistent with other coronaviruses and similarly exhibits numerous vulnerabilities throughout the glycan shield (10).", "Given the functional constraints of receptor binding sites and the resulting low mutation rates of these residues, there is likely selective pressure to use N-linked glycans to camouflage one of the most conserved and potentially vulnerable areas of their respective glycoproteins (30, 31)."]}
{"doc_id": 13065, "title": "", "abstract": ["Of the 22 sites on the S protein, 8 contain substantial populations of oligomannose-type glycans, highlighting how the processing of the SARS-CoV-2 S glycans is divergent from host glycoproteins (25).", "The surface of the envelope spike is dominated by host- derived glycans, with each trimer displaying 66 N-linked glycosylation sites.", "Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "For example, one of the most densely glycosylated viral spike proteins is HIV-1 Env, which exhibits ~60% oligomannose-type glycans (21, 34).", "This variant of the S protein contains all 22 glycans on the SARS-CoV-2 S protein (Fig. 1A)."]}
{"doc_id": 13066, "title": "", "abstract": ["Last, we detected trace levels of O-linked glycosylation at Thr323/Ser325 (T323/S325), with over 99% of these sites unmodified (fig. S4), suggesting that O-linked glycosylation of this region is minimal when the structure is native-like.", "The predominant oligomannose-type glycan structure observed across the protein, with the exception of N234, is Man5GlcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine), which demonstrates that these sites are largely accessible to α-1,2-mannosidases but are poor substrates for GlcNAcT-I, which is the gateway enzyme in the formation of hybrid- and complex-type glycans in the Golgi apparatus.", "These were determined to be complex-type glycans, consistent with steric accessibility of these residues.", "Although unoccupied glycosylation sites were detected on SARS-CoV-2 S, when quantified they were revealed to form a very minor component of the total peptide pool (table S2).", "Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization."]}
{"doc_id": 13067, "title": "", "abstract": ["Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3).", "The graphs summarize quantitative mass spectrometric analysis of the glycan population present at individual N-linked glycosylation sites simplified into categories of glycans.", "However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no observed mutations to N-linked glycosylation sites (10).", "Given the functional constraints of receptor binding sites and the resulting low mutation rates of these residues, there is likely selective pressure to use N-linked glycans to camouflage one of the most conserved and potentially vulnerable areas of their respective glycoproteins (30, 31).", "We characterized the N-linked glycans on extended flexible loop structures (N74 and N149) and at the membrane-proximal C terminus (N1158, N1173, N1194) that were not resolved in the cryo-EM maps (4)."]}
{"doc_id": 46032, "title": "", "abstract": ["Here we demonstrate that TRIM5 promotes innate immune signaling and that this activity is amplified by retroviral infection and interaction with the capsid lattice.", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "The experiments presented here demonstrate that TRIM5 is a multifunctional component of the innate immune system.", "TRIM5 promotes innate immune signaling", "Though TRIM5 is not sufficient to activate IFN-β (Fig. 1c), it promotes the first wave of innate immune signaling upstream of IFN-β and thereby contributes to the antiviral state established by LPS (Supplementary Fig. 1f)."]}
{"doc_id": 46033, "title": "", "abstract": ["The cellular factors required for TRIM5 E3 activity and inflammatory gene induction, UBC13, UEV1A and TAK1, also promoted capsid-specific restriction activity, indicating that the multiple functions of TRIM5 are mechanistically linked.", "TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by HIV-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm1,2.", "Shown is the fold rescue due to TRIM5 KD, with respect to the control KD. g–j, Products of in vitro reactions with ATP, Ub, UBE1, UBC13/UEV1A, and the indicated E3 Ub ligases were revealed by immunoblot for total Ub (g, i, and j), K63-linked Ub chains (left panel of h), or TRIM5 (right panel of h).", "Finally, two factors that disrupt the HIV-1 capsid-TRIM5Cyp interaction and block restriction activity - a non-immunosuppressive cyclosporine analogue1 or the TRIM5Cyp H436Q mutant protein13 \\- each eliminated the enhancement of E3 Ub ligase activity by the A14C/E45C capsid cylinders, without effect on the baseline activity in the absence of capsid (Fig. 4g and Supplementary Figs. 7d and 12b–d).", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h)."]}
{"doc_id": 46034, "title": "", "abstract": ["The cellular factors required for TRIM5 E3 activity and inflammatory gene induction, UBC13, UEV1A and TAK1, also promoted capsid-specific restriction activity, indicating that the multiple functions of TRIM5 are mechanistically linked.", "In addition to functioning as a retroviral capsid-specific restriction factor, TRIM5 synthesizes K63 Ub chains that activate TAK1 and inflammatory transcription, most probably via multimerization of the TAK1-associated Ub-binding protein TAB211 (Fig. 4h).", "Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signaling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.", "TRIM5 stimulated either of two luciferase reporters for AP-1 with a magnitude comparable to that of MAVS or the AP-1 transcription factor c-Jun (Fig. 1a and Supplementary Fig. 1a).", "Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice3,4 and several reports indicate that TRIM5 plays a role in signal transduction5–7, but the precise mechanism of restriction is unknown8."]}
{"doc_id": 55013, "title": "", "abstract": ["For CID MS/MS data acquisitions, ion trap normal scan rate was used, and for ETD the enhanced scan rate was used.", "(C) Immunoprecipitation of HA-Ub WT, S65D, S65E, and S65A from cells stably expressing YFP-Parkin revealed a stronger interaction between activated YFP- Parkin and HA-UbS65D and HA-UbS65E than WT or S65A.", "The eluted proteins were desalted and buffer exchanged using a PD-10 column with Solution B. The proteins were further purified by ion- exchange chromatography on a MonoQ column (GE Healthcare) using negative because since the wild-type and mutant Ub proteins were preferentially excluded from the column while the contaminants, including nucleic acids, remained bound."]}
{"doc_id": 55014, "title": "", "abstract": ["Furthermore, expression of ubiquitin S65A, a mutant that cannot be phosphorylated by PINK1, inhibited Parkin translocation to damaged mitochondria.", "Interestingly, PINK1 phosphorylates Ub at S65, a residue that is homologous with the S65 site PINK1 phosphorylates on the Parkin ubiquitin-like (UBL) domain.", "Using mass spectrometry, we discovered that endogenous PINK1 phosphorylated ubiquitin at serine 65, homologous to the site phosphorylated by PINK1 in Parkin’s ubiquitin-like domain.", "Although PINK1 phosphorylates Parkin, other PINK1 substrates appear to activate Parkin, as the mutation of all serine and threonine residues conserved between Drosophila and human, including Parkin S65, did not wholly impair Parkin translocation to mitochondria.", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria."]}
{"doc_id": 55015, "title": "", "abstract": ["PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays.", "These results explain a feed-forward mechanism of PINK1-mediated initiation of Parkin E3 ligase activity.", "These data indicate that phospho-Ub stimulates Parkin ligase activity and represents a mechanism of PINK1 activation of Parkin (Fig. 5 A).", "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria."]}
{"doc_id": 55016, "title": "", "abstract": ["Phosphorylation of Ub S65 by PINK1 mirrors PINK1 phosphorylation of Parkin’s UBL domain on the homologous Parkin S65 residue (Kondapalli et al., 2012).", "Interestingly, PINK1 phosphorylates Ub at S65, a residue that is homologous with the S65 site PINK1 phosphorylates on the Parkin ubiquitin-like (UBL) domain.", "Using mass spectrometry, we discovered that endogenous PINK1 phosphorylated ubiquitin at serine 65, homologous to the site phosphorylated by PINK1 in Parkin’s ubiquitin-like domain.", "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity", "Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays."]}
{"doc_id": 69022, "title": "", "abstract": ["Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "Type 2 diabetes is a global crisis that threatens the health and economy of all nations, particularly developing countries.", "This epidemic is primarily driven by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles.", "Type 2 diabetes is a global public health crisis that threatens the economies of all nations, particularly developing countries.", "The dynamics of the diabetes epidemic are changing rapidly."]}
{"doc_id": 69023, "title": "", "abstract": ["The combination of excessive energy intake and reduced energy output leads to increased obesity and insulin resistance.", "Fueled by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity.", "Excessive caloric intake is a major driving force behind escalating obesity and type 2 diabetes epidemics worldwide, but diet quality also has independent effects.", "The thrifty genotype hypothesis postulates that obesity and type 2 diabetes are caused by positive selection of genotypes for efficiency of metabolism and energy and fat storage, thereby conferring advantage in times of nutrient scarcity (46,47).", "This epidemic is primarily driven by rapid urbanization, nutrition transition, and increasingly sedentary lifestyles."]}
{"doc_id": 69024, "title": "", "abstract": ["These data suggest that the overall contribution of the identified genetic loci to type 2 diabetes is similar between Caucasians and other ethnic groups, and that these loci do not appear to explain ethnic differences in diabetes risk.", "These results suggest that the detrimental effects of a Westernized diet may be enhanced by greater genetic susceptibility.", "Recent advances in genome-wide association studies have contributed substantially to our understanding of diabetes pathophysiology, but currently identified genetic loci are insufficient to explain ethnic differences in diabetes risk.", "Recent advances in GWAS have substantially improved our understanding of the pathophysiology of diabetes, but the currently identified genetic susceptibility loci are insufficient to explain differences in diabetes risk across different ethnic groups or the rapid rise in diabetes prevalence over the past several decades.", "On the other hand, given the same dietary and lifestyle factors, some individuals may be more prone to type 2 diabetes than others because of different genetic backgrounds."]}
{"doc_id": 69025, "title": "", "abstract": ["Because many Asian adults who experienced undernutrition in early life are now adapting Westernized diets and lifestyles, their risk of developing diabetes and other metabolic diseases is substantially elevated.", "Nonetheless, interactions between Westernized diet and lifestyle and genetic background may accelerate the growth of diabetes in the context of rapid nutrition transition.", "In addition, intake of processed meat, red meat, and heme iron, which characterize the Western dietary pattern, showed significant interactions with GRS in relation to diabetes risk (P for interaction = 0.029, 0.02, and 0.0004, respectively).", "It is preferentially metabolized to lipid in the liver, leading to increased hepatic de novo lipogenesis, dyslipidemia, and insulin resistance (15).", "### Linking Western dietary pattern, inflammation, and type 2 diabetes"]}
{"doc_id": 88024, "title": "", "abstract": ["In summary, the two-hit model of inflammasome formation posits that IL-1β/IL-18 processing requires a first hit that is mediated by signals such as TLR and MyD88 resulting in increased pro–IL-1β/IL-18 transcription and a second hit that initiates the posttranslational processing of caspase-1, IL-1β, and IL-18 proteins by the inflammasome components.", "This is consistent with the roles of PYCARD and caspase-1 in inflammasome processing of IL-1β and IL-18.", "We attempted to directly activate the inflammasome with DSS in bone marrow–derived macrophages, and our initial analysis suggests that DSS does not directly induce the production of IL-1β (unpublished data).", "Components of the inflammasome function to process pro–IL-1β and –IL-18 into mature cytokines, thus an initial hypothesis centered on the concept that increased inflammation caused by inflammasome formation creates a local environment that is favorable for tumorigenesis.", "The processing and release of proinflammatory cytokines and chemokines, including IL-1β and IL-18, is fundamental to proper innate immune responses to pathogens and environmental insults in the gastrointestinal system."]}
{"doc_id": 88025, "title": "", "abstract": ["Mice receiving Nlrp3−/− but not WT bone marrow also demonstrated significantly increased colonic lesions (Fig. 7 E), including increased distal colon inflammation, hyperplasia, dysplasia, and area associated with disease (Fig. S4, A–F).", "All AOM/DSS-treated animals demonstrated increased colon inflammation compared with mock-treated mice; however, no tumors were observed via endoscopy in the Nlrp3−/−, Nlrc4−/−, or WT colons at this time point (Fig. 6 A).", "Loss of Nlrp3 results in augmented features of ulcerative colitis in the inflammation-driven tumor model.", "All AOM/DSS-challenged animals demonstrated increased colon inflammation compared with mock-treated mice.", "Together, these data suggest a protective role for both Pycard and Nlrp3 in acute colitis induced by DSS."]}
{"doc_id": 88026, "title": "", "abstract": ["Loss of Nlrp3 results in augmented features of ulcerative colitis in the inflammation-driven tumor model.", "Our data show that the inflammasome component NLRP3 also plays a role in reducing acute colitis and colitis-associated colon cancer.", "The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer", "To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice.", "In addition to the NLRs, the recently described AIM2 gene is of particular interest because it is reduced or absent in several cancers and its restoration caused cell cycle arrest in colon cancer cell types (Patsos et al., 2010)."]}
{"doc_id": 88027, "title": "", "abstract": ["This study is the first to address the role of NLR inflammasomes in CAC and demonstrates a protective role for PYCARD, caspase-1, and NLRP3 against CAC development.", "These data indicate that Nlrp3, but not Nlrc4, attenuates morbidity and clinical outcome associated with CAC, although the effects are reduced compared with those observed for Pycard−/− and Casp1−/− mice.", "Together, the clinical and histopathology data indicate that NLRP3 regulates gastrointestinal tumorigenesis through hematopoietic-derived cells in models of CAC.", "These data indicate that Nlrp3−/− mice exhibit an attenuated disease when compared with Pycard−/− and Casp1−/− mice; however, the composite data support the hypothesis that this gene product negatively regulates tumorigenesis in the CAC model.", "Our data show that the NLR inflammasome components PYCARD, caspase-1, and NLRP3 might function as inflammation and tumor suppressors in the inflammation-driven colon tumorigenesis model."]}
{"doc_id": 88028, "title": "", "abstract": ["This study is the first to address the role of NLR inflammasomes in CAC and demonstrates a protective role for PYCARD, caspase-1, and NLRP3 against CAC development.", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models.", "Together, these data suggest a protective role for both Pycard and Nlrp3 in acute colitis induced by DSS.", "To determine the role of a specific NLR inflammasome, mice lacking either NLRP3 or NLRC4 were assessed in the inflammation-driven colon tumorigenesis model (Fig. 5 A).", "However, the data presented throughout this study, have led us to propose a protective role for the inflammasome during chronic colitis and colitis-associated colon cancer."]}
{"doc_id": 88029, "title": "", "abstract": ["Although studies in humans and mice have found a significant role for IL-1β in tumorigenesis, the roles of the inflammasome components have not been studied.", "These data demonstrate that the inflammasome components, PYCARD and caspase-1, function to attenuate inflammation and hyperplasia/dysplasia in the inflammation-driven colon tumorigenesis model.", "Components of the inflammasome function to process pro–IL-1β and –IL-18 into mature cytokines, thus an initial hypothesis centered on the concept that increased inflammation caused by inflammasome formation creates a local environment that is favorable for tumorigenesis.", "Our data show that the NLR inflammasome components PYCARD, caspase-1, and NLRP3 might function as inflammation and tumor suppressors in the inflammation-driven colon tumorigenesis model.", "These clinical data suggest that PYCARD and caspase-1 are necessary for mouse survival and serve a protective role during inflammation-driven colon tumorigenesis."]}
{"doc_id": 88030, "title": "", "abstract": ["It is now commonly accepted that inflammation contributes to the initiation, promotion, and progression of tumor development.", "One possible explanation of enhanced tumorigenesis observed in the Pycard−/− and Casp1−/− mice can be attributed to their previously defined roles associated with programmed cell death.", "Once a tumor becomes established, macrophages and myeloid-derived cells create a local environment which can be immunosuppressive and is thus favorable for tumor growth, angiogenesis, and metastasis.", "The increased tumor burden is correlated with attenuated levels of IL-1β and IL-18 at the tumor site.", "A current dogma in cancer immunology suggests that inflammation functions as a tumor promoter."]}
{"doc_id": 88031, "title": "", "abstract": ["It should be noted that mice deficient in caspase-1 demonstrated a very severe phenotype in the acute colitis model and additional experiments were required to be halted because of humane reasons.", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models.", "The dextran sulfate sodium (DSS) model has been shown to recapitulate many of the clinical observations associated with UC in humans (Neufert et al., 2007).", "For example, mouse background and gender can have dramatic effects in the DSS model of colitis.", "To determine the cellular compartment responsible for the phenotype observed in the Nlrp3−/− mice, we generated chimeric animals by adoptive bone marrow transplantation, and then subjected the mice to the AOM/DSS colon tumorigenesis model (Fig. 7 A)."]}
{"doc_id": 88032, "title": "", "abstract": ["In this study, we show that components of the inflammasome have a profound protective influence on colitis and colitis-associated cancer (CAC).", "We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models.", "In our work, we also find that deficiencies in diverse inflammasome components can lead to enhanced colitis, as well as CAC that is associated with reduced inflammasome function at the tumor site.", "However, the data presented throughout this study, have led us to propose a protective role for the inflammasome during chronic colitis and colitis-associated colon cancer.", "Our data show that the inflammasome component NLRP3 also plays a role in reducing acute colitis and colitis-associated colon cancer."]}
{"doc_id": 17038, "title": "", "abstract": ["The contribution of RBD stability to ACE2 binding may be influenced by other factors in the full spike trimer, though our measurements on pseudotyped lentiviral particles (Figure 4H) indicate that a destabilizing RBD mutation (C432D) reduces ACE2-mediated cellular entry in the context of spike trimer.", "These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "However, our data also indicate that global RBD stability contributes to ACE2-binding affinity.", "Four of the mutations also increased RBD stability (Figures 4G and S4H), including one (V367F) that increased the melting temperature by 3.9°C. All five mutations also maintained ACE2 binding and antigenicity (Figure S4I), suggesting they could be useful for enhancing production of RBD-based vaccine immunogens.", "Similarly, mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 (Figure 3A), consistent with the destabilizing effect of surface-exposed hydrophobic patches (Schwehm et al., 1998)—but these hydrophobic residues form ACE2-packing contacts and are required for binding (Figures 3B and S5B)."]}
{"doc_id": 17039, "title": "", "abstract": ["We also validated that N439K, the most prevalent RBD mutation, which may have a very slight affinity-enhancing effect (Figures 7B and 7C), has no measurable impact on entry of spike-pseudotyped lentiviral particles (Figure 4H).", "The importance of such focusing is demonstrated by a recent study that identified RBD mutations enabling escape from RBM-directed neutralizing antibodies (Baum et al., 2020)—our data indicate that the escape occurs at sites that have high mutational tolerance (Figures S6C and S6D).", "Many single amino acid mutants also maintain expression comparable to unmutated SARS- CoV-2, indicating that a large mutational space is compatible with properly folded RBD protein.", "There are 10 surface- exposed asparagines for which RBD expression is unaffected or enhanced (top) when an NLGS motif is introduced via mutations to S or T at the i+2 site; for eight of these putative NLGS knock-ins (blue labels), the putative glycan is also tolerated for ACE2 binding (bottom), but for two (red labels), introduction of the NLGS motif is not tolerated for ACE2 binding.", "Four of the mutations also increased RBD stability (Figures 4G and S4H), including one (V367F) that increased the melting temperature by 3.9°C. All five mutations also maintained ACE2 binding and antigenicity (Figure S4I), suggesting they could be useful for enhancing production of RBD-based vaccine immunogens."]}
{"doc_id": 17040, "title": "", "abstract": ["These experiments recapitulated the deep mutational scanning (Figures 4A–4C), including confirmation that some mutations enhance expression (V367F and G502D) or ACE2 affinity (N501F, N501T, and Q498Y) in the context of yeast-expressed RBD.", "The trends observed for entry by the spike-pseudotyped lentiviral particles generally confirmed the deep mutational scanning: three of four mutations that were detrimental for RBD expression or ACE2 binding reduced pseudovirus entry, while a mutation that had little phenotypic effect in the deep mutational scan did not affect viral entry.", "Consistent with the deep mutational scanning, the only large phenotypic effect was increased expression of V367F (Figures 7C and 7D), which we also validated enhances thermal stability of mammalian-expressed RBD (Figures 4G and S4H).", "To validate the dynamic range of our deep mutational scanning, we re-cloned and tested RBD mutants in isogenic yeast-display assays.", "### Deep Mutational Scanning of All Amino Acid Mutations to the SARS-CoV-2 RBD"]}
{"doc_id": 17041, "title": "", "abstract": ["Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017).", "But a substantial number of mutations are well tolerated or even enhance ACE2 binding, including at ACE2 interface residues that vary across SARS-related coronaviruses.", "Mutations were selected that exhibited deleterious effects on RBD expression (C432D) or ACE2 binding (L455Y, N501D and G502), no strong phenotypic effect on either binding or expression (N439K), and affinity-enhancing effects (Q498Y and N501F).", "We do not see evidence for selection for enhanced ACE2 binding, as randomly sampled mutations generally contain mutations with stronger affinity-enhancing effects than observed in the GISAID mutation set.", "Affinity-enhancing mutations are accessible via single-nucleotide mutation from SARS-CoV-2 (Figure S7C), but none are observed among circulating viral sequences (Figure 7A), and observed mutations do not enhance ACE2 affinity more than randomly drawn samples of single-nucleotide mutations (Figure S7D)."]}
{"doc_id": 17042, "title": "", "abstract": ["Our discovery of affinity-enhancing mutations to the SARS-CoV-2 RBD raises the question of whether positive selection favors such mutations, since the relationship between receptor affinity and fitness can be complex for viruses that are well adapted to their hosts (Callaway et al., 2018; Hensley et al., 2009; Lang et al., 2020).", "Finally, interactive structure-based visualizations using dms-view (Hilton et al., 2020) are at https://jbloomlab.github.io/SARS-CoV-2-RBD_DMS/structures/ and project the effects of mutations onto a crystal structure of the ACE2-bound RBD (Lan et al., 2020) and a cryoelectron microscopy (cryo-EM) structure of the full spike ectodomain (Walls et al., 2020).", "Second, there are a number of RBD mutations that enhance ACE2 affinity, which implies evolutionary potential for compensation of deleterious mutations in the ACE2 interface in a manner reminiscent of multi-step escape pathways that have been described for other viruses (Bloom et al., 2010; Friedrich et al., 2004; Gong et al., 2013; Lynch et al., 2015; Wu et al., 2017).", "An initially surprising feature of SARS-CoV-2 was that its RBD tightly binds ACE2 despite differing in sequence from SARS-CoV-1 at many residues that had been defined as important for ACE2 binding (Andersen et al., 2020; Wan et al., 2020).", "Consistent with previous studies (Shang et al., 2020; Walls et al., 2020; Wrapp et al., 2020a), the SARS-CoV-1 RBD binds ACE2 with lower affinity than SARS-CoV-2 (Figures 1C and 1D)."]}
{"doc_id": 17043, "title": "", "abstract": ["We next integrated the yeast-display platform with deep mutational scanning to determine how all amino acid mutations to the SARS-CoV-2 RBD impact expression and binding affinity for ACE2.", "We also validated that mutations enhancing yeast surface expression improve soluble yield and stability of mammalian-expressed RBD protein.", "This platform enables RBD expression on the cell surface of yeast (Figure 1B), where it can be assayed for ligand-binding affinity or protein expression levels, a close correlate of protein folding efficiency and stability (Kowalski et al., 1998a, 1998b; Shusta et al., 1999).", "To enable rapid functional characterization of thousands of RBD variants, we developed a yeast-surface-display platform for measuring expression of folded RBD protein and its binding to ACE2 (Adams et al., 2016; Boder and Wittrup, 1997).", "Most mutations are deleterious for RBD expression and ACE2 binding, and we identify constrained regions on the RBD’s surface that may be desirable targets for vaccines and antibody-based therapeutics."]}
{"doc_id": 17044, "title": "", "abstract": ["For the statistical analysis of mutations observed among circulating SARS- CoV-2 isolates described in Figure S7, we used permutation tests to assess significant trends in effects of observed mutations compared to the distribution of randomly sampled mutation subsets.", "(B) Permutation tests indicating the action of purifying selection on binding (top) and expression (bottom) among circulating SARS-CoV-2 mutations.", "We represent expression as Δlog(MFI) relative to the unmutated SARS-CoV-2 RBD, such that a positive Δlog(MFI) indicates increased expression.", "(D) Permutation tests for positive selection for enhanced ACE2 affinity.", "The dashed horizontal line in Figure 4H showing the limit of detection was calculated as the minimum titer that would be determined in the case of a single positive event."]}
{"doc_id": 17045, "title": "", "abstract": ["The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor and is a major determinant of host range and a dominant target of neutralizing antibodies.", "Furthermore, RBD mutations have already appeared among SARS-CoV-2 pandemic isolates, including some near the ACE2-binding interface—but their impacts on receptor recognition and other biochemical phenotypes remain largely uncharacterized.", "Receptor binding domains of SARS-CoV-2 (328-531) (Walls et al., 2020), WIV1 (316-518), RaTG13 (359-562), ZC45 (324-508), and ZXC21 (323-507) were synthesized by GenScript into vector pcDNA3.1- with a preceding mu-phosphatase signal peptide and a C-terminal octahistidine tag.", "Mutagenesis of the SARS-CoV-2 RBD was performed in two independent replicates via the method described in Bloom (2014) with the modification that primers lengths were adjusted to ensure equal melting temperatures as described in Dingens et al. (2017) and we used NNS rather than NNN primers.", "# Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding"]}
{"doc_id": 85024, "title": "", "abstract": ["This suggests that DR has the potential to be the leading cause of visual impairment and blindness worldwide.", "Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults around the world (1).", "These composite outcomes serve as the primary outcomes for this report, which respectively, indicate presence of any DR and severe DR likely to result in vision loss if left untreated.", "Thus, the importance of modifiable risk factors for these vision-threatening stages of DR remains unclear.", "More important, prevalence estimates for the more severe and vision-threatening end points, such as PDR and DME, are scarce, due to the small numbers of these cases from individual population-based studies."]}
{"doc_id": 85025, "title": "", "abstract": ["Despite the significance of this problem, and the rising prevalence of diabetes notably in emerging Asian countries such as India and China (2,3), there are few precise contemporary estimates of the worldwide prevalence of DR, particularly severe vision-threatening stages of the disease, including proliferative DR (PDR) and diabetic macular edema (DME).", "Similar relationships were also evident in the prevalence patterns of PDR, DME, and VTDR.", "Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors.", "Any DR was defined as the presence of NPDR, PDR, DME, or any combination thereof; and VTDR was defined as the presence of PDR and/or DME.", "There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide."]}
{"doc_id": 85026, "title": "", "abstract": ["Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults around the world (1).", "This suggests that DR has the potential to be the leading cause of visual impairment and blindness worldwide.", "To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes.", "There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide.", "Global Prevalence and Major Risk Factors of Diabetic Retinopathy"]}
{"doc_id": 85027, "title": "", "abstract": ["On the basis of the data from all 35 studies on more than 20,000 participants with diabetes, we estimated that among individuals with diabetes, the overall prevalence of any DR was 34.6%, PDR was 7.0%, DME was 6.8%, and VTDR was 10.2%.", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "Our study shows that 35% of people with diabetes had some form of DR, and that 7% had PDR, 7% had DME, and 10% were affected by these vision-threatening stages.", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "Analyses confined to studies with similar methodologies and rigorous outcome definitions showed that the age-standardized prevalence was 35.4% (35.2–35.6) for any DR, 7.24% (7.15–7.33) for PDR, 7.48% (7.39–7.57) for DME, and 11.7% (11.6–11.8) for VTDR (Table 2)."]}
{"doc_id": 85028, "title": "", "abstract": ["Previous individual studies have shown considerable variability in DR prevalence estimates among individuals with both diagnosed and undiagnosed diabetes, with rates ranging from 17.6% in a study in India (4) to 33.2% in a large U.S. study (5).", "Analyses of these 35 studies showed that the overall age-standardized prevalence of any DR was 34.6% (95% CI 34.5–34.8), PDR was 6.96% (6.87–7.04), DME was 6.81% (6.74–6.89), and VTDR was 10.2% (10.1–10.3; data not shown).", "Analyses confined only to studies with similar methodologies and ophthalmologic definitions showed that the age-standardized prevalence of any DR was 35.4%, PDR was 7.2%, DME was 7.4%, and VTDR was 11.7%, among individuals with diabetes.", "On the basis of the data from all 35 studies on more than 20,000 participants with diabetes, we estimated that among individuals with diabetes, the overall prevalence of any DR was 34.6%, PDR was 7.0%, DME was 6.8%, and VTDR was 10.2%.", "In support of the latter hypothesis, a number of multiethnic cohort studies have reported a higher DR prevalence among Mexican Americans than in non-Hispanic whites (5,22,23)."]}
{"doc_id": 54021, "title": "", "abstract": ["Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation.", "Furthermore, aberrant expression of 53BP1 is more common in BRCA1/2 associated breast cancers, which may hint at a role for 53BP1 loss in these tumors.", "Here we identify 53BP1 as an essential factor for sustaining the growth arrest induced by Brca1 deletion.", "In an unbiased genetic screen we found that loss of 53BP1 rescues clonal outgrowth of Brca1 null ES cells.", "### 53BP1 loss is associated with BRCA1/2 mutation status"]}
{"doc_id": 54022, "title": "", "abstract": ["Furthermore, aberrant expression of 53BP1 is more common in BRCA1/2 associated breast cancers, which may hint at a role for 53BP1 loss in these tumors.", "The clinical relevance of these findings is indicated by our data showing that 53BP1 expression is reduced in a subset of basal-like/triple-negative breast cancers and in BRCA1/2 associated breast tumors.", "Although concomitant deletion of p53 partially alleviates these phenotypes11, the incomplete rescue suggests the involvement of other factors in BRCA1/2 associated cancers.", "We find reduced 53BP1 expression in subsets of sporadic triple-negative and BRCA-associated breast cancers, indicating the potential clinical implications of our findings.", "In contrast, Brca1Δ11/Δ11 mouse mammary tumors, which only express the BRCA1-Δ11 isoform, readily become resistant to cisplatin despite the fact that Brca1 exon 11 sequences are irreversibly deleted49."]}
{"doc_id": 54023, "title": "", "abstract": ["In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "### 53BP1 loss partially restores HR in Brca1 null cells", "We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway."]}
{"doc_id": 54024, "title": "", "abstract": ["In search for such factors, using a candidate gene approach, knockout of 53BP1 was recently shown by Cao et al to rescue Brca1 hypomorphic MEFs and mice from premature senescence12.", "This result confirms the recently described rescue of Brca1Δ11/Δ11 hypomorphic mice by 53BP1 knockout12.", "Similar to the observations with Brca1Δ11 hypomorphic mutants, clonal outgrowth of Brca1 null cells was rescued by a loss of function mutation of 53BP1.", "In an unbiased genetic screen we found that loss of 53BP1 rescues clonal outgrowth of Brca1 null ES cells.", "BRCA1-mutated tumors show genomic instability, mainly as a consequence of impaired recombinatorial DNA repair."]}
{"doc_id": 54025, "title": "", "abstract": ["While human BRCA1-mutated tumors can develop resistance to carboplatin by genetic reversion of the BRCA1 mutation48 – stressing the importance of BRCA1 function for HR – mouse mammary tumor models with large deletions in Brca1 cannot employ this mechanism and remain sensitive to cisplatin or carboplatin, even after multiple rounds of treatment47.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "The latter possibility is supported by the restoration of IR-induced RAD51 foci formation and the partial restoration of HR in 53BP1-depleted Brca1 null cells.", "Consistent with the role of BRCA2 as the loader of RAD51 onto DSBs, the initiating step of recombinational DNA repair, we did not detect any rescue of RAD51 foci in BRCA2-deficient cells when either p53 or 53BP1 were depleted (data not shown).", "In line with this, BRCA1-deficient tumors show excellent responses to therapies exploiting a HR defect, such as platinum drugs44 or PARP inhibitors45."]}
{"doc_id": 54026, "title": "", "abstract": ["Similar to the observations with Brca1Δ11 hypomorphic mutants, clonal outgrowth of Brca1 null cells was rescued by a loss of function mutation of 53BP1.", "This result confirms the recently described rescue of Brca1Δ11/Δ11 hypomorphic mice by 53BP1 knockout12.", "In search for such factors, using a candidate gene approach, knockout of 53BP1 was recently shown by Cao et al to rescue Brca1 hypomorphic MEFs and mice from premature senescence12.", "Although concomitant deletion of p53 partially alleviates these phenotypes11, the incomplete rescue suggests the involvement of other factors in BRCA1/2 associated cancers.", "In an unbiased genetic screen we found that loss of 53BP1 rescues clonal outgrowth of Brca1 null ES cells."]}
{"doc_id": 54027, "title": "", "abstract": ["Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "This effect of 53BP1 is specific to BRCA1 function, as 53BP1 depletion did not alleviate proliferation arrest or checkpoint responses in Brca2-deleted cells.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "Here we show that 53BP1 status specifically affects spontaneous induction of CHK2 phosphorylation when BRCA1 is lost.", "Since 53BP1 acts during the early chromatin remodeling events at the break, it is more likely to affect BRCA1-dependent signaling."]}
{"doc_id": 54028, "title": "", "abstract": ["Although shRNA-mediated inhibition of p53 suppressed the growth defects of Brca1-deleted cells (data not shown), it did not suppress cisplatin sensitivity, suggesting that p53 and 53BP1 provide distinct pathways for sustaining growth arrest in Brca1-deleted cells.", "shRNA-mediated depletion of 53BP1 enhanced RAD51 foci formation in the absence of BRCA1, suggesting up- regulation of HR in a BRCA1 independent manner.", "Our results are consistent with the data reported by Bunting et al on 53BP1 mediated suppression of DNA resection at DSBs and accumulation of single stranded DNA ends in BRCA1 and 53BP1 double-deficient cells42.", "To investigate how suppression of 53BP1 or p53 alleviates the impaired proliferation of Brca1 knockout ES cells, we analyzed cell cycle profiles of 4OHT-treated R26CreERT2;Brca1SCo/Δ cells treated with control shRNA or shRNA causing depletion of 53BP1 or p53, monitored by western blotting (Fig. 2a).", "Suppression of IR-induced CHK2 phosphorylation has been previously observed upon RNAi-mediated 53BP1 depletion in U2OS cells13 and in 53bp1−/− MEFs41."]}
{"doc_id": 54029, "title": "", "abstract": ["Whereas BRCA1 and BRCA2 function as tumor suppressors in breast and ovarian epithelium, homozygous deletion of BRCA1 or BRCA2 appears not to be tolerated during human or mouse development and in cultured primary cells such as mouse embryonic fibroblasts (MEFs) or stem cells10.", "There was significant association between 53BP1status and distant metastasis-free survival, with 53BP1 negative tumors having significantly lower metastasis- free survival (Fig. 5c) (p=0.001).", "Amongst the triple- negative tumors, those that lack normal 53BP1 staining have worse metastasis- free survival, (p=0.039) (Fig. 5d).", "Our results suggest that loss of 53BP1 may promote survival of BRCA1-deficient tumor cells after DNA damage induced by chemotherapy or irradiation.", "As cancers in this data set were mostly early stage, lymph node-negative cancers that did not receive any adjuvant treatment, these data suggest that early stage triple-negative tumors with reduced 53BP1 may have a greater likelihood of metastasis in the absence of systemic treatment, when compared with triple-negative tumors with intact 53BP1."]}
{"doc_id": 54030, "title": "", "abstract": ["We conclude that depletion of 53BP1 restores HR activity in Brca1 null cells to 10–50% of BRCA1-proficient cells.", "### 53BP1 loss partially restores HR in Brca1 null cells", "In conclusion, we have shown that 53BP1 loss alleviates the proliferation defect and DNA-damage hypersensitivity of Brca1 null cells and leads to partial restoration of HR in these cells.", "We show that cells lacking both BRCA1 and 53BP1 have a partially restored HR pathway.", "Importantly, loss of 53BP1 partially restores the homologous recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA- damaging agents."]}
{"doc_id": 100013, "title": "", "abstract": ["To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration.", "To test this hypothesis, we assessed the ability of FGF21 to recruit FGF signaling pathways in the liver and WAT of obese mice.", "This is consistent with our hypothesis that obese mice are resistant to FGF21.", "To confirm FGF21 resistance, we used this as a secondary readout for FGF21 action in these tissues.", "To examine the possible contribution of FGF21 resistance to obesity, we evaluated resistance at several time points after initiation of a high-fat diet."]}
{"doc_id": 100014, "title": "", "abstract": ["We found that DIO mice display a severely impaired signaling response to FGF21 and an attenuated effect to induce expression of target genes.", "When obese mice are treated with FGF21, they display both a significantly attenuated signaling response as assessed by extracellular mitogen-activated protein kinase 1 and 2 (ERK1/2) phosphorylation as well as an impaired induction of FGF21 target genes, including cFos and EGR1.", "To determine whether reduced expression of FGF21 receptors might contribute to the attenuated FGF21 signaling in obese mice, we assessed FGF21 receptor and co-receptor expression in the liver and WAT from obese and lean mice.", "We found that at low doses (25 and 50 ng/g), there was a severe impairment in the ability of FGF21 to activate signaling pathways in obese mice (Fig. 2A) characterized by a reduced level of hepatic ERK1/2 phosphorylation.", "In the DIO mice, the small reduction in FFAs in response to FGF21 was associated with only a minimal effect on HSL and perilipin expression, which did not reach statistical significance."]}
{"doc_id": 100015, "title": "", "abstract": ["To confirm whether FGF21 signaling is impaired in obese mice, we assessed immediate early gene expression downstream of ERK in obese and lean mice.", "When obese mice are treated with FGF21, they display both a significantly attenuated signaling response as assessed by extracellular mitogen-activated protein kinase 1 and 2 (ERK1/2) phosphorylation as well as an impaired induction of FGF21 target genes, including cFos and EGR1.", "To test whether FGF21 signaling is impaired in obese mice, we assessed FGF21-mediated ERK1/2 phosphorylation in the liver (A) and WAT (B).", "We found that at low doses (25 and 50 ng/g), there was a severe impairment in the ability of FGF21 to activate signaling pathways in obese mice (Fig. 2A) characterized by a reduced level of hepatic ERK1/2 phosphorylation.", "Induction of immediate early gene expression downstream of FGF21 signaling is impaired in obese mice."]}
{"doc_id": 100016, "title": "", "abstract": ["Nevertheless, FGF21 resistance can be added to the hormone- resistant states observed in obesity.", "However, we do not believe that FGF21 resistance is a major cause of obesity for several reasons.", "To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration.", "Although attenuated responses to FGF21 were not universal, these data suggest FGF21 resistance begins to manifest early during weight gain.", "However, the mediator of FGF21 resistance remains unknown."]}
{"doc_id": 100017, "title": "", "abstract": ["Subsequent studies have reported that chronic treatment of diet-induced obese (DIO) mice with FGF21 also leads to an improved metabolic profile (6,7).", "In addition, in humans, circulating FGF21 levels were found to correlate positively with BMI (17,19).", "Interestingly, despite high endogenous levels in obese mice, exogenous FGF21 administered at pharmacologic doses appears to exert actions to improve metabolic parameters and induces weight loss (6,7).", "Because the ability of FGF21 to lower circulating glucose levels is thought to be due, in part, to increased expression of GLUT1 in adipose tissue, we assessed GLUT1 mRNA expression in the WAT of these mice (Fig. 4B).", "To test this hypothesis, we examined the effects of exogenous FGF21 on signal transduction and gene expression in the liver and WAT of DIO and lean mice."]}
{"doc_id": 100018, "title": "", "abstract": ["Nevertheless, FGF21 resistance likely contributes significantly toward the complications associated with weight gain and obesity, such as glucose intolerance and elevated circulating NEFAs.", "To determine whether reduced expression of FGF21 receptors might contribute to the attenuated FGF21 signaling in obese mice, we assessed FGF21 receptor and co-receptor expression in the liver and WAT from obese and lean mice.", "To examine the possible contribution of FGF21 resistance to obesity, we evaluated resistance at several time points after initiation of a high-fat diet.", "To analyze the impact of obesity-associated FGF21 resistance on the physiologic improvements we associate with FGF21 action, we looked at serum parameters that are acutely regulated by FGF21.", "However, the mediator of FGF21 resistance remains unknown."]}
{"doc_id": 100019, "title": "", "abstract": ["Because increased FGF21 levels have been reported in genetically obese mice and obese humans, we assessed serum and liver and WAT mRNA levels in mice with diet-induced obesity.", "Surprisingly, however, FGF21 levels are elevated in obese ob/ob and db/db mice and correlate positively with BMI in humans.", "Circulating levels of FGF21 are increased in mice with diet-induced obesity.", "It is now clear that increased tissue expression and serum levels of FGF21 are associated with the obese state.", "In fact, in both rodent diet-induced obese (DIO) (16) and in genetically obese db/db (17) and ob/ob mice, FGF21 expression is increased in WAT and liver (18)."]}
{"doc_id": 60016, "title": "", "abstract": ["Ischaemic heart disease and stroke accounted for 15·2 million deaths (15·0 million to 15·6 million) in 2015, equating to 85·1% (84·7–85·5) of all deaths due to cardiovascular disease that year.", "| Total deaths (millions)", "In 2015, 30·9 million (30·3 million to 31·5 million) males and 24·9 million (24·5 million to 25·5 million) females died, representing an increase of 5·6 million male deaths and 2·3 million female deaths since 1990.", "In 2015, 55·8 million deaths (55·0 million to 56·6 million) occurred worldwide, an increase of 7·9 million deaths since 1990 and 2·2 million deaths since 2005 (table 4).", "For the period 2010–14, the UN Population Division estimates that 6·3 million deaths occurred globally among people aged 5–14 years, whereas GBD estimates this number at 4·6 million.170"]}
{"doc_id": 60017, "title": "", "abstract": ["In addition to these causes with increases, for some leading causes of death such as diabetes and chronic kidney disease, age-standardised death rates have stagnated globally and increased in some countries.", "Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems.", "For HIV/AIDS in many countries, deaths from HIV/AIDS have been misclassified as opportunistic infections, tuberculosis, cancer, digestive diseases, and immune deficiencies.", "Death rates due to HIV/AIDs peaked from 2003 to 2005 for many of these countries, after which sizeable gains in prolonged life occurred through to 2015.", "Yet, inequalities in life expectancy grew in many countries and territories, often driven by uneven progress in health by sex and increasing male deaths due to a subset of NCDs."]}
{"doc_id": 60018, "title": "", "abstract": ["Conversely, prevalence surveys do not show a matching increase in age-specific disease prevalence.", "This increase is due to population increases and ageing accompanied by a small but significant decrease in age-standardised death rates from Alzheimer's disease and other dementias, possibly reflecting the reduced burden of cardiovascular disease and the contribution of vascular brain injury to the dementia syndrome.105", "Shifts in population age structures also accounted for more than 23% of increased mortality due to cardiovascular disease (ischaemic heart disease and stroke), 24·2% for COPD, and at least 20% for several types of cancer (eg, pancreatic cancer and oesophageal cancer).", "Population ageing led to increasing mortality for most causes, but its relative contribution ranged from less than 4% for interpersonal violence and diarrhoeal diseases to 29·6% for Alzheimer's disease and other dementias.", "Changes due to population growth, population ageing, and changes in age- specific mortality rates are shown."]}
{"doc_id": 60019, "title": "", "abstract": ["Cause of death data for low SDI countries in sub-Saharan Africa were limited to a small number of mostly local verbal autopsy data often with small sample size.", "We expect the availability of cancer registry data in low-income and middle-income countries to increase due to the Global Initiative for Cancer Registry Development, which is led by IARC.", "A reverse trend is apparent in low-income and middle-income countries, partly because the growth in motorisation and traffic density is outpacing the reductions associated with infrastructural development and levels of law enforcement.", "Examination of epidemiological convergence among high-income, middle-income, and low-income countries showed the importance of evaluating both absolute and relative changes in mortality, as solely focusing on absolutes can mask rising relative inequality among certain age groups and causes.", "Underlying the global picture, though, are notably distinct regional trends, with substantial reductions in cirrhosis mortality in east Asia and central Europe, for example, and increases in cirrhosis mortality in central Asia and north Africa and the Middle East."]}
{"doc_id": 60020, "title": "", "abstract": ["The peak of the west African Ebola virus disease outbreak occurred in 2014, causing 12 800 deaths (10 300–15 300) that year.", "The increase in numbers of liver cancer deaths due to hepatitis B from 2005 to 2015 was not significant, which contrasted with the significant increases in deaths, often 20–30%, observed for many other types of cancer: this relative progress might be at least partly attributable to hepatitis B vaccination.", "The attributable fractions for Aeromonas, amoebiasis (Entamoeba histolytica), and H influenzae type b were not significant in children younger than 5 years at the global level.", "While mortality rates from most infectious diseases fell, dengue emerged as a notable counterexample.", "Below an SDI of 0·50, Group 1 causes, especially infectious diseases such as diarrhoeal diseases and lower respiratory infections, accounted for most premature mortality (as much as 72·5%, or roughly 141 513 YLLs per 100 000)."]}
{"doc_id": 20017, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "The efficacy of mRNA-1273 is in line with that of the recently reported BNT162b2 mRNA vaccine.16", "Findings were similar across key secondary analyses (Table S16), including assessment starting 14 days after dose 1 (225 cases with placebo, vs. 11 with mRNA-1273, indicating a vaccine efficacy of 95.2% [95% CI, 91.2 to 97.4]), and assessment including participants who were SARS-CoV-2 seropositive at baseline in the per-protocol analysis (187 cases with placebo, vs. 12 with mRNA-1273; one volunteer assigned to receive mRNA-1273 was inadvertently given placebo], indicating a vaccine efficacy of 93.6% [95% CI, 88.6 to 96.5]).", "This high apparent efficacy of mRNA-1273 is based on short-term data, and waning of efficacy over time has been demonstrated with other vaccines.20", "The Coronavirus Efficacy (COVE) phase 3 trial was launched in late July 2020 to assess the safety and efficacy of the mRNA-1273 vaccine in preventing SARS- CoV-2 infection."]}
{"doc_id": 20018, "title": "", "abstract": ["The Coronavirus Efficacy (COVE) phase 3 trial was launched in late July 2020 to assess the safety and efficacy of the mRNA-1273 vaccine in preventing SARS- CoV-2 infection.", "Also, the efficacy of the vaccine was tested in a setting of national recommendations for masking and social distancing, which may have translated into lower levels of infectious inoculum.", "At the first interim analysis on November 15, 2020, vaccine efficacy had been demonstrated in accordance with the prespecified statistical criteria.", "We report the primary analysis results of this ongoing pivotal phase 3 trial.", "The efficacy and safety of another mRNA vaccine, BNT162b2, was recently demonstrated.16"]}
{"doc_id": 20019, "title": "", "abstract": ["The efficacy and safety of another mRNA vaccine, BNT162b2, was recently demonstrated.16", "The anecdotal finding of a slight excess of Bell’s palsy in this trial and in the BNT162b2 vaccine trial arouses concern that it may be more than a chance event, and the possibility bears close monitoring.16", "The efficacy of mRNA-1273 is in line with that of the recently reported BNT162b2 mRNA vaccine.16", "Efficacy was similar across key secondary analyses, including assessment 14 days after the first dose, analyses that included participants who had evidence of SARS-CoV-2 infection at baseline, and analyses in participants 65 years of age or older.", "Findings were similar across key secondary analyses (Table S16), including assessment starting 14 days after dose 1 (225 cases with placebo, vs. 11 with mRNA-1273, indicating a vaccine efficacy of 95.2% [95% CI, 91.2 to 97.4]), and assessment including participants who were SARS-CoV-2 seropositive at baseline in the per-protocol analysis (187 cases with placebo, vs. 12 with mRNA-1273; one volunteer assigned to receive mRNA-1273 was inadvertently given placebo], indicating a vaccine efficacy of 93.6% [95% CI, 88.6 to 96.5])."]}
{"doc_id": 20020, "title": "", "abstract": ["Moderate, transient reactogenicity after vaccination occurred more frequently in the mRNA-1273 group.", "The overall incidence of unsolicited adverse events reported up to 28 days after vaccination and of serious adverse events reported throughout the entire trial was similar for mRNA-1273 and placebo.", "Overall, the local reactions to vaccination were mild; however, moderate-to-severe systemic side effects, such as fatigue, myalgia, arthralgia, and headache, were noted in about 50% of participants in the mRNA-1273 group after the second dose.", "The frequency of unsolicited adverse events, unsolicited severe adverse events, and serious adverse events reported during the 28 days after injection was generally similar among participants in the two groups (Tables S8 through S11).", "No evidence of vaccine-associated enhanced respiratory disease was noted, and fewer cases of severe Covid-19 or any Covid-19 were observed among participants who received mRNA-1273 than among those who received placebo (Tables S13 and S14)."]}
{"doc_id": 20021, "title": "", "abstract": ["Also, the efficacy of the vaccine was tested in a setting of national recommendations for masking and social distancing, which may have translated into lower levels of infectious inoculum.", "Vaccines are needed to reduce the morbidity and mortality associated with Covid-19, and multiple vaccine platforms have been involved in the rapid development of vaccine candidates.1-9", "The magnitude of mRNA-1273 vaccine efficacy at preventing symptomatic SARS- CoV-2 infection is higher than the efficacy observed for vaccines for respiratory viruses, such as the inactivated influenza vaccine against symptomatic, virologically confirmed disease in adults, for which studies have shown a pooled efficacy of 59%.19", "Numerous vaccine candidates in various stages of development are now being evaluated.11-13", "Pregnant women and children were excluded from this trial, and additional evaluation of the vaccine in these groups is planned."]}
{"doc_id": 20022, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "No evidence of vaccine-associated enhanced respiratory disease was noted, and fewer cases of severe Covid-19 or any Covid-19 were observed among participants who received mRNA-1273 than among those who received placebo (Tables S13 and S14).", "For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "Thirty participants in the trial had severe Covid-19; all 30 were in the placebo group (indicating vaccine efficacy of 100% [95% CI, could not be estimated to 1.0]), and one death among these participants was attributed to Covid-19 (Table S16)."]}
{"doc_id": 20023, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "A key secondary end point evaluated the efficacy of mRNA-1273 at preventing severe Covid-19.", "For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "The efficacy of the RNA-1273 vaccine in preventing Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection.", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline."]}
{"doc_id": 20024, "title": "", "abstract": ["The consistency of vaccine efficacy at the primary end point was evaluated across various subgroups, including age groups (18 to <65 years of age and ≥65 years), age and health risk for severe disease (18 to <65 years and not at risk; 18 to <65 years and at risk; and ≥65 years), sex (female or male), race and ethnic group, and risk for severe Covid-19 illness.", "Efficacy was similar across key secondary analyses, including assessment 14 days after the first dose, analyses that included participants who had evidence of SARS-CoV-2 infection at baseline, and analyses in participants 65 years of age or older.", "Also, the efficacy of the vaccine was tested in a setting of national recommendations for masking and social distancing, which may have translated into lower levels of infectious inoculum.", "A stratified Cox proportional hazards model was used to assess the vaccine efficacy of mRNA-1273 as compared with placebo in terms of the percentage hazard reduction.", "Participants were assessed for the presence of SARS-CoV-2–binding antibodies specific to the SARS-CoV-2 nucleocapsid protein (Roche Elecsys, Roche Diagnostics International) and had a nasopharyngeal swab for SARS-CoV-2 RT-PCR testing (Viracor, Eurofins Clinical Diagnostics) before each injection."]}
{"doc_id": 20025, "title": "", "abstract": ["Shortly after the SARS-CoV-2 genetic sequence was determined in January 2020, mRNA-1273, a lipid-nanoparticle (LNP)–encapsulated mRNA vaccine expressing the prefusion-stabilized spike glycoprotein, was developed by Moderna and the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID), within the National Institutes of Health (NIH).14", "The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.", "The efficacy of the RNA-1273 vaccine in preventing Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection.", "The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "The mRNA-1273 vaccine, provided as a sterile liquid at a concentration of 0.2 mg per milliliter, was administered by injection into the deltoid muscle according to a two-dose regimen."]}
{"doc_id": 20026, "title": "", "abstract": ["The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease.", "For the primary analysis, 196 cases of Covid-19 were diagnosed: 11 cases in the vaccine group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0) and 185 cases in the placebo group (56.5 per 1000 person-years; 95% CI, 48.7 to 65.3), indicating 94.1% efficacy of the mRNA-1273 vaccine (95% CI, 89.3 to 96.8%; P<0.001) for the prevention of symptomatic SARS-CoV-2 infection as compared with placebo (Figure 3A).", "Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P<0.001).", "The efficacy of the RNA-1273 vaccine in preventing Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection.", "The primary end point was the efficacy of the mRNA-1273 vaccine in preventing a first occurrence of symptomatic Covid-19 with onset at least 14 days after the second injection in the per-protocol population, among participants who were seronegative at baseline."]}
{"doc_id": 90023, "title": "", "abstract": ["These changes over time were also shown between 1999–2002 and 2007–2010.", "Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality.", "Furthermore, in 1997, the Scandinavian Simvastatin Survival Study found that lipid control significantly reduced major CVD events among people with diabetes (15).", "Yet, our data also show that there is much room for improvement.", "The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute of Diabetes and Digestive and Kidney Diseases or the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry."]}
{"doc_id": 90024, "title": "", "abstract": ["However, nearly 85% of adults aged >65 years achieved the less stringent A1C <8.0% (<64 mmol/mol) goal, but less than half of younger individuals achieved the more stringent goal of <7.0% (<53 mmol/mol) in 2007–2010.", "The proportion of participants with diabetes achieving A1C <8.0% (<64 mmol/mol) was 77.9% in 2007–2010; similar relationships by demographics and diabetes- related characteristics were evident.", "To compare study characteristics and the proportion who met ABC goals, results were age and sex standardized to the 2007–2010 NHANES population with diabetes using the age categories of 20–39 (7.9%), 40–59 (38.3%), and ≥60 (53.8%) years.", "Participants were 4,926 adults aged ≥20 years who self-reported a previous diagnosis of diabetes and completed the household interview and physical examination (n = 1,558 for valid LDL levels).", "The prevalence of meeting the A1C goal <7.0% (<53 mmol/mol) was higher for those aged ≥75 years than for those aged 20–49 years (P = 0.022) and was greater for non-Hispanic whites and non-Hispanic blacks than for Mexican Americans (P < 0.03 for both)."]}
{"doc_id": 90025, "title": "", "abstract": ["Moreover, whereas those without retinopathy and with shorter time since diagnosis were more likely to achieve an A1C <7.0% (<53 mmol/mol), nearly half of those without established CVD or retinopathy did not achieve this goal.", "A strength of this study was the use of a nationally representative sample allowing generalization to the U.S. adult noninstitutionalized population.", "Between 1988 and 2010, the response rates for the interview ranged from 78.4 to 86.0%; for the examination, response rates ranged from 75.4 to 80.0%.", "Results from Look AHEAD generally agree with our findings, and selected findings in the current study were replicated in a previous study using data from NHANES 1999–2006 (20).", "Improvement in meeting A1C <8.0% (<64 mmol/mol) was even more marked than for A1C <7.0% (<53 mmol/mol), with prevalence significantly increased between 1988–1994 (60.1%) and 2007–2010 (77.9%) and between 1999–2002 (66.3%) and 2007–2010 (all P < 0.01; Fig. 1)."]}
{"doc_id": 90026, "title": "", "abstract": ["Attaining ABC targets will require improved methods to increase adherence to prescribed medications, physical activity, healthy dietary choices, and access to support, including motivation and maintenance of behavior change.", "Data from a national sample of overweight and obese subjects with diabetes indicated that the majority reported trying to lose weight (75%), increase physical activity (57%), and reduce the number of calories and fat in their diet (71%) (21).", "Finally, with mainstream focus on the obesity and diabetes epidemics in the U.S. and increased attention to healthy behaviors, people may be more likely to seek care and physicians may be more vigilant about treating patients (18).", "Landmark studies in the 1990s, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, and the UK Prospective Diabetes Study (UKPDS), provided strong evidence that intensive glycemic therapy early in the course of type 1 and type 2 diabetes significantly reduced the risk of microvascular disease.", "No information was available on medication compliance to further assess individualization of treatment."]}
{"doc_id": 43025, "title": "", "abstract": ["Taken together, our behavioral results suggest that adult neurogenesis buffers the effect of prior stress in the NSF test, buffers the effect of inescapable stress in the forced swim test, and enhances reward- seeking behavior independent of stress in the sucrose preference test.", "In the hippocampus, a brain region densely populated with receptors for stress hormones, stress and glucocorticoids strongly inhibit adult neurogenesis3.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "We next examined whether adult neurogenesis regulates the behavioral response to stress in the novelty-suppressed feeding (NSF) test, which shows robust effects of antidepressants that are blocked by irradiation12, 18.", "Using transgenic and radiation methods to specifically inhibit adult neurogenesis, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis- deficient mice compared with intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis6, 7."]}
{"doc_id": 43026, "title": "", "abstract": ["Our data show that adult-born hippocampal granule neurons dynamically regulate stress reactivity at both the endocrine and behavioral levels.", "Since the production of new granule neurons is itself strongly regulated by stress and glucocorticoids,3 this system forms a loop through which stress, by inhibiting adult neurogenesis, could lead to enhanced responsiveness to future stress.", "Therefore, the most parsimonious interpretation of our results is that inhibition of adult neurogenesis in the dentate gyrus leads to hypersecretion of glucocorticoids in response to stress.", "Our findings above suggest that stress may be a key unexplored factor linking adult-born neurons to anxiety- and depression- like behaviors.", "Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5."]}
{"doc_id": 43027, "title": "", "abstract": ["Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking4, 5.", "A direct role for adult neurogenesis in depression-like behavior was observed in three behavioral paradigms that are commonly-used to assess antidepressant efficacy and characterize the development of a depressive phenotype in response to chronic stress12, 18, 25.", "However, normal anxiety- and depressive- like behavior in animals lacking neurogenesis has led to speculation that impaired neurogenesis does not directly contribute to the etiology of depression in adulthood4, 5.", "Mice lacking neurogenesis show increased anxiety/depression-like behaviors.", "A functional link between new neurons and anxiety/depression has been suggested by the demonstration that some antidepressant effects on behavior are blocked by irradiation12, 16-18."]}
{"doc_id": 62022, "title": "", "abstract": ["Given the high level of exposure to trauma in extremely poor countries such as these [36], research is urgently needed to determine the best approaches to study the prevalence of mental disorders in these settings.", "MDE is a significant public-health concern across all regions of the world and is strongly linked to social conditions.", "Future research on cross-national differences in depression needs to take this pattern into consideration, and to develop a workable strategy to deal with the possibility of differential recall error as a plausible contributor to cross-national differences in prevalence estimates.", "A justification for this line of thinking comes from an earlier cross-national WHO study of major depression in primary-care patients, which found strong similarity in the latent structure of depressive symptoms across 14 different countries in different parts of the world, but also found that countries with the highest prevalence estimates generally reported the lowest impairment associated with depression [15].", "Future research is needed to investigate the combination of demographic risk factors that are most strongly associated with MDE in the specific countries included in the WMH."]}
{"doc_id": 62023, "title": "", "abstract": ["Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to- face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI).", "Cross-tabulations were used to estimate the absolute and relative lifetime and 12-month prevalence of endorsing diagnostic stem questions and meeting DSM- IV/CIDI criteria for a diagnosis of MDE.", "Weissman et al. [5] published the first cross-national comparison of major depression as defined by the Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III) from 10 population-based surveys that used the Diagnostic Interview Schedule (DIS) [6].", "Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].", "DSM- IV MDE requires the presence of five of nine cardinal symptoms that persist for 2 weeks or longer, are present for most of the day nearly every day, and cause significant distress or impairment."]}
{"doc_id": 63019, "title": "", "abstract": ["XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway", "Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II.", "These results indicate that the assembly of the XBP1-HIF1α complex on target promoters is crucial for their transcription, via the recruitment of RNA polymerase II.", "HIF1α motif enrichment in the XBP1 ChIP-seq dataset suggested that XBP1 and HIF1α might interact within the same transcriptional complex.", "XBP1 depletion downregulated HIF1α targets VEGFA, PDK1, GLUT1, and DDIT4 expression in both normoxic and hypoxic conditions (Extended Data 6b), and these results were validated in breast cancer xenografts (Fig. 3e) and Hs578T cells (Extended Data 6c)."]}
{"doc_id": 63020, "title": "", "abstract": ["Quantification of cleaved Caspase-3 activity was performed using the PathScan Cleaved Caspase-3 (Asp175) sandwich ELISA kit (#7190, Cell Signaling) according to the manufacturer's recommendations.", "The following primary antibodies were used: CD31 (1:50, Abcam, ab28364), Cleaved Caspase 3 (1:200, Cell Signaling, #9664), CD44 (1:100, Novocastra), Ki67 (1:50, Dako, Clone MIB-1), and Carbonic Anhydrase IX (1:40, Novus Biologicals).", "### Caspase 3 ELISA Assay", "Experiments were performed in triplicate and data are shown as mean ± SD. h, Cleaved caspase 3 ELISA assays on CD44high/CD24low or CD44low/CD24high cells isolated from TAM treated MCF10A-ER-Src cells infected with control shRNA or XBP1 shRNA encoding lentivirus (72h after infection).", "EnVision+ system (Dako) was used to amplify Caspase 3 and Carbonic Anhydrase IX."]}
{"doc_id": 63021, "title": "", "abstract": ["Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis.", "In the setting of a tumor microenvironment, hypoxia further induces XBP1 activation, active XBP1s in turn interacts with HIF1α to stimulate and augment the transactivation of HIF1 target genes that promote cancer progression.", "Our experiments demonstrate that XBP1 functions to sustain the hypoxia response via regulating the HIF1α transcriptional program (Extended Data 8), which ensures maximum HIF activity and adaptive responses to the cytotoxic microenvironment of solid tumors.", "The scatter-plot of XBP1 and two publicly available HIF1α signature (Left panel: HIF1α pathway; Right panel: Hypoxia via HIF1α pathway) across different tumors were drawn for TNBC (a) and ER+ breast cancer patients (b), respectively.", "Immunohistochemical staining of CA9 and Cleaved Caspase 3 (consecutive sections) showed that cell death was not induced in hypoxic region in XBP1 knockdown tumors."]}
{"doc_id": 63022, "title": "", "abstract": ["Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.", "Hypoxia is a physiological UPR inducer in cancer19and XBP1s co-localizes with hypoxia marker CA9 in tumors20.", "XBP1 pathway activation correlates with poor patient survival in TNBC patients implying that UPR inhibitors in combination with standard chemotherapy may improve the effectiveness of anti-tumor therapies.", "Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "We determined UPR activation status in several breast cancer cell lines (BCCL)."]}
{"doc_id": 63023, "title": "", "abstract": ["Previous studies report UPR activation in various human tumors4-6, but XBP1's role in cancer progression in mammary epithelial cells is largely unknown.", "Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and imply that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.", "These results indicate that the assembly of the XBP1-HIF1α complex on target promoters is crucial for their transcription, via the recruitment of RNA polymerase II.", "These data establish a critical role of XBP1 in CD44high/CD24low cells within TNBC.", "Here, we report that XBP1 is activated in TNBC and plays a pivotal role in the tumorigenicity and progression of this human breast cancer subtype."]}
{"doc_id": 63024, "title": "", "abstract": ["Hypoxia is a physiological UPR inducer in cancer19and XBP1s co-localizes with hypoxia marker CA9 in tumors20.", "Hypoxia activates the UPR, and XBP1 knockdown also dramatically reduced mammosphere formation in hypoxic conditions (Extended Data.", "One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE12 and its substrate XBP13.", "a, Activation of UPR in different breast cancer cells.", "We determined UPR activation status in several breast cancer cell lines (BCCL)."]}
{"doc_id": 63025, "title": "", "abstract": ["HIF1α is a co-regulator of XBP1", "HIF1α is a co-regulator of XBP1", "XBP1 and HIF1α cooperatively regulate HIF1α targets in TNBC.", "Expression of the XBP1-regulated HIF1α program was also associated with decreased relapse free survival only in TNBC (p=0.00911) (Fig. 4d, Extended Data 9d).", "GST pull-down experiments showed that HIF1α interacts with the XBP1s N-terminus b-zip domain (Extended Data 4m, n)."]}
{"doc_id": 68023, "title": "", "abstract": ["Long intergenic noncoding RNAs (lincRNAs) are defined as intergenic (relative to current gene annotations) transcripts longer than 200 nucleotides in length that lack protein coding capacity.", "Due to the incomplete nature of the lincRNA structures resulting from de novo assembly, overlapping and nearby lincRNAs were considered to represent different potential models of the same lincRNA gene (rather than isoforms).", "The intergenic sequence used includes all portions of the uniquely mappable genome excluding RefSeq NM, NR and XR genes, Ensembl v61 genes including “lincRNAs” and “processed transcripts”, GENCODEv6 genes including “lincRNAs” and “processed transcripts”, H-Invitational “noncoding” transcripts, alternative and extended 5′ and 3′ UTRs of known human genes from UTRdb, extended protein coding gene structures derived from RNA-seq data (extended gene filter, described above), and published lincRNAs from Khalil et al. [18] and Cabili et al. [16].", "In order to avoid cataloging transcripts in these regions as lincRNAs, we created a filter based on extended boundaries of protein coding genes using RNA-seq data.", "Ensembl v61 “processed_transcript” and “lincRNA” categories, GENCODE v6 “processed_transcript” and “lincRNA” categories, RefSeq NR and XR genes, H-Invitational “noncoding” transcripts, ultra conserved elements (UCEs), and published lincRNAs from Khalil et al. [18] and Cabili et al. [16]."]}
{"doc_id": 68024, "title": "", "abstract": ["The GENCODE consortium (GENCODE v7) has manually curated approximately five thousand lincRNAs that are not restricted to particular tissues or structural features, however this annotation set contains only a small fraction of all lincRNAs because it does not take advantage of RNA-seq data to identify novel transcripts [19], [20].", "In sum, our findings corroborate recent reports of pervasive transcription across the human genome and demonstrate that intergenic transcription results in the production of a large number of previously unknown lincRNAs.", "We have identified a large number of putative lincRNAs with characteristics suggesting functionality.", "One functional lincRNA (MIAT) was first identified during the experimental interrogation of an intergenic TAS [35], and another lincRNA PTCSC3, was identified nearby a TAS found from a papillary thyroid carcinoma GWAS, perhaps representing the first of many such discoveries to come from intergenic TASs.", "Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs"]}
{"doc_id": 68025, "title": "", "abstract": ["Thus, the expression of lincRNAs appears to be specifically regulated.", "Because nearly half of all TASs are intergenic, it is possible that lincRNAs play a significant role in the majority of human traits and diseases thus far analyzed in GWASs.", "Furthermore, these lincRNAs are strongly enriched with intergenic sequences that were previously known to be functional in human traits and diseases.", "We found that the lincRNAs we identified have many characteristics that are inconsistent with noise, including specific regulation of their expression, the presence of conserved sequence and evidence for regulated processing.", "Replicates of each tissue type strongly clustered together, indicating that lincRNA differential expression is indeed reproducibly tissue-specific, supporting specific regulation of lincRNA expression."]}
{"doc_id": 99017, "title": "", "abstract": ["Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "Metformin improves healthspan and lifespan in mice", "Our model reveals a level of chronic metformin exposure that lengthens lifespan and also attenuates the deleterious effects of aging in male mice."]}
{"doc_id": 99018, "title": "", "abstract": ["It has been proposed that mild inhibition of the mitochondrial ETC complex I activity by metformin21,22 reduces ATP production and contributes to increase the AMP/ATP ratio, which, in turn, results in AMPK activation.", "Metformin improves healthspan and lifespan in mice", "Several studies provide evidence that metformin partially inhibits complex I of the electron transport chain (ETC) with subsequent alteration of the mitochondrial performance, but the molecular mechanisms underlying this process have not been characterized in detail21–23.", "### Metformin increases healthspan and longevity of mice", "The administration of this anti-diabetic drug did not alter several markers of mitochondrial content in both MEFs and the liver of treated mice (Fig. 3d, e and f), while causing only moderate increase, if any, in the expression of several subunits in the ETC complexes (Fig. 3g and h)."]}
{"doc_id": 99019, "title": "", "abstract": ["Consistent with this hypothesis, β-oxidation of fatty acids was found to be increased while lipid synthesis was decreased in primary hepatocytes and MEFs treated with metformin (Supplementary Fig. S1).", "In accordance with previous reports demonstrating that metformin increases the use of lipids as a source of energy35, the respiratory exchange ratio was decreased during both the light and dark phases and liver glyceride content was reduced in metformin-treated mice, indicating the preference for fat utilization (Fig. 1f and Supplementary Fig. S1).", "### Metformin increases healthspan and longevity of mice", "Moreover, the marked reduction in the amount of lysine-4-hydroxynonenal-modified proteins and 8-iso-PGF2α, a marker of lipid peroxidation, was consistent with decreased oxidative stress damage in the liver of metformin-treated mice (Fig. 4b and c).", "At a molecular level, metformin increases AMP- activated protein kinase activity and increases antioxidant protection, resulting in reductions in both oxidative damage accumulation and chronic inflammation."]}
{"doc_id": 99020, "title": "", "abstract": ["Several reports suggest that the actions of metformin resemble the effects of CR to some extent; microarray analyses have shown that metformin induces a gene expression profile that aligns with that of CR, although conflicting results have been shown in lifespan extension9–15.", "The overall interpretation of these results is that metformin exerts CR-like genomic and metabolic responses by inducing longevity-associated pathways in laboratory mice.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans.", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12."]}
{"doc_id": 99021, "title": "", "abstract": ["Food intake and body weight were measured on a biweekly or bimonthly basis for the duration of the study.", "All mice were fed daily and, with rare exceptions, all food was eaten each day.", "Mouse metabolic rate was assessed by indirect calorimetry in open-circuit oxymax chambers using the Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH).", "Mice were housed singly with water and food available ad lib, except for CR group, and maintained at 20–22 °C under a 12:12-h light-dark cycle (light period 0600–1800).", "### Animal models and diets"]}
{"doc_id": 99022, "title": "", "abstract": ["Our model reveals a level of chronic metformin exposure that lengthens lifespan and also attenuates the deleterious effects of aging in male mice.", "Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic.", "The ability of metformin to extend lifespan in the nematode C. elegans and the conflicting results in drosophila and mammals led us to study chronic metformin supplementation in laboratory mice9,10,12.", "In agreement with these data, a different strain of male mice (B6C3F1) supplemented with the same dose of metformin (0.1% w/w) resulted in a 4.15% extension of mean lifespan (Supplementary Fig. S1), χ2 = 3.43 and p= 0.064 in Gehan-Breslow survival test, which although is not significant suggests that the effects of metformin in longevity are not strain-specific.", "Our data show a level of chronic metformin exposure that leads to healthier and longer lives in mice, justifying further studies to determine if there is an exposure level that leads to improvement in healthspan and lifespan in humans."]}
{"doc_id": 99023, "title": "", "abstract": ["The fact that metformin treatment has been associated with reduced risk of cancer4 and cardiovascular disease raises the possibility of a beneficial role of metformin for other age-related diseases5.", "However, the beneficial effects of metformin might be explained, at least in part, by changes in the gut microbiota34, a process that has not been addressed in our study.", "While it is clear that in short-term in vitro models, metformin partially inhibits oxidative phosphorylation, we find no evidence for this with long-term exposure in vivo, suggesting that adaptation to metformin occurs, and is associated with benefits, including reduced oxidative stress and increased antioxidant defenses, leading to lower oxidative damage accumulation and inhibition of chronic inflammation.", "These findings are in agreement with current epidemiological data and raise the possibility of metformin-based interventions to promote healthy aging.", "In summary, the ability of metformin to reduce oxidative stress and inflammation suggests that this could partly be the reason why this drug confers health and lifespan benefits in laboratory mice."]}
{"doc_id": 70015, "title": "", "abstract": ["Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "Inhibition of TNF-α induced epithelial necroptosis in Casp8ΔIEC mice", "Recent data from other experimental systems have shown that inhibition of caspase activity in genetic models or by using specific caspase inhibitors can result in an apoptosis-independent type of programmed necrosis called necroptosis14.", "Collectively, our data suggest that deficient caspase-8 expression renders Paneth cells susceptible to TNF-α induced necroptosis highlighting a regulatory role of caspase-8 in antimicrobial defence and in maintaining immune homeostasis in the gut.", "Taken together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IEC from TNF-α induced necroptotic cell death."]}
{"doc_id": 70016, "title": "", "abstract": ["Indeed, we were able to demonstrate constitutive expression of RIP3, a kinase sensitizing cells to necroptosis17,18, in human Paneth cells.", "Finally, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease.", "Collectively, our data suggest that deficient caspase-8 expression renders Paneth cells susceptible to TNF-α induced necroptosis highlighting a regulatory role of caspase-8 in antimicrobial defence and in maintaining immune homeostasis in the gut.", "RIP3 seems to be essential for the molecular mechanisms driving necroptosis and expression of RIP3 has been demonstrated to correlate with the sensitivity of cells towards necroptosis17,18.", "Epithelial cell death was induced by tumor necrosis factor (TNF) -α, was associated with increased expression of receptor-interacting protein 3 (RIP3) and could be inhibited upon blockade of necroptosis."]}
{"doc_id": 70017, "title": "", "abstract": ["Moreover RIP3 was overexpressed in the small intestine of TNF-α treated Casp8ΔIEC mice when compared to control littermate mice (Fig. 3b, Supplementary Fig. 8d), suggesting that the lack of caspase-8 in the intestinal epithelium might sensitize IEC to RIP-mediated necroptotic cell death.", "Together, our data indicate that a lack of caspase-8 in IEC renders mice highly susceptible to spontaneous ileitis and experimentally induced colitis.", "This finding of spontaneous ileitis in the absence of caspase-8 in IEC was further supported by increased expression of the inflammation markers S100A9 and TNF-α and by elevated infiltration of the lamina propria with CD4+ T cells and granulocytes (Fig. 1c, Supplementary Fig. 3).", "Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8ΔIEC) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis.", "To investigate whether caspase-8 deficiency sensitizes mice to experimental intestinal inflammation in the large bowel, we subjected Casp8ΔIEC and control mice to dextran sodium sulfate (DSS), a well established model of experimental colitis."]}
{"doc_id": 70018, "title": "", "abstract": ["Necroptosis has been shown to be mediated by the kinases RIP1 and RIP315,16.", "RIP-mediated necroptosis can be blocked in vitro and in vivo by using necrostatin-1 (nec-1), an allosteric small-molecule inhibitor of the RIP1 kinase21.", "RIP-mediated necroptosis of Paneth cells in patients with Crohn's disease", "Beside the physical barrier established by the tight contact of cells, specialized epithelial cells such as Paneth cells and goblet cells provide innate immune defence functions by secreting mucus and antimicrobial peptides which hamper access and survival of bacteria adjacent to the epithelium2.", "Upon induction of necrosis, RIP3 is recruited to RIP1 to establish a necroptosis inducing protein complex."]}
{"doc_id": 70019, "title": "", "abstract": ["On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Targeting necroptotic cellular mechanisms emerges as a promising option in treating patients with IBD.", "Recent data from other experimental systems have shown that inhibition of caspase activity in genetic models or by using specific caspase inhibitors can result in an apoptosis-independent type of programmed necrosis called necroptosis14.", "Given the low expression of caspase-8 and high expression of RIP3 at the base of crypts, cells residing in this area may be susceptible to necroptosis upon stimulation with death receptor ligands such as TNF-α.", "Finally, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease."]}
{"doc_id": 70020, "title": "", "abstract": ["Taken together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IEC from TNF-α induced necroptotic cell death.", "Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IEC) and terminal ileitis.", "In summary our data uncover an unexpected function of caspase-8 in regulating necroptosis of intestinal epithelial cells and in maintaining immune homeostasis in the gut.", "Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "Moreover RIP3 was overexpressed in the small intestine of TNF-α treated Casp8ΔIEC mice when compared to control littermate mice (Fig. 3b, Supplementary Fig. 8d), suggesting that the lack of caspase-8 in the intestinal epithelium might sensitize IEC to RIP-mediated necroptotic cell death."]}
{"doc_id": 70021, "title": "", "abstract": ["Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8ΔIEC) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis.", "This finding of spontaneous ileitis in the absence of caspase-8 in IEC was further supported by increased expression of the inflammation markers S100A9 and TNF-α and by elevated infiltration of the lamina propria with CD4+ T cells and granulocytes (Fig. 1c, Supplementary Fig. 3).", "Specific deletion of caspase-8 in IEC was confirmed by PCR and Western blotting (Supplementary Fig. 1a, b).", "Together, our data indicate that a lack of caspase-8 in IEC renders mice highly susceptible to spontaneous ileitis and experimentally induced colitis.", "This conclusion was supported by electron microscopy of mice in which the caspase-8 deletion was induced in adult mice by injection with Tamoxifen (inducible Casp8ΔIEC) to detect early effects of caspase-8 deletion."]}
{"doc_id": 70022, "title": "", "abstract": ["Necroptosis has been shown to be mediated by the kinases RIP1 and RIP315,16.", "Finally, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease.", "Recent data from other experimental systems have shown that inhibition of caspase activity in genetic models or by using specific caspase inhibitors can result in an apoptosis-independent type of programmed necrosis called necroptosis14.", "Ultimately, our data for the first time demonstrate necroptosis in the terminal ileum of patients with Crohn's disease and suggest that regulating necroptosis in the intestinal epithelium is critical for the maintenance of intestinal immune homeostasis.", "Crohn's disease patients frequently show reduced Paneth and goblet cell numbers and reduced expression of Paneth cell derived defensins in areas of acute inflammation, suggesting that necroptosis might be involved in the pathogenesis of human IBD22."]}
{"doc_id": 70023, "title": "", "abstract": ["Necroptosis has been shown to be mediated by the kinases RIP1 and RIP315,16.", "RIP-mediated necroptosis can be blocked in vitro and in vivo by using necrostatin-1 (nec-1), an allosteric small-molecule inhibitor of the RIP1 kinase21.", "On the molecular level, caspase-8 has been demonstrated to proteolytically cleave and inactivate RIP1 and RIP3 thereby regulating the initiation of necroptosis20.", "Caspase-8 has recently been shown to suppress RIP3-RIP1-kinase-dependent necroptosis following death receptor activation14,17,18.", "Indeed, we were able to demonstrate constitutive expression of RIP3, a kinase sensitizing cells to necroptosis17,18, in human Paneth cells."]}
{"doc_id": 98024, "title": "", "abstract": ["Accumulation of senescent cells in fat with aging could be caused by increased generation of these cells owing to a combination of replicative, cytokine- induced, and metabolic stresses as well as reduced removal of senescent cells because of failure of immune cells from older individuals to respond efficiently to chemokines released by senescent cells.", "A high burden of senescent cells in obesity could have substantial clinical impact because: (i) senescent cells restricted to a single tissue can have widespread systemic effects (Keyes et al., 2006); (ii) many of the pro- inflammatory cytokines and chemokines released by these cells are associated with development of diabetes and metabolic disease; and (iii) fat is frequently the largest organ in humans.", "With respect to fat, senescent cells can be found in fat tissue and preadipocytes from juvenile animals and young adult humans with obesity (Fig. 3).", "Together, these findings suggest senescent cells could accumulate in fat tissue with chronological aging and that these cells might contribute to age-related fat tissue inflammation and dysfunction.", "Age-related changes in fat tissue inflammatory profiles resemble those in obesity, in which senescent preadipocytes and endothelial cells accumulate, as well as the senescent secretory phenotype reported in skin fibroblasts and other cell types in vitro [Table 2; (Krtolica & Campisi, 2002; Parrinello et al., 2005; Xue et al., 2007; Coppéet al., 2008; Minamino et al., 2009; Tchkonia et al., 2009; Cartwright et al., 2010)]."]}
{"doc_id": 98025, "title": "", "abstract": ["Preadipocytes and fat tissue endothelial cells may acquire an activated, pro-inflammatory, senescent-like phenotype in response to repeated replication, fatty acids, toxic metabolites, chronically high IGF-1, glucose, or other stimuli (gray = inflamed).", "Additionally, preadipocyte turnover is likely increased, because preadipocytes develop into new fat cells as fat cell number and removal increase (Cinti et al., 2005; Strissel et al., 2007).", "Fat cell dysfunction in obesity, coupled with reduced ability of preadipocytes to differentiate into fat cells, may contribute to failure to sequester fatty acids, systemic lipotoxicity, and insulin resistance.", "Impaired adipogenesis in obesity, associated with reduced downregulation of preadipocyte pro-inflammatory genes and restricted capacity to store excess fatty acid as triglyceride, may contribute to fat tissue inflammation, ectopic lipid accumulation, lipotoxicity, and insulin resistance, as occurs in aging (Unger, 2002; Xu et al., 2002; Listenberger et al., 2003; DeFronzo, 2004; Tchkonia et al., 2006a; Kim et al., 2007).", "Even preadipocytes become susceptible to lipotoxicity because of fatty acids in old age, related to reduced expression of adipogenic transcription factors and enzymes required for processing fatty acids into triglycerides (Guo et al., 2007)."]}
{"doc_id": 98026, "title": "", "abstract": ["Fat tissue, frequently the largest organ in humans, is at the nexus of mechanisms involved in longevity and age-related metabolic dysfunction.", "Fat tissue is at the nexus of mechanisms and pathways involved in longevity, genesis of age-related diseases, inflammation, and metabolic dysfunction.", "Conversely, life span is extended: (i) by caloric restriction [which preferentially leads to reduced visceral fat (Barzilai & Gupta, 1999; Masoro, 2006)]; (ii) in fat cell insulin receptor (FIRKO), insulin receptor substrate-1 (IRS-1), and S6 kinase-1 knockout mice [each of which has limited fat development (Bluher et al., 2003; Um et al., 2004; Selman et al., 2008, 2009)]; (iii) in growth hormone receptor knockout (GHRKO) mice [which have reduced IGF-1, delayed increase in the ratio of visceral to subcutaneous fat, and most likely reduced fat cell progenitor turnover (Berryman et al., 2008)]; (iv) with rapamycin treatment [which limits fat tissue development (Chang et al., 2009; Harrison et al., 2009)]; and (v) after surgical removal of visceral fat (Muzumdar et al., 2008).", "Thus, fat redistribution with aging occurs across species and is associated with age-related diseases, lipotoxicity, and reduced longevity, while retention of a high ratio of functioning subcutaneous to visceral fat is associated with enhanced longevity.", "Increased adiponectin, a cytokine that exists in several isoforms and that originates from fat as well as other tissues, has been associated with reduced risk of metabolic syndrome in the elderly (Lim et al. 2010; Stenholm et al., 2009)."]}
{"doc_id": 12039, "title": "", "abstract": ["Although limited clinical data exist, use of P2Y12 platelet function testing to guide the use of clopidogrel or ticagrelor in this setting might be considered.", "Do not coadminister or if available utilize P2Y12 monitoring or consider dose-reduced ticagrelor.∗| CYP3A4 Inhibition: Recommend decreasing dose to maximum of 50 mg twice a day.", "* * *      ---|---|---|---   Clopidogrel| Prasugrel| Ticagrelor| Cilostazol   Lopinavir/ritonavir| Lopinavir is a protease inhibitor; Ritonavir inhibits CYP3A4 metabolism increasing lopinavir levels.| CYP 3A4 Inhibition (minor pathway): Reduction in clopidogrel active metabolite.", "Investigational COVID-19 Therapy| Mechanism of Action of COVID-19 Therapy| P2Y12 Platelet Receptor Inhibitors", "Dose reduction recommendations for P2Y12 inhibitors or P2Y12 platelet function assay monitoring is not commonly practiced."]}
{"doc_id": 12040, "title": "", "abstract": ["For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "Further, 71% of COVID-19 patients who died fulfilled the International Society on Thrombosis and Haemostasis (ISTH) criteria (29) for DIC, compared with only 0.6% among survivors.", "For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "In view of the hemostatic derangements discussed previously and observations from prior viral illnesses (80), some clinicians use intermediate- or full- dose (therapeutic) parenteral anticoagulation (rather than prophylactic dosing) for routine care of patients with COVID-19 (81), hypothesizing that it may confer benefit to prevent microvascular thrombosis."]}
{"doc_id": 12041, "title": "", "abstract": ["For hospitalized patients with COVID-19 and not in DIC, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗§    Routine screening for VTE (e.g., bilateral lower extremity ultrasound) for hospitalized patients with COVID-19 with elevated D-dimer (>1,500 ng/ml) cannot be recommended at this point.||   Patients with moderate or severe COVID-19 and suspected or confirmed DIC (hospitalized)    For patients with moderate or severe COVID-19 and in DIC but without overt bleeding, prophylactic anticoagulation should be administered.∗†¶    For hospitalized patients with COVID-19 with suspected or confirmed DIC, but no overt bleeding, there are insufficient data to consider routine therapeutic or intermediate-dose parenteral anticoagulation with UFH or LMWH.∗    For patients with moderate or severe COVID-19 on chronic therapeutic anticoagulation, who develop suspected or confirmed DIC without overt bleeding, it is reasonable to consider the indication for anticoagulation and weigh with risk of bleeding when making clinical decisions regarding dose adjustments or discontinuation.", "The World Health Organization interim guidance statement recommends prophylactic daily low-molecular-weight heparins (LMWHs), or twice daily subcutaneous unfractionated heparin (UFH) (64).", "Further, 71% of COVID-19 patients who died fulfilled the International Society on Thrombosis and Haemostasis (ISTH) criteria (29) for DIC, compared with only 0.6% among survivors.", "Hospitalized patients with COVID-19 who have respiratory failure or comorbidities (e.g., active cancer, heart failure) (62), patients who are bedridden, and those requiring intensive care should receive pharmacological VTE prophylaxis, unless there are contraindications.", "For hospitalized patients with COVID-19 and not in DIC, prophylactic doses of anticoagulation should be administered to prevent VTE.∗†‡ If pharmacological prophylaxis is contraindicated, it is reasonable to consider intermittent pneumatic compression."]}
{"doc_id": 12042, "title": "", "abstract": ["Myocardial injury in COVID-19, as evidenced by elevated cardiac troponin levels or electrocardiographic and echocardiographic abnormalities, is associated with severe disease (5,36).", "However, the differential diagnosis for elevated troponin in COVID-19 is broad (37) and includes nonspecific myocardial injury, impaired renal function (leading to troponin accumulation), myocarditis, pulmonary embolism (PE), and type 1 and 2 myocardial infarction (MI) (38,39).", "Furthermore, higher troponin levels are associated with severe COVID-19 (5,36).", "In a study of 184 patients with severe COVID-19 from 3 academic medical centers in the Netherlands, the authors reported that 31% (95% confidence interval: 20% to 41%) of patients developed incident VTE.", "†High-risk COVID-19 refers to patients with high suspicion for or confirmed COVID-19, including individuals with high viral load, symptomatic with coughing or sneezing or other respiratory symptoms, and at risk for requiring intubation and aerosolizing viral particles."]}
{"doc_id": 12043, "title": "", "abstract": ["Aside from hemostatic derangements, immobility (a systemic inflammatory state), mechanical ventilation, and central venous catheters contribute to VTE risk within the ICU (105, 106, 107), nutritional deficiencies and liver dysfunction may also interfere with the production of coagulation factors (108).", "DIC is common in many patients with critical illness (113), including those with COVID-19 (7,114).", "In a retrospective study from China, among 81 patients with severe COVID-19 admitted to ICU, 20 (25%) developed incident VTE.", "The risk of VTE, which is increased in critically ill patients, is likely even higher in those with SARS-CoV-2 and critical illness.", "The vast majority of patients with symptomatic acute DVT, should be managed with anticoagulation, with home treatment whenever possible."]}
{"doc_id": 12044, "title": "", "abstract": ["In conclusion, thrombotic disease may be precedent factors or incident complications in patients with COVID-19.", "Factors may include inflammatory cytokine release and critical illness/underlying risk factors| Arterial thrombotic events| Data are continuing to emerge regarding the risk of thrombotic events associated with COVID-19 infection, and an international registry for ACS is planned.", "Rates of complications are unknown in patients with SARS-CoV-2, but rates of thrombosis and hemorrhage may be as high as 53% and 16%, respectively, in other populations with respiratory failure (110).", "Another consideration that has not yet been investigated is that the hemostatic changes seen with COVID-19 infection are related to liver dysfunction (34).", "Aside from hemostatic derangements, immobility (a systemic inflammatory state), mechanical ventilation, and central venous catheters contribute to VTE risk within the ICU (105, 106, 107), nutritional deficiencies and liver dysfunction may also interfere with the production of coagulation factors (108)."]}
{"doc_id": 12045, "title": "", "abstract": ["The limited outcome data that are available for ECMO in patients with SARS-CoV-2 suggest poor outcomes, with 5 of 6 patients dying in one series and 3 of 3 in another (20,26).", "Although no data specific to COVID-19 exist, it is reasonable to employ individualized risk stratification for thrombotic and hemorrhagic risk, followed by consideration of extended prophylaxis (for up to 45 days) for patients with elevated risk of VTE (e.g., reduced mobility, comorbidities such as active cancer, and [according to some authors in the writing group] elevated D-dimer >2 times the upper limit of normal) who have low risk of bleeding (74,77,78).", "Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis.", "Myocardial injury in COVID-19, as evidenced by elevated cardiac troponin levels or electrocardiographic and echocardiographic abnormalities, is associated with severe disease (5,36).", "Key Words: anticoagulant, antiplatelet, antithrombotic therapy, COVID-19, SARS-CoV-2, thrombosis"]}
{"doc_id": 87022, "title": "", "abstract": ["For example, cortical hubs have been suggested to be critical regions in Alzheimer’s disease, concentrating most of the amyloid-β deposition (Buckner et al., 2009).", "First, their topologically central role could mean that pathological attack on a hub will have a disproportionate impact on the network’s global efficiency of information processing (Albert et al., 2000); and thus be more likely to lead to clinical symptoms such as impairment of cognitive functions, that normally depend on integrative network processes.", "It has also been proposed that hubs may have greater susceptibility to oxidative stress, due to their higher rates of metabolic activity (Buckner et al., 2009; Saxena and Caroni, 2011); and a computational model of this pathological mechanism mirrored several neurophysiological aspects of Alzheimer’s disease (de Haan et al., 2012).", "However, there was not statistically robust evidence for hub-targeting lesions in all of the 26 disorders we evaluated specifically.", "However, we note that lesions might be concentrated on hubs purely because of their greater topological value: some disease processes might affect brain regions with uniform probability but lead to symptoms when the lesion happened to be in a hub; or some disease processes might be initiated locally, perhaps in a peripheral node, and only become symptomatic once they have propagated to topologically central nodes."]}
{"doc_id": 87023, "title": "", "abstract": ["On this basis, it seems intuitive that pathological lesions to network hubs are especially likely to be associated with clinically significant cognitive impairments.", "Echoing these results, here we provide evidence that the hubs of brain networks are generally central to clinical disorders.", "Conceptualizing the brain as a network (the ‘connectome’) (Sporns et al., 2005) has potentially important implications for understanding clinical brain disorders (Bullmore and Sporns, 2012; Fornito et al., 2012; Menon, 2013; Rubinov and Bullmore, 2013; van den Heuvel and Sporns, 2013).", "First, their topologically central role could mean that pathological attack on a hub will have a disproportionate impact on the network’s global efficiency of information processing (Albert et al., 2000); and thus be more likely to lead to clinical symptoms such as impairment of cognitive functions, that normally depend on integrative network processes.", "Meta-analysis of a large database of clinical MRI studies demonstrated that hub nodes of the DTI connectome were more likely to be pathologically lesioned by a wide range of brain disorders, results that were reproduced in relation to an independent normal functional brain network."]}
{"doc_id": 87024, "title": "", "abstract": ["For example, any disease process that restricts neuronal metabolism, e.g. ischaemia or oxidative stress, might be expected to have disproportionate impact on the most metabolically active (hub) nodes.", "The wiring cost of the DTI network, as measured by the median Euclidean distance between connected nodes, was reduced compared to that of a random network (P < 0.001, permutation test); but the distance distribution was fat- tailed indicating some unusually long distance connections (Fig. 1C).", "Image preprocessing included correction for eddy currents and subject motion, normalization into standardized space using an appropriate B-matrix rotation on the diffusion gradients (Leemans and Jones, 2009), before robust estimation of the tensor model (RESTORE) (Chang et al., 2005).", "For example, trans-synaptic transmission of a pathogenic agent has been suggested to explain the modular distribution of cortical abnormalities (Prusiner, 1984; Pearson et al., 1985; Raj et al., 2012); and this mechanism could also explain higher lesion concentration in hubs (Zhou et al., 2012).", "It has also been proposed that hubs may have greater susceptibility to oxidative stress, due to their higher rates of metabolic activity (Buckner et al., 2009; Saxena and Caroni, 2011); and a computational model of this pathological mechanism mirrored several neurophysiological aspects of Alzheimer’s disease (de Haan et al., 2012)."]}
{"doc_id": 87025, "title": "", "abstract": ["On this basis, it seems intuitive that pathological lesions to network hubs are especially likely to be associated with clinically significant cognitive impairments.", "First, their topologically central role could mean that pathological attack on a hub will have a disproportionate impact on the network’s global efficiency of information processing (Albert et al., 2000); and thus be more likely to lead to clinical symptoms such as impairment of cognitive functions, that normally depend on integrative network processes.", "As most studies have focused on neurodegenerative disorders, a number of disease-specific mechanisms have been proposed to account for the observed relationships between neuropathology and brain network organization (Zhou et al., 2012).", "Although we claim that the anatomical lesions of brain disorders are generally concentrated on normal network hubs, this does not mean that different disorders will necessarily involve an identical set of hubs, as shown for Alzheimer’s disease and schizophrenia.", "Other studies have highlighted the role of topological modularity in the anatomy of brain disorders, showing that focal grey matter abnormalities in neurodegenerative disorders are not randomly located with respect to the modular organization of the normal brain network (Seeley et al., 2009)."]}
{"doc_id": 16025, "title": "", "abstract": ["The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F).", "The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "The other antibodies grouped in the S-A epitope bin that compete with CC12.19 either showed no binding to RBD or RBD- SD constructs (CC12.20 and CC12.21) or showed binding to RBD-SD1 and RBD-SD1-2 but not RBD (CC12.23).", "Regardless, the RBD-A nAbs that directly compete with ACE2 are clearly the most preferred for prophylactic and therapeutic applications and as reagents to define nAb epitopes for vaccine design.", "We also assessed the affinity of all RBD-specific antibodies to soluble RBD by surface plasmon resonance (SPR) and found a poor correlation between affinity and neutralization potency (Fig. 4G and fig. S9)."]}
{"doc_id": 16026, "title": "", "abstract": ["The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "We next evaluated the mAbs for neutralization activity against SARS-CoV-2 and SARS-CoV-1 pseudoviruses."]}
{"doc_id": 16027, "title": "", "abstract": ["(A) A total of three noncompeting epitopes for RBD (RBD-A, RBD-B, and RBD-C) and three noncompeting epitopes for S (S-A, S-B, and S-C) were identified.", "All antibodies that expressed at measurable levels were tested for binding to S protein and RBD to determine their specificity and then screened for neutralization.", "In the first experiment, we tested nAb CC12.1, which targets the RBD-A epitope and has an in vitro IC50 neutralization of 0.019 μg/ml against pseudovirus, and in the second experiment, we tested nAb C12.23, which targets the S-B epitope with an IC50 neutralization of 22 μg/ml.", "However, one variant with a mutation in the ACE2 binding site [Gly476→Ser (G476S)] did show effectively complete resistance to one of the nAbs, and another variant (V367F) showed a 10-fold higher IC50 than the WA1 strain (fig. S10B).", "The antibody hits that were identified in the high-throughput screening were next evaluated for epitope specificity by biolayer interferometry using S and RBD proteins as capture antigens."]}
{"doc_id": 16028, "title": "", "abstract": ["The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "Among the antibodies evaluated, the results reveal three epitope bins for RBD (designated RBD-A, RBD-B, and RBD-C) and three epitope bins for the S protein (designated S-A, S-B, and S-C) (Fig. 4A and fig. S7).", "(A) A total of three noncompeting epitopes for RBD (RBD-A, RBD-B, and RBD-C) and three noncompeting epitopes for S (S-A, S-B, and S-C) were identified.", "In the first experiment, we tested nAb CC12.1, which targets the RBD-A epitope and has an in vitro IC50 neutralization of 0.019 μg/ml against pseudovirus, and in the second experiment, we tested nAb C12.23, which targets the S-B epitope with an IC50 neutralization of 22 μg/ml.", "The other antibodies grouped in the S-A epitope bin that compete with CC12.19 either showed no binding to RBD or RBD- SD constructs (CC12.20 and CC12.21) or showed binding to RBD-SD1 and RBD-SD1-2 but not RBD (CC12.23)."]}
{"doc_id": 16029, "title": "", "abstract": ["To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11).", "Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "# Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model", "As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters."]}
{"doc_id": 16030, "title": "", "abstract": ["The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins.", "The antibodies targeting the RBD-A epitope competed best against the ACE2 receptor, and the neutralization IC50 correlated well with the percent competition for ACE2 receptor binding for both S protein (Fig. 4E) and RBD (Fig. 4F)."]}
{"doc_id": 16031, "title": "", "abstract": ["The availability of both neutralizing and non-neutralizing antibodies generated in this study will facilitate evaluation of S protein immunogens for presentation of neutralizing and non-neutralizing epitopes and will promote effective vaccine design.", "The design of an immunogen that improves on the quality of nAbs elicited by natural infection may well emerge as an important goal of vaccine efforts (19).", "We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high- throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection.", "The antigens were captured on anti-HIS biosensors before addition of saturating concentrations (100 μg/ml) of antibodies that were then followed by competing antibodies at a lower concentration (25 μg/ml).", "The nAbs also define protective epitopes to guide vaccine design."]}
{"doc_id": 16032, "title": "", "abstract": ["Neutralizing antibodies (nAbs) to the causative agent of the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent potential prophylactic and therapeutic options and could help guide vaccine design.", "(C) MAbs were evaluated for neutralization of SARS-CoV-2 pseudovirus using HeLa-ACE2 target cells.", "The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins.", "We next evaluated the mAbs for neutralization activity against SARS-CoV-2 and SARS-CoV-1 pseudoviruses."]}
{"doc_id": 16033, "title": "", "abstract": ["S+ and S+/RBD+ memory B cells were present at an average frequency of 2.0 and 0.36%, respectively, across the eight donors (fig. S4A).", "As observed for heterologous B cell responses against different serotypes of flavivirus infection, there is a possibility, but no current experimental evidence, that subtherapeutic vaccine serum responses or subtherapeutic nAb titers could potentially exacerbate future coronavirus infection disease burden by expanding the viral replication and/or cell tropism of the virus.", "T.F.R., N.B., E.G., M.P., S.R., S.A.R., and D.M.S. recruited donors and collected and processed plasma and PBMC samples.", "Generally, nAbs with outstanding potency (known as super-antibodies) (4) can be isolated by deeply mining antibody responses of a sampling of infected donors.", "Single antigen-specific memory B cells were sorted, and their corresponding variable genes were recovered and cloned using a high-throughput production system that enabled antibody expression and characterization in under 2 weeks."]}
{"doc_id": 16034, "title": "", "abstract": ["Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and demonstrate their in vivo protective efficacy in a small animal model, suggesting their potential utility as a medical countermeasure.", "The anti-SARS-CoV-2 nAbs were delivered at five different concentrations to evaluate dose-dependent protection, starting at 2 mg per animal (average: 16.5 mg/kg) at the highest dose and 8 μg per animal at the lowest dose.", "Given concerns about antibody- mediated enhanced disease in SARS-CoV-2 infection, this observation merits further attention using larger animal group sizes.", "Neutralizing antibodies (nAbs) to the causative agent of the disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent potential prophylactic and therapeutic options and could help guide vaccine design.", "(A) SARS-CoV-2–specific human neutralizing mAb CC12.1 isolated from natural infection was administered at a starting dose of 2 mg per animal (average: 16.5 mg/kg) and subsequent serial fourfold dilutions."]}
{"doc_id": 16035, "title": "", "abstract": ["As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters.", "To investigate the relationship between in vitro neutralization and protection in vivo against SARS-CoV-2, we selected two mAbs for passive transfer and challenge experiments in a Syrian hamster animal model on the basis of a summary of the nAb data (table S3 and fig. S11).", "Fig. 5 A potent SARS-CoV-2 RBD-specific neutralizing mAb protects against weight loss and lung viral replication in Syrian hamsters.", "Potent neutralizing mAbs were selected to evaluate protection in the Syrian hamster model.", "## Passive transfer of neutralizing antibodies and SARS-CoV-2 challenge in Syrian hamsters"]}
{"doc_id": 16036, "title": "", "abstract": ["Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "In the first experiment, we tested nAb CC12.1, which targets the RBD-A epitope and has an in vitro IC50 neutralization of 0.019 μg/ml against pseudovirus, and in the second experiment, we tested nAb C12.23, which targets the S-B epitope with an IC50 neutralization of 22 μg/ml.", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins.", "Neutralizing titers in the PSV assay varied over a wide range for SARS-CoV-2 (Fig. 2D and fig. S2A) and were low or undetectable against SARS-CoV-1."]}
{"doc_id": 16037, "title": "", "abstract": ["The most potent neutralizing antibodies were those directed to RBD-A epitope, including two antibodies, CC6.29 and CC6.30, that neutralize SARS-CoV-2 pseudovirus with an IC50 of 2 ng/ml and 1 ng/ml, respectively (Fig. 4C).", "In contrast, there are fewer RBD-binding antibodies, but a larger proportion of these neutralize SARS-CoV-2 pseudovirus.", "Despite this trend, CC6.33 is directed against RBD-B and showed complete neutralization of SARS-CoV-2 with an IC50 of 39 ng/ml and also neutralized SARS-CoV-1 with an IC50 of 162 ng/ml.", "Only one of the Abs, directed to RBD-B, neutralized SARS-CoV-1 PSV, as may be anticipated given the differences in ACE2 contact residues between the two viruses (fig. S13) and given that the selections were performed with SARS-CoV-2 target proteins.", "Overall, the data highlight epitope RBD-A as the preferred target for eliciting neutralizing antibodies and suggest that corresponding increases in affinity of mAbs to RBD-A will likely result in corresponding increases in neutralization potency."]}
{"doc_id": 16038, "title": "", "abstract": ["The mAb CC12.19 appears to compete with antibodies targeting two different epitopes, RBD-B and S-A (fig. S7), which might indicate that this mAb targets an epitope spanning RBD-B and S-A. To evaluate epitope specificities further, we next assessed binding of the antibodies to extended RBD constructs with subdomains (SD) 1 and 2, including the independently folding RBD-SD1 and RBD-SD1-2 and the N-terminal domain (NTD) (Fig. 4B and fig. S8, A and B).", "Among the antibodies evaluated, the results reveal three epitope bins for RBD (designated RBD-A, RBD-B, and RBD-C) and three epitope bins for the S protein (designated S-A, S-B, and S-C) (Fig. 4A and fig. S7).", "(A) A total of three noncompeting epitopes for RBD (RBD-A, RBD-B, and RBD-C) and three noncompeting epitopes for S (S-A, S-B, and S-C) were identified.", "The other antibodies grouped in the S-A epitope bin that compete with CC12.19 either showed no binding to RBD or RBD- SD constructs (CC12.20 and CC12.21) or showed binding to RBD-SD1 and RBD-SD1-2 but not RBD (CC12.23).", "A small proportion of the binding antibodies showed neutralization activity, and, unexpectedly, that activity was equally distributed between RBD+/S+ and S+-only binders, despite a much larger number of S+-only binding supernatants, as exemplified by the three donors, CC6, CC12, and CC25 (Fig. 3A)."]}
{"doc_id": 72019, "title": "", "abstract": ["Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys", "These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific mAbs in SHIV-infected rhesus monkeys as well as an impact on host immune responses.", "We speculate that the therapeutic impact of these mAbs reflected not only their direct antiviral activity but also their impact on host antiviral immune responses.", "To evaluate the therapeutic potential of broad and potent HIV-1-specific mAbs in primates with an intact immune system, we infused cocktails of mAbs, as well as single mAbs, into chronically SHIV-infected rhesus monkeys.", "Our data demonstrate profound therapeutic efficacy of broad and potent HIV-1-specific mAbs in rhesus monkeys chronically infected with SHIV-SF162P3."]}
{"doc_id": 72020, "title": "", "abstract": ["PGT121 alone resulted in rapid virologic control to undetectable levels by day 7 in 4 of 4 animals, followed by viral rebound by day 42 to day 56 in 3 animals that again correlated with declines in serum PGT121 titers to undetectable levels (Fig. 3a, c; Extended Data Fig. 7; P=0.02 comparing viral loads on day 14 in PGT121 treated animals compared with controls).", "These observations suggest that PGT121 may have converted animals with low baseline viremia into “elite controllers”, although additional follow-up is required to assess the durability of this effect.", "To confirm that viral rebound was not associated with the development of viral resistance to the mAbs, we performed a second infusion of mAbs on day 105 in the monkeys that received PGT121 and 3BNC117.", "Taken together, baseline viral loads strongly correlated with the time to viral rebound (P=0.0002, Spearman rank-correlation test; Fig. 4e).", "a, Summary of the therapeutic effect of PGT121 alone or PGT121-containing mAb cocktails in the 18 rhesus monkeys chronically infected with SHIV-SF162P3, as well as in the subgroups of animals with baseline viral loads of <3.5 log RNA copies/ml (N=3) (b), 3.5–5.3 log RNA copies/ml (N=13) (c), and >5.3 log RNA copies/ml (N=2) (d)."]}
{"doc_id": 72021, "title": "", "abstract": ["Here we show that administration of a cocktail of HIV-1-specific mAbs, as well as the single glycan-dependent mAb PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic virus SHIV-SF162P3.", "Our studies demonstrate the therapeutic efficacy of PGT121 and PGT121-containing mAb cocktails in chronically SHIV-SF162P3 infected rhesus monkeys.", "Therapeutic efficacy of PGT121 or PGT121-containing mAb cocktails in chronically SHIV-infected rhesus monkeys", "a, Summary of the therapeutic effect of PGT121 alone or PGT121-containing mAb cocktails in the 18 rhesus monkeys chronically infected with SHIV-SF162P3, as well as in the subgroups of animals with baseline viral loads of <3.5 log RNA copies/ml (N=3) (b), 3.5–5.3 log RNA copies/ml (N=13) (c), and >5.3 log RNA copies/ml (N=2) (d).", "Plasma viral RNA (log copies/ml) in rhesus monkeys chronically infected with SHIV-SF162P3 following a single infusion (arrows) of PGT121, 3BCN117, and b12 (a); PGT121 and 3BNC117 (b); or the control mAb DEN3 (c)."]}
{"doc_id": 72022, "title": "", "abstract": ["Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys", "Monkey anti-human antibody titers following mAb administration", "Previous studies in humanized mice and humans using the earlier generation of HIV-1 Env-specific mAbs suggested that the therapeutic potential of mAbs would be severely limited by the rapid emergence of viral escape mutations in the context of diverse virus swarms15–17.", "Nevertheless, given the differences between SHIV-infected rhesus monkeys and HIV-1-infected humans, clinical trials are required to establish the therapeutic efficacy of potent neutralizing HIV-1-specific mAbs in humans.", "In humanized mice, combinations of mAbs have been shown to suppress viremia, but the therapeutic potential of these mAbs has not yet been evaluated in primates with an intact immune system."]}
{"doc_id": 58016, "title": "", "abstract": ["There is evidence that many lincRNAs act as scaffolds that regulate molecular (protein, RNA, DNA) interactions required for various signaling networks15–17 and this is accomplished, in part, by association with chromatin-modifying complexes.", "Other lincRNAs also associate with PRC2 and other chromatin complexes, suggesting potential gene repressive activity similar to that described for HOTAIR.15", "Rinn and coworkers have identified up to 3000 human long intervening non- coding RNAs (lincRNAs),14, 15 and biological characterization studies suggest that lincRNAs have important functions in both normal and cancer tissues.14–19", "The functions of some ncRNAs have been characterized and it is evident that they are key factors in gene regulation and influence normal and cancer cell phenotypes.4–8", "HOTAIRM1 and HOTTIP are lincRNAs associated with the HOXA locus, and both ncRNAs differentially modulate gene expression in various cell and tissue types, but genes/pathways modulated by these lincRNAs are PRC2-independent.37, 38"]}
{"doc_id": 58017, "title": "", "abstract": ["Furthermore, the result of Cox proportional hazard regression analysis consistently indicates that HOTAIR levels and N stage are strongly correlated with overall patient survival (p < 0.05) (Table S2).", "Significantly enriched biological pathways were identified, which produced nominal p-value < 0.05 and false discovery rates (FDR) < 0.25.", "In this same study,24 Kaplan-Meier survival analysis showed that patients with low HOTAIR expression (bottom 85%) had significantly increased overall survival compared to patients with high HOTAIR expression (top 15%), and additional summaries of patient data are provided in Supplemental Figure S1.", "The patients are classified into two groups according to their HOTAIR expression level (top 15%: high vs. bottom 85%: low) and GSEA was carried out to assess the effects of HOTAIR expression level on various biological pathways using these two classified data sets.", "Kaplan- Meier analysis and log-rank test were applied to evaluate a prognostic significance of HOTAIR expression level in terms of patient survival."]}
{"doc_id": 58018, "title": "", "abstract": ["Knockdown of HOTAIR in Panc1 cells resulted in significant (>1.5) changes in expression of 1006 genes and analysis of the data suggested that HOTAIR-mediated gene regulation plays a critical role in pancreatic cancer progression and will be a novel epigenetic molecular target for treating pancreatic cancer patients.", "Current studies are focused on mechanisms associated with suppression and activation of genes by HOTAIR in pancreatic cancer and development of therapeutic strategies that target HOTAIR.", "HOTAIR function was investigated in knockdown studies and indicates that this ncRNA enhances pancreatic cancer cell invasion, inhibits cell growth, modulates cell cycle progression, and induces apoptosis in vitro, and HOTAIR knockdown in L3.6pL cell inhibited tumor growth in athymic nude mice bearing these cells as xenografts (Fig. 5).", "Previous studies show that all seven genes exhibit tumor suppressor-like activities,27–36 and four genes, namely IL29, IL28A, IL28B and IFTM1, were among a subset of several interferon-regulated genes suppressed by HOTAIR in Panc1 cells (Supplemental Table S4).", "Thus, HOTAIR not only plays a role in invasion of pancreatic, breast, colon and liver cancer cells 20, 22, 23 but also exerts distinct pro- oncogenic activities in pancreatic cancer associated with increased cell survival and proliferation and repression of interferon-related genes."]}
{"doc_id": 58019, "title": "", "abstract": ["HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients.", "HOTAIR has also been characterized as a negative prognostic factor in breast, liver and colon cancer patients,20–23 and results of this study demonstrate that HOTAIR is also overexpressed in human pancreatic tumors compared to non- tumor tissue (Fig. 1).", "HOTAIR overexpression in pancreatic cancer cells.", "In contrast, HOTAIR knockdown in Panc1 and L3.6pL pancreatic cancer cells that overexpress this lincRNA decreased cell proliferation, altered cell cycle progression, and induced apoptosis, demonstrating an expanded function for HOTAIR in pancreatic cancer cells compared to other cancer cell lines.", "HOTAIR overexpression enhanced MiaPaCa2 and Panc28 cell invasion in a Boyden chamber assay (Fig. 4A) and this was consistent with previous functional studies in breast and colon cancer cells.20, 23"]}
{"doc_id": 58020, "title": "", "abstract": ["In this study, we show that HOTAIR expression is increased in pancreatic tumors compared to non- tumor tissue and is associated with more aggressive tumors.", "HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients.", "The activity of HOTAIR is due, in part, to interaction of HOTAIR with the Polycomb Repressive Complex 2 (PRC2) (EZH2, SUZ12 and EED) which enhances H3K27 trimethylation to decrease expression of multiple genes.", "HOTAIR has also been characterized as a negative prognostic factor in breast, liver and colon cancer patients,20–23 and results of this study demonstrate that HOTAIR is also overexpressed in human pancreatic tumors compared to non- tumor tissue (Fig. 1).", "HOTAIR expression and prognostic significance in pancreatic cancer."]}
{"doc_id": 58021, "title": "", "abstract": ["HOTAIR is a 2,158 bp lincRNA localized to a boundary in the HOXC gene cluster.", "In contrast, HOTAIR knockdown in Panc1 and L3.6pL pancreatic cancer cells that overexpress this lincRNA decreased cell proliferation, altered cell cycle progression, and induced apoptosis, demonstrating an expanded function for HOTAIR in pancreatic cancer cells compared to other cancer cell lines.", "Knockdown of HOTAIR (siHOTAIR) by RNA interference shows that HOTAIR plays an important role in pancreatic cancer cell invasion and as reported in other cancer cell lines.", "HOTAIR exhibited variable expression in pancreatic cancer cells, and knockdown of HOTAIR in Panc1 and L3.6pL pancreatic cancer cells by RNAi showed that HOTAIR was associated with enhanced cell invasion, cell proliferation, modulation of cell cycle progression, and induction of apoptosis.", "Among 3 genes repressed by HOTAIR overexpression in MDA-MB-231 cells (PCDHB5, PCDH10 and JAM2), two were enhanced after HOTAIR knockdown in Panc1 and L3.6pL cells, but only JAM2 expression was enhanced in both cell lines (Fig. 2C)."]}
{"doc_id": 58022, "title": "", "abstract": ["HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients.", "Current studies are focused on mechanisms associated with suppression and activation of genes by HOTAIR in pancreatic cancer and development of therapeutic strategies that target HOTAIR.", "Thus, HOTAIR not only plays a role in invasion of pancreatic, breast, colon and liver cancer cells 20, 22, 23 but also exerts distinct pro- oncogenic activities in pancreatic cancer associated with increased cell survival and proliferation and repression of interferon-related genes.", "In this study, we show that HOTAIR expression is increased in pancreatic tumors compared to non- tumor tissue and is associated with more aggressive tumors.", "HOTAIR function was investigated in knockdown studies and indicates that this ncRNA enhances pancreatic cancer cell invasion, inhibits cell growth, modulates cell cycle progression, and induces apoptosis in vitro, and HOTAIR knockdown in L3.6pL cell inhibited tumor growth in athymic nude mice bearing these cells as xenografts (Fig. 5)."]}
{"doc_id": 21061, "title": "", "abstract": ["Systemic and local side-effects after BNT162b2 and ChAdOx1 nCoV-19 vaccination occur at frequencies lower than reported in phase 3 trials.", "Similarly, rates of side-effects following the ChAdOx1 nCoV-19 vaccine were lower than expected.7", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "As with other studies examining COVID-19 vaccine effects in the general community, our data are limited by the vaccine rollout's focus on health-care workers, elderly people, and people who are clinically vulnerable.2", "The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials."]}
{"doc_id": 21062, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "Besides the original phase 1–3 trials, we found one published article and two preprints on data from Israel investigating the effectiveness of the Pfizer-BioNTech vaccine (BNT162b2), a preprint from the UK exploring the effectiveness of both the BNT162b2 and Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccines in individuals aged 70 years or older in the community, and a study that linked health records for all vaccinated people in Scotland to investigate COVID-19 hospitalisation and mortality after vaccination.", "The UK's Medicines and Healthcare products Regulatory Agency has given emergency use authorisation to three COVID-19 vaccines: the Pfizer-BioNTech mRNA vaccine (BNT162b2), the Oxford-AstraZeneca adenovirus-vectored vaccine (ChAdOx1 nCoV-19), and the Moderna mRNA vaccine (mRNA-1273).", "For example, in phase 3 clinical trials of the BNT162b2 vaccine,3 the most common events after the first dose were injection-site pain (71–83%), fatigue (34–47%), and headache (25–42%).", "For instance, whereas 51–59% of participants reported fatigue after the second BNT162b2 dose in the phase 3 trial of that vaccine,3 fatigue was reported by less than 15% of participants after the second dose in our study."]}
{"doc_id": 21063, "title": "", "abstract": ["The aim of this study was to investigate the adverse effects and infection rate of vaccinated people in a community (general population app users) scenario.", "Users reporting vaccination were then asked daily for the following 8 days whether they experienced adverse effects, including both systemic (whole body) and local effects.", "Our primary outcome was the proportion of app users reporting adverse effects within 8 days after vaccination and the probability of having an adverse event.", "In conclusion, short-term adverse effects of both vaccines are moderate in frequency, mild in severity, and short-lived.", "Among vaccinated app users, 159 101 (25·4%) of 627 383 indicated having one or more systemic adverse effect, and 257 209 (66·2%) of 388 430 reported one or more local adverse effect (table)."]}
{"doc_id": 21064, "title": "", "abstract": ["SO reports grants from Wellcome Trust, UK Research and Innovation (UKRI), and CDRF, during the conduct of the study.", "Strengths of our study include its large sample size; capture of data on SARS- CoV-2 RT-PCR or lateral flow test results, regardless of symptoms; the prospective real-time capture of information on symptoms; and the availability of both BNT162b2 and ChAdOx1 nCoV-19 vaccines in the UK, which allowed cross- vaccine comparison.", "Ethical approval for use of the app for research purposes in the UK was obtained from King's College London Ethics Committee (review reference LRS-19/20-18210), and all users provided consent for non-commercial use of their data.", "Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "Given preliminary evidence from small studies21, 22, 23 suggesting that reactogenicity is higher among individuals previously infected with SARS- CoV-2, we investigated the extent to which previous SARS-CoV-2 infection (based on self-reported previous positive PCR or lateral flow result) was associated with reports of adverse effects."]}
{"doc_id": 21065, "title": "", "abstract": ["Systemic solicited side-effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea; solicited local side-effects included local pain, swelling, tenderness, redness, itch, warmth, and swollen armpit glands (appendix p 6).", "The most commonly reported systemic side- effects were fatigue and headache overall (table) and by strata (appendix p 9).", "We found that systemic adverse effects, including headache and fatigue, affected fewer than one in four people and were less common in the community than expected from clinical trials.", "Finally, the systemic side-effects were collected from daily reports within 1 week from the injection date, so we cannot rule out that these effects might not be vaccine related.", "We observed the same trend for local effects as for systemic effects, whereby app users aged 55 years or younger reported more local side-effects than participants older than 55 years (figure 3), and women were more likely to report local side-effects than men (figure 3; appendix p 11)."]}
{"doc_id": 21066, "title": "", "abstract": ["When comparing systemic effects after one dose of each vaccine, reactogenicity was significantly higher in individuals who had one dose of the ChAdOx1 nCoV-19 vaccine than in those who had one dose of the BNT162b2 vaccine (116 473 [33·7%] of 345 280 compared with 38 155 [13·5%] of 282 103; adjusted p<0·0001).", "Given preliminary evidence from small studies21, 22, 23 suggesting that reactogenicity is higher among individuals previously infected with SARS- CoV-2, we investigated the extent to which previous SARS-CoV-2 infection (based on self-reported previous positive PCR or lateral flow result) was associated with reports of adverse effects.", "It has been shown that vaccines have increased immunogenicity in individuals with past infection and these people have higher antibody titres than those without previous infection.22, 23, 25", "It is possible, although it remains to be tested, that this increased reactogenicity relates to increased immunogenicity.", "We found, in a community setting, that self-reported infection rates of those vaccinated with the BNT162b2 or ChAdOx1 nCoV-19 vaccines were significantly lower than infection rates in unvaccinated controls."]}
{"doc_id": 21067, "title": "", "abstract": ["We aimed to investigate the safety and effectiveness of these vaccines in a UK community setting.", "We searched PubMed for articles published up to March 10, 2021, using the terms (“BNT162b2“ OR “mRNA Covid-19 Vaccine” OR “ChAdOx1 nCoV-19” OR “adenovirus-vectored Covid-19 vaccine”) AND (“effectiveness” OR “reinfection” OR “side-effects” OR “adverse effects” OR “reactogenicity” OR “phase IV”).", "Between Dec 8, 2020, and March 10, 2021, 655 590 vaccine doses were logged in the app in the UK, corresponding to 282 103 individuals (aged 16–99 years) who reported having received the first dose of the BNT162b2 vaccine, of whom 28 207 reported having had both doses of the BNT162b2 vaccine (a median of 41 days [IQR 21–63] apart), and 345 280 individuals who reported having had the first dose of ChAdOx1 nCoV-19.", "The first two vaccines have been rolled out across the UK since Dec 8, 2020, and Jan 4, 2021, respectively.1", "Between Dec 8, and March 10, 2021, 627 383 individuals reported being vaccinated with 655 590 doses: 282 103 received one dose of BNT162b2, of whom 28 207 received a second dose, and 345 280 received one dose of ChAdOx1 nCoV-19."]}
{"doc_id": 21068, "title": "", "abstract": ["Our study also has several limitations.", "As with other studies examining COVID-19 vaccine effects in the general community, our data are limited by the vaccine rollout's focus on health-care workers, elderly people, and people who are clinically vulnerable.2", "Additionally, our data provide evidence from the community to support early reports of higher frequency of side-effects in younger than in older individuals.3, 7", "Evidence before this study", "Due to a relatively small sample size in some of the strata, we did not differentiate between vaccine types but pooled all vaccinated contributors."]}
{"doc_id": 21069, "title": "", "abstract": ["The COVID Symptom Study app14 was developed by health data company ZOE Global, with input from King's College London (London, UK), the Massachusetts General Hospital (Boston, MA, USA), Lund University (Lund, Sweden), and Uppsala University (Uppsala, Sweden).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "In this large prospective observational study, we assessed adverse effects from the two COVID-19 vaccines in use in the UK at the time of writing (BNT162b2 and ChAdOx1 nCoV-19), as well as self-reported infection rates following one dose or two doses of BNT162b2 and one dose of ChAdOx1 nCoV-19.", "Logistic regressions were used for each of the specified strata to investigate whether adverse effects varied across different participant groups, and in individuals who had previously reported a positive test for COVID-19 (PCR or lateral flow positive at least 6 months before vaccination, PCR or lateral flow positive within the 6 months before vaccination, and no previously detected infection).", "We used data from 627 383 individuals who received the BNT162b2 or ChAdOx1 nCoV-19 vaccines between December, 2020, and March, 2021, and reported symptoms in real-time via the COVID Symptom Study app.14"]}
{"doc_id": 21070, "title": "", "abstract": ["US investigators are encouraged to coordinate data requests through the Coronavirus Pandemic Epidemiology (COPE) consortium (www.monganinstitute.org/cope-consortium).", "Local effects were similarly higher in individuals previously infected than in those without known past infection for both vaccines (figure 3).", "In this prospective observational study, we examined the proportion and probability of self-reported systemic and local side-effects within 8 days of vaccination in individuals using the COVID Symptom Study app who received one or two doses of the BNT162b2 vaccine or one dose of the ChAdOx1 nCoV-19 vaccine.", "In this large-scale, community-based study in the UK, we have investigated adverse effects and infection rates following administration of the two COVID-19 vaccines that are in use in the UK.", "# Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study"]}
{"doc_id": 21071, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "The UK's Medicines and Healthcare products Regulatory Agency has given emergency use authorisation to three COVID-19 vaccines: the Pfizer-BioNTech mRNA vaccine (BNT162b2), the Oxford-AstraZeneca adenovirus-vectored vaccine (ChAdOx1 nCoV-19), and the Moderna mRNA vaccine (mRNA-1273).", "Similarly, rates of side-effects following the ChAdOx1 nCoV-19 vaccine were lower than expected.7", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Systemic and local side-effects after BNT162b2 and ChAdOx1 nCoV-19 vaccination occur at frequencies lower than reported in phase 3 trials."]}
{"doc_id": 21072, "title": "", "abstract": ["The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials.", "Phase 3 trials reported the BNT162b2 vaccine to have an efficacy of 52% at 12 days after the first dose and of 95% after the second dose if administered 3–4 weeks apart in participants without previous SARS-CoV-2 infection.3", "The phase 2–3 trial of the ChAdOx1 nCoV-19 vaccine7 reported systemic adverse effects in 88% of participants aged 18–55 years who received the first injection, whereas we found a lower rate of 33·7% after the first dose in the overall sample and 46·9% in individuals aged 18–55 years (data not shown).", "Although our data, due to their observational nature, does not allow us to comment directly on effectiveness, the observed decrease of infection over time seems to be in line with efficacy reported in the BNT162b2 phase 3 trial3 and supports the UK Government's decision to delay the timing of the second injection to 12 weeks to maximise the number of people receiving at least one dose.", "Since the BNT162b2 phase 3 trial showed a decrease in infections from 12 days after vaccination,3 we analysed infection rates at 0–4, 5–11, 12–20, 21–44, and 45–59 days after vaccination."]}
{"doc_id": 21073, "title": "", "abstract": ["Although our data, due to their observational nature, does not allow us to comment directly on effectiveness, the observed decrease of infection over time seems to be in line with efficacy reported in the BNT162b2 phase 3 trial3 and supports the UK Government's decision to delay the timing of the second injection to 12 weeks to maximise the number of people receiving at least one dose.", "Furthermore, our data support results from randomised controlled trials in a large community-based scenario showing evidence of reduction in infection after 12 days and substantial protection after 3 weeks.", "This is an observational study, with data captured during a specific timeframe, and our study design does not allow an inference of causality.", "Because of the observational (non- interventional) nature of the study, the non-causal paths between outcomes and predictors that might involve age, sex, BMI, or health status need to be adjusted statistically.", "No consistent difference in occurrence of systemic or local adverse effects was observed between individuals who reported a positive test result within the past 6 months and those who reported they received a positive test result at least 6 months ago (figure 3)."]}
{"doc_id": 75024, "title": "", "abstract": ["Importantly, miR-200s have recently been shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional repressors Zeb1 and Zeb225-28.", "While implications for EMT in cancer progression are widely recognized, the potential role of the reverse process, mesenchymal-epithelial transition (MET) is less clear.", "MiR-200s also influence tumor cell secretome by direct targeting of Sec23a-mediated transport pathway, which affects cell-extrinsic tumor-stromal interactions.", "Thus, in addition to the well established function of miR-200s in regulating intrinsic cellular properties through Zeb1/2 and E-cadherin, miR-200s may also possess the potential to influence the microenvironment by directed targeting of Sec23a-dependent secretome.", "Here, we show that miR-200s promote metastatic colonization of breast cancer not only by influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1."]}
{"doc_id": 74018, "title": "", "abstract": ["However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology.", "Future studies should be aimed at understanding the connections between glial phagocytic activity and neuronal function, and possible interactions between microglia and astrocytes in Rett pathology.", "The role of glia in Rett syndrome has recently been recognized 7–9.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Neuropathologists have observed gliosis and cell loss in the cerebellum of deceased Rett syndrome patients 26, but this work has not received much attention, presumably since the disease is generally considered non- neurodegenerative."]}
{"doc_id": 74019, "title": "", "abstract": ["Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "Our present findings support previous publications describing the potential for clinical treatment of Rett pathology 6,29, while also suggesting the possibility of achieving this goal via augmentation or repopulation of brain phagocytes, or improvement of their phagocytic activity.", "Future studies should be aimed at understanding the connections between glial phagocytic activity and neuronal function, and possible interactions between microglia and astrocytes in Rett pathology.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome."]}
{"doc_id": 74020, "title": "", "abstract": ["These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "These benefits mediated by wild type microglia, however, were diminished when phagocytic activity was inhibited pharmacologically using annexin V to block phosphatydilserine residues on apoptotic targets, thus preventing recognition and engulfment by tissue- resident phagocytes.", "Microglial phagocytic activity is necessary for their beneficial effect in Mecp2−/y mouse brains", "Phagocytic activity per se is almost certainly just one aspect of glial involvement in Rett pathophysiology.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome"]}
{"doc_id": 74021, "title": "", "abstract": ["This, in turn, would lead to a crowded and sub-optimal CNS milieu within which neurons, already challenged by loss of Mecp2, might be further impaired in function.", "Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.", "We first studied microglial function in the context of Mecp2−/y male mice.", "Apneas and interbreath irregularity of these mice were also significantly reduced compared to control mice (Fig. 3i, j), and their open field activity was not significantly different from wild type counterparts (Fig. 3k).", "Jae and Mecp2tm2Bird) mice were subjected to lethal split-dose irradiation at P28 (the approximate age at which neurological signs appear 4)."]}
{"doc_id": 74022, "title": "", "abstract": ["Microglia have received increasing attention in the pathophysiology of several neurodegenerative and neuropsychiatric diseases 14–18.", "The inability of Mecp2-null microglia to clear debris as effectively as wild type microglia has the potential to contribute to the underlying neuropathology and/or the time course of appearance of symptoms in Mecp2-null mice 4,27.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome.", "Wild type microglia arrest pathology in a mouse model of Rett syndrome", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved."]}
{"doc_id": 74023, "title": "", "abstract": ["Rather, they suggest that Mecp2-null microglia, deficient in phagocytic function, may be unable to keep pace in clearing debris left behind from the normal process of neural cell death or membrane shedding.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "We first studied microglial function in the context of Mecp2−/y male mice.", "Along these lines, supplementation of wild type microglia could reduce debris levels and allow for improved neuronal function.", "Thus, via multiple approaches, wild type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology; lifespan was increased; breathing patterns were normalized; apneas were reduced; body weight was increased to near wild type, and locomotor activity was improved."]}
{"doc_id": 74024, "title": "", "abstract": ["Indeed, GFP+ cells in the parenchyma of bone marrow transplanted mice expressed CD11b (Fig. 3a) but not GFAP or NeuN (data not shown).", "Newly-engrafted microglia expressed detectable levels of wild type Mecp2 (data not shown) but nearby cells did not show any Mecp2 labeling, arguing against the possibility of protein or mRNA transfer from engrafted microglia into nearby cells as an underlying mechanism for the beneficial effect of bone marrow transplantation.", "We first studied microglial function in the context of Mecp2−/y male mice.", "We employed the widely-used LysmCre mouse—which results in a high degree of recombination in myeloid cells, granulocytes, and in significant numbers of microglia 21–23—in cross with Mecp2lox-stop mice.", "Figure 1"]}
{"doc_id": 74025, "title": "", "abstract": ["Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome.", "The role of glia in Rett syndrome has recently been recognized 7–9.", "Here we examined the role of another form of glia, microglia, in a murine model of Rett syndrome.", "However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology."]}
{"doc_id": 74026, "title": "", "abstract": ["Thus, it is possible that apoptotic debris would accumulate over time in the Mecp2-null brain, contributing to neuronal malfunction and accelerating disease progression.", "However, when bone marrow transplantation is preceded by irradiation-mediated immune ablation, bone marrow derived cells with microglia-like morphology and phenotype (expressing low levels of CD45 and high levels of CD11b) are found in the brain 13,14.", "The inability of Mecp2-null microglia to clear debris as effectively as wild type microglia has the potential to contribute to the underlying neuropathology and/or the time course of appearance of symptoms in Mecp2-null mice 4,27.", "Moreover, we have recently shown that intravenous injection of annexin V results in substantial blockade of phagocytic activity in the brain 24.", "Wild type→Mecp2−/y mice also exhibited an increase in brain weight (Fig. 1e, f), which was likely due to general growth of the mouse, since the reduced soma size characteristic of Mecp2-null neurons was not changed by bone marrow transplantation (Fig. 1g, h) and the brain to body weight ratio was normalized (Supplementary Fig. 1a)."]}
{"doc_id": 74027, "title": "", "abstract": ["Our data implicate microglia as major players in Rett pathophysiology, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for this devastating disorder.", "To further substantiate the role of myeloid cells in arrest of Rett pathology, we used a genetic approach.", "Accordingly, inhibition of phagocytosis might result in exacerbation of Rett pathology via these yet- unknown processes, even in the absence of deposits of easily observable cellular debris.", "However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology.", "These results suggest the importance of microglial phagocytic activity in Rett syndrome."]}
{"doc_id": 59016, "title": "", "abstract": ["EURODIAB Prospective Complications Study: Nish Chaturvedi (National Heart and Lung Institute, Imperial College, London, UK), John H Fuller (Epidemiology and Public Health, Royal Free and University College London Medical School, London, UK), Sabita S Soedamah-Muthu (Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands).", "In the primary analysis, we accepted different metrics for mediators, including systolic blood pressure or hypertension status for blood pressure; total, HDL and LDL cholesterol concentrations, or hypercholesterolaemia for serum cholesterol; and fasting and postprandial glucose, haemoglobin A1c, or diabetes status for blood glucose.", "| Number of cohorts   ---|---   Blood pressure   Systolic blood pressure| 95   Hypertension| 2   Cholesterol   Total serum cholesterol| 86   HDL cholesterol| 1   Hypercholesterolaemia| 1   Blood glucose   Fasting glucose| 39   Postprandial glucose*| 18   Haemoglobin A1c| 1   Diabetes| 19"]}
{"doc_id": 59017, "title": "", "abstract": ["Our results also suggest that the association between adiposity and cardiovascular disease is not completely explained by the three mediators in our analysis.", "Several pathways link adiposity and excess weight to cardiovascular disease via the mediators analysed in this study.", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16).", "PERM for the association of overweight with coronary heart disease was larger than that of obesity for most combinations of mediators, but the CIs overlapped (table 3)."]}
{"doc_id": 59018, "title": "", "abstract": ["This situation has created concerns about a potentially massive worldwide increase in cardiovascular diseases as a result of increased BMI and prevalence of overweight and obesity in most countries.13–15", "Despite the potentially large benefits of weight loss, interventions have had small long-term success, especially at the population level,7,8 leading to a worldwide rise in overweight and obesity.14", "Therefore, control of blood pressure and cholesterol might help to lessen the cardiovascular effects of the global obesity epidemic.", "By contrast, effective clinical and public health interventions for blood pressure and cholesterol are available, as evidenced by large decreases in these measures in some countries despite rises in obesity.14,16,17", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight."]}
{"doc_id": 59019, "title": "", "abstract": ["Obese individuals also benefit from interventions on mediators but will continue to have significantly raised risk.", "High body-mass index (BMI) is an important cardiovascular disease risk factor,2–4 and raised blood pressure, cholesterol, and glucose partly mediate its effects.5,6", "The metabolic factors also mediated more excess risk of overweight on stroke than of obesity, although the CIs overlapped (table 3).", "HRs and excess risk of overweight and obesity mediated through different combinations of metabolic risk factors", "We noted that metabolic factors mediate a larger proportion of the excess risk for overweight individuals than do those for obese individuals (although the 95% CIs overlapped)."]}
{"doc_id": 59020, "title": "", "abstract": ["Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI.", "Despite this potential, and some past successes, further reduction of blood pressure and cholesterol needs major improvements in both primary care and public health programmes.43", "CHD=coronary heart disease.", "CHD=coronary heart disease.", "Interventions that reduce high blood pressure, cholesterol, and glucose might address a substantial proportion of the effect of high BMI on cardiovascular disease."]}
{"doc_id": 59021, "title": "", "abstract": ["This situation has created concerns about a potentially massive worldwide increase in cardiovascular diseases as a result of increased BMI and prevalence of overweight and obesity in most countries.13–15", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators.", "We noted associations between both overweight and obesity and the risk of CHD and stroke in both Asian and western cohorts, and in both older (enrolment before 1990) and more recent cohorts (enrolment in or after 1990; appendix pp 15–16)."]}
{"doc_id": 59022, "title": "", "abstract": ["This situation has created concerns about a potentially massive worldwide increase in cardiovascular diseases as a result of increased BMI and prevalence of overweight and obesity in most countries.13–15", "Our finding that both overweight and obesity were associated with increased risk of coronary heart disease and stroke differed from reports by Flegal and colleagues,28 who recorded no effects for overweight on either cardiovascular disease mortality in one cohort, or on all-cause mortality in a meta- analysis.29", "Compared with having healthy weight, being overweight or obese was associated with an increased risk of coronary heart disease and stroke, with obesity having a larger effect than overweight.", "Our findings have implications for clinical prevention of cardiovascular disease as well as for public health programmes.", "Both overweight (BMI ≥25 to <30 kg/m2) and obesity (BMI ≥30 kg/m2) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m2), with 50% (44–58) of the excess risk of overweight and 44% (41–48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators."]}
{"doc_id": 14052, "title": "", "abstract": ["We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "Additional research in this area will be required to ascertain whether this is a contributing factor toward the development of COVID-19.", "These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020).", "Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "More severe cases of COVID-19 develop acute respiratory distress syndrome and acute lung injury, leading to morbidity and mortality caused by damage to the alveolar lumen leading to inflammation and pneumonia (Wolfel et al., 2020, Xu et al., 2020)."]}
{"doc_id": 14053, "title": "", "abstract": ["These data demonstrate that addition of IFN-I resulted in a dramatic reduction in virus replication, in agreement with the findings of others (Lokugamage et al., 2020).", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "Treatment of NHBE cells with IFN-I resulted in significant induction of 381 genes, most of these also differentially expressed in IAVΔNS1 infection, together outlining a robust innate immune response in these cells (Figure 2A).", "This dynamic seems to be in line with what we observed with SARS- CoV-2 because low levels of IFN-I and -III are likely produced in response to infection.", "The discrepancy between the levels of viral replication and IFN production/signaling suggests that, although SARS-CoV-2 is capable of engaging the IFN-I and IFN-III systems, this response is prevented by an antagonist that is rendered ineffective under high-MOI conditions."]}
{"doc_id": 14054, "title": "", "abstract": ["Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures"]}
{"doc_id": 14055, "title": "", "abstract": ["In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020).", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease."]}
{"doc_id": 14056, "title": "", "abstract": ["Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction.", "This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "### COVID-19 Patients Present Low IFN-I and -III and High Chemokine Signatures"]}
{"doc_id": 14057, "title": "", "abstract": ["Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "A recent study analyzing severe versus mild cases of COVID-19 showed that peripherally derived macrophages predominated in the lungs of severe cases (Liao et al., 2020)."]}
{"doc_id": 14058, "title": "", "abstract": ["Should this be true, drugs such as tocilizumab and anakinra may prove to be beneficial for treatment of COVID-19 (Norelli et al., 2018).", "Because a waning immune response would enable sustained viral replication, these findings may explain why serious cases of COVID-19 are more frequently observed in individuals with comorbidities.", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "These dynamics are also likely to contribute to development of COVID-19 during the course of infection (Wolfel et al., 2020).", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties."]}
{"doc_id": 14059, "title": "", "abstract": ["Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "It is also noteworthy that two of the cytokines uniquely elevated in response to SARS-CoV-2 are IL-6 and IL1RA, suggesting that there might be a parallel between COVID-19 and cytokine release syndrome (CRS), a complication commonly seen following CAR T-cell treatment (Giavridis et al., 2018).", "In addition to genes implicated in innate antiviral immunity, SARS- CoV-2 also induced robust levels of chemokines, including CCL2, CCL8, and CCL11 (Figure 4A).", "Despite a complete lack of IFN expression, the response to SARS-CoV-2 in NHBE cells still elicited a strong chemotactic and inflammatory response, indicated by expression of CCL20, CXCL1, IL-1B, IL-6, CXCL3, CXCL5, CXCL6, CXCL2, CXCL16, and TNF (Figures 2C and 2E; Table S2).", "# Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19"]}
{"doc_id": 14060, "title": "", "abstract": ["Although it remains to be determined whether the inappropriate inflammatory response to SARS-CoV-2 is responsible for the abnormally high lethality in older populations, it does explain why the virus is generally asymptomatic in young people with healthy and robust immune systems (Lu et al., 2020).", "Based on animal models, SARS-CoV-1 has been found to induce a robust cytokine response that generally shows a delay in IFN-I, culminating in improper recruitment of inflammatory monocyte-macrophage populations (Channappanavar et al., 2016).", "Genes significantly induced in response to SARS-CoV-2 included a subset of ISGs with no IFN-I or IFN-III detected by RNA-seq or semiquantitative PCR (Figure S4B; Table S4).", "Furthermore, high-MOI infection in these cells also led to high induction of IFNs and ISGs observed for HPIV3 and RSV, despite remarkable differences in viral replication (∼60% total reads in A549-ACE2 cells compared with ∼15% in Calu-3 cells) (Figures 1A and 1F).", "Given the moderate viral replication levels observed in vivo, one explanation for the low IFN expression could be that a small subset of cells is refractory to the antagonistic mechanism of SARS-CoV-2, producing sufficient amounts of IFN-I and/or IFN-III to guide immune cell activation and ISG induction."]}
{"doc_id": 14061, "title": "", "abstract": ["Moreover, analyses of cytokines and chemokines quantified in individual serum samples revealed enhancement of generalized inflammation among COVID-19 patients, marked by a significant increase in circulating IL-6, IL1RA, CCL2, CCL8 CXCL2, CXCL8, CXCL9, and CXCL16 levels (Figure 4C).", "This is consistent with data showing elevated circulating neutrophil levels among COVID-19 patients (Chen et al., 2020, Qin et al., 2020), which may have prognostic value for identifying individuals at risk for developing severe disease.", "Significant elevation of CXCL9 and CXCL16 (chemoattractants of T or natural killer (NK) cells, respectively), CCL8 and CCL2 (which recruit monocytes and/or macrophages), and CXCL8 (a classic neutrophil chemoattractant) suggest that the presence of these cells may be a primary driver of the signature pathology observed in COVID-19 patients (Proudfoot, 2002).", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties.", "In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction."]}
{"doc_id": 14062, "title": "", "abstract": ["In addition, our data suggest that neutrophils could also contribute to the disease observed in COVID-19 patients, as demonstrated by CXCL2 and CXCL8 induction.", "Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.", "It is also noteworthy that two of the cytokines uniquely elevated in response to SARS-CoV-2 are IL-6 and IL1RA, suggesting that there might be a parallel between COVID-19 and cytokine release syndrome (CRS), a complication commonly seen following CAR T-cell treatment (Giavridis et al., 2018).", "Taken together, the data presented here suggest that the response to SARS- CoV-2 is imbalanced with regard to controlling virus replication versus activation of the adaptive immune response.", "Because our data suggest that numerous chemokines and ILs are elevated in COVID-19 patients, future efforts should focus on U.S. Food and Drug Administration (FDA)-approved drugs that can be rapidly deployed and have immunomodulating properties."]}
{"doc_id": 14063, "title": "", "abstract": ["Differentially expressed genes (DEGs) were characterized for each sample (|L2FC| > 1, p-adjusted-value < 0.05) and were used as query to search for enriched biological processes (Gene ontology BP) and network analysis of protein interactions using STRING (Szklarczyk et al., 2019).", "(F) Heatmap depicting the expression levels of differentially expressed genes (DEGs) of the samples in (A) belonging to the indicated GO biological processes (GO: 0034097, GO: 0045087, GO: 0009615, GO: 0006954).", "(D) Heatmap indicating the expression levels of DEGs involved in IFN-I responses.", "(A) Volcano plot depicting DEGs in post-mortem lung samples of two COVID-19 patients compared with healthy lung biopsies.", "The graphs show the log2(fold change) of DEGs of infected compared with mock-infected animals."]}
{"doc_id": 79019, "title": "", "abstract": ["We observe more than 150 genomic regulatory blocks, similar to that containing FTO and IRX3, overlapping with noncoding SNPs associated with human disease and complex traits in GWAS (Methods and Supplementary Table 5), highlighting the need for a careful experimental pipeline to define the target gene(s) for each disease- associated noncoding SNP.", "Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type-2 diabetes (T2D) 1–3.", "We profiled the genomic interactions with promoters of genes located within a megabase window around the obesity-associated SNPs (mm9, chr8:93,725,000–94,725,000), including Fto and Rpgrip1l, and Irx3, a half-megabase downstream.", "A total of 15 human sequences in the broader FTO-IRX locus have been characterized as in vivo enhancers in mouse 17, 18, driving reporter expression in Irx3-expressing tissues, including eye, limb, brain, neural tube, and branchial arches 12, 19 (Supplementary Table 2).", "To assess the level of high-level conservation of the FTO/IRX5 locus, we used phastCons41 elements and scores as a measurement of conservation."]}
{"doc_id": 79020, "title": "", "abstract": ["FTO-promoter: chr16:53736860–53738096; IRX3-promoter: chr16:54319963–54322782.", "Together, these data posit that the obesity-associated FTO intron is mediating functional interactions with IRX3 in the human, mouse, and zebrafish genomes.", "The Fto promoter chiefly participates in genomic interactions proximal to the gene promoter.", "In the case of FTO, because the GWAS SNP occurs in an FTO intron, this gene was considered to be the target.", "No interactions are observed between the FTO promoter and the association interval."]}
{"doc_id": 79021, "title": "", "abstract": ["Utilizing a dataset of 153 brain samples from individuals of European ancestry 21, represented by cerebellum, we found significant association between 11 SNPs previously associated with increased body mass index (BMI), and expression of IRX3, but not FTO (Fig. 2a, Supplementary Table 3).", "We extracted the p-values for those SNPs in the locus with significant association (p<0.05) with IRX3 or FTO expression in adipose or cerebellum.", "No SNPs are associated with FTO expression (p-value>0.05).", "Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type-2 diabetes (T2D) 1–3.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition."]}
{"doc_id": 79022, "title": "", "abstract": ["We observe more than 150 genomic regulatory blocks, similar to that containing FTO and IRX3, overlapping with noncoding SNPs associated with human disease and complex traits in GWAS (Methods and Supplementary Table 5), highlighting the need for a careful experimental pipeline to define the target gene(s) for each disease- associated noncoding SNP.", "In those cases in which the nearest gene differs from the anchor gene, we propose that the anchor gene be used as the putative target and additional experimentation as shown in this work should be performed to precisely determine which is the target gene for the GWAS-affected regulatory element.", "Assignment of regulatory elements to targets is still a challenge, the simplest method being to assign them to the nearest gene.", "Our data posit that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition.", "These observations have direct implication on how to interpret the associations characterized for thousands of noncoding variants with human disease and related quantitative traits."]}
{"doc_id": 79023, "title": "", "abstract": ["While the molecular mechanisms linking these noncoding variants with obesity are not immediately obvious, subsequent studies in mice demonstrated that FTO expression levels influence body mass and composition phenotypes 4–6.", "Stratigopoulos G, et al. Regulation of Fto/Ftm gene expression in mice and humans.", "Kloting N, et al. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans.", "Multiple follow-up studies directly implicated FTO as a gene controlling body mass and composition.", "Our data suggest that the regulatory landscape of IRX3 spreads over megabase distances, whereas FTO expression is primarily regulated by regions proximal to its promoter."]}
{"doc_id": 79024, "title": "", "abstract": ["Under these models, our data support the notion that the broad expression patterns of FTO are primarily regulated by elements proximal to the promoter, and that IRX3 is endowed with an ancient, extensive cis-regulatory circuitry extending into FTO.", "Our data posit that the obesity-associated SNPs within FTO are functionally connected with regulation of IRX3 expression, and that IRX3 is an important determinant of body mass and composition.", "Our data suggest that the regulatory landscape of IRX3 spreads over megabase distances, whereas FTO expression is primarily regulated by regions proximal to its promoter.", "Having uncovered evidence of direct looping between FTO intronic regions and IRX3, we next showed that enhancers within the obesity-associated interval possess functional characteristics compatible with IRX3 expression.", "We next determined that gene expression studies in human brains corroborate our chromatin looping data, showing that the obesity-associated SNPs are associated with expression levels of IRX3, but not FTO."]}
{"doc_id": 79025, "title": "", "abstract": ["More specifically, ENCODE data suggest that the 47-kb obesity-associated interval is fraught with cis-regulatory elements, evidenced by an abundance of enhancer-associated chromatin marks, DNase hypersensitive sites, and transcription factor binding events across this genomic region (Fig. 1b).", "Furthermore, long-range enhancers within this region recapitulate aspects of IRX3 expression, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3.", "GWAS identified SNPs that might affect non-coding regulatory elements that, by their turn, regulate specific target genes.", "Our data and that of others 17 (Fig. 1b) demonstrate that the obesity-associated SNPs overlap several in vivo enhancers, raising the possibility that allelic variants may disrupt enhancer activity and alter expression of their target gene(s).", "While these enhancers lie outside the obesity association interval, they are consistent with our chromatin looping data pointing to a broad Irx3 regulatory landscape, extending into Fto."]}
{"doc_id": 64017, "title": "", "abstract": ["BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "To gain insight into the mechanism by which BRCA2 stimulates presynaptic complex formation, we measured its effect on the ATPase activity of RAD51.", "BRCA2 stimulates DNA strand exchange promoted by RAD51", "In support of this general concept, the promotion of RAD51 filament formation onto RPA-coated ssDNA was also demonstrated by Liu et al. (submitted) using a different full-length BRCA2 protein expression construct and preparation.", "If the RAD51 molecules bound to BRCA2 do indeed comprise the nucleus, then BRCA2 can stabilize a nascent filament of up to 4–6 RAD51 molecules."]}
{"doc_id": 64018, "title": "", "abstract": ["BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA", "As shown in Figure 4b & c, increasing amounts of BRCA2 stimulated DNA strand exchange as much as 20-fold, suggesting that BRCA2 accelerates formation of the RAD51 nucleoprotein filament at the presynaptic stage of recombination and alleviates the inhibition posed by RPA.", "Thus, it appears that direct interactions between human BRCA2, RAD51, and DNA are sufficient to stimulate the ability of RAD51 to gain access to the RPA- or SSB-coated ssDNA and to then displace them as the ensuing nucleoprotein filament is formed and extended.", "BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "When RPA was replaced by SSB, BRCA2 could still stimulate DNA strand exchange by RAD51 (Fig. 4d, and Supplementary Fig. 11b, right panel), implying that neither BRCA2 nor RAD51 need to interact directly with the ssDNA binding proteins,."]}
{"doc_id": 64019, "title": "", "abstract": ["BRCA2 focuses the assembly of RAD51 onto ssDNA and facilitates the RAD51-mediated displacement of RPA from ssDNA, which is a key regulatory step of DNA pairing.", "Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "These results suggest that the same mechanism for RAD51 nucleoprotein filament stabilization ascribed to the BRC repeats applies to BRCA221: namely, full length BRCA2 stabilizes the RAD51 bound to the ssDNA substrate by down-regulating its ATPase activity, an activity which is used to inactivate and turnover the RAD51 protein; however, quantitatively, this control is achieved at much lower concentrations of BRCA2 than the BRC repeats.", "RAD51 plays a central role in recombination, assembling onto single-stranded DNA (ssDNA) as a nucleoprotein filament, and catalyzing the invasion and exchange of homologous DNA sequences8,9.", "BRCA2 acts by: targeting RAD51 to ssDNA over double-stranded DNA; enabling RAD51 to displace Replication protein-A (RPA) from ssDNA; and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis."]}
{"doc_id": 64020, "title": "", "abstract": ["Our work has confirmed and extended prior expectations that the intact human BRCA2 protein mediates the rapid and ordered assembly of the RAD51 protein onto ssDNA, and helps to explain why cells lacking functional BRCA2 would be severely impaired for formation of this critical intermediate in recombinational repair.", "RAD51 plays a central role in recombination, assembling onto single-stranded DNA (ssDNA) as a nucleoprotein filament, and catalyzing the invasion and exchange of homologous DNA sequences8,9.", "Thus, in vertebrates, these functions have separated: BRCA2 targets RAD51 to ssDNA to mediate DNA strand invasion into a duplex donor to produce joint molecules by a distinctive mechanism, whereas RAD52 anneals RPA-ssDNA complexes in steps or pathways of recombinational repair that could include second-end capture in DSB repair, single-strand annealing (SSA), and synthesis-dependent strand annealing.", "An essential function of RAD51 in recombinational DNA repair is its capacity to homologously pair and exchange DNA strands.", "BRCA2 stimulates RAD51-mediated DNA strand exchange by promoting stable RAD51-ssDNA filament formation, overcoming inhibition by RPA"]}
{"doc_id": 42026, "title": "", "abstract": ["Neuroimaging studies have also reported abnormalities in biomarkers of energy metabolism in children with ASD.", "Several animal models of ASD reported abnormalities in energy metabolism.", "For example, a recent rat model of ASD demonstrated that the administration of propionic acid, a fermentation end product of enteric bacteria, induced mitochondrial dysfunction and led to certain brain, behavioral and metabolic changes consistent with ASD, including features such as repetitive behaviors, social interaction problems, hyperactivity, oxidative stress, lowered GSH levels, microglial activation and altered carnitine levels.61, 62, 64, 65", "The evidence for an association with either of these genes was mixed and thus inconclusive, possibly due to clinical and genetic heterogeneity between studies and small sample sizes.129", "Two studies reported significant correlations between markers of mitochondrial dysfunction and autism severity."]}
{"doc_id": 42027, "title": "", "abstract": ["These studies suggest that some individuals with ASD manifest increased oxidative stress that may originate from mitochondrial dysfunction.", "In fact, the phenotypic presentation of mitochondrial dysfunction in ASD is quite broad, ranging from significant to no neurological problems,25, 139, 142, 147 with some investigators describing children with ASD/MD as being indistinguishable from other children with ASD and others describing them as atypical for ASD.25, 132, 133, 142", "Over 20 years ago, Coleman and Blass23 hypothesized that individuals with ASD may have an abnormality in carbohydrate metabolism, and in 1998 Lombard24 proposed that ASD may be a disorder of impaired mitochondrial function.", "These two factors could act synergistically to cause significant mitochondrial impairment in individuals with ASD.", "A recent rat model of ASD demonstrated that the administration of propionic acid induced mitochondrial dysfunction and led to certain behavioral and biochemical features of ASD, such as repetitive behaviors, social interaction problems, hyperactivity, oxidative stress, lowered GSH levels and altered carnitine levels.61, 62, 64, 65"]}
{"doc_id": 42028, "title": "", "abstract": ["In this context, mitochondrial dysfunction could worsen a vulnerable system that is already under oxidative stress, resulting in an increase in the formation of ROS.", "The depletion of GSH in mitochondria makes cells more vulnerable to oxidative stress and damage from ROS originating from the mitochondria.36", "Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis", "The ETC is the predominant source and the major target of reactive oxygen species (ROS)20, 33 and is protected from damage caused by ROS by a mitochondrial-specific superoxide dismutase and antioxidants such as glutathione (GSH).33", "GSH depletion is associated with impaired mitochondrial function73 and increased ROS production.36"]}
{"doc_id": 42029, "title": "", "abstract": ["Overall, this evidence supports the notion that mitochondrial dysfunction is associated with ASD.", "Given the association between ASD and mitochondrial dysfunction, it is possible that mitochondrial dysfunction might have a role in the development, pathogenesis or severity of ASD.", "Abnormalities in synaptic transmission reported in ASD could also contribute to secondary mitochondrial dysfunction.", "Given the high energy demands of both the GI tract and cerebrovascular endothelium, mitochondrial dysfunction may also contribute to barrier dysfunction in the brain and GI tract in ASD.", "Abnormal calcium signaling, which has been implicated in ASD,212, 213 may also contribute to secondary mitochondrial dysfunction.26, 214"]}
{"doc_id": 42030, "title": "", "abstract": ["These studies suggest that some individuals with ASD manifest increased oxidative stress that may originate from mitochondrial dysfunction.", "In this context, exposures to environmental toxicants could contribute to secondary mitochondrial dysfunction in some children with ASD.9, 201", "Abnormal calcium signaling, which has been implicated in ASD,212, 213 may also contribute to secondary mitochondrial dysfunction.26, 214", "Biochemical abnormalities reported in some children with ASD could contribute to secondary mitochondrial dysfunction.", "Abnormalities in synaptic transmission reported in ASD could also contribute to secondary mitochondrial dysfunction."]}
{"doc_id": 49021, "title": "", "abstract": ["GCAMP3 fluorescence transients in both direct- and indirect-pathway SPNs during action initiation in a lever-pressing task", "Although we observed some behavior-related activation when transients were aligned to individual actions (e.g. magazine entries or lever presses, Supplementary Figure 14), the strongest phasic activation occurred before the initiation of a set of actions or action sequences (Fig. 3e,f), consistent with previous studies25.", "An action sequence (Fig. 3e,f) was defined as a series of action events (magazine entries and lever-presses) with inter-event interval <5 s.", "To examine the relationship between activity in direct- and indirect-pathway SPNs and specific self-paced voluntary actions we measured GCAMP3 fluorescence while mice performed a lever-pressing operant task.", "We used a two-lever free choice task in which mice were rewarded after making 10 lever presses, regardless of left or right lever pressing."]}
{"doc_id": 49022, "title": "", "abstract": ["The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum5,6 \\- the so-called direct and indirect pathways - have opposing effects on movement: while activity of direct-pathway SPNs purportedly facilitates movement, activity of indirect-pathway SPNs inhibits movement1,2.", "However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "If the direct and indirect pathways exert opposing effects on movement, as proposed in the classical model, we should expect to observe a higher frequency of transients in direct-pathway SPNs during ‘active’ states, and increased transient frequency in indirect-pathway SPNs during ‘inactive’ states.", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "This model has been difficult to test due to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals."]}
{"doc_id": 49023, "title": "", "abstract": ["Excitatory inputs to striatum arise from cortical and thalamic structures, while striatal inhibitory output diverges, with some neurons projecting directly to basal ganglia output nuclei (striatonigral SPNs) and others to intermediate nuclei (striatopallidal SPNs), giving rise to the direct and the indirect pathways that propagate throughout the basal ganglia6,7.", "Sensory stimuli evoked brief activation in both direct- and indirect-pathway SPNs", "i, Examples of striatal GFP fluorescence recorded in two freely moving D2-GFP mice.", "This sensory stimulus-evoked response was not seen in D2-GFP control mice (Fig. 2e).", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation"]}
{"doc_id": 49024, "title": "", "abstract": ["Excitatory inputs to striatum arise from cortical and thalamic structures, while striatal inhibitory output diverges, with some neurons projecting directly to basal ganglia output nuclei (striatonigral SPNs) and others to intermediate nuclei (striatopallidal SPNs), giving rise to the direct and the indirect pathways that propagate throughout the basal ganglia6,7.", "GCAMP3 fluorescence showed transient time-locked increases during the initiation of the session (chamber illumination and lever extension), with a similar temporal profile in both direct and indirect pathways in all animals tested (Fig. 2a-d); which is consistent with previous studies showing that SPNs respond to visual and auditory stimuli22.", "The resulting spectra were projected onto a 16-channel PMT array (the polychromator and PMT array assembly used in this study: PML-Spec, Becker & Hickl, Germany).", "Arrows indicate session start with complex visual (light on, both levers extended) and auditory (sound of lever extension) stimuli.", "The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum5,6 \\- the so-called direct and indirect pathways - have opposing effects on movement: while activity of direct-pathway SPNs purportedly facilitates movement, activity of indirect-pathway SPNs inhibits movement1,2."]}
{"doc_id": 49025, "title": "", "abstract": ["However, these optogenetic and lesion findings are not inconsistent with models postulating that co-activation of both pathways are important for action selection, with direct pathway neurons promoting the wanted motor program and indirect pathway neurons inhibiting competing motor programs.", "Although we observed some behavior-related activation when transients were aligned to individual actions (e.g. magazine entries or lever presses, Supplementary Figure 14), the strongest phasic activation occurred before the initiation of a set of actions or action sequences (Fig. 3e,f), consistent with previous studies25.", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "We also observed that neuronal activation in both pathways preceded movement initiation (with a latency appropriate for movement control).", "In contrast, non- selective global activation of an entire population of indirect-pathway SPNs26,27,28 would likely inhibit most motor programs and not only unwanted ones, leading to bradykinesia."]}
{"doc_id": 49026, "title": "", "abstract": ["Excitatory inputs to striatum arise from cortical and thalamic structures, while striatal inhibitory output diverges, with some neurons projecting directly to basal ganglia output nuclei (striatonigral SPNs) and others to intermediate nuclei (striatopallidal SPNs), giving rise to the direct and the indirect pathways that propagate throughout the basal ganglia6,7.", "Opposite results could be expected for global direct pathway manipulations.", "Concurrent Activation of Striatal Direct and Indirect Pathways During Action Initiation", "GCAMP3 was therefore expressed specifically in direct-pathway SPNs (axons projecting to GPi and SNr, Fig. 1e) in D1-Cre mice21, or in indirect-pathway SPNs (axons terminating in GPe, Fig. 1g, and specific expression in indirect-pathway SPNs, Supplementary Fig.3", "### Viral Expression of GCAMP3 in direct- and indirect-pathway striatal neurons"]}
{"doc_id": 49027, "title": "", "abstract": ["On the other hand, inhibiting or ablating most indirect-pathway SPNs would abolish suppression of unwanted motor programs and induce hyperkinesia.", "To further test the relationship between direct- and indirect-pathway SPN activity and the initiation of specific contraversive movement, we aligned the video frames to the onset of the GCAMP3 transients and compared the movement status within a 400 ms window before (-500 ms to -100 ms, Pre) and after (100 ms to 500 ms, Post) the onset of the transients (Fig. 4d,g).", "Both direct- and indirect-pathway SPNs showed strong activation immediately before and during contraversive movement", "According to these models, during normal behavior the coordinated activation of particular groups of direct and indirect-pathway SPNs would promote selection and initiation of a particular movement.", "Transients in both direct- and indirect-pathway SPNs of left striatum reliably preceded movement initiation, and predicted the occurrence of a contraversive movement or a complex movement (but not a straight or ipsilateral movement) within 500 ms of the start of the activity transient (Fig. 4e,f,h,i)."]}
{"doc_id": 49028, "title": "", "abstract": ["We developed a novel in-vivo method that allowed us to specifically measure direct- and indirect-pathway SPN activity using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCAMP3 in the dorsal striatum of D1-Cre (direct-pathway specific6,7) and A2A-Cre (indirect-pathway specific8,9) mice10.", "Future studies aimed at examining the changes in activity of direct- and indirect-pathway SPNs during basal ganglia disease should shed light onto the origin of the motor symptoms associated with basal ganglia dysfunction.", "Both direct- and indirect-pathway SPNs showed strong activation immediately before and during contraversive movement", "Optogenetic techniques have permitted the identification of specific cell-types in vivo via optical stimulation of recorded cells16 or via optical monitoring of the activity of cells of a specific cell-type17.", "Transients in both direct- and indirect-pathway SPNs of left striatum reliably preceded movement initiation, and predicted the occurrence of a contraversive movement or a complex movement (but not a straight or ipsilateral movement) within 500 ms of the start of the activity transient (Fig. 4e,f,h,i)."]}
{"doc_id": 71025, "title": "", "abstract": ["Persistent HIV-1 replication maintains the tissue reservoir during therapy", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "Under low drug concentrations, the virus may continue to replicate and evolve in sanctuary sites within the reservoir of cells in lymphoid tissue, and remain undetectable in the bloodstream for a time depending on viral population migration dynamics between the two compartments.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue."]}
{"doc_id": 71026, "title": "", "abstract": ["We therefore conclude that continued virus replication contributes to the viral reservoir.", "Our results, which reconstruct the dynamics of HIV-1 spread within the body, imply that in patients with no detectable viral RNA in plasma, the virus reservoir is constantly replenished by low-level virus replication in lymphoid tissue.", "From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "Our findings explain the failure of treatment intensification to fully suppress de novo infection and highlight issues surrounding the barriers to delivering antiretroviral drugs at clinically effective concentrations in the infectious viral reservoir."]}
{"doc_id": 71027, "title": "", "abstract": ["From these temporally and compartmentally structured sequence data, we conclude that continued virus production from infected cells in lymphoid tissue sanctuary sites, where drug concentrations are not fully suppressive, can continue to refill the viral reservoir and traffic to blood or lymphoid tissue18.", "Achieving optimal cellular pharmacokinetics and spatial distribution of antiretroviral drugs in lymphoid tissue to fully suppress viral replication and preserve immune function is, therefore, a prerequisite to the elimination of the viral reservoir and ultimately a cure for HIV-1 infection.", "In agreement with our phylogenetic inferences, these results suggest that the low-level viral replication in lymphoid tissues where antiretroviral drugs concentration are low could allow drug-sensitive strains to grow and spillover to the blood39.", "Lymphoid tissue is a key reservoir established by HIV-1 during acute infection.", "The dynamic nature of the viral population in lymphoid tissue sanctuaries, where infected cells can still produce new viruses, infect new target cells and replenish the pool, undermines previous estimates of the time necessary to purge the reservoir of latently infected cells and achieve virus eradication3."]}
{"doc_id": 18053, "title": "", "abstract": ["Beginning at 4 days post-infection (dpi), K18-hACE2 mice demonstrated marked weight loss, and by 7 dpi most animals had lost approximately 25% of their body weight (Fig 1a), with many becoming moribund.", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight starting at 4 days post infection (dpi) and began to succumb to disease at 7 dpi.", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight after 4 dpi and began to succumb to disease at 7 dpi.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "mRNA expression levels of hACE2 in the lungs of K18 hACE2 mice at 2, 4, and 7 dpi following SARS-CoV-2 infection (two experiments, n = 4 per time point, bars represent the mean ± SEM )."]}
{"doc_id": 18054, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "Analysis of hematoxylin and eosin-stained lung sections from K18-hACE2 mice infected with SARS-CoV-2 (Fig 2a) showed a progressive inflammatory process.", "Together, these findings provide evidence of a progressive and widespread viral pneumonia with perivascular and pan-alveolar inflammation characterized by immune cell infiltration, edema, and lung consolidation.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "Collectively, the RNA sequencing data from the lungs of K18-hACE2 mice show distinct immune signatures associated with early infection (days 2 and 4) and late (day 7) SARS-CoV-2 infection."]}
{"doc_id": 18055, "title": "", "abstract": ["While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying severe infection that recapitulates features of COVID-19 in humans, we acknowledge several limitations.", "Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "We examined additional tissues implicated in the pathogenesis of severe COVID-19 in humans, including the brain, heart, liver, kidney, and spleen.", "Although several animal species used in laboratory research have been evaluated for susceptibility to SARS-CoV-2 infection, none have recapitulated the severe disease seen in hospitalized human cases."]}
{"doc_id": 18056, "title": "", "abstract": ["Mild to moderate disease is seen in many rodent models of SARS-CoV-2 infection, including those expressing hACE2 via viral vectors or transgenes8,11,12,37.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "Although animal models have been evaluated for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, none have fully recapitulated the severe lung disease phenotypes seen in hospitalized human cases.", "Although several animal species used in laboratory research have been evaluated for susceptibility to SARS-CoV-2 infection, none have recapitulated the severe disease seen in hospitalized human cases.", "Thus, additional animal models are needed for understanding the biology of severe SARS-CoV-2 infection in the lung and evaluating the efficacy of antiviral and immunomodulatory countermeasures."]}
{"doc_id": 18057, "title": "", "abstract": ["Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures.", "Multiple strategies for introducing hACE2 into mice have been developed including (1) transient introduction of hACE2 via adenoviral viral vectors8, (2) expression of hACE2 as a transgene driven by heterologous gene promoters9,10, or (3) expression of hACE2 by the mouse ACE2 promoter11,12.", "The K18-hACE2 transgenic (K18-hACE2) mice, in which hACE2 expression is driven by the epithelial cell cytokeratin-18 (K18) promoter13, were originally developed to study SARS-CoV pathogenesis and cause lethal infection9."]}
{"doc_id": 18058, "title": "", "abstract": ["Hamsters, ferrets, and non-human primates develop mild to moderate viral disease and recover spontaneously4,5.", "By 4 dpi, these immune cell infiltrates involved a greater area of the lung with focal collections into adjacent alveolar spaces with alveolar wall thickening.", "Mild disease is a feature of SARS-CoV-2 infection in naturally susceptible animals including hamsters, ferrets, cats, and non-human primates5.", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "### Histopathological changes in the lung after SARS-CoV-2 infection."]}
{"doc_id": 18059, "title": "", "abstract": ["In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "Analysis of hematoxylin and eosin-stained lung sections from K18-hACE2 mice infected with SARS-CoV-2 (Fig 2a) showed a progressive inflammatory process."]}
{"doc_id": 18060, "title": "", "abstract": ["Brain tissues of K18-hACE2 mice with minimal or no detectable SARS-CoV-2 infection appeared normal without evidence of microglial activation or inflammation, whereas the one brain recovered with a high level of infection at 7 dpi showed inflamed meningeal vessels with extravasation of immune cells (e.g., neutrophils, lymphocytes, and monocytes) into the brain parenchyma, inflammation of the subarachnoid space and underlying parenchyma including microglial activation (Extended Data Fig 2b).", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "While these animals all support SARS- CoV-2 infection, only the model with hACE2 expression driven by the HFH4 promoter10 develops severe disease.", "Infection of the brain also was observed in K18-hACE2 mice infected with SARS-CoV9,14 but occurred earlier (at 3 to 4 dpi) and more uniformly.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection."]}
{"doc_id": 18061, "title": "", "abstract": ["Infection of the brain also was observed in K18-hACE2 mice infected with SARS-CoV9,14 but occurred earlier (at 3 to 4 dpi) and more uniformly.", "Human ACE2 is expressed in multiple tissues in the K18-hACE2 mouse9, which could allow for SARS-CoV-2 infection of multiple organs.", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "Brain tissues of K18-hACE2 mice with minimal or no detectable SARS-CoV-2 infection appeared normal without evidence of microglial activation or inflammation, whereas the one brain recovered with a high level of infection at 7 dpi showed inflamed meningeal vessels with extravasation of immune cells (e.g., neutrophils, lymphocytes, and monocytes) into the brain parenchyma, inflammation of the subarachnoid space and underlying parenchyma including microglial activation (Extended Data Fig 2b).", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection."]}
{"doc_id": 18062, "title": "", "abstract": ["### K18-hACE2 mice are highly susceptible to SARS-CoV-2 infection.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "We inoculated 8-week-old heterozygous K18-hACE2 mice of both sexes via intranasal route with 2.5×104 plaque forming units (PFU) of SARS-CoV-2 (strain 2019n-CoV/USA_WA1/2020).", "SARS-CoV-2 infection in K18-hACE2 mice.", "Conventional laboratory strains of mice cannot be infected efficiently by SARS-CoV-2 because hACE2 but not mouse ACE2 supports SARS-CoV-2 binding6,7."]}
{"doc_id": 18063, "title": "", "abstract": ["At 2 dpi, expression of SARS-CoV-2 RNA was localized predominantly to alveolar epithelial cells and a few airway epithelial cells.", "SARS- CoV-2-infected lung tissues show a massively upregulated innate immune response with signatures of NF-kB-dependent, type I and II interferon signaling, and leukocyte activation pathways.", "In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, and pulmonary disease.", "The binding of the SARS-CoV-2 spike protein to human angiotensin-I converting enzyme-2 (hACE2) targets the virus to type II pneumocytes within the lung, resulting in injury, inflammation, and subsequent respiratory distress1,2.", "In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes severe pulmonary disease."]}
{"doc_id": 18064, "title": "", "abstract": ["After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight starting at 4 days post infection (dpi) and began to succumb to disease at 7 dpi.", "After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly lost weight after 4 dpi and began to succumb to disease at 7 dpi.", "Of note, decreased lymphocyte numbers were observed with different inoculating doses of SARS-CoV-2 and present even in mice receiving only 102 PFU, prior to the beginning of weight loss at 6 dpi.", "Compared to mock-infected controls, at 4 dpi, a subset of SARS-CoV-2-infected K18-hACE2 mice began to show reduced exercise tolerance, as measured by decreased distance travelled.", "Serum D-dimer levels of mock-treated or SARS-CoV-2 infected animals at 2, 4, and 7 dpi (two independent experiments, n = 5 for naïve, n = 5 for 2 dpi, n = 6 for 4 dpi, and n = 5 for 7 dpi; one-way ANOVA with Dunnett’s test; * P = 0.0246)."]}
{"doc_id": 18065, "title": "", "abstract": ["A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "The development of severe disease following SARS-CoV-2 infection is an important feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to other hACE2 transgenic models remains unknown.", "The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "To assess for clinically-relevant changes in physiology over the course of SARS-CoV-2 infection in K18-hACE2 mice, we measured clinical chemistry and hematological parameters from peripheral blood samples (Fig 3).", "Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral- based countermeasures."]}
{"doc_id": 18066, "title": "", "abstract": ["The measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, and not in the conducting airways, which is consistent with both our histopathological analysis in mice and measurements of pulmonary function in humans with viral pneumonia and respiratory failure including COVID-1916.", "Given these parallel findings, studies in K18-hACE2 mice evaluating the role of specific immune pathways and cell subsets in disease pathogenesis could inform the selection of immunomodulatory agents for severe COVID-19.", "A subset of infected K18-hACE2 mice had high levels of viral RNA and infectious virus in the brain (Fig 1d–e), consistent with previous reports with SARS-CoV and SARS-CoV-2 in hACE2 transgenic mice9,12,14.", "Here, we evaluate transgenic mice expressing the human ACE2 receptor driven by the cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection.", "Thus, the K18-hACE2 mouse is an attractive small animal model for defining the mechanisms of the pathogenesis of severe COVID-19 and may be useful for evaluating countermeasures that reduce virus infection or associated pathological inflammatory responses."]}
{"doc_id": 10000, "title": "", "abstract": ["These results are consistent with a gut microbiota dependent mechanism whereby generation of TMAO impairs RCT, potentially contributing to the observed pro-atherosclerotic phenotype of these interventions.", "These findings raise the possibility that other dietary nutrients possessing a trimethylamine structure may also generate TMAO from gut microbiota and promote accelerated atherosclerosis.", "Using isotope tracer studies, clinical studies, and animal models employing germ-free mice, we demonstrate a role for gut microbiota metabolism of L-carnitine in atherosclerosis pathogenesis.", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated.", "(c) Summary scheme outlining pathway for microbiota participation in atherosclerosis via metabolism of dietary carnitine and choline forming TMA and TMAO, as well as the impact of TMAO on cholesterol and sterol metabolism in macrophages, liver and intestines."]}
{"doc_id": 10001, "title": "", "abstract": ["### Dietary L-carnitine promotes microbiota dependent atherosclerosis", "These results are consistent with not L-carnitine itself, but a down-stream microbiota-dependent metabolite that promotes the observed increased atherosclerosis burden (Fig. 5c).", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated.", "These observations are consistent with a proposed mechanism whereby oral carnitine ingestion contributes to atherosclerotic CVD risks via the microbiota metabolite TMAO.", "Chronic dietary L-carnitine supplementation in mice significantly altered cecal microbial composition, markedly enhanced synthesis of TMA/TMAO, and increased atherosclerosis, but not following suppression of intestinal microbiota."]}
{"doc_id": 10002, "title": "", "abstract": ["Herein we demonstrate that intestinal microbiota metabolism of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis.", "(c) Summary scheme outlining pathway for microbiota participation in atherosclerosis via metabolism of dietary carnitine and choline forming TMA and TMAO, as well as the impact of TMAO on cholesterol and sterol metabolism in macrophages, liver and intestines.", "Given the similarity in structure between L-carnitine and choline (Fig. 1a) we hypothesized that dietary L-carnitine in humans, like choline and phosphatidylcholine, might both produce TMA and TMAO in a gut microbiota- dependent fashion and be associated with atherosclerosis risk.", "In addition to the upregulation of macrophage scavenger receptors potentially contributing to enhanced “forward cholesterol transport”10, we show that TMAO, and its dietary precursors choline and carnitine, suppress reverse cholesterol transport through gut microbiota- dependent mechanisms in vivo.", "Chronic dietary L-carnitine supplementation in mice significantly altered cecal microbial composition, markedly enhanced synthesis of TMA/TMAO, and increased atherosclerosis, but not following suppression of intestinal microbiota."]}
{"doc_id": 10003, "title": "", "abstract": ["Omnivorous subjects are shown to produce significantly more TMAO than vegans/vegetarians following ingestion of L-carnitine through a microbiota-dependent mechanism.", "Interestingly, vegan/vegetarians challenged with d3-carnitine also had significantly more post-challenge plasma d3-carnitine compared to omnivorous subjects (Supplementary Fig. 7), a result that may reflect decreased intestinal microbial metabolism of carnitine prior to absorption.", "The differences observed in TMAO production following an “L-carnitine challenge” within omnivore versus vegan subjects is striking, consistent with the observed differences in microbial community composition.", "Analyses of data from vegan/vegetarians versus omnivores suggested that preceding dietary habits may modulate both intestinal microbiota composition and synthetic capacity to produce TMA/TMAO from dietary L-carnitine.", "A remarkable finding of the present studies is the magnitude with which long term dietary habits impact TMAO synthetic capacity in both humans (i.e. vegan and vegetarian vs. omnivore) and mice (normal chow vs. chronic carnitine supplementation)."]}
{"doc_id": 10004, "title": "", "abstract": ["Of note, we observed a significant increase in baseline plasma TMAO concentrations in what historically was called enterotype 2 (Prevotella) (P < 0.05), a relatively rare enterotype that previously in one study was associated with low animal fat and protein consumption18.", "A post-hoc nutritional survey performed amongst the volunteers suggested antecedent dietary habits (red meat consumption) may influence the capacity to generate TMAO from L-carnitine.", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated.", "Indeed, other studies have demonstrated variable results in associating human bacterial genera, including Bacteroides and Prevotella, to omnivorous and vegetarian eating habits17,51.", "(e) Baseline plasma concentrations of TMAO associates with Enterotype 2 (Prevotella) in male and female subjects with a characterized gut microbiome enterotype."]}
{"doc_id": 10005, "title": "", "abstract": ["These observations are consistent with a proposed mechanism whereby oral carnitine ingestion contributes to atherosclerotic CVD risks via the microbiota metabolite TMAO.", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated.", "These results are consistent with a gut microbiota dependent mechanism whereby generation of TMAO impairs RCT, potentially contributing to the observed pro-atherosclerotic phenotype of these interventions.", "These findings raise the possibility that other dietary nutrients possessing a trimethylamine structure may also generate TMAO from gut microbiota and promote accelerated atherosclerosis.", "Herein we demonstrate that intestinal microbiota metabolism of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis."]}
{"doc_id": 10006, "title": "", "abstract": ["Herein we demonstrate that intestinal microbiota metabolism of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis.", "These findings raise the possibility that other dietary nutrients possessing a trimethylamine structure may also generate TMAO from gut microbiota and promote accelerated atherosclerosis.", "Using isotope tracer studies, clinical studies, and animal models employing germ-free mice, we demonstrate a role for gut microbiota metabolism of L-carnitine in atherosclerosis pathogenesis.", "(c) Summary scheme outlining pathway for microbiota participation in atherosclerosis via metabolism of dietary carnitine and choline forming TMA and TMAO, as well as the impact of TMAO on cholesterol and sterol metabolism in macrophages, liver and intestines.", "# Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis"]}
{"doc_id": 10007, "title": "", "abstract": ["When subjects were classified into previously reported enterotypes18 based upon fecal microbial composition, individuals with an enterotype characterized by enriched proportions of the genus Prevotella (n=4) demonstrated higher (p<0.05) plasma TMAO levels than subjects with an enterotype notable for enrichment of Bacteroides (n=49) genus (Fig. 2e).", "Of note, we observed a significant increase in baseline plasma TMAO concentrations in what historically was called enterotype 2 (Prevotella) (P < 0.05), a relatively rare enterotype that previously in one study was associated with low animal fat and protein consumption18.", "The differences observed in TMAO production following an “L-carnitine challenge” within omnivore versus vegan subjects is striking, consistent with the observed differences in microbial community composition.", "Post-prandially the omnivore showed both an increase in TMAO and d3-TMAO levels in sequential plasma measurements (Fig. 2a), and in a 24 hour urine collection sample (Fig. 2b).", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated."]}
{"doc_id": 10008, "title": "", "abstract": ["Herein we demonstrate that intestinal microbiota metabolism of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis.", "These findings raise the possibility that other dietary nutrients possessing a trimethylamine structure may also generate TMAO from gut microbiota and promote accelerated atherosclerosis.", "Using isotope tracer studies, clinical studies, and animal models employing germ-free mice, we demonstrate a role for gut microbiota metabolism of L-carnitine in atherosclerosis pathogenesis.", "These results are consistent with not L-carnitine itself, but a down-stream microbiota-dependent metabolite that promotes the observed increased atherosclerosis burden (Fig. 5c).", "Intestinal microbiota metabolism of choline/phosphatidylcholine produces trimethylamine (TMA), which is further metabolized to a proatherogenic species, trimethylamine-N-oxide (TMAO)."]}
{"doc_id": 10009, "title": "", "abstract": ["Intestinal microbiota may thus participate in the well-established link between increased red meat consumption and CVD risk.", "The present studies also suggest a novel mechanism for the observed relationship between dietary red meat ingestion and accelerated atherosclerosis.", "We recently reported a novel pathway in both humans and mice linking microbiota metabolism of dietary choline/phosphatidylcholine to CVD pathogenesis9.", "Herein we demonstrate that intestinal microbiota metabolism of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis.", "The high consumption of meat in the developed world is linked to cardiovascular disease (CVD) risk, presumably due to the large content of saturated fats and cholesterol found in meat1,2."]}
{"doc_id": 10010, "title": "", "abstract": ["In an effort to identify additional mechanisms by which TMAO may promote atherosclerosis, we first noted that TMAO and its trimethylamine nutrient precursors are all cationic quaternary amines, and may have the potential to compete with arginine to limit its bioavailability and thus reduce nitric oxide synthesis.", "TMA is rapidly further oxidized by hepatic flavin monooxygenases to form trimethylamine-N-oxide (TMAO).", "These findings raise the possibility that other dietary nutrients possessing a trimethylamine structure may also generate TMAO from gut microbiota and promote accelerated atherosclerosis.", "How TMAO is mechanistically linked to development of accelerated atherosclerosis and which specific microbial species contribute to TMAO formation remains unknown.", "Finally, they show that TMAO modulates cholesterol and sterol metabolism at multiple sites in vivo with a net effect of increase in atherosclerosis (Fig. 6c)."]}
{"doc_id": 10011, "title": "", "abstract": ["Chronic dietary L-carnitine supplementation in mice significantly altered cecal microbial composition, markedly enhanced synthesis of TMA/TMAO, and increased atherosclerosis, but not following suppression of intestinal microbiota.", "Importantly, parallel studies in mice placed on oral antibiotic cocktail to suppress intestinal microbiota showed marked reductions in plasma TMA and TMAO levels (Fig. 5c), and complete inhibition in dietary L-carnitine-dependent increase in atherosclerosis (Fig. 5b).", "Finally, they show that TMAO modulates cholesterol and sterol metabolism at multiple sites in vivo with a net effect of increase in atherosclerosis (Fig. 6c).", "Conversely, an increased synthetic capacity for microbiota-dependent production of TMAO from carnitine may contribute to atherosclerosis, particularly in omnivores where carnitine consumption is elevated.", "These observations are consistent with a proposed mechanism whereby oral carnitine ingestion contributes to atherosclerotic CVD risks via the microbiota metabolite TMAO."]}
{"doc_id": 4000, "title": "", "abstract": ["In our Stage 1+2 analysis, we obtained suggestive evidence for association with ABCA7 SNP rs3752246 (PM = 5.8 × 10−7, and PJ = 5.0 × 10−7), which is a missense variant (G1527A) that may alter the function of the ABCA7 protein (see Supplementary Table 6 for functional SNPs in LD with SNPs yielding PM or PJ < 10−4).", "Hollingworth et al 12 report highly significant evidence for the association of an ABCA7 SNP rs3764650 with LOAD (PM = 4.5 × 10−17) that included data from our study.", "identified SNPs at ABCA7 as a novel LOAD locus, we included ABCA7 region SNPs in Stage 2 and provided the results to Hollingworth et al.12.", "This likely explains the genome-wide statistical significance for the ABCA7 locus in the accompanying manuscript12, which reaches only modest statistical significance in our dataset (rs3752246; PM = 1.0 × 10−5, PJ = 1.9 × 10−5).", "Meta-analysis using an external replication case-control sample (Stage 3) for SNPs from novel loci at which associations did not exceed the genome-wide statistical significance threshold (P = 5.0 × 10−8) in the ADGC meta-analysis (Stage 1+2)."]}
{"doc_id": 4001, "title": "", "abstract": ["Examining the amount of genetic effect attributable to these candidate genes, the most strongly associated SNPs at each locus other than APOE demonstrated population attributable fractions (PAFs) between 2.72–5.97% (Supplemental Table 9), with a cumulative PAF for non-APOE loci estimated to be as much as 35%; however, these estimates may vary widely between studies22, and the actual effect sizes are likely to be much smaller than those estimated here because of the ‘winner’s curse’.", "After adjustment, all loci had similar effect sizes to the unadjusted analyses with some showing a modest reduction in statistical significance.", "In Stages 1 and 2, strong evidence for association was also obtained for SNPs in CD33, a gene located approximately 6Mb from APOE, but the results did not reach genome-wide significance.", "We examined the influence of the APOE ε4 allele on the loci in Table 1, stratified by and in interactions with APOE ε4 allele carrier status.", "Also the results do not account for interaction among loci, and are not derived from appropriate population-based samples."]}
{"doc_id": 4002, "title": "", "abstract": ["To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "The minor allele (MAF = 0.27) at this SNP increased risk for LOAD (ORM = 1.11, 95% CI: 1.07–1.15) (Table 2, Fig. 1B).", "Hollingworth et al 12 report highly significant evidence for the association of an ABCA7 SNP rs3764650 with LOAD (PM = 4.5 × 10−17) that included data from our study.", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD."]}
{"doc_id": 4003, "title": "", "abstract": ["To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "Alzheimer Disease (AD) is a neurodegenerative disorder affecting more than 13% of individuals aged 65 years and older and 30%–50% aged 80 years and older4–5.", "A recent review of GWAS studies23 noted that risk alleles with small effect sizes (0.80 < OR < 1.2) likely exist for complex diseases such as LOAD but remain undetected, even with thousands of samples, because of insufficient power24.", "# Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease", "; 7,650 LOAD cases, 25,839 mixed-age controls)."]}
{"doc_id": 4004, "title": "", "abstract": ["Another gene consistently implicated in LOAD is SORL120 where at rs3781835 (previously reported P = 0.006), we obtained modest evidence for association (ORM = 0.72, 95% CI: 0.60–0.86, PM = 2.9 × 10−4; ORJ = 0.78, 95% CI: 0.59–0.86; PJ = 3.8 × 10−4).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "A recent review of GWAS studies23 noted that risk alleles with small effect sizes (0.80 < OR < 1.2) likely exist for complex diseases such as LOAD but remain undetected, even with thousands of samples, because of insufficient power24.", "A recent GWAS identified CR1, CLU, PICALM, and BIN1 as LOAD susceptibility loci1–3."]}
{"doc_id": 4005, "title": "", "abstract": ["Hollingworth et al 12 report highly significant evidence for the association of an ABCA7 SNP rs3764650 with LOAD (PM = 4.5 × 10−17) that included data from our study.", "identified SNPs at ABCA7 as a novel LOAD locus, we included ABCA7 region SNPs in Stage 2 and provided the results to Hollingworth et al.12.", "Stage 3 analysis yielded a genome-wide significance result for rs9349407 (PM = 8.6 × 10−9), identifying CD2AP as a novel LOAD locus.", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "The minor allele (MAF = 0.27) at this SNP increased risk for LOAD (ORM = 1.11, 95% CI: 1.07–1.15) (Table 2, Fig. 1B)."]}
{"doc_id": 4006, "title": "", "abstract": ["In our Stage 1+2 analysis, we obtained suggestive evidence for association with ABCA7 SNP rs3752246 (PM = 5.8 × 10−7, and PJ = 5.0 × 10−7), which is a missense variant (G1527A) that may alter the function of the ABCA7 protein (see Supplementary Table 6 for functional SNPs in LD with SNPs yielding PM or PJ < 10−4).", "Meta-analysis using an external replication case-control sample (Stage 3) for SNPs from novel loci at which associations did not exceed the genome-wide statistical significance threshold (P = 5.0 × 10−8) in the ADGC meta-analysis (Stage 1+2).", "To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "In the Stage 1+2 analysis, other SNPs gave smaller P values when compared to discovery SNP rs4938933, with the most significant SNP being rs4939338 (PM = 2.6 × 10−11, PJ = 4.6 × 10−11; ORM and ORJ = 0.87, 95% CI: 0.84–0.91) (Supplementary Table 5).", "Our Stage 1+2 analyses also confirmed the association of previously reported loci (BIN1, CR1, CLU, and PICALM) with LOAD (Table 1)."]}
{"doc_id": 4007, "title": "", "abstract": ["With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "A recent GWAS identified CR1, CLU, PICALM, and BIN1 as LOAD susceptibility loci1–3.", "For three of these (CD33, EPHA1, and CD2AP), Stage 3 analysis strengthened evidence for association.", "# Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease"]}
{"doc_id": 4008, "title": "", "abstract": ["We obtained genome-wide significant results at MS4A4A [rs4938933; Stages 1+2, meta-analysis (PM) = 1.7 × 10−9, joint analysis (PJ) = 1.7 × 10−9; Stages 1–3, PM = 8.2 × 10−12], CD2AP (rs9349407; Stages 1–3, PM = 8.6 × 10−9), EPHA1 (rs11767557; Stages 1–3 PM = 6.0 × 10−10), and CD33 (rs3865444; Stages 1–3, PM = 1.6 × 10−9).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "Five of these had not previously been associated with LOAD at a genome-wide significance level of P ≤ 5.0 × 10−8 (MS4A, EPHA1, CD33, ARID5B, and CD2AP).", "In the accompanying manuscript12, genome-wide significant results were also obtained at the MS4A locus (rs670139, PM = 5.0 × 10−12) using an independent sample.", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7)."]}
{"doc_id": 4009, "title": "", "abstract": ["To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3).", "Meta-analysis using an external replication case-control sample (Stage 3) for SNPs from novel loci at which associations did not exceed the genome-wide statistical significance threshold (P = 5.0 × 10−8) in the ADGC meta-analysis (Stage 1+2).", "We also examined SNPs with statistically significant GWAS results reported by others (GAB216, PCDH11X17, GOLM118, and MTHFD1L 19, Supplementary Table 7).", "In a combined analysis of ADGC results and those from Hollingworth et al.12, the evidence for this locus at rs4938933 increased to PM = 8.2 × 10−12 (Table 3: ORM = 0.89, 95% CI: 0.87–0.92; Fig. 1A)."]}
{"doc_id": 4010, "title": "", "abstract": ["A recent review of GWAS studies23 noted that risk alleles with small effect sizes (0.80 < OR < 1.2) likely exist for complex diseases such as LOAD but remain undetected, even with thousands of samples, because of insufficient power24.", "To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3).", "Our discovery dataset (Stage 1; 8,309 cases and 7,366 controls), was well-powered to detect associations exceeding the statistical significance threshold of P < 10−6 (Supplementary Table 9).", "Stage 2 data modestly strengthened this association, but the results did not reach genome-wide significance."]}
{"doc_id": 4011, "title": "", "abstract": ["To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "Meta-analysis using an external replication case-control sample (Stage 3) for SNPs from novel loci at which associations did not exceed the genome-wide statistical significance threshold (P = 5.0 × 10−8) in the ADGC meta-analysis (Stage 1+2).", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3).", "The Alzheimer Disease Genetics Consortium (ADGC), http://alois.med.upenn.edu/adgc/about/overview.html; ADNI database, (www.loni.ucla.edu/ADNI); ADNI investigators, http://www.loni.ucla.edu/ADNI/Collaboration/ADNI_Manuscript_Citations.pdf; APOE Genotyping kit from TIB MOLBIOL, http://www.roche- as.es/logs/LightMix%C2%AE_40-0445-16_ApoE-112-158_V080904.pdf; PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/; PREST, http://utstat.toronto.edu/sun/Software/Prest/; MACH, http://www.sph.umich.edu/csg/abecasis/mach/; EIGENSTRAT, http://genepath.med.harvard.edu/~reich/EIGENSTRAT.htm; The R Project for Statistical Computing, http://www.r-project.org/; Package GWAF in R, http://cran.r-project.org/web/packages/GWAF/index.html; Package gee in R, http://cran.r-project.org/web/packages/gee/index.html; UCSC Genome Browser, http://genome.ucsc.edu/; METAL, http://www.sph.umich.edu/csg/abecasis/Metal/; FUGUE, http://www.sph.umich.edu/csg/abecasis/fugue/.", "Results for MS4A are also included to show association results from the ADGC and accompanying manuscript12."]}
{"doc_id": 4012, "title": "", "abstract": ["To identify genetic variants associated with risk for AD, the ADGC assembled a discovery dataset [Stage 1; 8,309 LOAD cases, 7,366 cognitively normal controls (CNEs)] using data from eight cohorts and a ninth newly assembled cohort from the 29 NIA-funded Alzheimer Disease Centers (ADCs) (Supplementary Tables 1 and 2, Supplementary Note) with data coordinated by the National Alzheimer Coordinating Center (NACC) and samples coordinated by the National Cell Repository for Alzheimer Disease (NCRAD).", "Meta-analysis using an external replication case-control sample (Stage 3) for SNPs from novel loci at which associations did not exceed the genome-wide statistical significance threshold (P = 5.0 × 10−8) in the ADGC meta-analysis (Stage 1+2).", "A single SNP (rs3826656) in the 5’ region of CD33, was previously reported as an AD-related locus using a family-based approach as genome-wide significant (P = 6.6 × 10−6) 15.", "Gene:SNP| Cases| Controls| Total| ORM (95% CI)| PM| ORj (95% CI)| PJ   ---|---|---|---|---|---|---|---   CD2AP: rs9349407| | | | | | |     ADGC| 11840| 10931| 22771| 1.12 (1.07–1.18)| 1.0 × 10−6| 1.12 (1.07–1.17)| 2.1 × 10−6     External| 6922| 18896| 25818| 1.09 (1.03–1.15)| 0.002| -| -     ADGC + External| 18762| 29827| 48589| 1.11 (1.07–1.15)| 8.6 × 10−9| -| -      * * *      EPHA1: rs11767557| | | | | | |     ADGC| 11840| 10931| 22771| 0.87 (0.83–0.92)| 2.4 × 10−7| 0.87 (0.83–0.91)| 4.9 × 10−8     External| 6922| 24666| 31588| 0.91 (0.87–0.96)| 2.9 × 10−4| -| -     ADGC + External| 18762| 35597| 54359| 0.90 (0.86–0.93)| 6.0 × 10−10| -| -      * * *      ARID5B: rs2588969| | | | | | |     ADGC| 11840| 10931| 22771| 0.93 (0.89–0.97)| 0.001| 0.93 (0.89–0.97)| 7.8 × 10−4     External| 6922| 18896| 25818| 1.06 (1.01–1.11)| 0.018| -| -     ADGC + External| 18762| 29827| 48589| 0.99 (0.95–1.02)| 0.362| -| -      * * *      MS4A4A: rs4938933| | | | | | |     ADGC| 11840| 10931| 22771| 0.88 (0.85–0.92)| 1.7 × 10−9| 0.88 (0.85–0.92)| 1.7 × 10−9     External| 6922| 18896| 25818| 0.92 (0.88–0.97)| 5.4 × 10−4| -| -     ADGC + External| 18762| 29827| 48589| 0.89 (0.87–0.92)| 8.2 × 10−12| -| -      * * *      CD33: rs3865444| | | | | | |     ADGC| 11840| 10931| 22771| 0.89 (0.86–0.93)| 1.1 × 10−7| 0.89 (0.86–0.93)| 2.0 × 10−7     External| 6922| 18896| 25818| 0.92 (0.88–0.97)| 0.002| -| -     ADGC + External| 18762| 29827| 48589| 0.91 (0.88–0.93)| 1.6 × 10−9| -| -      Stage 1+2 analysis identified the MS4A gene cluster as a novel LOAD locus (PM = 1.7 × 10−9, PJ = 1.7 × 10−9)(Table 1, Fig. 1A).", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3)."]}
{"doc_id": 7000, "title": "", "abstract": ["Using simulations, based on parameter estimates from this mixture model, we estimated that 488 (95% confidence interval (CI) 456–521) of the independent replication SNPs, in addition to the 63 newly discovered and established loci, are associated with T2D susceptibility.", "Although the genetic contribution to T2D is well recognized, the current set of 56 established susceptibility loci, identified primarily through large-scale genome-wide association studies (GWAS)2–11, captures at best 10% of familial aggregation of the disease.", "The T2D-nominated component of Metabochip comprises 21,774 variants, including 5,057 “replication” SNPs that capture the strongest, independent (CEU r2< 0.2) autosomal association signals from the GWAS meta-analysis conducted by the DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium.", "We performed sex-differentiated meta-analysis32 (Online Methods and Supplementary Figs. 5 and 6) to test for association of each SNP with T2D, allowing for heterogeneity in allelic effects between males (20,219 cases, 54,604 controls) and females (14,621 cases, 60,377 controls), thereby identifying two additional loci achieving genome-wide significance (Table 2 and Supplementary Table 7).", "We estimated the posterior probability that each of the 3,412 independent replication SNPs is truly associated with T2D from the mixture distribution."]}
{"doc_id": 7001, "title": "", "abstract": ["However, the secondary signal at CDKN2A/B, which maps to the non-coding CDKN2B-AS1 (ANRIL) transcript, has not previously been implicated in T2D susceptibility.", "The lead SNPs from both meta-analyses are in strong linkage disequilibrium (LD) (HMG20A r2 = 0.89 and GRB14 r2 = 0.77 in CEU), and likely represent the same association signals.", "At six of the newly discovered loci, the lead T2D SNP showed strong cis-eQTL associations and was highly correlated (CEU r2 > 0.8) with the lead cis-eQTL SNP (Supplementary Table 13).", "We detected two loci at which multiple independent association signals attained genome-wide significance: KCNQ1 (rs163184, P = 1.2 × 10−11; rs231361, P = 1.2 × 10−9; CEU r2 = 0.01) and CDKN2A/B (rs10811661, P = 3.7 × 10−27; rs944801, P = 2.4 × 10−9; CEU r2 = 0.01) (Fig. 2).", "The “secondary” list incorporated the nearest transcript to the lead SNP at 77 additional loci with posterior probability of association of at least 75% from the mixture model, not already included in the primary list."]}
{"doc_id": 7002, "title": "", "abstract": ["Using simulations, based on parameter estimates from this mixture model, we estimated that 488 (95% confidence interval (CI) 456–521) of the independent replication SNPs, in addition to the 63 newly discovered and established loci, are associated with T2D susceptibility.", "For each of these SNPs, we reported the allelic OR (aligned to the T2D risk-allele) and P-values in: (i) our Stage 1 T2D meta-analysis; and (ii) a GWAS meta-analysis of 7,514 T1D cases and 9,045 population controls from European descent populations from the Type 1 Diabetes Genetics Consortium35.", "Finally, we noticed that the lead T2D SNP at the BCAR1 locus is genome-wide significant for type 1 diabetes (T1D)35, although risk is conferred by the opposite alleles.", "This genome-wide meta-analysis (“DIAGRAMv3”) includes data from 12,171 cases and 56,862 controls of European descent imputed up to 2.5 million autosomal SNPs, and augments the previously published “DIAGRAMv2” meta-analysis4 with four additional GWAS (Supplementary Table 1).", "We obtained summary statistics for lead SNPs in all newly discovered and established loci for glycemic traits in non-diabetic individuals from the MAGIC Investigators5, 34."]}
{"doc_id": 7003, "title": "", "abstract": ["Second, we extended our previous analysis4 of the physiological consequences of T2D risk alleles to include the newly identified loci.", "To eliminate potential bias in BMI allelic effect estimates at T2D susceptibility loci54, we restricted our attention to meta-analysis of population-based studies not ascertained for disease status for ~2.8 million directly genotyped and/or imputed SNPs.", "Using simulations, based on parameter estimates from this mixture model, we estimated that 488 (95% confidence interval (CI) 456–521) of the independent replication SNPs, in addition to the 63 newly discovered and established loci, are associated with T2D susceptibility.", "To control for potential confounders, we applied the modified GSEA approach to two negative control lists: (i) loci defined by the lowest ranked independent T2D replication SNPs from our Stage 2 meta-analysis; and (ii) loci for QT-interval on the basis of our Stage 2 meta-analysis for independent replication SNPs for this trait, excluding those within our primary and secondary lists of T2D susceptibility loci and those near monogenic diabetes genes.", "We performed sex-differentiated meta-analysis32 (Online Methods and Supplementary Figs. 5 and 6) to test for association of each SNP with T2D, allowing for heterogeneity in allelic effects between males (20,219 cases, 54,604 controls) and females (14,621 cases, 60,377 controls), thereby identifying two additional loci achieving genome-wide significance (Table 2 and Supplementary Table 7)."]}
{"doc_id": 7004, "title": "", "abstract": ["The associated lead variants at the eight newly identified loci were common (Stage 2 RAF 0.08–0.89) and had modest effects on T2D susceptibility (allelic odds ratios (OR) 1.07–1.14).", "Although the genetic contribution to T2D is well recognized, the current set of 56 established susceptibility loci, identified primarily through large-scale genome-wide association studies (GWAS)2–11, captures at best 10% of familial aggregation of the disease.", "Combining Stage 1 and Stage 2 meta-analyses (Supplementary Fig. 2), we identified eight new T2D susceptibility loci at genome-wide significance (P < 5 × 10−8) (Table 1, Supplementary Fig. 3 and Supplementary Table 2).", "The data support the view that much of the overall variance in T2D susceptibility can be attributed to the impact of a large number of common causal variants, most of very modest effect.", "We performed sex-differentiated meta-analysis32 (Online Methods and Supplementary Figs. 5 and 6) to test for association of each SNP with T2D, allowing for heterogeneity in allelic effects between males (20,219 cases, 54,604 controls) and females (14,621 cases, 60,377 controls), thereby identifying two additional loci achieving genome-wide significance (Table 2 and Supplementary Table 7)."]}
{"doc_id": 7005, "title": "", "abstract": ["The associated lead variants at the eight newly identified loci were common (Stage 2 RAF 0.08–0.89) and had modest effects on T2D susceptibility (allelic odds ratios (OR) 1.07–1.14).", "In so doing, we have added another 10 loci to the list of confirmed common variant signals: for several of these, we have identified strong positional candidates based on expression data and known biology.", "However, the paucity of low-frequency candidate alleles across 36 loci suggests that most causal variants at these loci are common.", "Although the genetic contribution to T2D is well recognized, the current set of 56 established susceptibility loci, identified primarily through large-scale genome-wide association studies (GWAS)2–11, captures at best 10% of familial aggregation of the disease.", "Genome-wide analyses of these data are consistent with a long tail of further common variant loci explaining much of the variation in susceptibility to T2D."]}
{"doc_id": 7006, "title": "", "abstract": ["We also considered surrogate estimates of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) derived by homeostasis model assessment in up to 38,238 individuals (from GWAS meta-analysis only since these traits were not investigated in the enlarged MAGIC Metabochip study).", "We obtained summary statistics for lead SNPs in all newly discovered and established loci for glycemic traits in non-diabetic individuals from the MAGIC Investigators5, 34.", "At the previously unreported loci, we observed nominal evidence of association (P < 0.05) in the South Asian10 and recent East Asian11 meta-analyses for the lead SNPs at MC4R and ZMIZ1 (Supplementary Table 3), with consistent directions of effect across all three ancestry groups.", "The risk allele at ANK1 has features (nominally significant reduction in HOMA-B) indicating a primary effect on beta-cell function, whereas those at GRB14 and AKNRD55 are characteristic of loci acting primarily through insulin resistance (increased HOMA-IR) (Supplementary Fig. 10 and Supplementary Table 10).", "Combining Stage 1 and Stage 2 meta-analyses (Supplementary Fig. 2), we identified eight new T2D susceptibility loci at genome-wide significance (P < 5 × 10−8) (Table 1, Supplementary Fig. 3 and Supplementary Table 2)."]}
{"doc_id": 7007, "title": "", "abstract": ["We used the published MAGIC meta-analysis (up to 37,037 non-diabetic individuals) of HOMA indices of beta-cell function and insulin sensitivity5 as these traits were not included in the enlarged Metabochip study34.", "We also considered surrogate estimates of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) derived by homeostasis model assessment in up to 38,238 individuals (from GWAS meta-analysis only since these traits were not investigated in the enlarged MAGIC Metabochip study).", "We also identified the most strongly associated cis-eQTL SNP for each flanking transcript.", "We performed sex-differentiated meta-analysis32 (Online Methods and Supplementary Figs. 5 and 6) to test for association of each SNP with T2D, allowing for heterogeneity in allelic effects between males (20,219 cases, 54,604 controls) and females (14,621 cases, 60,377 controls), thereby identifying two additional loci achieving genome-wide significance (Table 2 and Supplementary Table 7).", "Lead T2D SNPs at the remaining 24 loci were nominally associated with fasting glucose (P < 0.05), all with directionally consistent effects."]}
{"doc_id": 7008, "title": "", "abstract": ["This genome-wide meta-analysis (“DIAGRAMv3”) includes data from 12,171 cases and 56,862 controls of European descent imputed up to 2.5 million autosomal SNPs, and augments the previously published “DIAGRAMv2” meta-analysis4 with four additional GWAS (Supplementary Table 1).", "The Stage 2 meta-analysis consisted of 21,491 T2D cases and 55,647 controls across 25 studies from European descent populations and 1,178 T2D cases and 2,472 controls from one study of Pakistani descent (PROMIS) (Supplementary Table 1).", "The Stage 1 meta-analysis consisted of 12,171 T2D cases and 56,862 controls across 12 GWAS from European descent populations (Supplementary Table 1).", "For each SNP, summary statistics were aligned to the risk allele in our primarily European descent meta-analysis.", "Our primary investigation combined the DIAGRAMv3 (“Stage 1”) GWAS meta- analysis with a “Stage 2” meta-analysis comprising 22,669 cases and 58,119 controls genotyped with Metabochip, including 1,178 cases and 2,472 controls of Pakistani descent (PROMIS) (Online Methods and Supplementary Table 1)."]}
{"doc_id": 7009, "title": "", "abstract": ["For three of these (BCAR1, GLIS3 and RAD51L1), the T1D risk allele was protective for T2D, while at the others (C6orf173, COBL and C10orf59), the effects were coincident.", "In contrast, the lipid associations at CILP2 and GIPR ran counter to expected epidemiological correlations: T2D risk alleles were associated with reduced triglyceride levels at both loci, and at CILP2 with reduced LDL and total cholesterol.", "These data indicate that a substantial proportion of the variation in T2D risk is captured by common variant association signals that, individually, lie beyond unequivocal detection in single SNP analyses.", "Our data suggest that this may be the case, with a variety of analytical approaches pointing to cell cycle regulation, adipocytokine signalling and CREBBP-related transcription factor activity as key processes involved in T2D pathogenesis.", "If common causal alleles explain a substantial component of T2D susceptibility, the contribution of rare and low-frequency risk variants may be less than is often assumed: re-sequencing studies will soon provide empirical data to address this question."]}
{"doc_id": 7010, "title": "", "abstract": ["Assuming a T2D population prevalence of 8%, these 63 newly discovered and established autosomal loci together account for 5.7% of variance in disease susceptibility, as calculated by transforming dichotomous disease risk onto a continuous liability scale20 (Online Methods).", "We estimate that these variants jointly account for λS = 1.088 (95% CI 1.083–1.094), increasing the overall liability-scale variance explained to 10.7% (10.4–11.0%).", "The data support the view that much of the overall variance in T2D susceptibility can be attributed to the impact of a large number of common causal variants, most of very modest effect.", "These results are similar to those obtained from a complementary method integrating polygenic risk score analysis and approximate Bayesian computation23 applied to the DIAGRAMv2 meta-analysis4, which estimated that ~49% of liability-scale variance was explained by common variants genome-wide.", "Genome-wide analyses of these data are consistent with a long tail of further common variant loci explaining much of the variation in susceptibility to T2D."]}
{"doc_id": 7011, "title": "", "abstract": ["We identified proxies (CEU r2 > 0.8) for each lead T2D SNP in our newly discovered loci (also including GRB14 and HMG20A).", "This genome-wide meta-analysis (“DIAGRAMv3”) includes data from 12,171 cases and 56,862 controls of European descent imputed up to 2.5 million autosomal SNPs, and augments the previously published “DIAGRAMv2” meta-analysis4 with four additional GWAS (Supplementary Table 1).", "We used 1000 Genomes Project data13 to search for non-synonymous variants in strong LD (CEU r2 > 0.8) with lead SNPs at the newly discovered loci (Online Methods).", "To understand the extent to which additional variance might be attributable to multiple variants at established and newly discovered loci, we extended these analyses, focusing on the detection of independent (CEU r2 < 0.05) association signals that lie outside the recombination interval containing the lead SNP (Supplementary Table 2).", "Second, we extended our previous analysis4 of the physiological consequences of T2D risk alleles to include the newly identified loci."]}
{"doc_id": 7012, "title": "", "abstract": ["The data support the view that much of the overall variance in T2D susceptibility can be attributed to the impact of a large number of common causal variants, most of very modest effect.", "These data indicate that a substantial proportion of the variation in T2D risk is captured by common variant association signals that, individually, lie beyond unequivocal detection in single SNP analyses.", "Using simulations, based on parameter estimates from this mixture model, we estimated that 488 (95% confidence interval (CI) 456–521) of the independent replication SNPs, in addition to the 63 newly discovered and established loci, are associated with T2D susceptibility.", "Genome-wide analyses of these data are consistent with a long tail of further common variant loci explaining much of the variation in susceptibility to T2D.", "Although the genetic contribution to T2D is well recognized, the current set of 56 established susceptibility loci, identified primarily through large-scale genome-wide association studies (GWAS)2–11, captures at best 10% of familial aggregation of the disease."]}
{"doc_id": 36000, "title": "", "abstract": ["The use of RAS blockers as a causal link is an assumption that lacks evidence, as discussed here.", "Renin-Angiotensin System Blockers and the COVID-19 Pandemic", "This commentary discusses this concern and concludes that based on current evidence, there is no reason to abandon RAS blockers in patients receiving this important class of antihypertensive agents because of concerns of either increased risk of contracting SARS-CoV-2 or worsening its course.", "* Treatment with RAS blockers should not be discontinued because of concerns with coronavirus infection based on the currently available evidence.", "Here the decision should be based on clinical judgment and considering the pros and cons of RAS blockade in the acutely ill, such as the presence or absence of hypotension and kidney function."]}
{"doc_id": 36001, "title": "", "abstract": ["Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection.", "Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "ACE2 also binds and internalizes SARS-Cov-2 (severe acute respiratory syndrome coronavirus-2; B), after priming by the serine protease TMPRSS2 (transmembrane protease, serine 2).", "* ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells.", "In 2003, Li et al4 demonstrated that ACE2 is the receptor responsible for SARS coronavirus entry."]}
{"doc_id": 36002, "title": "", "abstract": ["Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs.", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "There are, however, limited reports that ACE inhibitors affect the expression of ACE2 in the heart and the kidney.19", "* Although angiotensin II type 1 receptor blockers have been suggested to upregulate ACE2, the evidence is not fully consistent and differs per angiotensin II type 1 receptor blocker and per organ.", "* There are no data supporting that ACE inhibitors or angiotensin II type 1 receptor blockers facilitate coronavirus entry by increasing ACE2 expression."]}
{"doc_id": 36003, "title": "", "abstract": ["Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "ACE2 also binds and internalizes SARS-Cov-2 (severe acute respiratory syndrome coronavirus-2; B), after priming by the serine protease TMPRSS2 (transmembrane protease, serine 2).", "* ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells.", "Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection.", "In this context, one can speculate that having increased ACE2 expression by preexisting ARBs treatment may actually be protective in the course of SARS-CoV-2 infection."]}
{"doc_id": 36004, "title": "", "abstract": ["The current data, however, are often conflicting and vary between ARBs and tissue (eg, heart versus kidney).", "Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs.", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "This is really at the crux of the question and the prevailing confusion and panic that we are witnessing in the medical community after the word came out that ACE2 is the receptor for SARS-CoV-2.", "Part of the confusion in social media and the public in general stands because, at times, ACE inhibitors are confused with ACE2 inhibitors."]}
{"doc_id": 36005, "title": "", "abstract": ["During the spread of the severe acute respiratory syndrome coronavirus-2, some reports of data still emerging and in need of full analysis indicate that certain groups of patients are at risk of COVID-19.", "Hence such information is desperately needed.", "* Treatment with RAS blockers should not be discontinued because of concerns with coronavirus infection based on the currently available evidence.", "This commentary discusses this concern and concludes that based on current evidence, there is no reason to abandon RAS blockers in patients receiving this important class of antihypertensive agents because of concerns of either increased risk of contracting SARS-CoV-2 or worsening its course.", "Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2"]}
{"doc_id": 36006, "title": "", "abstract": ["Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "In this context, one can speculate that having increased ACE2 expression by preexisting ARBs treatment may actually be protective in the course of SARS-CoV-2 infection.", "Even if the reported upregulation of tissue ACE2 by ARBs in animal studies and generally with high doses could be extrapolated to humans, this would not establish that it is sufficient to facilitate SARS-CoV-2 entry.", "During the spread of the severe acute respiratory syndrome coronavirus-2, some reports of data still emerging and in need of full analysis indicate that certain groups of patients are at risk of COVID-19.", "Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection."]}
{"doc_id": 36007, "title": "", "abstract": ["For instance, if 2% of ACE2 occurs in a soluble form, doubling would increase this to 4%, while still 96% of ACE2 is membrane-bound.", "Given the relationship with ADAM17, a clear distinction should be made between membrane-bound and soluble ACE2 because an increase in soluble ACE2, if anything, might imply a decrease in membrane-bound ACE2.", "Angiotensin II, via its AT1 (angiotensin II type 1) receptor, upregulates ADAM17, thus increasing soluble ACE2 levels.16", "However, given that by far the majority of ACE2 is membrane-bound, even a doubling is unlikely to significantly alter the amount of membrane-bound ACE2.", "In pathological states, shedding of ACE2 is often increased, resulting in elevated soluble ACE2 levels in blood, urine, and other body fluids.17,18"]}
{"doc_id": 36008, "title": "", "abstract": ["* Animal data support a potential protective pulmonary and cardiovascular effects of elevated ACE2 expression.", "During the spread of the severe acute respiratory syndrome coronavirus-2, some reports of data still emerging and in need of full analysis indicate that certain groups of patients are at risk of COVID-19.", "Many of those patients are treated with renin-angiotensin system blockers.", "This commentary discusses this concern and concludes that based on current evidence, there is no reason to abandon RAS blockers in patients receiving this important class of antihypertensive agents because of concerns of either increased risk of contracting SARS-CoV-2 or worsening its course.", "AT1 receptor blockers (ARBs) alter ACE2 expression more consistently in several studies, both at the mRNA and protein level.19–21"]}
{"doc_id": 36009, "title": "", "abstract": ["Subsequent cell entry relies on priming by the serine protease TMPRSS2 (transmembrane protease, serine 2).5", "ACE2 also binds and internalizes SARS-Cov-2 (severe acute respiratory syndrome coronavirus-2; B), after priming by the serine protease TMPRSS2 (transmembrane protease, serine 2).", "Importantly, SARS-CoV-2 entry into the cell could be blocked both by S-protein neutralizing antibodies and TMPRSS2 inhibitors (camostat mesylate).7", "This is unlikely to seriously affect SARS-CoV-2 entry, which depends on membrane- bound (full-length) ACE2.", "Those include broad spectrum antivirals such as favipiravir and remdesivir,28 TMPRSS2 inhibition with camostat mesylate,7 and ADAM17 upregulation."]}
{"doc_id": 36010, "title": "", "abstract": ["Theoretically, RAS blockade might (partly) reverse this, thus returning the percent of membrane-bound ACE2 to 97–98.", "For instance, if 2% of ACE2 occurs in a soluble form, doubling would increase this to 4%, while still 96% of ACE2 is membrane-bound.", "However, given that by far the majority of ACE2 is membrane-bound, even a doubling is unlikely to significantly alter the amount of membrane-bound ACE2.", "Shedding of membrane-bound ACE2 by a disintegrin and metalloprotease 17 (ADAM17) results in the occurrence of soluble (s) ACE2, which can no longer mediate SARS-Cov-2 entry and which might even prevent such entry by keeping the virus in solution.", "In pathological states, shedding of ACE2 is often increased, resulting in elevated soluble ACE2 levels in blood, urine, and other body fluids.17,18"]}
{"doc_id": 36011, "title": "", "abstract": ["Taken together, there is evidence from animal studies that ARBs may upregulate membrane-bound ACE2, whereas ACE inhibitors may not.", "ACE inhibitors should then have the same directional effect as ARBs, although for these drugs there is very limited data showing upregulation of ACE2.", "We therefore strongly recommend that patients who are taking ACE inhibitors or ARBs for high blood pressure, heart failure, or other medical indications should not withdraw their current treatment regimens unless they are specifically advised to do so by their physician or healthcare provider.", "If ARBs as a drug class would truly upregulate membrane-bound ACE2, it is reasonable to first assume that this is because of AT1 receptor blockade.", "There are some concerns that these agents, particularly ARBs, can affect the expression of ACE2 based on animal models that, however, have not been challenged with coronavirus infection to evaluate the impact of RAS blocker therapy."]}
{"doc_id": 36012, "title": "", "abstract": ["ACE inhibitors should then have the same directional effect as ARBs, although for these drugs there is very limited data showing upregulation of ACE2.", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "There are some concerns that these agents, particularly ARBs, can affect the expression of ACE2 based on animal models that, however, have not been challenged with coronavirus infection to evaluate the impact of RAS blocker therapy.", "We therefore strongly recommend that patients who are taking ACE inhibitors or ARBs for high blood pressure, heart failure, or other medical indications should not withdraw their current treatment regimens unless they are specifically advised to do so by their physician or healthcare provider.", "* There are no data supporting that ACE inhibitors or angiotensin II type 1 receptor blockers facilitate coronavirus entry by increasing ACE2 expression."]}
{"doc_id": 36013, "title": "", "abstract": ["Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "There are some concerns that these agents, particularly ARBs, can affect the expression of ACE2 based on animal models that, however, have not been challenged with coronavirus infection to evaluate the impact of RAS blocker therapy.", "Taken together, there is evidence from animal studies that ARBs may upregulate membrane-bound ACE2, whereas ACE inhibitors may not.", "Even if the reported upregulation of tissue ACE2 by ARBs in animal studies and generally with high doses could be extrapolated to humans, this would not establish that it is sufficient to facilitate SARS-CoV-2 entry.", "Moreover, it is unknown whether alternative antihypertensives do not carry the same risk."]}
{"doc_id": 36014, "title": "", "abstract": ["Renin-Angiotensin System Blockers and the COVID-19 Pandemic", "AT1R (Ang II, via its type 1 receptor) upregulates ADAM17, and AT1R blockers (ARBs) would prevent this.", "Keywords: ACE inhibitor, angiotensin receptor blocker, coronavirus, COVID-19, severe acute respiratory syndrome", "In this context, one can speculate that having increased ACE2 expression by preexisting ARBs treatment may actually be protective in the course of SARS-CoV-2 infection.", "AT1 receptor blockers (ARBs) alter ACE2 expression more consistently in several studies, both at the mRNA and protein level.19–21"]}
{"doc_id": 36015, "title": "", "abstract": ["Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "This commentary discusses this concern and concludes that based on current evidence, there is no reason to abandon RAS blockers in patients receiving this important class of antihypertensive agents because of concerns of either increased risk of contracting SARS-CoV-2 or worsening its course.", "In this context, one can speculate that having increased ACE2 expression by preexisting ARBs treatment may actually be protective in the course of SARS-CoV-2 infection.", "In closing, we see no reason to abandon or discontinue temporarily the use of RAS blockers preventatively in SARS-CoV-2 patients.29", "Importantly, SARS-CoV-2 entry into the cell could be blocked both by S-protein neutralizing antibodies and TMPRSS2 inhibitors (camostat mesylate).7"]}
{"doc_id": 36016, "title": "", "abstract": ["Renin-Angiotensin System Blockers and the COVID-19 Pandemic", "The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has already taken on pandemic proportions, having infected >100 000 people in 100 countries.1", "During the spread of the severe acute respiratory syndrome coronavirus-2, some reports of data still emerging and in need of full analysis indicate that certain groups of patients are at risk of COVID-19.", "Keywords: ACE inhibitor, angiotensin receptor blocker, coronavirus, COVID-19, severe acute respiratory syndrome", "This includes patients with hypertension, heart disease, diabetes mellitus, and clearly the elderly."]}
{"doc_id": 36017, "title": "", "abstract": ["Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection.", "A more specific approach might be using soluble recombinant ACE2 protein to intercept the virus from binding to the full-length ACE2 anchored in the cell plasma membrane.6", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "* ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells."]}
{"doc_id": 36018, "title": "", "abstract": ["In the lung, ACE2 expression occurs in type 2 pneumocytes and macrophages.", "* ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells.", "Generally, however, pulmonary ACE2 expression is low when compared with other organs like the intestine, testis, heart, and kidney.9–11", "In agreement with this assumption, angiotensin II acutely induced ACE2 internalization via its AT1 receptor in ACE2-transfected neuroblastoma cells.23", "AT1 receptor blockers (ARBs) alter ACE2 expression more consistently in several studies, both at the mRNA and protein level.19–21"]}
{"doc_id": 1000, "title": "", "abstract": ["Kinetics of mCherry-Parkin recruitment to mitochondria are enhanced by exogenous PINK1 expression.", "Consistent with a role for phosphorylation in the activation of Parkin, we found a kinase-deficient version of PINK1 fails to rescue Parkin recruitment to mitochondria in PINK1 null MEFs (even though PINK1 KD appears to be processed identically to wild- type PINK1).", "Accumulated PINK1 recruits Parkin to damaged mitochondria, which Parkin marks, likely by ubiquitination, for autophagic degradation.", "Thus, increased expression of PINK1 on the outer mitochondrial membrane is sufficient to recruit Parkin to mitochondria.", "Together, these data demonstrate that stable expression of PINK1 on mitochondria is sufficient for Parkin recruitment to mitochondria, regardless of membrane potential."]}
{"doc_id": 1001, "title": "", "abstract": ["Consistent with genetic studies in Drosophila, these findings show that Parkin translocation to depolarized mitochondria and Parkin-induced mitophagy are downstream of PINK1 expression, whereas PINK1 accumulation in response to depolarization is upstream of Parkin recruitment.", "Although these experiments suggest that the increased expression of PINK1 is due at least in part to inhibition of PINK1 cleavage, it is possible that increased transcription of PINK1 following depolarization might also be contributing to the increase in PINK1 abundance.", "Interestingly, overexpression of Parkin can partially compensate for PINK1 loss, but PINK1 overexpression cannot compensate for Parkin loss, suggesting that PINK1 functions upstream of Parkin in a common pathway.", "In addition, increased expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment and Parkin-induced mitophagy, suggesting that loss of membrane potential activates Parkin recruitment primarily through the up-regulation of mitochondrial PINK1.", "Although these findings do not prove new PINK1 synthesis is required for Parkin recruitment (cycloheximide blocks de novo synthesis of all proteins and thus may inhibit Parkin recruitment independently of PINK1 accumulation), they suggest that PINK1 accumulation and Parkin recruitment may be casually related."]}
{"doc_id": 1002, "title": "", "abstract": ["Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation.", "We have found that PINK1 levels and subsequently Parkin recruitment to mitochondria are dramatically regulated by the bioenergetic state of individual mitochondria, and that this unique regulation may allow PINK1 and Parkin to promote the selective and efficient turnover of mitochondria that have become damaged.", "Accumulated PINK1 recruits Parkin to damaged mitochondria, which Parkin marks, likely by ubiquitination, for autophagic degradation.", "Next, we tested whether Parkin recruitment to depolarized mitochondria is dependent on PINK1 expression.", "The stringent dependence of Parkin recruitment on PINK1 under depolarizing conditions is a little surprising given that, when overexpressed, Parkin can partially compensate for PINK1 loss in Drosophila and in mammalian cells [11]–[13],[20]."]}
{"doc_id": 1003, "title": "", "abstract": ["That inhibition of PINK1 cleavage by mitochondrial depolarization up-regulates the PINK1/Parkin mitophagy pathway also raises the possibility that inhibitors of PINK1's protease might up-regulate the pathway and have some therapeutic benefit.", "Recent studies have linked Parkin and PINK1 in a pathway critical for the maintenance of mitochondrial integrity and function.", "These data demonstrate that stable expression of PINK1 on the outer mitochondrial membrane is sufficient to induce mitophagy in the presence of Parkin, irrespective of membrane potential.", "In addition, increased expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment and Parkin-induced mitophagy, suggesting that loss of membrane potential activates Parkin recruitment primarily through the up-regulation of mitochondrial PINK1.", "Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation."]}
{"doc_id": 1004, "title": "", "abstract": ["These results suggest that PINK1 is necessary for the mitophagy of depolarized mitochondria following overexpression of Parkin.", "Figure 4 PINK1 is required for Parkin-induced autophagy of depolarized mitochondria.", "Consistent with genetic studies in Drosophila, these findings show that Parkin translocation to depolarized mitochondria and Parkin-induced mitophagy are downstream of PINK1 expression, whereas PINK1 accumulation in response to depolarization is upstream of Parkin recruitment.", "### PINK1 Expression Is Required for Parkin Recruitment to Depolarized Mitochondria and Parkin-Induced Mitophagy", "Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation."]}
{"doc_id": 1005, "title": "", "abstract": ["Next, we tested patient mutations in Parkin to see if they would affect Parkin recruitment to mitochondria and/or Parkin-induced mitophagy.", "We assessed the ability of Parkin mutants to induce mitophagy.", "Next, we assessed recruitment of Parkin mutants to depolarized mitochondria by immunoblotting.", "Next, we tested whether Parkin recruitment following increased PINK1 expression on the mitochondria is sufficient to induce mitophagy in the absence of depolarization with CCCP.", "To test whether PINK1 is necessary for Parkin- induced mitophagy, we treated primary PINK1−/− and PINK1+/+ MEFs transiently expressing YFP-Parkin with 20 µM CCCP for 24 h (Figure 4A and 4B)."]}
{"doc_id": 1006, "title": "", "abstract": ["We recently reported that the Parkinson disease-linked E3 ubiquitin ligase, Parkin, is selectively recruited to dysfunctional mitochondria with low membrane potential to promote their autophagic degradation, suggesting that a deficiency of mitochondrial quality control may underlie the observed mitochondrial dysfunction in Parkin knockout Drosophila and mice [11]–[15],[17],[21].", "Loss of PINK1 or Parkin function due to pathogenic mutations can disrupt this mitochondrial turnover pathway which may lead to the accumulation of dysfunctional mitochondria in vulnerable tissues—with a resultant increase in oxidative stress, depression of metabolism, and, eventually, accelerated cell death, which has been observed in Drosophila and, to a lesser extent, in mouse models of the disease [11]–[17].", "On damaged mitochondria with low membrane potentials (ΔΨ), however, PINK1 cleavage is blocked, leading to accumulation of mitochondrial PINK1 on the dysfunctional mitochondria.", "We recently reported that Parkin is selectively recruited to dysfunctional mitochondria with low membrane potential and, subsequently, promotes their autophagic degradation [21].", "Since neurons in the SN are postmitotic, any mitochondrial damage they acquire could accumulate over an organism's lifetime, leading to progressive mitochondrial dysfunction—including increased oxidative stress, decreased calcium buffering capacity, loss of ATP, and, eventually, cell death—unless quality control processes eliminate the damaged mitochondria."]}
{"doc_id": 1007, "title": "", "abstract": ["We recently reported that Parkin is selectively recruited to dysfunctional mitochondria with low membrane potential and, subsequently, promotes their autophagic degradation [21].", "We recently reported that the Parkinson disease-linked E3 ubiquitin ligase, Parkin, is selectively recruited to dysfunctional mitochondria with low membrane potential to promote their autophagic degradation, suggesting that a deficiency of mitochondrial quality control may underlie the observed mitochondrial dysfunction in Parkin knockout Drosophila and mice [11]–[15],[17],[21].", "Selective accumulation of PINK1 on the impaired mitochondria recruits Parkin, and Parkin, in turn, induces the degradation of the damaged mitochondria.", "Accumulated PINK1 recruits Parkin to damaged mitochondria, which Parkin marks, likely by ubiquitination, for autophagic degradation.", "We previously reported that ectopic Parkin can induce the autophagy of depolarized mitochondria [21]."]}
{"doc_id": 1008, "title": "", "abstract": ["In cells with high expression of PINK1, Parkin is recruited to mitochondria even in the absence of CCCP (Figure 5C and 5D), as has been reported previously [27].", "These data demonstrate that stable expression of PINK1 on the outer mitochondrial membrane is sufficient to induce mitophagy in the presence of Parkin, irrespective of membrane potential.", "To test whether stable expression of PINK1 on the mitochondria is sufficient for Parkin recruitment, we constructed a fusion protein that would be predicted to lack PINK1's proteolytic cleavage site and therefore exhibit greater stability on mitochondria.", "Nonetheless, we failed to see Parkin increase in the membrane fraction either under equal loading conditions or when loading was adjusted so that total Parkin was approximately equal in the two cell populations, further indicating that Parkin is not recruited to uncoupled mitochondria in the absence of PINK1 (Figure 3F, lower panel, and Figure S3B).", "Figure 6 Stable expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment."]}
{"doc_id": 1009, "title": "", "abstract": ["(D) M17 human neuroblastoma cells stably transduced with control shRNA or PINK1 shRNA were treated with 10 µM CCCP in serum for 3 h and imaged as in (A).", "(B) M17 human neuroblastoma cells stably transduced with control shRNA or PINK1 shRNA were treated with 20 µM CCCP in serum and fractionated.", "(C) M17 human neuroblastoma cells stably transduced with control shRNA or PINK1 shRNA were treated with 10 µM CCCP for 24 h and stained as in (A).", "(E) M17 cells stably transduced with control shRNA or PINK1 shRNA were treated with DMSO or 10 µM CCCP for 24 h and stained with Mitotracker Green (MTG).", "(B) M17 neuroblastoma cells stably transduced with control shRNA or PINK1 shRNA and transfected with YFP-Parkin were treated with DMSO or 10 µM CCCP for 3 h and fractionated into postnuclear supernatant (PNS), mitochondria-rich heavy membrane fraction (HMF), and supernatant (Sup)."]}
{"doc_id": 1010, "title": "", "abstract": ["In addition, increased expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment and Parkin-induced mitophagy, suggesting that loss of membrane potential activates Parkin recruitment primarily through the up-regulation of mitochondrial PINK1.", "Since PINK1 is genetically upstream of Parkin, we tested whether PINK1's activity might be activated by mitochondrial depolarization.", "It has been proposed that PINK1 may induce mitochondrial recruitment of Parkin through phosphorylation of threonines 175 and 217 in a highly conserved region/domain of Parkin, which has been recently named RING0 (Figure S5A) [27],[41].", "That inhibition of PINK1 cleavage by mitochondrial depolarization up-regulates the PINK1/Parkin mitophagy pathway also raises the possibility that inhibitors of PINK1's protease might up-regulate the pathway and have some therapeutic benefit.", "We find that patient mutations in PINK1 and Parkin disrupt the PINK1/Parkin mitochondrial turnover pathway at distinct steps, consistent with the potential relevance of this pathway for the development of Parkinson disease."]}
{"doc_id": 1011, "title": "", "abstract": ["Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation.", "To test whether stable expression of PINK1 on the mitochondria is sufficient for Parkin recruitment, we constructed a fusion protein that would be predicted to lack PINK1's proteolytic cleavage site and therefore exhibit greater stability on mitochondria.", "Expression of mitochondrial PINK1 is required for the recruitment of Parkin to the dysfunctional mitochondria and for their selective elimination by Parkin.", "We found that, similar to YFP-Parkin [21], PINK1-YFP accumulates selectively on mitochondria with low membrane potential, demonstrating that PINK1 is selectively stabilized on the depolarized mitochondria within a bioenergetically diverse population of mitochondria (Figure 1E and 1F).", "Selective accumulation of PINK1 on the impaired mitochondria recruits Parkin, and Parkin, in turn, induces the degradation of the damaged mitochondria."]}
{"doc_id": 1012, "title": "", "abstract": ["These data suggest that PINK1 promotes mitophagy in the context of endogenous levels of Parkin.", "These results suggest that PINK1 is necessary for the mitophagy of depolarized mitochondria following overexpression of Parkin.", "Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation.", "Considered together, these results demonstrate that PINK1 selectively accumulates on dysfunctional mitochondria with low membrane potentials.", "In addition, they support a novel model for the negative selection of damaged mitochondria, in which PINK1 signals mitochondrial dysfunction to Parkin, and Parkin promotes their elimination."]}
{"doc_id": 1013, "title": "", "abstract": ["To further assess the stability of PINK1 under depolarizing conditions, we performed the same set of experiments in the presence of MG132, an inhibitor of proteasomal degradation.", "Endogenous PINK1 accumulates similarly in HeLa cells, which display little or no endogenous Parkin expression, and HeLa cells stably expressing YFP-Parkin (Figure S2D).", "Consistent with these findings, we observed that exogenous PINK1-myc accumulates similarly in immortalized Parkin−/− and Parkin+/+ MEFs (Figure S2E).", "To test whether PINK1 accumulation following CCCP treatment is due to inhibition of its proteolytic cleavage, we assessed the effect of CCCP washout on PINK1 cleavage.", "We also tested whether PINK1 similarly accumulates in primary rat cortical neurons following depolarization with CCCP."]}
{"doc_id": 1014, "title": "", "abstract": ["By contrast, 90-min treatment with actinomycin D, an inhibitor of transcription, had a modest effect on Parkin recruitment to uncoupled mitochondria by confocal microscopy (Figure 7C and 7D), suggesting that new transcription of PINK1 is not required for Parkin recruitment.", "We found that whereas exogenous expression of PINK1 causes a significant increase in PINK1 transcription relative to untransfected HeLa cells, PINK1 transcription does not significantly increase following depolarization with CCCP (p = 0.4499).", "A 90-min treatment with cycloheximide, likewise, blocked Parkin recruitment to depolarized mitochondria by confocal microscopy (96.0±3.5% vs. 11.3±4.2%) (Figure 7C and 7D).", "Treatment of HeLa cells for 90 min with cycloheximide blocked the depolarization-induced accumulation of endogenous PINK1 in whole-cell lysates as well as in the mitochondria-rich membrane fraction (Figure 7A and 7B).", "By contrast, cotransfection of cytosolic PINK1 Δ1-110-YFP with Parkin produces no cells lacking mitochondria after 96 h."]}
{"doc_id": 1015, "title": "", "abstract": ["These results are consistent with endogenous PINK1 promoting mitochondrial degradation in the context of continued (or increased) mitochondrial biogenesis [37],[38].", "Thus, increased expression of PINK1 on the outer mitochondrial membrane is sufficient to recruit Parkin to mitochondria.", "It has been proposed that PINK1 may induce mitochondrial recruitment of Parkin through phosphorylation of threonines 175 and 217 in a highly conserved region/domain of Parkin, which has been recently named RING0 (Figure S5A) [27],[41].", "We have found that PINK1 levels and subsequently Parkin recruitment to mitochondria are dramatically regulated by the bioenergetic state of individual mitochondria, and that this unique regulation may allow PINK1 and Parkin to promote the selective and efficient turnover of mitochondria that have become damaged.", "Increased expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment."]}
{"doc_id": 1016, "title": "", "abstract": ["Finally, to test the localization of accumulated PINK1 on depolarized mitochondria, we performed a protease protection assay, using an antibody raised against PINK1's kinase domain.", "These data demonstrate that stable expression of PINK1 on the outer mitochondrial membrane is sufficient to induce mitophagy in the presence of Parkin, irrespective of membrane potential.", "Our results suggest that full-length mitochondrial PINK1 is the active form in the PINK1/Parkin pathway, and that cleavage of PINK1 into an unstable cytosolic form maintains low levels of PINK1 on healthy mitochondria in order to suppress the PINK1/Parkin pathway in the absence of mitochondrial damage.", "We found that, similar to YFP-Parkin [21], PINK1-YFP accumulates selectively on mitochondria with low membrane potential, demonstrating that PINK1 is selectively stabilized on the depolarized mitochondria within a bioenergetically diverse population of mitochondria (Figure 1E and 1F).", "Taken together, these results support a two-step model for the processing of PINK1: first, full-length PINK1 is cleaved into the ∼52-kDa short form in a voltage-dependent, proteasome-independent manner, and second, the short form of PINK1 is rapidly degraded by the proteasome (Figure 2B)."]}
{"doc_id": 1017, "title": "", "abstract": ["Taken together, these results support a two-step model for the processing of PINK1: first, full-length PINK1 is cleaved into the ∼52-kDa short form in a voltage-dependent, proteasome-independent manner, and second, the short form of PINK1 is rapidly degraded by the proteasome (Figure 2B).", "To further assess the stability of PINK1 under depolarizing conditions, we performed the same set of experiments in the presence of MG132, an inhibitor of proteasomal degradation.", "Full- length PINK1 (∼63 kDa), which is anchored in the mitochondrial membrane, is proteolytically cleaved into an ∼52-kDa cytosolic fragment that can be degraded by the proteasome [22],[28]–[30].", "The accumulation of this short form of PINK1 following treatment with MG132 suggests that it is unstable under basal conditions, as has been observed previously [22],[30] (Figure 2A, lane 1 vs. lane 2).", "On healthy mitochondria PINK1 is constitutively imported, proteolytically cleaved into a cytosolic form, and degraded by the proteasome, resulting in low levels of mitochondrial PINK1."]}
{"doc_id": 1018, "title": "", "abstract": ["Together these findings suggest that Parkin and PINK1 may function in an evolutionarily conserved pathway critical for the maintenance of mitochondrial integrity and function.", "We recently reported that the Parkinson disease-linked E3 ubiquitin ligase, Parkin, is selectively recruited to dysfunctional mitochondria with low membrane potential to promote their autophagic degradation, suggesting that a deficiency of mitochondrial quality control may underlie the observed mitochondrial dysfunction in Parkin knockout Drosophila and mice [11]–[15],[17],[21].", "In this model, PINK1 and Parkin form a pathway for sensing and selectively eliminating damaged mitochondria from the mitochondrial network.", "Recent studies have linked Parkin and PINK1 in a pathway critical for the maintenance of mitochondrial integrity and function.", "It has been proposed that PINK1 may induce mitochondrial recruitment of Parkin through phosphorylation of threonines 175 and 217 in a highly conserved region/domain of Parkin, which has been recently named RING0 (Figure S5A) [27],[41]."]}
{"doc_id": 1019, "title": "", "abstract": ["These results suggest that PINK1 is necessary for the mitophagy of depolarized mitochondria following overexpression of Parkin.", "These data suggest that PINK1 promotes mitophagy in the context of endogenous levels of Parkin.", "Previous studies in flies and mice, and in human cells suggest that PINK1 and Parkin are part of a common pathway that protects against damaged mitochondria; these organelles power the cell when healthy but can produce harmful reactive oxygen species when damaged.", "Together these findings suggest that Parkin and PINK1 may function in an evolutionarily conserved pathway critical for the maintenance of mitochondrial integrity and function.", "Recent studies have linked Parkin and PINK1 in a pathway critical for the maintenance of mitochondrial integrity and function."]}
{"doc_id": 1020, "title": "", "abstract": ["HeLa cells stably expressing YFP-Parkin were used in our initial experiments because it was unclear whether the stability of PINK1 would be affected by the absence of Parkin, as has been reported previously [29].", "To test whether accumulation of endogenous PINK1 following depolarization is necessary for Parkin recruitment, we treated HeLa cells with CCCP alone (for 60 min) or with CCCP plus cycloheximide, a general inhibitor of protein synthesis (cycloheximide was added 30 min before CCCP and maintained throughout the 60-min CCCP treatment).", "To assess whether PINK1 transcription is also regulated by membrane potential, we performed quantitative RT-PCR (qRT-PCR) of PINK1 levels in HeLa cells treated with DMSO or CCCP for 1 h.", "We have found that PINK1 levels and subsequently Parkin recruitment to mitochondria are dramatically regulated by the bioenergetic state of individual mitochondria, and that this unique regulation may allow PINK1 and Parkin to promote the selective and efficient turnover of mitochondria that have become damaged.", "Previous studies in flies and mice, and in human cells suggest that PINK1 and Parkin are part of a common pathway that protects against damaged mitochondria; these organelles power the cell when healthy but can produce harmful reactive oxygen species when damaged."]}
{"doc_id": 1021, "title": "", "abstract": ["Nonetheless, we failed to see Parkin increase in the membrane fraction either under equal loading conditions or when loading was adjusted so that total Parkin was approximately equal in the two cell populations, further indicating that Parkin is not recruited to uncoupled mitochondria in the absence of PINK1 (Figure 3F, lower panel, and Figure S3B).", "This is consistent with the absence of PINK1 mRNA up-regulation following uncoupling (Figure 2C).", "We also failed to detect YFP-Parkin recruitment at 24 h following CCCP in PINK1−/− MEFs (unpublished data), suggesting that little or no recruitment of YFP-Parkin to depolarized mitochondria occurs in the absence of PINK1.", "When MG132 is added during the final hour of treatment in HeLa cells treated with vehicle, an ∼52-kDa band appears, consistent with the cleavage product of full-length Parkin described in previous reports [22],[28],[30] (Figure 2A, lane 1 vs. lane 2).", "HeLa cells stably expressing YFP-Parkin were used in our initial experiments because it was unclear whether the stability of PINK1 would be affected by the absence of Parkin, as has been reported previously [29]."]}
{"doc_id": 1022, "title": "", "abstract": ["Knockdown of PARL did not appreciably change basal levels of endogenous PINK1 or augment the depolarization-induced accumulation of endogenous PINK1 in HeLa cells (Figure S2B).", "Although endogenous PARL could not be detected in HeLa cells, PARL shRNA inhibited expression of overexpressed PARL (Figure S2A and S2B).", "Together, these results suggest that PARL is dispensable for PINK1 cleavage.", "Although the intramembrane serine protease Rhomboid-7 appears to be required for PINK1 cleavage in Drosophila [31], our results suggest that PARL, its mammalian ortholog, is not required for PINK1 cleavage in mammalian cells.", "To examine whether the mammalian ortholog of Rhomboid-7, PARL, is responsible for PINK1 cleavage in mammalian cells, we tested whether PINK1-V5 accumulates in HeLa cells transfected with PARL shRNA and treated with CCCP."]}
{"doc_id": 1023, "title": "", "abstract": ["Together, these data demonstrate that stable expression of PINK1 on mitochondria is sufficient for Parkin recruitment to mitochondria, regardless of membrane potential.", "It has been proposed that PINK1 may induce mitochondrial recruitment of Parkin through phosphorylation of threonines 175 and 217 in a highly conserved region/domain of Parkin, which has been recently named RING0 (Figure S5A) [27],[41].", "The necessity of PINK1 expression for Parkin recruitment to membranes was also examined in the M17 cell line by immunoblotting.", "Consistent with a role for phosphorylation in the activation of Parkin, we found a kinase-deficient version of PINK1 fails to rescue Parkin recruitment to mitochondria in PINK1 null MEFs (even though PINK1 KD appears to be processed identically to wild- type PINK1).", "Expression of mitochondrial PINK1 is required for the recruitment of Parkin to the dysfunctional mitochondria and for their selective elimination by Parkin."]}
{"doc_id": 1024, "title": "", "abstract": ["Consistent with genetic studies in Drosophila, these findings show that Parkin translocation to depolarized mitochondria and Parkin-induced mitophagy are downstream of PINK1 expression, whereas PINK1 accumulation in response to depolarization is upstream of Parkin recruitment.", "Previous studies in flies and mice, and in human cells suggest that PINK1 and Parkin are part of a common pathway that protects against damaged mitochondria; these organelles power the cell when healthy but can produce harmful reactive oxygen species when damaged.", "### PINK1 Expression Is Required for Parkin Recruitment to Depolarized Mitochondria and Parkin-Induced Mitophagy", "In addition, increased expression of PINK1 on the outer mitochondrial membrane is sufficient for Parkin recruitment and Parkin-induced mitophagy, suggesting that loss of membrane potential activates Parkin recruitment primarily through the up-regulation of mitochondrial PINK1.", "PINK1 accumulation on mitochondria is both necessary and sufficient for Parkin recruitment to mitochondria, and disease- causing mutations in PINK1 and Parkin disrupt Parkin recruitment and Parkin- induced mitophagy at distinct steps."]}
{"doc_id": 1025, "title": "", "abstract": ["Here, we show that full-length PINK1 accumulates selectively on dysfunctional mitochondria, and that Parkin recruitment to depolarized mitochondria and subsequent Parkin-induced mitophagy are strictly dependent on PINK1's mitochondrial targeting signal and depolarization-induced accumulation.", "We recently reported that the Parkinson disease-linked E3 ubiquitin ligase, Parkin, is selectively recruited to dysfunctional mitochondria with low membrane potential to promote their autophagic degradation, suggesting that a deficiency of mitochondrial quality control may underlie the observed mitochondrial dysfunction in Parkin knockout Drosophila and mice [11]–[15],[17],[21].", "First, there may be mechanisms independent of PINK1 and depolarization that can recruit Parkin to dysfunctional mitochondria.", "Expression of mitochondrial PINK1 is required for the recruitment of Parkin to the dysfunctional mitochondria and for their selective elimination by Parkin.", "We recently reported that Parkin is selectively recruited to dysfunctional mitochondria with low membrane potential and, subsequently, promotes their autophagic degradation [21]."]}
{"doc_id": 1026, "title": "", "abstract": ["These data demonstrate that stable expression of PINK1 on the outer mitochondrial membrane is sufficient to induce mitophagy in the presence of Parkin, irrespective of membrane potential.", "To verify that increased expression of PINK1 on the outer mitochondrial membrane is sufficient to induce Parkin recruitment, we used a regulated heterodimerization system [40], in which the modified FRB domain was fused to PINK1 Δ1-110-YFP and the FKBP domain was fused to the outer mitochondrial membrane anchor of TOM20 (residues 1 through 33) (Figure S4A).", "Thus, increased expression of PINK1 on the outer mitochondrial membrane is sufficient to recruit Parkin to mitochondria.", "To assess whether PINK1 expression on the outer mitochondrial membrane is sufficient to recruit Parkin, we cotransfected mCherry-Parkin, FRB- PINK1Δ1-110-YFP, and TOM20-FKBP.", "It has been proposed that PINK1 may induce mitochondrial recruitment of Parkin through phosphorylation of threonines 175 and 217 in a highly conserved region/domain of Parkin, which has been recently named RING0 (Figure S5A) [27],[41]."]}
{"doc_id": 1027, "title": "", "abstract": ["On damaged mitochondria that have lost their membrane potential, however, PINK1 cleavage is inhibited, leading to high PINK1 expression on the dysfunctional mitochondria.", "Here, we show that expression of PINK1 on individual mitochondria is regulated by voltage- dependent proteolysis to maintain low levels of PINK1 on healthy, polarized mitochondria, while facilitating the rapid accumulation of PINK1 on mitochondria that sustain damage.", "Remarkably, levels of endogenous mitochondrial PINK1 respond robustly to changes in mitochondrial membrane potential.", "On damaged mitochondria with low membrane potentials (ΔΨ), however, PINK1 cleavage is blocked, leading to accumulation of mitochondrial PINK1 on the dysfunctional mitochondria.", "### PINK1 Cleavage Is Inhibited by Loss of Membrane Potential, Leading to Its Accumulation on the Outer Mitochondrial Membrane"]}
{"doc_id": 1028, "title": "", "abstract": ["Mutations in the UBL of Parkin exhibit a moderate loss in mitophagy activity (22.0±2.0% and 23.1±8.4% of cells exhibited no mitochondria for R42P and R46P, respectively); whereas mutations in the conserved cysteines of the RBR or truncations that resulted in loss of RING2 exhibit a severe mitophagy deficit (0±0% to 5.3±2.3%, depending on the mutation) (Figure 9D and 9E).", "Next, we tested patient mutations in Parkin to see if they would affect Parkin recruitment to mitochondria and/or Parkin-induced mitophagy.", "We found that although mutation of T175 and T217 to alanine blocked recruitment of Parkin to mitochondria, as was reported previously, the phosphomimetic mutants T175E, T217E, and T175, 217E do not translocate to mitochondria spontaneously.", "Interestingly, the R275W mutation in RING1 of Parkin causes only a minor disturbance of Parkin recruitment to depolarized mitochondria but severely disrupts mitophagy, suggesting that recruitment and mitophagy can be experimentally disassociated.", "We assessed the ability of Parkin mutants to induce mitophagy."]}
{"doc_id": 29000, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Here we show that adoptive transfer of purified IgG from convalescent macaques protects naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques"]}
{"doc_id": 29001, "title": "", "abstract": ["These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "Our data suggest the importance of SARS-CoV-2 vaccines to induce potent and durable humoral as well as cellular immune responses.", "We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective.", "These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5."]}
{"doc_id": 29002, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "Our data provide a key proof-of-concept that antibodies can protect against SARS-CoV-2 challenge in a dose dependent fashion.", "We employed logistic regression models to determine the antibody titer thresholds for protection against SARS-CoV-2 in this experiment.", "Collectively, these data provide key insights into the immunologic determinants and correlates of protection against SARS-CoV-2 and have important implications for the development of vaccines, immune-based therapeutics, and public health strategies.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1."]}
{"doc_id": 29003, "title": "", "abstract": ["Future studies could also be designed to evaluate the potential protective efficacy of cellular immune responses in the absence of antibody responses.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4)."]}
{"doc_id": 29004, "title": "", "abstract": ["Rhesus macaques were challenged by the intranasal and intratracheal routes with 105 TCID50 SARS-CoV-2.", "Rhesus macaques were challenged by the intranasal and intratracheal routes with 105 TCID50 SARS-CoV-2 on day 0 and then received intravenous infusion of 250 mg/kg, 25 mg/kg, or 0 mg/kg purified SARS-CoV-2 IgG on day 1.", "6 Indian-origin rhesus macaques were infected with 1.0×105 TCID50 SARS-CoV-2 by the intranasal and intratracheal routes on day 0 as described above, and then received an intravenous infusion of 250 mg/kg (Group I; N=2), 25 mg/kg (Group II; N=2), or 0 mg/kg (Sham; Group III; N=2) of the SARS-CoV-2 IgG stock on day 1.", "13 rhesus macaques were infected with 1.0×105 TCID50 SARS-CoV-2 by the intranasal and intratracheal routes as described above, and all animals demonstrated robust viral replication in BAL and NS as expected (data not shown).", "On day 0, all animals were challenged with 1.0×105 TCID50 SARS-CoV-2 by the intranasal and intratracheal routes, as we have previously described5."]}
{"doc_id": 29005, "title": "", "abstract": ["CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion."]}
{"doc_id": 29006, "title": "", "abstract": ["Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4).", "These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "These titers are comparable to those observed in convalescent macaques and are readily achievable by vaccination in humans.", "Following infusion, serum antibody titers were similar to those observed in the prior experiment (NAb titers approximately 500 in Group I and 50 in Group II) (data not shown)."]}
{"doc_id": 29007, "title": "", "abstract": ["Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4).", "Collectively, these data provide key insights into the immunologic determinants and correlates of protection against SARS-CoV-2 and have important implications for the development of vaccines, immune-based therapeutics, and public health strategies.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal."]}
{"doc_id": 29008, "title": "", "abstract": ["Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "These data indicate that relatively low titers of antibodies are sufficient for protection in both the upper and lower respiratory tracts.", "We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques."]}
{"doc_id": 29009, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Here we show that adoptive transfer of purified IgG from convalescent macaques protects naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "These data demonstrate that purified IgG from convalescent macaques, in the absence of cellular and innate immunity, can effectively protect naïve recipient macaques against SARS-CoV-2 challenge in both the upper and lower respiratory tracts in a dose-dependent fashion.", "In the therapeutic adoptive transfer study (N=6), animals were challenged with 1.0×105 TCID50 on day 0 and then received an IV infusion of 250 mg/kg, 25 mg/kg, or 0 mg/kg purified SARS- CoV-2 IgG (N=2/group) on day 1.", "Viral loads following therapeutic adoptive transfer of IgG after SARS-CoV-2 challenge."]}
{"doc_id": 29010, "title": "", "abstract": ["Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "We also observed that protection of convalescent animals against SARS-CoV-2 re-challenge was partially abrogated by CD8 depletion prior to re-challenge.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers."]}
{"doc_id": 29011, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective.", "We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers."]}
{"doc_id": 29012, "title": "", "abstract": ["CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers."]}
{"doc_id": 29013, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1."]}
{"doc_id": 29014, "title": "", "abstract": ["We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "It is possible, however, that the specific NAb threshold for protection identified in the present study (IC50 ∼50) may be model-specific and may be dependent on technical details, such as donor plasma characteristics, challenge virus stock infectivity and inoculum dose, and recipient macaque specifics.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective."]}
{"doc_id": 29015, "title": "", "abstract": ["To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers."]}
{"doc_id": 29016, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques.", "Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Our data provide a key proof-of-concept that antibodies can protect against SARS-CoV-2 challenge in a dose dependent fashion.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1."]}
{"doc_id": 29017, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "The protective efficacy of several SARS-CoV-2 vaccine candidates2–7 and the protective efficacy of natural immunity against re-exposure to SARS-CoV-21 have recently been reported in rhesus macaques.", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "Recent studies have reported protective efficacy of both natural immunity1 and vaccine-induced immunity2–7 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenge in rhesus macaques."]}
{"doc_id": 29018, "title": "", "abstract": ["These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "However, the importance of humoral and cellular immunity for protection against SARS-CoV-2 infection remains to be determined.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1."]}
{"doc_id": 29019, "title": "", "abstract": ["We speculate that NAb titers above a certain threshold are sufficient for protection but that CD8+ T cells may also contribute to protection when NAb titers decline.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "These data indicate that relatively low titers of antibodies are sufficient for protection in both the upper and lower respiratory tracts.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "These data demonstrate that relatively low NAb titers are sufficient to protect against SARS-CoV-2 in rhesus macaques."]}
{"doc_id": 29020, "title": "", "abstract": ["Collectively, these data provide key insights into the immunologic determinants and correlates of protection against SARS-CoV-2 and have important implications for the development of vaccines, immune-based therapeutics, and public health strategies.", "These regression models indicated that pseudovirus NAb titers of approximately 50 (Fig. 2a, ​,d),d), RBD ELISA titers of approximately 100 (Fig. 2b, ​,e),e), and S ELISA titers of approximately 400 (Fig. 2c, ​,f)f) were required for protection.", "The protective efficacy of several SARS-CoV-2 vaccine candidates2–7 and the protective efficacy of natural immunity against re-exposure to SARS-CoV-21 have recently been reported in rhesus macaques.", "Following re-challenge, S-specific IFN-γ+ CD8+ T cell responses were undetectable in the CD8-depleted animals, as expected, but increased in the undepleted sham controls (P=0.0157, two-sided Mann-Whitney test; Extended Data Fig. 7).", "We profiled S-, RBD-, and nucleocapsid (N)-specific antibody responses in the recipient animals by systems serology9,10, as we previously observed diverse Fc functional antibody responses in SARS-CoV-2 infected animals1."]}
{"doc_id": 29021, "title": "", "abstract": ["To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective.", "Viral loads following therapeutic adoptive transfer of IgG after SARS-CoV-2 challenge.", "Our data suggest the importance of SARS-CoV-2 vaccines to induce potent and durable humoral as well as cellular immune responses.", "Viral loads following prophylactic adoptive transfer of IgG prior to SARS- CoV-2 challenge."]}
{"doc_id": 29022, "title": "", "abstract": ["Given the clinical interest in the therapeutic use of convalescent plasma for SARS-CoV-2 infection in humans12,13, we next assessed the therapeutic efficacy of purified IgG in infected rhesus macaques.", "Such high serum NAb titers in recipient macaques likely exceed typical serum NAb titers achieved in human recipients of convalescent human plasma4,17, and thus implications for the clinical use of convalescent plasma for treatment of SARS-CoV-2 infection remain limited.", "In the present study, we show that polyclonal antibodies from convalescent macaques, in the absence of cellular and innate immune responses, protect when administered at an appropriate titer.", "Binding ELISA titers to spike (S) and the receptor binding domain (RBD) similarly showed a titration of antibody titers in the recipient animals on day 0 (Extended Data Fig. 2b, ​,c).c).", "The present data also demonstrate the therapeutic efficacy of convalescent plasma for treatment of SARS-CoV-2 infection, which is currently being explored in clinical trials12,13."]}
{"doc_id": 29023, "title": "", "abstract": ["These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "Mouse-anti-NHP secondary detectors were added (40μL at 0.65μg/mL) for each antibody isotype (IgG1, IgG2, IgG3, IgG4, Nonhuman Primate Reagent Resource) and allowed to bind for an hour.", "However, our data should be interpreted cautiously, because only high serum NAb titers in recipient animals (approximately 500) showed therapeutic efficacy in this model, whereas lower serum NAb titers in recipient animals (approximately 50) did not have detectable efficacy.", "It is possible, however, that the specific NAb threshold for protection identified in the present study (IC50 ∼50) may be model-specific and may be dependent on technical details, such as donor plasma characteristics, challenge virus stock infectivity and inoculum dose, and recipient macaque specifics."]}
{"doc_id": 29024, "title": "", "abstract": ["To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers."]}
{"doc_id": 29025, "title": "", "abstract": ["However, the importance of humoral and cellular immunity for protection against SARS-CoV-2 infection remains to be determined.", "Our data provide a key proof-of-concept that antibodies can protect against SARS-CoV-2 challenge in a dose dependent fashion.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "CD8 depletion in these animals resulted in loss of protection in the upper respiratory tract against SARS-CoV-2 re-challenge, suggesting that CD8+ T cells are likely critical for virologic control if NAb titers are suboptimal or subprotective."]}
{"doc_id": 29026, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "IFN-γ S-specific CD4+ T cell responses assessed by intracellular cytokine staining in non-depleted (Sham) and CD8 depleted (anti-CD8α) rhesus macaques prior to and following SARS-CoV-2 re-challenge.", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "(a) IFN-γ S-specific CD8+ T cell responses assessed by intracellular cytokine staining in non-depleted (Sham) and CD8 depleted (anti-CD8α) rhesus macaques prior to and following SARS-CoV-2 re-challenge."]}
{"doc_id": 29027, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "However, the importance of humoral and cellular immunity for protection against SARS-CoV-2 infection remains to be determined.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers."]}
{"doc_id": 29028, "title": "", "abstract": ["These data demonstrate that relatively low antibody titers are sufficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may also contribute to protection if antibody responses are suboptimal.", "CD8 depletion studies also showed that cellular immunity can contribute to protection against SARS-CoV-2 re-challenge in convalescent macaques with waning antibody titers.", "Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion."]}
{"doc_id": 29029, "title": "", "abstract": ["These regression models indicated that pseudovirus NAb titers of approximately 50 (Fig. 2a, ​,d),d), RBD ELISA titers of approximately 100 (Fig. 2b, ​,e),e), and S ELISA titers of approximately 400 (Fig. 2c, ​,f)f) were required for protection.", "Our data also extend recent studies that have shown that potent RBD-specific monoclonal antibodies can protect against SARS-CoV-2 challenge in macaques15,16.", "Differences in (a) pseudovirus NAb titers, (b) RBD ELISA titer, and (c) S (FLED) ELISA titer between protected and not protected animals.", "These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5.", "(a) Log10 pseudovirus neutralizing antibody (NAb) titers, (b) Log10 S-specific ELISA titers, and (c) Log10 RBD-specific ELISA titers in rhesus macaques following intravenous infusion of 250 mg/kg, 25 mg/kg, 2.5 mg/kg of purified SARS-CoV-2 IgG or sham IgG on day −3."]}
{"doc_id": 29030, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Here we show that adoptive transfer of purified IgG from convalescent macaques protects naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "These data demonstrate that purified IgG from convalescent macaques, in the absence of cellular and innate immunity, can effectively protect naïve recipient macaques against SARS-CoV-2 challenge in both the upper and lower respiratory tracts in a dose-dependent fashion.", "We assessed the protective efficacy of this purified IgG stock in an adoptive transfer study in rhesus macaques.", "We previously reported that 9 rhesus macaques infected with SARS-CoV-2 by the intranasal and intratracheal routes were protected against SARS-CoV-2 re- challenge1."]}
{"doc_id": 22000, "title": "", "abstract": ["Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies."]}
{"doc_id": 22001, "title": "", "abstract": ["In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2)."]}
{"doc_id": 22002, "title": "", "abstract": ["Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."]}
{"doc_id": 22003, "title": "", "abstract": ["Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "The higher expression of ACE2 in African Americans is also noteworthy, because COVID-19 outcomes in African Americans, Africans, or other persons of African descent have not yet been reported in any detail.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes."]}
{"doc_id": 22004, "title": "", "abstract": ["The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene."]}
{"doc_id": 22005, "title": "", "abstract": ["Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity."]}
{"doc_id": 22006, "title": "", "abstract": ["Sputum gene expression of ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) is strongly correlated in both (A) healthy participants and (B) participants with asthma.", "In induced sputum cells collected at the baseline visit, the expression levels of ACE2 were lower than the expression levels of TMPRSS2, and some sputum samples had undetectable ACE2 (Figure 1A).", "In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "To exclude differences in sputum cell differentials as confounders of these findings, sputum cell differentials were added to the list of covariates in the multivariate mixed effects model."]}
{"doc_id": 22007, "title": "", "abstract": ["Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Second, for the corticosteroid results reported here, the data were not generated in a randomized, prospective, or placebo-controlled study.", "The lack of agreement for the effects of inhaled versus systemic corticosteroids and SARS-CoV-2 genes in the SARP-3 cohort may be explained by multiple factors, including the possibility that the time point chosen for assessing the effects of TA on sputum cell gene expression was not optimal for the detection of any effect of TA on ACE2 or TMPRSS2 gene expression in lung cells.", "ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) are statistically significantly lower in patients on inhaled corticosteroids than in the control group of subjects not on inhaled corticosteroids."]}
{"doc_id": 22008, "title": "", "abstract": ["In addition, we hypothesized that corticosteroids, a common treatment for asthma, may affect ACE2 or TMPRSS2 gene expression in sputum cells.", "Among patients with asthma, it is possible that demographic or biological factors influence susceptibility to SARS-CoV-2 infection or severity of COVID-19 disease.", "These findings can inform prospective study of COVID-19 outcomes in specific asthma subgroups, including subgroups taking ICS in different dose strengths.", "Finally, our findings were generated in patients with asthma and should not be extrapolated to patients without asthma without further study.", "Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2)."]}
{"doc_id": 22009, "title": "", "abstract": ["In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "ACE2 and TMPRSS2 expression levels increased slightly with age but were significantly higher in males than in females and in African Americans than in white individuals (Figure 3 and Tables E1 and E2).", "The higher expression of ACE2 that we report in male patients is notable because of the high mortality of COVID-19 in males (1, 5).", "We found that TMPRSS2 gene expression in sputum cells was higher than ACE2 expression and that TMPRSS2 correlated strongly with ACE.", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes."]}
{"doc_id": 22010, "title": "", "abstract": ["In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic."]}
{"doc_id": 22011, "title": "", "abstract": ["The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "ACE2 and TMPRSS2 expression mediate SARS-CoV-2 infection of host lung cells (3), and it is reasonable to infer that increases in their expression in lung cells will increase susceptibility to SARS-CoV-2 infection or lead to more severe COVID-19 disease.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity."]}
{"doc_id": 22012, "title": "", "abstract": ["We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "Hypertension is also a risk factor for COVID-19 morbidity (1), but we did not find increases in ACE2 expression in sputum cells from patients with asthma with and without hypertension.", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes."]}
{"doc_id": 22013, "title": "", "abstract": ["Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."]}
{"doc_id": 22014, "title": "", "abstract": ["In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2).", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene."]}
{"doc_id": 22015, "title": "", "abstract": ["Non–asthma-related factors, such as male sex, African American race, and metabolic disease (diabetes mellitus), may be more important and more generalizable risks for susceptibility to SARS-CoV-2 infection and more severe COVID-19 morbidity.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "We selected covariates in the multivariate mixed effects models on the basis of two categories: covariates hypothesized as susceptibility factors for SARS-CoV-2 infection (age, body mass index, sex, race, diabetes, hypertension, and use of inhaled corticosteroids) and covariates that represented outcomes of asthma control and severity (FEV1% predicted, Asthma Control Test scores, and asthma exacerbations).", "The higher expression of ACE2 that we report in male patients is notable because of the high mortality of COVID-19 in males (1, 5)."]}
{"doc_id": 22016, "title": "", "abstract": ["The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene."]}
{"doc_id": 22017, "title": "", "abstract": ["The S (spike) protein of SARS- CoV-2 binds the ACE1 (angiotensin converting enzyme 2) receptor to mediate virus attachment to host cell membranes, and virus cell entry also depends on S protein priming by host cell proteases, including TMPRSS2 (transmembrane protease, serine 2) (2, 3).", "ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells.", "ACE2 (angiotensin-converting enzyme 2), and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells.", "TMPRSS2 is a transmembrane protease that modifies spike proteins in multiple viruses—including SARS-CoV, SARS-CoV-2, Middle East Respiratory Syndrome–CoV, and influenza A and B—to promote viral infection and spread (3).", "Sputum gene expression of ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) is strongly correlated in both (A) healthy participants and (B) participants with asthma."]}
{"doc_id": 22018, "title": "", "abstract": ["We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "COVID-19–related Genes in Sputum Cells in Asthma.", "Sputum gene expression of ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) is strongly correlated in both (A) healthy participants and (B) participants with asthma."]}
{"doc_id": 22019, "title": "", "abstract": ["Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2).", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene."]}
{"doc_id": 22020, "title": "", "abstract": ["In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "Among patients with asthma, it is possible that demographic or biological factors influence susceptibility to SARS-CoV-2 infection or severity of COVID-19 disease.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity."]}
{"doc_id": 22021, "title": "", "abstract": ["Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "Sputum gene expression of ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) is strongly correlated in both (A) healthy participants and (B) participants with asthma.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2."]}
{"doc_id": 22022, "title": "", "abstract": ["In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "Among patients with asthma, it is possible that demographic or biological factors influence susceptibility to SARS-CoV-2 infection or severity of COVID-19 disease."]}
{"doc_id": 22023, "title": "", "abstract": ["Hypertension is also a risk factor for COVID-19 morbidity (1), but we did not find increases in ACE2 expression in sputum cells from patients with asthma with and without hypertension.", "Coronavirus disease, or COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be more severe in patients with chronic lung disease, including patients with asthma (1).", "Among patients with asthma, it is possible that demographic or biological factors influence susceptibility to SARS-CoV-2 infection or severity of COVID-19 disease.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity."]}
{"doc_id": 22024, "title": "", "abstract": ["ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2).", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity."]}
{"doc_id": 22025, "title": "", "abstract": ["In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."]}
{"doc_id": 22026, "title": "", "abstract": ["Gene expression of ACE2 was lower than TMPRSS2, and expression levels of both genes were similar between subects with asthma and healthy subjects.", "Measurements and Main Results: Gene expression of ACE2 was lower than TMPRSS2, and expression levels of both genes were similar in asthma and health.", "The expression of ACE2 and TMPRSS2 did not differ significantly in health and in asthma (Figures 1A and 1B).", "Sputum gene expression of ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane protease serine 2) is strongly correlated in both (A) healthy participants and (B) participants with asthma.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity."]}
{"doc_id": 22027, "title": "", "abstract": ["Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity."]}
{"doc_id": 28000, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "They also highlight the exacerbation of healthcare disparities from COVID-19 driven by social and economic factors that place certain groups at increased risks for both SUD as well as risk and adverse outcomes from COVID-19."]}
{"doc_id": 28001, "title": "", "abstract": ["Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "They also highlight the exacerbation of healthcare disparities from COVID-19 driven by social and economic factors that place certain groups at increased risks for both SUD as well as risk and adverse outcomes from COVID-19.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "Social adversity is likely to have contributed not only to the higher risk for COVID-19 among patients with SUD but also to the even higher risk among African Americans patients with SUD."]}
{"doc_id": 28002, "title": "", "abstract": ["To the extent that chronic use of tobacco, alcohol and other drugs is associated with cardiovascular (arrhythmias, cardiac insufficiency, and myocardial infarction), pulmonary (COPD, pulmonary hypertension), and metabolic diseases (diabetes, hypertension) [6–10] all of which are risk factors for COVID-19 infection and for worse outcomes [11–13] one can also predict that individuals with SUD including OUD would be at increased risk for adverse COVID-19 outcomes [2].", "Currently there is little research on the effects of other drugs including opioids, cannabis, cocaine and alcohol on the susceptibility to COVID-19 infection and to adverse outcomes [2].", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Preliminary reports regarding higher risk for adverse outcomes with COVID-19 and smoking have been inconclusive [14–16].", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30)."]}
{"doc_id": 28003, "title": "", "abstract": ["Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "Among patients with recent diagnosis of OUD, African Americans had significantly higher risk of COVID-19 than Caucasians (4.162 [3.13–5.533], after adjusting for age, gender, and insurance types (Fig. 2).", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25).", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "Hospitalization rates for COVID-19 patients with a recent diagnosis of SUD were significantly higher for African Americans (53.66%), than for Caucasians (37.70%) (P < 0.0001) (Fig. 3b)."]}
{"doc_id": 28004, "title": "", "abstract": ["Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults.", "Among patients with a recent diagnosis of SUD, seniors were more likely to develop COVID-19 compared to adults (AOR = 1.307 (1.207–1.416]) and African Americans were more likely to develop COVID-19 compared to Caucasians (AOR = 2.173 [2.01–2.349], after adjusting for age, gender and insurance types.", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "Among patients with recent diagnosis of OUD, African Americans had significantly higher risk of COVID-19 than Caucasians (4.162 [3.13–5.533], after adjusting for age, gender, and insurance types (Fig. 2).", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans."]}
{"doc_id": 28005, "title": "", "abstract": ["First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Patients with SUD often have multiple comorbidities, including cardiovascular, pulmonary, metabolic diseases, and increased susceptibility to infections [6–10], which are also risk factors for COVID-19 [11–13].", "In our study, we showed that patients with SUDs has significantly higher prevalence of comorbidities, which are known risk factors for COVID-19, as compared to patients without SUDs."]}
{"doc_id": 28006, "title": "", "abstract": ["Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "These enriched comorbidities in African Americans with SUD could underly their higher susceptibility to COVID-19 and their risk for adverse COVID outcomes along with socioeconomic disparities."]}
{"doc_id": 28007, "title": "", "abstract": ["Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "The AOR between those with lifetime SUD and COVID-19 was 1.459 [1.421–1.499]; for whom, individuals with OUD had the largest risk (AOR = 2.42 [2.247–2.607], followed by cocaine-UD (AOR = 1.57 [1.393–1.77], AUD (AOR = 1.417 [1.335–1.504], and TUD (AOR = 1.332 [1.294–1.372].", "Among patients with SUD subtypes, individuals with OUD had the largest risk (AOR = 10.244 [9.107–11.524]), followed by TUD (AOR = 8.222 ([7.925–8.530]), AUD (AOR = 7.752 [7.04–8.536]), Cocaine-UD (AOR = 6.53 [5.242–8.134]) and CUD (AOR = 5.296 [4.392–6.388]) (Fig. 1a).", "The analyses showed that a recent diagnosis of SUD significantly increased the risk of COVID-19 that was highest for recent diagnosis of OUD followed by TUD, AUD and Cocaine-UD, and lowest for CUD.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25)."]}
{"doc_id": 28008, "title": "", "abstract": ["Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Among patients with recent diagnosis of OUD, African Americans had significantly higher risk of COVID-19 than Caucasians (4.162 [3.13–5.533], after adjusting for age, gender, and insurance types (Fig. 2).", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25)."]}
{"doc_id": 28009, "title": "", "abstract": ["Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes.", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults.", "We examined prevalence of known COVID-19 risk factors among African Americans and Caucasians with recent diagnosis of SUD (and its subtypes)."]}
{"doc_id": 28010, "title": "", "abstract": ["Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes.", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "Social adversity is likely to have contributed not only to the higher risk for COVID-19 among patients with SUD but also to the even higher risk among African Americans patients with SUD.", "We examined prevalence of known COVID-19 risk factors among African Americans and Caucasians with recent diagnosis of SUD (and its subtypes)."]}
{"doc_id": 28011, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "To the extent that chronic use of tobacco, alcohol and other drugs is associated with cardiovascular (arrhythmias, cardiac insufficiency, and myocardial infarction), pulmonary (COPD, pulmonary hypertension), and metabolic diseases (diabetes, hypertension) [6–10] all of which are risk factors for COVID-19 infection and for worse outcomes [11–13] one can also predict that individuals with SUD including OUD would be at increased risk for adverse COVID-19 outcomes [2].", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "In our study, we showed that patients with SUDs has significantly higher prevalence of comorbidities, which are known risk factors for COVID-19, as compared to patients without SUDs.", "Individuals with OUD had the greatest risk for COVID-19 among patients with SUD (Fig. 1) but they did not have more comorbidities (known COVID-19 risk factors) than those with other SUDs."]}
{"doc_id": 28012, "title": "", "abstract": ["Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "Hospitalization rates for COVID-19 patients with a recent diagnosis of SUD were significantly higher for African Americans (53.66%), than for Caucasians (37.70%) (P < 0.0001) (Fig. 3b).", "To the extent that chronic use of tobacco, alcohol and other drugs is associated with cardiovascular (arrhythmias, cardiac insufficiency, and myocardial infarction), pulmonary (COPD, pulmonary hypertension), and metabolic diseases (diabetes, hypertension) [6–10] all of which are risk factors for COVID-19 infection and for worse outcomes [11–13] one can also predict that individuals with SUD including OUD would be at increased risk for adverse COVID-19 outcomes [2].", "Among 12,030 COVID-19 patients, 3620 were hospitalized (30.09%) and the rate was significantly higher among the African Americans (35.56%) than the Caucasians (26.36%) (P < 0.0001).", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes."]}
{"doc_id": 28013, "title": "", "abstract": ["The status of COVID-19 was based on the concept “Coronavirus infection (disorder)” (SNOMED- CT Concept Code 186747009) and we further limited the diagnosis time frame to within the past year to capture the timing of new cases arising during the COVID-19 pandemic.", "Currently, there is little if any quantitative analysis of the risks and outcomes for COVID-19 infection in individuals suffering from an OUD and those suffering from other substance use in the US.", "This is a retrospective case- control study of electronic health records (EHRs) data of 73,099,850 unique patients, of whom 12,030 had a diagnosis of COVID-19.", "COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States", "Among 1880 COVID-19 patients with lifetime SUD, 770 were hospitalized (40.96%), a rate significantly higher than for all COVID-19 patients (30.09%) (P < 0.0001) and also significantly higher among the African Americans (50.65%) than the Caucasians (35.24%) (P < 0.0001)."]}
{"doc_id": 28014, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "Patients with recent SUD diagnosis had significantly higher risk of developing COVID-19 compared to patients without recent SUD diagnosis, after adjusting for age, gender, race, and insurance types.", "Patients with both SUD and COVID-19 also had significantly worse outcomes (death, hospitalization) than general COVID-19 patients."]}
{"doc_id": 28015, "title": "", "abstract": ["First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30)."]}
{"doc_id": 28016, "title": "", "abstract": ["These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "Individuals with OUD had the greatest risk for COVID-19 among patients with SUD (Fig. 1) but they did not have more comorbidities (known COVID-19 risk factors) than those with other SUDs.", "Patients with recent SUD diagnosis had significantly higher risk of developing COVID-19 compared to patients without recent SUD diagnosis, after adjusting for age, gender, race, and insurance types.", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians."]}
{"doc_id": 28017, "title": "", "abstract": ["Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "Among 1050 COVID-19 patients with recent diagnosis of SUD, 100 died (9.52%), a rate significantly higher than that for general COVID-19 patients (P = 0.003) and similar to that for COVID-19 patients with lifetime SUD (9.57%).", "The analyses showed that a recent diagnosis of SUD significantly increased the risk of COVID-19 that was highest for recent diagnosis of OUD followed by TUD, AUD and Cocaine-UD, and lowest for CUD.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25)."]}
{"doc_id": 28018, "title": "", "abstract": ["Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25).", "Individuals with OUD had the greatest risk for COVID-19 among patients with SUD (Fig. 1) but they did not have more comorbidities (known COVID-19 risk factors) than those with other SUDs.", "Patients with recent diagnosis of OUD had higher risk of COVID-19 than other SUD subtypes, however, the prevalence of risk factors for COVID-19 was not higher than for other SUD subtypes."]}
{"doc_id": 28019, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "The analyses showed that a recent diagnosis of SUD significantly increased the risk of COVID-19 that was highest for recent diagnosis of OUD followed by TUD, AUD and Cocaine-UD, and lowest for CUD.", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "In summary, our findings at a macroscopic level provide evidence that SUD should be considered a condition that increases risk for COVID-19, a comorbidity that has particularly deleterious effects to African Americans.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support."]}
{"doc_id": 28020, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations)."]}
{"doc_id": 28021, "title": "", "abstract": ["Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30).", "Among 1,880 COVID-19 patients with lifetime SUD, 180 died (9.57%), a rate significantly higher than the death rate of 6.57% for all COVID-19 patients (P < 0.0001).", "Among 1050 COVID-19 patients with recent diagnosis of SUD, 100 died (9.52%), a rate significantly higher than that for general COVID-19 patients (P = 0.003) and similar to that for COVID-19 patients with lifetime SUD (9.57%).", "Patients with lifetime SUD diagnosis had significantly higher risk of developing COVID-19 compared to patients without SUD, after adjusting for age, gender, race, and insurance types.", "In our study, we showed that patients with SUDs has significantly higher prevalence of comorbidities, which are known risk factors for COVID-19, as compared to patients without SUDs."]}
{"doc_id": 28022, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "Second, due to limited sample sizes for COVID-19 cases among patients with SUD (1880 cases for all SUD and 210 for OUD), the large number of SUD-associated comorbidities, as well as inter-dependency among comorbidities (e.g., diabetes, hypertension, and obesity), we are currently unable to control for these comorbidities as well as their associated medications, behaviors and other socioeconomic factors in order to assess the direct effects of addictive drugs or of SUD as a disease entity on COVID-19 risk.", "Social adversity is likely to have contributed not only to the higher risk for COVID-19 among patients with SUD but also to the even higher risk among African Americans patients with SUD.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support."]}
{"doc_id": 28023, "title": "", "abstract": ["Finally, our findings also underscore the importance of providing support for the treatment and recovery of individuals with SUD as part of the strategy to control the COVID pandemic.", "Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "However, the prevalence of known risk factor for COVID-19 among patients with OUD was not higher than patients with other types of SUD."]}
{"doc_id": 28024, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "The global pandemic of COVID-19 is colliding with the epidemic of opioid use disorders (OUD) and other substance use disorders (SUD) in the United States (US).", "COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States", "Currently there is little research on the effects of other drugs including opioids, cannabis, cocaine and alcohol on the susceptibility to COVID-19 infection and to adverse outcomes [2].", "The global pandemic of COVID-19 is colliding in the United States (US) with the epidemic of opioid use disorders (OUD) and overdose mortality [2–4]."]}
{"doc_id": 28025, "title": "", "abstract": ["Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians, an effect that was strongest for African Americans with OUD and they also had worse outcomes (death and hospitalizations).", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "Among patients with recent diagnosis of SUD, African Americans had significantly higher risk of COVID-19 than Caucasians (AOR = 2.173 [2.01–2.349], P < 10−30), with strongest effect for OUD (AOR = 4.162 [3.13–5.533], P < 10−25)."]}
{"doc_id": 32000, "title": "", "abstract": ["Furthermore, social isolation has deleterious impacts on mental wellness (2).", "PA, physical activity.", "Sedentary leisure behaviors increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001).", "Temporary closure to places of employment, restaurants, fitness facilities, and other public places has forced abrupt changes to habitual dietary and physical activity patterns.", "Leisure sedentary behaviors increased more on weekdays compared with weekend days."]}
{"doc_id": 32001, "title": "", "abstract": ["An increase in healthy snacking was reported by 25.8% of participants, whereas 43.5% reported an increase in unhealthy snacking.", "Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Reported negative eating behavior changes included increased consumption of sweets and sugar‐sweetened beverages.", "To assess changes in dietary behaviors, the short form included items on cooking and eating out habits as well as snacking prior to and during the pandemic.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food."]}
{"doc_id": 32002, "title": "", "abstract": ["Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "Participant characteristics for respondents who reported eating less healthy, more healthy, and no change in health quality of diet from the start of the COVID‐19 pandemic.", "Participants were asked the frequency of engaging in eight unhealthful dietary behaviors for an average week before the COVID‐19 outbreak and again since the COVID‐19 outbreak.", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19."]}
{"doc_id": 32003, "title": "", "abstract": ["Reported negative eating behavior changes included increased consumption of sweets and sugar‐sweetened beverages.", "Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic."]}
{"doc_id": 32004, "title": "", "abstract": ["Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "By contrast, 17.3% of participants reported losing weight, which was consistent across BMI groups (obesity: 18.0%; overweight: 18.0%; normal weight: 17.8%).", "Approximately one‐third of the participants had normal weight (32.2%), overweight (32.1%), and obesity (34.0%).", "In total, 7,753 participants were included; 32.2% of the sample were individuals with normal weight, 32.1% had overweight, and 34.0% had obesity."]}
{"doc_id": 32005, "title": "", "abstract": ["Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "With the government‐mandated stay‐at‐home orders, individuals with obesity had the largest increase to healthy eating behaviors (1.13 [0.08] compared with 0.67 [0.08] and 0.83 [0.08] for normal weight and overweight, respectively, P < 0.001).", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001)."]}
{"doc_id": 32006, "title": "", "abstract": ["Scores ranged from 8 to 24, with a higher cumulative score indicative of a healthier diet.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Overall, scores for healthy eating have increased.", "Although the current survey does not capture diet composition per se, individuals reported a combination of positive and negative changes in eating behaviors."]}
{"doc_id": 32007, "title": "", "abstract": ["This finding is confirmed by a report from Hunter Food and Beverage Communications, who surveyed 1,005 individuals living in the US and showed that 54% of individuals reported cooking more frequently since the start of the pandemic (10).", "During the pandemic, overall scores for healthy eating increased (P < 0.001), owing to less eating out and increased cooking (P < 0.001).", "The COVID‐19 pandemic has produced significant health effects, well beyond the virus itself.", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D)."]}
{"doc_id": 32008, "title": "", "abstract": ["Government mandates together with fear of contracting the virus have significantly impacted lifestyle behaviors alongside declines in mental health.", "Furthermore, social isolation has deleterious impacts on mental wellness (2).", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "Increased anxiety has been observed after other extreme natural disasters (12, 13), highlighting the equivalent impact of the pandemic on mental health.", "This study assessed lifestyle changes across different BMI classifications in response to the global pandemic."]}
{"doc_id": 32009, "title": "", "abstract": ["To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "Responses for pre‐COVID 19 behaviors as well as behaviors during the stay‐at‐home orders for diet, sedentary behaviors, physical activity, mental health, and sleep are presented in Table 1."]}
{"doc_id": 32010, "title": "", "abstract": ["Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "By contrast, 17.3% of participants reported losing weight, which was consistent across BMI groups (obesity: 18.0%; overweight: 18.0%; normal weight: 17.8%).", "Approximately one‐third of the participants had normal weight (32.2%), overweight (32.1%), and obesity (34.0%).", "In total, 7,753 participants were included; 32.2% of the sample were individuals with normal weight, 32.1% had overweight, and 34.0% had obesity."]}
{"doc_id": 32011, "title": "", "abstract": ["Declines in healthful eating behaviors were coincident with reductions in physical activity, and these negative behaviors were characteristic of individuals reporting weight gain in response to the pandemic outbreak.", "A perceived shift toward unhealthy eating was accompanied by increases in sedentary behaviors, declines in physical activity, a later sleep onset time, and nearly twice the increase in reported anxiety compared with those eating healthier.", "Respondents who reported weight gain had little change in eating behaviors but demonstrated the largest declines in physical activity.", "Declines to physical activity were less for participants residing in the US compared with outside of the US (Supporting Information Table S1).", "Our study provides additional evidence that declines in physical activity are characterized by a shift toward lower‐intensity activities."]}
{"doc_id": 32012, "title": "", "abstract": ["Physical activity (Figures 2B‐2C) declined 18.32 (4.63) min/wk and, after accounting for exercise intensity, declined by 111.88 (22.07) weekly MET minutes (both P < 0.001).", "Metabolic equivalents (METs) for physical activities from the survey were chosen from the Compendium of Physical Activities (7).", "Mean reported physical activity levels prior to the pandemic were 348.06 (6.09) min/wk (1,453.40 [29.96] MET minutes) and during the pandemic were 329.74 (6.19) min/wk (1,341.52 [29.80] MET minutes).", "All analyses were set as α ≤ 0.05 as the predetermined level of significance.", "Intensity‐adjusted physical activity was computed by multiplying the time spent in each activity by the corresponding MET value."]}
{"doc_id": 32013, "title": "", "abstract": ["Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "Reports from people with obesity show that they are differentially affected, showing both the greatest improvements to unhealthful dietary behaviors as well as the sharpest declines in mental health and the highest incidence of weight gain as a result of stay‐at‐home orders.", "This study is the first to survey thousands of people across the globe on lifestyle behavior changes in response to stay‐at‐home orders.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001)."]}
{"doc_id": 32014, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Overall, scores for healthy eating have increased.", "The REAP‐s increased (0.81 [0.04], P < 0.001), indicating overall healthier eating.", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders."]}
{"doc_id": 32015, "title": "", "abstract": ["Reports from people with obesity show that they are differentially affected, showing both the greatest improvements to unhealthful dietary behaviors as well as the sharpest declines in mental health and the highest incidence of weight gain as a result of stay‐at‐home orders.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "With the government‐mandated stay‐at‐home orders, individuals with obesity had the largest increase to healthy eating behaviors (1.13 [0.08] compared with 0.67 [0.08] and 0.83 [0.08] for normal weight and overweight, respectively, P < 0.001).", "With increased cases of weight gain and significant declines to mental health, COVID‐19 may impact clinical practice for years to come."]}
{"doc_id": 32016, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages."]}
{"doc_id": 32017, "title": "", "abstract": ["During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "In total, 7,753 participants were included; 32.2% of the sample were individuals with normal weight, 32.1% had overweight, and 34.0% had obesity.", "Approximately one‐third of the participants had normal weight (32.2%), overweight (32.1%), and obesity (34.0%).", "By contrast, 17.3% of participants reported losing weight, which was consistent across BMI groups (obesity: 18.0%; overweight: 18.0%; normal weight: 17.8%)."]}
{"doc_id": 32018, "title": "", "abstract": ["Although validated instruments were used as availability allowed, investigator‐created questions were necessary to capture the current unique environment.", "All data were self‐reported using a combination of validated questionnaires with minor modifications, together with investigator‐created questions unique to the survey aims and pandemic.", "Deidentified data were collected using Research Electronic Data Capture (REDCap) (4).", "Participants were required to complete the short form but could provide more detailed responses using the long form instrument if desired.", "All authors participated in data interpretation."]}
{"doc_id": 32019, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages."]}
{"doc_id": 32020, "title": "", "abstract": ["Overall anxiety significantly increased (8.78 [0.21], P < 0.001), and 20% of participants reported symptomatic anxiety, an increase of 14% compared with before the pandemic.", "Anxiety scores increased 8.78 ± 0.21 during the pandemic, and the magnitude of increase was significantly greater in people with obesity (P ≤ 0.01).", "Symptomatic anxiety was not different between BMI subgroups before the pandemic (P = 0.06), but it was significantly higher in participants with obesity (24%) compared with normal weight (17%) and overweight (17%) during (P < 0.001) the pandemic.", "Reported anxiety scores nearly doubled in response to the pandemic, and 20% of the sample reported that symptoms were severe enough to interfere with daily routines.", "Individuals with obesity reported significantly higher anxiety before the pandemic compared with participants with normal weight and overweight (10.43 [0.31] vs. 8.99 [0.32] and 8.14 [0.32], respectively P < 0.001)."]}
{"doc_id": 32021, "title": "", "abstract": ["EWF and RAB analyzed the data.", "Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "Sedentary leisure behaviors increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001).", "Respondents who reported weight gain had little change in eating behaviors but demonstrated the largest declines in physical activity.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001)."]}
{"doc_id": 32022, "title": "", "abstract": ["Behaviors during the pandemic were assessed sequentially by using the phrase “since the COVID‐19 outbreak in your country or region.”", "In total, 12,476 individuals provided consent, and 7,753 individuals completed the first COVID‐19 question and were therefore included in the analysis (Figure 1).", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19.", "The COVID‐19 pandemic therefore has the potential to also threaten noncommunicable diseases such as obesity.", "Importantly, because many of the responses to questions about pre‐pandemic behaviors significantly differed from perceived behaviors during COVID‐19, we can assume that individuals recognize changes to their own behavior and emotions, to some extent."]}
{"doc_id": 32023, "title": "", "abstract": ["Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "Approximately one‐third of the participants had normal weight (32.2%), overweight (32.1%), and obesity (34.0%).", "Respondents who reported weight gain had little change in eating behaviors but demonstrated the largest declines in physical activity.", "With the government‐mandated stay‐at‐home orders, individuals with obesity had the largest increase to healthy eating behaviors (1.13 [0.08] compared with 0.67 [0.08] and 0.83 [0.08] for normal weight and overweight, respectively, P < 0.001)."]}
{"doc_id": 32024, "title": "", "abstract": ["Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "For the most represented countries outside the US (e.g., Canada, the UK, Australia, and Ireland), large cities and capitol regions were all under government‐enforced social distance or stay‐at‐home orders at the opening of this study.", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "This study is the first to survey thousands of people across the globe on lifestyle behavior changes in response to stay‐at‐home orders.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders."]}
{"doc_id": 32025, "title": "", "abstract": ["Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "During the pandemic, overall scores for healthy eating increased (P < 0.001), owing to less eating out and increased cooking (P < 0.001).", "With the government‐mandated stay‐at‐home orders, individuals with obesity had the largest increase to healthy eating behaviors (1.13 [0.08] compared with 0.67 [0.08] and 0.83 [0.08] for normal weight and overweight, respectively, P < 0.001).", "This finding is confirmed by a report from Hunter Food and Beverage Communications, who surveyed 1,005 individuals living in the US and showed that 54% of individuals reported cooking more frequently since the start of the pandemic (10).", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001)."]}
{"doc_id": 32026, "title": "", "abstract": ["Sedentary leisure behaviors increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001).", "Leisure sedentary behaviors increased more on weekdays compared with weekend days.", "Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "A perceived shift toward unhealthy eating was accompanied by increases in sedentary behaviors, declines in physical activity, a later sleep onset time, and nearly twice the increase in reported anxiety compared with those eating healthier.", "Leisure sedentary activities increased by 16.83 (0.84) minutes (P < 0.001) and 21.25 (0.90) minutes (P < 0.001) on weekend days and weekdays, respectively."]}
{"doc_id": 32027, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages."]}
{"doc_id": 32028, "title": "", "abstract": ["Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19.", "During the pandemic, overall scores for healthy eating increased (P < 0.001), owing to less eating out and increased cooking (P < 0.001).", "With the government‐mandated stay‐at‐home orders, individuals with obesity had the largest increase to healthy eating behaviors (1.13 [0.08] compared with 0.67 [0.08] and 0.83 [0.08] for normal weight and overweight, respectively, P < 0.001).", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001)."]}
{"doc_id": 32029, "title": "", "abstract": ["A perceived shift toward unhealthy eating was accompanied by increases in sedentary behaviors, declines in physical activity, a later sleep onset time, and nearly twice the increase in reported anxiety compared with those eating healthier.", "Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "### Sedentary and physical activity", "Sedentary leisure behaviors increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001).", "Reported negative eating behavior changes included increased consumption of sweets and sugar‐sweetened beverages."]}
{"doc_id": 32030, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Outcome|  n | Pre| During|  P value   ---|---|---|---|---   Dietary behaviors short form | | | |   Eating meals from restaurants or consuming prepared food (n) | 5,362| 2.0 ± 0.0| 1.1 ± 0.0| < 0.001   Cooking dinners at home (n) | 5,360| 4.5 ± 0.0| 5.2 ± 0.0| < 0.001   Dietary behaviors long form | | | |   REAP‐s total (score) | 4,071| 18.3 ± 0.1| 19.1 ± 0.0| < 0.001   Frequency of breakfast skipping (score) | 4,066| 2.2 ± 0.0| 2.3 ± 0.0| < 0.001   Frequency of eating four or meals from a restaurant (score) | 4,066| 2.5 ± 0.0| 2.8 ± 0.0| < 0.001   Frequency of eating two or more meals from fast food (score) | 4,065| 2.5 ± 0.0| 2.7 ± 0.0| < 0.001   Frequency of eating fried foods (score) | 4,062| 2.3 ± 0.0| 2.5 ± 0.0| < 0.001   Frequency of drinking sugar‐sweetened beverages (score) | 4,063| 2.3 ± 0.0| 2.4 ± 0.0| 0.0004   Frequency of eating sweets or desserts (score) | 4,063| 2.0 ± 0.0| 1.9 ± 0.0| < 0.001   Frequency of eating less than two servings of fruit per day (score) | 4,067| 2.0 ± 0.0| 2.1 ± 0.7| < 0.001   Frequency of eating less than two servings of vegetables per day (score) | 4,067| 2.2 ± 0.0| 2.3 ± 0.7| 0.42", "Declines in healthful eating behaviors were coincident with reductions in physical activity, and these negative behaviors were characteristic of individuals reporting weight gain in response to the pandemic outbreak."]}
{"doc_id": 32031, "title": "", "abstract": ["For sedentary activity, changes in sedentary leisure behaviors (such as watching television, using the phone for entertainment, and playing video games) on weekdays and weekend days were assessed.", "Leisure sedentary behaviors increased more on weekdays compared with weekend days.", "Leisure sedentary activities increased by 16.83 (0.84) minutes (P < 0.001) and 21.25 (0.90) minutes (P < 0.001) on weekend days and weekdays, respectively.", "For weekend days, 194.84 (1.56) min/d were spent in sedentary leisure behaviors, which rose to 211.66 (1.11) min/d during the pandemic.", "Mean reported times spent in leisure sedentary behaviors on weekdays were 169.55 (1.16) min/d prior to the pandemic and 190.79 (1.15) min/d during the pandemic."]}
{"doc_id": 32032, "title": "", "abstract": ["Reported negative eating behavior changes included increased consumption of sweets and sugar‐sweetened beverages.", "An increase in healthy snacking was reported by 25.8% of participants, whereas 43.5% reported an increase in unhealthy snacking.", "Furthermore, social isolation has deleterious impacts on mental wellness (2).", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages.", "This finding is confirmed by a report from Hunter Food and Beverage Communications, who surveyed 1,005 individuals living in the US and showed that 54% of individuals reported cooking more frequently since the start of the pandemic (10)."]}
{"doc_id": 32033, "title": "", "abstract": ["Sleep onset and wake times before and during COVID‐19 were presented as time in hours and minutes in 5‐minute increments.", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19.", "For weekend days, 194.84 (1.56) min/d were spent in sedentary leisure behaviors, which rose to 211.66 (1.11) min/d during the pandemic.", "With increased cases of weight gain and significant declines to mental health, COVID‐19 may impact clinical practice for years to come.", "Mean reported physical activity levels prior to the pandemic were 348.06 (6.09) min/wk (1,453.40 [29.96] MET minutes) and during the pandemic were 329.74 (6.19) min/wk (1,341.52 [29.80] MET minutes)."]}
{"doc_id": 32034, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders.", "The topics included the following: breakfast skipping; consuming less than two fruits and vegetables per day; eating four or more meals from a sit‐down or takeout restaurant; eating fast food two or more times; eating fried foods; eating sweets, and desserts; and drinking more than 16 ounces of sugar‐sweetened beverages."]}
{"doc_id": 32035, "title": "", "abstract": ["Weight gain was reported in 27.5% of the total sample compared with 33.4% in participants with obesity.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001).", "Nonscientific reports have begun to illustrate the impacts of weight gain throughout the pandemic.", "Symptomatic anxiety was not different between BMI subgroups before the pandemic (P = 0.06), but it was significantly higher in participants with obesity (24%) compared with normal weight (17%) and overweight (17%) during (P < 0.001) the pandemic.", "Declines in healthful eating behaviors were coincident with reductions in physical activity, and these negative behaviors were characteristic of individuals reporting weight gain in response to the pandemic outbreak."]}
{"doc_id": 32036, "title": "", "abstract": ["To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "The COVID‐19 pandemic has produced significant health effects, well beyond the virus itself.", "Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "Behaviors during the pandemic were assessed sequentially by using the phrase “since the COVID‐19 outbreak in your country or region.”"]}
{"doc_id": 32037, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Although the current survey does not capture diet composition per se, individuals reported a combination of positive and negative changes in eating behaviors.", "A perceived shift toward unhealthy eating was accompanied by increases in sedentary behaviors, declines in physical activity, a later sleep onset time, and nearly twice the increase in reported anxiety compared with those eating healthier.", "During the stay‐at‐home orders, 27.3% of the sample reported weight gain, and weight gain was more prevalent with obesity compared with overweight and normal weight (33.4% vs. 20.5% and 24.7%, respectively, P < 0.001)."]}
{"doc_id": 32038, "title": "", "abstract": ["The study was open between April 3, 2020, and May 3, 2020.", "The delivery of the survey was intentionally set to capture behavioral changes in response to the initial phase of the pandemic, and at the time the study opened (April 3, 2020), 41 of the 50 US states were following a statewide stay‐at‐home order.", "The online survey targeting adults was distributed in April 2020 and collected information on dietary behaviors, physical activity, and mental health.", "These disproportionate increases could be attributed to changes in structured workdays, time gained from ceasing a workplace commute, or a replacement of other forms of entertainment that would typically occur outside the home.", "The findings of the entire study sample did not differ from a subsample restricted to the US alone."]}
{"doc_id": 32039, "title": "", "abstract": ["Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "Stay‐at‐home orders in response to the coronavirus disease 2019 (COVID‐19) pandemic have forced abrupt changes to daily routines.", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "Declines in healthful eating behaviors were coincident with reductions in physical activity, and these negative behaviors were characteristic of individuals reporting weight gain in response to the pandemic outbreak.", "This study is the first to survey thousands of people across the globe on lifestyle behavior changes in response to stay‐at‐home orders."]}
{"doc_id": 32040, "title": "", "abstract": ["To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "This provides evidence that behavioral and emotional changes in response to the COVID‐19 pandemic are indeed of global concern.", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "Participants were asked the frequency of engaging in eight unhealthful dietary behaviors for an average week before the COVID‐19 outbreak and again since the COVID‐19 outbreak."]}
{"doc_id": 32041, "title": "", "abstract": ["PA, physical activity.", "As individuals across the globe have become confined to their homes, daily work and household responsibilities have shifted.", "However, these changes are likely attributable to overall lower levels of physical activity of participants residing in the US prior to the pandemic.", "White | 27.1| 17.1| 45.8| 10.1|   Other | 28.9| 19.4| 42.4| 9.3|   Country (%) | | | | | < 0.001   US | 24.4| 18.8| 47.8| 9.0|   Other | 33.6| 24.4| 39.8| 12.6|   Working from home because of COVID‐19 (%) | 29.5| 34.3| 32.0| 25.6| < 0.001   Laid off because of COVID‐19 (%) | 19.4| 15.6| 12.1| 15.5| < 0.001   Change to REAP‐s (total score) | 0.00 ± 0.08| 1.83 ± 0.10| 0.91 ± 0.06| 0.77 ± 0.14| < 0.001   Change in PA (min) | −70.76 ± 9.01| 24.54 ± 11.20| 3.58 ± 6.93| −42.3 ± 15.56| < 0.001   Change in PA (intensity‐adjusted min) | −322.89 ± 42.98| 55.59 ± 53.43| −12.00 ± 33.08| −243.7 ± 74.23| < 0.001   Change to sedentary behaviors (min per weekday) | 27.6 ± 1.99| 21.95 ± 2.32| 16.85 ± 1.31| 19.29 ± 3.18| < 0.001   Change to sedentary behaviors (min per weekend day) | 21.58 ± 1.88| 15.55 ± 2.13| 14.44 ± 1.24| 15.64 ± 2.73| 0.009   Change in sleep onset (min) | 56.82 ± 3.29| 42.04 ± 4.49| 33.54 ± 2.09| 44.54 ± 5.08| < 0.001   Change in sleep wake (min) | 69.46 ± 4.41| 63.68 ± 5.35| 52.45 ± 3.00| 55.78 ± 6.59| 0.008   Change in GAD‐7 anxiety score | 12.37 ± 0.45| 9.32 ± 0.54| 6.52 ± 0.28| 8.12 ± 0.69| < 0.001", "### How might these results change the focus of clinical practice?"]}
{"doc_id": 32042, "title": "", "abstract": ["Eating meals from restaurants and consuming preprepared food declined from 1.98 times per week to 1.08 times per week (P < 0.001), while cooking meals at home increased from 4.49 to 5.18 days per week (P < 0.001).", "Stay‐at‐home orders in response to the coronavirus disease 2019 (COVID‐19) pandemic have forced abrupt changes to daily routines.", "This finding is confirmed by a report from Hunter Food and Beverage Communications, who surveyed 1,005 individuals living in the US and showed that 54% of individuals reported cooking more frequently since the start of the pandemic (10).", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19."]}
{"doc_id": 32043, "title": "", "abstract": ["The reported decline in physical activity is supported by objective data from Fitbit, Inc, whose monitor data detected a 7%‐38% decline globally since the start of the pandemic (11).", "Declines in healthful eating behaviors were coincident with reductions in physical activity, and these negative behaviors were characteristic of individuals reporting weight gain in response to the pandemic outbreak.", "However, these changes are likely attributable to overall lower levels of physical activity of participants residing in the US prior to the pandemic.", "Mean reported physical activity levels prior to the pandemic were 348.06 (6.09) min/wk (1,453.40 [29.96] MET minutes) and during the pandemic were 329.74 (6.19) min/wk (1,341.52 [29.80] MET minutes).", "Despite individuals with obesity having lower physical activity than individuals with normal weight and overweight before the pandemic, the change in physical activity did not differ between BMI groups (both P > 0.05)."]}
{"doc_id": 32044, "title": "", "abstract": ["To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "Responses for pre‐COVID 19 behaviors as well as behaviors during the stay‐at‐home orders for diet, sedentary behaviors, physical activity, mental health, and sleep are presented in Table 1."]}
{"doc_id": 32045, "title": "", "abstract": ["For sedentary activity, changes in sedentary leisure behaviors (such as watching television, using the phone for entertainment, and playing video games) on weekdays and weekend days were assessed.", "Leisure sedentary behaviors increased more on weekdays compared with weekend days.", "Leisure sedentary activities increased by 16.83 (0.84) minutes (P < 0.001) and 21.25 (0.90) minutes (P < 0.001) on weekend days and weekdays, respectively.", "For weekend days, 194.84 (1.56) min/d were spent in sedentary leisure behaviors, which rose to 211.66 (1.11) min/d during the pandemic.", "Mean reported times spent in leisure sedentary behaviors on weekdays were 169.55 (1.16) min/d prior to the pandemic and 190.79 (1.15) min/d during the pandemic."]}
{"doc_id": 32046, "title": "", "abstract": ["Eating behaviors were significantly changed with COVID‐19 (Figure 2A).", "The COVID‐19 pandemic disproportionally affected health behaviors of individuals with obesity (Figures 2A‐2D).", "This provides evidence that behavioral and emotional changes in response to the COVID‐19 pandemic are indeed of global concern.", "Participant characteristics for respondents who reported eating less healthy, more healthy, and no change in health quality of diet from the start of the COVID‐19 pandemic.", "Behaviors during the pandemic were assessed sequentially by using the phrase “since the COVID‐19 outbreak in your country or region.”"]}
{"doc_id": 32047, "title": "", "abstract": ["These disproportionate increases could be attributed to changes in structured workdays, time gained from ceasing a workplace commute, or a replacement of other forms of entertainment that would typically occur outside the home.", "Sedentary leisure behaviors increased, while time spent in physical activity (absolute time and intensity adjusted) declined (P < 0.001).", "A perceived shift toward unhealthy eating was accompanied by increases in sedentary behaviors, declines in physical activity, a later sleep onset time, and nearly twice the increase in reported anxiety compared with those eating healthier.", "Mean reported times spent in leisure sedentary behaviors on weekdays were 169.55 (1.16) min/d prior to the pandemic and 190.79 (1.15) min/d during the pandemic.", "Not surprisingly, those who reported weight loss had improvements in their healthy eating score, increases to physical activity, and a blunted increase in sedentary behaviors."]}
{"doc_id": 32048, "title": "", "abstract": ["The delivery of the survey was intentionally set to capture behavioral changes in response to the initial phase of the pandemic, and at the time the study opened (April 3, 2020), 41 of the 50 US states were following a statewide stay‐at‐home order.", "The study was open between April 3, 2020, and May 3, 2020.", "The online survey targeting adults was distributed in April 2020 and collected information on dietary behaviors, physical activity, and mental health.", "All data were self‐reported using a combination of validated questionnaires with minor modifications, together with investigator‐created questions unique to the survey aims and pandemic.", "The findings of the entire study sample did not differ from a subsample restricted to the US alone."]}
{"doc_id": 23000, "title": "", "abstract": ["Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Given the disproportionate burden of severe COVID-19 disease and death in older adults, it is important to understand mechanisms that underlie this age- related vulnerability.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults."]}
{"doc_id": 23001, "title": "", "abstract": ["Therefore, age-associated weaker type 1 IFN responses coupled with direct viral suppression could serve as a critical innate immune mechanism that leads to poor cell mediated immunity and increased vulnerability of older adults to SARS-CoV-2 infection with therapeutic implication (Sallard et al., 2020).", "Although age-related change in innate and adaptive immunity against SARS-CoV-2 infection are yet to be investigated in detail, its impairment and dysregulation in older adults can be inferred.", "On the other hand, children with COVID-19 manifested lower levels of T cell activation than adult COVID-19 patients (Moratto et al., 2020), suggesting better immune system control and regulation in response to SARS-CoV-2 infection in children.", "Insights into children’s defense mechanisms against SARS-CoV-2 infection may shed light on age-related vulnerability in older adults from a different perspective.", "Studies aimed at defining factors that impact the quality and titer of antibody, including SARS-CoV-2 neutralization reveal that older age, male sex, and hospitalization with severe COVID-19 are all factors that contribute to greater antiviral antibody responses against SARS-CoV-2 (Klein et al., 2020)."]}
{"doc_id": 23002, "title": "", "abstract": ["We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Age-related immune system remodeling, or immunosenescence, is considered to be the major reason for increased susceptibility to infection, particularly respiratory infections such as influenza, as well as impaired immune responses to vaccination (Li et al., 2011; Pawelec, 2018).", "Zhang and colleagues suggest aberrant CD8 T cell activation as a potential mechanism for cardiac injury in severe COVID-19 (Zhang et al., 2020c).", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Th17 activation is also believed to play a role in contributing to cytokine storm in severe COVID-19, suppression of which is proposed to be a mechanism underlying anti-IL-6R therapy (Lagunas-Rangel and Chavez-Valencia, 2020) and other immunotherapies (Wu and Yang, 2020)."]}
{"doc_id": 23003, "title": "", "abstract": ["As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "Given the disproportionate burden of severe COVID-19 disease and death in older adults, it is important to understand mechanisms that underlie this age- related vulnerability.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults."]}
{"doc_id": 23004, "title": "", "abstract": ["For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes."]}
{"doc_id": 23005, "title": "", "abstract": ["Age-related immune system remodeling, or immunosenescence, is considered to be the major reason for increased susceptibility to infection, particularly respiratory infections such as influenza, as well as impaired immune responses to vaccination (Li et al., 2011; Pawelec, 2018).", "Therefore, age-associated weaker type 1 IFN responses coupled with direct viral suppression could serve as a critical innate immune mechanism that leads to poor cell mediated immunity and increased vulnerability of older adults to SARS-CoV-2 infection with therapeutic implication (Sallard et al., 2020).", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020).", "Immune hypothesis for age-related vulnerability in older adults"]}
{"doc_id": 23006, "title": "", "abstract": ["Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups."]}
{"doc_id": 23007, "title": "", "abstract": ["We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020).", "Levels of other inflammatory mediators including interferon (IFN)-γ induced protein 10 (IP-10, or CXCL-10) and monocyte chemotactic protein-3 (MCP-3) are also acutely elevated in COVID-19 patients, and such elevation is associated with disease severity and progression (Lagunas-Rangel and Chavez-Valencia, 2020; Lin et al., 2020; Yang et al., 2020)."]}
{"doc_id": 23008, "title": "", "abstract": ["When a safe and efficacious COVID-19 vaccine becomes available, the demand of the ongoing pandemic can post huge challenges on large-scale production and distribution of the vaccine.", "An effective public health and socioeconomic response to control the pandemic must be based on a scientific understanding of COVID-19.", "With rapid progress in COVID-19 vaccine development, it is promising and hopeful that there will be one or several safe and effective COVID-19 vaccines in the near future.", "Effective and safe vaccination against SARS-CoV-2 is the best strategy to stop viral spread and control the pandemic.", "Two phase 1/2 clinical trials of two different adenovirus-vectored COVID-19 vaccines have reported robust antibody and T-cell responses to the vaccines with acceptable side effects in healthy adults (Folegatti et al., 2020; Zhu et al., 2020a)."]}
{"doc_id": 23009, "title": "", "abstract": ["That is, deaths among patients in hospital at the study end point were 3.3 % or lower in patients aged in the 40s or younger, 4.8 % among those in their 50s, 6.4 % in their 60s, 12.6 % in their 70s, to 25.9 % in their 80s and above (Richardson et al., 2020).", "China: Early data from China demonstrate that case fatality ratio (CFR) of COVID-19 increases with age, from 0.4 % or lower in patients aged in the 40s or younger, 1.3 % among those in their 50s, 3.6 % in their 60s, 8% in their 70s, to 14.8 % in their 80s or older; the overall CFR is 2.3 % (Wu et al., 2020; Zhu et al., 2020b).", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults.", "Again, CFRs are from less than 0.4 % or lower in patients aged in the 40s or younger, 1% among those in their 50s, 3.5 % in their 60s, 12.8 % in their 70s, to 20.2 % in their 80s and above; the overall CFR is 7.2 % (Onder et al., 2020)."]}
{"doc_id": 23010, "title": "", "abstract": ["Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults."]}
{"doc_id": 23011, "title": "", "abstract": ["Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Given the disproportionate burden of severe COVID-19 disease and death in older adults, it is important to understand mechanisms that underlie this age- related vulnerability.", "Aging in COVID-19: Vulnerability, immunity and intervention", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "Here we propose an immune hypothesis for COVID-19 vulnerability of older adults."]}
{"doc_id": 23012, "title": "", "abstract": ["Given the disproportionate burden of severe COVID-19 disease and death in older adults, it is important to understand mechanisms that underlie this age- related vulnerability.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults.", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults."]}
{"doc_id": 23013, "title": "", "abstract": ["A striking feature of this global effort is the diverse vaccine development platforms, from the traditional inactivated or live attenuated virus, viral protein subunit, to replicating or non-replicating viral vectors and novel platforms based on DNA or mRNA (Thanh Le et al., 2020).", "Novel vaccine platforms based on DNA or mRNA enable great flexibility in terms of antigen manipulation and potential for speed.", "An advantage of the traditional vaccine platform is that this is a mature technology that has already been employed in the production of licensed vaccines with existing large-scale production capacity (recombinant viral protein subunits).", "It may be necessary to develop different vaccines on specific vaccine platforms for older adults versus those for children and young adults.", "Intense worldwide efforts for COVID-19 vaccine development began after the genetic sequence of SARS-CoV-2 was published on January 11th 2020, and has since advanced at previously unimaginable speed with the first vaccine candidate entering human clinical trials on March 16th."]}
{"doc_id": 23014, "title": "", "abstract": ["We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "Levels of other inflammatory mediators including interferon (IFN)-γ induced protein 10 (IP-10, or CXCL-10) and monocyte chemotactic protein-3 (MCP-3) are also acutely elevated in COVID-19 patients, and such elevation is associated with disease severity and progression (Lagunas-Rangel and Chavez-Valencia, 2020; Lin et al., 2020; Yang et al., 2020).", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020)."]}
{"doc_id": 23015, "title": "", "abstract": ["Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups."]}
{"doc_id": 23016, "title": "", "abstract": ["For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults.", "Data from a large case series of 5700 COVID-19 patients who were admitted to hospitals in New York City have shown a strikingly similar trend of age-related increases in COVID-19 deaths."]}
{"doc_id": 23017, "title": "", "abstract": ["The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first reported in Wuhan, China in December 2019, moved across the globe at an unprecedented speed, and is having a profound and yet still unfolding health and socioeconomic impacts.", "As of October 19, 2020, there were over 40 million confirmed COVID-19 cases and over 1.1 million deaths worldwide, affecting 189 countries and territories [Fig. 1 , (Johns Hopkins University Coronavirus Resource Center, 2020, https://coronavirus.jhu.edu/map.html].", "Intense worldwide efforts for COVID-19 vaccine development began after the genetic sequence of SARS-CoV-2 was published on January 11th 2020, and has since advanced at previously unimaginable speed with the first vaccine candidate entering human clinical trials on March 16th.", "The rapid growth of the number of older adults in the world’s largest population, termed an \"aging tsunami\" by some, coupled with the unique socioeconomic context, ongoing healthcare reform, and nascent development of geriatrics, creates significant challenges for China to fight against COVID-19, particularly during the early days of the pandemic (Fang et al., 2015; Li et al., 2018; Yip et al., 2019).", "An effective public health and socioeconomic response to control the pandemic must be based on a scientific understanding of COVID-19."]}
{"doc_id": 23018, "title": "", "abstract": ["Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020).", "China: Early data from China demonstrate that case fatality ratio (CFR) of COVID-19 increases with age, from 0.4 % or lower in patients aged in the 40s or younger, 1.3 % among those in their 50s, 3.6 % in their 60s, 8% in their 70s, to 14.8 % in their 80s or older; the overall CFR is 2.3 % (Wu et al., 2020; Zhu et al., 2020b)."]}
{"doc_id": 23019, "title": "", "abstract": ["As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020)."]}
{"doc_id": 23020, "title": "", "abstract": ["We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020).", "Here we propose an immune hypothesis for COVID-19 vulnerability of older adults.", "Given the disproportionate burden of severe COVID-19 disease and death in older adults, it is important to understand mechanisms that underlie this age- related vulnerability.", "We will first review some of the published data currently available, and then propose an immune hypothesis for age- related vulnerability to severe COVID-19 and adverse health outcomes."]}
{"doc_id": 30000, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment.", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations."]}
{"doc_id": 30001, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology."]}
{"doc_id": 30002, "title": "", "abstract": ["Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "In support of this notion, there have been instances of dementia in the elderly following viral infection, including respiratory viruses such as influenza (Honjo et al., 2009).", "This work is supported in part by grants from the National Institute on Aging RF1AG028271 and R03AG067061 to R.M.B.", "The high prevalence of these risk factors, worldwide, but especially in the U.S. and other developed countries, is likely driven by increased consumption of the typical Western diet (WD) consisting of high amounts of saturated fat (HFD), refined carbohydrates and sugars, and low levels of fiber, unsaturated fats, and antioxidants (Cordain et al., 2005).", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations."]}
{"doc_id": 30003, "title": "", "abstract": ["Data suggest that minorities have increased barriers to access healthy food choices and nutritional education, likely due to increased rates of poverty and decreased access to quality healthcare in the U.S. (Dharmasena et al., 2016).", "As mentioned earlier, the high rates of obesity and diabetes among minority populations may account, at least in part, for the health disparities observed in response to COVID-19 in these groups (Dharmasena et al., 2016).", "The high prevalence of these risk factors, worldwide, but especially in the U.S. and other developed countries, is likely driven by increased consumption of the typical Western diet (WD) consisting of high amounts of saturated fat (HFD), refined carbohydrates and sugars, and low levels of fiber, unsaturated fats, and antioxidants (Cordain et al., 2005).", "Thus, the access to healthy, fresh whole foods should be made more readily available to those who cannot normally afford it in order to relieve the chronic disease burden in these communities.", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities."]}
{"doc_id": 30004, "title": "", "abstract": ["In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment."]}
{"doc_id": 30005, "title": "", "abstract": ["Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "The impact of nutrition on COVID-19 susceptibility and long-term consequences", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment."]}
{"doc_id": 30006, "title": "", "abstract": ["Therefore, it is our recommendation that individuals refrain from eating foods high in saturated fats and sugar and instead consume high amounts of fiber, whole grains, unsaturated fats, and antioxidants to boost immune function (Connaughton et al., 2016).", "The high prevalence of these risk factors, worldwide, but especially in the U.S. and other developed countries, is likely driven by increased consumption of the typical Western diet (WD) consisting of high amounts of saturated fat (HFD), refined carbohydrates and sugars, and low levels of fiber, unsaturated fats, and antioxidants (Cordain et al., 2005).", "Briefly, excessive SFA consumption can induce a lipotoxic state and activate the innate immune system via activation of toll-like receptor 4 expressed on macrophages, dendritic cells, and neutrophils.", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality.", "Therefore, consumption of a WD significantly impairs adaptive immunity while ramping up innate immunity, leading to chronic inflammation and severely impairing host defense against viral pathogens."]}
{"doc_id": 30007, "title": "", "abstract": ["While all groups are affected by the COVID-19 pandemic, the elderly, underrepresented minorities, and those with underlying medical conditions are at the greatest risk.", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "This has important implications in host defense against viruses."]}
{"doc_id": 30008, "title": "", "abstract": ["Therefore, it is our recommendation that individuals refrain from eating foods high in saturated fats and sugar and instead consume high amounts of fiber, whole grains, unsaturated fats, and antioxidants to boost immune function (Connaughton et al., 2016).", "Therefore, consumption of a WD significantly impairs adaptive immunity while ramping up innate immunity, leading to chronic inflammation and severely impairing host defense against viral pathogens.", "This triggers activation of canonical inflammatory signaling pathways that produce proinflammatory mediators and other effectors of the innate immune system (Rogero and Calder, 2018).", "WD consumption activates the innate immune system and impairs adaptive immunity, leading to chronic inflammation and impaired host defense against viruses.", "Briefly, excessive SFA consumption can induce a lipotoxic state and activate the innate immune system via activation of toll-like receptor 4 expressed on macrophages, dendritic cells, and neutrophils."]}
{"doc_id": 30009, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020).", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016)."]}
{"doc_id": 30010, "title": "", "abstract": ["While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "While all groups are affected by the COVID-19 pandemic, the elderly, underrepresented minorities, and those with underlying medical conditions are at the greatest risk.", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality."]}
{"doc_id": 30011, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19."]}
{"doc_id": 30012, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations.", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology."]}
{"doc_id": 30013, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "Thus, profound challenges of the immune system like COVID-19 could potentiate the neuroinflammatory response and disease onset in these vulnerable groups."]}
{"doc_id": 30014, "title": "", "abstract": ["Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations."]}
{"doc_id": 30015, "title": "", "abstract": ["The high prevalence of these risk factors, worldwide, but especially in the U.S. and other developed countries, is likely driven by increased consumption of the typical Western diet (WD) consisting of high amounts of saturated fat (HFD), refined carbohydrates and sugars, and low levels of fiber, unsaturated fats, and antioxidants (Cordain et al., 2005).", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality.", "The WD, which is high in saturated fatty acids (SFAs), can lead to chronic activation of the innate immune system and an inhibition of the adaptive immune system.", "Therefore, it is our recommendation that individuals refrain from eating foods high in saturated fats and sugar and instead consume high amounts of fiber, whole grains, unsaturated fats, and antioxidants to boost immune function (Connaughton et al., 2016).", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery."]}
{"doc_id": 30016, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Given that, even in the most at-risk populations, the vast majority of COVID-19 patients are expected to recover, there could be a number of indirect long-term consequences of the disease.", "Furthermore, peripheral inflammation caused by COVID-19 may have long-term consequences in those that recover, leading to chronic medical conditions such as dementia and neurodegenerative disease, likely through neuroinflammatory mechanisms that can be compounded by an unhealthy diet.", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations.", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery."]}
{"doc_id": 30017, "title": "", "abstract": ["Data suggest that minorities have increased barriers to access healthy food choices and nutritional education, likely due to increased rates of poverty and decreased access to quality healthcare in the U.S. (Dharmasena et al., 2016).", "The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Furthermore, peripheral inflammation caused by COVID-19 may have long-term consequences in those that recover, leading to chronic medical conditions such as dementia and neurodegenerative disease, likely through neuroinflammatory mechanisms that can be compounded by an unhealthy diet.", "Given that, even in the most at-risk populations, the vast majority of COVID-19 patients are expected to recover, there could be a number of indirect long-term consequences of the disease.", "As mentioned earlier, the high rates of obesity and diabetes among minority populations may account, at least in part, for the health disparities observed in response to COVID-19 in these groups (Dharmasena et al., 2016)."]}
{"doc_id": 30018, "title": "", "abstract": ["Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "In support of this notion, there have been instances of dementia in the elderly following viral infection, including respiratory viruses such as influenza (Honjo et al., 2009).", "Indeed, studies show that consuming healthy foods has a rapid anti-inflammatory effect, even in the presence of obesity pathology (Connaughton et al., 2016).", "A change in these policies could also have long-term benefits on disease prevention, including COVID-19, by increasing the efficacy of vaccines, given that vaccines have been shown to be less effective in obese individuals (Green and Beck, 2017)."]}
{"doc_id": 30019, "title": "", "abstract": ["The impact of nutrition on COVID-19 susceptibility and long-term consequences", "COVID-19 is a respiratory disease caused by the novel coronavirus, SARS-CoV-2, that has reached pandemic status.", "Given that, even in the most at-risk populations, the vast majority of COVID-19 patients are expected to recover, there could be a number of indirect long-term consequences of the disease.", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19."]}
{"doc_id": 30020, "title": "", "abstract": ["Therefore, it is our recommendation that individuals refrain from eating foods high in saturated fats and sugar and instead consume high amounts of fiber, whole grains, unsaturated fats, and antioxidants to boost immune function (Connaughton et al., 2016).", "The WD, which is high in saturated fatty acids (SFAs), can lead to chronic activation of the innate immune system and an inhibition of the adaptive immune system.", "WD consumption activates the innate immune system and impairs adaptive immunity, leading to chronic inflammation and impaired host defense against viruses.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "In addition to innate immunity, WD or HFD consumption inhibits T and B lymphocyte function in the adaptive immune system, potentially via an increase in oxidative stress."]}
{"doc_id": 30021, "title": "", "abstract": ["In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations.", "The impact of nutrition on COVID-19 susceptibility and long-term consequences", "Furthermore, peripheral inflammation caused by COVID-19 may have long-term consequences in those that recover, leading to chronic medical conditions such as dementia and neurodegenerative disease, likely through neuroinflammatory mechanisms that can be compounded by an unhealthy diet."]}
{"doc_id": 2000, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "These data indicate that inhibition of the mTOR pathway can reduce Aβ42 levels in vivo and block or delay AD in mice.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model."]}
{"doc_id": 2001, "title": "", "abstract": ["Thus, our data indicate that rapamycin treatment can ameliorate learning deficits and abolish memory impairments in PDAPP mice.", "The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "Rapamycin-fed transgenic PDAPP mice, however, showed improved learning ( Figure 1a ) and memory ( Figure 1b ), with improved performances on the last day of training and retention of the former location of the escape platform restored to levels indistinguishable from those of non-transgenic littermates ( Figure 1b ).", "b, Rapamycin restores spatial memory in PDAPP mice.", "We used rapamycin administration and behavioral tools in a mouse model of AD as well as standard biochemical and immunohistochemical measures in brain tissue to provide answers for this question."]}
{"doc_id": 2002, "title": "", "abstract": ["Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Although rapamycin treatment did not activate autophagy nor reduce endogenous mouse Aβ levels, it inhibited mTOR function in non-transgenic littermate brains, and this group showed trends to improved learning and retention."]}
{"doc_id": 2003, "title": "", "abstract": ["The role of the mTOR pathway and of autophagy in AD is thus still unclear.", "# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease", "We cannot rule out, however, mTOR- dependent effects on cognition that may be additive to the benefit of reduced Aβ in our model system.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease."]}
{"doc_id": 2004, "title": "", "abstract": ["Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.", "Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.", "Rapamycin, already used in clinical settings, may thus be a potentially effective therapy for the prevention or treatment of AD.", "Inhibition of the mTOR pathway by rapamycin activates autophagy[40].", "The target of rapamycin (TOR) pathway is a major signaling hub that integrates nutrient/growth factor availability with cell metabolism[12] through two distinct complexes, mTORC1 and mTORC2[13]."]}
{"doc_id": 2005, "title": "", "abstract": ["Rapamycin, already used in clinical settings, may thus be a potentially effective therapy for the prevention or treatment of AD.", "Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined.", "Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined.", "While excessive autophagic activity can lead to cell death, increased autophagy has been shown to facilitate the clearance of aggregation- prone proteins such as Aβ[20], [21], [22], pathological prion protein[23], [24], and α-synuclein[25], and to promote neuronal survival in a variety of neurodegenerative disease models.", "Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD."]}
{"doc_id": 2006, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "These data indicate that inhibition of the mTOR pathway can reduce Aβ42 levels in vivo and block or delay AD in mice."]}
{"doc_id": 2007, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Activation of autophagy was prominent in transgenic, but not in non-transgenic, PDAPP mice ( Fig. 3 ), suggesting that the reduction in Aβ and the improvement in cognitive function may be due in part to increased autophagy in neurons, possibly as a response to high levels of Aβ in transgenic mice.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "In addition, rapamycin treatment did not induce autophagy and did not affect levels of endogenous Aβ in non-transgenic mice, suggesting that autophagy may have a key role in reducing Aβ42 in transgenic PDAPP brains.", "Supporting the notion that autophagy may have a protective role in AD, deletion of the beclin 1 gene in PDAPP mice impaired autophagy and resulted in large increases in Aβ levels and accelerated Aβ deposition[26]."]}
{"doc_id": 2008, "title": "", "abstract": ["Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Our data suggest that the reduction in Aβ42 levels and the improvement in cognitive function in rapamycin-treated PDAPP mice may be a consequence of the induction of autophagy in hippocampus ( Fig. 3 ) by high levels of Aβ in PDAPP transgenic brains.", "To determine the mechanism by which rapamycin treatment abolishes AD-like cognitive deficits in transgenic PDAPP mice, we examined (a) mTOR activity and (b) the proteolytic processes that generate of Aβ in PDAPP mouse brains.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ."]}
{"doc_id": 2009, "title": "", "abstract": ["As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Supporting the notion that autophagy may have a protective role in AD, deletion of the beclin 1 gene in PDAPP mice impaired autophagy and resulted in large increases in Aβ levels and accelerated Aβ deposition[26].", "In addition, rapamycin treatment did not induce autophagy and did not affect levels of endogenous Aβ in non-transgenic mice, suggesting that autophagy may have a key role in reducing Aβ42 in transgenic PDAPP brains.", "While excessive autophagic activity can lead to cell death, increased autophagy has been shown to facilitate the clearance of aggregation- prone proteins such as Aβ[20], [21], [22], pathological prion protein[23], [24], and α-synuclein[25], and to promote neuronal survival in a variety of neurodegenerative disease models.", "Activation of autophagy was prominent in transgenic, but not in non-transgenic, PDAPP mice ( Fig. 3 ), suggesting that the reduction in Aβ and the improvement in cognitive function may be due in part to increased autophagy in neurons, possibly as a response to high levels of Aβ in transgenic mice."]}
{"doc_id": 2010, "title": "", "abstract": ["The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Our data suggest that the reduction in Aβ42 levels and the improvement in cognitive function in rapamycin-treated PDAPP mice may be a consequence of the induction of autophagy in hippocampus ( Fig. 3 ) by high levels of Aβ in PDAPP transgenic brains.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "a, Rapamycin improves learning in PDAPP mice."]}
{"doc_id": 2011, "title": "", "abstract": ["Consistent with our and others' previous observations [11], [29], [31], [32], [35], we observed significant deficits in learning and memory in control-fed transgenic PDAPP animals ( Figure 1a and b ).", "Our observations are thus consistent with a recent report that showed that the life-extending effect of TOR inhibition in C. elegans requires autophagy[46].", "Data are mean ± SEM.", "On the other hand, the endosomal-lysosomal system is a major site of Aβ production[27], [28] and it was recently demonstated that Aβ is generated during macroautophagy both in vitro and in vivo[19].", "Data are means ± SEM."]}
{"doc_id": 2012, "title": "", "abstract": ["As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Prolonged rapamycin treatment may thus release mTOR-mediated inhibition of autophagy and allow for the reduction of Aβ levels through this clearance mechanism in transgenic PDAPP brains.", "Activation of autophagy was prominent in transgenic, but not in non-transgenic, PDAPP mice ( Fig. 3 ), suggesting that the reduction in Aβ and the improvement in cognitive function may be due in part to increased autophagy in neurons, possibly as a response to high levels of Aβ in transgenic mice.", "Taken together, our results suggest that autophagy is induced by rapamycin-mediated mTOR inhibition specifically as a response to high Aβ levels in hippocampi of rapamycin-treated PDAPP mice."]}
{"doc_id": 2013, "title": "", "abstract": ["To determine whether the decreased LC3-II/β-actin ratios in hippocampi of rapamycin-treated PDAPP mice resulted from the induction of autophagic flux, we examined LC3 distribution, as well as levels of p62SQSTM, an ubiquitin-binding scaffold protein that is specifically degraded by autophagy[22], [45], in hippocampi of control- and rapamycin-treated PDAPP mice.", "In agreement with the expected induction of autophagy by rapamycin-mediated inhibition of mTOR, LC3-II/β-actin ratios in hippocampi of rapamycin-treated PDAPP mice were significantly decreased ( Fig. 3a–b ).", "To determine whether rapamycin treatment affected autophagy in PDAPP brains, we examined LC3-II and β-actin in hippocampus of control- and rapamycin-treated PDAPP mice.", "In contrast, no differences in LC3-II/β-actin ratios were observed between control- and rapamycin-treated non-transgenic littermates ( Fig. 3a–b ), suggesting that rapamycin may induce autophagy as a response to high Aβ levels in hippocampi of transgenic PDAPP mice.", "Consistent with this observation, levels of the autophagosomal substrate p62SQSTM were significantly decreased in hippocampi of rapamycin-treated PDAPP mice ( Figure 3f–g )."]}
{"doc_id": 2014, "title": "", "abstract": ["The induction of autophagy is associated with increased levels of microtubule-associated- protein-light-chain-3 (LC3)-II, the lipidated form of LC3[42], with respect to levels of a control protein such as β-actin or β-tubulin[43].", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Taken together, our results suggest that autophagy is induced by rapamycin-mediated mTOR inhibition specifically as a response to high Aβ levels in hippocampi of rapamycin-treated PDAPP mice.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Thus mTORC2 activity indirectly inhibits autophagy through inactivation of FOXO3."]}
{"doc_id": 2015, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "In addition, rapamycin treatment did not induce autophagy and did not affect levels of endogenous Aβ in non-transgenic mice, suggesting that autophagy may have a key role in reducing Aβ42 in transgenic PDAPP brains.", "Prolonged rapamycin treatment may thus release mTOR-mediated inhibition of autophagy and allow for the reduction of Aβ levels through this clearance mechanism in transgenic PDAPP brains.", "Activation of autophagy was prominent in transgenic, but not in non-transgenic, PDAPP mice ( Fig. 3 ), suggesting that the reduction in Aβ and the improvement in cognitive function may be due in part to increased autophagy in neurons, possibly as a response to high levels of Aβ in transgenic mice."]}
{"doc_id": 2016, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "In summary, our data suggest that inhibition of mTOR by rapamycin[5], an intervention that extends lifespan in mice[5], [6], can slow or block AD progression in a transgenic mouse model of the disease.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model."]}
{"doc_id": 2017, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "To determine the mechanism by which rapamycin treatment abolishes AD-like cognitive deficits in transgenic PDAPP mice, we examined (a) mTOR activity and (b) the proteolytic processes that generate of Aβ in PDAPP mouse brains.", "In summary, our data suggest that inhibition of mTOR by rapamycin[5], an intervention that extends lifespan in mice[5], [6], can slow or block AD progression in a transgenic mouse model of the disease."]}
{"doc_id": 2018, "title": "", "abstract": ["mTOR also regulates autophagy through mTORC2.", "Activation of autophagy was prominent in transgenic, but not in non-transgenic, PDAPP mice ( Fig. 3 ), suggesting that the reduction in Aβ and the improvement in cognitive function may be due in part to increased autophagy in neurons, possibly as a response to high levels of Aβ in transgenic mice.", "On the other hand, the endosomal-lysosomal system is a major site of Aβ production[27], [28] and it was recently demonstated that Aβ is generated during macroautophagy both in vitro and in vivo[19].", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "We cannot rule out, however, mTOR- dependent effects on cognition that may be additive to the benefit of reduced Aβ in our model system."]}
{"doc_id": 2019, "title": "", "abstract": ["While excessive autophagic activity can lead to cell death, increased autophagy has been shown to facilitate the clearance of aggregation- prone proteins such as Aβ[20], [21], [22], pathological prion protein[23], [24], and α-synuclein[25], and to promote neuronal survival in a variety of neurodegenerative disease models.", "Autophagy is a major degradation pathway for organelles and aggregated proteins[18] such as those that cause multiple neurodegenerative diseases including AD.", "Supporting the notion that autophagy may have a protective role in AD, deletion of the beclin 1 gene in PDAPP mice impaired autophagy and resulted in large increases in Aβ levels and accelerated Aβ deposition[26].", "Autophagy is a key pathway for the clearance of aggregation-prone proteins and may have a protective role in proteinopathies[20], [39].", "The role of autophagy in AD, however, is not clear[19], [27]."]}
{"doc_id": 2020, "title": "", "abstract": ["The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy."]}
{"doc_id": 2021, "title": "", "abstract": ["These data indicate that inhibition of the mTOR pathway by long-term rapamycin treatment can reduce Aβ42 levels in vivo and block or delay AD in mice.", "Although rapamycin treatment did not activate autophagy nor reduce endogenous mouse Aβ levels, it inhibited mTOR function in non-transgenic littermate brains, and this group showed trends to improved learning and retention.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Our data suggest that the reduction in Aβ42 levels and the improvement in cognitive function in rapamycin-treated PDAPP mice may be a consequence of the induction of autophagy in hippocampus ( Fig. 3 ) by high levels of Aβ in PDAPP transgenic brains."]}
{"doc_id": 2022, "title": "", "abstract": ["Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.", "Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.", "Rapamycin, already used in clinical settings, may thus be a potentially effective therapy for the prevention or treatment of AD.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy."]}
{"doc_id": 2023, "title": "", "abstract": ["Thus, our data indicate that rapamycin treatment can ameliorate learning deficits and abolish memory impairments in PDAPP mice.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "a, Rapamycin improves learning in PDAPP mice."]}
{"doc_id": 2024, "title": "", "abstract": ["Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease"]}
{"doc_id": 2025, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "In summary, our data suggest that inhibition of mTOR by rapamycin[5], an intervention that extends lifespan in mice[5], [6], can slow or block AD progression in a transgenic mouse model of the disease.", "These data indicate that inhibition of the mTOR pathway by long-term rapamycin treatment can reduce Aβ42 levels in vivo and block or delay AD in mice.", "Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined."]}
{"doc_id": 2026, "title": "", "abstract": ["In addition, the reduction in Aβ42 did not likely arise from increased degradation, since levels of the two major Aβ-degrading activities, neprilysin (NEP)[35], and insulin-degrading enzyme (IDE)[38] were unchanged in brains of control- and rapamycin-fed PDAPP mice as well ( Fig. 2f, j–k ).", "In addition, mTORC1 inhibits autophagy when nutrients and energy are plentiful through the phosphorylation of Unc51-like kinase 1 (ULK1) and mAtg13, the mammalian homologs of the yeast kinase Atg1 and Atg13 respectively, which are essential for the formation of pre-autophagosomal structures [14].", "Supporting the notion that autophagy may have a protective role in AD, deletion of the beclin 1 gene in PDAPP mice impaired autophagy and resulted in large increases in Aβ levels and accelerated Aβ deposition[26].", "This may be a result of the inhibition of the mTOR pathway, which is expected to mimic the unfed state by decreasing mTOR activity.", "Phosphorylation of p70 was significantly reduced in hippocampi of both PDAPP transgenic and non-transgenic littermate controls, indicating that mTOR activity was inhibited ( Fig. 3h–i )."]}
{"doc_id": 2027, "title": "", "abstract": ["In contrast, no differences in LC3-II/β-actin ratios were observed between control- and rapamycin-treated non-transgenic littermates ( Fig. 3a–b ), suggesting that rapamycin may induce autophagy as a response to high Aβ levels in hippocampi of transgenic PDAPP mice.", "a and b, LC3-II levels are decreased in hippocampi of rapamycin-treated transgenic PDAPP mice (*, P = 0.0009), but not in hippocampi of rapamycin-treated non-transgenic littermates.", "In agreement with the expected induction of autophagy by rapamycin-mediated inhibition of mTOR, LC3-II/β-actin ratios in hippocampi of rapamycin-treated PDAPP mice were significantly decreased ( Fig. 3a–b ).", "Thus, decreased LC3-II levels may be observed as a consequence of robust induction of autophagic flux[43], [44].", "LC3-II is created during autophagosome formation and is subsequently degraded as autophagosomes mature into autolysosomes."]}
{"doc_id": 2028, "title": "", "abstract": ["# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model."]}
{"doc_id": 2029, "title": "", "abstract": ["Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "# Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease", "These data indicate that inhibition of the mTOR pathway can reduce Aβ42 levels in vivo and block or delay AD in mice.", "The data presented here are, to our knowledge, the first to show that inhibition of mTOR by rapamycin decreased Aβ42 levels ( Fig. 2 ) and rescued cognitive function ( Fig. 1 ) in a mouse model of AD."]}
{"doc_id": 2030, "title": "", "abstract": ["Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Aβ42, a major toxic species in AD[7], in the PDAPP transgenic mouse model.", "Here we show that long-term mTOR inhibition by rapamycin inhibited mTOR in brain, prevented AD-like cognitive deficits ( Fig. 1 ) and lowered levels of Aβ42 ( Fig. 2 ) in the PDAPP transgenic mouse model.", "Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease.", "Thus, our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can lower Aβ levels and slow or block AD progression in a transgenic mouse model of the disease, possibly by stimulating autophagy.", "To determine the mechanism by which rapamycin treatment abolishes AD-like cognitive deficits in transgenic PDAPP mice, we examined (a) mTOR activity and (b) the proteolytic processes that generate of Aβ in PDAPP mouse brains."]}
{"doc_id": 2031, "title": "", "abstract": ["As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Aβ and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Aβ.", "Inhibition of the mTOR pathway by rapamycin activates autophagy[40].", "Taken together, our results suggest that autophagy is induced by rapamycin-mediated mTOR inhibition specifically as a response to high Aβ levels in hippocampi of rapamycin-treated PDAPP mice.", "In agreement with the expected induction of autophagy by rapamycin-mediated inhibition of mTOR, LC3-II/β-actin ratios in hippocampi of rapamycin-treated PDAPP mice were significantly decreased ( Fig. 3a–b ).", "As expected from the inhibition of mTOR, autophagy was strongly activated in hippocampus of rapamycin-treated mice."]}
{"doc_id": 25000, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "Suicide risk and prevention during the COVID-19 pandemic"]}
{"doc_id": 25001, "title": "", "abstract": ["Providing community support for those living alone and encouraging families and friends to check in is helpful.", "Monitoring demands and capacity of mental health-care providers over the coming months is also essential to ensure resources are directed to those parts of the system under greatest pressure.", "Mental health services should develop clear remote assessment and care pathways for people who are suicidal, and staff training to support new ways of working.", "Digital training resources would enable those who have not previously worked with people who are suicidal to take active roles in mental health services and helplines.", "The effects might be worse in resource-poor settings where economic adversity is compounded by inadequate welfare supports."]}
{"doc_id": 25002, "title": "", "abstract": ["Mental health services should develop clear remote assessment and care pathways for people who are suicidal, and staff training to support new ways of working.", "Digital training resources would enable those who have not previously worked with people who are suicidal to take active roles in mental health services and helplines.", "Making evidence-based online resources and interventions freely available at scale could benefit population mental health.", "Some services are developing expertise in conducting psychiatric assessments and delivering interventions remotely (eg, by telephone or digitally); these new working practices should be implemented more widely, but with consideration that not all patients will feel comfortable with such interactions and they may present implications for privacy.", "Monitoring demands and capacity of mental health-care providers over the coming months is also essential to ensure resources are directed to those parts of the system under greatest pressure."]}
{"doc_id": 25003, "title": "", "abstract": ["COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Suicide risk and prevention during the COVID-19 pandemic"]}
{"doc_id": 25004, "title": "", "abstract": ["Suicide risk and prevention during the COVID-19 pandemic", "COVID-19 Suicide Prevention Research Collaboration:", "Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the appendix.", "Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses."]}
{"doc_id": 25005, "title": "", "abstract": ["COVID-19 Suicide Prevention Research Collaboration:", "These efforts need to be appropriately resourced and coordinated.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the appendix.", "Suicide risk and prevention during the COVID-19 pandemic"]}
{"doc_id": 25006, "title": "", "abstract": ["Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour.", "The suicide-related consequences of the pandemic might vary depending on countries' public health control measures, sociocultural and demographic structures, availability of digital alternatives to face-to-face consultation, and existing supports.", "The likely adverse effects of the pandemic on people with mental illness, and on population mental health in general, might be exacerbated by fear, self- isolation, and physical distancing.4", "The pandemic could adversely affect other known precipitants of suicide."]}
{"doc_id": 25007, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "There is some evidence that deaths by suicide increased in the USA during the 1918–19 influenza pandemic2 and among older people in Hong Kong during the 2003 severe acute respiratory syndrome (SARS) epidemic.3", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families.", "Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "Suicide risk and prevention during the COVID-19 pandemic"]}
{"doc_id": 25008, "title": "", "abstract": ["Those with psychiatric disorders might experience worsening symptoms and others might develop new mental health problems, especially depression, anxiety, and post- traumatic stress (all associated with increased suicide risk).", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour.", "The likely adverse effects of the pandemic on people with mental illness, and on population mental health in general, might be exacerbated by fear, self- isolation, and physical distancing.4", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families."]}
{"doc_id": 25009, "title": "", "abstract": ["COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours."]}
{"doc_id": 25010, "title": "", "abstract": ["However, research evidence and the experience of national strategies provide a strong basis for suicide prevention.", "These efforts need to be appropriately resourced and coordinated.", "A wide-ranging interdisciplinary response that recognises how the pandemic might heighten risk and applies knowledge about effective suicide prevention approaches is key.", "COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "Preventing suicide therefore needs urgent consideration."]}
{"doc_id": 25011, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours.", "COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness."]}
{"doc_id": 25012, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours.", "COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness."]}
{"doc_id": 25013, "title": "", "abstract": ["Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour.", "The likely adverse effects of the pandemic on people with mental illness, and on population mental health in general, might be exacerbated by fear, self- isolation, and physical distancing.4", "A wide-ranging interdisciplinary response that recognises how the pandemic might heighten risk and applies knowledge about effective suicide prevention approaches is key.", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable."]}
{"doc_id": 25014, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness.", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families.", "Those with psychiatric disorders might experience worsening symptoms and others might develop new mental health problems, especially depression, anxiety, and post- traumatic stress (all associated with increased suicide risk).", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour."]}
{"doc_id": 25015, "title": "", "abstract": ["These are unprecedented times.", "Repeat representative cross-sectional and longitudinal surveys will help identify increases in population-level risk, as might anonymised real-time data on caller concerns from helplines.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses."]}
{"doc_id": 25016, "title": "", "abstract": ["There is some evidence that deaths by suicide increased in the USA during the 1918–19 influenza pandemic2 and among older people in Hong Kong during the 2003 severe acute respiratory syndrome (SARS) epidemic.3", "Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "Irresponsible media reporting of suicide can lead to spikes in suicides.8", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families.", "Suicide is likely to become a more pressing concern as the pandemic spreads and has longer-term effects on the general population, the economy, and vulnerable groups."]}
{"doc_id": 25017, "title": "", "abstract": ["Suicide risk and prevention during the COVID-19 pandemic", "These are unprecedented times.", "Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "COVID-19=coronavirus disease 2019.", "COVID-19 Suicide Prevention Research Collaboration:"]}
{"doc_id": 25018, "title": "", "abstract": ["Those with psychiatric disorders might experience worsening symptoms and others might develop new mental health problems, especially depression, anxiety, and post- traumatic stress (all associated with increased suicide risk).", "Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "There is some evidence that deaths by suicide increased in the USA during the 1918–19 influenza pandemic2 and among older people in Hong Kong during the 2003 severe acute respiratory syndrome (SARS) epidemic.3", "Monitoring demands and capacity of mental health-care providers over the coming months is also essential to ensure resources are directed to those parts of the system under greatest pressure."]}
{"doc_id": 25019, "title": "", "abstract": ["There is some evidence that deaths by suicide increased in the USA during the 1918–19 influenza pandemic2 and among older people in Hong Kong during the 2003 severe acute respiratory syndrome (SARS) epidemic.3", "Loss of employment and financial stressors are well-recognised risk factors for suicide.6", "Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "Suicide is likely to become a more pressing concern as the pandemic spreads and has longer-term effects on the general population, the economy, and vulnerable groups.", "The pandemic could adversely affect other known precipitants of suicide."]}
{"doc_id": 25020, "title": "", "abstract": ["However, research evidence and the experience of national strategies provide a strong basis for suicide prevention.", "Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the appendix.", "The views and recommendations in this Comment are endorsed by the International Association of Suicide Prevention, the American Foundation for Suicide Prevention, and the International Academy of Suicide Research.", "Preventing suicide therefore needs urgent consideration.", "COVID-19 Suicide Prevention Research Collaboration:"]}
{"doc_id": 25021, "title": "", "abstract": ["Some services are developing expertise in conducting psychiatric assessments and delivering interventions remotely (eg, by telephone or digitally); these new working practices should be implemented more widely, but with consideration that not all patients will feel comfortable with such interactions and they may present implications for privacy.", "Making evidence-based online resources and interventions freely available at scale could benefit population mental health.", "Mental health services should develop clear remote assessment and care pathways for people who are suicidal, and staff training to support new ways of working.", "Some might not seek help, fearing that services are overwhelmed and that attending face-to-face appointments might put them at risk.", "The response must capitalise on, but extend beyond, general mental health policies and practices."]}
{"doc_id": 25022, "title": "", "abstract": ["Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the appendix."]}
{"doc_id": 25023, "title": "", "abstract": ["A wide-ranging interdisciplinary response that recognises how the pandemic might heighten risk and applies knowledge about effective suicide prevention approaches is key.", "The effects might be worse in resource-poor settings where economic adversity is compounded by inadequate welfare supports.", "Mental health consequences are likely to be present for longer and peak later than the actual pandemic.", "COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "The consequences for mental health services are already being felt (eg, increased workloads and the need to find new ways of working)."]}
{"doc_id": 25024, "title": "", "abstract": ["Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours.", "Suicide risk and prevention during the COVID-19 pandemic", "Irresponsible media reporting of suicide can lead to spikes in suicides.8"]}
{"doc_id": 34000, "title": "", "abstract": ["* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19.", "As the majority of severe COVID-19 events occurred in patients over the age of 50 years, these data particularly highlight the risk of combination and thiopurine monotherapies in older patients with IBD.", "However, it is also possible that immunosuppressive medications may be associated with a decreased risk of adverse COVID-19 outcomes by limiting the cytokine storm characteristic of severe COVID-19.15 16", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD."]}
{"doc_id": 34001, "title": "", "abstract": ["On multivariable analysis, any mesalamine/sulfasalazine use was associated with severe COVID-19 compared with no use (aOR 1.47, 95% CI 1.05 to 2.07) (table 4).", "Our data also suggest that mesalamine/sulfasalazine therapy may be associated with severe COVID-19, but this association requires further replication in other populations.", "In an active comparator analysis, mesalamine/sulfasalazine monotherapy was significantly associated with severe COVID-19 compared with TNF antagonist monotherapy.", "In adjusted analyses, mesalamine/sulfasalazine monotherapy was associated with severe COVID-19 when compared with TNF antagonist monotherapy (aOR 3.52, 95% CI 1.93 to 6.45) (table 4).", "* Mesalamine/sulfasalazine may be associated with an increased the risk of severe COVID-19, particularly when compared with TNF antagonists."]}
{"doc_id": 34002, "title": "", "abstract": ["Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19.", "The SECURE-IBD database (www.covidibd.org) was created to monitor outcomes of COVID-19 occurring in paediatric and adult patients with IBD.", "Our primary outcome was severe COVID-19, defined as a composite of ICU admission, mechanical ventilation and/or death, consistent with existing COVID-19 literature.18", "Effect of IBD medications on COVID-19 outcomes: results from an international registry"]}
{"doc_id": 34003, "title": "", "abstract": ["The SECURE-IBD database (www.covidibd.org) was created to monitor outcomes of COVID-19 occurring in paediatric and adult patients with IBD.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19.", "Physicians and other healthcare providers voluntarily reported cases of PCR-confirmed or antibody- confirmed COVID-19 occurring in IBD patients.", "We investigated the impact of different medication classes on the risk of severe COVID-19 in patients with IBD using the SECURE-IBD registry."]}
{"doc_id": 34004, "title": "", "abstract": ["This is in line with previous studies that have observed a higher risk of viral infections in patients treated with thiopurines alone or in combination with TNF antagonists.12", "In over 1400 patients from this international database, we observed that patients on thiopurine monotherapy and combination therapy were at higher risk of a requiring ICU admission, mechanical ventilation and/or death compared with TNF antagonist monotherapy.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19.", "Our data suggest that COVID-19 should be added to the list of potential infectious complications associated with thiopurine therapy in IBD."]}
{"doc_id": 34005, "title": "", "abstract": ["Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease.", "Patients treated with mesalamine/sulfasalazine monotherapy did not appear to be at increased risk of severe COVID-19 compared with patients on no medications, though patients with IBD on no medications are likely a heterogenous group (mild disease, postsurgery and so on) and not an ideal comparison population.", "Our data also suggest that mesalamine/sulfasalazine therapy may be associated with severe COVID-19, but this association requires further replication in other populations.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk."]}
{"doc_id": 34006, "title": "", "abstract": ["In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Additionally, in select high-risk patients (ie, older age or multiple comorbidities) in stable remission on TNF antagonist combination therapy, consideration of discontinuing the thiopurine while the COVID-19 pandemic continues may be warranted.", "Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "We observed that thiopurine monotherapy and combination therapy were both significantly associated with severe COVID-19, compared with TNF antagonist monotherapy.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2)."]}
{"doc_id": 34007, "title": "", "abstract": ["Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19.", "We investigated the impact of different medication classes on the risk of severe COVID-19 in patients with IBD using the SECURE-IBD registry.", "In addition, as this was a registry-based cohort with convenience sampling, there is the possibility of reporting bias that could lead to over-representation or under-representation of more severe cases of COVID-19.", "Finally, similar to the first SECURE-IBD report, we continue to observe an increased risk of severe COVID-19 in patients on corticosteroids."]}
{"doc_id": 34008, "title": "", "abstract": ["Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "However, it is also possible that immunosuppressive medications may be associated with a decreased risk of adverse COVID-19 outcomes by limiting the cytokine storm characteristic of severe COVID-19.15 16", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD."]}
{"doc_id": 34009, "title": "", "abstract": ["* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Our data also suggest that mesalamine/sulfasalazine therapy may be associated with severe COVID-19, but this association requires further replication in other populations.", "In addition, most of our data suggest the possibility that TNF antagonist therapy may have a protective effect against the development of severe COVID-19 relative to other IBD therapies.", "Effect of IBD medications on COVID-19 outcomes: results from an international registry"]}
{"doc_id": 34010, "title": "", "abstract": ["Patients on both mesalamine/sulfasalazine and TNF antagonists concomitantly were also more likely to have severe COVID-19 compared with TNF antagonist monotherapy (9.3% vs 3%, p=0.008).", "Patients on TNF antagonists were younger, more likely to have CD and be on concomitant thiopurine therapy, and less likely to be of Asian race, or have comorbidities compared with all other patients not on a TNF antagonist (online supplemental table 3).", "In unadjusted analyses, integrin antagonist patients had a higher proportion with severe COVID-19 compared with those on TNF antagonists (7.2% vs 2.2%, p=0.007).", "Patients on TNF antagonists (monotherapy or combination therapy) were more likely to have CD.", "Combination therapy and thiopurine monotherapy both had a significantly higher proportion of patients with severe COVID-19 compared with TNF antagonist monotherapy (8.8% and 9.2% vs 2.2%, respectively, p<0.001)."]}
{"doc_id": 34011, "title": "", "abstract": ["Additionally, in select high-risk patients (ie, older age or multiple comorbidities) in stable remission on TNF antagonist combination therapy, consideration of discontinuing the thiopurine while the COVID-19 pandemic continues may be warranted.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Combination therapy was considered coprescription of a TNF antagonist with a thiopurine.", "* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "Proportion of patients with IBD with severe COVID-19 and aORs comparing TNF antagonist monotherapy with thiopurine monotherapy and combination therapy."]}
{"doc_id": 34012, "title": "", "abstract": ["Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Combination therapy and thiopurine monotherapy both had a significantly higher proportion of patients with severe COVID-19 compared with TNF antagonist monotherapy (8.8% and 9.2% vs 2.2%, respectively, p<0.001).", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19.", "We observed that thiopurine monotherapy and combination therapy were both significantly associated with severe COVID-19, compared with TNF antagonist monotherapy."]}
{"doc_id": 34013, "title": "", "abstract": ["* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "We observed that thiopurine monotherapy and combination therapy were both significantly associated with severe COVID-19, compared with TNF antagonist monotherapy.", "Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2)."]}
{"doc_id": 34014, "title": "", "abstract": ["Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "SECURE-IBD is a convenience sample with many patients being from the USA and of white race and subsequently may not be fully representative of the worldwide IBD population.", "For the current analyses, we used SECURE-IBD data collected from inception (13 March 2020) to 9 June 2020.", "Our results are largely consistent with the first analysis of SECURE-IBD data but add more granular data on the impact of IBD medications on severe COVID-19.", "Each SECURE-IBD survey item met criteria for deidentified data, in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Safe Harbor De-Identification standards."]}
{"doc_id": 34015, "title": "", "abstract": ["Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "Our data suggest that COVID-19 should be added to the list of potential infectious complications associated with thiopurine therapy in IBD.", "Physicians and other healthcare providers voluntarily reported cases of PCR-confirmed or antibody- confirmed COVID-19 occurring in IBD patients.", "Effect of IBD medications on COVID-19 outcomes: results from an international registry"]}
{"doc_id": 34016, "title": "", "abstract": ["The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease.", "Among all patients, after adjusting for age, sex, race (black vs non-Hispanic white, Asian vs non-Hispanic white), Hispanic versus non-Hispanic ethnicity, disease type, disease activity, cardiovascular disease, TNF antagonist, thiopurine, diabetes, lung disease and cancer, corticosteroid use was significantly associated with severe COVID-19 (aOR 3.24, 95% CI 1.78 to 5.90).", "However, the number of reported cases available at that time limited the ability to fully evaluate the risk of these and other IBD therapies.", "Combination therapy patients, compared with TNF antagonist monotherapy, were more likely to be Asian race, be on concomitant sulfasalazine/mesalamine or corticosteroids and have cardiovascular disease.", "Finally, similar to the first SECURE-IBD report, we continue to observe an increased risk of severe COVID-19 in patients on corticosteroids."]}
{"doc_id": 34017, "title": "", "abstract": ["Mesalamine and sulfasalazine appear to be associated with severe COVID-19 infection in many of our comparisons.", "Observed associations of mesalamine/sulfasalazine with increased incidence of severe COVID-19 relative to TNF antagonists could also be a result of unadjusted confounding such as from differences in socioeconomic status or access to care, although in the USA differences in TNF antagonist therapy were not observed between patients with commercial versus Medicaid insurance for low-income populations.24", "On multivariable analysis, any mesalamine/sulfasalazine use was associated with severe COVID-19 compared with no use (aOR 1.47, 95% CI 1.05 to 2.07) (table 4).", "In adjusted analyses, mesalamine/sulfasalazine monotherapy was associated with severe COVID-19 when compared with TNF antagonist monotherapy (aOR 3.52, 95% CI 1.93 to 6.45) (table 4).", "In an active comparator analysis, mesalamine/sulfasalazine monotherapy was significantly associated with severe COVID-19 compared with TNF antagonist monotherapy."]}
{"doc_id": 34018, "title": "", "abstract": ["In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2).", "We observed that thiopurine monotherapy and combination therapy were both significantly associated with severe COVID-19, compared with TNF antagonist monotherapy.", "Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "Combination therapy and thiopurine monotherapy both had a significantly higher proportion of patients with severe COVID-19 compared with TNF antagonist monotherapy (8.8% and 9.2% vs 2.2%, respectively, p<0.001)."]}
{"doc_id": 34019, "title": "", "abstract": ["Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2).", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "Combination therapy and thiopurine monotherapy both had a significantly higher proportion of patients with severe COVID-19 compared with TNF antagonist monotherapy (8.8% and 9.2% vs 2.2%, respectively, p<0.001)."]}
{"doc_id": 34020, "title": "", "abstract": ["Additionally, in select high-risk patients (ie, older age or multiple comorbidities) in stable remission on TNF antagonist combination therapy, consideration of discontinuing the thiopurine while the COVID-19 pandemic continues may be warranted.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19.", "In addition, most of our data suggest the possibility that TNF antagonist therapy may have a protective effect against the development of severe COVID-19 relative to other IBD therapies.", "Higher baseline TNF levels have been associated with an increased risk of death in COVID-19, and the use of TNF antagonists as a COVID-19 treatment has been advocated by some experts in order to blunt the robust inflammatory response seen in severe disease.15 22"]}
{"doc_id": 34021, "title": "", "abstract": ["The SECURE-IBD database (www.covidibd.org) was created to monitor outcomes of COVID-19 occurring in paediatric and adult patients with IBD.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "1439 cases from 47 countries were included (mean age 44.1 years, 51.4% men) of whom 112 patients (7.8%) had severe COVID-19.", "Eighty-two patients (5.7%) were admitted to an ICU, 66 (4.6%) required mechanical ventilation and 49 died (3.4%) due to COVID-19 or related complications.", "Although most cases of COVID-19 are mild, the disease can become severe and result in hospitalisation, respiratory failure or death with reported case fatality rates ranging from 2.3% to 7.2%.2 3"]}
{"doc_id": 34022, "title": "", "abstract": ["* These findings provide data to help clinicians and patients with IBD make informed, shared decisions about risks of medications in the COVID-19 era.", "However, the number of reported cases available at that time limited the ability to fully evaluate the risk of these and other IBD therapies.", "While our findings warrant replication in large population-based cohorts, these data can assist physicians and patients with IBD in shared clinical decision making during the era of COVID-19.", "Data are available on reasonable request.", "For the current analyses, we used SECURE-IBD data collected from inception (13 March 2020) to 9 June 2020."]}
{"doc_id": 34023, "title": "", "abstract": ["* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "* These findings provide data to help clinicians and patients with IBD make informed, shared decisions about risks of medications in the COVID-19 era.", "In addition, most of our data suggest the possibility that TNF antagonist therapy may have a protective effect against the development of severe COVID-19 relative to other IBD therapies.", "However, on multivariable analysis, TNF antagonist therapy was not significantly associated with severe COVID-19 (adjusted OR (aOR) 0.69, 95% CI 0.43 to 1.10).", "Finally, similar to the first SECURE-IBD report, we continue to observe an increased risk of severe COVID-19 in patients on corticosteroids."]}
{"doc_id": 34024, "title": "", "abstract": ["* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "However, it is also possible that immunosuppressive medications may be associated with a decreased risk of adverse COVID-19 outcomes by limiting the cytokine storm characteristic of severe COVID-19.15 16", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19.", "The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease."]}
{"doc_id": 34025, "title": "", "abstract": ["Patients on mesalamine/sulfasalazine appeared to have increased risk of severe COVID-19 as well, though these differences varied based on the reference group used.", "Patients on any mesalamine or sulfasalazine had a higher risk of severe COVID-19 compared with those not on mesalamine or sulfasalazine.", "In sensitivity analyses, the increased risk of severe COVID-19 with mesalamine/sulfasalazine monotherapy, compared with TNF antagonist monotherapy, was still significant after stratifying by disease type (CD: aOR 3.50, 95% CI 1.48 to 8.28; UC: aOR 5.74, 95% CI 1.15 to 28.76).", "* Mesalamine/sulfasalazine may be associated with an increased the risk of severe COVID-19, particularly when compared with TNF antagonists.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk."]}
{"doc_id": 34026, "title": "", "abstract": ["* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease.", "The impact of combination therapy on increased COVID-19 disease severity appears to be driven primarily by thiopurines as the effect estimates for thiopurine monotherapy and combination therapy compared with TNF antagonist monotherapy were similar."]}
{"doc_id": 34027, "title": "", "abstract": ["Effect of IBD medications on COVID-19 outcomes: results from an international registry", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "The SECURE-IBD database (www.covidibd.org) was created to monitor outcomes of COVID-19 occurring in paediatric and adult patients with IBD.", "We investigated the impact of different medication classes on the risk of severe COVID-19 in patients with IBD using the SECURE-IBD registry.", "We sought to evaluate COVID-19 clinical course in patients with IBD treated with different medication classes and combinations."]}
{"doc_id": 34028, "title": "", "abstract": ["In addition, most of our data suggest the possibility that TNF antagonist therapy may have a protective effect against the development of severe COVID-19 relative to other IBD therapies.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease.", "The impact of combination therapy on increased COVID-19 disease severity appears to be driven primarily by thiopurines as the effect estimates for thiopurine monotherapy and combination therapy compared with TNF antagonist monotherapy were similar."]}
{"doc_id": 34029, "title": "", "abstract": ["The multivariable models a priori included age, sex, disease phenotype (CD or UC/IBD-U), corticosteroid use and cardiovascular disease as well as any other variables significant in univariable analysis at the p<0.05 level.", "Among all patients, after adjusting for age, sex, race (black vs non-Hispanic white, Asian vs non-Hispanic white), Hispanic versus non-Hispanic ethnicity, disease type, disease activity, cardiovascular disease, TNF antagonist, thiopurine, diabetes, lung disease and cancer, corticosteroid use was significantly associated with severe COVID-19 (aOR 3.24, 95% CI 1.78 to 5.90).", "Mesalamine/sulfasalazine, n (%)| 43 (10.5)| 61 (39.4)| <0.001| 27 (25.7)| <0.001   Corticosteroid, n (%)| 17 (4.1)| 16 (10.3)| 0.005| 16 (15.2)| <0.001   Severe COVID-19, n (%)| 9 (2.2)| 15 (9.7)| <0.001| 10 (9.5)| <0.001   Death from COVID-19 or related complications, n (%)| 3 (0.7)| 3 (1.9)| 0.36| 3 (2.9)| 0.17", "§Model adjusted for age, sex, race (Asian vs non-Asian), disease type, disease activity, cardiovascular disease and corticosteroids.", "§Model adjusted for age, sex, race (Asian vs non-Asian), disease type, disease activity, cardiovascular disease, corticosteroids and sulfasalazine/mesalamine."]}
{"doc_id": 34030, "title": "", "abstract": ["Specific risk factors for severe COVID-19 include increasing age, high fever, cardiovascular disease, diabetes, obesity, chronic obstructive pulmonary disease and chronic kidney disease.2 5–7", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "The strengths of this study include the robust, worldwide collaboration that enabled us to assemble clinical data on a large, geographically diverse sample of IBD patients and rapidly define the course of COVID-19 in this population.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19."]}
{"doc_id": 34031, "title": "", "abstract": ["SECURE-IBD is a convenience sample with many patients being from the USA and of white race and subsequently may not be fully representative of the worldwide IBD population.", "Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is a large, international registry created to monitor outcomes of IBD patients with confirmed COVID-19.", "Confirmed duplicates were excluded from analysis.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "The authors would like to acknowledge all healthcare providers who reported cases to the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) registry."]}
{"doc_id": 5000, "title": "", "abstract": ["Figure 1 Average expression of important genes and gene signatures across the intrinsic breast cancer subtypes.", "Evaluation of the intrinsic breast cancer molecular subtypes in histologically diverse types.", "Average expression of additional selected genes and gene signatures across the breast cancer subtypes.", "Mean expression of the top highly expressed (n = 833) and low expressed (n = 642) genes in claudin-low cell lines across 337 human breast tumor samples classified according to intrinsic subtype, including the normal breast-like group.", "We identified those genes whose expression distinguished each human tumor subtype using significance analysis of microarrays (SAM) in our UNC337 tumor database, including a list defining the normal breast-like group (Figure 2a)."]}
{"doc_id": 5001, "title": "", "abstract": ["We next explored the mRNA expression of the TIC gene markers CD44 and CD24 and cell surface markers of epithelial differentiation such as MUC1, CD49f, and epithelial cell adhesion molecule (EpCAM) across the intrinsic subtypes (basal-like, claudin-low, luminal A, luminal B, HER2-enriched) and the normal breast-like group to determine their differentiation status.", "Further immunohistochemical analysis of 103 breast tumors of the UNC337 data set revealed that compared to the basal-like subtype, the claudin-low tumor subtype had a preponderance for low to absent expression of E-cadherin and claudin 3 (45% vs. 11% for E-cadherin, P < 0.05; 59% vs. 11% for claudin 3, P < 0.005; χ2 test).", "Next, we sought to determine whether tumor cells with undifferentiated or mesenchymal features (as defined by immunofluorescence) exist within the different breast cancer intrinsic subtypes, similar to that performed by Creighton et al. [7].", "Mean expression of the top highly expressed (n = 833) and low expressed (n = 642) genes in claudin-low cell lines across 337 human breast tumor samples classified according to intrinsic subtype, including the normal breast-like group.", "Finally, we evaluated the prognostic ability of the differentiation predictor in the UNC337 and NKI295 breast cancer patient data sets."]}
{"doc_id": 5002, "title": "", "abstract": ["Overall, claudin-low tumors highly expressed genes involved in immune system response (i.e. CD79b, CD14 and vav1), cell communication (chemokine [C-X-C motif] ligand 12), extracellular matrix (vimentin, fibroblast growth factor 7), cell differentiation (Krüppel-like factor 2, interleukin 6), cell migration (integrin a5, moesin) and angiogenesis (vascular endothelial growth factor C, matrix metallopeptidase 9) [29].", "Because primary human claudin-low tumors are highly enriched for immune system genes (and lymphocytes) when supervised analyses are performed, the expression of nonepithelial cell genes would likely increase the false positivity of the human claudin-low predictor when applied to other tumor data sets, because, for instance, tumors would be called claudin-low or not based upon the high expression of immune cell genes.", "Concordant with the expression of markers of mesenchyme and immunity, we observed high expression of stromal-specific and lymphocyte- or granulocyte- specific gene signatures in claudin-low tumors compared to the other intrinsic subtypes [16,17,19] (Figure 1b, Figure S2 in Additional file 1).", "Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features.", "For example, within the top highly expressed genes in claudin-low tumors versus all others, there are several wound response-related genes (i.e., CD28, CD52) that are not expressed by the breast cancer cell lines (Figure 2b), potentially due to significant immune or stromal cell content in the tumor."]}
{"doc_id": 5003, "title": "", "abstract": ["More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7].", "Thus, our data suggest that claudin-low tumors, compared with the other intrinsic breast tumor subtypes, are the most enriched for stem cell and/or TIC features, and on the basis of our vimentin immunofluorescence staining, it appears that these mesenchymal features are present within epithelial cells, which is a feature not seen in normal breast tissues.", "Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features.", "A potential explanation for this similar scenario of basal-like and claudin-low tumors is that chemoresistant cells with TIC or mesenchymal properties are present at diagnosis in these two tumor subtypes as suggested by our immunofluorescence dual staining (Figure S9 in Additional file 1).", "These nine murine claudin-low tumor samples were derived from six different mouse models (Brca1Co/Co;TgMMTV-Cre;p53+/-, DMBA-induced, p53-/- transplant, p53+/- IR, TgMMTV-Neu and TgWAP-T121) and overall showed similar enrichment for EMT markers and human mesenchymal and stem cell-like signatures, including decreased expression of proliferative- and luminal-associated genes (Figure S6 in Additional file 1)."]}
{"doc_id": 5004, "title": "", "abstract": ["More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7].", "Although we have not performed functional tumor cell repopulating assays on human claudin-low tumors to show their enrichment for TICs because of the low incidence of these tumors (i.e., ~7 to 14%), there is, however, evidence that the claudin-low cell lines identified here show stem cell properties and may be highly enriched for TICs.", "Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features.", "It is possible that the signature set of genes that are high in claudin-low tumors (and cell lines) are also high in nonepithelial cells, including fibroblasts and other mesenchyme-derived cells.", "The molecular characterization of the claudin-low intrinsic subtype in tumors and cell lines reveals a breast cancer differentiation hierarchy that resembles the normal epithelial mammary developmental cascade."]}
{"doc_id": 5005, "title": "", "abstract": ["In breast cancer, gene expression analyses have defined five tumor subtypes (luminal A, luminal B, HER2-enriched, basal-like and claudin-low), each of which has unique biologic and prognostic features.", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes.", "The molecular characterization of the claudin-low intrinsic subtype in tumors and cell lines reveals a breast cancer differentiation hierarchy that resembles the normal epithelial mammary developmental cascade.", "Compared to the luminal A, luminal B, HER2-enriched, and basal-like subtypes, claudin-low tumors showed inconsistent expression of basal keratins (keratins 5, 14 and 17) and low expression of HER2 and luminal markers such as ER, PR, GATA3, keratins 18 and 19 and the luminal gene cluster (Figure 1a).", "Similarly, when compared to all other tumors (basal-like, HER2-enriched, luminal A, luminal B and normal breast-like) as a single group, the claudin-low tumor subtype maintained its characteristic for low to absent expression of E-cadherin and claudin 3 (45% vs. 15% for E-cadherin, P < 0.005; 59% vs. 22% for claudin 3, P < 0.001; χ2 test) (Figure S3 in Additional file 1)."]}
{"doc_id": 5006, "title": "", "abstract": ["The claudin- low nine-cell line centroid predictor developed here will assist immediately in identifying the claudin-low subtype and its possible predictive value in any neoadjuvant clinical trial with associated microarray data.", "To complement these clustering analyses, we developed a claudin-low centroid- based predictor using the UNC337 tumor data set and the SigClust-defined claudin-low group versus all others, and objectively classified the 52 cell lines as claudin-low or not; as expected, the human tumor-based claudin-low predictor identified these nine cell lines as claudin-low (Figure S5 in Additional file 1).", "Therefore, we developed a claudin-low centroid-based predictor using the cell line database of Neve et al. [21].", "The nine-cell line claudin-low predictor identified 37 samples (~11%) as claudin-low, including the 28 claudin-low samples previously identified by hierarchical clustering.", "Overall, the nine-cell line claudin-low predictor showed 87.5% sensitivity, 97.0% specificity, and 75.7% and 98.7% positive and negative predictive values, respectively, if the SigClust-defined claudin-low group is considered the gold standard."]}
{"doc_id": 5007, "title": "", "abstract": ["More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7].", "These nine cell lines (MDA-MB-435, MDA-MB-436, Hs578T, BT549, MDA-MB-231, MDA-MB-157, SUM1315MO2, SUM159PT and HBL100) showed a gene expression pattern similar to the claudin-low tumor subtype with the lowest expression of genes involved in epithelial cell-cell adhesion (i.e., E-cadherin and claudins 3, 4 and 7), luminal differentiation (i.e., CD24, EpCAM) and high values for the CD44/CD24 and CD49f/EpCAM mRNA ratios (Figure S4, Table S3 in Additional file 1).", "We also evaluated the potential association between claudin-low tumors and treatment response by using the MDACC breast cancer patient data set (133 pretreated samples) of tumors treated with neoadjuvant anthracycline/taxane- based chemotherapy [13].", "The molecular characterization of the claudin-low intrinsic subtype in tumors and cell lines reveals a breast cancer differentiation hierarchy that resembles the normal epithelial mammary developmental cascade.", "In this study, we comprehensively characterize the claudin-low subtype using an updated human tumor database and multiple independent data sets and present the pathological and chemotherapy response characteristics of this subtype of \"triple negative\" breast cancers."]}
{"doc_id": 5008, "title": "", "abstract": ["We also used publicly available microarray and patient clinical data from the following breast cancer data sets: NKI295 [11,12], MDACC133 [13] and NKI113 [14].", "Using their microarray data, we developed a genomic differentiation predictor that classifies breast tumors on the basis of their differentiation status along a continuous MaSC → pL → mL epithelial hierarchy.", "All human tumor and normal tissue samples were collected using Institutional Review Board (IRB)-approved protocols and were obtained from fresh frozen invasive breast carcinomas that were profiled as described previously using oligo microarrays (Agilent Technologies, Santa Clara, CA, USA) [8]; we used all the microarrays from Herschkowitz et al. [5], Parker et al. [9] and Hennessy et al. [6], plus 39 new additional samples presented here.", "We analyzed a data set that included Affymetrix U133A gene expression microarrays of 52 breast cancer cell lines [21].", "As expected, we observed the same pattern using the breast cancer cell line data [21] (Figure 4d)."]}
{"doc_id": 5009, "title": "", "abstract": ["These findings suggest that claudin-low tumors show some chemotherapy sensitivity but overall have a poor prognosis and may not be managed effectively with existing chemotherapy regimens.", "Notably, claudin-low tumors showed a lower pathological complete response (pCR) rate after anthracycline/taxane-based chemotherapy compared to basal-like tumors (38.9% vs. 73.3% pCR rates; P = 0.08, Fisher's exact test), but their pCR rate was higher than luminal A or B tumors; interestingly, the apparent pCR rate of the basal-like tumors increased from 59% (reported in Parker et al. [9]) to ~73% when the claudin- low subtype was included, because among 18 claudin-low tumors identified in this set, 12 (67%) of 18 of them were previously identified as basal-like and the response rate of this subgroup of patients was 41.7%.", "Thus, as has been described for basal-like tumors [4], claudin-low tumors show some chemotherapy sensitivity, yet patients with these tumors still have poor survival outcomes overall (Figure 3b).", "A potential explanation for this similar scenario of basal-like and claudin-low tumors is that chemoresistant cells with TIC or mesenchymal properties are present at diagnosis in these two tumor subtypes as suggested by our immunofluorescence dual staining (Figure S9 in Additional file 1).", "Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation."]}
{"doc_id": 5010, "title": "", "abstract": ["These nine cell lines (MDA-MB-435, MDA-MB-436, Hs578T, BT549, MDA-MB-231, MDA-MB-157, SUM1315MO2, SUM159PT and HBL100) showed a gene expression pattern similar to the claudin-low tumor subtype with the lowest expression of genes involved in epithelial cell-cell adhesion (i.e., E-cadherin and claudins 3, 4 and 7), luminal differentiation (i.e., CD24, EpCAM) and high values for the CD44/CD24 and CD49f/EpCAM mRNA ratios (Figure S4, Table S3 in Additional file 1).", "The molecular characterization of the claudin-low intrinsic subtype in tumors and cell lines reveals a breast cancer differentiation hierarchy that resembles the normal epithelial mammary developmental cascade.", "It is interesting to note that two claudin-low cell lines, Hs578T and MDA-MB-157, were derived from metaplastic [39] and medullary [40] carcinomas.", "Here, we comprehensively characterize the recently identified claudin-low tumor subtype.", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes."]}
{"doc_id": 5011, "title": "", "abstract": ["Conversely, similar survival curves were observed between claudin-low tumors and the other poor prognosis subtypes such as luminal B, HER2-enriched and basal-like tumors (Figure 3b).", "Thus, as has been described for basal-like tumors [4], claudin-low tumors show some chemotherapy sensitivity, yet patients with these tumors still have poor survival outcomes overall (Figure 3b).", "These data suggest that tumors with an undifferentiated phenotype similar to the normal MaSC and/or early progenitors have a poorer prognosis compared to tumors with a more mature luminal phenotype, and this association is independent of the luminal B and HER2-enriched subtypes and the common clinical variables.", "In this article, we characterize an important new disease group, namely the claudin-low subtype of breast cancer, and show that these tumors have a poor prognosis and features of mesenchymal and mammary stem cells.", "A potential explanation for this similar scenario of basal-like and claudin-low tumors is that chemoresistant cells with TIC or mesenchymal properties are present at diagnosis in these two tumor subtypes as suggested by our immunofluorescence dual staining (Figure S9 in Additional file 1)."]}
{"doc_id": 5012, "title": "", "abstract": ["The validity of the claudin-low sample cluster was confirmed by parsing the dendogram with SigClust [22] (P < 0.001); notably, this clustering analysis placed the claudin-low tumors in close proximity to the basal-like subtype and was composed of 32 arrays, representing 32 patients (~12% of all patients).", "Conversely, the CD49f+/EpCAM-/low cells from the basal-like SUM149PT cell line showed the presence of a mesenchymal/claudin-low-like gene expression profile, with high expression of genes involved in wound response (i.e., interleukin 6, chemokine [C-X-C motif], ligand 1), angiogenesis (i.e., VEGFA) and extracellular matrix (i.e., vimentin, SNAI1), while genes involved in luminal differentiation (i.e., keratin 19, CD24) and cell-cell adhesion such as E-cadherin or claudin 7 were low (Figure 7c and Supplemental Data in Additional file 2).", "The nine-cell line claudin-low predictor identified 37 samples (~11%) as claudin-low, including the 28 claudin-low samples previously identified by hierarchical clustering.", "Mean expression of the top highly expressed (n = 833) and low expressed (n = 642) genes in claudin-low cell lines across 337 human breast tumor samples classified according to intrinsic subtype, including the normal breast-like group.", "More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7]."]}
{"doc_id": 5013, "title": "", "abstract": ["Thus, our data suggest that claudin-low tumors, compared with the other intrinsic breast tumor subtypes, are the most enriched for stem cell and/or TIC features, and on the basis of our vimentin immunofluorescence staining, it appears that these mesenchymal features are present within epithelial cells, which is a feature not seen in normal breast tissues.", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes.", "Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features.", "In contrast to the basal-like subtype, we provide evidence that claudin-low tumors are more enriched in epithelial-to- mesenchymal transition (EMT) features, immune system responses, and stem cell- associated biological processes.", "Although we have not performed functional tumor cell repopulating assays on human claudin-low tumors to show their enrichment for TICs because of the low incidence of these tumors (i.e., ~7 to 14%), there is, however, evidence that the claudin-low cell lines identified here show stem cell properties and may be highly enriched for TICs."]}
{"doc_id": 5014, "title": "", "abstract": ["To determine for the first time the clinical-pathological characteristics of human claudin-low breast tumors, we evaluated our breast cancer patient database (UNC337) and two independent gene expression data sets (NKI295 and MDACC133) [11-13] using the nine-cell line claudin-low predictor and the previously published PAM50 subtype predictor (Figure 3a) because these two objective centroid predictors have been demonstrated to be the most robust to classify breast tumors into discrete subtypes.", "We then used the nine-cell line claudin-low predictor to identify this subtype in a mouse tumor database [5], which represents 13 different mouse models grouped in 10 different classes on the basis of their gene expression profiles (Groups I to X).", "To complement these clustering analyses, we developed a claudin-low centroid- based predictor using the UNC337 tumor data set and the SigClust-defined claudin-low group versus all others, and objectively classified the 52 cell lines as claudin-low or not; as expected, the human tumor-based claudin-low predictor identified these nine cell lines as claudin-low (Figure S5 in Additional file 1).", "The therapeutic implication of the claudin-low subtype will require additional retrospective and prospective evaluations, but what does appear clearer is that the intrinsic subtypes of breast cancer may be reflective of distinct stages of mammary epithelial cell development and that the claudin-low tumors (and cell lines) show the least differentiated phenotype.", "Thus, our data suggest that claudin-low tumors, compared with the other intrinsic breast tumor subtypes, are the most enriched for stem cell and/or TIC features, and on the basis of our vimentin immunofluorescence staining, it appears that these mesenchymal features are present within epithelial cells, which is a feature not seen in normal breast tissues."]}
{"doc_id": 5015, "title": "", "abstract": ["These distinct tumors were found in both human and murine breast tumor data sets and were characterized by the low gene expression of tight junction proteins claudin 3, 4 and 7 and E-cadherin, a calcium-dependent cell-cell adhesion glycoprotein.", "Consistent with this finding, we observed a high mRNA expression of known transcriptional repressors of E-cadherin such as SNAI1, SNAI2, TWIST1, TWIST2, ZEB1 and ZEB2, and other EMT-inducing factors such as hypoxia-inducible factor-1a in claudin-low tumors [31] (Figure 1b, Figure S2 in Additional file 1).", "Conversely, the CD49f+/EpCAM-/low cells from the basal-like SUM149PT cell line showed the presence of a mesenchymal/claudin-low-like gene expression profile, with high expression of genes involved in wound response (i.e., interleukin 6, chemokine [C-X-C motif], ligand 1), angiogenesis (i.e., VEGFA) and extracellular matrix (i.e., vimentin, SNAI1), while genes involved in luminal differentiation (i.e., keratin 19, CD24) and cell-cell adhesion such as E-cadherin or claudin 7 were low (Figure 7c and Supplemental Data in Additional file 2).", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes.", "These findings, together with the low expression of epithelial cell-cell adhesion molecules such as E-cadherin, are consistent with an EMT (changes in cell phenotype between epithelial and mesenchymal states) [31] in claudin-low tumors and a potential recruitment of multiple types of leukocytes into these tumors."]}
{"doc_id": 5016, "title": "", "abstract": ["Claudin-low tumors are characterized by the low to absent expression of luminal differentiation markers, high enrichment for epithelial-to-mesenchymal transition markers, immune response genes and cancer stem cell-like features.", "These findings, together with the low expression of epithelial cell-cell adhesion molecules such as E-cadherin, are consistent with an EMT (changes in cell phenotype between epithelial and mesenchymal states) [31] in claudin-low tumors and a potential recruitment of multiple types of leukocytes into these tumors.", "These distinct tumors were found in both human and murine breast tumor data sets and were characterized by the low gene expression of tight junction proteins claudin 3, 4 and 7 and E-cadherin, a calcium-dependent cell-cell adhesion glycoprotein.", "Similarly, when compared to all other tumors (basal-like, HER2-enriched, luminal A, luminal B and normal breast-like) as a single group, the claudin-low tumor subtype maintained its characteristic for low to absent expression of E-cadherin and claudin 3 (45% vs. 15% for E-cadherin, P < 0.005; 59% vs. 22% for claudin 3, P < 0.001; χ2 test) (Figure S3 in Additional file 1).", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes."]}
{"doc_id": 5017, "title": "", "abstract": ["The molecular characterization of the claudin-low intrinsic subtype in tumors and cell lines reveals a breast cancer differentiation hierarchy that resembles the normal epithelial mammary developmental cascade.", "The therapeutic implication of the claudin-low subtype will require additional retrospective and prospective evaluations, but what does appear clearer is that the intrinsic subtypes of breast cancer may be reflective of distinct stages of mammary epithelial cell development and that the claudin-low tumors (and cell lines) show the least differentiated phenotype.", "Identification of the claudin-low subtype in a panel of breast cancer cell lines.", "### Molecular characterization of the claudin-low breast tumor subtype", "These nine cell lines (MDA-MB-435, MDA-MB-436, Hs578T, BT549, MDA-MB-231, MDA-MB-157, SUM1315MO2, SUM159PT and HBL100) showed a gene expression pattern similar to the claudin-low tumor subtype with the lowest expression of genes involved in epithelial cell-cell adhesion (i.e., E-cadherin and claudins 3, 4 and 7), luminal differentiation (i.e., CD24, EpCAM) and high values for the CD44/CD24 and CD49f/EpCAM mRNA ratios (Figure S4, Table S3 in Additional file 1)."]}
{"doc_id": 5018, "title": "", "abstract": ["More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7].", "Thus, our data suggest that claudin-low tumors, compared with the other intrinsic breast tumor subtypes, are the most enriched for stem cell and/or TIC features, and on the basis of our vimentin immunofluorescence staining, it appears that these mesenchymal features are present within epithelial cells, which is a feature not seen in normal breast tissues.", "Overall, these studies suggest that the claudin-low tumor subtype lacks common epithelial cell features and is enriched for TIC features.", "Although we have not performed functional tumor cell repopulating assays on human claudin-low tumors to show their enrichment for TICs because of the low incidence of these tumors (i.e., ~7 to 14%), there is, however, evidence that the claudin-low cell lines identified here show stem cell properties and may be highly enriched for TICs.", "Molecular characterization of the claudin-low subtype reveals that these tumors are significantly enriched in EMT and stem cell-like features while showing a low expression of luminal and proliferation-associated genes."]}
{"doc_id": 5019, "title": "", "abstract": ["Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation.", "Thus, as has been described for basal-like tumors [4], claudin-low tumors show some chemotherapy sensitivity, yet patients with these tumors still have poor survival outcomes overall (Figure 3b).", "Conversely, similar survival curves were observed between claudin-low tumors and the other poor prognosis subtypes such as luminal B, HER2-enriched and basal-like tumors (Figure 3b).", "These findings suggest that claudin-low tumors show some chemotherapy sensitivity but overall have a poor prognosis and may not be managed effectively with existing chemotherapy regimens.", "Conversely, the majority of triple-negative tumors were either basal-like (39 to 54%) or claudin-low (25 to 39%), followed by HER2-enriched (7 to 14%), luminal B (4 to 7%), luminal A (4 to 5%) and normal breast-like (1%)."]}
{"doc_id": 5020, "title": "", "abstract": ["More recently, a tumor initiating cell (TIC) genomic signature derived from CD44+/CD24-/low-sorted cells and mammospheres obtained from primary human breast tumors was found to be exclusively enriched by gene expression in the claudin-low subtype [6,7], and the expression of this CD44+/CD24-/low/claudin-low profile increased in posttreatment samples after neoadjuvant chemotherapy or hormone therapy [7].", "The validity of the claudin-low sample cluster was confirmed by parsing the dendogram with SigClust [22] (P < 0.001); notably, this clustering analysis placed the claudin-low tumors in close proximity to the basal-like subtype and was composed of 32 arrays, representing 32 patients (~12% of all patients).", "Here, we comprehensively characterize the recently identified claudin-low tumor subtype.", "Since the pathological examination of claudin-low tumors identified special histological features, we applied the nine-cell line claudin-low predictor to a publicly available database of histologically diverse subtypes of breast cancer (n = 113, NKI113) [14], which includes 10 medullary carcinomas, 20 metaplastic carcinomas and 22 invasive lobular carcinomas (ILC).", "Further immunohistochemical analysis of 103 breast tumors of the UNC337 data set revealed that compared to the basal-like subtype, the claudin-low tumor subtype had a preponderance for low to absent expression of E-cadherin and claudin 3 (45% vs. 11% for E-cadherin, P < 0.05; 59% vs. 11% for claudin 3, P < 0.005; χ2 test)."]}
{"doc_id": 5021, "title": "", "abstract": ["Thus, our data suggest that claudin-low tumors, compared with the other intrinsic breast tumor subtypes, are the most enriched for stem cell and/or TIC features, and on the basis of our vimentin immunofluorescence staining, it appears that these mesenchymal features are present within epithelial cells, which is a feature not seen in normal breast tissues.", "The validity of the claudin-low sample cluster was confirmed by parsing the dendogram with SigClust [22] (P < 0.001); notably, this clustering analysis placed the claudin-low tumors in close proximity to the basal-like subtype and was composed of 32 arrays, representing 32 patients (~12% of all patients).", "These nine murine claudin-low tumor samples were derived from six different mouse models (Brca1Co/Co;TgMMTV-Cre;p53+/-, DMBA-induced, p53-/- transplant, p53+/- IR, TgMMTV-Neu and TgWAP-T121) and overall showed similar enrichment for EMT markers and human mesenchymal and stem cell-like signatures, including decreased expression of proliferative- and luminal-associated genes (Figure S6 in Additional file 1).", "Compared to the luminal A, luminal B, HER2-enriched, and basal-like subtypes, claudin-low tumors showed inconsistent expression of basal keratins (keratins 5, 14 and 17) and low expression of HER2 and luminal markers such as ER, PR, GATA3, keratins 18 and 19 and the luminal gene cluster (Figure 1a).", "Interestingly, all claudin-low samples identified by the centroid predictor (n = 9) were included in Group II, which we previously highlighted for its mesenchymal features (i.e., spindle-shaped cells)."]}
{"doc_id": 5022, "title": "", "abstract": ["These data suggest that tumors with an undifferentiated phenotype similar to the normal MaSC and/or early progenitors have a poorer prognosis compared to tumors with a more mature luminal phenotype, and this association is independent of the luminal B and HER2-enriched subtypes and the common clinical variables.", "In terms of prognosis, Kaplan-Meier survival analysis revealed that claudin-low tumors have a worse prognosis compared to luminal A tumors in both the UNC337 (hazard ratio [HR] of 2.83 and 5.66 for relapse-free survival [RFS] and overall survival [OS], respectively; P < 0.05) and NKI295 data sets (HR of 4.71 and 17.98 for RFS and OS, respectively; P < 0.001).", "Conversely, similar survival curves were observed between claudin-low tumors and the other poor prognosis subtypes such as luminal B, HER2-enriched and basal-like tumors (Figure 3b).", "In this article, we characterize an important new disease group, namely the claudin-low subtype of breast cancer, and show that these tumors have a poor prognosis and features of mesenchymal and mammary stem cells.", "In breast cancer, gene expression analyses have defined five tumor subtypes (luminal A, luminal B, HER2-enriched, basal-like and claudin-low), each of which has unique biologic and prognostic features."]}
{"doc_id": 9000, "title": "", "abstract": ["We show that the transcriptome changes observed in ASD brain converge with GWAS data in supporting the genetic basis of synaptic and neuronal signaling dysfunction in ASD, while immune changes have a less pronounced genetic component and thus are most likely either secondary phenomena or caused by environmental factors.", "Our system-level analysis of the ASD brain transcriptome demonstrates the existence of convergent molecular abnormalities in ASD for the first time, providing a molecular neuropathological basis for the disease, whose genetic, epigenetic, or environmental etiologies can now be directly explored.", "To identify potential A2BP1-dependent differential splicing (DS) events in ASD brain, we performed high-throughput RNA sequencing (RNA-Seq) on 3 autism samples with significant down-regulation of A2BP1 (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels.", "To test whether these findings were replicable, and to further validate the results in an independent dataset, we obtained tissue from an additional frontal cortex region (BA44/45) from nine ASD cases and five controls (DS2; Supplementary Table 4).", "Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder."]}
{"doc_id": 9001, "title": "", "abstract": ["Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis.", "This module, which was upregulated in ASD brain, showed significant similarity to two modules identified in previous studies of normal human brain8: an astrocyte module and a microglial module.", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers.", "We show that the transcriptome changes observed in ASD brain converge with GWAS data in supporting the genetic basis of synaptic and neuronal signaling dysfunction in ASD, while immune changes have a less pronounced genetic component and thus are most likely either secondary phenomena or caused by environmental factors.", "Similarly, the majority of the autism modules (87%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain."]}
{"doc_id": 9002, "title": "", "abstract": ["Moreover, using a published autism GWAS dataset, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism.", "We found that the top module (M12) showed highly significant enrichment for neuronal markers (Supplementary Table 9), and high overlap with two neuronal modules previously identified as part of the human brain transcriptional network8: a PVALB+ interneuron module and a module of genes involved in synaptic function.", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers.", "In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic etiology for this process.", "B. Relevant gene ontology categories enriched in the set of genes containing exons differentially spliced between low-A2BP1 autism cases and controls."]}
{"doc_id": 9003, "title": "", "abstract": ["We show that the transcriptome changes observed in ASD brain converge with GWAS data in supporting the genetic basis of synaptic and neuronal signaling dysfunction in ASD, while immune changes have a less pronounced genetic component and thus are most likely either secondary phenomena or caused by environmental factors.", "Since immune molecules and cells such as microglia play a role in synaptic development and function26, we speculate that the observed immune up- regulation may be related to abnormal ongoing plasticity in ASD brain.", "These results indicate that (a) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (b) the upregulation of immune response genes in the autistic brain observed by us and others25 has no evidence of a common genetic component.", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers.", "We also demonstrate for the first time alterations in differential splicing associated with A2BP1/FOX1 levels in ASD brain, and show that many of the affected exons belong to genes involved in synaptic function."]}
{"doc_id": 9004, "title": "", "abstract": ["Since immune molecules and cells such as microglia play a role in synaptic development and function26, we speculate that the observed immune up- regulation may be related to abnormal ongoing plasticity in ASD brain.", "These results indicate that (a) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (b) the upregulation of immune response genes in the autistic brain observed by us and others25 has no evidence of a common genetic component.", "The genome-wide analysis performed here significantly extends previous findings implicating synaptic dysfunction, as well as microglial and immune dysregulation in ASD6 by providing an unbiased systematic assessment of transcriptional alterations and their genetic basis.", "Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.", "Using high-throughput RNA-sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in ASD brain."]}
{"doc_id": 9005, "title": "", "abstract": ["# Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2).", "We observed a highly significant overlap between DE genes in frontal and temporal cortex (p = 10E-44; Figure 1b), supporting the robustness of the data and indicating that the autism-specific expression changes are consistent across these cortical areas.", "For each individual, we profiled three regions previously implicated in autism5: superior temporal gyrus (STG /Brodmann’s area [BA] 41/42), prefrontal cortex (BA9) and cerebellar vermis.", "These data suggest that typical regional differences, many of which are observed during fetal development10, are attenuated in frontal and temporal lobe in autism brain, pointing to abnormal developmental patterning as a potential pathophsyiological driver in ASD."]}
{"doc_id": 9006, "title": "", "abstract": ["Gene ontology (GO) enrichment analysis (Methods) revealed that the 209 genes downregulated in autistic cortex were enriched for GO categories related to synaptic function, whereas the upregulated genes (N=235) showed enrichment for GO categories implicated in immune and inflammatory response (Supplementary Table 3).", "As a negative control, we performed the same set-enrichment analysis using two GWAS studies for non-psychiatric disease performed on the same genotyping platform: a genome-wide association for hair color23, and a GWAS study of Warfarin maintenance dose24 finding no significant enrichment of the association signal (Figure 4b, Supplementary Figure 4).", "In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic etiology for this process.", "M12 showed highly significant enrichment for association signals (p = 5E-4), but neither M16 nor the list of DE genes showed such enrichment (Figure 4).", "These results indicate that (a) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (b) the upregulation of immune response genes in the autistic brain observed by us and others25 has no evidence of a common genetic component."]}
{"doc_id": 9007, "title": "", "abstract": ["Gene ontology (GO) enrichment analysis (Methods) revealed that the 209 genes downregulated in autistic cortex were enriched for GO categories related to synaptic function, whereas the upregulated genes (N=235) showed enrichment for GO categories implicated in immune and inflammatory response (Supplementary Table 3).", "These results indicate that (a) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (b) the upregulation of immune response genes in the autistic brain observed by us and others25 has no evidence of a common genetic component.", "In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic etiology for this process.", "Enrichment p values are shown for an autism GWAS dataset (Wang et al.27, AGRE discovery cohort) as well as two control datasets consisting of GWAS studies of non-psychiatric traits: Han et al.23", "Moreover, using a published autism GWAS dataset, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism."]}
{"doc_id": 9008, "title": "", "abstract": ["We found that the top module (M12) showed highly significant enrichment for neuronal markers (Supplementary Table 9), and high overlap with two neuronal modules previously identified as part of the human brain transcriptional network8: a PVALB+ interneuron module and a module of genes involved in synaptic function.", "Moreover, using a published autism GWAS dataset, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism.", "Similarly, the majority of the autism modules (87%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.", "Analysis of DE from a data set10 of gene expression in developing fetal human brain showed a highly significant (p = 5.8E-9) overlap of DE genes with those found in controls in this study, independently confirming that these genes differentiate normal temporal and frontal lobes.", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers."]}
{"doc_id": 9009, "title": "", "abstract": ["The comparison between autism and control groups revealed two network modules whose eigengenes were highly correlated with disease status, and not any of the potential confounding variables (Supplementary Table 9).", "Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.", "These data suggest that typical regional differences, many of which are observed during fetal development10, are attenuated in frontal and temporal lobe in autism brain, pointing to abnormal developmental patterning as a potential pathophsyiological driver in ASD.", "The RNA-Seq data thus provides validation of the functional groups of genes identified by co-expression analysis, and evidence for a convergence of transcriptional and alternative-splicing abnormalities in the synaptic and signaling pathogenesis of ASD.", "To identify potential A2BP1-dependent differential splicing (DS) events in ASD brain, we performed high-throughput RNA sequencing (RNA-Seq) on 3 autism samples with significant down-regulation of A2BP1 (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels."]}
{"doc_id": 9010, "title": "", "abstract": ["These results indicate that (a) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (b) the upregulation of immune response genes in the autistic brain observed by us and others25 has no evidence of a common genetic component.", "The first three of these genes have previously been implicated in autism14–16, while the fourth is a homologue of the autism susceptibility gene CNTNAP217.", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers.", "The second module of co-expressed genes highly related to autism disease status, M16, was enriched for astrocyte markers and markers of activated microglia (Supplementary Table 9), as well as for genes belonging to immune and inflammatory GO categories (Figure 2).", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2)."]}
{"doc_id": 9011, "title": "", "abstract": ["A. GWAS set enrichment analysis using the discovery AGRE cohort from Wang et al.27", "Gene ontology (GO) enrichment analysis (Methods) revealed that the 209 genes downregulated in autistic cortex were enriched for GO categories related to synaptic function, whereas the upregulated genes (N=235) showed enrichment for GO categories implicated in immune and inflammatory response (Supplementary Table 3).", "Enrichment p values are shown for an autism GWAS dataset (Wang et al.27, AGRE discovery cohort) as well as two control datasets consisting of GWAS studies of non-psychiatric traits: Han et al.23", "As a negative control, we performed the same set-enrichment analysis using two GWAS studies for non-psychiatric disease performed on the same genotyping platform: a genome-wide association for hair color23, and a GWAS study of Warfarin maintenance dose24 finding no significant enrichment of the association signal (Figure 4b, Supplementary Figure 4).", "In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic etiology for this process."]}
{"doc_id": 9012, "title": "", "abstract": ["Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.", "A. Heatmap of top 200 genes differentially expressed between autism and control cortex samples.", "Enrichment p values are shown for an autism GWAS dataset (Wang et al.27, AGRE discovery cohort) as well as two control datasets consisting of GWAS studies of non-psychiatric traits: Han et al.23", "Red-autism samples, black-control samples.", "The RNA-Seq data thus provides validation of the functional groups of genes identified by co-expression analysis, and evidence for a convergence of transcriptional and alternative-splicing abnormalities in the synaptic and signaling pathogenesis of ASD."]}
{"doc_id": 9013, "title": "", "abstract": ["Remarkably, the direction of expression differences between autism and controls was the same as in the initial cohort for all but 2 of the 81 overlapping DE probes.", "The comparison between autism and control groups revealed two network modules whose eigengenes were highly correlated with disease status, and not any of the potential confounding variables (Supplementary Table 9).", "To identify discrete groups of co-expressed genes showing transcriptional differences between autism and controls, we constructed a co-expression network using the entire dataset, composed of both autism and control samples (Methods).", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2).", "This was not simply an issue of statistical thresholds, as relaxing the statistical criteria for DE to an FDR of 5%, identified over 500 DE genes in controls, and only 8 in ASD brains, confirming the large difference observed in regional cortical differential gene expression between ASD cases and controls (Figure 1d, Methods)."]}
{"doc_id": 9014, "title": "", "abstract": ["To identify discrete groups of co-expressed genes showing transcriptional differences between autism and controls, we constructed a co-expression network using the entire dataset, composed of both autism and control samples (Methods).", "We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1/FOX1, and a module enriched for immune genes and glial markers.", "In addition, five previously validated A2BP1 targets showed evidence of alternative splicing, four of which (ATP5C1, ATP2B1, GRIN1 and MEF2C) were confirmed as having differential splicing between ASD samples with low A2BP1 expression and control samples, indicating that we were able to identify a high proportion of the expected A2BP1-dependent DS events.", "The RNA-Seq data thus provides validation of the functional groups of genes identified by co-expression analysis, and evidence for a convergence of transcriptional and alternative-splicing abnormalities in the synaptic and signaling pathogenesis of ASD.", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2)."]}
{"doc_id": 9015, "title": "", "abstract": ["Ninety-seven genes were differentially expressed in BA44/45 in DS2, and 81 of these were also DE in our initial cohort (p=1.2E-93, hypergeometric test; Figure 1b, c).", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2).", "In addition, comparison of these DE results with another, smaller study of the STG in ASD7, revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).", "We observed a highly significant overlap between DE genes in frontal and temporal cortex (p = 10E-44; Figure 1b), supporting the robustness of the data and indicating that the autism-specific expression changes are consistent across these cortical areas.", "This was not simply an issue of statistical thresholds, as relaxing the statistical criteria for DE to an FDR of 5%, identified over 500 DE genes in controls, and only 8 in ASD brains, confirming the large difference observed in regional cortical differential gene expression between ASD cases and controls (Figure 1d, Methods)."]}
{"doc_id": 9016, "title": "", "abstract": ["Supervised hierarchical clustering based on the top 200 DE genes showed distinct clustering of the majority of autism cortex samples (Figure 1a), including one case that was simultaneously found to have a 15q duplication (Methods, Supplementary Table 1), which is known to cause 1% of ASD6.", "A. Heatmap of top 200 genes differentially expressed between autism and control cortex samples.", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2).", "Moreover, using a published autism GWAS dataset, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism.", "Remarkably, the direction of expression differences between autism and controls was the same as in the initial cohort for all but 2 of the 81 overlapping DE probes."]}
{"doc_id": 9017, "title": "", "abstract": ["The genome-wide analysis performed here significantly extends previous findings implicating synaptic dysfunction, as well as microglial and immune dysregulation in ASD6 by providing an unbiased systematic assessment of transcriptional alterations and their genetic basis.", "We identified 444 genes showing significant expression changes in autism cortex samples (DS1, Figure 1b), and only 2 genes differentially expressed (DE) between the autism and control groups in cerebellum (Methods), indicating that gene expression changes associated with autism were more pronounced in cerebral cortex, which became the focus of further analysis (Supplementary Table 2).", "We show that the transcriptome changes observed in ASD brain converge with GWAS data in supporting the genetic basis of synaptic and neuronal signaling dysfunction in ASD, while immune changes have a less pronounced genetic component and thus are most likely either secondary phenomena or caused by environmental factors.", "The striking attenuation of gene expression differences observed here between frontal and temporal cortex in ASD likely represents a defect of developmental patterning and provides a strong rationale for further studies to assess the pervasiveness of transcriptional patterning abnormalities across the ASD brain.", "Our system-level analysis of the ASD brain transcriptome demonstrates the existence of convergent molecular abnormalities in ASD for the first time, providing a molecular neuropathological basis for the disease, whose genetic, epigenetic, or environmental etiologies can now be directly explored."]}
{"doc_id": 35000, "title": "", "abstract": ["In primary human lung epithelial cell cultures, RDV is potently antiviral against circulating contemporary human CoVs, SARS-CoV (EC50 = 0.07 µM), MERS-CoV (EC50 = 0.07 µM), and related zoonotic bat CoVs17,21.", "To ensure that our reporter virus behaved similarly to WT MERS-CoV, we first demonstrated that MERS-nLUC and wild-type (WT) MERS-CoV EMC 2012 strain replicate to similar levels in the absence of drug treatment and are similarly susceptible to the antiviral activity of RDV (WT EC50 = 0.12 µM; MERS-nLUC EC50 = 0.09 µM) in the human lung epithelial cell line, Calu-3 (Supplementary Fig. 1).", "Lung sectioning, hematoxylin and eosin staining as well as MERS-CoV antigen (primary antibody 1:500, sera from mice vaccinated with MERS-CoV nucleocapsid antigen) staining was performed by the Animal Histopathology & Laboratory Medicine Core at UNC.", "First, we assessed antiviral efficacy and cytoxicity in the Calu-3 human lung cell line as compared with the appropriate vehicle control.", "To determine if virus replication kinetics and RDV susceptibility were similar among wild-type (WT) MERS-CoV EMC 2012 and MERS-nLUC, we performed comparative antiviral assays the human lung epithelial cell line, Calu-3 2B4 (kindly provided by Dr. Chien Tseng University of Texas Medical Branch)."]}
{"doc_id": 35001, "title": "", "abstract": ["Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "To more stringently assess the therapeutic potential of RDV and LPV/RTV-IFNb and to better model the human scenario where MERS-CoV patients most likely would initiate treatment after infection, we performed a series of therapeutic efficacy studies in mice.", "In contrast, human equivalent doses of RDV are demonstrably efficacious in mice infected with SARS- and MERS-CoV and in nonhuman primates infected with EBOV thus demonstrating a more suitable PK/PD relationship17.", "Second, we evaluated the in vivo efficacy of prophylactic RDV as compared to vehicle with two different doses of MERS-CoV in a new transgenic mouse model of MERS-CoV pathogenesis with improved pharmacokinetics for nucleotide prodrugs.", "Thus, we provide in vivo evidence of the potential for RDV to treat MERS-CoV infections."]}
{"doc_id": 35002, "title": "", "abstract": ["As we sought to understand this result, we found little experimental congruency among reports detailing the prophylactic or therapeutic efficacy of type I interferons in animal models of MERS-CoV11,37,38.", "Third, we assessed the therapeutic efficacy of the above treatment regimens in a mouse model of MERS-CoV pathogenesis, but did not include an IFNb, only arm and these studies were performed twice.", "Second, we evaluated the in vivo efficacy of prophylactic RDV as compared to vehicle with two different doses of MERS-CoV in a new transgenic mouse model of MERS-CoV pathogenesis with improved pharmacokinetics for nucleotide prodrugs.", "The only in vivo study assessing the therapeutic efficacy of LPV/RTV or IFNb against MERS-CoV published thus far was performed in common marmosets where modest improvements in clinical outcomes were noted11.", "We recently reported that therapeutic RDV improves disease outcomes and reduces viral loads in SARS-CoV-infected mice17."]}
{"doc_id": 35003, "title": "", "abstract": ["LPV is a human immunodeficiency virus 1 (HIV-1) protease inhibitor that is usually combined with RTV to increase LPV half-life through the inhibition of cytochrome P4507.", "Thus, we combined LPV (5 µM) and RTV (1.09 µM) at a fixed molar ratio of 4.6:1 in combination with increasing concentrations of IFNb.", "We then combined a dose response of human IFNb with a fixed concentration of LPV/RTV (molar ratio of 4.6:1, (5 µM Lopinavir and 1.1 µM Ritonavir) based on the human plasma equivalent maximal concentration of LPV as determined by CED (i.e., 5 µM).", "Thus, this study was aimed at determining if the maximal amount of LPV attainable in humans provided an additive or synergistic antiviral effect when combined with IFNb.", "The antiviral activity of the LPV/RTV-IFNb combination (EC50 = 160 IU/mL) was indistinguishable from that of IFNb alone (EC50 = 175 IU/mL) (P = 0.62, Wilcoxon matched-pairs signed rank test) (Fig. 1f)."]}
{"doc_id": 35004, "title": "", "abstract": ["These results are similar to those obtained for SARS-CoV, where therapeutic treatment initiated after peak virus titer and lung damage failed to improve outcomes yet significantly reduced viral titer17.", "Similarly, only RDV treatment significantly reduced virus lung titers on 6 dpi (vehicle median 7.8E + 05 pfu/lobe, RDV median 125 pfu/lobe, P = 0.0001, one-way ANOVA with Kruskal–Wallis test) (Fig. 5d), which we corroborated with viral antigen labeling in lung tissue sections (Fig. 5e).", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "We recently reported that therapeutic RDV improves disease outcomes and reduces viral loads in SARS-CoV-infected mice17.", "Similar therapeutic studies (Supplementary Fig. 6) were performed but with a lethal dose of MERS-CoV (5E + 05 pfu) where no treatment improved survival (Supplementary Fig. 6a, d) or lung hemorrhage (Supplementary Fig. 6b, e), but therapeutic RDV significantly reduced lung viral load on 6 dpi (Supplementary Fig. S6c) (P = 0.03, Mann–Whitney test)."]}
{"doc_id": 35005, "title": "", "abstract": ["Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that remdesivir (RDV) and IFNb have superior antiviral activity to LPV and RTV in vitro.", "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations."]}
{"doc_id": 35006, "title": "", "abstract": ["These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Together, these data demonstrate that RDV and IFNb have superior in vitro antiviral activity compared with LPV and RTV, and that RTV does not significantly enhance the antiviral activity of LPV in vitro.", "The antiviral activity of the LPV/RTV-IFNb combination (EC50 = 160 IU/mL) was indistinguishable from that of IFNb alone (EC50 = 175 IU/mL) (P = 0.62, Wilcoxon matched-pairs signed rank test) (Fig. 1f)."]}
{"doc_id": 35007, "title": "", "abstract": ["The only in vivo study assessing the therapeutic efficacy of LPV/RTV or IFNb against MERS-CoV published thus far was performed in common marmosets where modest improvements in clinical outcomes were noted11.", "Nevertheless, the studies noted above demonstrate that type I interferon can exert an antiviral effect on MERS-CoV in vivo when given subcutaneously (IFN alpha, rhesus macaque) and intranasally (IFNb, adenovirus hDPP4 model)37–39.", "These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb).", "In contrast, studies evaluating the antiviral activity of type I and type II interferons have reported IFNb as the most potent interferon (EC50 1.37–17 IU/mL) in reducing MERS-CoV replication in vitro8,10."]}
{"doc_id": 35008, "title": "", "abstract": ["Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations.", "Here, we show that remdesivir (RDV) and IFNb have superior antiviral activity to LPV and RTV in vitro.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb)."]}
{"doc_id": 35009, "title": "", "abstract": ["Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "We found potent inhibition of MERS-CoV with IFNb (EC50 = 175 international units (IU)/mL) (Fig. 1e), CC50 values >2800 IU/mL and an SI > 16.", "Similar to our previous reports, RDV showed potent inhibition of MERS-CoV replication with a EC50 of 0.09 µM, no observable cytotoxicity up to 10 μM and a selectivity index (SI = EC50/CC50) > 10017.", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18."]}
{"doc_id": 35010, "title": "", "abstract": ["In mice, both prophylactic and therapeutic RDV improve pulmonary function and reduce lung viral loads and severe lung pathology.", "As with our SARS-CoV studies with RDV, here we provide similar evidence for MERS-CoV with diminished weight loss, improved pulmonary function, and reduced virus replication with both prophylactic and therapeutic RDV17.", "In contrast, therapeutic RDV diminished weight loss, lung hemorrhage, and virus replication during an ongoing MERS-CoV infection, but the degree of clinical benefit is dependent on viral dose and time of treatment initiation.", "Similar therapeutic studies (Supplementary Fig. 6) were performed but with a lethal dose of MERS-CoV (5E + 05 pfu) where no treatment improved survival (Supplementary Fig. 6a, d) or lung hemorrhage (Supplementary Fig. 6b, e), but therapeutic RDV significantly reduced lung viral load on 6 dpi (Supplementary Fig. S6c) (P = 0.03, Mann–Whitney test).", "Unlike the prophylactic study in Fig. 4b, therapeutic LPV + RTV-IFNb low improved pulmonary function as compared with vehicle with significantly reduced EF50 and PenH (P < 0.05, two-way ANOVA with Tukey’s multiple comparison test) and baseline levels of Rpef by 5 dpi (P < 0.05, two-way ANOVA with Tukey’s multiple comparison test) (Fig. 6b)."]}
{"doc_id": 35011, "title": "", "abstract": ["These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations.", "The only in vivo study assessing the therapeutic efficacy of LPV/RTV or IFNb against MERS-CoV published thus far was performed in common marmosets where modest improvements in clinical outcomes were noted11.", "The antiviral activity of the LPV/RTV-IFNb combination (EC50 = 160 IU/mL) was indistinguishable from that of IFNb alone (EC50 = 175 IU/mL) (P = 0.62, Wilcoxon matched-pairs signed rank test) (Fig. 1f).", "Although the antiviral activity of LPV against MERS-CoV has been reported in Vero cells (concentration causing a 50% reduction in replication (EC50) = 8 µM), other studies report complete inactivity similar to that of RTV8,9.", "Together, these data demonstrate that RDV and IFNb have superior in vitro antiviral activity compared with LPV and RTV, and that RTV does not significantly enhance the antiviral activity of LPV in vitro."]}
{"doc_id": 35012, "title": "", "abstract": ["We found potent inhibition of MERS-CoV with IFNb (EC50 = 175 international units (IU)/mL) (Fig. 1e), CC50 values >2800 IU/mL and an SI > 16.", "Similar to our previous reports, RDV showed potent inhibition of MERS-CoV replication with a EC50 of 0.09 µM, no observable cytotoxicity up to 10 μM and a selectivity index (SI = EC50/CC50) > 10017.", "Nevertheless, the studies noted above demonstrate that type I interferon can exert an antiviral effect on MERS-CoV in vivo when given subcutaneously (IFN alpha, rhesus macaque) and intranasally (IFNb, adenovirus hDPP4 model)37–39.", "Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "As we sought to understand this result, we found little experimental congruency among reports detailing the prophylactic or therapeutic efficacy of type I interferons in animal models of MERS-CoV11,37,38."]}
{"doc_id": 35013, "title": "", "abstract": ["Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral with potent in vitro efficacy against multiple genetically unrelated RNA viruses16–18.", "Similar to our previous reports, RDV showed potent inhibition of MERS-CoV replication with a EC50 of 0.09 µM, no observable cytotoxicity up to 10 μM and a selectivity index (SI = EC50/CC50) > 10017.", "Efficacy testing of antiviral regimens in humans like those in the MIRACLE trial are essential to progress antiviral development and prioritize therapies most likely to improve clinical outcomes in MERS-CoV patients."]}
{"doc_id": 35014, "title": "", "abstract": ["Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb).", "Second, we evaluated the in vivo efficacy of prophylactic RDV as compared to vehicle with two different doses of MERS-CoV in a new transgenic mouse model of MERS-CoV pathogenesis with improved pharmacokinetics for nucleotide prodrugs."]}
{"doc_id": 3000, "title": "", "abstract": ["Therefore our working model of the innate immune pathway activated by cytosolic HIV DNA starts with an unknown sensor (that may preferentially recognize ssDNA) that signals through STING, TBK1 and IRF3 to activate IFN expression.", "However, siRNA against another membrane-associated adaptor Sting (also known as MITA, ERIS27-29), recently identified to mediate innate immune responses to cytosolic DNA27,28, strongly inhibited HIV-stimulated IFN-β expression (Fig. 6b).", "TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "Thus, HIV DNA is detected by a pathway that signals though STING, TBK1 and IRF3 and does not involve any known DNA sensor (Supplementary Fig. 4).", "HIV-stimulated innate immune signaling also requires the adaptor protein STING and the protein kinase TBK1."]}
{"doc_id": 3001, "title": "", "abstract": ["However, siRNA against another membrane-associated adaptor Sting (also known as MITA, ERIS27-29), recently identified to mediate innate immune responses to cytosolic DNA27,28, strongly inhibited HIV-stimulated IFN-β expression (Fig. 6b).", "The innate immune pathway uncovered in this study will improve understanding of how HIV intersects with innate immunity and may also shed light on autoimmune and inflammatory syndromes linked to TREX1 mutation.", "HIV-stimulated innate immune signaling also requires the adaptor protein STING and the protein kinase TBK1.", "(c) Innate immune factors involved in HIV-stimulated IFN response do not affect HIV DNA accumulation.", "See Supplementary Fig. 4 for a model of the innate immune pathway stimulated by HIV DNA."]}
{"doc_id": 3002, "title": "", "abstract": ["Therefore, TREX1 deficiency decreased HIV replication and spreading in the culture.", "When IRF3 and TREX1 expression were both suppressed, HIV replication was partially rescued, suggesting that IRF3-dependent IFN-β induction contributes to inhibiting HIV replication caused by TREX1 siRNA (Fig. 5d).", "Therefore, during wild-type HIV infection of primary human cells, TREX1 suppresses HIV-induced IFN-β activation through IRF3 to promote HIV replication.", "To gain insight into how TREX1 suppresses HIV-stimulated IFN-β induction, we measured cytosolic HIV DNA and IFN-β mRNA in WT and Trex1−/− cells during single-round HIV-Luc infection (MOI =1) (Fig. 3a).", "These results strongly suggest that TREX1 suppresses IFN-β induction by digesting cytosolic DNA."]}
{"doc_id": 3003, "title": "", "abstract": ["HIV-stimulated innate immune signaling also requires the adaptor protein STING and the protein kinase TBK1.", "The innate immune pathway uncovered in this study will improve understanding of how HIV intersects with innate immunity and may also shed light on autoimmune and inflammatory syndromes linked to TREX1 mutation.", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "(c) Innate immune factors involved in HIV-stimulated IFN response do not affect HIV DNA accumulation.", "We therefore investigated whether HIV might use TREX1 to avoid triggering antiviral innate immunity."]}
{"doc_id": 3004, "title": "", "abstract": ["We did not examine whether TREX1 affects IFN production by pDCs, the major source of Type I IFNs during HIV infection.", "To test whether the enzymatic activity of TREX1 is required to enhance HIV infection, we determined whether expressing WT or D18N TREX1 in Trex1−/− cells could rescue HIV-Luc infectivity (Fig. 4e).", "Incomplete RT products, however, would not bind integrase and therefore would be susceptible to TREX1 degradation.", "TREX1 siRNA similarly reduced HIV production, measured by flow cytometry analysis of intracellular p24.", "One possibility is that TREX1 might sort productive vs non- productive HIV RT products."]}
{"doc_id": 3005, "title": "", "abstract": ["Fig. 1 TREX1 deficiency inhibits HIV replication and activates IFN-β in response to HIV infection", "When IRF3 and TREX1 expression were both suppressed, HIV replication was partially rescued, suggesting that IRF3-dependent IFN-β induction contributes to inhibiting HIV replication caused by TREX1 siRNA (Fig. 5d).", "In Trex1−/− mouse cells and human CD4+ T cells and macrophages in which TREX1 was inhibited by RNA interference, cytosolic HIV DNA accumulated, and HIV infection induced type I IFN that inhibited HIV replication and spreading.", "Autointegration in the absence of Trex1 was indistinguishable in Trex1−/− and Trex1−/−Irf3−/− cells (Fig. 2c), suggesting that autointegration is not altered by endogenous IFN-β production and that the two effects of TREX1 on HIV infection (blocking autointegration and inhibiting IFN-β induction) operate independently.", "### TREX1 inhibits IFN production in response to HIV"]}
{"doc_id": 3006, "title": "", "abstract": ["Few copies of HIV DNA integrate, leaving behind HIV DNA in the cytosol to be cleared by host enzymes.", "The remaining HIV DNA is cleared by TREX1, since cytosolic HIV DNA builds up when TREX1 function is deficient or inhibited and can be removed by expression of enzymatically active TREX1.", "Although cytosolic HIV DNA was ~10-fold more abundant in Trex1−/− than WT MEFs, HIV DNA integration was reduced in Trex1−/− vs WT cells, suggesting that most HIV DNA that accumulated in Trex1−/− cells did not contribute to productive infection (Fig. 3e).", "At an MOI of 1, HIV infection produces many reverse transcripts (although only one per incoming gRNA), but very few copies manage to integrate into the host chromosome.", "Other host nucleases might also help digest cytosolic HIV DNA."]}
{"doc_id": 3007, "title": "", "abstract": ["We previously found that the ER- associated SET complex, which contains 3 DNases (APE1, NM23-H1, TREX1) and other proteins (SET, pp32, HMGB2), binds to the HIV PIC and protects the integrase (IN)-activated DNA ends from self-attack in suicidal autointegration2.", "For further evidence that TREX1 is responsible for removing extraneous cytosolic HIV DNA, we assessed whether TREX1 interacts with HIV DNA during infection with wild-type HIVIIIB.", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "One could also imagine that two subpopulations of TREX1 are involved in different actions: the SET complex-associated TREX1 inhibits autointegration; while TREX1 outside the SET complex is enzymatically active and removes excess HIV DNA.", "# The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1"]}
{"doc_id": 3008, "title": "", "abstract": ["For further evidence that TREX1 is responsible for removing extraneous cytosolic HIV DNA, we assessed whether TREX1 interacts with HIV DNA during infection with wild-type HIVIIIB.", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "To gain insight into how TREX1 suppresses HIV-stimulated IFN-β induction, we measured cytosolic HIV DNA and IFN-β mRNA in WT and Trex1−/− cells during single-round HIV-Luc infection (MOI =1) (Fig. 3a).", "In Trex1−/− mouse cells and human CD4+ T cells and macrophages in which TREX1 was inhibited by RNA interference, cytosolic HIV DNA accumulated, and HIV infection induced type I IFN that inhibited HIV replication and spreading.", "Similar results were obtained following TREX1 RNAi in human peripheral blood CD4+ T cells infected with HIVIIIB (Fig. 5f-l)."]}
{"doc_id": 3009, "title": "", "abstract": ["HIV-stimulated IFN activation in Trex1−/− cells is eliminated by treating infected cells with an RT inhibitor, but not an IN inhibitor, suggesting that HIV DNA, but not gRNA, is the nucleic acid that triggers innate immunity.", "See Supplementary Fig. 4 for a model of the innate immune pathway stimulated by HIV DNA.", "HIV-stimulated innate immune signaling also requires the adaptor protein STING and the protein kinase TBK1.", "Therefore our working model of the innate immune pathway activated by cytosolic HIV DNA starts with an unknown sensor (that may preferentially recognize ssDNA) that signals through STING, TBK1 and IRF3 to activate IFN expression.", "The innate immune pathway uncovered in this study will improve understanding of how HIV intersects with innate immunity and may also shed light on autoimmune and inflammatory syndromes linked to TREX1 mutation."]}
{"doc_id": 3010, "title": "", "abstract": ["TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "The cytosolic exonuclease TREX1 suppressed IFN triggered by HIV.", "# The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1", "These results strongly suggest that TREX1 suppresses IFN-β induction by digesting cytosolic DNA."]}
{"doc_id": 3011, "title": "", "abstract": ["We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "Many of our experiments used genetically deficient mouse cells to demonstrate that Trex1 helps HIV evade innate immune detection and define the HIV DNA- stimulated IFN signaling pathway.", "The remaining HIV DNA is cleared by TREX1, since cytosolic HIV DNA builds up when TREX1 function is deficient or inhibited and can be removed by expression of enzymatically active TREX1.", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "WT TREX1 partially rescued HIV infection, but the enzymatically inactive D18N mutant had no effect, indicating that TREX1's exonuclease activity is needed for both inhibiting autointegration and blocking IFN-β induction."]}
{"doc_id": 3012, "title": "", "abstract": ["TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "These results strongly suggest that TREX1 suppresses IFN-β induction by digesting cytosolic DNA.", "These results strongly suggest that TREX1 metabolizes cytosolic HIV DNA.", "To gain insight into how TREX1 suppresses HIV-stimulated IFN-β induction, we measured cytosolic HIV DNA and IFN-β mRNA in WT and Trex1−/− cells during single-round HIV-Luc infection (MOI =1) (Fig. 3a)."]}
{"doc_id": 3013, "title": "", "abstract": ["TREX1 mutations are associated with inflammatory and autoimmune diseases, including Aicardi- Goutieres syndrome, chilblain lupus, and systemic lupus erythematosus (SLE), some of which have increased type I IFN3-5.", "TREX1 mutations that interfere with TREX1 enzymatic function or localization are associated with SLE and other autoimmune/inflammatory diseases3-5.", "It would be worth evaluating whether TREX1 polymorphisms or autoimmune disease are associated with reduced HIV transmission or a more benign disease course.", "The innate immune pathway uncovered in this study will improve understanding of how HIV intersects with innate immunity and may also shed light on autoimmune and inflammatory syndromes linked to TREX1 mutation.", "The human fibroblast line carrying the D18N heterozygous mutation in TREX1 was derived from a chilblain lupus patient."]}
{"doc_id": 3014, "title": "", "abstract": ["We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "The cytosolic exonuclease TREX1 suppressed IFN triggered by HIV.", "Therefore, during wild-type HIV infection of primary human cells, TREX1 suppresses HIV-induced IFN-β activation through IRF3 to promote HIV replication.", "To gain insight into how TREX1 suppresses HIV-stimulated IFN-β induction, we measured cytosolic HIV DNA and IFN-β mRNA in WT and Trex1−/− cells during single-round HIV-Luc infection (MOI =1) (Fig. 3a).", "When IRF3 and TREX1 expression were both suppressed, HIV replication was partially rescued, suggesting that IRF3-dependent IFN-β induction contributes to inhibiting HIV replication caused by TREX1 siRNA (Fig. 5d)."]}
{"doc_id": 3015, "title": "", "abstract": ["TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "These results strongly suggest that TREX1 metabolizes cytosolic HIV DNA.", "TREX1 might bind to HIV DNA nonspecifically in the cytosol, but as an exonuclease can only efficiently digest HIV DNA that contains broken ends or single strand overhangs.", "# The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1"]}
{"doc_id": 3016, "title": "", "abstract": ["HIV infection of its main target cells, macrophages and CD4+ T cells, does not induce cell-autonomous IFNs35.", "Although cytosolic HIV DNA was ~10-fold more abundant in Trex1−/− than WT MEFs, HIV DNA integration was reduced in Trex1−/− vs WT cells, suggesting that most HIV DNA that accumulated in Trex1−/− cells did not contribute to productive infection (Fig. 3e).", "Some HIV DNA accumulated in the cytoplasm of HIV-infected cells, even when TREX1 is normally expressed, but did not activate IFN expression.", "IFN-β induction and accumulation of cytosolic HIV DNA increased in tandem in Trex1−/− cells as the amount of virus used for infection was increased, but even the highest viral dose (MOI=8) did not stimulate IFN-β expression in WT cells (Fig. 3c,d).", "However, HIV infection of T cells and macrophages does not trip these alarms."]}
{"doc_id": 3017, "title": "", "abstract": ["We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "# The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1", "For further evidence that TREX1 is responsible for removing extraneous cytosolic HIV DNA, we assessed whether TREX1 interacts with HIV DNA during infection with wild-type HIVIIIB.", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "### TREX1 inhibits IFN production in response to HIV"]}
{"doc_id": 3018, "title": "", "abstract": ["Nevirapine, which inhibits HIV reverse transcription, but not the IN inhibitor raltegravir, which acts after HIV DNA synthesis, inhibited IFN-β and IL-6 expression in response to HIV in Trex1−/− cells (Fig. 1e,f), suggesting that HIV reverse- transcribed DNA, rather than genomic RNA (gRNA), was triggering the response.", "HIV-stimulated IFN activation in Trex1−/− cells is eliminated by treating infected cells with an RT inhibitor, but not an IN inhibitor, suggesting that HIV DNA, but not gRNA, is the nucleic acid that triggers innate immunity.", "### TREX1 inhibits IFN production in response to HIV", "Inhibiting a gene required for HIV-stimulated IFN signaling in Trex1−/− cells should reduce IFN-β expression.", "HIV-stimulated IFN production in cells deficient in TREX1 did not involve known nucleic acid sensors."]}
{"doc_id": 3019, "title": "", "abstract": ["The HIV-stimulated IFN response in cells deficient in TREX1, like the response to endogenous retroelement DNA and transfected DNA7, is IRF3-dependent.", "These data confirm that the HIV- stimulated IFN-β response is IRF3-dependent and imply the involvement of a cytosolic detection pathway.", "TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "(b) IRF3, TBK1 and STING are required for HIV-stimulated IFN-β induction in Trex1−/− cells.", "Fig. 6 HIV-stimulated IFN induction requires IRF3, TBK1 and STING"]}
{"doc_id": 3020, "title": "", "abstract": ["(c) TREX1 metabolizes reverse-transcribed HIV DNA and transfected ssDNA and dsDNA in both mouse and human fibroblasts.", "The RNA:DNA hybrid was generated by hybridizing ssDNA and ssRNA at equimolar concentrations.", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "TREX1 recognizes ssDNA or dsDNA with single strand overhangs – the kind of DNA in failed RT products.", "These results strongly suggest that TREX1 metabolizes cytosolic HIV DNA."]}
{"doc_id": 37000, "title": "", "abstract": ["COVID-19 inequities contribute to the cycle of inequalities in health and health care access and consequent mistrust: Inequities in COVID-19 impacts can exacerbate mistrust—and, in turn, lead to suboptimal health care behaviors.", "Inequities affecting Black Americans are believed to stem from systemic racism, which has led to higher levels of social risk factors such as unstable housing and homelessness, poverty, and lower-wage, higher-risk employment, which in turn are associated with a greater prevalence of underlying health conditions, such as hypertension, diabetes, and obesity (which are risk factors for severe COVID-19 disease and death).8–10", "Medical mistrust, a result of systemic racism, is prevalent among Black Americans and may play a role in COVID-19 inequities.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22"]}
{"doc_id": 37001, "title": "", "abstract": ["Descriptive statistics (means, SDs, and frequencies) were calculated for all study variables.", "In addition, we controlled for the intervention group in all models.", "The adherence models were conducted with the subset of 49 participants whose MEMS data were available from the parent study during the COVID-19 pandemic (ie, whose data for the past month were downloaded after April 1, 2020).", "### Statistical Analysis", "Social/economic impacts and health care impacts were summed into one negative COVID-19 impact score."]}
{"doc_id": 37002, "title": "", "abstract": ["Medical mistrust, a result of systemic racism, is prevalent among Black Americans and may play a role in COVID-19 inequities.", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22", "Medical mistrust is particularly prevalent among Black Americans, compared with other races/ethnicities.13,14", "Medical mistrust, defined as “distrust of health care providers, the health care system, medical treatments, and the government as a steward of public health,”11,12 is a response to current and historical systemic racism in health care and society as a whole and may play a role in COVID-19 inequities."]}
{"doc_id": 37003, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Other surveys across several countries have similarly found that greater mistrust is associated with lower engagement in COVID-19 protective behaviors.33–36", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001].", "Little is known how general medical mistrust related to COVID-19 might impact COVID-19-related behaviors, including vaccine and treatment hesitancy, in the United States.", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively]."]}
{"doc_id": 37004, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Pearson correlations indicated that participants with less than a high school education showed higher levels of general COVID-19 mistrust (r = 0.27, P = 0.007), vaccine hesitancy (r = 0.20, P = 0.04), and treatment hesitancy (r = 0.23, P = 0.02).", "From May to July 2020, participants completed telephone interviews on negative COVID-19 impacts, general COVID-19 mistrust (eg, about the government withholding information), COVID-19 vaccine and treatment hesitancy, and trust in COVID-19 information sources.", "Moreover, service providers or health professionals were the most trusted, followed by local public health officials or agencies and local (eg, Los Angeles or CA) government officials (Table 3).", "Our results suggest avenues for delivering public health messages around COVID-19 to which individuals may be more receptive, such as through their health care providers or community-based, nonpolitical entities."]}
{"doc_id": 37005, "title": "", "abstract": ["Mistrust may be further increasing due to the US sociopolitical climate in 2020, in which members of the federal administration used divisive rhetoric (eg, in support of racist movements) at a time when there was a call for action and widespread Black Lives Matter protests to stop police brutality.53–55", "When individuals see the pandemic surging in their own communities, whereas testing is restricted, the disconnect between the US administration's statements and local realities can breed further mistrust.", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "(Note that, under this definition, conspiracy beliefs are not necessarily false, harmful, unjustified, or irrational.) For example, the media has reported that Black individuals do not trust the health care system's or government's responses to COVID-19.29,30", "The least trusted source was the federal government, including the US President, followed by social media."]}
{"doc_id": 37006, "title": "", "abstract": ["| % (n) Endorsed (Strongly/Slightly Agree)   ---|---   General COVID-19-related medical mistrust|   A lot of information about COVID-19 is being held back by the government| 62% (63)   The government cannot be trusted to tell the truth about COVID-19| 60% (61)   The government is hiding information about COVID-19| 58% (59)   Black people should be suspicious of information from the government about COVID-19| 51% (51)   When it comes to COVID-19, the government is lying to us| 50% (50)   COVID-19 is manmade| 50% (50)   There is a cure for COVID-19, but it is being withheld from Black people| 30% (30)   When it comes to COVID-19, Black people cannot trust health care providers| 20% (20)   When it comes to COVID-19, doctors have the best interests of patients in mind*| 74% (75)   When it comes to COVID-19, Black people will receive the same medical care from health care providers as people from other groups*| 50% (50)   Endorsed any mistrust belief| 97% (98)   No.", "Nearly all participants (97%) endorsed at least one general COVID-19 mistrust belief, and more than half endorsed at least one COVID-19 vaccine or treatment hesitancy belief.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "From May to July 2020, participants completed telephone interviews on negative COVID-19 impacts, general COVID-19 mistrust (eg, about the government withholding information), COVID-19 vaccine and treatment hesitancy, and trust in COVID-19 information sources.", "Our study is the first to report COVID-19 mistrust among Black Americans living with HIV, most of whom were sexual minority individuals, and to demonstrate the negative impact of COVID-19 on ART adherence."]}
{"doc_id": 37007, "title": "", "abstract": ["Our study is the first to report COVID-19 mistrust among Black Americans living with HIV, most of whom were sexual minority individuals, and to demonstrate the negative impact of COVID-19 on ART adherence.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "Studies on medical mistrust related to COVID-19 using nationally representative samples of Black Americans are needed, to inform interventions and policy solutions at the individual and structural levels that can address mistrust and reduce COVID-19 inequities."]}
{"doc_id": 37008, "title": "", "abstract": ["Furthermore, research is needed that includes multiple racial/ethnic groups living with HIV, to compare levels of mistrust and vaccine hesitancy across groups.", "The sample showed high levels of general COVID-19 mistrust and high levels of hesitancy related to treatment and a future vaccine (Table 2).", "Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively]."]}
{"doc_id": 37009, "title": "", "abstract": ["Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22", "Results indicated that participants who experienced more negative impacts from the pandemic showed lower ART adherence, both continuously [b (SE) = −5.19 (2.08), P = 0.02] and dichotomously [OR (95% CI) = 0.59 (0.39–0.89), P = 0.01].", "We derived continuous adherence (ie, percentage of total scheduled doses taken) and dichotomous adherence (>80% of doses taken vs. ≤80% of doses taken), as a benchmark of “good” adherence (ie, likely to result in a suppressed HIV viral load).52", "Participants experiencing more negative COVID-19 impacts showed lower ART adherence, assessed among a subset of 49 participants [b (SE) = −5.19 (2.08), P = 0.02].", "Participants were recruited from the participant pool of a parent study that is a randomized controlled trial of a community-based motivational interviewing intervention to improve ART adherence among Black Americans living with HIV (NCT03331978)."]}
{"doc_id": 37010, "title": "", "abstract": ["| % (n) Endorsed (Strongly/Slightly Agree)   ---|---   General COVID-19-related medical mistrust|   A lot of information about COVID-19 is being held back by the government| 62% (63)   The government cannot be trusted to tell the truth about COVID-19| 60% (61)   The government is hiding information about COVID-19| 58% (59)   Black people should be suspicious of information from the government about COVID-19| 51% (51)   When it comes to COVID-19, the government is lying to us| 50% (50)   COVID-19 is manmade| 50% (50)   There is a cure for COVID-19, but it is being withheld from Black people| 30% (30)   When it comes to COVID-19, Black people cannot trust health care providers| 20% (20)   When it comes to COVID-19, doctors have the best interests of patients in mind*| 74% (75)   When it comes to COVID-19, Black people will receive the same medical care from health care providers as people from other groups*| 50% (50)   Endorsed any mistrust belief| 97% (98)   No.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Our study is the first to report COVID-19 mistrust among Black Americans living with HIV, most of whom were sexual minority individuals, and to demonstrate the negative impact of COVID-19 on ART adherence.", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy."]}
{"doc_id": 37011, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "Our study is the first to report COVID-19 mistrust among Black Americans living with HIV, most of whom were sexual minority individuals, and to demonstrate the negative impact of COVID-19 on ART adherence.", "Studies on medical mistrust related to COVID-19 using nationally representative samples of Black Americans are needed, to inform interventions and policy solutions at the individual and structural levels that can address mistrust and reduce COVID-19 inequities."]}
{"doc_id": 37012, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV", "In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "Medical mistrust, a result of systemic racism, is prevalent among Black Americans and may play a role in COVID-19 inequities."]}
{"doc_id": 37013, "title": "", "abstract": ["In this time of heightened mistrust, only interventions that are developed by and in partnership with communities, following community-based participatory research principles,69 can increase the percentage of individuals tested and lay the groundwork for treatment and vaccine uptake.", "In an online survey in England, higher endorsement of COVID-19 conspiracy beliefs was associated with less willingness to accept a future vaccine and less adherence to health-protective (eg, social distancing) behaviors.32", "To prevent widening health inequities, health care providers should engage with communities to tailor strategies to overcome mistrust and deliver evidence-based information, to encourage COVID-19 vaccine and treatment uptake.", "Furthermore, research is needed that includes multiple racial/ethnic groups living with HIV, to compare levels of mistrust and vaccine hesitancy across groups.", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001]."]}
{"doc_id": 37014, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Moreover, those who had higher levels of medical mistrust around the COVID-19 government response, as well as around COVID-19 origins and treatment, were less willing to obtain treatment or a future vaccine.", "The sample showed high levels of general COVID-19 mistrust and high levels of hesitancy related to treatment and a future vaccine (Table 2).", "More than half of participants showed hesitancy regarding a COVID-19 future vaccine or treatment across the items, with about a third saying they would not get vaccinated or treated.", "Nearly all participants (97%) endorsed at least one general COVID-19 mistrust belief, and more than half endorsed at least one COVID-19 vaccine or treatment hesitancy belief."]}
{"doc_id": 37015, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "In an online survey in England, higher endorsement of COVID-19 conspiracy beliefs was associated with less willingness to accept a future vaccine and less adherence to health-protective (eg, social distancing) behaviors.32", "Moreover, those who had higher levels of medical mistrust around the COVID-19 government response, as well as around COVID-19 origins and treatment, were less willing to obtain treatment or a future vaccine.", "Three items, developed for this study, assessed COVID-19 vaccine hesitancy (ie, “If a vaccine were available to prevent COVID-19, I would not want to get it”; “…I would not trust it”; and “…I am worried that it could be harmful”; α = 0.90) on the scale 1 = strongly disagree, 2 = slightly disagree, 3 = neither disagree nor agree or unsure, 4 = slightly agree, and 5 = strongly agree."]}
{"doc_id": 37016, "title": "", "abstract": ["The least trusted source was the federal government, including the US President, followed by social media.", "Social service and health care providers were the most trusted sources.", "A theme running through our results was that health care and social service providers are more trusted than other sources of information about the pandemic.", "Inequities affecting Black Americans are believed to stem from systemic racism, which has led to higher levels of social risk factors such as unstable housing and homelessness, poverty, and lower-wage, higher-risk employment, which in turn are associated with a greater prevalence of underlying health conditions, such as hypertension, diabetes, and obesity (which are risk factors for severe COVID-19 disease and death).8–10", "Participants in the parent study were recruited through a community-based HIV service organization in Los Angeles County, CA, using flyers and outreach to staff and clients of relevant community organizations; referrals from providers; online and print advertisements, radio shows, and online promotions; and in-person outreach onsite (at the community partner organization), at community events, and on the street (eg, near health care facilities)."]}
{"doc_id": 37017, "title": "", "abstract": ["In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "Our study is the first to report COVID-19 mistrust among Black Americans living with HIV, most of whom were sexual minority individuals, and to demonstrate the negative impact of COVID-19 on ART adherence.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "Nearly all participants (97%) endorsed at least one general COVID-19 mistrust belief, and more than half endorsed at least one COVID-19 vaccine or treatment hesitancy belief."]}
{"doc_id": 37018, "title": "", "abstract": ["Social service and health care providers were the most trusted sources.", "Moreover, service providers or health professionals were the most trusted, followed by local public health officials or agencies and local (eg, Los Angeles or CA) government officials (Table 3).", "A theme running through our results was that health care and social service providers are more trusted than other sources of information about the pandemic.", "These results are consistent with a US survey (with a primarily White sample) finding that doctors were the most trusted sources for COVID-19 information.37", "Participants were less likely to believe that health care providers would be dishonest and were more likely to trust information from providers than from other sources, especially elected officials."]}
{"doc_id": 37019, "title": "", "abstract": ["In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "Little is known how general medical mistrust related to COVID-19 might impact COVID-19-related behaviors, including vaccine and treatment hesitancy, in the United States."]}
{"doc_id": 37020, "title": "", "abstract": ["Little is known how general medical mistrust related to COVID-19 might impact COVID-19-related behaviors, including vaccine and treatment hesitancy, in the United States.", "Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively].", "Other surveys across several countries have similarly found that greater mistrust is associated with lower engagement in COVID-19 protective behaviors.33–36", "COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV"]}
{"doc_id": 37021, "title": "", "abstract": ["These results are consistent with a US survey (with a primarily White sample) finding that doctors were the most trusted sources for COVID-19 information.37", "COVID-19 inequities may widen unless public health officials engage with communities to determine tailored approaches, including effective strategies, sources, and messaging, to deliver evidence-based information and overcome mistrust around COVID-19.", "| % (n) Endorsed (Strongly/Slightly Agree)   ---|---   General COVID-19-related medical mistrust|   A lot of information about COVID-19 is being held back by the government| 62% (63)   The government cannot be trusted to tell the truth about COVID-19| 60% (61)   The government is hiding information about COVID-19| 58% (59)   Black people should be suspicious of information from the government about COVID-19| 51% (51)   When it comes to COVID-19, the government is lying to us| 50% (50)   COVID-19 is manmade| 50% (50)   There is a cure for COVID-19, but it is being withheld from Black people| 30% (30)   When it comes to COVID-19, Black people cannot trust health care providers| 20% (20)   When it comes to COVID-19, doctors have the best interests of patients in mind*| 74% (75)   When it comes to COVID-19, Black people will receive the same medical care from health care providers as people from other groups*| 50% (50)   Endorsed any mistrust belief| 97% (98)   No.", "Participants were asked the extent to which they trusted 11 different COVID-19 information sources (eg, health care providers and federal government) on the scale 1 = strongly distrust, 2 = slightly distrust, 3 = not sure, 4 = slightly trust, and 5 = strongly trust.", "Trust in Sources of Information About COVID-19"]}
{"doc_id": 37022, "title": "", "abstract": ["Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "Medical mistrust, a result of systemic racism, is prevalent among Black Americans and may play a role in COVID-19 inequities.", "Medical mistrust is particularly prevalent among Black Americans, compared with other races/ethnicities.13,14", "Medical mistrust is a key mediator of the association between discrimination and worse health outcomes and behaviors among Black Americans.23,24", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22"]}
{"doc_id": 37023, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Covariates for multivariate models included sociodemographic characteristics that were associated with the outcomes at an alpha level of 0.05 in bivariate analyses (age for adherence and education for COVID-19 treatment and vaccine hesitancy).", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively].", "Multiple linear regression analyses were conducted predicting COVID-19 treatment and vaccine hesitancy with general COVID-19 mistrust.", "Pearson correlations indicated that participants with less than a high school education showed higher levels of general COVID-19 mistrust (r = 0.27, P = 0.007), vaccine hesitancy (r = 0.20, P = 0.04), and treatment hesitancy (r = 0.23, P = 0.02)."]}
{"doc_id": 37024, "title": "", "abstract": ["Moreover, those who had higher levels of medical mistrust around the COVID-19 government response, as well as around COVID-19 origins and treatment, were less willing to obtain treatment or a future vaccine.", "Less than a third (31%) had been tested for COVID-19, and only one participant was found to be positive; 8 said that they had experienced COVID-19 symptoms, and of those 8, 6 were tested (5 tested negative and 1 tested positive) and 2 were not tested (and did not think they were infected).", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "More than half of participants showed hesitancy regarding a COVID-19 future vaccine or treatment across the items, with about a third saying they would not get vaccinated or treated.", "Of the 136 active participants in the parent study, 103 participants were reached during the time frame (May–July, 2020), and 101 participants completed the 15–20 minutes COVID-19 telephone interview; 33 participants could not be contacted after multiple attempts and 2 participants declined."]}
{"doc_id": 37025, "title": "", "abstract": ["Participants were recruited from the participant pool of a parent study that is a randomized controlled trial of a community-based motivational interviewing intervention to improve ART adherence among Black Americans living with HIV (NCT03331978).", "Participants were 101 HIV-positive Black Americans (age: M = 50.3 years; SD = 11.5; 86% cisgender men; 77% sexual minority) enrolled in a randomized controlled trial of a community-based ART adherence intervention in Los Angeles County, CA.", "Three-quarters felt that health care providers have patients' best interests in mind, and only a fifth said that Black people cannot trust health care providers (Table 2).", "Inequities affecting Black Americans are believed to stem from systemic racism, which has led to higher levels of social risk factors such as unstable housing and homelessness, poverty, and lower-wage, higher-risk employment, which in turn are associated with a greater prevalence of underlying health conditions, such as hypertension, diabetes, and obesity (which are risk factors for severe COVID-19 disease and death).8–10", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24"]}
{"doc_id": 37026, "title": "", "abstract": ["Note: Sample size range = 84–101 except for n = 58 and 52 for the work-related items, respectively, which were not applicable for those not working prepandemic and for ART adherence, which was limited to the subsample of n = 49 with available data.", "The sample size for “my employer” was 32 as most participants were not working; sample sizes ranged from 85 to 101 for all other items; Scale = 1, strongly distrust to 5, strongly trust.", "Overall (of the 101 participants in the sample), participants were close to 50 years age on average, and many were of lower socioeconomic status, with only 14% employed and 41% with less than $10,000 annual household income.", "Participants were 101 HIV-positive Black Americans (age: M = 50.3 years; SD = 11.5; 86% cisgender men; 77% sexual minority) enrolled in a randomized controlled trial of a community-based ART adherence intervention in Los Angeles County, CA.", "Limitations of the study include the convenience sample, the low number of women and younger adults in the sample, the lack of concurrent viral suppression data (due to not being able to conduct venipuncture with parent study participants during the pandemic), and the relatively low sample size for the electronically monitored adherence data (due to restricted in-person data collection during the pandemic)."]}
{"doc_id": 37027, "title": "", "abstract": ["In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "The adherence models were conducted with the subset of 49 participants whose MEMS data were available from the parent study during the COVID-19 pandemic (ie, whose data for the past month were downloaded after April 1, 2020).", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "Participants experiencing more negative COVID-19 impacts showed lower ART adherence, assessed among a subset of 49 participants [b (SE) = −5.19 (2.08), P = 0.02]."]}
{"doc_id": 37028, "title": "", "abstract": ["Trust in Sources of Information About COVID-19", "These results are consistent with a US survey (with a primarily White sample) finding that doctors were the most trusted sources for COVID-19 information.37", "Participants were asked the extent to which they trusted 11 different COVID-19 information sources (eg, health care providers and federal government) on the scale 1 = strongly distrust, 2 = slightly distrust, 3 = not sure, 4 = slightly trust, and 5 = strongly trust.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "#### Trust in COVID-19 Information Sources"]}
{"doc_id": 37029, "title": "", "abstract": ["This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001].", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "In this study, responses on the COVID-19 mistrust scale were associated with responses on general medical mistrust and HIV-related mistrust scales."]}
{"doc_id": 37030, "title": "", "abstract": ["In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "Furthermore, research is needed that includes multiple racial/ethnic groups living with HIV, to compare levels of mistrust and vaccine hesitancy across groups.", "In a convenience sample of HIV-positive Black Americans, we examined associations of COVID-19-related medical mistrust with COVID-19 vaccine and COVID-19 treatment hesitancy and negative impacts of COVID-19 on antiretroviral therapy (ART) adherence.", "COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV."]}
{"doc_id": 37031, "title": "", "abstract": ["Thus, antiracist policies that aim to decrease COVID-19 inequities, with tailored interventions for Black communities, may simultaneously improve COVID-19 outcomes and reduce mistrust.", "Studies on medical mistrust related to COVID-19 using nationally representative samples of Black Americans are needed, to inform interventions and policy solutions at the individual and structural levels that can address mistrust and reduce COVID-19 inequities.", "Authentic community engagement that establishes equal partnerships with stakeholders up front—and shifts power to communities, to identify and determine community-defined solutions—are needed to address mistrust and access inequities, and ensure that COVID-19 services are responsive to community needs.", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "COVID-19 inequities may widen unless public health officials engage with communities to determine tailored approaches, including effective strategies, sources, and messaging, to deliver evidence-based information and overcome mistrust around COVID-19."]}
{"doc_id": 33000, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Potato chips, red meat, and sugary drink intakes all increased significantly (P = 0.005 to < 0.001) during the lockdown.", "By contrast, potato chip, red meat, and sugary drink intakes increased significantly during the lockdown (P value range, 0.005 to < 0.001).", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown."]}
{"doc_id": 33001, "title": "", "abstract": ["Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "There was an inverse correlation between change in sports participation and both a change in number of meals per day (r = −0.35, P = 0.027) and change in screen time (r = −0.27, borderline significant at P = 0.084).", "The lifestyle questionnaire consisted of 12 questions about sports activity participation, screen time, sleep behavior, and eating habits, focusing on servings of red meat, pasta, snacks, fruits, and vegetables.", "Wang et al. (4) in 2015 found that during summer breaks, children consumed fewer vegetables and more added sugar and watched more television, but they were also more active."]}
{"doc_id": 33002, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors."]}
{"doc_id": 33003, "title": "", "abstract": ["Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "There was an inverse correlation between change in sports participation and both a change in number of meals per day (r = −0.35, P = 0.027) and change in screen time (r = −0.27, borderline significant at P = 0.084)."]}
{"doc_id": 33004, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Results of questionnaire survey a", "The sample included 41 children and adolescents with obesity participating in a longitudinal observational study located in Verona, Italy.", "The participant’s countries of origin included Italy (35), North Africa (4), and Albania (2).", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown."]}
{"doc_id": 33005, "title": "", "abstract": ["Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19."]}
{"doc_id": 33006, "title": "", "abstract": ["Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "Pearson correlation analyses were conducted to assess the associations between diet, activity, and sleep pre‐ and peri‐lockdown behavior changes.", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study"]}
{"doc_id": 33007, "title": "", "abstract": ["The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study"]}
{"doc_id": 33008, "title": "", "abstract": ["Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "There was an inverse correlation between change in sports participation and both a change in number of meals per day (r = −0.35, P = 0.027) and change in screen time (r = −0.27, borderline significant at P = 0.084)."]}
{"doc_id": 33009, "title": "", "abstract": ["Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "School environments provide structure and routine around mealtimes, physical activity, and sleep schedule, the three predominant lifestyle factors implicated in obesity risk.", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001)."]}
{"doc_id": 33010, "title": "", "abstract": ["Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "Children and adolescents gain more weight during summer vacations than during the structured school year, leading to the hypothesis that the coronavirus disease 2019 lockdown will lead to unfavorable changes in lifestyle behaviors among homebound youths with obesity.", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19.", "In this pre‐ and peri‐lockdown observational study, the baseline in‐person interviews and later telephone interviews at the second evaluation were conducted with parents and focused on their child’s lifestyle behaviors."]}
{"doc_id": 33011, "title": "", "abstract": ["These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "Children and adolescents gain more weight during summer vacations than during the structured school year, leading to the hypothesis that the coronavirus disease 2019 lockdown will lead to unfavorable changes in lifestyle behaviors among homebound youths with obesity.", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors."]}
{"doc_id": 33012, "title": "", "abstract": ["Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "In sum, the tragic COVID‐19 pandemic has collateral effects extending beyond those of direct viral infection."]}
{"doc_id": 33013, "title": "", "abstract": ["Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "There was an inverse correlation between change in sports participation and both a change in number of meals per day (r = −0.35, P = 0.027) and change in screen time (r = −0.27, borderline significant at P = 0.084)."]}
{"doc_id": 33014, "title": "", "abstract": ["Children and adolescents struggling with obesity are placed in an unfortunate position of isolation that appears to create an unfavorable environment for maintaining healthy lifestyle behaviors.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19.", "The sample included 41 children and adolescents with obesity participating in a longitudinal observational study located in Verona, Italy.", "Children and adolescents gain more weight during summer vacations than during the structured school year, leading to the hypothesis that the coronavirus disease 2019 lockdown will lead to unfavorable changes in lifestyle behaviors among homebound youths with obesity."]}
{"doc_id": 33015, "title": "", "abstract": ["The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown."]}
{"doc_id": 33016, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "The lifestyle questionnaire consisted of 12 questions about sports activity participation, screen time, sleep behavior, and eating habits, focusing on servings of red meat, pasta, snacks, fruits, and vegetables.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001)."]}
{"doc_id": 33017, "title": "", "abstract": ["Potato chips, red meat, and sugary drink intakes all increased significantly (P = 0.005 to < 0.001) during the lockdown.", "By contrast, potato chip, red meat, and sugary drink intakes increased significantly during the lockdown (P value range, 0.005 to < 0.001).", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "There were no changes in reported vegetable intake; fruit intake increased (P = 0.055) during the lockdown.", "The authors additionally postulated that homes will be stocked during the lockdown with ultraprocessed and calorie‐dense foods, a suggestion now strongly supported by recent observations in real‐world settings (6)."]}
{"doc_id": 33018, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "School environments provide structure and routine around mealtimes, physical activity, and sleep schedule, the three predominant lifestyle factors implicated in obesity risk.", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown."]}
{"doc_id": 33019, "title": "", "abstract": ["Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001).", "Wang et al. (4) in 2015 found that during summer breaks, children consumed fewer vegetables and more added sugar and watched more television, but they were also more active.", "There was an inverse correlation between change in sports participation and both a change in number of meals per day (r = −0.35, P = 0.027) and change in screen time (r = −0.27, borderline significant at P = 0.084).", "In support of this hypothesis, a 2007 study by von Hippel et al. (2) reported the effects of school versus nonschool environments on overweight in childhood."]}
{"doc_id": 33020, "title": "", "abstract": ["Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Time spent in sports during the lockdown were considered as any physical activity (e.g., jogging, playing in the backyard, etc.) given that it was not possible during the lockdown to participate in organized sports.", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study"]}
{"doc_id": 33021, "title": "", "abstract": ["Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "The authors did not detect racial differences in these effects.", "Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "The only sex difference in lifestyle question responses was between males and females for change in meals per day.", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown."]}
{"doc_id": 33022, "title": "", "abstract": ["The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "Additionally, government officials and policy makers may want to consider the deleterious lifestyle effects of the lockdown on youths with obesity when making decisions regarding when and how to loosen restrictions.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "Children and adolescents struggling with obesity are placed in an unfortunate position of isolation that appears to create an unfavorable environment for maintaining healthy lifestyle behaviors."]}
{"doc_id": 33023, "title": "", "abstract": ["Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors."]}
{"doc_id": 33024, "title": "", "abstract": ["Potato chips, red meat, and sugary drink intakes all increased significantly (P = 0.005 to < 0.001) during the lockdown.", "By contrast, potato chip, red meat, and sugary drink intakes increased significantly during the lockdown (P value range, 0.005 to < 0.001).", "There were no changes in reported vegetable intake; fruit intake increased (P = 0.055) during the lockdown.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "There were no changes in vegetable intake, and fruit intake increased (marginal significance, P = 0.055)."]}
{"doc_id": 33025, "title": "", "abstract": ["Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications."]}
{"doc_id": 4013, "title": "", "abstract": ["A recent GWAS identified CR1, CLU, PICALM, and BIN1 as LOAD susceptibility loci1–3.", "identified SNPs at ABCA7 as a novel LOAD locus, we included ABCA7 region SNPs in Stage 2 and provided the results to Hollingworth et al.12.", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "Our Stage 1+2 analyses also confirmed the association of previously reported loci (BIN1, CR1, CLU, and PICALM) with LOAD (Table 1)."]}
{"doc_id": 4014, "title": "", "abstract": ["Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "We obtained genome-wide significant results at MS4A4A [rs4938933; Stages 1+2, meta-analysis (PM) = 1.7 × 10−9, joint analysis (PJ) = 1.7 × 10−9; Stages 1–3, PM = 8.2 × 10−12], CD2AP (rs9349407; Stages 1–3, PM = 8.6 × 10−9), EPHA1 (rs11767557; Stages 1–3 PM = 6.0 × 10−10), and CD33 (rs3865444; Stages 1–3, PM = 1.6 × 10−9).", "In Stages 1 and 2, strong evidence for association was also obtained for SNPs in CD33, a gene located approximately 6Mb from APOE, but the results did not reach genome-wide significance.", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "Genes with previous case-control genome-wide statistically significant associations: CR13, CLU 1,3, PICALM1, BIN12."]}
{"doc_id": 4015, "title": "", "abstract": ["A recent GWAS identified CR1, CLU, PICALM, and BIN1 as LOAD susceptibility loci1–3.", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "Our observation of genome-wide significant associations at MS4A4A, CD2AP, EPHA1, and CD33 extend our understanding of the genetic architecture of LOAD and confirm the emerging consensus that common genetic variation plays a significant role in the etiology of LOAD.", "identified SNPs at ABCA7 as a novel LOAD locus, we included ABCA7 region SNPs in Stage 2 and provided the results to Hollingworth et al.12.", "Our Stage 1+2 analyses also confirmed the association of previously reported loci (BIN1, CR1, CLU, and PICALM) with LOAD (Table 1)."]}
{"doc_id": 4016, "title": "", "abstract": ["# Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease", "With our findings and those by Hollingsworth et al.12, there are now ten LOAD susceptibility loci (APOE, CR1, CLU, PICALM, BIN1, EPHA1, MS4A, CD33, CD2AP, and ABCA7).", "The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3).", "SNPs from these nine loci were carried forward to Stage 2.", "A recent GWAS identified CR1, CLU, PICALM, and BIN1 as LOAD susceptibility loci1–3."]}
{"doc_id": 7013, "title": "", "abstract": ["The low LD between GWAS and Metabochip lead SNPs at DGKB and KCNQ1 (both CEU r2 = 0.00) arises because they “switch” between independent association signals at these loci (Fig. 2).", "The lead SNPs from both meta-analyses are in strong linkage disequilibrium (LD) (HMG20A r2 = 0.89 and GRB14 r2 = 0.77 in CEU), and likely represent the same association signals.", "As noted earlier, lead SNPs at several newly identified loci are in strong LD with variants associated with other T2D-related metabolic traits.", "The “secondary” list incorporated the nearest transcript to the lead SNP at 77 additional loci with posterior probability of association of at least 75% from the mixture model, not already included in the primary list.", "At the previously unreported loci, we observed nominal evidence of association (P < 0.05) in the South Asian10 and recent East Asian11 meta-analyses for the lead SNPs at MC4R and ZMIZ1 (Supplementary Table 3), with consistent directions of effect across all three ancestry groups."]}
{"doc_id": 7014, "title": "", "abstract": ["For comparison, we undertook false-discovery rate (FDR) analysis of the 64,646 SNPs on the Metabochip selected for replication of any trait, using P-values from the combined meta-analysis (Online Methods).", "This custom array of 196,725 variants was designed to facilitate cost-effective follow-up of nominal associations for T2D and other metabolic and cardiovascular traits, and to enhance fine-mapping of established loci12.", "The T2D-nominated content of Metabochip includes a further 16,717 variants, most chosen from 1000 Genomes Project pilot data13, to fine-map 27 established susceptibility loci.", "Across 36 fine-mapping regions on Metabochip that contain T2D susceptibility loci (including 27 explicitly chosen by DIAGRAM), we compared the characteristics of previously reported lead SNPs (defined by GWAS and HapMap imputation) and those emerging from the Stage 2 Metabochip meta-analysis.", "As expected, the estimated allelic ORs of the 488 SNPs are modest (1.01–1.11 in Stage 2), and larger samples would be required to establish association at genome-wide significance."]}
{"doc_id": 7015, "title": "", "abstract": ["For most T2D susceptibility loci, the underlying causal variants and the genes through which they act are yet to be identified, and the pathophysiological processes mediating disease risk remain unclear.", "In particular, it will be important to determine whether, as the number of susceptibility loci increases, there is evidence that the pathophysiological mechanisms implicated by human genetics coalesce around a limited set of core pathways and networks.", "Although the genetic contribution to T2D is well recognized, the current set of 56 established susceptibility loci, identified primarily through large-scale genome-wide association studies (GWAS)2–11, captures at best 10% of familial aggregation of the disease.", "While such a model poses challenges for accumulating genome-wide significant evidence of association at a specific variant, it does suggest that genetic profiling based on the entirety of sequence variation has the potential to provide useful risk stratification for T2D.", "They report several new susceptibility loci, including two that show sex-differentiated effects on disease risk."]}
{"doc_id": 7016, "title": "", "abstract": ["For three of these (BCAR1, GLIS3 and RAD51L1), the T1D risk allele was protective for T2D, while at the others (C6orf173, COBL and C10orf59), the effects were coincident.", "Finally, we noticed that the lead T2D SNP at the BCAR1 locus is genome-wide significant for type 1 diabetes (T1D)35, although risk is conferred by the opposite alleles.", "In addition to the nine loci previously reported (MTNR1B, DGKB, ADCY5, PROX1, GCK, GCKR, TCF7L2, SLC30A8 and C2CD4A)4,5, four more T2D association signals were genome-wide significant for fasting glucose: CDKN2A/B (P = 5.7 × 10−18), ARAP1 (P = 1.2 × 10−10), IGF2BP2 (P = 1.8 × 10−8) and CDKAL1 (P = 2.0 × 10−8) (Supplementary Table 9).", "Second, we extended our previous analysis4 of the physiological consequences of T2D risk alleles to include the newly identified loci.", "Summary statistics were aligned to the T2D risk allele from the combined meta- analysis."]}
{"doc_id": 7017, "title": "", "abstract": ["However, at only two loci did the lead SNP after Metabochip fine-mapping have substantially lower MAF and higher OR than the previously reported GWAS lead SNP: PROX1 (rs17712208, MAF = 0.03, OR = 1.20; rs340874, MAF = 0.48, OR = 1.06) and KLF14 (7-130116320, MAF = 0.02, OR = 1.10; rs972283, MAF = 0.48, OR = 1.01).", "Across 36 fine-mapping regions on Metabochip that contain T2D susceptibility loci (including 27 explicitly chosen by DIAGRAM), we compared the characteristics of previously reported lead SNPs (defined by GWAS and HapMap imputation) and those emerging from the Stage 2 Metabochip meta-analysis.", "We obtained summary statistics (RAFs, association P-values, allelic ORs and 95% CIs) for lead SNPs at the newly discovered loci in meta-analyses of T2D GWAS in: (i) 5,561 cases and 14,458 controls of South Asian descent10, excluding 1,958 overlapping samples from PROMIS that were also included in our study, comprising 568,976 directly genotyped autosomal SNPs; and (ii) 6,952 cases and 11,865 controls of East Asian descent11, comprising 2,626,356 directly genotyped and imputed autosomal SNPs.", "At six of the newly discovered loci, the lead T2D SNP showed strong cis-eQTL associations and was highly correlated (CEU r2 > 0.8) with the lead cis-eQTL SNP (Supplementary Table 13).", "As noted earlier, lead SNPs at several newly identified loci are in strong LD with variants associated with other T2D-related metabolic traits."]}
{"doc_id": 36019, "title": "", "abstract": ["Here it should be stressed that the carboxypeptidase ACE2 has multiple substrates and that an alteration in the level of one of these substrates (angiotensin II, occurring at fmol/mL levels, ie, many orders of magnitude below the actual ACE2 concentration!) cannot possibly make a meaningful difference in its substrate load.", "In agreement with this assumption, angiotensin II acutely induced ACE2 internalization via its AT1 receptor in ACE2-transfected neuroblastoma cells.23", "Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs.", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2"]}
{"doc_id": 36020, "title": "", "abstract": ["Taken together, there is evidence from animal studies that ARBs may upregulate membrane-bound ACE2, whereas ACE inhibitors may not.", "During acute lung injury, alveolar ACE2 appears to be downregulated.25,26", "If ARBs as a drug class would truly upregulate membrane-bound ACE2, it is reasonable to first assume that this is because of AT1 receptor blockade.", "There are some concerns that these agents, particularly ARBs, can affect the expression of ACE2 based on animal models that, however, have not been challenged with coronavirus infection to evaluate the impact of RAS blocker therapy.", "We like to point out that a potentially beneficial pulmonary effect of ARBs needs to be considered as well."]}
{"doc_id": 36021, "title": "", "abstract": ["* Animal data support a potential protective pulmonary and cardiovascular effects of elevated ACE2 expression.", "Indeed, animal data support elevated ACE2 expression as conferring potential protective pulmonary and cardiovascular effects.", "During acute lung injury, alveolar ACE2 appears to be downregulated.25,26", "Much of the work on ACE2 has centered on the biologic effects related to the formation of angiotensin-(1–7) from angiotensin II.13,14", "The carboxypeptidase ACE2 converts Ang II (angiotensin II) to Ang-(1–7) and Ang I to Ang-(1–9) (A), yet is not blocked by ACE (angiotensin-converting enzyme) inhibitors, which prevent the conversion of Ang I to Ang II."]}
{"doc_id": 36022, "title": "", "abstract": ["The current data, however, are often conflicting and vary between ARBs and tissue (eg, heart versus kidney).", "Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs.", "Moreover, there are no data to support the notion that ACE inhibitor or angiotensin II type 1 receptor blocker administration facilitates coronavirus entry by increasing ACE2 expression in either animals or humans.", "There are, however, limited reports that ACE inhibitors affect the expression of ACE2 in the heart and the kidney.19", "ACE inhibitors should then have the same directional effect as ARBs, although for these drugs there is very limited data showing upregulation of ACE2."]}
{"doc_id": 36023, "title": "", "abstract": ["Here it should be stressed that the carboxypeptidase ACE2 has multiple substrates and that an alteration in the level of one of these substrates (angiotensin II, occurring at fmol/mL levels, ie, many orders of magnitude below the actual ACE2 concentration!) cannot possibly make a meaningful difference in its substrate load.", "In agreement with this assumption, angiotensin II acutely induced ACE2 internalization via its AT1 receptor in ACE2-transfected neuroblastoma cells.23", "Given that ACE2 (angiotensin-converting enzyme 2) is the receptor that allows coronavirus entry into cells, the idea has come up that preexisting use of renin-angiotensin system (RAS) blockers might increase the risk of developing a severe and fatal SARS-CoV-2 infection.2", "Although angiotensin II type 1 receptor blockers have been shown to upregulate ACE2 in experimental animals, the evidence is not always consistent and differs among the diverse angiotensin II type 1 receptor blockers and differing organs.", "Because the ACE2 (angiotensin-converting enzyme 2) protein is the receptor that facilitates coronavirus entry into cells, the notion has been popularized that treatment with renin-angiotensin system blockers might increase the risk of developing a severe and fatal severe acute respiratory syndrome coronavirus-2 infection."]}
{"doc_id": 36024, "title": "", "abstract": ["This is unlikely to seriously affect SARS-CoV-2 entry, which depends on membrane- bound (full-length) ACE2.", "Importantly, SARS-CoV-2 entry into the cell could be blocked both by S-protein neutralizing antibodies and TMPRSS2 inhibitors (camostat mesylate).7", "Shedding of membrane-bound ACE2 by a disintegrin and metalloprotease 17 (ADAM17) results in the occurrence of soluble (s) ACE2, which can no longer mediate SARS-Cov-2 entry and which might even prevent such entry by keeping the virus in solution.", "Two recent reports confirmed that SARS-CoV-2 also enters the cell via this route.7,8", "Even if the reported upregulation of tissue ACE2 by ARBs in animal studies and generally with high doses could be extrapolated to humans, this would not establish that it is sufficient to facilitate SARS-CoV-2 entry."]}
{"doc_id": 1029, "title": "", "abstract": ["HeLa YFP-Parkin, E18 Rat cortical neurons, PINK1+/+ SV40-transformed MEF cells, PINK1−/− SV40-transformed MEF, M17 neuroblastoma control shRNA, M17 neuroblastoma PINK1, Mfn1/2−/− MEF, and Parl−/− MEF cell lines have been described previously [21],[25],[29],[33],[57],[58].", "YFP-Parkin, YFP-Parkin mutants, mCherry- Parkin, PINK1-YFP, PINK1KD-YFP, PINK1 Δ1-110-YFP, and Opa3-PINK1 Δ1-110-YFP are in C1 or N1 Clontech vectors.", "As was reported previously, wild-type YFP-Parkin is recruited to mitochondria in the majority of HeLa cells (94.7±5.8%) by confocal microscopy, following treatment with 10 µM CCCP for 1 h (Figure 9A and 9B).", "YFP- Parkin was expressed less in the PINK1 shRNA cells compared to control shRNA cells, possibly because the transfection efficiency is lower in these cells and/or because Parkin is less stable in the absence of PINK1, as has been observed previously [29].", "Similar to results with Parkin reported previously [21], we found that PINK1-YFP accumulates preferentially on damaged mitochondria with low membrane potential (Figure 1G)."]}
{"doc_id": 29031, "title": "", "abstract": ["(a) Log10 sgRNA copies/ml (limit of quantification 50 copies/ml) were assessed in bronchoalveolar lavage (BAL) following re-challenge.", "(a) Log10 sgRNA copies/ml (limit of quantification 50 copies/ml) were assessed in bronchoalveolar lavage (BAL) following challenge.", "In contrast, NAb and ELISA titers increased sharply in Groups III and IV by day 10–14 following challenge, presumably reflecting the autologous antibody response to productive infection1.", "Log10 sgRNA copies/ml (limit of quantification 50 copies/ml) were assessed in bronchoalveolar lavage (BAL) and log10 sgRNA copies/swab (limit of quantification 50 copies/swab) were assessed in nasal swabs (NS) following challenge.", "NAb responses also increased in both groups following re-challenge (Extended Data Fig. 9), consistent with our previous findings1."]}
{"doc_id": 29032, "title": "", "abstract": ["Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "These regression models indicated that pseudovirus NAb titers of approximately 50 (Fig. 2a, ​,d),d), RBD ELISA titers of approximately 100 (Fig. 2b, ​,e),e), and S ELISA titers of approximately 400 (Fig. 2c, ​,f)f) were required for protection.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "NAb responses also increased in both groups following re-challenge (Extended Data Fig. 9), consistent with our previous findings1."]}
{"doc_id": 29033, "title": "", "abstract": ["Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "To determine the neutralization activity of the antisera from vaccinated animals, HEK293T-hACE2 cells were seeded in 96-well tissue culture plates at a density of 1.75 × 104 cells/well overnight.", "Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Following re-challenge, S-specific IFN-γ+ CD8+ T cell responses were undetectable in the CD8-depleted animals, as expected, but increased in the undepleted sham controls (P=0.0157, two-sided Mann-Whitney test; Extended Data Fig. 7).", "CD8+ T cell responses following CD8 depletion and SARS-CoV-2 re-challenge."]}
{"doc_id": 29034, "title": "", "abstract": ["Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "If antibodies are near or below the threshold titer required for protection, then cellular immune responses may be important for rapid virologic control.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "Our data suggest the importance of SARS-CoV-2 vaccines to induce potent and durable humoral as well as cellular immune responses."]}
{"doc_id": 29035, "title": "", "abstract": ["Protein antigens included prefusion stabilized spike ectodomain (S), receptor binding domain (RBD), nucleocapsid (N), and S1+S2 (Aalto Bio Reagents; Sino Biological).", "We profiled S-, RBD-, and nucleocapsid (N)-specific antibody responses in the recipient animals by systems serology9,10, as we previously observed diverse Fc functional antibody responses in SARS-CoV-2 infected animals1.", "Binding ELISA titers to spike (S) and the receptor binding domain (RBD) similarly showed a titration of antibody titers in the recipient animals on day 0 (Extended Data Fig. 2b, ​,c).c).", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4).", "Briefly, the packaging construct psPAX2 (AIDS Resource and Reagent Program), luciferase reporter plasmid pLenti-CMV Puro-Luc (Addgene), and spike protein expressing pcDNA3.1-SARS-CoV-2 SΔCT were co-transfected into HEK293T cells with calcium phosphate."]}
{"doc_id": 29036, "title": "", "abstract": ["To determine a threshold in antibody titers predicting protection, we classified protected and not protected animals with logistic regression models fitted using the R function ‘glm’.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4)."]}
{"doc_id": 29037, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Our findings have important implications for vaccines and immune-based therapeutics.", "These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5.", "Our data suggest the importance of SARS-CoV-2 vaccines to induce potent and durable humoral as well as cellular immune responses.", "Collectively, these data provide key insights into the immunologic determinants and correlates of protection against SARS-CoV-2 and have important implications for the development of vaccines, immune-based therapeutics, and public health strategies."]}
{"doc_id": 29038, "title": "", "abstract": ["These data suggest that cellular immunity, including CD8+ T cells, can contribute to protection of convalescent animals against SARS-CoV-2 re-challenge in the setting of waning and subprotective antibody titers.", "To evaluate the potential role of cellular immune responses in protection against SARS-CoV-2, we CD8 depleted14 convalescent rhesus macaques prior to re-challenge1.", "Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques", "Depletion of CD8+ T cells in convalescent animals partially abrogated the protective efficacy of natural immunity against SARS-CoV-2 re-challenge, suggesting the importance of cellular immunity in the context of waning or subprotective antibody titers.", "Collectively, these data provide key insights into the immunologic determinants and correlates of protection against SARS-CoV-2 and have important implications for the development of vaccines, immune-based therapeutics, and public health strategies."]}
{"doc_id": 29039, "title": "", "abstract": ["Future studies could also be designed to evaluate the potential protective efficacy of cellular immune responses in the absence of antibody responses.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "To evaluate the role of CD8+ T cells cells in contributing to protective efficacy against re-challenge, macaques received a single intravenous infusion of 50 mg/kg of the anti-CD8α CDR-grafted rhesus IgG1 antibody MT807R1 (MassBiologics, Mattapan, MA) (N=5), the anti-CD8β rhesus IgG1 antibody CD8b255R1 (MassBiologics, Mattapan, MA) (N=3), or a sham control antibody (N=5) at week 7 after primary infection, reflecting day −3 relative to re- challenge.", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4).", "Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1)."]}
{"doc_id": 29040, "title": "", "abstract": ["Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "These regression models indicated that pseudovirus NAb titers of approximately 50 (Fig. 2a, ​,d),d), RBD ELISA titers of approximately 100 (Fig. 2b, ​,e),e), and S ELISA titers of approximately 400 (Fig. 2c, ​,f)f) were required for protection.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "### Pseudovirus neutralization assay."]}
{"doc_id": 29041, "title": "", "abstract": ["Our data demonstrate that adoptive transfer of purified polyclonal IgG from convalescent macaques robustly protected naïve recipient rhesus macaques against SARS-CoV-2 challenge in a dose dependent fashion.", "Our findings have important implications for vaccines and immune-based therapeutics.", "These findings extend our DNA and Ad26 vaccine studies in rhesus macaques in which we observed that NAb titers and other Fc functional antibody responses correlated with protective efficacy4,5.", "Our data suggest the importance of SARS-CoV-2 vaccines to induce potent and durable humoral as well as cellular immune responses.", "Systems serology immune correlates."]}
{"doc_id": 29042, "title": "", "abstract": ["To determine a threshold in antibody titers predicting protection, we classified protected and not protected animals with logistic regression models fitted using the R function ‘glm’.", "Both neutralizing antibody (NAb) titers as well as Fc functional antibody responses correlated with protection4,5, but direct data demonstrating the immunologic determinants of protection have been lacking.", "Correlation analysis showed that NAb titers correlated with protective efficacy (P=0.013 for BAL, P=0.023 for NS, two-sided Spearman rank-correlation tests; Fig. 2) and that NAb titers effectively differentiated fully protected vs. non-protected animals (P=0.0082, two-sided Mann-Whitney test; Fig. 2).", "Following re-challenge, these animals developed increased log10 neutralizing antibody (NAb) titers of 2.56–3.38 (median 3.07) using a luciferase-based pseudovirus neutralization assay1,4,8 (Extended Data Fig. 1).", "Other antibody features also correlated with protective efficacy, including IgG1, ADCD, ADNKA, and ADNP (P=0.00032, P=0.00097, P=0.0048, and P=0.0074, respectively, two-sided Spearman rank-correlation tests; Extended Data Fig. 4)."]}
{"doc_id": 22028, "title": "", "abstract": ["Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2).", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies."]}
{"doc_id": 22029, "title": "", "abstract": ["Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene.", "The decrease in gene expression for ACE2 and TMPRSS2 provides some reassurance that ICS use will not increase the risk of infection with SARS-CoV-2 or morbidity from COVID-19, but this finding should be explored in prospective studies.", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity."]}
{"doc_id": 22030, "title": "", "abstract": ["In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes.", "The higher expression of ACE2 that we report in male patients is notable because of the high mortality of COVID-19 in males (1, 5).", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes."]}
{"doc_id": 22031, "title": "", "abstract": ["Using this analysis approach, ACE2 and TMPRSS2 expression levels were significantly lower in patients with asthma taking ICS than in those not taking ICS, especially in those taking higher doses of ICS (Figure 4A and Tables E1 and E2).", "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes.", "In summary, in a large cohort of well-characterized patients with asthma, we report higher sputum cell expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus and lower expression in patients taking inhaled corticosteroids.", "ACE2 and TMPRSS2 expression was lower in patients taking ICS than in patients not taking ICS, a finding of high clinical relevance because of concern that the immunosuppressive effects of ICS could put patients with asthma at risk during the COVID-19 pandemic.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."]}
{"doc_id": 22032, "title": "", "abstract": ["The similar increases in both genes in the same patient subgroups provide a mechanism for a “double hit” susceptibility for SARS-CoV-2 infection and COVID-19 morbidity in these patients.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."]}
{"doc_id": 22033, "title": "", "abstract": ["Coronavirus disease, or COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be more severe in patients with chronic lung disease, including patients with asthma (1).", "Non–asthma-related factors, such as male sex, African American race, and metabolic disease (diabetes mellitus), may be more important and more generalizable risks for susceptibility to SARS-CoV-2 infection and more severe COVID-19 morbidity.", "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity.", "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes.", "Hypertension is also a risk factor for COVID-19 morbidity (1), but we did not find increases in ACE2 expression in sputum cells from patients with asthma with and without hypertension."]}
{"doc_id": 28026, "title": "", "abstract": ["The outcome measure was diagnosis of COVID-19.", "The outcome measures were COVID-19 diagnosis, rates of death, and hospitalization.", "Other demographic groups were not included due to insufficient sample sizes for COVID-19 cases.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes."]}
{"doc_id": 28027, "title": "", "abstract": ["These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "However, these comorbidities alone may not be sufficient to explain the observed several-fold increase of COVID-19 diagnosis in African Americans as compared to Caucasians or their increased death rates.", "Social adversity is likely to have contributed not only to the higher risk for COVID-19 among patients with SUD but also to the even higher risk among African Americans patients with SUD.", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans."]}
{"doc_id": 28028, "title": "", "abstract": ["Patients with SUD often have multiple comorbidities, including cardiovascular, pulmonary, metabolic diseases, and increased susceptibility to infections [6–10], which are also risk factors for COVID-19 [11–13].", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "In our study, we showed that patients with SUDs has significantly higher prevalence of comorbidities, which are known risk factors for COVID-19, as compared to patients without SUDs.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans."]}
{"doc_id": 28029, "title": "", "abstract": ["The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults.", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P < 10−30), an effect that was strongest for individuals with OUD (AOR = 10.244 [9.107–11.524], P < 10−30), followed by individuals with tobacco use disorder (TUD) (AOR = 8.222 ([7.925–8.530], P < 10−30)."]}
{"doc_id": 28030, "title": "", "abstract": ["These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Based on EHR patient data in the US we show that individuals with SUD, particularly recent OUD, were at increased risk for COVID-19 and these effects were exacerbated in African Americans compared to Caucasians.", "They also highlight the exacerbation of healthcare disparities from COVID-19 driven by social and economic factors that place certain groups at increased risks for both SUD as well as risk and adverse outcomes from COVID-19.", "Since EHR adoption and health IT use generally lags in rural areas due to lack of financial and technical resources, patients from rural areas are likely less represented in our study population."]}
{"doc_id": 28031, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Social adversity is likely to have contributed not only to the higher risk for COVID-19 among patients with SUD but also to the even higher risk among African Americans patients with SUD.", "Patients with SUD often have multiple comorbidities, including cardiovascular, pulmonary, metabolic diseases, and increased susceptibility to infections [6–10], which are also risk factors for COVID-19 [11–13].", "Second, due to limited sample sizes for COVID-19 cases among patients with SUD (1880 cases for all SUD and 210 for OUD), the large number of SUD-associated comorbidities, as well as inter-dependency among comorbidities (e.g., diabetes, hypertension, and obesity), we are currently unable to control for these comorbidities as well as their associated medications, behaviors and other socioeconomic factors in order to assess the direct effects of addictive drugs or of SUD as a disease entity on COVID-19 risk.", "In addition, there is minimal data on how race and other demographic factors affect the risk and outcomes of COVID-19 among patients with SUD including OUD."]}
{"doc_id": 28032, "title": "", "abstract": ["First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Patients with SUD often have multiple comorbidities, including cardiovascular, pulmonary, metabolic diseases, and increased susceptibility to infections [6–10], which are also risk factors for COVID-19 [11–13].", "In addition, there is minimal data on how race and other demographic factors affect the risk and outcomes of COVID-19 among patients with SUD including OUD.", "Consistent with other reports [12, 13], our study showed that seniors were more likely to develop COVID-19 than adults, which was also expected since hypertension, diabetes, obesity, cardiovascular diseases, and weakened immune function are more common in seniors than in adults."]}
{"doc_id": 28033, "title": "", "abstract": ["These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Currently, there is little if any quantitative analysis of the risks and outcomes for COVID-19 infection in individuals suffering from an OUD and those suffering from other substance use in the US.", "First, the central hypothesis of this study was that comorbidities associated with SUD, including type 2 diabetes, hypertension, heart disease, chronic kidney, lung, and liver diseases, largely contributed to patients’ risk to COVID-19 and its adverse outcomes.", "To the extent that chronic use of tobacco, alcohol and other drugs is associated with cardiovascular (arrhythmias, cardiac insufficiency, and myocardial infarction), pulmonary (COPD, pulmonary hypertension), and metabolic diseases (diabetes, hypertension) [6–10] all of which are risk factors for COVID-19 infection and for worse outcomes [11–13] one can also predict that individuals with SUD including OUD would be at increased risk for adverse COVID-19 outcomes [2].", "Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes."]}
{"doc_id": 28034, "title": "", "abstract": ["Other factors including access to healthcare, socioeconomic status and other social adversity components may have contributed negatively to their increased risk of COVID-19 as well as to the adverse outcomes.", "It is also confounded by the likelihood that patients with specific SUDs (e.g., Cocaine-UD and OUD) might have been less likely to be tested due to socioeconomic factors or stigma.", "To the extent that chronic use of tobacco, alcohol and other drugs is associated with cardiovascular (arrhythmias, cardiac insufficiency, and myocardial infarction), pulmonary (COPD, pulmonary hypertension), and metabolic diseases (diabetes, hypertension) [6–10] all of which are risk factors for COVID-19 infection and for worse outcomes [11–13] one can also predict that individuals with SUD including OUD would be at increased risk for adverse COVID-19 outcomes [2].", "These results suggest that while comorbidities associated with SUD likely contributed to the increased risk of COVID-19 and to worse outcomes among SUD patients, specific pharmacological effects of drugs of abuse (e.g., opioid induced respiratory depression) as well as behavioral and socioeconomic factors could facilitate COVID-19 infection and increase risk for adverse outcomes.", "Additional limitations for this study include: (1) possible ascertainment bias as illicit SUD might have been underreported and individuals with SUD particularly illicit SUD are less likely to access healthcare, which would result in their lower representation in EHR, (2) the EHR database did not encode for current or active drug use, which is why we relied on a recent SUD diagnoses assuming that those patients were more likely to be active drug users, and (3) due to limited information of socioeconomic information on the EHR data, we were unable to assess the effects of social adversity and its interaction with medical conditions to COVID-19 risk, race disparity and adverse outcomes among patients with SUD."]}
{"doc_id": 28035, "title": "", "abstract": ["The analyses showed that a recent diagnosis of SUD significantly increased the risk of COVID-19 that was highest for recent diagnosis of OUD followed by TUD, AUD and Cocaine-UD, and lowest for CUD.", "These findings identify individuals with SUD as a vulnerable population, especially African Americans with SUDs, who are at significantly increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat SUD as part of the strategy to control the pandemic while ensuring that there are no disparities in access to healthcare support for African Americans.", "In summary, our findings at a macroscopic level provide evidence that SUD should be considered a condition that increases risk for COVID-19, a comorbidity that has particularly deleterious effects to African Americans.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "Previous studies showed that with this large-scale and standardized EHR database, large case-control studies can be undertaken efficiently [20–24], including our recent studies [23, 24]."]}
{"doc_id": 28036, "title": "", "abstract": ["It is estimated that more than 70,000 people will die in the US from an overdose in 2019 mostly from opioid overdoses, which are driven by the respiratory depressant effects of opioids.", "It is also confounded by the likelihood that patients with specific SUDs (e.g., Cocaine-UD and OUD) might have been less likely to be tested due to socioeconomic factors or stigma.", "These findings identify individuals with SUD, especially individuals with OUD and African Americans, as having increased risk for COVID-19 and its adverse outcomes, highlighting the need to screen and treat individuals with SUD as part of the strategy to control the pandemic while ensuring no disparities in access to healthcare support.", "(3) We examined rates of death and hospitalization among patients with COVID-19 and SUD and compared outcomes of African Americans to those of Caucasians with SUD.", "The higher prevalence of kidney, pulmonary, liver, cardiovascular, metabolic, and immune- related disorders in COVID-19 patients with SUD and also in African Americans are likely contribute to their higher risk."]}
{"doc_id": 32049, "title": "", "abstract": ["Changes to sleep quality varied; 43.8% reported worsened sleep quality, while 10.2% reported improved sleep quality.", "The reported decline in physical activity is supported by objective data from Fitbit, Inc, whose monitor data detected a 7%‐38% decline globally since the start of the pandemic (11).", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "Nonscientific reports have begun to illustrate the impacts of weight gain throughout the pandemic.", "However, these changes are likely attributable to overall lower levels of physical activity of participants residing in the US prior to the pandemic."]}
{"doc_id": 32050, "title": "", "abstract": ["During the pandemic, overall scores for healthy eating increased (P < 0.001), owing to less eating out and increased cooking (P < 0.001).", "Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "To assess changes in dietary behaviors, the short form included items on cooking and eating out habits as well as snacking prior to and during the pandemic.", "Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "Increased overall healthy eating scores were primarily due to the reduction in eating foods prepared outside the home, an almost unavoidable change to food intake that resulted from stay‐at‐home orders."]}
{"doc_id": 32051, "title": "", "abstract": ["With increased cases of weight gain and significant declines to mental health, COVID‐19 may impact clinical practice for years to come.", "To assess the widespread impacts of the COVID‐19 pandemic on health behaviors, the aim of this study was to quantify changes in habitual dietary behaviors, physical activity, sleep, sedentary behaviors, and mental health before and during the initial peak of the COVID‐19 pandemic.", "The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in Adults", "This provides evidence that behavioral and emotional changes in response to the COVID‐19 pandemic are indeed of global concern.", "Most participants reported being concerned or moderately concerned for their own physical health (75.0%) or the health of a family member (87.5%) as it relates to COVID‐19."]}
{"doc_id": 32052, "title": "", "abstract": ["Behaviors during the pandemic were assessed sequentially by using the phrase “since the COVID‐19 outbreak in your country or region.”", "Reported anxiety scores nearly doubled in response to the pandemic, and 20% of the sample reported that symptoms were severe enough to interfere with daily routines.", "Anxiety scores increased 8.78 ± 0.21 during the pandemic, and the magnitude of increase was significantly greater in people with obesity (P ≤ 0.01).", "Increased anxiety has been observed after other extreme natural disasters (12, 13), highlighting the equivalent impact of the pandemic on mental health.", "Nonscientific reports have begun to illustrate the impacts of weight gain throughout the pandemic."]}
{"doc_id": 32053, "title": "", "abstract": ["Positive reported eating behavior changes included a lower frequency of breakfast skipping, a lower frequency of eating four or more meals at a restaurant, a lower frequency of eating two or more meals from fast food, a lower frequency of consuming fried foods, and an increased frequency of eating fruit.", "Although the current survey does not capture diet composition per se, individuals reported a combination of positive and negative changes in eating behaviors.", "Other positive dietary changes included a reduction in fried foods, which are generally a product of restaurant dining and fast food.", "Participant characteristics for reported eating behavior changes are presented in Table 2.", "For the most represented countries outside the US (e.g., Canada, the UK, Australia, and Ireland), large cities and capitol regions were all under government‐enforced social distance or stay‐at‐home orders at the opening of this study."]}
{"doc_id": 32054, "title": "", "abstract": ["As individuals across the globe have become confined to their homes, daily work and household responsibilities have shifted.", "Temporary closure to places of employment, restaurants, fitness facilities, and other public places has forced abrupt changes to habitual dietary and physical activity patterns.", "Stay‐at‐home orders have resulted in overall changes to dietary behavior, increases in sedentary behavior alongside decreases in physical activity, and declines in mental health.", "Stay‐at‐home orders in response to the coronavirus disease 2019 (COVID‐19) pandemic have forced abrupt changes to daily routines.", "For participants who reported healthier eating behaviors, physical activity increased, and this group had the greatest percentage of participants working from home as a result of COVID‐19."]}
{"doc_id": 23021, "title": "", "abstract": ["Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Together, they lead to disproportionately severe COVID-19 and high mortality in older adults.", "Data from a large case series of 5700 COVID-19 patients who were admitted to hospitals in New York City have shown a strikingly similar trend of age-related increases in COVID-19 deaths."]}
{"doc_id": 23022, "title": "", "abstract": ["Therefore, age-associated weaker type 1 IFN responses coupled with direct viral suppression could serve as a critical innate immune mechanism that leads to poor cell mediated immunity and increased vulnerability of older adults to SARS-CoV-2 infection with therapeutic implication (Sallard et al., 2020).", "For example, senescence-related impairment of the type 1 IFN response is responsible for enhanced influenza viral replication in cell culture (Kim et al., 2016) and older adults manifest impaired type 1 IFN response to influenza vaccination (Thakar et al., 2015).", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults.", "Age-related immune system remodeling, or immunosenescence, is considered to be the major reason for increased susceptibility to infection, particularly respiratory infections such as influenza, as well as impaired immune responses to vaccination (Li et al., 2011; Pawelec, 2018).", "Immune hypothesis for age-related vulnerability in older adults"]}
{"doc_id": 23023, "title": "", "abstract": ["For severe COVID-19 disease, major risk factors include age, male sex, obesity, smoking, and comorbid chronic conditions such as hypertension, type 2 diabetes mellitus, and others (Wu et al., 2020; Zhou et al., 2020a; Garibaldi et al., 2020).", "Overwhelming evidence from around the world suggests that age itself is the most significant risk factor for severe COVID-19 disease and its adverse health outcomes.", "Aging itself is a prominent risk factor for severe disease and death from COVID-19.", "Taken together, it is unmistakable that aging is an important risk factor for severe COVID-19 disease and its adverse health outcomes including hospitalization, ICU admission, and death.", "Clinical experience thus far indicates that COVID-19 is highly heterogeneous, ranging from being asymptomatic and mild to severe and causing death."]}
{"doc_id": 23024, "title": "", "abstract": ["China: Early data from China demonstrate that case fatality ratio (CFR) of COVID-19 increases with age, from 0.4 % or lower in patients aged in the 40s or younger, 1.3 % among those in their 50s, 3.6 % in their 60s, 8% in their 70s, to 14.8 % in their 80s or older; the overall CFR is 2.3 % (Wu et al., 2020; Zhu et al., 2020b).", "As shown in Fig. 4 , data reported by the US Center for Disease Control and Prevention (CDC) also demonstrate significantly higher rates of hospitalizations, ICU admissions, and deaths secondary to COVID-19 among older adults (> 65 years) than any younger age groups.", "On the other hand, children with COVID-19 manifested lower levels of T cell activation than adult COVID-19 patients (Moratto et al., 2020), suggesting better immune system control and regulation in response to SARS-CoV-2 infection in children.", "Data from a large case series of 5700 COVID-19 patients who were admitted to hospitals in New York City have shown a strikingly similar trend of age-related increases in COVID-19 deaths.", "Children are overwhelmingly spared from severe COVID-19 disease except for the extremely rare occurrence of multisystem inflammatory syndrome in children (MIS-C), also called Kawasaki disease-like syndrome (Lingappan et al., 2020; Viner and Whittaker, 2020)."]}
{"doc_id": 23025, "title": "", "abstract": ["Aging in COVID-19: Vulnerability, immunity and intervention", "Here we propose an immune hypothesis for COVID-19 vulnerability of older adults.", "It is postulated that age-related decline of de novo T cell responsiveness and/or impact from comorbid conditions, particularly persistent viral infections such as chronic cytomegalovirus (CMV) infection could serve as potential causes of COVID-19 vulnerability in older adults (Kadambari et al., 2020; Moss, 2020; Nicoli et al., 2020).", "However, about 7% of confirmed COVID-19 cases were among these vulnerable elderly individuals.", "We hypothesize that age-related decline and dysregulation of immune function, i.e., immunosenescence and inflammaging play a major role in contributing to heightened vulnerability to severe COVID-19 outcomes in older adults."]}
{"doc_id": 30022, "title": "", "abstract": ["Thus, now more than ever, wider access to healthy foods should be a top priority and individuals should be mindful of healthy eating habits to reduce susceptibility to and long-term complications from COVID-19.", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality.", "The impact of nutrition on COVID-19 susceptibility and long-term consequences", "In sum, it is critical to consider the impact of lifestyle habits, such as consumption of unhealthy diets, on the susceptibility to COVID-19 and recovery.", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016)."]}
{"doc_id": 30023, "title": "", "abstract": ["COVID-19 is a respiratory disease caused by the novel coronavirus, SARS-CoV-2, that has reached pandemic status.", "Given that, even in the most at-risk populations, the vast majority of COVID-19 patients are expected to recover, there could be a number of indirect long-term consequences of the disease.", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020).", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "Furthermore, peripheral inflammation caused by COVID-19 may have long-term consequences in those that recover, leading to chronic medical conditions such as dementia and neurodegenerative disease, likely through neuroinflammatory mechanisms that can be compounded by an unhealthy diet."]}
{"doc_id": 30024, "title": "", "abstract": ["Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Furthermore, peripheral inflammation caused by COVID-19 may have long-term consequences in those that recover, leading to chronic medical conditions such as dementia and neurodegenerative disease, likely through neuroinflammatory mechanisms that can be compounded by an unhealthy diet.", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020).", "COVID-19 is a respiratory disease caused by the novel coronavirus, SARS-CoV-2, that has reached pandemic status."]}
{"doc_id": 30025, "title": "", "abstract": ["Moreover, T and B cell counts were also significantly lower in patients with severe COVID-19 (Qin et al., 2020); thus, there could be a potential interaction between WD consumption and COVID-19 on adaptive immunity impairment.", "As mentioned earlier, the high rates of obesity and diabetes among minority populations may account, at least in part, for the health disparities observed in response to COVID-19 in these groups (Dharmasena et al., 2016).", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020).", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "Specifically, HFD-induced oxidative stress impairs T and B cell proliferation and maturation, and induces B cell apoptosis, which contributes to B cell immunodepression (Green and Beck, 2017)."]}
{"doc_id": 30026, "title": "", "abstract": ["Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "The high rate of consumption of diets high in saturated fats, sugars, and refined carbohydrates (collectively called Western diet, WD) worldwide, contribute to the prevalence of obesity and type 2 diabetes, and could place these populations at an increased risk for severe COVID-19 pathology and mortality.", "As mentioned earlier, the high rates of obesity and diabetes among minority populations may account, at least in part, for the health disparities observed in response to COVID-19 in these groups (Dharmasena et al., 2016).", "In addition to potential long-term lung damage, the possible impacts on neurological function are not insignificant.", "Furthermore, the large number of people that will recover from COVID-19 may lead to a spike in chronic medical conditions that could be further exacerbated by unhealthy diets or in vulnerable populations."]}
{"doc_id": 30027, "title": "", "abstract": ["COVID-19 is a respiratory disease caused by the novel coronavirus, SARS-CoV-2, that has reached pandemic status.", "While all groups are affected by the COVID-19 pandemic, the elderly, underrepresented minorities, and those with underlying medical conditions are at the greatest risk.", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020).", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities."]}
{"doc_id": 30028, "title": "", "abstract": ["As mentioned earlier, the high rates of obesity and diabetes among minority populations may account, at least in part, for the health disparities observed in response to COVID-19 in these groups (Dharmasena et al., 2016).", "Indeed, studies show that consuming healthy foods has a rapid anti-inflammatory effect, even in the presence of obesity pathology (Connaughton et al., 2016).", "A change in these policies could also have long-term benefits on disease prevention, including COVID-19, by increasing the efficacy of vaccines, given that vaccines have been shown to be less effective in obese individuals (Green and Beck, 2017).", "The high prevalence of these risk factors, worldwide, but especially in the U.S. and other developed countries, is likely driven by increased consumption of the typical Western diet (WD) consisting of high amounts of saturated fat (HFD), refined carbohydrates and sugars, and low levels of fiber, unsaturated fats, and antioxidants (Cordain et al., 2005).", "This is especially relevant to COVID-19 patients given the high rate of infection among lung alveolar epithelial cells and the involvement of lung tissue inflammation and alveolar damage in COVID-19 pathology (Xu et al., 2020)."]}
{"doc_id": 30029, "title": "", "abstract": ["Given that the elderly and African American communities have a greater inherent sensitivity to inflammatory modulators, consumption of unhealthy diets by these groups could pose an amplified risk to severe COVID-19 pathology.", "While COVID-19 affects all groups, severe pathology and mortality is disproportionately highest in the elderly, underrepresented minorities (blacks/African Americans and Latinos), and/or in those with underlying comorbidities.", "While all groups are affected by the COVID-19 pandemic, the elderly, underrepresented minorities, and those with underlying medical conditions are at the greatest risk.", "Obesity and type 2 diabetes, two prominent risk factors for severe COVID-19, may underlie the health disparity observed in these populations (Dietz and Santos-Burgoa, 2020, Dharmasena et al., 2016).", "The impact of nutrition on COVID-19 susceptibility and long-term consequences"]}
{"doc_id": 25025, "title": "", "abstract": ["The response must capitalise on, but extend beyond, general mental health policies and practices.", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour.", "Some might not seek help, fearing that services are overwhelmed and that attending face-to-face appointments might put them at risk.", "Mental health consequences are likely to be present for longer and peak later than the actual pandemic.", "Other concerns in these settings include social effects of banning religious gatherings and funerals, interpersonal violence, and vulnerable migrant workers."]}
{"doc_id": 25026, "title": "", "abstract": ["The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "COVID-19-related stigma and misinformation may be particularly acute in these settings; many of the solutions proposed above will be applicable globally, but additional efforts will be required in resource-poor settings.", "Suicide risk might be increased because of stigma towards individuals with COVID-19 and their families.", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness.", "Those with psychiatric disorders might experience worsening symptoms and others might develop new mental health problems, especially depression, anxiety, and post- traumatic stress (all associated with increased suicide risk)."]}
{"doc_id": 25027, "title": "", "abstract": ["Social isolation, entrapment, and loneliness contribute to suicide risk7 and are likely to increase during the pandemic, particularly for bereaved individuals.", "The likely adverse effects of the pandemic on people with mental illness, and on population mental health in general, might be exacerbated by fear, self- isolation, and physical distancing.4", "The pandemic will cause distress and leave many people vulnerable to mental health problems and suicidal behaviour.", "Suicide is likely to become a more pressing concern as the pandemic spreads and has longer-term effects on the general population, the economy, and vulnerable groups.", "Other concerns in these settings include social effects of banning religious gatherings and funerals, interpersonal violence, and vulnerable migrant workers."]}
{"doc_id": 25028, "title": "", "abstract": ["Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness.", "Loss of employment and financial stressors are well-recognised risk factors for suicide.6", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "COVID-19=coronavirus disease 2019."]}
{"doc_id": 25029, "title": "", "abstract": ["Public health responses to mitigating suicide risk associated with the COVID-19 pandemic", "The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be profound1 and there are suggestions that suicide rates will rise, although this is not inevitable.", "Some suicide and self-harm registers are now collecting data on COVID-19-related stressors contributing to the episode; summaries of these data will facilitate timely public health responses.", "These mental health problems will be experienced by the general population and those with high levels of exposure to illness caused by COVID-19, such as frontline health-care workers and those who develop the illness.", "Comprehensive responses should be informed by enhanced surveillance of COVID-19-related risk factors contributing to suicidal behaviours."]}
{"doc_id": 25030, "title": "", "abstract": ["Some services are developing expertise in conducting psychiatric assessments and delivering interventions remotely (eg, by telephone or digitally); these new working practices should be implemented more widely, but with consideration that not all patients will feel comfortable with such interactions and they may present implications for privacy.", "Making evidence-based online resources and interventions freely available at scale could benefit population mental health.", "Mental health services should develop clear remote assessment and care pathways for people who are suicidal, and staff training to support new ways of working.", "The consequences for mental health services are already being felt (eg, increased workloads and the need to find new ways of working).", "Digital training resources would enable those who have not previously worked with people who are suicidal to take active roles in mental health services and helplines."]}
{"doc_id": 34032, "title": "", "abstract": ["Physicians and other healthcare providers voluntarily reported cases of PCR-confirmed or antibody- confirmed COVID-19 occurring in IBD patients.", "Our results are largely consistent with the first analysis of SECURE-IBD data but add more granular data on the impact of IBD medications on severe COVID-19.", "While our findings warrant replication in large population-based cohorts, these data can assist physicians and patients with IBD in shared clinical decision making during the era of COVID-19.", "These findings warrant confirmation in large population-based cohorts.", "Over a third of patients (37.2%) had at least one comorbidity in addition to IBD, the most common being hypertension (13.7%), lung disease (9.3%) and cardiovascular disease (7.6%)."]}
{"doc_id": 34033, "title": "", "abstract": ["* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "In sensitivity analyses, the increased risk of severe COVID-19 with mesalamine/sulfasalazine monotherapy, compared with TNF antagonist monotherapy, was still significant after stratifying by disease type (CD: aOR 3.50, 95% CI 1.48 to 8.28; UC: aOR 5.74, 95% CI 1.15 to 28.76).", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19.", "Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2)."]}
{"doc_id": 34034, "title": "", "abstract": ["In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "* Based on data on over 1400 patients with IBD from an international registry, compared with TNF monotherapy, thiopurine monotherapy and the combination thiopurines with TNF antagonists are associated with significantly increased risk of severe COVID-19.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "When exploring comparisons between different classes of biologicals, patients on IL-12/23 antagonists, compared with those on TNF antagonists, were more likely to have CD and have any comorbidity and less likely to be on concomitant mesalamine/sulfasalazine therapy (online supplemental table 6).", "Patients on both mesalamine/sulfasalazine and TNF antagonists concomitantly were also more likely to have severe COVID-19 compared with TNF antagonist monotherapy (9.3% vs 3%, p=0.008)."]}
{"doc_id": 34035, "title": "", "abstract": ["Specific risk factors for severe COVID-19 include increasing age, high fever, cardiovascular disease, diabetes, obesity, chronic obstructive pulmonary disease and chronic kidney disease.2 5–7", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19.", "Overall, 112 patients (7.8%) experienced the primary outcome of severe COVID-19 with most being age 50 years or older (88/112, 79%).", "Cardiovascular disease was included a priori as this has consistently been one of the stronger comorbidities associated with adverse COVID-19 outcomes.20 21", "Among all patients, after adjusting for age, sex, race (black vs non-Hispanic white, Asian vs non-Hispanic white), Hispanic versus non-Hispanic ethnicity, disease type, disease activity, cardiovascular disease, TNF antagonist, thiopurine, diabetes, lung disease and cancer, corticosteroid use was significantly associated with severe COVID-19 (aOR 3.24, 95% CI 1.78 to 5.90)."]}
{"doc_id": 34036, "title": "", "abstract": ["This is in line with previous studies that have observed a higher risk of viral infections in patients treated with thiopurines alone or in combination with TNF antagonists.12", "Our results are largely consistent with the first analysis of SECURE-IBD data but add more granular data on the impact of IBD medications on severe COVID-19.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "Physicians and other healthcare providers voluntarily reported cases of PCR-confirmed or antibody- confirmed COVID-19 occurring in IBD patients.", "In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD."]}
{"doc_id": 34037, "title": "", "abstract": ["* These findings provide data to help clinicians and patients with IBD make informed, shared decisions about risks of medications in the COVID-19 era.", "Data are available on reasonable request.", "Among TNF antagonist users, 284 patients were on an intravenous TNF antagonist (infliximab) while 231 were on a subcutaneous medication (adalimumab, golimumab or certolizumab).", "While our findings warrant replication in large population-based cohorts, these data can assist physicians and patients with IBD in shared clinical decision making during the era of COVID-19.", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2)."]}
{"doc_id": 34038, "title": "", "abstract": ["Physicians and other healthcare providers voluntarily reported cases of PCR-confirmed or antibody- confirmed COVID-19 occurring in IBD patients.", "While our findings warrant replication in large population-based cohorts, these data can assist physicians and patients with IBD in shared clinical decision making during the era of COVID-19.", "We investigated the impact of different medication classes on the risk of severe COVID-19 in patients with IBD using the SECURE-IBD registry.", "Over a third of patients (37.2%) had at least one comorbidity in addition to IBD, the most common being hypertension (13.7%), lung disease (9.3%) and cardiovascular disease (7.6%).", "Patients with IBD frequently require treatment with immunosuppressant medications that can increase the risk of serious viral and bacterial infections.11–14"]}
{"doc_id": 34039, "title": "", "abstract": ["In sensitivity analyses, the increased risk of severe COVID-19 with mesalamine/sulfasalazine monotherapy, compared with TNF antagonist monotherapy, was still significant after stratifying by disease type (CD: aOR 3.50, 95% CI 1.48 to 8.28; UC: aOR 5.74, 95% CI 1.15 to 28.76).", "The increased risk of severe COVID-19 with corticosteroid treatment seen in SECURE-IBD is likely not in conflict with these results and may reflect the impact of steroids based on stage of disease.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "On multivariable analysis, compared with TNF antagonist monotherapy, patients on combination therapy (aOR 4.01, 95% CI 1.65 to 9.78) and thiopurine monotherapy (aOR 4.08, 95% CI 1.73 to 9.61) had a significantly increased risk of severe COVID-19 (figure 1 and table 2).", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk."]}
{"doc_id": 34040, "title": "", "abstract": ["In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "Using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, a large international registry of IBD patients with COVID-19, we previously reported that corticosteroids and mesalamine/sulfasalazine are associated with an increased risk of severe COVID-19, defined as requirement for ICU admission, ventilator support or death, while tumour necrosis factor (TNF) antagonists did not impact this risk.17", "Compared with tumour necrosis factor (TNF) antagonist monotherapy, thiopurine monotherapy (adjusted OR (aOR) 4.08, 95% CI 1.73 to 9.61) and combination therapy with TNF antagonist and thiopurine (aOR 4.01, 95% CI 1.65 to 9.78) were associated with an increased risk of severe COVID-19.", "We observed that thiopurine monotherapy and combination therapy were both significantly associated with severe COVID-19, compared with TNF antagonist monotherapy.", "However, on multivariable analysis, TNF antagonist therapy was not significantly associated with severe COVID-19 (adjusted OR (aOR) 0.69, 95% CI 0.43 to 1.10)."]}
{"doc_id": 34041, "title": "", "abstract": ["In conclusion, TNF antagonist combination therapy with thiopurines and thiopurine monotherapy may be associated with a higher risk of severe COVID-19 in patients with IBD.", "* Prior data have suggested that patients with IBD on mesalamine/sulfasalazine may be at increased risk for severe COVID-19, while patients on tumour necrosis factor (TNF) antagonists do not appear to be at increased risk.", "Finally, similar to the first SECURE-IBD report, we continue to observe an increased risk of severe COVID-19 in patients on corticosteroids.", "In addition, most of our data suggest the possibility that TNF antagonist therapy may have a protective effect against the development of severe COVID-19 relative to other IBD therapies.", "* Patients with IBD who are older, have additional comorbidities and are on oral corticosteroids appear to be at increased risk of adverse outcomes from COVID-19."]}
{"doc_id": 34042, "title": "", "abstract": ["COVID-19, caused by SARS-CoV-2, was first reported in December 2019 and has rapidly spread throughout the world leading to an international pandemic.1", "In addition, as this was a registry-based cohort with convenience sampling, there is the possibility of reporting bias that could lead to over-representation or under-representation of more severe cases of COVID-19.", "We investigated the impact of different medication classes on the risk of severe COVID-19 in patients with IBD using the SECURE-IBD registry.", "Patients treated with mesalamine/sulfasalazine monotherapy did not appear to be at increased risk of severe COVID-19 compared with patients on no medications, though patients with IBD on no medications are likely a heterogenous group (mild disease, postsurgery and so on) and not an ideal comparison population.", "These findings warrant confirmation in large population-based cohorts."]}
{"doc_id": 9018, "title": "", "abstract": ["The statistical criteria were relaxed to p<0.05 for the replication dataset since it involved fewer samples.", "To test whether these findings were replicable, and to further validate the results in an independent dataset, we obtained tissue from an additional frontal cortex region (BA44/45) from nine ASD cases and five controls (DS2; Supplementary Table 4).", "Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.", "Genes with the highest correlation with the module eigengene value (i.e intramodular hubs) are shown in larger size.", "Our system-level analysis of the ASD brain transcriptome demonstrates the existence of convergent molecular abnormalities in ASD for the first time, providing a molecular neuropathological basis for the disease, whose genetic, epigenetic, or environmental etiologies can now be directly explored."]}
{"doc_id": 9019, "title": "", "abstract": ["After filtering for high-quality array data (Methods), we retained 58 cortex samples (29 autism, 29 controls) and 21 cerebellum samples (11 autism, 10 controls) for further analysis (see Methods for detailed sample description).", "Furthere detailed information on data analysis is available in Methods.", "Thus, DE analysis produced robust and highly reproducible results, warranting further refined analysis.", "## METHODS SUMMARY", "The genome-wide analysis performed here significantly extends previous findings implicating synaptic dysfunction, as well as microglial and immune dysregulation in ASD6 by providing an unbiased systematic assessment of transcriptional alterations and their genetic basis."]}
{"doc_id": 9020, "title": "", "abstract": ["This was not simply an issue of statistical thresholds, as relaxing the statistical criteria for DE to an FDR of 5%, identified over 500 DE genes in controls, and only 8 in ASD brains, confirming the large difference observed in regional cortical differential gene expression between ASD cases and controls (Figure 1d, Methods).", "We next applied weighted-gene co-expression network analysis (WGCNA)8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.", "This module, which was upregulated in ASD brain, showed significant similarity to two modules identified in previous studies of normal human brain8: an astrocyte module and a microglial module.", "The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions8.", "We found that the top module (M12) showed highly significant enrichment for neuronal markers (Supplementary Table 9), and high overlap with two neuronal modules previously identified as part of the human brain transcriptional network8: a PVALB+ interneuron module and a module of genes involved in synaptic function."]}
{"doc_id": 35015, "title": "", "abstract": ["Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb).", "Ongoing and future studies are aimed at determining if MERS-CoV is capable of generating resistance to RDV in vitro and whether the mutational spectra are similar to those obtained by MHV and SARS-CoV which shift EC50 values only 3–5-fold52.", "In contrast, human equivalent doses of RDV are demonstrably efficacious in mice infected with SARS- and MERS-CoV and in nonhuman primates infected with EBOV thus demonstrating a more suitable PK/PD relationship17.", "Here, we show that remdesivir (RDV) and IFNb have superior antiviral activity to LPV and RTV in vitro."]}
{"doc_id": 35016, "title": "", "abstract": ["Together, these data argue that levels of free biologically active LPV achieved in humans are well below those that exert robust antiviral effects on MERS-CoV replication in cell culture systems.", "Although the antiviral activity of LPV against MERS-CoV has been reported in Vero cells (concentration causing a 50% reduction in replication (EC50) = 8 µM), other studies report complete inactivity similar to that of RTV8,9.", "Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb).", "To ensure that our reporter virus behaved similarly to WT MERS-CoV, we first demonstrated that MERS-nLUC and wild-type (WT) MERS-CoV EMC 2012 strain replicate to similar levels in the absence of drug treatment and are similarly susceptible to the antiviral activity of RDV (WT EC50 = 0.12 µM; MERS-nLUC EC50 = 0.09 µM) in the human lung epithelial cell line, Calu-3 (Supplementary Fig. 1)."]}
{"doc_id": 35017, "title": "", "abstract": ["Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb).", "Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral with potent in vitro efficacy against multiple genetically unrelated RNA viruses16–18."]}
{"doc_id": 35018, "title": "", "abstract": ["Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012.", "In 2012, Middle East respiratory syndrome coronavirus (MERS-CoV), was discovered as the causative agent of a severe respiratory syndrome in the Kingdom of Saudi Arabia (KSA), has since caused at least 2468 cases and 851 deaths globally1.", "MERS-CoV continues to cause human infections globally and thus is listed as a priority pathogen with pandemic potential by World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).", "Similar to severe acute respiratory syndrome CoV (SARS-CoV), MERS-CoV has spread to over 27 countries via air travel of infected people5.", "Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33."]}
{"doc_id": 35019, "title": "", "abstract": ["Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral with potent in vitro efficacy against multiple genetically unrelated RNA viruses16–18.", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "Similar to our previous reports, RDV showed potent inhibition of MERS-CoV replication with a EC50 of 0.09 µM, no observable cytotoxicity up to 10 μM and a selectivity index (SI = EC50/CC50) > 10017.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb.", "Here, we show that RDV provides superior antiviral activity against MERS-CoV in vitro and in vivo as compared with LPV/RTV-IFNb."]}
{"doc_id": 35020, "title": "", "abstract": ["In 2012, Middle East respiratory syndrome coronavirus (MERS-CoV), was discovered as the causative agent of a severe respiratory syndrome in the Kingdom of Saudi Arabia (KSA), has since caused at least 2468 cases and 851 deaths globally1.", "Similar to severe acute respiratory syndrome CoV (SARS-CoV), MERS-CoV has spread to over 27 countries via air travel of infected people5.", "Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012.", "Moreover, RDV administered prior to infection also prevented mortality (P = 0.0037, Mantel–Cox test) in those administered a lethal dose (i.e., 5E + 05 pfu) (Fig. 2b).", "### Reporting summary"]}
{"doc_id": 35021, "title": "", "abstract": ["Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "There are no approved treatments for MERS-CoV infection although a combination of lopinavir, ritonavir and interferon beta (LPV/RTV-IFNb) is currently being evaluated in humans in the Kingdom of Saudi Arabia.", "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "In primary human lung epithelial cell cultures, RDV is potently antiviral against circulating contemporary human CoVs, SARS-CoV (EC50 = 0.07 µM), MERS-CoV (EC50 = 0.07 µM), and related zoonotic bat CoVs17,21.", "In contrast, studies evaluating the antiviral activity of type I and type II interferons have reported IFNb as the most potent interferon (EC50 1.37–17 IU/mL) in reducing MERS-CoV replication in vitro8,10."]}
{"doc_id": 35022, "title": "", "abstract": ["Nevertheless, the studies noted above demonstrate that type I interferon can exert an antiviral effect on MERS-CoV in vivo when given subcutaneously (IFN alpha, rhesus macaque) and intranasally (IFNb, adenovirus hDPP4 model)37–39.", "In contrast, studies evaluating the antiviral activity of type I and type II interferons have reported IFNb as the most potent interferon (EC50 1.37–17 IU/mL) in reducing MERS-CoV replication in vitro8,10.", "Since IFNb was shown to be the most potent against MERS-CoV when comparing the antiviral activity of multiple type I and type II interferons in Vero cells, IFNb was selected to use in the MIRACLE trial8,10.", "These data suggest that the observed in vitro antiviral activity of the LPV/RTV-IFNb combination on MERS-CoV is dominated by IFNb when LPV/RTV is used at clinically relevant concentrations.", "Multiple U.S. Food and Drug Administration (FDA) approved therapies have been evaluated for antiviral activity against MERS-CoV in vitro including lopinavir (LPV), ritonavir (RTV), and interferon beta (IFNb)."]}
{"doc_id": 35023, "title": "", "abstract": ["Overall, our work suggests that RDV may improve disease outcomes in CoV-infected patients, serve to protect health care workers in areas with endemic MERS-CoV and prove valuable in preventing future epidemics in the event of novel CoV emergence in the future.", "For CoV, metagenomic studies in wild animals have revealed a great diversity of viruses and hosts, and have even identified viruses similar to current and past epidemic strains in bats31,32.", "MERS-CoV continues to cause human infections globally and thus is listed as a priority pathogen with pandemic potential by World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI).", "Currently, there are no FDA- approved treatments for any human CoV infection.", "Thus, broad-spectrum therapies effective against known epidemic and zoonotic strains likely to seed future emergence, have the potential to diminish epidemic disease today and diminish future outbreaks."]}
{"doc_id": 35024, "title": "", "abstract": ["Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "In primary human lung epithelial cell cultures, RDV is potently antiviral against circulating contemporary human CoVs, SARS-CoV (EC50 = 0.07 µM), MERS-CoV (EC50 = 0.07 µM), and related zoonotic bat CoVs17,21.", "Overall, our work suggests that RDV may improve disease outcomes in CoV-infected patients, serve to protect health care workers in areas with endemic MERS-CoV and prove valuable in preventing future epidemics in the event of novel CoV emergence in the future.", "Virus replication in the lung peaks at 2 dpi in the lungs of mice infected with SARS-CoV or MERS-CoV and infection progresses to mortality or recovery by 7–10 dpi, depending on virus dose17,24.", "The utility of the common marmoset as a model of MERS-CoV pathogenesis is controversial with one study detailing severe respiratory disease yet another reporting similarly mild disease among mock and MERS-CoV-infected animals41,42."]}
{"doc_id": 35025, "title": "", "abstract": ["Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral nucleotide prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus (EBOV), Marburg, MERS-CoV, SARS-CoV, respiratory syncytial virus (RSV), Nipah virus (NiV), and Hendra virus16–18.", "Upon emergence of SARS- and MERS-CoV, patients were administered off-label antivirals (e.g., ribavirin, LPV, RTV) and immunomodulators (e.g., corticosteroids, interferon alpha-2a/2b, IFNb) as single agents or in combination in an attempt to ameliorate severe disease outcomes with very limited success33.", "Remdesivir (RDV, GS-5734) is a broad-spectrum antiviral with potent in vitro efficacy against multiple genetically unrelated RNA viruses16–18.", "Several prophylactic studies were performed to determine if drug regimens could affect virus replication and/or disease progression.", "Emerging viral diseases typically have very few if any effective treatment options."]}
{"doc_id": 35026, "title": "", "abstract": ["Nevertheless, the studies noted above demonstrate that type I interferon can exert an antiviral effect on MERS-CoV in vivo when given subcutaneously (IFN alpha, rhesus macaque) and intranasally (IFNb, adenovirus hDPP4 model)37–39.", "Thus, the micromolar EC50 observed for LPV against MERS-CoV coupled with protein binding and insufficient levels of free LPV in plasma is likely responsible for the modest antiviral effect with LPV/RTV-IFNb prophylaxis and minimal impact on disease with therapeutic administration in our mouse model.", "Third, we assessed the therapeutic efficacy of the above treatment regimens in a mouse model of MERS-CoV pathogenesis, but did not include an IFNb, only arm and these studies were performed twice.", "Second, we evaluated the in vivo efficacy of prophylactic RDV as compared to vehicle with two different doses of MERS-CoV in a new transgenic mouse model of MERS-CoV pathogenesis with improved pharmacokinetics for nucleotide prodrugs.", "To determine if prophylactic LPV/RTV-IFNb improved outcomes following MERS-CoV infection, we first confirmed that subcutaneous human equivalent doses (H.E.D.) of IFNb exerted a biological effect in mice."]}
{"doc_id": 3021, "title": "", "abstract": ["When TREX1 is inhibited by RNAi, HIV infection of primary cells triggers Type I IFN expression and secretion.", "We did not examine whether TREX1 affects IFN production by pDCs, the major source of Type I IFNs during HIV infection.", "# The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1", "In Trex1−/− mouse cells and human CD4+ T cells and macrophages in which TREX1 was inhibited by RNA interference, cytosolic HIV DNA accumulated, and HIV infection induced type I IFN that inhibited HIV replication and spreading.", "### TREX1 inhibits IFN production in response to HIV"]}
{"doc_id": 3022, "title": "", "abstract": ["We did not examine whether TREX1 affects IFN production by pDCs, the major source of Type I IFNs during HIV infection.", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "The cytosolic exonuclease TREX1 suppressed IFN triggered by HIV.", "Fig. 1 TREX1 deficiency inhibits HIV replication and activates IFN-β in response to HIV infection", "(c-e) Increasing multiplicity of infection (MOI) leads to more cytosolic HIV DNA accumulation and IFN-β expression in Trex1−/− MEF, but not to more chromosomal integration, compared to WT MEF."]}
{"doc_id": 3023, "title": "", "abstract": ["When IRF3 and TREX1 expression were both suppressed, HIV replication was partially rescued, suggesting that IRF3-dependent IFN-β induction contributes to inhibiting HIV replication caused by TREX1 siRNA (Fig. 5d).", "We showed here that the host cytoplasmic exonuclease TREX1 helps HIV evade innate immunity by digesting reverse transcripts that are not imported into the nucleus and would otherwise induce IFNs.", "TREX1 promotes HIV replication in two ways – it inhibits autointegration and suppresses the IFN response.", "TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate IFN expression via a TBK1, STING and IRF3 dependent pathway.", "The cytosolic exonuclease TREX1 suppressed IFN triggered by HIV."]}
{"doc_id": 3024, "title": "", "abstract": ["HIV-stimulated IFN production in cells deficient in TREX1 did not involve known nucleic acid sensors.", "Fig. 3 Cytosolic HIV DNA in Trex1−/− cells is the trigger for IFN expression", "The accumulation of HIV DNA in Trex1−/− or TREX1 mutant cells is consistent with a previous report that ssDNA derived from endogenous retroelements is increased in the cytosol of Trex1−/− cells7.", "Cytosolic HIV DNA steadily increased for the first 20 h post infection (hpi) and then achieved a 3-4 fold higher plateau in Trex1−/− compared to WT cells.", "These results strongly suggest that TREX1 metabolizes cytosolic HIV DNA."]}
{"doc_id": 3025, "title": "", "abstract": ["However, siRNA against another membrane-associated adaptor Sting (also known as MITA, ERIS27-29), recently identified to mediate innate immune responses to cytosolic DNA27,28, strongly inhibited HIV-stimulated IFN-β expression (Fig. 6b).", "Nonetheless, human immune cells susceptible to HIV can differ from MEF in their ability to activate innate immune pathways.", "For example, IFN-β was induced by HIV in human immune cells, but not MEFs.", "HIV-stimulated IFN activation in Trex1−/− cells is eliminated by treating infected cells with an RT inhibitor, but not an IN inhibitor, suggesting that HIV DNA, but not gRNA, is the nucleic acid that triggers innate immunity.", "Thus, secreted IFN-β inhibits multiple steps in the early phase of HIV-1 infection."]}
{"doc_id": 3026, "title": "", "abstract": ["dsDNA was generated by hybridizing ‘Gag-100 forward’ and ‘Gag-100 reverse’ at equimolar concentrations (by heating at 100 °C for 3 min followed by slowly cooling to room temperature).", "Virus was harvested in 3 batches every 12 h from 48-72 h post transfection, and concentrated approximately 10-fold using Centricon filters (Millipore, cat#UFC910024) according to the manufacturer's instructions.", "Transfections were performed using 2 μl Lipofectamine 2000 (Invitrogen) and 100 nM siRNA in 24-well plates, or using Amaxa nucleofection for primary cells.", "Rescue experiments were performed by transfecting MEFs using the Amaxa nucleofector kit (cat# VPD-1004) and sorting for GFP+ cells 24 h post transfection.", "For experiments that measure stage-specific HIV-1 DNAs, viral supernatants were pretreated with 40 U/ml Turbo DNase (Ambion) at 37 °C for 30 min before infection."]}
{"doc_id": 37032, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively].", "Multiple linear regression analyses were conducted predicting COVID-19 treatment and vaccine hesitancy with general COVID-19 mistrust.", "The sample showed high levels of general COVID-19 mistrust and high levels of hesitancy related to treatment and a future vaccine (Table 2).", "### Associations of General COVID-19 Mistrust With Vaccine and Treatment Hesitancy"]}
{"doc_id": 37033, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Multiple linear regression analyses were conducted predicting COVID-19 treatment and vaccine hesitancy with general COVID-19 mistrust.", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively].", "Three items, developed for this study, assessed COVID-19 vaccine hesitancy (ie, “If a vaccine were available to prevent COVID-19, I would not want to get it”; “…I would not trust it”; and “…I am worried that it could be harmful”; α = 0.90) on the scale 1 = strongly disagree, 2 = slightly disagree, 3 = neither disagree nor agree or unsure, 4 = slightly agree, and 5 = strongly agree.", "### Associations of General COVID-19 Mistrust With Vaccine and Treatment Hesitancy"]}
{"doc_id": 37034, "title": "", "abstract": ["Moreover, those who had higher levels of medical mistrust around the COVID-19 government response, as well as around COVID-19 origins and treatment, were less willing to obtain treatment or a future vaccine.", "Follow-up sensitivity analyses predicting the single items measuring willingness to get COVID-19 treatment, or to get a future vaccine, yielded similar results.", "In an online survey in England, higher endorsement of COVID-19 conspiracy beliefs was associated with less willingness to accept a future vaccine and less adherence to health-protective (eg, social distancing) behaviors.32", "Accordingly, a national survey conducted in October 2020, several months after this study was conducted, suggests that, in the general population, a substantial proportion (34%) said that they would definitely or probably not get a free and safe COVID-19 vaccine; this percentage was much higher among Black Americans (49%) than among Whites (33%).68", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001]."]}
{"doc_id": 37035, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "In this study, in a convenience sample of Black Americans living with HIV, we examined levels of general COVID-19 mistrust related to COVID-19 and assessed associations between general COVID-19 mistrust and COVID-19 treatment and future vaccine hesitancy, hypothesizing that greater mistrust would be associated with greater hesitancy.", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively]."]}
{"doc_id": 37036, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Greater COVID-19 mistrust was related to greater vaccine and treatment hesitancy [b (SE) = 0.85 (0.14), P < 0.0001 and b (SE) = 0.88 (0.14), P < 0.0001, respectively].", "Pearson correlations indicated that participants with less than a high school education showed higher levels of general COVID-19 mistrust (r = 0.27, P = 0.007), vaccine hesitancy (r = 0.20, P = 0.04), and treatment hesitancy (r = 0.23, P = 0.02).", "A national US survey of a mostly White sample found that belief in COVID-19 conspiracies was associated with lower vaccine intentions.37", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001]."]}
{"doc_id": 37037, "title": "", "abstract": ["Nearly all participants (97%) endorsed at least one general COVID-19 mistrust belief, and more than half endorsed at least one COVID-19 vaccine or treatment hesitancy belief.", "A national US survey of a mostly White sample found that belief in COVID-19 conspiracies was associated with lower vaccine intentions.37", "This study suggests that medical mistrust around COVID-19 is high and may be a barrier to the uptake of COVID-19 treatment and future vaccination among Black Americans living with HIV.", "Greater general COVID-19 mistrust was associated with lower willingness to get a future vaccine [b (SE) = 0.81 (0.17), P < 0.0001] or to get treatment [b (SE) = 0.97 (0.16), P < 0.0001].", "Other surveys across several countries have similarly found that greater mistrust is associated with lower engagement in COVID-19 protective behaviors.33–36"]}
{"doc_id": 37038, "title": "", "abstract": ["Greater general COVID-19 mistrust was significantly associated with greater vaccine hesitancy [b (SE) = 0.85 (0.14), P < 0.0001] and treatment hesitancy [b (SE) = 0.88 (0.14), P < 0.0001] in multivariate models controlling for education level and intervention condition.", "Medical mistrust has been associated with suboptimal health behaviors among Black individuals with HIV and other conditions, such as medication nonadherence and low health care engagement, as well as poor self-reported health, lower quality of life, and decreased uptake of screening and preventative behaviors16–21 and vaccines.22", "Thus, high levels of medical mistrust among Black Americans may arise from history, knowledge, and continuous and repeated discrimination and harmful experiences toward their racial/ethnic group by the health care system and government, which in turn may affect health behaviors because it motivates distrust of governmental and public health information and avoidance of health care, as a self-protective coping strategy.24", "Moreover, those who had higher levels of medical mistrust around the COVID-19 government response, as well as around COVID-19 origins and treatment, were less willing to obtain treatment or a future vaccine.", "Medical mistrust, defined as “distrust of health care providers, the health care system, medical treatments, and the government as a steward of public health,”11,12 is a response to current and historical systemic racism in health care and society as a whole and may play a role in COVID-19 inequities."]}
{"doc_id": 37039, "title": "", "abstract": ["The most common negative consequence was decreased work hours (33%), followed by not being able to pay important bills, rent or utilities (29%), and having difficulty getting places due to less access to public transportation (25%).", "| M (SD) or % (n)   ---|---   Sociodemographic Characteristics|   Age| 50.3 (11.5)   Male (cisgender)| 87% (88)   Gay, bisexual, or other nonheterosexual identity| 77% (78)   Education level: less than high school| 13% (13)   Stable housing, past year| 50% (50)   Employed (full-time or part-time)| 14% (14)   Annual income level: less than $10,000| 41% (40)   Ever incarcerated (as an adult)| 52% (53)   Health-related Characteristics|   Years since HIV diagnosis| 19.8 (10.1)   Average % of ART doses taken (past month continuous)| 73.7 (24.4)   >80% of ART doses taken (past month, dichotomous)| 53% (26)   Tested for COVID-19|   No, but do not think I have it| 68% (69)   No, but I may have it| 1% (1)   Yes, tested positive| 1% (1)   Yes, tested negative| 30% (30)   Any COVID-19 symptoms| 8% (8)   Anyone in household diagnosed with COVID-19| 4% (3)   Negative Social/Economic Impacts|   Reduced your work hours| 33% (17)   Could not pay important bills, rent or utilities| 29% (29)   Had difficulty getting places due to less access to public transportation| 25% (25)   Lost your job or closed your business| 19% (11)   Could not get enough food to eat| 19% (19)   Had to spend a lot more time taking care of a family member| 14% (14)   Had to move or relocate| 12% (12)   Lost housing| 5% (5)   Became homeless| 8% (7)   Increase in conflict with a partner or spouse| 8% (8)   Had a child at home who could not go to school| 7% (7)   Family or friends had to move into your home| 4% (4)   Experienced at least one negative social/economic impact| 58% (59)   No.", "Mistrust was widespread across the sample, most of whom were sexual minority individuals, and did not significantly vary by most sociodemographic characteristics—although those with less than a high school education showed higher mistrust.", "The authors have no conflicts of interest to disclose.", "Supported by the National Institute of Nursing Research, the National Institutes of Health Office of The Director, and the National Institute on Minority Health and Health Disparities (R01NR017334, R01MD014722), and supported by the Center for HIV Identification, Prevention, and Treatment Services, funded by the National Institute of Mental Health (P30MH058107) and the Harvard Center for AIDS Research, funded by the National Institute of Allergy and Infectious Diseases (P30 AI060354)."]}
{"doc_id": 33026, "title": "", "abstract": ["The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications.", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "In sum, the tragic COVID‐19 pandemic has collateral effects extending beyond those of direct viral infection.", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19."]}
{"doc_id": 33027, "title": "", "abstract": ["Children and adolescents struggling with obesity are placed in an unfortunate position of isolation that appears to create an unfavorable environment for maintaining healthy lifestyle behaviors.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Children and adolescents gain more weight during summer vacations than during the structured school year, leading to the hypothesis that the coronavirus disease 2019 lockdown will lead to unfavorable changes in lifestyle behaviors among homebound youths with obesity.", "Of the seven studies, six found “accelerated” weight gain during the summer, particularly among black, Hispanic, and overweight children and adolescents.", "There are reasons to be concerned about housebound children and adolescents who have overweight and obesity; previous studies have supported the hypothesis that these youths will fare worse on weight‐control lifestyle programs while at home compared with when they are engaged in their usual school curriculum (1)."]}
{"doc_id": 33028, "title": "", "abstract": ["Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Time spent in sports during the lockdown were considered as any physical activity (e.g., jogging, playing in the backyard, etc.) given that it was not possible during the lockdown to participate in organized sports.", "Lifestyle information including diet, activity, and sleep behaviors was collected at baseline and 3 weeks into the national lockdown during which home confinement was mandatory.", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors."]}
{"doc_id": 33029, "title": "", "abstract": ["Children and adolescents gain more weight during summer vacations than during the structured school year, leading to the hypothesis that the coronavirus disease 2019 lockdown will lead to unfavorable changes in lifestyle behaviors among homebound youths with obesity.", "There are reasons to be concerned about housebound children and adolescents who have overweight and obesity; previous studies have supported the hypothesis that these youths will fare worse on weight‐control lifestyle programs while at home compared with when they are engaged in their usual school curriculum (1).", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "Children and adolescents struggling with obesity are placed in an unfortunate position of isolation that appears to create an unfavorable environment for maintaining healthy lifestyle behaviors."]}
{"doc_id": 33030, "title": "", "abstract": ["The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "The aim of this longitudinal clinical study was to test the hypothesis that factors contributing to weight gain among children and adolescents with overweight and obesity are exacerbated during a pandemic‐associated lockdown.", "Baseline reported activities included running/soccer (24.4%), swimming (17.1%), jogging (22.0%), volleyball/basketball (9.8%), and dancing (9.8%); only 4.9% reported no sports activities.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown."]}
{"doc_id": 33031, "title": "", "abstract": ["The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "In sum, the tragic COVID‐19 pandemic has collateral effects extending beyond those of direct viral infection.", "The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications.", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”"]}
{"doc_id": 33032, "title": "", "abstract": ["The coronavirus disease 2019 (COVID‐19) pandemic has had far‐reaching health, social, and economic implications.", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "In sum, the tragic COVID‐19 pandemic has collateral effects extending beyond those of direct viral infection.", "Among them is the abrupt cessation of school programs for children and adolescents in Italy who by mandate had to remain in their homes during the “lockdown” aimed at containing and mitigating spread of COVID‐19."]}
{"doc_id": 33033, "title": "", "abstract": ["Effects of COVID‐19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study", "These and other observations led Rundle et al. (1) to recently advance the argument that the COVID‐19 pandemic, by restricting children from attending school, will exacerbate the risk factors for “weight gain associated with summer recess.”", "The aim of this study was to test the hypothesis that youths with obesity, when removed from structured school activities and confined to their homes during the coronavirus disease 2019 pandemic, will display unfavorable trends in lifestyle behaviors.", "The current study strongly supports the hypothesis advanced by Rundle et al. (1) positing that the COVID‐19 pandemic will “exacerbate all of the risk factors for weight gain associated with summer recess.”", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period."]}
{"doc_id": 33034, "title": "", "abstract": ["Sleep time increased significantly (0.65 [SD 1.29] h/d, P = 0.003), and sports time decreased significantly by 2.30 (SD 4.60) h/wk (P = 0.003).", "Time spent in sports activities decreased by 2.30 (SD 4.60) h/wk (P = 0.003), and sleep time increased by 0.65 (SD 1.29) h/d (P = 0.003).", "Findings from this longitudinal observational study, conducted in Italy, support the hypothesis that unfavorable changes in eating, sleep, and activity behaviors occur in children and adolescents with obesity during a nonschool lockdown period.", "Specifically, our longitudinal study of children and adolescents with obesity affirmed that eating, activity, and sleep behaviors changed in an unfavorable direction 3 weeks into their confinement during the national lockdown.", "Screen time increased by 4.85 (SD 2.40) h/d (P < 0.001)."]}
{"doc_id": 31000, "title": "", "abstract": ["SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease."]}
{"doc_id": 31001, "title": "", "abstract": ["Cirrhosis is characterised by immune dysregulation, leading to concerns that these patients may be at increased risk of complications following SARS-CoV-2 infection.4", "SARS- CoV-2 infection in patients with cirrhosis therefore appears to be a particularly lethal combination and represents the coming together of biological processes characterised by immune dysregulation in the context of viral infection and disordered coagulation.", "Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Chronic liver disease (CLD) and cirrhosis are associated with immune dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes following SARS-CoV-2 infection."]}
{"doc_id": 31002, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001)."]}
{"doc_id": 31003, "title": "", "abstract": ["In patients with cirrhosis who had acute hepatic decompensation, 21% had no respiratory symptoms at presentation.", "Compared to non-CLD patients, those with CLD had comparable rates of respiratory symptoms (81% vs. 80%; p = 0.774) but higher rates of gastrointestinal symptoms (12% vs. 21%; p <0.001) at presentation.", "Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms.", "There were no differences in the proportion of CLD patients with and without cirrhosis presenting with respiratory symptoms (80% vs. 80%; p = 0.853), gastrointestinal symptoms (21% vs. 21%; p = 0.928) or no symptoms (13% vs. 14%; p = 0.832).", "Importantly, 22% of those with acute hepatic decompensation did not have respiratory symptoms typical of COVID-19 at the time of diagnosis, thus highlighting the importance of maintaining a low threshold for SARS-CoV-2 testing in patients presenting with complications of cirrhosis."]}
{"doc_id": 31004, "title": "", "abstract": ["However, even in patients with acute hepatic decompensation, lung disease remained the predominant cause of death, again suggesting that SARS- CoV-2-induced liver dysfunction may help propagate respiratory failure.", "Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "Of the 123 patients with cirrhosis who died, cause of death was secondary to COVID-19 lung disease in 87 (71%), liver related in 23 (19%), and cardiac related in 6 (5%)."]}
{"doc_id": 31005, "title": "", "abstract": ["Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality rates in those with cirrhosis increased according to Child-Pugh class; A 33 (19%), B 44 (35%), and C 46 (51%) (Fig. 2; Table S5).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22"]}
{"doc_id": 31006, "title": "", "abstract": ["These findings have important implications for the risk stratification of patients with CLD across the globe during the COVID-19 pandemic.", "These data have important implications for the risk stratification of patients with CLD across the globe during the COVID-19 pandemic.", "Our data will also help inform clinical decisions regarding both the escalation of care to ICU and the use of COVID-19 palliative care guidelines in patients with advanced liver disease who undergo rapid inpatient clinical deterioration.25", "These findings have important prognostic implications and highlight the need for careful monitoring of patients with cirrhosis throughout their hospital admission.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31007, "title": "", "abstract": ["Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001).", "Within the whole cirrhosis cohort, mortality was higher in those with ACLF than in those without (65% vs. 22%; p <0.001).", "In the total CLD cohort model, mortality was not significantly different in CLD patients without cirrhosis compared to non-CLD patients -3.4% (95% CI -7.2 to 0.31%; p = 0.248).", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%)."]}
{"doc_id": 31008, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "For patients with cirrhosis, navigating through the COVID-19 pandemic is extremely challenging.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications."]}
{"doc_id": 31009, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001).", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series."]}
{"doc_id": 31010, "title": "", "abstract": ["Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality rates in those with cirrhosis increased according to Child-Pugh class; A 33 (19%), B 44 (35%), and C 46 (51%) (Fig. 2; Table S5).", "However, among those with cirrhosis there was an incremental increase in mortality with each Child-Pugh class compared with non-CLD: Child-Pugh A +2.0% (95% CI -6.2% to 10.2%; p = 0.631), Child-Pugh B +20.0% (95% CI 8.8%–31.3%; p <0.001), Child-Pugh C +38.1% (95% CI 27.1%–49.2%; p <0.001) (Fig 5 A).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22"]}
{"doc_id": 31011, "title": "", "abstract": ["Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Within the whole cirrhosis cohort, mortality was higher in those with ACLF than in those without (65% vs. 22%; p <0.001).", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Furthermore, in contrast to CLD patients without cirrhosis who display a striking age-related gradient for mortality with the highest risk of death in the 8th decade of life, mortality in patients with cirrhosis was more evenly distributed across age categories including a high mortality rate (31%) in those under 40 years (Fig. 3)."]}
{"doc_id": 31012, "title": "", "abstract": ["An AUC analysis was performed to assess the ability of scoring systems to predict mortality in patients with cirrhosis following SARS-CoV-2 infection.", "Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Receiver-operating characteristic (ROC) curves were calculated, and the area under the curve (AUC) was evaluated to determine the score accuracy (c-statistic) of baseline Child-Pugh score, MELD, and CLIF-C organ failure score as predictors of mortality following SARS-CoV-2 in patients with cirrhosis.", "To compare the effect of the liver disease stage on risk of death, propensity score 1:1 matched samples (using nearest neighbour approach) were constructed with death as the outcome and liver disease status as the treatment variable for each of CLD without cirrhosis, CTP-A, CTP-B, and CTP-C. Covariables included in the propensity score model were selected as those thought to be independently associated with mortality for those with SARS-COV-2 but unlikely to be greatly otherwise associated with CLD whilst also aiming to provide matched variance ratios of between 0.5–2.0."]}
{"doc_id": 31013, "title": "", "abstract": ["Within the whole cirrhosis cohort, mortality was higher in those with ACLF than in those without (65% vs. 22%; p <0.001).", "Among the 179 patients with cirrhosis and acute hepatic decompensation, 89 (50%) met criteria for ACLF.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series."]}
{"doc_id": 31014, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "The high mortality in patients with cirrhosis should also prompt consideration of novel targeted therapies such as dexamethasone with proven efficacy in hospitalized patients with COVID-19."]}
{"doc_id": 31015, "title": "", "abstract": ["In the largest such cohort to date, we demonstrate that baseline liver disease stage and alcohol-related liver disease are independent risk factors for death from COVID-19.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31016, "title": "", "abstract": ["However, even in patients with acute hepatic decompensation, lung disease remained the predominant cause of death, again suggesting that SARS- CoV-2-induced liver dysfunction may help propagate respiratory failure.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "Of the 123 patients with cirrhosis who died, cause of death was secondary to COVID-19 lung disease in 87 (71%), liver related in 23 (19%), and cardiac related in 6 (5%).", "SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort."]}
{"doc_id": 31017, "title": "", "abstract": ["This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11)."]}
{"doc_id": 31018, "title": "", "abstract": ["SARS- CoV-2 infection in patients with cirrhosis therefore appears to be a particularly lethal combination and represents the coming together of biological processes characterised by immune dysregulation in the context of viral infection and disordered coagulation.", "Cirrhosis is characterised by immune dysregulation, leading to concerns that these patients may be at increased risk of complications following SARS-CoV-2 infection.4", "Chronic liver disease (CLD) and cirrhosis are associated with immune dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes following SARS-CoV-2 infection.", "Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort."]}
{"doc_id": 31019, "title": "", "abstract": ["We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "However, given the profound multi-systemic involvement of COVID-19, particularly in the severe and critical forms of disease, liver injury is likely to be multifactorial with contributions from systemic inflammation, intrahepatic immune activation, microvascular thrombosis, perturbations of the gut-liver-axis, and drug toxicity.[32], [33], [34], [35], [36] In our cohort, patients who suffered acute hepatic decompensation had a 2-fold increased rate of mortality compared to those without and case fatality strongly correlated with degree of organ failure.", "Case fatality rates after each of these stages in the COVID-19 disease course were also heavily influenced by baseline liver disease severity (Table 2).", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31020, "title": "", "abstract": ["Decompensation events in those with cirrhosis included new or worsening ascites 109 (28%), hepatic encephalopathy 104 (27%), spontaneous bacterial peritonitis 13 (3%), and variceal haemorrhage 11 (3%).", "Rates of decompensation events differed significantly according to stage of liver disease (51 [30%], 70 [56%], and 58 [64%] in patients with Child-Pugh A, B, and C cirrhosis, respectively) (Fig. 6 A).", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, and/or variceal haemorrhage.", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, or variceal haemorrhage."]}
{"doc_id": 31021, "title": "", "abstract": ["Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "SARS- CoV-2 infection in patients with cirrhosis therefore appears to be a particularly lethal combination and represents the coming together of biological processes characterised by immune dysregulation in the context of viral infection and disordered coagulation."]}
{"doc_id": 31022, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "In the total CLD cohort model, mortality was not significantly different in CLD patients without cirrhosis compared to non-CLD patients -3.4% (95% CI -7.2 to 0.31%; p = 0.248).", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "Death occurred in 150/745 (20%) of the total CLD cohort, including 27/359 (8%) CLD patients without cirrhosis and 123/386 (32%) patients with cirrhosis.", "Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001)."]}
{"doc_id": 31023, "title": "", "abstract": ["Of the 123 patients with cirrhosis who died, cause of death was secondary to COVID-19 lung disease in 87 (71%), liver related in 23 (19%), and cardiac related in 6 (5%).", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "Death occurred in 150/745 (20%) of the total CLD cohort, including 27/359 (8%) CLD patients without cirrhosis and 123/386 (32%) patients with cirrhosis."]}
{"doc_id": 31024, "title": "", "abstract": ["The approach to each patient will be guided by individual risk, institutional resources and the local burden of COVID-19, however resumption of hepatology services wherever possible in order to prevent liver disease progression may ultimately represent the best strategy to protect patients from poor outcomes following future SARS-CoV-2 infection.", "The high mortality in patients with cirrhosis should also prompt consideration of novel targeted therapies such as dexamethasone with proven efficacy in hospitalized patients with COVID-19.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27", "This highlights the importance of carefully evaluating drug hepatotoxicity during COVID-19 clinical trials to ensure that patients with cirrhosis are not unnecessarily denied potentially disease-modifying treatments.26", "For patients with cirrhosis, navigating through the COVID-19 pandemic is extremely challenging."]}
{"doc_id": 31025, "title": "", "abstract": ["However, even in patients with acute hepatic decompensation, lung disease remained the predominant cause of death, again suggesting that SARS- CoV-2-induced liver dysfunction may help propagate respiratory failure.", "The mechanisms for enhanced respiratory compromise in patients with CLD and SARS-CoV-2 require further investigation but may include altered pulmonary dynamics through worsening ascites or encephalopathy, immune dysfunction in viral infection, increased burden of venous thromboembolic disease, and coexisting lung disease (e.g. hepatopulmonary syndrome, portopulmonary hypertension, or hepatic hydrothorax).", "In light of our data, which links liver disease severity with death following SARS-CoV-2 infection, a careful balance must be struck between protecting these patients from exposure to the virus whilst striving to deliver gold-standard treatment.", "Cirrhosis is characterised by immune dysregulation, leading to concerns that these patients may be at increased risk of complications following SARS-CoV-2 infection.4", "SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort."]}
{"doc_id": 31026, "title": "", "abstract": ["Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11)."]}
{"doc_id": 31027, "title": "", "abstract": ["Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "Mortality rates in those with cirrhosis increased according to Child-Pugh class; A 33 (19%), B 44 (35%), and C 46 (51%) (Fig. 2; Table S5).", "However, among those with cirrhosis there was an incremental increase in mortality with each Child-Pugh class compared with non-CLD: Child-Pugh A +2.0% (95% CI -6.2% to 10.2%; p = 0.631), Child-Pugh B +20.0% (95% CI 8.8%–31.3%; p <0.001), Child-Pugh C +38.1% (95% CI 27.1%–49.2%; p <0.001) (Fig 5 A).", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series."]}
{"doc_id": 31028, "title": "", "abstract": ["Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease."]}
{"doc_id": 31029, "title": "", "abstract": ["Decompensation events in those with cirrhosis included new or worsening ascites 109 (28%), hepatic encephalopathy 104 (27%), spontaneous bacterial peritonitis 13 (3%), and variceal haemorrhage 11 (3%).", "Rates of decompensation events differed significantly according to stage of liver disease (51 [30%], 70 [56%], and 58 [64%] in patients with Child-Pugh A, B, and C cirrhosis, respectively) (Fig. 6 A).", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, and/or variceal haemorrhage.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, or variceal haemorrhage."]}
{"doc_id": 31030, "title": "", "abstract": ["Decompensation events in those with cirrhosis included new or worsening ascites 109 (28%), hepatic encephalopathy 104 (27%), spontaneous bacterial peritonitis 13 (3%), and variceal haemorrhage 11 (3%).", "Rates of decompensation events differed significantly according to stage of liver disease (51 [30%], 70 [56%], and 58 [64%] in patients with Child-Pugh A, B, and C cirrhosis, respectively) (Fig. 6 A).", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, and/or variceal haemorrhage.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, or variceal haemorrhage."]}
{"doc_id": 31031, "title": "", "abstract": ["Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "However, given the profound multi-systemic involvement of COVID-19, particularly in the severe and critical forms of disease, liver injury is likely to be multifactorial with contributions from systemic inflammation, intrahepatic immune activation, microvascular thrombosis, perturbations of the gut-liver-axis, and drug toxicity.[32], [33], [34], [35], [36] In our cohort, patients who suffered acute hepatic decompensation had a 2-fold increased rate of mortality compared to those without and case fatality strongly correlated with degree of organ failure.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series."]}
{"doc_id": 31032, "title": "", "abstract": ["The mechanisms for enhanced respiratory compromise in patients with CLD and SARS-CoV-2 require further investigation but may include altered pulmonary dynamics through worsening ascites or encephalopathy, immune dysfunction in viral infection, increased burden of venous thromboembolic disease, and coexisting lung disease (e.g. hepatopulmonary syndrome, portopulmonary hypertension, or hepatic hydrothorax).", "However, even in patients with acute hepatic decompensation, lung disease remained the predominant cause of death, again suggesting that SARS- CoV-2-induced liver dysfunction may help propagate respiratory failure.", "Decompensation events in those with cirrhosis included new or worsening ascites 109 (28%), hepatic encephalopathy 104 (27%), spontaneous bacterial peritonitis 13 (3%), and variceal haemorrhage 11 (3%).", "Cirrhosis is characterised by immune dysregulation, leading to concerns that these patients may be at increased risk of complications following SARS-CoV-2 infection.4", "Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms."]}
{"doc_id": 31033, "title": "", "abstract": ["After adjusting for baseline characteristics, factors associated with death in the total CLD cohort were age (odds ratio [OR] 1.02; 1.01–1.04), Child-Pugh A (OR 1.90; 1.03–3.52), B (OR 4.14; 2.4–7.65), or C (OR 9.32; 4.80–18.08) cirrhosis and alcohol-related liver disease (OR 1.79; 1.03–3.13).", "The non-CLD cohort differed significantly from the CLD cohort with regards to age, sex, ethnicity, smoking status, baseline serum creatinine, and rates of co-morbidities including heart disease, diabetes mellitus, HCC and non-HCC malignancy (Table S3).", "When either stepwise forwards or backwards selection of variables was used with a threshold of p <0.2, the same factors remained significantly associated with death: age (OR 1.03/year; 95% CI 1.01–1.04; p = 0.002), Child-Pugh A (OR 2.09; 95% CI 1.18–3.72; p = 0.012), B (OR 4.38; 95% CI 2.41–7.95; p = <0.001), C (OR 9.42; 95% CI 4.96–17.90; p = <0.001) and ALD (OR 1.66; 95% CI 1.02–2.68; p = 0.041).", "Among patients with CLD, factors significantly associated with death on univariable analysis were age (OR 1.03 per year; 95% CI 1.01–1.04; p <0.001), White ethnicity (OR 2.52; 95% CI 1.73–3.68; p <0.001), heart disease (OR 1.76; 95% CI 1.16–2.66; p = 0.008), and baseline serum creatinine (OR 1.19 per mg/dl; 95% CI 1.04–1.38; p = 0.014) (Table 1).", "Among patients with CLD, multivariable analysis of factors associated with death demonstrated persisting positive asso-ciations between age (OR 1.02; 95% CI 1.01–1.04; p = 0.011), the different stages of cirrhosis compared with CLD without cirrhosis; Child-Pugh A (OR 1.90; 95% CI 1.03–3.52; p = 0.040), B (OR 4.14; 95% CI 2.4–7.65; p <0.001), C (OR 9.32; 95% CI 4.80–18.08; p <0.001) and ALD (OR 1.79; 95% CI 1.03–3.13; p = 0.040) (Table 1)."]}
{"doc_id": 31034, "title": "", "abstract": ["Importantly, 22% of those with acute hepatic decompensation did not have respiratory symptoms typical of COVID-19 at the time of diagnosis, thus highlighting the importance of maintaining a low threshold for SARS-CoV-2 testing in patients presenting with complications of cirrhosis.", "In patients with cirrhosis who had acute hepatic decompensation, 21% had no respiratory symptoms at presentation.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "There were no differences in the proportion of CLD patients with and without cirrhosis presenting with respiratory symptoms (80% vs. 80%; p = 0.853), gastrointestinal symptoms (21% vs. 21%; p = 0.928) or no symptoms (13% vs. 14%; p = 0.832).", "Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms."]}
{"doc_id": 31035, "title": "", "abstract": ["However, there were significantly higher rates of requirement for ICU (p <0.001), admission to ICU (p <0.001), renal replacement therapy (p = 0.002), and death (p = <0.001) with increasing liver disease severity (Fig. 2 ).", "Chi squared test for trend was used to compare outcome proportions between the stages of liver disease (CLD without cirrhosis, Child-Pugh A, Child-Pugh B, Child-Pugh C) including hospitalisation (p = 0.690), requirement for ICU (p <0.001), admission to ICU (p <0.001), RRT (p <0.001), invasive ventilation (p = 0.227), and death (p <0.001).", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "Within the total CLD cohort, 668 (90%) were hospitalised, 235 (32%) were judged to require ICU care, 177 (24%) were ultimately admitted to ICU, 132 (18%) received invasive ventilation, 32 (4%) commenced renal replacement therapy, and 150 (20%) died.", "As the severity of liver disease progresses from CLD without cirrhosis through to each Child-Pugh class of cirrhosis we observed a stepwise increased risk of all major adverse outcomes including ICU requirement and death."]}
{"doc_id": 31036, "title": "", "abstract": ["Mortality in patients with cirrhosis increased according to Child- Pugh class (A [19%], B [35%], C [51%]) and the main cause of death was from respiratory failure (71%).", "Child-Pugh class was also associated with death compared to CLD without cirrhosis; Child-Pugh A (OR 2.94; 95% CI 1.70–5.08; p <0.001), B (OR 6.76; 95% CI 3.95–11.58; p <0.001), and C (OR 12.57; 95% CI 7.12–22.18; p <0.001).", "However, among those with cirrhosis there was an incremental increase in mortality with each Child-Pugh class compared with non-CLD: Child-Pugh A +2.0% (95% CI -6.2% to 10.2%; p = 0.631), Child-Pugh B +20.0% (95% CI 8.8%–31.3%; p <0.001), Child-Pugh C +38.1% (95% CI 27.1%–49.2%; p <0.001) (Fig 5 A).", "Compared to patients without CLD (n = 620), propensity-score-matched analysis revealed significant increases in mortality in those with Child-Pugh B (+20.0% [8.8%–31.3%]) and C (+38.1% [27.1%–49.2%]) cirrhosis.", "Mortality rates in those with cirrhosis increased according to Child-Pugh class; A 33 (19%), B 44 (35%), and C 46 (51%) (Fig. 2; Table S5)."]}
{"doc_id": 31037, "title": "", "abstract": ["This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "For patients with cirrhosis, navigating through the COVID-19 pandemic is extremely challenging.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications."]}
{"doc_id": 31038, "title": "", "abstract": ["Receiver-operating characteristic (ROC) curves were calculated, and the area under the curve (AUC) was evaluated to determine the score accuracy (c-statistic) of baseline Child-Pugh score, MELD, and CLIF-C organ failure score as predictors of mortality following SARS-CoV-2 in patients with cirrhosis.", "Although baseline Child-Pugh score, baseline MELD, and CLIF-C organ failure score were all significantly associated with mortality, their ability to effectively discriminate those who survived or died following SARS-CoV-2 infection was limited (AUROC of 0.65, 0.64, and 0.75, respectively) (Fig. S3).", "An AUC analysis was performed to assess the ability of scoring systems to predict mortality in patients with cirrhosis following SARS-CoV-2 infection.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study."]}
{"doc_id": 31039, "title": "", "abstract": ["Within the whole cirrhosis cohort, mortality was higher in those with ACLF than in those without (65% vs. 22%; p <0.001).", "The EASL Chronic Liver Failure Consortium (CLIF-C) definitions were used to determine the presence of acute- on-chronic liver failure (ACLF) in patients with acute hepatic decompensation, and to calculate the CLIF-C organ failure score.16 , 17", "Among the 179 patients with cirrhosis and acute hepatic decompensation, 89 (50%) met criteria for ACLF.", "Rates of mortality were increased in patients with acute hepatic decompensation compared to those with compensated cirrhosis (44% vs. 22%; p <0.001).", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, and/or variceal haemorrhage."]}
{"doc_id": 31040, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Mortality was 32% in patients with cirrhosis compared to 8% in those without (p <0.001).", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease."]}
{"doc_id": 31041, "title": "", "abstract": ["Decompensation events in those with cirrhosis included new or worsening ascites 109 (28%), hepatic encephalopathy 104 (27%), spontaneous bacterial peritonitis 13 (3%), and variceal haemorrhage 11 (3%).", "Rates of decompensation events differed significantly according to stage of liver disease (51 [30%], 70 [56%], and 58 [64%] in patients with Child-Pugh A, B, and C cirrhosis, respectively) (Fig. 6 A).", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, and/or variceal haemorrhage.", "Acute hepatic decompensation was defined as one or more of new or worsening ascites, new or worsening hepatic encephalopathy, spontaneous bacterial peritonitis, or variceal haemorrhage."]}
{"doc_id": 31042, "title": "", "abstract": ["In the largest such cohort to date, we demonstrate that baseline liver disease stage and alcohol-related liver disease are independent risk factors for death from COVID-19.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "As the severity of liver disease progresses from CLD without cirrhosis through to each Child-Pugh class of cirrhosis we observed a stepwise increased risk of all major adverse outcomes including ICU requirement and death.", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31043, "title": "", "abstract": ["Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31044, "title": "", "abstract": ["Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study", "Between 25th March and 8th July 2020, data on 745 patients with CLD and SARS- CoV-2 (including 386 with and 359 without cirrhosis) were collected by 2 international registries and compared to data on non-CLD patients with SARS- CoV-2 from a UK hospital network.", "In this large, multinational cohort of patients with CLD and laboratory confirmed SARS-CoV-2 infection we show that baseline liver disease severity is a major determinant of outcome.", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11)."]}
{"doc_id": 31045, "title": "", "abstract": ["In the largest such cohort to date, we demonstrate that baseline liver disease stage and alcohol-related liver disease are independent risk factors for death from COVID-19.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "Case fatality rates after each of these stages in the COVID-19 disease course were also heavily influenced by baseline liver disease severity (Table 2).", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications."]}
{"doc_id": 31046, "title": "", "abstract": ["In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "However, patients with advanced liver disease did have a particularly poor prognosis following SARS-CoV-2 infection with diminishing chances of recovery as they moved through the disease course.", "Of the 123 patients with cirrhosis who died, cause of death was secondary to COVID-19 lung disease in 87 (71%), liver related in 23 (19%), and cardiac related in 6 (5%).", "Rates of mortality in patients with CLD and SARS-CoV-2 infection following hospitalisation, admission to intensive care unit, and invasive ventilation separated by liver disease stage."]}
{"doc_id": 31047, "title": "", "abstract": ["Compared to non-CLD patients, those with CLD had comparable rates of respiratory symptoms (81% vs. 80%; p = 0.774) but higher rates of gastrointestinal symptoms (12% vs. 21%; p <0.001) at presentation.", "There were no differences in the proportion of CLD patients with and without cirrhosis presenting with respiratory symptoms (80% vs. 80%; p = 0.853), gastrointestinal symptoms (21% vs. 21%; p = 0.928) or no symptoms (13% vs. 14%; p = 0.832).", "In the total CLD cohort model, mortality was not significantly different in CLD patients without cirrhosis compared to non-CLD patients -3.4% (95% CI -7.2 to 0.31%; p = 0.248).", "This demonstrated similar findings: CLD without cirrhosis +4.4% (95% CI -6.9% to 15.8%; p = 0.445), Child-Pugh A +8.5% (95% CI -9.2 to 26.2; p = 0.349), Child- Pugh B +17.8% (95% CI 2.5–33.1%; p = 0.023), and Child-Pugh C +50.5% (95% CI 28.1%–72.8%; p ≤0.001) (Fig. 5B).", "Fifty-eight patients in the total CLD cohort were declined ICU admission despite having severe enough disease; this was due to intensive care being deemed inappropriate in 54 (93%) and lack of ICU availability in 4 (7%)."]}
{"doc_id": 31048, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31049, "title": "", "abstract": ["Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "High mortality rates from COVID-19 among patients with cirrhosis have been reported in several recently published series.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27"]}
{"doc_id": 31050, "title": "", "abstract": ["Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms.", "Among the 179 patients with cirrhosis and acute hepatic decompensation, 89 (50%) met criteria for ACLF.", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients."]}
{"doc_id": 31051, "title": "", "abstract": ["This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "For patients with cirrhosis, navigating through the COVID-19 pandemic is extremely challenging.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications."]}
{"doc_id": 24000, "title": "", "abstract": ["Psychological distress was assessed using the standardized total score on the Patient Health Questionnaire-4 (PHQ-4).", "Psychological distress was assessed using the widely used and well-validated four-item Patient Health Questionnaire (PHQ-4) (Kroenke et al., 2009; Löwe et al., 2010).", "The PHQ-4 has been validated in the US (Kroenke et al., 2009) and has shown high levels of agreement with longer scales and similar correlations with measures of functional status (Lowe et al., 2010) and is sensitive to changes in mental health (Kroenke et al., 2019).", "Sample characteristics and psychological distress scores (PHQ-4) for population subgroups across eight waves of the Understanding America Study (UAS) (N = 7319; Obs.", "However, the PHQ-4 is a validated and widely used indicator of self-reported psychological distress and difficulties that was highly reliable in this study."]}
{"doc_id": 24001, "title": "", "abstract": ["The longer-term effects of the COVID-19 crisis on mental health are currently unknown.", "However, we found little evidence that patterns of change in distress during the COVID-19 crisis differed between these two groups.", "Alongside the physical disease burden that COVID-19 has caused, there are major concerns that the insecurity and isolation caused by the COVID-19 crisis and measures to mitigate the virus transmission may have substantial and potentially long- lasting population mental health effects (Campion et al., 2020; Holmes et al., 2020; Pfefferbaum and North, 2020).", "However, the COVID-19 crisis is unique in both its scale and wide ranging social and economic consequences, so understanding how distress levels have responded to the pandemic is of importance.", "Psychological distress and adaptation to the COVID-19 crisis in the United States"]}
{"doc_id": 24002, "title": "", "abstract": ["There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001).", "There is evidence that large-scale stressful events, such as natural disasters, can have enduring effects on mental health particularly following direct exposure to trauma (Kukihara et al., 2014; Neria et al., 2008).", "Nonetheless, it will now be important to examine how specific mental health symptoms have been affected during the course of the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic."]}
{"doc_id": 24003, "title": "", "abstract": ["Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "However, this spike in distress started to decrease from late April onwards and by June levels of distress were similar to levels reported in March.", "All subgroups showed a decline in distress levels between the start of April and June 24-July 20 that was significant at the p < .001 level, except Black (magnitude of decline: d = 0.25, 95% CI [0.12, 0.37], p < .01) and other race/ethnicity participants (d = 0.17, 95% CI [0.01, 0.35], p < .05), as shown in Table 3.", "Distress levels then decreased by another −0.08 SD (95% CI [-0.11,-0.05], p < .001) in early May and declined fully to baseline levels by the end of June 2020 (d = −0.31, 95% CI [-0.35,-0.27], p < .001), as shown in Table 2."]}
{"doc_id": 24004, "title": "", "abstract": ["Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "That psychological distress diminishing markedly as the number of cases and deaths attributed to COVID-19 in the US continued to rise (Schuchat, 2020) and overtake other countries at first appears paradoxical.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Initial findings from the early period of the COVID-19 pandemic suggest that mental health did worsen.", "It is now important that the large-scale decline in worry, nervousness, loss of interest, and feelings of hopelessness during the COVID-19 crisis suggested by the current study (Kroenke et al., 2009; Löwe et al., 2010) is examined across different nations and the mechanisms and implications of this effect investigated."]}
{"doc_id": 24005, "title": "", "abstract": ["Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "Given that the US response to the virus has differed to other countries, it is unclear whether the observed trajectory of recovery from initial distress will be observed in other nations, particularly where lockdown measures were more severe or economic supports less readily available.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Because our baseline distress assessment was administered immediately prior to the introduction of lockdown restrictions it is possible that we underestimated the rise in distress from initial levels."]}
{"doc_id": 24006, "title": "", "abstract": ["Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "That psychological distress diminishing markedly as the number of cases and deaths attributed to COVID-19 in the US continued to rise (Schuchat, 2020) and overtake other countries at first appears paradoxical.", "The objective of the present was to examine how psychological distress has changed during the initial stages of the COVID-19 pandemic in the United States and to examine whether there are population sub-groups who are particularly vulnerable to persistent distress during the crisis, including those with pre-existing mental health diagnoses.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US."]}
{"doc_id": 24007, "title": "", "abstract": ["Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Extensive evidence has documented how people adapt to major negative life events (e.g. military deployment, bereavement, onset of disability or chronic illness) and the most common responses to such events are classified as ‘resilience’ (i.e. minimal impact on mental health) or ‘recovery’ (i.e. an initial increase in distress followed by recovery) (Bonanno, 2004; Infurna and Luthar, 2018).", "However, another body of evidence suggests that although mental health has suffered following the emergence of the COVID-19 crisis, in the longer-term people's mental health may be largely resilient (Galatzer-Levy et al., 2018).", "Resilience has been defined broadly as the ability to recover from negative emotional experiences by flexibly adapting to stressful circumstances (Tugade and Fredrickson, 2004; Habersaat et al., 2020)."]}
{"doc_id": 24008, "title": "", "abstract": ["However, there is a lack of longitudinal research that has examined how mental health has changed throughout the pandemic within the same sample of participants.", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "The objective of the present was to examine how psychological distress has changed during the initial stages of the COVID-19 pandemic in the United States and to examine whether there are population sub-groups who are particularly vulnerable to persistent distress during the crisis, including those with pre-existing mental health diagnoses.", "There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "Initial findings from the early period of the COVID-19 pandemic suggest that mental health did worsen."]}
{"doc_id": 24009, "title": "", "abstract": ["Distress levels subsequently declined to mid- March levels by June 2020 (d = –0.31, 95% CI [–0.34, –0.27], p < .001).", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "Distress levels then decreased by another −0.08 SD (95% CI [-0.11,-0.05], p < .001) in early May and declined fully to baseline levels by the end of June 2020 (d = −0.31, 95% CI [-0.35,-0.27], p < .001), as shown in Table 2.", "An examination of the descriptive statistics for distress levels showed that distress was lowest at baseline (March 10–18: M = 1.85, SD = 2.81) and then increased by 0.76 points in the second survey wave (April 1–14: M = 2.61, SD = 3.09) and subsequently declined until June (April 15–28: M = 2.28, SD = 3.01; April 29-May 12: M = 2.03, SD = 2.78; May 13–26: M = 1.86, SD = 2.75; May 27-June 9: M = 1.80, SD = 2.73; June 10–23: M = 1.73, SD = 2.74) at which point distress remained stable (June 24-July 20: M = 1.75, SD = 2.79).", "However, this spike in distress started to decrease from late April onwards and by June levels of distress were similar to levels reported in March."]}
{"doc_id": 24010, "title": "", "abstract": ["There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This helped ensure that the daily incomes of Americans and their ability to meet basic needs was minimally compromised during the initial stage of the pandemic.", "The objective of the present was to examine how psychological distress has changed during the initial stages of the COVID-19 pandemic in the United States and to examine whether there are population sub-groups who are particularly vulnerable to persistent distress during the crisis, including those with pre-existing mental health diagnoses."]}
{"doc_id": 24011, "title": "", "abstract": ["This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "The objective of the present was to examine how psychological distress has changed during the initial stages of the COVID-19 pandemic in the United States and to examine whether there are population sub-groups who are particularly vulnerable to persistent distress during the crisis, including those with pre-existing mental health diagnoses.", "Given that the US response to the virus has differed to other countries, it is unclear whether the observed trajectory of recovery from initial distress will be observed in other nations, particularly where lockdown measures were more severe or economic supports less readily available.", "Across the sociodemographic groups examined and those with pre-existing mental health conditions we observed a sharp rise in distress followed by a recovery to baseline distress levels."]}
{"doc_id": 24012, "title": "", "abstract": ["However, this spike in distress started to decrease from late April onwards and by June levels of distress were similar to levels reported in March.", "Taken together, these analyses demonstrated a robust pattern whereby distress increased from March 10–18 to April 1–14 and declined subsequently.", "There was some attrition during the survey and it is possible that those with recovering levels of distress may have been more likely to continue to participate in later waves of data collection.", "Distress levels subsequently declined to mid- March levels by June 2020 (d = –0.31, 95% CI [–0.34, –0.27], p < .001).", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic."]}
{"doc_id": 24013, "title": "", "abstract": ["Distress levels subsequently declined to mid- March levels by June 2020 (d = –0.31, 95% CI [–0.34, –0.27], p < .001).", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "Distress levels then decreased by another −0.08 SD (95% CI [-0.11,-0.05], p < .001) in early May and declined fully to baseline levels by the end of June 2020 (d = −0.31, 95% CI [-0.35,-0.27], p < .001), as shown in Table 2.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "An examination of the descriptive statistics for distress levels showed that distress was lowest at baseline (March 10–18: M = 1.85, SD = 2.81) and then increased by 0.76 points in the second survey wave (April 1–14: M = 2.61, SD = 3.09) and subsequently declined until June (April 15–28: M = 2.28, SD = 3.01; April 29-May 12: M = 2.03, SD = 2.78; May 13–26: M = 1.86, SD = 2.75; May 27-June 9: M = 1.80, SD = 2.73; June 10–23: M = 1.73, SD = 2.74) at which point distress remained stable (June 24-July 20: M = 1.75, SD = 2.79)."]}
{"doc_id": 24014, "title": "", "abstract": ["In the current study the reliability of the PHQ-4 ranged from 0.88 to 0.91 across the eight study waves.", "However, we found that the demographic and mental health characteristics of our baseline/Wave 1 sample did not differ from the composition of subsequent waves (see Tables S1 and S2) suggesting that these exclusions did significantly impact the representativeness of the Wave 1 sample.", "The PHQ-4 has been validated in the US (Kroenke et al., 2009) and has shown high levels of agreement with longer scales and similar correlations with measures of functional status (Lowe et al., 2010) and is sensitive to changes in mental health (Kroenke et al., 2019).", "However, the PHQ-4 is a validated and widely used indicator of self-reported psychological distress and difficulties that was highly reliable in this study.", "The construct validity of the PHQ-4 has been tested in the general population where the PHQ-4 has been shown to correlate with relevant self-report scales and known demographic risk factors for depression and anxiety (Kroenke et al., 2009)."]}
{"doc_id": 24015, "title": "", "abstract": ["Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001).", "Distress levels subsequently declined to mid- March levels by June 2020 (d = –0.31, 95% CI [–0.34, –0.27], p < .001).", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "Regression estimates of the magnitude of the increase (March 10–18 to April 1–14) and decrease (April 1–14 to June 24 - July 20) in psychological distress for those diagnosed with each mental health condition in the Understanding America Study (UAS).", "Specifically, we estimated the increase in distress between March 10–18 and April 1–14 and the decrease in distress from this point to the June 24-July 20 wave for each subgroup."]}
{"doc_id": 24016, "title": "", "abstract": ["Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001).", "As displayed in Table 4 , across diagnosed conditions distress tended to increase from March to early April, and significant declines in distress were subsequently observed among those diagnosed with anxiety disorder, ADHD, depression, OCD, and other mental health conditions.", "The increase in psychological distress from March 10–18 to April 1-14 was statistically significant at the p < .001 level for all population subgroups examined (see Table 3 ) with the exception of Black participants (d = 0.14, 95% CI [0.01, 0.27], p < .05).", "Regression estimates of the magnitude of the increase (March 10–18 to April 1–14) and decrease (April 1–14 to June 24 - July 20) in psychological distress for those diagnosed with each mental health condition in the Understanding America Study (UAS).", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US."]}
{"doc_id": 24017, "title": "", "abstract": ["That psychological distress diminishing markedly as the number of cases and deaths attributed to COVID-19 in the US continued to rise (Schuchat, 2020) and overtake other countries at first appears paradoxical.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US."]}
{"doc_id": 24018, "title": "", "abstract": ["There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "The objective of the present was to examine how psychological distress has changed during the initial stages of the COVID-19 pandemic in the United States and to examine whether there are population sub-groups who are particularly vulnerable to persistent distress during the crisis, including those with pre-existing mental health diagnoses.", "Nonetheless, it will now be important to examine how specific mental health symptoms have been affected during the course of the pandemic.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "However, there is a lack of longitudinal research that has examined how mental health has changed throughout the pandemic within the same sample of participants."]}
{"doc_id": 24019, "title": "", "abstract": ["Likewise, adopting a similar approach by comparing different samples of US adults, a study by McGinty et al. (2020) found that both psychological distress and loneliness were higher in April 2020 compared to 2018.", "Regression estimates of cumulative and wave-to-wave changes in psychological distress levels between March 10th to July 20th, 2020 in the Understanding America Study (UAS) (N = 7319; Obs.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "Standardized change in psychological distress from March 10–18, 2020 to seven subsequent waves of the Understanding America Study conducted between April 1st and July 20th, 2020.", "We analyzed longitudinal nationally representative data from eight waves of the Understanding America Study (UAS) collected between March 10th and July 20th, 2020 (N = 7319 Observations = 46,145)."]}
{"doc_id": 24020, "title": "", "abstract": ["For instance, a reduction in perceived infection risk may underpin both a decreased sense of threat and anxiety and lower levels of adherence to social distancing and other transmission prevention measures (Habersaat et al., 2020).", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "It is also important to note that while adaptation and a recovery in psychological distress was the average response in this study, there may be groups who we did not identify who will experience more prolonged psychological difficulties due to the COVID-19 pandemic."]}
{"doc_id": 24021, "title": "", "abstract": ["Note: All models are adjusted for covariates (participant age, sex, race/ethnicity, household income, and the presence of a pre-existing mental health condition).", "Note: All models are adjusted for covariates (participant age, sex, race/ethnicity, household income, and the presence of a pre-existing mental health condition).", "Differences in distress trends were examined by age, sex, race/ethnicity, and household income and by the presence of a pre-existing mental health diagnosis.", "Estimates are adjusted for age, sex, race/ethnicity, household income and the presence of a pre-existing mental health condition.", "Across the sociodemographic groups examined and those with pre-existing mental health conditions we observed a sharp rise in distress followed by a recovery to baseline distress levels."]}
{"doc_id": 24022, "title": "", "abstract": ["Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "Distress levels then decreased by another −0.08 SD (95% CI [-0.11,-0.05], p < .001) in early May and declined fully to baseline levels by the end of June 2020 (d = −0.31, 95% CI [-0.35,-0.27], p < .001), as shown in Table 2.", "However, the trajectory observed of an initial sharp rise in distress followed by gradual return to baseline levels (a ‘recovery’ response) has been identified as a common response in research examining adaptation to other types of major life stressor (Infurna and Luthar, 2018).", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic."]}
{"doc_id": 24023, "title": "", "abstract": ["After adjustment for demographic characteristics and the presence of mental health conditions there was evidence for a sharp statistically significant 0.27 standard deviation (SD) (95% CI [0.23,.31], P < .001) increase in distress from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "In line with overall results, by June/July 2020 psychological distress levels were indistinguishable from baseline among those with previous mental health diagnoses.", "Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001).", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "Distress levels then decreased by another −0.08 SD (95% CI [-0.11,-0.05], p < .001) in early May and declined fully to baseline levels by the end of June 2020 (d = −0.31, 95% CI [-0.35,-0.27], p < .001), as shown in Table 2."]}
{"doc_id": 24024, "title": "", "abstract": ["This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "After adjustment for demographic characteristics and the presence of mental health conditions there was evidence for a sharp statistically significant 0.27 standard deviation (SD) (95% CI [0.23,.31], P < .001) increase in distress from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "In this observational population-based study, we examined how psychological distress changed following the emergence of the COVID-19 crisis in the United States and tested whether certain population subgroups were vulnerable to persistent distress during the crisis."]}
{"doc_id": 24025, "title": "", "abstract": ["Initial findings from the early period of the COVID-19 pandemic suggest that mental health did worsen.", "There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "Nonetheless, it will now be important to examine how specific mental health symptoms have been affected during the course of the pandemic.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic."]}
{"doc_id": 24026, "title": "", "abstract": ["On average those with pre-existing diagnosed mental health conditions reported baseline (March 10–18) distress levels 0.77 SD (95% CI [0.73,0.80], p < .001) above those not reporting mental health conditions.", "Across the sociodemographic groups examined and those with pre-existing mental health conditions we observed a sharp rise in distress followed by a recovery to baseline distress levels.", "On average, psychological distress levels were highest for those diagnosed with mental health conditions (M = 3.55, SD = 3.41), followed by those aged 18–35 (M = 2.68, SD = 3.26), those on low incomes (M = 2.38, SD = 3.18), and females (M = 2.35, SD = 3.04).", "In line with overall results, by June/July 2020 psychological distress levels were indistinguishable from baseline among those with previous mental health diagnoses.", "Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001)."]}
{"doc_id": 26000, "title": "", "abstract": ["We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "The COVID-19-related death (mean, 4.13% ± 2.70%; median, 3.40; IQR, 2.22–5.61) varied among different counties (Table 1 and S1).", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality."]}
{"doc_id": 26001, "title": "", "abstract": ["Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US."]}
{"doc_id": 26002, "title": "", "abstract": ["Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "The goal of the study was to provide evidence on the association of COVID-19 with respect to race, income level, poverty, education, and the impact of preventative measures such as social distancing.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "Finally, access to insurance was a protective factor in terms of mortality from COVID-19, but access to insurance did not significantly associate with the rate of infection."]}
{"doc_id": 26003, "title": "", "abstract": ["Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "### Counties with a Higher Total Population, More Diverse Demographics, Higher Education, and Income Level Are at a Higher Risk of COVID-19 Infection", "The goal of the study was to provide evidence on the association of COVID-19 with respect to race, income level, poverty, education, and the impact of preventative measures such as social distancing."]}
{"doc_id": 26004, "title": "", "abstract": ["Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "The conflicting results for counties’ population could be related to the population density, easier access to the high quality of healthcare, and more experience managing the COVID-19 infection due to the higher number of patients.", "### Counties with a Higher Total Population, More Diverse Demographics, Higher Education, and Income Level Are at a Higher Risk of COVID-19 Infection", "We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts)."]}
{"doc_id": 26005, "title": "", "abstract": ["There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "This is the first systematic study on the racial, health, and economic disparity, as well as education, mobility, and COVID-19 infection in the US with the available data from the most severely impacted states.", "As states release the racial and ethnic demographic data of COVID-19 cases, in addition to the increased spread of this disease to the central states, it is imperative that we understand the patterns of infection and death to reduce the risks, especially for high-risk population, and resolve issues that impede the provision of optimal care.", "Furthermore, as the association between COVID-19-related fatality and infection is different among different race and health status, it is important to further study the impact of the immune system and immune-boosting strategies in the at-risk population (such as people with certain disabilities or those residing in elderly community centers), as preventive measure along with other measures based on social distancing guidelines and the ability to work from home."]}
{"doc_id": 26006, "title": "", "abstract": ["Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "### Counties with a Higher Total Population, More Diverse Demographics, Higher Education, and Income Level Are at a Higher Risk of COVID-19 Infection", "The conflicting results for counties’ population could be related to the population density, easier access to the high quality of healthcare, and more experience managing the COVID-19 infection due to the higher number of patients.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4)."]}
{"doc_id": 26007, "title": "", "abstract": ["The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4)."]}
{"doc_id": 26008, "title": "", "abstract": ["Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "The goal of the study was to provide evidence on the association of COVID-19 with respect to race, income level, poverty, education, and the impact of preventative measures such as social distancing.", "− 0.44, 95% CI − 0.58, − 0.30, q < 4.2E-08, men) is associated with a lower rate of COVID-19."]}
{"doc_id": 26009, "title": "", "abstract": ["We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4)."]}
{"doc_id": 26010, "title": "", "abstract": ["Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "In a recent study, the Centers for Disease Control and Prevention (CDC) reported data from fourteen states and suggested that the US Black population may be disproportionally affected by COVID-19 [3].", "African Americans were more vulnerable to COVID-19 than other ethnic groups (1981 African American infected cases versus 658 Whites per million).", "Finally, historical data have taught us that minorities and people of color tend to be more affected by different diseases [27–30].", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19."]}
{"doc_id": 26011, "title": "", "abstract": ["Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "### Counties with a Higher Total Population, More Diverse Demographics, Higher Education, and Income Level Are at a Higher Risk of COVID-19 Infection", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "The conflicting results for counties’ population could be related to the population density, easier access to the high quality of healthcare, and more experience managing the COVID-19 infection due to the higher number of patients."]}
{"doc_id": 26012, "title": "", "abstract": ["We have also explored the association between total population and various confounding factors, such as mobility data when analyzing the death rate and found that the total population is still an important protective factor (see Table S6, Fig. S7 and S8).", "Implications of the results from this study highlight the value of the targeted interventions, as different counties, even within the same state, may have different characteristics and different needs.", "This observation is consistent with the influenza A (H1N1) pandemic where other studies showed evidence of racial and ethnic disparities in the population affected both in exposure, severity, and mortality of the disease [8, 9].", "The variables used in this study include county-level information on total population, mobility, race, poverty level, median income, education, disability, and rate of the insured population.", "Our observation is also aligned with a recent analysis of health differences in 3053 US counties, showing that rural areas are more likely to have poorer health outcomes [19]."]}
{"doc_id": 26013, "title": "", "abstract": ["Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "The goal of the study was to provide evidence on the association of COVID-19 with respect to race, income level, poverty, education, and the impact of preventative measures such as social distancing.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19."]}
{"doc_id": 26014, "title": "", "abstract": ["Populations with a higher disability [20] and lower median income [21] might be less mobile, have more comorbidities [22, 23], and also less likely benefit from timely high-quality care [24] and high-quality nutrition; all of these factors could be equally important to combating this pandemic [25, 26].", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "The association of poverty and disability makes the conclusion of this study more complex and beyond the analysis of social determinants.", "Our findings highlight that race (especially Black) is a risk factor for the infection.", "It has been reported that age 65 and older, body mass index ≥ 40, diabetes [5] immunosuppression, smoking, hypertension, and cardiovascular diseases are underlying conditions that increase the risk of death from COVID-19 [6, 7]."]}
{"doc_id": 26015, "title": "", "abstract": ["Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4).", "0.46, CI 0.31, 0.62, q < 8.1E-08, men) are associated with a higher rate of infection while a higher percentage of non-Hispanic Whites (est.", "Another protective factor in terms of rate of infection for the counties analyzed was a higher percentage of disability (est."]}
{"doc_id": 26016, "title": "", "abstract": ["It has been reported that age 65 and older, body mass index ≥ 40, diabetes [5] immunosuppression, smoking, hypertension, and cardiovascular diseases are underlying conditions that increase the risk of death from COVID-19 [6, 7].", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "Furthermore, in our stepwise regression model, minorities specifically Black and Hispanic women, poverty, and level of education among non-Hispanic Whites, disability, the total county population, and level of mobility are predictors of the rate of COVID-19 infection (Table S4)."]}
{"doc_id": 26017, "title": "", "abstract": ["Our data show a significant association among different socioeconomic determinants, such as poverty level, education, and income (see Table S2).", "In particular, counties with a higher percentage of people below the poverty level had a significantly lower percentage of the population with higher education (Pearson correlation, − 0.52, p < 0.005 for Bachelor’s degree; Pearson correlation, − 0.61, p < 0.005 for high school), as well as a lower percentage of people insured, but a higher percentage of people on Medicaid (Pearson correlation, 0.77, p < 0.005) or on disability (Pearson correlation, 0.41, p < 0.005; see Table S2 for more details).", "The latter is expected since Medicaid is significantly associated with the rate of poverty (Pearson correlation, 0.769, p < 0.005) as well as the rate of disability (Pearson correlation, 0.428, p < 0.005).", "Counties with a higher percentage of residents below the poverty level had a higher percentage of Blacks (Pearson correlation, 0.52, p < 0.005 for men; Pearson correlation, 0.50, p < 0.005 for women) and a lower percentage of non-Hispanic Whites (Pearson correlation, − 0.30, p < 0.005 for men; Pearson correlation, − 0.33, p < 0.005 for women).", "Comparison of counties with higher or lower than median death rates provided further evidence of the association of lower median income and higher poverty levels across all the races with mortality."]}
{"doc_id": 26018, "title": "", "abstract": ["In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "Racial, Economic, and Health Inequality and COVID-19 Infection in the United States"]}
{"doc_id": 26019, "title": "", "abstract": ["By adding the interaction terms in the linear regression model (death rate~poverty + disability + poverty:disability) of death rate, we do not observe a significant interaction (p = 0.469), suggesting these two variables could be independent in their contribution to the risk of mortality.", "The association of poverty and disability makes the conclusion of this study more complex and beyond the analysis of social determinants.", "The latter is expected since Medicaid is significantly associated with the rate of poverty (Pearson correlation, 0.769, p < 0.005) as well as the rate of disability (Pearson correlation, 0.428, p < 0.005).", "The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "However, counties with higher proportion with disability and poverty rates had a higher death rate."]}
{"doc_id": 26020, "title": "", "abstract": ["Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "The goal of this study is to report the associations of COVID-19 with respect to race, health, and economic inequality in the United States.", "Racial, Economic, and Health Inequality and COVID-19 Infection in the United States", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19."]}
{"doc_id": 26021, "title": "", "abstract": ["We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "The included states were California, Michigan, New York, New Jersey, Louisiana, Pennsylvania, and Massachusetts; (2) analysis of COVID-19-related infection and death rate across all the states in the US with race/ethnicity information on the affected subject when available.", "The study was conducted at two levels: (1) analysis of population characteristics (44 variables) for 369 counties in seven states which had the highest rate of COVID-19 infection as of April 9, 2020, along with COVID-19 infection and mortality rates.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "− 0.44, 95% CI − 0.58, − 0.30, q < 4.2E-08, men) is associated with a lower rate of COVID-19."]}
{"doc_id": 26022, "title": "", "abstract": ["As of April 16, 2020, we have observed that African Americans, as defined in the reports, have a higher rate of COVID-19 infection and a higher death rate.", "### COVID-19 Infection and Mortality Are Higher Among African Americans", "African Americans were more vulnerable to COVID-19 than other ethnic groups (1981 African American infected cases versus 658 Whites per million).", "The number of African Americans infected by COVID-19 is 64,605 (1981 cases per million) with the number of deaths reaching 6181 (211 deaths per million), while the number of Whites, as defined in the reports, is 104,914 (658 cases per million) infected and 9806 (76 deaths per million) dead leading to a disproportional percentage of African Americans infected (p < 0.0001) by COVID-19 and dead (p < 0.0001) as the result.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US."]}
{"doc_id": 40000, "title": "", "abstract": ["While reduced activity was observed in NMC-nCoV02-infected ferrets between 2 and 6 dpi with occasional coughs, there was no detectable body weight loss, nor were there any fatalities during the experimental period.", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed.", "Interestingly, all six DC ferrets showed increased body temperatures (∼39°C) with reduced activity between 4 and 6 days post contact (dpc) and no detectable body weight loss (Figures S1A and S1B).", "However, none of the IC ferrets showed increased body temperature or weight loss over the 12 days of the studies (Figures S1C and S1D).", "NMC-nCoV02-infected ferrets had elevated body temperatures, from 38.1°C to 40.3°C, between 2 and 8 dpi; these returned to normal by 8 dpi (Figure 1 A)."]}
{"doc_id": 40001, "title": "", "abstract": ["To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "12 −24 month old male and female ferrets, which were confirmed as Influenza A (H1N1, H3N1), MERS-CoV, and SARS-CoV antibody free ferrets by the standard enzyme-linked immunosorbent assay (ELISA) previously described elsewhere (El- Duah et al., 2019, Park et al., 2014, Woo et al., 2005), were infected through intranasal (IN) route with NMC2019-nCoV02 virus, an isolate of SARS-CoV-2 from a COVID-19 confirmed patient in Korea, 2020 February, at a dose of 105.5 TCID50 per ferrets (n = 2).", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "To assess the replication of SARS-CoV-2 in ferret organs, an additional 12 ferrets were infected with NMC-nCoV02 or PBS via the IN route and 3 ferrets were sacrificed at 4, 8, and 12 dpi."]}
{"doc_id": 40002, "title": "", "abstract": ["Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "In this study, we established an infection and transmission ferret animal model for COVID-19.", "Therefore, an animal model that recapitulates the COVID-19 clinical symptoms in human infection is urgently needed in order to decipher the transmission routes and pathobiology of this virus and to allow testing of pharmaceutical interventions.", "These data indicate that the efficient establishment of COVID-19 clinical features in ferrets exposed to infected animals requires direct contact, recapitulating human-to-human transmission.", "The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide."]}
{"doc_id": 40003, "title": "", "abstract": ["Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission."]}
{"doc_id": 40004, "title": "", "abstract": ["Although viral spike RNA was detected in sera of infected ferrets, the viral copy number was low (peaked titer 0.35 log10 copies/mL) and dropped below detection limits earlier than in nasal wash and saliva specimens.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "In IN infected ferret group, NMC-nCoV02 was isolated from both saliva and nasal washes specimens as early as 2 dpi and persisted until 4 and 6 dpi, respectively (Table 1).", "This further supports the significance of ferrets as animal model for human respiratory viral infection."]}
{"doc_id": 40005, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "In this study, we established an infection and transmission ferret animal model for COVID-19.", "To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease."]}
{"doc_id": 40006, "title": "", "abstract": ["The virus was also detected in saliva specimens from 2 dpi (1.73 log10 copies/mL) through 8 dpi.", "Viral RNA was also detected in intestine (0.93 log10 copies/g) and kidney (0.87 log10 copies/g) at 4 dpi.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed."]}
{"doc_id": 40007, "title": "", "abstract": ["To understand how this virus rapidly spreads within a community, and to inform infection control messaging, it is essential to develop an experimental animal model that can support the active infection, shedding, and transmission of SARS-CoV-2 to sentinel animals.", "#### Experimental Animals", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "Given that SARS-CoV-2 shares higher sequence homology with SARS-CoV (79% homology) than with MERS-CoV (50% homology), the entry receptor for SARS-CoV, human Angiotensin-converting enzyme 2 (hACE2), was considered as a receptor candidate for SARS-CoV-2 (Lu et al., 2020).", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals."]}
{"doc_id": 40008, "title": "", "abstract": ["Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets.", "12 −24 month old male and female ferrets, which were confirmed as Influenza A (H1N1, H3N1), MERS-CoV, and SARS-CoV antibody free ferrets by the standard enzyme-linked immunosorbent assay (ELISA) previously described elsewhere (El- Duah et al., 2019, Park et al., 2014, Woo et al., 2005), were infected through intranasal (IN) route with NMC2019-nCoV02 virus, an isolate of SARS-CoV-2 from a COVID-19 confirmed patient in Korea, 2020 February, at a dose of 105.5 TCID50 per ferrets (n = 2).", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "IHC analyses showed that a number of cells in the nasal turbinate, trachea, lung, and intestine sections of NMC-nCoV02-infected ferrets (Figures 1I–1L), but not PBS-treated control ferrets (Figures 1E–1H), were positive for SARS-CoV-2 antigen."]}
{"doc_id": 40009, "title": "", "abstract": ["To understand how this virus rapidly spreads within a community, and to inform infection control messaging, it is essential to develop an experimental animal model that can support the active infection, shedding, and transmission of SARS-CoV-2 to sentinel animals.", "In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "This further supports the significance of ferrets as animal model for human respiratory viral infection.", "In this study, we established an infection and transmission ferret animal model for COVID-19.", "Because gastrointestinal involvement is a characteristic of coronavirus infections of animals and humans (Leung et al., 2003), we also collected fecal and urine specimens."]}
{"doc_id": 40010, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "The SARS-CoV-2 was found to efficiently infect ferrets and induce moderate increases in body temperature (∼38.5-40.3°C)."]}
{"doc_id": 40011, "title": "", "abstract": ["In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "Therefore, given the rapid spreading characteristics of SASRS-CoV-2 in humans, ferret model would be a useful tool to evaluate the efficacy of prophylactic anti-virals and preventive vaccines."]}
{"doc_id": 40012, "title": "", "abstract": ["12 −24 month old male and female ferrets, which were confirmed as Influenza A (H1N1, H3N1), MERS-CoV, and SARS-CoV antibody free ferrets by the standard enzyme-linked immunosorbent assay (ELISA) previously described elsewhere (El- Duah et al., 2019, Park et al., 2014, Woo et al., 2005), were infected through intranasal (IN) route with NMC2019-nCoV02 virus, an isolate of SARS-CoV-2 from a COVID-19 confirmed patient in Korea, 2020 February, at a dose of 105.5 TCID50 per ferrets (n = 2).", "To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "(A–C) Six ferrets were inoculated intranasally with 105.5 TCID50 of virus.", "To access the replication of the virus in ferrets following SARS-CoV-2 infection in various organs, additional 9 ferrets were infected with SARS- CoV-2 by IN route.", "To assess the replication of SARS-CoV-2 in ferret organs, an additional 12 ferrets were infected with NMC-nCoV02 or PBS via the IN route and 3 ferrets were sacrificed at 4, 8, and 12 dpi."]}
{"doc_id": 40013, "title": "", "abstract": ["Further, as suspected in recent COVID-19 patients (Kim et al., 2020, Xu et al., 2020), we detected the infectious viruses in urine and fecal specimens of virus-infected ferrets.", "12 −24 month old male and female ferrets, which were confirmed as Influenza A (H1N1, H3N1), MERS-CoV, and SARS-CoV antibody free ferrets by the standard enzyme-linked immunosorbent assay (ELISA) previously described elsewhere (El- Duah et al., 2019, Park et al., 2014, Woo et al., 2005), were infected through intranasal (IN) route with NMC2019-nCoV02 virus, an isolate of SARS-CoV-2 from a COVID-19 confirmed patient in Korea, 2020 February, at a dose of 105.5 TCID50 per ferrets (n = 2).", "Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "On the other hand, only 1 of 6 IC ferrets showed a positive SN titer of 16.", "IHC analyses showed that a number of cells in the nasal turbinate, trachea, lung, and intestine sections of NMC-nCoV02-infected ferrets (Figures 1I–1L), but not PBS-treated control ferrets (Figures 1E–1H), were positive for SARS-CoV-2 antigen."]}
{"doc_id": 40014, "title": "", "abstract": ["The SARS-CoV-2 has been found to have high human-to-human transmission through close contact with infected patients, leading to rapid global spread by infected travelers from China.", "In late December of 2019, a novel coronavirus disease (COVID-19) was identified in Wuhan City, Hubei Province, China from patients with severe pneumonia (Zhu et al., 2020).", "Clinical features of SARS-CoV-2 infections were recorded.", "The SARS-CoV-2 was found to efficiently infect ferrets and induce moderate increases in body temperature (∼38.5-40.3°C).", "In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted."]}
{"doc_id": 40015, "title": "", "abstract": ["These data show that airborne transmission is likely but is considerably less robust than direct contact transmission.", "To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "These data indicate that the efficient establishment of COVID-19 clinical features in ferrets exposed to infected animals requires direct contact, recapitulating human-to-human transmission.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "#### Study Design for Animal-to-Animal Transmission"]}
{"doc_id": 40016, "title": "", "abstract": ["At 8 dpi, viral RNA was still detected in nasal turbinate, trachea, lungs, kidney, and intestine (Figure 1B).", "In addition, viral RNA was detected in saliva and fecal specimens of the DC group for 8 days, whereas the urine specimens contained detectable viral RNA until 4 dpc.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "Viral RNA was also detected in intestine (0.93 log10 copies/g) and kidney (0.87 log10 copies/g) at 4 dpi.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted."]}
{"doc_id": 40017, "title": "", "abstract": ["All animal studies were carried out in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) in Chungbuk National University.", "Following the fortuitous discovery of the natural susceptibility of ferrets to human influenza viruses, ferret models were found to highly reproduce the human disease manifestation of several respiratory viruses, including respiratory syncytial virus, parainfluenzaviruses, and SARS-CoV-1 (Capraro et al., 2008, Chan et al., 2018, Enkirch and von Messling, 2015, Park et al., 2018).", "This further supports the significance of ferrets as animal model for human respiratory viral infection.", "In this study, we established an infection and transmission ferret animal model for COVID-19.", "Therefore, given the rapid spreading characteristics of SASRS-CoV-2 in humans, ferret model would be a useful tool to evaluate the efficacy of prophylactic anti-virals and preventive vaccines."]}
{"doc_id": 40018, "title": "", "abstract": ["The highest amount of viral RNA was detected in nasal washes and peaked at 4 dpi (3.83 log10 copies/mL), persisting until 8 dpi before dropping below detection limits at 10 dpi (Table 1).", "Similarly to the IN infected group, the DC group had the highest virus copy numbers (3.27 log10 copies/mL) in nasal washes, with RNA detected through 8 dpc.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "At 8 dpi, viral RNA was still detected in nasal turbinate, trachea, lungs, kidney, and intestine (Figure 1B).", "Nasal washes from specimen-inoculated ferrets were collected at 2, 4, and 6 dpi and infected onto Vero cells for virus isolation."]}
{"doc_id": 40019, "title": "", "abstract": ["While reduced activity was observed in NMC-nCoV02-infected ferrets between 2 and 6 dpi with occasional coughs, there was no detectable body weight loss, nor were there any fatalities during the experimental period.", "Interestingly, all six DC ferrets showed increased body temperatures (∼39°C) with reduced activity between 4 and 6 days post contact (dpc) and no detectable body weight loss (Figures S1A and S1B).", "Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "After 12 days of infection, all remaining ferrets, including IN infection (n = 6), DC (n = 6), and IC (n = 6), had returned to normal ranges of body temperature and body weight, and all specimens were negative for viral RNA."]}
{"doc_id": 40020, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "To assess the replication of SARS-CoV-2 in ferret organs, an additional 12 ferrets were infected with NMC-nCoV02 or PBS via the IN route and 3 ferrets were sacrificed at 4, 8, and 12 dpi."]}
{"doc_id": 40021, "title": "", "abstract": ["Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "To investigate SARS-CoV-2 replication and shedding in each group of ferrets, we collected blood, nasal washes, saliva, urine, and fecal specimens every other day for 12 days."]}
{"doc_id": 40022, "title": "", "abstract": ["At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets.", "Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed.", "Male and female ferrets, 12- to 20- month old and sero-negative for influenza A viruses, MERS-CoV, and SARS-CoV (ID Bio Corporation) were maintained in the isolator (woori IB Corporation) in BSL3 of Chungbuk National University."]}
{"doc_id": 40023, "title": "", "abstract": ["Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "While reduced activity was observed in NMC-nCoV02-infected ferrets between 2 and 6 dpi with occasional coughs, there was no detectable body weight loss, nor were there any fatalities during the experimental period.", "After 12 days of infection, all remaining ferrets, including IN infection (n = 6), DC (n = 6), and IC (n = 6), had returned to normal ranges of body temperature and body weight, and all specimens were negative for viral RNA.", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed.", "Clinical features of SARS-CoV-2 infections were recorded."]}
{"doc_id": 40024, "title": "", "abstract": ["With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi."]}
{"doc_id": 40025, "title": "", "abstract": ["At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "12 −24 month old male and female ferrets, which were confirmed as Influenza A (H1N1, H3N1), MERS-CoV, and SARS-CoV antibody free ferrets by the standard enzyme-linked immunosorbent assay (ELISA) previously described elsewhere (El- Duah et al., 2019, Park et al., 2014, Woo et al., 2005), were infected through intranasal (IN) route with NMC2019-nCoV02 virus, an isolate of SARS-CoV-2 from a COVID-19 confirmed patient in Korea, 2020 February, at a dose of 105.5 TCID50 per ferrets (n = 2)."]}
{"doc_id": 40026, "title": "", "abstract": ["To evaluate the infectious virus titer in each specimen, collected nasal washes and saliva specimens were inoculated onto Vero cells for virus isolation.", "Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs.", "In IN infected ferret group, NMC-nCoV02 was isolated from both saliva and nasal washes specimens as early as 2 dpi and persisted until 4 and 6 dpi, respectively (Table 1).", "bIsolated viruses from nasal wash samples inoculated in ferrets.", "In DC ferret group, virus was isolated from the nasal washes at 4 dpc (2.4 log10 TCID50/mL) and 6 dpc (1.0 log10 TCID50/mL) but not in saliva specimens (Table 1)."]}
{"doc_id": 40027, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "To assess the replication of SARS-CoV-2 in ferret organs, an additional 12 ferrets were infected with NMC-nCoV02 or PBS via the IN route and 3 ferrets were sacrificed at 4, 8, and 12 dpi.", "To access the replication of the virus in ferrets following SARS-CoV-2 infection in various organs, additional 9 ferrets were infected with SARS- CoV-2 by IN route.", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi."]}
{"doc_id": 40028, "title": "", "abstract": ["Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "Therefore, given the rapid spreading characteristics of SASRS-CoV-2 in humans, ferret model would be a useful tool to evaluate the efficacy of prophylactic anti-virals and preventive vaccines.", "To understand how this virus rapidly spreads within a community, and to inform infection control messaging, it is essential to develop an experimental animal model that can support the active infection, shedding, and transmission of SARS-CoV-2 to sentinel animals.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017)."]}
{"doc_id": 40029, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "To evaluate the transmission mode of the virus, naive ferrets (n = 2/group) were placed in direct contact (DC) (co-housed) or indirect contact (IC) (housed in cages with a permeable partition separating them from infected ferrets) with infected ferrets two days after the primary infection.", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020."]}
{"doc_id": 40030, "title": "", "abstract": ["Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "For the IC group, 2 out of 6 ferrets were positive for viral RNA in nasal washes and fecal specimens at 4 dpc, although viral RNA copy numbers were lower (0.53 and 0.52 log10 copies/mL, respectively) than in DC ferrets.", "To evaluate the transmission mode of the virus, naive ferrets (n = 2/group) were placed in direct contact (DC) (co-housed) or indirect contact (IC) (housed in cages with a permeable partition separating them from infected ferrets) with infected ferrets two days after the primary infection.", "Although viral spike RNA was detected in sera of infected ferrets, the viral copy number was low (peaked titer 0.35 log10 copies/mL) and dropped below detection limits earlier than in nasal wash and saliva specimens."]}
{"doc_id": 40031, "title": "", "abstract": ["Nasal washes specimens showed higher virus titers (1.83–2.88 log10 TCID50/mL) than saliva specimens (0.82–0.92 log10 TCID50/mL).", "The highest amount of viral RNA was detected in nasal washes and peaked at 4 dpi (3.83 log10 copies/mL), persisting until 8 dpi before dropping below detection limits at 10 dpi (Table 1).", "Similarly to the IN infected group, the DC group had the highest virus copy numbers (3.27 log10 copies/mL) in nasal washes, with RNA detected through 8 dpc.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "Quantitation of Viral RNA in Specimens (Serum, Feces, Nasal Wash, Saliva, and Urine) from Each Group of Ferrets"]}
{"doc_id": 40032, "title": "", "abstract": ["Further, the lung histopathology showed that, compared with PBS-treated ferrets, NMC-nCoV02-infected ferrets at 4 dpi showed increased immune infiltration and cell debris in the alveolar wall, bronchial epithelium, and bronchial lumen (Figure S2), evidencing acute bronchiolitis by NMC-nCoV02 infection.", "Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs.", "Each tissue (n = 3 per group) was collected at 4, 8, and 12 dpi.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "However, both viral RNA detection and virus recovery failed in all tested tissues at 12 dpi."]}
{"doc_id": 40033, "title": "", "abstract": ["The highest amount of viral RNA was detected in nasal washes and peaked at 4 dpi (3.83 log10 copies/mL), persisting until 8 dpi before dropping below detection limits at 10 dpi (Table 1).", "Nasal washes specimens showed higher virus titers (1.83–2.88 log10 TCID50/mL) than saliva specimens (0.82–0.92 log10 TCID50/mL).", "Similarly to the IN infected group, the DC group had the highest virus copy numbers (3.27 log10 copies/mL) in nasal washes, with RNA detected through 8 dpc.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "In DC ferret group, virus was isolated from the nasal washes at 4 dpc (2.4 log10 TCID50/mL) and 6 dpc (1.0 log10 TCID50/mL) but not in saliva specimens (Table 1)."]}
{"doc_id": 40034, "title": "", "abstract": ["Viral RNA was also detected in intestine (0.93 log10 copies/g) and kidney (0.87 log10 copies/g) at 4 dpi.", "At 8 dpi, viral RNA was still detected in nasal turbinate, trachea, lungs, kidney, and intestine (Figure 1B).", "In addition, viral RNA was detected in saliva and fecal specimens of the DC group for 8 days, whereas the urine specimens contained detectable viral RNA until 4 dpc.", "Moreover, we were able to detect viral RNA in blood (for 4 dpi), nasal washes (for 8 dpi), urine (for 8 dpi), and fecal (for 8 dpi) specimens.", "In correlation with viral RNA copy numbers (Figure 1B), the highest infectious virus titer was detected in nasal turbinate (3.23 log10 TCID50/g) and lung tissue (1.4 log10 TCID50/g) at 4 dpi, whereas infectious virus recovery failed from trachea, kidney, and intestine tissues, which carried less than 1.13 log10 viral RNA copies/g (Figure 1C)."]}
{"doc_id": 40035, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "This further supports the significance of ferrets as animal model for human respiratory viral infection.", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015)."]}
{"doc_id": 40036, "title": "", "abstract": ["Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "Although viral spike RNA was detected in sera of infected ferrets, the viral copy number was low (peaked titer 0.35 log10 copies/mL) and dropped below detection limits earlier than in nasal wash and saliva specimens.", "Further, as suspected in recent COVID-19 patients (Kim et al., 2020, Xu et al., 2020), we detected the infectious viruses in urine and fecal specimens of virus-infected ferrets.", "To further confirm viral replication in infected ferrets, immunohistochemistry (IHC) and histopathological examinations were conducted (Figure 1 and Figure S2).", "IHC analyses showed that a number of cells in the nasal turbinate, trachea, lung, and intestine sections of NMC-nCoV02-infected ferrets (Figures 1I–1L), but not PBS-treated control ferrets (Figures 1E–1H), were positive for SARS-CoV-2 antigen."]}
{"doc_id": 40037, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017)."]}
{"doc_id": 40038, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "The SARS-CoV-2 has been found to have high human-to-human transmission through close contact with infected patients, leading to rapid global spread by infected travelers from China.", "These data show that airborne transmission is likely but is considerably less robust than direct contact transmission.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals."]}
{"doc_id": 40039, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed.", "On the other hand, it is also possible that SARS-CoV-2 replicates weaker but persists longer in vivo than SARS-CoV-1, ultimately leading an asymptomatic carrier with a persistent infection to effectively spread the virus."]}
{"doc_id": 40040, "title": "", "abstract": ["Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015)."]}
{"doc_id": 40041, "title": "", "abstract": ["However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015).", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi."]}
{"doc_id": 40042, "title": "", "abstract": ["Although IN infection group showed the highest mean SN titers compared the other groups, the SN titers of both IN infection and DC groups ranged between 32 and128 (Figure 1D).", "(D) Serum neutralizing (SN) antibody titers (GMT) against NMC-nCoV02 (100 TCID50) were measured onto Vero cells after 12 days of experiment (n = 6 per group).", "Although viral spike RNA was detected in sera of infected ferrets, the viral copy number was low (peaked titer 0.35 log10 copies/mL) and dropped below detection limits earlier than in nasal wash and saliva specimens.", "On the other hand, only 1 of 6 IC ferrets showed a positive SN titer of 16.", "Nasal washes specimens showed higher virus titers (1.83–2.88 log10 TCID50/mL) than saliva specimens (0.82–0.92 log10 TCID50/mL)."]}
{"doc_id": 40043, "title": "", "abstract": ["Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Further, as suspected in recent COVID-19 patients (Kim et al., 2020, Xu et al., 2020), we detected the infectious viruses in urine and fecal specimens of virus-infected ferrets."]}
{"doc_id": 40044, "title": "", "abstract": ["In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals.", "IHC analyses showed that a number of cells in the nasal turbinate, trachea, lung, and intestine sections of NMC-nCoV02-infected ferrets (Figures 1I–1L), but not PBS-treated control ferrets (Figures 1E–1H), were positive for SARS-CoV-2 antigen."]}
{"doc_id": 40045, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts.", "SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication."]}
{"doc_id": 40046, "title": "", "abstract": ["Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "To assess the replication of SARS-CoV-2 in ferret organs, an additional 12 ferrets were infected with NMC-nCoV02 or PBS via the IN route and 3 ferrets were sacrificed at 4, 8, and 12 dpi.", "To access the replication of the virus in ferrets following SARS-CoV-2 infection in various organs, additional 9 ferrets were infected with SARS- CoV-2 by IN route."]}
{"doc_id": 40047, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts."]}
{"doc_id": 40048, "title": "", "abstract": ["These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "Following the fortuitous discovery of the natural susceptibility of ferrets to human influenza viruses, ferret models were found to highly reproduce the human disease manifestation of several respiratory viruses, including respiratory syncytial virus, parainfluenzaviruses, and SARS-CoV-1 (Capraro et al., 2008, Chan et al., 2018, Enkirch and von Messling, 2015, Park et al., 2018).", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015)."]}
{"doc_id": 40049, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "This further supports the significance of ferrets as animal model for human respiratory viral infection.", "Following the fortuitous discovery of the natural susceptibility of ferrets to human influenza viruses, ferret models were found to highly reproduce the human disease manifestation of several respiratory viruses, including respiratory syncytial virus, parainfluenzaviruses, and SARS-CoV-1 (Capraro et al., 2008, Chan et al., 2018, Enkirch and von Messling, 2015, Park et al., 2018).", "These data indicate that the efficient establishment of COVID-19 clinical features in ferrets exposed to infected animals requires direct contact, recapitulating human-to-human transmission.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease."]}
{"doc_id": 40050, "title": "", "abstract": ["In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "Therefore, given the rapid spreading characteristics of SASRS-CoV-2 in humans, ferret model would be a useful tool to evaluate the efficacy of prophylactic anti-virals and preventive vaccines.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017)."]}
{"doc_id": 40051, "title": "", "abstract": ["IHC analyses showed that a number of cells in the nasal turbinate, trachea, lung, and intestine sections of NMC-nCoV02-infected ferrets (Figures 1I–1L), but not PBS-treated control ferrets (Figures 1E–1H), were positive for SARS-CoV-2 antigen.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "With regard to potential airborne transmission of SARS-CoV-2, viral RNA was detected in nasal washes and fecal specimens in IC ferrets and persisted for 4 days after indirect contact; only one of the two positive animals seroconverted.", "Further, as suspected in recent COVID-19 patients (Kim et al., 2020, Xu et al., 2020), we detected the infectious viruses in urine and fecal specimens of virus-infected ferrets."]}
{"doc_id": 40052, "title": "", "abstract": ["Although fatalities were not observed, SARS- CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection.", "While reduced activity was observed in NMC-nCoV02-infected ferrets between 2 and 6 dpi with occasional coughs, there was no detectable body weight loss, nor were there any fatalities during the experimental period.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets."]}
{"doc_id": 40053, "title": "", "abstract": ["To demonstrate ferret-to-ferret transmission in an experimental setting, ferrets (n = 2) were inoculated via the intranasal (IN) route with 105.5 TCID50 of NMC-nCoV02, a strain that was isolated from a COVID-19-confirmed patient in South Korea in February of 2020.", "Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission.", "These data indicate that the efficient establishment of COVID-19 clinical features in ferrets exposed to infected animals requires direct contact, recapitulating human-to-human transmission.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "To evaluate the transmission mode of the virus, naive ferrets (n = 2/group) were placed in direct contact (DC) (co-housed) or indirect contact (IC) (housed in cages with a permeable partition separating them from infected ferrets) with infected ferrets two days after the primary infection."]}
{"doc_id": 40054, "title": "", "abstract": ["Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "In this study, we established an infection and transmission ferret animal model for COVID-19.", "Correspondingly, Bao et al. (2020) reported weight loss and virus replication in lungs of hACE2 transgenic mice following SARS-CoV-2 infection; however, no other clinical symptoms such as cough or fever were observed.", "These data indicate that the efficient establishment of COVID-19 clinical features in ferrets exposed to infected animals requires direct contact, recapitulating human-to-human transmission."]}
{"doc_id": 40055, "title": "", "abstract": ["These results indicate that ferret is highly susceptible for the infection of SARS-CoV-2 derived from body fluids, and infectious SARS-CoV-2 sheds through urine and fecal specimens of infected ferrets.", "We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "Interestingly, ferrets in direct contact with SARS-CoV-2-infected ferrets were positive for SARS-CoV-2 infection as early as 2 dpc, suggesting that rapid transmission occurred even prior to infected ferrets reaching their highest viral RNA copy numbers in nasal washes at 4 dpi.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017)."]}
{"doc_id": 41000, "title": "", "abstract": ["Dysregulation of TH17 cells and production of IL-17 in the skin, synovial space and endothelium promote the production of downstream pro-inflammatory molecules such as IL-1β, TNF and IL-6 and neutrophil chemoattractants such as IL-8, CCL20 and CCL2.", "By targeting IL-17, which operates ‘upstream’ of both IL-1 and IL-6 and results in a reduction of neutrophil recruitment, several factors known to play major roles in ARDS would be inhibited.", "Furthermore, addition of exogenous IL-17 further exacerbated LPS-induced production of TNF, IL-1β, IL-6 and CXCL2, revealing the role of IL-17 as a key upstream modulator of the inflammatory pathway.", "In ARDS, IL-17 augments the destruction of the lung parenchyma through maladaptive neutrophil recruitment, by stimulating the production of pro-inflammatory mediators and through the prevention of apoptosis due to the induction of granulocyte colony-stimulating factor expression7.", "Therefore, IL-17 presents itself as a plausible target."]}
{"doc_id": 41001, "title": "", "abstract": ["Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Therefore, IL-17 presents itself as a plausible target.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "In consideration of this, a recent correspondence in The Lancet suggests that all patients with COVID-19 should be screened for hyper- inflammation in order to identify those who would benefit from targeted immunosuppression or immunomodulation to prevent acute lung injury (ALI)3."]}
{"doc_id": 41002, "title": "", "abstract": ["Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6.", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis."]}
{"doc_id": 41003, "title": "", "abstract": ["Both secukinumab and ixekizumab are approved for psoriasis, psoriatic arthritis and ankylosing spondylitis; brodalumab is approved for the treatment of psoriasis alone.", "Three commercially available options exist: secukinumab (human monoclonal antibody to IL-17), ixeki-zumab (humanized monoclonal antibody to IL-17) and brodalumab (human monoclonal antibody to the IL-17 receptor).", "IL-17 inhibition has been adopted as a common and successful strategy to reduce the injury associated with inflammatory autoimmune diseases including psoriasis and psoriatic arthritis.", "Compared with placebo, clinical trials showed a moderate increase in upper respiratory infections (URIs) for patients treated with secukinumab and a similar number of URIs for patients treated with ixekizumab, whereas treatment with brodalumab resulted in a lower rate of URIs.", "Better substantiated is the low-risk profile of therapies inhibiting IL-17, as these have been in wide use for more than 4 years."]}
{"doc_id": 41004, "title": "", "abstract": ["In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Increased IL-17 levels in mice with LPS-induced ALI correlate with increased lung injury scores, greater protein-rich inflammatory lung infiltration and decreased overall survival.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered."]}
{"doc_id": 41005, "title": "", "abstract": ["Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6."]}
{"doc_id": 41006, "title": "", "abstract": ["COVID-19: a case for inhibiting IL-17?", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "Indeed, several clinical trials investigating inhibitors of the IL-1 receptor (anakinra) and the IL-6 receptor (tocilizumab) are ongoing, as are debates about the effectiveness or harm of corticosteroids.", "Experimental immunomodulatory treatment of COVID-19 is ongoing, both in controlled clinical trials and also in an uncontrolled fashion on a compassionate basis."]}
{"doc_id": 41007, "title": "", "abstract": ["Experimental immunomodulatory treatment of COVID-19 is ongoing, both in controlled clinical trials and also in an uncontrolled fashion on a compassionate basis.", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "COVID-19: a case for inhibiting IL-17?", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6."]}
{"doc_id": 41008, "title": "", "abstract": ["Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6.", "Increased IL-17 levels in mice with LPS-induced ALI correlate with increased lung injury scores, greater protein-rich inflammatory lung infiltration and decreased overall survival.", "For MERS-CoV, SARS-CoV and SARS-CoV-2, the severity of disease was shown to positively correlate with levels of IL-17 and other T helper 17 (TH17) cell-related pro-inflammatory cytokines, such as IL-1, IL-6, IL-15, TNF and IFNγ1,6."]}
{"doc_id": 41009, "title": "", "abstract": ["COVID-19: a case for inhibiting IL-17?", "Experimental immunomodulatory treatment of COVID-19 is ongoing, both in controlled clinical trials and also in an uncontrolled fashion on a compassionate basis.", "Therefore, using these drugs in the acute setting of COVID-19 should not carry an increased risk of secondary infections.", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6)."]}
{"doc_id": 41010, "title": "", "abstract": ["In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6.", "Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered."]}
{"doc_id": 41011, "title": "", "abstract": ["These two factors appear to influence whether the prevailing effect of its expression is protective or whether it leads to a detrimental hyper- inflammatory state.", "Demonstrating the protective effects, mice lacking functional IL-17 receptor (Il17ra−/−) signalling were shown to be more susceptible than wild-type mice to secondary pneumonia caused by Staphylococcus aureus following infection with influenza A4.", "Its predominant role seems to be dependent on where the cytokine is expressed (gut, lung or skin) and what the precipitating trigger is.", "Dysregulation of TH17 cells and production of IL-17 in the skin, synovial space and endothelium promote the production of downstream pro-inflammatory molecules such as IL-1β, TNF and IL-6 and neutrophil chemoattractants such as IL-8, CCL20 and CCL2.", "In consideration of this, a recent correspondence in The Lancet suggests that all patients with COVID-19 should be screened for hyper- inflammation in order to identify those who would benefit from targeted immunosuppression or immunomodulation to prevent acute lung injury (ALI)3."]}
{"doc_id": 41012, "title": "", "abstract": ["This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "COVID-19: a case for inhibiting IL-17?", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6."]}
{"doc_id": 41013, "title": "", "abstract": ["For MERS-CoV, SARS-CoV and SARS-CoV-2, the severity of disease was shown to positively correlate with levels of IL-17 and other T helper 17 (TH17) cell-related pro-inflammatory cytokines, such as IL-1, IL-6, IL-15, TNF and IFNγ1,6.", "Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "In a small sample of patients with COVID-19, the elevation of IL-17 in addition to 14 other distinct cytokines was positively correlated with an increased Murray score for lung injury.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6).", "Increased IL-17 levels in mice with LPS-induced ALI correlate with increased lung injury scores, greater protein-rich inflammatory lung infiltration and decreased overall survival."]}
{"doc_id": 41014, "title": "", "abstract": ["This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "COVID-19: a case for inhibiting IL-17?", "It should be noted that COVID-19 mortality is also associated with myocarditis in the setting of ARDS.", "Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung."]}
{"doc_id": 8000, "title": "", "abstract": ["The SVF from inguinal fat depots of 8–12 week old BALB/C mice were prepared and differentiated for 6 days as described in 20.", "Primary mouse stromal-vascular fractions from adipose tissues were differentiated as described6.", "a, SVF from the inguinal fat depot was differentiated into adipocytes for 6 days in the presence of saline, recombinant Fndc5 (20 nM), or BMP-7 (3.3 μM).", "d, SVF from the inguinal fat depot, differentiated into adipocytes for 6 days in the presence of saline or recombinant Fndc5 (20 nM), IL-15 (10μM) or VEGFβ (50μM).", "c, Clark electrode measurements of oxygen consumption in SVF from the inguinal fat depot, differentiated into adipocytes for 6 days in the presence of saline or recombinant Fndc5 (20 nM)."]}
{"doc_id": 8001, "title": "", "abstract": ["QPCR against brown fat and thermogenic genes in epididymal fat, classical brown fat (BAT) (a) and subcutaneous, inguinal (b) fat depots in MCK-PGC1α transgenics or littermate controls.", "Since it is the subcutaneous white adipose depot that has the greatest tendency to turn on a thermogenic gene program and alter the systemic energy balance of mice6, we re-investigated this with regard to browning of the white adipose tissues in two types of exercise.", "We therefore analyzed the adipose tissue of the PGC1α transgenic mice for expression of genes related to a thermogenic gene program and genes characteristic of brown fat development.", "A key question is how Fndc5 is able to stimulate a thermogenic gene program.", "Muscle secretion of a hormone that activates adipose thermogenesis during this process might provide a broader, more robust defense against hypothermia."]}
{"doc_id": 8002, "title": "", "abstract": ["Irisin is induced with exercise in mice and humans, and mildly increased irisin levels in blood cause an increase in energy expenditure in mice with no changes in movement or food intake.", "Irisin is induced in exercise and activates profound changes in the subcutaneous adipose tissue, stimulating browning and UCP1 expression.", "PGC1α is induced in muscle by exercise and stimulates many of the best known beneficial effects of exercise in muscle: mitochondrial biogenesis, angiogenesis and fiber-type switching2.", "Exercise benefits a variety of organ systems in mammals, and some of the best- recognized effects of exercise on muscle are mediated by the transcriptional coactivator PGC1α Here we show that PGC1α expression in muscle stimulates an increase in expression of Fndc5, a membrane protein that is cleaved and secreted as a new hormone, irisin.", "We examined blood levels of irisin after exercise in mice and human subjects."]}
{"doc_id": 8003, "title": "", "abstract": ["Thus, moderate increases in circulating irisin can induce browning of white adipose tissues in vivo, including increased expression of UCP1.", "Irisin is induced in exercise and activates profound changes in the subcutaneous adipose tissue, stimulating browning and UCP1 expression.", "Thus, muscle- specific expression of PGC1α drives browning of subcutaneous white adipose tissue, possibly recapitulating part of the exercise program.", "The effect on browning of the adipose tissues from PGC1α-expressing muscle could be due to either direct muscle-fat signaling or to another, indirect mechanism.", "Irisin acts on white adipose cells in culture and in vivo to stimulate UCP1 expression and a broad program of brown fat-like development."]}
{"doc_id": 8004, "title": "", "abstract": ["This suggests that irisin accounts for a significant fraction of this activity secreted by muscle cells with forced PGC1α expression.", "IL-15 has previously been reported as being secreted from muscle under the influence of exercise8, while the regulation of Fndc5, VEGFβ, Lrg1 and TIMP4 by exercise has not been described.", "It is important to note that the evidence provided here does not exclude a role for other tissues besides muscle in the biological regulation and secretion of irisin.", "Since this distinct, secreted polypeptide has not been previously described and signals from muscle to other tissues (see above and below), we named it irisin, after Iris, the Greek messenger goddess.", "This paper describes a new polypeptide hormone, irisin, which is regulated by PGC1α, secreted from muscle into blood and activates thermogenic function in adipose tissues."]}
{"doc_id": 8005, "title": "", "abstract": ["This strongly suggests that PGC1α might stimulate the secretion of factors from skeletal muscle that affects the function of other tissues.", "The expression of this same set of genes was also examined in muscle biopsies from human subjects before and after a controlled period of endurance exercise7 (Fig. 2c).", "These effects of irisin on mitochondrial gene expression in the fat were not seen in skeletal muscle in vivo or in cultured myocytes (Supplementary Fig. S10).", "This suggests that irisin accounts for a significant fraction of this activity secreted by muscle cells with forced PGC1α expression.", "a, qPCR against indicated genes in skeletal muscle from MCK-PGC1α transgenic mice or littermate controls (n=7 from each group)."]}
{"doc_id": 8006, "title": "", "abstract": ["We also utilized immunohistochemistry to study cells treated with Fndc5 and observed a robust increase in UCP1-positive adipocytes with multilocular lipid droplets (Supplementary Fig. S4).", "Plasma levels of irisin were increased 3–4 fold (Fig. 5a).", "The expression of irisin increased UCP1 gene expression to the same degree as in lean mice (Supplementary fig 9).", "Importantly, the Fndc5-mediated increase in UCP1 was significantly reduced when cells were simultaneously subjected to the selective PPARα antagonist GW6471 (Fig. 3f).", "The Fndc5 gene encodes a type I membrane protein that is processed proteolytically to form a new hormone secreted into blood, termed irisin."]}
{"doc_id": 8007, "title": "", "abstract": ["One potentially important transcription factor induced by Fndc5, identified using gene expression arrays, was PPARα This nuclear receptor has been shown to drive UCP1 expression and several other genes involved in browning of adipose cells10.", "PGC1α (PPARγ coactivator-1 α) is a transcriptional coactivator that mediates many biological programs related to energy metabolism.", "Identification of candidate secreted proteins controlled by PGC1α", "Originally described as a coactivator of PPARγ that modulated expression of uncoupling protein 1 (UCP1) and thermogenesis in brown fat1, it has also been shown to control mitochondrial biogenesis and oxidative metabolism in many cell types.", "Together, these data suggest that Fndc5 acts to induce UCP1 gene expression, at least in part, via PPARα."]}
{"doc_id": 8008, "title": "", "abstract": ["Exogenously administered irisin induces the browning of subcutaneous fat and thermogenesis, and it presumably could be prepared and delivered as an injectable polypeptide.", "Irisin is induced in exercise and activates profound changes in the subcutaneous adipose tissue, stimulating browning and UCP1 expression.", "Thus, moderate increases in circulating irisin can induce browning of white adipose tissues in vivo, including increased expression of UCP1.", "Figure 6 Irisin induces browning of white adipose tissues in vivo and protects against diet induced obesity and diabetes", "The changes in gene expression in the subcutaneous adipose tissues were accompanied by a clear increase in the number of UCP1 positive, multilocular adipocytes (Fig. 6c)."]}
{"doc_id": 8009, "title": "", "abstract": ["These data illustrate that even moderately increased levels of circulating irisin potently increases energy expenditure, reduces body weight and improves diet-induced insulin resistance.", "These effects of irisin on mitochondrial gene expression in the fat were not seen in skeletal muscle in vivo or in cultured myocytes (Supplementary Fig. S10).", "Irisin is induced with exercise in mice and humans, and mildly increased irisin levels in blood cause an increase in energy expenditure in mice with no changes in movement or food intake.", "Indeed, we have observed that the signal peptide is removed, and the mature protein is further proteolytically cleaved and glycosylated, to release the 112 aa polypeptide irisin.", "The ability of the anti-Fndc5 antibodies to react with irisin allowed us to investigate the contribution made by irisin to the browning activity secreted by muscle cells expressing PGC1α."]}
{"doc_id": 6000, "title": "", "abstract": ["One possible explanation is that SAMHD1-mediated restriction may require a myeloid cell-specific molecule.", "Alternatively, cell type specific differences in early post-entry events involved in viral core uncoating and/or reverse transcription complex function may make HIV/SIV prone to SAMHD1 specifically in myeloid cells25,26.", "Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4DCAF1 E3 complex.", "FLAG-SAMHD1 was transiently co- expressed with myc-tagged SIVmac Vpx, VpxQ76A, or HIV-1 Vpr, in HEK293T cells.", "SAMHD1 was co-expressed with wild type SIVmac Vpx, a VpxQ76A variant that does not bind DCAF1, or HIV-1 Vpr that does not bind SAMHD1, in HEK 293T cells."]}
{"doc_id": 6001, "title": "", "abstract": ["Then we set out to investigate the role of SAMHD1 in HIV-1 infection in MDM.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4DCAF1 in MDM."]}
{"doc_id": 6002, "title": "", "abstract": ["In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome- dependent degradation of the protein.", "Figure 4 SAMHD1 inhibits HIV-1 infection in macrophages"]}
{"doc_id": 6003, "title": "", "abstract": ["The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4DCAF1 E3 ubiquitin ligase (Supplementary Figure 5).", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs.", "In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism5,6."]}
{"doc_id": 6004, "title": "", "abstract": ["We conclude that Vpx specifically binds to, and recruits SAMHD1 to the DCAF1-DDB1 module of CRL4DCAF1 E3 ubiquitin ligase.", "Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4DCAF1 E3 complex.", "We conclude that Vpx programs SAMHD1 for destruction in MDM.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "Our above biochemical and functional studies with VpxQ76A variants suggested that Vpx uses the CRL4DCAF1 E3 ubiquitin ligase to program SAMHD1 degradation."]}
{"doc_id": 6005, "title": "", "abstract": ["The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4DCAF1 E3 ubiquitin ligase (Supplementary Figure 5).", "Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs.", "Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome- dependent degradation of the protein.", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Figure 3 Vpx programs SAMHD1 for proteasomal degradation in MDM, via CRL4DCAF1 E3"]}
{"doc_id": 6006, "title": "", "abstract": ["Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4DCAF1 in MDM.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4DCAF1 E3 ubiquitin ligase (Supplementary Figure 5).", "This evidence supports the model in which Vpx relieves the inhibition of HIV-1 infection in MDM by targeting an unknown anti-viral inhibitory protein for proteasome-dependent degradation, via the CRL4DCAF1 E3 ubiquitin ligase.", "Figure 3 Vpx programs SAMHD1 for proteasomal degradation in MDM, via CRL4DCAF1 E3"]}
{"doc_id": 6007, "title": "", "abstract": ["Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4DCAF1 in MDM.", "Human epitope-tagged SAMHD1 was co-expressed with Vpx, or Vpr, in HEK 293T cells and Vpx/Vpr immune complexes were analyzed by Western blotting.", "The most abundant of the candidate proteins uncovered in this screen was the innate immune SAM-domain HD-domain containing protein 1 (SAMHD1), which co- purified with both Vpx (6 spectra) and Vpx-CRL4DCAF1 complex (37 spectra), but not with CRL4DCAF1 complex alone (Supplementary Table I).", "The indicated FLAG-tagged Vpx and Vpr proteins were transiently co-expressed with myc-tagged SAMHD1 in HEK 293T cells.", "FLAG-SAMHD1 was transiently co- expressed with myc-tagged SIVmac Vpx, VpxQ76A, or HIV-1 Vpr, in HEK293T cells."]}
{"doc_id": 6008, "title": "", "abstract": ["One possible explanation is that SAMHD1-mediated restriction may require a myeloid cell-specific molecule.", "SAMHD1 is expressed in HEK 293T cells, undifferentiated THP-1 cells and other non-myeloid cell types that do not possess a Vpx-sensitive mechanism restricting primate lentivirus infection (Supplementary Figures 6 and 7).", "Alternatively, cell type specific differences in early post-entry events involved in viral core uncoating and/or reverse transcription complex function may make HIV/SIV prone to SAMHD1 specifically in myeloid cells25,26.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "One unanswered question is how myeloid cell specificity of SAMHD1-mediated inhibition of HIV-1 infection is achieved?"]}
{"doc_id": 6009, "title": "", "abstract": ["In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.", "Then we set out to investigate the role of SAMHD1 in HIV-1 infection in MDM."]}
{"doc_id": 6010, "title": "", "abstract": ["Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome- dependent degradation of the protein.", "This evidence supports the model in which Vpx relieves the inhibition of HIV-1 infection in MDM by targeting an unknown anti-viral inhibitory protein for proteasome-dependent degradation, via the CRL4DCAF1 E3 ubiquitin ligase.", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "To assess whether Vpx-mediated relief of the inhibition of HIV-1 infection in macrophages is also linked to CRL4DCAF1, we co-infected human MDM with VSV-G-pseudotyped HIV-1 NL4-3-derived single cycle reporter virus encoding the GFP reporter (HIV-1–GFP) in the presence of VSV-G-pseudotyped SIV VLP loaded with HIV-2 Rod Vpx (SIV VLP(Vpx)) or with a Vpx variant (VpxQ76A), that does not bind to DCAF112.", "The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4DCAF1 E3 ubiquitin ligase (Supplementary Figure 5)."]}
{"doc_id": 6011, "title": "", "abstract": ["We conclude that Vpx specifically binds to, and recruits SAMHD1 to the DCAF1-DDB1 module of CRL4DCAF1 E3 ubiquitin ligase.", "Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4DCAF1 E3 complex.", "Our above biochemical and functional studies with VpxQ76A variants suggested that Vpx uses the CRL4DCAF1 E3 ubiquitin ligase to program SAMHD1 degradation.", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4DCAF1 in MDM."]}
{"doc_id": 6012, "title": "", "abstract": ["SAMHD1 is expressed in HEK 293T cells, undifferentiated THP-1 cells and other non-myeloid cell types that do not possess a Vpx-sensitive mechanism restricting primate lentivirus infection (Supplementary Figures 6 and 7).", "Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4DCAF1 in MDM.", "SAMHD1 was co-expressed with wild type SIVmac Vpx, a VpxQ76A variant that does not bind DCAF1, or HIV-1 Vpr that does not bind SAMHD1, in HEK 293T cells.", "FLAG-SAMHD1 was transiently co- expressed with myc-tagged SIVmac Vpx, VpxQ76A, or HIV-1 Vpr, in HEK293T cells.", "Human epitope-tagged SAMHD1 was co-expressed with Vpx, or Vpr, in HEK 293T cells and Vpx/Vpr immune complexes were analyzed by Western blotting."]}
{"doc_id": 6013, "title": "", "abstract": ["Alternatively, cell type specific differences in early post-entry events involved in viral core uncoating and/or reverse transcription complex function may make HIV/SIV prone to SAMHD1 specifically in myeloid cells25,26.", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "One possible explanation is that SAMHD1-mediated restriction may require a myeloid cell-specific molecule."]}
{"doc_id": 6014, "title": "", "abstract": ["Recent studies of TREX1 suggest that it plays a role in the control of retrotransposon and endogenous retroviral elements, and in inhibiting the innate immune response to HIV-1 DNA in T cells and macrophages by clearing excess of viral cDNA9,24.", "The most abundant of the candidate proteins uncovered in this screen was the innate immune SAM-domain HD-domain containing protein 1 (SAMHD1), which co- purified with both Vpx (6 spectra) and Vpx-CRL4DCAF1 complex (37 spectra), but not with CRL4DCAF1 complex alone (Supplementary Table I).", "The SAMHD1-targeting pool comprised the siRNAs to the following target sequences: J-013950-09: GACAAUGAGUUGCGUAUUU; J-013950-10: CAUGUUUGAUGGACGAAUUU; J-013950-11: AAGUAUUGCUAGACGUGAA and J-013950-12: UUAGUUAUAUCCAGCGAUU.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "siRNA pools targeting SAMHD1 (L-013950-01), DCAF1 (L-021119-01) and control non-targeting siRNA pools “NT1” (D-001206-14-05) and “NT2” (D-001810-10), were purchased from Dharmacon."]}
{"doc_id": 6015, "title": "", "abstract": ["In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis.", "Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "Figure 4 SAMHD1 inhibits HIV-1 infection in macrophages"]}
{"doc_id": 6016, "title": "", "abstract": ["The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4DCAF1 E3 ubiquitin ligase (Supplementary Figure 5).", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs.", "In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism5,6.", "SAMHD1 co-precipitated efficiently with both Vpx variants, but not with Vpr (Figure 2b)."]}
{"doc_id": 6017, "title": "", "abstract": ["By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4DCAF1 E3 complex.", "Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs.", "Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome- dependent degradation of the protein.", "We conclude that Vpx programs SAMHD1 for destruction in MDM."]}
{"doc_id": 6018, "title": "", "abstract": ["One unanswered question is how myeloid cell specificity of SAMHD1-mediated inhibition of HIV-1 infection is achieved?", "Figure 4 SAMHD1 inhibits HIV-1 infection in macrophages", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis.", "One possible explanation is that SAMHD1-mediated restriction may require a myeloid cell-specific molecule."]}
{"doc_id": 6019, "title": "", "abstract": ["Our above biochemical and functional studies with VpxQ76A variants suggested that Vpx uses the CRL4DCAF1 E3 ubiquitin ligase to program SAMHD1 degradation.", "Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte- derived dendritic cells in a Vpx glutamine Q76 dependent manner (data not shown) implicating SAMHD1 as the key AGS protein inhibiting lentivirus infection in myeloid cells.", "Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4DCAF1 E3 complex.", "We conclude that Vpx specifically binds to, and recruits SAMHD1 to the DCAF1-DDB1 module of CRL4DCAF1 E3 ubiquitin ligase.", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation."]}
{"doc_id": 38000, "title": "", "abstract": ["Participants generally had good knowledge of the main mode of disease transmission and common symptoms of COVID-19.", "When asked what percent of individuals infected with COVID-19 experience a fatal disease course, the median estimate given by participants was 5.0% (IQR 2.0%-15.0%) among US participants and 3.0% (IQR 2.0%-10.0%) among UK participants.", "Lastly, it is important to note that while the general public appeared to be well informed about the common symptoms of COVID-19, over one-fourth of the participants selected a health care–seeking option that could lead to further transmission of SARS-CoV-2.", "Most participants in both the United States and the United Kingdom recognized fever, cough, and shortness of breath as three common symptoms and signs of COVID-19 (Figure 4).", "Thus, clear messaging on the recommended care-seeking action when experiencing some of the core symptoms of COVID-19 will be crucial."]}
{"doc_id": 38001, "title": "", "abstract": ["This study aimed to apply rapid online surveying to determine knowledge and perceptions of coronavirus disease 2019 (COVID-19) among the general public in the United States and the United Kingdom.", "This study tests a rapid online survey methodology to determine knowledge and misperceptions of COVID-19 among the general adult population in both the United States and the United Kingdom.", "It was possible to conduct an in-depth online assessment of knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom in a short time frame.", "Regarding the survey findings, the general public in both the United States and the United Kingdom held several important misconceptions about COVID-19.", "When asked “when they have been infected, what age groups are most likely to die from the illness caused by the new coronavirus” and presented with the option to select “children,” “young adults,” or “older adults” (selecting more than option was possible), 96.3% (95% CI 95.6%-96.9%) of participants in the United States and 98.3% (95% CI 97.7%-98.7%) of participants in the United Kingdom selected “older adults.”"]}
{"doc_id": 38002, "title": "", "abstract": ["This study’s findings on the levels of knowledge and prevalence of misconceptions regarding COVID-19 could inform relevant information campaigns by public health authorities and the media as well as communication of health care workers with patients.", "In order to investigate to what degree dis- and misinformation about COVID-19 has affected the general public’s beliefs about the condition, participants were directly asked whether they believed several falsehoods listed on the WHO’s “myth busters” website [12], which the WHO selected because these myths were circulating on social media [13].", "This study aimed to apply rapid online surveying to determine knowledge and perceptions of coronavirus disease 2019 (COVID-19) among the general public in the United States and the United Kingdom.", "These characteristics may be both correlated with their knowledge and perceptions of COVID-19 as well as with their decision to participate in the study or to create a profile with Prolific.", "This study tests a rapid online survey methodology to determine knowledge and misperceptions of COVID-19 among the general adult population in both the United States and the United Kingdom."]}
{"doc_id": 38003, "title": "", "abstract": ["Given these limitations, rapid online surveys, which demand minimal human resources (beyond those needed to design the questionnaire) and could reach large numbers of respondents in a short time frame, may be a valuable tool to assess (and monitor over time) knowledge and perceptions of an infectious disease in the midst of an outbreak.", "Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate of phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks.", "More broadly, rapid online surveys could be an important tool in tracking the public’s knowledge and misperceptions during rapidly moving infectious disease outbreaks.", "Rapid online surveys are a promising method to assess and track knowledge and perceptions in the midst of rapidly evolving infectious disease outbreaks.", "The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media."]}
{"doc_id": 38004, "title": "", "abstract": ["For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "These characteristics may be both correlated with their knowledge and perceptions of COVID-19 as well as with their decision to participate in the study or to create a profile with Prolific.", "In order to investigate to what degree dis- and misinformation about COVID-19 has affected the general public’s beliefs about the condition, participants were directly asked whether they believed several falsehoods listed on the WHO’s “myth busters” website [12], which the WHO selected because these myths were circulating on social media [13].", "This study’s findings on the levels of knowledge and prevalence of misconceptions regarding COVID-19 could inform relevant information campaigns by public health authorities and the media as well as communication of health care workers with patients.", "When asked what percent of individuals infected with COVID-19 experience a fatal disease course, the median estimate given by participants was 5.0% (IQR 2.0%-15.0%) among US participants and 3.0% (IQR 2.0%-10.0%) among UK participants."]}
{"doc_id": 38005, "title": "", "abstract": ["This study has several limitations.", "Distribution of the responses to questions on COVID-19 prevalence among individuals of East-Asian ethnicity.", "For instance, such information provision may highlight the comparatively low case fatality rate, the low risk posed by individuals of East-Asian ethnicity living in the United States and the United Kingdom, and that children do not appear to be at a heightened risk of dying from COVID-19.", "Participants also likely overestimated the prevalence of COVID-19 among East-Asian individuals in their communities.", "An online questionnaire was administered to 3000 adults residing in the United States and 3000 adults residing in the United Kingdom who had registered with Prolific Academic to participate in online research."]}
{"doc_id": 38006, "title": "", "abstract": ["Given these limitations, rapid online surveys, which demand minimal human resources (beyond those needed to design the questionnaire) and could reach large numbers of respondents in a short time frame, may be a valuable tool to assess (and monitor over time) knowledge and perceptions of an infectious disease in the midst of an outbreak.", "More broadly, rapid online surveys could be an important tool in tracking the public’s knowledge and misperceptions during rapidly moving infectious disease outbreaks.", "Rapid online surveys are a promising method to assess and track knowledge and perceptions in the midst of rapidly evolving infectious disease outbreaks.", "The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media.", "Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate of phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks."]}
{"doc_id": 38007, "title": "", "abstract": ["Likely as a result of this perception, a substantial proportion thought that they should refrain from frequenting Chinese restaurants, stated that they would refuse Uber rides to individuals of East-Asian ethnicity, and thought that receiving a package from China poses a risk of a SARS-CoV-2 infection.", "It was possible to conduct an in-depth online assessment of knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom in a short time frame.", "The study was implemented in two rounds of 1500 participants each in the United States and the United Kingdom, such that the total target sample size in each country was 3000.", "Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19", "#### Perceptions of the Risk Posed by Community Members of East-Asian Ethnicity"]}
{"doc_id": 38008, "title": "", "abstract": ["However, a substantial proportion of participants also thought that using a hand dryer, rinsing your nose with saline, taking antibiotics, and gargling with mouthwash were effective prevention measures: 43.5% (95% CI 41.7%-45.2%) and 36.0% (95% CI 34.3%-37.8%) of US and UK participants, respectively, selected at least one of these options.", "For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "Furthermore, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants agreed with the following statement: “Consistently wearing a face mask is highly effective in protecting you from getting infected with the new coronavirus.", "A total of 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants responded with “yes” to the question, “Do you think it would be prudent for you to not eat at Chinese restaurants for the next few weeks to reduce the risk of getting infected with the new coronavirus?” Approximately a quarter of participants (29.0%, 95% CI 27.4%- 30.7% of US participants and 24.4%, 95% CI 22.9%-26.0% of UK participants) thought one may become infected with SARS-CoV-2 by receiving a package from China.", "Furthermore, 17.3% (516/2986) of US participants and 13.7% (409/2988) of UK participants were currently students."]}
{"doc_id": 38009, "title": "", "abstract": ["Phone surveys are faster to conduct but have increasingly suffered from low response rates (typically well below 10% [2]), which can be a major source of bias even when extensive weighting adjustments are made [3].", "Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate of phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks.", "In addition, unless they use interactive voice response (which tends to further decrease the response rate [4]), phone surveys require substantial human resources to conduct the interviews.", "In my view, this issue is unlikely to have caused major bias in this study because (1) there was no evidence of a bimodal distribution in the time taken to complete the survey (Multimedia Appendix 1); (2) while it was physically possible to complete the survey in under 90 seconds when randomly clicking on responses, only 2 participants completed the survey in under 2 minutes; and (3) the monetary reward (US $1.50) was relatively small, and thus, for most participants, unlikely to be the main motivation for participating in the study.", "Population- representative household surveys generally take many months of preparation and data collection [1]."]}
{"doc_id": 38010, "title": "", "abstract": ["In my view, this issue is unlikely to have caused major bias in this study because (1) there was no evidence of a bimodal distribution in the time taken to complete the survey (Multimedia Appendix 1); (2) while it was physically possible to complete the survey in under 90 seconds when randomly clicking on responses, only 2 participants completed the survey in under 2 minutes; and (3) the monetary reward (US $1.50) was relatively small, and thus, for most participants, unlikely to be the main motivation for participating in the study.", "It was possible to conduct an in-depth online assessment of knowledge and perceptions of COVID-19 among the general public in the United States and the United Kingdom in a short time frame.", "Figure 1 shows that each of the two rounds of the survey took 2-3 days to conduct.", "It took 2-3 days to obtain a completed questionnaire of 22 knowledge and perception questions from 1500 adults in each the United States and the United Kingdom, when allowing enrollment only in relatively granular strata by age, sex, and ethnicity (and each of these variables’ combinations).", "First, participants who took less than 2 minutes to complete the questionnaire were excluded from the analysis because this indicated random clicking."]}
{"doc_id": 38011, "title": "", "abstract": ["When faced with rapidly moving infectious disease outbreaks, such as the coronavirus disease 2019 (COVID-19), assessing knowledge and perceptions of relevant populations has to be accomplished in a short time frame if the findings are to be informative to the public health response.", "Regarding the survey findings, the general public in both the United States and the United Kingdom held several important misconceptions about COVID-19.", "In order to investigate to what degree dis- and misinformation about COVID-19 has affected the general public’s beliefs about the condition, participants were directly asked whether they believed several falsehoods listed on the WHO’s “myth busters” website [12], which the WHO selected because these myths were circulating on social media [13].", "This study tests a rapid online survey methodology to determine knowledge and misperceptions of COVID-19 among the general adult population in both the United States and the United Kingdom.", "Moving forward, information campaigns on COVID-19 may need to balance the messaging of two important facts about the COVID-19 epidemic that could be interpreted by the general public to stand in direct conflict with each other: (1) The case fatality rate of COVID-19 appears to be lower than that of other recent infectious disease outbreaks such as Ebola infection [22], SARS [23], and the Middle East respiratory syndrome (MERS) [23,24]."]}
{"doc_id": 38012, "title": "", "abstract": ["Participants also likely overestimated the prevalence of COVID-19 among East-Asian individuals in their communities.", "Participants in both countries likely overestimated the probability of a fatal disease course among those infected with SARS-CoV-2 (while plagued by uncertainty, the case fatality rate is currently believed to lie below 1% [17]), thought that children were at an especially high risk of death from COVID-19 (which is currently not believed to be the case [5,17-19]), and believed that common surgical masks are highly effective in protecting them from SARS-CoV-2 infection.", "The median increased to 1.0% (IQR 0.0%-5.0%) among both US and UK participants when asking about the prevalence of COVID-19 among “adults of East-Asian ethnicity in your neighborhood who wear a face mask.”", "For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "Following an informed consent form, the questionnaire asked participants about the cause, current state, and future development of the COVID-19 epidemic; the risk of a fatal disease course; knowledge of symptoms and recommended health care–seeking behavior; measures to prevent an infection with SARS-CoV-2; and their perception of the risk posed by individuals of East-Asian ethnicity in their community."]}
{"doc_id": 38013, "title": "", "abstract": ["However, a substantial proportion of participants also thought that using a hand dryer, rinsing your nose with saline, taking antibiotics, and gargling with mouthwash were effective prevention measures: 43.5% (95% CI 41.7%-45.2%) and 36.0% (95% CI 34.3%-37.8%) of US and UK participants, respectively, selected at least one of these options.", "A total of 92.6% (95% CI 91.6%-93.4%) of US participants and 86.0% (95% CI 84.7%-87.2%) of UK participants selected each of the following three responses as effective measures for preventing infection with SARS-CoV-2: washing your hands; avoiding close contact with people who are sick; and avoiding touching your eyes, nose, and mouth with unwashed hands (Figure 6).", "However, 53.8% (95% CI 52.1%-55.6%) in the United States and 39.1% (95% CI 37.4%-40.9%) in the United Kingdom also thought that children were at a high risk of death when infected.", "Almost all participants in both countries (96.3%, 95% CI 95.6%-97.0% in the United States and 97.5%, 95% CI 96.9%-98.0% in the United Kingdom) responded that adults with other health problems were more likely to experience a fatal disease course than those without any other health problems.", "Around half (53.8%, 95% CI 52.1%-55.6%) of US participants and 39.1% (95% CI 37.4%-40.9%) of UK participants thought that children were at an especially high risk of death when infected with SARS-CoV-2."]}
{"doc_id": 27000, "title": "", "abstract": ["Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "To examine how repeated population screening would reduce the average infectiousness of individuals, we first modeled the viral loads and infectiousness curves of 10,000 simulated individuals using the predicted viral trajectories of SARS-CoV-2 infections based on key features of latency, growth, peak, and decline identified in the literature (Fig. 1A; see Materials and Methods).", "Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A).", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "Two models were used to simulate SARS-CoV-2 dynamics, both based on a typical compartmental framework."]}
{"doc_id": 27001, "title": "", "abstract": ["Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A).", "New developments in SARS-CoV-2 diagnostics have the potential to reduce cost substantially, allowing for expanded testing or greater frequency of testing and can reduce turnaround time to minutes (7–9).", "Successful population screening testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) depends on understanding both the dynamics of spread between individuals and the dynamics of the virus within the human body.", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "These tests should not be held to the same degree of sensitivity as clinical tests, particularly if doing so encumbers rapid deployment of faster cheaper SARS-CoV-2 assays."]}
{"doc_id": 27002, "title": "", "abstract": ["Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "Testing frequency was found to be the primary driver of population- level epidemic control, with only a small margin of improvement provided by using a more sensitive test.", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "On the basis of results from our previous analyses, we considered a less sensitive but rapid test with LOD 105 cp/ml and a 0-day delay in results and further assumed that 10% of would- be positive samples would be negative because of improper sample collection."]}
{"doc_id": 27003, "title": "", "abstract": ["These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "Testing frequency was found to be the primary driver of population- level epidemic control, with only a small margin of improvement provided by using a more sensitive test.", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time.", "Effectiveness of screening is compromised by delays in reporting."]}
{"doc_id": 27004, "title": "", "abstract": ["Critically, the ability of SARS-CoV-2 to spread from individuals who are presymptomatic, symptomatic, or essentially asymptomatic (1–3) means that diagnosis and isolation based on symptoms alone will be unable to prevent ongoing spread (4, 5).", "We considered that 35% of patients would undergo symptomatic isolation within 3 days of their peak viral load if they had not been tested and isolated first, and 65% would have sufficiently mild or no symptoms such that they would not isolate unless they were detected by testing.", "To further address whether our results depended on the exact 35% fraction of individuals assumed to be behaviorally symptomatic, we performed sensitivity analyses with fewer (20%) or more (50%) symptomatic individuals and found no meaningful difference in results (fig. S4).", "Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central.", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2."]}
{"doc_id": 27005, "title": "", "abstract": ["We suggest that the U.S. Food and Drug Administration, other agencies, or state governments encourage the development and use of alternative faster and lower- cost tests for public health and repeated population screening purposes, even if they have poorer LODs.", "Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "On the basis of results from our previous analyses, we considered a less sensitive but rapid test with LOD 105 cp/ml and a 0-day delay in results and further assumed that 10% of would- be positive samples would be negative because of improper sample collection.", "These tests should not be held to the same degree of sensitivity as clinical tests, particularly if doing so encumbers rapid deployment of faster cheaper SARS-CoV-2 assays.", "Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A)."]}
{"doc_id": 27006, "title": "", "abstract": ["These results highlight that delays in reporting lead to markedly less effective control of viral spread and emphasize that fast reporting of results is critical in any screening regimen.", "(C and D) Relative to no testing (gray bars), repeated population screening suppresses the total number of infections in both models when testing every day or every 3 days, but delayed results lead to only partial mitigation of total cases, even for testing every day or 3 days.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions.", "Marked reductions in total infectiousness of the individuals were observed by testing daily or every third day, 62 to 66% reduction when testing weekly, and 45 to 47% under biweekly testing (Fig. 1C).", "(A and B) The impact of testing every day, 3 days, weekly, or biweekly on the reproductive number R, calculated as 100 × (R0 − R)/R0, is shown for LODs 103 and 105 and delays of 0, 1, or 2 days (small text below the axis)."]}
{"doc_id": 27007, "title": "", "abstract": ["Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "Marked reductions in total infectiousness of the individuals were observed by testing daily or every third day, 62 to 66% reduction when testing weekly, and 45 to 47% under biweekly testing (Fig. 1C).", "Our findings show that the impact of repeated population screening can be expressed as a reduction of the reproductive number R. By mapping a given testing regimen to a reduction in R, the impact of testing regimen can be approximated and generalized without complicated simulations.", "We found that testing 75% of individuals every 3 days was sufficient to drive the epidemic toward extinction within 6 weeks and reduce cumulative incidence by 88% and that other combinations also had successful but less rapid mitigating impacts, particularly when compared with no intervention (Fig. 6).", "(A and B) More frequent testing reduces the effective reproductive number R, shown as the percentage by which R0 is reduced, 100 × (R0 − R)/R0."]}
{"doc_id": 27008, "title": "", "abstract": ["We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time.", "If the availability of point-of-care or self- administered screening tests leads to faster turnaround time or more frequent testing, then our results suggest that they would have high epidemiological value.", "An important variable in testing is the time between a test’s sample collection and the reporting of a diagnosis."]}
{"doc_id": 27009, "title": "", "abstract": ["These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "If the availability of point-of-care or self- administered screening tests leads to faster turnaround time or more frequent testing, then our results suggest that they would have high epidemiological value.", "Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "Testing frequency was found to be the primary driver of population- level epidemic control, with only a small margin of improvement provided by using a more sensitive test.", "We suggest that the U.S. Food and Drug Administration, other agencies, or state governments encourage the development and use of alternative faster and lower- cost tests for public health and repeated population screening purposes, even if they have poorer LODs."]}
{"doc_id": 27010, "title": "", "abstract": ["These results highlight that delays in reporting lead to markedly less effective control of viral spread and emphasize that fast reporting of results is critical in any screening regimen.", "(C and D) Relative to no testing (gray bars), repeated population screening suppresses the total number of infections in both models when testing every day or every 3 days, but delayed results lead to only partial mitigation of total cases, even for testing every day or 3 days.", "Marked reductions in total infectiousness of the individuals were observed by testing daily or every third day, 62 to 66% reduction when testing weekly, and 45 to 47% under biweekly testing (Fig. 1C).", "(C and D) Relative to no testing (gray bars), screening suppresses the total number of infections in both models when testing every day or every 3 days but only partially mitigates total cases for weekly or biweekly testing.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions."]}
{"doc_id": 27011, "title": "", "abstract": ["On the basis of results from our previous analyses, we considered a less sensitive but rapid test with LOD 105 cp/ml and a 0-day delay in results and further assumed that 10% of would- be positive samples would be negative because of improper sample collection.", "(C) Population screening programs using tests at LODs of 103 and 105 at frequencies indicated and with results returned after 0, 1, or 2 days (indicated by small text beneath bars) were applied to 10,000 individuals’ trajectories of whom 35% were symptomatic and self-isolated after peak viral load if they had not been tested and isolated first.", "We then examined scenarios of testing every 3 days and every 7 days, with either 50 or 75% of individuals participating, starting from a partially mitigated R0 = 1.5.", "We found that testing 75% of individuals every 3 days was sufficient to drive the epidemic toward extinction within 6 weeks and reduce cumulative incidence by 88% and that other combinations also had successful but less rapid mitigating impacts, particularly when compared with no intervention (Fig. 6).", "Viral load appears to peak before symptom onset (21) and peaks within 2 days of challenge in a macaque model (43, 44), although it should be noted that macaque challenge doses were high."]}
{"doc_id": 27012, "title": "", "abstract": ["At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "Testing frequency was found to be the primary driver of population- level epidemic control, with only a small margin of improvement provided by using a more sensitive test.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions.", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening:"]}
{"doc_id": 27013, "title": "", "abstract": ["Last, high-sensitivity screening tests, when applied during the viral decline accompanying recovery, are unlikely to substantially affect transmission because such individuals detected have low, if any, infectiousness (14).", "Viral load appears to peak before symptom onset (21) and peaks within 2 days of challenge in a macaque model (43, 44), although it should be noted that macaque challenge doses were high.", "Viral loads were drawn from a simple viral kinetics model intended to capture (i) a variable latent period, (ii) a rapid growth phase from the lower limit of PCR detectability to a peak viral load, (iii) a slower decay phase, and (iv) prolonged clearance for symptomatic infections versus asymptomatic infections.", "D.B.L., E.L., S.S., J.M.B., J.A.H., M.J.M., and R.P. developed the viral load model.", "The use of serology, repeat testing 24 or 48 hours apart, or some other test to distinguish low–viral load patients on the upslope of infection from those in the recovery phase could allow for more effective quarantine decisions."]}
{"doc_id": 27014, "title": "", "abstract": ["Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening:", "Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions."]}
{"doc_id": 27015, "title": "", "abstract": ["Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "The reliance on testing as a means to safely reopen societies has placed a microscope on the analytical sensitivity of virus assays, with a gold standard of quantitative real-time polymerase chain reaction (RT-qPCR).", "These assays, however, largely do not meet the gold standard for analytical sensitivity, which has encumbered the widespread use of these assays (10).", "Viral loads appear to become undetectable by PCR within 3 weeks of symptom onset (45, 48, 50), but detectability and timing may differ, depending on the degree or presence of symptoms (50, 51).", "Second, the exact performance differences between testing schemes will depend on whether our model truly captures viral kinetics and infectiousness profiles (21), particularly during the acceleration phase between exposure and peak viral load."]}
{"doc_id": 27016, "title": "", "abstract": ["Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A).", "Successful population screening testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) depends on understanding both the dynamics of spread between individuals and the dynamics of the virus within the human body.", "New developments in SARS-CoV-2 diagnostics have the potential to reduce cost substantially, allowing for expanded testing or greater frequency of testing and can reduce turnaround time to minutes (7–9).", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central."]}
{"doc_id": 27017, "title": "", "abstract": ["Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6)."]}
{"doc_id": 27018, "title": "", "abstract": ["Viral load appears to peak before symptom onset (21) and peaks within 2 days of challenge in a macaque model (43, 44), although it should be noted that macaque challenge doses were high.", "After infection, individuals undergo a period of incubation during which viral titers are too low to detect, followed by exponential viral growth, leading to peak viral load and infectiousness and ending with declining titers and clearance.", "Viral loads were drawn from a simple viral kinetics model intended to capture (i) a variable latent period, (ii) a rapid growth phase from the lower limit of PCR detectability to a peak viral load, (iii) a slower decay phase, and (iv) prolonged clearance for symptomatic infections versus asymptomatic infections.", "Peak viral loads are difficult to measure because of lack of prospective sampling studies of individuals before exposure and infection, but viral loads have been reported in the range of O(104) to O(109) cp/ml (12, 47, 48).", "(A) An example viral load trajectory is shown with LOD thresholds of two tests and a hypothetical positive test on day 6, 2 days after peak viral load."]}
{"doc_id": 27019, "title": "", "abstract": ["As a consequence, the use of population screening testing to identify infectious individuals presents one possible means to break enough transmission chains to suppress the ongoing pandemic and reopen societies, with or without a vaccine.", "For instance, the infrequent use of a sensitive test will identify not only (i) those with a low viral load in the beginning of the infection, who must be isolated to limit viral spread, but also (ii) those in the recovery period, who still have detectable virus or RNA but are below the infectious threshold (13, 14).", "The impact of repeated population screening on transmission dynamics led us to hypothesize that testing could be used as an active tool to mitigate an ongoing epidemic.", "We found that testing 75% of individuals every 3 days was sufficient to drive the epidemic toward extinction within 6 weeks and reduce cumulative incidence by 88% and that other combinations also had successful but less rapid mitigating impacts, particularly when compared with no intervention (Fig. 6).", "Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A)."]}
{"doc_id": 27020, "title": "", "abstract": ["Marked reductions in total infectiousness of the individuals were observed by testing daily or every third day, 62 to 66% reduction when testing weekly, and 45 to 47% under biweekly testing (Fig. 1C).", "Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "Direct examination of simulations showed that with no testing or biweekly testing, infections were uncontrolled, whereas screening weekly with either LOD = 103 or 105 effectively attenuated surges of infections (examples are shown in Fig. 3).", "Simulation trajectories show the number of infected individuals in a population of N = 20,000 with a constant rate of external infection set to 1/N per person per day, i.e., around one imported case per day, and full participation in the testing regimen.", "(C and D) Relative to no testing (gray bars), screening suppresses the total number of infections in both models when testing every day or every 3 days but only partially mitigates total cases for weekly or biweekly testing."]}
{"doc_id": 27021, "title": "", "abstract": ["Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time.", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity.", "Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening:", "For instance, the infrequent use of a sensitive test will identify not only (i) those with a low viral load in the beginning of the infection, who must be isolated to limit viral spread, but also (ii) those in the recovery period, who still have detectable virus or RNA but are below the infectious threshold (13, 14)."]}
{"doc_id": 27022, "title": "", "abstract": ["We considered that 35% of patients would undergo symptomatic isolation within 3 days of their peak viral load if they had not been tested and isolated first, and 65% would have sufficiently mild or no symptoms such that they would not isolate unless they were detected by testing.", "To further address whether our results depended on the exact 35% fraction of individuals assumed to be behaviorally symptomatic, we performed sensitivity analyses with fewer (20%) or more (50%) symptomatic individuals and found no meaningful difference in results (fig. S4).", "Critically, the ability of SARS-CoV-2 to spread from individuals who are presymptomatic, symptomatic, or essentially asymptomatic (1–3) means that diagnosis and isolation based on symptoms alone will be unable to prevent ongoing spread (4, 5).", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central."]}
{"doc_id": 27023, "title": "", "abstract": ["Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A).", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "Successful population screening testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) depends on understanding both the dynamics of spread between individuals and the dynamics of the virus within the human body.", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "These tests should not be held to the same degree of sensitivity as clinical tests, particularly if doing so encumbers rapid deployment of faster cheaper SARS-CoV-2 assays."]}
{"doc_id": 27024, "title": "", "abstract": ["Scenarios show the impact of a test with LOD 105, no delay in results, and with 10% of samples assumed to be incorrectly collected (and therefore negative) to reflect decreased sensitivity incurred at sample collection in a mass testing scenario.", "Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "If the availability of point-of-care or self- administered screening tests leads to faster turnaround time or more frequent testing, then our results suggest that they would have high epidemiological value.", "We found that testing 75% of individuals every 3 days was sufficient to drive the epidemic toward extinction within 6 weeks and reduce cumulative incidence by 88% and that other combinations also had successful but less rapid mitigating impacts, particularly when compared with no intervention (Fig. 6).", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity."]}
{"doc_id": 27025, "title": "", "abstract": ["Thus, the choice of the final control point in our symptomatic viral load model (Fig. 7B), which corresponds to the latest time at which an individual is infectious, is, at most, 9 days after symptom onset.", "This result was robust to the modeled relationship between infectiousness and viral load in both simulation models and for various test sensitivities and frequencies (fig. S5).", "Second, the exact performance differences between testing schemes will depend on whether our model truly captures viral kinetics and infectiousness profiles (21), particularly during the acceleration phase between exposure and peak viral load.", "We note that a comprehensive review of viral loads, shedding, and infectiousness (18) found that, across the surveyed literature, no virus could be cultured beyond 9 days after symptoms.", "A fraction 1−f of individuals self- isolate on the day of symptom onset, which occurs 0 to 3 days after peak viral load, to mimic symptom-driven isolation (I → SQ), with f = 0.65 for both models and with f = 0.8 and f = 0.5 explored in sensitivity analyses (fig. S4)."]}
{"doc_id": 27026, "title": "", "abstract": ["New developments in SARS-CoV-2 diagnostics have the potential to reduce cost substantially, allowing for expanded testing or greater frequency of testing and can reduce turnaround time to minutes (7–9).", "Notably, even weekly testing with 50% participation was able to reduce the peak and length of the outbreak, illustrating how even partial screening using a test with 100× lower molecular sensitivity than PCR can have public health benefits when used frequently (Fig. 6).", "If the availability of point-of-care or self- administered screening tests leads to faster turnaround time or more frequent testing, then our results suggest that they would have high epidemiological value.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions.", "These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity."]}
{"doc_id": 27027, "title": "", "abstract": ["As a consequence, the use of population screening testing to identify infectious individuals presents one possible means to break enough transmission chains to suppress the ongoing pandemic and reopen societies, with or without a vaccine.", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "Testing frequency was found to be the primary driver of population- level epidemic control, with only a small margin of improvement provided by using a more sensitive test.", "The relationship between test sensitivity and the frequency of testing required to control outbreaks in both the fully mixed model and the agent- based model generalize beyond the examples shown in Fig. 2 and are also seen at other testing frequencies, sensitivities, and asymptomatic fractions.", "The impact of repeated population screening on transmission dynamics led us to hypothesize that testing could be used as an active tool to mitigate an ongoing epidemic."]}
{"doc_id": 39000, "title": "", "abstract": ["We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the first reports from Wuhan in China in December, 2019, and the outbreak was characterised as a pandemic by WHO on March 12, 2020.1", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Maintaining HIV care during the COVID-19 pandemic", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic."]}
{"doc_id": 39001, "title": "", "abstract": ["In response to these challenges, WHO, UNAIDS, and the Global Network of People Living With HIV are working together to ensure continued provision of HIV prevention, testing, and treatment services.6, 7, 8", "Community-based organisations have also played an important part in maintaining HIV services.", "Third, the COVID-19 pandemic might also hinder ART continuation.", "People living with HIV can refill antiviral drugs either at the nearest local Center for Disease Control and Prevention or by post, to maintain enrolment in treatment programmes and to continue ART.6", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services."]}
{"doc_id": 39002, "title": "", "abstract": ["We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "People living with HIV who should have initiated antiretroviral therapy (ART) in hospital might be deterred or delayed because hospitals are busy treating patients with COVID-19.", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3"]}
{"doc_id": 39003, "title": "", "abstract": ["Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "People living with HIV who should have initiated antiretroviral therapy (ART) in hospital might be deterred or delayed because hospitals are busy treating patients with COVID-19.", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Third, the COVID-19 pandemic might also hinder ART continuation.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services."]}
{"doc_id": 39004, "title": "", "abstract": ["As COVID-19 continues to spread around the world, many locations are facing the risk of SARS-CoV-2 infection and barriers and challenges for maintaining the HIV care continuum.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Approximately 37·9 million people living with HIV2 are at risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic."]}
{"doc_id": 39005, "title": "", "abstract": ["Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Third, the COVID-19 pandemic might also hinder ART continuation.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services."]}
{"doc_id": 39006, "title": "", "abstract": ["First, implementation of quarantine, social distancing, and community containment measures have reduced access to routine HIV testing, which challenges completion of UNAIDS' first 90-90-90 target globally, that 90% of all people living with HIV will know their HIV status.", "Community-based organisations have also played an important part in maintaining HIV services.", "Even with availability of HIV self-testing kits in some areas,4 testing remains a big challenge in settings with scarce access to these kits.", "Therefore, increased efforts are needed to augment access and to facilitate testing.", "HIV testing is the vital first step towards initiation into the HIV care continuum.3"]}
{"doc_id": 39007, "title": "", "abstract": ["In response to these challenges, WHO, UNAIDS, and the Global Network of People Living With HIV are working together to ensure continued provision of HIV prevention, testing, and treatment services.6, 7, 8", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Community-based organisations have also played an important part in maintaining HIV services.", "UNAIDS is working with the BaiHuaLin alliance of people living with HIV and other community partners to reach and help those who will run out of antiviral drugs in the near future.6"]}
{"doc_id": 39008, "title": "", "abstract": ["Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "As COVID-19 continues to spread around the world, many locations are facing the risk of SARS-CoV-2 infection and barriers and challenges for maintaining the HIV care continuum.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic."]}
{"doc_id": 39009, "title": "", "abstract": ["We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Maintaining HIV care during the COVID-19 pandemic", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Third, the COVID-19 pandemic might also hinder ART continuation.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic."]}
{"doc_id": 31052, "title": "", "abstract": ["The high mortality in patients with cirrhosis should also prompt consideration of novel targeted therapies such as dexamethasone with proven efficacy in hospitalized patients with COVID-19.", "Our data will also help inform clinical decisions regarding both the escalation of care to ICU and the use of COVID-19 palliative care guidelines in patients with advanced liver disease who undergo rapid inpatient clinical deterioration.25", "The approach to each patient will be guided by individual risk, institutional resources and the local burden of COVID-19, however resumption of hepatology services wherever possible in order to prevent liver disease progression may ultimately represent the best strategy to protect patients from poor outcomes following future SARS-CoV-2 infection.", "This highlights the importance of carefully evaluating drug hepatotoxicity during COVID-19 clinical trials to ensure that patients with cirrhosis are not unnecessarily denied potentially disease-modifying treatments.26", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease."]}
{"doc_id": 31053, "title": "", "abstract": ["Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort.", "Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "In light of our data, which links liver disease severity with death following SARS-CoV-2 infection, a careful balance must be struck between protecting these patients from exposure to the virus whilst striving to deliver gold-standard treatment.", "SARS- CoV-2 infection in patients with cirrhosis therefore appears to be a particularly lethal combination and represents the coming together of biological processes characterised by immune dysregulation in the context of viral infection and disordered coagulation."]}
{"doc_id": 31054, "title": "", "abstract": ["Acute hepatic decompensation was only reported in 3 (1%) patients with CLD without cirrhosis.", "Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms.", "However, given the profound multi-systemic involvement of COVID-19, particularly in the severe and critical forms of disease, liver injury is likely to be multifactorial with contributions from systemic inflammation, intrahepatic immune activation, microvascular thrombosis, perturbations of the gut-liver-axis, and drug toxicity.[32], [33], [34], [35], [36] In our cohort, patients who suffered acute hepatic decompensation had a 2-fold increased rate of mortality compared to those without and case fatality strongly correlated with degree of organ failure.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis."]}
{"doc_id": 31055, "title": "", "abstract": ["However, given the profound multi-systemic involvement of COVID-19, particularly in the severe and critical forms of disease, liver injury is likely to be multifactorial with contributions from systemic inflammation, intrahepatic immune activation, microvascular thrombosis, perturbations of the gut-liver-axis, and drug toxicity.[32], [33], [34], [35], [36] In our cohort, patients who suffered acute hepatic decompensation had a 2-fold increased rate of mortality compared to those without and case fatality strongly correlated with degree of organ failure.", "The association between liver disease and adverse COVID-19 outcomes is also evidenced by recent findings from our registries which show that restoring hepatic function by liver transplantation in patients with decompensated cirrhosis returns the risk of mortality back to that of the general population.27", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "However, the mechanisms through which alcohol consumption and ALD may impact on the pathogenesis of COVID-19 are not explained by the current study and require further exploration.", "We aimed to determine the impact of COVID-19 on patients with pre-existing liver disease, which currently remains ill-defined."]}
{"doc_id": 31056, "title": "", "abstract": ["Half of those with hepatic decompensation had acute-on-chronic liver failure.", "SARS-CoV-2 infection in patients with cirrhosis also appears to precipitate marked deterioration in liver function with high rates of acute hepatic decompensation (46%) observed in our cohort.", "Within the 386 patients with cirrhosis, acute hepatic decompensation events following SARS-CoV-2 infection were reported to have occurred in 179 (46%) patients.", "Acute hepatic decompensation occurred in 46% of patients with cirrhosis, of whom 21% had no respiratory symptoms.", "Acute hepatic decompensation was only reported in 3 (1%) patients with CLD without cirrhosis."]}
{"doc_id": 31057, "title": "", "abstract": ["Indeed, the significance of hepatic dysfunction in patients with bacterial chest sepsis is well recognized, with the presence of CLD already integrated into validated prognostic scoring systems for community acquired pneumonia.23 , 24", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "A precise understanding of outcomes from COVID-19 in patients across the entire spectrum of liver disease severity is therefore urgently required in order to enable accurate risk stratification.", "We aimed to determine the impact of COVID-19 on patients with pre-existing liver disease, which currently remains ill-defined.", "Case fatality rates after each of these stages in the COVID-19 disease course were also heavily influenced by baseline liver disease severity (Table 2)."]}
{"doc_id": 31058, "title": "", "abstract": ["However, given the profound multi-systemic involvement of COVID-19, particularly in the severe and critical forms of disease, liver injury is likely to be multifactorial with contributions from systemic inflammation, intrahepatic immune activation, microvascular thrombosis, perturbations of the gut-liver-axis, and drug toxicity.[32], [33], [34], [35], [36] In our cohort, patients who suffered acute hepatic decompensation had a 2-fold increased rate of mortality compared to those without and case fatality strongly correlated with degree of organ failure.", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "We aimed to determine the impact of COVID-19 on patients with pre-existing liver disease, which currently remains ill-defined.", "We show for the first time that stage of liver disease is strongly associated with COVID-19 mortality and report high rates of hepatic decompensation and death in patients with cirrhosis.", "Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease."]}
{"doc_id": 31059, "title": "", "abstract": ["Despite modest sample sizes, the former study showed higher mortality in cirrhosis patients with SARS-CoV-2 compared with bacterial infection (34% vs. 17%; p = 0.03), and the latter study demonstrated a trend towards increased mortality in hospitalised cirrhosis patients with COVID-19 compared to those without (30% vs. 20%; p = 0.11).", "Our observed rates of mortality in cirrhosis patients with COVID-19 (32%) also far exceeded those previously reported in hospitalised patients with cirrhosis in the era preceding COVID-19 (5-8%),20 , 21 and in patients with cirrhosis admitted with influenza (18%).22", "Whilst patients with CLD without cirrhosis appear to have a similar risk of mortality following SARS-CoV-2 infection to patients without liver disease, patients with cirrhosis have an elevated risk (Fig. 5) with a mortality of 32% observed in the current study.", "In the current study, the predominant cause of death was COVID-19-related lung injury, with only 19% of mortality in the patients with cirrhosis accounted for by liver-related complications.", "Of those with cirrhosis and acute hepatic decompensation who died (n = 78), cause of death was reported to be COVID-19-related lung disease in 50 (64%), liver related in 18 (23%), and cardiac related in 5 (6%)."]}
{"doc_id": 24027, "title": "", "abstract": ["Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001).", "Consistent with other studies examining mental health (e.g. Daly et al., 2020; McGinty et al., 2020), we found evidence that distress increased from mid-March to early-April 2020 as the pandemic first emerged in the US.", "The increase in psychological distress from March 10–18 to April 1-14 was statistically significant at the p < .001 level for all population subgroups examined (see Table 3 ) with the exception of Black participants (d = 0.14, 95% CI [0.01, 0.27], p < .05).", "After adjustment for demographic characteristics and the presence of mental health conditions there was evidence for a sharp statistically significant 0.27 standard deviation (SD) (95% CI [0.23,.31], P < .001) increase in distress from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US."]}
{"doc_id": 24028, "title": "", "abstract": ["However, we found that the demographic and mental health characteristics of our baseline/Wave 1 sample did not differ from the composition of subsequent waves (see Tables S1 and S2) suggesting that these exclusions did significantly impact the representativeness of the Wave 1 sample.", "Initial findings from the early period of the COVID-19 pandemic suggest that mental health did worsen.", "Because there have been concerns about COVID-19 related declines in mental health among individuals with existing mental health diagnoses (Campion et al., 2020; Holmes et al., 2020; Pfefferbaum and North, 2020), we examined changes in distress across a range of pre-existing mental health conditions (e.g. depression, anxiety, ADHD, PTSD).", "After adjustment for demographic characteristics and the presence of mental health conditions there was evidence for a sharp statistically significant 0.27 standard deviation (SD) (95% CI [0.23,.31], P < .001) increase in distress from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "27.5% of the sample reported being diagnosed with a mental health condition prior to the COVID-19 crisis."]}
{"doc_id": 24029, "title": "", "abstract": ["There is evidence that large-scale stressful events, such as natural disasters, can have enduring effects on mental health particularly following direct exposure to trauma (Kukihara et al., 2014; Neria et al., 2008).", "Because our baseline distress assessment was administered immediately prior to the introduction of lockdown restrictions it is possible that we underestimated the rise in distress from initial levels.", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "After adjustment for demographic characteristics and the presence of mental health conditions there was evidence for a sharp statistically significant 0.27 standard deviation (SD) (95% CI [0.23,.31], P < .001) increase in distress from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "However, another body of evidence suggests that although mental health has suffered following the emergence of the COVID-19 crisis, in the longer-term people's mental health may be largely resilient (Galatzer-Levy et al., 2018)."]}
{"doc_id": 24030, "title": "", "abstract": ["The longer-term effects of the COVID-19 crisis on mental health are currently unknown.", "Alongside the physical disease burden that COVID-19 has caused, there are major concerns that the insecurity and isolation caused by the COVID-19 crisis and measures to mitigate the virus transmission may have substantial and potentially long- lasting population mental health effects (Campion et al., 2020; Holmes et al., 2020; Pfefferbaum and North, 2020).", "However, another body of evidence suggests that although mental health has suffered following the emergence of the COVID-19 crisis, in the longer-term people's mental health may be largely resilient (Galatzer-Levy et al., 2018).", "There are also reports of survivors of the 2003 SARS virus being at increased risk of long-term psychological problems (Lee et al., 2007; Mak et al., 2009) and it will be important to examine whether COVID-19 also impacts on mental health among survivors.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic."]}
{"doc_id": 24031, "title": "", "abstract": ["The magnitude of the increase in distress amongst other groups ranged from a 0.21 SD rise in the low-income group to a 0.36 SD rise in the other race/ethnicity group.", "Amongst this group distress increasing by 0.28 SD (95% CI [0.24, 0.32], p < .001) and subsequently decreasing by −0.29 SD (95% CI [-0.33, −0.24], p < .001) (see Table S3).", "There are a constellation of factors that may contribute to worsening of mental health and increased distress during the pandemic, including personal worries over risk of infection and concerns about the health of others, financial uncertainty, work and school closures, and reduced social contact (Brooks et al., 2020; Holmes et al., 2020; Shevlin et al., 2020).", "Future investigations (including detailed qualitative studies) examining the mechanisms underpinning the decline in distress (e.g. changes in financial concerns, risk perceptions, use of coping strategies) may inform efforts to promote resilience in other populations.", "Participants were grouped into four approximately even sized age groups (18–34, 35–49, 50–64, 65+ years) and three household income groups (≤$40,00, $40,000–$100,000 ≥$100,000 gross per annum)."]}
{"doc_id": 24032, "title": "", "abstract": ["On average, psychological distress levels were highest for those diagnosed with mental health conditions (M = 3.55, SD = 3.41), followed by those aged 18–35 (M = 2.68, SD = 3.26), those on low incomes (M = 2.38, SD = 3.18), and females (M = 2.35, SD = 3.04).", "Strengths of the present study include the repeated longitudinal assessment of psychological distress in a large nationally representative sample of US adults.", "The increase in psychological distress from March 10–18 to April 1-14 was statistically significant at the p < .001 level for all population subgroups examined (see Table 3 ) with the exception of Black participants (d = 0.14, 95% CI [0.01, 0.27], p < .05).", "On average psychological distress increased significantly by 0.27 standard deviations (95% CI [0.23,0.31], p < .001) from March 10–18 to April 1–14, 2020 as the COVID-19 crisis emerged and lockdown restrictions began in the US.", "Those diagnosed with mental health conditions experienced a statistically significant increase in distress from March 10–18 to April 1–14 that was of the same magnitude to other participants (d = 0.27, 95% CI [0.18, 0.36]) and showed a similar recovery in their distress levels by June 24-July 20 (d = 0.27, 95% CI [0.21, 0.37], p < .001)."]}
{"doc_id": 24033, "title": "", "abstract": ["Those aged 65+ (M = 1.25, SD = 2.09), and Black participants (M = 1.49, SD = 2.44) reported the lowest levels of psychological distress, as shown in Table 1.", "On average, psychological distress levels were highest for those diagnosed with mental health conditions (M = 3.55, SD = 3.41), followed by those aged 18–35 (M = 2.68, SD = 3.26), those on low incomes (M = 2.38, SD = 3.18), and females (M = 2.35, SD = 3.04).", "On average those with pre-existing diagnosed mental health conditions reported baseline (March 10–18) distress levels 0.77 SD (95% CI [0.73,0.80], p < .001) above those not reporting mental health conditions.", "Likewise, adopting a similar approach by comparing different samples of US adults, a study by McGinty et al. (2020) found that both psychological distress and loneliness were higher in April 2020 compared to 2018.", "Strengths of the present study include the repeated longitudinal assessment of psychological distress in a large nationally representative sample of US adults."]}
{"doc_id": 24034, "title": "", "abstract": ["Because there have been concerns about COVID-19 related declines in mental health among individuals with existing mental health diagnoses (Campion et al., 2020; Holmes et al., 2020; Pfefferbaum and North, 2020), we examined changes in distress across a range of pre-existing mental health conditions (e.g. depression, anxiety, ADHD, PTSD).", "It is now important that the large-scale decline in worry, nervousness, loss of interest, and feelings of hopelessness during the COVID-19 crisis suggested by the current study (Kroenke et al., 2009; Löwe et al., 2010) is examined across different nations and the mechanisms and implications of this effect investigated.", "Substantial increases in distress in the US during the emergence of the COVID-19 crisis largely diminished in the weeks that followed and this suggests that population level resilience in mental health may be occurring in response to the pandemic.", "This study identified substantial increases in distress in the US during the emergence of the COVID-19 crisis that largely diminished in the weeks that followed and suggests that population level resilience in mental health may be occurring in response to the pandemic.", "The COVID-19 crisis has also made it more difficult for mental health services to operate and this is particularly concerning because those with underlying mental health difficulties may be particularly vulnerable Campion et al. (2020); Corruble (2020); Pfefferbaum and North (2020)."]}
{"doc_id": 26023, "title": "", "abstract": ["The complexity of managing patients with the coronavirus disease 2019 (COVID-19), a global pandemic [1] originated in China [2], has led to the widespread implementation of preventative measures such as social distancing and mask use [3] in many countries including the United States (US).", "This observation is consistent with the H1N1 pandemic, where studies have shown evidence of racial and ethnic disparities in the population affected in terms of exposure, severity, and mortality of the disease [8, 9].", "### Objectives", "Populations with a higher disability [20] and lower median income [21] might be less mobile, have more comorbidities [22, 23], and also less likely benefit from timely high-quality care [24] and high-quality nutrition; all of these factors could be equally important to combating this pandemic [25, 26].", "This observation is consistent with the influenza A (H1N1) pandemic where other studies showed evidence of racial and ethnic disparities in the population affected both in exposure, severity, and mortality of the disease [8, 9]."]}
{"doc_id": 26024, "title": "", "abstract": ["There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "The goal of the study was to provide evidence on the association of COVID-19 with respect to race, income level, poverty, education, and the impact of preventative measures such as social distancing.", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts)."]}
{"doc_id": 26025, "title": "", "abstract": ["Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "It has been reported that age 65 and older, body mass index ≥ 40, diabetes [5] immunosuppression, smoking, hypertension, and cardiovascular diseases are underlying conditions that increase the risk of death from COVID-19 [6, 7].", "In this study, we conducted an ecological-based analysis to explore racial and economic inequality associated with the infection rate and risk of mortality due to COVID-19 in the US.", "There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "Furthermore, as the association between COVID-19-related fatality and infection is different among different race and health status, it is important to further study the impact of the immune system and immune-boosting strategies in the at-risk population (such as people with certain disabilities or those residing in elderly community centers), as preventive measure along with other measures based on social distancing guidelines and the ability to work from home."]}
{"doc_id": 26026, "title": "", "abstract": ["The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "However, counties with higher proportion with disability and poverty rates had a higher death rate.", "By adding the interaction terms in the linear regression model (death rate~poverty + disability + poverty:disability) of death rate, we do not observe a significant interaction (p = 0.469), suggesting these two variables could be independent in their contribution to the risk of mortality.", "Our analysis highlights that counties with a higher total population, more diverse demographics, higher education, and income level are at a higher risk of COVID-19 infection; however, counties with a smaller population, higher disability rates, and higher poverty levels have a higher rate of mortality.", "Populations with a higher disability [20] and lower median income [21] might be less mobile, have more comorbidities [22, 23], and also less likely benefit from timely high-quality care [24] and high-quality nutrition; all of these factors could be equally important to combating this pandemic [25, 26]."]}
{"doc_id": 26027, "title": "", "abstract": ["Finally, access to insurance was a protective factor in terms of mortality from COVID-19, but access to insurance did not significantly associate with the rate of infection.", "a Bivariate analysis of factors for mortality due to COVID-19.", "We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761–256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "It has been reported that age 65 and older, body mass index ≥ 40, diabetes [5] immunosuppression, smoking, hypertension, and cardiovascular diseases are underlying conditions that increase the risk of death from COVID-19 [6, 7]."]}
{"doc_id": 26028, "title": "", "abstract": ["The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "Populations with a higher disability [20] and lower median income [21] might be less mobile, have more comorbidities [22, 23], and also less likely benefit from timely high-quality care [24] and high-quality nutrition; all of these factors could be equally important to combating this pandemic [25, 26].", "The association of poverty and disability makes the conclusion of this study more complex and beyond the analysis of social determinants.", "Access to the infected patient information and mortality data was not possible, and only aggregated data were used.", "These observations might be due to the workforce of essential services, poverty, and access to care."]}
{"doc_id": 40056, "title": "", "abstract": ["We demonstrated that SARS-CoV-2-infected ferrets showed high virus titers in upper respiratory tracts (nasal washes) and consequently transmitted to naive ferrets by direct contact at high efficiency, suggesting that SARS-CoV-2 ferret model recapitulates aspects of human infection and transmission.", "In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "Findings suggest that SARS-CoV-2 can be shed through multiple routes of body discharge specimens, with these potentially serving as sources for viral transmission to those in close contact with infected individuals.", "To understand how this virus rapidly spreads within a community, and to inform infection control messaging, it is essential to develop an experimental animal model that can support the active infection, shedding, and transmission of SARS-CoV-2 to sentinel animals.", "Taken together, this demonstrates the presence of SARS-CoV-2 in multiple sources from infected ferrets, potentially explaining the rapid transmission to naive hosts in close contact with the infected hosts."]}
{"doc_id": 40057, "title": "", "abstract": ["Further, the lung histopathology showed that, compared with PBS-treated ferrets, NMC-nCoV02-infected ferrets at 4 dpi showed increased immune infiltration and cell debris in the alveolar wall, bronchial epithelium, and bronchial lumen (Figure S2), evidencing acute bronchiolitis by NMC-nCoV02 infection.", "Although viral spike RNA was detected in sera of infected ferrets, the viral copy number was low (peaked titer 0.35 log10 copies/mL) and dropped below detection limits earlier than in nasal wash and saliva specimens.", "After 12 days of infection, all remaining ferrets, including IN infection (n = 6), DC (n = 6), and IC (n = 6), had returned to normal ranges of body temperature and body weight, and all specimens were negative for viral RNA.", "While reduced activity was observed in NMC-nCoV02-infected ferrets between 2 and 6 dpi with occasional coughs, there was no detectable body weight loss, nor were there any fatalities during the experimental period.", "However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017)."]}
{"doc_id": 40058, "title": "", "abstract": ["However, there are also limitations in the SARS-CoV-2 ferret model, as SARS-CoV-2 infected ferrets showed only mild clinical symptoms and relatively lower virus titers in lungs of infected animals than SARS-CoV-1-infected or MERS-CoV-infected hACE2 or hDPP4 transgenic mice (Glass et al., 2004 and Li et al., 2017).", "In order to understand the rapid spreading characteristics of SARS-CoV-2, additional animal models that mimic high human- to-human transmission of SARS-CoV-2 infections are warranted.", "Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.", "We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease.", "Given that ferret ACE2 has been shown to contain critical SARS-CoV binding residues (Wan et al., 2020), we performed infection and direct and indirect contact transmission studies using a ferret model previously developed for influenza virus infections (Park et al., 2018; Bouvier, 2015)."]}
{"doc_id": 41015, "title": "", "abstract": ["COVID-19 is caused by SARS-CoV-2, a betacoronavirus closely related to MERS- CoV and SARS-CoV, the causative agents of Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), respectively.", "COVID-19 seems to follow a similar pattern, with 81% of fatal cases diagnosed with ARDS2.", "It should be noted that COVID-19 mortality is also associated with myocarditis in the setting of ARDS.", "In consideration of this, a recent correspondence in The Lancet suggests that all patients with COVID-19 should be screened for hyper- inflammation in order to identify those who would benefit from targeted immunosuppression or immunomodulation to prevent acute lung injury (ALI)3.", "Experimental immunomodulatory treatment of COVID-19 is ongoing, both in controlled clinical trials and also in an uncontrolled fashion on a compassionate basis."]}
{"doc_id": 41016, "title": "", "abstract": ["Indeed, several clinical trials investigating inhibitors of the IL-1 receptor (anakinra) and the IL-6 receptor (tocilizumab) are ongoing, as are debates about the effectiveness or harm of corticosteroids.", "Currently, there is no specific treatment available for this disease and off-label investigations of many FDA-approved therapeutics, including remdesivir, hydroxychloroquine, azithromycin and tocilizumab, in an effort to demonstrate improved outcomes, are ongoing.", "The shift to pro-inflammatory cytokine production in the lungs is pathologically characterized by diffuse alveolar damage with numerous neutrophils and protein rich oedema in the alveolar space.", "Dysregulation of TH17 cells and production of IL-17 in the skin, synovial space and endothelium promote the production of downstream pro-inflammatory molecules such as IL-1β, TNF and IL-6 and neutrophil chemoattractants such as IL-8, CCL20 and CCL2.", "These two factors appear to influence whether the prevailing effect of its expression is protective or whether it leads to a detrimental hyper- inflammatory state."]}
{"doc_id": 41017, "title": "", "abstract": ["This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "COVID-19: a case for inhibiting IL-17?", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6."]}
{"doc_id": 41018, "title": "", "abstract": ["Dysregulation of TH17 cells and production of IL-17 in the skin, synovial space and endothelium promote the production of downstream pro-inflammatory molecules such as IL-1β, TNF and IL-6 and neutrophil chemoattractants such as IL-8, CCL20 and CCL2.", "Furthermore, addition of exogenous IL-17 further exacerbated LPS-induced production of TNF, IL-1β, IL-6 and CXCL2, revealing the role of IL-17 as a key upstream modulator of the inflammatory pathway.", "A TH17 type-dominant immunophenotype has been reported to drive more severe viral myocarditis10.", "The risk of serious infections is unchanged or low over the short term.", "MERS-CoV and SARS-CoV cause high mortality, most often resulting from progressive inflammatory viral pneumonia that clinically culminates in ARDS1."]}
{"doc_id": 41019, "title": "", "abstract": ["Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "By targeting IL-17, which operates ‘upstream’ of both IL-1 and IL-6 and results in a reduction of neutrophil recruitment, several factors known to play major roles in ARDS would be inhibited.", "It should be noted that COVID-19 mortality is also associated with myocarditis in the setting of ARDS.", "In ARDS, IL-17 augments the destruction of the lung parenchyma through maladaptive neutrophil recruitment, by stimulating the production of pro-inflammatory mediators and through the prevention of apoptosis due to the induction of granulocyte colony-stimulating factor expression7.", "Immunomodulation is not a novel idea as a means to improve outcomes of COVID-19 ARDS."]}
{"doc_id": 41020, "title": "", "abstract": ["This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Therefore, using these drugs in the acute setting of COVID-19 should not carry an increased risk of secondary infections.", "Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "Experimental immunomodulatory treatment of COVID-19 is ongoing, both in controlled clinical trials and also in an uncontrolled fashion on a compassionate basis.", "In consideration of this, a recent correspondence in The Lancet suggests that all patients with COVID-19 should be screened for hyper- inflammation in order to identify those who would benefit from targeted immunosuppression or immunomodulation to prevent acute lung injury (ALI)3."]}
{"doc_id": 41021, "title": "", "abstract": ["Taken together, these analyses of patients with coronavirus-induced lung disease suggest that IL-17 can serve as both a biomarker of disease severity and a potential target of therapy to mitigate the damage of SARS-CoV-2, particularly to the lung.", "By targeting IL-17, which operates ‘upstream’ of both IL-1 and IL-6 and results in a reduction of neutrophil recruitment, several factors known to play major roles in ARDS would be inhibited.", "Therefore, IL-17 presents itself as a plausible target.", "However, in the setting of ALI/ARDS triggered by betacoronaviruses, IL-17 appears to be markedly elevated, with evidence that it contributes to immunopathology1,6.", "COVID-19: a case for inhibiting IL-17?"]}
{"doc_id": 41022, "title": "", "abstract": ["Here, we discuss the current literature describing known contributions of IL-17 to COVID-19-related acute respiratory distress syndrome (ARDS) and present arguments why anti- IL-17 therapy in COVID-19 should be considered.", "COVID-19: a case for inhibiting IL-17?", "This suggests that potential anti- IL-17 therapy may play a role in decreasing morbidity and mortality related to COVID-19 virally induced myocarditis.", "Assessing the performance of this cytokine as a biomarker of disease, IL-17 had an area under the receiver operating curve score of 0.926, indicating a very good ability to distinguish between severe and mild COVID-19 cases6.", "Similar TH1-type and TH17-type pro-inflammatory cytokine profiles are observed in patients with MERS and in patients with COVID-19, including elevated IL-17 (refs1,6)."]}
{"doc_id": 8010, "title": "", "abstract": ["PGC1α (PPARγ coactivator-1 α) is a transcriptional coactivator that mediates many biological programs related to energy metabolism.", "Originally described as a coactivator of PPARγ that modulated expression of uncoupling protein 1 (UCP1) and thermogenesis in brown fat1, it has also been shown to control mitochondrial biogenesis and oxidative metabolism in many cell types.", "This suggested that PGC1α causes the muscle cells to secrete molecule(s) that can induce a thermogenic gene program in the cells.", "We therefore analyzed the adipose tissue of the PGC1α transgenic mice for expression of genes related to a thermogenic gene program and genes characteristic of brown fat development.", "PGC1α is induced in muscle by exercise and stimulates many of the best known beneficial effects of exercise in muscle: mitochondrial biogenesis, angiogenesis and fiber-type switching2."]}
{"doc_id": 6020, "title": "", "abstract": ["Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the anti-viral defence.", "Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1).", "In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis.", "This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.", "Failure to infect macrophages and dendritic cells by HIV-2 and SIVmac viruses encoding mutant Vpx proteins deficient in association with this E3 suggested that Vpx usurps CRL4DCAF1 to overcome the inhibition of infection in myeloid cells12,13."]}
{"doc_id": 6021, "title": "", "abstract": ["Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome- dependent degradation of the protein.", "By contrast, in the DCAF1 depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited providing further evidence for our hypothesis that Vpx utilizes CRL4DCAF1 E3 to program SAMHD1 degradation.", "Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs.", "For studies with proteasome inhibitor MG132, MDM were cultured in the presence or absence of MG132 (1 μg/ml) for one hour and then infected with 3-fold dilutions of SIVmac Vpx-loaded SIV VLP for additional 3 hours, in the continuous presence or absence of MG132, and harvested for western blot analysis of SAMHD1 levels.", "Our above biochemical and functional studies with VpxQ76A variants suggested that Vpx uses the CRL4DCAF1 E3 ubiquitin ligase to program SAMHD1 degradation."]}
{"doc_id": 38014, "title": "", "abstract": ["Using numbers from the latest census in the United States and the United Kingdom, a given number of places for taking the questionnaire were opened on the Prolific platform in each stratum to achieve the same distribution of participants by age, sex, and ethnicity as those in the general population.", "It took 2-3 days to obtain a completed questionnaire of 22 knowledge and perception questions from 1500 adults in each the United States and the United Kingdom, when allowing enrollment only in relatively granular strata by age, sex, and ethnicity (and each of these variables’ combinations).", "Following an informed consent form, the questionnaire asked participants about the cause, current state, and future development of the COVID-19 epidemic; the risk of a fatal disease course; knowledge of symptoms and recommended health care–seeking behavior; measures to prevent an infection with SARS-CoV-2; and their perception of the risk posed by individuals of East-Asian ethnicity in their community.", "For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "Participants completed the questionnaire between February 23 and March 2, 2020."]}
{"doc_id": 38015, "title": "", "abstract": ["This study has several limitations.", "The responses from these individuals are not shown in the histogram below.", "Conflicts of Interest: None declared.", "Eligible participants enrolled in the study on a first-come, first-served basis.", "The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media."]}
{"doc_id": 38016, "title": "", "abstract": ["For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "This study aimed to apply rapid online surveying to determine knowledge and perceptions of coronavirus disease 2019 (COVID-19) among the general public in the United States and the United Kingdom.", "COVID-19 was first reported in Wuhan, China, in December 2019 [5].", "This study tests a rapid online survey methodology to determine knowledge and misperceptions of COVID-19 among the general adult population in both the United States and the United Kingdom.", "This study’s findings on the levels of knowledge and prevalence of misconceptions regarding COVID-19 could inform relevant information campaigns by public health authorities and the media as well as communication of health care workers with patients."]}
{"doc_id": 38017, "title": "", "abstract": ["For instance, 37.8% (95% CI 36.1%-39.6%) of US participants and 29.7% (95% CI 28.1%-31.4%) of UK participants thought that wearing a common surgical mask was “highly effective” in protecting them from acquiring COVID-19, and 25.6% (95% CI 24.1%-27.2%) of US participants and 29.6% (95% CI 28.0%-31.3%) of UK participants thought it was prudent to refrain from eating at Chinese restaurants.", "However, a substantial proportion of participants had misconceptions about how to prevent an infection and the recommended care-seeking behavior.", "Lastly, it is important to note that while the general public appeared to be well informed about the common symptoms of COVID-19, over one-fourth of the participants selected a health care–seeking option that could lead to further transmission of SARS-CoV-2.", "A total of 74.8% (95% CI 73.2%-76.4%) of US participants and 81.2% (95% CI 79.8%-82.6%) of UK participants correctly selected “droplets of saliva that land in the mouths or noses of people who are nearby when an infected person sneezes or coughs” as the main mode of SARS-CoV-2 transmission (Multimedia Appendix 1).", "However, a substantial proportion of participants also thought that using a hand dryer, rinsing your nose with saline, taking antibiotics, and gargling with mouthwash were effective prevention measures: 43.5% (95% CI 41.7%-45.2%) and 36.0% (95% CI 34.3%-37.8%) of US and UK participants, respectively, selected at least one of these options."]}
{"doc_id": 38018, "title": "", "abstract": ["Public health information campaigns may also want to directly target some of the mis- and disinformation that has circulated on social media [9,12,20].", "The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media.", "Those who self-reported looking up an answer online for a question were excluded from the analysis for that particular question.", "Such assessments are crucial because ensuring that the general public is well informed about a condition like COVID-19 could reduce unnecessary anxiety as well as reduce disease transmission and thus ultimately save lives.", "For instance, such information provision may highlight the comparatively low case fatality rate, the low risk posed by individuals of East-Asian ethnicity living in the United States and the United Kingdom, and that children do not appear to be at a heightened risk of dying from COVID-19."]}
{"doc_id": 38019, "title": "", "abstract": ["Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate of phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks.", "More broadly, rapid online surveys could be an important tool in tracking the public’s knowledge and misperceptions during rapidly moving infectious disease outbreaks.", "When faced with rapidly moving infectious disease outbreaks, such as the coronavirus disease 2019 (COVID-19), assessing knowledge and perceptions of relevant populations has to be accomplished in a short time frame if the findings are to be informative to the public health response.", "Such assessments are crucial because ensuring that the general public is well informed about a condition like COVID-19 could reduce unnecessary anxiety as well as reduce disease transmission and thus ultimately save lives.", "Given these limitations, rapid online surveys, which demand minimal human resources (beyond those needed to design the questionnaire) and could reach large numbers of respondents in a short time frame, may be a valuable tool to assess (and monitor over time) knowledge and perceptions of an infectious disease in the midst of an outbreak."]}
{"doc_id": 38020, "title": "", "abstract": ["Participants were reminded of the importance not to look up answers online prior to taking the survey and were asked at the end of the survey (while being reassured that their payment is not influenced by whether they volunteer information on having looked up an answer online) which, if any, questions they searched for an answer online prior to responding.", "However, I, as the researcher, had no access to any identifying information about the research participants, and participants were reminded of this fact prior to answering the question.", "The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media.", "In addition, unless they use interactive voice response (which tends to further decrease the response rate [4]), phone surveys require substantial human resources to conduct the interviews.", "Eligible participants enrolled in the study on a first-come, first-served basis."]}
{"doc_id": 38021, "title": "", "abstract": ["The speed with which COVID-19 is spreading across the world calls for rapid assessments of the population’s knowledge and perceptions of this infection [7].", "This study’s findings on the levels of knowledge and prevalence of misconceptions regarding COVID-19 could inform relevant information campaigns by public health authorities and the media as well as communication of health care workers with patients.", "COVID-19 was first reported in Wuhan, China, in December 2019 [5].", "Participants also likely overestimated the prevalence of COVID-19 among East-Asian individuals in their communities.", "The course of the COVID-19 epidemic in the United States and the United Kingdom will likely be strongly impacted by how the population behaves, which is in turn influenced by what people know and believe about this disease [8]."]}
{"doc_id": 27028, "title": "", "abstract": ["Delays in reporting decrease the epidemiological impact of testing-driven isolation.", "Clustered refusal of testing or refusal to isolate upon testing positive could present challenging barriers to implementation.", "As a consequence, the use of population screening testing to identify infectious individuals presents one possible means to break enough transmission chains to suppress the ongoing pandemic and reopen societies, with or without a vaccine.", "Widespread testing and isolation of infected individuals drive prevalence downward for both (A) the fully mixed compartmental model and (B) the agent- based model.", "Second, during the exponential growth of the virus, the time difference between 103 and 105 cp/ml is short, allowing only a limited window in which only the more sensitive test could diagnose individuals."]}
{"doc_id": 27029, "title": "", "abstract": ["On the basis of results from our previous analyses, we considered a less sensitive but rapid test with LOD 105 cp/ml and a 0-day delay in results and further assumed that 10% of would- be positive samples would be negative because of improper sample collection.", "Third, we assumed that the collection of samples for testing, if performed on a large scale, could result in imperfect sample collection, causing an increase in the false-negative rate, independent of an assay’s analytical sensitivity.", "Scenarios show the impact of a test with LOD 105, no delay in results, and with 10% of samples assumed to be incorrectly collected (and therefore negative) to reflect decreased sensitivity incurred at sample collection in a mass testing scenario.", "Repeating these simulations using a test with LOD 106 led to similar results (fig. S8).", "These assays, however, largely do not meet the gold standard for analytical sensitivity, which has encumbered the widespread use of these assays (10)."]}
{"doc_id": 27030, "title": "", "abstract": ["Three features of the viral increase, infectivity, and decline during SARS- CoV-2 infection led us to hypothesize that there might be minimal differences in effective screening regimens using viral detection tests of different sensitivities, such as RT-qPCR with a limit of detection (LOD) at 103 cp/ml (6) compared to often cheaper or faster assays with higher LODs [i.e., around 105 cp/ml (7–9)] such as point-of-care nucleic acid loop-mediated isothermal amplification (LAMP) and rapid antigen tests (Fig. 1A).", "At least for viruses with infection kinetics similar to SARS- CoV-2, we find that speed of reporting is much more important than sensitivity, although more sensitive tests are nevertheless somewhat more effective.", "Our results lead us to conclude that repeated population screening of asymptomatic individuals can be used to limit the spread of SARS-CoV-2.", "These tests should not be held to the same degree of sensitivity as clinical tests, particularly if doing so encumbers rapid deployment of faster cheaper SARS-CoV-2 assays.", "Successful population screening testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) depends on understanding both the dynamics of spread between individuals and the dynamics of the virus within the human body."]}
{"doc_id": 27031, "title": "", "abstract": ["We suggest that the U.S. Food and Drug Administration, other agencies, or state governments encourage the development and use of alternative faster and lower- cost tests for public health and repeated population screening purposes, even if they have poorer LODs.", "(C and D) Relative to no testing (gray bars), repeated population screening suppresses the total number of infections in both models when testing every day or every 3 days, but delayed results lead to only partial mitigation of total cases, even for testing every day or 3 days.", "Successful population screening testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) depends on understanding both the dynamics of spread between individuals and the dynamics of the virus within the human body.", "Repeated population screening suppresses an ongoing epidemic.", "As a consequence, the use of population screening testing to identify infectious individuals presents one possible means to break enough transmission chains to suppress the ongoing pandemic and reopen societies, with or without a vaccine."]}
{"doc_id": 39010, "title": "", "abstract": ["We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Maintaining HIV care during the COVID-19 pandemic", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen."]}
{"doc_id": 39011, "title": "", "abstract": ["Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Maintaining HIV care during the COVID-19 pandemic", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "People living with HIV who are faced with ART discontinuation not only could undergo physical health deterioration but also might suffer great psychological pressure.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3"]}
{"doc_id": 39012, "title": "", "abstract": ["People living with HIV who should have initiated antiretroviral therapy (ART) in hospital might be deterred or delayed because hospitals are busy treating patients with COVID-19.", "Approximately 37·9 million people living with HIV2 are at risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19.", "Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the first reports from Wuhan in China in December, 2019, and the outbreak was characterised as a pandemic by WHO on March 12, 2020.1", "People living with HIV who are faced with ART discontinuation not only could undergo physical health deterioration but also might suffer great psychological pressure.", "The US Department of Health and Human Services released interim guidance for COVID-19 and people living with HIV on March 20, 2020,10 which emphasised that people living with HIV should maintain at least a 30-day supply and ideally a 90-day supply of ART and all other drugs, by mail-order delivery if possible."]}
{"doc_id": 39013, "title": "", "abstract": ["Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Community-based organisations have also played an important part in maintaining HIV services.", "Third, the COVID-19 pandemic might also hinder ART continuation.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Maintaining HIV care during the COVID-19 pandemic"]}
{"doc_id": 39014, "title": "", "abstract": ["The situation could be worse in places with weak health-care systems.", "This work was supported by the National Key Research and Development Program of China (2017YFE0103800), the National Nature Science Foundation of China (81703282 and 81903371), the National Institute of Allergy and Infectious Diseases (NIAID 1R01AI114310-01 and K24AI143471), the University of North Carolina Center for AIDS Research (NIAID 5P30AI050410), National Institute of Mental Health (R34MH109359 and R34MH119963), and National Science and Technology Major Project (2018ZX10101-001-001-003).", "Community-based organisations have also played an important part in maintaining HIV services.", "In response to these challenges, WHO, UNAIDS, and the Global Network of People Living With HIV are working together to ensure continued provision of HIV prevention, testing, and treatment services.6, 7, 8", "We thank Gifty Marley for proofreading services."]}
{"doc_id": 39015, "title": "", "abstract": ["Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the first reports from Wuhan in China in December, 2019, and the outbreak was characterised as a pandemic by WHO on March 12, 2020.1", "As COVID-19 continues to spread around the world, many locations are facing the risk of SARS-CoV-2 infection and barriers and challenges for maintaining the HIV care continuum.", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Approximately 37·9 million people living with HIV2 are at risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic."]}
{"doc_id": 39016, "title": "", "abstract": ["First, implementation of quarantine, social distancing, and community containment measures have reduced access to routine HIV testing, which challenges completion of UNAIDS' first 90-90-90 target globally, that 90% of all people living with HIV will know their HIV status.", "Hospital visits could be restricted because of implementation of city lockdowns or traffic controls.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Community-based organisations have also played an important part in maintaining HIV services.", "Therefore, increased efforts are needed to augment access and to facilitate testing."]}
{"doc_id": 39017, "title": "", "abstract": ["We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Maintaining HIV care during the COVID-19 pandemic", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Third, the COVID-19 pandemic might also hinder ART continuation."]}
{"doc_id": 39018, "title": "", "abstract": ["Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the first reports from Wuhan in China in December, 2019, and the outbreak was characterised as a pandemic by WHO on March 12, 2020.1", "Third, the COVID-19 pandemic might also hinder ART continuation.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Maintaining HIV care during the COVID-19 pandemic"]}
{"doc_id": 39019, "title": "", "abstract": ["First, implementation of quarantine, social distancing, and community containment measures have reduced access to routine HIV testing, which challenges completion of UNAIDS' first 90-90-90 target globally, that 90% of all people living with HIV will know their HIV status.", "In response to these challenges, WHO, UNAIDS, and the Global Network of People Living With HIV are working together to ensure continued provision of HIV prevention, testing, and treatment services.6, 7, 8", "The situation could be worse in places with weak health-care systems.", "Furthermore, because many public health authorities globally are focused on COVID-19 control, allocation of resources for HIV care could be diminished, and circumstances surrounding the HIV care continuum could worsen.", "Hospitals in Thailand are to dispense antiviral drugs in 3–6-month doses to meet the needs of people living with HIV and reduce facility visits.9"]}
{"doc_id": 39020, "title": "", "abstract": ["First, implementation of quarantine, social distancing, and community containment measures have reduced access to routine HIV testing, which challenges completion of UNAIDS' first 90-90-90 target globally, that 90% of all people living with HIV will know their HIV status.", "Community-based organisations have also played an important part in maintaining HIV services.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "The Thai Red Cross AIDS Research Centre set up a visible platform outside their anonymous clinic with a screening system for every client, providing HIV testing and prevention supplies (eg, condoms, postexposure prophylaxis, and pre-exposure prophylaxis).9", "Even with availability of HIV self-testing kits in some areas,4 testing remains a big challenge in settings with scarce access to these kits."]}
{"doc_id": 39021, "title": "", "abstract": ["Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "People living with HIV who should have initiated antiretroviral therapy (ART) in hospital might be deterred or delayed because hospitals are busy treating patients with COVID-19.", "Third, the COVID-19 pandemic might also hinder ART continuation.", "Maintaining HIV care during the COVID-19 pandemic"]}
{"doc_id": 39022, "title": "", "abstract": ["Therefore, increased efforts are needed to augment access and to facilitate testing.", "We recommend that governments, community-based organisations, and international partners should work together to maintain the HIV care continuum during the COVID-19 pandemic, with particular efforts made to ensure timely access to, and to avoid disruption of, routine HIV services.", "Second, timely linkage to HIV care could be hindered during the COVID-19 pandemic.", "Although some international institutions, in collaboration with governments and community partners, are working to sustain HIV service provision for people living with HIV, the COVID-19 pandemic presents several barriers and challenges to the HIV care continuum.3", "First, implementation of quarantine, social distancing, and community containment measures have reduced access to routine HIV testing, which challenges completion of UNAIDS' first 90-90-90 target globally, that 90% of all people living with HIV will know their HIV status."]}
